PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Freundlieb, N; Philipp, S; Schneider, SA; Bruggemann, N; Klein, C; Gerloff, C; Hummel, FC				Freundlieb, Nils; Philipp, Stephan; Schneider, Susanne A.; Brueggemann, Norbert; Klein, Christine; Gerloff, Christian; Hummel, Friedhelm C.			No Association of the BDNF Val66met Polymorphism with Implicit Associative Vocabulary and Motor Learning	PLOS ONE			English	Article							CORTICAL PLASTICITY; WORKING-MEMORY; HUMAN BRAIN; GENE; PERFORMANCE; VARIANT; CORTEX; NEUROTROPHINS; INVENTORY; DISORDER	Brain-derived neurotrophic factor (BDNF) has been suggested to play a major role in plasticity, neurogenesis and learning in the adult brain. The BDNF gene contains a common val66met polymorphism associated with decreased activity-dependent excretion of BDNF and a potential influence on behaviour, more specifically, on motor learning. The objective of this study was to determine the influence of the BDNF val66met polymorphism on short-term implicit associative learning and whether its influence is cognitive domain-specific (motor vs. language). A sample of 38 young healthy participants was genotyped, screened for background and neuropsychological differences, and tested with two associative implicit learning paradigms in two different cognitive domains, i.e., motor and vocabulary learning. Subjects performed the serial reaction time task (SRTT) to determine implicit motor learning and a recently established associative vocabulary learning task (AVL) for implicit learning of action and object words. To determine the influence of the BDNF polymorphism on domain-specific implicit learning, behavioural improvements in the two tasks were compared between val/val (n = 22) and met carriers (val/met: n = 15 and met/met: n = 1). There was no evidence for an impact of the BDNF val66met polymorphism on the behavioural outcome in implicit short-term learning paradigms in young healthy subjects. Whether this polymorphism plays a relevant role in long-term training paradigms or in subjects with impaired neuronal plasticity or reduced learning capacity, such as aged individuals, demented patients or patients with brain lesions, has to be determined in future studies.	[Schneider, Susanne A.; Brueggemann, Norbert; Klein, Christine] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Brain Imaging & Neurostimulat BINS Lab, Hamburg, Germany; [Schneider, Susanne A.; Brueggemann, Norbert; Klein, Christine] Univ Lubeck, Dept Neurol, Schilling Sect Clin & Mol Neurogenet, Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Hummel, FC (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Brain Imaging & Neurostimulat BINS Lab, Hamburg, Germany.	f.hummel@uke.de	Klein, Christine/AGK-8003-2022	Klein, Christine/0000-0003-2102-3431; Hummel, Friedhelm/0000-0002-4746-4633; Gerloff, Christian/0000-0002-6484-8882	GlaxoSmithKline-Stiftung	GlaxoSmithKline-Stiftung	NF reports having received a travel grant by the "GlaxoSmithKline-Stiftung'' to attend "SfN Neuroscience 2011" in Washington, D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SP, SS, NB, CG, CK and FH reported no financial interests or potential conflicts of interest which are relevant to the matter of the manuscript.; NF reports having received a travel grant by the "GlaxoSmithKline-Stiftung" to attend "SfN Neuroscience 2011" in Washington, D.C. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Aschenbrenner S, 2000, WORTFLUSSIGKEITS TES; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Beck AT, 1995, BECK DEPRESSIONS INV; Brickenkamp R, 2002, TEST D2 AUFMERKSAMKE; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Freundlieb N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037033; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Hansell NK, 2007, GENES BRAIN BEHAV, V6, P260, DOI 10.1111/j.1601-183X.2006.00254.x; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Ho BC, 2006, ARCH GEN PSYCHIAT, V63, P731, DOI 10.1001/archpsyc.63.7.731; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jayasekeran V, 2011, GASTROENTEROLOGY, V141, P827, DOI 10.1053/j.gastro.2011.05.047; Joundi RA, 2012, EXP BRAIN RES   0901; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Liuzzi G, 2010, CURR BIOL, V20, P1745, DOI 10.1016/j.cub.2010.08.034; McHughen SA, 2011, EXP BRAIN RES, V213, P415, DOI 10.1007/s00221-011-2791-z; McHughen SA, 2010, CEREB CORTEX, V20, P1254, DOI 10.1093/cercor/bhp189; Nagel IE, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.001.2008; Nakamura K, 2011, NEUROSCI LETT, V487, P264, DOI 10.1016/j.neulet.2010.10.034; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rey A., 1959, MANUEL TEST COPIE FI; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765; Schule C, 2006, PSYCHONEUROENDOCRINO, V31, P1019, DOI 10.1016/j.psyneuen.2006.06.002; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Ventriglia M, 2002, MOL PSYCHIATR, V4, P8; Voti PL, 2011, EXP BRAIN RES, V212, P91, DOI 10.1007/s00221-011-2700-5; Witte AV, 2012, J NEUROSCI, V32, P4553, DOI 10.1523/JNEUROSCI.6010-11.2012	46	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48327	10.1371/journal.pone.0048327	http://dx.doi.org/10.1371/journal.pone.0048327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152767	gold, Green Published, Green Submitted			2022-12-25	WOS:000311234600005
J	Omoto, M; Yoshida, S; Miyashita, H; Kawakita, T; Yoshida, K; Kishino, A; Kimura, T; Shibata, S; Tsubota, K; Okano, H; Shimmura, S				Omoto, Masahiro; Yoshida, Satoru; Miyashita, Hideyuki; Kawakita, Tetsuya; Yoshida, Kenji; Kishino, Akiyoshi; Kimura, Toru; Shibata, Shinsuke; Tsubota, Kazuo; Okano, Hideyuki; Shimmura, Shigeto			The Semaphorin 3A Inhibitor SM-345431 Accelerates Peripheral Nerve Regeneration and Sensitivity in a Murine Corneal Transplantation Model	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; AXON GUIDANCE; SPINAL-CORD; FUNCTIONAL RECOVERY; NEURITE OUTGROWTH; TEAR SECRETION; SUBSTANCE-P; GROWTH; ANGIOGENESIS; EXPRESSION	Background: Peripheral nerve damage of the cornea is a complication following surgery or infection which may lead to decreased visual function. We examined the efficacy of the semaphorin 3A inhibitor, SM-345431, in promoting regeneration of peripheral nerves in a mouse corneal transplantation model. Methodology/Principal Findings: P0-Cre/Floxed-EGFP mice which express EGFP in peripheral nerves cells were used as recipients of corneal transplantation with syngeneic wild-type mouse cornea donors. SM-345431 was administered subconjunctivally every 2 days while control mice received vehicle only. Mice were followed for 3 weeks and the length of regenerating nerves was measured by EGFP fluorescence and immunohistochemistry against beta III tubulin. Cornea sensitivity was also measured by the Cochet-Bonnet esthesiometer. CD31 staining was used to determine corneal neovascularization as a possible side effect of SM-345431. Regeneration of beta III tubulin positive peripheral nerves was significantly higher in SM-345431 treated mice compared to control. Furthermore, corneal sensitivity significantly improved in the SM-345431 group by 3 weeks after transplantation. Neovascularization was limited to the peripheral cornea with no difference between SM-345431 group and control. Conclusions/Significance: Subconjunctival injections of SM-345431 promoted a robust network of regenerating nerves as well as functional recovery of corneal sensation in a mouse keratoplasty model, suggesting a novel therapeutic strategy for treating neurotrophic corneal disease. Citation: Omoto M, Yoshida S, Miyashita H, Kawakita T, Yoshida K, et al. (2012) The Semaphorin 3A Inhibitor SM-345431 Accelerates Peripheral Nerve Regeneration and Sensitivity in a Murine Corneal Transplantation Model. PLoS ONE 7(11): e47716. doi:10.1371/journal.pone.0047716	[Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Omoto, Masahiro; Yoshida, Satoru; Miyashita, Hideyuki; Kawakita, Tetsuya; Tsubota, Kazuo; Shimmura, Shigeto] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yoshida, Kenji; Kishino, Akiyoshi; Kimura, Toru] Dainippon Sumitomo Pharma Co Ltd, Genom Sci Labs, Tokyo, Japan	Keio University; Keio University; Dainippon Sumitomo Pharmaceutical Company	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	hidokano@a2.keio.jp; shige@z8.keio.jp	Shibata, Shinsuke/AAM-6620-2020; Shimmura, Shigeto/J-4678-2013; Okano, Hideyuki/I-7584-2019		Minisitry of Education, Culture, Sports, Science and Technology (Kakenhi) [19791272, 2179172]	Minisitry of Education, Culture, Sports, Science and Technology (Kakenhi)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a grant from the Minisitry of Education, Culture, Sports, Science and Technology (Kakenhi) no. 19791272 and no. 2179172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Afonso AA, 1999, OPHTHALMOLOGY, V106, P803, DOI 10.1016/S0161-6420(99)90170-7; Aras C, 2000, J REFRACT SURG, V16, P362; Benitez-del-Castillo JM, 2001, CORNEA, V20, P30, DOI 10.1097/00003226-200101000-00005; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brown SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P926, DOI 10.1001/archopht.1997.01100160096021; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cao ZY, 2002, INVEST OPHTH VIS SCI, V43, P2897; Chang JH, 2005, FEBS LETT, V579, P3601, DOI 10.1016/j.febslet.2005.05.043; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chikama T, 1998, LANCET, V351, P1783, DOI 10.1016/S0140-6736(98)24024-4; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Cook G, 1998, CURR OPIN NEUROBIOL, V8, P64, DOI 10.1016/S0959-4388(98)80009-3; Cursiefen C, 2004, INVEST OPHTH VIS SCI, V45, P1117, DOI 10.1167/iovs.03-0940; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Gabison E, 2004, EXP EYE RES, V78, P579, DOI 10.1016/j.exer.2003.09.005; Gallar J, 2010, INVEST OPHTH VIS SCI, V51, P4516, DOI 10.1167/iovs.10-5225; Halberstadt M, 2002, BRIT J OPHTHALMOL, V86, P646, DOI 10.1136/bjo.86.6.646; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kaplan N, 2012, INVEST OPHTH VIS SCI, V53, P936, DOI 10.1167/iovs.11-8685; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kikuchi K, 2003, J BIOL CHEM, V278, P42985, DOI 10.1074/jbc.M302395200; Ko JA, 2008, BIOCHEM BIOPH RES CO, V377, P104, DOI 10.1016/j.bbrc.2008.09.085; Ko JA, 2010, BIOCHEM BIOPH RES CO, V403, P305, DOI 10.1016/j.bbrc.2010.11.022; Kubilus JK, 2010, DEV BIOL, V344, P172, DOI 10.1016/j.ydbio.2010.04.032; Kumagai K, 2003, J ANTIBIOT, V56, P610, DOI 10.7164/antibiotics.56.610; Li YN, 2012, EXP EYE RES, V96, P24, DOI 10.1016/j.exer.2012.01.007; Lwigale PY, 2007, DEV BIOL, V306, P750, DOI 10.1016/j.ydbio.2007.04.012; Maddula S, 2011, OPHTHALMOLOGY, V118, P591, DOI 10.1016/j.ophtha.2011.01.041; MATHERS WD, 1988, ARCH OPHTHALMOL-CHIC, V106, P210; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Morishige N, 2008, EXP EYE RES, V86, P669, DOI 10.1016/j.exer.2008.01.012; Morishige N, 2010, BIOCHEM BIOPH RES CO, V395, P451, DOI 10.1016/j.bbrc.2010.03.124; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Rosenberg ME, 2000, INVEST OPHTH VIS SCI, V41, P2915; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Stuart PM, 2003, INVEST OPHTH VIS SCI, V44, P93, DOI 10.1167/iovs.02-0299; Tanelian DL, 1997, NAT MED, V3, P1398, DOI 10.1038/nm1297-1398; Toda I, 2001, AM J OPHTHALMOL, V132, P1, DOI 10.1016/S0002-9394(01)00959-X; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323	44	32	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e47716	10.1371/journal.pone.0047716	http://dx.doi.org/10.1371/journal.pone.0047716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152758	Green Published, Green Submitted, gold			2022-12-25	WOS:000312272600006
J	Asplund, J; Sandling, A; Wardle, DA				Asplund, Johan; Sandling, Aron; Wardle, David A.			Lichen Specific Thallus Mass and Secondary Compounds Change across a Retrogressive Fire-Driven Chronosequence	PLOS ONE			English	Article							LOBARIA-PULMONARIA; EPIPHYTIC LICHENS; ECOSYSTEM PROPERTIES; SOLAR-RADIATION; USE EFFICIENCY; ISLAND AREA; WIDE-RANGE; LIGHT; GROWTH; WATER	In the long-term absence of major disturbances ecosystems enter a state of retrogression, which involves declining soil fertility and consequently a reduction in decomposition rates. Recent studies have looked at how plant traits such as specific leaf mass and amounts of secondary compounds respond to declining soil fertility during retrogression, but there are no comparable studies for lichen traits despite increasing recognition of the role that lichens can play in ecosystem processes. We studied a group of 30 forested islands in northern Sweden differing greatly in fire history, and collectively representing a retrogressive chronosequence, spanning 5000 years. We used this system to explore how specific thallus mass (STM) and carbon based secondary compounds (CBSCs) change in three common epiphytic lichen species (Hypogymnia phsyodes, Melanohalea olivacea and Parmelia sulcata) as soil fertility declines during this retrogression. We found that STMs of lichens increased sharply during retrogression, and for all species soil N to P ratio (which increased during retrogression) was a strong predictor of STM. When expressed per unit area, medullary CBSCs in all species and cortical CBSCs in P. sulcata increased during retrogression. Meanwhile, when expressed per unit mass, only cortical CBSCs in H. physodes responded to retrogression, and in the opposite direction. Given that lichen functional traits are likely to be important in driving ecological processes that drive nutrient and carbon cycling in the way that plant functional traits are, the changes that they undergo during retrogression could potentially be significant for the functioning of the ecosystem. Citation: Asplund J, Sandling A, Wardle DA (2012) Lichen Specific Thallus Mass and Secondary Compounds Change across a Retrogressive Fire-Driven Chronosequence. PLoS ONE 7(11): e49081. doi:10.1371/journal.pone.0049081	[Asplund, Johan; Sandling, Aron; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Asplund, Johan] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway	Swedish University of Agricultural Sciences; Norwegian University of Life Sciences	Asplund, J (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden.	johan.asplund@slu.se	Wardle, David A./F-6031-2011	Wardle, David A./0000-0002-0476-7335; Asplund, Johan/0000-0001-5610-4480	Swedish Research Council [2010-6553]; Wallenberg Scholars award	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Scholars award	This work was funded by a grant from the Swedish Research Council (Vetenskapsradet, http://www.vr.se) to JA (2010-6553) and a Wallenberg Scholars award (http://www.wallenberg.com/kaw/) to DAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaleo D, 2008, MYCOLOGIA, V100, P565, DOI 10.3852/07-162R; Asplund J, 2008, OECOLOGIA, V155, P93, DOI 10.1007/s00442-007-0891-z; Bansal S, 2012, OECOLOGIA, V169, P661, DOI 10.1007/s00442-011-2246-z; Cordell S, 2001, OECOLOGIA, V127, P198, DOI 10.1007/s004420000588; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Crutsinger GM, 2008, FUNCT ECOL, V22, P816, DOI 10.1111/j.1365-2435.2008.01435.x; Dahlman L, 2003, FUNCT ECOL, V17, P821, DOI 10.1046/j.0269-8463.2003.00804.x; FARMER AM, 1990, LICHENOLOGIST, V22, P191, DOI 10.1017/S0024282990000147; FEIGE GB, 1993, J CHROMATOGR, V646, P417, DOI 10.1016/0021-9673(93)83356-W; Fritz O, 2009, BRYOLOGIST, V112, P488, DOI 10.1639/0007-2745-112.3.488; Gauslaa Y, 2006, OECOLOGIA, V147, P406, DOI 10.1007/s00442-005-0283-1; Gauslaa Y, 2005, OECOLOGIA, V143, P94, DOI 10.1007/s00442-004-1768-z; Gauslaa Y, 2003, PHOTOCH PHOTOBIO SCI, V2, P424, DOI 10.1039/b212532c; Gauslaa Y, 1998, FLORA, V193, P249; Gauslaa Y, 2009, NEW PHYTOL, V181, P683, DOI 10.1111/j.1469-8137.2008.02690.x; Gauslaa Y, 2011, BOTANY, V89, P787, DOI 10.1139/B11-070; Grime J. P., 2001, PLANT STRATEGIES VEG; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2003, BIOGEOCHEMISTRY, V64, P129, DOI 10.1023/A:1024966026225; Huneck S., 1973, LICHENS, P495, DOI DOI 10.1016/B978-0-12-044950-7.50020-9; Johansson O, 2011, NEW PHYTOL, V191, P795, DOI 10.1111/j.1469-8137.2011.03739.x; KNOPS JMH, 1991, LICHENOLOGIST, V23, P309, DOI 10.1017/S0024282991000452; Knops JMH, 1996, ECOL MONOGR, V66, P159, DOI 10.2307/2963473; Lagerstrom A, 2013, PLANT SOIL, V367, P183, DOI 10.1007/s11104-012-1159-x; Lawrey JD, 2009, MYCOL SER, V27, P167; Leppik E, 2011, LICHENOLOGIST, V43, P257, DOI 10.1017/S002428291100003X; Makkonen S, 2007, ANN BOT-LONDON, V99, P877, DOI 10.1093/aob/mcm042; McEvoy M, 2007, SYMBIOSIS, V43, P143; McEvoy M, 2006, MYCOL PROG, V5, P221, DOI 10.1007/s11557-006-0514-9; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P216, DOI 10.1017/CBO9780511790478.012; Nybakken L, 2004, OECOLOGIA, V140, P211, DOI 10.1007/s00442-004-1583-6; Nybakken L, 2007, J CHEM ECOL, V33, P1607, DOI 10.1007/s10886-007-9339-5; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Palmqvist K, 2000, PLANT CELL ENVIRON, V23, P1, DOI 10.1046/j.1365-3040.2000.00529.x; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Perez-Harguindeguy N, 2003, AUSTRAL ECOL, V28, P642, DOI 10.1046/j.1442-9993.2003.01321.x; Pihl Karlsson G, 2009, OVERVAKNING LUFTFORO; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Santiago LS, 2007, ECOLOGY, V88, P1126, DOI 10.1890/06-1841; SNELGAR WP, 1981, NEW PHYTOL, V87, P403, DOI 10.1111/j.1469-8137.1981.tb03211.x; Solhaug KA, 2012, PROG BOT, V73, P283, DOI 10.1007/978-3-642-22746-2_11; Solhaug KA, 2010, PLANTA, V231, P1003, DOI 10.1007/s00425-010-1103-3; Solhaug KA, 2009, FLORA, V204, P40, DOI 10.1016/j.flora.2007.12.002; SONESSON M, 1989, OIKOS, V56, P402, DOI 10.2307/3565626; Swift M. J., 1979, Decomposition in terrestrial ecosystems.; Thell A., 2011, NORDIC LICHEN FLORA, V4; Vatne S, 2011, FUNGAL ECOL, V4, P350, DOI 10.1016/j.funeco.2011.03.007; Vitousek, 2004, NUTR CYCLING LIMITAT; WALKER J, 1983, PAC SCI, V37, P471; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x; Whitehead D, 2005, OECOLOGIA, V144, P233, DOI 10.1007/s00442-005-0068-6	55	8	8	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49081	10.1371/journal.pone.0049081	http://dx.doi.org/10.1371/journal.pone.0049081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145078	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000312269500074
J	Taniguchi, Y; Kawakami, M				Taniguchi, Yukinori; Kawakami, Masaru			Variation in the Mechanical Unfolding Pathway of p53DBD Induced by Interaction with p53 N-Terminal Region or DNA	PLOS ONE			English	Article							MOLECULE FORCE SPECTROSCOPY; TUMOR-SUPPRESSOR P53; BINDING DOMAIN; DIHYDROFOLATE-REDUCTASE; TRANSACTIVATION DOMAIN; SINGLE PROTEIN; STABILITY; MICROSCOPY; RESISTANCE; REVEALS	The tumor suppressor p53 plays a crucial role in the cell cycle checkpoints, DNA repair, and apoptosis. p53 consists of a natively unfolded N-terminal region (NTR), central DNA binding domain (DBD), C-terminal tetramerization domain, and regulatory region. In this paper, the interactions between the DBD and the NTR, and between the DBD and DNA were investigated by measuring changes in the mechanical unfolding trajectory of the DBD using atomic force microscopy (AFM)-based single molecule force spectroscopy. In the absence of DNA, the DBD (94-293, 200 amino acids (AA)) showed two different mechanical unfolding patterns. One indicated the existence of an unfolding intermediate consisting of approximately 60 AA, and the other showed a 100 AA intermediate. The DBD with the NTR did not show such unfolding patterns, but heterogeneous unfolding force peaks were observed. Of the heterogeneous patterns, we observed a high frequency of force peaks indicating the unfolding of a domain consisting of 220 AA, which is apparently larger than that of a sole DBD. This observation implies that a part of NTR binds to the DBD, and the mechanical unfolding happens not solely on the DBD but also accompanying a part of NTR. When DNA is bound, the mechanical unfolding trajectory of p53NTR+DBD showed a different pattern from that without DNA. The pattern was similar to that of the DBD alone, but two consecutive unfolding force peaks corresponding to 60 and 100 AA sub-domains were observed. These results indicate that interactions with the NTR or DNA alter the mechanical stability of DBD and result in drastic changes in the mechanical unfolding trajectory of the DBD. Citation: Taniguchi Y, Kawakami M (2012) Variation in the Mechanical Unfolding Pathway of p53DBD Induced by Interaction with p53 N-Terminal Region or DNA. PLoS ONE 7(11): e49003. doi:10.1371/journal.pone.0049003	[Taniguchi, Yukinori; Kawakami, Masaru] JAIST, Sch Mat Sci, Nomi, Ishikawa, Japan	Japan Advanced Institute of Science & Technology (JAIST)	Kawakami, M (corresponding author), JAIST, Sch Mat Sci, Nomi, Ishikawa, Japan.	kmasaru@jaist.ac.jp	Taniguchi, Yukinori/C-7039-2008		Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Japan Society for the Promotion of Science (JSPS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V, 2011, J BIOL CHEM, V286, P28056, DOI 10.1074/jbc.M111.249045; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Arad-Haase G, 2010, BIOPHYS J, V99, P238, DOI 10.1016/j.bpj.2010.04.004; Bertz M, 2009, J MOL BIOL, V393, P1097, DOI 10.1016/j.jmb.2009.08.066; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Bizzarri AR, 2011, PHYS CHEM CHEM PHYS, V13, P2738, DOI 10.1039/c0cp01474e; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Brockwell DJ, 2002, BIOPHYS J, V83, P458, DOI 10.1016/S0006-3495(02)75182-5; Butler JS, 2005, J MOL BIOL, V350, P906, DOI 10.1016/j.jmb.2005.05.060; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Horejs C, 2011, J BIOL CHEM, V286, P27416, DOI 10.1074/jbc.M111.251322; Huang F, 2009, P NATL ACAD SCI USA, V106, P20758, DOI 10.1073/pnas.0909644106; Ishida S, 2000, JPN J CANCER RES, V91, P174, DOI 10.1111/j.1349-7006.2000.tb00929.x; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Junker JP, 2005, BIOPHYS J, V89, pL46, DOI 10.1529/biophysj.105.072066; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Klein C, 2001, J BIOL CHEM, V276, P49020, DOI 10.1074/jbc.M107516200; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Natan E, 2011, J MOL BIOL, V409, P358, DOI 10.1016/j.jmb.2011.03.047; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Sadler DP, 2009, J MOL BIOL, V393, P237, DOI 10.1016/j.jmb.2009.08.015; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Taniguchi Y, 2008, BIOPHYS J, V95, P5296, DOI 10.1529/biophysj.108.141275; Taniguchi Y, 2010, LANGMUIR, V26, P10433, DOI 10.1021/la101658a; Taranta M, 2008, J MOL RECOGNIT, V21, P63, DOI 10.1002/jmr.869; Terakawa T, 2011, BIOPHYS J, V101, P1450, DOI 10.1016/j.bpj.2011.08.003; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang CC, 2011, BIOPHYS J, V100, P1094, DOI 10.1016/j.bpj.2011.01.011; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105	41	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49003	10.1371/journal.pone.0049003	http://dx.doi.org/10.1371/journal.pone.0049003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145047	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500059
J	Cann, GM; Gulzar, ZG; Cooper, S; Li, R; Luo, SJ; Tat, M; Stuart, S; Schroth, G; Srinivas, S; Ronaghi, M; Brooks, JD; Talasaz, AH				Cann, Gordon M.; Gulzar, Zulfiqar G.; Cooper, Samantha; Li, Robin; Luo, Shujun; Tat, Mai; Stuart, Sarah; Schroth, Gary; Srinivas, Sandhya; Ronaghi, Mostafa; Brooks, James D.; Talasaz, AmirAli H.			mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PROGRESSION; CARCINOMA; APOPTOSIS; BIOMARKERS; SURVIVAL; BLOOD	Circulating tumor cells (CTC) mediate metastatic spread of many solid tumors and enumeration of CTCs is currently used as a prognostic indicator of survival in metastatic prostate cancer patients. Some evidence suggests that it is possible to derive additional information about tumors from expression analysis of CTCs, but the technical difficulty of isolating and analyzing individual CTCs has limited progress in this area. To assess the ability of a new generation of MagSweeper to isolate intact CTCs for downstream analysis, we performed mRNA-Seq on single CTCs isolated from the blood of patients with metastatic prostate cancer and on single prostate cancer cell line LNCaP cells spiked into the blood of healthy donors. We found that the MagSweeper effectively isolated CTCs with a capture efficiency that matched the CellSearch platform. However, unlike CellSearch, the MagSweeper facilitates isolation of individual live CTCs without contaminating leukocytes. Importantly, mRNA-Seq analysis showed that the MagSweeper isolation process did not have a discernible impact on the transcriptional profile of single LNCaPs isolated from spiked human blood, suggesting that any perturbations caused by the MagSweeper process on the transcriptional signature of isolated cells are modest. Although the RNA from patient CTCs showed signs of significant degradation, consistent with reports of short half-lives and apoptosis amongst CTCs, transcriptional signatures of prostate tissue and of cancer were readily detectable with single CTC mRNA-Seq. These results demonstrate that the MagSweeper provides access to intact CTCs and that these CTCs can potentially supply clinically relevant information.	[Cann, Gordon M.; Cooper, Samantha; Li, Robin; Luo, Shujun; Tat, Mai; Stuart, Sarah; Schroth, Gary; Ronaghi, Mostafa; Talasaz, AmirAli H.] Illumina Inc, Dept Diagnost Res, Hayward, CA USA; [Gulzar, Zulfiqar G.; Brooks, James D.] Stanford Univ, Med Ctr, Dept Urol, Stanford, CA 94305 USA; [Srinivas, Sandhya] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA	Illumina; Stanford University; Stanford University	Ronaghi, M (corresponding author), Illumina Inc, Dept Diagnost Res, Hayward, CA USA.	mronaghi@illumina.com; jdbrooks@stanford.edu; atalasaz@gmail.com			Department of Defense [W81XWH-10-1-0510]	Department of Defense(United States Department of Defense)	This study was supported in part by Department of Defense grant W81XWH-10-1-0510 (to JDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2326; Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Ateeq B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001498; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; Danila DC, 2011, CANCER J, V17, P438, DOI 10.1097/PPO.0b013e31823e69ac; del Prete MJ, 2002, FASEB J, V16, P2003, DOI 10.1096/fj.02-0392fje; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GHOSSEIN RA, 1995, J CLIN ONCOL, V13, P1195, DOI 10.1200/JCO.1995.13.5.1195; Gulzar ZG, 2012, ONCOGENE; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hudolin T, 2006, PROSTATE, V66, P13, DOI 10.1002/pros.20312; Larson CJ, 2004, CYTOM PART A, V62A, P46, DOI 10.1002/cyto.a.20073; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ntouroupi TG, 2008, BRIT J CANCER, V99, P789, DOI 10.1038/sj.bjc.6604545; Paris PL, 2009, CANCER LETT, V277, P164, DOI 10.1016/j.canlet.2008.12.007; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi E, 2010, CLIN CANCER RES, V16, P5233, DOI 10.1158/1078-0432.CCR-10-1449; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Swennenhuis JF, 2009, CYTOM PART A, V75A, P520, DOI 10.1002/cyto.a.20718; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; von Boehmer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021366; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490	46	109	114	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49144	10.1371/journal.pone.0049144	http://dx.doi.org/10.1371/journal.pone.0049144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145101	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800219
J	Gonzalez-Bernal, E; Greenlees, M; Brown, GP; Shine, R				Gonzalez-Bernal, Edna; Greenlees, Matthew; Brown, Gregory P.; Shine, Richard			Cane Toads on Cowpats: Commercial Livestock Production Facilitates Toad Invasion in Tropical Australia	PLOS ONE			English	Article							BUFO-MARINUS; BIOTIC INVASIONS; WATER-LOSS; WET-DRY; IMPACTS; CONSEQUENCES; DESICCATION; DRIVERS; ECOLOGY; SPREAD	Habitat disturbance and the spread of invasive organisms are major threats to biodiversity, but the interactions between these two factors remain poorly understood in many systems. Grazing activities may facilitate the spread of invasive cane toads (Rhinella marina) through tropical Australia by providing year-round access to otherwise-seasonal resources. We quantified the cane toad's use of cowpats (feces piles) in the field, and conducted experimental trials to assess the potential role of cowpats as sources of prey, water, and warmth for toads. Our field surveys show that cane toads are found on or near cowpats more often than expected by chance. Field-enclosure experiments show that cowpats facilitate toad feeding by providing access to dung beetles. Cowpats also offer moist surfaces that can reduce dehydration rates of toads and are warmer than other nearby substrates. Livestock grazing is the primary form of land use over vast areas of Australia, and pastoral activities may have contributed substantially to the cane toad's successful invasion of that continent.	[Gonzalez-Bernal, Edna; Greenlees, Matthew; Brown, Gregory P.; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Shine, R (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au	Brown, Gregory P./F-9897-2011; González-Bernal, Edna/AAH-9372-2021	Brown, Gregory P./0000-0002-2924-9040; Gonzalez-Bernal, Edna/0000-0001-7817-4156	Australian Research Council [FF561365]	Australian Research Council(Australian Research Council)	The work was funded by Australian Research Council grant FF561365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018277; Australian Government, 2009, AUSTR NAT RES ATL LA; Australian State of the Environment Committee, 2006, IND REP COMM MIN ENV; BAILEY P, 1976, Australian Wildlife Research, V3, P185; Bock CE, 2007, J ARID ENVIRON, V71, P229, DOI 10.1016/j.jaridenv.2007.03.004; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Child T, 2008, AUSTRAL ECOL, V33, P630, DOI 10.1111/j.1442-9993.2007.01829.x; Child T, 2009, J TROP ECOL, V25, P193, DOI 10.1017/S0266467408005695; COWIE ID, 1993, BIOL CONSERV, V63, P127, DOI 10.1016/0006-3207(93)90500-Z; Davis Adrian L. V., 2001, Diversity and Distributions, V7, P161, DOI 10.1111/j.1472-4642.2001.00102.x; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Fisher A, 2004, 3 NO TERR DES KNOWL; Florance D, 2011, P ROY SOC B-BIOL SCI, V278, P2900, DOI 10.1098/rspb.2011.0032; FREELAND WJ, 1991, WILDLIFE RES, V18, P431, DOI 10.1071/WR9910431; Griffen BD, 2008, J ANIM ECOL, V77, P32, DOI 10.1111/j.1365-2656.2007.01304.x; Gurevitch J, 2006, ECOL LETT, V9, P919, DOI 10.1111/j.1461-0248.2006.00951.x; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; Hobbs RJ, 2001, CONSERV BIOL, V15, P1522, DOI 10.1046/j.1523-1739.2001.01092.x; HOBBS RJ, 1988, AUST J ECOL, V13, P171, DOI 10.1111/j.1442-9993.1988.tb00966.x; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kolbe JJ, 2010, ECOL APPL, V20, P2273, DOI 10.1890/09-1973.1; LEVER C., 2001, CANE TOAD HIST ECOLO; Loydi A, 2009, PLANT ECOL, V201, P471, DOI 10.1007/s11258-008-9468-0; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pizzatto L, 2008, BEHAV ECOL SOCIOBIOL, V63, P123, DOI 10.1007/s00265-008-0642-0; Price-Rees SJ, 2012, AM NAT, V179, P413, DOI 10.1086/664184; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Seabrook L, 2006, LANDSCAPE URBAN PLAN, V78, P373, DOI 10.1016/j.landurbplan.2005.11.007; Sharp BR, 2003, J BIOGEOGR, V30, P783, DOI 10.1046/j.1365-2699.2003.00840.x; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Smallbone LT, 2011, LANDSCAPE URBAN PLAN, V101, P43, DOI 10.1016/j.landurbplan.2011.01.002; SPOTILA JR, 1976, COMP BIOCHEM PHYS A, V55, P407, DOI 10.1016/0300-9629(76)90069-4; Tingley R, 2012, OIKOS, V121, P1959, DOI 10.1111/j.1600-0706.2012.20422.x; Tingley R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025979; Tracy CR, 2007, J HERPETOL, V41, P597, DOI 10.1670/07-006.1; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Warfe DM, 2011, FRESHWATER BIOL, V56, P2169, DOI 10.1111/j.1365-2427.2011.02660.x; Waterhouse D. F., 1974, Scientific American, V230, P100	49	20	23	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49351	10.1371/journal.pone.0049351	http://dx.doi.org/10.1371/journal.pone.0049351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145158	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800249
J	Lindh, J; Magnusson, M; Grunewald, M; Hulth, A				Lindh, Johan; Magnusson, Mans; Grunewald, Maria; Hulth, Anette			Head Lice Surveillance on a Deregulated OTC-Sales Market: A Study Using Web Query Data	PLOS ONE			English	Article							BARTONELLA-QUINTANA; BODY LICE	The head louse, Pediculus humanus capitis, is an obligate ectoparasite that causes infestations of humans. Studies have demonstrated a correlation between sales figures for over-the-counter (OTC) treatment products and the number of humans with head lice. The deregulation of the Swedish pharmacy market on July 1, 2009, decreased the possibility to obtain complete sale figures and thereby the possibility to obtain yearly trends of head lice infestations. In the presented study we wanted to investigate whether web queries on head lice can be used as substitute for OTC sales figures. Via Google Insights for Search and Vardguiden medical web site, the number of queries on "huvudloss" (head lice) and "harloss" (lice in hair) were obtained. The analysis showed that both the Vardguiden series and the Google series were statistically significant (p<0.001) when added separately, but if the Google series were already included in the model, the Vardguiden series were not statistically significant (p=0.5689). In conclusion, web queries can detect if there is an increase or decrease of head lice infested humans in Sweden over a period of years, and be as reliable a proxy as the OTC-sales figures.	[Lindh, Johan; Magnusson, Mans; Grunewald, Maria; Hulth, Anette] Swedish Inst Communicable Dis Control, Solna, Sweden; [Lindh, Johan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet	Lindh, J (corresponding author), Swedish Inst Communicable Dis Control, Solna, Sweden.	johan.lindh@smi.se	Hulth, Anette/E-2162-2017	Hulth, Anette/0000-0002-3132-808X				Angelakis E, 2011, FEMS IMMUNOL MED MIC, V62, P244, DOI 10.1111/j.1574-695X.2011.00804.x; Bauer E, 2009, PARASITOL RES, V104, P677, DOI 10.1007/s00436-008-1245-4; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Buczek A, 2004, EUR J EPIDEMIOL, V19, P491, DOI 10.1023/B:EJEP.0000027347.76908.61; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; CLORE ER, 1990, J SCHOOL HEALTH, V60, P212, DOI 10.1111/j.1746-1561.1990.tb05917.x; Dukic VM, 2011, EMERG INFECT DIS, V17, P1068, DOI [10.3201/eid1706.101451, 10.3201/eid/1706.101451]; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Fox J., 2010, TIME SERIES REGRESSI; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Google, 2012, GOOGL INS SEARCH; Hulth A, 2011, EURO SURVEILL, V16; Hulth A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-252; Hulth A, 2010, EMERG INFECT DIS, V16, P1319, DOI 10.3201/eid1608.100093; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Lebwohl M, 2007, PEDIATRICS, V119, P965, DOI 10.1542/peds.2006-3087; Leo NP, 2005, PARASITOL RES, V98, P44, DOI 10.1007/s00436-005-0013-y; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Rukke BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032686; Speare R, 1999, INT J DERMATOL, V38, P285, DOI 10.1046/j.1365-4362.1999.00680.x; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]	23	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48666	10.1371/journal.pone.0048666	http://dx.doi.org/10.1371/journal.pone.0048666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144923	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800093
J	Mayol, G; Martin-Subero, JI; Rios, J; Queiros, A; Kulis, M; Sunol, M; Esteller, M; Gomez, S; Garcia, I; de Torres, C; Rodriguez, E; Galvan, P; Mora, J; Lavarino, C				Mayol, Gemma; Martin-Subero, Jose I.; Rios, Jose; Queiros, Ana; Kulis, Marta; Sunol, Mariona; Esteller, Manel; Gomez, Soledad; Garcia, Idoia; de Torres, Carmen; Rodriguez, Eva; Galvan, Patricia; Mora, Jaume; Lavarino, Cinzia			DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis	PLOS ONE			English	Article							CYCLIN D1; PATHOLOGY CLASSIFICATION; PROMOTER METHYLATION; EXPRESSION; RASSF1A; HYPERMETHYLATION; LANDSCAPE; DISCOVERY; LYMPHOMAS; PROFILES	Neuroblastoma (NB) pathogenesis has been reported to be closely associated with numerous genetic alterations. However, underlying DNA methylation patterns have not been extensively studied in this developmental malignancy. Here, we generated microarray-based DNA methylation profiles of primary neuroblastic tumors. Stringent supervised differential methylation analyses allowed us to identify epigenetic changes characteristic for NB tumors as well as for clinical and biological subtypes of NB. We observed that gene-specific loss of DNA methylation is more prevalent than promoter hypermethylation. Remarkably, such hypomethylation affected cancer-related biological functions and genes relevant to NB pathogenesis such as CCND1, SPRR3, BTC, EGF and FGF6. In particular, differential methylation in CCND1 affected mostly an evolutionary conserved functionally relevant 3' untranslated region, suggesting that hypomethylation outside promoter regions may play a role in NB pathogenesis. Hypermethylation targeted genes involved in cell development and proliferation such as RASSF1A, POU2F2 or HOXD3, among others. The results derived from this study provide new candidate epigenetic biomarkers associated with NB as well as insights into the molecular pathogenesis of this tumor, which involves a marked gene-specific hypomethylation.	[Mayol, Gemma; Gomez, Soledad; Garcia, Idoia; de Torres, Carmen; Rodriguez, Eva; Galvan, Patricia; Mora, Jaume; Lavarino, Cinzia] Hosp St Joan de Deu, Fdn St Joan de Deu, Dev Tumor Biol Lab, Barcelona, Spain; [Martin-Subero, Jose I.; Queiros, Ana] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain; [Rios, Jose] Univ Autonoma Barcelona, Lab Biostat & Epidemiol, E-08193 Barcelona, Spain; [Rios, Jose] Hosp Clin Barcelona, Clin Pharmacol Serv, IDIBAPS, Barcelona, Spain; [Kulis, Marta] Hosp Clin Barcelona, Hematopathol Unit, Barcelona, Spain; [Sunol, Mariona] Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain; [Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain; [Esteller, Manel] ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA	Lavarino, C (corresponding author), Hosp St Joan de Deu, Fdn St Joan de Deu, Dev Tumor Biol Lab, Barcelona, Spain.	clavarino@fsjd.org	Ríos, José/AAZ-2341-2020; Esteller, Manel/L-5956-2014	Ríos, José/0000-0002-0716-8784; Esteller, Manel/0000-0003-4490-6093; Mora, Jaume/0000-0002-9386-5980; Galvan, Patricia/0000-0002-8153-0307; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Gomez-Gonzalez, Soledad/0000-0002-0578-4276; Queiros, Ana/0000-0001-8585-4803; Kulis, Marta/0000-0001-8104-9620	Spanish Ministry of Health (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria) [PI070286]; Spanish Society against Cancer (Asociacion Espanola Contra el Cancer); Hospital Sant Joan de Deu of Barcelona [BR201102]; Spanish Ministry of Science and Innovation [SAF2009-08663]; ICREA Funding Source: Custom	Spanish Ministry of Health (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos IIISpanish Government); Spanish Society against Cancer (Asociacion Espanola Contra el Cancer); Hospital Sant Joan de Deu of Barcelona; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Health (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, 2007; PI070286) and Spanish Society against Cancer (Asociacion Espanola Contra el Cancer, 2007). G. M. is supported by a grant of Hospital Sant Joan de Deu of Barcelona (Grant BR201102), S. G. by a donation from the NEN association and J.I.M-S. studies on epigenomics are supported by the Spanish Ministry of Science and Innovation (RyC contract and SAF2009-08663).	Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Buckley PG, 2011, INT J CANCER, V128, P2296, DOI 10.1002/ijc.25584; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Caren H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-66; Chen G, 2012, STEM CELLS, V30, P623, DOI 10.1002/stem.1021; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deshpande A, 2009, CELL CYCLE, V8, P3592, DOI 10.4161/cc.8.21.9993; Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Grau E, 2011, MOL CARCINOGEN, V50, P153, DOI 10.1002/mc.20700; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Kamimatsuse A, 2009, PEDIATR BLOOD CANCER, V52, P777, DOI 10.1002/pbc.21977; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Lavarino C, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-36; Lavarino C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-44; Liu LY, 2011, INT J CANCER, V129, P2454, DOI 10.1002/ijc.25908; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Michalowski MB, 2008, PEDIATR BLOOD CANCER, V50, P29, DOI 10.1002/pbc.21279; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Molenaar JJ, 2003, GENE CHROMOSOME CANC, V36, P242, DOI 10.1002/gcc.10166; Pizzi S, 2005, J PATHOL, V206, P409, DOI 10.1002/path.1784; Richter J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-455; Sano H, 2006, EUR J CANCER, V42, P1113, DOI 10.1016/j.ejca.2005.11.031; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Taniguchi Y, 2011, J ANAT, V219, P589, DOI 10.1111/j.1469-7580.2011.01425.x; Theodorou E, 2009, GENE DEV, V23, P575, DOI 10.1101/gad.1772509; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wulf P, 1999, DEV BRAIN RES, V116, P169, DOI 10.1016/S0165-3806(99)00092-9; Zhang J, 2011, J CLIN PATHOL, V64, P25, DOI 10.1136/jcp.2010.082404	48	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48401	10.1371/journal.pone.0048401	http://dx.doi.org/10.1371/journal.pone.0048401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144874	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800054
J	Wu, WH; Zhang, J; Zheng, MQ; Zhong, YH; Yang, J; Zhao, YH; Wu, WP; Ye, W; Wen, J; Wang, Q; Lu, JX				Wu, Wenhe; Zhang, Jie; Zheng, Meiqin; Zhong, Yuhong; Yang, Jie; Zhao, Yuhong; Wu, Wenping; Ye, Wei; Wen, Jie; Wang, Qi; Lu, Jianxin			An Aptamer-Based Biosensor for Colorimetric Detection of Escherichia coli O157: H7	PLOS ONE			English	Article							SPINACH-ASSOCIATED OUTBREAK; IMMUNOMAGNETIC SEPARATION; ALFALFA SPROUTS; IMMUNOSENSOR; SALMONELLA; ENRICHMENT; MONOLAYER; PCR; POLYMERIZATION; MOLECULES	Background: An aptamer based biosensor (aptasensor) was developed and evaluated for rapid colorimetric detection of Escherichia coli (E. coli) O157:H7. Methodology/Principal Findings: The aptasensor was assembled by modifying the truncated lipopolysaccharides (LPS)-binding aptamer on the surface of nanoscale polydiacetylene (PDA) vesicle using peptide bonding between the carboxyl group of the vesicle and the amine group of the aptamer. Molecular recognition between E. coli O157:H7 and aptamer at the interface of the vesicle lead to blue-red transition of PDA which was readily visible to the naked eyes and could be quantified by colorimetric responses (CR). Confocal laser scanning microscope (CLSM) and transmission electron microscopy (TEM) was used to confirm the specific interactions between the truncated aptamer and E. coli O157:H7. The aptasensor could detect cellular concentrations in a range of 10(4) similar to, 10(8) colony-forming units (CFU)/ml within 2 hours and its specificity was 100% for detection of E. coli O157:H7. Compared with the standard culture method, the correspondent rate was 98.5% for the detection of E. coli O157:H7 on 203 clinical fecal specimens with our aptasensor. Conclusions: The new aptasensor represents a significant advancement in detection capabilities based on the combination of nucleic acid aptamer with PDA vesicle, and offers a specific and convenient screening method for the detection of pathogenic bacteria. This technic could also be applied in areas from clinical analysis to biological terrorism defense, especially in low-resource settings.	[Wang, Qi] Dalian Med Univ, Hosp Affiliated 2, Dept Resp Med, Dalian, Peoples R China; [Wu, Wenhe; Zhang, Jie; Zhong, Yuhong; Yang, Jie; Zhao, Yuhong; Wu, Wenping; Ye, Wei; Wen, Jie; Lu, Jianxin] Wenzhou Med Coll, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zheng, Meiqin] Wenzhou Med Coll, Affiliated Eye Hosp, Dept Clin Lab Med, Wenzhou, Peoples R China	Dalian Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, Q (corresponding author), Dalian Med Univ, Hosp Affiliated 2, Dept Resp Med, Dalian, Peoples R China.	wqdmu@yahoo.com.cn; jxlu313@163.com			National Science and Technology Major Project of China [2008ZX10003-003]; National High Technology Research and Development Program of China (863) [2007AA022008]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Key Laboratory of Laboratory Medicine, Ministry of Education, Key Science and Technology Innovation Team of Zhejiang [2010R50048]; Wenzhou Science and Technology Foundation [Y20080080]	National Science and Technology Major Project of China; National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Key Laboratory of Laboratory Medicine, Ministry of Education, Key Science and Technology Innovation Team of Zhejiang; Wenzhou Science and Technology Foundation	This study was supported by National Science and Technology Major Project of China (2008ZX10003-003), the National High Technology Research and Development Program of China (863) (2007AA022008), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and Key Laboratory of Laboratory Medicine, Ministry of Education, Key Science and Technology Innovation Team of Zhejiang (2010R50048), Major Project of Wenzhou Science and Technology Foundation (Y20080080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DJ, 2003, J AM CHEM SOC, V125, P8976, DOI 10.1021/ja0299001; Chen Y, 2011, CURR ORG CHEM, V15, P518, DOI 10.2174/138527211794474438; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ENKELMANN V, 1984, ADV POLYM SCI, V63, P91; Gould L. Hannah, 2011, Morbidity and Mortality Weekly Report, V60, P1197; Hesselberth J, 2000, J Biotechnol, V74, P15, DOI 10.1016/S1389-0352(99)00005-7; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jelinek R, 2007, TOP CURR CHEM, V277, P155, DOI 10.1007/128_2007_112; Jin HY, 2005, WORLD J GASTROENTERO, V11, P5811, DOI 10.3748/wjg.v11.i37.5811; Johnston LM, 2005, J FOOD PROTECT, V68, P2256, DOI 10.4315/0362-028X-68.11.2256; Jonas U, 1999, J AM CHEM SOC, V121, P4580, DOI 10.1021/ja984190d; Jung YK, 2010, ADV FUNCT MATER, V20, P3092, DOI 10.1002/adfm.201001008; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Lee J, 2008, J AM CHEM SOC, V130, P5010, DOI 10.1021/ja709996c; Lee J, 2009, ADV MATER, V21, P3674, DOI 10.1002/adma.200900639; Ma ZF, 1998, J AM CHEM SOC, V120, P12678, DOI 10.1021/ja982663a; Mao XL, 2006, BIOSENS BIOELECTRON, V21, P1178, DOI 10.1016/j.bios.2005.04.021; Park CH, 1996, J CLIN MICROBIOL, V34, P988, DOI 10.1128/JCM.34.4.988-990.1996; Parker CT, 2012, APPL ENVIRON MICROB, V78, P455, DOI 10.1128/AEM.06251-11; Radke SA, 2005, BIOSENS BIOELECTRON, V20, P1662, DOI 10.1016/j.bios.2004.07.021; Reppy MA, 2007, CHEM COMMUN, P4317, DOI 10.1039/b703691d; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Su XL, 2004, BIOSENS BIOELECTRON, V19, P563, DOI 10.1016/S0956-5663(03)00254-9; Subramanian A, 2006, BIOSENS BIOELECTRON, V21, P998, DOI 10.1016/j.bios.2005.03.007; Tims TB, 2003, J MICROBIOL METH, V55, P141, DOI 10.1016/S0167-7012(03)00133-7; TOMIOKA Y, 1989, J CHEM PHYS, V91, P5694, DOI 10.1063/1.457523; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang LX, 2007, J FOOD PROTECT, V70, P1366, DOI 10.4315/0362-028X-70.6.1366; Wang YX, 2011, SENSORS-BASEL, V11, P2728, DOI 10.3390/s110302728; Weagant SD, 2011, INT J FOOD MICROBIOL, V149, P209, DOI 10.1016/j.ijfoodmicro.2011.06.008; Wolter A, 2008, ANAL CHEM, V80, P5854, DOI 10.1021/ac800318b; Yang LJ, 2004, ANAL CHEM, V76, P1107, DOI 10.1021/ac0352575	32	52	58	20	291	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48999	10.1371/journal.pone.0048999	http://dx.doi.org/10.1371/journal.pone.0048999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145045	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800182
J	Chow, JPH; Poon, RYC				Chow, J. P. H.; Poon, R. Y. C.			The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery	ONCOGENE			English	Article						cell cycle; checkpoint; ionizing radiation	CELL-CYCLE; SOMATIC WEE1; PHOSPHORYLATION; CDC2; INACTIVATION; CHK1; ACTIVATION; ABROGATION; COMPLEXES; CLEAVAGE	Inhibition of cyclin-dependent kinase 1 (CDK1) by phosphorylation is a key regulatory mechanism for both the unperturbed cell cycle and the DNA damage checkpoint. Although both WEE1 and MYT1 can phosphorylate CDK1, little is known about the contribution of MYT1. We found that in contrast to WEE1, MYT1 was not important for the normal cell cycle or checkpoint activation. Time-lapse microscopy indicated that MYT1 did, however, have a rate-determining role during checkpoint recovery. Depletion of MYT1 induced precocious mitotic entry when the checkpoint was abrogated with inhibitors of either CHK1 or WEE1, indicating that MYT1 contributes to checkpoint recovery independently of WEE1. The acceleration of checkpoint recovery in MYT1-depleted cells was due to a lowering of threshold for CDK1 activation. The kinase activity of MYT1 was high during checkpoint activation and reduced during checkpoint recovery. Importantly, although depletion of MYT1 alone did not affect long-term cell growth, it potentiated with DNA damage to inhibit cell growth in clonogenic survival and tumor xenograft models. These results reveal the functions of MYT1 in checkpoint recovery and highlight the potential of MYT1 as a target for anti-cancer therapies.	[Poon, R. Y. C.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	rycpoon@ust.hk		Poon, Randy/0000-0001-5571-6231	 [AOE-MG/M-08/06];  [HKU7/CRG/09]	; 	We thank Helen Piwnica-Worms and Katsumi Yamashita for generous gifts of reagents. This work was supported in part by grants AOE-MG/M-08/06 and HKU7/CRG/09 to RYCP.	Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Chan YW, 2009, ONCOGENE, V28, P170, DOI 10.1038/onc.2008.369; Chan YW, 2008, J BIOL CHEM, V283, P15716, DOI 10.1074/jbc.M800629200; Chan YW, 2008, CELL CYCLE, V7, P1449, DOI 10.4161/cc.7.10.5880; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Chen Y, 2012, MOL CANCER RES, V10, P626, DOI 10.1158/1541-7786.MCR-11-0491; Chow JPH, 2011, MOL CELL BIOL, V31, P1478, DOI 10.1128/MCB.00891-10; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Mizuarai S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-34; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nakajima H, 2008, J CELL BIOL, V181, P89, DOI 10.1083/jcb.200708176; Nakajo N, 2000, GENE DEV, V14, P328; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; On KF, 2011, MOL CANCER THER, V10, P784, DOI 10.1158/1535-7163.MCT-10-0809; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Ruiz EJ, 2008, MOL CELL, V32, P210, DOI 10.1016/j.molcel.2008.08.029; Siu WY, 1999, EXP CELL RES, V250, P131, DOI 10.1006/excr.1999.4551; Stumpff J, 2004, CURR BIOL, V14, P2143, DOI 10.1016/j.cub.2004.11.050; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wells NJ, 1999, J CELL SCI, V112, P3361; Yam CH, 2000, J BIOL CHEM, V275, P3158, DOI 10.1074/jbc.275.5.3158; Yam CH, 2001, P NATL ACAD SCI USA, V98, P497, DOI 10.1073/pnas.240461397	36	41	41	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4778	4788		10.1038/onc.2012.504	http://dx.doi.org/10.1038/onc.2012.504			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23146904				2022-12-25	WOS:000325274700006
J	van Veenendaal, NR; Ulmer, B; Boskovski, MT; Fang, XF; Khokha, MK; Wendler, CC; Blum, M; Rivkees, SA				van Veenendaal, Nicole R.; Ulmer, Baerbel; Boskovski, Marko T.; Fang, Xiefan; Khokha, Mustafa K.; Wendler, Christopher C.; Blum, Martin; Rivkees, Scott A.			Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos	FASEB JOURNAL			English	Article						thyroid; Graves' disease; methimazole; situs; teratogenicity	THYROID-DYSFUNCTION; ANTITHYROID DRUGS; PREGNANCY; MANAGEMENT; CILIA; HYPERTHYROIDISM; EXPRESSION; HYPOTHYROIDISM; TROPICALIS; MOUSE	Antithyroid medications are the preferred therapy for the treatment of Graves' disease during pregnancy. Propylthiouracil (PTU) is favored over methimazole (MMI) due to potential teratogenic concerns with MMI. This study was to determine the teratogenic potential of MMI and PTU using a validated Xenopus tropicalis embryo model. Embryos were exposed to 1 mM PTU (EC50 = 0.88 mM), 1 mM MMI, or vehicle control (water) from stages 2 to 45. Treated embryos were examined for gross morphological defects, ciliary function, and gene expression by in situ hybridization. Exposure to PTU, but not MMI, led to cardiac and gut looping defects and shortening along the anterior-posterior axis. PTU exposure during gastrulation (stage 8-12.5) was identified as the critical period of exposure leading to left-right (LR) patterning defects. Abnormal cilia polarization, abnormal cilia-driven leftward flow at the gastrocoel roof plate (GRP), and aberrant expression of both Coco and Pitx2c were associated with abnormal LR symmetry observed following PTU exposure. PTU is teratogenic during late blastula, gastrulation, and neurulation; whereas MMI is not. PTU alters ciliary-driven flow and disrupts the normal genetic program involved in LR axis determination. These studies have important implications for women taking PTU during early pregnancy.-Van Veenendaal, N.R., Ulmer, B., Boskovski, M. T., Fang, X., Khokha, M. K., Wendler, C. C., Blum, M., Rivkees, S. A. Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos. FASEB J. 27, 684-691 (2013). www.fasebj.org	[van Veenendaal, Nicole R.; Boskovski, Marko T.; Fang, Xiefan; Khokha, Mustafa K.; Wendler, Christopher C.; Rivkees, Scott A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Boskovski, Marko T.; Khokha, Mustafa K.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ulmer, Baerbel; Blum, Martin] Univ Hohenheim, Inst Zool, Stuttgart, Germany; [van Veenendaal, Nicole R.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Fang, Xiefan; Wendler, Christopher C.; Rivkees, Scott A.] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA	Yale University; Yale University; University Hohenheim; University of Amsterdam; Academic Medical Center Amsterdam; State University System of Florida; University of Florida	Rivkees, SA (corresponding author), Univ Florida, Coll Med, Dept Pediat, POB 100296, Gainesville, FL 32610 USA.	srivkees@ufl.edu	Fang, Xiefan/G-1186-2015; Ulmer, Bärbel/AAB-9564-2020	Fang, Xiefan/0000-0002-7804-7832; 	U.S. National Institutes of Health [1R01DE018825, 1R01HD065200]; Deutsche Forschungsgemeinschaft [BL-285/10-1]; Nuffic Dutch Huygens Talent Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nuffic Dutch Huygens Talent Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by U.S. National Institutes of Health grants 1R01DE018825 (to M. K. K.) and 1R01HD065200 (to S. A. R), by grant BL-285/10-1 from the Deutsche Forschungsgemeinschaft (to M. B.), and by The Nuffic Dutch Huygens Talent Scholarship (to N.R.V.V.). The authors thank Michael Slocum for Xenopus husbandry, Sarah Kirschner for setting up Xenopus matings used in this study, and Isabelle Schneider, Thomas Thumberger, and Peter Walentek for help with GRP and flow analysis.	Abalovich M, 2007, J CLIN ENDOCR METAB, V92, pS1, DOI 10.1210/jc.2007-0141; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alten L, 2012, DEVELOPMENT, V139, P1276, DOI 10.1242/dev.072728; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Benavides VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035213; Beyer T, 2012, CURR BIOL, V22, P33, DOI 10.1016/j.cub.2011.11.027; Blum M, 2007, DIFFERENTIATION, V75, P133, DOI 10.1111/j.1432-0436.2006.00124.x; Blum M, 2009, DEV DYNAM, V238, P1215, DOI 10.1002/dvdy.21855; Braverman L. E., 2003, DIS THYROID; BURROW GN, 1985, NEW ENGL J MED, V313, P562, DOI 10.1056/NEJM198508293130907; Calikoglu AS, 1996, NEUROSCI LETT, V213, P132; Chan GW, 2007, NAT CLIN PRACT ENDOC, V3, P470, DOI 10.1038/ncpendmet0508; Chattaway JM, 2007, ANN PHARMACOTHER, V41, P1018, DOI 10.1345/aph.1H535; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Clementi M, 2010, J CLIN ENDOCR METAB, V95, pE337, DOI 10.1210/jc.2010-0652; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; Diav-Citrin O, 2002, TERATOLOGY, V65, P38, DOI 10.1002/tera.1095.abs; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Fantz CR, 1999, CLIN CHEM, V45, P2250; Glinka A, 1996, MECH DEVELOP, V60, P221, DOI 10.1016/S0925-4773(96)00624-7; Glinoer D, 1998, THYROID, V8, P859, DOI 10.1089/thy.1998.8.859; GOLDEY ES, 1995, TOXICOL APPL PHARM, V135, P67, DOI 10.1006/taap.1995.1209; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Koren G, 2006, THER DRUG MONIT, V28, P12, DOI 10.1097/01.ftd.0000192135.54477.d9; KREMENTZ ET, 1957, SURGERY, V41, P619; Lenhart KF, 2011, DEVELOPMENT, V138, P4405, DOI 10.1242/dev.071092; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; Marx H, 2008, BRIT MED J, V336, P663, DOI 10.1136/bmj.39462.709005.AE; Mestman JH, 1998, ENDOCRIN METAB CLIN, V27, P127, DOI 10.1016/S0889-8529(05)70303-0; Mouche I, 2011, METHODS MOL BIOL, V691, P257, DOI 10.1007/978-1-60761-849-2_15; Okosieme OE, 2008, EXPERT OPIN PHARMACO, V9, P2281, DOI [10.1517/14656566.9.13.2281, 10.1517/14656566.9.13.2281 ]; Roti E, 1996, J CLIN ENDOCR METAB, V81, P1679, DOI 10.1210/jc.81.5.1679; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Setter PW, 2006, EXP CELL RES, V312, P2880, DOI 10.1016/j.yexcr.2006.05.014; Shi HH, 2010, COMP BIOCHEM PHYS C, V152, P62, DOI 10.1016/j.cbpc.2010.02.013; Shook DR, 2004, DEV BIOL, V270, P163, DOI 10.1016/j.ydbio.2004.02.021; Sive H. L., 2010, EARLY DEV XECOPUS LA; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; STANISSTREET M, 1990, TERATOLOGY, V41, P721, DOI 10.1002/tera.1420410609; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tindall AJ, 2007, BIOL CELL, V99, P151, DOI 10.1042/BC20060074; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; ZOLCINSKI A, 1964, Ginekol Pol, V35, P593	53	13	13	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					684	691		10.1096/fj.12-218073	http://dx.doi.org/10.1096/fj.12-218073			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23150524	Green Published			2022-12-25	WOS:000314358000027
J	Huo, TY; Barth, RF; Yang, WL; Nakkula, RJ; Koynova, R; Tenchov, B; Chaudhury, AR; Agius, L; Boulikas, T; Elleaume, H; Lee, RJ				Huo, Tianyao; Barth, Rolf F.; Yang, Weilian; Nakkula, Robin J.; Koynova, Rumiana; Tenchov, Boris; Chaudhury, Abhik Ray; Agius, Lawrence; Boulikas, Teni; Elleaume, Helene; Lee, Robert J.			Preparation, Biodistribution and Neurotoxicity of Liposomal Cisplatin following Convection Enhanced Delivery in Normal and F98 Glioma Bearing Rats	PLOS ONE			English	Article							CELL LUNG-CANCER; INTRACEREBRAL DELIVERY; PHOTON IRRADIATION; BRAIN; CARBOPLATIN; FORMULATION; ISSUES; DRUGS; NEUROPATHOLOGY; PATHOLOGISTS	The purpose of this study was to evaluate two novel liposomal formulations of cisplatin as potential therapeutic agents for treatment of the F98 rat glioma. The first was a commercially produced agent, Lipoplatin (TM), which currently is in a Phase III clinical trial for treatment of non-small cell lung cancer (NSCLC). The second, produced in our laboratory, was based on the ability of cisplatin to form coordination complexes with lipid cholesteryl hemisuccinate (CHEMS). The in vitro tumoricidal activity of the former previously has been described in detail by other investigators. The CHEMS liposomal formulation had a Pt loading efficiency of 25% and showed more potent in vitro cytotoxicity against F98 glioma cells than free cisplatin at 24 h. In vivo CHEMS liposomes showed high retention at 24 h after intracerebral (i.e.) convection enhanced delivery (CED) to F98 glioma bearing rats. Neurotoxicologic studies were carried out in non-tumor bearing Fischer rats following i.e. CED of Lipoplatin (TM) or CHEMS liposomes or their "hollow'' counterparts. Unexpectedly, Lipoplatin (TM) was highly neurotoxic when given i.e. by CED and resulted in death immediately following or within a few days after administration. Similarly "hollow'' Lipoplatin (TM) liposomes showed similar neurotoxicity indicating that this was due to the liposomes themselves rather than the cisplatin. This was particularly surprising since Lipoplatin (TM) has been well tolerated when administered intravenously. In contrast, CHEMS liposomes and their "hollow'' counterparts were clinically well tolerated. However, a variety of dose dependent neuropathologic changes from none to severe were seen at either 10 or 14 d following their administration. These findings suggest that further refinements in the design and formulation of cisplatin containing liposomes will be required before they can be administered i.e. by CED for the treatment of brain tumors and that a formulation that may be safe when given systemically may be highly neurotoxic when administered directly into the brain.	[Huo, Tianyao; Barth, Rolf F.; Yang, Weilian; Nakkula, Robin J.; Chaudhury, Abhik Ray] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Koynova, Rumiana; Tenchov, Boris; Lee, Robert J.] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Agius, Lawrence] Mater Dei Hosp, Dept Pathol, Msida, Malta; [Agius, Lawrence] Univ Malta, Sch Med, Msida, Malta; [Boulikas, Teni] Regulon Inc, Mountain View, CA USA; [Elleaume, Helene] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Malta; European Synchrotron Radiation Facility (ESRF)	Barth, RF (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	rolf.barth@osumc.edu	Koynova, Rumiana/A-5938-2009; Tenchov, Boris/W-5547-2019; Elleaume, Hélène/F-2554-2013	Koynova, Rumiana/0000-0003-4698-6832; Elleaume, Hélène/0000-0002-3991-9503	Musella Foundation; Brad Kaminsky Foundation; Kevin Mullin Memorial Fund	Musella Foundation; Brad Kaminsky Foundation; Kevin Mullin Memorial Fund	Support for this study was generously provided by the Musella Foundation, the Brad Kaminsky Foundation, and the Kevin Mullin Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Biston MC, 2004, CANCER RES, V64, P2317, DOI 10.1158/0008-5472.CAN-03-3600; Bobyk L, EXP CLIN CA IN PRESS; Bolon B, 2011, TOXICOL PATHOL, V39, P234, DOI 10.1177/0192623310385142; Boulikas T, 2005, ANTICANCER RES, V25, P3031; Boulikas T, 2009, EXPERT OPIN INV DRUG, V18, P1197, DOI 10.1517/13543780903114168; Burger KNJ, 2002, NAT MED, V8, P81, DOI 10.1038/nm0102-81; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; Charest G, 2012, INT J RADIAT ONCOL, V84, P244, DOI 10.1016/j.ijrobp.2011.10.054; Charest G, 2010, J NEURO-ONCOL, V97, P187, DOI 10.1007/s11060-009-0011-5; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Dickinson PJ, 2010, NEURO-ONCOLOGY, V12, P928, DOI 10.1093/neuonc/noq046; Fiandaca MS, 2011, TOXINS, V3, P369, DOI 10.3390/toxins3040369; Hall WA, 2009, CURR DRUG TARGETS, V10, P126, DOI 10.2174/138945009787354575; Hamelers IHL, 2007, J LIPOSOME RES, V17, P183, DOI 10.1080/08982100701530290; Hubbs AF, 2011, TOXICOL PATHOL, V39, P301, DOI 10.1177/0192623310390705; Husain K, 2004, PHARMACOL RES, V50, P291, DOI 10.1016/j.phrs.2004.04.001; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Krug HF, 2011, ANGEW CHEM INT EDIT, V50, P1260, DOI 10.1002/anie.201001037; Mamot C, 2004, J NEURO-ONCOL, V68, P1, DOI 10.1023/B:NEON.0000024743.56415.4b; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Miyata S, 2011, NEUROSURGERY, V68, P1380, DOI 10.1227/NEU.0b013e31820b52aa; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Ostermann K, 2011, J NEURO-ONCOL, V103, P635, DOI 10.1007/s11060-010-0435-y; Perry A, 2006, ACTA NEUROPATHOL, V111, P197, DOI 10.1007/s00401-005-0023-y; Phillips WT, 2012, NEURO-ONCOLOGY, V14, P416, DOI 10.1093/neuonc/nos060; Raizer J, 2011, TOXICOL PATHOL, V39, P152, DOI 10.1177/0192623310391482; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Rousseau J, 2007, CLIN CANCER RES, V13, P5195, DOI 10.1158/1078-0432.CCR-07-1002; Rousseau J, 2010, J NEURO-ONCOL, V98, P287, DOI 10.1007/s11060-009-0074-3; Rousseau J, 2009, INT J RADIAT ONCOL, V73, P530, DOI 10.1016/j.ijrobp.2008.09.018; Saito R, 2004, CANCER RES, V64, P2572, DOI 10.1158/0008-5472.CAN-03-3631; Serpe L, 2006, NANOMATERIALS CANC T, V6, P1, DOI DOI 10.1002/9783527610419.NTLS0060; SIDDIK ZH, 1987, BRIT J CANCER, V55, P375, DOI 10.1038/bjc.1987.75; Stathopoulos GP, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/581363; Stathopoulos GP, 2011, CANCER CHEMOTH PHARM, V68, P945, DOI 10.1007/s00280-011-1572-5; Stathopoulos GP, 2010, ANN ONCOL, V21, P2227, DOI 10.1093/annonc/mdq234; Wittgen BPH, 2007, CLIN CANCER RES, V13, P2414, DOI 10.1158/1078-0432.CCR-06-1480; Yang WL, 2011, J NEURO-ONCOL, V101, P379, DOI 10.1007/s11060-010-0272-z; Yang WL, 1996, NEUROSURGERY, V38, P985, DOI 10.1097/00006123-199605000-00027	41	43	45	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48752	10.1371/journal.pone.0048752	http://dx.doi.org/10.1371/journal.pone.0048752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152799	Green Published, gold			2022-12-25	WOS:000311234600010
J	Feder, AF; Petrov, DA; Bergland, AO				Feder, Alison F.; Petrov, Dmitri A.; Bergland, Alan O.			LDx: Estimation of Linkage Disequilibrium from High-Throughput Pooled Resequencing Data	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; STATISTICAL-METHOD; NEXT-GENERATION; DNA SAMPLES; POPULATION; INFERENCE; POLYMORPHISM; SELECTION; SNPS	High-throughput pooled resequencing offers significant potential for whole genome population sequencing. However, its main drawback is the loss of haplotype information. In order to regain some of this information, we present LDx, a computational tool for estimating linkage disequilibrium (LD) from pooled resequencing data. LDx uses an approximate maximum likelihood approach to estimate LD (r(2)) between pairs of SNPs that can be observed within and among single reads. LDx also reports r(2) estimates derived solely from observed genotype counts. We demonstrate that the LDx estimates are highly correlated with r(2) estimated from individually resequenced strains. We discuss the performance of LDx using more stringent quality conditions and infer via simulation the degree to which performance can improve based on read depth. Finally we demonstrate two possible uses of LDx with real and simulated pooled resequencing data. First, we use LDx to infer genomewide patterns of decay of LD with physical distance in D. melanogaster population resequencing data. Second, we demonstrate that r(2) estimates from LDx are capable of distinguishing alternative demographic models representing plausible demographic histories of D. melanogaster. Citation: Feder AF, Petrov DA, Bergland AO (2012) LDx: Estimation of Linkage Disequilibrium from High-Throughput Pooled Resequencing Data. PLoS ONE 7(11): e48588. doi:10.1371/journal.pone.0048588	[Feder, Alison F.; Petrov, Dmitri A.; Bergland, Alan O.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Feder, Alison F.] Univ Penn, Dept Math, Philadelphia, PA 19104 USA	Stanford University; University of Pennsylvania	Feder, AF (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	afeder@stanford.edu		Feder, Alison/0000-0003-2915-089X; Petrov, Dmitri/0000-0002-3664-9130	National Institutes of Health (NIH) [1R01GM089926, P50HG002568]; NIH National Research Service Award fellowship [F32 GM097837-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100366, F32GM097837, R01GM089926] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by the National Institutes of Health (NIH) grants 1R01GM089926 and P50HG002568 to DAP and the NIH National Research Service Award fellowship (F32 GM097837-01) to AOB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Beerli P, 1999, GENETICS, V152, P763; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397; Gillespie J. H., 2004, POPULATION GENETICS; Hajirasouliha I, 2008, BIOINFORMATICS, V24, pI32, DOI 10.1093/bioinformatics/btn173; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Itoh M, 2010, J HERED, V101, P26, DOI 10.1093/jhered/esp079; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Long QA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015292; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Magwene PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002255; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pritchard JK, 2000, GENETICS, V155, P945; Shaw SH, 1998, GENOME RES, V8, P111, DOI 10.1101/gr.8.2.111; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su SY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-513; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vilella AJ, 2005, BIOINFORMATICS, V21, P2791, DOI 10.1093/bioinformatics/bti403; Zhu Y, 2012, PLOS ONE IN PRESS	30	49	50	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48588	10.1371/journal.pone.0048588	http://dx.doi.org/10.1371/journal.pone.0048588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152785	Green Published, gold, Green Submitted			2022-12-25	WOS:000312272600012
J	Komarov, I; D'Souza, RM				Komarov, Ivan; D'Souza, Roshan M.			Accelerating the Gillespie Exact Stochastic Simulation Algorithm Using Hybrid Parallel Execution on Graphics Processing Units	PLOS ONE			English	Article							SYSTEMS	The Gillespie Stochastic Simulation Algorithm (GSSA) and its variants are cornerstone techniques to simulate reaction kinetics in situations where the concentration of the reactant is too low to allow deterministic techniques such as differential equations. The inherent limitations of the GSSA include the time required for executing a single run and the need for multiple runs for parameter sweep exercises due to the stochastic nature of the simulation. Even very efficient variants of GSSA are prohibitively expensive to compute and perform parameter sweeps. Here we present a novel variant of the exact GSSA that is amenable to acceleration by using graphics processing units (GPUs). We parallelize the execution of a single realization across threads in a warp (fine-grained parallelism). A warp is a collection of threads that are executed synchronously on a single multi-processor. Warps executing in parallel on different multi-processors (coarse-grained parallelism) simultaneously generate multiple trajectories. Novel data-structures and algorithms reduce memory traffic, which is the bottleneck in computing the GSSA. Our benchmarks show an 8 x -120 x performance gain over various state-of-the-art serial algorithms when simulating different types of models. Citation: Komarov I, D'Souza RM (2012) Accelerating the Gillespie Exact Stochastic Simulation Algorithm Using Hybrid Parallel Execution on Graphics Processing Units. PLoS ONE 7(11): e46693. doi: 10.1371/journal.pone.0046693	[Komarov, Ivan; D'Souza, Roshan M.] Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	D'Souza, RM (corresponding author), Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA.	dsouza@uwm.edu	Valiyaveettill, Suresh/D-4848-2009	Valiyaveettill, Suresh/0000-0001-6990-660X	National Science Foundation [CNS-0968519, CCF-1013278]	National Science Foundation(National Science Foundation (NSF))	This work was partially funded by the National Science Foundation under grants CNS-0968519 and CCF-1013278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrage K, 2006, PARALLEL COMPUTING B, P79; Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; Dittamo C, 2009, 2009 INTERNATIONAL CONFERENCE ON COMPUTER MODELING AND SIMULATION, PROCEEDINGS, P156, DOI 10.1109/ICCMS.2009.42; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; Kirk D, 2010, PROGRAMMING MASSIVEL; Klingbeil G, 2011, BIOINFORMATICS, V27, P1170, DOI 10.1093/bioinformatics/btr068; Li H., 2006, TECHNICAL REPORT; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Macchiarulo L, 2008, IEEE ENG MED BIO, P1343, DOI 10.1109/IEMBS.2008.4649413; MCCOLLUMA JM, 2005, J COMPUT BIOL CHEM, V30, P39; MEAKIN P, 1988, ANNU REV PHYS CHEM, V39, P237, DOI 10.1146/annurev.pc.39.100188.001321; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Ramaswamy R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3297948; Rathinam M, 2003, J CHEM PHYS, V119, P12784, DOI 10.1063/1.1627296; Sanders J., 2010, CUDA EXAMPLE INTRO G; Schulze TP, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036704; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; Stone JE, 2010, COMPUT SCI ENG, V12, P66, DOI 10.1109/MCSE.2010.69; Tian TH, 2004, J CHEM PHYS, V121, P10356, DOI 10.1063/1.1810475; Tian TH, 2005, Eighth International Conference on High-Performance Computing in Asia-Pacific Region, Proceedings, P621, DOI 10.1109/HPCASIA.2005.67; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1	26	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e46693	10.1371/journal.pone.0046693	http://dx.doi.org/10.1371/journal.pone.0046693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152751	Green Submitted, Green Published, gold			2022-12-25	WOS:000312272600001
J	Wang, SY; Lee, YL; Lai, YH; Chen, JJW; Wu, WL; Yuann, JMP; Su, WL; Chuang, SM; Hou, MH				Wang, Sheng-Yu; Lee, Yueh-Luen; Lai, Yi-Hua; Chen, Jeremy J. W.; Wu, Wen-Lin; Yuann, Jeu-Ming P.; Su, Wang-Lin; Chuang, Show-Mei; Hou, Ming-Hon			Spermine Attenuates the Action of the DNA Intercalator, Actinomycin D, on DNA Binding and the Inhibition of Transcription and DNA Replication	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; POLYAMINE METABOLISM; CRYSTALLOGRAPHIC ANALYSIS; ANTICANCER DRUGS; IN-VITRO; C-MYC; PROTECTION; COMPLEX; RNA; MITHRAMYCIN	The anticancer activity of DNA intercalators is related to their ability to intercalate into the DNA duplex with high affinity, thereby interfering with DNA replication and transcription. Polyamines (spermine in particular) are almost exclusively bound to nucleic acids and are involved in many cellular processes that require nucleic acids. Until now, the effects of polyamines on DNA intercalator activities have remained unclear because intercalation is the most important mechanism employed by DNA binding drugs. Herein, using actinomycin D (ACTD) as a model, we have attempted to elucidate the effects of spermine on the action of ACTD, including its DNA-binding ability, RNA and DNA polymerase interference, and its role in the transcription and replication inhibition of ACTD within cells. We found that spermine interfered with the binding and stabilization of ACTD to DNA. The presence of increasing concentrations of spermine enhanced the transcriptional and replication activities of RNA and DNA polymerases, respectively, in vitro treated with ActD. Moreover, a decrease in intracellular polyamine concentrations stimulated by methylglyoxal-bis(guanylhydrazone) (MGBG) enhanced the ACTD-induced inhibition of c-myc transcription and DNA replication in several cancer cell lines. The results indicated that spermine attenuates ACTD binding to DNA and its inhibition of transcription and DNA replication both in vitro and within cells. Finally, a synergistic antiproliferative effect of MGBG and ACTD was observed in a cell viability assay. Our findings will be of significant relevance to future developments in combination with cancer therapy by enhancing the anticancer activity of DNA interactors through polyamine depletion. Citation: Wang S-Y, Lee Y-L, Lai Y-H, Chen JJW, Wu W-L, et al. (2012) Spermine Attenuates the Action of the DNA Intercalator, Actinomycin D, on DNA Binding and the Inhibition of Transcription and DNA Replication. PLoS ONE 7(11): e47101. doi: 10.1371/journal.pone.0047101	[Wang, Sheng-Yu; Su, Wang-Lin; Hou, Ming-Hon] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Wang, Sheng-Yu; Wu, Wen-Lin; Hou, Ming-Hon] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Lee, Yueh-Luen] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Lai, Yi-Hua; Chen, Jeremy J. W.; Chuang, Show-Mei] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Yuann, Jeu-Ming P.] Ming Chuan Univ, Dept Biotechnol, Taipei, Taoyuan County, Taiwan	National Chung Hsing University; National Chung Hsing University; National Health Research Institutes - Taiwan; National Chung Hsing University; Ming Chuan University	Hou, MH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	mhho@dragon.nchu.edu.tw	Lee, Alan Yueh-Luen/B-1097-2010	Chen, Jeremy J.W./0000-0003-1049-3825; Hou, Ming-hon/0000-0003-4170-1527; Lee, Alan Yueh-Luen/0000-0003-0252-0571; Chuang, Show-Mei/0000-0003-2986-0736	National Science Council (NSC) [100-2113-M-005-004-MY3]; NSC [98-2311-B-037-001-MY3]; National Health Research Institutes, Taiwan [100A1-CA-PP-08, 101A1-CA-PP-08]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council (NSC) grant 100-2113-M-005-004-MY3 to MHH. This work was partly supported by NSC grants (98-2311-B-037-001-MY3) and National Health Research Institutes (100A1-CA-PP-08 and 101A1-CA-PP-08), Taiwan to YLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; Amendola R, 2009, CURR CANCER DRUG TAR, V9, P118, DOI 10.2174/156800909787580935; CAMPBELL VW, 1994, AM J MED SCI, V307, P167, DOI 10.1097/00000441-199403000-00002; CANTOR CR, 1965, J MOL BIOL, V13, P65, DOI 10.1016/S0022-2836(65)80080-8; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chang YM, 2012, INT J MOL SCI, V13, P3394, DOI 10.3390/ijms13033394; D'Agostino L, 2006, IUBMB LIFE, V58, P75, DOI 10.1080/15216540600662525; D'Agostino L, 2005, FEBS J, V272, P3777, DOI 10.1111/j.1742-4658.2005.04782.x; D'Agostino L, 2002, EUR J BIOCHEM, V269, P4317, DOI 10.1046/j.1432-1033.2002.03128.x; Douki T, 2000, RADIAT RES, V153, P29, DOI 10.1667/0033-7587(2000)153[0029:PARIDO]2.0.CO;2; Egli M, 1998, BIOPOLYMERS, V48, P234, DOI 10.1002/(SICI)1097-0282(1998)48:4<234::AID-BIP4>3.0.CO;2-H; FRUGIER M, 1994, NUCLEIC ACIDS RES, V22, P2784, DOI 10.1093/nar/22.14.2784; Gniazdowski M, 2003, CURR MED CHEM, V10, P909, DOI 10.2174/0929867033457683; GRILLO MA, 1985, INT J BIOCHEM, V17, P943, DOI 10.1016/0020-711X(85)90238-1; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Ha HC, 1998, BIOCHEM BIOPH RES CO, V244, P298, DOI 10.1006/bbrc.1998.8258; Hall JP, 2011, P NATL ACAD SCI USA, V108, P17610, DOI 10.1073/pnas.1108685108; HOFFMANN JS, 1991, BIOCHEM PHARMACOL, V42, P1393, DOI 10.1016/0006-2952(91)90450-J; Hou MH, 2005, NUCLEIC ACIDS RES, V33, P1352, DOI 10.1093/nar/gki276; Hou MH, 2002, NUCLEIC ACIDS RES, V30, P4910, DOI 10.1093/nar/gkf619; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Hou MH, 2008, BIOCHEMISTRY-US, V47, P5493, DOI 10.1021/bi701915f; Hou MH, 2009, BIOCHEMISTRY-US, V48, P4691, DOI 10.1021/bi900092w; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043792; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; JAIN S, 1989, BIOCHEMISTRY-US, V28, P2360, DOI 10.1021/bi00432a002; KAMITORI S, 1992, J MOL BIOL, V225, P445, DOI 10.1016/0022-2836(92)90931-9; Kang HJ, 2009, BIOCHEMISTRY-US, V48, P7392, DOI 10.1021/bi9006836; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11428, DOI 10.1073/pnas.89.23.11428; Kumar N, 2009, NUCLEIC ACIDS RES, V37, P3321, DOI 10.1093/nar/gkp196; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; MARCUS SL, 1981, J BIOL CHEM, V256, P3460; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Martinez R, 2005, CURR MED CHEM, V12, P127, DOI 10.2174/0929867053363414; MATTHEWS HR, 1993, BIOESSAYS, V15, P561, DOI 10.1002/bies.950150811; Newton GL, 1996, RADIAT RES, V145, P776, DOI 10.2307/3579370; Niyazi H, 2012, NAT CHEM, V4, P621, DOI [10.1038/NCHEM.1397, 10.1038/nchem.1397]; OLLER AR, 1991, BIOCHEMISTRY-US, V30, P2543, DOI 10.1021/bi00223a035; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Palchaudhuri R, 2007, CURR OPIN BIOTECH, V18, P497, DOI 10.1016/j.copbio.2007.09.006; PANAGIOTIDIS CA, 1995, NUCLEIC ACIDS RES, V23, P1800, DOI 10.1093/nar/23.10.1800; Piestrzeniewicz M, 1998, ACTA BIOCHIM POL, V45, P127, DOI 10.18388/abp.1998_4295; REUSSER F, 1975, BIOCHIM BIOPHYS ACTA, V383, P266, DOI 10.1016/0005-2787(75)90055-6; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Robinson H, 2001, BIOCHEMISTRY-US, V40, P5587, DOI 10.1021/bi002859z; Boer DR, 2009, DALTON T, P399, DOI 10.1039/b809873p; SARRIS AH, 1977, BIOCHIM BIOPHYS ACTA, V474, P268, DOI 10.1016/0005-2787(77)90201-5; Song H, 2012, NAT CHEM, V4, P615, DOI [10.1038/nchem.1375, 10.1038/NCHEM.1375]; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TARI LW, 1995, NUCLEIC ACIDS RES, V23, P2065, DOI 10.1093/nar/23.11.2065; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; WHITE RJ, 1989, BIOCHEMISTRY-US, V28, P4277, DOI 10.1021/bi00436a024; Wilmanska D, 2001, Z NATURFORSCH C, V56, P886; Xiao L, 2007, MOL BIOL CELL, V18, P4579, DOI 10.1091/mbc.E07-07-0675; Yang XL, 1999, PHARMACOL THERAPEUT, V83, P181, DOI 10.1016/S0163-7258(99)00020-0; Yuann JMP, 2012, BBA-PROTEINS PROTEOM, V1824, P1009, DOI 10.1016/j.bbapap.2012.05.011	57	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e47101	10.1371/journal.pone.0047101	http://dx.doi.org/10.1371/journal.pone.0047101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144800	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500002
J	Fichorova, RN; Lee, YJ; Yamamoto, HS; Takagi, Y; Hayes, GR; Goodman, RP; Chepa-Lotrea, X; Buck, OR; Murray, R; Kula, T; Beach, DH; Singh, BN; Nibert, ML				Fichorova, Raina N.; Lee, Yujin; Yamamoto, Hidemi S.; Takagi, Yuko; Hayes, Gary R.; Goodman, Russell P.; Chepa-Lotrea, Xenia; Buck, Olivia R.; Murray, Ryan; Kula, Tomasz; Beach, David H.; Singh, Bibhuti N.; Nibert, Max L.			Endobiont Viruses Sensed by the Human Host - Beyond Conventional Antiparasitic Therapy	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; HUMAN-IMMUNODEFICIENCY-VIRUS; TRICHOMONAS-VAGINALIS LIPOPHOSPHOGLYCAN; FEMALE REPRODUCTIVE-TRACT; NEISSERIA-GONORRHOEAE; EPITHELIAL-CELLS; VIRAL-INFECTION; EXPRESSION; WOMEN; METRONIDAZOLE	Wide-spread protozoan parasites carry endosymbiotic dsRNA viruses with uncharted implications to the human host. Among them, Trichomonas vaginalis, a parasite adapted to the human genitourinary tract, infects globally similar to 250 million each year rendering them more susceptible to devastating pregnancy complications (especially preterm birth), HIV infection and HPV-related cancer. While first-line antibiotic treatment (metronidazole) commonly kills the protozoan pathogen, it fails to improve reproductive outcome. We show that endosymbiotic Trichomonasvirus, highly prevalent in T. vaginalis clinical isolates, is sensed by the human epithelial cells via Toll-like receptor 3, triggering Interferon Regulating Factor -3, interferon type I and proinflammatory cascades previously implicated in preterm birth and HIV-1 susceptibility. Metronidazole treatment amplified these proinflammatory responses. Thus, a new paradigm targeting the protozoan viruses along with the protozoan host may prevent trichomoniasis-attributable inflammatory sequelae.	[Fichorova, Raina N.; Lee, Yujin; Yamamoto, Hidemi S.; Chepa-Lotrea, Xenia; Buck, Olivia R.; Murray, Ryan] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol, Boston, MA 02115 USA; [Fichorova, Raina N.; Lee, Yujin; Yamamoto, Hidemi S.; Chepa-Lotrea, Xenia; Buck, Olivia R.; Murray, Ryan] Brigham & Womens Hosp, Boston, MA 02115 USA; [Takagi, Yuko; Goodman, Russell P.; Kula, Tomasz; Nibert, Max L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Obstet & Gynecol, Syracuse, NY USA; [Beach, David H.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Fichorova, RN (corresponding author), Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol, Boston, MA 02115 USA.	rfichorova@rics.bwh.harvard.edu	Fichorova, Raina/G-9969-2014; Takagi, Yuko/M-3283-2018	Takagi, Yuko/0000-0002-4567-0986	National Institutes of Health/National Institute of Allergy and Infectious Diseases [5R01AI079085-03, ARRA 1RC1AI086788-01, 1R56AI091889-01A1]; Harvard Catalyst Pilot Grant through The Harvard Clinical and Translational Science Center; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [5UL1RR025758-02]; Harvard University and its affiliated academic health care centers; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086788, R01AI079085, R56AI091889] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Catalyst Pilot Grant through The Harvard Clinical and Translational Science Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University and its affiliated academic health care centers; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants 5R01AI079085-03 (RNF, BNS), ARRA 1RC1AI086788-01 (RNF, BNS, MLN) and 1R56AI091889-01A1 (RNF, BNS and MLN), and by Harvard Catalyst Pilot Grant (RNF and MLN) through The Harvard Clinical and Translational Science Center, which is funded by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 5UL1RR025758-02 and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano M., 2002, Current Molecular Medicine (Hilversum), V2, P677, DOI 10.2174/1566524023361925; Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Bessarab IN, 2000, VIROLOGY, V267, P350, DOI 10.1006/viro.1999.0129; Bhattacharyya S, 2001, MOL CELL BIOCHEM, V216, P47, DOI 10.1023/A:1011048210691; Canny GO, 2006, J INFECT DIS, V194, P498, DOI 10.1086/505712; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chesson HW, 2004, SEX TRANSM DIS, V31, P547, DOI 10.1097/01.olq.0000137900.63660.98; Draper D, 1998, J INFECT DIS, V178, P815, DOI 10.1086/515366; EDWARDS DI, 1979, J ANTIMICROB CHEMOTH, V5, P499, DOI 10.1093/jac/5.5.499; Faupel-Badger JM, 2011, AM J REPROD IMMUNOL; Feola DJ, 2002, PHARMACOTHERAPY, V22, P1508, DOI 10.1592/phco.22.16.1508.33691; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 2011, CYTOKINE, V55, P134, DOI 10.1016/j.cyto.2011.03.016; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Fichorova RN, 2011, MBIO, V2, DOI DOI 10.1128/MBIO.00280-11; FLEGR J, 1987, FOLIA MICROBIOL, V32, P345, DOI 10.1007/BF02877224; Fraga J, 2007, ACTA PROTOZOOL, V46, P93; Fraga J, 2012, INFECT GENET EVOL, V12, P113, DOI 10.1016/j.meegid.2011.10.020; Genc MR, 2004, AM J OBSTET GYNECOL, V190, P1191, DOI 10.1016/j.ajog.2003.11.007; Ghosh M, 2009, AM J REPROD IMMUNOL, V62, P60, DOI 10.1111/j.1600-0897.2009.00713.x; Goodman RP, 2011, J VIROL, V85, P4258, DOI 10.1128/JVI.00220-11; Goodman RP, 2011, ARCH VIROL, V156, P171, DOI 10.1007/s00705-010-0832-8; GRODSTEIN F, 1993, AM J EPIDEMIOL, V137, P577, DOI 10.1093/oxfordjournals.aje.a116711; Gulmezoglu AM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000220.pub2; Iqbal SM, 2005, J INFECT DIS, V192, P728, DOI 10.1086/432482; Iversen AKN, 1998, J INFECT DIS, V178, P1334, DOI 10.1086/314433; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034; KHOSHNAN A, 1994, J VIROL, V68, P4035, DOI 10.1128/JVI.68.6.4035-4038.1994; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Martel RR, 2002, ASSAY DRUG DEV TECHN, V1, P61, DOI 10.1089/154065802761001310; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Okun N, 2005, OBSTET GYNECOL, V105, P857, DOI 10.1097/01.AOG.0000157108.32059.8f; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Polo S, 1999, AIDS, V13, P447, DOI 10.1097/00002030-199903110-00002; Rodriguez N, 2012, EMBO MOL MED, V4, P952, DOI 10.1002/emmm.201101094; Secor WE, 2012, EXPERT REV ANTI-INFE, V10, P107, DOI [10.1586/eri.11.159, 10.1586/ERI.11.159]; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Shafir SC, 2009, CLIN MICROBIOL REV, V22, P37, DOI 10.1128/CMR.00002-08; Sin WX, 2012, IMMUNOL RES, V53, P25, DOI 10.1007/s12026-012-8293-7; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; Snipes LJ, 2000, J CLIN MICROBIOL, V38, P3004, DOI 10.1128/JCM.38.8.3004-3009.2000; Stark JR, 2009, JNCI-J NATL CANCER I, V101, P1406, DOI 10.1093/jnci/djp306; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Trifonova RT, 2006, ANTIMICROB AGENTS CH, V50, P4005, DOI 10.1128/AAC.00588-06; Upcroft JA, 2001, ANTIMICROB AGENTS CH, V45, P1810, DOI 10.1128/AAC.45.6.1810-1814.2001; Van Der Pol B, 2005, J INFECT DIS, V192, P2039, DOI 10.1086/498217; Viikki M, 2000, ACTA ONCOL, V39, P71, DOI 10.1080/028418600431003; WANG AL, 1991, ANNU REV MICROBIOL, V45, P251, DOI 10.1146/annurev.mi.45.100191.001343; Weber B, 2003, J CLIN PATHOL, V56, P542, DOI 10.1136/jcp.56.7.542; Wendel KA, 2002, J INFECT DIS, V186, P558, DOI 10.1086/341832; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; WOOD BA, 1975, BRIT J VENER DIS, V51, P51; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001	64	93	97	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48418	10.1371/journal.pone.0048418	http://dx.doi.org/10.1371/journal.pone.0048418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144878	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800058
J	Perkins, G; Yap, TA; Pope, L; Cassidy, AM; Dukes, JP; Riisnaes, R; Massard, C; Cassier, PA; Miranda, S; Clark, J; Denholm, KA; Thway, K; De Castro, DG; Attard, G; Molife, LR; Kaye, SB; Banerji, U; de Bono, JS				Perkins, Geraldine; Yap, Timothy A.; Pope, Lorna; Cassidy, Amy M.; Dukes, Juliet P.; Riisnaes, Ruth; Massard, Christophe; Cassier, Philippe A.; Miranda, Susana; Clark, Jeremy; Denholm, Katie A.; Thway, Khin; De Castro, David Gonzalez; Attard, Gerhardt; Molife, L. Rhoda; Kaye, Stan B.; Banerji, Udai; de Bono, Johann S.			Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; LUNG-CANCER; BRAF MUTATIONS; BREAST-CANCER; NUCLEIC-ACIDS; TUMOR; KRAS; SURVIVAL; PIK3CA; SERUM	Tumor genomic instability and selective treatment pressures result in clonal disease evolution; molecular stratification for molecularly targeted drug administration requires repeated access to tumor DNA. We hypothesized that circulating plasma DNA (cpDNA) in advanced cancer patients is largely derived from tumor, has prognostic utility, and can be utilized for multiplex tumor mutation sequencing when repeat biopsy is not feasible. We utilized the Sequenom MassArray System and OncoCarta panel for somatic mutation profiling. Matched samples, acquired from the same patient but at different time points were evaluated; these comprised formalin-fixed paraffin-embedded (FFPE) archival tumor tissue (primary and/or metastatic) and cpDNA. The feasibility, sensitivity, and specificity of this high-throughput, multiplex mutation detection approach was tested utilizing specimens acquired from 105 patients with solid tumors referred for participation in Phase I trials of molecularly targeted drugs. The median cpDNA concentration was 17 ng/ml (range: 0.5-1600); this was 3-fold higher than in healthy volunteers. Moreover, higher cpDNA concentrations associated with worse overall survival; there was an overall survival (OS) hazard ratio of 2.4 (95% CI 1.4, 4.2) for each 10-fold increase in cpDNA concentration and in multivariate analyses, cpDNA concentration, albumin, and performance status remained independent predictors of OS. These data suggest that plasma DNA in these cancer patients is largely derived from tumor. We also observed high detection concordance for critical 'hot-spot' mutations (KRAS, BRAF, PIK3CA) in matched cpDNA and archival tumor tissue, and important differences between archival tumor and cpDNA. This multiplex sequencing assay can be utilized to detect somatic mutations from plasma in advanced cancer patients, when safe repeat tumor biopsy is not feasible and genomic analysis of archival tumor is deemed insufficient. Overall, circulating nucleic acid biomarker studies have clinically important multi-purpose utility in advanced cancer patients and further studies to pursue their incorporation into the standard of care are warranted.	[Perkins, Geraldine; Yap, Timothy A.; Pope, Lorna; Cassidy, Amy M.; Dukes, Juliet P.; Riisnaes, Ruth; Massard, Christophe; Miranda, Susana; Clark, Jeremy; Thway, Khin; De Castro, David Gonzalez; Attard, Gerhardt; Kaye, Stan B.; Banerji, Udai; de Bono, Johann S.] Inst Canc Res, Div Clin Studies, Sutton, Surrey, England; [Yap, Timothy A.; Massard, Christophe; Cassier, Philippe A.; Denholm, Katie A.; Attard, Gerhardt; Molife, L. Rhoda; Kaye, Stan B.; Banerji, Udai; de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Drug Dev Unit, Sutton, Surrey, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	de Bono, JS (corresponding author), Inst Canc Res, Div Clin Studies, Sutton, Surrey, England.	johann.de-bono@icr.ac.uk	Yap, Timothy/AAV-3573-2020	Dukes, Juliet/0000-0002-9537-8203; Mulick, Amy/0000-0002-4009-2080; Perkins, Geraldine/0000-0002-4960-2534; Attard, Gerhardt/0000-0002-4811-7983; Banerji, Udai/0000-0003-1503-3123; Miranda, Susana/0000-0002-5936-2706; de Bono, Johann S/0000-0002-2034-595X	Drug Development Unit of the Royal Marsden NHS Foundation Trust; Institute of Cancer Research from Cancer Research UK; Experimental Cancer Medicine Centre; National Institute for Health Research Biomedical Research Centre; French National Institute of Cancer (Institut National du Cancer, InCA, France); Scott Minerd Prostate Cancer Foundation Young Investigator Award; Cancer Research UK [13239] Funding Source: researchfish; National Institute for Health Research [CL-2008-22-001] Funding Source: researchfish	Drug Development Unit of the Royal Marsden NHS Foundation Trust; Institute of Cancer Research from Cancer Research UK; Experimental Cancer Medicine Centre; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); French National Institute of Cancer (Institut National du Cancer, InCA, France); Scott Minerd Prostate Cancer Foundation Young Investigator Award; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The Drug Development Unit of the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research is supported in part by a program grant from Cancer Research UK. Support was also provided by the Experimental Cancer Medicine Centre (to The Institute of Cancer Research) and the National Institute for Health Research Biomedical Research Centre (jointly to the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research). GP was supported by a grant from the French National Institute of Cancer (Institut National du Cancer, InCA, France). TY is recipient of the 2011 Scott Minerd Prostate Cancer Foundation Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Arkenau HT, 2009, J CLIN ONCOL, V27, P2692, DOI 10.1200/JCO.2008.19.5081; Board RE, 2009, BRIT J CANCER, V101, P1724, DOI 10.1038/sj.bjc.6605371; Board RE, 2008, CLIN CHEM, V54, P757, DOI 10.1373/clinchem.2007.098376; Board RE, 2010, BREAST CANCER RES TR, V120, P461, DOI 10.1007/s10549-010-0747-9; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen H, 2010, EJSO-EUR J SURG ONC, V36, P657, DOI 10.1016/j.ejso.2010.05.014; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Goebel G, 2005, DIS MARKERS, V21, P105, DOI 10.1155/2005/218759; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Lefebure B, 2010, ANN SURG, V251, P275, DOI 10.1097/SLA.0b013e3181c35c87; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Schwarzenbach H, 2011, MOL BIOSYST, V7, P2848, DOI 10.1039/c1mb05197k; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870	27	122	132	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47020	10.1371/journal.pone.0047020	http://dx.doi.org/10.1371/journal.pone.0047020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144797	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800012
J	Sabin, JA; Marini, M; Nosek, BA				Sabin, Janice A.; Marini, Maddalena; Nosek, Brian A.			Implicit and Explicit Anti-Fat Bias among a Large Sample of Medical Doctors by BMI, Race/Ethnicity and Gender	PLOS ONE			English	Article							ASSOCIATION TEST; PSYCHOLOGICAL-RESEARCH; PHYSICIANS ATTITUDES; HEALTH-PROFESSIONALS; AVERSIVE RACISM; OBESITY; OVERWEIGHT; METAANALYSIS; STABILITY; CHILDREN	Overweight patients report weight discrimination in health care settings and subsequent avoidance of routine preventive health care. The purpose of this study was to examine implicit and explicit attitudes about weight among a large group of medical doctors (MDs) to determine the pervasiveness of negative attitudes about weight among MDs. Test-takers voluntarily accessed a public Web site, known as Project Implicit (R), and opted to complete the Weight Implicit Association Test (IAT) (N = 359,261). A sub-sample identified their highest level of education as MD (N = 2,284). Among the MDs, 55% were female, 78% reported their race as white, and 62% had a normal range BMI. This large sample of test-takers showed strong implicit anti-fat bias (Cohen's d=1.0). MDs, on average, also showed strong implicit anti-fat bias (Cohen's d=0.93). All test-takers and the MD sub-sample reported a strong preference for thin people rather than fat people or a strong explicit anti-fat bias. We conclude that strong implicit and explicit anti-fat bias is as pervasive among MDs as it is among the general public. An important area for future research is to investigate the association between providers' implicit and explicit attitudes about weight, patient reports of weight discrimination in health care, and quality of care delivered to overweight patients.	[Sabin, Janice A.] Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; [Marini, Maddalena; Nosek, Brian A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Marini, Maddalena] Univ Modena & Reggio Emilia, Dept Commun & Econ, Reggio Emilia, Italy	University of Washington; University of Washington Seattle; University of Virginia; Universita di Modena e Reggio Emilia	Sabin, JA (corresponding author), Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA.	sabinja@u.washington.edu		Nosek, Brian/0000-0001-6797-5476	Project Implicit, Inc.	Project Implicit, Inc.	This project was supported by Project Implicit, Inc. BN is an officer of Project Implicit, a non-profit organization that includes in its mission, "To develop and deliver methods for investigating and applying phenomena of implicit social cognition, including especially phenomena of implicit bias based on age, race, gender or other factors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DA, 2004, OBES RES, V12, P1587, DOI 10.1038/oby.2004.198; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cooper LA, 2012, AM J PUBLIC HEALTH, V102, P979, DOI 10.2105/AJPH.2011.300558; Cronk BC, 2003, BEHAV RES METH INSTR, V34; Cunningham WA, 2001, PSYCHOL SCI, V12, P163, DOI 10.1111/1467-9280.00328; Davis NJ, 2007, MED ED ONLINE, V13; Davis RN, 1999, BEHAV RES METH INS C, V31, P572, DOI 10.3758/BF03200737; Dovidio JF, 2000, PSYCHOL SCI, V11, P315, DOI 10.1111/1467-9280.00262; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Egloff B, 2005, J PERS ASSESS, V84, P82, DOI 10.1207/s15327752jpa8401_14; Flores G, 2010, PEDIATRICS, V125, pE979, DOI 10.1542/peds.2010-0188; Forman-Hoffman Valerie, 2006, BMC Fam Pract, V7, P35, DOI 10.1186/1471-2296-7-35; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Jay M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-106; Kim J, 2006, OBESITY, V14, P1107, DOI 10.1038/oby.2006.126; Kraut R, 2004, AM PSYCHOL, V59, P105, DOI 10.1037/0003-066X.59.2.105; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nosek BA, 2002, J SOC ISSUES, V58, P161, DOI 10.1111/1540-4560.00254; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Nosek BA, 2007, EUROPEAN REV SOCIAL, P36; Nosek BA, 2007, IMPLICIT ASS TEST AG; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Penner LA, 2010, J EXP SOC PSYCHOL, V46, P436, DOI 10.1016/j.jesp.2009.11.004; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Sabin JA, 2012, AM J PUBLIC HEALTH, V102, P988, DOI 10.2105/AJPH.2011.300621; Sabin JA, 2009, J HEALTH CARE POOR U, V20, P896, DOI 10.1353/hpu.0.0185; Schwartz MB, 2003, OBES RES, V11, P1033, DOI 10.1038/oby.2003.142; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Story M, 2003, PREV MED, V37, pS3, DOI 10.1016/j.ypmed.2003.08.008; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; van Gerwin M, 2008, OBES REV, P1; Warner CH, 2008, MIL MED, V173, P978, DOI 10.7205/MILMED.173.10.978; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003	42	190	190	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48448	10.1371/journal.pone.0048448	http://dx.doi.org/10.1371/journal.pone.0048448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23144885	Green Published, gold			2022-12-25	WOS:000311935800065
J	Yamagata, Y; Parietti, V; Stockholm, D; Corre, G; Poinsignon, C; Touleimat, N; Delafoy, D; Besse, C; Tost, J; Galy, A; Paldi, A				Yamagata, Yoshiaki; Parietti, Veronique; Stockholm, Daniel; Corre, Guillaume; Poinsignon, Catherine; Touleimat, Nizar; Delafoy, Damien; Besse, Celine; Tost, Joerg; Galy, Anne; Paldi, Andras			Lentiviral Transduction of CD34(+) Cells Induces Genome-Wide Epigenetic Modifications	PLOS ONE			English	Article							LONG-TERM HEALTH; DNA-METHYLATION; GENE-THERAPY; CHROMATIN-STRUCTURE; HETEROGENEITY; LEDGF/P75; PATTERNS; CULTURE; CONTEXT; ORIGIN	Epigenetic modifications may occur during in vitro manipulations of stem cells but these effects have remained unexplored in the context of cell and gene therapy protocols. In an experimental model of ex vivo gene modification for hematopoietic gene therapy, human CD34(+) cells were cultured shortly in the presence of cytokines then with a gene transfer lentiviral vector (LV) expected to transduce cells but to have otherwise limited biological effects on the cells. At the end of the culture, the population of cells remained largely similar at the phenotypic level but some epigenetic changes were evident. Exposure of CD34(+) cells to cytokines increased nuclear expression of epigenetic regulators SIRT1 or DNMT1 and caused genome-wide DNA methylation changes. Surprisingly, the LV caused additional and distinct effects. Large-scale genomic DNA methylation analysis showed that balanced methylation changes occurred in about 200 genes following culture of CD34(+) cells in the presence of cytokines but 900 genes were modified following addition of the LV, predominantly increasing CpG methylation. Epigenetic effects resulting from ex vivo culture and from the use of LV may constitute previously unsuspected sources of biological effects in stem cells and may provide new biomarkers to rationally optimize gene and cell therapy protocols.	[Yamagata, Yoshiaki; Parietti, Veronique; Stockholm, Daniel; Corre, Guillaume; Poinsignon, Catherine; Galy, Anne; Paldi, Andras] Genethon, U951, INSERM, Evry, France; [Yamagata, Yoshiaki; Parietti, Veronique; Stockholm, Daniel; Corre, Guillaume; Galy, Anne; Paldi, Andras] Genethon, UMRS 951, Ecole Prat Hautes Etud, Evry, France; [Yamagata, Yoshiaki] Yamaguchi Univ, Dept Obstet & Gynaecol, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Poinsignon, Catherine; Galy, Anne] Univ Evry Val dEssonne, UMRS 951, Genethon, Evry, France; [Touleimat, Nizar; Delafoy, Damien; Besse, Celine; Tost, Joerg] CEA Inst Genom, Ctr Natl Genotypage, Evry, France; [Tost, Joerg] Fdn Jean Dausset CEPH, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Yamaguchi University; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH	Galy, A (corresponding author), Genethon, U951, INSERM, Evry, France.	galy@genethon.fr; paldi@genethon.fr	Corre, Guillaume/G-8392-2015; Tost, Joerg/H-7129-2019; Stockholm, Daniel/J-7912-2013; Paldi, Andras/J-5757-2013; corre, guillaume/T-9696-2019; Galy, Anne HM/J-4439-2013; PARIETTI, Veronique/GSD-4261-2022	Corre, Guillaume/0000-0002-0755-8336; Tost, Joerg/0000-0002-2683-0817; corre, guillaume/0000-0002-0755-8336; Galy, Anne HM/0000-0002-0153-4392; 	Yamaguchi University in Japan; AXA; Genopole Research-Evry, Conseil General de l'Esson; University Evry Val d'Essone	Yamaguchi University in Japan; AXA; Genopole Research-Evry, Conseil General de l'Esson; University Evry Val d'Essone	YY was supported by the Yamaguchi University in Japan and GC was a recipient of an AXA doctoral fellowship. This study was supported in part by the equipment funds from "Genopole Research-Evry, Conseil General de l'Esson and the University Evry Val d'Essone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002292; Benchaouir R, 2007, CYTOM PART A, V71A, P251, DOI 10.1002/cyto.a.20367; Biasco L, 2011, EMBO MOL MED, V3, P89, DOI 10.1002/emmm.201000108; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Charrier S, 2011, GENE THER, V18, P479, DOI 10.1038/gt.2010.163; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114; De Vos WH, 2010, CYTOM PART A, V77A, P64, DOI 10.1002/cyto.a.20807; Dumoulin JC, 2010, HUM REPROD, V25, P605, DOI 10.1093/humrep/dep456; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Fernandez-Gonzalez R, 2007, MOL REPROD DEV, V74, P1149, DOI 10.1002/mrd.20746; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Grace KS, 2009, SEMIN REPROD MED, V27, P409, DOI 10.1055/s-0029-1237429; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hemberger M, 2010, SCIENCE, V330, P598, DOI 10.1126/science.1199006; Horii T, 2010, CELL REPROGRAM, V12, P551, DOI 10.1089/cell.2009.0104; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Issa JP, 2011, NAT GENET, V43, P724, DOI 10.1038/ng.897; Jeanson-Leh L, 2007, BIOCHEM BIOPH RES CO, V362, P498, DOI 10.1016/j.bbrc.2007.08.013; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kennedy DR, 2009, BIOL BLOOD MARROW TR, V15, P662, DOI 10.1016/j.bbmt.2009.03.014; Leonard S, 2011, J VIROL, V85, P9568, DOI 10.1128/JVI.00468-11; Lin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023891; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; Nakao M, 2001, GENE, V278, P25, DOI 10.1016/S0378-1119(01)00721-1; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Nelissen EC, 2012, HUM REPROD; Palmke N, 2011, METHODS, V53, P175, DOI 10.1016/j.ymeth.2010.07.006; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Wei H, 2010, BBA-GENE REGUL MECH, V1799, P296, DOI 10.1016/j.bbagrm.2009.08.007; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yamagata Y, 2012, EPIGENETICS-US, V7, P141, DOI 10.4161/epi.7.2.18906; Yoder KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017862	45	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48943	10.1371/journal.pone.0048943	http://dx.doi.org/10.1371/journal.pone.0048943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145033	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800175
J	Yu, WQ; Zeidel, ML; Hill, WG				Yu, Weiqun; Zeidel, Mark L.; Hill, Warren G.			Cellular Expression Profile for Interstitial Cells of Cajal in Bladder - A Cell Often Misidentified as Myocyte or Myofibroblast	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; SMOOTH-MUSCLE-CELLS; KIT-POSITIVE CELLS; GUINEA-PIG; URINARY-BLADDER; CONNEXIN EXPRESSION; GAP-JUNCTIONS; MERLIN; IDENTIFICATION; PROGENITORS	Background: Interstitial cells of Cajal (ICC) have been identified in urinary bladder of several species, but their presence in mice remains uncertain. Meanwhile, dozens of reports indicate that dysregulation of connexin 43 plays an important role in bladder overactivity, but its localization has not been clearly defined, with reports of expression in either the smooth muscle or in myofibroblasts. We recently identified a population of ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase2) positive cells that resemble ICC and are distinct from smooth muscle, fibroblasts, myofibroblasts and neurons. Thus we sought to define more clearly the molecular signature of ICC and in doing so resolve some of these uncertainties. Principle findings: Immunofluorescent localization revealed that NTPDase2-positive cells lie closely adjacent to smooth muscle but are separate from them. NTPDase2 positive cells exhibited co-localization with the widely accepted ICC marker - c-kit. They were further shown to co-localize with other ICC markers CD34 and Ano1, but not with mast cell marker tryptase. Significantly, they show convincing co-localization with connexin 43, which was not present in smooth muscle. The identity of these cells as ICC was further confirmed by the presence of three mesenchymal markers - vimentin, desmin, and PDGF beta receptor, which indicates their mesenchymal origin. Finally, we observed for the first time, the presence of merlin/neurofibromin 2 in ICC. Normally considered a neuronal protein, the presence of merlin suggests ICC in bladder may have a role in neurotransmission. Conclusions: NTPDase2 positive cells in mice bladder are ICC, which can be defined by the presence of c-Kit, CD34, Ano1, NTPDase2, connexin 43, vimentin, desmin, PDGF beta receptor and merlin/NF2. These data establish a definitive molecular expression profile, which can be used to assist in explorations of their functional roles, and the presence of NTPDase2 suggests that purinergic signaling plays a role in regulation of ICC function.	[Yu, Weiqun; Zeidel, Mark L.; Hill, Warren G.] Beth Israel Deaconess Med Ctr, Dept Med, Lab Voiding Dysfunct, Boston, MA 02215 USA; [Yu, Weiqun; Zeidel, Mark L.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Hill, Warren G.] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Yu, Weiqun; Zeidel, Mark L.; Hill, Warren G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yu, WQ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Lab Voiding Dysfunct, Boston, MA 02215 USA.	wyu2@bidmc.harvard.edu	Hill, Warren/AAM-1917-2020	Hill, Warren/0000-0002-2772-7264	National Institute of Diabetes and Digestive and Kidney Diseases [DK083299]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083299] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by grant DK083299 from the National Institute of Diabetes and Digestive and Kidney Diseases (www2.niddk.nih.gov) to WGH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arock M, 2010, EXPERT REV HEMATOL, V3, P497, DOI [10.1586/ehm.10.42, 10.1586/EHM.10.42]; Biers SM, 2006, BJU INT, V97, P612, DOI 10.1111/j.1464-410X.2005.05988.x; Burnstock G, 2002, AUTON NEUROSCI-BASIC, V97, P68, DOI 10.1016/S1566-0702(02)00005-X; Burnstock G, 1999, J ANAT, V194, P335, DOI 10.1046/j.1469-7580.1999.19430335.x; Chan FX, 2010, VIRCHOWS ARCH, V457, P381, DOI 10.1007/s00428-010-0946-0; Chen H, 2007, AM J PHYSIOL-CELL PH, V292, pC497, DOI 10.1152/ajpcell.00147.2006; Choi KM, 2007, NEUROGASTROENT MOTIL, V19, P585, DOI 10.1111/j.1365-2982.2007.00936.x; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Davidson RA, 2005, J UROLOGY, V173, P1385, DOI 10.1097/01.ju.0000146272.80848.37; Faussone Pellegrini M S, 1977, Arch Ital Anat Embriol, V82, P157; Flaiz C, 2008, GLIA, V56, P506, DOI 10.1002/glia.20629; Formey A, 2011, CELL TISSUE RES, V343, P509, DOI 10.1007/s00441-010-1114-1; Fukasawa T, 2000, JPN J CANCER RES, V91, P1241, DOI 10.1111/j.1349-7006.2000.tb00910.x; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Haefliger JA, 2002, EXP CELL RES, V274, P216, DOI 10.1006/excr.2001.5465; Hanani M, 2012, BRAIN RES; Hashitani H, 2001, J PHYSIOL-LONDON, V530, P273, DOI 10.1111/j.1469-7793.2001.0273l.x; Hwang DG, 2011, AM J CLIN PATHOL, V135, P448, DOI 10.1309/AJCP0PPKOBNDT9LB; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ikeda Y, 2007, AM J PHYSIOL-RENAL, V293, pF1018, DOI 10.1152/ajprenal.00183.2007; Johnston L, 2008, AM J PHYSIOL-RENAL, V294, pF645, DOI 10.1152/ajprenal.00526.2007; Johnston L, 2010, J UROLOGY, V184, P370, DOI 10.1016/j.juro.2010.03.005; Junquera C, 2007, J CELL MOL MED, V11, P776, DOI 10.1111/j.1582-4934.2007.00064.x; Kim Sun-Ouck, 2010, Int Neurourol J, V14, P48, DOI 10.5213/inj.2010.14.1.48; Koh BH, 2012, J CELL MOL MED, V16, P691, DOI 10.1111/j.1582-4934.2011.01506.x; Komuro T, 1996, J AUTONOM NERV SYST, V61, P169, DOI 10.1016/S0165-1838(96)00078-1; Kurahashi M, 2008, NEUROGASTROENT MOTIL, V20, P521, DOI 10.1111/j.1365-2982.2007.01055.x; Lagou M, 2006, BJU INT, V97, P1332, DOI 10.1111/j.1464-410X.2006.06203.x; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; McCloskey KD, 2009, BRIT J PHARMACOL, V156, P273, DOI 10.1111/j.1476-5381.2008.00006.x; McCloskey Karen D, 2011, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-16499-6_11; McCloskey KD, 2002, J UROLOGY, V168, P832, DOI 10.1016/S0022-5347(05)64752-0; McCloskey KD, 2005, J UROLOGY, V173, P296, DOI 10.1097/01.ju.0000141581.00922.f4; Mostafa RM, 2010, WORLD J GASTROENTERO, V16, P3239, DOI 10.3748/wjg.v16.i26.3239; Nakayama S, 2007, J CELL MOL MED, V11, P958, DOI 10.1111/j.1582-4934.2007.00107.x; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Nemeth L, 2000, J PEDIATR SURG, V35, P823, DOI 10.1053/jpsu.2000.6851; Neuhaus J, 2005, BJU INT, V96, P670, DOI 10.1111/j.1464-410X.2005.05703.x; Neuhaus J, 2009, EUR UROL, V55, P491, DOI 10.1016/j.eururo.2008.03.090; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Nunomura S, 2012, INT IMMUNOL, V24, P593, DOI 10.1093/intimm/dxs070; Okada S, 2011, BJU INT, V108, pE97, DOI 10.1111/j.1464-410X.2010.09870.x; Papaspyrou G, 2011, MELANOMA RES, V21, P475, DOI 10.1097/CMR.0b013e32834b58cf; Pezzone MA, 2003, AM J PHYSIOL-RENAL, V284, pF925, DOI 10.1152/ajprenal.00138.2002; Piotrowska AP, 2004, BJU INT, V94, P143, DOI 10.1111/j.1464-410X.2004.04914.x; Popescu LM, 2005, J CELL MOL MED, V9, P479, DOI 10.1111/j.1582-4934.2005.tb00376.x; Pylkkanen L, 2003, HUM PATHOL, V34, P872, DOI 10.1016/S0046-8177(03)00349-6; Rangwala R, 2005, J BIOL CHEM, V280, P11790, DOI 10.1074/jbc.M414154200; Roosen Alexander, 2009, Eur Urol, V55, P497, DOI 10.1016/j.eururo.2008.03.091; Rulina AV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1650, DOI 10.1134/S0006297910130092; Shafik A, 2004, UROLOGY, V64, P809, DOI 10.1016/j.urology.2004.05.031; Streutker CJ, 2007, HISTOPATHOLOGY, V50, P176, DOI 10.1111/j.1365-2559.2006.02493.x; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Taddei A, 2008, TUMORI J, V94, P551; THUNEBERG L, 1982, ADV ANAT EMBRYOL CEL, V71, P1; Vahabi B, 2011, BJU INT, V107, P1480, DOI 10.1111/j.1464-410X.2010.09507.x; Van Nassauw L, 2006, AUTON NEUROSCI-BASIC, V126, P299, DOI 10.1016/j.autneu.2006.02.018; Wang XY, 2011, PANCREAS, V40, P137, DOI 10.1097/MPA.0b013e3181f690ff; Wang YQ, 2010, J SURG RES, V164, pE213, DOI 10.1016/j.jss.2010.04.040; Ward SM, 2000, J NEUROSCI, V20, P1393; Won KJ, 2005, P NATL ACAD SCI USA, V102, P14913, DOI 10.1073/pnas.0503628102; Yu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018704; Yuzuriha Shunsuke, 2012, Eplasty, V12, pe13	65	34	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48897	10.1371/journal.pone.0048897	http://dx.doi.org/10.1371/journal.pone.0048897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145014	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800165
J	Chen, B; Kemkemer, R; Deibler, M; Spatz, J; Gao, HJ				Chen, Bin; Kemkemer, Ralf; Deibler, Martin; Spatz, Joachim; Gao, Huajian			Cyclic Stretch Induces Cell Reorientation on Substrates by Destabilizing Catch Bonds in Focal Adhesions	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; STRESS FIBERS; ENDOTHELIAL-CELLS; DYNAMIC REORIENTATION; TENSIONAL HOMEOSTASIS; FORCE; CYTOSKELETON; CONTRACTION; ORIENTATION; MECHANICS	A minimal model of cellular mechanosensing system that consists of a single stress fiber adhering on a substrate via two focal adhesions made of catch bonds is adopted to investigate the phenomena of cell reorientation on substrates induced by an applied uniaxial cyclic stretch. The model indicates that the catch bonds in the focal adhesions experience a periodically oscillating internal force with amplitude and frequency controlled by two intrinsic clocks of the stress fiber, one associated with localized activation and the other with homogeneous activation of sarcomere units along the stress fiber. It is shown that this oscillating force due to cyclic stretch tends to destabilize focal adhesions by reducing the lifetime of catch bonds. The resulting slide or relocation of focal adhesions then causes the associated stress fiber to shorten and rotate to configurations nearly perpendicular to the stretching direction. These predicted behaviors from our model are consistent with a wide range of experimental observations.	[Chen, Bin] Zhejiang Univ, Dept Engn Mech, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Bin] ASTAR, Inst High Performance Comp, Singapore, Singapore; [Kemkemer, Ralf; Deibler, Martin; Spatz, Joachim] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Deibler, Martin; Spatz, Joachim] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany; [Gao, Huajian] Brown Univ, Sch Engn, Providence, RI 02912 USA	Zhejiang University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Max Planck Society; Ruprecht Karls University Heidelberg; Brown University	Chen, B (corresponding author), Zhejiang Univ, Dept Engn Mech, Hangzhou 310003, Zhejiang, Peoples R China.	chenb6@zju.edu.cn; huajian_gao@brown.edu	Gao, Huajian/F-9360-2010; Spatz, Joachim P/A-1107-2017	Gao, Huajian/0000-0002-8656-846X; Spatz, Joachim P/0000-0003-3419-9807	Fundamental Research Funds for Central Universities, China [2011XZZX002]; A*Star Visiting Investigator Program, "Size Effects in Small Scale Materials"	Fundamental Research Funds for Central Universities, China; A*Star Visiting Investigator Program, "Size Effects in Small Scale Materials"(Agency for Science Technology & Research (A*STAR))	BC acknowledges the support provided by the Fundamental Research Funds for Central Universities, China (2011XZZX002). H.G. acknowledges the generous support provided by a Humboldt Research Award for senior scientists from the Alexander von Humboldt Foundation in Germany. This work was supported by the A*Star Visiting Investigator Program, "Size Effects in Small Scale Materials", hosted at the Institute of High Performance Computing in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Chen B, 2011, BIOPHYS J, V101, P396, DOI 10.1016/j.bpj.2011.05.061; Chen B, 2010, BIOPHYS J, V98, P2154, DOI 10.1016/j.bpj.2010.02.007; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; DARTSCH PC, 1986, ACTA ANAT, V125, P108; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; KANDA K, 1993, CELL TRANSPLANT, V2, P475, DOI 10.1177/096368979300200606; Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2011, CELL HEALTH CYTOSKEL, V3, P13, DOI 10.2147/CHC.S14984; Kemkemer Ralf, 1999, Cell Biochemistry and Biophysics, V30, P167, DOI 10.1007/BF02738066; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Krishnan R, 2012, AM J PHYSIOL-CELL PH, V303, pC368, DOI 10.1152/ajpcell.00074.2012; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mizutani T, 2004, CELL MOTIL CYTOSKEL, V59, P242, DOI 10.1002/cm.20037; Moretti M, 2004, J MATER SCI-MATER M, V15, P1159, DOI 10.1023/B:JMSM.0000046400.18607.72; Na S, 2007, J THEOR BIOL, V246, P87, DOI 10.1016/j.jtbi.2006.11.015; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pereverzev YV, 2006, BIOPHYS J, V91, pL19, DOI 10.1529/biophysj.106.087288; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Prezhdo OV, 2009, ACCOUNTS CHEM RES, V42, P693, DOI 10.1021/ar800202z; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Russell RJ, 2009, BIOPHYS J, V97, P1578, DOI 10.1016/j.bpj.2009.07.017; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Todon A, 2011, J BIOMECH, V45, P728; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wang JHC, 2000, J THEOR BIOL, V202, P33, DOI 10.1006/jtbi.1999.1035; Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745	57	45	45	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48346	10.1371/journal.pone.0048346	http://dx.doi.org/10.1371/journal.pone.0048346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152769	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000010
J	de Lange, Z; Pieters, M; Jerling, JC; Kruger, A; Rijken, DC				de Lange, Zelda; Pieters, Marlien; Jerling, Johann C.; Kruger, Annamarie; Rijken, Dingeman C.			Plasma Clot Lysis Time and Its Association with Cardiovascular Risk Factors in Black Africans	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; HUMAN ADIPOSE-TISSUE; MYOCARDIAL-INFARCTION; FIBRINOLYTIC CAPACITY; HIGH-INCOME; DISEASE; FAT; HYPOFIBRINOLYSIS; FIBRINOGEN; MIDDLE	Studies in populations of European descent show longer plasma clot lysis times (CLT) in patients with cardiovascular disease (CVD) than in controls. No data are available on the association between CVD risk factors and fibrinolytic potential in black Africans, a group undergoing rapid urbanisation with increased CVD prevalence. We investigated associations between known CVD risk factors and CLT in black Africans and whether CLTs differ between rural and urban participants in light of differences in CVD risk. Data from 1000 rural and 1000 urban apparently healthy black South Africans (35-60 years) were cross-sectionally analysed. Increased PAI-1(act), BMI, HbA1c, triglycerides, the metabolic syndrome, fibrinogen concentration, CRP, female sex and positive HIV status were associated with increased CLTs, while habitual alcohol consumption associated with decreased CLT. No differences in CLT were found between age and smoking categories, contraceptive use or hyper- and normotensive participants. Urban women had longer CLT than rural women while no differences were observed for men. CLT was associated with many known CVD risk factors in black Africans. Differences were however observed, compared to data from populations of European descent available in the literature, suggesting possible ethnic differences. The effect of urbanisation on CLT is influenced by traditional CVD risk factors and their prevalence in urban and rural communities. Citation: de Lange Z, Pieters M, Jerling JC, Kruger A, Rijken DC (2012) Plasma Clot Lysis Time and Its Association with Cardiovascular Risk Factors in Black Africans. PLoS ONE 7(11): e48881. doi:10.1371/journal.pone.0048881	[de Lange, Zelda; Pieters, Marlien; Jerling, Johann C.] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa; [Kruger, Annamarie] North West Univ, Africa Unit Transdisciplinary Hlth Res, Potchefstroom, South Africa; [Rijken, Dingeman C.] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands	North West University - South Africa; North West University - South Africa; Erasmus University Rotterdam; Erasmus MC	Pieters, M (corresponding author), North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa.	marlien.pieters@nwu.ac.za	de Lange, Zelda/AAH-3529-2021	de Lange, Zelda/0000-0002-7250-2419; Jerling, Johann/0000-0003-2600-3536	Medical Research Council of South Africa, National Research Foundation of South Africa [GUNFA2006041100003]; South African Sugar Association [214]	Medical Research Council of South Africa, National Research Foundation of South Africa; South African Sugar Association	Funding provided by Medical Research Council of South Africa, National Research Foundation of South Africa (Grant number:GUNFA2006041100003) and South African Sugar Association (Project 214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Bastelica D, 2002, ARTERIOSCL THROM VAS, V22, P173, DOI 10.1161/hq0102.101552; Carter AM, 2007, ARTERIOSCL THROM VAS, V27, P2783, DOI 10.1161/ATVBAHA.107.153221; COLLEN D, 1991, BLOOD, V78, P3114; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; Fourie C, 2011, CARDIOVASC J AFR, V22, P134, DOI [10.5830/CVJA-2010-056, CVJ-21.049]; Fuster, 2010, PROMOTING CARDIOVASC; Gorog DA, 2010, J AM COLL CARDIOL, V55, P2701, DOI 10.1016/j.jacc.2009.11.095; Guimaraes AHC, 2009, BRIT J HAEMATOL, V145, P115, DOI 10.1111/j.1365-2141.2008.07568.x; Hadigan C, 2001, J CLIN ENDOCR METAB, V86, P939, DOI 10.1210/jc.86.2.939; Kim PY, 2007, J THROMB HAEMOST, V5, P1250, DOI 10.1111/j.1538-7836.2007.02426.x; Leander K, 2012, THROMB HAEMOSTASIS, V107, P1092, DOI 10.1160/TH11-11-0760; Lisman T, 2005, BLOOD, V105, P1102, DOI 10.1182/blood-2004-08-3253; Lisman T, 2001, GASTROENTEROLOGY, V121, P131, DOI 10.1053/gast.2001.25481; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Meltzer ME, 2009, BRIT J HAEMATOL, V145, P121, DOI 10.1111/j.1365-2141.2008.07569.x; Meltzer ME, 2008, PLOS MED, V5, P751, DOI 10.1371/journal.pmed.0050097; Pieters M, 2011, CARDIOVASC J S AFR, V8, P4; Pieters M, 2011, THROMB HAEMOSTASIS, V106, P448, DOI 10.1160/TH11-03-0192; Pieters M, 2010, BLOOD COAGUL FIBRIN, V21, P736, DOI 10.1097/MBC.0b013e32834014e2; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Siegerink B, 2012, BRIT J HAEMATOL, V156, P252, DOI 10.1111/j.1365-2141.2011.08935.x; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Vorster HH, 2002, PUBLIC HEALTH NUTR, V5, P239, DOI 10.1079/PHN2001299; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48881	10.1371/journal.pone.0048881	http://dx.doi.org/10.1371/journal.pone.0048881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145007	Green Published, gold			2022-12-25	WOS:000312269500042
J	Hartner, A; Menendez-Castro, C; Cordasic, N; Marek, I; Volkert, G; Klanke, B; Rascher, W; Hilgers, KF				Hartner, Andrea; Menendez-Castro, Carlos; Cordasic, Nada; Marek, Ines; Volkert, Gudrun; Klanke, Bernd; Rascher, Wolfgang; Hilgers, Karl F.			Tubulointerstitial De Novo Expression of the alpha 8 Integrin Chain in a Rodent Model of Renal Fibrosis - A Potential Target for Anti-Fibrotic Therapy?	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; OSTEOPONTIN EXPRESSION; EXTRACELLULAR-MATRIX; KIDNEY; INJURY; CELLS; RAT; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; IDENTIFICATION	In the normal kidney, the alpha 8 integrin chain is expressed only on mesangial cells and vascular smooth muscle cells. alpha 8 integrin ligates several matrix molecules including fibronectin, osteopontin and fibrillin-1. Recently, we detected de novo expression of alpha 8 integrin on epithelial cells in renal cysts. We hypothesized that the alpha 8 integrin chain is induced in tubular epithelia undergoing dedifferentiation and contributes to the fibrotic response in the tubulointerstitium (TI) after unilateral ureteral obstruction (UUO). After induction of UUO in rats by ligation of the right ureter, increased expression of the alpha 8 integrin chain and its ligands was observed. In the TI, alpha 8 integrin was localized to cytokeratin-positive epithelial cells and to interstitial fibroblasts; and colocalized with its ligands. In mice underexpressing alpha 8 integrin UUO led to collagen deposition and fibroblast activation comparable to wild types. Mice lacking alpha 8 integrin showed even more TI damage, fibroblast activation and collagen deposition after UUO compared to wild type mice. We conclude that the expression of the alpha 8 integrin chain and its ligands is strongly induced in the TI after UUO, but underexpression of alpha 8 integrin does not attenuate TI fibrosis. Mice lacking the alpha 8 integrin chain are even more susceptible to TI damage than wild type mice. Thus, interactions of alpha 8 integrin with its ligands do not seem to contribute to the development or progression of TI fibrosis in UUO. Targeting alpha 8 integrin might not be a useful approach for anti-fibrotic therapy.	[Hartner, Andrea; Menendez-Castro, Carlos; Marek, Ines; Rascher, Wolfgang] Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany; [Cordasic, Nada; Volkert, Gudrun; Klanke, Bernd; Hilgers, Karl F.] Univ Hosp Erlangen, Dept Hypertens & Nephrol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Hartner, A (corresponding author), Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany.	andrea.hartner@uk-erlangen.de			Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB 423, A2]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB 423, Project A2 to A.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no competing financial, personal, or professional interests for the authors.	Amann K, 2011, NEPHROL DIAL TRANSPL; Benoit YD, 2010, BIOCHEM BIOPH RES CO, V399, P434, DOI 10.1016/j.bbrc.2010.07.107; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; BOSSY B, 1991, EMBO J, V10, P2375, DOI 10.1002/j.1460-2075.1991.tb07776.x; Bouzeghrane F, 2005, AM J PHYSIOL-HEART C, V289, pH982, DOI 10.1152/ajpheart.00151.2005; Bouzeghrane F, 2004, J MOL CELL CARDIOL, V36, P343, DOI 10.1016/j.yjmcc.2003.11.007; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Brenner BM, 1997, KIDNEY INT, pS124; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Cook HT, 2002, AM J PATHOL, V161, P1265, DOI 10.1016/S0002-9440(10)64403-3; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Hartner A, 1999, KIDNEY INT, V56, P1468, DOI 10.1046/j.1523-1755.1999.00662.x; Hartner A, 2002, AM J PATHOL, V160, P861, DOI 10.1016/S0002-9440(10)64909-7; Hartner A, 2001, AM J KIDNEY DIS, V38, P153, DOI 10.1053/ajkd.2001.25209; Konishi A, 2003, J STEROID BIOCHEM, V85, P439, DOI 10.1016/S0960-0760(03)00198-5; Kuphal S, 2008, CANCER SCI, V99, P229, DOI 10.1111/j.1349-7006.2007.00678.x; Levine D, 2000, AM J PATHOL, V156, P1927, DOI 10.1016/S0002-9440(10)65066-3; Perdih A, 2010, CURR MED CHEM, V17, P2371, DOI 10.2174/092986710791698558; Ruiz V, 2003, AM J PHYSIOL-LUNG C, V285, pL1026, DOI 10.1152/ajplung.00183.2003; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; SCHNAPP LM, 1995, J CELL SCI, V108, P537; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Thibault G, 2001, AM J PHYSIOL-CELL PH, V281, pC1457, DOI 10.1152/ajpcell.2001.281.5.C1457; Uno Y, 2000, J VESTIBUL RES-EQUIL, V10, P283; Wang AG, 2006, MOL VIS, V12, P76; White LR, 2007, AM J PHYSIOL-RENAL, V292, pF567, DOI 10.1152/ajprenal.00212.2006; Yeh YC, 2010, AM J PATHOL, V177, P1743, DOI 10.2353/ajpath.2010.091183; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Yoo KH, 2006, KIDNEY INT, V70, P1735, DOI 10.1038/sj.ki.5000357; Zeltner R, 2008, NEPHRON CLIN PRACT, V108, pC169, DOI 10.1159/000116887	32	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48362	10.1371/journal.pone.0048362	http://dx.doi.org/10.1371/journal.pone.0048362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144868	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500020
J	Japtok, L; Schaper, K; Baumer, W; Radeke, HH; Jeong, SK; Kleuser, B				Japtok, Lukasz; Schaper, Katrin; Baeumer, Wolfgang; Radeke, Heinfried H.; Jeong, Se Kyoo; Kleuser, Burkhard			Sphingosine 1-Phosphate Modulates Antigen Capture by Murine Langerhans Cells via the S1P(2) Receptor Subtype	PLOS ONE			English	Article							ALLERGIC CONTACT-DERMATITIS; DENDRITIC CELLS; BONE-MARROW; SPHINGOSINE-1-PHOSPHATE RECEPTOR; ATOPIC-DERMATITIS; T-CELLS; IN-VIVO; MIGRATION; HYPERSENSITIVITY; SKIN	Dendritic cells (DCs) play a pivotal role in the development of cutaneous contact hypersensitivity (CHS) and atopic dermatitis as they capture and process antigen and present it to T lymphocytes in the lymphoid organs. Recently, it has been indicated that a topical application of the sphingolipid sphingosine 1-phosphate (S1P) prevents the inflammatory response in CHS, but the molecular mechanism is not fully elucidated. Here we indicate that treatment of mice with S1P is connected with an impaired antigen uptake by Langerhans cells (LCs), the initial step of CHS. Most of the known actions of S1P are mediated by a family of five specific G protein-coupled receptors. Our results indicate that S1P inhibits macropinocytosis of the murine LC line XS52 via S1P(2) receptor stimulation followed by a reduced phosphatidylinositol 3-kinase (PI3K) activity. As down-regulation of S1P(2) not only diminished S1P-mediated action but also enhanced the basal activity of LCs on antigen capture, an autocrine action of S1P has been assumed. Actually, S1P is continuously produced by LCs and secreted via the ATP binding cassette transporter ABCC1 to the extracellular environment. Consequently, inhibition of ABCC1, which decreased extracellular S1P levels, markedly increased the antigen uptake by LCs. Moreover, stimulation of sphingosine kinase activity, the crucial enzyme for S1P formation, is connected not only with enhanced S1P levels but also with diminished antigen capture. These results indicate that S1P is essential in LC homeostasis and influences skin immunity. This is of importance as previous reports suggested an alteration of S1P levels in atopic skin lesions. Citation: Japtok L, Schaper K, Baumer W, Radeke HH, Jeong SK, et al. (2012) Sphingosine 1-Phosphate Modulates Antigen Capture by Murine Langerhans Cells via the S1P(2) Receptor Subtype. PLoS ONE 7(11): e49427. doi:10.1371/journal.pone.0049427	[Japtok, Lukasz; Kleuser, Burkhard] Univ Potsdam, Dept Toxicol, Inst Nutr Sci, Fac Math & Nat Sci, Potsdam, Germany; [Schaper, Katrin; Baeumer, Wolfgang] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Radeke, Heinfried H.] Clin Johann Wolfgang Goethe Univ, Pharmazentrum Frankfurt, Frankfurt, Germany; [Jeong, Se Kyoo] Neopharm Co Ltd, Taejon, South Korea	University of Potsdam; University of Veterinary Medicine Hannover, Foundation; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kleuser, B (corresponding author), Univ Potsdam, Dept Toxicol, Inst Nutr Sci, Fac Math & Nat Sci, Potsdam, Germany.	kleuser@uni-potsdam.de	Radeke, Heinfried H/E-3772-2013	Radeke, Heinfried H/0000-0002-4499-2510; Baumer, Wolfgang/0000-0002-4346-5911; Kleuser, Burkhard/0000-0002-1888-9595	German Research Foundation (DFG) [DFG Kl988 7/1, DFG BA2071/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant of the German Research Foundation (DFG) to BK and WB (DFG Kl988 7/1, DFG BA2071/3-1). The Funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Baumer W, 2011, J INVEST DERMATOL, V131, P266, DOI 10.1038/jid.2010.252; Baumer W, 2005, BRIT J DERMATOL, V153, P136, DOI 10.1111/j.1365-2133.2005.06745.x; Baumer W, 2003, EUR J PHARMACOL, V481, P271, DOI 10.1016/j.ejphar.2003.09.031; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bennett CL, 2007, J IMMUNOL, V179, P6830, DOI 10.4049/jimmunol.179.10.6830; Blot V, 2009, SYNTHESIS-STUTTGART, P759, DOI 10.1055/s-0028-1083373; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Gollmann G, 2008, INT IMMUNOL, V20, P911, DOI 10.1093/intimm/dxn050; Guaguere E, 2004, VET DERMATOL, V15, P61, DOI 10.1111/j.1365-3164.2004.00376.x; Hackstein H, 2002, BLOOD, V100, P1084, DOI 10.1182/blood.V100.3.1084; Hara-Chikuma M, 2012, FASEB J, V26, P211, DOI 10.1096/fj.11-186627; Hla T, 2001, PROSTAG OTH LIPID M, V64, P135, DOI 10.1016/S0090-6980(01)00109-5; Hong JH, 2008, J INVEST DERMATOL, V128, P2166, DOI 10.1038/jid.2008.66; Japtok L, 2009, CURR OPIN INVEST DR, V10, P1183; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kitajima T, 1996, J IMMUNOL, V157, P2340; Kumar A, 2009, EXPERT OPIN THER TAR, V13, P1013, DOI 10.1517/14728220903039722; Lan YY, 2008, TRANSPL IMMUNOL, V20, P88, DOI 10.1016/j.trim.2008.07.004; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Martino A, 2007, J BIOSCIENCES, V32, P1207, DOI 10.1007/s12038-007-0122-0; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Monti P, 2003, TRANSPLANTATION, V75, P137, DOI 10.1097/00007890-200301150-00025; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Ocana-Morgner C, 2011, J IMMUNOL, V186, P5345, DOI 10.4049/jimmunol.1003461; Olivera A, 2011, ADV EXP MED BIOL, V716, P123, DOI 10.1007/978-1-4419-9533-9_8; Radeke HH, 2005, J IMMUNOL, V174, P2778, DOI 10.4049/jimmunol.174.5.2778; Reines I, 2009, J INVEST DERMATOL, V129, P1954, DOI 10.1038/jid.2008.454; Rose L, 2012, EXP DERMATOL, V21, P25, DOI 10.1111/j.1600-0625.2011.01395.x; Romani N, 2012, J INVEST DERMATOL, V132, P872, DOI 10.1038/jid.2011.437; Ruedl C, 2001, J IMMUNOL, V166, P7178, DOI 10.4049/jimmunol.166.12.7178; Ruwisch L, 2001, N-S ARCH PHARMACOL, V363, P358, DOI 10.1007/s002100000365; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Schroder M, 2011, MOL IMMUNOL, V48, P1139, DOI 10.1016/j.molimm.2011.02.007; Schuppel M, 2008, J INVEST DERMATOL, V128, P1747, DOI 10.1038/sj.jid.5701259; SCHUHMACHERS G, 1995, J INVEST DERMATOL, V105, P225, DOI 10.1111/1523-1747.ep12317512; Seo EY, 2006, J INVEST DERMATOL, V126, P1187, DOI 10.1038/sj.jid.5700234; Sparber F, 2010, IMMUNOBIOLOGY, V215, P770, DOI 10.1016/j.imbio.2010.05.014; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; SULLIVAN S, 1986, J IMMUNOL, V137, P2460; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van de Ven R, 2006, J IMMUNOL, V176, P5191, DOI 10.4049/jimmunol.176.9.5191; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Wood SH, 2009, J DERMATOL SCI, V55, P27, DOI 10.1016/j.jdermsci.2009.03.005; XU S, 1995, J IMMUNOL, V154, P2697; Yanagawa Y, 2010, J IMMUNOL, V185, P5762, DOI 10.4049/jimmunol.1001899; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880	63	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49427	10.1371/journal.pone.0049427	http://dx.doi.org/10.1371/journal.pone.0049427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145172	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500109
J	Liu, SF; Chang, SY; Lee, TC; Chuang, LY; Guh, JY; Hung, CY; Hung, TJ; Hung, YJ; Chen, PY; Hsieh, PF; Yang, YL				Liu, Shu-Fen; Chang, Shan-Yu; Lee, Tao-Chen; Chuang, Lea-Yea; Guh, Jinn-Yuh; Hung, Chien-Ya; Hung, Tsung-Jen; Hung, Yu-Ju; Chen, Po-Yi; Hsieh, Pei-fang; Yang, Yu-Lin			Dioscorea alata Attenuates Renal Interstitial Cellular Fibrosis by Regulating Smad- and Epithelial-Mesenchymal Transition Signaling Pathways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ANGIOTENSIN-II; TGF-BETA; TISSUE FIBROSIS; DISEASE; TRANSDIFFERENTIATION; CELLS	Renal interstitial fibrosis is characterized by increased extracellular matrix (ECM) synthesis. Epithelial-mesenchymal transition (EMT) in kidneys is driven by regulated expression of fibrogenic cytokines such as transforming growth factor-beta (TGF-beta). Yam, or Dioscorea alata (DA) is an important herb in Chinese medicine widely used for the treatment of clinical diabetes mellitus. However, the fibrosis regulatory effect of DA is unclear. Thus, we examined TGF-beta signaling mechanisms against EMT in rat fibroblast cells (NRK-49F). The characterization of DA water-extracts used various methods; after inducing cellular fibrosis in NRK-49F cells by treatment with beta-hydroxybutyrate (beta-HB) (10 mM), we used Western blotting to examine the protein expression in the TGF-beta-related signal protein type I and type II TGF-beta receptors, Smads2 and Smad3 (Smad2/3), pSmad2 and Smad3 (pSmad2/3), Smads4, Smads7, and EMT markers. These markers included E-cadherin, alpha-smooth muscle actin (alpha-MA), and matrix metalloproteinase-2 (MMP-2). Bioactive TGF-beta and fibronectin levels in the culture media were determined using ELISA. Expressions of fibronectin and Snail transcription factor, an EMT-regulatory transcription factor, were assessed by immunofluorescence staining. DA extract dose-dependently (50-200 mu g/mL) suppressed beta-HB-induced expression of fibronectin in NRK-49F cells concomitantly with the inhibition of Smad2/3, pSmad2/3, and Smad4. By contrast, Smad7 expression was significantly increased. DA extract caused a decrease in alpha-SMA (alpha-smooth muscle actin) and MMP-2 levels, and an increase in E-cadherin expression. We propose that DA extract might act as a novel fibrosis antagonist, which acts partly by down regulating the TGF-beta/smad signaling pathway and modulating EMT expression. Citation: Liu S-F, Chang S-Y, Lee T-C, Chuang L-Y, Guh J-Y, et al. (2012) Dioscorea alata Attenuates Renal Interstitial Cellular Fibrosis by Regulating Smad- and Epithelial-Mesenchymal Transition Signaling Pathways. PLoS ONE 7(11): e47482. doi:10.1371/journal.pone.0047482	[Chang, Shan-Yu; Hung, Tsung-Jen; Hsieh, Pei-fang; Yang, Yu-Lin] Chung Hwa Univ Med Technol, Dept Grad Inst Biomed Sci, Tainan, Taiwan; [Liu, Shu-Fen; Guh, Jinn-Yuh] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Tao-Chen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Chuang, Lea-Yea] Kaohsiung Med Univ, Dept Biochem, Kaohsiung, Taiwan; [Hung, Chien-Ya] Chung Hwa Univ Med Technol, Dept Food Nutr, Tainan, Taiwan; [Hung, Yu-Ju] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Chen, Po-Yi] Chung Hwa Univ Med Technol, Dept Optometry, Tainan, Taiwan; [Yang, Yu-Lin] Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan	Chung Hua University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chung Hua University; National Taiwan University; Chung Hua University; Chung Hua University	Yang, YL (corresponding author), Chung Hwa Univ Med Technol, Dept Grad Inst Biomed Sci, Tainan, Taiwan.	call0955443221@gmail.com		Hung, Yu-Ju/0000-0003-4568-9983	National Science Council, Taiwan [NSC 99-2628-B-273-001 -MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from the National Science Council, Taiwan (NSC 99-2628-B-273-001 -MY3). http://web1.nsc.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BOHLE A, 1994, EXP NEPHROL, V2, P205; Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chang HY, 2011, J AGR FOOD CHEM, V59, P5357, DOI 10.1021/jf200598w; Chang SJ, 2004, J AGR FOOD CHEM, V52, P1720, DOI 10.1021/jf0345954; Cook HT, 2010, AM J PATHOL, V176, P22, DOI 10.2353/ajpath.2010.090898; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Luft FC, 1999, J MOL MED, V77, P517, DOI 10.1007/s001099900033; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Olayemi J, 2010, AFRICAN J BIOTECHNOL, V6; ONG ACM, 1994, KIDNEY INT, V45, P345, DOI 10.1038/ki.1994.44; Peters H, 1997, KIDNEY INT, V51, P1481, DOI 10.1038/ki.1997.203; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Stahl PJ, 2001, AM J PATHOL, V159, P1187, DOI 10.1016/S0002-9440(10)62503-5; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg M, 2002, AM J PATHOL, V160, P2001, DOI 10.1016/S0002-9440(10)61150-9	24	22	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e47482	10.1371/journal.pone.0047482	http://dx.doi.org/10.1371/journal.pone.0047482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144821	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500009
J	Hsu, PC; Tsai, WC; Lin, TH; Su, HM; Voon, WC; Lai, WT; Sheu, SH				Hsu, Po-Chao; Tsai, Wei-Chung; Lin, Tsung-Hsien; Su, Ho-Ming; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Association of Arterial Stiffness and Electrocardiography-Determined Left Ventricular Hypertrophy with Left Ventricular Diastolic Dysfunction	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; PRESERVED EJECTION FRACTION; HEART-FAILURE; SYSTOLIC FUNCTION; AORTIC STIFFNESS; RISK; IMPACT; ATHEROSCLEROSIS; VALIDATION; PROGNOSIS	Objectives: Increased arterial stiffness is associated with left ventricular diastolic dysfunction (LVDD), but this association may be influenced by left ventricular (LV) performance. Left ventricular hypertrophy (LVH) is not only a significant determinant of LV performance, but is also correlated with LVDD. This study is designed to compare LV diastolic function among patients divided by brachial-ankle pulse wave velocity (baPWV) and electrocardiography (ECG)-determined LVH and to assess whether increased baPWV and ECG-determined LVH are independently associated with LVDD. Methods: This cross-sectional study enrolled 270 patients and classified them into four groups according to the median value of baPWV and with/without ECG-determined LVH. The baPWV was measured using an ABI-form device. ECG-determined LVH was defined by Sokolow-Lyon criterion. LVDD was defined as impaired relaxation, pseudonormal, and restrictive mitral inflow patterns. Groups 1, 2, 3, and 4 were patients with lower baPWV and without ECG-determined LVH, lower baPWV but with ECG-determined LVH, higher baPWV but without ECG-determined LVH, and higher baPWV and with ECG-determined LVH respectively. Results: Early diastolic mitral velocity (Ea) was gradually decreased from group 1 to group 4 (p = 0.027). Patients in group 4 had the highest prevalence of LVDD (all p<0.001). After multivariate analysis, both baPWV and ECG-determined LVH were independent determinants of Ea (beta = -0.02, P<0.001; beta = -1.77, P<0.001 respectively) and LVDD (odds ratio = 1.02, P = 0.011 and odds ratio = 3.53, P = 0.013 repectively). Conclusion: Our study showed the group with higher baPWV and ECG-determined LVH had the lowest Ea and highest prevalence of LVDD. In addition, both baPWV and ECG-determined LVH were independently associated with Ea and LVDD. Hence, assessment of arterial stiffness by baPWV and LVH by ECG may be useful in identifying the high risk group of LVDD.	[Hsu, Po-Chao; Tsai, Wei-Chung; Lin, Tsung-Hsien; Su, Ho-Ming; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Lin, Tsung-Hsien; Su, Ho-Ming; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	cobeshm@seed.net.tw	蘇, 河名/AAE-9843-2019	Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250				Abhayaratna WP, 2006, HEART, V92, P1259, DOI 10.1136/hrt.2005.080150; Abhayaratna WP, 2008, J HYPERTENS, V26, P758, DOI 10.1097/HJH.0b013e3282f55038; Abhayaratna WP, 2006, AM J CARDIOL, V98, P1387, DOI 10.1016/j.amjcard.2006.06.035; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eren M, 2004, HEART, V90, P37, DOI 10.1136/heart.90.1.37; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Fox ER, 2007, AM HEART J, V153, P238, DOI 10.1016/j.ahj.2006.09.013; Gates PE, 2003, EUR HEART J, V24, P2213, DOI 10.1016/j.ehj.2003.09.026; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; HESS OM, 1993, CIRCULATION, V87, P73; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hsu PC, 2011, HYPERTENS RES, V34, P462, DOI 10.1038/hr.2010.262; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; KANNEL WB, 1987, AM J CARDIOL, V60, pI85; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lorell BH, 2000, CIRCULATION, V102, P470; Masugata H, 2005, HYPERTENS RES, V28, P965, DOI 10.1291/hypres.28.965; Miyano I, 2010, HYPERTENS RES, V33, P678, DOI 10.1038/hr.2010.56; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; Samdarshi TE, 2009, AM HEART J, V158, P209, DOI 10.1016/j.ahj.2009.05.020; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; STORK T, 1995, CARDIOVASC DRUG THER, V9, P533, DOI 10.1007/BF00877866; Su HM, 2012, ATHEROSCLEROSIS, V223, P171, DOI 10.1016/j.atherosclerosis.2012.04.022; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; VILLARI B, 1993, J AM COLL CARDIOL, V22, P1477, DOI 10.1016/0735-1097(93)90560-N; Weber T, 2007, J CARD FAIL, V13, P353, DOI 10.1016/j.cardfail.2007.02.008; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yambe M, 2004, HYPERTENS RES, V27, P625, DOI 10.1291/hypres.27.625; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253	36	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49100	10.1371/journal.pone.0049100	http://dx.doi.org/10.1371/journal.pone.0049100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145083	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800204
J	Jiang, YJ; Zhu, JH; Wu, L; Xu, GL; Dai, JW; Liu, XF				Jiang, Yongjun; Zhu, Juehua; Wu, Li; Xu, Gelin; Dai, Jianwu; Liu, Xinfeng			Tetracycline Inhibits Local Inflammation Induced by Cerebral Ischemia via Modulating Autophagy	PLOS ONE			English	Article							MUSCLE-CELL MIGRATION; TUMOR-NECROSIS-FACTOR; KAPPA-B-KINASE; EPITHELIAL-CELLS; BECLIN 1; GM-CSF; MINOCYCLINE; STROKE; DOXYCYCLINE; ACTIVATION	Background: Tetracycline exerts neuroprotection via suppressing the local inflammation induced by cerebral ischemia. However, the underlying mechanism is not completely clear. Methodology/Principal Findings: The mRNA and protein expressions of tumor necrosis factor alpha and interleukin 6 and the number of activated microglia were measured to detect the inflammatory process in the ischemic hemisphere. The key proteins of nuclear factor kappa B pathway and the binding activity of nuclear factor kappa B were also measured. Two key components of autophagy, Beclin 1 and LC3, were detected by western blotting. Pretreatment with tetracycline inhibited the mRNA and protein expressions of tumor necrosis factor a and interleukin 6 and decreased the numbers of activated and phagocytotic microglia. Tetracycline down regulated the total and phosphorylated expressions of IKK, I kappa B and p65 (P<0.05). The autophagy inhibitor, 3-methyladenine, inhibited inflammation and activation of nuclear factor kappa B pathway. The levels of Beclin 1 and LC3 were decreased by 3-methyladenine and tetracycline. Conclusions/Significance: Our data suggested that pretreatment of tetracycline may inhibit autophagy in the ischemic stroke brain and then suppress the inflammatory process via inhibiting the activation of nuclear factor kappa B pathway.	[Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing, Peoples R China; [Jiang, Yongjun; Zhu, Juehua; Wu, Li; Xu, Gelin; Liu, Xinfeng] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Nanjing University	Dai, JW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing, Peoples R China.	jwdai@genetics.ac.cn; xfliu2@yahoo.com.cn		Xu, Gelin/0000-0002-6194-0341	National Natural Science Fundation of China [31200817]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Fundation of China (31200817). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostanci N, 2011, CYTOKINE, V56, P656, DOI 10.1016/j.cyto.2011.08.039; Buschini E, 2011, PROG NEUROBIOL, V95, P14, DOI 10.1016/j.pneurobio.2011.05.011; Cai ZY, 2011, PHARMACOL REP, V63, P381, DOI 10.1016/S1734-1140(11)70504-7; Ci XX, 2011, J CLIN IMMUNOL, V31, P216, DOI 10.1007/s10875-010-9481-7; Colleran A, 2011, J BIOL CHEM, V286, P22886, DOI 10.1074/jbc.M110.199950; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Hoyt JC, 2006, J IMMUNOL, V176, P567, DOI 10.4049/jimmunol.176.1.567; Huang Y, 2011, INT IMMUNOPHARMACOL, V11, P1143, DOI 10.1016/j.intimp.2011.03.011; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Jiang Y, 2011, NEUROSCIENCE, V172, P398, DOI 10.1016/j.neuroscience.2010.10.054; Jiang Y, 2011, NEUROSCIENCE; Jiang YJ, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/372423; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kes VB, 2008, CLIN BIOCHEM, V41, P1330, DOI 10.1016/j.clinbiochem.2008.08.080; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Liu BN, 2010, EXP HEMATOL, V38, P877, DOI 10.1016/j.exphem.2010.06.004; Liu WT, 2011, AUTOPHAGY, V7, P166, DOI 10.4161/auto.7.2.14043; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Puyal J, 2009, AUTOPHAGY, V5, P1060, DOI 10.4161/auto.5.7.9728; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Sperti C, 2010, WORLD J GASTRO ONCOL, V2, P272, DOI 10.4251/wjgo.v2.i6.272; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang JR, 2008, AUTOPHAGY, V4, P947, DOI 10.4161/auto.6787; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wideroe M, 2012, EUR J NEUROSCI; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xia WL, 2010, CLIN EXP PHARMACOL P, V37, P253, DOI 10.1111/j.1440-1681.2009.05279.x; Yao JHS, 2004, CIRC RES, V95, P364, DOI 10.1161/01.RES.0000138581.04174.2f; Yao JHS, 2007, NEUROCHEM INT, V50, P524, DOI 10.1016/j.neuint.2006.10.008; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	47	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48672	10.1371/journal.pone.0048672	http://dx.doi.org/10.1371/journal.pone.0048672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144925	Green Published, gold			2022-12-25	WOS:000311935800095
J	Kaspersen, MD; Larsen, PB; Kofod-Olsen, E; Fedder, J; Bonde, J; Hollsberg, P				Kaspersen, Maja D.; Larsen, Peter B.; Kofod-Olsen, Emil; Fedder, Jens; Bonde, Jesper; Hollsberg, Per			Human Herpesvirus-6A/B Binds to Spermatozoa Acrosome and Is the Most Prevalent Herpesvirus in Semen from Sperm Donors	PLOS ONE			English	Article							INFERTILITY PATIENTS; SIMPLEX-VIRUS; CYTOMEGALOVIRUS; INFECTION; PARAMETERS; BLOOD; DNA	An analysis of all known human herpesviruses has not previously been reported on sperm from normal donors. Using an array-based detection method, we determined the cross-sectional frequency of human herpesviruses in semen from 198 Danish sperm donors. Fifty-five of the donors had at least one ejaculate that was positive for one or more human herpesvirus. Of these 27.3% (n = 15) had a double herpesvirus infection. If corrected for the presence of multiple ejaculates from some donors, the adjusted frequency of herpesviruses in semen was 27.2% with HSV-1 in 0.4%; HSV-2 in 0.1%; EBV in 6.3%; HCMV in 2.7%; HHV-6A/B in 13.5%; HHV-7 in 4.2%, whereas none of the samples had detectable VZV or HHV-8. Subsequently, we examined longitudinally data on ejaculates from 11 herpesvirus-positive donors. Serial analyses revealed that a donor who tested positive for herpesvirus at one time point did not necessarily remain positive over time. For the most frequently found herpesvirus, HHV-6A/B, we examined its association with sperm. For HHV-6A/B PCR-positive semen samples, HHV-6A/B could be detected on the sperm by flow cytometry. Conversely, PCR-negative semen samples were negative by flow cytometry. HHV-6B was shown to associate with sperm within minutes in a concentration dependent manner. Confocal microscopy demonstrated that HHV-6B associated with the sperm head, but only to sperm with an intact acrosome. Taken together, our data suggest that HHV-6A/B could be transported to the uterus via binding to the sperm acrosome. Moreover, we find a 10 times higher frequency of HHV-7 in semen from healthy individuals than previously detected. Further research is required to determine the potential risk of using herpesvirus-positive donor semen. Longitudinally analyses of ejaculate series indicate that implementation of quarantine for a donor shown to shed a herpesvirus is not a tenable solution.	[Kaspersen, Maja D.; Kofod-Olsen, Emil; Hollsberg, Per] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Larsen, Peter B.] Cryos Int Sperm Bank, Aarhus, Denmark; [Fedder, Jens] Odense Univ Hosp, Fertil Clin, DK-5000 Odense, Denmark; [Bonde, Jesper] Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark; [Bonde, Jesper] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen	Hollsberg, P (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	ph@microbiology.au.dk	Bonde, Jesper H/F-1478-2013; Bonde, Jesper/AAN-5930-2020	Bonde, Jesper/0000-0003-4853-6747	Faculty of Health, Aarhus University; Lundbeck Foundation; Sanofi Pasteur MSD ApS	Faculty of Health, Aarhus University; Lundbeck Foundation(Lundbeckfonden); Sanofi Pasteur MSD ApS	This study was supported by grants from The Faculty of Health, Aarhus University, and The Lundbeck Foundation, and an unrestricted grant from Sanofi Pasteur MSD ApS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM SOC REPR MED, 1998, FERTIL STERIL S3, V70, pS1; ANDO Y, 1992, LANCET, V340, P1289, DOI 10.1016/0140-6736(92)92990-W; Bezold G, 2001, FERTIL STERIL, V76, P416, DOI 10.1016/S0015-0282(01)01920-3; Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; Bocharova E N, 2007, Dokl Biol Sci, V412, P82, DOI 10.1134/S0012496607010279; Bocharova E N, 2003, Dokl Biol Sci, V391, P379, DOI 10.1023/A:1025179307236; Diafouka F, 2007, EUR J CLIN MICROBIOL, V26, P295, DOI 10.1007/s10096-007-0271-y; Eggert-Kruse W, 2009, FERTIL STERIL, V91, P67, DOI 10.1016/j.fertnstert.2007.11.014; Kapranos N, 2003, FERTIL STERIL, V79, P1566, DOI 10.1016/S0015-0282(03)00370-4; Kaspersen MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018095; Leong HN, 2007, J MED VIROL, V79, P45, DOI 10.1002/jmv.20760; Levy R, 1997, FERTIL STERIL, V68, P820, DOI 10.1016/S0015-0282(97)00340-3; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; Mansat A, 1997, HUM REPROD, V12, P1663, DOI 10.1093/humrep/12.8.1663; MCGOWAN MP, 1983, INT J ANDROL, V6, P331, DOI 10.1111/j.1365-2605.1983.tb00547.x; Michou V, 2012, ANDROLOGIA, V44, P174, DOI 10.1111/j.1439-0272.2010.01121.x; Naumenko Victor A, 2011, Herpesviridae, V2, P7, DOI 10.1186/2042-4280-2-7; Neofytou E, 2009, FERTIL STERIL, V91, P2487, DOI 10.1016/j.fertnstert.2008.03.074; Oster B, 2006, J CLIN VIROL, V37, pS63, DOI 10.1016/S1386-6532(06)70014-2; Pallier C, 2002, HUM REPROD, V17, P1281, DOI 10.1093/humrep/17.5.1281; Thomas R, 2006, J MED VIROL, V78, P1204, DOI 10.1002/jmv.20682; Wang FZ, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P850	22	22	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48810	10.1371/journal.pone.0048810	http://dx.doi.org/10.1371/journal.pone.0048810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144982	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800142
J	Kim, H; Choi, JA; Park, GS; Kim, JH				Kim, Hyunju; Choi, Jung-A; Park, Geun-Soo; Kim, Jae-Hong			BLT2 Up-Regulates Interleukin-8 Production and Promotes the Invasiveness of Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; LEUKOTRIENE B-4 RECEPTOR; INDEPENDENT GROWTH; PANCREATIC-CANCER; CARCINOMA CELLS; OVARIAN-CANCER; METASTASIS; PATHWAY; EXPRESSION; TRANSCRIPTION	Background: The elevated production of interleukin (IL)-8 is critically associated with invasiveness and metastatic potential in breast cancer cells. However, the intracellular signaling pathway responsible for up-regulation of IL-8 production in breast cancer cells has remained unclear. Methodology/Principal Findings: In this study, we report that the expression of BLT2 is markedly up-regulated in the highly aggressive human breast cancer cell lines MDA-MB-231 and MDA-MB-435 compared with MCF-10A immortalized human mammary epithelial cells, as determined by RT-PCR, real-time PCR and FACS analysis. Blockade of BLT2 with BLT2 siRNA knockdown or BLT2 inhibitor treatment downregulated IL-8 production and thereby diminished the invasiveness of aggressive breast cancer cells, analyzed by Matrigel invasion chamber assays. We further characterized the downstream signaling mechanism by which BLT2 stimulates IL-8 production and identified critical mediatory roles for the generation of reactive oxygen species (ROS) and the consequent activation of the transcription factor NF-kappa B. Moreover, blockade of BLT2 suppressed the formation of metastatic lung nodules by MDA-MB-231 cells in both experimental and orthotopic metastasis models. Conclusions/Significance: Taken together, our study demonstrates that a BLT2-ROS-NF-kappa B pathway up-regulates IL-8 production in MDA-MB-231 and MDA-MB-435 cells, thereby contributing to the invasiveness of these aggressive breast cancer cells. Our findings provide insight into the molecular mechanism of invasiveness in breast cancer.	[Kim, Hyunju; Choi, Jung-A; Park, Geun-Soo; Kim, Jae-Hong] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea.	jhongkim@korea.ac.kr	Park, Geun-Soo/I-3344-2015; Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	Senior Researcher Project [2012R1A2A2A01044526]; General Researcher Project [2012-0001877]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) [2012M3A9C5048709]; Ministry of Education, Science and Technology (MEST), Republic of Korea; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1220020]	Senior Researcher Project; General Researcher Project; Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by the grants from the Senior Researcher Project (No. 2012R1A2A2A01044526), the General Researcher Project (2012-0001877), and the Bio & Medical Technology Development Program (2012M3A9C5048709) of the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea, and also by the grant from the National R&D Program for Cancer Control (1220020), Ministry for Health and Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; De Larco JE, 2003, P NATL ACAD SCI USA, V100, P13988, DOI 10.1073/pnas.2335921100; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Hennig R, 2005, NEOPLASIA, V7, P417, DOI 10.1593/neo.04559; Inoue K, 2000, CANCER RES, V60, P2290; Kim EY, 2010, ONCOGENE, V29, P1167, DOI 10.1038/onc.2009.412; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kim GY, 2010, J IMMUNOL, V184, P3946, DOI 10.4049/jimmunol.0901735; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Seo JM, 2012, J BIOL CHEM, V287, P13840, DOI 10.1074/jbc.M111.317131; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Sveinbjornsson B, 2008, FASEB J, V22, P3525, DOI 10.1096/fj.07-103457; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Woo CH, 2006, BIOCHEM BIOPH RES CO, V351, P972, DOI 10.1016/j.bbrc.2006.10.154; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Yao C, 2007, INT J CANCER, V121, P1949, DOI 10.1002/ijc.22930; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	39	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49186	10.1371/journal.pone.0049186	http://dx.doi.org/10.1371/journal.pone.0049186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145117	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800227
J	Lin, J; Yu, Y; Shigdar, S; Fang, DZ; Du, JR; Wei, MQ; Danks, A; Liu, K; Duan, W				Lin, Jia; Yu, Yan; Shigdar, Sarah; Fang, Ding Zhi; Du, Jun Rong; Wei, Ming Q.; Danks, Andrew; Liu, Ke; Duan, Wei			Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-Containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal Cancer	PLOS ONE			English	Article							CO-ENCAPSULATING DOXORUBICIN; PROMOTES CELL-ADHESION; MULTIDRUG-RESISTANCE; DRUG-DELIVERY; COLON-CANCER; INTRACELLULAR DELIVERY; INDUCED CARDIOMYOPATHY; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODY; POLYETHYLENE-GLYCOL	Sulfatide is a glycosphingolipid known to interact with several extracellular matrix proteins, such as tenascin-C which is overexpressed in many types of cancer including that of the colon. In view of the limited success of chemotherapy in colorectal cancer and high toxicity of doxorubicin (DOX), a sulfatide-containing liposome (SCL) encapsulation approach was taken to overcome these barriers. This study assessed the in vitro cytotoxicity, biodistribution, therapeutic efficacy and systemic toxicity in vivo of sulfatide-containing liposomal doxorubicin (SCL-DOX) using human colonic adenocarcinoma HT-29 xenograft as the experimental model. In vitro, SCL-DOX was shown to be delivered into the nuclei and displayed prolonged retention compared with the free DOX. The use of this nanodrug delivery system to deliver DOX for treatment of tumor-bearing mice produced a much improved therapeutic efficacy in terms of tumor growth suppression and extended survival in contrast to the free drug. Furthermore, treatment of tumor-bearing mice with SCL-DOX resulted in a lower DOX uptake in the principal sites of toxicity of the free drug, namely the heart and skin, as well as reduced myelosuppression and diminished cardiotoxicity. Such natural lipid-guided nanodrug delivery systems may represent a new strategy for the development of effective anticancer chemotherapeutics targeting the tumor microenvironment for both primary tumor and micrometastases.	[Lin, Jia; Yu, Yan; Shigdar, Sarah; Duan, Wei] Deakin Univ, Sch Med, Fac Hlth, Waurn Ponds, Vic, Australia; [Fang, Ding Zhi] Sichuan Univ, W China Sch Preclin & Forens Med, Dept Biochem & Mol Biol, Chengdu 610064, Peoples R China; [Du, Jun Rong] Sichuan Univ, W China Sch Pharm, Dept Pharmacol & Biopharmaceut, Chengdu 610064, Peoples R China; [Wei, Ming Q.] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Wei, Ming Q.] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Danks, Andrew] Monash Univ, Monash Med Ctr, Dept Neurosurg, Clayton, Vic, Australia; [Liu, Ke] Sichuan Univ, Fac Life Sci, Chengdu 610064, Peoples R China	Deakin University; Sichuan University; Sichuan University; Griffith University; Griffith University; Menzies Health Institute Queensland; Monash University; Sichuan University	Duan, W (corresponding author), Deakin Univ, Sch Med, Fac Hlth, Waurn Ponds, Vic, Australia.	wduan@deakin.edu.au	Liu, Ke/D-3380-2015; Duan, Wei/A-5181-2015; Shigdar, Sarah/AFR-0438-2022	Liu, Ke/0000-0002-4683-9325; Duan, Wei/0000-0001-5782-9184; Shigdar, Sarah/0000-0001-8084-8447	National Health and Medical Research Council [479505]; Australia-India Strategic Research Fund [ST01-0013]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by grants from National Health and Medical Research Council (#479505); Australia-India Strategic Research Fund, (ST01-0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 2012, INT J NANOMED, V7, P2007, DOI 10.2147/IJN.S29242; ADAMS E, 1948, YALE J BIOL MED, V21, P17; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Allen Theresa M., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P513, DOI 10.2174/187152006778699121; Alvarez-Cedron L, 1999, J CHROMATOGR B, V721, P271, DOI 10.1016/S0378-4347(98)00475-7; Bhattacharya A, 2009, CLIN COLORECTAL CANC, V8, P155, DOI 10.3816/CCC.2009.n.025; Brellier F, 2012, J CELL MOL MED, V16, P32, DOI 10.1111/j.1582-4934.2011.01360.x; Cabanes A, 1999, CLIN CANCER RES, V5, P687; Campbell Robert B., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P503, DOI 10.2174/187152006778699077; Charrois GJR, 2003, BBA-BIOMEMBRANES, V1609, P102, DOI 10.1016/S0005-2736(02)00661-2; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De Santis R, 2006, CLIN CANCER RES, V12, P2191, DOI 10.1158/1078-0432.CCR-05-2526; Drummond DC, 1999, PHARMACOL REV, V51, P691; El Bayoumil T, 2009, CLIN CANCER RES, V15, P1973, DOI 10.1158/1078-0432.CCR-08-2392; He H, 2010, GLYCOCONJUGATE J, V27, P27, DOI 10.1007/s10719-009-9249-6; Herman EH, 1999, J CLIN ONCOL, V17, P2237, DOI 10.1200/JCO.1999.17.7.2237; Jung SH, 2009, INT J PHARMACEUT, V382, P254, DOI 10.1016/j.ijpharm.2009.08.002; Koh E, 2004, CIRC J, V68, P163, DOI 10.1253/circj.68.163; Li B, 2012, INT J NANOMED, V7, P187, DOI 10.2147/IJN.S27864; Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023; MANIL L, 1995, PHARMACEUT RES, V12, P85, DOI 10.1023/A:1016290704772; Miura R, 1999, J BIOL CHEM, V274, P11431, DOI 10.1074/jbc.274.16.11431; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Oliveira RAG, 2003, ABSOLUTE RECOMMENDAT, P39; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; OUDARD S, 1991, CANCER CHEMOTH PHARM, V28, P259; Park K, 2007, J CONTROL RELEASE, V120, P1, DOI 10.1016/j.jconrel.2007.05.003; Pesheva P, 1997, J NEUROSCI, V17, P4642; Sala-Vila A, 2011, CRIT REV FOOD SCI, V51, P855, DOI 10.1080/10408398.2010.483527; Sawant RR, 2012, AAPS J, V14, P303, DOI 10.1208/s12248-012-9330-0; Segal NH, 2009, ANNU REV MED, V60, P207, DOI 10.1146/annurev.med.60.041807.132435; Shao K, 2007, CELL MOL LIFE SCI, V64, P506, DOI 10.1007/s00018-007-6419-1; Shao K, 2006, J CONTROL RELEASE, V115, P150, DOI 10.1016/j.jconrel.2006.07.024; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Szepeshazi K, 2002, CANCER RES, V62, P781; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Townson K, 2007, GLYCOBIOLOGY, V17, P1156, DOI 10.1093/glycob/cwm095; UNEZAKI S, 1994, PHARMACEUT RES, V11, P1180, DOI 10.1023/A:1018949218380; Urva SR, 2009, J CHROMATOGR B, V877, P837, DOI 10.1016/j.jchromb.2009.02.018; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang JC, 2005, BIOL PHARM BULL, V28, P822, DOI 10.1248/bpb.28.822; Wu J, 2007, J PHARM PHARM SCI, V10, P350; Xiong XB, 2005, J CONTROL RELEASE, V107, P262, DOI 10.1016/j.jconrel.2005.03.030; Xu L, 2011, J PHARM SCI-US, V100, P38, DOI 10.1002/jps.22243; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y	46	18	19	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49277	10.1371/journal.pone.0049277	http://dx.doi.org/10.1371/journal.pone.0049277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145140	gold, Green Published			2022-12-25	WOS:000311935800240
J	Papazi, A; Andronis, E; Ioannidis, NE; Chaniotakis, N; Kotzabasis, K				Papazi, Aikaterini; Andronis, Efthimios; Ioannidis, Nikolaos E.; Chaniotakis, Nikolaos; Kotzabasis, Kiriakos			High Yields of Hydrogen Production Induced by Meta-Substituted Dichlorophenols Biodegradation from the Green Alga Scenedesmus obliquus	PLOS ONE			English	Article							DEPRIVED CHLAMYDOMONAS-REINHARDTII; CYCLIC ELECTRON FLOW; PHOTOSYSTEM-II; BACTERIAL-DEGRADATION; PATHWAY RESPIRATION; PHENOLIC-COMPOUNDS; OXYGEN EVOLUTION; H-2 PRODUCTION; CARBON-SOURCES; PHOTOPRODUCTION	Hydrogen is a highly promising energy source with important social and economic implications. The ability of green algae to produce photosynthetic hydrogen under anaerobic conditions has been known for years. However, until today the yield of production has been very low, limiting an industrial scale use. In the present paper, 73 years after the first report on H-2-production from green algae, we present a combinational biological system where the biodegradation procedure of one meta-substituted dichlorophenol (m-dcp) is the key element for maintaining continuous and high rate H-2-production (>100 times higher than previously reported) in chloroplasts and mitochondria of the green alga Scenedesmus obliquus. In particular, we report that reduced m-dcps (biodegradation intermediates) mimic endogenous electron and proton carriers in chloroplasts and mitochondria, inhibit Photosystem II (PSII) activity (and therefore O-2 production) and enhance Photosystem I (PSI) and hydrogenase activity. In addition, we show that there are some indications for hydrogen production from sources other than chloroplasts in Scenedesmus obliquus. The regulation of these multistage and highly evolved redox pathways leads to high yields of hydrogen production and paves the way for an efficient application to industrial scale use, utilizing simple energy sources and one meta-substituted dichlorophenol as regulating elements.	[Papazi, Aikaterini; Andronis, Efthimios; Ioannidis, Nikolaos E.; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Chaniotakis, Nikolaos] Univ Crete, Dept Chem, Iraklion, Crete, Greece	University of Crete; University of Crete	Kotzabasis, K (corresponding author), Univ Crete, Dept Biol, Voutes Univ Campus, Iraklion, Crete, Greece.	kotzab@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021	Kotzabasis, Kiriakos/0000-0002-1002-6365				Andronis EA, 2010, PLANTA, V231, P437, DOI 10.1007/s00425-009-1060-x; Annachhatre AP, 1996, BIOTECHNOL ADV, V14, P35, DOI 10.1016/0734-9750(96)00002-X; Antal TK, 2003, BBA-BIOENERGETICS, V1607, P153, DOI 10.1016/j.bbabio.2003.09.008; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Atkin OK, 2002, PLANT PHYSIOL, V128, P212, DOI 10.1104/pp.010326; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; Bishop NL, 1971, PREPARATION PHOTOSYN; BOYD SA, 1984, APPL ENVIRON MICROB, V47, P272, DOI 10.1128/AEM.47.2.272-277.1984; Chandra AK, 2002, INT J MOL SCI, V3, P407, DOI 10.3390/i3040407; Chochois V, 2009, PLANT PHYSIOL, V151, P631, DOI 10.1104/pp.109.144576; Cournac L, 2000, J BIOL CHEM, V275, P17256, DOI 10.1074/jbc.M908732199; Cournac L, 2002, PLANT PHYSIOL, V129, P1921, DOI 10.1104/pp.001636; Day DA, 1996, PLANT PHYSIOL, V110, P1, DOI 10.1104/pp.110.1.1; DELIEU T, 1981, NEW PHYTOL, V89, P165, DOI 10.1111/j.1469-8137.1981.tb07480.x; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; Diaz E, 2004, INT MICROBIOL, V7, P173; DOLFING J, 1992, ENVIRON SCI TECHNOL, V26, P2213, DOI 10.1021/es00035a021; Embley TM, 1998, NATURE, V396, P517, DOI 10.1038/24994; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Gaffron H, 1939, NATURE, V143, P204, DOI 10.1038/143204a0; Gaffron H, 1939, BIOL ZENTRALBL, V43, P402; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Gomes JRB, 2003, J PHYS CHEM A, V107, P869, DOI 10.1021/jp026707k; GRAVES DA, 1988, PLANT PHYSIOL, V87, P603, DOI 10.1104/pp.87.3.603; Gupta KJ, 2011, MITOCHONDRION, V11, P537, DOI 10.1016/j.mito.2011.03.005; Heinen A, 2007, AM J PHYSIOL-HEART C, V293, pH1400, DOI 10.1152/ajpheart.00198.2007; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Holden M, 1965, CHLOROPHYLL CHEM BIO, P462; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Igamberdiev AU, 2009, ANN BOT-LONDON, V103, P259, DOI 10.1093/aob/mcn100; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; Jebaraj S, 2006, RENEW SUST ENERG REV, V10, P281, DOI 10.1016/j.rser.2004.09.004; Juarez MJB, 2008, BIORESOURCE TECHNOL, V99, P2392, DOI 10.1016/j.biortech.2007.05.010; Kosourov S, 2002, BIOTECHNOL BIOENG, V78, P731, DOI 10.1002/bit.10254; Kosourov S, 2007, J BIOTECHNOL, V128, P776, DOI 10.1016/j.jbiotec.2006.12.025; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Liu XJ, 2009, J APPL PHYCOL, V21, P239, DOI 10.1007/s10811-008-9355-z; Lovell CR, 2002, MAR ECOL PROG SER, V229, P11, DOI 10.3354/meps229011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Melis A, 2006, INT J HYDROGEN ENERG, V31, P1563, DOI 10.1016/j.ijhydene.2006.06.038; Melis A, 2007, ADV EXP MED BIOL, V616, P108; Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P261, DOI 10.1016/j.bbabio.2007.02.008; Nixon PJ, 2000, PHILOS T R SOC B, V355, P1541, DOI 10.1098/rstb.2000.0714; Papazi A, 2008, J BIOTECHNOL, V135, P366, DOI 10.1016/j.jbiotec.2008.05.009; Papazi A, 2007, J BIOTECHNOL, V129, P706, DOI 10.1016/j.jbiotec.2007.02.021; PENTTINEN OP, 1995, ANN ZOOL FENN, V32, P287; Petroutsos D, 2008, PHYTOCHEMISTRY, V69, P707, DOI 10.1016/j.phytochem.2007.09.002; Philipps G, 2012, PLANTA, V235, P729, DOI 10.1007/s00425-011-1537-2; Rakmi Abd. Rahman, 2007, Journal of Applied Sciences, V7, P2160; RAVANEL P, 1985, ECOTOX ENVIRON SAFE, V9, P300, DOI 10.1016/0147-6513(85)90048-X; ROSENKRANS AM, 1983, BIOTECHNOL BIOENG, V25, P1897, DOI 10.1002/bit.260250716; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; SENGER H, 1986, PHYSIOL PLANTARUM, V68, P119, DOI 10.1111/j.1399-3054.1986.tb06605.x; SENGER H, 1979, PLANTA, V145, P53, DOI 10.1007/BF00379927; SIEDOW JN, 1995, PLANT CELL, V7, P821, DOI 10.1105/tpc.7.7.821; SIMINIS CI, 1993, PHYSIOL PLANTARUM, V87, P263, DOI 10.1111/j.1399-3054.1993.tb01729.x; STEIERT JG, 1987, APPL ENVIRON MICROB, V53, P907, DOI 10.1128/AEM.53.5.907-910.1987; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Sudhir PR, 2005, J BIOCHEM MOL BIOL, V38, P481; Tamburic B, 2011, INT J HYDROGEN ENERG, V36, P7872, DOI 10.1016/j.ijhydene.2010.11.074; TERADA H, 1981, BIOCHIM BIOPHYS ACTA, V639, P225, DOI 10.1016/0304-4173(81)90011-2; Tolleter D, 2011, PLANT CELL, V23, P2619, DOI 10.1105/tpc.111.086876; Torzillo G, 2009, INT J HYDROGEN ENERG, V34, P4529, DOI 10.1016/j.ijhydene.2008.07.093; Tsygankov A, 2002, INT J HYDROGEN ENERG, V27, P1239, DOI 10.1016/S0360-3199(02)00108-8; Ukpaka CP, 2011, J BACTERIOL RES, V3, P42; Valle M, 1998, J AOAC INT, V81, P571; WEGER HG, 1990, PLANT PHYSIOL, V93, P356, DOI 10.1104/pp.93.1.356; WEINBACH EC, 1965, J BIOL CHEM, V240, P1811; White AL, 2006, INT J HYDROGEN ENERG, V31, P455, DOI 10.1016/j.ijhydene.2005.04.028; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129	76	37	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49037	10.1371/journal.pone.0049037	http://dx.doi.org/10.1371/journal.pone.0049037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145057	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800188
J	Russo, A; Palumbo, L; Fornengo, C; Di Gaetano, C; Ricceri, F; Guarrera, S; Critelli, R; Anselmino, M; Piazza, A; Gaita, F; Bergerone, S; Matullo, G				Russo, Alessia; Palumbo, Luigi; Fornengo, Cristina; Di Gaetano, Cornelia; Ricceri, Fulvio; Guarrera, Simonetta; Critelli, Rossana; Anselmino, Matteo; Piazza, Alberto; Gaita, Fiorenzo; Bergerone, Serena; Matullo, Giuseppe			Telomere Length Variation in Juvenile Acute Myocardial Infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; EUROPEAN-SOCIETY; PULSE PRESSURE; OF-CARDIOLOGY; RISK; ATHEROSCLEROSIS; ASSOCIATION; YOUNG; PREVENTION	Leukocyte telomere length (LTL) provides a potential marker of biological age, closely related to the endothelial dysfunction and consequently to the atherosclerotic process. To investigate the relationship between the LTL and the risk of premature acute myocardial infarction and to evaluate the predictive value of LTL on the onset of major cardiovascular events, 199 patients from 18 to 48 years old with first diagnosis of acute myocardial infarction were enrolled and were matched with 190 controls for sex and age (+/- 1 year). Clinical data and coronary artery disease were evaluated at enrollment and at follow up. LTL was measured at enrollment using a quantitative PCR-based method. No significant differences were observed in LTL between cases and controls (p = 0.20) and with the presence of coronary artery disease in patients (p = 0.47). Hypercholesterolemic cases presented LTL significantly longer than cases without hypercholesterolemia (t/s: 0.82 +/- 0.16 p = 0.79 and t/s norm: 0.79 +/- 0.19 p = 0.01), as confirmed in multivariate regression analysis (p = 0.005, beta = 0.09). Furthermore, multivariate regression analysis showed LTL significantly shorter in hypertensive cases than in normotensive cases (p = 0.04, beta = -0.07). One hundred seventy-one cases (86%) ended the average follow up of 9 +/- 5 years, 92 (54%) presented a major cardiovascular event. At multivariate regression analysis the LTL detected at enrollment did not represent a predictive factor of major cardiovascular events nor it significantly impacted with cumulative events. Based on present cohort of young Italian patients, the LTL did not represent a marker of acute myocardial infarction nor had a predictive role at medium term follow up.	[Russo, Alessia; Di Gaetano, Cornelia; Ricceri, Fulvio; Critelli, Rossana; Piazza, Alberto; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Russo, Alessia; Di Gaetano, Cornelia; Ricceri, Fulvio; Guarrera, Simonetta; Critelli, Rossana; Piazza, Alberto; Matullo, Giuseppe] Human Genet Fdn, HuGeF, Turin, Italy; [Palumbo, Luigi; Fornengo, Cristina; Anselmino, Matteo; Gaita, Fiorenzo; Bergerone, Serena] Univ Turin, San Giovanni Battista Hosp, Div Cardiol, Dept Internal Med, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Matullo, G (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	giuseppe.matullo@unito.it	Ricceri, Fulvio/I-9910-2018; Di Gaetano, Cornelia/AAA-5477-2019; Guarrera, Simonetta/AAB-8482-2022; Matullo, Giuseppe/K-6383-2016	Ricceri, Fulvio/0000-0001-8749-9737; Di Gaetano, Cornelia/0000-0001-8938-7093; Matullo, Giuseppe/0000-0003-0674-7757; Piazza, Alberto/0000-0002-2355-4183; RUSSO, ALESSIA/0000-0002-5494-2218; Gaita, Fiorenzo/0000-0003-3178-6205; Critelli, Rossana/0000-0001-8982-6762; Anselmino, Matteo/0000-0002-6311-4270	Progetto di ricerca sanitaria finalizzata REGIONE PIEMONTE Anno bis; Italian Ministry of Education, University and Research; Progetti Ricerca Interesse Nazionale [20073RH73W_005]; Human Genetics Foundation (HuGeF)	Progetto di ricerca sanitaria finalizzata REGIONE PIEMONTE Anno bis; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Human Genetics Foundation (HuGeF)	This work was supported by the Progetto di ricerca sanitaria finalizzata REGIONE PIEMONTE Anno 2008 bis [to AP and GM], by grants from the Italian Ministry of Education, University and Research, Progetti Ricerca Interesse Nazionale [2007 - prot. 20073RH73W_005 to AP], and by a grant from the Human Genetics Foundation (HuGeF) to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anderson RE, 2008, AM HEART J, V155, P706, DOI 10.1016/j.ahj.2007.11.016; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Choudhury L, 1999, AM J MED, V107, P254, DOI 10.1016/S0002-9343(99)00218-1; De Meyer T, 2009, EUR HEART J, V30, P3074, DOI 10.1093/eurheartj/ehp324; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Dei Cas A, 2011, NUTR METAB CARDIOVAS; Doughty M, 2002, AM HEART J, V143, P56, DOI 10.1067/mhj.2002.120300; Egred M, 2005, POSTGRAD MED J, V81, P741, DOI 10.1136/pgmj.2004.027532; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fornengo C, 2010, MINERVA CARDIOANGIOL, V58, P433; Fournier JA, 2004, AM J CARDIOL, V94, P989, DOI 10.1016/j.amjcard.2004.06.051; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Giannotti G, 2010, HYPERTENSION, V55, P1389, DOI 10.1161/HYPERTENSIONAHA.109.141614; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Huzen J, 2010, FRONT BIOSCI-LANDMRK, V15, P35, DOI 10.2741/3604; Imazio M, 1998, G Ital Cardiol, V28, P505; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mainous AG, 2010, ATHEROSCLEROSIS, V210, P262, DOI 10.1016/j.atherosclerosis.2009.10.047; Maubaret CG, 2010, J MOL MED, V88, P785, DOI 10.1007/s00109-010-0624-3; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Yang ZW, 2009, HYPERTENSION, V53, P639, DOI 10.1161/HYPERTENSIONAHA.108.123752; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004	37	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49206	10.1371/journal.pone.0049206	http://dx.doi.org/10.1371/journal.pone.0049206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145125	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800231
J	Xu, WC; Allbritton, N; Lawrence, DS				Xu, Weichen; Allbritton, Nancy; Lawrence, David S.			Src Kinase Regulation in Progressively Invasive Cancer	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; FOCAL ADHESION KINASE; PROSTATE-CANCER; CAPILLARY-ELECTROPHORESIS; ALPHA-6-BETA-1 INTEGRIN; COMBINATORIAL LIBRARY; ACINAR MORPHOGENESIS; EPITHELIAL-CELLS; HIGH-AFFINITY; SINGLE CELLS	Metastatic progression is a multistep process that involves tumor growth and survival, motility and invasion, and subsequent proliferation in an inappropriate environment. The Src protein tyrosine kinase has been implicated in many of the biochemical pathways that drive these behaviors. Although Src itself is only rarely mutated in human tumors, its aberrant activity has been noted in various cancers and suggested to serve as a barometer of metastatic potential. With these features in mind, we examined Src kinase regulation at the structural, enzymatic, and expression levels as a function of progressively invasive prostate cancer cell lines. Surprisingly, both total Src content and kinase activity decrease with increasing cell line aggressiveness, an observation that appears to be inconsistent with the well-documented role of Src in the signaling pathways that drive growth and invasion. However, we do observe a direct correlation between Src kinase specific activity (total Src kinase activity/total Src content) and metastatic aggressiveness, possibly suggesting that in highly aggressive cell lines, key signaling enzymes are globally recruited to drive the cancerous phenotype. In addition, although the expected enhanced phosphorylation of Src at Tyr-416 (activation site) is present in the most aggressive prostate cancer cell lines, unexpectedly high phosphorylation levels at the Tyr-527 inhibitory site are observed as well. The latter, rather than representative of inhibited enzyme, is more indicative of primed Src responsive to local phosphorylated binding partners.	[Allbritton, Nancy; Lawrence, David S.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA; [Xu, Weichen; Lawrence, David S.] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC USA; [Allbritton, Nancy] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Allbritton, Nancy; Lawrence, David S.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lawrence, DS (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA.	lawrencd@email.unc.edu		Xu, Weichen/0000-0002-2198-1122	National Institutes of Health [5R01CA140173]; NATIONAL CANCER INSTITUTE [R01CA140173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant 5R01CA140173 to DSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Anderson GJ, 2011, ANAL CHEM, V83, P1350, DOI 10.1021/ac102671n; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bello-DeOcampo D, 2001, MUTAT RES-FUND MOL M, V480, P209, DOI 10.1016/S0027-5107(01)00201-9; Bello-Deocampo D, 2001, PROSTATE, V46, P142, DOI 10.1002/1097-0045(20010201)46:2<142::AID-PROS1018>3.0.CO;2-B; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; Borland LM, 2008, ANNU REV ANAL CHEM, V1, P191, DOI 10.1146/annurev.anchem.1.031207.113100; Braunwalder AF, 1996, ANAL BIOCHEM, V234, P23, DOI 10.1006/abio.1996.0044; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Chaiswing L, 2008, CANCER RES, V68, P5820, DOI 10.1158/0008-5472.CAN-08-0162; Chaiswing Luksana, 2011, Cancers (Basel), V3, P3557, DOI 10.3390/cancers3033557; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Choudhury AD, 2012, EUR UROL, V62, P577, DOI 10.1016/j.eururo.2012.05.054; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Hsieh TC, 2009, ANTICANCER RES, V29, P4025; Hudson TS, 2007, CANCER RES, V67, P8396, DOI 10.1158/0008-5472.CAN-06-4069; Kottegoda S, 2008, ANAL CHEM, V80, P5358, DOI 10.1021/ac8003242; Lawrence DS, 2007, CHEMBIOCHEM, V8, P373, DOI 10.1002/cbic.200600473; Lee JH, 2004, J AM CHEM SOC, V126, P3394, DOI 10.1021/ja037300b; Lee JH, 2008, CHEMBIOCHEM, V9, P507, DOI 10.1002/cbic.200700583; Lee TR, 1999, J MED CHEM, V42, P784, DOI 10.1021/jm980663f; Lee TR, 2000, J MED CHEM, V43, P1173, DOI 10.1021/jm990462r; Li H, 2004, BIOCHEMISTRY-US, V43, P1599, DOI 10.1021/bi035597k; Li H, 2001, J CHROMATOGR B, V757, P79, DOI 10.1016/S0378-4347(01)00080-9; Li HS, 2005, CHEM BIOL, V12, P905, DOI 10.1016/j.chembiol.2005.06.007; LIU XQ, 1993, ONCOGENE, V8, P1119; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; Pathak BR, 2010, ASIAN J ANDROL, V12, P677, DOI 10.1038/aja.2010.56; Proctor A, 2012, ANALYST, V137, P3028, DOI 10.1039/c2an16162a; Rijksen G, 1996, BREAST CANCER RES TR, V39, P139, DOI 10.1007/BF01806180; Rivat C, 2003, FASEB J, V17, P1721, DOI 10.1096/fj.03-0132fje; Rivette AS, 2005, J EXP THER ONCOL, V5, P111; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Shen K, 2001, J BIOL CHEM, V276, P47311, DOI 10.1074/jbc.M106568200; Sims CE, 1998, ANAL CHEM, V70, P4570, DOI 10.1021/ac9802269; Sims CE, 2003, CURR OPIN BIOTECH, V14, P23, DOI 10.1016/S0958-1669(02)00002-2; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Van Slambrouck S, 2009, INT J ONCOL, V34, P1717, DOI 10.3892/ijo_00000302; Wang QZ, 2006, J AM CHEM SOC, V128, P14016, DOI 10.1021/ja065852z; Wang QZ, 2010, ACS CHEM BIOL, V5, P887, DOI 10.1021/cb100099h; Wang QZ, 2006, J AM CHEM SOC, V128, P1808, DOI 10.1021/ja0577692; Wang QZ, 2005, J AM CHEM SOC, V127, P7684, DOI 10.1021/ja050789j; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Webber MM, 2001, PROSTATE, V47, P1; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yeh RH, 2002, PHARMACOL THERAPEUT, V93, P179, DOI 10.1016/S0163-7258(02)00187-0; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964	64	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48867	10.1371/journal.pone.0048867	http://dx.doi.org/10.1371/journal.pone.0048867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145001	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800157
J	Khan, MA; Han, YP; Zhao, YF; Troggio, M; Korban, SS				Khan, Muhammad Awais; Han, Yuepeng; Zhao, Youfu Frank; Troggio, Michela; Korban, Schuyler S.			A Multi-Population Consensus Genetic Map Reveals Inconsistent Marker Order among Maps Likely Attributed to Structural Variations in the Apple Genome	PLOS ONE			English	Article							LINKAGE MAP; SEGMENTAL DUPLICATIONS; BRASSICA-NAPUS; CONSTRUCTION; INTEGRATION; STRATEGIES; RFLP; AFLP	Genetic maps serve as frameworks for determining the genetic architecture of quantitative traits, assessing structure of a genome, as well as aid in pursuing association mapping and comparative genetic studies. In this study, a dense genetic map was constructed using a high-throughput 1,536 EST-derived SNP GoldenGate genotyping platform and a global consensus map established by combining the new genetic map with four existing reliable genetic maps of apple. The consensus map identified markers with both major and minor conflicts in positioning across all five maps. These major inconsistencies among marker positions were attributed either to structural variations within the apple genome, or among mapping populations, or genotyping technical errors. These also highlighted problems in assembly and anchorage of the reference draft apple genome sequence in regions with known segmental duplications. Markers common across all five apple genetic maps resulted in successful positioning of 2875 markers, consisting of 2033 SNPs and 843 SSRs as well as other specific markers, on the global consensus map. These markers were distributed across all 17 linkage groups, with an average of 169 +/- 33 marker per linkage group and with an average distance of 0.70 +/- 0.14 cM between markers. The total length of the consensus map was 1991.38 cM with an average length of 117.14 +/- 24.43 cM per linkage group. A total of 569 SNPs were mapped onto the genetic map, consisting of 140 recombinant individuals, from our recently developed apple Oligonucleotide pool assays (OPA). The new functional SNPs, along with the dense consensus genetic map, will be useful for high resolution QTL mapping of important traits in apple and for pursuing comparative genetic studies in Rosaceae.	[Khan, Muhammad Awais; Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Han, Yuepeng] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Zhao, Youfu Frank] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Troggio, Michela] Fdn Edmund Mach, Ist Agr San Michele All Adige, Res & Innovat Ctr, Trento, Italy	University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; University of Illinois System; University of Illinois Urbana-Champaign; Fondazione Edmund Mach	Korban, SS (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.	korban@illinois.edu		Khan, Muhammad Awais/0000-0002-0424-7727	United States Department of Agriculture/National Institute of Food and Agriculture Specialty Crop Research Initiative (USDA-NIFA-SCRI) [AG 2009-51181-06023]; Chinese Academy of Sciences [2011T2S25]	United States Department of Agriculture/National Institute of Food and Agriculture Specialty Crop Research Initiative (USDA-NIFA-SCRI); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by a grant received from United States Department of Agriculture/National Institute of Food and Agriculture Specialty Crop Research Initiative (USDA-NIFA-SCRI) grant AG 2009-51181-06023. This project was also partially supported by the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (2011T2S25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Cardle L, 2000, GENETICS, V156, P847; Celton JM, 2009, TREE GENET GENOMES, V5, P93, DOI 10.1007/s11295-008-0171-z; Celton Jean-Marc, 2009, BMC Res Notes, V2, P182, DOI 10.1186/1756-0500-2-182; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; DARVASI A, 1994, GENETICS, V138, P1365; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Fishman L, 2001, GENETICS, V159, P1701; Han YP, 2011, J EXP BOT, V62, P5117, DOI 10.1093/jxb/err215; Han YP, 2010, CRIT REV PLANT SCI, V29, P265, DOI 10.1080/07352689.2010.502075; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jackson BN, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P35, DOI 10.1109/CSB.2005.26; JACOBS JME, 1995, THEOR APPL GENET, V91, P289, DOI 10.1007/BF00220891; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r28; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; Khan MA, 2012, GENE, V494, P196, DOI 10.1016/j.gene.2011.12.001; Khan MA, 2012, PLANT MOL BIOL REP, V30, P247, DOI 10.1007/s11105-011-0334-1; Liebhard R, 2003, THEOR APPL GENET, V106, P1497, DOI 10.1007/s00122-003-1209-0; Lombard V, 2001, THEOR APPL GENET, V103, P491, DOI 10.1007/s001220100560; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; N'Diaye A, 2008, TREE GENET GENOMES, V4, P727, DOI 10.1007/s11295-008-0146-0; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Sebastian RL, 2000, THEOR APPL GENET, V100, P75, DOI 10.1007/s001220050011; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Williams E, 1975, AGR EXPT STATION B; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Wu Yonghui, 2008, Comput Syst Bioinformatics Conf, V7, P285, DOI 10.1142/9781848162648_0025; Yan Z, 2005, THEOR APPL GENET, V110, P766, DOI 10.1007/s00122-004-1903-6; Yap IV, 2003, GENETICS, V165, P2235	40	47	48	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47864	10.1371/journal.pone.0047864	http://dx.doi.org/10.1371/journal.pone.0047864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144832	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400030
J	Xu, K; Chan, YP; Rajashankar, KR; Khetawat, D; Yan, LY; Kolev, MV; Broder, CC; Nikolov, DB				Xu, Kai; Chan, Yee-Peng; Rajashankar, Kanagalaghatta R.; Khetawat, Dimple; Yan, Lianying; Kolev, Momchil V.; Broder, Christopher C.; Nikolov, Dimitar B.			New Insights into the Hendra Virus Attachment and Entry Process from Structures of the Virus G Glycoprotein and Its Complex with Ephrin-B2	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE PROTEIN; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTION; PARAMYXOVIRUS FUSION; RECEPTOR-BINDING; HN; DOMAIN; NIPAH; IDENTIFICATION; RESIDUES	Hendra virus and Nipah virus, comprising the genus Henipavirus, are recently emerged, highly pathogenic and often lethal zoonotic agents against which there are no approved therapeutics. Two surface glycoproteins, the attachment (G) and fusion (F), mediate host cell entry. The crystal structures of the Hendra G glycoprotein alone and in complex with the ephrin-B2 receptor reveal that henipavirus uses Tryptophan 122 on ephrin-B2/B3 as a "latch" to facilitate the G-receptor association. Structural-based mutagenesis of residues in the Hendra G glycoprotein at the receptor binding interface document their importance for viral attachments and entry, and suggest that the stability of the Hendra-G-ephrin attachment complex does not strongly correlate with the efficiency of viral entry. In addition, our data indicates that conformational rearrangements of the G glycoprotein head domain upon receptor binding may be the trigger leading to the activation of the viral F fusion glycoprotein during virus infection.	[Xu, Kai; Kolev, Momchil V.; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; [Chan, Yee-Peng; Khetawat, Dimple; Yan, Lianying; Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, Adv Photon Source, NE Collaborat Access Team, Argonne, IL 60439 USA	Memorial Sloan Kettering Cancer Center; Uniformed Services University of the Health Sciences - USA; United States Department of Energy (DOE); Argonne National Laboratory	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	nikolovd@mskcc.org	Broder, Christopher/E-1169-2013; kolev, mihail/D-1476-2015	kolev, mihail/0000-0002-5226-4759	Department of Health and Human Services, National Institutes of Health [AI054715, AI077995]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077995, R01AI054715] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Department of Health and Human Services, National Institutes of Health, grants AI054715 and AI077995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2010, HENDRA VIRUS EQUINE; [Anonymous], 2012, HENDRA VIRUS EQUINE; [Anonymous], 2009, HENDRA VIRUS HUMAN E; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Bishop Kimberly A., 2008, V8, P155; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Bossart KN, 2009, VIRAL ENTRY HOST CEL; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2010, J VIROL, V84, P6208, DOI 10.1128/JVI.00317-10; Brindley MA, 2010, PROTEIN J; Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016; Chan YP, 2012, J VIROL, V86, P11457, DOI 10.1128/JVI.01318-12; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Colf LA, 2007, NAT STRUCT MOL BIOL, V14, P1227, DOI 10.1038/nsmb1342; Colgrave ML, 2012, GLYCOBIOLOGY, V22, P572, DOI 10.1093/glycob/cwr180; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Dutch RE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000881; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Hashiguchi T, 2007, P NATL ACAD SCI US; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khetawat D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-312; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Negrete OA, 2007, J VIROL, V81, P10804, DOI 10.1128/JVI.00999-07; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Rockx B, 2010, J VIROL, V84, P9831, DOI 10.1128/JVI.01163-10; Ryan C, 2006, GLYCOCONJUGATE J, V23, P135, DOI 10.1007/s10719-006-5446-8; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Stone-Hulslander J, 1999, J VIROL, V73, P3630, DOI 10.1128/JVI.73.5.3630-3637.1999; StoneHulslander J, 1997, J VIROL, V71, P6287, DOI 10.1128/JVI.71.9.6287-6295.1997; Takimoto T, 2002, J VIROL, V76, P13028, DOI 10.1128/JVI.76.24.13028-13033.2002; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Xu K, 2008, P NATL ACAD SCI US; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2008, VIROLOGY, V378, P282, DOI 10.1016/j.virol.2008.05.023; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	59	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48742	10.1371/journal.pone.0048742	http://dx.doi.org/10.1371/journal.pone.0048742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144952	gold, Green Submitted, Green Published			2022-12-25	WOS:000310741400061
J	Perez-Ramirez, E; Acevedo, P; Allepuz, A; Gerrikagoitia, X; Alba, A; Busquets, N; Diaz-Sanchez, S; Alvarez, V; Abad, FX; Barral, M; Majo, N; Hofle, U				Perez-Ramirez, Elisa; Acevedo, Pelayo; Allepuz, Alberto; Gerrikagoitia, Xeider; Alba, Anna; Busquets, Nuria; Diaz-Sanchez, Sandra; Alvarez, Vega; Xavier Abad, Francesc; Barral, Marta; Majo, Natalia; Hoefle, Ursula			Ecological Factors Driving Avian Influenza Virus Dynamics in Spanish Wetland Ecosystems	PLOS ONE			English	Article							UNIVERSAL PRIMER SET; WILD BIRDS; ACTIVE SURVEILLANCE; NEURAMINIDASE GENE; A VIRUSES; PCR ASSAY; WATER; AMPLIFICATION; TRANSMISSION; CIRCULATION	Studies exploring the ecological interactions between avian influenza viruses (AIV), natural hosts and the environment are scarce. Most work has focused on viral survival and transmission under laboratory conditions and through mathematical modelling. However, more integrated studies performed under field conditions are required to validate these results. In this study, we combined information on bird community, environmental factors and viral epidemiology to assess the contribution of biotic and abiotic factors in the occurrence of low pathogenic AIV in Spanish wetlands. For that purpose, seven locations in five different wetlands were studied during two years (2007-2009), including seven sampling visits by location. In each survey, fresh faeces (n = 4578) of wild birds and water samples were collected for viral detection. Also, the vegetation structure, water physical properties of wetlands, climatic conditions and wild bird community composition were determined. An overall AIV prevalence of 1.7%+/- 60.4 was detected in faecal samples with important fluctuations among seasons and locations. Twenty-six AIV were isolated from the 78 RRT-PCR positive samples and eight different haemagglutinines and five neuraminidases were identified, being the combination H3N8 the most frequent. Variation partitioning procedures identified the combination of space and time variables as the most important pure factor independently to other factors - explaining the variation in AIV prevalence (36.8%), followed by meteorological factor (21.5%) and wild bird community composition/vegetation structure (21.1%). These results contribute to the understanding of AIV ecological drivers in Spanish ecosystems and provide useful guidelines for AIV risk assessment identifying potential hotspots of AIV activity.	[Perez-Ramirez, Elisa; Diaz-Sanchez, Sandra; Hoefle, Ursula] UCLM JCCM CSIC, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Acevedo, Pelayo] Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain; [Acevedo, Pelayo; Allepuz, Alberto; Alba, Anna; Busquets, Nuria; Xavier Abad, Francesc; Majo, Natalia] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Allepuz, Alberto; Majo, Natalia] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Gerrikagoitia, Xeider; Alvarez, Vega; Barral, Marta] NEIKER Inst Vasco Invest & Desarrollo Agr, Dept Anim Hlth, Derio, Bizkaia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidad de Malaga; IRTA; Autonomous University of Barcelona	Perez-Ramirez, E (corresponding author), UCLM JCCM CSIC, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain.	elisaperezramirez@gmail.com	Acevedo, Pelayo/L-6737-2013; Pérez-Ramírez, Elisa/ABH-2191-2020; Barral, Marta/F-7174-2015; Abad, Xavier/ABE-8449-2021; Allepuz, Alberto/N-2398-2014; Busquets, Núria/T-8431-2017; Masferrer, Natàlia Majó/AAV-3696-2021; Sanchez, Sandra Diaz/M-4317-2015; Höfle, Ursula/F-8585-2013	Acevedo, Pelayo/0000-0002-3509-7696; Pérez-Ramírez, Elisa/0000-0001-7701-9816; Barral, Marta/0000-0003-3749-1221; Allepuz, Alberto/0000-0003-3518-1991; Sanchez, Sandra Diaz/0000-0002-7205-3174; Höfle, Ursula/0000-0002-6868-079X; Gerrikagoitia, Xeider/0000-0001-9398-2012; Abad Morejon de Giron, Xavier/0000-0003-1818-1236; ALVAREZ MAIZTEGUI, VEGA/0000-0001-8006-2778; Majo, Natalia/0000-0003-0189-9751	INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria) [FAU2006-00019-C03-00]; Department of Environment, Territorial Planning, Agriculture and Fisheries of the Basque Government; Beatriu de Pinos fellowship; Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa, of the Generalitat de Catalunya; COFUND Programme-Marie Curie Actions under 7th Marc Programme of the European Community	INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria)(Instituto de Investigacion Agropecuaria (INIA)); Department of Environment, Territorial Planning, Agriculture and Fisheries of the Basque Government; Beatriu de Pinos fellowship; Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa, of the Generalitat de Catalunya(Generalitat de Catalunya); COFUND Programme-Marie Curie Actions under 7th Marc Programme of the European Community	This work was financially supported by INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria), project FAU2006-00019-C03-00 and by Department of Environment, Territorial Planning, Agriculture and Fisheries of the Basque Government. P. Acevedo was supported by a Beatriu de Pinos fellowship funded by Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa, of the Generalitat de Catalunya and the COFUND Programme-Marie Curie Actions under 7th Marc Programme of the European Community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-77; Alzaga V, 2009, NATURWISSENSCHAFTEN, V96, P1157, DOI 10.1007/s00114-009-0577-y; Barral M, 2008, BMC VET RES, V4; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Busquets N, 2010, J GEN VIROL, V91, P2307, DOI 10.1099/vir.0.021592-0; Busquets N, 2010, VIRUS RES, V149, P10, DOI 10.1016/j.virusres.2009.12.005; Caron A, 2011, ECOHEALTH, V8, P109, DOI 10.1007/s10393-010-0356-4; Cattoli G, 2007, AVIAN DIS, V51, P414, DOI 10.1637/7562-033106R.1; De Marco MA, 2004, VET MICROBIOL, V98, P197, DOI 10.1016/j.vetmic.2003.10.018; Deboosere N, 2011, APPL ENVIRON MICROB, V77, P3802, DOI 10.1128/AEM.02484-10; EBERHARDT LL, 1978, J WILDLIFE MANAGE, V42, P1, DOI 10.2307/3800685; Fereidouni SR, 2009, VET MICROBIOL, V135, P253, DOI 10.1016/j.vetmic.2008.09.077; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; Henaux V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010997; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOSMER DW, 1989, APPL LOGISTIC REGRES; Irwin CK, 2011, APPL ENVIRON MICROB, V77, P1049, DOI 10.1128/AEM.02733-09; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; Kalthoff D, 2010, VET MICROBIOL, V140, P237, DOI 10.1016/j.vetmic.2009.08.022; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Lebarbenchon C, 2010, AVIAN DIS, V54, P446, DOI 10.1637/8665-022509-ResNote.1; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Linz George M., 1998, Prairie Naturalist, V30, P243; Munster JV, 2007, PLOS PATHOG, V3; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; OIE, 2009, MANUAL DIAGNOSTIC TE; Owen M, 1990, WATERFOWL ECOLOGY; Pannwitz G, 2009, J WILDLIFE DIS, V45, P512, DOI 10.7589/0090-3558-45.2.512; Perez-Ramirez E, 2010, VET MICROBIOL, V146, P200, DOI 10.1016/j.vetmic.2010.05.008; Real R, 2003, J BIOGEOGR, V30, P939, DOI 10.1046/j.1365-2699.2003.00871.x; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Si YL, 2010, ECOL SOC, V15, DOI 10.5751/es-03622-150326; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Stallknecht D. E., 2008, AVIAN INFLUENZA, V1, P43, DOI DOI 10.1002/9780813818634.ch3; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; Suarez D. L., 2008, AVIAN INFLUENZA, P3; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Tsukamoto K, 2008, J CLIN MICROBIOL, V46, P3048, DOI 10.1128/JCM.02386-07; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x; Vilagines P, 1997, WATER SCI TECHNOL, V35, P455, DOI 10.2166/wst.1997.0777; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wetlands International, 2005, AEWA TECHNICAL SERIE; Yasue M, 2006, BIOSCIENCE, V56, P923, DOI 10.1641/0006-3568(2006)56[923:TEOHAI]2.0.CO;2; Zarkov IS, 2006, REV MED VET-TOULOUSE, V157, P471; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	59	16	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e46418	10.1371/journal.pone.0046418	http://dx.doi.org/10.1371/journal.pone.0046418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152749	Green Submitted, Green Published, gold			2022-12-25	WOS:000311234000003
J	Taylor, WA; Mejia, EM; Mitchell, RW; Choy, PC; Sparagna, GC; Hatch, GM				Taylor, William A.; Mejia, Edgard M.; Mitchell, Ryan W.; Choy, Patrick C.; Sparagna, Genevieve C.; Hatch, Grant M.			Human Trifunctional Protein Alpha Links Cardiolipin Remodeling to Beta-Oxidation	PLOS ONE			English	Article							RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; BARTH-SYNDROME PATIENTS; ACYLTRANSFERASE CONTROLS; ENDOTHELIAL LINEAGES; HEART MITOCHONDRIA; PHOSPHATIDYLGLYCEROL; BIOSYNTHESIS; DEFICIENCY; METABOLISM	Cardiolipin (CL) is a mitochondrial membrane phospholipid which plays a key role in apoptosis and supports mitochondrial respiratory chain complexes involved in the generation of ATP. In order to facilitate its role CL must be remodeled with appropriate fatty acids. We previously identified a human monolysocardiolipin acyltransferase activity which remodels CL via acylation of monolysocardiolipin (MLCL) to CL and was identical to the alpha subunit of trifunctional protein (alpha TFP) lacking the first 227 amino acids. Full length alpha TFP is an enzyme that plays a prominent role in mitochondrial beta-oxidation, and in this study we assessed the role, if any, which this metabolic enzyme plays in the remodeling of CL. Purified human recombinant alpha TFP exhibited acyl-CoA acyltransferase activity in the acylation of MLCL to CL with linoleoyl-CoA, oleoyl-CoA and palmitoyl-CoA as substrates. Expression of alpha TFP increased radioactive linoleate or oleate or palmitate incorporation into CL in HeLa cells. Expression of alpha TFP in Barth Syndrome lymphoblasts, which exhibit reduced tetralinoleoyl-CL, elevated linoleoyl-CoA acylation of MLCL to CL in vitro, increased mitochondrial respiratory Complex proteins and increased linoleate-containing species of CL. Knock down of alpha TFP in Barth Syndrome lymphoblasts resulted in greater accumulation of MLCL than those with normal alpha TFP levels. The results clearly indicate that the human alpha TFP exhibits MLCL acyltransferase activity for the resynthesis of CL from MLCL and directly links an enzyme of mitochondrial beta-oxidation to CL remodeling. Citation: Taylor WA, Mejia EM, Mitchell RW, Choy PC, Sparagna GC, et al. (2012) Human Trifunctional Protein Alpha Links Cardiolipin Remodeling to Beta-Oxidation. PLoS ONE 7(11): e48628. doi:10.1371/journal.pone.0048628	[Taylor, William A.; Mejia, Edgard M.; Mitchell, Ryan W.; Hatch, Grant M.] Univ Manitoba, Manitoba Inst Child Hlth, Ctr Res & Treatment Atherosclerosis, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada; [Sparagna, Genevieve C.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Manitoba; University of Colorado System; University of Colorado Boulder	Hatch, GM (corresponding author), Univ Manitoba, Manitoba Inst Child Hlth, Ctr Res & Treatment Atherosclerosis, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada.	hatchgm@ms.umanitoba.ca			Canadian Institutes of Health Research; Barth Syndrome Foundation (USA); Barth Syndrome Foundation (Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Barth Syndrome Foundation (USA); Barth Syndrome Foundation (Canada)	This work was supported by grants from the Canadian Institutes of Health Research and the Barth Syndrome Foundation (USA & Canada). GMH is a Canada Research Chair in Molecular Cardiolipin Metabolism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Boles RG, 1998, J PEDIATR-US, V132, P924, DOI 10.1016/S0022-3476(98)70385-3; BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894; Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; CARPENTER K, 1992, BIOCHEM BIOPH RES CO, V183, P443, DOI 10.1016/0006-291X(92)90501-B; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Fould B, 2010, BIOCHEMISTRY-US, V49, P8608, DOI 10.1021/bi100742w; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Hatch GM, 1998, INT J MOL MED, V1, P33; Hatch GM, 2004, BIOCHEM CELL BIOL, V82, P99, DOI 10.1139/o03-074; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Hayes B, 2007, IRISH J MED SCI, V176, P189, DOI 10.1007/s11845-007-0025-y; HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; KAMIJO T, 1994, J CLIN INVEST, V93, P1740, DOI 10.1172/JCI117158; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; Kirkman HN, 2007, TRENDS BIOCHEM SCI, V32, P44, DOI 10.1016/j.tibs.2006.11.003; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma BJ, 1999, J LIPID RES, V40, P1837; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; RUSTOW B, 1989, BIOCHIM BIOPHYS ACTA, V1002, P261, DOI 10.1016/0005-2760(89)90296-8; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Taylor WA, 2003, J BIOL CHEM, V278, P12716, DOI 10.1074/jbc.M210329200; Taylor WA, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-9; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Valianpour F, 2002, CLIN CHEM, V48, P1390; van Gestel RA, 2010, J PROTEOMICS, V73, P806, DOI 10.1016/j.jprot.2009.11.009; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; YAMAOKA S, 1990, J NUTR, V120, P415, DOI 10.1093/jn/120.5.415; YANG SY, 1995, BIOCHEMISTRY-US, V34, P6441, DOI 10.1021/bi00019a025; Yao KW, 1996, J BIOL CHEM, V271, P17816, DOI 10.1074/jbc.271.30.17816; Zhuravleva E, 2012, MOL CELL BIOL, V32, P2685, DOI 10.1128/MCB.00312-12	50	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48628	10.1371/journal.pone.0048628	http://dx.doi.org/10.1371/journal.pone.0048628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152787	Green Published, Green Submitted, gold			2022-12-25	WOS:000312272600014
J	Jesse, S; Lehnert, S; Jahn, O; Parnetti, L; Soininen, H; Herukka, SK; Steinacker, P; Tawfik, S; Tumani, H; von Arnim, CAF; Neumann, M; Kretzschmar, HA; Kulaksiz, H; Lenter, M; Wiltfang, J; Ferger, B; Hengerer, B; Otto, M				Jesse, Sarah; Lehnert, Stefan; Jahn, Olaf; Parnetti, Lucilla; Soininen, Hilkka; Herukka, Sanna-Kaisa; Steinacker, Petra; Tawfik, Saskia; Tumani, Hayrettin; von Arnim, Christine A. F.; Neumann, Manuela; Kretzschmar, Hans A.; Kulaksiz, Hasan; Lenter, Martin; Wiltfang, Jens; Ferger, Boris; Hengerer, Bastian; Otto, Markus			Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson's Disease Dementia	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID; LEWY BODIES; PROTEIN AGGREGATION; MOLECULAR-BASIS; TASK-FORCE; WORK GROUP; ALZHEIMERS; BRAIN; GLYCOSYLATION	The prevalence of Parkinson's disease (PD) increases with age. Up to 50% of PD show cognitive decline in terms of a mild cognitive impairment already in early stages that predict the development of dementia, which can occur in up to 80% of PD patients over the long term, called Parkinson's disease dementia (PDD). So far, diagnosis of PD/PDD is made according to clinical and neuropsychological examinations while laboratory data is only used for exclusion of other diseases. The aim of this study was the identification of possible biomarkers in cerebrospinal fluid (CSF) of PD, PDD and controls (CON) which predict the development of dementia in PD. For this, a proteomic approach optimized for CSF was performed using 18 clinically well characterized patients in a first step with subsequent validation using 84 patients. Here, we detected differentially sialylated isoforms of Serpin A1 as marker for differentiation of PD versus PDD in CSF. Performing 2D-immunoblots, all PDD patients could be identified correctly (sensitivity 100%). Ten out of 24 PD patients showed Serpin A1 isoforms in a similar pattern like PDD, indicating a specificity of 58% for the test-procedure. In control samples, no additional isoform was detected. On the basis of these results, we conclude that differentially sialylated products of Serpin A1 are an interesting biomarker to indicate the development of a dementia during the course of PD. Citation: Jesse S, Lehnert S, Jahn O, Parnetti L, Soininen H, et al. (2012) Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson's Disease Dementia. PLoS ONE 7(11): e48783. doi:10.1371/journal.pone.0048783	[Jesse, Sarah; Lehnert, Stefan; Steinacker, Petra; Tawfik, Saskia; Tumani, Hayrettin; von Arnim, Christine A. F.; Otto, Markus] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany; [Jahn, Olaf] DFG Res Ctr Mol Physiol Brain, Gottingen, Germany; [Soininen, Hilkka; Herukka, Sanna-Kaisa] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Soininen, Hilkka; Herukka, Sanna-Kaisa] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Neumann, Manuela] Univ Zurich, Inst Neuropathol, Zurich, Switzerland; [Kretzschmar, Hans A.] Univ Munich, Inst Neuropathol, D-8000 Munich, Germany; [Kulaksiz, Hasan] Univ Ulm, Dept Internal Med, D-7900 Ulm, Germany; [Lenter, Martin; Ferger, Boris; Hengerer, Bastian] Boehringer Ingelheim GmbH & Co KG, CNS Dis Res, Biberach, Germany; [Wiltfang, Jens] Univ Essen Gesamthsch, Dept Psychiat, Essen, Germany; [Parnetti, Lucilla] Univ Perugia, Dept Neurol, I-06100 Perugia, Italy	Ulm University; Max Planck Society; German Research Foundation (DFG); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Zurich; University of Munich; Ulm University; Boehringer Ingelheim; University of Duisburg Essen; University of Perugia	Otto, M (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	markus.otto@uni-ulm.de	Jahn, Olaf/AAD-8212-2020; Cruz e Silva, Odete/AAH-5595-2020; Parnetti, Lucilla/K-8258-2016; Otto, Markus/F-4304-2015; Neumann, Manuela/F-6558-2011	Jahn, Olaf/0000-0002-3397-8924; Parnetti, Lucilla/0000-0001-5722-3967; Otto, Markus/0000-0003-4273-4267; Neumann, Manuela/0000-0002-6232-4057; Wiltfang, Jens/0000-0003-1492-5330	Landesstiftung Baden-Wurttemberg [P-LS-Prot/42]; European Comission (cNeupro, NeuroTAS)	Landesstiftung Baden-Wurttemberg; European Comission (cNeupro, NeuroTAS)	This work was supported by the Landesstiftung Baden-Wurttemberg (P-LS-Prot/42) and the European Comission (cNeupro, NeuroTAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 1999, INT J GERIATR PSYCH, V14, P866, DOI 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.3.CO;2-Q; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Andersson M, 2011, INT J GERIATR PSYCH, V26, P100, DOI 10.1002/gps.2496; Bothe MR, 2010, J NEURAL TRANSM, V117, P353, DOI 10.1007/s00702-010-0370-2; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2000, ACTA NEUROPATHOL, V99, P489, DOI 10.1007/s004010051150; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Caballol N, 2007, MOVEMENT DISORD, V22, pS358, DOI 10.1002/mds.21677; Crowther DC, 2002, HUM MUTAT, V20, P1, DOI 10.1002/humu.10100; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Di Napoli Mario, 2007, Expert Rev Neurother, V7, P1693, DOI 10.1586/14737175.7.12.1693; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Geser F, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20535; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; GROSS V, 1982, EUR J BIOCHEM, V129, P317, DOI 10.1111/j.1432-1033.1982.tb07054.x; Hwang H, 2010, MASS SPECTROM REV, V29, P79, DOI 10.1002/mas.20221; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Jellinger KA, 2009, BBA-MOL BASIS DIS, V1792, P730, DOI 10.1016/j.bbadis.2008.07.006; Jesse S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010079; Jesse S, 2009, CNS NEUROSCI THER, V15, P157, DOI 10.1111/j.1755-5949.2008.00064.x; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kok KF, 2007, NETH J MED, V65, P160; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lehnert S, 2012, EXP NEUROL, V234, P499, DOI 10.1016/j.expneurol.2012.01.024; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; Lomas DA, 2005, BIOCHEM SOC T, V33, P321, DOI 10.1042/BST0330321; Louis ED, 1997, ARCH NEUROL-CHICAGO, V54, P260, DOI 10.1001/archneur.1997.00550150024011; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mukaetova-Ladinska EB, 2006, MECH AGEING DEV, V127, P188, DOI 10.1016/j.mad.2005.09.014; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; Parnetti L, 2008, BIOL PSYCHIAT, V64, P850, DOI 10.1016/j.biopsych.2008.02.016; Poewe W, 2008, INT J CLIN PRACT, V62, P1581, DOI 10.1111/j.1742-1241.2008.01869.x; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Rongve A, 2006, DRUG AGING, V23, P807, DOI 10.2165/00002512-200623100-00004; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schnack C, 2008, NEUROSCIENCE, V154, P1450, DOI 10.1016/j.neuroscience.2008.02.049; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singh B, 2009, MATURITAS, V62, P230, DOI 10.1016/j.maturitas.2008.12.022; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Wolters EC, 2006, J NEURAL TRANSM-SUPP, P309; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394	58	25	25	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48783	10.1371/journal.pone.0048783	http://dx.doi.org/10.1371/journal.pone.0048783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144969	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500034
J	Liu, L; Chen, SJ				Liu, Liang; Chen, Shi-Jie			Coarse-Grained Prediction of RNA Loop Structures	PLOS ONE			English	Article							DISCRETE MOLECULAR-DYNAMICS; KNOWLEDGE-BASED POTENTIALS; VIRTUAL BOND MODEL; DE-NOVO PREDICTION; PROTEIN DATA-BANK; SECONDARY STRUCTURE; POLYNUCLEOTIDE CHAINS; CONFIGURATIONAL STATISTICS; 3-DIMENSIONAL STRUCTURES; FOLDING THERMODYNAMICS	One of the key issues in the theoretical prediction of RNA folding is the prediction of loop structure from the sequence. RNA loop free energies are dependent on the loop sequence content. However, most current models account only for the loop length-dependence. The previously developed "Vfold'' model (a coarse-grained RNA folding model) provides an effective method to generate the complete ensemble of coarse-grained RNA loop and junction conformations. However, due to the lack of sequence-dependent scoring parameters, the method is unable to identify the native and near-native structures from the sequence. In this study, using a previously developed iterative method for extracting the knowledge-based potential parameters from the known structures, we derive a set of dinucleotide-based statistical potentials for RNA loops and junctions. A unique advantage of the approach is its ability to go beyond the the (known) native structures by accounting for the full free energy landscape, including all the nonnative folds. The benchmark tests indicate that for given loop/junction sequences, the statistical potentials enable successful predictions for the coarse-grained 3D structures from the complete conformational ensemble generated by the Vfold model. The predicted coarse-grained structures can provide useful initial folds for further detailed structural refinement.	[Chen, Shi-Jie] Univ Missouri, Dept Phys, Columbia, MO 65211 USA; Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Chen, SJ (corresponding author), Univ Missouri, Dept Phys, Columbia, MO 65211 USA.	chenshi@missouri.edu		Chen, Shi-Jie/0000-0002-8093-7244	National Institutes of Health (NIH) [GM063732]; National Science Foundation (NSF) [MCB0920067, MCB0920411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063732] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grant GM063732 and National Science Foundation (NSF) grants MCB0920067 and MCB0920411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernauer J, 2011, RNA, V17, P1066, DOI 10.1261/rna.2543711; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bida JP, 2012, RNA, V18, P385, DOI 10.1261/rna.027201.111; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Cao S, 2005, RNA, V11, P1884, DOI 10.1261/rna.2109105; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cao S, 2012, NUCLEIC ACIDS RES, V40, P4681, DOI 10.1093/nar/gks052; Cao S, 2011, J PHYS CHEM B, V115, P4216, DOI 10.1021/jp112059y; Cao S, 2010, RNA, V16, P538, DOI 10.1261/rna.1800210; Cao S, 2009, RNA, V15, P696, DOI 10.1261/rna.1429009; Capriotti E, 2008, CURR BIOINFORM, V3, P32; Capriotti E, 2011, BIOINFORMATICS, V27, P1086, DOI 10.1093/bioinformatics/btr093; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Cruz J, 2012, RNA, V8, P1; Dale T, 2000, RNA, V6, P608, DOI 10.1017/S1355838200992495; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Dima RI, 2005, J MOL BIOL, V347, P53, DOI 10.1016/j.jmb.2004.12.012; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Duarte CM, 1998, J MOL BIOL, V284, P1465, DOI 10.1006/jmbi.1998.2233; FERRO DR, 1977, ACTA CRYSTALLOGR A, V33, P345, DOI 10.1107/S0567739477000862; Flores SC, 2010, RNA, V16, P1769, DOI 10.1261/rna.2112110; Flory P. J., 1969, BIOPOLYMERS, V8, P699, DOI DOI 10.1002/BIP.1969.360080514; Gherghe CM, 2009, J AM CHEM SOC, V131, P2541, DOI 10.1021/ja805460e; Giese MR, 1998, BIOCHEMISTRY-US, V37, P1094, DOI 10.1021/bi972050v; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huang SY, 2006, J COMPUT CHEM, V27, P1866, DOI 10.1002/jcc.20504; Hyeon C, 2007, BIOPHYS J, V92, P731, DOI 10.1529/biophysj.106.093062; Jonikas MA, 2009, RNA, V15, P189, DOI 10.1261/rna.1270809; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Laing C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/283101; Leontis N., 2012, RNA 3D STRUCTURE ANA; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2002, BIOCHIMIE, V84, P961, DOI 10.1016/S0300-9084(02)01463-3; Liu LA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3447385; Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Murray LJW, 2003, P NATL ACAD SCI USA, V100, P13904, DOI 10.1073/pnas.1835769100; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; OLSON WK, 1975, MACROMOLECULES, V8, P272, DOI 10.1021/ma60045a006; OLSON WK, 1980, MACROMOLECULES, V13, P721, DOI 10.1021/ma60075a045; OLSON WK, 1972, BIOPOLYMERS, V11, P1, DOI 10.1002/bip.1972.360110102; Parisien M, 2012, J STRUCT BI IN PRESS; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Pasquali S, 2010, J PHYS CHEM B, V114, P11957, DOI 10.1021/jp102497y; Rother K, 2011, J MOL MODELING, P1; Schlick T, 2011, Q REV BIOPHYS, V44, P191, DOI 10.1017/S0033583510000284; Schudoma C, 2010, NUCLEIC ACIDS RES, V38, P970, DOI 10.1093/nar/gkp1010; Serra MJ, 1997, BIOCHEMISTRY-US, V36, P4844, DOI 10.1021/bi962608j; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; Sharma S, 2008, BIOINFORMATICS, V24, P1951, DOI 10.1093/bioinformatics/btn328; Skolnick J, 2000, PROTEINS, V38, P3, DOI 10.1002/(SICI)1097-0134(20000101)38:1<3::AID-PROT2>3.0.CO;2-S; Sorin EJ, 2003, BIOPHYS J, V85, P790, DOI 10.1016/S0006-3495(03)74520-2; Sripakdeevong P, 2011, P NATL ACAD SCI USA, V108, P20573, DOI 10.1073/pnas.1106516108; Thomas PD, 1996, J MOL BIOL, V257, P457, DOI 10.1006/jmbi.1996.0175; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Vecenie CJ, 2006, BIOCHEMISTRY-US, V45, P1400, DOI 10.1021/bi051750u; Villa A, 2006, J CHEM THEORY COMPUT, V2, P1228, DOI 10.1021/ct600160z; Wadley LM, 2007, J MOL BIOL, V372, P942, DOI 10.1016/j.jmb.2007.06.058; Wu JC, 2009, J MOL BIOL, V391, P769, DOI 10.1016/j.jmb.2009.06.036; Xia Z, 2010, J PHYS CHEM B, V114, P13497, DOI 10.1021/jp104926t; Yang SC, 2010, J PHYS CHEM B, V114, P10039, DOI 10.1021/jp1057308; Zhang J, 2009, RNA, V15, P2248, DOI 10.1261/rna.1723609; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	74	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48460	10.1371/journal.pone.0048460	http://dx.doi.org/10.1371/journal.pone.0048460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144887	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500021
J	Therrien, AS; Lyons, J; Balasubramaniam, R				Therrien, Amanda S.; Lyons, James; Balasubramaniam, Ramesh			Sensory Attenuation of Self-Produced Feedback: The Lombard Effect Revisited	PLOS ONE			English	Article							THETA-BURST STIMULATION; PRIMATE AUDITORY-CORTEX; FINGER FORCE PRODUCTION; PRIMARY MOTOR CORTEX; CEREBRAL-BLOOD-FLOW; SPEECH PRODUCTION; VISUAL FEEDBACK; VOICE; MODULATION; VOCALIZATIONS	The Lombard effect describes the automatic and involuntary increase in vocal intensity that speakers exhibit in a noisy environment. Previous studies of the Lombard effect have typically focused on the relationship between speaking and hearing. Automatic and involuntary increases in motor output have also been noted in studies of finger force production, an effect attributed to mechanisms of sensory attenuation. The present study tested the hypothesis that sensory attenuation mechanisms also underlie expression of the Lombard effect. Participants vocalized phonemes in time with a metronome, while auditory and visual feedback of their performance were manipulated or removed during the course of the trial. We demonstrate that providing a visual reference to calibrate somatosensory-based judgments of current vocal intensity resulted in reduced expression of the Lombard effect. Our results suggest that sensory attenuation effects typically seen in fingertip force production play an important role in the control of speech volume. Citation: Therrien AS, Lyons J, Balasubramaniam R (2012) Sensory Attenuation of Self-Produced Feedback: The Lombard Effect Revisited. PLoS ONE 7(11): e49370. doi:10.1371/journal.pone.0049370	[Therrien, Amanda S.; Lyons, James; Balasubramaniam, Ramesh] McMaster Univ, Dept Kinesiol, Sensorimotor Neurosci Lab, Hamilton, ON, Canada	McMaster University	Therrien, AS (corresponding author), McMaster Univ, Dept Kinesiol, Sensorimotor Neurosci Lab, Hamilton, ON, Canada.	therrias@mcmaster.ca	Balasubramaniam, Ramesh/GWC-4248-2022; Therrien, Amanda/GWU-9587-2022; Lyons, James L/A-9076-2008	Balasubramaniam, Ramesh/0000-0001-7575-3080; Lyons, James L/0000-0003-1995-8836; Therrien, Amanda/0000-0003-0396-860X	Natural Sciences and Engineering Research Council [PGSD-392103-2010]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/index_eng.asp) doctoral scholarship (PGSD-392103-2010) awarded to AST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Burnett TA, 1997, J VOICE, V11, P202, DOI 10.1016/S0892-1997(97)80079-3; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; Crone NE, 2001, NEUROLOGY, V57, P2045, DOI 10.1212/WNL.57.11.2045; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Dhanjal NS, 2008, J NEUROSCI, V28, P9969, DOI 10.1523/JNEUROSCI.2607-08.2008; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Erickson D, 2002, PHONETICA, V59, P134, DOI 10.1159/000066067; Ford JM, 2001, BIOL PSYCHIAT, V50, P540, DOI 10.1016/S0006-3223(01)01166-0; Garnier M, 2010, J SPEECH LANG HEAR R, V53, P588, DOI 10.1044/1092-4388(2009/08-0138); Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; Larsell O, 1923, J COMP NEUROL, V36, P89, DOI 10.1002/cne.900360202; Laugesen S, 2009, J AM ACAD AUDIOL, V20, P503, DOI 10.3766/jaaa.20.8.5; Laukkanen AM, 2004, J VOICE, V18, P475, DOI 10.1016/j.jvoice.2003.05.007; LETOWSKI T, 1993, EAR HEARING, V14, P332, DOI 10.1097/00003446-199310000-00004; Leydon C, 2003, J ACOUST SOC AM, V114, P1575, DOI 10.1121/1.1603230; Lombard E, 1911, ANN MALADIES OREILLE, P101; Love EK, 2010, ANIM BEHAV, V80, P509, DOI 10.1016/j.anbehav.2010.05.031; Nasir SM, 2008, NAT NEUROSCI, V11, P1217, DOI 10.1038/nn.2193; Nasir SM, 2006, CURR BIOL, V16, P1918, DOI 10.1016/j.cub.2006.07.069; Patel R, 2008, J SPEECH LANG HEAR R, V51, P209, DOI 10.1044/1092-4388(2008/016); PAUS T, 1995, J NEUROPHYSIOL, V74, P2179, DOI 10.1152/jn.1995.74.5.2179; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; PICK HL, 1989, J ACOUST SOC AM, V85, P894, DOI 10.1121/1.397561; Pittman AL, 2001, J SPEECH LANG HEAR R, V44, P487, DOI 10.1044/1092-4388(2001/038); RUDOLPH CY, 1975, J COMMUN DISORD, V8, P317, DOI 10.1016/0021-9924(75)90032-5; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Smotherman MS, 2007, BEHAV BRAIN RES, V182, P315, DOI 10.1016/j.bbr.2007.03.008; Therrien AS, 2011, NEUROPSYCHOLOGIA, V49, P2941, DOI 10.1016/j.neuropsychologia.2011.06.023; Therrien AS, 2010, NEUROSCI LETT, V479, P69, DOI 10.1016/j.neulet.2010.05.033; Therrien AS, 2010, EXP BRAIN RES, V201, P673, DOI 10.1007/s00221-009-2084-y; TONKINSON S, 1994, J VOICE, V8, P24, DOI 10.1016/S0892-1997(05)80316-9; Toyomura A, 2007, NEUROSCIENCE, V146, P499, DOI 10.1016/j.neuroscience.2007.02.023; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710; Voss M, 2007, NEUROPSYCHOLOGIA, V45, P2712, DOI 10.1016/j.neuropsychologia.2007.04.008; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Zollinger SA, 2011, CURR BIOL, V21, pR614, DOI 10.1016/j.cub.2011.06.003	44	14	59	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49370	10.1371/journal.pone.0049370	http://dx.doi.org/10.1371/journal.pone.0049370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053KE	23145166	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500105
J	Wei, N; Zhang, L; Huang, H; Chen, Y; Zheng, J; Zhou, X; Yi, F; Du, Q; Liang, ZC				Wei, Na; Zhang, Lei; Huang, Huang; Chen, Yue; Zheng, Jie; Zhou, Xiao; Yi, Fan; Du, Quan; Liang, Zicai			siRNA Has Greatly Elevated Mismatch Tolerance at 3 '-UTR Sites	PLOS ONE			English	Article							RNAI ENZYME COMPLEX; DOUBLE-STRANDED-RNA; MESSENGER-RNAS; CAENORHABDITIS-ELEGANS; GENE-REGULATION; AGO PROTEINS; TARGET RNA; ARGONAUTE; INTERFERENCE; MICRORNA	It has been noted that target sites located in the coding region or the 3'-untranslated region (3'-UTR) can be silenced to significantly different levels by the same siRNA, but little is known about at what specificity the silencing was achieved. In an exploration of positional effects on siRNA specificity by luciferase reporter system, we surprisingly discovered that siRNA had greatly elevated tolerance towards mismatches in target sites in the 3'-UTR of the mRNA compared with the same target sites cloned in the coding region. Assessment of changes in protein and mRNA levels suggested that the differential mismatch tolerance might have resulted from location-specific translational repression in the 3'-UTR. Ablation of argonaute proteins by AGO-specific siRNAs revealed that the AGO2 had major impact on siRNA silencing activity against sites in both coding region and 3'-UTR, while the silencing of nonnucleolytic AGO proteins (AGO1, AGO3 and AGO4) did not significantly affect silencing of sites in either region. This paper revealed the discovery that the specificity of an siRNA can be affected by the location of its target site. Citation: Wei N, Zhang L, Huang H, Chen Y, Zheng J, et al. (2012) siRNA Has Greatly Elevated Mismatch Tolerance at 3'-UTR Sites. PLoS ONE 7(11): e49309. doi:10.1371/journal.pone.0049309	[Wei, Na; Zhang, Lei; Huang, Huang; Zheng, Jie; Zhou, Xiao; Yi, Fan; Du, Quan; Liang, Zicai] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Chen, Yue; Du, Quan] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China	Peking University; Peking University	Du, Q (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	quan.du@pku.edu.cn; liangz@pku.edu.cn	Liang, Zicai/A-2646-2013; Huang, Huang/AAG-6281-2019	Huang, Huang/0000-0002-8377-4823	National Natural Science Foundation of China [30871385, 30873187]; Beijing Natural Science Foundation [5092011]; National Basic Research Program of China [2011CBA01102]; Shanghai Science and Technology Committee [10411969100]; Department of Education of China [20090001110052, 200800010019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Department of Education of China	This work was supported by the National Natural Science Foundation of China, 30871385 and 30873187; Beijing Natural Science Foundation, 5092011; the National Basic Research Program of China, 2011CBA01102; a grant from Shanghai Science and Technology Committee, 10411969100; and the Department of Education of China, 20090001110052 and 200800010019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Du Q, 2004, BIOCHEM BIOPH RES CO, V325, P243, DOI 10.1016/j.bbrc.2004.09.222; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Gusella M, 2007, PHARMACOGENOMICS, V8, P985, DOI 10.2217/14622416.8.8.985; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hikami K, 2011, ARTHRITIS RHEUM-US, V63, P755, DOI 10.1002/art.30188; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martin SE, 2006, FEBS LETT, V580, P3694, DOI 10.1016/j.febslet.2006.05.056; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wang J, 2006, BIOCHEM BIOPH RES CO, V340, P491, DOI 10.1016/j.bbrc.2005.12.035; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733	38	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49309	10.1371/journal.pone.0049309	http://dx.doi.org/10.1371/journal.pone.0049309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145149	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500101
J	Zhang, Y; Luo, CX; Zou, K; Xie, ZW; Brandman, O; Ouyang, Q; Li, H				Zhang, Yi; Luo, Chunxiong; Zou, Ke; Xie, Zhengwei; Brandman, Onn; Ouyang, Qi; Li, Hao			Single Cell Analysis of Yeast Replicative Aging Using a New Generation of Microfluidic Device	PLOS ONE			English	Article							LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; PROTEIN; INHERITANCE; LONGEVITY; MSN4P; MSN2P	A major limitation to yeast aging study has been the inability to track mother cells and observe molecular markers during the aging process. The traditional lifespan assay relies on manual micro-manipulation to remove daughter cells from the mother, which is laborious, time consuming, and does not allow long term tracking with high resolution microscopy. Recently, we have developed a microfluidic system capable of retaining mother cells in the microfluidic chambers while removing daughter cells automatically, making it possible to observe fluorescent reporters in single cells throughout their lifespan. Here we report the development of a new generation of microfluidic device that overcomes several limitations of the previous system, making it easier to fabricate and operate, and allowing functions not possible with the previous design. The basic unit of the device consists of microfluidic channels with pensile columns that can physically trap the mother cells while allowing the removal of daughter cells automatically by the flow of the fresh media. The whole microfluidic device contains multiple independent units operating in parallel, allowing simultaneous analysis of multiple strains. Using this system, we have reproduced the lifespan curves for the known long and short-lived mutants, demonstrating the power of the device for automated lifespan measurement. Following fluorescent reporters in single mother cells throughout their lifespan, we discovered a surprising change of expression of the translation elongation factor TEF2 during aging, suggesting altered translational control in aged mother cells. Utilizing the capability of the new device to trap mother-daughter pairs, we analyzed mother-daughter inheritance and found age dependent asymmetric partitioning of a general stress response reporter between mother and daughter cells.	[Zhang, Yi; Luo, Chunxiong; Zou, Ke; Xie, Zhengwei; Ouyang, Qi] Peking Univ, Ctr Quantitat Biol, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China; [Zhang, Yi; Luo, Chunxiong; Zou, Ke; Xie, Zhengwei; Ouyang, Qi] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Zhang, Yi; Zou, Ke; Li, Hao] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Zhang, Yi; Zou, Ke; Li, Hao] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Brandman, Onn] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Ouyang, Qi] Peking Univ, Peking Tsinghua Ctr Life Sci, Dept Phys, Beijing 100871, Peoples R China	Peking University; Peking University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Peking University	Ouyang, Q (corresponding author), Peking Univ, Ctr Quantitat Biol, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China.	qi@pku.edu.cn; haoli@genome.ucsf.edu		Luo, Chunxiong/0000-0001-8974-7693; Zhang, Yi/0000-0001-6609-8635	NIH [R01 (GM070808)]; Packard Fellowship in Science and Engineering; NIH Center for Systems and Synthetic Biology [P50 GM081879]; National Natural Science Foundation (NSF) of China [10721463]; Ministry of Science and Technology (MOST) of China [2009CB918500]; Chinese Scholarship Council(CSC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM070808] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship in Science and Engineering; NIH Center for Systems and Synthetic Biology; National Natural Science Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); Chinese Scholarship Council(CSC)(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH R01 (GM070808) and a Packard Fellowship in Science and Engineering to HL, the NIH Center for Systems and Synthetic Biology (P50 GM081879), National Natural Science Foundation (NSF) of China (10721463), and by the Ministry of Science and Technology (MOST) of China (2009CB918500). It was also supported by Chinese Scholarship Council(CSC) scholarship to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Ballou CE, 1982, MOL BIOL YEAST SACCH; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Garreau H, 2000, MICROBIOL-UK, V146, P2113, DOI 10.1099/00221287-146-9-2113; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Koschwanez J, 2005, AUT SCI ENG IEEE INT, DOI [10.1109/COASE.2005.1506738, DOI 10.1109/COASE.2005.1506738]; Lai CY, 2002, GENETICS, V162, P73; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Luo CX, 2009, BIOMED MICRODEVICES, V11, P981, DOI 10.1007/s10544-009-9315-7; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Powell CD, 2003, MICROBIOL-SGM, V149, P3129, DOI 10.1099/mic.0.25940-0; Ryley J, 2006, YEAST, V23, P1065, DOI 10.1002/yea.1412; Schekman R, 1982, SECRETARY PROCESS YE; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; VANONI M, 1983, J BACTERIOL, V156, P1282, DOI 10.1128/JB.156.3.1282-1291.1983; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x	29	38	39	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48275	10.1371/journal.pone.0048275	http://dx.doi.org/10.1371/journal.pone.0048275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144860	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500017
J	Davis, AP; Gole, TW; Baena, S; Moat, J				Davis, Aaron P.; Gole, Tadesse Woldemariam; Baena, Susana; Moat, Justin			The Impact of Climate Change on Indigenous Arabica Coffee (Coffea arabica): Predicting Future Trends and Identifying Priorities	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIOCLIMATE ENVELOPE MODELS; GENETIC DIVERSITY; MOUNTAINS; RANGE; AFLP	Precise modelling of the influence of climate change on Arabica coffee is limited; there are no data available for indigenous populations of this species. In this study we model the present and future predicted distribution of indigenous Arabica, and identify priorities in order to facilitate appropriate decision making for conservation, monitoring and future research. Using distribution data we perform bioclimatic modelling and examine future distribution with the HadCM3 climate model for three emission scenarios (A1B, A2A, B2A) over three time intervals (2020, 2050, 2080). The models show a profoundly negative influence on indigenous Arabica. In a locality analysis the most favourable outcome is a c. 65% reduction in the number of pre-existing bioclimatically suitable localities, and at worst an almost 100% reduction, by 2080. In an area analysis the most favourable outcome is a 38% reduction in suitable bioclimatic space, and the least favourable a c. 90% reduction, by 2080. Based on known occurrences and ecological tolerances of Arabica, bioclimatic unsuitability would place populations in peril, leading to severe stress and a high risk of extinction. This study establishes a fundamental baseline for assessing the consequences of climate change on wild populations of Arabica coffee. Specifically, it: (1) identifies and categorizes localities and areas that are predicted to be under threat from climate change now and in the short-to medium-term (2020-2050), representing assessment priorities for ex situ conservation; (2) identifies 'core localities' that could have the potential to withstand climate change until at least 2080, and therefore serve as long-term in situ storehouses for coffee genetic resources; (3) provides the location and characterization of target locations (populations) for on-the-ground monitoring of climate change influence. Arabica coffee is confimed as a climate sensitivite species, supporting data and inference that existing plantations will be neagtively impacted by climate change.	[Davis, Aaron P.; Baena, Susana; Moat, Justin] Royal Bot Gardens, Herbarium, Richmond, Surrey, England; [Gole, Tadesse Woldemariam] Environm & Coffee Forest Forum, Addis Ababa, Ethiopia	Royal Botanic Gardens, Kew	Davis, AP (corresponding author), Royal Bot Gardens, Herbarium, Richmond, Surrey, England.	a.davis@kew.org; j.moat@kew.org	Gole, Tadesse/AAE-5470-2021; Hill, Jason/A-8919-2008	Hill, Jason/0000-0001-7609-6713; Moat, Justin/0000-0002-5513-3615	Bentham-Moxon Trust (Royal Botanic Gardens, Kew); USAID JGMUST; World Coffee Research (WCR)	Bentham-Moxon Trust (Royal Botanic Gardens, Kew); USAID JGMUST(United States Agency for International Development (USAID)); World Coffee Research (WCR)	Part of this study was funded by the Bentham-Moxon Trust (Royal Botanic Gardens, Kew) (http://www.kew.org/about-kew/policies-information/bentham-moxon/grants/index.htm). Fieldwork in South Sudan was funded by the USAID JGMUST Project and World Coffee Research (WCR) (http://worldcoffeeresearch.org/). Publication costs were supported by World Coffee Research (WCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adugna G, 2005, Z PFLANZENK PFLANZEN, V112, P134; ALEGRE G., 1959, Agron. trop., V14, P23; Anthony F, 2002, THEOR APPL GENET, V104, P894, DOI 10.1007/s00122-001-0798-8; Anthony F, 2001, EUPHYTICA, V118, P53, DOI 10.1023/A:1004013815166; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Baeten L, 2009, J ECOL, V97, P109, DOI 10.1111/j.1365-2745.2008.01455.x; Baeten L, 2010, PLANT ECOL EVOL, V143, P19, DOI 10.5091/plecevo.2010.414; Baker PS, 2007, SCAA C HAND LONG BEA; Burkhardt J., 2007, 21st International Conference on Coffee Science, Montpellier, France, 11-15 September, 2006, P1032; CAMARGO A P D, 1985, Pesquisa Agropecuaria Brasileira, V20, P831; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; DaMatta Fábio Murilo, 2004, Braz. J. Plant Physiol., V16, P1, DOI 10.1590/S1677-04202004000100001; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; Davis AP, 2009, ANN MO BOT GARD, V96, P68, DOI 10.3417/2006205; Davis AP, 2004, BOT J LINN SOC, V146, P237, DOI 10.1111/j.1095-8339.2004.00328.x; Demel Teketay., 1999, WALIA J ETHIOPIAN WI, V20, P28; Dessalegn Y, 2008, AFR J BIOTECHNOL, V7, P3193; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellis CJ, 2011, SYST BIODIVERS, V9, P307, DOI 10.1080/14772000.2011.634448; ESRI, 2012, ARCGIS REL 10 1; Franco CM, 1958, INFLUENCE TEMPERATUR; Franklin, 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Friis I, 1979, P 9 PLEN M AETFAT, P63; Friis Ib, 2010, Kongelige Danske Videnskabernes Selskab Biologiske Skrifter, V58, P9; Gole TW, 2003, THESIS U BONN GERMAN; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Haggar J, 2011, COFFEE CLIMATE CHANG; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hein L, 2006, ECOL ECON, V60, P176, DOI 10.1016/j.ecolecon.2005.11.022; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; HOLMGREN PK, 1990, INDEX HERBARIORUM 1; Honnay O, 2002, ECOL LETT, V5, P525, DOI 10.1046/j.1461-0248.2002.00346.x; International Coffee Organization (ICO), 2012, TRAD STAT; IPCC (Intergovernmental Panel on Climate Change), 2000, SPECIAL REPORT EMISS; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Labouisse JP, 2008, GENET RESOUR CROP EV, V55, P1079, DOI 10.1007/s10722-008-9361-7; Lashermes P, 1996, EUPHYTICA, V87, P59, DOI 10.1007/BF00022965; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Mendesil E., 2003, ETHIOPIAN J BIOL SCI, V2, P61; Meyer FrederickG., 1968, FAO COFFEE MISSION E, P1; Montagnon C, 1996, GENET RESOUR CROP EV, V43, P221, DOI 10.1007/BF00123274; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Camargo Marcelo Bento Paes de, 2010, Bragantia, V69, P239, DOI 10.1590/S0006-87052010000100030; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Ramirez J, 2008, HIGH RESOLUTION STAT; Ramirez J, 2010, 1 CIAT CGIAR CCAFS; Ridley FV, 2011, THESIS DURHAM U; Rija AA, 2011, TROP CONSERV SCI, V4, P359, DOI 10.1177/194008291100400311; Schmitt, 2006, ECOLOGY DEV SERIES, V48; Senbeta F., 2007, Sinet, Ethiopian Journal of Science, V30, P13; Senbeta F, 2006, BIODIVERSITY ECOLOGY; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Taye K, 2006, ECOLOGY DEV SERIES, V46; Tesfaye T, 2006, KOMMUNIKATION BERATU, V72; Thomas A. S., 1942, EMPIRE JOUR EXP AGRIC, V10, P207; Titus A., 2008, Indian Coffee, V72, P19; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wrigley G, 1980, COFFEE TROPICAL AGR; Zullo Junior J., 2006, Meteorological Applications, V13, P69, DOI 10.1017/S135048270600257X	70	242	252	1	241	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47981	10.1371/journal.pone.0047981	http://dx.doi.org/10.1371/journal.pone.0047981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144840	Green Published, gold			2022-12-25	WOS:000311935800032
J	Kuboyama, K; Fujikawa, A; Masumura, M; Suzuki, R; Matsumoto, M; Noda, M				Kuboyama, Kazuya; Fujikawa, Akihiro; Masumura, Makoto; Suzuki, Ryoko; Matsumoto, Masahito; Noda, Masaharu			Protein Tyrosine Phosphatase Receptor Type Z Negatively Regulates Oligodendrocyte Differentiation and Myelination	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCAN; SUBSTRATE-TRAPPING SYSTEM; LONG-TERM POTENTIATION; MOLECULE HB-GAM; ZETA/RPTP-BETA; DEFICIENT MICE; 6B4 PROTEOGLYCAN/PHOSPHACAN; MULTIPLE-SCLEROSIS	Background: Fyn tyrosine kinase-mediated down-regulation of Rho activity through activation of p190RhoGAP is crucial for oligodendrocyte differentiation and myelination. Therefore, the loss of function of its counterpart protein tyrosine phosphatase (PTP) may enhance myelination during development and remyelination in demyelinating diseases. To test this hypothesis, we investigated whether Ptprz, a receptor-like PTP (RPTP) expressed abuntantly in oligodendrocyte lineage cells, is involved in this process, because we recently revealed that p190RhoGAP is a physiological substrate for Ptprz. Methodology/Principal Findings: We found an early onset of the expression of myelin basic protein (MBP), a major protein of the myelin sheath, and early initiation of myelination in vivo during development of the Ptprz-deficient mouse, as compared with the wild-type. In addition, oligodendrocytes appeared earlier in primary cultures from Ptprz-deficient mice than wild-type mice. Furthermore, adult Ptprz-deficient mice were less susceptible to experimental autoimmune encephalomyelitis (EAE) induced by active immunization with myelin/oligodendrocyte glycoprotein (MOG) peptide than were wild-type mice. After EAE was induced, the tyrosine phosphorylation of p190RhoGAP increased significantly, and the EAE-induced loss of MBP was markedly suppressed in the white matter of the spinal cord in Ptprz-deficient mice. Here, the number of T-cells and macrophages/microglia infiltrating into the spinal cord did not differ between the two genotypes after MOG immunization. All these findings strongly support the validity of our hypothesis. Conclusions/Significance: Ptprz plays a negative role in oligodendrocyte differentiation in early central nervous system (CNS) development and remyelination in demyelinating CNS diseases, through the dephosphorylation of substrates such as p190RhoGAP.	[Kuboyama, Kazuya; Fujikawa, Akihiro; Masumura, Makoto; Suzuki, Ryoko; Matsumoto, Masahito; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Japan; [Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan; [Masumura, Makoto] Asubio Pharma Co Ltd, Fac Pharmacol 2, Chuo Ku, Kobe, Hyogo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Asubio Pharma Co., Ltd.	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Japan.	madon@nibb.ac.jp	Matsumoto, Masahito/ABB-3002-2021; Noda, Masaharu/D-7146-2016; Fujikawa, Akihiro/K-9805-2015	Noda, Masaharu/0000-0002-3796-524X; Fujikawa, Akihiro/0000-0002-3950-0550; Kuboyama, Kazuya/0000-0002-9878-1209	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [24700387, 24500390] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Clements JM, 1997, J NEUROIMMUNOL, V74, P85, DOI 10.1016/S0165-5728(96)00210-X; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Kurazono S, 2001, NEUROSCI LETT, V304, P169, DOI 10.1016/S0304-3940(01)01778-5; Lafont D, 2009, BEHAV BRAIN RES, V201, P29, DOI 10.1016/j.bbr.2009.01.025; Larsen PH, 2004, J NEUROSCI, V24, P7597, DOI 10.1523/JNEUROSCI.2092-04.2004; LEVY JB, 1993, J BIOL CHEM, V268, P10573; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Massa PT, 2004, J NEUROSCI RES, V77, P15, DOI 10.1002/jnr.20155; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; Nakahara J, 2005, NEUROSCI LETT, V379, P116, DOI 10.1016/j.neulet.2004.12.066; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; Revest JM, 1999, EUR J NEUROSCI, V11, P1134, DOI 10.1046/j.1460-9568.1999.00521.x; Scarisbrick IA, 2008, CURR TOP MICROBIOL, V318, P133; Scarlato M, 2000, J NEUROSCI RES, V59, P430, DOI 10.1002/(SICI)1097-4547(20000201)59:3<430::AID-JNR18>3.0.CO;2-7; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066	45	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48797	10.1371/journal.pone.0048797	http://dx.doi.org/10.1371/journal.pone.0048797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144976	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800138
J	Li, WX; Chen, SF; Chen, LP; Yang, GY; Li, JT; Liu, HZ; Zhu, W				Li, Wen-Xue; Chen, Si-Fan; Chen, Li-Ping; Yang, Guang-Yu; Li, Jun-Tao; Liu, Hua-Zhang; Zhu, Wei			Thimerosal-Induced Apoptosis in Mouse C2C12 Myoblast Cells Occurs through Suppression of the PI3K/Akt/Survivin Pathway	PLOS ONE			English	Article							MERCURY-INDUCED AUTOIMMUNITY; SKELETAL-MUSCLE; OXIDATIVE STRESS; DOWN-REGULATION; SATELLITE CELL; SURVIVIN; CASPASE-3; ACTIVATION; EXPRESSION; DEATH	Background: Thimerosal, a mercury-containing preservative, is one of the most widely used preservatives and found in a variety of biological products. Concerns over its possible toxicity have reemerged recently due to its use in vaccines. Thimerosal has also been reported to be markedly cytotoxic to neural tissue. However, little is known regarding thimerosal-induced toxicity in muscle tissue. Therefore, we investigated the cytotoxic effect of thimerosal and its possible mechanisms on mouse C2C12 myoblast cells. Methodology/Principal Findings: The study showed that C2C12 myoblast cells underwent inhibition of proliferation and apoptosis after exposure to thimerosal (125-500 nM) for 24, 48 and 72 h. Thimerosal caused S phase arrest and induced apoptosis as assessed by flow cytometric analysis, Hoechst staining and immunoblotting. The data revealed that thimerosal could trigger the leakage of cytochrome c from mitochondria, followed by cleavage of caspase-9 and caspase-3, and that an inhibitor of caspase could suppress thimerosal-induced apoptosis. Thimerosal inhibited the phosphorylation of Akt(ser473) and survivin expression. Wortmannin, a PI3K inhibitor, inhibited Akt activity and decreased survivin expression, resulting in increased thimerosal-induced apoptosis in C2C12 cells, while the activation of PI3K/Akt pathway by mIGF-I (50 ng/ml) increased the expression of survivin and attenuated apoptosis. Furthermore, the inhibition of survivin expression by siRNA enhanced thimerosal-induced cell apoptosis, while overexpression of survivin prevented thimerosal-induced apoptosis. Taken together, the data show that the PI3K/Akt/survivin pathway plays an important role in the thimerosal-induced apoptosis in C2C12 cells. Conclusions/Significance: Our results suggest that in C2C12 myoblast cells, thimerosal induces S phase arrest and finally causes apoptosis via inhibition of PI3K/Akt/survivin signaling followed by activation of the mitochondrial apoptotic pathway.	[Li, Wen-Xue; Chen, Si-Fan; Yang, Guang-Yu; Li, Jun-Tao; Liu, Hua-Zhang; Zhu, Wei] Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou, Guangdong, Peoples R China; [Chen, Li-Ping] Sun Yet Sen Univ, Sch Publ Hlth, Fac Toxicol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, HZ (corresponding author), Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou, Guangdong, Peoples R China.	gouscon@qq.com	li, wenxue/K-7505-2014	li, wenxue/0000-0002-0346-5300				Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Bagenstose LM, 1999, IMMUNOL RES, V20, P67, DOI 10.1007/BF02786508; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126; Blum R, 2006, MOL CANCER THER, V5, P2337, DOI 10.1158/1535-7163.MCT-06-0193; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chandele A, 2004, NEOPLASIA, V6, P29, DOI 10.1016/S1476-5586(04)80051-4; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019780; Cheng TY, 2008, CONTACT DERMATITIS, V59, P353, DOI 10.1111/j.1600-0536.2008.01468.x; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Dupont-Versteegden EE, 2006, WORLD J GASTROENTERO, V12, P7463, DOI 10.3748/wjg.v12.i46.7463; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Friday BB, 2001, J CELL SCI, V114, P303; Geier DA, 2007, J TOXICOL ENV HEAL B, V10, P575, DOI 10.1080/10937400701389875; Geier David A, 2003, Pediatr Rehabil, V6, P97, DOI 10.1080/1363849031000139315; Geier MR, 2003, EXP BIOL MED, V228, P660, DOI 10.1177/153537020322800603; Goon ATJ, 2006, PEDIATR DERMATOL, V23, P117, DOI 10.1111/j.1525-1470.2006.00193.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457; Hammonds LM, 2009, INT J DERMATOL, V48, P271, DOI 10.1111/j.1365-4632.2009.03890.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Herdman ML, 2006, TOXICOL SCI, V92, P246, DOI 10.1093/toxsci/kfj205; Hishiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016828; Hu H, 1999, IMMUNOLOGY, V96, P348; Humphrey ML, 2005, NEUROTOXICOLOGY, V26, P407, DOI 10.1016/j.neuro.2005.03.008; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Lee S, 2006, ENVIRON TOXICOL PHAR, V22, P194, DOI 10.1016/j.etap.2006.03.003; Liao JW, 2006, TOXICOLOGY, V219, P73, DOI 10.1016/j.tox.2005.11.002; Liu SI, 2007, TOXICOL SCI, V100, P109, DOI 10.1093/toxsci/kfm205; Makani S, 2002, GENES IMMUN, V3, P270, DOI 10.1038/sj.gene.6363854; Maurice JM, 2010, ACTA PHARMACOL SIN, V31, P493, DOI 10.1038/aps.2010.20; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Meech R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011612; Miyake M, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-17; Miyake M, 2011, J CELL PHYSIOL, V226, P1128, DOI 10.1002/jcp.22434; Miyake T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028628; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Nierenberg DW, 1998, NEW ENGL J MED, V338, P1672, DOI 10.1056/NEJM199806043382305; Peroukides S, 2010, HISTOL HISTOPATHOL, V25, P299, DOI 10.14670/HH-25.299; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Primeau AJ, 2002, CAN J APPL PHYSIOL, V27, P349, DOI 10.1139/h02-020; Pronsato L, 2012, J ENDOCRINOL, V212, P371, DOI 10.1530/JOE-11-0234; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Salucci S, 2010, MICRON, V41, P966, DOI 10.1016/j.micron.2010.07.002; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Singleton JR, 2000, ENDOCRINOLOGY, V141, P2945, DOI 10.1210/en.141.8.2945; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Suneja T, 2001, J AM ACAD DERMATOL, V45, P23, DOI 10.1067/mjd.2001.113473; Tamm I, 1998, CANCER RES, V58, P5315; Tang C, 2009, ANTI-CANCER DRUG, V20, P249, DOI 10.1097/CAD.0b013e328327d476; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tews DS, 1997, NEUROPATH APPL NEURO, V23, P331, DOI 10.1046/j.1365-2990.1997.5998059.x; Tews DS, 1997, J NEUROPATH EXP NEUR, V56, P150, DOI 10.1097/00005072-199702000-00005; Tophkhane C, 2007, INT J ONCOL, V31, P867; Tudela E, 2008, CUTAN OCUL TOXICOL, V27, P187, DOI 10.1080/15569520802143436; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vescovo G, 2001, ACTA PHYSIOL SCAND, V171, P305, DOI 10.1046/j.1365-201x.2001.00832.x; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wattanakrai Penpun, 2007, Journal of the Medical Association of Thailand, V90, P1775; Woo KJ, 2006, MOL CARCINOGEN, V45, P657, DOI 10.1002/mc.20202; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yel L, 2005, INT J MOL MED, V16, P971; Yen YP, 2012, ARCH TOXICOL; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	73	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49064	10.1371/journal.pone.0049064	http://dx.doi.org/10.1371/journal.pone.0049064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145070	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800196
J	Liu, Y; Duan, YY; He, Y; Wang, J; Xia, MR; Yu, CS; Dong, HQ; Ye, J; Butzkueven, H; Li, KC; Shu, N				Liu, Yaou; Duan, Yunyun; He, Yong; Wang, Jun; Xia, Mingrui; Yu, Chunshui; Dong, Huiqing; Ye, Jing; Butzkueven, Helmut; Li, Kuncheng; Shu, Ni			Altered Topological Organization of White Matter Structural Networks in Patients with Neuromyelitis Optica	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; DIFFUSION-TENSOR; FUNCTIONAL CONNECTIVITY; SMALL-WORLD; DEFAULT-MODE; ANATOMICAL NETWORK; BRAIN ACTIVITY; MRI; ARCHITECTURE; IMPAIRMENT	Objective: To investigate the topological alterations of the whole-brain white-matter (WM) structural networks in patients with neuromyelitis optica (NMO). Methods: The present study involved 26 NMO patients and 26 age-and sex-matched healthy controls. WM structural connectivity in each participant was imaged with diffusion-weighted MRI and represented in terms of a connectivity matrix using deterministic tractography method. Graph theory-based analyses were then performed for the characterization of brain network properties. A multiple linear regression analysis was performed on each network metric between the NMO and control groups. Results: The NMO patients exhibited abnormal small-world network properties, as indicated by increased normalized characteristic path length, increased normalized clustering and increased small-worldness. Furthermore, largely similar hub distributions of the WM structural networks were observed between NMO patients and healthy controls. However, regional efficiency in several brain areas of NMO patients was significantly reduced, which were mainly distributed in the default-mode, sensorimotor and visual systems. Furthermore, we have observed increased regional efficiency in a few brain regions such as the orbital parts of the superior and middle frontal and fusiform gyri. Conclusion: Although the NMO patients in this study had no discernible white matter T2 lesions in the brain, we hypothesize that the disrupted topological organization of WM networks provides additional evidence for subtle, widespread cerebral WM pathology in NMO.	[Liu, Yaou; Duan, Yunyun; Yu, Chunshui; Li, Kuncheng] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China; [He, Yong; Wang, Jun; Xia, Mingrui; Shu, Ni] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Dong, Huiqing; Ye, Jing] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing, Peoples R China; [Butzkueven, Helmut] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	Capital Medical University; Beijing Normal University; Capital Medical University; University of Melbourne	Li, KC (corresponding author), Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China.	kunchengli55@gmail.com; nshu55@gmail.com	Shu, Ni/B-9583-2014; He, Yong/C-2161-2009; He, Yong/Q-5756-2018; Xia, Mingrui/J-3267-2019	Xia, Mingrui/0000-0003-4615-9132; He, Yong/0000-0002-7039-2850; Yu, Chunshui/0000-0001-5648-5199; Butzkueven, Helmut/0000-0003-3940-8727	National Science Foundation of China [81101038, 30930029, 30800267, 30870667, 81030028]; Beijing Natural Science Foundation [7102090]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Science Foundation of China (Nos. 81101038, 30930029, 30800267, 30870667 and 81030028), and the Beijing Natural Science Foundation (No. 7102090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Blanc F, 2008, ARCH NEUROL-CHICAGO, V65, P84, DOI 10.1001/archneurol.2007.16; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Cramer SC, 2001, MULT SCLER, V7, P364; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu Y, 2012, MULT SCLER J, V18, P1013, DOI 10.1177/1352458511431731; Liu Y, 2011, EUR J RADIOL, V80, P407, DOI 10.1016/j.ejrad.2010.05.002; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mikulis DJ, 2002, NEUROLOGY, V58, P794, DOI 10.1212/WNL.58.5.794; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Rocca MA, 2004, NEUROIMAGE, V21, P1061, DOI 10.1016/j.neuroimage.2003.10.013; Rocca MA, 2004, NEUROLOGY, V62, P476, DOI 10.1212/01.WNL.0000106946.08741.41; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schoonheim MM, 2012, MULT SCLER J, V18, P164, DOI 10.1177/1352458511422245; Schoonheim MM, 2010, NEUROLOGY, V74, P1246, DOI 10.1212/WNL.0b013e3181db9957; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2009, IEEE T MED IMAGING, V28, P1023, DOI 10.1109/TMI.2008.2012113	57	31	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48846	10.1371/journal.pone.0048846	http://dx.doi.org/10.1371/journal.pone.0048846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144994	Green Published, gold			2022-12-25	WOS:000311935800152
J	Nostl, A; Marsh, JE; Sorqvist, P				Nostl, Anatole; Marsh, John E.; Sorqvist, Patrik			Expectations Modulate the Magnitude of Attentional Capture by Auditory Events	PLOS ONE			English	Article							MISMATCH NEGATIVITY; INVOLUNTARY ATTENTION; ACOUSTIC NOVELTY; DISTRACTION; HABITUATION; SEQUENCES; MEMORY; MODEL; POTENTIALS; ACTIVATION	What determines the magnitude of attentional capture by deviant sound events? We combined the cross-modal oddball distraction paradigm with sequence learning to address this question. Participants responded to visual targets, each preceded by tones that formed a repetitive cross-trial standard sequence. In Experiment 1, with the standard tone sequence ...-660-440-660-880-.... Hz, either the 440 Hz or the 880 Hz standard was occasionally replaced by one of two deviant tones (220 Hz and 1100 Hz), that either differed slightly (by 220 Hz) or markedly (by 660 Hz) from the replaced standard. In Experiment 2, with the standard tone sequence ...-220-660-440-660-880-660-1100-... Hz, the 440 Hz and the 880 Hz standard was occasionally replaced by either a 220 Hz or a 1100 Hz pattern deviant. In both experiments, a high-pitch deviant was more captivating when it replaced a low-pitch standard, and a low-pitch deviant was more captivating when it replaced a high-pitch standard. These results indicate that the magnitude of attentional capture by deviant sound events depends on the discrepancy between the deviant event and the expected event, not on perceived local change.	[Nostl, Anatole; Marsh, John E.; Sorqvist, Patrik] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden; [Marsh, John E.] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England; [Sorqvist, Patrik] Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden	University of Gavle; University of Central Lancashire; Linkoping University	Nostl, A (corresponding author), Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden.	anatole.nostl@hig.se	Marsh, John E/J-8914-2012	Marsh, John Everett/0000-0002-9494-1287; Sorqvist, Patrik/0000-0002-7584-2275	Swedish Research Council [2010-2042]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The research reported in this paper was financially supported by a grant from the Swedish Research Council (2010-2042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendixen A, 2007, J COGNITIVE NEUROSCI, V19, P1664, DOI 10.1162/jocn.2007.19.10.1664; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Corral MJ, 2008, NEUROREPORT, V19, P1535, DOI 10.1097/WNR.0b013e3283110416; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cowan N., 1995, ATTENTION MEMORY INT; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Hughes RW, 2007, J EXP PSYCHOL LEARN, V33, P1050, DOI 10.1037/0278-7393.33.6.1050; Hughes RW, 2005, J EXP PSYCHOL LEARN, V31, P736, DOI 10.1037/0278-7393.31.4.736; Jaramillo M, 2000, NEUROSCI LETT, V290, P101, DOI 10.1016/S0304-3940(00)01344-6; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; NORDBY H, 1988, PSYCHOPHYSIOLOGY, V25, P262, DOI 10.1111/j.1469-8986.1988.tb01239.x; Parmentier FBR, 2008, COGNITION, V106, P408, DOI 10.1016/j.cognition.2007.03.008; Parmentier FBR, 2011, COGNITION, V119, P374, DOI 10.1016/j.cognition.2011.02.001; Parmentier FBR, 2008, COGNITION, V109, P345, DOI 10.1016/j.cognition.2008.09.005; SAMS M, 1984, PSYCHOPHYSIOLOGY, V21, P434, DOI 10.1111/j.1469-8986.1984.tb00223.x; Schadow J, 2009, NEUROIMAGE, V47, P651, DOI 10.1016/j.neuroimage.2009.04.074; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Schroger E, 2005, ACTA ACUST UNITED AC, V91, P490; Schroger E, 2007, PLOS ONE, V11, P1; Sorqvist P, 2012, PSYCHON B REV, V19, P245, DOI 10.3758/s13423-011-0203-9; UNGER SM, 1964, J EXP PSYCHOL, V67, P11, DOI 10.1037/h0044510; Vachon F, 2012, J EXP PSYCHOL LEARN, V38, P164, DOI 10.1037/a0025054; van Zuijen TL, 2005, COGNITIVE BRAIN RES, V23, P270, DOI 10.1016/j.cogbrainres.2004.10.007; Yago E, 2001, NEUROREPORT, V12, P4093, DOI 10.1097/00001756-200112210-00046	25	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48569	10.1371/journal.pone.0048569	http://dx.doi.org/10.1371/journal.pone.0048569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23144902	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800076
J	Roberts, BN; Christini, DJ				Roberts, Byron N.; Christini, David J.			The Relative Influences of Phosphometabolites and pH on Action Potential Morphology during Myocardial Reperfusion: A Simulation Study	PLOS ONE			English	Article							GUINEA-PIG HEART; EXTRACELLULAR POTASSIUM; CONTRACTILE FUNCTION; CONDUCTION BLOCK; CARDIAC-MUSCLE; ISCHEMIA; MODEL; ARRHYTHMIAS; EXCITATION; ACIDOSIS	Myocardial ischemia-reperfusion (IR) injury represents a constellation of pathological processes that occur when ischemic myocardium experiences a restoration of perfusion. Reentrant arrhythmias, which represent a particularly lethal manifestation of IR injury, can result when ischemic tissue exhibits decreased excitability and/or changes of action potential duration (APD), conditions that precipitate unidirectional conduction block. Many of the cellular components that are involved with IR injury are modulated by pH and/or phosphometabolites such as ATP and phosphocreatine (PCr), all of which can be manipulated in vivo and potentially in the clinical setting. Using a mathematical model of the cardiomyocyte that we previously developed to study ischemia and reperfusion, we performed a series of simulations with the aim of determining whether pH-or phosphometabolite-related processes play a more significant role in generating changes in excitability and action potential morphology that are associated with the development of reentry. In our simulations, persistent shortening of APD, action potential amplitude (APA), and depolarization of the resting membrane potential were more severe when ATP and PCr availability were suppressed during reperfusion than when extracellular pH recovery was inhibited. Reduced phosphometabolite availability and pH recovery affected multiple ion channels and exchangers. Some of these effects were the result of direct modulation by phosphometabolites and/or acidosis, while others resulted from elevated sodium and calcium loads during reperfusion. In addition, increasing ATP and PCr availability during reperfusion was more beneficial in terms of increasing APD and APA than was increasing the amount of pH recovery. Together, these results suggest that therapies directed at increasing ATP and/or PCr availability during reperfusion may be more beneficial than perturbing pH recovery with regard to mitigating action potential changes that increase the likelihood of reentrant arrhythmias.	[Christini, David J.] Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY USA; Weill Cornell Med Coll, Dept Physiol Biophys & Syst Biol, New York, NY USA	Cornell University; Cornell University	Christini, DJ (corresponding author), Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY USA.	dchristi@med.cornell.edu		Christini, David/0000-0003-0852-2922	Tri-Institutional Training Program in Computational Biology Medicine; Kenny Gordon Foundation; National Institutes of Health [R01HL094620]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094620] Funding Source: NIH RePORTER	Tri-Institutional Training Program in Computational Biology Medicine; Kenny Gordon Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: 1. Tri-Institutional Training Program in Computational Biology & Medicine (http://www.triiprograms.org/cbm/); 2. Kenny Gordon Foundation (http://www.kennygordonfoundation.com); 3. National Institutes of Health Grant #R01HL094620. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JZ, 2001, AM J PHYSIOL-HEART C, V281, pH2398, DOI 10.1152/ajpheart.2001.281.6.H2398; Befroy DE, 1999, AM J PHYSIOL-HEART C, V276, pH1236, DOI 10.1152/ajpheart.1999.276.4.H1236; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; CASCIO WE, 1992, CIRC RES, V70, P409, DOI 10.1161/01.RES.70.2.409; Crampin EJ, 2006, BIOPHYS J, V90, P3074, DOI 10.1529/biophysj.105.070557; DOERING AE, 1993, J PHYSIOL-LONDON, V466, P481; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Gaur N, 2009, CIRC RES, V105, P1196, DOI 10.1161/CIRCRESAHA.109.202267; Inserte J, 2008, CARDIOVASC RES, V77, P782, DOI 10.1093/cvr/cvm082; Jie X, 2010, HEART RHYTHM, V7, P379, DOI 10.1016/j.hrthm.2009.11.014; KLEBER AG, 1983, CIRC RES, V52, P442, DOI 10.1161/01.RES.52.4.442; Lakireddy V, 2005, AM J PHYSIOL-HEART C, V288, pH400, DOI 10.1152/ajpheart.00502.2004; Levchenko TS, 2010, METHODS MOL BIOL, V605, P361, DOI 10.1007/978-1-60327-360-2_25; MANDEL F, 1982, CIRC RES, V50, P310, DOI 10.1161/01.RES.50.2.310; Michailova A, 2005, BIOPHYS J, V88, P2234, DOI 10.1529/biophysj.104.046284; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; ORCHARD CH, 1994, CARDIOVASC RES, V28, P1312, DOI 10.1093/cvr/28.9.1312; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; Preckel B, 1998, J CARDIOVASC PHARM, V31, P179, DOI 10.1097/00005344-199802000-00002; Qu ZL, 2006, BIOPHYS J, V91, P793, DOI 10.1529/biophysj.106.080945; QUAN WL, 1990, CIRC RES, V66, P367, DOI 10.1161/01.RES.66.2.367; Roberts BN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002241; Terkildsen JR, 2007, AM J PHYSIOL-HEART C, V293, pH3036, DOI 10.1152/ajpheart.00771.2007; Tran K, 2009, BIOPHYS J, V96, P2029, DOI 10.1016/j.bpj.2008.11.045; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Xu L, 1996, CIRC RES, V79, P1100, DOI 10.1161/01.RES.79.6.1100; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47117	10.1371/journal.pone.0047117	http://dx.doi.org/10.1371/journal.pone.0047117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144801	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800014
J	Shindoh, N; Yoda, A; Yoda, Y; Sullivan, TJ; Weigert, O; Lane, AA; Kopp, N; Bird, L; Rodig, SJ; Fox, EA; Weinstock, DM				Shindoh, Nobuaki; Yoda, Akinori; Yoda, Yuka; Sullivan, Timothy J.; Weigert, Oliver; Lane, Andrew A.; Kopp, Nadja; Bird, Liat; Rodig, Scott J.; Fox, Edward A.; Weinstock, David M.			Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EML4-ALK FUSION GENE; LUNG-CANCER; EXPRESSION; CRLF2; ALK; LIBRARIES; MELANOMA; CELLS	There is a pressing need for methods to define the functional relevance of genetic alterations identified by next-generation sequencing of cancer specimens. We developed new approaches to efficiently construct full-length cDNA libraries from small amounts of total RNA, screen for transforming and resistance phenotypes, and deconvolute by next-generation sequencing. Using this platform, we screened a panel of cDNA libraries from primary specimens and cell lines in cytokine-dependent murine Ba/F3 cells. We demonstrate that cDNA library-based screening can efficiently identify DNA and RNA alterations that confer either cytokine-independent proliferation or resistance to targeted inhibitors, including RNA alterations and intergenic fusions. Using barcoded next-generation sequencing, we simultaneously deconvoluted cytokinein-dependent clones recovered after transduction of 21 cDNA libraries. This approach identified multiple gain-of-function alleles, including KRAS G12D, NRAS Q61K and an activating splice variant of ERBB2. This approach has broad applicability for identifying transcripts that confer proliferation, resistance and other phenotypes in vitro and potentially in vivo.	[Shindoh, Nobuaki; Yoda, Akinori; Yoda, Yuka; Weigert, Oliver; Lane, Andrew A.; Kopp, Nadja; Bird, Liat; Weinstock, David M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sullivan, Timothy J.; Fox, Edward A.] Dana Farber Canc Inst, Microarray Core, Boston, MA 02115 USA; [Rodig, Scott J.; Fox, Edward A.; Weinstock, David M.] Harvard Univ, Sch Med, Boston, MA USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Shindoh, Nobuaki] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Astellas Pharmaceuticals	Weinstock, DM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	dweinstock@partners.org	Rodig, Scott/Y-3889-2019	Lane, Andrew/0000-0001-7380-0226	Stand Up to Cancer Innovative Research Grant [SU2C-AACR-IRG0409]; American Cancer Society Research Scholar Grant [RSG-10-181-01-RMC]; Astellas Pharma Inc.; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER	Stand Up to Cancer Innovative Research Grant; American Cancer Society Research Scholar Grant(American Cancer Society); Astellas Pharma Inc.(Astellas Pharmaceuticals); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Stand Up to Cancer Innovative Research Grant SU2C-AACR-IRG0409 and American Cancer Society Research Scholar Grant RSG-10-181-01-RMC to DMW. NS was partially supported by Astellas Pharma Inc. OW was partially supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colleoni GWB, 2000, AM J PATHOL, V156, P781, DOI 10.1016/S0002-9440(10)64945-0; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; KERBEL RS, 1984, INVAS METAST, V4, P31; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; LEE F, 1985, P NATL ACAD SCI USA, V82, P4360, DOI 10.1073/pnas.82.13.4360; Mitra D, 2009, MOL CANCER THER, V8, P2152, DOI 10.1158/1535-7163.MCT-09-0295; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	18	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49201	10.1371/journal.pone.0049201	http://dx.doi.org/10.1371/journal.pone.0049201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145123	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800229
J	Tiwari, VK; Riera-Lizarazu, O; Gunn, HL; Lopez, K; Iqbal, MJ; Kianian, SF; Leonard, JM				Tiwari, Vijay K.; Riera-Lizarazu, Oscar; Gunn, Hilary L.; Lopez, KaSandra; Iqbal, M. Javed; Kianian, Shahryar F.; Leonard, Jeffrey M.			Endosperm Tolerance of Paternal Aneuploidy Allows Radiation Hybrid Mapping of the Wheat D-Genome and a Measure of gamma Ray-Induced Chromosome Breaks	PLOS ONE			English	Article							GENE-RICH REGIONS; 1ST-GENERATION WHOLE-GENOME; IRRADIATED POLLEN; ARABIDOPSIS-THALIANA; MAP CONSTRUCTION; SEED DEVELOPMENT; PHYSICAL MAP; CELL; IDENTIFICATION; MUTATIONS	Physical mapping and genome sequencing are underway for the approximate to 17 Gb wheat genome. Physical mapping methods independent of meiotic recombination, such as radiation hybrid (RH) mapping, will aid precise anchoring of BAC contigs in the large regions of suppressed recombination in Triticeae genomes. Reports of endosperm development following pollination with irradiated pollen at dosages that cause embryo abortion prompted us to investigate endosperm as a potential source of RH mapping germplasm. Here, we report a novel approach to construct RH based physical maps of all seven D-genome chromosomes of the hexaploid wheat 'Chinese Spring', simultaneously. An 81-member subset of endosperm samples derived from 20-Gy irradiated pollen was genotyped for deletions, and 737 markers were mapped on seven D-genome chromosomes. Analysis of well-defined regions of six chromosomes suggested a map resolution of similar to 830 kb could be achieved; this estimate was validated with assays of markers from a sequenced contig. We estimate that the panel contains similar to 6,000 deletion bins for D-genome chromosomes and will require similar to 18,000 markers for high resolution mapping. Map-based deletion estimates revealed a majority of 1-20 Mb interstitial deletions suggesting mutagenic repair of double-strand breaks in pollen provides a useful resource for RH mapping and map based cloning studies.	[Tiwari, Vijay K.; Gunn, Hilary L.; Lopez, KaSandra; Leonard, Jeffrey M.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Riera-Lizarazu, Oscar] Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India; [Iqbal, M. Javed; Kianian, Shahryar F.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA	Oregon State University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); North Dakota State University Fargo	Leonard, JM (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.	jeff.leonard@oregonstate.edu	Riera-Lizarazu, Oscar/ABG-7568-2021; Tiwari, Vijay/AAD-7197-2021	Riera-Lizarazu, Oscar/0000-0002-7477-4063; 	National Science Foundation, Plant Genome Research Program (NSF-PGRP) [DBI-082210]	National Science Foundation, Plant Genome Research Program (NSF-PGRP)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by funding from the National Science Foundation, Plant Genome Research Program (NSF-PGRP) grant No. DBI-082210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Berard A, 2009, PLANT BIOTECHNOL J, V7, P364, DOI 10.1111/j.1467-7652.2009.00404.x; BIRCHLER JA, 1991, GENETICS, V127, P609; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; CHOJECKI AJS, 1986, ANN BOT-LONDON, V58, P809, DOI 10.1093/oxfordjournals.aob.a087263; Chowdhary BP, 2003, GENOME RES, V13, P742, DOI 10.1101/gr.917503; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; ENGVILD KC, 1985, THEOR APPL GENET, V69, P457, DOI 10.1007/BF00251084; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; FALQUE M, 1994, EUPHYTICA, V75, P19, DOI 10.1007/BF00024527; Faris JD, 2000, GENETICS, V154, P823; Francki MG, 2009, MOL GENET GENOMICS, V281, P181, DOI 10.1007/s00438-008-0403-9; Gao WX, 2004, GENETICS, V167, P1317, DOI 10.1534/genetics.103.020479; Gill KS, 1996, GENETICS, V144, P1883; Gill KS, 1996, GENETICS, V143, P1001; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; Grossniklaus U, 2001, CURR OPIN PLANT BIOL, V4, P21, DOI 10.1016/S1369-5266(00)00130-8; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Haiminen N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-194; Hitte Christophe, 2008, V422, P65, DOI 10.1007/978-1-59745-581-7_5; Hossain KG, 2004, GENETICS, V168, P415, DOI 10.1534/genetics.103.022590; Hudson TJ, 2001, NAT GENET, V29, P201, DOI 10.1038/ng1001-201; JI LH, 1994, MOL GEN GENET, V243, P17, DOI 10.1007/BF00283871; Jones HB, 1996, GENOME RES, V6, P761, DOI 10.1101/gr.6.8.761; Kalavacharla V, 2006, GENETICS, V173, P1089, DOI 10.1534/genetics.106.056481; Kladnik A, 2006, J CEREAL SCI, V43, P209, DOI 10.1016/j.jcs.2005.09.004; Kowles R.V., 1988, INT REV CYTOL, P97, DOI [10.1016/s0074-7696(08)62007-0, DOI 10.1016/S0074-7696(08)62007-0]; Kwok C, 1998, NUCLEIC ACIDS RES, V26, P3562, DOI 10.1093/nar/26.15.3562; LAWRENCE S, 1991, P NATL ACAD SCI USA, V88, P7477, DOI 10.1073/pnas.88.17.7477; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Luo MC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-122; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; Morita R, 2009, GENES GENET SYST, V84, P361, DOI 10.1266/ggs.84.361; Musial K, 1998, ANN BOT-LONDON, V82, P747, DOI 10.1006/anbo.1998.0747; Musial K, 1999, SEX PLANT REPROD, V12, P110, DOI 10.1007/s004970050179; Naito K, 2005, GENETICS, V169, P881, DOI 10.1534/genetics.104.033654; Newell W, 1998, GENOME RES, V8, P493, DOI 10.1101/gr.8.5.493; Nguyen H. N., 2007, V8, P21, DOI 10.1007/7089_2007_107; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; PANDEY KK, 1986, HEREDITY, V57, P37, DOI 10.1038/hdy.1986.84; PANDEY KK, 1978, GENETICA, V49, P53; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Rakhmatullina EM, 2007, RUSS J GENET+, V43, P396, DOI 10.1134/S1022795407040072; Riera-Lizarazu O, 2010, CYTOGENET GENOME RES, V129, P234, DOI 10.1159/000312723; Riera-Lizarazu O, 2000, GENETICS, V156, P327; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Sandhu D, 2001, GENETICS, V157, P1735; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; SNAPE JW, 1983, THEOR APPL GENET, V65, P103, DOI 10.1007/BF00264875; SNIEZKO R, 1987, EUPHYTICA, V36, P287, DOI 10.1007/BF00730675; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; STADLER LJ, 1948, GENETICS, V33, P273; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Vizir IY, 1999, J HERED, V90, P412, DOI 10.1093/jhered/90.3.412; VIZIR IY, 1994, GENETICS, V137, P1111; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; Wardrop J, 2004, THEOR APPL GENET, V108, P343, DOI 10.1007/s00122-003-1434-6; Wardrop J, 2002, PLANT J, V31, P223, DOI 10.1046/j.1365-313X.2002.01351.x; Xu HL, 1999, P NATL ACAD SCI USA, V96, P2554, DOI 10.1073/pnas.96.5.2554; You FM, 2010, NUCLEIC ACIDS RES, V38, pW313, DOI 10.1093/nar/gkq425	66	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48815	10.1371/journal.pone.0048815	http://dx.doi.org/10.1371/journal.pone.0048815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144983	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800143
J	Wikberg, EC; Sicotte, P; Campos, FA; Ting, N				Wikberg, Eva C.; Sicotte, Pascale; Campos, Fernando A.; Ting, Nelson			Between-Group Variation in Female Dispersal, Kin Composition of Groups, and Proximity Patterns in a Black-and-White Colobus Monkey (Colobus vellerosus)	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; SOCIAL-BEHAVIOR; REPRODUCTIVE SUCCESS; GENETIC-STRUCTURE; FOREST FRAGMENTS; HOWLER MONKEYS; VERVET MONKEYS; BOABENG-FIEMA; POPULATION; INFANTICIDE	A growing body of evidence shows within-population variation in natal dispersal, but the effects of such variation on social relationships and the kin composition of groups remain poorly understood. We investigate the link between dispersal, the kin composition of groups, and proximity patterns in a population of black-and-white colobus (Colobus vellerosus) that shows variation in female dispersal. From 2006 to 2011, we collected behavioral data, demographic data, and fecal samples of 77 males and 92 females residing in eight groups at Boabeng-Fiema, Ghana. A combination of demographic data and a genetic network analysis showed that although philopatry was female-biased, only about half of the females resided in their natal groups. Only one group contained female-female dyads with higher average relatedness than randomly drawn animals of both sexes from the same group. Despite between-group variation in female dispersal and kin composition, female-female dyads in most of the study groups had higher proximity scores than randomly drawn dyads from the same group. We conclude that groups fall along a continuum from female dispersed, not kin-based, and not bonded to female philopatric, kin-based, and bonded. We found only partial support for the predicted link between dispersal, kin composition, and social relationships. In contrast to most mammals where the kin composition of groups is a good predictor of the quality of female-female relationships, this study provides further support for the notion that kinship is not necessary for the development and maintenance of social bonds in some gregarious species.	[Wikberg, Eva C.; Sicotte, Pascale; Campos, Fernando A.] Univ Calgary, Dept Anthropol, Calgary, AB, Canada; [Ting, Nelson] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Ting, Nelson] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Calgary; University of Oregon; University of Oregon	Wikberg, EC (corresponding author), Univ Calgary, Dept Anthropol, Calgary, AB, Canada.	ecwikber@ucalgary.ca; nting@uoregon.edu	Wikberg, Eva/P-9480-2019; Campos, Fernando A./I-2525-2019	Wikberg, Eva/0000-0001-5782-2978; Campos, Fernando A./0000-0001-9826-751X	Wenner Gren Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)	Wenner Gren Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Wenner Gren Foundation (http://www.wennergren.org/), Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Armitage KB, 2012, MOL ECOL, V21, P532, DOI 10.1111/j.1365-294X.2011.05323.x; Berman CM, 2008, BEHAVIOUR, V145, P863, DOI 10.1163/156853908784089252; Blundell GM, 2002, MOL ECOL, V11, P289, DOI 10.1046/j.0962-1083.2001.01440.x; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Chapais B, 2001, INT J PRIMATOL, V22, P203, DOI 10.1023/A:1005619430744; Chapais Bernard, 1992, P29; CHENEY DL, 1983, AM NAT, V122, P392, DOI 10.1086/284142; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Crockett Carolyn M., 1993, P104; Csaardi G, 2010, NETWORK ANAL VISUALI; Di Fiore A, 2005, INT J PRIMATOL, V26, P1137, DOI 10.1007/s10764-005-6462-4; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; Eikenaar C, 2010, BEHAVIOUR, V147, P1577, DOI 10.1163/000579510X510511; FARGEY P J, 1992, Oryx, V26, P151; Fontanillas P, 2004, EVOLUTION, V58, P886; Gerlach G, 1998, ETHOLOGY, V104, P487; Gompper ME, 1997, ANIM BEHAV, V53, P781, DOI 10.1006/anbe.1996.0344; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hall J.B., 1981, DISTRIBUTION ECOLOGY, DOI 10.1007/978-94-009-8650-3; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HARCOURT AH, 1979, ANIM BEHAV, V27, P251, DOI 10.1016/0003-3472(79)90145-3; Harris TR, 2009, MOL ECOL, V18, P1777, DOI 10.1111/j.1365-294X.2009.04139.x; HAUSFATER G, 1982, SCIENCE, V217, P752, DOI 10.1126/science.217.4561.752; Holmes TD, 2011, THESIS U CALGARY CAN; HORROCKS J, 1983, ANIM BEHAV, V31, P772, DOI 10.1016/S0003-3472(83)80234-6; Isbell LA, 1996, BEHAVIOUR, V133, P1, DOI 10.1163/156853996X00017; Jack KM, 2009, BEHAVIOUR, V146, P471, DOI 10.1163/156853909X404420; Kankam BO, 2010, PUBLIC SPHERE POLITI, P115; Kapsalis E, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P153; Kawai M., 1965, JAPANESE MONKEYS, P66; Kawamura S., 1965, JAPANESE MONKEYS, P105; Korstjens AH, 2002, BEHAVIOUR, V139, P203, DOI 10.1163/156853902760102654; Kurland J A, 1977, Contrib Primatol, V12, P1; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Manly B., 1998, RANDOMIZATION BOOTST; MISSAKIAN E A, 1972, Primates, V13, P169, DOI 10.1007/BF01840878; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; MOORE J, 1992, INT J PRIMATOL, V13, P361, DOI 10.1007/BF02547823; Morelli TL, 2009, BEHAVIOUR, V146, P499, DOI 10.1163/15683908X399554; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Nutt KJ, 2008, MOL ECOL, V17, P3541, DOI 10.1111/j.1365-294X.2008.03858.x; OATES JF, 1983, FOLIA PRIMATOL, V40, P83, DOI 10.1159/000156092; OATES JF, 1977, Z TIERPSYCHOL, V45, P1; Perez-Gonzalez J, 2009, MOL ECOL, V18, P4617, DOI 10.1111/j.1365-294X.2009.04386.x; Pope TR, 2000, BEHAV ECOL SOCIOBIOL, V48, P253, DOI 10.1007/s002650000236; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robbins AM, 2009, ANIM BEHAV, V77, P831, DOI 10.1016/j.anbehav.2008.12.005; Rollins LA, 2012, MOL ECOL, V21, P1727, DOI 10.1111/j.1365-294X.2012.05492.x; SADE DS, 1965, AM J PHYS ANTHROPOL, V23, P1, DOI 10.1002/ajpa.1330230115; Saj TL, 2007, INT J PRIMATOL, V28, P337, DOI 10.1007/s10764-007-9125-9; Saj TL, 2007, AM J PHYS ANTHROPOL, V133, P994, DOI 10.1002/ajpa.20609; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Strier Karen B., 1994, Yearbook of Physical Anthropology, V37, P233; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Teichroeb JA, 2008, BEHAVIOUR, V145, P727, DOI 10.1163/156853908783929160; Teichroeb JA, 2011, BEHAVIOUR, V148, P765, DOI 10.1163/000579511X577157; Teichroeb JA, 2009, BEHAVIOUR, V146, P551, DOI 10.1163/156853909X426363; Teichroeb JA, 2009, AM J PRIMATOL, V71, P49, DOI 10.1002/ajp.20617; THERNEAU T., 2011, SURVIVAL ANAL INCLUD; Ting N, 2008, J HUM EVOL, V55, P312, DOI 10.1016/j.jhevol.2008.02.011; Tucker AD, 1998, BEHAV ECOL SOCIOBIOL, V44, P85, DOI 10.1007/s002650050519; Van Belle S, 2012, AM J PRIMATOL, V74, P948, DOI 10.1002/ajp.22047; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wong SNP, 2006, PRIMATES, V47, P365, DOI 10.1007/s10329-006-0186-8; Wong SNP, 2006, AM J PRIMATOL, V68, P465, DOI 10.1002/ajp.20242; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Yao H, 2011, AM J PRIMATOL, V73, P1280, DOI 10.1002/ajp.21000	74	29	29	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48740	10.1371/journal.pone.0048740	http://dx.doi.org/10.1371/journal.pone.0048740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144951	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800117
J	El Majdoub, F; Elawady, M; Blau, T; Buhrle, C; Hoevels, M; Runge, M; Muller, RP; Deckert, M; Sturm, V; Maarouf, M				El Majdoub, Faycal; Elawady, Moataz; Blau, Tobias; Buehrle, Christian; Hoevels, Mauritius; Runge, Matthias; Mueller, Rolf-Peter; Deckert, Martina; Sturm, Volker; Maarouf, Mohammad			Intracranial Ependymoma: Long-Term Results in a Series of 21 Patients Treated with Stereotactic (125)Iodine Brachytherapy	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; I-125 SEEDS; CHILDREN; CHEMOTHERAPY; THERAPY; IRRADIATION; CHILDHOOD; CANCER; TUMORS; GRADE	Background: We evaluated the long-term outcome in patients harboring intracranial ependymomas treated with interstitial brachytherapy (IBT). Methods: Twenty-one patients (M/F = 9/12; median age: 29 years; range: 8-70 years), diagnosed with intracranial ependymoma (1 WHO I, 11 WHO II, 9 WHO III) were treated with IBT using stereotactically implanted 125 Iodine seeds between 1987 and 2010, either primarily, as adjuvant therapy following incomplete resection, or as salvage treatment upon tumor recurrence. Sixteen of 21 patients underwent microsurgical resection prior to IBT; in 5 patients, IBT was performed primarily after stereotactic biopsy for histological diagnosis. The cumulative tumor surface dose ranged from 50-65 Gy treating a median tumor volume of 3.6 ml (range, 0.3-11.6 ml). A median follow-up period of 105.3 months (range, 12.7-286.2 months) was evaluated. Results: Actuarial 2-, 5- and 10-years overall-and disease-specific survival rates after IBT were each 90% and 100% at all times for ependymomas WHO I/II, for anaplastic ependymomas WHO III 100%, 100%, 70% and 100%, 100%, 86%, respectively. The neurological status of seven patients improved, while there was no change in 12 and deterioration in 2 patients, respectively. Follow-up MR images disclosed a complete tumor remission in 3, a partial remission in 12 and a stable disease in 6 patients. Treatment-associated morbidity only occurred in a single patient. Conclusions: This study shows that stereotactic IBT for intracranial ependymomas is safe and can provide a high degree of local tumor control. Due to the low rate of side effects, IBT may evolve into an attractive alternative to microsurgery in ependymomas located in eloquent areas or as a salvage treatment.	[El Majdoub, Faycal; Elawady, Moataz; Buehrle, Christian; Hoevels, Mauritius; Runge, Matthias; Sturm, Volker; Maarouf, Mohammad] Univ Hosp, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany; [Blau, Tobias; Deckert, Martina] Univ Hosp, Dept Neuropathol, Cologne, Germany; [Mueller, Rolf-Peter] Univ Hosp, Dept Radiat Oncol, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	El Majdoub, F (corresponding author), Univ Hosp, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany.	faycal.el-majdoub@uk-koeln.de	Deckert, Martina/P-2842-2016					CHAMBERLAIN MC, 1995, ARCH NEUROL-CHICAGO, V52, P162, DOI 10.1001/archneur.1995.00540260066018; Combs SE, 2008, INT J RADIAT ONCOL, V71, P972, DOI 10.1016/j.ijrobp.2007.12.036; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; Duffner PK, 1998, PEDIATR NEUROSURG, V28, P215, DOI 10.1159/000028654; El Majdoub F, 2009, STRAHLENTHER ONKOL, V185, P109, DOI 10.1007/s00066-009-1911-1; Grill J, 2001, J CLIN ONCOL, V19, P1288, DOI 10.1200/JCO.2001.19.5.1288; Kilday JP, 2009, MOL CANCER RES, V7, P765, DOI 10.1158/1541-7786.MCR-08-0584; Koot RW, 2000, CANCER-AM CANCER SOC, V88, P2796; Korinthenberg R, 2010, INT J RAD ONCOL BIOL; Korshunov A, 2004, CANCER, V100, P1230, DOI 10.1002/cncr.20075; Korshunov A, 2010, J CLIN ONCOL, V28, P3182, DOI 10.1200/JCO.2009.27.3359; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maarouf M, 2010, STRAHLENTHER ONKOL; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Massimino M, 2009, FUTURE ONCOL, V5, P207, DOI 10.2217/14796694.5.2.207; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Needle MN, 1997, CANCER-AM CANCER SOC, V80, P341, DOI 10.1002/(SICI)1097-0142(19970715)80:2<341::AID-CNCR23>3.3.CO;2-N; Paulino AC, 2002, AM J CLIN ONCOL-CANC, V25, P117, DOI 10.1097/00000421-200204000-00003; Perilongo G, 1997, MED PEDIATR ONCOL, V29, P79; Peyre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012932; POLLACK IF, 1995, NEUROSURGERY, V37, P655, DOI 10.1227/00006123-199510000-00008; Robertson PL, 1998, J NEUROSURG, V88, P695, DOI 10.3171/jns.1998.88.4.0695; ROUSSEAU P, 1994, INT J RADIAT ONCOL, V28, P381, DOI 10.1016/0360-3016(94)90061-2; Ruda R, 2008, CURR OPIN NEUROL, V21, P754, DOI 10.1097/WCO.0b013e328317efe8; Shim KW, 2009, CHILD NERV SYST, V25, P1167, DOI 10.1007/s00381-009-0900-0; STURM V, 1983, ACTA NEUROCHIR, V68, P11, DOI 10.1007/BF01406197; SUTTON LN, 1991, PEDIATR NEUROSURG, V16, P57, DOI 10.1159/000120509; Timmermann B, 2000, INT J RADIAT ONCOL, V46, P287, DOI 10.1016/S0360-3016(99)00414-9; Treuer H, 2005, RADIOTHER ONCOL, V77, P202, DOI 10.1016/j.radonc.2005.08.006; VOGES J, 1993, ACTA NEUROCHIR, V122, P127, DOI 10.1007/BF01446999	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47266	10.1371/journal.pone.0047266	http://dx.doi.org/10.1371/journal.pone.0047266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144811	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400019
J	Felten, A; Brinckmann, D; Landsberg, G; Scheidtmann, KH				Felten, A.; Brinckmann, D.; Landsberg, G.; Scheidtmann, K. H.			Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly	ONCOGENE			English	Article						AR; ZIPK; AATF/Che-1; TSG101; Mdm2; ubiquitination	RESPONSIVE PROMOTERS; RECRUITMENT; MDM2; PROTEASOME; ALPHA; COREGULATORS; DEGRADATION; HOMOLOG; HDAC1	We have recently identified apoptosis-antagonizing transcription factor (AATF), tumor-susceptibility gene 101 (TSG101) and zipperinteracting protein kinase (ZIPK) as novel coactivators of the androgen receptor (AR). The mechanisms of coactivation remained obscure, however. Here we investigated the interplay and interdependence between these coactivators and the AR using the endogenous prostate specific antigen (PSA) gene as model for AR-target genes. Chromatin immunoprecipitation in combination with siRNA-mediated knockdown revealed that recruitment of AATF and ZIPK to the PSA enhancer was dependent on AR, whereas recruitment of TSG101 was dependent on AATF. Association of AR and its coactivators with the PSA enhancer or promoter occurred in cycles. Dissociation of AR-transcription complexes was due to degradation because inhibition of the proteasome system by MG132 caused accumulation of AR at enhancer/promoter elements. Moreover, inhibition of degradation strongly reduced transcription, indicating that continued and efficient transcription is based on initiation, degradation and reinitiation cycles. Interestingly, knockdown of ZIPK by siRNA had a similar effect as MG132, leading to reduced transcription but enhanced accumulation of AR at androgen-response elements. In addition, knockdown of ZIPK, as well as overexpression of a dominant-negative ZIPK mutant, diminished polyubiquitination of AR. Furthermore, ZIPK cooperated with the E3 ligase Mdm2 in AR-dependent transactivation, assembled into a single complex on chromatin and phosphorylated Mdm2 in vitro. These results suggest that ZIPK has a crucial role in regulation of ubiquitination and degradation of the AR, and hence promoter clearance and efficient transcription.	[Felten, A.; Brinckmann, D.; Landsberg, G.; Scheidtmann, K. H.] Univ Bonn, Inst Genet, D-53111 Bonn, Germany	University of Bonn	Felten, A (corresponding author), Univ Bonn, Dept Psychol, Kaiser Karl Ring 9, D-53111 Bonn, Germany.	andrea.felten@uni-bonn-diff.de			German Research Association [Sche246/20-1]	German Research Association(German Research Foundation (DFG))	We thank Dr Klemens Rottner and Dr Walter Witke from the Institute of Genetics (Bonn, Germany) for their hospitality during revision and Dr Maurizio Fanciulli (Regina Elena Cancer Institute, Rome, Italy) for antibodies against AATF/Che-1. This work was supported by the German Research Association to KHS (Sche246/20-1).	Bi J, 2009, INT J CANCER, V124, P1587, DOI 10.1002/ijc.24164; Brognard J, 2011, CANCER RES, V71, P3152, DOI 10.1158/0008-5472.CAN-10-3543; Bruno T, 2002, CANCER CELL, V2, P387, DOI 10.1016/S1535-6108(02)00182-4; Burch LR, 2004, J MOL BIOL, V337, P115, DOI 10.1016/j.jmb.2003.10.081; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; De Nicola F, 2007, J BIOL CHEM, V282, P19685, DOI 10.1074/jbc.M610282200; Di Padova M, 2003, J BIOL CHEM, V278, P36496, DOI 10.1074/jbc.M306694200; Engemann H, 2002, NUCLEIC ACIDS RES, V30, P1408, DOI 10.1093/nar/30.6.1408; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Felten A, 2007, BIOL CHEM, V388, P569, DOI 10.1515/BC.2007.073; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hinojos CAD, 2005, TRENDS ENDOCRIN MET, V16, P12, DOI 10.1016/j.tem.2004.11.006; Johnsen S A, 2006, Ernst Schering Found Symp Proc, P1; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Keppler BR, 2011, BBA-GENE REGUL MECH, V1809, P109, DOI 10.1016/j.bbagrm.2010.08.005; Leister P, 2008, ONCOGENE, V27, P3292, DOI 10.1038/sj.onc.1210995; Leister P., 2003, SIGNAL TRANSDUCTION, V3, P17, DOI [10.1002/sita.200300020, DOI 10.1002/SITA.200300020]; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Natrajan R, 2012, J PATHOL, V227, P29, DOI 10.1002/path.4003; Page G, 1999, FEBS LETT, V462, P187, DOI 10.1016/S0014-5793(99)01529-X; Passananti C, 2007, BIOCHEM CELL BIOL, V85, P477, DOI 10.1139/O07-062; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Saji S, 2001, BIOCHEM BIOPH RES CO, V281, P259, DOI 10.1006/bbrc.2001.4339; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Scheidtmann KH, 2007, SIGNAL TRANSDUCTION, V7, P248, DOI 10.1002/sita.200600112; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	40	12	12	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4981	4988		10.1038/onc.2012.503	http://dx.doi.org/10.1038/onc.2012.503			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23146908				2022-12-25	WOS:000325717800014
J	Landman, AS; Danielian, PS; Lees, JA				Landman, A. S.; Danielian, P. S.; Lees, J. A.			Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation	ONCOGENE			English	Article						pRB; p107; Prx1-Cre; cartilage; chondrocytes; enchondroma	RETINOBLASTOMA PROTEIN; CELL-CYCLE; TUMOR-SUPPRESSOR; BONE-DEVELOPMENT; RB-LOSS; EXPRESSION; DEFICIENT; MUTATION; GENE; DIFFERENTIATION	The pocket proteins pRB, p107 and p130 have established roles in regulating the cell cycle through the control of E2F activity. The pocket proteins regulate differentiation of a number of tissues in both cell cycle-dependent and -independent manners. Prior studies showed that mutation of p107 and p130 in the mouse leads to defects in cartilage development during endochondral ossification, the process by which long bones form. Despite evidence of a role for pRB in osteoblast differentiation, it is unknown whether it functions during cartilage development. Here, we show that mutation of Rb in the early mesenchyme of p107-mutant mice results in severe cartilage defects in the growth plates of long bones. This is attributable to inappropriate chondrocyte proliferation that persists after birth and leads to the formation of enchondromas in the growth plates as early as 8 weeks of age. Genetic crosses show that development of these tumorigenic lesions is E2f3 dependent. These results reveal an overlapping role for pRB and p107 in cartilage development, endochondral ossification and enchondroma formation that reflects their coordination of cell-cycle exit at appropriate developmental stages.	[Landman, A. S.; Danielian, P. S.; Lees, J. A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lees, JA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave,Bldg 76-461B, Cambridge, MA 02139 USA.	jalees@mit.edu		Danielian, Paul/0000-0003-2651-0386	National Cancer Institute [CA121921]; Ludwig Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA121921] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Rbc/c, p107<SUP>-/-</SUP> and Rosa26-LSL-LacZ transgenic mice were kindly provided by Tyler Jacks (MIT). We are grateful to Seth Berman for initial mouse colony generation, and Julie West for immuno-histochemistry assistance, as well as all members of the Lees laboratory for helpful discussions throughout this work. We thank MIT Swanson Biotechnology Center members Eliza Vasile for assistance with mCT data collection and analysis and Alicia Caron for histological sectioning and H&E staining. We also thank Roderick Bronson for histopathological analyses and advice. This work was supported by a grant to JAL from the National Cancer Institute (CA121921), and a Ludwig Graduate Fellowship to ASL. JAL is a Ludwig Scholar.	Asp J, 2001, J ORTHOPAED RES, V19, P149, DOI 10.1016/S0736-0266(00)00022-X; Asp J, 2000, INT J CANCER, V85, P782, DOI 10.1002/(SICI)1097-0215(20000315)85:6<782::AID-IJC7>3.0.CO;2-O; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Berman SD, 2009, P NATL ACAD SCI USA, V106, P14932, DOI 10.1073/pnas.0902408106; Boeuf S, 2008, J PATHOL, V216, P158, DOI 10.1002/path.2389; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; GURNEY JG, 1995, CANCER, V75, P2186, DOI 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; Miller MD, 2004, REV ORTHOPAEDICS, Vxv; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Politi K, 2004, AM J PATHOL, V164, P325, DOI 10.1016/S0002-9440(10)63122-7; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Ropke M, 2006, ONCOL REP, V15, P89; Rossi F, 2002, DEV BIOL, V247, P271, DOI 10.1006/dbio.2002.0691; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Saavedra HI, 2002, CELL GROWTH DIFFER, V13, P215; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Scheijen B, 2003, MOL CELL BIOL, V23, P3656, DOI 10.1128/MCB.23.10.3656-3668.2003; Schrage YM, 2009, AM J PATHOL, V174, P979, DOI 10.2353/ajpath.2009.080623; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wenzel PL, 2007, GENE DEV, V21, P85, DOI 10.1101/gad.1485307; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Yamaguchi T, 1996, ANTICANCER RES, V16, P2009; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zheng QP, 2009, J BONE MINER RES, V24, P1022, DOI [10.1359/JBMR.081249, 10.1359/jbmr.081249]; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	51	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4798	4805		10.1038/onc.2012.496	http://dx.doi.org/10.1038/onc.2012.496			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23146901	Green Accepted, Green Submitted			2022-12-25	WOS:000325274700008
J	Puchulu-Campanella, E; Chu, HY; Anstee, DJ; Galan, JA; Tao, WA; Low, PS				Puchulu-Campanella, Estela; Chu, Haiyan; Anstee, David J.; Galan, Jacob A.; Tao, W. Andy; Low, Philip S.			Identification of the Components of a Glycolytic Enzyme Metabolon on the Human Red Blood Cell Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-II; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ERYTHROCYTE-MEMBRANE; MULTIPROTEIN COMPLEX; TRANSPORT METABOLON; CYTOPLASMIC DOMAIN; STATISTICAL-MODEL; PROTEIN COMPLEXES; BAND-3; ALDOLASE	Glycolytic enzymes (GEs) have been shown to exist in multienzyme complexes on the inner surface of the human erythrocyte membrane. Because no protein other than band 3 has been found to interact with GEs, and because several GEs do not bind band 3, we decided to identify the additional membrane proteins that serve as docking sites for GE on the membrane. For this purpose, a method known as "label transfer" that employs a photoactivatable trifunctional cross-linking reagent to deliver a biotin from a derivatized GE to its binding partner on the membrane was used. Mass spectrometry analysis of membrane proteins that were biotinylated following rebinding and photoactivation of labeled GAPDH, aldolase, lactate dehydrogenase, and pyruvate kinase revealed not only the anticipated binding partner, band 3, but also the association of GEs with specific peptides in alpha- and beta-spectrin, ankyrin, actin, p55, and protein 4.2. More importantly, the labeled GEs were also found to transfer biotin to other GEs in the complex, demonstrating for the first time that GEs also associate with each other in their membrane complexes. Surprisingly, a new GE binding site was repeatedly identified near the junction of the membrane-spanning and cytoplasmic domains of band 3, and this binding site was confirmed by direct binding studies. These results not only identify new components of the membrane-associated GE complexes but also provide molecular details on the specific peptides that form the interfacial contacts within each interaction.	[Puchulu-Campanella, Estela; Chu, Haiyan; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Galan, Jacob A.; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Anstee, David J.] Natl Hlth Serv Blood & Transplant, Bristol Inst Transfus Sci, Bristol BS34 7QG, Avon, England	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; NHS Blood & Transplant (NHSBT)	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	plow@purdue.edu	Tao, Weiguo/AAL-2777-2020; Anstee, David/AAE-9231-2020; Tao, Andy/N-1290-2019	Tao, Weiguo/0000-0002-5535-5517; Galan, Jacob/0000-0003-3304-0474; Low, Philip/0000-0001-9042-5528; Puchulu-Campanella, Estela/0000-0002-3951-3925	National Institutes of Health [R01GM24417-33, R01GM088317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317, R01GM024417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM24417-33 and R01GM088317.	Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Chu HY, 2012, P NATL ACAD SCI USA, V109, P12794, DOI 10.1073/pnas.1209014109; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Emara M, 2012, J BIOL CHEM, V287, P5756, DOI 10.1074/jbc.M111.312520; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; ERCOLANI L, 1992, AM J PHYSIOL, V262, pF892, DOI 10.1152/ajprenal.1992.262.5.F892; Franco T, 2010, TRANSFUS CLIN BIOL, V17, P87, DOI 10.1016/j.tracli.2010.05.008; Gallagher P., 2003, HEMATOLOGY INFANCY C, P560; Harper SL, 2010, J BIOL CHEM, V285, P11003, DOI 10.1074/jbc.M109.083048; HARRISON ML, 1991, J BIOL CHEM, V266, P4106; Hassoun H, 1998, BLOOD, V92, P1785, DOI 10.1182/blood.V92.5.1785.417k17_1785_1792; Hoffman JF, 2009, J GEN PHYSIOL, V134, P351, DOI 10.1085/jgp.200910270; Hurst GB, 2004, J AM SOC MASS SPECTR, V15, P832, DOI 10.1016/S1044-0305(04)00154-0; KANT JA, 1973, J BIOL CHEM, V248, P8457; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KELLEY GE, 1984, BIOCHIM BIOPHYS ACTA, V778, P67, DOI 10.1016/0005-2736(84)90448-6; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Kovacic L, 2007, BIOORG CHEM, V35, P295, DOI 10.1016/j.bioorg.2006.12.002; Lewis IA, 2009, P NATL ACAD SCI USA, V106, P18515, DOI 10.1073/pnas.0905999106; Li B., 2009, THESIS CONCORDIA U M; LOW PS, 1990, BIOMED BIOCHIM ACTA, V49, pS135; Mankelow TJ, 2012, BLOOD CELL MOL DIS, V49, P1, DOI 10.1016/j.bcmd.2012.03.001; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; MCDANIEL CF, 1974, J BIOL CHEM, V249, P6478; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; MURTHY SNP, 1981, J BIOL CHEM, V256, P1203; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; OVADI J, 1978, EUR J BIOCHEM, V90, P499, DOI 10.1111/j.1432-1033.1978.tb12629.x; OVADI J, 1988, TRENDS BIOCHEM SCI, V13, P486, DOI 10.1016/0968-0004(88)90237-X; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; Raikar LS, 2006, J CELL BIOCHEM, V98, P861, DOI 10.1002/jcb.20732; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; Simpson R. J., 2003, PROTEINS PROTEOMICS, P529; Sowah D, 2011, AM J PHYSIOL-CELL PH, V301, pC336, DOI 10.1152/ajpcell.00005.2011; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; SRERE PA, 1990, FEBS LETT, V268, P360, DOI 10.1016/0014-5793(90)81286-W; STECK TL, 1976, BIOCHEMISTRY-US, V15, P1154, DOI 10.1021/bi00650a030; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stochaj Wayne R, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4543; STRAPAZON E, 1977, BIOCHEMISTRY-US, V16, P2966, DOI 10.1021/bi00632a025; Su Y, 2011, AM J PHYSIOL-RENAL, V300, pF157, DOI 10.1152/ajprenal.00228.2010; Su Y, 2006, MOL CELL BIOCHEM, V289, P159, DOI 10.1007/s11010-006-9159-x; Tiffert T, 2011, J GEN PHYSIOL, V138, P381, DOI 10.1085/jgp.201110660; TSAI IH, 1982, J BIOL CHEM, V257, P1438; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; Zhang DC, 2000, BLOOD, V96, P2925	60	77	82	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					848	858		10.1074/jbc.M112.428573	http://dx.doi.org/10.1074/jbc.M112.428573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23150667	Green Published, hybrid			2022-12-25	WOS:000313570300010
J	Wu, D; Ozaki, T; Yoshihara, Y; Kubo, N; Nakagawara, A				Wu, Dan; Ozaki, Toshinori; Yoshihara, Yukari; Kubo, Natsumi; Nakagawara, Akira			Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; MULTIPLE CHROMOSOMAL TRANSLOCATIONS; ACTIVATES P53; AML1 GENE; GROWTH; APOPTOSIS; P300; MDM2; BETA; EXPRESSION	Representative tumor suppressor p53 plays a critical role in the regulation of proper DNA damage response. In this study, we have found for the first time that Runt-related transcription factor 1 (RUNX1) contributes to p53-dependent DNA damage response. Upon adriamycin (ADR) exposure, p53 as well as RUNX1 were strongly induced in p53-proficient HCT116 and U2OS cells, which were closely associated with significant transactivation of p53 target genes, such as p21(WAF1), BAX, NOXA, and PUMA. RUNX1 was exclusively expressed in the cell nucleus and formed a complex with p53 in response to ADR. Chromatin immunoprecipitation assay demonstrated that p53 together with RUNX1 are efficiently recruited onto p53 target gene promoters following ADR exposure, indicating that RUNX1 is involved in p53-mediated transcriptional regulation. Indeed, forced expression of RUNX1 stimulated the transcriptional activity of p53 in response to ADR. Consistent with these observations, knockdown of RUNX1 attenuated ADR-mediated induction of p53 target genes and suppressed ADR-dependent apoptosis. Furthermore, RUNX1 was associated with p300 histone acetyltransferase, and ADR-dependent acetylation of p53 at Lys-373/382 was markedly inhibited in RUNX1 knockdown cells. In addition, knockdown of RUNX1 resulted in a significant decrease in the amount of p53-p300 complex following ADR exposure. Taken together, our present results strongly suggest that RUNX1 is required for the stimulation of p53 in response to DNA damage and also provide novel insight into understanding the molecular mechanisms behind p53-dependent DNA damage response.	[Wu, Dan; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Lab Innovat Canc Therapeut, Chuoh Ku, Chiba 2608717, Japan; [Wu, Dan; Ozaki, Toshinori; Yoshihara, Yukari; Kubo, Natsumi] Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chuoh Ku, Chiba 2608717, Japan	Chiba Cancer Center; Chiba Cancer Center	Ozaki, T (corresponding author), Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.	tozaki@chiba-cc.jp; akiranak@chiba-cc.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Hamaguchi Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hamaguchi Foundation(Hamaguchi Foundation for the Advancement of Biochemistry)	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Hamaguchi Foundation.	D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Guo H, 2011, J BIOL CHEM, V286, P208, DOI 10.1074/jbc.M110.149013; Hanamoto T, 2005, J BIOL CHEM, V280, P16665, DOI 10.1074/jbc.M414323200; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kawai H, 2001, J BIOL CHEM, V276, P45928, DOI 10.1074/jbc.M107770200; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Prives C, 1999, J PATHOL, V187, P112; Roumier C, 2003, LEUKEMIA, V17, P9, DOI 10.1038/sj.leu.2402766; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; TAKAHASHI A, 1995, BLOOD, V86, P607, DOI 10.1182/blood.V86.2.607.bloodjournal862607; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Velculescu VE, 1996, CLIN CHEM, V42, P858; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wen Z, 2012, MOL CELL BIOL, V32, P26, DOI 10.1128/MCB.05513-11; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yamada C, 2010, J BIOL CHEM, V285, P16693, DOI 10.1074/jbc.M109.055525; Yamaguchi Y, 2004, J BIOL CHEM, V279, P15630, DOI 10.1074/jbc.M400355200; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yoshihara Y, 2012, BIOCHEM BIOPH RES CO, V421, P57, DOI 10.1016/j.bbrc.2012.03.108; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	36	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1353	1364		10.1074/jbc.M112.402594	http://dx.doi.org/10.1074/jbc.M112.402594			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23148227	hybrid, Green Published			2022-12-25	WOS:000313570300056
J	Chen, CY; Abell, AM; Moon, YS; Kim, KH				Chen, Chih-Yu; Abell, Allison Martorano; Moon, Yang Soo; Kim, Kee-Hong			An Advanced Glycation End Product (AGE)-Receptor for AGEs (RAGE) Axis Restores Adipogenic Potential of Senescent Preadipocytes through Modulation of p53 Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; LIFE-SPAN; OXIDANT STRESS; GLYOXALASE-I; RECEPTOR; INFLAMMATION; DIFFERENTIATION; ATHEROSCLEROSIS; EXPRESSION	The impaired adipogenic potential of senescent preadipocytes is a hallmark of adipose aging and aging-related adipose dysfunction. Although advanced glycation end products (AGEs) derived from both foods and endogenous nonenzymatic glycation and AGE-associated signaling pathways are known to play a key role in aging and its related diseases, the role of AGEs in adipose aging remains elusive. We show a novel pro-adipogenic function of AGEs in replicative senescent preadipocytes and mouse embryonic fibroblasts, as well as primary preadipocytes isolated from aged mice. Using glycated bovine serum albumin (BSA) as a model protein of AGEs, we found that glycated BSA restores the impaired adipogenic potential of senescent preadipocytes in vitro and ex vivo. However, glycated BSA showed no effect on adipogenesis in nonsenescent preadipocytes. The AGE-induced receptor for AGE (RAGE) expression is required for the pro-adipogenic function of AGEs in senescent preadipocytes. RAGEis required for impairment of p53 expression and p53 function in regulating p21 expression in senescent preadipocytes. We also observed a direct binding between RAGE and p53 in senescent preadipocytes. Taken together, our findings reveal a novel pro-adipogenic function of the AGE-RAGE axis in p53-regulated adipogenesis of senescent preadipocytes, providing new insights into aging-dependent adiposity by diet-driven and/or endogenous glycated proteins.	[Chen, Chih-Yu; Abell, Allison Martorano; Kim, Kee-Hong] Purdue Univ, Dept Food Sci, W Lafayette, IN 47906 USA; [Moon, Yang Soo] Gyeongnam Natl Univ Sci & Technol, Dept Anim Sci & Biotechnol, Jinju 660758, South Korea	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Gyeongnam National University of Science and Technology	Kim, KH (corresponding author), Purdue Univ, Dept Food Sci, W Lafayette, IN 47906 USA.	keehong@purdue.edu			Taiwan Government; Ralph W. and Grace M. Showalter Trust Award from Purdue University; Technology Development Program for Agriculture and Forestry, Korea [PJ007981]	Taiwan Government; Ralph W. and Grace M. Showalter Trust Award from Purdue University; Technology Development Program for Agriculture and Forestry, Korea	This work was supported in part by a study abroad scholarship from the Taiwan Government (to C. Y. C.), a start-up fund and a Ralph W. and Grace M. Showalter Trust Award from Purdue University (to K. H. K.), and Next-Generation BioGreen 21 Grant PJ007981 from Technology Development Program for Agriculture and Forestry, Korea (to Y. S. M.).	Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Brune M, 2013, ONCOGENE, V32, P1460, DOI 10.1038/onc.2012.150; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Cai WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC624, DOI 10.1152/ajpcell.00463.2009; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; CHUMLEA WC, 1992, INT J OBESITY, V16, P125; Constance CM, 1996, MOL CELL BIOL, V16, P3878; Cui M, 2009, J CELL PHYSIOL, V219, P132, DOI 10.1002/jcp.21657; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; Dumble M, 2004, ANN NY ACAD SCI, V1019, P171, DOI 10.1196/annals.1297.027; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; Hallenborg P, 2009, EXPERT OPIN THER TAR, V13, P235, DOI [10.1517/14712590802680141 , 10.1517/14712590802680141]; Harcourt BE, 2011, KIDNEY INT, V80, P191, DOI 10.1038/ki.2011.57; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kang R, 2011, AUTOPHAGY, V7, P442, DOI 10.4161/auto.7.4.14681; Kawabata K, 2011, BBA-PROTEINS PROTEOM, V1814, P1246, DOI 10.1016/j.bbapap.2011.06.006; Kim CY, 2011, J NUTR BIOCHEM, V22, P910, DOI 10.1016/j.jnutbio.2010.08.003; Kim J, 2012, J NEUROSCI RES, V90, P1136, DOI 10.1002/jnr.23014; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Liu WY, 2012, DEV BIOL, V361, P27, DOI 10.1016/j.ydbio.2011.10.011; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Monden M, 2013, DIABETES, V62, P478, DOI 10.2337/db11-1116; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; Peppa M, 2008, HORM-INT J ENDOCRINO, V7, P123, DOI 10.1007/BF03401503; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Riuzzi F, 2006, J BIOL CHEM, V281, P8242, DOI 10.1074/jbc.M509436200; Sandu O, 2005, DIABETES, V54, P2314, DOI 10.2337/diabetes.54.8.2314; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Sebekova K, 2005, ANN NY ACAD SCI, V1043, P482, DOI 10.1196/annals.1333.055; Sebekova K, 2003, AM J KIDNEY DIS, V41, pS48, DOI 10.1053/ajkd.2003.50084; Sell DR, 2000, FASEB J, V14, P145, DOI 10.1096/fasebj.14.1.145; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046; Sun L, 2009, CARDIOVASC RES, V82, P371, DOI 10.1093/cvr/cvp036; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Tang DL, 2010, AUTOPHAGY, V6, P1181, DOI 10.4161/auto.6.8.13367; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Tikellis C, 2008, AM J PHYSIOL-ENDOC M, V295, pE323, DOI 10.1152/ajpendo.00024.2008; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Ueno H, 2010, ATHEROSCLEROSIS, V211, P431, DOI 10.1016/j.atherosclerosis.2010.04.006; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; WEISSMANSHOMER P, 1975, MECH AGEING DEV, V4, P159, DOI 10.1016/0047-6374(75)90017-2; Yanagisawa K, 1998, METABOLISM, V47, P1348, DOI 10.1016/S0026-0495(98)90303-1; Zhang L, 2009, CELL MOL LIFE SCI, V66, P3923, DOI 10.1007/s00018-009-0121-4	66	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44498	44507		10.1074/jbc.M112.399790	http://dx.doi.org/10.1074/jbc.M112.399790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150674	Green Published, hybrid			2022-12-25	WOS:000312938600046
J	Ramadoss, S; Chen, XH; Wang, CY				Ramadoss, Sivakumar; Chen, Xiaohong; Wang, Cun-Yu			Histone Demethylase KDM6B Promotes Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; JMJD3 CONTRIBUTES; GENE-EXPRESSION; H3K27ME3 DEMETHYLASE; STEM-CELLS; PROGRESSION; SNAIL; EZH2; TRANSCRIPTION; UTX	Epithelial-mesenchymal transition (EMT) is a critical event that occurs in embryonic development, tissue repair control, organ fibrosis, and carcinoma invasion and metastasis. Although significant progress has been made in understanding the molecular regulation of EMT, little is known about how chromatin is modified in EMT. Chromatin modifications through histone acetylation and methylation determine the precise control of gene expression. Recently, histone demethylases were found to play important roles in gene expression through demethylating mono-, di-, or trimethylated lysines. KDM6B (also known as JMJD3) is a histone demethylase that might activate gene expression by removing repressive histone H3 lysine 27 trimethylation marks from chromatin. Here we report that KDM6B played a permissive role in TGF-beta-induced EMT in mammary epithelial cells by stimulating SNAI1 expression. KDM6B was induced by TGF-beta, and the knockdown of KDM6B inhibited EMT induced by TGF-beta. Conversely, overexpression of KDM6B induced the expression of mesenchymal genes and promoted EMT. Chromatin immunoprecipitation (ChIP) assays revealed that KDM6B promoted SNAI1 expression by removing histone H3 lysine trimethylation marks. Consistently, our analysis of the Oncomine database found that KDM6B expression was significantly increased in invasive breast carcinoma compared with normal breast tissues. The knockdown of KDM6B significantly inhibited breast cancer cell invasion. Collectively, our study uncovers a novel epigenetic mechanism regulating EMT and tumor cell invasion, and has important implication in targeting cancer metastasis.	[Ramadoss, Sivakumar; Chen, Xiaohong; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, 33-030A CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu		Ramadoss, Sivakumar/0000-0001-7943-7501	National Institutes of Health [CA132134, R3713848, DE15964]; NATIONAL CANCER INSTITUTE [R01CA132134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132134, R3713848, and DE15964.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Anderton JA, 2011, ONCOGENE, V30, P2037, DOI 10.1038/onc.2010.579; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Ding L, 2006, CANCER RES, V66, P4095, DOI 10.1158/0008-5472.CAN-05-4300; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gong Y, 2011, CANCER-AM CANCER SOC, V117, P5476, DOI 10.1002/cncr.26179; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hubner MR, 2010, COLD SH Q B, V75, P43, DOI 10.1101/sqb.2010.75.020; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	47	123	127	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44508	44517		10.1074/jbc.M112.424903	http://dx.doi.org/10.1074/jbc.M112.424903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152497	hybrid, Green Published			2022-12-25	WOS:000312938600047
J	Qu, CS; Ma, ZW; Yang, J; Liu, Y; Bi, J; Huang, L				Qu, Chang-Sheng; Ma, Zong-Wei; Yang, Jin; Liu, Yang; Bi, Jun; Huang, Lei			Human Exposure Pathways of Heavy Metals in a Lead-Zinc Mining Area, Jiangsu Province, China	PLOS ONE			English	Article							HEALTH-RISK ASSESSMENT; EARLY KIDNEY DAMAGE; HUNAN PROVINCE; POLLUTION; SOILS; CONTAMINATION; CITY; MULTIPATHWAY; VEGETABLES; WATER	Heavy metal pollution is becoming a serious issue in developing countries such as China, and the public is increasingly aware of its adverse health impacts in recent years. We assessed the potential health risks in a lead-zinc mining area and attempted to identify the key exposure pathways. We evaluated the spatial distributions of personal exposure using indigenous exposure factors and field monitoring results of water, soil, food, and indoor and outdoor air samples. The risks posed by 10 metals and the contribution of inhalation, ingestion and dermal contact pathways to these risks were estimated. Human hair samples were also analyzed to indicate the exposure level in the human body. Our results show that heavy metal pollution may pose high potential health risks to local residents, especially in the village closest to the mine (V1), mainly due to Pb, Cd and Hg. Correspondingly, the residents in V1 had higher Pb (8.14 mg/kg) levels in hair than those in the other two villages. Most of the estimated risks came from soil, the intake of self-produced vegetables and indoor air inhalation. This study highlights the importance of site-specific multipathway health risk assessments in studying heavy-metal exposures in China.	[Qu, Chang-Sheng; Ma, Zong-Wei; Bi, Jun; Huang, Lei] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China; [Yang, Jin] Fudan Univ, Dept Environm Sci & Engn, Shanghai 200433, Peoples R China; [Liu, Yang] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Qu, Chang-Sheng] Jiangsu Prov Acad Environm Sci, Nanjing, Peoples R China	Nanjing University; Fudan University; Emory University; Rollins School Public Health	Huang, L (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China.	jbi@nju.edu.cn; huanglei@nju.edu.cn	Liu, Yang/AAA-7224-2019; Ma, Zongwei/ABG-4851-2020	Liu, Yang/0000-0001-5477-2186; Ma, Zongwei/0000-0003-0257-5695	National Natural Science Foundation [41171411, 41271014, 41201545]; Jiangsu Natural Science Foundation [BK2012733]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation (41171411, 41271014 & 41201545) and the Jiangsu Natural Science Foundation (BK2012733). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al Jassir MS, 2005, B ENVIRON CONTAM TOX, V75, P1020, DOI 10.1007/s00128-005-0851-4; Albering HJ, 1999, ENVIRON HEALTH PERSP, V107, P37, DOI [10.2307/3434287, 10.1289/ehp.9910737]; Ashe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033305; Baastrup R, 2008, ENVIRON HEALTH PERSP, V116, P231, DOI 10.1289/ehp.10623; Benin AL, 1999, ENVIRON HEALTH PERSP, V107, P279, DOI 10.2307/3434594; Chadha A, 1998, J AIR WASTE MANAGE, V48, P3, DOI 10.1080/10473289.1998.10463666; Chen HM, 1999, AMBIO, V28, P130; Chen SC, 2006, SCI TOTAL ENVIRON, V366, P112, DOI 10.1016/j.scitotenv.2005.08.047; Cheng SP, 2003, ENVIRON SCI POLLUT R, V10, P192, DOI 10.1065/espr2002.11.141.1; [储彬彬 CHU Bin-bin], 2010, [岩矿测试, Rock and Mineral Analysis], V29, P5; Gao Y, 2011, ENVIRON SCI TECHNOL, V45, P8065; Goulle JP, 2005, FORENSIC SCI INT, V153, P39, DOI 10.1016/j.forsciint.2005.04.020; Granero S, 2002, ENVIRON INT, V28, P159, DOI 10.1016/S0160-4120(02)00024-7; Carneiro MFH, 2011, BIOL TRACE ELEM RES, V143, P815, DOI 10.1007/s12011-010-8947-z; Hough RL, 2004, ENVIRON HEALTH PERSP, V112, P215, DOI 10.1289/ehp.5589; Hu J, 2011, ENV SCI TECHNOL; Huang XF, 2009, INT J ENVIRON HEAL R, V19, P405, DOI 10.1080/09603120902795598; Jarup L, 2000, OCCUP ENVIRON MED, V57, P668, DOI 10.1136/oem.57.10.668; Li JB, 2006, WATER AIR SOIL POLL, V171, P5, DOI 10.1007/s11270-005-9005-x; LI JF, 1999, GUANGXI AGR ECOL SCI, V1, P80; Lin HT, 2004, J FOOD DRUG ANAL, V12, P167; Lu CS, 2004, ENVIRON RES, V96, P283, DOI 10.1016/j.envres.2004.01.009; MacIntosh DL, 1996, ENVIRON HEALTH PERSP, V104, P202, DOI 10.2307/3432790; Man YB, 2010, ENVIRON INT, V36, P570, DOI 10.1016/j.envint.2010.04.014; Mari M, 2009, ENVIRON INT, V35, P1034, DOI 10.1016/j.envint.2009.05.004; Marin CM, 2003, HUM ECOL RISK ASSESS, V9, P1655, DOI 10.1080/714044790; MEP (Ministry of Ecology and Environment of the People's Republic of China), 2012, NAT AMB AIR QUAL STA; Nadal M, 2005, ARCH ENVIRON CON TOX, V49, P290, DOI 10.1007/s00244-004-0262-2; NRC, 1983, RISK ASS FED GOV MAN; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Oyoo-Okoth E, 2010, ECOTOX ENVIRON SAFE, V73, P1797, DOI 10.1016/j.ecoenv.2010.07.040; Pereira R, 2004, SCI TOTAL ENVIRON, V327, P81, DOI 10.1016/j.scitotenv.2004.01.017; Putila JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025886; Qin JF, 2004, GUANGDONG TRACE META, P29; QU LY, 2004, J GUIZHOU U TECHNOL, V33, P92; Rashed MN, 2008, CLEAN-SOIL AIR WATER, V36, P850, DOI 10.1002/clen.200800062; Rasmussen PE, 2001, SCI TOTAL ENVIRON, V267, P125, DOI 10.1016/S0048-9697(00)00775-0; Sanders AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031354; THATCHER TL, 1995, ATMOS ENVIRON, V29, P1487, DOI 10.1016/1352-2310(95)00016-R; Thomas LDK, 2009, ENVIRON HEALTH PERSP, V117, P181, DOI 10.1289/ehp.11641; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; USEPA, 1989, EPA540189002 OFF SOL; USEPA (United States Environmental Protection Agency), 1997, EXPOSURE FACTORS HDB; Vyskocil A, 2000, ENVIRON TOXICOL PHAR, V8, P111, DOI 10.1016/S1382-6689(00)00032-6; Wang HY, 2003, WATER AIR SOIL POLL, V147, P79, DOI 10.1023/A:1024522111341; Wang QYD, 2001, SOIL SEDIMENT CONTAM, V10, P497, DOI 10.1080/20015891109392; Wang T, 2009, ENVIRON POLLUT, V157, P2445, DOI 10.1016/j.envpol.2009.03.010; Wang XQ, 2010, J SOIL SEDIMENT, V10, P827, DOI 10.1007/s11368-010-0196-4; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Wang Y., 1993, SHANGHAI AGR TECHNOL, V2, P26; WorldHealthOrganization, 2000, AIR QUAL GUID EUR, Vsecond; Zeng HA, 2009, PEDOSPHERE, V19, P562, DOI 10.1016/S1002-0160(09)60150-8; Zhai Feng-ying, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P485; Zhang L, 2007, ENVIRON INT, V33, P108, DOI 10.1016/j.envint.2006.06.022; Zhou JM, 2007, PEDOSPHERE, V17, P588, DOI 10.1016/S1002-0160(07)60069-1; ZHOU RD, 2002, CHIN J HLTH LAB TECH, V12, P582	56	170	175	14	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e46793	10.1371/journal.pone.0046793	http://dx.doi.org/10.1371/journal.pone.0046793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152752	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234600004
J	da Costa, DCF; Casanova, FA; Quarti, J; Malheiros, MS; Sanches, D; dos Santos, PS; Fialho, E; Silva, JL				Ferraz da Costa, Danielly Cristiny; Casanova, Fabiana Alves; Quarti, Julia; Malheiros, Maite Santos; Sanches, Daniel; dos Santos, Patricia Souza; Fialho, Eliane; Silva, Jerson L.			Transient Transfection of a Wild-Type p53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells	PLOS ONE			English	Article							MOLECULAR-MECHANISM; MUTANT P53; PROLIFERATION; INHIBITOR; EXPRESSION; GROWTH; MCF-7; PHOSPHORYLATION; CHEMOPREVENTION; ANGIOGENESIS	Resveratrol is a promising chemopreventive agent that mediates many cellular targets involved in cancer signaling pathways. p53 has been suggested to play a role in the anticancer properties of resveratrol. We investigated resveratrol-induced cytotoxicity in H1299 cells, which are non-small lung cancer cells that have a partial deletion of the gene that encodes the p53 protein. The results for H1299 cells were compared with those for three cell lines that constitutively express wild-type p53: breast cancer MCF-7, adenocarcinomic alveolar basal epithelia A549 and non-small lung cancer H460. Cell viability assays revealed that resveratrol reduced the viability of all four of these cell lines in a dose- and time-dependent manner. MCF-7, A549 and H460 cells were more sensitive to resveratrol than were H1299 cells when exposed to the drug for 24 h at concentrations above 100 mu M. Resveratrol also increased the p53 protein levels in MCF-7 cells without altering the p53 mRNA levels, suggesting a post-translational modulation of the protein. The resveratrol-induced cytotoxicity in these cells was partially mediated by p53 and involved the activation of caspases 9 and 7 and the cleavage of PARP. In H1299 cells, resveratrol-induced cytotoxicity was less pronounced and (in contrast to MCF-7 cells) cell death was not accompanied by caspase activation. These findings are consistent with the observation that MCF-7 cells were positively labeled by TUNEL following exposure to 100 mu M resveratrol whereas H1299 cells under similar conditions were not labeled by TUNEL. The transient transfection of a wild-type p53-GFP gene caused H1299 cells to become more responsive to the pro-apoptotic properties of resveratrol, similarly to findings in the p53-positive MCF-7 cells. Our results suggest a possible therapeutic strategy based on the use of resveratrol for the treatment of tumors that are typically unresponsive to conventional therapies because of the loss of normal p53 function.	[Ferraz da Costa, Danielly Cristiny; Casanova, Fabiana Alves; Malheiros, Maite Santos; Sanches, Daniel; dos Santos, Patricia Souza; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Ferraz da Costa, Danielly Cristiny; Malheiros, Maite Santos; Sanches, Daniel; dos Santos, Patricia Souza; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Casanova, Fabiana Alves; Quarti, Julia; Fialho, Eliane] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	Fialho, Eliane/AAF-8856-2019; Silva, Jerson/J-8984-2014; SILVA, JERSON Lima/GRF-1442-2022	Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); Fundacao do Cancer of Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao do Cancer of Brazil	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); and Fundacao do Cancer of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Baarine M, 2011, GENES NUTR, V6, P161, DOI 10.1007/s12263-011-0232-z; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bielawski K, 2006, BIOCHEM PHARMACOL, V72, P320, DOI 10.1016/j.bcp.2006.04.028; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Casanova F, 2012, J CELL BIOCHEM, V113, P2586, DOI 10.1002/jcb.24134; Davis CD, 2010, SEMIN ONCOL, V37, P243, DOI 10.1053/j.seminoncol.2010.05.001; De Amicis F, 2011, FASEB J, V25, P3695, DOI 10.1096/fj.10-178871; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Fimia GM, 2011, PLOS ONE, V6; Fujimoto A, 2009, BASIC CLIN PHARMACOL, V104, P455, DOI 10.1111/j.1742-7843.2009.00386.x; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Gatz SA, 2008, CARCINOGENESIS, V29, P519, DOI 10.1093/carcin/bgm283; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Hsieh TC, 2005, BIOCHEM BIOPH RES CO, V334, P223, DOI 10.1016/j.bbrc.2005.06.073; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joe AK, 2002, CLIN CANCER RES, V8, P893; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; Li GW, 2011, PHYTOMEDICINE, V18, P704, DOI 10.1016/j.phymed.2010.11.015; Li Y, 2009, EUR J PHARMACOL, V609, P13, DOI 10.1016/j.ejphar.2009.03.004; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Mann JR, 2005, NAT CLIN PRACT ONCOL, V2, P202, DOI 10.1038/ncponc0140; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; Marcsek ZL, 2007, CELL BIOL INT, V31, P1214, DOI 10.1016/j.cellbi.2007.01.039; Niles RM, 2003, CANCER LETT, V190, P157, DOI 10.1016/S0304-3835(02)00676-6; Pan MH, 2010, J AGR FOOD CHEM, V58, P226, DOI 10.1021/jf903067g; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pezzuto JM, 2008, PHARM BIOL, V46, P443, DOI 10.1080/13880200802116610; Pozo-Guisado E, 2002, BIOCHEM PHARMACOL, V64, P1375, DOI 10.1016/S0006-2952(02)01296-0; Reagan-Shaw S, 2008, PHOTOCHEM PHOTOBIOL, V84, P415, DOI 10.1111/j.1751-1097.2007.00279.x; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; She QB, 2001, CANCER RES, V61, P1604; Shih A, 2002, J CLIN ENDOCR METAB, V87, P1223, DOI 10.1210/jc.87.3.1223; Shih A, 2001, BIOCHEMISTRY-US, V40, P2870, DOI 10.1021/bi001978b; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Thomasset SC, 2007, INT J CANCER, V120, P451, DOI 10.1002/ijc.22419; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weng CJ, 2010, J AGR FOOD CHEM, V58, P2886, DOI 10.1021/jf904182y; Zahid M, 2008, FREE RADICAL BIO MED, V45, P136, DOI 10.1016/j.freeradbiomed.2008.03.017	54	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48746	10.1371/journal.pone.0048746	http://dx.doi.org/10.1371/journal.pone.0048746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152798	Green Submitted, Green Published, gold			2022-12-25	WOS:000311234000027
J	Yang, ML; Zhang, LL; Wang, C; Liu, H; Boden, G; Yang, GY; Li, L				Yang, Mengliu; Zhang, Lili; Wang, Chong; Liu, Hua; Boden, Guenther; Yang, Gangyi; Li, Ling			Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin Resistance	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FIBROBLAST GROWTH FACTOR-21; TYPE-2 DIABETES-MELLITUS; GLUCOSE-TOLERANCE; CELL APOPTOSIS; MICE; OBESITY; NIDDM; NORMALIZATION; PATHOGENESIS	Background: Liraglutide is a glucagon-like peptide-1 analogue that stimulates insulin secretion and improves beta-cell function. However, it is not clear whether liraglutide achieves its glucose lowering effect only by its known effects or whether other as yet unknown mechanisms are involved. The aim of this study was to examine the effects of liraglutide on Fibroblast growth factor-21 (FGF-21) activity in High-fat diet (HFD) fed ApoE(-/-) mice with adiponectin (Acrp30) knockdown. Method: HFD-fed ApoE(-/-) mice were treated with adenovirus vectors expressing shAcrp30 to produce insulin resistance. Hyperinsulinemic-euglycemic clamp studies were performed to evaluate insulin sensitivity of the mouse model. QRT-PCR and Western blot were used to measure the mRNA and protein expression of the target genes. Results: The combination of HFD, ApoE deficiency, and hypoadiponectinemia resulted in an additive effect on insulin resistance. FGF-21 mRNA expressions in both liver and adipose tissues were significantly increased while FGF-21 receptor 1 (FGFR-1) and beta-Klotho mRNA levels in adipose tissue, as well as FGFR-1-3 and beta-Klotho mRNA levels in liver were significantly decreased in this model. Liraglutide treatment markedly improved insulin resistance and increased FGF-21 expression in liver and FGFR-3 in adipose tissue, restored beta-Klotho mRNA expression in adipose tissue as well as FGFR-1-3, beta-Klotho levels and phosphorylation of FGFR1 up to the levels observed in control mice in liver. Liraglutide treatment also further increased FGF-21 proteins in liver and plasma. In addition, as shown by hyperinsulinemic-euglycemic clamp, liraglutide treatment also markedly improved glucose metabolism and insulin sensitivity in these animals. Conclusion: These findings demonstrate an additive effect of HFD, ApoE deficiency, and adiponectin knockdown on insulin resistance and unveil that the regulation of glucose metabolism and insulin sensitivity by liraglutide may be partly mediated via increased FGF-21 and its receptors action.	[Yang, Mengliu; Zhang, Lili; Wang, Chong; Yang, Gangyi; Li, Ling] Chongqing Med Univ, Coll Lab Med, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China; [Yang, Mengliu; Zhang, Lili; Wang, Chong; Yang, Gangyi; Li, Ling] Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Chongqing, Peoples R China; [Liu, Hua] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Boden, Guenther] Temple Univ, Sch Med, Div Endocrinol Diabet Metab, Philadelphia, PA 19122 USA; [Boden, Guenther] Temple Univ, Sch Med, Clin Res Ctr, Philadelphia, PA 19122 USA	Chongqing Medical University; Chongqing Medical University; University of Mississippi; University of Mississippi Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Yang, GY (corresponding author), Chongqing Med Univ, Coll Lab Med, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China.	gangyiyang@yahoo.com.cn; lingli31@yahoo.com.cn	Zhang, Lili/AAN-9126-2020	Yang, Gangyi/0000-0002-6458-6747	National Natural Science Foundation of China [30871199, 30771037, 30971388, 81070640]; Doctoral Fund of the Ministry of Education of China [20105503110002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (30871199, 30771037, 30971388 and 81070640), and the Doctoral Fund of the Ministry of Education of China (20105503110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bregenbolt S, 2005, BIOCHEM BIOPH RES CO, V330, P577, DOI 10.1016/j.bbrc.2005.03.013; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; [陈瑜 CHEN Yu], 2009, [中国糖尿病杂志, Chinese Journal of Diabetes], V17, P590; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; HOLST JJ, 1994, GASTROENTEROLOGY, V107, P1848, DOI 10.1016/0016-5085(94)90831-1; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; KREYMANN B, 1987, LANCET, V2, P1300; Li K, 2010, J ENDOCRINOL INVEST, V33, P96, DOI [10.1007/BF03346561, 10.3275/6481]; Li K, 2009, EUR J ENDOCRINOL, V161, P391, DOI 10.1530/EJE-09-0335; Li L, 2008, DIABETES OBES METAB, V10, P921, DOI 10.1111/j.1463-1326.2007.00832.x; Li L, 2009, CYTOKINE, V45, P12, DOI 10.1016/j.cyto.2008.10.006; Li L, 2008, DIABETES RES CLIN PR, V82, P209, DOI 10.1016/j.diabres.2008.07.012; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Rachman J, 1997, DIABETOLOGIA, V40, P205, DOI 10.1007/s001250050664; RUTTI S, 2009, DIABETES S1, V58, pP1592; To AWM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016991; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	33	41	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48392	10.1371/journal.pone.0048392	http://dx.doi.org/10.1371/journal.pone.0048392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152772	Green Published, gold, Green Submitted			2022-12-25	WOS:000311234000013
J	Beez, S; Demmer, P; Puccetti, E				Beez, Sabine; Demmer, Philipp; Puccetti, Elena			Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RAR alpha and PLZF/RAR alpha with Interfering Peptides	PLOS ONE			English	Article							RAR-ALPHA; BTB/POZ DOMAIN; GENE-TRANSFER; PML; CELLS; DIFFERENTIATION; RECEPTOR; OLIGOMERIZATION; TRANSLOCATION; PATHOGENESIS	In acute promyelocytic leukemia (APL), hematopoietic differentiation is blocked and immature blasts accumulate in the bone marrow and blood. APL is associated with chromosomal aberrations, including t(15; 17) and t(11; 17). For these two translocations, the retinoic acid receptor alpha (RAR alpha) is fused to the promyelocytic leukemia (PML) gene or the promyelocytic zinc finger (PLZF) gene, respectively. Both fusion proteins lead to the formation of a high-molecular- weight complex. High-molecular-weight complexes are caused by the "coiled-coil" domain of PML or the BTB/POZ domain of PLZF. PML/RAR alpha without the "coiled-coil" fails to block differentiation and mediates an all-trans retinoic acid- response. Similarly, mutations in the BTB/POZ domain disrupt the high-molecular- weight complex, abolishing the leukemic potential of PLZF/RAR alpha. Specific interfering polypeptides were used to target the oligomerization domain of PML/RAR alpha or PLZF/RAR alpha. PML/RAR alpha and PLZF/RAR alpha were analyzed for the ability to form high-molecular- weight complexes, the protein stability and the potential to induce a leukemic phenotype in the presence of the interfering peptides. Expression of these interfering peptides resulted in a reduced replating efficiency and overcame the differentiation block induced by PML/RAR alpha and PLZF/RAR alpha in murine hematopoietic stem cells. This expression also destabilized the PLZF/RARa-induced high-molecular-weight complex formation and caused the degradation of the fusion protein. Targeting fusion proteins through interfering peptides is a promising approach to further elucidate the biology of leukemia. Citation: Beez S, Demmer P, Puccetti E (2012) Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RAR alpha and PLZF/RAR alpha with Interfering Peptides. PLoS ONE 7(11): e48636. doi:10.1371/journal.pone.0048636	[Beez, Sabine; Puccetti, Elena] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany; [Demmer, Philipp] Goethe Univ Frankfurt, Dept Hematol, Frankfurt, Germany	Philipps University Marburg; Goethe University Frankfurt	Puccetti, E (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany.	puccetti@imt.uni-marburg.de			Deutsche Krebshilfe e.V. [DKH-107062]; Deutsche Forschungsgemeinschaft [DFG-TR 17-N01]	Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by the Deutsche Krebshilfe e.V. (DKH-107062) and the Deutsche Forschungsgemeinschaft (DFG-TR 17-N01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 1998, HUM GENE THER, V9, P1561, DOI 10.1089/hum.1998.9.11-1561; Beissert T, 2003, BLOOD, V102, P2985, DOI 10.1182/blood-2003-03-0811; Benedetti L, 1997, BLOOD, V90, P1175, DOI 10.1182/blood.V90.3.1175.1175_1175_1185; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; GRIGNANI F, 1995, CANCER RES, V55, P440; Grignani F, 1999, ONCOGENE, V18, P6313, DOI 10.1038/sj.onc.1203029; Grignani F, 1996, CURR TOP MICROBIOL, V211, P269; Grignani F, 1998, CANCER RES, V58, P14; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; He LZ, 1999, ONCOGENE, V18, P5278, DOI 10.1038/sj.onc.1203088; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; NERVI C, 1992, CANCER RES, V52, P3687; Puccetti E, 2005, CANCER RES, V65, P6080, DOI 10.1158/0008-5472.CAN-04-3631; Puccetti E, 2004, LEUKEMIA, V18, P1169, DOI 10.1038/sj.leu.2403367; Puccetti E, 2001, Hematol J, V2, P385, DOI 10.1038/sj.thj.6200138; Puccetti E, 2002, CANCER RES, V62, P7050; Racanicchi S, 2005, EMBO J, V24, P1232, DOI 10.1038/sj.emboj.7600593; Seshire A, 2012, LEUKEMIA, V26, P1338, DOI 10.1038/leu.2011.331; Steinert G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022540; Sternsdorf T, 1999, MOL CELL BIOL, V19, P5170; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Wichmann C, 2007, CANCER RES, V67, P2280, DOI 10.1158/0008-5472.CAN-06-3360; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	28	7	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48636	10.1371/journal.pone.0048636	http://dx.doi.org/10.1371/journal.pone.0048636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152790	gold, Green Published, Green Submitted			2022-12-25	WOS:000312272600016
J	Huang, TL; Wei, W; Su, JF; Zhang, HH; Li, N				Huang, Tinglin; Wei, Wei; Su, Junfeng; Zhang, Haihan; Li, Na			Denitrification Performance and Microbial Community Structure of a Combined WLA-OBCO System	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; DRINKING-WATER; RECIRCULATING SYSTEM; NITRATE REMOVAL; CARBON SOURCE; SEDIMENTS; PURIFICATION; GROUNDWATER; DNA	The contamination of surface water by nitrogen due to fertilizer application and discharge of wastewater is an increasingly serious problem. A multifunctional device, which combines water-lifting and aeration (WLA) with oligotrophic biological contact oxidation (OBCO), was developed for pretreatment of raw water to reduce nitrogen. The performance of nitrogen removal and changes in microbial community structure were investigated. The results showed that the combined technique of WLA-OBCO was feasible, and that ammonium, nitrate, total nitrogen and total organic carbon were effectively removed. Meanwhile, nitrite was mostly undetectable. The PCR-DGGE and clone sequencing results revealed that alpha-proteobacterium was the largest bacterial group, and Pseudomonas strains Y3 and J8 were the dominant bacteria. Citation: Huang T, Wei W, Su J, Zhang H, Li N (2012) Denitrification Performance and Microbial Community Structure of a Combined WLA-OBCO System. PLoS ONE 7(11): e48339. doi:10.1371/journal.pone.0048339	[Huang, Tinglin; Su, Junfeng; Zhang, Haihan; Li, Na] Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Shaanxi, Peoples R China; [Wei, Wei] Tianjin Waterworks Grp Co Ltd, Tianjin, Peoples R China	Xi'an University of Architecture & Technology	Huang, TL (corresponding author), Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Shaanxi, Peoples R China.	huangtinglin@xauat.edu.cn	su, jun feng/AAD-2372-2022	Feng, Su/0000-0001-8434-0851	National Natural Science Foundation of China (NSFC) [50830303]; National Science & Technology Pillar Program [2012BAC04B02]; Shaanxi Provincial Science & Technology Innovative Project [2011KTCG03-07]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program; Shaanxi Provincial Science & Technology Innovative Project	This work was financially supported by the National Natural Science Foundation of China (NSFC)(Grant No. 50830303), the National Science & Technology Pillar Program (Grant No. 2012BAC04B02), and also by Shaanxi Provincial Science & Technology Innovative Project (Grant No. 2011KTCG03-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutel MW, 2006, ECOL ENG, V28, P271, DOI 10.1016/j.ecoleng.2006.05.009; Beutel MW, 2000, DYNAMICS CONTROL NUT; Buttiglieri G, 2005, DESALINATION, V178, P211, DOI 10.1016/j.desal.2004.11.038; Chen CL, 2004, APPL MICROBIOL BIOT, V63, P466, DOI 10.1007/s00253-003-1286-7; Fabbricino M, 2007, DESALINATION, V210, P163, DOI 10.1016/j.desal.2006.05.041; Fan B, 2001, ACTA SCI CIRCUMSTANT, V21, P39; Gomez MA, 2000, J HAZARD MATER, V80, P69, DOI 10.1016/S0304-3894(00)00282-X; HEATON THE, 1983, J HYDROL, V62, P243, DOI 10.1016/0022-1694(83)90105-1; Huang T. L., 2007, WATER TECHNOLOGY, V1, P13, DOI [10.3969/j.issn.1673-9353.2007.04.004, DOI 10.3969/J.ISSN.1673-9353.2007.04.004]; [黄廷林 Huang Tinglin], 2008, [给水排水, Water & Wastewater Engineering], V34, P52; Huang TL, 2006, ACTA SCI CIRCUMSTANT, V26, P786; Janez V, 2006, ACTA CHIM SLOV, V53, P396; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; [季民 Ji Min], 2002, [给水排水, Water & wastewater engineeting], V28, P26; Lee KC, 2002, WATER RES, V36, P2040, DOI 10.1016/S0043-1354(01)00425-0; Li MY, 2006, FOOD MICROBIOL, V23, P607, DOI 10.1016/j.fm.2006.01.004; Luo QF, 2003, J SAFETY ENV, V3, P58; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ovez B, 2006, PROCESS BIOCHEM, V41, P1539, DOI 10.1016/j.procbio.2006.02.015; Rivas Z, 2000, WATER AIR SOIL POLL, V117, P27, DOI 10.1023/A:1005189710803; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; Shnel N, 2002, AQUACULT ENG, V26, P191, DOI 10.1016/S0144-8609(02)00013-4; Shrimali M, 2001, ENVIRON POLLUT, V112, P351, DOI 10.1016/S0269-7491(00)00147-0; Singer A, 2008, AQUACULT ENG, V39, P72, DOI 10.1016/j.aquaeng.2008.07.001; Tian Wei-jun, 2008, Huanjing Kexue, V29, P1308; TSAI YL, 1991, APPL ENVIRON MICROB, V57, P1070, DOI 10.1128/AEM.57.4.1070-1074.1991; WILSON GB, 1990, J HYDROL, V113, P51, DOI 10.1016/0022-1694(90)90166-U; Xu M, 2005, STUDY BIOL CONTACT O	28	10	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48339	10.1371/journal.pone.0048339	http://dx.doi.org/10.1371/journal.pone.0048339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152768	Green Submitted, Green Published, gold			2022-12-25	WOS:000312272600011
J	Baptista, MS; Ren, HP; Swarts, JCM; Carareto, R; Nijmeijer, H; Grebogi, C				Baptista, Murilo S.; Ren, Hai-Peng; Swarts, Johen C. M.; Carareto, Rodrigo; Nijmeijer, Henk; Grebogi, Celso			Collective Almost Synchronisation in Complex Networks	PLOS ONE			English	Article							GENERALIZED SYNCHRONIZATION; CHAOS; TRANSITION; BEHAVIOR; SYSTEM; PHASE	This work introduces the phenomenon of Collective Almost Synchronisation (CAS), which describes a universal way of how patterns can appear in complex networks for small coupling strengths. The CAS phenomenon appears due to the existence of an approximately constant local mean field and is characterised by having nodes with trajectories evolving around periodic stable orbits. Common notion based on statistical knowledge would lead one to interpret the appearance of a local constant mean field as a consequence of the fact that the behaviour of each node is not correlated to the behaviours of the others. Contrary to this common notion, we show that various well known weaker forms of synchronisation (almost, time-lag, phase synchronisation, and generalised synchronisation) appear as a result of the onset of an almost constant local mean field. If the memory is formed in a brain by minimising the coupling strength among neurons and maximising the number of possible patterns, then the CAS phenomenon is a plausible explanation for it.	[Baptista, Murilo S.; Ren, Hai-Peng; Carareto, Rodrigo; Grebogi, Celso] Univ Aberdeen, SUPA, Inst Complex Syst & Math Biol, Aberdeen, Scotland; [Ren, Hai-Peng] Xian Univ Technol, Dept Informat & Control Engn, Xian, Peoples R China; [Swarts, Johen C. M.; Nijmeijer, Henk] Eindhoven Univ Technol, Dynam & Control Grp, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands; [Carareto, Rodrigo] Univ Sao Paulo, Escola Politecn, Sao Paulo, Brazil	University of Aberdeen; Xi'an University of Technology; Eindhoven University of Technology; Universidade de Sao Paulo	Baptista, MS (corresponding author), Univ Aberdeen, SUPA, Inst Complex Syst & Math Biol, Aberdeen, Scotland.	murilo.baptista@abdn.ac.uk	Carareto, Rodrigo/D-1717-2015; baptista, murilo s/B-7277-2008	Grebogi, Celso/0000-0002-9811-4617; Ren, Hai-Peng/0000-0003-3834-5103	EPSRC [EP/1032606/1]; Northern Research Partnership; FAPESP; National Natural Science Foundation of China [60804040, 61172070]; EPSRC [EP/I032606/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I032606/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Northern Research Partnership; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MSB acknowledges the EPSRC grant EP/1032606/1 and the partial financial support of the Northern Research Partnership. R. Carareto acknowledges the financial support of FAPESP. HPR acknowledges the partial financial support of National Natural Science Foundation of China Grant 60804040 and 61172070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 1996, PHYS REV E, V53, P4528, DOI 10.1103/PhysRevE.53.4528; Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Almendral JA, 2011, CHAOS, V21, DOI 10.1063/1.3570920; [Anonymous], 2002, LYAPUNOV EXPONENTS S; Arnold, 1965, AMS TRANSLATIONS, V46, P213, DOI 10.1090/trans2/046/11; Baptista MS, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036203; Baptista MS, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056228; Batista CAS, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016218; Cont R, 2000, MACROECON DYN, V4, P170; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Femat R, 1999, PHYS LETT A, V262, P50, DOI 10.1016/S0375-9601(99)00667-2; FUJISAKA H, 1983, PROG THEOR PHYS, V69, P32, DOI 10.1143/PTP.69.32; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034101; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3532801; Gomez-Gardenes J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.128701; Gomez-Gardenes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012313; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Guan SG, 2009, CHAOS, V19, DOI 10.1063/1.3087531; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Hilhorst HJ, 2009, BRAZ J PHYS, V39, P371, DOI 10.1590/S0103-97332009000400005; Hramov AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.067201; Hu AH, 2010, CHAOS, V20, DOI 10.1063/1.3309017; Hung YC, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016202; JENSEN MH, 1984, PHYS REV A, V30, P1960, DOI 10.1103/PhysRevA.30.1960; Jirsa VK, 2008, COGN NEURODYNAMICS, V2, P29, DOI 10.1007/s11571-007-9030-0; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Leyva I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168702; Luccioli S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158104; McGraw PN, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.015101; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Pereira T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026216; Pereira T, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036201; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; Steur E, 2011, IEEE T CIRCUITS-I, V58, P1358, DOI 10.1109/TCSI.2010.2097670; Steur E, 2009, PHYSICA D, V238, P2119, DOI 10.1016/j.physd.2009.08.007; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Zhou CS, 2006, CHAOS, V16, DOI 10.1063/1.2150381; Zillmer R, 2006, PHYS REV E, V74, P1	41	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48118	10.1371/journal.pone.0048118	http://dx.doi.org/10.1371/journal.pone.0048118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144851	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500015
J	Farajollahi, A; Healy, SP; Unlu, I; Gaugler, R; Fonseca, DM				Farajollahi, Ary; Healy, Sean P.; Unlu, Isik; Gaugler, Randy; Fonseca, Dina M.			Effectiveness of Ultra-Low Volume Nighttime Applications of an Adulticide against Diurnal Aedes albopictus, a Critical Vector of Dengue and Chikungunya Viruses	PLOS ONE			English	Article							DIPTERA-CULICIDAE; FIELD EFFICACY; BG-SENTINEL; AEGYPTI; MALATHION; MOSQUITO; THRESHOLDS; INFECTION; EPIDEMIC; AEROSOLS	Aedes albopictus, the Asian tiger mosquito, continues expanding its geographic range and involvement in mosquito-borne diseases such as chikungunya and dengue. Vector control programs rarely attempt to suppress this diurnal species with an ultra-low volume (ULV) adulticide because for maximum efficacy applications are conducted at night. During 2009-2011 we performed experimental nighttime applications of a novel adulticide (DUET (R)) against field populations of Ae. albopictus within an urban site composed of approximately 1,000 parcels (home and yard) in northeastern USA. Dual applications at mid label rate of the adulticide spaced one or two days apart accomplished significantly higher control (85.0 +/- 5.4% average reduction) than single full rate applications (73.0 +/- 5.4%). Our results demonstrate that nighttime ULV adulticiding is effective in reducing Ae. albopictus abundance and highlight its potential for use as part of integrated pest management programs and during disease epidemics when reducing human illness is of paramount importance.	[Farajollahi, Ary; Healy, Sean P.; Unlu, Isik; Gaugler, Randy; Fonseca, Dina M.] Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Farajollahi, Ary; Unlu, Isik] Mercer Cty Mosquito Control, W Trenton, NJ USA; [Healy, Sean P.] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NY USA	Rutgers State University New Brunswick	Farajollahi, A (corresponding author), Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08903 USA.	afarajollahi@mercercounty.org	Gaugler, Randy/K-3898-2013; Fonseca, Dina Madeira/B-9951-2011; Fonseca, Dina/HHS-1320-2022	Fonseca, Dina Madeira/0000-0003-4726-7100; 	USDA and Rutgers University [USDA-ARS-58-6615-8-105]	USDA and Rutgers University	This work was funded by a cooperative Agreement between USDA and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber JAS, 2007, J AM MOSQUITO CONTR, V23, P55, DOI 10.2987/8756-971X(2007)23[55:FTOMAP]2.0.CO;2; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Carrieri M, 2008, J AM MOSQUITO CONTR, V24, P377, DOI 10.2987/5612.1; Centers for Disease Control and Prevention, 2003, EP EP W NIL VIR US G; Cooperband MF, 2010, J MED ENTOMOL, V47, P1099, DOI 10.1603/ME10021; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; DOWLING M. A. C., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P590, DOI 10.1016/0035-9203(55)90034-1; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Estrada-Franco JG, 1995, BIOL DIS RELATIONSHI, V42, P1; European Centre for Disease Prevention and Control, 2009, TECHNICAL REPORT; Farajollahi A, 2009, J MED ENTOMOL, V46, P599; Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426; FOCKS DA, 1987, AM J TROP MED HYG, V36, P639, DOI 10.4269/ajtmh.1987.36.639; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Fonseca DM, 2012, PEST MANAG IN PRESS; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; HAILE DG, 1982, MOSQ NEWS, V42, P576; HENDERSON CF, 1955, J ECON ENTOMOL, V48, P157, DOI 10.1093/jee/48.2.157; Hoffmann WC, 2009, J AM MOSQUITO CONTR, V25, P332, DOI 10.2987/09-5883.1; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; LOFGREN CS, 1970, B WORLD HEALTH ORGAN, V42, P15; Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305; Obenauer PJ, 2010, ENVIRON ENTOMOL, V39, P1608, DOI 10.1603/EN09322; Office of the New Jersey State Climatologist, 2012, MONTHL CLIM TABL; PERICH MJ, 1990, J AM MOSQUITO CONTR, V6, P1; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; READ NR, 1994, J AM MOSQUITO CONTR, V10, P79; Reiter P, 1997, DENGUE DENGUE HEMORR, P1; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2; Sokal R. R, 1981, BIOMETRY; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2	40	53	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49181	10.1371/journal.pone.0049181	http://dx.doi.org/10.1371/journal.pone.0049181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145115	Green Published, gold			2022-12-25	WOS:000312269500084
J	Gouet, C; Aburto, B; Vergara, C; Sanhueza, M				Gouet, Camilo; Aburto, Belen; Vergara, Cecilia; Sanhueza, Magdalena			On the Mechanism of Synaptic Depression Induced by CaMKIIN, an Endogenous Inhibitor of CaMKII	PLOS ONE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY; DENDRITIC SPINES; RECEPTOR; MEMORY; TRANSLOCATION; PLASTICITY; INDUCTION; AUTOPHOSPHORYLATION	Activity-dependent synaptic plasticity underlies, at least in part, learning and memory processes. NMDA receptor (NMDAR)dependent long-term potentiation (LTP) is a major synaptic plasticity model. During LTP induction, Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated, autophosphorylated and persistently translocated to the postsynaptic density, where it binds to the NMDAR. If any of these steps is inhibited, LTP is disrupted. The endogenous CaMKII inhibitor proteins CaMKIIN alpha,beta are rapidly upregulated in specific brain regions after learning. We recently showed that transient application of peptides derived from CaMKIIN alpha (CN peptides) persistently depresses synaptic strength and reverses LTP saturation, as it allows further LTP induction in previously saturated pathways. The treatment disrupts basal CaMKII-NMDAR interaction and decreases bound CaMKII fraction in spines. To unravel CaMKIIN function and to further understand CaMKII role in synaptic strength maintenance, here we more deeply investigated the mechanism of synaptic depression induced by CN peptides (CN-depression) in rat hippocampal slices. We showed that CN-depression does not require glutamatergic synaptic activity or Ca2+ signaling, thus discarding unspecific triggering of activity-dependent long-term depression (LTD) in slices. Moreover, occlusion experiments revealed that CN-depression and NMDAR-LTD have different expression mechanisms. We showed that CN-depression does not involve complex metabolic pathways including protein synthesis or proteasome-mediated degradation. Remarkably, CN-depression cannot be resolved in neonate rats, for which CaMKII is mostly cytosolic and virtually absent at the postsynaptic densities. Overall, our results support a direct effect of CN peptides on synaptic CaMKII-NMDAR binding and suggest that CaMKIIN alpha,beta could be critical plasticity-related proteins that may operate as cell-wide homeostatic regulators preventing saturation of LTP mechanisms or may selectively erase LTP-induced traces in specific groups of synapses. Citation: Gouet C, Aburto B, Vergara C, Sanhueza M (2012) On the Mechanism of Synaptic Depression Induced by CaMKIIN, an Endogenous Inhibitor of CaMKII. PLoS ONE 7(11): e49293. doi: 10.1371/journal.pone.0049293	[Gouet, Camilo; Aburto, Belen; Vergara, Cecilia; Sanhueza, Magdalena] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Aburto, Belen; Sanhueza, Magdalena] Univ Chile, Millennium Inst Cell Dynam & Biotechnol, Santiago, Chile	Universidad de Chile; Universidad de Chile	Sanhueza, M (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	masanhue@uchile.cl	Vergara, Cecilia/H-6964-2014	Vergara, Cecilia/0000-0002-4015-7438	Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1080630]; Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN [ICM-P05-001-F]	Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN	This work was supported by Fondo Nacional de Ciencia y Tecnologia (FONDECYT) 1080630, Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN ICM-P05-001-F (MS, BA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiria SA, 2010, J NEUROCHEM, V112, P150, DOI 10.1111/j.1471-4159.2009.06436.x; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Carlier E, 2000, BIOCHEM BIOPH RES CO, V274, P394, DOI 10.1006/bbrc.2000.3145; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Cheriyan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016495; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Feng BH, 2011, BRAIN RES, V1419, P46, DOI 10.1016/j.brainres.2011.08.051; Fitzjohn SM, 2002, CELL CALCIUM, V32, P405, DOI 10.1016/S0143416002001999; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lengyel I, 2004, EUR J NEUROSCI, V20, P3063, DOI 10.1111/j.1460-9568.2004.03748.x; Lepicard EM, 2006, EUR J NEUROSCI, V23, P3063, DOI 10.1111/j.1460-9568.2006.04830.x; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Radwanska K, 2010, GENES BRAIN BEHAV, V9, P648, DOI 10.1111/j.1601-183X.2010.00595.x; Saha S, 2007, BRAIN RES, V1148, P38, DOI 10.1016/j.brainres.2007.02.018; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Swulius MT, 2010, J COMP NEUROL, V518, P4243, DOI 10.1002/cne.22451; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	51	13	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49293	10.1371/journal.pone.0049293	http://dx.doi.org/10.1371/journal.pone.0049293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145145	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500099
J	Hayes, C; Jordan, MS; Hodson, FJ; Ritchard, L				Hayes, Chris; Jordan, Meredith S.; Hodson, Fiona J.; Ritchard, Linda			Ceasing Intrathecal Therapy in Chronic Non-Cancer Pain: An Invitation to Shift from Biomedical Focus to Active Management	PLOS ONE			English	Article							COMPREHENSIVE MEDICAL-MANAGEMENT; REFRACTORY CANCER PAIN; DRUG-RELATED TOXICITY; EFFICACY; DELIVERY; BACLOFEN; OPIOIDS; SUPPRESSION; SPASTICITY; SURVIVAL	Objective: To report long term experience (1997-2009) of intrathecal (IT) therapy for chronic non-cancer pain in the context of our team's increasing emphasis on active management. Design: Descriptive case series. Setting: Australian tertiary multidisciplinary pain center, Hunter Integrated Pain Service (HIPS). Intervention: This case series reports the changing use of IT implanted drug delivery systems (IDDSs) for chronic non-cancer pain over 13 years. Initially IT therapy was used selectively following multidisciplinary assessment and double blind IT trial. Typical therapy combined opioid with clonidine. Multidimensional management was offered. Treatment strategy changed in 2003 due to HIPS experience of limited therapeutic gains and equivocal support for IT therapy in the literature. Subsequently IT therapy was no longer initiated for non-cancer pain and those on established regimes were encouraged to shift to oral/transdermal opioids with greater emphasis on active management. Patient education and consultation were key elements. Where IT cessation was elective gradual dose reduction commenced as an outpatient. In elective and urgent cases ketamine infusion and oral clonidine were used during hospital admissions to cover the switch to oral/transdermal opioids. Over the study period transition occurred to a broader management framework in which IT therapy for chronic non-cancer pain was no longer supported by HIPS. Results: 25 patients were managed using IDDSs; 8 implanted by HIPS and 17 by other teams. Dose escalation and adverse effects were common. 24 of 25 patients ceased IT therapy; 7 (29%) with urgent IDDS related complications, 16 (67%) electively and 1 due to an unrelated death. The remaining patient returned to her original team to continue IT therapy. One post-explantation patient transferred to another team to recommence IT therapy. The remainder were successfully maintained on oral/transdermal opioids combined with active management. Citation: Hayes C, Jordan MS, Hodson FJ, Ritchard L (2012) Ceasing Intrathecal Therapy in Chronic Non-Cancer Pain: An Invitation to Shift from Biomedical Focus to Active Management. PLoS ONE 7(11): e49124. doi:10.1371/journal.pone.0049124	[Hayes, Chris; Jordan, Meredith S.; Hodson, Fiona J.; Ritchard, Linda] Hunter Integrated Pain Serv, Newcastle, NSW, Australia		Hayes, C (corresponding author), Hunter Integrated Pain Serv, Newcastle, NSW, Australia.	Chris.Hayes@hnehealth.nsw.gov.au	Hayes, Chris/AAA-2593-2019	Hayes, Chris/0000-0001-7163-0390				Abs R, 2000, J CLIN ENDOCR METAB, V85, P2215, DOI 10.1210/jc.85.6.2215; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Budd K, 2006, BIOMED PHARMACOTHER, V60, P310, DOI 10.1016/j.biopha.2006.06.015; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Eccleston C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub2; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Guzman J, 2001, BMJ-BRIT MED J, V322, P1511, DOI 10.1136/bmj.322.7301.1511; Hassenbusch SJ, 2004, J PAIN SYMPTOM MANAG, V27, P540, DOI 10.1016/j.jpainsymman.2004.03.001; Hayes C, 2011, PAIN MED, V12, P1738, DOI 10.1111/j.1526-4637.2011.01267.x; Hoving MA, 2009, EUR J PAEDIATR NEURO, V13, P240, DOI 10.1016/j.ejpn.2008.04.013; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kessler RC, 1992, AUSTR NZ J PUBLIC HL, V25, P494; Krames E S, 1997, J Pain Symptom Manage, V14, pS3, DOI 10.1016/S0885-3924(97)00166-8; Krames ES, 1996, J PAIN SYMPTOM MANAG, V11, P333, DOI 10.1016/0885-3924(96)00010-3; Main C., 2000, PAIN MANAGEMENT INTE; Maron J, 1996, CLIN J PAIN, V12, P174, DOI 10.1097/00002508-199609000-00005; Middel B, 1997, J NEUROL NEUROSUR PS, V63, P204, DOI 10.1136/jnnp.63.2.204; Molloy Allan R, 2006, Pain Pract, V6, P96; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Nicholas MK, 2007, EUR J PAIN, V11, P153, DOI 10.1016/j.ejpain.2005.12.008; Patel VB, 2009, PAIN PHYSICIAN, V12, P345; Roberts LJ, 2002, CLIN J PAIN, V18, P144, DOI 10.1097/00002508-200205000-00002; Smith TJ, 2005, ANN ONCOL, V16, P825, DOI 10.1093/annonc/mdi156; Smith TJ, 2002, J CLIN ONCOL, V20, P4040, DOI 10.1200/JCO.2002.02.118; Sylvester Robert K, 2004, Am J Hosp Palliat Care, V21, P143, DOI 10.1177/104990910402100214; Turner JA, 2007, CLIN J PAIN, V23, P180, DOI 10.1097/01.ajp.0000210955.93878.44; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; Van Schaeybroeck P, 2000, NEUROSURGERY, V46, P603, DOI 10.1097/00006123-200003000-00017; Williams JE, 2000, HEALTH TECHNOL ASSES, V4, p[3, 1]	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49124	10.1371/journal.pone.0049124	http://dx.doi.org/10.1371/journal.pone.0049124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145093	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500076
J	Horne, DJ; Campo, M; Ortiz, JR; Oren, E; Arentz, M; Crothers, K; Narita, M				Horne, David J.; Campo, Monica; Ortiz, Justin R.; Oren, Eyal; Arentz, Matthew; Crothers, Kristina; Narita, Masahiro			Association between Smoking and Latent Tuberculosis in the US Population: An Analysis of the National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; DRUG-SUSCEPTIBILITY ASSAY; UNITED-STATES; INFECTION; PREVALENCE; METAANALYSIS; REACTIVITY; EXPOSURE; SMOKERS; TOBACCO	Background: Evidence of an association between cigarette smoking and latent tuberculosis infection (LTBI) is based on studies in special populations and/or from high prevalence settings. We sought to evaluate the association between LTBI and smoking in a low prevalence TB setting using population-based data from the National Health and Nutrition Examination Survey (NHANES). Methods: In 1999-2000, NHANES assessed LTBI (defined as a tuberculin skin test measurement >= 10 mm) in participants, and those >= 20 years of age were queried regarding their tobacco use and serum cotinine was measured. We evaluated the association of LTBI with self-reported smoking history and smoking intensity in multivariable logistic regression models that adjusted for known confounders (gender, age, birthplace, race/ethnicity, poverty, education, history of BCG vaccination, and history of household exposure to tuberculosis disease). Results: Estimated LTBI prevalence was 5.3% among those >= 20 years of age. The LTBI prevalence among never smokers, current smokers, and former smokers was 4.1%, 6.6%, and 6.2%, respectively. In a multivariable model, current smoking was associated with LTBI (OR 1.8; 95% CI, 1.1-2.9). The association between smoking and LTBI was strongest for Mexican-American and black individuals. In multivariate analysis stratified by race/ethnicity, cigarette packs per day among Mexican-American smokers and cotinine levels among black smokers, were significantly associated with LTBI. Conclusions: In the large, representative, population-based NHANES sample, smoking was independently associated with significantly increased risks of LTBI. In certain populations, a greater risk of LTBI corresponded with increased smoking exposure.	[Horne, David J.; Campo, Monica; Ortiz, Justin R.; Arentz, Matthew; Crothers, Kristina; Narita, Masahiro] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Ortiz, Justin R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Oren, Eyal; Narita, Masahiro] Publ Hlth Seattle & King Cty, TB Control Program, Seattle, WA USA; [Oren, Eyal; Narita, Masahiro] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horne, DJ (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.	dhorne@uw.edu	Arentz, Matt/GVU-4315-2022; Oren, Eyal/AAD-5561-2019	Arentz, Matthew/0000-0002-1107-7754; Ortiz, Justin/0000-0002-3138-5965; Narita, Masahiro/0000-0001-5825-5450; Oren, Eyal/0000-0001-7817-3516; Crothers, Kristina/0000-0001-9702-0371	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [K23 AI 85036-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI085036] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [K23 AI 85036-01 to DJH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RH, 1997, AM J PREV MED, V13, P175, DOI 10.1016/S0749-3797(18)30190-9; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; Brunet L, 2011, EUR RESPIR J, V38, P139, DOI 10.1183/09031936.00137710; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Jason J, 2002, INFECT IMMUN, V70, P6188, DOI 10.1128/IAI.70.11.6188-6195.2002; Khan K, 2008, AM J RESP CRIT CARE, V177, P455, DOI 10.1164/rccm.200706-950OC; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; McCurdy SA, 1997, AM J IND MED, V32, P600, DOI 10.1002/(SICI)1097-0274(199712)32:6&lt;600::AID-AJIM5&gt;3.0.CO;2-T; Mengatto L, 2006, MEM I OSWALDO CRUZ, V101, P535, DOI 10.1590/S0074-02762006000500009; Mohammadzadeh A, 2006, J MED MICROBIOL, V55, P1657, DOI 10.1099/jmm.0.46442-0; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Oursler KK, 2002, CLIN INFECT DIS, V34, P752, DOI 10.1086/338784; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Plant AJ, 2002, EPIDEMIOL INFECT, V128, P37, DOI 10.1017/S0950268801006434; Pontino M. V., 2006, Rev. argent. microbiol., V38, P145; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Singh P, 2007, J CLIN MICROBIOL, V45, P76, DOI 10.1128/JCM.00951-06; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Solsona J, 2001, EUR J EPIDEMIOL, V17, P123, DOI 10.1023/A:1017580329538; Tho DQ, 2011, INT J TUBERC LUNG D, V15, P799, DOI 10.5588/ijtld.10.0599; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van Zyl-Smit RN, 2010, INFECT DIS CLIN N AM, V24, P693, DOI 10.1016/j.idc.2010.04.012; World Health Organization, 2007, WHO UN MON TB TOB CO	31	31	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49050	10.1371/journal.pone.0049050	http://dx.doi.org/10.1371/journal.pone.0049050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145066	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500069
J	Srivastava, AK; Sharma, RK; Yolcu, ES; Ulker, V; MacLeod, K; Dinc, G; Shirwan, H				Srivastava, Abhishek K.; Sharma, Rajesh K.; Yolcu, Esma S.; Ulker, Vahap; MacLeod, Kathryn; Dinc, Gunes; Shirwan, Haval			Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8(+) T and NK Cell Dependent Manner	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; 4-1BB LIGAND; CANCER; EXPRESSION; APOPTOSIS; SUPPRESSION; EXPANSION; DEPLETION; VACCINES	Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and potential to generate long-term immunological responses that can safeguard against recurrences. However, TAA-based subunit vaccines require potent adjuvants for therapeutic efficacy. Using a novel form of the 4-1BBL costimulatory molecule, SA-4-1BBL, as the adjuvant of choice, we previously demonstrated that a single vaccination with survivin (SVN) as a bona fide self TAA was effective in eradicating weakly immunogenic 3LL tumors in >70% of C57BL/6 mice. The present study was designed to i) assess the therapeutic efficacy of a prime-boost vaccination and ii) investigate the mechanistic basis of vaccine efficacy. Our data shows that a prime-boost vaccination strategy was effective in eradicating 3LL lung carcinoma in 100% of mice. The vaccine efficacy was correlated with increased percentages of CD8(+) T cells expressing IFN-gamma as well as potent killing responses of both CD8(+) T and NK cells in the absence of detectable antibodies to ssDNA as a sign of autoimmunity. Antibody depletion of CD8(+) T cells one day before vaccination completely abrogated therapeutic efficacy, whereas depletion of CD4(+) T cells had no effect. Importantly, NK cell depletion had a moderate (similar to 50% reduction), but significant (p<0.05) effect on vaccine efficacy. Taken together, these results shed light on the mechanistic basis of the SA-4-1BBL/SVN subunit vaccine formulation in a lung carcinoma model and demonstrate the robust therapeutic efficacy of the prime-boost immunization strategy with important clinical implications.	[Srivastava, Abhishek K.; Sharma, Rajesh K.; Yolcu, Esma S.; Dinc, Gunes; Shirwan, Haval] Univ Louisville, Inst Cellular Therapeut, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Srivastava, Abhishek K.; Sharma, Rajesh K.; Yolcu, Esma S.; Dinc, Gunes; Shirwan, Haval] Univ Louisville, James Brown Canc Ctr, Louisville, KY 40292 USA; [Ulker, Vahap; MacLeod, Kathryn] ApoVax Inc, Louisville, KY USA	University of Louisville; University of Louisville	Shirwan, H (corresponding author), Univ Louisville, Inst Cellular Therapeut, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	haval.shirwan@louisville.edu	Srivastava, Abhishek/M-7577-2014		National Institutes of Health [R43 AI071618, R41 CA121665, R44 AI071618, R43AI074176]; Kentucky Lung Cancer Research Program; W. M. Keck Foundation; Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL CANCER INSTITUTE [R41CA121665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI071618, R43AI071618, R43AI074176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program; W. M. Keck Foundation(W.M. Keck Foundation); Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in parts by grants from the National Institutes of Health (R43 AI071618, R41 CA121665, R44 AI071618, and R43AI074176), Kentucky Lung Cancer Research Program, W. M. Keck Foundation, and the Commonwealth of Kentucky Research Challenge Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 2000, BLOOD, V96, P1921; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Assudani D, 2008, CANCER RES, V68, P9892, DOI 10.1158/0008-5472.CAN-08-3134; Ciesielski MJ, 2006, CANCER IMMUNOL IMMUN, V55, P1491, DOI 10.1007/s00262-006-0138-6; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Elpek KG, 2007, J IMMUNOL, V178, P6840, DOI 10.4049/jimmunol.178.11.6840; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Fransen MF, 2011, CLIN CANCER RES, V17, P2270, DOI 10.1158/1078-0432.CCR-10-2888; Fransen MF, 2012, J IMMUNOL JIMMUNOL, DOI [10.4049/jimmunol.1201540, DOI 10.4049/JIMMU-N0L.1201540]; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Honma I, 2009, CANCER IMMUNOL IMMUN, V58, P1803, DOI 10.1007/s00262-009-0691-x; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JOHNSON DR, 1990, P NATL ACAD SCI USA, V87, P5183, DOI 10.1073/pnas.87.13.5183; JUULMADSEN HR, 1990, APMIS, V98, P624, DOI 10.1111/j.1699-0463.1990.tb04980.x; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; LaCelle MG, 2009, CLIN CANCER RES, V15, P6881, DOI 10.1158/1078-0432.CCR-09-1113; Madireddi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042459; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Miyazaki A, 2011, CANCER SCI, V102, P324, DOI 10.1111/j.1349-7006.2010.01789.x; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Nagaraj S, 2007, J IMMUNOTHER, V30, P169, DOI 10.1097/01.cji.0000211329.83890.ba; Sacchi A, 1988, Adv Exp Med Biol, V233, P141; Schabowsky RH, 2007, CURR OPIN INVEST DR, V8, P1002; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Schmidt SM, 2003, BLOOD, V102, P571, DOI 10.1182/blood-2002-08-2554; Schmitz M, 2000, CANCER RES, V60, P4845; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma RK, 2010, VACCINE, V28, P5794, DOI 10.1016/j.vaccine.2010.06.073; Sharma RK, 2010, CANCER RES, V70, P3945, DOI 10.1158/0008-5472.CAN-09-4480; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Sorensen RB, 2008, CANCER BIOL THER, V7, P1885, DOI 10.4161/cbt.7.12.6935; Tonini G, 2005, BRIT J CANCER, V92, P2225, DOI 10.1038/sj.bjc.6602632; Tsuruma Tetsuhiro, 2004, J Transl Med, V2, P19, DOI 10.1186/1479-5876-2-19; Wang P, 2012, MOL CARCINOGEN, V51, P586, DOI 10.1002/mc.20829; Xiang R, 2005, CANCER RES, V65, P553; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhou H, 2005, P NATL ACAD SCI USA, V102, P10846, DOI 10.1073/pnas.0502208102	41	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48463	10.1371/journal.pone.0048463	http://dx.doi.org/10.1371/journal.pone.0048463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144888	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500022
J	Tency, I; Verstraelen, H; Kroes, I; Holtappels, G; Verhasselt, B; Vaneechoutte, M; Verhelst, R; Temmerman, M				Tency, Inge; Verstraelen, Hans; Kroes, Ivo; Holtappels, Gabriele; Verhasselt, Bruno; Vaneechoutte, Mario; Verhelst, Rita; Temmerman, Marleen			Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor	PLOS ONE			English	Article							AMNIOTIC-FLUID MATRIX-METALLOPROTEINASE-9; PREMATURE RUPTURE; FETAL MEMBRANES; PARTURITION; SECRETION; DECIDUA; GELATINASES; BIOMARKERS; INFECTION; PREGNANCY	Background: Matrix metalloproteinases (MMPs) are involved in remodeling of the extracellular matrix (ECM) during pregnancy and parturition. Aberrant ECM degradation by MMPs or an imbalance between MMPs and their tissue inhibitors (TIMPs) have been implicated in the pathogenesis of preterm labor, however few studies have investigated MMPs or TIMPs in maternal serum. Therefore, the purpose of this study was to determine serum concentrations of MMP-3, MMP-9 and all four TIMPs as well as MMP:TIMP ratios during term and preterm labor. Methods: A case control study with 166 singleton pregnancies, divided into four groups: (1) women with preterm birth, delivering before 34 weeks (PTB); (2) gestational age (GA) matched controls, not in preterm labor; (3) women at term in labor and (4) at term not in labor. MMP and TIMP concentrations were measured using Luminex technology. Results: MMP-9 and TIMP-4 concentrations were higher in women with PTB vs. GA matched controls (resp. p = 0.01 and p<0.001). An increase in MMP-9:TIMP-1 and MMP-9:TIMP-2 ratio was observed in women with PTB compared to GA matched controls (resp. p = 0.02 and p<0.001) as well as compared to women at term in labor (resp. p = 0.006 and p<0.001). Multiple regression results with groups recoded as three key covariates showed significantly higher MMP-9 concentrations, higher MMP-9:TIMP-1 and MMP-9:TIMP-2 ratios and lower TIMP-1 and -2 concentrations for preterm labor. Significantly higher MMP-9 and TIMP-4 concentrations and MMP-9:TIMP-2 ratios were observed for labor. Conclusions: Serum MMP-9:TIMP-1 and MMP-9:TIMP-2 balances are tilting in favor of gelatinolysis during preterm labor. TIMP-1 and -2 concentrations were lower in preterm gestation, irrespective of labor, while TIMP-4 concentrations were raised in labor. These observations suggest that aberrant serum expression of MMP:TIMP ratios and TIMPs reflect pregnancy and labor status, providing a far less invasive method to determine enzymes essential in ECM remodeling during pregnancy and parturition. Citation: Tency I, Verstraelen H, Kroes I, Holtappels G, Verhasselt B, et al. (2012) Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor. PLoS ONE 7(11): e49042. doi:10.1371/journal.pone.0049042	[Tency, Inge; Verhelst, Rita; Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Dept Obstet & Gynecol, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Holtappels, Gabriele] Univ Ghent, Fac Med & Hlth Sci, Dept Otorhinolaryngol, Upper Airways Res Lab, B-9000 Ghent, Belgium; [Verhasselt, Bruno; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Tency, I (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Obstet & Gynecol, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium.	inge.tency@ugent.be	Vaneechoutte, Mario/A-6189-2009; Verstraelen, Hans/AAA-8694-2019; Verstraelen, Hans/A-5602-2008	Vaneechoutte, Mario/0000-0002-4586-203X; Verstraelen, Hans/0000-0002-4070-1587; Verhasselt, Bruno/0000-0002-4645-1144	Special Research Fund of the University of Ghent	Special Research Fund of the University of Ghent	This research was supported by the Special Research Fund of the University of Ghent. The funders had no role in the development of the study design, data collection and analysis, decision to submit the paper for publication, or preparation of the manuscript.	Amalinei Cornelia, 2007, Rom J Morphol Embryol, V48, P323; Athayde N, 1999, J Matern Fetal Med, V8, P213; Athayde N, 1998, AM J OBSTET GYNECOL, V179, P1248, DOI 10.1016/S0002-9378(98)70141-3; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brou L, 2012, BJOG-INT J OBSTET GY, V119, P458, DOI 10.1111/j.1471-0528.2011.03266.x; Brunner S, 2010, AM J CARDIOL, V105, P429, DOI 10.1016/j.amjcard.2009.10.013; BRYANTGREENWOOD GD, 1995, AM J OBSTET GYNECOL, V172, P63, DOI 10.1016/0002-9378(95)90085-3; CLARK IM, 1994, BIOCHEM BIOPH RES CO, V203, P874, DOI 10.1006/bbrc.1994.2264; Cockle JV, 2007, REPROD SCI, V14, P629, DOI 10.1177/1933719107304563; Edwards R K, 2001, Infect Dis Obstet Gynecol, V9, P209, DOI 10.1155/S1064744901000345; Fainardi E, 2009, MULT SCLER J, V15, P547, DOI 10.1177/1352458509102372; Fortunato SJ, 1998, AM J REPROD IMMUNOL, V40, P395, DOI 10.1111/j.1600-0897.1998.tb00424.x; Fortunato SJ, 2001, AM J OBSTET GYNECOL, V184, P1399, DOI 10.1067/mob.2001.115122; Fortunato SJ, 1997, AM J OBSTET GYNECOL, V177, P731, DOI 10.1016/S0002-9378(97)70260-6; Fortunato SJ, 1999, J PERINAT MED, V27, P362, DOI 10.1515/JPM.1999.049; Fortunato SJ, 1999, OBSTET GYNECOL, V94, P435, DOI 10.1016/S0029-7844(99)00336-1; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldman S, 2003, MOL HUM REPROD, V9, P367, DOI 10.1093/molehr/gag040; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Harirah H, 2002, OBSTET GYNECOL, V99, P80, DOI 10.1016/S0029-7844(01)01632-5; Jiang ZX, 2010, RHEUMATOL INT, V30, P1219, DOI 10.1007/s00296-009-1135-9; Kisand K, 2011, CLIN CHEM LAB MED, V49, P229, DOI 10.1515/CCLM.2011.049; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Locksmith GJ, 1999, OBSTET GYNECOL, V94, P1, DOI 10.1016/S0029-7844(99)00011-3; Locksmith GJ, 2001, AM J OBSTET GYNECOL, V184, P159, DOI 10.1067/mob.2001.108860; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Makrakis E, 2003, J Matern Fetal Neonatal Med, V14, P170, DOI 10.1080/713606616; Maymon E, 2001, J PERINAT MED, V29, P308, DOI 10.1515/JPM.2001.044; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P887, DOI 10.1067/mob.2000.108878; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Murray GI, 2001, J PATHOL, V195, P135, DOI 10.1002/1096-9896(200109)195:2<135::AID-PATH939>3.0.CO;2-G; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Olafsdottir IS, 2010, RESPIROLOGY, V15, P530, DOI 10.1111/j.1440-1843.2010.01718.x; Orsi NA, 2007, J REPROD IMMUNOL, V75, P97, DOI 10.1016/j.jri.2007.03.002; Park KH, 2003, J PERINAT MED, V31, P12, DOI 10.1515/JPM.2003.002; Poon LCY, 2009, PRENATAL DIAG, V29, P553, DOI 10.1002/pd.2234; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Riley SC, 1999, MOL HUM REPROD, V5, P376, DOI 10.1093/molehr/5.4.376; Riley SC, 1999, J ENDOCRINOL, V162, P351, DOI 10.1677/joe.0.1620351; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2002, AM J OBSTET GYNECOL, V187, P1125, DOI 10.1067/mob.2002.127312; Rouy D, 2005, ANAL BIOCHEM, V338, P294, DOI 10.1016/j.ab.2004.10.052; Tarr GP, 2011, CLIN BIOCHEM, V44, P1346, DOI 10.1016/j.clinbiochem.2011.08.1139; TWOROGER SS, 2006, ONCOLOGY, V15, P1578, DOI DOI 10.1158/1055-9965.EPI-06-0629; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; VadilloOrtega F, 1996, AM J OBSTET GYNECOL, V174, P1371, DOI 10.1016/S0002-9378(96)70687-7; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Woessner JF, 2000, METH MOL B, V151, P1, DOI 10.1385/1-59259-046-2:001; Yonemoto H, 2006, PLACENTA, V27, P669, DOI 10.1016/j.placenta.2005.05.014	51	39	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49042	10.1371/journal.pone.0049042	http://dx.doi.org/10.1371/journal.pone.0049042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145060	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500065
J	van de Klundert, MAA; van Hemert, FJ; Zaaijer, HL; Kootstra, NA				van de Klundert, Maarten A. A.; van Hemert, Formijn J.; Zaaijer, Hans L.; Kootstra, Neeltje A.			The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENE TRANSACTIVATION; TRANSCRIPTION FACTOR; HBV REACTIVATION; TRANSGENIC MICE; REPLICATION; BINDING; INFECTION; RECEPTOR; CELLS	The hepatitis B virus (HBV) genome encodes the X protein (HBx), a ubiquitous transactivator that is required for HBV replication. Expression of the HBx protein has been associated with the development of HBV infection-related hepatocellular carcinoma (HCC). Previously, we generated a 3D structure of HBx by combined homology and ab initio in silico modelling. This structure showed a striking similarity to the human thymine DNA glycosylase (TDG), a key enzyme in the base excision repair (BER) pathway. To further explore this finding, we investigated whether both proteins interfere with or complement each other's functions. Here we show that TDG does not affect HBV replication, but that HBx strongly inhibits TDG-initiated base excision repair (BER), a major DNA repair pathway. Inhibition of the BER pathway may contribute substantially to the oncogenic effect of HBV infection. Citation: van de Klundert MAA, van Hemert FJ, Zaaijer HL, Kootstra NA (2012) The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair. PLoS ONE 7(11): e48940. doi:10.1371/journal.pone.0048940	[van de Klundert, Maarten A. A.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, CINIMA, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [van de Klundert, Maarten A. A.; Zaaijer, Hans L.] Ctr Infect & Immun Amsterdam CINIMA, Dept Blood Borne Infect, Amsterdam, Netherlands; [van Hemert, Formijn J.] Univ Amsterdam, Acad Med Ctr, CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Zaaijer, Hans L.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, CINIMA, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	N.A.Kootstra@amc.uva.nl	van de Klundert, Maarten/AAD-6207-2019	Kootstra, Neeltje A./0000-0001-9429-7754; van de Klundert, Maarten/0000-0001-6407-9481	Sanquin Blood Supply Foundation	Sanquin Blood Supply Foundation	This work was funded by Sanquin Blood Supply Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumert TF, 1996, J CLIN INVEST, V98, P2268, DOI 10.1172/JCI119037; Baumert TF, 1998, J VIROL, V72, P6785, DOI 10.1128/JVI.72.8.6785-6795.1998; Chung C, 2007, CANCER SCI, V98, P1758, DOI 10.1111/j.1349-7006.2007.00591.x; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; He Y, 2010, MED ONCOL, V27, P1227, DOI 10.1007/s12032-009-9363-0; Hodgson AJ, 2012, VIROLOGY, V426, P73, DOI 10.1016/j.virol.2012.01.021; Hsu C, 2004, J FORMOS MED ASSOC, V103, P483; Hsu CH, 2004, ANTICANCER RES, V24, P3035; Jia L, 1999, INT J CANCER, V80, P875, DOI 10.1002/(SICI)1097-0215(19990315)80:6<875::AID-IJC13>3.3.CO;2-Q; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim K, 2008, BIOCHEM J, V416, P219, DOI 10.1042/BJ20081336; Kong HJ, 2000, FEBS LETT, V483, P114, DOI 10.1016/S0014-5793(00)02091-3; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; Leupin O, 2005, J VIROL, V79, P4238, DOI 10.1128/JVI.79.7.4238-4245.2005; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li SY, 2010, ACTA BIOCH BIOPH SIN, V42, P381, DOI 10.1093/abbs/gmq032; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Liu XH, 2008, WORLD J GASTROENTERO, V14, P1346, DOI 10.3748/wjg.14.1346; Liu Y, 2011, J VIRAL HEPATITIS, V18, pE439, DOI 10.1111/j.1365-2893.2011.01463.x; Manzano-Alonso ML, 2011, WORLD J GASTROENTERO, V17, P1531, DOI [10.3748/wjg.v17.i12. 1531, 10.3748/wjg.v17.i12.1531]; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Mathonnet G, 2004, MUTAT RES-FUND MOL M, V554, P305, DOI 10.1016/j.mrfmmm.2004.05.010; MURAKAMI S, 1994, J BIOL CHEM, V269, P15118; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Qadri I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-48; Sitterlin D, 2000, ONCOGENE, V19, P4427, DOI 10.1038/sj.onc.1203770; Sitterlin D, 1997, J VIROL, V71, P6194, DOI 10.1128/JVI.71.8.6194-6199.1997; van de Klundert MAA, 2012, J VIRAL HEPATITIS, V19, pE34, DOI 10.1111/j.1365-2893.2011.01506.x; van Hemert FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023392; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Wentz MJ, 2000, VIRUS RES, V68, P87, DOI 10.1016/S0168-1702(00)00160-X; Zaaijer HL, 2008, J VIRAL HEPATITIS, V15, P239, DOI 10.1111/j.1365-2893.2007.00938.x; Zheng YY, 2007, VIROLOGY, V363, P454, DOI 10.1016/j.virol.2007.01.040; Zhu HZ, 2004, EXP MOL PATHOL, V76, P44, DOI 10.1016/j.yexmp.2003.09.001	39	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48940	10.1371/journal.pone.0048940	http://dx.doi.org/10.1371/journal.pone.0048940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145031	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500052
J	Anderson, SM; Brunzell, DH				Anderson, Shawn M.; Brunzell, Darlene H.			Low Dose Nicotine and Antagonism of beta 2 Subunit Containing Nicotinic Acetylcholine Receptors Have Similar Effects on Affective Behavior in Mice	PLOS ONE			English	Article							CONDITIONED EMOTIONAL RESPONSE; VENTRAL TEGMENTAL AREA; ELEVATED PLUS-MAZE; MARBLE-BURYING BEHAVIOR; SOCIAL-INTERACTION TEST; FORCED SWIM TEST; CIGARETTE-SMOKING; ALPHA-6 SUBUNITS; PLACE PREFERENCE; ANIMAL-MODELS	Nicotine leads to both activation and desensitization (inactivation) of nicotinic acetylcholine receptors (nAChRs). This study tested the hypothesis that nicotine and a selective antagonist of beta 2*nAChRs would have similar effects on affective behavior. Adult C57BL/6J male mice were tested in a conditioned emotional response (CER) assay which evaluates the ability of an aversive stimulus to inhibit goal-directed behavior. Mice lever-pressed for a saccharin reinforcer according to a variable schedule of reinforcement during sessions in which two presentations of a compound light/tone conditioned stimulus (CS) co-terminated with a 0.1 or 0.3 mA, 0.5 s footshock unconditioned stimulus (US). During testing in the absence of the US, mice received doses of i.p. nicotine (0, 0.0032, 0.01, 0.032, 0.1 mg/kg) or a selective beta 2 subunit containing nAChR (beta 2*nAChR) antagonist dihydro-beta-erythroidine (0, 0.1, 0.3, 1.0, 3.0 mg/kg DH beta E). There was a dose-dependent effect of nicotine revealing that only low doses (0.01, 0.032 mg/kg) increased CER suppression ratios (SR) in these mice. DHbE also dose-dependently increased SR at the 3 mg/kg dose. In ethological measures of fear-/anxiety-like behavior, these doses of nicotine and DHbE significantly reduced digging behavior in a marble burying task and 0.3 mg/kg DHbE promoted open-arm activity in the elevated plus maze. Doses of nicotine and DHbE that altered affective behavior had no effect on locomotor activity. Similar to previous reports with anxiolytic drugs, low dose nicotine and DHbE reversed SR in a CER assay, decreased digging in a marble burying assay and increased open arm activity in the elevated plus maze. This study provides evidence that inactivation of beta 2*nAChRs reduces fear-like and anxiety-like behavior in rodents and suggests that smokers may be motivated to smoke in part to desensitize their beta 2*nAChRs. These data further identify beta 2*nAChR antagonism as a potential therapeutic strategy for relief of negative affect and anxiety.	[Anderson, Shawn M.; Brunzell, Darlene H.] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Brunzell, Darlene H.] Virginia Commonwealth Univ, Sch Med, Interdept Neurosci Grad Program, Richmond, VA USA; [Brunzell, Darlene H.] Virginia Commonwealth Univ, Sch Med, Inst Drug & Alcohol Studies, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Brunzell, DH (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	dbrunzell@vcu.edu			National Institutes of Health (NIH) [T32DA007027]; Thomas F. and Kate Miller Jeffress Memorial Trust [J-951]; NIH [DA031289]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031289, T32DA007027] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas F. and Kate Miller Jeffress Memorial Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the agencies that have supported this research: SM Anderson was supported by a National Institutes of Health (NIH) Training Grant T32DA007027 to W. L. Dewey, and this work was supported by a Thomas F. and Kate Miller Jeffress Memorial Trust research grant J-951 and NIH R01 grant DA031289 to D. H. Brunzell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNAU Z, 1961, J COMP PHYSIOL PSYCH, V54, P428, DOI 10.1037/h0042199; Bahi A, 2009, BIOL PSYCHIAT, V66, P1139, DOI 10.1016/j.biopsych.2009.07.004; Bencan Z, 2008, PHYSIOL BEHAV, V95, P408, DOI 10.1016/j.physbeh.2008.07.009; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; Berlin I, 2003, ADDICTION, V98, P1575, DOI 10.1046/j.1360-0443.2003.00523.x; Britton JC, 2011, DEPRESS ANXIETY, V28, P5, DOI 10.1002/da.20733; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P907, DOI 10.1001/archpsyc.63.8.907; BROEKKAMP CL, 1986, EUR J PHARMACOL, V126, P223, DOI 10.1016/0014-2999(86)90051-8; Brunzell D, 2006, PSYCHOPHARMACOLOGY, V184, P328, DOI 10.1007/s00213-005-0099-z; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Caldarone BJ, 2011, PSYCHOPHARMACOLOGY, V217, P199, DOI 10.1007/s00213-011-2271-y; Carter BL, 2006, NICOTINE TOB RES, V8, P361, DOI 10.1080/14622200600670215; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; CHANCE WT, 1977, PSYCHOPHARMACOLOGY, V55, P19, DOI 10.1007/BF00432812; Cheeta S, 2001, PHARMACOL BIOCHEM BE, V70, P491, DOI 10.1016/S0091-3057(01)00641-4; Chefer SI, 1998, LIFE SCI, V63, pPL355, DOI 10.1016/S0024-3205(98)00514-1; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; CORRIGALL WA, 1994, BRAIN RES, V653, P278, DOI 10.1016/0006-8993(94)90401-4; COURT J, 1995, ALZ DIS ASSOC DIS, V9, P6, DOI 10.1097/00002093-199501002-00003; Craske MG, 2008, BEHAV RES THER, V46, P954, DOI 10.1016/j.brat.2008.04.011; Davis JA, 2006, PSYCHOPHARMACOLOGY, V184, P345, DOI 10.1007/s00213-005-0047-y; DAVIS M, 1990, PHARMACOL THERAPEUT, V47, P147, DOI 10.1016/0163-7258(90)90084-F; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; DeBiasi M, 2010, STRESS MOL BEHAV, P37; DECKER MW, 1995, EUR J PHARMACOL, V280, P79, DOI 10.1016/0014-2999(95)00191-M; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; DeNoble VJ, 2006, PSYCHOPHARMACOLOGY, V184, P266, DOI 10.1007/s00213-005-0054-z; Dixon CI, 2008, PHARMACOL BIOCHEM BE, V90, P1, DOI 10.1016/j.pbb.2008.01.015; Donny EC, 2000, EUR J PHARMACOL, V402, P231, DOI 10.1016/S0014-2999(00)00532-X; Egashira N, 2008, EUR J PHARMACOL, V592, P103, DOI 10.1016/j.ejphar.2008.06.100; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; Fenster CP, 1997, J NEUROSCI, V17, P5747; Fidler JA, 2009, NICOTINE TOB RES, V11, P1182, DOI 10.1093/ntr/ntp120; File SE, 1998, BEHAV NEUROSCI, V112, P1423, DOI 10.1037/0735-7044.112.6.1423; File SE, 2000, PHARMACOL BIOCHEM BE, V66, P65, DOI 10.1016/S0091-3057(00)00198-2; Fujita M, 2000, J NUCL MED, V41, P1552; Garrett KM, 1998, BEHAV GENET, V28, P125, DOI 10.1023/A:1021424108213; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Gould TJ, 1999, BEHAV BRAIN RES, V102, P31, DOI 10.1016/S0166-4328(98)00157-0; Gould TJ, 2003, INTEGR PHYS BEH SCI, V38, P124, DOI 10.1007/BF02688830; Grabus SD, 2006, PSYCHOPHARMACOLOGY, V184, P456, DOI 10.1007/s00213-006-0305-7; Grady SR, 2012, NEUROPHARMACOLOGY, V62, P1935, DOI 10.1016/j.neuropharm.2011.12.026; Grady SR, 2010, NEUROPHARMACOLOGY, V58, P1054, DOI 10.1016/j.neuropharm.2010.01.013; Hall BJ, 2010, NEUROSCI LETT, V474, P84, DOI 10.1016/j.neulet.2010.03.011; ICHIMARU Y, 1995, JPN J PHARMACOL, V68, P65, DOI 10.1254/jjp.68.65; Irvine EE, 1999, BEHAV PHARMACOL, V10, P691, DOI 10.1097/00008877-199911000-00016; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Johnson NJT, 1996, PSYCHOPHARMACOLOGY, V124, P355, DOI 10.1007/BF02247441; Kimes AS, 2008, NEUROIMAGE, V39, P717, DOI 10.1016/j.neuroimage.2007.09.015; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V98, P21, DOI 10.1016/j.pbb.2010.12.002; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Lazev AB, 1999, EXP CLIN PSYCHOPHARM, V7, P56, DOI 10.1037/1064-1297.7.1.56; Le Foll B, 2008, NEUROSCI LETT, V443, P236, DOI 10.1016/j.neulet.2008.07.074; Le Foll B, 2008, BEHAV PHARMACOL, V19, P13, DOI 10.1097/FBP.0b013e3282f3cf84; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; LESTER RAJ, 1995, J NEUROPHYSIOL, V74, P195, DOI 10.1152/jn.1995.74.1.195; Levin ED, 2010, J PHARMACOL EXP THER, V332, P933, DOI 10.1124/jpet.109.162073; Littel M, 2007, J PSYCHOPHARMACOL, V21, P873, DOI 10.1177/0269881107078494; Liu LW, 2012, MOL PHARMACOL, V81, P541, DOI 10.1124/mol.111.076661; Liu X, 2003, NEUROREPORT, V14, P1503, DOI 10.1097/00001756-200308060-00020; LIVSON N, 1988, INT J ADDICT, V23, P535, DOI 10.3109/10826088809039218; Lu Y, 1999, J PHARMACOL EXP THER, V291, P1127; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Marks MJ, 2010, J MOL NEUROSCI, V40, P96, DOI 10.1007/s12031-009-9264-x; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Martin JR, 2002, PHARMACOL BIOCHEM BE, V71, P615, DOI 10.1016/S0091-3057(01)00713-4; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Mathiasen LS, 2007, BEHAV PHARMACOL, V18, P191, DOI 10.1097/FBP.0b013e32814fcdd4; McDonough BE, 2001, PSYCHOPHARMACOLOGY, V154, P282; McGranahan TM, 2011, J NEUROSCI, V31, P10891, DOI 10.1523/JNEUROSCI.0937-11.2011; Mineur YS, 2009, GENES BRAIN BEHAV, V8, P257, DOI 10.1111/j.1601-183X.2008.00468.x; Mineur YS, 2007, NEUROPHARMACOLOGY, V52, P1256, DOI 10.1016/j.neuropharm.2007.01.006; Morris HV, 2006, EUR J NEUROSCI, V23, P2495, DOI 10.1111/j.1460-9568.2006.04775.x; Newman MB, 2002, EXP CLIN PSYCHOPHARM, V10, P18, DOI 10.1037//1064-1297.10.1.18; Newman MB, 2001, PROG NEURO-PSYCHOPH, V25, P609, DOI 10.1016/S0278-5846(00)00178-0; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; NJUNGE K, 1991, BRIT J PHARMACOL, V104, P105, DOI 10.1111/j.1476-5381.1991.tb12392.x; Olausson P, 2004, PSYCHOPHARMACOLOGY, V171, P173, DOI 10.1007/s00213-003-1575-y; Ouagazzal AM, 1999, PSYCHOPHARMACOLOGY, V144, P54, DOI 10.1007/s002130050976; Palmatier MI, 2005, NEUROPSYCHOPHARMACOL, V30, P731, DOI 10.1038/sj.npp.1300629; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; PAULY JR, 1993, NEUROENDOCRINOLOGY, V57, P262, DOI 10.1159/000126368; PAULY JR, 1991, J PHARMACOL EXP THER, V258, P1127; Pelleymounter MA, 2002, J PHARMACOL EXP THER, V302, P145, DOI 10.1124/jpet.302.1.145; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PERKINS KA, 1992, BRIT J ADDICT, V87, P1037; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Picciotto MR, 2001, PHARMACOL THERAPEUT, V92, P89, DOI 10.1016/S0163-7258(01)00161-9; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Power AE, 2002, BEHAV BRAIN RES, V134, P307, DOI 10.1016/S0166-4328(02)00046-3; Rabenstein RL, 2006, PSYCHOPHARMACOLOGY, V189, P395, DOI 10.1007/s00213-006-0568-z; Rollema H, 2009, EUR J PHARMACOL, V605, P114, DOI 10.1016/j.ejphar.2009.01.002; Roni MA, 2011, NEUROSCI LETT, V504, P237, DOI 10.1016/j.neulet.2011.09.035; Rose JE, 2003, AM J PSYCHIAT, V160, P323, DOI 10.1176/appi.ajp.160.2.323; RUBBOLI F, 1994, EUR J NEUROSCI, V6, P1596, DOI 10.1111/j.1460-9568.1994.tb00550.x; SCOBIE SR, 1970, PSYCHOPHARMACOLOGIA, V16, P272, DOI 10.1007/BF00404733; Sehlmeyer C, 2011, PSYCHOL MED, V41, P789, DOI 10.1017/S0033291710001248; Sharma Anil, 2009, Handb Exp Pharmacol, P145, DOI 10.1007/978-3-540-69248-5_6; Shiffman S, 2004, J CONSULT CLIN PSYCH, V72, P192, DOI 10.1037/0022-006X.72.2.192; Shiffman S, 1997, ADDICT BEHAV, V22, P797, DOI 10.1016/S0306-4603(97)00063-4; Skara S, 2001, AM J HEALTH BEHAV, V25, P147, DOI 10.5993/AJHB.25.2.7; Slot LAB, 2008, BEHAV PHARMACOL, V19, P145, DOI 10.1097/FBP.0b013e3282f62cb2; Staley JK, 2005, J NUCL MED, V46, P1466; Stanhope KJ, 1996, PSYCHOPHARMACOLOGY, V128, P293, DOI 10.1007/s002130050137; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Turner JR, 2010, J PHARMACOL EXP THER, V334, P665, DOI 10.1124/jpet.110.166280; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Varani AP, 2012, NEUROPHARMACOLOGY, V63, P863, DOI 10.1016/j.neuropharm.2012.06.006; Vaupel DB, 1998, NEUROREPORT, V9, P2311, DOI 10.1097/00001756-199807130-00030; Walters CL, 2006, PSYCHOPHARMACOLOGY, V184, P339, DOI 10.1007/s00213-005-0295-x; Waters AM, 2009, J ABNORM PSYCHOL, V118, P311, DOI 10.1037/a0015635; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; WHITING PJ, 1988, J NEUROSCI, V8, P3395; Wiley JL, 1995, EUR J PHARMACOL, V294, P101, DOI 10.1016/0014-2999(95)00506-4; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	131	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48665	10.1371/journal.pone.0048665	http://dx.doi.org/10.1371/journal.pone.0048665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144922	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800092
J	Andrade, CS; Jesus, RP; Andrade, TB; Oliveira, NS; Nabity, SA; Ribeiro, GS				Andrade, Carine S.; Jesus, Rosangela P.; Andrade, Taciana B.; Oliveira, Neyara S.; Nabity, Scott A.; Ribeiro, Guilherme S.			Prevalence and Characteristics Associated with Malnutrition at Hospitalization among Patients with Acquired Immunodeficiency Syndrome in Brazil	PLOS ONE			English	Article							HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; NUTRITIONAL-STATUS; RANDOMIZED-TRIAL; BODY-COMPOSITION; MORTALITY; AIDS; HIV/AIDS; SURVIVAL; VIRUS	Background: Brazil's National STD/AIDS Program is considered a model of success worldwide. However, AIDS-associated malnutrition continues in subgroups of Brazilian patients despite access to free highly active antiretroviral therapy (HAART). We aimed to identify the prevalence of malnutrition and associated factors among patients hospitalized with AIDS. Methods: We conducted a cross-sectional nutritional assessment among 127 adults hospitalized with AIDS in Brazil's third largest city. Using anthropometric measurements, we determined the prevalence of malnutrition (body mass index <18.5 kg/m(2)) at hospitalization. Prevalence ratios of malnutrition by demographic, socioeconomic, and clinical conditions were estimated using log-binomial regression. Results: One-third of participants were first informed of their HIV disease during the current hospitalization and recent treatment interruption was common (71%) among those on HAART. Forty-three percent were malnourished and 35% had severe weight loss at admission. Patient characteristics independently associated with malnutrition were older age (2% increased prevalence for each year; 95% confidence interval [CI] 0-4%) and very low daily per capita household income. Living on <USD 2.00, USD 2.00-4.99 or USD 5.00-9.99 increased the prevalence of malnutrition by 2.01 (95% CI 1.06-3.81), 1.75 (95% CI 0.92-3.35) and 1.42 (95% CI 0.76-2.65) times, respectively, compared to >= USD 10.00 per day. Chronic diarrhea was marginally associated with malnutrition (RR 1.42; 95% CI 0.99-2.04). Overall, 16% of the patients died during hospitalization. We observed a trend toward higher in-hospital case fatality among malnourished patients (22% vs. 12% for patients with and without malnutrition, respectively; chi square P = 0.14). Conclusions: Unacceptably high rates of malnutrition persist in Brazilians hospitalized with AIDS and our results reinforce the importance of nutritional evaluations in these patients. Improved early testing and treatment adherence strategies may continue to help reduce AIDS-related morbidity and mortality in Brazil, yet novel interventions to disrupt the cycle of poverty, HIV, and malnutrition are also urgently needed.	[Nabity, Scott A.; Ribeiro, Guilherme S.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil; [Andrade, Carine S.; Jesus, Rosangela P.; Andrade, Taciana B.; Oliveira, Neyara S.] Univ Fed Bahia, Sch Nutr, Salvador, BA, Brazil; [Nabity, Scott A.] Duke Univ, Sch Med, Durham, NC USA; [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Duke University; Universidade Federal da Bahia	Ribeiro, GS (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.	gsribeiro@ufba.br	Ribeiro, Guilherme/B-6624-2008	Ribeiro, Guilherme/0000-0002-6798-2059	Brazilian National Council for Scientific and Technological Development; Foundation for Research Support in the State of Bahia; Duke Global Health Institute	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support in the State of Bahia; Duke Global Health Institute	This study was supported by the Brazilian National Council for Scientific and Technological Development through a research scholarship to TBA, the Foundation for Research Support in the State of Bahia through research scholarships to CSA and NSO, and the Duke Global Health Institute through a clinical research grant to SAN. The funding sources had no involvement in study design, data collection, analysis, interpretation, report writing, or publication. The authors had full access to all data and accept full responsibility for the content of this report.	Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; BLACKBURN GL, 1979, MED CLIN N AM, V63, P1103, DOI 10.1016/S0025-7125(16)31663-7; Brazilian Institute of Geography and Statistics, 2011, SUMM 2010 DEM CENS; Brazilian Ministry of Health, 2008, REC ANT THER AD INF; Brazilian Ministry of Health, 2011, HIV LIP SYNDR; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; CHUMLEA WC, 1988, J AM DIET ASSOC, V88, P564; CHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2; Dourado I, 2006, REV SAUDE PUBL, V40, P9, DOI 10.1590/S0034-89102006000800003; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; Gibson R.S., 1993, NUTR ASSESSMENT LAB; Health Surveillance Secretariat Brazilian Ministry of Health, 2012, PROGR REP BRAZ RESP; Heath KV, 2002, INT J EPIDEMIOL, V31, P1016, DOI 10.1093/ije/31.5.1016; HECKER LM, 1990, NUTR REV, V48, P393, DOI 10.1111/j.1753-4887.1990.tb02888.x; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Jaime PC, 2006, REV SAUDE PUBL, V40, P634, DOI 10.1590/S0034-89102006000500012; Jiamton S, 2003, AIDS, V17, P2461, DOI 10.1097/00002030-200311210-00008; Khan Y, 2010, PEDIATR CLIN N AM, V57, P1409, DOI 10.1016/j.pcl.2010.09.016; Knox TA, 2003, CLIN INFECT DIS, V36, pS63, DOI 10.1086/367560; Kosmiski L, 2011, AM J CLIN NUTR, V94, p1677S, DOI 10.3945/ajcn.111.012625; KOTLER DP, 1984, ANN INTERN MED, V101, P421, DOI 10.7326/0003-4819-101-4-421; KOTLER DP, 1990, ANN INTERN MED, V113, P444; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Kroll AF, 2012, ARQ BRAS ENDOCRINOL, V56, P137, DOI 10.1590/S0004-27302012000200007; Lee RD, 1995, NUTR ASSESSMENT, P289; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; Melchior JC, 1999, NUTRITION, V15, P865, DOI 10.1016/S0899-9007(99)00210-5; Municipal Secretary of Health, 2012, TABNET SALV HOSP SAL; Niyongabo T, 1999, NUTRITION, V15, P740, DOI 10.1016/S0899-9007(99)00146-X; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Salomon J, 2002, BRIT J NUTR, V87, pS111, DOI 10.1079/BJN2001464; Semba RD, 2010, FOOD NUTR BULL, V31, pS345, DOI 10.1177/15648265100314S404; Silva Erika Ferrari Rafael, 2010, Rev. bras. epidemiol., V13, P677, DOI 10.1590/S1415-790X2010000400012; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; Thibault R, 2011, CURR OPIN CLIN NUTR, V14, P261, DOI 10.1097/MCO.0b013e3283455d60; Villamor E, 2006, EUR J CLIN NUTR, V60, P163, DOI 10.1038/sj.ejcn.1602281; Wanke CA, 2000, CLIN INFECT DIS, V31, P803, DOI 10.1086/314027; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48717	10.1371/journal.pone.0048717	http://dx.doi.org/10.1371/journal.pone.0048717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144941	Green Published, gold			2022-12-25	WOS:000311935800107
J	Bundschuh, M; Seitz, F; Rosenfeldt, RR; Schulz, R				Bundschuh, Mirco; Seitz, Frank; Rosenfeldt, Ricki R.; Schulz, Ralf			Titanium Dioxide Nanoparticles Increase Sensitivity in the Next Generation of the Water Flea Daphnia magna	PLOS ONE			English	Article							ENGINEERED NANOMATERIALS; CHRONIC TOXICITY; FISH	The nanoparticle industry is expected to become a trillion dollar business in the near future. Therefore, the unintentional introduction of nanoparticles into the environment is increasingly likely. However, currently applied risk-assessment practices require further adaptation to accommodate the intrinsic nature of engineered nanoparticles. Combining a chronic flow-through exposure system with subsequent acute toxicity tests for the standard test organism Daphnia magna, we found that juvenile offspring of adults that were previously exposed to titanium dioxide nanoparticles exhibit a significantly increased sensitivity to titanium dioxide nanoparticles compared with the offspring of unexposed adults, as displayed by lower 96 h-EC50 values. This observation is particularly remarkable because adults exhibited no differences among treatments in terms of typically assessed endpoints, such as sensitivity, number of offspring, or energy reserves. Hence, the present study suggests that ecotoxicological research requires further development to include the assessment of the environmental risks of nanoparticles for the next and hence not directly exposed generation, which is currently not included in standard test protocols.	[Bundschuh, Mirco; Seitz, Frank; Rosenfeldt, Ricki R.; Schulz, Ralf] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	University of Koblenz & Landau	Schulz, R (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	R.Schulz@uni-landau.de	Bundschuh, Mirco/H-4559-2014; Schulz, Ralf/G-3674-2011; Schulz, Ralf/ABI-4526-2020	Bundschuh, Mirco/0000-0003-4876-220X; Schulz, Ralf/0000-0002-6348-6971; Schulz, Ralf/0000-0002-6348-6971; Seitz, Frank/0000-0002-3181-0140	Ministry of Science Rhineland-Palatinate (MBWJK); German Research Foundation (DFG); Fix-Stiftung, Landau	Ministry of Science Rhineland-Palatinate (MBWJK); German Research Foundation (DFG)(German Research Foundation (DFG)); Fix-Stiftung, Landau(Russian Academy of Sciences)	The Ministry of Science Rhineland-Palatinate (MBWJK) funded this study, which is linked with studies conducted within the research group INTERNANO, which is funded by the German Research Foundation (DFG). Moreover, we acknowledge the Fix-Stiftung, Landau for financial support of the research infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD DJ, 1991, ECOTOX ENVIRON SAFE, V22, P1, DOI 10.1016/0147-6513(91)90040-V; Behra R, 2008, NAT NANOTECHNOL, V3, P253, DOI 10.1038/nnano.2008.113; Borenstein M., 2009, INTRO METAANALYSIS; Bundschuh M, 2011, CHEMOSPHERE, V85, P1563, DOI 10.1016/j.chemosphere.2011.07.060; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Ferry JL, 2009, NAT NANOTECHNOL, V4, P441, DOI [10.1038/NNANO.2009.157, 10.1038/nnano.2009.157]; Gottschalk F, 2011, ENVIRON POLLUT, V159, P3439, DOI 10.1016/j.envpol.2011.08.023; Hall S, 2009, NANOTOXICOLOGY, V3, P91, DOI 10.1080/17435390902788078; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Ji K, 2008, ENVIRON TOXICOL CHEM, V27, P2159, DOI 10.1897/07-523.1; Klaine SJ, 2012, ENVIRON TOXICOL CHEM, V31, P3, DOI 10.1002/etc.733; OECD, 2008, OECD GUID; OECD, 2004, OECD GUID; Ortiz-Rodriguez R, 2012, J EXP BIOL, V215, P2795, DOI 10.1242/jeb.069211; Owen R, 2007, ENVIRON SCI TECHNOL, V41, P5582; Panacek A, 2011, ENVIRON SCI TECHNOL, V45, P4974, DOI 10.1021/es104216b; Ritz C, 2008, USE R, P1; Vandegehuchte MB, 2010, COMP BIOCHEM PHYS C, V151, P278, DOI 10.1016/j.cbpc.2009.11.007; von der Kammer F, 2012, ENVIRON TOXICOL CHEM, V31, P32, DOI 10.1002/etc.723; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Zaffagnini F., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P245	21	34	34	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48956	10.1371/journal.pone.0048956	http://dx.doi.org/10.1371/journal.pone.0048956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145038	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800177
J	Cinek, O; Tapia, G; Witso, E; Kramna, L; Holkova, K; Rasmussen, T; Stene, LC; Ronningen, KS				Cinek, Ondrej; Tapia, German; Witso, Elisabet; Kramna, Lenka; Holkova, Katerina; Rasmussen, Trond; Stene, Lars C.; Ronningen, Kjersti S.			Enterovirus RNA in Peripheral Blood May Be Associated with the Variants of rs1990760, a Common Type 1 Diabetes Associated Polymorphism in IFIH1	PLOS ONE			English	Article							BETA-CELL AUTOIMMUNITY; MULTIPLE-SCLEROSIS; FUNCTION MUTATIONS; MONONUCLEAR-CELLS; RISK-FACTOR; RIG-I; INFECTIONS; LOCUS; MDA5; RECOGNITION	Objective: Polymorphisms in the IFIH1 (common rs1990760 and four rare rs35667974, rs35337543, rs35744605, rs35732034) have been convincingly associated with type 1 diabetes. The encoded protein (interferon-induced helicase C domain-containing protein 1) senses double-stranded RNA during replication of Picornavirales, including Enterovirus, a genus suspected in the etiology of type 1 diabetes. We therefore investigated whether the polymorphisms are associated with differences in the frequency of enterovirus RNA in blood. Research Design and Methods: The study included 1001 blood samples, each from a child participating in the Norwegian 'Environmental Triggers of Type 1 Diabetes: the MIDIA study'. The enterovirus RNA was tested using qualitative semi-nested real-time reverse transcriptase PCR on RNA extracted from frozen cell packs after removal of plasma. Stool samples previously analyzed for enterovirus RNA were available in 417 children. Results: The genotypes of IFIH1 rs1990760 were associated with different frequencies of enterovirus RNA in blood (7.0%, 14.4% and 9.5% bloods were enterovirus positive among children carrying the Ala/Ala, Ala/Thr and Thr/Thr genotypes, respectively, p = 0.012). This association remained essentially unchanged after adjustment for age and calendar year. The presence of enterovirus in the concomitantly sampled stool further increased the likelihood of enterovirus RNA in blood (odds ratio 2.40, CI 95% 1.13-4.70), but did not affect the association with IFIH1 rs1990760. The rare polymorphisms (individually, or pooled) were not significantly associated with enterovirus RNA in blood. Conclusions: The common IFIH1 SNP may modify the frequency of enterovirus RNA in blood of healthy children. This effect can help explain the association of IFIH1 with type 1 diabetes.	[Cinek, Ondrej; Kramna, Lenka; Holkova, Katerina] Charles Univ Prague, Dept Paediat, Fac Med 2, Prague, Czech Republic; [Cinek, Ondrej; Kramna, Lenka; Holkova, Katerina] Univ Hosp Motol, Prague, Czech Republic; [Tapia, German; Witso, Elisabet; Rasmussen, Trond; Stene, Lars C.] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Ronningen, Kjersti S.] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway	Charles University Prague; Motol University Hospital; Norwegian Institute of Public Health (NIPH); University of Oslo; National Hospital Norway	Cinek, O (corresponding author), Charles Univ Prague, Dept Paediat, Fac Med 2, Prague, Czech Republic.	Ondrej.Cinek@Lfmotol.cuni.cz	Tapia, German/AAS-8467-2020; Kramná, Lenka/AAA-1772-2022; Cinek, Ondrej/AAF-6664-2020	Tapia, German/0000-0002-1770-1183; Cinek, Ondrej/0000-0002-0526-8714	Norwegian Organization for Health and Rehabilitation [2008/0182]; Ministry of Health of the Czech Republic [IGA MZ 11465-5]; Research Council of Norway [135893/330, 155300/320, 156477/730, 166515/V50]; Norwegian Diabetes Association; ISPAD Research Fellowship ((International Society for Pediatric and Adolescent Diabetes)	Norwegian Organization for Health and Rehabilitation; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Research Council of Norway(Research Council of Norway); Norwegian Diabetes Association; ISPAD Research Fellowship ((International Society for Pediatric and Adolescent Diabetes)	This study and the MIDIA project were funded by the Norwegian Organization for Health and Rehabilitation (2008/0182), the Ministry of Health of the Czech Republic (IGA MZ 11465-5), the Research Council of Norway (grants 135893/330, 155300/320, 156477/730 and 166515/V50) and the Norwegian Diabetes Association. O.C. was supported by the ISPAD Research Fellowship ((International Society for Pediatric and Adolescent Diabetes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminkeng F, 2009, HUM IMMUNOL, V70, P706, DOI 10.1016/j.humimm.2009.06.013; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Chistiakov DA, 2010, HUM IMMUNOL, V71, P1128, DOI 10.1016/j.humimm.2010.08.005; Chistiakov DA, 2010, VIRAL IMMUNOL, V23, P3, DOI 10.1089/vim.2009.0071; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008; Fuchtenbusch M, 2001, J AUTOIMMUN, V17, P333, DOI 10.1006/jaut.2001.0550; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Graves PM, 2003, DIABETES RES CLIN PR, V59, P51, DOI 10.1016/S0168-8227(02)00198-5; Jermendy A, 2010, DIABETOLOGIA, V53, P98, DOI 10.1007/s00125-009-1561-y; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Liu S, 2008, HUM MOL GENET; Lonnrot M, 2000, J MED VIROL, V61, P214, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;214::AID-JMV7&gt;3.0.CO;2-9; Martinez A, 2008, EUR J HUM GENET, V16, P861, DOI 10.1038/ejhg.2008.16; Moya-Suri V, 2005, J MED MICROBIOL, V54, P879, DOI 10.1099/jmm.0.46015-0; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oikarinen M, 2008, DIABETOLOGIA, V51, P1796, DOI 10.1007/s00125-008-1107-8; Oikarinen M, 2012, DIABETES, V61, P687, DOI 10.2337/db11-1157; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Pallansch MA, 1997, FIELDS VIROLOGY, P723; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Sadeharju K, 2003, CLIN EXP IMMUNOL, V132, P271, DOI 10.1046/j.1365-2249.2003.02147.x; Salminen K, 2003, J MED VIROL, V69, P91, DOI 10.1002/jmv.10260; Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stene LC, 2012, CLIN EXP IMMUNOL, V168, P12, DOI 10.1111/j.1365-2249.2011.04555.x; Stene LC, 2007, J AUTOIMMUN, V29, P44, DOI 10.1016/j.jaut.2007.04.003; Sutherland A, 2007, J CLIN ENDOCR METAB, V92, P3338, DOI 10.1210/jc.2007-0173; Tauriainen S, 2010, SEMIN IMMUNOPATHOL; Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001; Witso E, 2012, VIRAL IMMUNOL, V25, P187, DOI 10.1089/vim.2012.0001; Witso E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027781; Zouk H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011564	38	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48409	10.1371/journal.pone.0048409	http://dx.doi.org/10.1371/journal.pone.0048409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144876	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800056
J	Fong, JJ; Brown, JM; Fujita, MK; Boussau, B				Fong, Jonathan J.; Brown, Jeremy M.; Fujita, Matthew K.; Boussau, Bastien			A Phylogenomic Approach to Vertebrate Phylogeny Supports a Turtle-Archosaur Affinity and a Possible Paraphyletic Lissamphibia	PLOS ONE			English	Article							LIVING AMPHIBIANS; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; TREE SELECTION; SPECIES TREES; MIXED MODELS; SISTER GROUP; EVOLUTION; ORIGIN; GENE	In resolving the vertebrate tree of life, two fundamental questions remain: 1) what is the phylogenetic position of turtles within amniotes, and 2) what are the relationships between the three major lissamphibian (extant amphibian) groups? These relationships have historically been difficult to resolve, with five different hypotheses proposed for turtle placement, and four proposed branching patterns within Lissamphibia. We compiled a large cDNA/EST dataset for vertebrates (75 genes for 129 taxa) to address these outstanding questions. Gene-specific phylogenetic analyses revealed a great deal of variation in preferred topology, resulting in topologically ambiguous conclusions from the combined dataset. Due to consistent preferences for the same divergent topologies across genes, we suspected systematic phylogenetic error as a cause of some variation. Accordingly, we developed and tested a novel statistical method that identifies sites that have a high probability of containing biased signal for a specific phylogenetic relationship. After removing putatively biased sites, support emerged for a sister relationship between turtles and either crocodilians or archosaurs, as well as for a caecilian-salamander sister relationship within Lissamphibia, with Lissamphibia potentially paraphyletic.	[Fong, Jonathan J.; Fujita, Matthew K.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Fong, Jonathan J.; Brown, Jeremy M.; Fujita, Matthew K.; Boussau, Bastien] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Fong, Jonathan J.] Seoul Natl Univ, Coll Nat Sci, Seoul 151742, South Korea; [Brown, Jeremy M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Fujita, Matthew K.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Fujita, Matthew K.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Fujita, Matthew K.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Boussau, Bastien] Univ Lyon, Lab Biometrie & Biol Evolut, Villeurbanne, France	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Seoul National University (SNU); Louisiana State University System; Louisiana State University; Harvard University; Harvard University; University of Texas System; University of Texas Arlington; VetAgro Sup	Fong, JJ (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	jfong@snu.ac.kr	Brown, Jeremy/B-4544-2010	Brown, Jeremy/0000-0002-1447-8633; Boussau, Bastien/0000-0003-0776-4460; FONG, Jonathan/0000-0002-3648-6730	National Science Foundation (NSF) [DEB-0909811, DBI-0905867, DBI-0905714]; Human Frontiers Science Program Postdoctoral Fellowship; Centre National de la Recherche Scientifique; Museum of Vertebrate Zoology	National Science Foundation (NSF)(National Science Foundation (NSF)); Human Frontiers Science Program Postdoctoral Fellowship; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Museum of Vertebrate Zoology	Funding for this work came from the National Science Foundation (NSF) Doctoral Dissertation Improvement Grant (DEB-0909811 [JJF]), NSF Postdoctoral Fellowship in Biology (DBI-0905867 [JMB], DBI-0905714 [MKF]), Human Frontiers Science Program Postdoctoral Fellowship (BB), Centre National de la Recherche Scientifique (BB), and Museum of Vertebrate Zoology (JJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson J, 2008, EVOL BIOL, V35, P231, DOI 10.1007/s11692-008-9044-5; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; Bhullar Bhart-Anjan S., 2009, Breviora, V518, P1, DOI 10.3099/0006-9698-518.1.1; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Cannatella David C., 2009, P353; CARROLL RL, 1980, ZOOL J LINN SOC-LOND, V68, P1, DOI 10.1111/j.1096-3642.1980.tb01916.x; Carroll RL, 2001, J PALEONTOL, V75, P1202, DOI 10.1666/0022-3360(2001)075<1202:TOAERO>2.0.CO;2; CARROLL RL, 2004, RECENT ADV ORIGIN EA, P321; Carroll RL, 2009, THE RISE OF AMPHIBIA; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Cranston KA, 2009, SYST BIOL, V58, P489, DOI 10.1093/sysbio/syp054; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Darwin C., 1877, DIFFERENT FORMS FLOW; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; EDWARDS SV, 1991, P ROY SOC B-BIOL SCI, V243, P99, DOI 10.1098/rspb.1991.0017; Feller AE, 1998, MOL PHYLOGENET EVOL, V9, P509, DOI 10.1006/mpev.1998.0500; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Gaffney E.S., 1980, Systematics Association Special Volume Series, P593; Gauthier J., 1985, P185; Hedges S. Blair, 1993, Herpetological Monographs, V7, P27, DOI 10.2307/1466949; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; LEE MSY, 1995, BIOL REV, V70, P459, DOI 10.1111/j.1469-185X.1995.tb01197.x; Lee MSY, 1996, NATURE, V379, P812, DOI 10.1038/379812a0; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; Maddison D. R., 2005, MACCLADE 4 ANALYSIS; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; MEYER A, 1994, TRENDS ECOL EVOL, V9, P278, DOI 10.1016/0169-5347(94)90028-0; Miller M. A., 2010, CIPRES PORTALS; Milner Andrew R., 1993, Herpetological Monographs, V7, P8, DOI 10.2307/1466948; Nagashima H, 2009, SCIENCE, V325, P193, DOI 10.1126/science.1173826; Nylander J.A.A., 2004, MRMODELTEST 23 PROGR; PARSONS TS, 1963, Q REV BIOL, V38, P26, DOI 10.1086/403748; Pattengale ND, 2010, LECT N BIOINFORMAT, V6053, P128, DOI 10.1007/978-3-642-13078-6_16; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Thomson RC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-19; Trueb L, 1991, ORIGINS HIGHER GROUP, P233; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wilgenbusch JC, 2004, AWTY A SYSTEM FOR GR; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; Yates AM, 2000, ZOOL J LINN SOC-LOND, V128, P77, DOI 10.1111/j.1096-3642.2000.tb00650.x; Yates TL, 2004, ASSEMBLING THE TREE OF LIFE, P7; Zardoya R, 2001, P NATL ACAD SCI USA, V98, P7380, DOI 10.1073/pnas.111455498	73	52	52	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48990	10.1371/journal.pone.0048990	http://dx.doi.org/10.1371/journal.pone.0048990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145043	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800181
J	Hashimoto, Y; Minami, T; Nakauchi, S				Hashimoto, Yohei; Minami, Tetsuto; Nakauchi, Shigeki			Electrophysiological Differences in the Processing of Affect Misattribution	PLOS ONE			English	Article							AUTOMATIC ACTIVATION; BRAIN POTENTIALS; EXPLICIT CATEGORIZATION; NATURAL SCENES; TIME-COURSE; ATTENTION; IMPLICIT; EMOTION; ERP; ATTITUDES	The affect misattribution procedure (AMP) was proposed as a technique to measure an implicit attitude to a prime image [1]. In the AMP, neutral symbols (e.g., a Chinese pictograph, called the target) are presented, following an emotional stimulus (known as the prime). Participants often misattribute the positive or negative affect of the priming images to the targets in spite of receiving an instruction to ignore the primes. The AMP effect has been investigated using behavioral measures; however, it is difficult to identify when the AMP effect occurs in emotional processing-whether the effect may occur in the earlier attention allocation stage or in the later evaluation stage. In this study, we examined the neural correlates of affect misattribution, using event-related potential (ERP) dividing the participants into two groups based on their tendency toward affect misattribution. The ERP results showed that the amplitude of P2 was larger for the prime at the parietal location in participants showing a low tendency to misattribution than for those showing a high tendency, while the effect of judging neutral targets amiss according to the primes was reflected in the late processing of targets (LPP). In addition, the topographic pattern analysis revealed that EPN-like component to targets was correlated with the difference of AMP tendency as well as P2 to primes and LPP to targets. Taken together, the mechanism of the affective misattribution was closely related to the attention allocation processing. Our findings provide neural evidence that evaluations of neutral targets are misattributed to emotional primes.	[Minami, Tetsuto] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi, Japan; [Hashimoto, Yohei; Nakauchi, Shigeki] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan	Toyohashi University of Technology; Toyohashi University of Technology	Minami, T (corresponding author), Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi, Japan.	minami@tut.jp	Minami, Tetsuto/F-6585-2010; Minami, Tetsuto/N-1366-2019	Minami, Tetsuto/0000-0003-3034-6195; Minami, Tetsuto/0000-0003-3034-6195; Nakauchi, Shigeki/0000-0002-4954-6915	Japan Society for the Promotion of Science from the Ministry of Education, Culture, Sports, Science, and Technology [22300076, 23700311]; SCOPE from the Ministry of Internal Affairs and Communications, Japan; Center for Biomedical Imaging (CIBM) of Geneva; Center for Biomedical Imaging (CIBM) of Lausanne; Grants-in-Aid for Scientific Research [23700311, 22300076] Funding Source: KAKEN	Japan Society for the Promotion of Science from the Ministry of Education, Culture, Sports, Science, and Technology; SCOPE from the Ministry of Internal Affairs and Communications, Japan; Center for Biomedical Imaging (CIBM) of Geneva; Center for Biomedical Imaging (CIBM) of Lausanne; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 22300076, 23700311) from the Ministry of Education, Culture, Sports, Science, and Technology, and the SCOPE from the Ministry of Internal Affairs and Communications, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Cartool software (brainmapping.unige.ch/cartool) has been programmed by Denis Brunet, from the Functional Brain Mapping Laboratory, Geneva, Switzerland, and is supported by the Center for Biomedical Imaging (CIBM) of Geneva and Lausanne.	Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Codispoti M, 2006, PROG BRAIN RES, V156, P53, DOI 10.1016/S0079-6123(06)56003-0; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Dolcos F, 2002, COGN AFFECT BEHAV NE, V2, P252, DOI 10.3758/CABN.2.3.252; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; Gawronski B, 2008, PERS SOC PSYCHOL B, V34, P1276, DOI 10.1177/0146167208318952; Gawronski B, 2010, COGNITION EMOTION, V24, P1008, DOI 10.1080/02699930903112712; Hajcak G, 2008, EMOTION, V8, P250, DOI 10.1037/1528-3542.8.2.250; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hawkins CB, 2011, TRENDS COGNITIVE SCI, V15; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Hinojosa JA, 2009, COGN AFFECT BEHAV NE, V9, P173, DOI 10.3758/CABN.9.2.173; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Lang P. J., 2005, INT AFFECTIVE PICTUR; Moratti S, 2011, J NEUROSCI, V31, P17278, DOI 10.1523/JNEUROSCI.2917-11.2011; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Oikawa M, 2011, COGNITION EMOTION, V25, P156, DOI 10.1080/02699931003680061; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Shariff AF, 2009, EMOTION, V9, P631, DOI 10.1037/a0017089; Weinberg A, 2011, J COGNITIVE NEUROSCI, V23, P2994, DOI 10.1162/jocn.2011.21630; Werheid K, 2005, INT J PSYCHOPHYSIOL, V55, P209, DOI 10.1016/j.ijpsycho.2004.07.006; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021	32	9	9	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49132	10.1371/journal.pone.0049132	http://dx.doi.org/10.1371/journal.pone.0049132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145097	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800216
J	Huang, CT; Ruan, SY; Liao, WY; Kuo, YW; Lin, CY; Tsai, YJ; Ho, CC; Yu, CJ				Huang, Chun-Ta; Ruan, Sheng-Yuan; Liao, Wei-Yu; Kuo, Yao-Wen; Lin, Chi-Ying; Tsai, Yi-Ju; Ho, Chao-Chi; Yu, Chong-Jen			Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions	PLOS ONE			English	Article							SOLITARY PULMONARY NODULES; ULTRASONOGRAPHY; SHEATH; FLUOROSCOPY; DIAGNOSIS; TRIAL	Background: The risk of endobronchial ultrasound-guided transbronchial biopsy-related pneumothorax is a major concern and warrants further studies. The aim of our study was to estimate the risk of pneumothorax after this procedure and identify its risk factors. Methods: From 2007 to 2011, 399 patients who underwent endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions were included in this study. The variables analyzed included patient factors, lesion factors and procedure factors. Multivariate logistic regression analysis was used to identify independent risk factors for pneumothorax. Results: The incidence of pneumothorax was 3.3% (13/399). Chest tube placement was required for 31% (4/13) of pneumothoraces. Independent risk factors for pneumothorax included pulmonary emphysema (OR, 55.09; 95% CI, 9.37-324.03; p < 0.001) and probe position adjacent to the lesion (OR, 17.01; 95% CI, 2.85-101.64; p = 0.002). The number of biopsy specimens, age, sex, history of prior lung surgery and lesion size, location and character did not influence the risk of pneumothorax in our analyses. Conclusions: The risk of pneumothorax after endobronchial ultrasound-guided transbronchial biopsy is low. To further reduce the risk of pneumothorax, every effort should be made to advance the endobronchial ultrasound probe into the bronchus where it is imaged within the target lesion before embarking on transbronchial biopsy.	[Huang, Chun-Ta; Ruan, Sheng-Yuan; Liao, Wei-Yu; Ho, Chao-Chi; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Kuo, Yao-Wen; Lin, Chi-Ying] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Br, Yunlin, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Sch Med, Taipei, Taiwan; [Ruan, Sheng-Yuan] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Taiwan University	Ho, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	ccho1203@ntu.edu.tw	Kuo, Yao-Wen/AAT-7124-2021; Liao, Wei-Yu/HGE-3881-2022	Kuo, Yao-Wen/0000-0003-1124-0539; RUAN, SHENG-YUAN/0000-0002-7949-7253; Yu, Chong-Jen/0000-0001-5664-9392; HUANG, CHUN-TA/0000-0002-5234-4986; LIAO, WEI-YU/0000-0001-6383-3470; HO, CHAO-CHI/0000-0002-8156-2413	Taiwan National Science Council [NSC 101-2321-B-002-027]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was sponsored by the Taiwan National Science Council (NSC 101-2321-B-002-027). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, AM REV RESP DIS, V132, P182; Chung YH, 2007, RESP MED, V101, P738, DOI 10.1016/j.rmed.2006.08.014; Eberhardt R, 2009, EUR RESPIR J, V34, P1284, DOI 10.1183/09031936.00166708; Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC; FOSTER WL, 1993, RADIOGRAPHICS, V13, P311, DOI 10.1148/radiographics.13.2.8460222; Herth FJF, 2006, CHEST, V129, P147, DOI 10.1378/chest.129.1.147; Herth FJF, 2002, EUR RESPIR J, V20, P972, DOI 10.1183/09031936.02.00032001; Hiraki T, 2010, AM J ROENTGENOL, V194, P809, DOI 10.2214/AJR.09.3224; Huang CT, 2009, RESPIROLOGY, V14, P859, DOI 10.1111/j.1440-1843.2009.01585.x; Izbicki G, 2006, CHEST, V129, P1561, DOI 10.1378/chest.129.6.1561; Kazerooni EA, 1996, RADIOLOGY, V198, P371, DOI 10.1148/radiology.198.2.8596834; Kikuchi E, 2004, EUR RESPIR J, V24, P533, DOI 10.1183/09031936.04.00138603; Ko JP, 2001, RADIOLOGY, V218, P491, DOI 10.1148/radiology.218.2.r01fe33491; Kurimoto N, 2004, CHEST, V126, P959, DOI 10.1378/chest.126.3.959; Ouellette DR, 2006, CHEST, V130, P1185, DOI 10.1378/chest.130.4.1185; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; Topal U, 2003, EUR J RADIOL, V48, P263, DOI 10.1016/S0720-048X(03)00058-5; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Yoshikawa M, 2007, CHEST, V131, P1788, DOI 10.1378/chest.06-2506	20	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49125	10.1371/journal.pone.0049125	http://dx.doi.org/10.1371/journal.pone.0049125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145094	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800213
J	Imbach, LL; Werth, E; Kallweit, U; Sarnthein, J; Scammell, TE; Baumann, CR				Imbach, Lukas L.; Werth, Esther; Kallweit, Ulf; Sarnthein, Johannes; Scammell, Thomas E.; Baumann, Christian R.			Inter-Hemispheric Oscillations in Human Sleep	PLOS ONE			English	Article							INTERHEMISPHERIC EEG ASYMMETRY; WORLD NETWORK ORGANIZATION; CYCLIC ALTERNATING PATTERN; RAPID-EYE-MOVEMENT; FUNCTIONAL CONNECTIVITY; LOCAL SLEEP; DYNAMICS; RAT; REM; CLASSIFICATION	Sleep is generally categorized into discrete stages based on characteristic electroencephalogram (EEG) patterns. This traditional approach represents sleep architecture in a static way, but it cannot reflect variations in sleep across time and across the cortex. To investigate these dynamic aspects of sleep, we analyzed sleep recordings in 14 healthy volunteers with a novel, frequency-based EEG analysis. This approach enabled comparison of sleep patterns with low inter-individual variability. We then implemented a new probability dependent, automatic classification of sleep states that agreed closely with conventional manual scoring during consolidated sleep. Furthermore, this analysis revealed a previously unrecognized, interhemispheric oscillation during rapid eye movement (REM) sleep. This quantitative approach provides a new way of examining the dynamic aspects of sleep, shedding new light on the physiology of human sleep.	[Imbach, Lukas L.; Werth, Esther; Kallweit, Ulf; Baumann, Christian R.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Sarnthein, Johannes] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Scammell, Thomas E.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Harvard University; Beth Israel Deaconess Medical Center	Imbach, LL (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	lukas.imbach@usz.ch	Werth, E/AAN-7955-2021; Kallweit, Ulf/AAM-3989-2021; Sarnthein, Johannes/E-7959-2010	Sarnthein, Johannes/0000-0001-9141-381X; Baumann, Christian/0000-0003-3417-1978; Imbach, Lukas/0000-0002-6135-8642; Werth, Esther/0000-0002-5099-3122				Achermann P, 2001, BRAIN RES, V913, P220, DOI 10.1016/S0006-8993(01)02796-2; ARMITAGE R, 1990, SLEEP, V13, P69; ARMITAGE R, 1989, PSYCHOPHYSIOLOGY, V26, P329, DOI 10.1111/j.1469-8986.1989.tb01928.x; Asyali MH, 2007, COMPUT BIOL MED, V37, P1600, DOI 10.1016/j.compbiomed.2007.03.001; Bandyopadhyay Sanghamitra, 2007, P1, DOI 10.1007/3-540-49607-6_1; Behn CGD, 2010, SLEEP, V33, P297, DOI 10.1093/sleep/33.3.297; Carrubba S, 2012, J NEUROSCI METH, V208, P1, DOI 10.1016/j.jneumeth.2012.04.018; Chapotot F, 2010, INT J ADAPT CONTROL, V24, P409, DOI 10.1002/acs.1147; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ferri R, 2008, CLIN NEUROPHYSIOL, V119, P2026, DOI 10.1016/j.clinph.2008.04.294; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P449, DOI 10.1016/j.clinph.2006.10.021; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Iber C., 2007, AASM MANUAL SCORING; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; Kubicki S, 1996, J CLIN NEUROPHYSIOL, V13, P285, DOI 10.1097/00004691-199607000-00003; Liang SF, 2012, J NEUROSCI METH, V205, P169, DOI 10.1016/j.jneumeth.2011.12.022; Lopour BA, 2011, J COMPUT NEUROSCI, V30, P471, DOI 10.1007/s10827-010-0272-1; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MUKHAMETOV LM, 1987, NEUROSCI LETT, V79, P128, DOI 10.1016/0304-3940(87)90684-7; MUKHAMETOV LM, 1985, EXPERIENTIA, V41, P1034, DOI 10.1007/BF01952128; MUKHAMETOV LM, 1977, BRAIN RES, V134, P581, DOI 10.1016/0006-8993(77)90835-6; Murphy M, 2011, CURR TOP MED CHEM, V11, P2438, DOI 10.2174/156802611797470303; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Parrino L, 2012, SLEEP MED REV, V16, P27, DOI 10.1016/j.smrv.2011.02.003; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Rattenborg NC, 2000, NEUROSCI BIOBEHAV R, V24, P817, DOI 10.1016/S0149-7634(00)00039-7; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; Rattenborg NC, 2001, BRAIN BEHAV EVOLUT, V58, P323, DOI 10.1159/000057573; Rector DM, 2009, NEUROSCIENCE, V159, P115, DOI 10.1016/j.neuroscience.2008.11.031; Rector DM, 2005, BRAIN RES, V1047, P45, DOI 10.1016/j.brainres.2005.04.002; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Ronzhina M, 2012, SLEEP MED REV, V16, P251, DOI 10.1016/j.smrv.2011.06.003; Shannahoff-Khalsa DS, 2001, SLEEP MED, V2, P333, DOI 10.1016/S1389-9457(00)00066-6; Shih-Chieh L, 2008, METHODS NEURAL ENSEM; Siri B, 2007, J PHYSIOL-PARIS, V101, P136, DOI 10.1016/j.jphysparis.2007.10.003; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TERZANO MG, 1985, SLEEP, V8, P137, DOI 10.1093/sleep/8.2.137; Vyazovskiy VV, 2008, J NEUROPHYSIOL, V99, P969, DOI 10.1152/jn.01154.2007; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyazovskiy VV, 2002, J NEUROPHYSIOL, V88, P2280, DOI 10.1152/jn.00304.2002; WARNER BF, 1978, COMP BIOCHEM PHYS A, V59, P139, DOI 10.1016/0300-9629(78)90195-0; Webb A. R., 2003, STAT PATTERN RECOGNI; Wehrle R, 2007, EUR J NEUROSCI, V25, P863, DOI 10.1111/j.1460-9568.2007.05314.x; Wilson MT, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051910; Zoubek L, 2007, BIOMED SIGNAL PROCES, V2, P171, DOI 10.1016/j.bspc.2007.05.005	51	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48660	10.1371/journal.pone.0048660	http://dx.doi.org/10.1371/journal.pone.0048660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144920	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800090
J	Jiang, L; Jiang, JC; Wang, JY; Ding, XD; Liu, JF; Zhang, Q				Jiang, Li; Jiang, Jicai; Wang, Jiying; Ding, Xiangdong; Liu, Jianfeng; Zhang, Qin			Genome-Wide Identification of Copy Number Variations in Chinese Holstein	PLOS ONE			English	Article							SEGMENTAL DUPLICATIONS; GENE DUPLICATION; ASIP GENE; SNP; EXPRESSION; ASSOCIATION; CATTLE; CNV; SUSCEPTIBILITY; DELETIONS	Recent studies of mammalian genomes have uncovered the vast extent of copy number variations (CNVs) that contribute to phenotypic diversity. Compared to SNP, a CNV can cover a wider chromosome region, which may potentially incur substantial sequence changes and induce more significant effects on phenotypes. CNV has been becoming an alternative promising genetic marker in the field of genetic analyses. Here we firstly report an account of CNV regions in the cattle genome in Chinese Holstein population. The Illumina Bovine SNP50K Beadchips were used for screening 2047 Holstein individuals. Three different programes (PennCNV, cnvPartition and GADA) were implemented to detect potential CNVs. After a strict CNV calling pipeline, a total of 99 CNV regions were identified in cattle genome. These CNV regions cover 23.24 Mb in total with an average size of 151.69 Kb. 52 out of these CNV regions have frequencies of above 1%. 51 out of these CNV regions completely or partially overlap with 138 cattle genes, which are significantly enriched for specific biological functions, such as signaling pathway, sensory perception response and cellular processes. The results provide valuable information for constructing a more comprehensive CNV map in the cattle genome and offer an important resource for investigation of genome structure and genomic variation underlying traits of interest in cattle.	[Jiang, Li; Jiang, Jicai; Wang, Jiying; Ding, Xiangdong; Liu, Jianfeng; Zhang, Qin] China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, Q (corresponding author), China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	qzhang@cau.edu.cn		Jiang, Jicai/0000-0001-6890-7539; Jiang, Li/0000-0002-0648-2173; Liu, Jian-Feng/0000-0002-5766-7864	Ministry of Agriculture of China [2011-G2A(2)]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Natural Science Foundations of China [30972092]; Natural Science Foundations of Beijing [6102016]; New-Century Training Program for Talents of the Ministry of Education of China [NETC-10-0783]; China Postdoctoral Science Foundation [2011M500037]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Beijing; New-Century Training Program for Talents of the Ministry of Education of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the 948 Program of the Ministry of Agriculture of China (2011-G2A(2)), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Natural Science Foundations of China (30972092), the Natural Science Foundations of Beijing (6102016), the New-Century Training Program for Talents of the Ministry of Education of China (NETC-10-0783) and the China Postdoctoral Science Foundation (2011M500037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, NAT GENET, V37, P532, DOI 10.1038/ng1551; Aguade M, 2009, MOL BIOL EVOL, V26, P61, DOI 10.1093/molbev/msn227; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bodin L, 2005, J BIOMED BIOTECHNOL, P248, DOI 10.1155/JBB.2005.248; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; Clop A, 2011, ANIM GENET; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cusco I, 2008, GENOME RES, V18, P683, DOI 10.1101/gr.073197.107; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; de Bustos C, 2006, GENOMICS, V88, P152, DOI 10.1016/j.ygeno.2006.03.016; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Frank B, 2007, CARCINOGENESIS, V28, P1442, DOI 10.1093/carcin/bgm033; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang W, 2008, ANIM GENET, V39, P554, DOI 10.1111/j.1365-2052.2008.01749.x; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kamath BM, 2009, HUM MUTAT, V30, P371, DOI 10.1002/humu.20863; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khatib H, 2008, J DAIRY SCI, V91, P784, DOI 10.3168/jds.2007-0669; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Kohler JR, 2007, AM J HUM GENET, V81, P684, DOI 10.1086/520823; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kuhn C, 2004, GENETICS, V167, P1873, DOI 10.1534/genetics.103.022749; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margareto J, 2009, CANCER INVEST, V27, P541, DOI 10.1080/07357900802563044; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Mileyko Y, 2008, P NATL ACAD SCI USA, V105, P16659, DOI 10.1073/pnas.0806239105; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Quillard T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008244; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rincon G, 2011, J DAIRY SCI, V94, P6116, DOI 10.3168/jds.2011-4764; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Shastry BS, 2009, MOL MED REP, V2, P143, DOI 10.3892/mmr_00000074; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Springfield Charles L, 2004, Congest Heart Fail, V10, P14, DOI 10.1111/j.1527-5299.2004.03409.x; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tchinda J, 2006, BIOTECHNIQUES, V41, P385, DOI 10.2144/000112275; Tchorz JS, 2009, HEPATOLOGY, V50, P871, DOI 10.1002/hep.23048; Wang J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-23; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Yau C, 2008, CYTOGENET GENOME RES, V123, P307, DOI 10.1159/000184722; Young JM, 2008, AM J HUM GENET, V83, P228, DOI 10.1016/j.ajhg.2008.07.005; Zhan BJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-557; Zollner S, 2009, GENET EPIDEMIOL, V33, P357, DOI 10.1002/gepi.20391	75	43	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48732	10.1371/journal.pone.0048732	http://dx.doi.org/10.1371/journal.pone.0048732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144949	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800115
J	Kang, WF; Hebert, JM				Kang, Wenfei; Hebert, Jean M.			A Sox2 BAC Transgenic Approach for Targeting Adult Neural Stem Cells	PLOS ONE			English	Article							BRAIN; MOUSE; NEUROGENESIS; MUTATIONS; MULTIPOTENT; PROGENITORS; PRECURSORS; EXPRESSION; REVEALS; EMBRYO	The transcription factor gene Sox2 is expressed in embryonic neural stem/progenitor cells and previous evidence suggests that it is also expressed in adult neural stem cells. To target Sox2-expressing neural stem/progenitor cells in a temporal manner, we generated a bacterial artificial chromosome (BAC) transgenic mouse line, in which an inducible form of Cre, CreER (TM), is expressed under Sox2 regulatory elements. Inducible Cre activity in these mice was characterized using floxed reporters. During development, the Sox2-CreER transgenic mice show inducible Cre activity specifically in CNS stem/progenitor cells, making them a useful tool to regulate the expression of floxed genes temporally in embryonic neural stem/progenitor cells. In the adult, we examined the cell-specific expression of Sox2 and performed long-term lineage tracing. Four months after the transient induction of Cre activity, recombined GFAP+stem-like cells and DCX+ neuroblasts were still abundant in the neurogenic regions including the subventricular zone (SVZ), rostral migratory stream (RMS), and subgranular zone (SGZ) of the dentate gyrus. These results provide definitive in vivo evidence that Sox2 is expressed in neural stem cells (NSC) in both the SVZ and SGZ that are capable of self-renewal and long-term neurogenesis. Therefore, Sox2-CreER mice should be useful in targeting floxed genes in adult neural stem cells.	[Hebert, Jean M.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hebert, JM (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.	jean.hebert@einstein.yu.edu			National Institutes of Health (NIH); National Institute of Mental Health (NIMH) [MH083804, MH070596]; National Institute of Neurological Disorders and Stroke (NINDS) [NS073761]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070596, R01MH083804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073761] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health (NIH), National Institute of Mental Health (NIMH) MH083804, MH070596, and National Institute of Neurological Disorders and Stroke (NINDS), NS073761. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jinno S, 2011, NEUROSCIENCE, V180, P41, DOI 10.1016/j.neuroscience.2011.02.013; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Sisodiya SM, 2006, EPILEPSIA, V47, P534, DOI 10.1111/j.1528-1167.2006.00464.x; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Zappone MV, 2000, DEVELOPMENT, V127, P2367	26	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49038	10.1371/journal.pone.0049038	http://dx.doi.org/10.1371/journal.pone.0049038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145058	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800189
J	Keim, V; Manzano, D; Fernandez, FJ; Closa, M; Andrade, P; Caudepon, D; Bortolotti, C; Vega, MC; Arro, M; Ferrer, A				Keim, Veronica; Manzano, David; Fernandez, Francisco J.; Closa, Marta; Andrade, Paola; Caudepon, Daniel; Bortolotti, Cristina; Vega, M. Cristina; Arro, Montserrat; Ferrer, Albert			Characterization of Arabidopsis FPS Isozymes and FPS Gene Expression Analysis Provide Insight into the Biosynthesis of Isoprenoid Precursors in Seeds	PLOS ONE			English	Article							FARNESYL-DIPHOSPHATE SYNTHASE; MEVALONIC ACID PATHWAY; PEROXISOMAL LOCALIZATION; PYROPHOSPHATE SYNTHASE; MOLECULAR-CLONING; PROTEOME ANALYSIS; LEAF PEROXISOMES; LESION FORMATION; THALIANA; PURIFICATION	Arabidopsis thaliana contains two genes encoding farnesyl diphosphate (FPP) synthase (FPS), the prenyl diphoshate synthase that catalyzes the synthesis of FPP from isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). In this study, we provide evidence that the two Arabidopsis short FPS isozymes FPS1S and FPS2 localize to the cytosol. Both enzymes were expressed in E. coli, purified and biochemically characterized. Despite FPS1S and FPS2 share more than 90% amino acid sequence identity, FPS2 was found to be more efficient as a catalyst, more sensitive to the inhibitory effect of NaCl, and more resistant to thermal inactivation than FPS1S. Homology modelling for FPS1S and FPS2 and analysis of the amino acid differences between the two enzymes revealed an increase in surface polarity and a greater capacity to form surface salt bridges of FPS2 compared to FPS1S. These factors most likely account for the enhanced thermostability of FPS2. Expression analysis of FPS::GUS genes in seeds showed that FPS1 and FPS2 display complementary patterns of expression particularly at late stages of seed development, which suggests that Arabidopsis seeds have two spatially segregated sources of FPP. Functional complementation studies of the Arabidopsis fps2 knockout mutant seed phenotypes demonstrated that under normal conditions FPS1S and FPS2 are functionally interchangeable. A putative role for FPS2 in maintaining seed germination capacity under adverse environmental conditions is discussed.	[Keim, Veronica; Manzano, David; Andrade, Paola; Caudepon, Daniel; Bortolotti, Cristina; Arro, Montserrat; Ferrer, Albert] CSIC IRTA UAB UB, CRAG, Dept Mol Genet, Barcelona, Spain; [Keim, Veronica; Manzano, David; Closa, Marta; Andrade, Paola; Caudepon, Daniel; Bortolotti, Cristina; Arro, Montserrat; Ferrer, Albert] Univ Barcelona, Dept Biochem & Mol Biol, Fac Pharm, Barcelona, Spain; [Fernandez, Francisco J.; Vega, M. Cristina] Ctr Biol Res CIB CSIC, Dept Struct & Quantitat Biol, Madrid, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Ferrer, A (corresponding author), CSIC IRTA UAB UB, CRAG, Dept Mol Genet, Campus UAB, Barcelona, Spain.	albertferrer@ub.edu	Manzano, David/L-5195-2014; Ferrer, Albert/AAI-4595-2021; Fernandez, Francisco J./C-3647-2011; Vega, M. Cristina/C-3640-2011	Manzano, David/0000-0002-5483-7223; Ferrer, Albert/0000-0002-0741-2388; Fernandez, Francisco J./0000-0002-5015-1849; ARRO PLANS, MONTSERRAT/0000-0002-7118-7402; Vega, M. Cristina/0000-0003-0628-8378	Spanish Ministerio de Ciencia e Innovacion [BIO2009-06984, CSD2007-00036, PET2008_0101, BFU2010-22260-C02-02]; European Regional Development Fund [BIO2009-06984, CSD2007-00036, PET2008_0101, BFU2010-22260-C02-02]; Generalitat de Catalunya [SGR-00914]; European Commission Framework Programme 7 (FP7 Project ComplexINC) [279039]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Regional Development Fund(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); European Commission Framework Programme 7 (FP7 Project ComplexINC)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (cofinanced by the European Regional Development Fund) (BIO2009-06984 and CSD2007-00036 to A.F., and PET2008_0101 and BFU2010-22260-C02-02 to M.C.V.), the Generalitat de Catalunya (SGR-00914 to A.F.), and the European Commission Framework Programme 7 (FP7 Project ComplexINC No. 279039 to M.C.V.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The excellent technical support from Patricia Lorden and members of the Greenhouse and Microscopy facilities at CRAG and the Serveis Cientifico-Tecnics of the University of Barcelona is greatly appreciated. The authors also thank the Galicia Supercomputing Center (CESGA) for the provision of computational support. V.K. and D.C. were recipients of PhD fellowships from the Spanish Ministerio de Educacion y Ciencia.	Adeli K, 2011, AM J PHYSIOL-ENDOC M, V301, pE1051, DOI 10.1152/ajpendo.00399.2011; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; ATTUCCI S, 1995, ARCH BIOCHEM BIOPHYS, V321, P493, DOI 10.1006/abbi.1995.1422; Bach TJ, 1999, CRIT REV BIOCHEM MOL, V34, P107, DOI 10.1080/10409239991209237; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Blaszczyk L, 2011, BIOCHEMISTRY-US, V50, P7080, DOI 10.1021/bi200659b; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; Burke JJ, 2000, PLANT PHYSIOL, V123, P575, DOI 10.1104/pp.123.2.575; Closa M, 2010, PLANT J, V63, P512, DOI 10.1111/j.1365-313X.2010.04253.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; CROWELL DN, 1992, PLANT PHYSIOL, V100, P2090, DOI 10.1104/pp.100.4.2090; Cunillera N, 2000, PLANT MOL BIOL, V44, P747, DOI 10.1023/A:1026588708849; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; DALE S, 1995, EUR J BIOCHEM, V233, P506, DOI 10.1111/j.1432-1033.1995.506_2.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong YW, 2009, J EXP BIOL, V212, P169, DOI 10.1242/jeb.024505; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; FRAY RG, 1995, PLANT J, V8, P693, DOI 10.1046/j.1365-313X.1995.08050693.x; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gaffe J, 2000, PLANT PHYSIOL, V123, P1351, DOI 10.1104/pp.123.4.1351; Guirimand G, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P139, DOI 10.1007/978-3-642-04670-4_8; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Hodzic A, 2008, BIOPHYS J, V94, P3935, DOI 10.1529/biophysj.107.123224; HUGUENEY P, 1990, FEBS LETT, V273, P235, DOI 10.1016/0014-5793(90)81093-4; Ingram GC, 2010, PROTOPLASMA, V247, P195, DOI 10.1007/s00709-010-0184-y; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kovacs WJ, 2007, HISTOCHEM CELL BIOL, V127, P273, DOI 10.1007/s00418-006-0254-6; Koyama T, 2000, BIOCHEMISTRY-US, V39, P463, DOI 10.1021/bi991621b; KOYAMA T, 1993, J BIOCHEM-TOKYO, V113, P355, DOI 10.1093/oxfordjournals.jbchem.a124051; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Li CP, 1996, GENE, V171, P193, DOI 10.1016/0378-1119(95)00880-2; Liu SL, 2011, GENOME BIOL EVOL, V3, P1419, DOI 10.1093/gbe/evr114; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADERN D, 1995, EUR J BIOCHEM, V230, P1088, DOI 10.1111/j.1432-1033.1995.tb20659.x; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Manzano D, 2004, PLANTA, V219, P982, DOI 10.1007/s00425-004-1301-y; Manzano D, 2006, PLANT MOL BIOL, V61, P195, DOI 10.1007/s11103-006-6263-y; Masferrer A, 2002, PLANT J, V30, P123, DOI 10.1046/j.1365-313X.2002.01273.x; Mekkriengkrai D, 2004, BIOSCI BIOTECH BIOCH, V68, P2360, DOI 10.1271/bbb.68.2360; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nguyen H, 2000, PROTOPLASMA, V212, P99, DOI 10.1007/BF01279351; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pan ZQ, 1996, ARCH BIOCHEM BIOPHYS, V332, P196, DOI 10.1006/abbi.1996.0333; Ranzer LK, 2009, MAR BIOTECHNOL, V11, P62, DOI 10.1007/s10126-008-9120-y; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Reineke LC, 2008, J BIOL CHEM, V283, P19011, DOI 10.1074/jbc.M803109200; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sanmiya K, 1999, PLANT CELL PHYSIOL, V40, P348, DOI 10.1093/oxfordjournals.pcp.a029549; Sapir-Mir M, 2008, PLANT PHYSIOL, V148, P1219, DOI 10.1104/pp.108.127951; Schmidt A, 2007, PHYTOCHEMISTRY, V68, P2649, DOI 10.1016/j.phytochem.2007.05.037; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2002, PLANT J, V31, P61, DOI 10.1046/j.1365-313X.2002.01333.x; Sen SE, 2007, INSECT BIOCHEM MOLEC, V37, P1198, DOI 10.1016/j.ibmb.2007.07.011; Simkin AJ, 2011, PLANTA, V234, P903, DOI 10.1007/s00425-011-1444-6; Stangeland B, 2002, PLANT MOL BIOL REP, V20, P107, DOI 10.1007/BF02799426; Suzuki M, 2007, LIPIDS, V42, P47, DOI 10.1007/s11745-006-1000-5; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Thabet I, 2011, J PLANT PHYSIOL, V168, P2110, DOI 10.1016/j.jplph.2011.06.017; Tholl D, 2001, ARCH BIOCHEM BIOPHYS, V386, P233, DOI 10.1006/abbi.2000.2212; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Vandermoten S, 2009, CELL MOL LIFE SCI, V66, P3685, DOI 10.1007/s00018-009-0100-9; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Wang KC, 2000, BBA-MOL CELL BIOL L, V1529, P33, DOI 10.1016/S1388-1981(00)00136-0; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005	79	29	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49109	10.1371/journal.pone.0049109	http://dx.doi.org/10.1371/journal.pone.0049109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145086	gold, Green Published			2022-12-25	WOS:000311935800206
J	Mirzayans, F; Lavy, R; Penner-Chea, J; Berry, FB				Mirzayans, Farideh; Lavy, Rotem; Penner-Chea, Jonathan; Berry, Fred B.			Initiation of Early Osteoblast Differentiation Events through the Direct Transcriptional Regulation of Msx2 by FOXC1	PLOS ONE			English	Article							MUTATION CONGENITAL-HYDROCEPHALUS; FORKHEAD/WINGED-HELIX GENE; HOMEOBOX GENE; SKULL OSSIFICATION; BONE; DEFECTS; EXPRESSION; HAPLOINSUFFICIENCY; SKELETOGENESIS; IDENTIFICATION	Hierarchal transcriptional regulatory networks function to control the correct spatiotemporal patterning of the mammalian skeletal system. One such factor, the forkhead box transcription factor FOXC1 is necessary for the correct formation of the axial and craniofacial skeleton. Previous studies have demonstrated that the frontal and parietal bones of the skull fail to develop in mice deficient for Foxc1. Furthermore expression of the Msx2 homeobox gene, an essential regulator of calvarial bone development is absent in the skull mesenchymal progenitors of Foxc1 mutant mice. Thus we sought to determine whether Msx2 was a direct target of FOXC1 transcriptional regulation. Here, we demonstrate that elevated expression of FOXC1 can increase endogenous Msx2 mRNA levels. Chromatin immunoprecipitation experiments reveal that FOXC1 occupies a conserved element in the MSX2 promoter. Using a luciferase reporter assay, we demonstrate that FOXC1 can stimulate the activity of the both human and mouse MSX2 promoters. We also report that reducing FOXC1 levels by RNA interference leads to a decrease in MSX2 expression. Finally, we demonstrate that heterologous expression of Foxc1 in C2C12 cells results in elevated alkaline phosphatase activity and increased expression of Runx2 and Msx2. These data indicate that Foxc1 expression leads to a similar enhanced osteogenic differentiation phenotype as observed with Msx2 overexpression. Together these findings suggest that a Foxc1->Msx2 regulatory network functions in the initial stages of osteoblast differentiation.	[Mirzayans, Farideh; Penner-Chea, Jonathan; Berry, Fred B.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Lavy, Rotem; Berry, Fred B.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta	Berry, FB (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	fberry@ualberta.ca			Canadian Institutes of Health Research [MOP-245378]; Shriners Hospital for Children	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shriners Hospital for Children	Funding was provided by the Canadian Institutes of Health Research MOP-245378 (http://www.cihr.ca/) and The Shriners Hospital for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei M, 2004, DEV DYNAM, V231, P758, DOI 10.1002/dvdy.20182; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; De Coster PJ, 2007, J ORAL PATHOL MED, V36, P447, DOI 10.1111/j.1600-0714.2007.00553.x; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Gruneberg H, 1951, J GENET, V45, P327; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Hosokawa R, 2007, DEV BIOL, V310, P140, DOI 10.1016/j.ydbio.2007.07.038; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Mavrogiannis LA, 2001, NAT GENET, V27, P17, DOI 10.1038/83703; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Rice David P., 2008, V12, P22, DOI 10.1159/000115030; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Sommer P, 2006, DEV GROWTH DIFFER, V48, P297, DOI 10.1111/j.1440-169x.2006.00866.x; Song HJM, 2004, PLAST RECONSTR SURG, V113, P1685, DOI 10.1097/01.PRS.0000117363.43699.5B; Tamimi Y, 2006, HUM MOL GENET, V15, P3229, DOI 10.1093/hmg/ddl400; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Wuyts W, 2000, HUM MOL GENET, V9, P1251, DOI 10.1093/hmg/9.8.1251; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	35	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49095	10.1371/journal.pone.0049095	http://dx.doi.org/10.1371/journal.pone.0049095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145080	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800201
J	Nanchen, D; Rodondi, N; Cornuz, J; Hillier, T; Ensrud, KE; Cauley, JA; Bauer, DC				Nanchen, David; Rodondi, Nicolas; Cornuz, Jacques; Hillier, Teresa; Ensrud, Kristine E.; Cauley, Jane A.; Bauer, Douglas C.		Study Osteoporotic Fractures Res G	Mortality Associated with Diabetes and Cardiovascular Disease in Older Women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; ALL-CAUSE; RISK; MELLITUS; MEN; METAANALYSIS; DURATION; IMPACT	Background: Current guidelines for the prevention of cardiovascular disease (CVD) recommend diabetes as a CVD risk equivalent. However, reports that have examined the risk of diabetes in comparison to pre-existing CVD are lacking among older women. We aimed to assess whether diabetes was associated with a similar risk of total and cause-specific mortality as a history of CVD in older women. Methodology/Principal Findings: We studied 9218 women aged 68 years or older enrolled in a prospective cohort study (Study of Osteoporotic Fracture) during a mean follow-up period of 11.7 years and compared all-cause, cardiovascular and coronary heart disease mortality among 4 groups: non-diabetic women with and without existing CVD, diabetic women with and without existing CVD. Mean (SD) age of the participants was 75.2 (5.3) years, 3.5% reported diabetes and 6.8% reported existing CVD. During follow-up, 5117 women died with 36% from CVD. The multivariate adjusted risk of cardiovascular mortality was increased among both non-diabetic women with CVD (hazard ratio (HR) 2.32, 95% CI: 1.97-2.74, P<0.001) and diabetic women without CVD (HR 2.06, CI: 1.62-2.64, P<0.001) compared to non-diabetic women without existing CVD. All-cause, cardiovascular and coronary mortality of non-diabetic women with CVD were not significantly different from diabetic women without CVD. Conclusions/Significance: Older diabetic women without CVD have a similar risk of cardiovascular mortality compared to non-diabetic women with pre-existing CVD. The equivalence of diabetes and CVD seems to extend to older women, supporting current guidelines for cardiovascular prevention.	[Nanchen, David; Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Nanchen, David] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Rodondi, Nicolas] Univ Bern, Dept Gen Internal Med, Bern, Switzerland; [Hillier, Teresa] Kaiser Permanente NW Hawaii, Ctr Hlth Res, Portland, OR USA; [Ensrud, Kristine E.] Univ Minnesota, Ctr Chron Dis Outcomes Res, Vet Affairs Med Ctr, St Paul, MN 55108 USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Med, St Paul, MN 55108 USA; [Ensrud, Kristine E.] Univ Minnesota, Div Epidemiol & Community Hlth, St Paul, MN 55108 USA; [Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA	University of Lausanne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bern; Kaiser Permanente; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Nanchen, D (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland.	david.nanchen@chuv.ch	Nanchen, David/AAQ-1118-2021	Nanchen, David/0000-0002-2493-3505; Cauley, Jane A/0000-0003-0752-4408; Ensrud, Kristine/0000-0002-9069-3036; Rodondi, Nicolas/0000-0001-9083-6896	Swiss National Science Foundation [PBLAP3-132943]; Public Health Service [HL40489]; National Institutes of Health; National Institute on Aging [AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, 2 R01 AG027574-22A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035583, K24AR051895, R01AR035584, R01AR035582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027576, R01AG005394, R01AG005407, F32AG005407, R01AG027574] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Swiss National Science Foundation grant [PBLAP3-132943] to DN, and Public Health Service grant [HL40489] to JAC. The Study of Osteoporotic Fractures is supported by National Institutes of Health funding. The National Institute on Aging provides support under the following grant numbers: AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, and 2 R01 AG027574-22A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Bulugahapitiya U, 2009, DIABETIC MED, V26, P142, DOI 10.1111/j.1464-5491.2008.02640.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Eberly LE, 2003, DIABETES CARE, V26, P848, DOI 10.2337/diacare.26.3.848; Evans JMM, 2002, BRIT MED J, V324, P939, DOI 10.1136/bmj.324.7343.939; Executive summary ADA standards of medical care in diabetes, 2012, DIABETES CARE S1, V35, ps4; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Fox CS, 2004, DIABETES CARE, V27, P704, DOI 10.2337/diacare.27.3.704; Gonzalez-Clemente JM, 2007, REV ESP CARDIOL, V60, P1167, DOI 10.1157/13111789; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Gregg EW, 1998, ANN INTERN MED, V129, P81, DOI 10.7326/0003-4819-129-2-199807150-00002; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Hillier TA, 2005, DIABETES CARE, V28, P2258, DOI 10.2337/diacare.28.9.2258; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lotufo PA, 2001, ARCH INTERN MED, V161, P242, DOI 10.1001/archinte.161.2.242; Natarajan S, 2005, ARCH INTERN MED, V165, P430, DOI 10.1001/archinte.165.4.430; NEWMAN AB, 1991, J CLIN EPIDEMIOL, V44, P15, DOI 10.1016/0895-4356(91)90196-G; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; Pajunen P, 2005, DIABETOLOGIA, V48, P2519, DOI 10.1007/s00125-005-0019-0; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Rodondi N, 2007, J INTERN MED, V261, P238, DOI 10.1111/j.1365-2796.2007.01769.x; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Wannamethee SG, 2011, ARCH INTERN MED, V171, P404, DOI 10.1001/archinternmed.2011.2; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48818	10.1371/journal.pone.0048818	http://dx.doi.org/10.1371/journal.pone.0048818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144985	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800144
J	Qiao, RM; Chuang, YD; Yan, SS; Yang, WL				Qiao, Ruimin; Chuang, Yi-De; Yan, Shishen; Yang, Wanli			Soft X-Ray Irradiation Effects of Li2O2, Li2CO3 and Li2O Revealed by Absorption Spectroscopy	PLOS ONE			English	Article							LITHIUM; BATTERIES; AIR; ELECTROLYTE; CARBONATE; BEAMLINE; O-2	Li2O2, Li2CO3, and Li2O are three critical compounds in lithium-air and lithium-ion energy storage systems. Extensive measurements have been carried out to study the chemical species and their evolutions at difference stages of the device operation. While x-ray spectroscopy has been demonstrated to be one of the most powerful tools for such purpose, no systematic study on the irradiation effects have been reported. Here we carry out extensive time, position, and irradiation dependent Li K-edge soft x-ray absorption spectroscopy on these compounds with so far the best energy resolution. The ultra-high resolution in the current study allows the features in the absorption spectra to be well-resolved. The spectral lineshape thus serves as the fingerprints of these compounds, enabling the tracking of their evolution under x- ray irradiation. We found that both Li2O2 and Li2CO3 evidently evolve towards Li2O under the soft x- ray irradiation with Li2CO3 exhibiting a surprisingly higher sensitivity to x-rays than Li2O2. On the other hand, Li2O remains the most stable compound despite experiencing substantial irradiation dose. We thus conclude that high resolution soft x- ray spectroscopy could unambiguously fingerprint different chemical species, but special cautions on irradiation effects would be needed in performing the experiments and interpreting the data properly.	[Qiao, Ruimin; Yan, Shishen] Shandong Univ, Sch Phys, Jinan 250100, Shandong, Peoples R China; [Qiao, Ruimin; Chuang, Yi-De; Yang, Wanli] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	Shandong University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Yan, SS (corresponding author), Shandong Univ, Sch Phys, Jinan 250100, Shandong, Peoples R China.	shishenyan@sdu.edu.cn; wlyang@lbl.gov	Yang, Wanli/D-7183-2011; Qiao, Ruimin/E-9023-2013	Yang, Wanli/0000-0003-0666-8063; Chuang, Yi-De/0000-0002-2773-3840	U. S. Department of Energy [DE-AC02-05CH11231]; National Natural Science Foundation of China [51125004, 10974120]; National Basic Research Program of China [2013CB922303]	U. S. Department of Energy(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	The Advanced Light Source at Lawrence Berkeley National Laboratory was supported by the U. S. Department of Energy (http://energy.gov) under Contract No. DE-AC02-05CH11231. This work was also supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn) No. 51125004 and No. 10974120, and the National Basic Research Program of China (http://www.973.gov.cn) No. 2013CB922303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2006, J POWER SOURCES, V153, P328, DOI 10.1016/j.jpowsour.2005.05.067; Abraham KM, 1996, J ELECTROCHEM SOC, V143, P1, DOI 10.1149/1.1836378; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Augustsson A, 2004, PHYS CHEM CHEM PHYS, V6, P4185, DOI 10.1039/b313434b; Balbuena P. B., 2004, LITHIUM ION BATTERIE; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/NMAT3191, 10.1038/nmat3191]; Cazaux J, 1997, J MICROSC-OXFORD, V188, P106, DOI 10.1046/j.1365-2818.1997.2550812.x; Chan MKY, 2011, J PHYS CHEM LETT, V2, P2483, DOI 10.1021/jz201072b; Cho IH, 2010, ELECTROCHEM SOLID ST, V13, pA168, DOI 10.1149/1.3481711; Coffey T, 2002, J ELECTRON SPECTROSC, V122, P65, DOI 10.1016/S0368-2048(01)00342-5; Cook PL, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3267849; Cota LG, 2005, ACTA CRYSTALLOGR B, V61, P133, DOI 10.1107/S0108768105003629; Debart A, 2008, ANGEW CHEM INT EDIT, V47, P4521, DOI 10.1002/anie.200705648; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; EFFENBERGER H, 1979, Z KRISTALLOGR, V150, P133, DOI 10.1524/zkri.1979.150.1-4.133; El Ouatani L, 2009, J ELECTROCHEM SOC, V156, pA468, DOI 10.1149/1.3111891; Fister TT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3664620; FONG R, 1990, J ELECTROCHEM SOC, V137, P2009, DOI 10.1149/1.2086855; FOPPL H, 1957, Z ANORG ALLG CHEM, V291, P12, DOI 10.1002/zaac.19572910104; Freunberger SA, 2011, J AM CHEM SOC, V133, P8040, DOI 10.1021/ja2021747; Goodenough JB, 2007, REPORT BASIC ENERGY; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Harris SJ, 2010, CHEM PHYS LETT, V485, P265, DOI 10.1016/j.cplett.2009.12.033; He P, 2010, ELECTROCHEM COMMUN, V12, P1686, DOI 10.1016/j.elecom.2010.09.025; Huggins R. A., 2008, ADV BATTERIES MAT SC; JIA JJ, 1995, REV SCI INSTRUM, V66, P1394, DOI 10.1063/1.1145985; Johnson PS, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3613638; Jung YS, 2012, ADV ENERGY MATER, V2, P1022, DOI 10.1002/aenm.201100750; Karan NK, 2012, J PHYS CHEM C, V116, P18132, DOI 10.1021/jp306298e; Kim YS, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3458910; Kumar B, 2010, J ELECTROCHEM SOC, V157, pA50, DOI 10.1149/1.3256129; Lee JS, 2011, ADV ENERGY MATER, V1, P34, DOI 10.1002/aenm.201000010; Li YL, 2012, J MATER CHEM, V22, P20170, DOI 10.1039/c2jm34718k; Lu YC, 2011, ENERG ENVIRON SCI, V4, P2999, DOI 10.1039/c1ee01500a; McCloskey BD, 2011, J PHYS CHEM LETT, V2, P1161, DOI 10.1021/jz200352v; Mitchell RR, 2011, ENERG ENVIRON SCI, V4, P2952, DOI 10.1039/c1ee01496j; Nagaura T., 1990, PROG BATT SOLAR CELL, V9, P209; Nazri G.-A., 2003, LITHIUM BATTERIES SC, DOI [10.1007/978-0-387-92675-9, DOI 10.1007/978-0-387-92675-9]; Ochida M, 2012, J ELECTROCHEM SOC, V159, pA961, DOI 10.1149/2.031207jes; Ogasawara T, 2006, J AM CHEM SOC, V128, P1390, DOI 10.1021/ja056811q; Olovsson W, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.041102; Peng ZQ, 2011, ANGEW CHEM INT EDIT, V50, P6351, DOI 10.1002/anie.201100879; Reininger R, 2007, AIP CONF PROC, V879, P509; RUHL E, 1991, CHEM PHYS, V154, P323, DOI 10.1016/0301-0104(91)80082-S; Shirley EL, 1998, PHYS REV LETT, V80, P794, DOI 10.1103/PhysRevLett.80.794; Tsuji J, 2002, X-RAY SPECTROM, V31, P319, DOI 10.1002/xrs.577; Wang F, 2011, ACS NANO, V5, P1190, DOI 10.1021/nn1028168; Wang YG, 2010, J POWER SOURCES, V195, P358, DOI 10.1016/j.jpowsour.2009.06.109; Xiao J, 2011, J POWER SOURCES, V196, P5674, DOI 10.1016/j.jpowsour.2011.02.060; Xu K, 2004, CHEM REV, V104, P4303, DOI 10.1021/cr030203g; Xu W, 2011, J POWER SOURCES, V196, P3894, DOI 10.1016/j.jpowsour.2010.12.065	51	94	95	3	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49182	10.1371/journal.pone.0049182	http://dx.doi.org/10.1371/journal.pone.0049182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145116	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800226
J	Ho, QT; Verboven, P; Yin, XY; Struik, PC; Nicolai, BM				Quang Tri Ho; Verboven, Pieter; Yin, Xinyou; Struik, Paul C.; Nicolai, Bart M.			A Microscale Model for Combined CO2 Diffusion and Photosynthesis in Leaves	PLOS ONE			English	Article							GAS-EXCHANGE; MESOPHYLL CONDUCTANCE; INTERNAL CONDUCTANCE; CARBON-DIOXIDE; CHLOROPHYLL FLUORESCENCE; TEMPERATURE RESPONSE; BIOCHEMICAL-MODEL; STOMATAL CONDUCTANCE; LEAF PHOTOSYNTHESIS; CRITICAL-APPRAISAL	Transport of CO2 in leaves was investigated by combining a 2-D, microscale CO2 transport model with photosynthesis kinetics in wheat (Triticum aestivum L.) leaves. The biophysical microscale model for gas exchange featured an accurate geometric representation of the actual 2-D leaf tissue microstructure and accounted for diffusive mass exchange of CO2. The resulting gas transport equations were coupled to the biochemical Farquhar-von Caemmerer-Berry model for photosynthesis. The combined model was evaluated using gas exchange and chlorophyll fluorescence measurements on wheat leaves. In general a good agreement between model predictions and measurements was obtained, but a discrepancy was observed for the mesophyll conductance at high CO2 levels and low irradiance levels. This may indicate that some physiological processes related to photosynthesis are not incorporated in the model. The model provided detailed insight into the mechanisms of gas exchange and the effects of changes in ambient CO2 concentration or photon flux density on stomatal and mesophyll conductance. It represents an important step forward to study CO2 diffusion coupled to photosynthesis at the leaf tissue level, taking into account the leaf's actual microstructure.	[Quang Tri Ho; Verboven, Pieter; Nicolai, Bart M.] Katholieke Univ Leuven, Flanders Ctr Postharvest Technol BIOSYST MeBioS, Louvain, Belgium; [Yin, Xinyou; Struik, Paul C.] Wageningen Univ, Ctr Crop Syst Anal, Wageningen, Netherlands	KU Leuven; Wageningen University & Research	Nicolai, BM (corresponding author), Katholieke Univ Leuven, Flanders Ctr Postharvest Technol BIOSYST MeBioS, Louvain, Belgium.	bart.nicolai@biw.kuleuven.be	nicolai, bart M/L-6129-2013	nicolai, bart M/0000-0001-5267-1920; Yin, Xinyou/0000-0001-8273-8022; Verboven, Pieter/0000-0001-9542-8285	Research Council of the K.U. Leuven [OT 08/023]; Research Fund Flanders [G.0603.08]; Institute for the Promotion of Innovation by Science and Technology in Flanders [IWT-050633]	Research Council of the K.U. Leuven(KU Leuven); Research Fund Flanders; Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The authors wish to thank the Research Council of the K.U. Leuven (OT 08/023), the Research Fund Flanders (project G.0603.08), and the Institute for the Promotion of Innovation by Science and Technology in Flanders (project IWT-050633) for financial support. Wageningen based authors have contributed to this work within the programme BioSolar Cells. Quang Tri Ho is a postdoctoral fellow of the Research Fund Flanders (FWO Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto T, 2002, PLANT CELL ENVIRON, V25, P1399, DOI 10.1046/j.0016-8025.2002.00906.x; Archontoulis SV, 2012, J EXP BOT, V63, P895, DOI 10.1093/jxb/err321; Badger MR, 1978, CARNEGIE I WASHINGTO, P355; Bernacchi CJ, 2002, PLANT PHYSIOL, V130, P1992, DOI 10.1104/pp.008250; BONGI G, 1989, PLANT PHYSIOL, V90, P1408, DOI 10.1104/pp.90.4.1408; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; COLMAN B, 1985, PLANT CELL ENVIRON, V8, P449, DOI 10.1111/j.1365-3040.1985.tb01680.x; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; DIMARCO G, 1990, J PLANT PHYSIOL, V136, P538, DOI 10.1016/S0176-1617(11)80210-5; Dreyer E, 2001, TREE PHYSIOL, V21, P223, DOI 10.1093/treephys/21.4.223; Dupuy L, 2010, P NATL ACAD SCI USA, V107, P2711, DOI 10.1073/pnas.0906322107; Evans JR, 2006, NEW PHYTOL, V171, P771, DOI 10.1111/j.1469-8137.2006.01789.x; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; Evans JR, 2009, PLANT CELL PHYSIOL, V50, P698, DOI 10.1093/pcp/pcp041; Evans JR, 1996, PLANT PHYSIOL, V110, P339, DOI 10.1104/pp.110.2.339; Evans JR, 2003, PLANT CELL ENVIRON, V26, P547, DOI 10.1046/j.1365-3040.2003.00985.x; EVANS JR, 1994, AUST J PLANT PHYSIOL, V21, P475, DOI 10.1071/PP9940475; Evans JR, 2000, PHOTOSYNTHESIS PHYSL, P321, DOI DOI 10.1007/0-306-48137-5_14; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; Farquhar G. D., 1982, Encyclopedia of plant physiology. New series. Volume 12B. Physiological plant ecology. II. Water relations and carbon assimilation. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P549; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gillon JS, 2000, PLANT PHYSIOL, V123, P201, DOI 10.1104/pp.123.1.201; GOUDRIAAN J, 1978, PHOTOSYNTHETICA, V12, P241; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Ho QT, 2009, NEW PHYTOL, V182, P163, DOI 10.1111/j.1469-8137.2008.02732.x; Ho QT, 2010, J EXP BOT, V61, P2071, DOI 10.1093/jxb/erq026; Hu YC, 2005, PLANTA, V220, P838, DOI 10.1007/s00425-004-1401-8; James RA, 2006, PLANT CELL ENVIRON, V29, P2185, DOI 10.1111/j.1365-3040.2006.01592.x; Jolly W, 1985, MODERN INORGANIC CHE; Kaiser H, 2009, PLANT CELL ENVIRON, V32, P1091, DOI 10.1111/j.1365-3040.2009.01990.x; Kim SH, 2003, ANN BOT-LONDON, V91, P771, DOI 10.1093/aob/mcg080; KNABNER P, 2003, NUMERICAL METHODS EL; Kuroki S, 2004, POSTHARVEST BIOL TEC, V33, P255, DOI 10.1016/j.postharvbio.2004.04.002; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Lide D. R., 1999, HDB CHEM PHYS; LLOYD J, 1992, PLANT CELL ENVIRON, V15, P873, DOI 10.1111/j.1365-3040.1992.tb01021.x; LORETO F, 1992, PLANT PHYSIOL, V98, P1437, DOI 10.1104/pp.98.4.1437; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Mendoza F, 2007, PLANTA, V226, P559, DOI 10.1007/s00425-007-0504-4; Moghaddam PR, 1998, J AGR SCI, V131, P59, DOI 10.1017/S0021859698005632; Morison JIL, 2007, PLANT PHYSIOL, V145, P680, DOI 10.1104/pp.107.107318; MORISON JIL, 1983, PLANT CELL ENVIRON, V6, P103, DOI 10.1111/j.1365-3040.1983.tb01882.x; Morison JIL, 2005, PLANT PHYSIOL, V139, P254, DOI 10.1104/pp.105.062950; PARKHURST DF, 1994, NEW PHYTOL, V126, P449, DOI 10.1111/j.1469-8137.1994.tb04244.x; PARKHURST DF, 1990, PLANT PHYSIOL, V94, P1024, DOI 10.1104/pp.94.3.1024; Pieruschka R, 2005, J EXP BOT, V56, P857, DOI 10.1093/jxb/eri072; Ho QT, 2011, PLANT PHYSIOL, V155, P1158, DOI 10.1104/pp.110.169391; SHARKEY TD, 1985, BOT REV, V51, P53, DOI 10.1007/BF02861058; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; SYVERTSEN JP, 1995, PLANT CELL ENVIRON, V18, P149, DOI 10.1111/j.1365-3040.1995.tb00348.x; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; TERASHIMA I, 1985, ANN BOT-LONDON, V56, P489, DOI 10.1093/oxfordjournals.aob.a087034; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Tholen D, 2008, PLANT CELL ENVIRON, V31, P1688, DOI 10.1111/j.1365-3040.2008.01875.x; Tholen D, 2011, PLANT PHYSIOL, V156, P90, DOI 10.1104/pp.111.172346; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; Verboven P, 2008, PLANT PHYSIOL, V147, P518, DOI 10.1104/pp.108.118935; Verboven P, 2012, NEW PHYTOL, V193, P420, DOI 10.1111/j.1469-8137.2011.03934.x; Vesala T, 1996, NEW PHYTOL, V132, P235, DOI 10.1111/j.1469-8137.1996.tb01843.x; Vogelmann TC, 2002, PLANT CELL ENVIRON, V25, P1313, DOI 10.1046/j.1365-3040.2002.00910.x; von Caemmerer S, 2000, TECHNIQUES PLANT SCI, V2, P196; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; VONCAEMMERER S, 1994, PLANTA, V195, P88, DOI 10.1007/BF00206296; VONCAEMMERER S, 1991, AUST J PLANT PHYSIOL, V18, P287, DOI 10.1071/pp9910287; Warren CR, 2004, J EXP BOT, V55, P2313, DOI 10.1093/jxb/erh239; Yin X, 2004, PLANT CELL ENVIRON, V27, P1211, DOI 10.1111/j.1365-3040.2004.01224.x; Yin X, 2009, NJAS-WAGEN J LIFE SC, V57, P27, DOI 10.1016/j.njas.2009.07.001; Yin XY, 2009, PLANT CELL ENVIRON, V32, P1513, DOI 10.1111/j.1365-3040.2009.02016.x; Yin XY, 2009, PLANT CELL ENVIRON, V32, P448, DOI 10.1111/j.1365-3040.2009.01934.x	77	22	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48376	10.1371/journal.pone.0048376	http://dx.doi.org/10.1371/journal.pone.0048376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144870	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800049
J	Quiroga, AD; Lian, JH; Lehner, R				Quiroga, Ariel D.; Lian, Jihong; Lehner, Richard			Carboxylesterase1/Esterase-x Regulates Chylomicron Production in Mice	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; APOLIPOPROTEIN-E; PLASMA-CLEARANCE; PARTICLE-SIZE; HEART-DISEASE; IN-VIVO; SECRETION; REMNANTS; RECEPTOR; LACKING	Elevated postprandial plasma triacylglycerol (TG) concentrations are commonly associated with obesity and the risk of cardiovascular disease. Dietary fat contributes to this condition through the production of chylomicrons. Carboxylesterases have been mainly studied for their role in drug metabolism, but recently they have been shown to participate in lipid metabolism; however, their role in intestinal lipid metabolism is unknown. Carboxylesterase1/esterase-x (Ces1/Es-x) deficient mice become obese, hyperlipidemic and develop hepatic steatosis even on standard chow diet. Here, we aimed to explore the role of Ces1/Es-x in intestinal lipid metabolism. Six-month old wild-type and Ces1/Es-x deficient mice were maintained on chow diet and intestinal lipid metabolism and plasma chylomicron clearance were analyzed. Along the intestine Ces1/Es-x protein is expressed only in proximal jejunum. Ablation of Ces1/Es-x expression results in postprandial hyperlipidemia due to increased secretion of chylomicrons. The secreted chylomicrons have aberrant protein composition, which results in their reduced clearance. In conclusion, Ces1/Es-x participates in the regulation of chylomicron assembly and secretion. Ces1/Es-x might act as a lipid sensor in enterocytes regulating chylomicron secretion rate. Ces1/Es-x might represent an attractive pharmacological target for the treatment of lipid abnormalities associated with obesity, insulin resistance and fatty liver disease.	[Quiroga, Ariel D.; Lian, Jihong; Lehner, Richard] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada; [Quiroga, Ariel D.; Lian, Jihong; Lehner, Richard] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Lehner, Richard] Univ Alberta, Dept Cell Biol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Lehner, R (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada.	richard.lehner@ualberta.ca		Lehner, Richard/0000-0002-6008-1805	Canadian Institutes of Health Research [MOP-106518]; Women and Children Health Research Institute; Heart and Stroke Foundation of Canada; Canadian Lipoprotein Conference/Merck Research Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women and Children Health Research Institute; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Lipoprotein Conference/Merck Research Award	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-106518). Some lipid analyses were performed by the Lipid Analysis Core, which receives support from the Women and Children Health Research Institute. RL is an Alberta Innovates-Health Solutions Scientist. ADQ is a recipient of a postdoctoral fellowship from the Heart and Stroke Foundation of Canada and of a Canadian Lipoprotein Conference/Merck Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; Cartwright IJ, 1999, J LIPID RES, V40, P1357; CHAJEKSHAUL T, 1983, J LIPID RES, V24, P831; Cooper AD, 1997, J LIPID RES, V38, P2173; FIELDING CJ, 1976, J LIPID RES, V17, P419; FOJO SS, 1992, J INTERN MED, V231, P669, DOI 10.1111/j.1365-2796.1992.tb01256.x; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; GULDUR T, 1992, Biochemical Society Transactions, V20, p104S; HERZ J, 1995, P NATL ACAD SCI USA, V92, P4611, DOI 10.1073/pnas.92.10.4611; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Iqbal J, 2008, CELL METAB, V7, P445, DOI 10.1016/j.cmet.2008.03.005; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; Ko KWS, 2009, BBA-MOL CELL BIOL L, V1791, P1133, DOI 10.1016/j.bbalip.2009.07.006; Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126; Martins IJ, 1996, J LIPID RES, V37, P2696; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; QUARFORD.SH, 1966, BIOCHIM BIOPHYS ACTA, V116, P382, DOI 10.1016/0005-2760(66)90019-1; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Rensen PCN, 1996, J BIOL CHEM, V271, P14791, DOI 10.1074/jbc.271.25.14791; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; TAJIMA S, 1983, J BIOL CHEM, V258, P73; TSO P, 1981, AM J PHYSIOL, V241, pG487, DOI 10.1152/ajpgi.1981.241.6.G487; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang LC, 2002, GASTROENTEROLOGY, V122, P469, DOI 10.1053/gast.2002.31102; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Werner A, 2006, AM J PHYSIOL-GASTR L, V290, pG1177, DOI 10.1152/ajpgi.00127.2005; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yu KCW, 2001, FRONT BIOSCI-LANDMRK, V6, pD332, DOI 10.2741/Yu	29	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49515	10.1371/journal.pone.0049515	http://dx.doi.org/10.1371/journal.pone.0049515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145182	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800263
J	Song, Q; Li, TH; Cong, PS; Sun, JM; Li, DP; Tang, SN				Song, Qi; Li, Tonghua; Cong, Peisheng; Sun, Jiangming; Li, Dapeng; Tang, Shengnan			Predicting Turns in Proteins with a Unified Model	PLOS ONE			English	Article							SECONDARY STRUCTURE INFORMATION; SUPPORT VECTOR MACHINE; PSI-BLAST PROFILES; NEURAL-NETWORK; BETA-TURNS; ALPHA-TURNS; GAMMA-TURNS; ALIGNMENT; DISORDER	Motivation: Turns are a critical element of the structure of a protein; turns play a crucial role in loops, folds, and interactions. Current prediction methods are well developed for the prediction of individual turn types, including alpha-turn, beta-turn, and gamma-turn, etc. However, for further protein structure and function prediction it is necessary to develop a uniform model that can accurately predict all types of turns simultaneously. Results: In this study, we present a novel approach, TurnP, which offers the ability to investigate all the turns in a protein based on a unified model. The main characteristics of TurnP are: (i) using newly exploited features of structural evolution information (secondary structure and shape string of protein) based on structure homologies, (ii) considering all types of turns in a unified model, and (iii) practical capability of accurate prediction of all turns simultaneously for a query. TurnP utilizes predicted secondary structures and predicted shape strings, both of which have greater accuracy, based on innovative technologies which were both developed by our group. Then, sequence and structural evolution features, which are profile of sequence, profile of secondary structures and profile of shape strings are generated by sequence and structure alignment. When TurnP was validated on a non-redundant dataset (4,107 entries) by five-fold cross-validation, we achieved an accuracy of 88.8% and a sensitivity of 71.8%, which exceeded the most state-of-the-art predictors of certain type of turn. Newly determined sequences, the EVA and CASP9 datasets were used as independent tests and the results we achieved were outstanding for turn predictions and confirmed the good performance of TurnP for practical applications.	[Song, Qi; Li, Tonghua; Cong, Peisheng; Sun, Jiangming; Li, Dapeng; Tang, Shengnan] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China	Tongji University	Li, TH (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	Lith@tongji.edu.cn	Sun, Jiangming/AFT-1203-2022	Sun, Jiangming/0000-0001-6814-1297	National Natural Science Foundation of China [21275108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are thankful for the financial support of the National Natural Science Foundation of China (21275108), (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Branden C, 1991, MOTIFS PROTEIN STRUC, P13; Chou KC, 1997, J PROTEIN CHEM, V16, P575, DOI 10.1023/A:1026366706677; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Fuchs PFJ, 2005, PROTEINS, V59, P828, DOI 10.1002/prot.20461; Guruprasad K, 2003, J PEPT RES, V61, P243, DOI 10.1034/j.1399-3011.2003.00054.x; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jahandideh S, 2007, J THEOR BIOL, V249, P785, DOI 10.1016/j.jtbi.2007.09.002; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaur H, 2004, BIOINFORMATICS, V20, P2751, DOI 10.1093/bioinformatics/bth322; Kaur H, 2004, PROTEINS, V55, P83, DOI 10.1002/prot.10569; Kaur H, 2003, PROTEIN SCI, V12, P923, DOI 10.1110/ps.0241703; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kaur H, 2002, BIOINFORMATICS, V18, P498, DOI 10.1093/bioinformatics/18.3.498; Kirschner A, 2008, GENE, V422, P22, DOI 10.1016/j.gene.2008.06.008; Li DP, 2012, BIOINFORMATICS, V28, P32, DOI 10.1093/bioinformatics/btr611; Lin HN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S4; Meissner M, 2009, PROTEINS, V74, P344, DOI 10.1002/prot.22164; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Pereira F. C. N., 2001, P 18 INT C MACH LEAR, P282; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Schrodinger LDD, 2010, PYMOL MOL GRAPHICS S; Shi XB, 2011, J THEOR BIOL, V286, P24, DOI 10.1016/j.jtbi.2011.07.001; Sun J, 2012, NUCL ACIDS RES; Sun JM, 2012, MOL CELL PROTEOMICS; Tang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-283; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang Y, 2006, PROTEINS, V65, P49, DOI 10.1002/prot.21062; Wang Y, 2006, BIOCHEM BIOPH RES CO, V347, P574, DOI 10.1016/j.bbrc.2006.06.066; Xiong WW, 2009, NUCLEIC ACIDS RES, V37, P5632, DOI 10.1093/nar/gkp628; Zhu YJ, 2012, AMINO ACIDS, V42, P1749, DOI 10.1007/s00726-011-0889-z	34	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48389	10.1371/journal.pone.0048389	http://dx.doi.org/10.1371/journal.pone.0048389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144872	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800052
J	Wong, AWK; Huang, J; Chen, HC				Wong, Andus Wing-Kuen; Huang, Jian; Chen, Hsuan-Chih			Phonological Units in Spoken Word Production: Insights from Cantonese	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; DIET-INDUCED OBESITY; HEPATIC STEATOSIS; LIVER; CHOLESTEROL; MICE; ACCUMULATION; INJURY; HEART	Evidence from previous psycholinguistic research suggests that phonological units such as phonemes have a privileged role during phonological planning in Dutch and English (aka the segment-retrieval hypothesis). However, the syllable-retrieval hypothesis previously proposed for Mandarin assumes that only the entire syllable unit (without the tone) can be prepared in advance in speech planning. Using Cantonese Chinese as a test case, the present study was conducted to investigate whether the syllable-retrieval hypothesis can be applied to other Chinese spoken languages. In four implicit priming (form-preparation) experiments, participant were asked to learn various set of prompt-response di-syllabic word pairs and to utter the corresponding response word upon seeing each prompt. The response words in a block were wither phonologically related (homogeneous) or unrelated (heterogeneous). Participants' naming responses were significantly faster in the homogenous than in the heterogeneous conditions when the response words shared the same word-initial syllable (without the tone) (Exps.1 and 4) or body (Exps.3 and 4), but not when they shared merely the same word-initial phoneme (Exp.2). Furthermore, the priming effect observed in the syllable-related condition was significantly larger than that in the body-related condition (Exp.4). Although the observed syllable priming effects and the null effect of word-initial phoneme are consistent with the syllable-retrieval hypothesis, the body-related (sub-syllabic) priming effects obtained in this Cantonese study are not. These results suggest that the syllable-retrieval hypothesis is not generalizable to all Chinese spoken languages and that both syllable and sub-syllabic constituents are legitimate planning units in Cantonese speech production.	[Huang, Jian; Chen, Hsuan-Chih] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Wong, Andus Wing-Kuen] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Hong Kong	Chen, HC (corresponding author), Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.	hcchen@psy.cuhk.edu.hk		WONG, Wing Kuen/0000-0002-6015-1359; Wong, Andus/0000-0003-2036-7152	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK441008]; University of Hong Kong; Sciences of Learning Strategic Research Theme of the University of Hong Kong	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); Sciences of Learning Strategic Research Theme of the University of Hong Kong	This research was supported by a General Research Fund grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (CUHK441008) to Hsuan-Chih Chen. This work was also supported in part by the Faculty (Education) Research Fund (22nd round) from the University of Hong Kong and the Sciences of Learning Strategic Research Theme of the University of Hong Kong to Andus Wing-Kuen Wong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Derikx JPM, 2007, SHOCK, V28, P544, DOI 10.1097/shk.0b013e3180644e32; Engels W, 1999, MOL CELL BIOCHEM, V192, P53, DOI 10.1023/A:1006855214237; Fisher E, 2007, MOL GENET METAB, V91, P278, DOI 10.1016/j.ymgme.2007.03.002; GLATZ JFC, 1988, NEWS PHYSIOL SCI, V3, P41; GOLLIN G, 1993, SURGERY, V113, P545; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hong J, 2008, DIABETIC MED, V25, P73, DOI 10.1111/j.1464-5491.2007.02329.x; Kamijo-Ikemori A, 2011, DIABETES CARE, V34, P691, DOI 10.2337/dc10-1392; Kamijo-Ikemori A, 2009, NEPHROL DIAL TRANSPL, V24, P788, DOI 10.1093/ndt/gfn573; Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Magnusson AL, 2004, J CLIN ENDOCR METAB, V89, P4607, DOI 10.1210/jc.2003-032234; Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; McArthur MJ, 1999, J LIPID RES, V40, P1371; MORROW FD, 1979, FED PROC, V38, P280; Newberry EP, 2008, AM J PHYSIOL-GASTR L, V294, pG307, DOI 10.1152/ajpgi.00377.2007; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Peng XE, 2012, GENE; Rolf B, 1995, BBA-LIPID LIPID MET, V1259, P245, DOI 10.1016/0005-2760(95)00170-0; SAAD MF, 1994, DIABETES, V43, P1114, DOI 10.2337/diabetes.43.9.1114; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Weickert MO, 2007, AM J PHYSIOL-ENDOC M, V293, pE1078, DOI 10.1152/ajpendo.00337.2007; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463	34	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48776	10.1371/journal.pone.0048776	http://dx.doi.org/10.1371/journal.pone.0048776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144965	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800129
J	Yang, J; Kim, J; Kim, W; Kim, YH				Yang, Joonhyuk; Kim, Jinwook; Kim, Wonjoon; Kim, Young Hwan			Measuring User Similarity Using Electric Circuit Analysis: Application to Collaborative Filtering	PLOS ONE			English	Article							RECOMMENDATION; INFORMATION	We propose a new technique of measuring user similarity in collaborative filtering using electric circuit analysis. Electric circuit analysis is used to measure the potential differences between nodes on an electric circuit. In this paper, by applying this method to transaction networks comprising users and items, i.e., user-item matrix, and by using the full information about the relationship structure of users in the perspective of item adoption, we overcome the limitations of one-to-one similarity calculation approach, such as the Pearson correlation, Tanimoto coefficient, and Hamming distance, in collaborative filtering. We found that electric circuit analysis can be successfully incorporated into recommender systems and has the potential to significantly enhance predictability, especially when combined with user-based collaborative filtering. We also propose four types of hybrid algorithms that combine the Pearson correlation method and electric circuit analysis. One of the algorithms exceeds the performance of the traditional collaborative filtering by 37.5% at most. This work opens new opportunities for interdisciplinary research between physics and computer science and the development of new recommendation systems	[Kim, Wonjoon] Korea Adv Inst Sci & Technol, Dept Management Sci, Grad Sch Culture Technol, Taejon 305701, South Korea; [Kim, Jinwook; Kim, Young Hwan] Pohang Univ Sci & Technol, Dept Elect Engn, Pohang, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH)	Kim, W (corresponding author), Korea Adv Inst Sci & Technol, Dept Management Sci, Grad Sch Culture Technol, Taejon 305701, South Korea.	wonjoon.kim@kaist.edu	Kim, Wonjoon/C-1649-2011; Yang, Joonhyuk/A-5483-2009	Kim, Wonjoon/0000-0002-2568-2066; Yang, Joonhyuk/0000-0002-2846-5868	Korean Government under National Research Foundation of Korea Grant [NRF-2011-013-B00051]; KAIST (Korea Advanced Institute of Science and Technology) under grant "High Risk High Return Project'' [N10120006]	Korean Government under National Research Foundation of Korea Grant(National Research Foundation of Korea); KAIST (Korea Advanced Institute of Science and Technology) under grant "High Risk High Return Project''	Funding for this research was provided in part by Korean Government under National Research Foundation of Korea Grant (NRF-2011-013-B00051) and KAIST (Korea Advanced Institute of Science and Technology) under grant "High Risk High Return Project'' (N10120006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Barab?si AL., 2002, AM J PHYS, V71, P409, DOI [10.1119/1.1538577, DOI 10.1119/1.1538577]; Bastian M., 2009, 3 INT AAAI C WEBL SO; Breese JS, 1998, EMPIRICAL ANAL PREDI; Cechinel C, 2012, INFORM PROC IN PRESS; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Claypool Mark, 2001, P 6 INT C INTELLIGEN, P33, DOI DOI 10.1145/359784.359836; Dell'Amico M, 2010, ACM T INFORM SYST, V29, DOI 10.1145/1877766.1877771; Golbeck J, 2006, LECT NOTES COMPUT SC, V3986, P93; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Hannon J., 2010, P 4 ACM C REC SYST R, P199, DOI DOI 10.1145/1864708.1864746; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; HO CW, 1975, IEEE T CIRCUITS SYST, VCA22, P504, DOI 10.1109/TCS.1975.1084079; Hofmann T, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P688; Huang Z, 2007, MANAGE SCI, V53, P1146, DOI 10.1287/mnsc.1060.0619; Huang Z, 2011, INFORMS J COMPUT, V23, P138, DOI 10.1287/ijoc.1100.0385; Huang Z, 2009, INFORMS J COMPUT, V21, P286, DOI 10.1287/ijoc.1080.0292; Kautz H, 1997, COMMUN ACM, V40, P63, DOI 10.1145/245108.245123; KOREN Y, 2008, KDD, P426, DOI DOI 10.1145/1401890.1401944; Lee JS, 2005, EXPERT SYST APPL, V29, P700, DOI 10.1016/j.eswa.2005.04.037; Lemire D, 2005, INFORM RETRIEVAL, V8, P129, DOI 10.1023/B:INRT.0000048492.50961.a6; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu FK, 2010, EXPERT SYST APPL, V37, P4772, DOI 10.1016/j.eswa.2009.12.061; Liu H., 2005, PROG FISH SCI, P54; Melville P, 2002, PROC NATL AI, V2002, P87; Mild A., 2001, Active Media Technology. 6th International Computer Science Conference, AMT 2002. Proceedings (Lecture Notes in Computer Science Vol.2252), P302; Morita M., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P272; Resnick P., 1994, Transcending Boundaries, CSCW '94. Proceedings of the Conference on Computer Supported Cooperative Work, P175, DOI 10.1145/192844.192905; Rousseeuw PJ, 1990, FINDING GROUPS DATA; Sarwar B., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P158, DOI 10.1145/352871.352887; Schein A. I., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P253, DOI 10.1145/564376.564421; Sonny Han Seng Chee, 2001, Data Warehousing and Knowledge Discovery. Third International Conference, DaWaK 2001. Proceedings (Lecture Notes in Computer Science Vol.2114), P141; Su X., 2009, ADV ARTIF INTELL, V4, P2009, DOI DOI 10.1155/2009/421425; Su XY, 2006, PROC INT C TOOLS ART, P497; Ungar L.H., 1998, AAAI WORKSH REC SYST, V1, P114	35	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49126	10.1371/journal.pone.0049126	http://dx.doi.org/10.1371/journal.pone.0049126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145095	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800214
J	Yin, LF; Hu, MJ; Wang, F; Kuang, HH; Zhang, Y; Schnabel, G; Li, GQ; Luo, CX				Yin, Liang-Fen; Hu, Meng-Jun; Wang, Fei; Kuang, Hanhui; Zhang, Yu; Schnabel, Guido; Li, Guo-Qing; Luo, Chao-Xi			Frequent Gain and Loss of Introns in Fungal Cytochrome b Genes	PLOS ONE			English	Article							GROUP-II INTRONS; BASIDIOMYCOTA AGROCYBE-AEGERITA; RIBOSOMAL-RNA GENES; HOMING ENDONUCLEASE; MITOCHONDRIAL INTRONS; PHYLOGENETIC ANALYSIS; READING FRAME; CYT-B; SEQUENCES; YEAST	In this study, all available cytochrome b (Cyt b) genes from the GOBASE database were compiled and the evolutionary dynamics of the Cyt b gene introns was assessed. Cyt b gene introns were frequently present in the fungal kingdom and some lower plants, but generally absent or rare in Chromista, Protozoa, and Animalia. Fungal Cyt b introns were found at 35 positions in Cyt b genes and the number of introns varied at individual positions from a single representative to 32 different introns at position 131, showing a wide and patchy distribution. Many homologous introns were present at the same position in distantly related species but absent in closely related species, suggesting that introns of the Cyt b genes were frequently lost. On the other hand, highly similar intron sequences were observed in some distantly related species rather than in closely related species, suggesting that these introns were gained independently, likely through lateral transfers. The intron loss-and-gain events could be mediated by transpositions that might have occurred between nuclear and mitochondria. Southern hybridization analysis confirmed that some introns contained repetitive sequences and might be transposable elements. An intron gain in Botryotinia fuckeliana prevented the development of Qol fungicide resistance, suggesting that intron loss-and-gain events were not necessarily beneficial to their host organisms.	[Yin, Liang-Fen; Hu, Meng-Jun; Wang, Fei; Li, Guo-Qing; Luo, Chao-Xi] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Yin, Liang-Fen; Hu, Meng-Jun; Wang, Fei; Li, Guo-Qing; Luo, Chao-Xi] Huazhong Agr Univ, Key Lab Crop Dis Monitoring & Safety Control Hube, Wuhan, Peoples R China; [Kuang, Hanhui; Zhang, Yu] Huazhong Agr Univ, Coll Hort & Forestry, Wuhan, Peoples R China; [Schnabel, Guido] Clemson Univ, Sch Agr Forestry & Environm Sci, Clemson, SC USA	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Clemson University	Luo, CX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	cxluo@mail.hzau.edu.cn			Project of National Natural Science Foundation of China [31071703]; Program for New Century Excellent Talents in University [NCET-08-0783]; Special Fund for Agro-scientific Research in the Public Interest [200903039-3]	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-scientific Research in the Public Interest	This work is supported by the Project of National Natural Science Foundation of China (Grant No. 31071703), the Program for New Century Excellent Talents in University (NCET-08-0783), and partially by the Special Fund for Agro-scientific Research in the Public Interest (200903039-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzel A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-324; Belfort M, 2002, MOBILE INTRONS PATHW; BURKE JM, 1988, GENE, V73, P273, DOI 10.1016/0378-1119(88)90493-3; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Chec T, 1988, GENE, V73, P259; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; COLLINS RA, 1988, NUCLEIC ACIDS RES, V16, P1125, DOI 10.1093/nar/16.3.1125; Coulombe-Huntington J, 2007, GENOME RES, V17, P23, DOI 10.1101/gr.5703406; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; DELASALLE H, 1982, CELL, V28, P721, DOI 10.1016/0092-8674(82)90051-4; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gonzalez P, 1999, NUCLEIC ACIDS RES, V27, P1754, DOI 10.1093/nar/27.7.1754; Gonzalez P, 1998, GENE, V220, P45, DOI 10.1016/S0378-1119(98)00421-1; Grasso V, 2006, PEST MANAG SCI, V62, P465, DOI 10.1002/ps.1236; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P634, DOI 10.1073/pnas.91.2.634; Hily JM, 2011, PEST MANAG SCI, V67, P385, DOI 10.1002/ps.2074; Hu MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024990; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; LABOUESSE M, 1984, EUR J BIOCHEM, V144, P85, DOI 10.1111/j.1432-1033.1984.tb08434.x; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; LAROCHE J, 1995, MOL BIOL EVOL, V12, P1151; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; Lei Xin, 2007, Acta Zoologica Sinica, V53, P95; Luo CX, 2010, PEST MANAG SCI, V66, P1308, DOI 10.1002/ps.2016; Luo CX, 2005, PHYTOPATHOLOGY, V95, P640, DOI 10.1094/PHYTO-95-0640; Meng Q, 2005, J BIOL CHEM, V280, P35085, DOI 10.1074/jbc.C500328200; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Nesbo CL, 2003, P NATL ACAD SCI USA, V100, P10806, DOI 10.1073/pnas.1434268100; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Pellenz S, 2002, J MOL EVOL, V55, P302, DOI 10.1007/s00239-001-2327-4; PEREA J, 1985, EMBO J, V4, P3281, DOI 10.1002/j.1460-2075.1985.tb04078.x; Piaggio AJ, 2001, MOL PHYLOGENET EVOL, V20, P335, DOI 10.1006/mpev.2001.0975; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Roy SW, 2006, GENOME RES, V16, P750, DOI 10.1101/gr.4845406; Roy SW, 2005, P NATL ACAD SCI USA, V102, P713, DOI 10.1073/pnas.0408274102; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Sandegren L, 2004, J BIOL CHEM, V279, P22218, DOI 10.1074/jbc.M400929200; Sierotzki H, 2007, PEST MANAG SCI, V63, P225, DOI 10.1002/ps.1330; Sverdlov AV, 2004, GENE, V338, P85, DOI 10.1016/j.gene.2004.05.027; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Vun VF, 2011, GENET MOL RES, V10, P368, DOI 10.4238/vol10-1gmr1048; Webb DM, 2005, MOL PHYLOGENET EVOL, V36, P233, DOI 10.1016/j.ympev.2005.03.015; Zhuo DG, 2007, P NATL ACAD SCI USA, V104, P882, DOI 10.1073/pnas.0604777104	54	20	21	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49096	10.1371/journal.pone.0049096	http://dx.doi.org/10.1371/journal.pone.0049096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145081	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800202
J	Zetes, DE; Tolomeo, JA; Holley, MC				Zetes, Deborah E.; Tolomeo, Jason A.; Holley, Matthew C.			Structure and Mechanics of Supporting Cells in the Guinea Pig Organ of Corti	PLOS ONE			English	Article							OUTER HAIR CELL; COCHLEA; STIFFNESS; HEARING; FORCE; MICROTUBULES; ORGANIZATION; MODULATION; EPITHELIUM; FREQUENCY	The mechanical properties of the mammalian organ of Corti determine its sensitivity to sound frequency and intensity, and the structure of supporting cells changes progressively with frequency along the cochlea. From the apex (low frequency) to the base (high frequency) of the guinea pig cochlea inner pillar cells decrease in length incrementally from 75-55 mu m whilst the number of axial microtubules increases from 1,300-2,100. The respective values for outer pillar cells are 120-65 mu m and 1,500-3,000. This correlates with a progressive decrease in the length of the outer hair cells from > 100 mu m to 20 mu m. Deiters'cell bodies vary from 60-50 mu m long with relatively little change in microtubule number. Their phalangeal processes reflect the lengths of outer hair cells but their microtubule numbers do not change systematically. Correlations between cell length, microtubule number and cochlear location are poor below 1 kHz. Cell stiffness was estimated from direct mechanical measurements made previously from isolated inner and outer pillar cells. We estimate that between 200 Hz and 20 kHz axial stiffness, bending stiffness and buckling limits increase, respectively, similar to 3, 6 and 4 fold for outer pillar cells, similar to 2, 3 and 2.5 fold for inner pillar cells and similar to 7, 20 and 24 fold for the phalangeal processes of Deiters'cells. There was little change in the Deiters'cell bodies for any parameter. Compensating for effective cell length the pillar cells are likely to be considerably stiffer than Deiters'cells with buckling limits 10-40 times greater. These data show a clear relationship between cell mechanics and frequency. However, measurements from single cells alone are insufficient and they must be combined with more accurate details of how the multicellular architecture influences the mechanical properties of the whole organ.	[Zetes, Deborah E.; Tolomeo, Jason A.; Holley, Matthew C.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Holley, MC (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.c.holley@sheffield.ac.uk		Holley, Matthew/0000-0001-9547-1953	The Wellcome Trust-Project Grant [033968]	The Wellcome Trust-Project Grant	Funding was provided by the The Wellcome Trust-Project Grant 033968. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELBORG C, 1972, Acta Oto-Laryngologica Supplement, P49; BURKITT HG, 1993, WHEATHERS FUNCTIONAL; COOPER NP, 1994, HEARING RES, V78, P221, DOI 10.1016/0378-5955(94)90028-0; COOPER NP, 1995, HEARING RES, V82, P225, DOI 10.1016/0378-5955(94)00180-X; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; DULON D, 1994, BIOCHEM BIOPH RES CO, V201, P1263, DOI 10.1006/bbrc.1994.1841; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; FLOCK A, 1984, NATURE, V310, P597, DOI 10.1038/310597a0; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; GUMMER AW, 1981, J ACOUST SOC AM, V70, P1298, DOI 10.1121/1.387144; Hallworth R, 1997, HEARING RES, V114, P204, DOI 10.1016/S0378-5955(97)00167-6; Hallworth R, 1995, J NEUROPHYSIOL, V74, P2319, DOI 10.1152/jn.1995.74.6.2319; HOLLEY MC, 1992, J CELL SCI, V102, P569; IURATO S, 1961, Z ZELLFORSCH MIK ANA, V53, P259, DOI 10.1007/BF00339444; JAVEL E, 1994, HEARING RES, V81, P167, DOI 10.1016/0378-5955(94)90163-5; Jensen-Smith H, 2007, CELL MOTIL CYTOSKEL, V64, P705, DOI 10.1002/cm.20217; KELLY JP, 1989, ACTA OTO-LARYNGOL, P97; KELLY JP, 1989, ACTA OTO-LARYNGOL, P123; KELLY JP, 1989, ACTA OTO-LARYNGOL, P113; KIKUCHI T, 1991, ACTA OTO-LARYNGOL, V111, P286, DOI 10.3109/00016489109137389; MILLER CE, 1985, J ACOUST SOC AM, V77, P1465, DOI 10.1121/1.392041; Nam JH, 2010, BIOPHYS J, V98, P2813, DOI 10.1016/j.bpj.2010.03.052; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; OLSON ES, 1994, J ACOUST SOC AM, V95, P395, DOI 10.1121/1.408331; PROSEN CA, 1990, HEARING RES, V44, P179, DOI 10.1016/0378-5955(90)90079-5; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; SAITO K, 1982, J ELECTRON MICROSC, V31, P278; Schumacher KR, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907758; SLEPECKY NB, 1996, COCHLEA, V8, P44; Spector AA, 1998, J ACOUST SOC AM, V103, P1007, DOI 10.1121/1.421217; Tolomeo JA, 1996, BIOPHYS J, V71, P421, DOI 10.1016/S0006-3495(96)79244-5; Tolomeo JA, 1997, BIOPHYS J, V73, P2241, DOI 10.1016/S0006-3495(97)78255-9; Tolomeo JA, 1997, DIVERSITY AUDITORY M, P556; Zelenskaya A, 2005, BIOPHYS J, V88, P2982, DOI 10.1529/biophysj.104.052225; Zheng JF, 2007, J NEUROPHYSIOL, V97, P994, DOI 10.1152/jn.00774.2006	36	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49338	10.1371/journal.pone.0049338	http://dx.doi.org/10.1371/journal.pone.0049338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145154	Green Accepted, Green Published, gold			2022-12-25	WOS:000311935800245
J	Zitserman, D; Gupta, S; Kruger, WD; Karbowniczek, M; Roegiers, F				Zitserman, Diana; Gupta, Sapna; Kruger, Warren D.; Karbowniczek, Magdalena; Roegiers, Fabrice			The TSC1/2 Complex Controls Drosophila Pigmentation through TORC1-Dependent Regulation of Catecholamine Biosynthesis	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; MESSENGER-RNA; CELL-GROWTH; TRANSLATION; EXPRESSION; DOPAMINE; PATHWAY; NOTCH; FORM; RHEB	In Drosophila, the pattern of adult pigmentation is initiated during late pupal stages by the production of catecholamines DOPA and dopamine, which are converted to melanin. The pattern and degree of melanin deposition is controlled by the expression of genes such as ebony and yellow as well as by the enzymes involved in catecholamine biosynthesis. In this study, we show that the conserved TSC/TORC1 cell growth pathway controls catecholamine biosynthesis in Drosophila during pigmentation. We find that high levels of Rheb, an activator of the TORC1 complex, promote premature pigmentation in the mechanosensory bristles during pupal stages, and alter pigmentation in the cuticle of the adult fly. Disrupting either melanin synthesis by RNAi knockdown of melanogenic enzymes such as tyrosine hydroxylase (TH), or downregulating TORC1 activity by Raptor knockdown, suppresses the Rheb-dependent pigmentation phenotype in vivo. Increased Rheb activity drives pigmentation by increasing levels of TH in epidermal cells. Our findings indicate that control of pigmentation is linked to the cellular nutrient-sensing pathway by regulating levels of a critical enzyme in melanogenesis, providing further evidence that inappropriate activation of TORC1, a hallmark of the human tuberous sclerosis complex tumor syndrome disorder, can alter metabolic and differentiation pathways in unexpected ways.	[Zitserman, Diana; Gupta, Sapna; Kruger, Warren D.; Karbowniczek, Magdalena; Roegiers, Fabrice] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Roegiers, F (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	fabrice.roegiers@fccc.edu	kruger, warren/A-6407-2008; Kruger, Warren/Y-2541-2018	kruger, warren/0000-0002-4990-3695; 	NIH [RO1 NS059971]; Epigenetics and Progenitor Cells Keystone Program at Fox Chase Cancer Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059971] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epigenetics and Progenitor Cells Keystone Program at Fox Chase Cancer Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH RO1 NS059971 and the Epigenetics and Progenitor Cells Keystone Program at Fox Chase Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amcheslavsky A, 2011, J CELL BIOL, V193, P695, DOI 10.1083/jcb.201103018; Ashburner M, 2005, DROSOPHILA; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Karbowniczek M, 2010, J CLIN INVEST, V120, P93, DOI 10.1172/JCI40221; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koch PB, 1998, DEVELOPMENT, V125, P2303; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Neckameyer W, 2001, J NEUROBIOL, V47, P280, DOI 10.1002/neu.1035; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tong X, 2010, MOL BIOL CELL, V21, P802, DOI 10.1091/mbc.E09-09-0831; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zitserman D, 2011, JOVE-J VIS EXP, DOI 10.3791/2706	32	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48720	10.1371/journal.pone.0048720	http://dx.doi.org/10.1371/journal.pone.0048720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144943	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800109
J	Gabory, A; Ferry, L; Fajardy, I; Jouneau, L; Gothie, JD; Vige, A; Fleur, C; Mayeur, S; Gallou-Kabani, C; Gross, MS; Attig, L; Vambergue, A; Lesage, J; Reusens, B; Vieau, D; Remacle, C; Jais, JP; Junien, C				Gabory, Anne; Ferry, Laure; Fajardy, Isabelle; Jouneau, Luc; Gothie, Jean-David; Vige, Alexandre; Fleur, Cecile; Mayeur, Sylvain; Gallou-Kabani, Catherine; Gross, Marie-Sylvie; Attig, Linda; Vambergue, Anne; Lesage, Jean; Reusens, Brigitte; Vieau, Didier; Remacle, Claude; Jais, Jean-Philippe; Junien, Claudine			Maternal Diets Trigger Sex-Specific Divergent Trajectories of Gene Expression and Epigenetic Systems in Mouse Placenta	PLOS ONE			English	Article							HIGH-FAT DIET; ANIMAL-MODELS; FETAL-GROWTH; HISTONE H3; METHYLATION; OBESITY; CHROMOSOME; EXPOSURE; RESTRICTION; ADAPTATIONS	Males and females responses to gestational overnutrition set the stage for subsequent sex-specific differences in adult onset non communicable diseases. Placenta, as a widely recognized programming agent, contibutes to the underlying processes. According to our previous findings, a high-fat diet during gestation triggers sex-specific epigenetic alterations within CpG and throughout the genome, together with the deregulation of clusters of imprinted genes. We further investigated the impact of diet and sex on placental histology, transcriptomic and epigenetic signatures in mice. Both basal gene expression and response to maternal high-fat diet were sexually dimorphic in whole placentas. Numerous genes showed sexually dimorphic expression, but only 11 genes regardless of the diet. In line with the key role of genes belonging to the sex chromosomes, 3 of these genes were Y-specific and 3 were X-specific. Amongst all the genes that were differentially expressed under a high-fat diet, only 16 genes were consistently affected in both males and females. The differences were not only quantitative but remarkably qualitative. The biological functions and networks of genes dysregulated differed markedly between the sexes. Seven genes of the epigenetic machinery were dysregulated, due to effects of diet, sex or both, including the Y- and X-linked histone demethylase paralogues Kdm5c and Kdm5d, which could mark differently male and female epigenomes. The DNA methyltransferase cofactor Dnmt3l gene expression was affected, reminiscent of our previous observation of changes in global DNA methylation. Overall, this striking sexual dimorphism of programming trajectories impose a considerable revision of the current dietary interventions protocols.	[Gabory, Anne; Ferry, Laure; Jouneau, Luc; Gothie, Jean-David; Fleur, Cecile; Attig, Linda; Junien, Claudine] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Gabory, Anne; Ferry, Laure; Jouneau, Luc; Gothie, Jean-David; Fleur, Cecile; Attig, Linda; Junien, Claudine] ENVA, Maisons Alfort, France; [Gabory, Anne; Vige, Alexandre; Gallou-Kabani, Catherine; Gross, Marie-Sylvie; Attig, Linda; Junien, Claudine] Univ Paris 05, Hop Necker Enfants Malad, Fac Med, INSERM,AP HP,U781,SBIM, Paris, France; [Fajardy, Isabelle; Vambergue, Anne] CHRU Lille, Unite Environm Perinatal & Croissance, Biol & Pathol Ctr, EA 4489,Dept Diabetol,Huriez Hosp, Lille, France; [Mayeur, Sylvain; Lesage, Jean; Vieau, Didier] Univ Lille 1, Unite Environm Perinatal & Croissance, EA 4489, Villeneuve Dascq, France; [Reusens, Brigitte; Remacle, Claude] Catholic Univ Louvain, Inst Life Sci, Cell Biol Lab, B-1348 Louvain, Belgium; [Jais, Jean-Philippe] Hop Necker Enfants Malad, Serv Biostat & Informat Med, Paris, France; [Junien, Claudine] Univ Versailles St Quentin En Yvelines, Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Junien, C (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	claudine.junien@jouy.inra.fr	lesage, jean/R-5019-2018; Jouneau, Luc/AAC-4711-2020	lesage, jean/0000-0002-6329-1613; vieau, didier/0000-0002-3254-3662; Gabory, Anne/0000-0002-0059-7375	Fondation Coeur et Arteres (FCA) [05-T4]; Institut Benjamin Delessert; Agence Nationale pour la Recherche [ANR 06-PNRA-022-01]; Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab" OSEO-ISI	Fondation Coeur et Arteres (FCA); Institut Benjamin Delessert; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab" OSEO-ISI	This work was supported by the Fondation Coeur et Arteres (FCA No 05-T4), the Institut Benjamin Delessert, the Agence Nationale pour la Recherche (ANR 06-PNRA-022-01) and Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab" OSEO-ISI (18/12/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2011, PLACENTA, V32, pS81, DOI 10.1016/j.placenta.2010.12.019; Attig L, 2010, CURR OPIN CLIN NUTR, V13, P284, DOI 10.1097/MCO.0b013e328338aa61; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; BARKER DJP, 1992, EUR J CLIN NUTR, V46, pS3; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; BROWN MJ, 1987, AM J OBSTET GYNECOL, V156, P716, DOI 10.1016/0002-9378(87)90085-8; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Clifton VL, 2010, GROWTH HORM IGF RES, V20, P39, DOI 10.1016/j.ghir.2009.07.004; Clifton VL, 2009, AUST NZ J OBSTET GYN, V49, P619, DOI 10.1111/j.1479-828X.2009.01077.x; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Cross JC, 2006, NUTR REV, V64, pS12, DOI 10.1301/nr.may.S12-S18; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; de Carvalho Claudia Marcia Benedetto, 2005, J Mol Genet Med, V1, P63; Deplus R, 2002, NUCLEIC ACIDS RES, V30, P3831, DOI 10.1093/nar/gkf509; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Gabory A, 2011, AM J CLIN NUTR, V94, p1943S, DOI 10.3945/ajcn.110.000927; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gheorghe CP, 2009, PLACENTA, V30, P411, DOI 10.1016/j.placenta.2009.03.002; Gheorghe C, 2006, J SOC GYNECOL INVEST, V13, P256, DOI 10.1016/j.jsgi.2006.02.007; Gheorghe CP, 2010, INT J DEV BIOL, V54, P507, DOI 10.1387/ijdb.082770cg; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Hayes EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033370; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kokalj-Vokac N, 1998, CHROMOSOME RES, V6, P161, DOI 10.1023/A:1009299331871; Kulkarni A, 2010, DNA CELL BIOL; Lash GE, 2010, PLACENTA, V31, pS4, DOI 10.1016/j.placenta.2009.12.008; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Li N, 2008, P NATL ACAD SCI USA, V105, P17055, DOI 10.1073/pnas.0807765105; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; Lim AL, 2010, SEMIN CELL DEV BIOL, V21, P201, DOI 10.1016/j.semcdb.2009.10.008; Lu DS, 2001, CANCER RES, V61, P6755; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nathanielsz PW, 2007, OBSTET GYN CLIN N AM, V34, P201, DOI 10.1016/j.ogc.2007.03.006; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Reynolds LP, 2010, J ANIM SCI, V88, pE61, DOI 10.2527/jas.2009-2359; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sibley CP, 2010, PLACENTA, V31, pS70, DOI 10.1016/j.placenta.2009.12.020; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	70	134	136	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47986	10.1371/journal.pone.0047986	http://dx.doi.org/10.1371/journal.pone.0047986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144842	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400034
J	Toosizadeh, N; Nussbaum, MA; Bazrgari, B; Madigan, ML				Toosizadeh, Nima; Nussbaum, Maury A.; Bazrgari, Babak; Madigan, Michael L.			Load-Relaxation Properties of the Human Trunk in Response to Prolonged Flexion: Measuring and Modeling the Effect of Flexion Angle	PLOS ONE			English	Article							HUMAN LUMBAR SPINE; LOW-BACK-PAIN; STRESS-RELAXATION; IN-VIVO; MECHANICAL-PROPERTIES; SKELETAL-MUSCLE; NEUTRAL ZONE; INTERVERTEBRAL JOINTS; PASSIVE STIFFNESS; VERTEBRAL COLUMN	Experimental studies suggest that prolonged trunk flexion reduces passive support of the spine. To understand alterations of the synergy between active and passive tissues following such loadings, several studies have assessed the time-dependent behavior of passive tissues including those within spinal motion segments and muscles. Yet, there remain limitations regarding load-relaxation of the lumbar spine in response to flexion exposures and the influence of different flexion angles. Ten healthy participants were exposed for 16 min to each of five magnitudes of lumbar flexion specified relative to individual flexion-relaxation angles (i.e., 30, 40, 60, 80, and 100%), during which lumbar flexion angle and trunk moment were recorded. Outcome measures were initial trunk moment, moment drop, parameters of four viscoelastic models (i.e., Standard Linear Solid model, the Prony Series, Schapery's Theory, and the Modified Superposition Method), and changes in neutral zone and viscoelastic state following exposure. There were significant effects of flexion angle on initial moment, moment drop, changes in normalized neutral zone, and some parameters of the Standard Linear Solid model. Initial moment, moment drop, and changes in normalized neutral zone increased exponentially with flexion angle. Kelvin-solid models produced better predictions of temporal behaviors. Observed responses to trunk flexion suggest nonlinearity in viscoelastic properties, and which likely reflected viscoelastic behaviors of spinal (lumbar) motion segments. Flexion-induced changes in viscous properties and neutral zone imply an increase in internal loads and perhaps increased risk of low back disorders. Kelvin-solid models, especially the Prony Series model appeared to be more effective at modeling load-relaxation of the trunk.	[Toosizadeh, Nima; Nussbaum, Maury A.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA; [Nussbaum, Maury A.; Madigan, Michael L.] Virginia Tech, Dept Biomed Engn & Sci, Blacksburg, VA USA; [Bazrgari, Babak] Univ Kentucky, Dept Biomed Engn, Lexington, KY USA; [Madigan, Michael L.] Virginia Tech, Dept Engn Sci & Mech, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Kentucky; Virginia Polytechnic Institute & State University	Nussbaum, MA (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	nussbaum@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431; Madigan, Michael/0000-0002-4299-3851	Centers for Disease Control and Prevention (CDC) [R01-OH008504]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008504] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by award R01-OH008504 from the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BC, 1957, PROC R SOC SER B-BIO, V146, P281, DOI 10.1098/rspb.1957.0011; Adams MA, 1996, CLIN BIOMECH, V11, P194, DOI 10.1016/0268-0033(96)00002-2; ADAMS MA, 1995, CLIN BIOMECH, V10, P3, DOI 10.1016/0268-0033(95)90432-9; Ambrosetti-Giudici S, 2010, CLIN BIOMECH, V25, P97, DOI 10.1016/j.clinbiomech.2009.10.017; Arjmand N, 2005, SPINE, V30, P2637, DOI 10.1097/01.brs.0000187907.02910.4f; Bakker EWP, 2009, SPINE, V34, pE281, DOI 10.1097/BRS.0b013e318195b257; Bazrgari B., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P351, DOI 10.1080/10255840701436974; Bazrgari B, 2011, ERGONOMICS, V54, P1043, DOI 10.1080/00140139.2011.614357; BEST TM, 1994, J BIOMECH, V27, P413, DOI 10.1016/0021-9290(94)90017-5; Brereton LC, 1999, HUM MOVEMENT SCI, V18, P839, DOI 10.1016/S0167-9457(99)00043-3; Brown MD, 2002, SPINE, V27, P954, DOI 10.1097/00007632-200205010-00014; Burdorf A, 1997, SCAND J WORK ENV HEA, V23, P243, DOI 10.5271/sjweh.217; BURNS ML, 1984, J BIOMECH, V17, P113, DOI 10.1016/0021-9290(84)90129-5; Chaffin D.B., 1991, OCCUPATIONAL BIOMECH; Gay RE, 2006, CLIN BIOMECH, V21, P914, DOI 10.1016/j.clinbiomech.2006.04.009; GLANTZ SA, 1974, J BIOMECH, V7, P137, DOI 10.1016/0021-9290(74)90052-9; GREVEN K, 1976, PFLUG ARCH EUR J PHY, V362, P255, DOI 10.1007/BF00581178; Groth KM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2904464; Guan YB, 2007, J BIOMECH, V40, P1975, DOI 10.1016/j.jbiomech.2006.09.027; Hawkins D, 2009, J BIOMECH, V42, P2813, DOI 10.1016/j.jbiomech.2009.08.023; Hendershot B, 2011, CLIN BIOMECH, V26, P250, DOI 10.1016/j.clinbiomech.2010.09.019; Hult E, 1995, Proc Inst Mech Eng H, V209, P105, DOI 10.1243/PIME_PROC_1995_209_326_02; Jackson M, 2001, SPINE, V26, P715, DOI 10.1097/00007632-200104010-00003; KAZARIAN LE, 1975, ORTHOP CLIN N AM, V6, P3; KELLER TS, 1990, SPINE, V15, P751, DOI 10.1097/00007632-199008000-00004; Keller TS, 2002, J SPINAL DISORD TECH, V15, P312, DOI 10.1097/00024720-200208000-00009; Keller TS, 1999, J SPINAL DISORD, V12, P313; KOELLER W, 1986, J BIOMECH, V19, P807, DOI 10.1016/0021-9290(86)90131-4; KUMAR S, 1995, SPINE, V20, P160, DOI 10.1097/00007632-199501150-00006; LEHMAN SL, 1982, MATH BIOSCI, V62, P107, DOI 10.1016/0025-5564(82)90064-5; Linke WA, 2004, PHYS MED BIOL, V49, P3613, DOI 10.1088/0031-9155/49/16/009; Little JS, 2005, ANN BIOMED ENG, V33, P391, DOI 10.1007/s10439-005-1742-x; Luo WB, 2001, ACTA MECH SOLIDA SIN, V14, P195; Machiraju C, 2006, COMPUT METH PROG BIO, V83, P29, DOI 10.1016/j.cmpb.2006.05.004; Magnusson S. P., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P342; Magnusson SP, 1996, SCAND J MED SCI SPOR, V6, P323; Magnusson SP, 2000, MED SCI SPORT EXER, V32, P1160, DOI 10.1097/00005768-200006000-00020; McClure P, 1998, SPINE, V23, P216, DOI 10.1097/00007632-199801150-00013; McCook DT, 2009, J ELECTROMYOGR KINES, V19, P754, DOI 10.1016/j.jelekin.2007.11.002; MCGILL S, 1994, SPINE, V19, P696, DOI 10.1097/00007632-199403001-00009; McGill S, 2007, LOW BACK DISORDERS E; MCGILL SM, 1991, J ORTHOPAED RES, V9, P91, DOI 10.1002/jor.1100090112; MCGILL SM, 1992, CLIN BIOMECH, V7, P43, DOI 10.1016/0268-0033(92)90007-Q; Nussbaum MA, 1996, CLIN BIOMECH, V11, P25, DOI 10.1016/0268-0033(95)00031-3; OLIVER MJ, 1995, CLIN BIOMECH, V10, P363, DOI 10.1016/0268-0033(95)00001-2; Olson MW, 2009, J ELECTROMYOGR KINES, V19, P30, DOI 10.1016/j.jelekin.2007.06.011; OXLAND TR, 1992, J ORTHOP RES, V10, P573, DOI 10.1002/jor.1100100412; Panjabi MM, 2003, J ELECTROMYOGR KINES, V13, P371, DOI 10.1016/S1050-6411(03)00044-0; PANJABI MM, 1992, J SPINAL DISORD, V5, P390, DOI 10.1097/00002517-199212000-00002; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413, DOI 10.2106/00004623-199403000-00012; Parkinson RJ, 2004, CLIN BIOMECH, V19, P330, DOI 10.1016/j.clinbiomech.2004.01.002; Provenzano PP, 2002, BIOMECH MODEL MECHAN, V1, P45, DOI 10.1007/s10237-002-0004-1; Purslow PP, 1998, J EXP BIOL, V201, P135; Raschke U, 1996, J BIOMECH, V29, P1597, DOI 10.1016/S0021-9290(96)80011-X; Roy AL, 2003, J ELECTROMYOGR KINES, V13, P469, DOI 10.1016/S1050-6411(03)00060-9; Roylance D, 2001, ENG VISCOELASTICITY, V2139, P24; Ryan ED, 2012, SCAND J MED SCI SPOR, V22, P179, DOI 10.1111/j.1600-0838.2010.01285.x; Ryan ED, 2010, EUR J APPL PHYSIOL, V108, P207, DOI 10.1007/s00421-009-1284-2; SANJEEVI R, 1982, J BIOMECH, V15, P107, DOI 10.1016/0021-9290(82)90042-2; Sarver JJ, 2003, J BIOMECH ENG-T ASME, V125, P754, DOI 10.1115/1.1615247; Scannell JP, 2003, PHYS THER, V83, P907, DOI 10.1093/ptj/83.10.907; Shin G, 2007, CLIN BIOMECH, V22, P965, DOI 10.1016/j.clinbiomech.2007.06.003; Shin G, 2009, SPINE, V34, P1873, DOI 10.1097/BRS.0b013e3181aa6a55; Stokes IAF, 2003, J ELECTROMYOGR KINES, V13, P397, DOI 10.1016/S1050-6411(03)00046-4; Strganac TW, 1996, INT J SOLIDS STRUCT, V33, P4561, DOI 10.1016/0020-7683(95)00283-9; TAYLOR DC, 1990, AM J SPORT MED, V18, P300, DOI 10.1177/036354659001800314; Thompson RE, 2003, CLIN BIOMECH, V18, P89, DOI 10.1016/S0268-0033(02)00180-8; Thornton GM, 1997, J ORTHOPAED RES, V15, P652, DOI 10.1002/jor.1100150504; Toosizadeh N, 2010, IN VIVO LOAD RELAXAT; Troyer KL, 2011, ACTA BIOMATER, V7, P700, DOI 10.1016/j.actbio.2010.09.003; TRUONG XT, 1974, AM J PHYSIOL, V226, P256, DOI 10.1152/ajplegacy.1974.226.2.256; TWOMEY L, 1982, SPINE, V7, P116, DOI 10.1097/00007632-198203000-00005; TWOMEY LT, 1983, ARCH PHYS MED REHAB, V64, P322; YAHIA LH, 1991, J BIOMED ENG, V13, P399, DOI 10.1016/0141-5425(91)90021-X; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020; Youssef J, 2008, CLIN BIOMECH, V23, P870, DOI 10.1016/j.clinbiomech.2008.03.069	76	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48625	10.1371/journal.pone.0048625	http://dx.doi.org/10.1371/journal.pone.0048625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144913	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400058
J	Menoret, S; Fontaniere, S; Jantz, D; Tesson, L; Thinard, R; Remy, S; Usal, C; Ouisse, LH; Fraichard, A; Anegon, I				Menoret, Severine; Fontaniere, Sandra; Jantz, Derek; Tesson, Laurent; Thinard, Reynald; Remy, Severine; Usal, Claire; Ouisse, Laure-Helene; Fraichard, Alexandre; Anegon, Ignacio			Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases	FASEB JOURNAL			English	Article						rat immunology; transplantation; ZFNs; TALENs	KNOCKOUT RATS; EMBRYO MICROINJECTION; GENE; MECHANISMS; RECOMBINATION; TRANSGENESIS	Despite the recent availability of gene-specific nucleases, such as zinc-finger nucleases (ZFNs) and transcription activator-like nucleases (TALENs), there is still a need for new tools to modify the genome of different species in an efficient, rapid, and less costly manner. One aim of this study was to apply, for the first time, engineered meganucleases to mutate an endogenous gene in animal zygotes. The second aim was to target the mouse and rat recombination activating gene 1 (Rag1) to describe, for the first time, Rag1 knockout immunodeficient rats. We microinjected a plasmid encoding a meganuclease for Rag1 into the pronucleus of mouse and rat zygotes. Mutant animals were detected by PCR sequencing of the targeted sequence. A homozygous RAG1-deficient rat line was generated and immunophenotyped. Meganucleases were efficient, because 3.4 and 0.6% of mouse and rat microinjected zygotes, respectively, generated mutated animals. RAG1-deficient rats showed significantly decreased proportions and numbers of immature and mature T and B lymphocytes and normal NK cells vs. littermate wild-type controls. In summary, we describe the use of engineered meganucleases to inactivate an endogenous gene with efficiencies comparable to those of ZFNs and TALENs. Moreover, we generated an immunodeficient rat line useful for studies in which there is a need for biological parameters to be analyzed in the absence of immune responses.-Menoret, S., Fontaniere, S., Jantz, D., Tesson, L., Thinard, R., Remy, S., Usal, C., Ouisse, L.-H., Fraichard, A., Anegon, A. Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases. FASEB J. 27, 703-711 (2013). www.fasebj.org	[Menoret, Severine; Tesson, Laurent; Thinard, Reynald; Remy, Severine; Usal, Claire; Ouisse, Laure-Helene; Anegon, Ignacio] CNRS, INSERM, UMR 1064, Ctr Res Transplantat & Immunol & Platform Transge, Nantes, France; [Menoret, Severine; Tesson, Laurent; Thinard, Reynald; Remy, Severine; Usal, Claire; Ouisse, Laure-Helene; Anegon, Ignacio] CHU Nantes, ITUN, F-44093 Nantes, France; [Fontaniere, Sandra; Fraichard, Alexandre] genOway, Lyon, France; [Jantz, Derek] Precis Biosci, Durham, NC USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Anegon, I (corresponding author), CHU Nantes, INSERM, UMR 1064, 30 Blvd Jean Monnet, F-44093 Nantes, France.	ignacio.anegon@inserm.fr	Anegon, Ignacio/I-7498-2018; Anegon, Ignacio/I-7760-2018		Region Pays de la Loire; Biogenouest; Infrastructures en Biologie Sante et Agronomie	Region Pays de la Loire(Region Pays de la Loire); Biogenouest; Infrastructures en Biologie Sante et Agronomie	The authors acknowledge E. Corbett (Department of Immunobiology, Yale University, New Haven, CT, USA) for the gift of the anti-RAG1 monoclonal antibody. This work was funded in part by Region Pays de la Loire, Biogenouest, and Infrastructures en Biologie Sante et Agronomie. D.J. is an employee and shareholder of Precision BioSciences, Inc.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Chu XY, 2012, MOL PHARMACOL, V81, P220, DOI 10.1124/mol.111.074179; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Guillot C, 2000, J IMMUNOL, V164, P5258, DOI 10.4049/jimmunol.164.10.5258; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Menoret S, 2010, EUR J IMMUNOL, V40, P2932, DOI 10.1002/eji.201040939; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840; Nguyen TH, 2009, CURR GENE THER, V9, P136, DOI 10.2174/156652309787909481; ONO K, 1972, TRANSPLANTATION, V14, P137; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Petrie-Hanson L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-8; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Remy S, 2010, TRANSGENIC RES, V19, P363, DOI 10.1007/s11248-009-9323-7; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yamamoto S, 2012, TRANSGENIC RES, V21, P743, DOI 10.1007/s11248-011-9564-0	31	73	77	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					703	711		10.1096/fj.12-219907	http://dx.doi.org/10.1096/fj.12-219907			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23150522				2022-12-25	WOS:000314358000029
J	Orth, JHC; Fester, I; Siegert, P; Weise, M; Lanner, U; Kamitani, S; Tachibana, T; Wilson, BA; Schlosser, A; Horiguchi, Y; Aktories, K				Orth, Joachim H. C.; Fester, Ines; Siegert, Peter; Weise, Markus; Lanner, Ulrike; Kamitani, Shigeki; Tachibana, Taro; Wilson, Brenda A.; Schlosser, Andreas; Horiguchi, Yasuhiko; Aktories, Klaus			Substrate specificity of Pasteurella multocida toxin for alpha subunits of heterotrimeric G proteins	FASEB JOURNAL			English	Article						PMT; GTPase domain; helical domain; deamidation; oncogene	HELICAL DOMAIN; CRYSTAL-STRUCTURE; MITOGENIC TOXIN; ACTIVATION; CANCER; GTPASE; GROWTH; RHOA; G-ALPHA(13); INVOLVEMENT	Pasteurella multocida is the causative agent of a number of epizootic and zoonotic diseases. Its major virulence factor associated with atrophic rhinitis in animals and dermonecrosis in bite wounds is P. multocida toxin (PMT). PMT stimulates signal transduction pathways downstream of heterotrimeric G proteins, leading to effects such as mitogenicity, blockade of apoptosis, or inhibition of osteoblast differentiation. On the basis of G alpha(i2), it was demonstrated that the toxin deamidates an essential glutamine residue of the G alpha(i2) subunit, leading to constitutive activation of the G protein. Here, we studied the specificity of PMT for its G-protein targets by mass spectrometric analyses and by utilizing a monoclonal antibody, which recognizes specifically G proteins deamidated by PMT. The studies revealed deamidation of 3 of 4 families of heterotrimeric G proteins (G alpha(q/11), G alpha(i1,2,3), and G alpha(12/13) of mouse or human origin) by PMT but not by a catalytic inactive toxin mutant. With the use of G-protein fragments and chimeras of responsive or unresponsive G proteins, the structural basis for the discrimination of heterotrimeric G proteins was studied. Our results elucidate substrate specificity of PMT on the molecular level and provide evidence for the underlying structural reasons of substrate discrimination.-Orth, J. H. C., Fester, I., Siegert, P., Weise, M., Lanner, U., Kamitani, S., Tachibana, T, Wilson, B. A., Schlosser, A., Horiguchi, Y., Aktories, K. Substrate specificity of Pasteurella multocida toxin for alpha subunits of heterotrimeric G proteins. FASEB J. 27, 832-842 (2013). www.fasebj.org	[Orth, Joachim H. C.; Fester, Ines; Siegert, Peter; Weise, Markus; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79106 Freiburg, Germany; [Lanner, Ulrike; Schlosser, Andreas] Univ Freiburg, Zentrum Biosyst Anal, D-79106 Freiburg, Germany; [Kamitani, Shigeki; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Suita, Osaka 565, Japan; [Tachibana, Taro] Osaka City Univ, Grad Sch Engn, Dept Bioengn, Osaka, Japan; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Freiburg; University of Freiburg; Osaka University; Osaka Metropolitan University; University of Illinois System; University of Illinois Urbana-Champaign	Orth, JHC (corresponding author), Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	joachim.orth@pharmakol.uni-freiburg.de; klaus.aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Kamitani, Shigeki/0000-0002-1268-4652	Deutsche Forschungsgemeinschaft [SFB 746]; U.S. National Institutes of Health [R01-AI-038936]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038396] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was financially supported by the Deutsche Forschungsgemeinschaft, SFB 746 (to J.O. and K. A.), and U.S. National Institutes of Health grant R01-AI-038936 (to B. A. W.). The authors thank Dr. S. Offermanns (Max-Planck-Institut fur Herz- und Lungenforschung, Bad Nauheim, Germany) for the kind gift of G alpha<INF>q/11</INF>-deficient cells and Silke Fieber and Petra Bartholome for excellent technical assistance. The authors thank Dr. Mengfei Ho and Dr. Shuhong Luo (University of Illinois at Urbana-Champaign, Urbana, IL, USA) for construction of the plasmids containing flag-tagged G alpha proteins.	Aminova LR, 2008, PROTEIN SCI, V17, P945, DOI 10.1110/ps.083445408; Aminova LR, 2007, CELL MICROBIOL, V9, P2485, DOI 10.1111/j.1462-5822.2007.00975.x; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Busch C, 2001, INFECT IMMUN, V69, P3628, DOI 10.1128/IAI.69.6.3628-3634.2001; Dohlman HG, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003013; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Entschladen F, 2011, CELL CYCLE, V10, P1086, DOI 10.4161/cc.10.7.15208; Gudermann T, 2000, N-S ARCH PHARMACOL, V361, P345, DOI 10.1007/s002109900208; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hildebrand D, 2010, CELL MICROBIOL, V12, P1732, DOI 10.1111/j.1462-5822.2010.01504.x; Kamitani S, 2011, FEBS J, V278, P2702, DOI 10.1111/j.1742-4658.2011.08197.x; Kamitani S, 2010, J BIOL CHEM, V285, P25467, DOI 10.1074/jbc.M110.102285; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Kreutz B, 2007, CELL SIGNAL, V19, P1681, DOI 10.1016/j.cellsig.2007.03.004; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130; Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0; Lax AJ, 2001, INT J MED MICROBIOL, V291, P261, DOI 10.1078/1438-4221-00129; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2004, J BIOL CHEM, V279, P34150, DOI 10.1074/jbc.M405353200; Orth JHC, 2003, BIOCHEMISTRY-US, V42, P4971, DOI 10.1021/bi0272959; Orth JHC, 2008, J BIOL CHEM, V283, P23288, DOI 10.1074/jbc.M803435200; Orth JHC, 2007, CELL SIGNAL, V19, P2174, DOI 10.1016/j.cellsig.2007.06.016; Orth JHC, 2007, J BIOL CHEM, V282, P3050, DOI 10.1074/jbc.M609018200; Orth JHC, 2010, TOXINS, V2, P205, DOI 10.3390/toxins2020205; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Preuss I, 2010, CELL MICROBIOL, V12, P1174, DOI 10.1111/j.1462-5822.2010.01462.x; Pullinger GD, 2001, INFECT IMMUN, V69, P7839, DOI 10.1128/IAI.69.12.7839-7850.2001; Pullinger Gillian D, 2007, Open Biochem J, V1, P7, DOI 10.2174/1874091X00701010007; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Seo B, 2000, J BIOL CHEM, V275, P2239, DOI 10.1074/jbc.275.3.2239; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Ward PN, 1998, INFECT IMMUN, V66, P5636, DOI 10.1128/IAI.66.12.5636-5642.1998; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Wilson BA, 2000, INFECT IMMUN, V68, P4531, DOI 10.1128/IAI.68.8.4531-4538.2000; Wilson BA, 1997, J BIOL CHEM, V272, P1268, DOI 10.1074/jbc.272.20.12961; Wilson BA, 2010, FUTURE MICROBIOL, V5, P1185, DOI [10.2217/fmb.10.91, 10.2217/FMB.10.91]; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	52	30	33	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					832	842		10.1096/fj.12-213900	http://dx.doi.org/10.1096/fj.12-213900			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23150526	Green Published			2022-12-25	WOS:000314358000041
J	Boundy, S; Safo, MK; Wang, L; Musayev, FN; O'Farrell, HC; Rife, JP; Archer, GL				Boundy, Sam; Safo, Martin K.; Wang, Lei; Musayev, Faik N.; O'Farrell, Heather C.; Rife, Jason P.; Archer, Gordon L.			Characterization of the Staphylococcus aureus rRNA Methyltransferase Encoded by orfX, the Gene Containing the Staphylococcal Chromosome Cassette mec (SCCmec) Insertion Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHICILLIN RESISTANCE; CRYSTAL-STRUCTURE; CALORIMETRY; PROTEINS; YBEA	The gene orfX is conserved among all staphylococci, and its complete sequence is maintained upon insertion of the staphylococcal chromosome cassette mec (SCCmec) genomic island, containing the gene encoding resistance to beta-lactam antibiotics (mecA), into its C terminus. The function of OrfX has not been determined. We show that OrfX was constitutively produced during growth, that orfX could be inactivated without altering bacterial growth, and that insertion of SCCmec did not alter gene expression. We solved the crystal structure of OrfX at 1.7 angstrom and found that it belongs to the S-adenosyl-L-methionine (AdoMet)-dependent alpha/beta-knot superfamily of SPOUT methyltransferases (MTases), with a high structural homology to YbeA, the gene product of the Escherichia coli 70 S ribosomal MTase RlmH. MTase activity was confirmed by demonstrating the OrfX-dependent methylation of the Staphylococcus aureus 70 S ribosome. When OrfX was crystallized in the presence of its AdoMet substrate, we found that each monomer of the homodimeric structure bound AdoMet in its active site. Solution studies using isothermal titration calorimetry confirmed that each monomer bound AdoMet but with different binding affinities (K-d = 52 +/- 0.4 and 606 +/- 2 mu M). In addition, the structure shows that the AdoMet-binding pocket, formed by a deep trefoil knot, contains a bound phosphate molecule, which is the likely nucleotide methylation site. This study represents the first characterization of a staphylococcal ribosomal MTase and provides the first crystal structure of a member of the alpha/beta-knot superfamily of SPOUT MTases in the RlmH or COG1576 family with bound AdoMet.	[Boundy, Sam; Wang, Lei; Archer, Gordon L.] Virginia Commonwealth Univ, Div Infect Dis, Dept Med, Richmond, VA 23298 USA; [O'Farrell, Heather C.; Rife, Jason P.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA; [Safo, Martin K.; Musayev, Faik N.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Archer, GL (corresponding author), Virginia Commonwealth Univ, Div Infect Dis, Dept Med, Sanger Hall,Rm 1-018,POB 980565,1101 E Marshall S, Richmond, VA 23298 USA.	garcher@vcu.edu	Wang, Lei/F-4512-2012; Safo, Martin/AAJ-9833-2020; Musayev, Faik/AAY-2010-2020	Boundy, Sam/0000-0003-0541-1776	National Institutes of Health from NIAID [2R01 AI035705]; National Institutes of Health from NCI [CA 16059-28]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035705] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 AI035705 from NIAID (to G. L. A.).; The structural biology resources were supported in part by National Institutes of Health Grant CA 16059-28 from NCI to the Virginia Commonwealth University Massey Cancer Center.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Chen HY, 2010, J MOL CELL BIOL, V2, P366, DOI 10.1093/jmcb/mjq034; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ero R, 2008, RNA, V14, P2223, DOI 10.1261/rna.1186608; Farrar CE, 2005, J NUTR BIOCHEM, V16, P554, DOI 10.1016/j.jnutbio.2005.02.004; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Li JN, 1999, RNA, V5, P395, DOI 10.1017/S1355838299980834; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; McGhee GC, 2011, PHYTOPATHOLOGY, V101, P192, DOI 10.1094/PHYTO-04-10-0128; Niemeyer DM, 1996, J BACTERIOL, V178, P5464, DOI 10.1128/jb.178.18.5464-5471.1996; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; Purta E, 2008, RNA, V14, P2234, DOI 10.1261/rna.1198108; Sass P, 2012, J BACTERIOL, V194, P2107, DOI 10.1128/JB.06631-11; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Wang L, 2012, J BACTERIOL, V194, P486, DOI 10.1128/JB.05047-11	24	44	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					132	140		10.1074/jbc.M112.385138	http://dx.doi.org/10.1074/jbc.M112.385138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150671	Green Published, hybrid			2022-12-25	WOS:000313197200013
J	Cooper, I; Sasson, K; Teichberg, VI; Schnaider-Beeri, M; Fridkin, M; Shechter, Y				Cooper, Itzik; Sasson, Keren; Teichberg, Vivian I.; Schnaider-Beeri, Michal; Fridkin, Mati; Shechter, Yoram			Peptide Derived from HIV-1 TAT Protein Destabilizes a Monolayer of Endothelial Cells in an in Vitro Model of the Blood-Brain Barrier and Allows Permeation of High Molecular Weight Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL CHARACTERIZATION; TIGHT JUNCTIONS; DELIVERY; PERMEABILITY; TRANSDUCTION; EXPRESSION; ASSIGNMENT; DOMAIN; VIVO	Most chemotherapeutic agents are blood-brain barrier (BBB) impermeants. HIV-1-derived TAT protein variants contain a transmembrane domain, which may enable them to cross the BBB and reach the brain. Here we synthesized CAYGRK-KRRQRRR, a peptide containing a cysteine moiety attached to the N terminus of the transmembrane domain (C-TAT peptide), and studied its effects in an in vitro BBB model, which we found to reflect penetration by a receptor-independent pathway. Incubation of the brain capillary endothelial cell monolayer with 0.3-0.6 mu mol/ml of this C-TAT peptide, for a period of 1-2 h, destabilizes brain capillary endothelial cell monolayer and introduces the ability of impermeant therapeutic agents including high molecular weight proteins to penetrate it substantially. The cysteinyl moiety at position 1 of the C-TAT peptide contributes largely to the destabilizing potency and the penetration efficacy of impermeant substances. The destabilizing effect was reversed using heparin. In summary, experimental conditions allowing a significant increase in entry of impermeant low and high molecular weight substances from the luminal (blood) to the abluminal side (brain) were found in an in vitro BBB model reflecting in vivo protein penetrability by a receptor-independent pathway.	[Cooper, Itzik; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sasson, Keren; Shechter, Yoram] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Fridkin, Mati] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Cooper, Itzik; Schnaider-Beeri, Michal] Sheba Med Ctr, Sagol Neurosci Ctr, IL-52621 Ramat Gan, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center	Cooper, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	itzik.cooper@sheba.health.gov.il; mati.fridkin@weizmann.ac.il; yoram.shechter@weizmann.ac.il		cooper, itzik/0000-0003-0723-5542	Weizmann Institute of Science-Sheba Medical Center grant for Biomedical Research	Weizmann Institute of Science-Sheba Medical Center grant for Biomedical Research	This work was supported by a joint Weizmann Institute of Science-Sheba Medical Center grant for Biomedical Research.	Abbott NJ, 2008, CURR DRUG METAB, V9, P901, DOI 10.2174/138920008786485182; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Banks WA, 2005, EXP NEUROL, V193, P218, DOI 10.1016/j.expneurol.2004.11.019; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Brown RC, 2004, BRAIN RES, V1014, P221, DOI 10.1016/j.brainres.2004.04.034; Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Cooper I, 2011, J NEUROCHEM, V116, P467, DOI 10.1111/j.1471-4159.2010.06934.x; Dakwar GR, 2012, J CONTROL RELEASE, V160, P315, DOI 10.1016/j.jconrel.2011.12.042; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Doolittle N D, 1998, J Neurosci Nurs, V30, P81; Doolittle ND, 2007, J NEURO-ONCOL, V81, P81, DOI 10.1007/s11060-006-9209-y; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gregoire C, 2001, BIOPOLYMERS, V62, P324, DOI 10.1002/bip.10000; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Huber JD, 2002, AM J PHYSIOL-HEART C, V283, pH1531, DOI 10.1152/ajpheart.00027.2002; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Jarajapu YPR, 2005, J GENE MED, V7, P908, DOI 10.1002/jgm.738; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pardridge WM, 2008, BIOCONJUGATE CHEM, V19, P1327, DOI 10.1021/bc800148t; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; RUTTEN MJ, 1987, BRAIN RES, V425, P301, DOI 10.1016/0006-8993(87)90513-0; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shechter Y, 2002, J MED CHEM, V45, P4264, DOI 10.1021/jm020042t; STONE LA, 1995, NEUROLOGY, V45, P1122, DOI 10.1212/WNL.45.6.1122; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; YANG GY, 1994, STROKE, V25, P1658, DOI 10.1161/01.STR.25.8.1658; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6	36	19	25	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44676	44683		10.1074/jbc.M112.395384	http://dx.doi.org/10.1074/jbc.M112.395384			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150670	hybrid, Green Published			2022-12-25	WOS:000312938600063
J	Fredebohm, J; Boettcher, M; Eisen, C; Gaida, MM; Heller, A; Keleg, S; Tost, J; Greulich-Bode, KM; Hotz-Wagenblatt, A; Lathrop, M; Giese, NA; Hoheisel, JD				Fredebohm, Johannes; Boettcher, Michael; Eisen, Christian; Gaida, Matthias M.; Heller, Anette; Keleg, Shereen; Tost, Joerg; Greulich-Bode, Karin M.; Hotz-Wagenblatt, Agnes; Lathrop, Mark; Giese, Nathalia A.; Hoheisel, Joerg D.			Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DUCTAL ADENOCARCINOMAS; EPITHELIAL-CELLS; INVASION; MARKER; GENE; GEMCITABINE; EXPRESSION; MUTATIONS; VARIANTS	Standard cancer cell lines do not model the intratumoural heterogeneity situation sufficiently. Clonal selection leads to a homogeneous population of cells by genetic drift. Heterogeneity of tumour cells, however, is particularly critical for therapeutically relevant studies, since it is a prerequisite for acquiring drug resistance and reoccurrence of tumours. Here, we report the isolation of a highly tumourigenic primary pancreatic cancer cell line, called JoPaca-1 and its detailed characterization at multiple levels. Implantation of as few as 100 JoPaca-1 cells into immunodeficient mice gave rise to tumours that were histologically very similar to the primary tumour. The high heterogeneity of JoPaca-1 was reflected by diverse cell morphology and a substantial number of chromosomal aberrations. Comparative whole-genome sequencing of JoPaca-1 and BxPC-3 revealed mutations in genes frequently altered in pancreatic cancer. Exceptionally high expression of cancer stem cell markers and a high clonogenic potential in vitro and in vivo was observed. All of these attributes make this cell line an extremely valuable model to study the biology of and pharmaceutical effects on pancreatic cancer.	[Fredebohm, Johannes; Boettcher, Michael; Eisen, Christian; Greulich-Bode, Karin M.; Hotz-Wagenblatt, Agnes; Hoheisel, Joerg D.] German Canc Res Ctr, Heidelberg, Germany; [Gaida, Matthias M.] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Heller, Anette; Keleg, Shereen; Giese, Nathalia A.] Univ Heidelberg Hosp, European Pancreas Ctr, Heidelberg, Germany; [Tost, Joerg; Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, Evry, France	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; CEA; UDICE-French Research Universities; Universite Paris Saclay	Fredebohm, J (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	J.Fredebohm@dkfz-heidelberg.de	Tost, Joerg/H-7129-2019	Tost, Joerg/0000-0002-2683-0817; Boettcher, Michael/0000-0003-0986-4465	German Ministry of Education and Research (BMBF) as part of the NGFN PaCaNet consortium [BMBF-01GS08117]	German Ministry of Education and Research (BMBF) as part of the NGFN PaCaNet consortium	The work was financially supported by the German Ministry of Education and Research (BMBF) as part of the NGFN PaCaNet consortium (BMBF-01GS08117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdani MSS, 2012, J PROTEOMICS, V75, P3747, DOI 10.1016/j.jprot.2012.04.042; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Argani P, 2001, CLIN CANCER RES, V7, P3862; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Beesley J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024987; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bhagwandin VJ, 2009, BBA-MOL BASIS DIS, V1792, P248, DOI 10.1016/j.bbadis.2009.02.007; Chari ST, 2007, SEMIN ONCOL, V34, P284, DOI 10.1053/j.seminoncol.2007.05.005; Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2; Czekanska EM, 2011, METHODS MOL BIOL, V740, P27, DOI 10.1007/978-1-61779-108-6_5; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diergaarde B, 2010, PANCREATOLOGY, V10, P194, DOI 10.1159/000236023; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Du ZY, 2011, DIGEST DIS SCI, V56, P741, DOI 10.1007/s10620-010-1340-0; Eisold S, 2004, CANCER-AM CANCER SOC, V100, P1978, DOI 10.1002/cncr.20193; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Furukawa T, 1996, AM J PATHOL, V148, P1763; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaviraghi M, 2011, BIOSCIENCE REP, V31, P45, DOI 10.1042/BSR20100018; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Greer JB, 2007, GUT, V56, P601, DOI 10.1136/gut.2006.101220; Greulich-Bode Karin M., 2009, P183, DOI 10.1007/978-3-540-70581-9_18; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hayashi T, 2012, CANCER SCI, V103, P889, DOI 10.1111/j.1349-7006.2012.02235.x; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hu G, 2012, INT J ONCOL, V40, P798, DOI 10.3892/ijo.2011.1254; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Innocenti F, 2012, CLIN CANCER RES, V18, P577, DOI 10.1158/1078-0432.CCR-11-1387; Jain R, 2010, APPL IMMUNOHISTO M M, V18, P9, DOI 10.1097/PAI.0b013e3181ad36ea; Jhala N, 2006, AM J CLIN PATHOL, V126, P572, DOI 10.1309/CEV30BE088CBDQD9; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kahlert C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-275; Kato N, 2012, CYTOPATHOLOGY, V23, P120, DOI 10.1111/j.1365-2303.2011.00847.x; Kern SE, 2011, J PATHOL, V223, P295, DOI 10.1002/path.2813; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Klein AP, 2009, CANCER EPIDEM BIOMAR, V18, P1328, DOI 10.1158/1055-9965.EPI-09-0056; Kloppel Gunter, 2004, Curr Gastroenterol Rep, V6, P111, DOI 10.1007/s11894-004-0037-y; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; Lee AJ, 2011, BIOCHEM PHARMACOL, V83, P1013; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lee HJ, 2011, J KOREAN SURG SOC, V81, P263, DOI 10.4174/jkss.2011.81.4.263; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lehnert L, 1999, ANN NY ACAD SCI, V880, P83, DOI 10.1111/j.1749-6632.1999.tb09512.x; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meng YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-61; Moriyama T, 2010, CANCER-AM CANCER SOC, V116, P3357, DOI 10.1002/cncr.25121; Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rasheed Zeshaan, 2010, J Vis Exp, DOI 10.3791/2169; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rizzato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027921; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Tamura K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000179; Ulrich AB, 2002, PANCREAS, V24, P111, DOI 10.1097/00006676-200203000-00001; University JH, 2012, ONL MEND INH MAN OMI; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Vizio B, 2012, ONCOL REP, V27, P69, DOI 10.3892/or.2011.1461; Wang XX, 2011, PATHOL ONCOL RES, V17, P429, DOI 10.1007/s12253-010-9316-0; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Watanabe Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023320; Welsch T, 2009, CLIN EXP METASTAS, V26, P701, DOI 10.1007/s10585-009-9269-4; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250	80	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48503	10.1371/journal.pone.0048503	http://dx.doi.org/10.1371/journal.pone.0048503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152778	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000018
J	Koyuncu, CF; Arslan, S; Durmaz, I; Cetin-Atalay, R; Gunduz-Demir, C				Koyuncu, Can Fahrettin; Arslan, Salim; Durmaz, Irem; Cetin-Atalay, Rengul; Gunduz-Demir, Cigdem			Smart Markers for Watershed-Based Cell Segmentation	PLOS ONE			English	Article							UNSUPERVISED SEGMENTATION; AUTOMATED SEGMENTATION; PHASE IDENTIFICATION; NUCLEI; TRACKING; IMAGES; CLASSIFICATION	Automated cell imaging systems facilitate fast and reliable analysis of biological events at the cellular level. In these systems, the first step is usually cell segmentation that greatly affects the success of the subsequent system steps. On the other hand, similar to other image segmentation problems, cell segmentation is an ill-posed problem that typically necessitates the use of domain-specific knowledge to obtain successful segmentations even by human subjects. The approaches that can incorporate this knowledge into their segmentation algorithms have potential to greatly improve segmentation results. In this work, we propose a new approach for the effective segmentation of live cells from phase contrast microscopy. This approach introduces a new set of "smart markers'' for a marker-controlled watershed algorithm, for which the identification of its markers is critical. The proposed approach relies on using domain-specific knowledge, in the form of visual characteristics of the cells, to define the markers. We evaluate our approach on a total of 1,954 cells. The experimental results demonstrate that this approach, which uses the proposed definition of smart markers, is quite effective in identifying better markers compared to its counterparts. This will, in turn, be effective in improving the segmentation performance of a marker-controlled watershed algorithm.	[Koyuncu, Can Fahrettin; Arslan, Salim; Gunduz-Demir, Cigdem] Bilkent Univ, Dept Comp Engn, Ankara, Turkey; [Durmaz, Irem; Cetin-Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University	Gunduz-Demir, C (corresponding author), Bilkent Univ, Dept Comp Engn, Ankara, Turkey.	gunduz@cs.bilkent.edu.tr	Koyuncu, Can Fahrettin/Q-8676-2019; Cetin-Atalay, Rengul/O-9826-2014; Cetin-Atalay, Rengul/F-5780-2013; Sahin, Irem Durmaz/A-3501-2019	Koyuncu, Can Fahrettin/0000-0001-5990-2226; Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; Sahin, Irem Durmaz/0000-0001-5037-7883; Arslan, Salim/0000-0002-4329-0947	Scientific and Technological Research Council of Turkey [TUBITAK 109E206]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the Scientific and Technological Research Council of Turkey under the project number TUBITAK 109E206. http://www.tubitak.gov.tr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga PSU, 2001, PATTERN RECOGN, V34, P1449, DOI 10.1016/S0031-3203(00)00076-5; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cheng JR, 2009, IEEE T BIO-MED ENG, V56, P741, DOI 10.1109/TBME.2008.2008635; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Harder N, 2006, LECT NOTES COMPUT SC, V4190, P840; Jung C, 2010, IEEE T BIO-MED ENG, V57, P2825, DOI 10.1109/TBME.2010.2060486; Jung C, 2010, IEEE T BIO-MED ENG, V57, P2600, DOI 10.1109/TBME.2010.2060336; Kayser G, 2006, ANAL QUANT CYTOL, V28, P27; Kayser K, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-6; Lin G, 2005, CYTOM PART A, V63A, P20, DOI 10.1002/cyto.a.20099; Lindblad J, 2004, CYTOM PART A, V57A, P22, DOI 10.1002/cyto.a.10107; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park M., 2009, P 1 INT C INT MULT C, P53; Plissiti ME, 2011, PATTERN RECOGN LETT, V32, P838, DOI 10.1016/j.patrec.2011.01.008; Tosun AB, 2009, PATTERN RECOGN, V42, P1104, DOI 10.1016/j.patcog.2008.07.007; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wang M, 2008, BIOINFORMATICS, V24, P94, DOI 10.1093/bioinformatics/btm530; Xiong GL, 2006, IEEE T CIRCUITS-I, V53, P2415, DOI 10.1109/TCSI.2006.884461; Yang XD, 2006, IEEE T CIRCUITS-I, V53, P2405, DOI 10.1109/TCSI.2006.884469; Zhang B, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P476; Zhou H, 2005, P ANN INT IEEE EMBS, P6484; Zhou XB, 2009, IEEE T INF TECHNOL B, V13, P152, DOI 10.1109/TITB.2008.2007098; Zimmer C, 2002, IEEE T MED IMAGING, V21, P1212, DOI 10.1109/TMI.2002.806292	24	27	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48664	10.1371/journal.pone.0048664	http://dx.doi.org/10.1371/journal.pone.0048664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152792	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000025
J	Liang, SN; Borondo, F; Lan, BL				Liang, Shiuan-Ni; Borondo, Florentino; Lan, Boon Leong			Newtonian versus Special-Relativistic Statistical Predictions for Low-Speed Scattering	PLOS ONE			English	Article							ARNOLD DIFFUSION; DIMENSIONS; SYSTEMS	The statistical predictions of Newtonian and special-relativistic mechanics, which are calculated from an initially Gaussian ensemble of trajectories, are compared for a low-speed scattering system. The comparisons are focused on the mean dwell time, transmission and reflection coefficients, and the position and momentum means and standard deviations. We find that the statistical predictions of the two theories do not always agree as conventionally expected. The predictions are close if the scattering is non-chaotic but they are radically different if the scattering is chaotic and the initial ensemble is well localized in phase space. Our result indicates that for low-speed chaotic scattering, special-relativistic mechanics must be used, instead of the standard practice of using Newtonian mechanics, to obtain empirically-correct statistical predictions from an initially well-localized Gaussian ensemble.	[Liang, Shiuan-Ni; Lan, Boon Leong] Monash Univ, Sch Sci, Selangor, Malaysia; [Borondo, Florentino] Univ Autonoma Madrid, Dept Quim, E-28049 Madrid, Spain; [Borondo, Florentino] Univ Autonoma Madrid, Inst Mixto Ciencias Matemat CSIC UAM UCM UC3M, Madrid, Spain	Monash University; Monash University Sunway; Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Matematicas (ICMAT)	Lan, BL (corresponding author), Monash Univ, Sch Sci, Selangor, Malaysia.	lan.boon.leong@monash.edu	Borondo, Florentino/ABF-4253-2021	Borondo, Florentino/0000-0003-3094-8911; Liang, Shiuan-Ni/0000-0001-9953-339X	Fundamental Research Grant Scheme [FRGS/2/2010/ST/MUSM/02/1]	Fundamental Research Grant Scheme	This work was supported by a Fundamental Research Grant Scheme, FRGS/2/2010/ST/MUSM/02/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy Y, 2000, DISCRETE DYN NAT SOC, V4, P283, DOI 10.1155/S1026022600000261; Ball P, 2004, NATURE, V427, P482, DOI 10.1038/427482a; Beeker A, 1993, CHAOS, V3, P487, DOI 10.1063/1.165954; Cho A, 2005, SCIENCE, V307, P866, DOI 10.1126/science.307.5711.866; French A. P., 1968, SPECIAL RELATIVITY; Hartle J.B., 2003, GRAVITY INTRO EINSTE; Horwitz LP, 2000, DISCRETE DYN NAT SOC, V4, P77, DOI 10.1155/S1026022600000078; KARIMABADI H, 1989, PHYS REV LETT, V62, P2342, DOI 10.1103/PhysRevLett.62.2342; Lai Y. C., 2010, TRANSIENT CHAOS; Lan BL, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036201; Lan BL, 2010, COMMUN NONLINEAR SCI, V15, P2497, DOI 10.1016/j.cnsns.2009.10.008; Lan BL, 2009, CHAOS SOLITON FRACT, V42, P534, DOI 10.1016/j.chaos.2009.01.021; Lan BL, 2006, CHAOS, V16, DOI 10.1063/1.2218379; Liang SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036430; LONGCOPE DW, 1987, PHYS REV LETT, V59, P1500, DOI 10.1103/PhysRevLett.59.1500; Matrasulov DU, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016213; Matrasulov DU, 1999, PHYS REV A, V60, P700, DOI 10.1103/PhysRevA.60.700; McComb W. D., 1999, DYNAMICS RELATIVITY; Pospelov M, 2004, PHYS TODAY, V57, P40, DOI 10.1063/1.1784301	19	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48447	10.1371/journal.pone.0048447	http://dx.doi.org/10.1371/journal.pone.0048447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152774	Green Published, gold, Green Submitted			2022-12-25	WOS:000311234000015
J	Yoshimura, S; Isobe, N; Yonekawa, T; Matsushita, T; Masaki, K; Sato, S; Kawano, Y; Yamamoto, K; Kira, J				Yoshimura, Satoshi; Isobe, Noriko; Yonekawa, Tomomi; Matsushita, Takuya; Masaki, Katsuhisa; Sato, Shinya; Kawano, Yuji; Yamamoto, Ken; Kira, Jun-ichi		S Japan Multiple Sclerosis Genetic	Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; ANTI-AQUAPORIN-4 ANTIBODY; ENVIRONMENTAL-FACTORS; NEUROMYELITIS-OPTICA; DIAGNOSTIC-CRITERIA; ALLELES CORRELATE; DISEASE-ACTIVITY; HLA-A; RISK; HETEROGENEITY	Background: Nationwide surveys conducted in Japan over the past thirty years have revealed a four-fold increase in the estimated number of multiple sclerosis (MS) patients, a decrease in the age at onset, and successive increases in patients with conventional MS, which shows an involvement of multiple sites in the central nervous system, including the cerebrum and cerebellum. We aimed to clarify whether genetic and infectious backgrounds correlate to distinct disease phenotypes of MS in Japanese patients. Methodology/Principal Findings: We analyzed HLA-DRB1 and -DPB1 alleles, and IgG antibodies specific for Helicobacter pylori, Chlamydia pneumoniae, varicella zoster virus, and Epstein-Barr virus nuclear antigen (EBNA) in 145 MS patients and 367 healthy controls (HCs). Frequencies of DRB1*0405 and DPB1*0301 were significantly higher, and DRB1*0901 and DPB1*0401 significantly lower, in MS patients as compared with HCs. MS patients with DRB1*0405 had a significantly earlier age of onset and lower Progression Index than patients without this allele. The proportion and absolute number of patients with DRB1*0405 successively increased with advancing year of birth. In MS patients without DRB1*0405, the frequency of the DRB1*1501 allele was significantly higher, while the DRB1*0901 allele was significantly lower, compared with HCs. Furthermore, DRB1*0405-negative MS patients were significantly more likely to be positive for EBNA antibodies compared with HCs. Conclusions: Our study suggests that MS patients harboring DRB1*0405, a genetic risk factor for MS in the Japanese population, have a younger age at onset and a relatively benign disease course, while DRB1*0405-negative MS patients have features similar to Western-type MS in terms of association with Epstein-Barr virus infection and DRB1*1501. The recent increase of MS in young Japanese people may be caused, in part, by an increase in DRB1*0405-positive MS patients. Citation: Yoshimura S, Isobe N, Yonekawa T, Matsushita T, Masaki K, et al. (2012) Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients. PLoS ONE 7(11): e48592. doi:10.1371/journal.pone.0048592	[Yoshimura, Satoshi; Isobe, Noriko; Yonekawa, Tomomi; Masaki, Katsuhisa; Sato, Shinya; Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Matsushita, Takuya] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Clin Neuroimmunol, Fukuoka 812, Japan; [Kawano, Yuji] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Matsuyama, Ehime 790, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal, Fukuoka 812, Japan	Kyushu University; Kyushu University; Ehime University; Kyushu University	Kira, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan.	kira@neuro.med.kyushu-u.ac.jp	Isobe, Noriko/AAJ-3043-2020	Isobe, Noriko/0000-0001-9525-4254	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan [H20-Nanchi-Ippan-016]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22390178]; Bayer Schering Pharma	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bayer Schering Pharma(Bayer AG)	This work was supported in part by the Health and Labour Sciences Research Grant on Intractable Diseases (H20-Nanchi-Ippan-016) from the Ministry of Health, Labour and Welfare, Japan, and the grant-in-aid (B; no. 22390178) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jun-ichi Kira is an advisory board member for Merck Serono and a consultant for Biogen Idec Japan. He has received payment for lectures from Bayer Schering Pharma, Cosmic Corporation and Biogen Idec Japan. Takuya Matsushita received a grant and payment for manuscript preparation and development of educational presentations from Bayer Schering Pharma, and received payment for the development of educational presentations from Mitsubishi Tanabe Pharma. None of the funding listed above relates to this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online on the guide for authors.	Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Buljevac D, 2005, J NEUROL NEUROSUR PS, V76, P1377, DOI 10.1136/jnnp.2004.048504; DEKKER JW, 1993, TISSUE ANTIGENS, V41, P31, DOI 10.1111/j.1399-0039.1993.tb01974.x; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; Fujisao S, 1996, HUM IMMUNOL, V45, P131, DOI 10.1016/0198-8859(95)00169-7; Fukazawa T, 2000, TISSUE ANTIGENS, V55, P199, DOI 10.1034/j.1399-0039.2000.550302.x; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; Ishizu T, 2009, J NEUROL SCI, V280, P22, DOI 10.1016/j.jns.2009.01.008; Kikuchi S, 2003, NEUROLOGY, V60, P647, DOI 10.1212/01.WNL.0000048202.09147.9E; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Kira J, 1996, ANN NEUROL, V40, P569; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Li W, 2009, MULT SCLER J, V15, P1411, DOI 10.1177/1352458509348961; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Matsuoka T, 2008, J NEUROL SCI, V266, P115, DOI 10.1016/j.jns.2007.09.010; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Matsushita T, 2009, MULT SCLER J, V15, P834, DOI 10.1177/1352458509104595; Matsushita T, 2009, TISSUE ANTIGENS, V73, P171, DOI 10.1111/j.1399-0039.2008.01172.x; Minohara M, 2006, J NEUROIMMUNOL, V178, P156, DOI 10.1016/j.jneuroim.2006.05.026; MITSUNAGA S, 1992, HUM IMMUNOL, V34, P203, DOI 10.1016/0198-8859(92)90113-2; Nakashima I, 2005, J NEUROIMMUNOL, V159, P133, DOI 10.1016/j.jneuroim.2004.09.011; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; Ono T, 1998, TISSUE ANTIGENS, V52, P539, DOI 10.1111/j.1399-0039.1998.tb03084.x; Osoegawa M, 2009, MULT SCLER J, V15, P159, DOI 10.1177/1352458508098372; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; POSER S, 1981, J NEUROL, V225, P219, DOI 10.1007/BF00313751; Qiu W, 2011, MULT SCLER J, V17, P382, DOI 10.1177/1352458510391345; Romero-Pinel L, 2011, EUR J NEUROL, V18, P1258, DOI 10.1111/j.1468-1331.2011.03379.x; Sundstrom P, 2008, MULT SCLER J, V14, P1120, DOI 10.1177/1352458508092353; Tanaka K, 2007, MULT SCLER J, V13, P850, DOI 10.1177/1352458507076976; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wu JS, 2010, J NEUROL SCI, V288, P63, DOI 10.1016/j.jns.2009.10.005; Yamasaki K, 1999, BRAIN, V122, P1689, DOI 10.1093/brain/122.9.1689; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	45	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48592	10.1371/journal.pone.0048592	http://dx.doi.org/10.1371/journal.pone.0048592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152786	gold, Green Published, Green Submitted			2022-12-25	WOS:000312272600013
J	Chen, PC; Hayashi, MAF; Oliveira, EB; Karpel, RL				Chen, Pei-Chun; Hayashi, Mirian A. F.; Oliveira, Eduardo Brandt; Karpel, Richard L.			DNA-Interactive Properties of Crotamine, a Cell-Penetrating Polypeptide and a Potential Drug Carrier	PLOS ONE			English	Article							RATTLESNAKE CROTALUS-DURISSUS; SOUTH-AMERICAN RATTLESNAKE; NUCLEIC-ACIDS; INTRACELLULAR DELIVERY; NONCOOPERATIVE BINDING; PROTEIN TRANSDUCTION; CONTAINING PEPTIDES; AROMATIC RESIDUES; GENE DELIVERY; AMINO-ACIDS	Crotamine, a 42-residue polypeptide derived from the venom of the South American rattlesnake Crotalus durissus terrificus, has been shown to be a cell-penetrating protein that targets chromosomes, carries plasmid DNA into cells, and shows specificity for actively proliferating cells. Given this potential role as a nucleic acid-delivery vector, we have studied in detail the binding of crotamine to single- and double-stranded DNAs of different lengths and base compositions over a range of ionic conditions. Agarose gel electrophoresis and ultraviolet spectrophotometry analysis indicate that complexes of crotamine with long-chain DNAs readily aggregate and precipitate at low ionic strength. This aggregation, which may be important for cellular uptake of DNA, becomes less likely with shorter chain length. 25-mer oligonucleotides do not show any evidence of such aggregation, permitting the determination of affinities and size via fluorescence quenching experiments. The polypeptide binds non-cooperatively to DNA, covering about 5 nucleotide residues when it binds to single (ss) or (ds) double stranded molecules. The affinities of the protein for ss-vs. ds-DNA are comparable, and inversely proportional to salt levels. Analysis of the dependence of affinity on [NaCl] indicates that there are a maximum of,3 ionic interactions between the protein and DNA, with some of the binding affinity attributable to non-ionic interactions. Inspection of the three-dimensional structure of the protein suggests that residues 31 to 35, Arg-Trp-Arg-Trp-Lys, could serve as a potential DNA-binding site. A hexapeptide containing this sequence displayed a lower DNA binding affinity and salt dependence as compared to the full-length protein, likely indicative of a more suitable 3D structure and the presence of accessory binding sites in the native crotamine. Taken together, the data presented here describing crotamine-DNA interactions may lend support to the design of more effective nucleic acid drug delivery vehicles which take advantage of crotamine as a carrier with specificity for actively proliferating cells. Citation: Chen P-C, Hayashi MAF, Oliveira EB, Karpel RL (2012) DNA-Interactive Properties of Crotamine, a Cell-Penetrating Polypeptide and a Potential Drug Carrier. PLoS ONE 7(11): e48913. doi:10.1371/journal.pone.0048913	[Chen, Pei-Chun; Karpel, Richard L.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA; [Hayashi, Mirian A. F.] Univ Fed Sao Paulo UNIFESP, Dept Farmacol, Sao Paulo, Brazil; [Oliveira, Eduardo Brandt] Univ Sao Paulo, Fac Med, Dept Bioquim & Imunol, Ribeirao Preto, Brazil	University System of Maryland; University of Maryland Baltimore County; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Karpel, RL (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.	karpel@umbc.edu	Hayashi, Mirian/ABG-2663-2020; , Mirian/C-7458-2012	, Mirian/0000-0001-6437-4923	University of Maryland Baltimore County Designated Research Initiative Fund, an Undergraduate Research Award; Fundao de Amparo a Pesquisa do Estado de So Paulo [FAPESP]; National Council of Technological and Scientific Development [CNPq]	University of Maryland Baltimore County Designated Research Initiative Fund, an Undergraduate Research Award; Fundao de Amparo a Pesquisa do Estado de So Paulo [FAPESP]; National Council of Technological and Scientific Development [CNPq](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by a grant from the University of Maryland Baltimore County Designated Research Initiative Fund (R.L.K.), an Undergraduate Research Award (P.-C.C.), and support by Fundao de Amparo a Pesquisa do Estado de So Paulo [FAPESP] and National Council of Technological and Scientific Development [CNPq] M.A.F.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasseur R, 2010, BBA-BIOMEMBRANES, V1798, P2177, DOI 10.1016/j.bbamem.2010.09.001; BRUN F, 1975, BIOCHEMISTRY-US, V14, P558, DOI 10.1021/bi00674a015; Caron NJ, 2001, MOL THER, V3, P310, DOI 10.1006/mthe.2001.0279; Choi HS, 2006, BBA-GEN SUBJECTS, V1760, P1604, DOI 10.1016/j.bbagen.2006.09.011; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Dalla Valle L, 2011, DEV COMP IMMUNOL; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Edenhofer F, 2008, CURR PHARM DESIGN, V14, P3628, DOI 10.2174/138161208786898833; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Endoh T, 2009, ADV DRUG DELIVER REV, V61, P704, DOI 10.1016/j.addr.2009.04.005; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FRIED MG, 1993, EUR J BIOCHEM, V218, P469, DOI 10.1111/j.1432-1033.1993.tb18398.x; Harada Hiroshi, 2006, Breast Cancer, V13, P16, DOI 10.2325/jbcs.13.16; Hayashi MAF, 2008, TOXICON, V52, P508, DOI 10.1016/j.toxicon.2008.06.029; HELENE C, 1981, CRC CR REV BIOCH MOL, V10, P213, DOI 10.3109/10409238109113600; Howl J, 2007, BIOCHEM SOC T, V35, P767, DOI 10.1042/BST0350767; Hoyer J, 2012, ACC CHEM RES; Kerkis A, 2006, IUBMB LIFE, V58, P7, DOI 10.1080/15216540500494508; Kerkis A, 2004, FASEB J, V18, P1407, DOI 10.1096/fj.03-1459fje; Kerkis I, 2010, EXPERT OPIN INV DRUG, V19, P1515, DOI 10.1517/13543784.2010.534457; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P1226, DOI 10.1021/bi00354a006; Lee JY, 2011, INT J CANCER, V128, P2470, DOI 10.1002/ijc.25578; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; LIU TY, 1989, ANAL BIOCHEM, V182, P383, DOI 10.1016/0003-2697(89)90612-X; MAURIZOT JC, 1978, BIOCHEMISTRY-US, V17, P2096, DOI 10.1021/bi00604a012; MAYER R, 1979, J BIOL CHEM, V254, P75; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Nascimento FD, 2012, MOL PHARMACEUT, V9, P211, DOI 10.1021/mp2000605; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Oguiura N, 2011, J ANTIBIOT, V64, P327, DOI 10.1038/ja.2011.10; Pereira A, 2011, EXPERT OPIN INV DRUG, V20, P1189, DOI 10.1517/13543784.2011.602064; Radis-Baptista G, 1999, TOXICON, V37, P973, DOI 10.1016/S0041-0101(98)00226-8; Record MT, 1998, ADV PROTEIN CHEM, V51, P281; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; TOULME JJ, 1974, P NATL ACAD SCI USA, V71, P3185, DOI 10.1073/pnas.71.8.3185; Tsodikov OV, 2001, BIOPHYS J, V81, P1960, DOI 10.1016/S0006-3495(01)75847-X; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vonk FJ, 2011, BIOESSAYS, V33, P269, DOI 10.1002/bies.201000117; Yamane ES, 2012, BIOCHIMIE IN PRESS; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	46	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48913	10.1371/journal.pone.0048913	http://dx.doi.org/10.1371/journal.pone.0048913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145017	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500045
J	Langemeijer, EV; Slinger, E; de Munnik, S; Schreiber, A; Maussang, D; Vischer, H; Verkaar, F; Leurs, R; Siderius, M; Smit, MJ				Langemeijer, Ellen V.; Slinger, Erik; de Munnik, Sabrina; Schreiber, Andreas; Maussang, David; Vischer, Henry; Verkaar, Folkert; Leurs, Rob; Siderius, Marco; Smit, Martine J.			Constitutive beta-Catenin Signaling by the Viral Chemokine Receptor US28	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MUSCLE-CELL MIGRATION; HUMAN CYTOMEGALOVIRUS; COLON-CANCER; CARCINOMA-CELLS; HOMOLOG PUS28; CYCLIN D1; PATHWAY; ACTIVATION; PROMOTES	Chronic activation of Wnt/beta-catenin signaling is found in a variety of human malignancies including melanoma, colorectal and hepatocellular carcinomas. Interestingly, expression of the HCMV-encoded chemokine receptor US28 in intestinal epithelial cells promotes intestinal neoplasia in transgenic mice, which is associated with increased nuclear accumulation of beta-catenin. In this study we show that this viral receptor constitutively activates beta-catenin and enhances beta-catenin-dependent transcription. Our data illustrate that this viral receptor does not activate beta-catenin via the classical Wnt/Frizzled signaling pathway. Analysis of US28 mediated signaling indicates the involvement of the Rho-Rho kinase (ROCK) pathway in the activation of beta-catenin. Moreover, cells infected with HCMV show significant increases in beta-catenin stabilization and signaling, which is mediated to a large extent by expression of US28. The modulation of the beta-catenin signal transduction pathway by a viral chemokine receptor provides alternative regulation of this pathway, with potential relevance for the development of colon cancer and virus-associated diseases.	[Langemeijer, Ellen V.; Slinger, Erik; de Munnik, Sabrina; Schreiber, Andreas; Maussang, David; Vischer, Henry; Verkaar, Folkert; Leurs, Rob; Siderius, Marco; Smit, Martine J.] Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Smit, MJ (corresponding author), Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Amsterdam, Netherlands.	mj.smit@vu.nl	Leurs, Rob/ABB-4299-2021; Leurs, Rob/AAC-8508-2022	Leurs, Rob/0000-0003-1354-2848; Smit, Martine/0000-0003-2713-0238; Langemeijer, E.V./0000-0002-3222-7328	Netherlands Organization for Scientific Research; Royal Netherlands Academy of Arts and Sciences; Echo grant	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Arts and Sciences; Echo grant	This work was supported by The Netherlands Organization for Scientific Research (to E.L., S.d.M., F.V. and M.J.S.), The Royal Netherlands Academy of Arts and Sciences (to M.J.S.) and Echo grant (to E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cinatl J, 2004, FEMS MICROBIOL REV, V28, P59, DOI 10.1016/j.femsre.2003.07.005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hulshof JW, 2006, BIOORGAN MED CHEM, V14, P7213, DOI 10.1016/j.bmc.2006.06.054; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lara E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-170; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027496; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2009, METHOD ENZYMOL, V460, P151, DOI 10.1016/S0076-6879(09)05207-0; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Melnick M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-42; Melnychuk RM, 2004, J VIROL, V78, P8382, DOI 10.1128/jvi.78.15.8382-8391.2004; Minisini R, 2003, J VIROL, V77, P4489, DOI 10.1128/JVI.77.8.4489-4501.2003; Moepps B, 2008, CELL SIGNAL, V20, P1528, DOI 10.1016/j.cellsig.2008.04.010; Nager M., 2012, CHEMOTHER RES PRACT; Narasipura SD, 2012, J VIROL, V86, P1911, DOI 10.1128/JVI.06266-11; Polakis P, 2000, GENE DEV, V14, P1837; Rampias T, 2010, MOL CANCER RES, V8, P433, DOI 10.1158/1541-7786.MCR-09-0345; Schlaeger EJ, 1999, CYTOTECHNOLOGY, V30, P71, DOI 10.1023/A:1008000327766; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Stassen FR, 2006, J CLIN VIROL, V35, P349, DOI 10.1016/j.jcv.2005.11.007; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vomaske Jennifer, 2010, Herpesviridae, V1, P2, DOI 10.1186/2042-4280-1-2; Vomaske J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000304; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	48	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48935	10.1371/journal.pone.0048935	http://dx.doi.org/10.1371/journal.pone.0048935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145028	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500049
J	Romanova, EV; Sasaki, K; Alexeeva, V; Vilim, FS; Jing, J; Richmond, TA; Weiss, KR; Sweedler, JV				Romanova, Elena V.; Sasaki, Kosei; Alexeeva, Vera; Vilim, Ferdinand S.; Jing, Jian; Richmond, Timothy A.; Weiss, Klaudiusz R.; Sweedler, Jonathan V.			Urotensin II in Invertebrates: From Structure to Function in Aplysia californica	PLOS ONE			English	Article							CAUDAL NEUROSECRETORY-SYSTEM; SOMATOSTATIN-LIKE MATERIAL; GENE-EXPRESSION; NERVOUS-SYSTEM; NEUROPEPTIDE PRECURSORS; ENDOGENOUS LIGAND; ORPHAN RECEPTOR; BUCCAL GANGLIA; MESSENGER-RNA; BRAIN-STEM	Neuropeptides are ancient signaling molecules that are involved in many aspects of organism homeostasis and function. Urotensin II (UII), a peptide with a range of hormonal functions, previously has been reported exclusively in vertebrates. Here, we provide the first direct evidence that UII-like peptides are also present in an invertebrate, specifically, the marine mollusk Aplysia californica. The presence of UII in the central nervous system (CNS) of Aplysia implies a more ancient gene lineage than vertebrates. Using representational difference analysis, we identified an mRNA of a protein precursor that encodes a predicted neuropeptide, we named Aplysia urotensin II (apUII), with a sequence and structural similarity to vertebrate UII. With in-situ hybridization and immunohistochemistry, we mapped the expression of apUII mRNA and its prohormone in the CNS and localized apUII-like immunoreactivity to buccal sensory neurons and cerebral A-cluster neurons. Mass spectrometry performed on individual isolated neurons, and tandem mass spectrometry on fractionated peptide extracts, allowed us to define the posttranslational processing of the apUII neuropeptide precursor and confirm the highly conserved cyclic nature of the mature neuropeptide apUII. Electrophysiological analysis of the central effects of a synthetic apUII suggests it plays a role in satiety and/or aversive signaling in feeding behaviors. Finding the homologue of vertebrate UII in the numerically small CNS of an invertebrate animal model is important for gaining insights into the molecular mechanisms and pathways mediating the bioactivity of UII in the higher metazoan. Citation: Romanova EV, Sasaki K, Alexeeva V, Vilim FS, Jing J, et al. (2012) Urotensin II in Invertebrates: From Structure to Function in Aplysia californica. PLoS ONE 7(11): e48764. doi:10.1371/journal.pone.0048764	[Romanova, Elena V.; Richmond, Timothy A.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Romanova, Elena V.; Richmond, Timothy A.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL USA; [Sasaki, Kosei; Alexeeva, Vera; Vilim, Ferdinand S.; Weiss, Klaudiusz R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Icahn School of Medicine at Mount Sinai	Sweedler, JV (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Jing, Jian/0000-0003-1422-143X; Romanova, Elena/0000-0002-2040-3312	National Institute on Drug Abuse (NIDA) [P30 DA018310]; National Institute of Neurological Disorders and Stroke (NINDS) [NS066587, NS070583, NS031609]; National Resource for Aplysia at the University of Miami under NIH National Center for Research Resources [RR10294]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR010294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS031609, R01NS070583, R01NS031609, R01NS066587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Resource for Aplysia at the University of Miami under NIH National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by Award Number P30 DA018310 from the National Institute on Drug Abuse (NIDA) and Award Numbers NS066587, NS070583, NS031609 from the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Stanislav Rubakhin for sharing his expertise on the preparation of cultured neurons for MS analysis. A. californica were partially provided by the National Resource for Aplysia at the University of Miami under NIH National Center for Research Resources grant RR10294.	Amare A, 2007, PEPTIDES, V28, P1282, DOI 10.1016/j.peptides.2007.04.014; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; ANGERER RC, 1975, CELL, V6, P29, DOI 10.1016/0092-8674(75)90070-7; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERN HA, 1969, J ENDOCRINOL, V45, pR11; Chartrel N, 2004, J NEUROCHEM, V91, P110, DOI 10.1111/j.1471-4159.2004.02698.x; Christie AE, 2011, GEN COMP ENDOCRINOL; Christie AE, 2011, GEN COMP ENDOCR, V170, P144, DOI 10.1016/j.ygcen.2010.09.018; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; CONLON JM, 1992, BIOCHEM BIOPH RES CO, V188, P578, DOI 10.1016/0006-291X(92)91095-8; Conlon JM, 1997, REGUL PEPTIDES, V69, P95, DOI 10.1016/S0167-0115(97)02135-6; CONLON JM, 1990, FEBS LETT, V266, P37, DOI 10.1016/0014-5793(90)81500-N; CONLON JM, 1992, NEUROENDOCRINOLOGY, V55, P230; Coulouarn Y, 2001, MECH DEVELOP, V101, P187, DOI 10.1016/S0925-4773(00)00548-7; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; Desai N, 2008, CARDIOL REV, V16, P142, DOI 10.1097/CRD.0b013e31815c8048; do Rego JC, 2008, PEPTIDES, V29, P838, DOI 10.1016/j.peptides.2007.12.016; Do-Rego JC, 2005, PSYCHOPHARMACOLOGY, V183, P103, DOI 10.1007/s00213-005-0140-2; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Douglas SA, 2000, TRENDS CARDIOVAS MED, V10, P229, DOI 10.1016/S1050-1738(00)00069-4; Dschietzig T, 2002, REGUL PEPTIDES, V110, P33, DOI 10.1016/S0167-0115(02)00158-1; Dun SL, 2001, NEUROSCI LETT, V305, P9, DOI 10.1016/S0304-3940(01)01804-3; Elshourbagy NA, 2002, BRIT J PHARMACOL, V136, P9, DOI 10.1038/sj.bjp.0704671; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; FIORE L, 1975, BRAIN RES, V92, P336, DOI 10.1016/0006-8993(75)90280-2; Floyd PD, 1999, J NEUROSCI, V19, P7732; Friedman AK, 2010, J NEUROSCI, V30, P8906, DOI 10.1523/JNEUROSCI.1287-10.2010; Furukawa Y, 2003, J NEUROPHYSIOL, V89, P3114, DOI 10.1152/jn.00014.2003; Furukawa Y, 2001, J NEUROSCI, V21, P8247, DOI 10.1523/JNEUROSCI.21-20-08247.2001; Gartlon J, 2001, PSYCHOPHARMACOLOGY, V155, P426, DOI 10.1007/s002130100715; GONZALEZ GC, 1991, PEPTIDES, V12, P787, DOI 10.1016/0196-9781(91)90134-B; GONZALEZ GC, 1992, PEPTIDES, V13, P695, DOI 10.1016/0196-9781(92)90175-3; GONZALEZ GC, 1995, NEUROREPORT, V6, P541, DOI 10.1097/00001756-199502000-00033; HARRISON LM, 1994, PEPTIDES, V15, P1309, DOI 10.1016/0196-9781(94)90159-7; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Hoek RM, 1997, P NATL ACAD SCI USA, V94, P14072, DOI 10.1073/pnas.94.25.14072; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Hunt BD, 2010, N-S ARCH PHARMACOL, V382, P1, DOI 10.1007/s00210-010-0503-z; Hurwitz I, 1997, J NEUROPHYSIOL, V78, P1305, DOI 10.1152/jn.1997.78.3.1305; Husson SJ, 2009, PEPTIDES, V30, P449, DOI 10.1016/j.peptides.2008.07.021; JAHANPARWAR B, 1976, COMP BIOCHEM PHYS A, V54, P347, DOI 10.1016/S0300-9629(76)80124-7; Jegou S, 2006, J COMP NEUROL, V495, P21, DOI 10.1002/cne.20845; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jing JA, 2010, J NEUROSCI, V30, P16545, DOI 10.1523/JNEUROSCI.4264-10.2010; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASEK RJ, 1971, SCIENCE, V172, P278, DOI 10.1126/science.172.3980.278; Le Roith D, 1984, COEXISTENCE NEUROACT, P411; LEROITH D, 1985, BIOCHIM BIOPHYS ACTA, V838, P335, DOI 10.1016/0304-4165(85)90231-4; LEROITH D, 1985, ENDOCRINOLOGY, V117, P2093, DOI 10.1210/endo-117-5-2093; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Li L, 2001, J NEUROCHEM, V77, P1569, DOI 10.1046/j.1471-4159.2001.00360.x; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Liu QY, 1999, BIOCHEM BIOPH RES CO, V266, P174, DOI 10.1006/bbrc.1999.1796; LLOYD PE, 1985, J NEUROSCI, V5, P1851; Lovejoy DA, 1999, GEN COMP ENDOCR, V115, P1, DOI 10.1006/gcen.1999.7298; Lovejoy DA, 2009, GEN COMP ENDOCR, V164, P15, DOI 10.1016/j.ygcen.2009.04.014; McDonald J, 2007, J ANESTH, V21, P378, DOI 10.1007/s00540-007-0524-z; MILLER MW, 1994, J NEUROSCI, V14, P7008; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Mousley A, 2005, PARASITOLOGY, V131, pS143, DOI 10.1007/S0031182005008553; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nusbaum MP, 2012, CURR OPIN NEUROBIOL, V22, P592, DOI 10.1016/j.conb.2012.01.003; Ong KL, 2005, CARDIOVASC DRUG THER, V19, P65, DOI 10.1007/s10557-005-6899-x; ONO JK, 1992, J NEUROSCI METH, V44, P71, DOI 10.1016/0165-0270(92)90115-T; OSHEA M, 1985, ANNU REV NEUROSCI, V8, P171; Parmentier C, 2011, ENDOCRINOLOGY, V152, P2330, DOI 10.1210/en.2010-1500; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Pi CH, 2006, GENOMICS, V88, P809, DOI 10.1016/j.ygeno.2006.06.014; Proekt A, 2005, J NEUROSCI, V25, P9637, DOI 10.1523/JNEUROSCI.2932-05.2005; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samarova EI, 2005, BRAIN RES BULL, V67, P40, DOI 10.1016/j.brainresbull.2005.05.023; Sasaki K, 2009, J NEUROSCI, V29, P11732, DOI 10.1523/JNEUROSCI.3051-09.2009; Sawada M, 1999, J NEUROSCI RES, V56, P547, DOI 10.1002/(SICI)1097-4547(19990601)56:5<547::AID-JNR10>3.3.CO;2-C; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; Shemesh OA, 2010, ACTA NEUROPATHOL, V120, P209, DOI 10.1007/s00401-010-0689-7; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; Soloviev M, 2010, PEPTIDOMIC APPROACHE, P275; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; SUSSWEIN AJ, 1988, J NEUROSCI, V8, P2049; Sweedler JV, 2002, J NEUROSCI, V22, P7797; Tostivint H, 2006, P NATL ACAD SCI USA, V103, P2237, DOI 10.1073/pnas.0510700103; Tostivint H, 2008, MOL CELL ENDOCRINOL, V286, P5, DOI 10.1016/j.mce.2008.02.029; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vilim FS, 2010, J NEUROSCI, V30, P131, DOI 10.1523/JNEUROSCI.3282-09.2010; Vilim FS, 2001, PEPTIDES, V22, P2027, DOI 10.1016/S0196-9781(01)00561-7; Vilim FS, 2007, SAN DIEG CA NEUR M P; Walters ET, 2009, BRAIN BEHAV EVOLUT, V74, P206, DOI 10.1159/000258667; Walters ET, 2004, J COMP NEUROL, V471, P219, DOI 10.1002/cne.20042; Watanabe T, 2009, CURR MED CHEM, V16, P550, DOI 10.2174/092986709787458515; WAUGH D, 1995, GEN COMP ENDOCR, V99, P323, DOI 10.1006/gcen.1995.1116; WAUGH D, 1993, GEN COMP ENDOCR, V92, P419, DOI 10.1006/gcen.1993.1178; Wu JS, 2010, J NEUROPHYSIOL, V103, P2174, DOI 10.1152/jn.01054.2009; Yampolsky LY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S10; YUI R, 1985, PEPTIDES, V6, P411, DOI 10.1016/0196-9781(85)90407-3	105	27	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48764	10.1371/journal.pone.0048764	http://dx.doi.org/10.1371/journal.pone.0048764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144960	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500032
J	Braun, N; Fritz, P; Ulmer, C; Latus, J; Kimmel, M; Biegger, D; Ott, G; Reimold, F; Thon, KP; Dippon, J; Segerer, S; Alscher, MD				Braun, Niko; Fritz, Peter; Ulmer, Christoph; Latus, Joerg; Kimmel, Martin; Biegger, Dagmar; Ott, German; Reimold, Fabian; Thon, Klaus-Peter; Dippon, Juergen; Segerer, Stephan; Alscher, M. Dominik			Histological Criteria for Encapsulating Peritoneal Sclerosis - A Standardized Approach	PLOS ONE			English	Article							DIALYSIS PATIENTS; DIAGNOSIS; PATHOLOGY; EXPERIENCE; MODELS; CXCR3; TIME	Background: The two most relevant pathologies of long-term peritoneal dialysis (PD) are simple sclerosis and encapsulating peritoneal sclerosis (EPS). The histological differentiation of those two entities is difficult. The Aim of the study was to establish a method to standardize and facilitate the differentiation between simple sclerosis and EPS Methods: We investigated 58 peritoneal biopsies - 31 EPS patients and 27 PD patients. Two blinded investigators analyzed 20 histological characteristics in EPS and PD patients. Results: The following findings were significantly more common in EPS than in patients on PD without EPS: fibroblast like cells (FLC) (p<0.0001), mesothelial denudation (p<0.0001), decreased cellularity (p=0.008), fibrin deposits (p<0.03), Fe deposits (p=0.05), podoplanin vascular (p<0.0001), podoplanin avascular (p<0.0001). Using all predictor variables we trained the classification method Random Forest to categorize future cases. Podoplanin vascular and avascular were taken together (p<0.0001), FLC (p<0.0001), mesothelial denudation (p=0.0005), calcification (p=0.0026), acellular areas (p=0.0094), and fibrin deposits (p=0.0336) showed up as significantly important predictor variables. Estimated misclassification error rate when classifying new cases turned out to be 14%. Conclusion: The introduced statistical method allows discriminating between simple sclerosis and EPS. The misclassification error will likely improve with every new case added to the database.	[Braun, Niko; Latus, Joerg; Kimmel, Martin; Reimold, Fabian; Alscher, M. Dominik] Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Stuttgart, Germany; [Fritz, Peter; Biegger, Dagmar] Univ Tubingen, Margarete Fischer Bosch Inst Clin Pharmacol, Tubingen, Germany; [Ulmer, Christoph; Thon, Klaus-Peter] Robert Bosch Krankenhaus, Dept Surg, Stuttgart, Germany; [Ott, German] Robert Bosch Krankenhaus, Div Pathol, Dept Diagnost Med, Stuttgart, Germany; [Reimold, Fabian] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA; [Dippon, Juergen] Univ Stuttgart, Dept Math, Stuttgart, Germany; [Segerer, Stephan] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch Krankenhaus; Harvard University; Beth Israel Deaconess Medical Center; University of Stuttgart; University of Zurich; University Zurich Hospital	Latus, J (corresponding author), Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Stuttgart, Germany.	Joerg.latus@rbk.de	Kimmel, Martin/AAM-2514-2021	Segerer, Stephan/0000-0002-1936-9719; Alscher, Mark Dominik/0000-0002-9658-1211; Latus, Joerg/0000-0003-0584-4870	Robert-Bosch Foundation; Sabine- Dorges- Foundation	Robert-Bosch Foundation; Sabine- Dorges- Foundation	This work was supported by the Robert-Bosch Foundation and the Sabine- Dorges- Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher D M, 2007, Minerva Urol Nefrol, V59, P269; Alscher DM, 2007, AM J KIDNEY DIS, V49, P452, DOI 10.1053/j.ajkd.2006.11.040; Braun N, 2009, NEPHRON CLIN PRACT, V113, pC88, DOI 10.1159/000228540; Braun N, 2011, NEPHROL THER; Braun N, 2010, NEPHROL DIAL TRANSPL; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown EA, 2009, PERITON DIALYSIS INT, V29, P595; Brown EA, 2009, PERITON DIALYSIS INT, V29, P502; Brown MC, 2009, CLIN J AM SOC NEPHRO, V4, P1222, DOI 10.2215/CJN.01260209; Duman S, 2009, PERITON DIALYSIS INT, V29, pS40; Garosi G, 2005, PERITON DIALYSIS INT, V25, pS110; Goodlad C, 2011, NEPHROL DIAL TRANSPL, V26, P1374, DOI 10.1093/ndt/gfq533; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Honda K, 1996, NEPHRON, V72, P171, DOI 10.1159/000188837; Honda Kazuho, 2003, Adv Perit Dial, V19, P169; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Kalof AN, 2009, ADV ANAT PATHOL, V16, P62, DOI 10.1097/PAP.0b013e3181915e94; Kawanishi H, 2005, PERITON DIALYSIS INT, V25, pS14; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; Sampimon DE, 2011, NEPHROL DIAL TRANSPL, V26, P291, DOI 10.1093/ndt/gfq343; Segerer S, 2005, TRANSPL INT, V18, P676, DOI 10.1111/j.1432-2277.2005.00117.x; Segerer S, 2004, AM J PATHOL, V164, P635, DOI 10.1016/S0002-9440(10)63152-5; Sherif AM, 2008, THER APHER DIAL, V12, P33, DOI 10.1111/j.1744-9987.2007.00538.x; Summers AM, 2005, KIDNEY INT, V68, P2381, DOI 10.1111/j.1523-1755.2005.00701.x; Summers AM, 2011, PERITON DIALYSIS INT, V31, P245, DOI 10.3747/pdi.2010.00086; Summers AM, 2008, PERITON DIALYSIS INT, V28, pS16; Tagaya N, 2009, J HEPATO-BILIARY-PAN, V16, P283, DOI 10.1007/s00534-009-0085-7; Tarzi RM, 2008, CLIN J AM SOC NEPHRO, V3, P1702, DOI 10.2215/CJN.01820408; Team R. D. C., 2008, R LANG ENV STAT COMP; Ti JP, 2010, AM J ROENTGENOL, V195, pW50, DOI 10.2214/AJR.09.3175; Vlijm A, 2009, PERITON DIALYSIS INT, V29, P517; von Ruhland CJ, 2003, PERITON DIALYSIS INT, V23, P428; Zheng YZ, 2011, J GASTROEN HEPATOL, V26, P888, DOI 10.1111/j.1440-1746.2011.06657.x	35	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48647	10.1371/journal.pone.0048647	http://dx.doi.org/10.1371/journal.pone.0048647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144917	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000311935800087
J	de Toledo, M; Anguille, C; Roger, L; Roux, P; Gadea, G				de Toledo, Marion; Anguille, Christelle; Roger, Laureline; Roux, Pierre; Gadea, Gilles			Cooperative Anti-Invasive Effect of Cdc42/Rac1 Activation and ROCK Inhibition in SW620 Colorectal Cancer Cells with Elevated Blebbing Activity	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; E-CADHERIN EXPRESSION; SMALL GTPASES; IN-VIVO; MESENCHYMAL TRANSITION; ACTIN CYTOSKELETON; RAC ACTIVATION; TUMOR; METASTASIS; ADHESION	Rho GTPases are key regulators of tumour cell invasion and therefore constitute attractive targets for the design of anticancer agents. Several strategies have been developed to modulate their increased activities during cancer progression. Interestingly, none of these approaches took into account the existence of the well-known antagonistic relationship between RhoA and Rac1. In this study, we first compared the invasiveness of a collection of colorectal cancer cell lines with their RhoA, Rac1 and Cdc42 activities. A marked decrease of active Cdc42 and Rac1 correlated with the high invasive potential of the cell lines established from metastatic sites of colorectal adenocarcinoma (LoVo, SKCo1, SW620 and CoLo205). Conversely, no correlation between RhoA activity and invasiveness was detected, whereas the activity of its kinase effector ROCK was higher in cancer cell lines with a more invasive phenotype. In addition, invasiveness in these colon cancer cell lines was correlated with a typical round and blebbing morphology. We then tested whether treatment with PDGF to restore Cdc42 and Rac1 activities and/or with Y27632, a chemical inhibitor of ROCK, could decrease the invasiveness of SW620 cells. The association of both treatments substantially decreased the invasive potential of SW620 cells and this effect was accompanied by loss of membrane blebbing, restoration of a more elongated cell morphology and re-establishment of E-cadherin-dependent adherens junctions. This study paves the road to the development of therapeutic strategies in which different Rho GTPase modulators are combined to modulate the cross-talk between Rho GTPases and their specific input in metastatic progression.	[Anguille, Christelle; Roux, Pierre; Gadea, Gilles] CNRS, Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France; [de Toledo, Marion] CNRS, Inst Genet Mol Montpellier, UMR 5535, Montpellier, France; [Roger, Laureline] Cardiff Univ, Sch Med, Inst Canc & Genet, Cardiff, S Glam, Wales	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Cardiff University	Gadea, G (corresponding author), CNRS, Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France.	gilles.gadea@crbm.cnrs.fr	Roux, Pierre/D-8833-2017; de Toledo, Marion/Q-3594-2019; Gilles, Gadea/M-9966-2015	de Toledo, Marion/0000-0002-7638-0041; Gilles, Gadea/0000-0001-6325-4866	Ligue Nationale contre le Cancer (equipe labellisee); Association pour la Recherche contre le Cancer [17029]; Institut National de la Sante et de la Recherche Medicale; Le Centre national de la recherche scientifique	Ligue Nationale contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Le Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS))	This research was supported by the Ligue Nationale contre le Cancer (equipe labellisee), Association pour la Recherche contre le Cancer (contrat 17029), Institut National de la Sante et de la Recherche Medicale, and Le Centre national de la recherche scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; El-Sibai M, 2007, J CELL SCI, V120, P3465, DOI 10.1242/jcs.005942; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Mardilovich K, 2012, FUTURE ONCOL, V8, P165, DOI [10.2217/fon.11.143, 10.2217/FON.11.143]; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; OKA H, 1993, CANCER RES, V53, P1696; Ory S, 2000, J CELL SCI, V113, P1177; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; SCHIPPER JH, 1991, CANCER RES, V51, P6328; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; UMBAS R, 1994, CANCER RES, V54, P3929; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Walker K, 2005, CURR OPIN GENET DEV, V15, P62, DOI 10.1016/j.gde.2004.11.001; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wyckoff JB, 2000, CANCER RES, V60, P2504; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200	57	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48344	10.1371/journal.pone.0048344	http://dx.doi.org/10.1371/journal.pone.0048344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144867	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800047
J	Kim, JY; Park, SC; Lee, JK; Choi, SJ; Hahm, KS; Park, Y				Kim, Jin-Young; Park, Seong-Cheol; Lee, Jong-Kook; Choi, Sang Joon; Hahm, Kyung-Soo; Park, Yoonkyung			Novel Antibacterial Activity of beta(2)-Microglobulin in Human Amniotic Fluid	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; PEPTIDE; CATHELICIDINS; VIABILITY; PROTEINS; DEFENSE	An antibacterial protein (about 12 kDa) was isolated from human amniotic fluid through dialysis, ultrafiltration and C18 reversed-phase HPLC steps. Automated Edman degradation showed that the N-terminal sequence of the antibacterial protein was NH2-Ile-Gln-Arg-Thr-Pro-Lys-Ile-Gln-Val-Tyr-Ser-Arg-His-Pro-Ala-Glu-Asn-Gly-. The N-terminal sequence of the antibacterial protein was found to be identical to that of b2-microglobulin, a component of MHC class I molecules, which are present on all nucleated cells. Matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) revealed that the molecular mass of the antibacterial protein was 11,631 Da. This antibacterial protein, beta M-2, possessed potent antibacterial activity against pathogenic bacteria. Specially, antibacterial activity was observed in potassium buffer, and potassium ion was found to be critical for the antibacterial activity. Interestingly, the antibacterial action of beta M-2 was associated with dissipation of the transmembrane potential, but the protein did not cause damage to the membrane that would result in SYTOX green uptake. In addition, stimulation of WISH amniotic epithelial cells with the bacterial endotoxin lipopolysaccharide (LPS) induced dose-dependent upregulation of beta M-2 mRNA expression. These results suggest that beta M-2 contributes to a self-defense response when amniotic cells are exposed to pathogens.	[Kim, Jin-Young; Park, Seong-Cheol; Lee, Jong-Kook; Park, Yoonkyung] Chosun Univ, Res Ctr Proteinaceous Mat, Kwangju 501759, South Korea; [Choi, Sang Joon] Chosun Univ, Sch Med, Dept Obstet & Gynecol, Kwangju 501759, South Korea; [Hahm, Kyung-Soo] Bioleaders Corp, Taejon, South Korea; [Park, Yoonkyung] Chosun Univ, Dept Biotechnol, Kwangju 501759, South Korea	Chosun University; Chosun University; Chosun University	Park, Y (corresponding author), Chosun Univ, Res Ctr Proteinaceous Mat, Kwangju 501759, South Korea.	y_k_park@chosun.ac.kr		Park, Seong-Cheol/0000-0001-9051-0183	National Research Foundation of Korea; Korea government (MEST) [2011-0017532]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (MEST) (No. 2011-0017532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Cooper EH, 1980, MED PEDIATR ONCOL, V23, P247; ELSBACH P, 1993, IMMUNOBIOLOGY, V187, P417, DOI 10.1016/S0171-2985(11)80354-2; GALASK RP, 1970, AM J OBSTET GYNECOL, V106, P59, DOI 10.1016/0002-9378(70)90126-2; Kim HS, 2002, J IMMUNOL, V168, P2356, DOI 10.4049/jimmunol.168.5.2356; Kim JY, 2007, BBA-PROTEINS PROTEOM, V1774, P1221, DOI 10.1016/j.bbapap.2007.06.013; LEHRER RI, 1993, J LAB CLIN MED, V121, P193; Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975; MILLER J, 1976, AM J OBSTET GYNECOL, V125, P212, DOI 10.1016/0002-9378(76)90595-0; Niall H D, 1973, Methods Enzymol, V27, P942; Oliveira FR, 2002, BRAZ J MED BIOL RES, V35, P215, DOI 10.1590/S0100-879X2002000200010; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; Park SC, 2008, BBA-BIOMEMBRANES, V1778, P229, DOI 10.1016/j.bbamem.2007.09.020; Pouvreau L, 2001, J AGR FOOD CHEM, V49, P2864, DOI 10.1021/jf010126v; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPITZNAGEL JK, 1990, J CLIN INVEST, V86, P1381, DOI 10.1172/JCI114851; Valueva TA, 2000, BIOL CHEM, V381, P1215, DOI 10.1515/BC.2000.149; Xie J, 2003, TRENDS IMMUNOL, V24, P228, DOI 10.1016/S1471-4906(03)00076-0; Yang D, 2001, J LEUKOCYTE BIOL, V69, P691; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O	23	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47642	10.1371/journal.pone.0047642	http://dx.doi.org/10.1371/journal.pone.0047642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144825	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800025
J	King, AJ; Deng, QL; Tyson, R; Sharp, JC; Matwiy, J; Tomanek, B; Dunn, JF				King, Alison J.; Deng, Qunli; Tyson, Randy; Sharp, Jonathan C.; Matwiy, Jarod; Tomanek, Boguslaw; Dunn, Jeff F.			In Vivo Open-Bore MRI Reveals Region- and Sub-Arc-Specific Lengthening of the Unloaded Human Posterior Cruciate Ligament	PLOS ONE			English	Article							TIBIOFEMORAL KINEMATICS; KNEE; DEFICIENCY; MOVEMENT; FLEXION; TRANSLATION; SENSITIVITY; CONTACT; MOTION	Open-bore MRI scanners allow joint soft tissue to be imaged over a large, uninterrupted range of flexion. Using an open-bore scanner, 3D para-sagittal images of the posterior cruciate ligament (PCL) were collected from seven healthy subjects in unloaded, recumbent knee extension and flexion. PCL length was measured from one 2D MRI slice partition per flexion angle, per subject. The anterior surface of the PCL lengthened significantly between extension and flexion (p<0.001). Conversely, the posterior surface did not. Changes were not due to the PCL moving relative to the 2D slice partition; measurements made from 3D reconstructions, which compensated for PCL movement, did not differ significantly from measurements made from 2D slice partitions. In a second experiment, videos of knee flexion were made by imaging two subjects at several flexion angles. Videos allowed soft tissue tracking; examples are included. In a third experiment, unloaded knees of seven healthy, recumbent subjects were imaged at extension and at 40 degrees, 70 degrees, 90 degrees, 100 degrees, 110 degrees and 120 degrees flexion. The distance between PCL attachments increased between extension and 100 degrees, and then decreased (p<0.001). The anterior surface of the PCL lengthened over the flexion angles measured (p<0.01). The posterior surface of the PCL lengthened between extension and 40 degrees and then shortened (p<0.001). Both attachment separation and anterior surface length increased dramatically between extension and 40 degrees, but varied less afterwards. Results indicate that PCL dynamics differ between terminal extension and active function sub-arcs. Also, attachment separation cannot predict the lengthening of all parts of the PCL, nor can lengthening of one part of the PCL predict the lengthening of another part. A potential connection between lengthening and loading is discussed. We conclude that low-field MRI can assess ligament lengthening during flexion, and that the dynamics of the PCL for any given region and sub-arc should be measured directly.	[King, Alison J.; Tomanek, Boguslaw; Dunn, Jeff F.] Univ Calgary, Fac Med, Dept Radiol, Calgary, AB, Canada; [King, Alison J.; Dunn, Jeff F.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Deng, Qunli; Tyson, Randy; Sharp, Jonathan C.; Tomanek, Boguslaw] Natl Res Council Canada, Inst Biodiagnost W, Calgary, AB, Canada; [Matwiy, Jarod] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada	University of Calgary; University of Calgary; National Research Council Canada; National Research Council Canada	Dunn, JF (corresponding author), Univ Calgary, Fac Med, Dept Radiol, Calgary, AB, Canada.	dunnj@ucalgary.ca	Tomanek, Boguslaw/J-4720-2014; Tomanek, Boguslaw/AAD-7594-2019	Tomanek, Boguslaw/0000-0003-2602-0280; Sharp, Jonathan/0000-0002-9736-7487	Alberta Heritage Foundation for Medical Research Interdisciplinary Team Grant in Osteoarthritis	Alberta Heritage Foundation for Medical Research Interdisciplinary Team Grant in Osteoarthritis	The authors gratefully acknowledge salary support for AJK from the Alberta Heritage Foundation for Medical Research Interdisciplinary Team Grant in Osteoarthritis (http://www.oarthritis.com/). The Canada Foundation for Innovation (http://www.innovation.ca/en) provided support for computers and software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalbersberg S, 2005, J BIOMECH, V38, P1780, DOI 10.1016/j.jbiomech.2004.09.003; Ahad NA, 2011, SAINS MALAYS, V40, P637; AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257; Amiri S, 2011, KNEE, V18, P34, DOI 10.1016/j.knee.2010.01.003; BRUDER H, 1988, MAGNET RESON MED, V7, P35, DOI 10.1002/mrm.1910070105; BRUNNER P, 1979, J MAGN RESON, V33, P83, DOI 10.1016/0022-2364(79)90192-6; Carpenter RD, 2009, ARTHROSCOPY, V25, P760, DOI 10.1016/j.arthro.2009.01.014; Chandrasekaran S, 2012, KNEE, V19, P60, DOI 10.1016/j.knee.2010.11.010; Chwaluk A, 2009, FOLIA MORPHOL, V68, P8; Covey DC, 2008, AM J SPORT MED, V36, P480, DOI 10.1177/0363546507311097; Covey DC, 2004, AM J SPORT MED, V32, P1866, DOI 10.1177/0363546504267152; Darcy SP, 2008, J BIOMECH, V41, P854, DOI 10.1016/j.jbiomech.2007.10.025; Dragoo JL, 2010, CLIN BIOMECH, V25, P433, DOI 10.1016/j.clinbiomech.2010.01.011; Fanelli GC, 2010, SPORTS MED ARTHROSC, V18, P221, DOI 10.1097/JSA.0b013e3181fdf0c4; Freeman MAR, 2005, J BIOMECH, V38, P197, DOI 10.1016/j.jbiomech.2004.02.006; Goyal K, 2012, AM J SPORT MED, V40, P777, DOI 10.1177/0363546511435783; Grassmayr MJ, 2008, J SCI MED SPORT, V11, P433, DOI 10.1016/j.jsams.2007.07.007; GROOD ES, 1988, J BONE JOINT SURG AM, V70A, P88, DOI 10.2106/00004623-198870010-00014; Haacke E. M., 1999, MAGNETIC RESONANCE I; Hermans S, 2009, AM J SPORT MED, V37, P1499, DOI 10.1177/0363546509333479; Howell D, 2002, STAT METHODS PSYCHOL; Huiskes, 2005, BASIC ORTHOPAEDIC BI, P91; KELLER PM, 1993, AM J SPORT MED, V21, P132, DOI 10.1177/036354659302100122; Komatsu T, 2005, J ORTHOP RES, V23, P334, DOI 10.1016/j.orthres.2004.08.001; Kozanek M, 2009, J BIOMECH, V42, P1877, DOI 10.1016/j.jbiomech.2009.05.003; Logan M, 2004, AM J SPORT MED, V32, P1915, DOI 10.1177/0363546504265005; Lopez-Vidriero E, 2010, SPORTS MED ARTHROSC, V18, P230, DOI 10.1097/JSA.0b013e3181fbaf38; Meddis R., 1984, STAT USING RANKS; Mountain KM, 2011, MAGN RESON MED, V66, P520, DOI 10.1002/mrm.23036; Nakagawa S, 2004, J BONE JOINT SURG BR, V86B, P450, DOI 10.1302/0301-620X.86B3.14330; Park JS, 2006, AM J ROENTGENOL, V187, P364, DOI 10.2214/AJR.05.0339; Race A, 1996, J BIOMECH, V29, P873, DOI 10.1016/0021-9290(95)00161-1; Scarvell JM, 2004, J ORTHOPAED RES, V22, P788, DOI 10.1016/j.orthres.2003.10.011; Shapiro LM, 2012, OSTEOARTHR CARTILAGE, V20, P69, DOI 10.1016/j.joca.2011.11.003; Sharp JC, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3202410; Shefelbine SJ, 2006, J ORTHOP RES, V24, P1208, DOI 10.1002/jor.20139; von Eisenhart-Rothe R, 2004, J ORTHOP RES, V22, P275, DOI 10.1016/j.orthres.2003.08.009; Williams A, 2004, KNEE, V11, P81, DOI 10.1016/j.knee.2003.12.004; Yao J, 2008, J ORTHOP RES, V26, P673, DOI 10.1002/jor.20553; Zaffagnini S, 2004, KNEE SURG SPORT TR A, V12, P420, DOI 10.1007/s00167-004-0502-z	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48714	10.1371/journal.pone.0048714	http://dx.doi.org/10.1371/journal.pone.0048714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144939	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800105
J	Maiya, R; Lee, S; Berger, KH; Kong, EC; Slawson, JB; Griffith, LC; Takamiya, K; Huganir, RL; Margolis, B; Heberlein, U				Maiya, Rajani; Lee, Seonok; Berger, Karen H.; Kong, Eric C.; Slawson, Justin B.; Griffith, Leslie C.; Takamiya, Kogo; Huganir, Richard L.; Margolis, Ben; Heberlein, Ulrike			DlgS97/SAP97, a Neuronal Isoform of Discs Large, Regulates Ethanol Tolerance	PLOS ONE			English	Article							CAMKII-DEPENDENT PHOSPHORYLATION; SYNAPSE-ASSOCIATED PROTEIN-97; NMDA RECEPTOR SUBUNITS; LONG-TERM-MEMORY; DROSOPHILA-MELANOGASTER; INDUCED BEHAVIORS; MAGUK PROTEINS; SAP97; SENSITIVITY; PATHWAY	From a genetic screen for Drosophila melanogaster mutants with altered ethanol tolerance, we identified intolerant (intol), a novel allele of discs large 1 (dlg1). Dlg1 encodes Discs Large 1, a MAGUK (Membrane Associated Guanylate Kinase) family member that is the highly conserved homolog of mammalian PSD-95 and SAP97. The intol mutation disrupted specifically the expression of DlgS97, a SAP97 homolog, and one of two major protein isoforms encoded by dlg1 via alternative splicing. Expression of the major isoform, DlgA, a PSD-95 homolog, appeared unaffected. Ethanol tolerance in the intol mutant could be partially restored by transgenic expression of DlgS97, but not DlgA, in specific neurons of the fly's brain. Based on co-immunoprecipitation, DlgS97 forms a complex with N-methyl-D-aspartate (NMDA) receptors, a known target of ethanol. Consistent with these observations, flies expressing reduced levels of the essential NMDA receptor subunit dNR1 also showed reduced ethanol tolerance, as did mutants in the gene calcium/calmodulin-dependent protein kinase (caki), encoding the fly homolog of mammalian CASK, a known binding partner of DlgS97. Lastly, mice in which SAP97, the mammalian homolog of DlgS97, was conditionally deleted in adults failed to develop rapid tolerance to ethanol's sedative/hypnotic effects. We propose that DlgS97/SAP97 plays an important and conserved role in the development of tolerance to ethanol via NMDA receptor-mediated synaptic plasticity.	[Maiya, Rajani; Berger, Karen H.; Kong, Eric C.; Heberlein, Ulrike] Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Lee, Seonok; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Slawson, Justin B.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Takamiya, Kogo] Miyazaki Univ, Grad Sch Med, Fac Med, Dept Neurosci, Kiyotake, Miyazaki, Japan; [Huganir, Richard L.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Huganir, Richard L.] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD USA; [Margolis, Ben] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Brandeis University; University of Miyazaki; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Michigan System; University of Michigan	Heberlein, U (corresponding author), Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	heberleinu@janelia.hhmi.org		Griffith, Leslie/0000-0003-3164-9876; Takamiya, Kogo/0000-0001-7240-6307	State of California [63-55]; National Institutes of health/National Institute on Alcohol Abuse and Alcoholism; Ruth Kirschstein National Research Service [F32AA15470-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA015470, R01AA010035] Funding Source: NIH RePORTER	State of California; National Institutes of health/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Ruth Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the State of California (63-55) and National Institutes of health/National Institute on Alcohol Abuse and Alcoholism grants to UH and Ruth Kirschstein National Research Service Award (F32AA15470-02) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Anders DL, 1999, ALCOHOL CLIN EXP RES, V23, P357, DOI 10.1111/j.1530-0277.1999.tb04122.x; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Bachmann A, 2010, J NEUROSCI, V30, P5811, DOI 10.1523/JNEUROSCI.0778-10.2010; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; Berger KH, 2008, ALCOHOL CLIN EXP RES, V32, P895, DOI 10.1111/j.1530-0277.2008.00659.x; Berger KH, 2004, ALCOHOL CLIN EXP RES, V28, P1469, DOI 10.1097/01.ALC.0000141817.15993.98; Bhandari P, 2009, ALCOHOL CLIN EXP RES, V33, P1794, DOI 10.1111/j.1530-0277.2009.01018.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Chandler LJ, 1998, TRENDS PHARMACOL SCI, V19, P491, DOI 10.1016/S0165-6147(98)01268-1; COHAN FM, 1986, GENETICS, V114, P145; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cowmeadow RB, 2006, ALCOHOL CLIN EXP RES, V30, P745, DOI 10.1111/j.1530-0277.2006.00087.x; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Devineni AV, FLY AUSTIN, V5, P191; Dimitrijevic N, 2005, EUR J PHARMACOL, V519, P246, DOI 10.1016/j.ejphar.2005.07.016; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Gardoni F, 2008, EUR J PHARMACOL, V585, P147, DOI 10.1016/j.ejphar.2008.01.048; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hodge JJL, 2006, NEURON, V51, P327, DOI 10.1016/j.neuron.2006.06.020; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kong EC, 2010, ALCOHOL CLIN EXP RES, V34, P302, DOI 10.1111/j.1530-0277.2009.01093.x; Krishnan HR, ALCOHOL CLIN EXP RES; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li CP, 2008, ALCOHOL ALCOHOLISM, V43, P529, DOI 10.1093/alcalc/agn045; Li D, J PHYSL, V589, P4491; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mendoza C, 2003, J NEUROSCI, V23, P2093; Mendoza-Topaz C, 2008, J NEUROSCI, V28, P304, DOI 10.1523/JNEUROSCI.4395-07.2008; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Niethammer M, 1996, J NEUROSCI, V16, P2157; Sato Y, 2006, ANESTH ANALG, V103, P117, DOI 10.1213/01.ane.0000220944.27963.b1; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Scholz H, 2005, J NEUROBIOL, V63, P199, DOI 10.1002/neu.20127; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Slawson JB, 2011, GENETICS, V187, P171, DOI 10.1534/genetics.110.123406; Thomas U, 2010, J NEUROGENET, V24, P109, DOI 10.3109/01677063.2010.493589; Urizar NL, 2007, J NEUROSCI, V27, P4541, DOI 10.1523/JNEUROSCI.0305-07.2007; Venkatesh K, 1997, CURR BIOL, V7, P500, DOI 10.1016/S0960-9822(06)00221-1; Wang L, 2005, J BIOL CHEM, V280, P26992, DOI 10.1074/jbc.M503555200; Wolf FW, 2002, J NEUROSCI, V22, P11035; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Wu PH, 1996, J PHARMACOL EXP THER, V276, P1283; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Yang XJ, 2003, ALCOHOL CLIN EXP RES, V27, P1220, DOI 10.1097/01.ALC.0000081626.02910.19; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	65	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48967	10.1371/journal.pone.0048967	http://dx.doi.org/10.1371/journal.pone.0048967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145041	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800179
J	Makowiecki, K; Hammond, G; Rodger, J				Makowiecki, Kalina; Hammond, Geoff; Rodger, Jennifer			Different Levels of Food Restriction Reveal Genotype-Specific Differences in Learning a Visual Discrimination Task	PLOS ONE			English	Article							DIETARY RESTRICTION; MICE; EXPRESSION; ACQUISITION; PARAMETERS; SURVIVAL; WEIGHT; DESIGN; MEMORY	In behavioural experiments, motivation to learn can be achieved using food rewards as positive reinforcement in food-restricted animals. Previous studies reduce animal weights to 80-90% of free-feeding body weight as the criterion for food restriction. However, effects of different degrees of food restriction on task performance have not been assessed. We compared learning task performance in mice food-restricted to 80 or 90% body weight (BW). We used adult wildtype (WT; C57Bl/6j) and knockout (ephrin-A2(-/-)) mice, previously shown to have a reverse learning deficit. Mice were trained in a two-choice visual discrimination task with food reward as positive reinforcement. When mice reached criterion for one visual stimulus (80% correct in three consecutive 10 trial sets) they began the reverse learning phase, where the rewarded stimulus was switched to the previously incorrect stimulus. For the initial learning and reverse phase of the task, mice at 90% BW took almost twice as many trials to reach criterion as mice at 80% BW. Furthermore, WT 80 and 90% BW groups significantly differed in percentage correct responses and learning strategy in the reverse learning phase, whereas no differences between weight restriction groups were observed in ephrin-A2(-/-) mice. Most importantly, genotype-specific differences in reverse learning strategy were only detected in the 80% BW groups. Our results indicate that increased food restriction not only results in better performance and a shorter training period, but may also be necessary for revealing behavioural differences between experimental groups. This has important ethical and animal welfare implications when deciding extent of diet restriction in behavioural studies.	[Makowiecki, Kalina; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Makowiecki, Kalina; Hammond, Geoff] Univ Western Australia, Sch Psychol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	jennifer.rodger@uwa.edu.au	Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229; Makowiecki, Kalina/0000-0003-4550-3819				Arnall S, 2010, BEHAV BRAIN RES, V209, P109, DOI 10.1016/j.bbr.2010.01.023; Australian Government, 2004, AUSTR COD PRACT CAR; Balogh SA, 1999, BRAIN RES, V836, P38, DOI 10.1016/S0006-8993(99)01586-3; Balogh SA, 1998, DEV BRAIN RES, V111, P291, DOI 10.1016/S0165-3806(98)00138-2; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Coelho JS, 2010, APPETITE, V54, P229, DOI 10.1016/j.appet.2009.12.003; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Forestell CA, 2001, PHYSIOL BEHAV, V72, P559, DOI 10.1016/S0031-9384(00)00439-X; Gursoy E, 2001, EXP BIOL MED, V226, P97, DOI 10.1177/153537020122600206; Hashimoto T, 2005, NEUROREPORT, V16, P1129, DOI 10.1097/00001756-200507130-00019; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Hubert MF, 2000, TOXICOL SCI, V58, P195, DOI 10.1093/toxsci/58.1.195; Janis LS, 1999, J NEUROSCI, V19, P4962; Joseph J, 2009, J NEUROSCI, V29, P12795, DOI 10.1523/JNEUROSCI.3520-09.2009; Kasanen IHE, 2009, LAB ANIM-UK, V43, P215, DOI 10.1258/la.2008.008066; KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; LIPP HP, 1991, BEHAV BRAIN RES, V45, P135, DOI 10.1016/S0166-4328(05)80079-8; Steckler T, 2001, BEHAV BRAIN RES, V125, P237, DOI 10.1016/S0166-4328(01)00305-9; Tucci V, 2006, BEHAV BRAIN RES, V173, P22, DOI 10.1016/j.bbr.2006.05.031; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Wilks TA, 2010, EUR J NEUROSCI, V31, P613, DOI 10.1111/j.1460-9568.2010.07111.x; YEHUDA S, 1991, INT J NEUROSCI, V57, P81, DOI 10.3109/00207459109150349	24	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48703	10.1371/journal.pone.0048703	http://dx.doi.org/10.1371/journal.pone.0048703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144936	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800103
J	Riehl, T; Kaiser, S				Riehl, Torben; Kaiser, Stefanie			Conquered from the Deep Sea? A New Deep-Sea Isopod Species from the Antarctic Shelf Shows Pattern of Recent Colonization	PLOS ONE			English	Article							PINE ISLAND BAY; POPULATION DIFFERENTIATION DECREASES; LAST GLACIAL MAXIMUM; ROSS ICE SHELF; SOUTHERN-OCEAN; ASELLOTA CRUSTACEA; MITOCHONDRIAL-DNA; CRYPTIC SPECIATION; DRAKE PASSAGE; LIFE-HISTORY	The Amundsen Sea, Antarctica, is amongst the most rapidly changing environments of the world. Its benthic inhabitants are barely known and the BIOPEARL 2 project was one of the first to biologically explore this region. Collected during this expedition, Macrostylis roaldi sp. nov. is described as the first isopod discovered on the Amundsen-Sea shelf. Amongst many characteristic features, the most obvious characters unique for M. roaldi are the rather short pleotelson and short operculum as well as the trapezoid shape of the pleotelson in adult males. We used DNA barcodes (COI) and additional mitochondrial markers (12S, 16S) to reciprocally illuminate morphological results and nucleotide variability. In contrast to many other deep-sea isopods, this species is common and shows a wide distribution. Its range spreads from Pine Island Bay at inner shelf right to the shelf break and across 1,000 m bathymetrically. Its gene pool is homogenized across space and depth. This is indicative for a genetic bottleneck or a recent colonization history. Our results suggest further that migratory or dispersal capabilities of some species of brooding macrobenthos have been underestimated. This might be relevant for the species' potential to cope with effects of climate change. To determine where this species could have survived the last glacial period, alternative refuge possibilities are discussed.	[Riehl, Torben; Kaiser, Stefanie] Univ Hamburg, Bioctr, Grindel & Zool Museum, Hamburg, Germany; [Riehl, Torben] German Ctr Marine Biodivers Res, Hamburg, Germany	University of Hamburg	Riehl, T (corresponding author), Univ Hamburg, Bioctr, Grindel & Zool Museum, Hamburg, Germany.	t.riehl@gmx.de	Riehl, Torben/C-3711-2013	Riehl, Torben/0000-0002-7363-4421; Kaiser, Stefanie/0000-0003-2026-4663	"Census of the Diversity of Abyssal Marine Life'' taxonomic exchange fellowship; Stiftung Universitat Hamburg; "German national academic foundation'' (Studienstiftung des Deutschen Volkes); University of Hamburg ("Innovationsfond'')	"Census of the Diversity of Abyssal Marine Life'' taxonomic exchange fellowship; Stiftung Universitat Hamburg; "German national academic foundation'' (Studienstiftung des Deutschen Volkes); University of Hamburg ("Innovationsfond'')	Two LAB visits at the National Museum of National History of Torben Riehl were partly funded by the "Census of the Diversity of Abyssal Marine Life'' taxonomic exchange fellowship and the "Stiftung Universitat Hamburg''. Preparation of this manuscript benefitted from a Ph.D. fellowship to the first author by the "German national academic foundation'' (Studienstiftung des Deutschen Volkes) and a travel grant from the same source. Stefanie Kaiser acknowledges a grant provided by the University of Hamburg ("Innovationsfond''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; Barnes DKA, 2010, GLOBAL CHANGE BIOL, V16, P3297, DOI 10.1111/j.1365-2486.2010.02198.x; Barnes DKA, 2010, J BIOGEOGR, V37, P1648, DOI 10.1111/j.1365-2699.2010.02320.x; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Birstein YA, 1973, DEEP WATER ISOPODS C, P1; Birstein YA, 1970, FAUNA KURILE KAMCHAT, P308; Bonn WJ, 1998, PALAEOGEOGR PALAEOCL, V139, P195, DOI 10.1016/S0031-0182(97)00144-2; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; Brandt A, 2004, ZOOTAXA, P1; BRANDT A, 1992, MAR BIOL, V113, P415, DOI 10.1007/BF00349167; Brandt A, 2011, DEEP-SEA RES PT II, V58, P1962, DOI 10.1016/j.dsr2.2011.01.008; Brandt A., 1991, Berichte zur Polarforschung, V98, P1; Brandt A, 2002, P BIOL SOC WASH, V115, P616; BRANDT A, 1992, ZOOL SCR, V21, P57, DOI 10.1111/j.1463-6409.1992.tb00310.x; Brandt A, 1999, SCI MAR, V63, P261, DOI 10.3989/scimar.1999.63s1261; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; Brenke N, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787444015; BREY T, 1994, NATURE, V368, P297, DOI 10.1038/368297a0; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Brix Saskia, 2011, Zootaxa, V2838, P79; Brix S, 2010, POLAR BIOL, V33, P515, DOI 10.1007/s00300-009-0729-8; Brokeland W, 2010, ZOOTAXA, P1; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Clarke A, 2003, ECOSY WORLD, V28, P239; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Coleman Charles Oliver, 2009, Zoosystematics and Evolution, V85, P305, DOI 10.1002/zoos.200900008; Coleman CO, 2003, ORG DIVERS EVOL, V3; DALLWITZ MJ, 1993, ADVANCES IN COMPUTER METHODS FOR SYSTEMATIC BIOLOGY, P287; DALLWITZ MJ, 1980, TAXON, V29, P41, DOI 10.2307/1219595; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; Dowdeswell JA, 2006, GEOL SOC AM BULL, V118, P606, DOI 10.1130/B25791.1; Drummond A. J., 2011, GENEIOUS V5 4; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; ETTER RJ, 1990, DEEP-SEA RES, V37, P1251, DOI 10.1016/0198-0149(90)90041-S; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; FRANCE SC, 1994, MAR BIOL, V118, P67, DOI 10.1007/BF00699220; Gurjenowa E., 1933, P391; Gutt J, 2011, DEEP-SEA RES PT II, V58, P74, DOI 10.1016/j.dsr2.2010.05.024; Hansen H.J., 1916, DAN INGOLF EXPED, V3, P1; HARRISON K, 1989, CRUSTACEANA, V56, P317, DOI 10.1163/156854089X00284; HART CW, 1985, P BIOL SOC WASH, V98, P288; Havermans C, 2011, DEEP-SEA RES PT II, V58, P230, DOI 10.1016/j.dsr2.2010.09.028; Held C, 2000, MOL PHYLOGENET EVOL, V15, P165, DOI 10.1006/mpev.1999.0739; Held C, 2005, SCI MAR, V69, P175, DOI 10.3989/scimar.2005.69s2175; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; HELMUTH B, 1994, MAR BIOL, V120, P421, DOI 10.1007/BF00680216; Hessler R.R., 1983, Systematics Association Special Volume Series, P227; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; HESSLER RR, 1975, MAR BIOL, V32, P155, DOI 10.1007/BF00388508; HESSLER RR, 1989, SARSIA, V74, P145, DOI 10.1080/00364827.1989.10413424; Hessler RR., 1970, DESMOSOMATIDAE ISOPO; Hoelzel AR, 1999, BIOL J LINN SOC, V68, P23, DOI 10.1111/j.1095-8312.1999.tb01156.x; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jarman SN, 2002, HEREDITY, V88, P280, DOI 10.1038/sj.hdy.6800041; Kaiser S, 2008, CLIM RES, V37, P165, DOI 10.3354/cr00761; Kaiser S, 2007, DEEP-SEA RES PT II, V54, P1776, DOI 10.1016/j.dsr2.2007.07.006; Kaiser S, 2011, DEEP-SEA RES PT II, V58, P91, DOI 10.1016/j.dsr2.2010.05.017; Kaiser Stefanie, 2009, Marine Biodiversity, V39, P27; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kavanagh FA, 2007, INVERTEBR SYST, V21, P487, DOI 10.1071/IS06031; KELLOGG TB, 1987, J GEOPHYS RES-SOLID, V92, P8859, DOI 10.1029/JB092iB09p08859; Krabbe K, 2010, POLAR BIOL, V33, P281, DOI 10.1007/s00300-009-0703-5; Kussakin O.G., 1999, MARINE BRACKISH WA 2; Latreille P, 1802, HIST NATURELLE GEN P, DOI [DOI 10.5962/BHL.TITLE.15764, 10.5962/bhl.title.11138]; Lawver LA, 2011, AM GEOPHYS UNION SP, V63, P5, DOI 10.1029/2010SP001017; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; LIPPS JH, 1979, SCIENCE, V203, P447, DOI 10.1126/science.203.4379.447; Lowe AL, 2003, J GLACIOL, V49, P125, DOI 10.3189/172756503781830971; Lowe AL, 2002, QUATERNARY SCI REV, V21, P1879, DOI 10.1016/S0277-3791(02)00006-9; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Machida RJ, 2002, MAR BIOTECHNOL, V4, P406, DOI 10.1007/s10126-002-0033-x; Meinert FVA, 1890, CRUSTACEA MALACOSTRA, V3, P147; Menzel L, 2011, DEEP-SEA RES PT I, V58, P839, DOI 10.1016/j.dsr.2011.05.008; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; Menzies RJ, 1962, VEMA RES SERIES, V1, P79; Menzies RJ, 1972, ANTON BRUUN REPORT, V9, P1; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mezhov B.V., 1993, Arthropoda Selecta, V2, P3; MEZHOV BV, 1988, ZOOL ZH, V67, P983; Mezhov BV, 1992, ARTHROPODA SEL, V1, P83; Nitsche FO, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001694; O'Loughlin PM, 2011, DEEP-SEA RES PT II, V58, P264, DOI 10.1016/j.dsr2.2010.10.011; Okey TA, 1997, CONT SHELF RES, V17, P877, DOI 10.1016/S0278-4343(96)00067-2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2010, MAR BIOL, V157, P1783, DOI 10.1007/s00227-010-1451-3; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Raupach MJ, 2004, DEEP-SEA RES PT II, V51, P1787, DOI 10.1016/j.dsr2.2004.06.035; Riddle MJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001327; Riehl T., 2012, ZOOTAXA, V3277, P1, DOI [DOI 10.11646/ZOOTAXA.3277.1.1, 10.11646/zootaxa.3277.1.1]; Riehl T, 2010, ZOOKEYS, P9, DOI 10.3897/zookeys.57.310; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Sars G. O., 1864, FORHANDHLINGER VIDEN, P205; Sars G.O., 1899, ACCOUNT CRUSTACEA NO; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; STOCKTON WL, 1982, DEEP-SEA RES, V29, P819, DOI 10.1016/0198-0149(82)90048-6; Strugnell JM, 2011, DEEP-SEA RES PT II, V58, P196, DOI 10.1016/j.dsr2.2010.05.015; Strugnell JM, 2008, CLADISTICS, V24, P853, DOI 10.1111/j.1096-0031.2008.00234.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; THISTLE D, 1987, DEEP-SEA RES, V34, P73, DOI 10.1016/0198-0149(87)90123-3; THISTLE D, 1985, MAR GEOL, V66, P91, DOI 10.1016/0025-3227(85)90024-6; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Tsang LM, 2009, MOL ECOL, V18, P1463, DOI 10.1111/j.1365-294X.2009.04090.x; Wagele J.-.W., 1989, EVOLUTION PHYLOGENET; Weber DS, 2000, CURR BIOL, V10, P1287, DOI 10.1016/S0960-9822(00)00759-4; WILKENS H, 1986, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V83, P223; WILSON GD, 1983, J CRUSTACEAN BIOL, V3, P127, DOI 10.2307/1547858; WILSON GDF, 1987, ANNU REV ECOL SYST, V18, P185, DOI 10.1146/annurev.ecolsys.18.1.185; Wilson GDF, 1989, DYSTEMATIC REVISION; Wilson George D.F., 2008, Zootaxa, V1680, P1; Wilson GDF, 2008, DEEP-SEA RES PT II, V55, P2634, DOI 10.1016/j.dsr2.2008.07.014; Wilson GDF, 2009, MOL PHYLOGENET EVOL, V51, P349, DOI 10.1016/j.ympev.2009.02.001; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Wolff T., 1962, Galathea Report, V6, P1; WOLFF TORBEN, 1956, GALATHEA REPTS, V2, P85; WRIGHT S., 1938, Science (Washington), V87, P430; Wright S, 1943, GENETICS, V28, P114; Wurzberg L, 2011, DEEP-SEA RES PT II, V58, P2027, DOI 10.1016/j.dsr2.2011.05.013; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x	137	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49354	10.1371/journal.pone.0049354	http://dx.doi.org/10.1371/journal.pone.0049354			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145160	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800251
J	Snyder, JS; Ferrante, SC; Cameron, HA				Snyder, Jason S.; Ferrante, Sarah C.; Cameron, Heather A.			Late Maturation of Adult-Born Neurons in the Temporal Dentate Gyrus	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; FOS EXPRESSION; SPATIAL MEMORY; GRANULE CELLS; TOTAL NUMBER; RAT; STRESS; ARC; SURVIVAL; DORSAL	Hippocampal function varies along its septotemporal axis, with the septal (dorsal) pole more frequently involved in spatial learning and memory and the temporal (ventral) pole playing a greater role in emotional behaviors. One feature that varies across these subregions is adult neurogenesis. New neurons are more numerous in the septal hippocampus but are more active in the temporal hippocampus during water maze training. However, many other aspects of adult neurogenesis remain unexplored in the context of septal versus temporal subregions. In addition, the dentate gyrus contains another functionally important anatomical division along the transverse axis, with the suprapyramidal blade showing greater experience-related activity than the infrapyramidal blade. Here we ask whether new neurons differ in their rates of survival and maturation along the septotemporal and transverse axes. We found that neurogenesis is initially higher in the infrapyramidal than suprapyramidal blade, but these cells are less likely to survive, resulting in similar densities of neurons in the two blades by four weeks. Across the septotemporal axis, neurogenesis was higher in septal than temporal pole, while the survival rate of new neurons did not differ. Maturation was assessed by immunostaining for the neuronal marker, NeuN, which increases in expression level with maturation, and for the immediate-early gene, Arc, which suggests a neuron is capable of undergoing activity-dependent synaptic plasticity. Maturation occurred approximately 1-2 weeks earlier in the septal pole than in the temporal pole. This suggests that septal neurons may contribute to function sooner; however, the prolonged maturation of new temporal neurons may endow them with a longer window of plasticity during which their functions could be distinct from those of the mature granule cell population. These data point to subregional differences in new neuron maturation and suggest that changes in neurogenesis could alter different hippocampus-dependent behaviors with different time courses.	[Snyder, Jason S.; Ferrante, Sarah C.; Cameron, Heather A.] NIMH, Unit Neuroplast, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Snyder, JS (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jasonscottsnyder@psych.ubc.ca	Cameron, Heather/E-6221-2011	Cameron, Heather/0000-0002-3245-5777; Snyder, Jason/0000-0002-5509-0272	National Institutes of Health, National Institute of Mental Health [1ZIAMH002784]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002784] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Mental Health, 1ZIAMH002784. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bast T, 2009, PLOS BIOL, V7, P730, DOI 10.1371/journal.pbio.1000089; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Choi YS, 2007, ARCH PHARM RES, V30, P646, DOI 10.1007/BF02977661; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; de Hoz L, 2003, HIPPOCAMPUS, V13, P587, DOI 10.1002/hipo.10079; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferbinteanu J, 2001, HIPPOCAMPUS, V11, P187, DOI 10.1002/hipo.1036; Fevurly RD, 2004, J NEUROENDOCRINOL, V16, P970, DOI 10.1111/j.1365-2826.2004.01257.x; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Hight K, 2010, BRAIN RES, V1337, P32, DOI 10.1016/j.brainres.2010.04.012; HORTNAGL H, 1991, NEUROSCIENCE, V45, P261, DOI 10.1016/0306-4522(91)90224-C; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Sandoval CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017689; Jinno S, 2011, HIPPOCAMPUS, V21, P467, DOI 10.1002/hipo.20762; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; KORBO L, 1990, J NEUROSCI METH, V31, P93, DOI 10.1016/0165-0270(90)90153-7; Kuipers SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004885; Leuner B, 2012, HIPPOCAMPUS, V22, P861, DOI 10.1002/hipo.20947; McDonald RJ, 2006, EUR J NEUROSCI, V24, P1789, DOI 10.1111/j.1460-9568.2006.05064.x; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Olariu A, 2007, J COMP NEUROL, V501, P659, DOI 10.1002/cne.21268; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rahimi O, 2007, PROG BRAIN RES, V163, P167, DOI 10.1016/S0079-6123(07)63010-6; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Satvat E, 2011, J NEUROSCI, V31, P7163, DOI 10.1523/JNEUROSCI.0094-11.2011; Segal M, 2010, HIPPOCAMPUS, V20, P1332, DOI 10.1002/hipo.20751; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Snyder JS, 2012, BEHAV BRAIN RES, V227, P384, DOI 10.1016/j.bbr.2011.06.024; Snyder JS, 2012, BEHAV BRAIN RES, V227, P330, DOI 10.1016/j.bbr.2011.06.025; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2011, NEUROBIOL AGING, V32, P1149, DOI 10.1016/j.neurobiolaging.2009.05.022; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2009, HIPPOCAMPUS, V19, P898, DOI 10.1002/hipo.20552; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; SWANSON LW, 1975, SCIENCE, V189, P303, DOI 10.1126/science.49928; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tanti A, 2012, NEUROPHARMACOLOGY, V63, P374, DOI 10.1016/j.neuropharm.2012.04.022; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WIMER RE, 1990, BRAIN RES, V534, P94, DOI 10.1016/0006-8993(90)90116-S; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011764	66	68	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48757	10.1371/journal.pone.0048757	http://dx.doi.org/10.1371/journal.pone.0048757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144957	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800122
J	Valenti, L; Rametta, R; Dongiovanni, P; Motta, BM; Canavesi, E; Pelusi, S; Pulixi, EA; Fracanzani, AL; Fargion, S				Valenti, Luca; Rametta, Raffaela; Dongiovanni, Paola; Motta, Benedetta M.; Canavesi, Elena; Pelusi, Serena; Pulixi, Edoardo A.; Fracanzani, Anna L.; Fargion, Silvia			The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; SERUM FERRITIN; HEPCIDIN; PREVALENCE; VARIANTS; FIBROSIS; RISK; HYPERFERRITINEMIA; HEMOCHROMATOSIS	Background & Aims: Hepatic iron accumulation due to altered trafficking is frequent in patients with nonalcoholic fatty liver disease (NAFLD), and is associated with more severe liver damage and hepatocellular carcinoma. The p.Ala736Val TMPRSS6 variant influences iron metabolism regulating the transcription of the hepatic hormone hepcidin, but its role in the pathogenesis of iron overload disorders is controversial. Aim of this study was to evaluate the whether the TMPRSS6 p.Ala736Val variant influences hepatic iron accumulation in a well-characterized series of Italian patients with histological NAFLD. Methods: 216 patients with histological NAFLD. TMPRSS6 and HFE variants were assessed by allele specific PCR, liver histology by the NAFLD activity score and Perls' staining for iron. Results: Homozygosity for the p.736Val allele previously linked to higher hepcidin did not influence transferrin saturation (TS), but was associated with lower hepatic iron stores (p = 0.01), and ferritin levels (median 223 IQR 102-449 vs. 308 IQR 141-618 ng/ml; p = 0.01). Homozygosity for TMPRSS6 p.736Val was nearly associated with lower ballooning (p = 0.05), reflecting hepatocellular damage related to oxidative stress. The influence of TMPRSS6 on hepatic iron accumulation was more marked in patients negative for HFE genotypes predisposing to iron overload (p.Cys282Tyr + and p.His63Asp +/+; p = 0.01), and the p. 736Val variant was negatively associated with hepatic iron accumulation independently of age, gender, HFE genotype, and beta-thalassemia trait (OR 0.59, 0.39-0.88). Conclusions: The p.Ala736Val TMPRSS6 variant influences secondary hepatic iron accumulation in patients with NAFLD.	[Valenti, Luca; Rametta, Raffaela; Dongiovanni, Paola; Motta, Benedetta M.; Canavesi, Elena; Pelusi, Serena; Pulixi, Edoardo A.; Fracanzani, Anna L.; Fargion, Silvia] Univ Milan, Dept Pathophysiol & Transplantat, Sect Internal Med, Fdn Ca Granda IRCCS Osped Maggiore Policlin, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Valenti, L (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Sect Internal Med, Fdn Ca Granda IRCCS Osped Maggiore Policlin, Milan, Italy.	luca.valenti@unimi.it	pelusi, serena/AAC-2725-2022; Motta, Benedetta Maria/AAA-8559-2020; Valenti, Luca/B-3695-2009; Dongiovanni, Paola/AAC-9965-2019; Fracanzani, Anna Ludovica/J-8986-2018	Motta, Benedetta Maria/0000-0002-6681-2170; Valenti, Luca/0000-0001-8909-0345; Dongiovanni, Paola/0000-0003-4343-7213; Fracanzani, Anna Ludovica/0000-0001-5918-0171; rametta, raffaela/0000-0003-0091-9394	Associazione Malattie Metaboliche del Fegato ONLUS	Associazione Malattie Metaboliche del Fegato ONLUS	The work was supported by the the Associazione Malattie Metaboliche del Fegato ONLUS (non-profit organization for the study and the cure of metabolic liver diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Bugianesi E, 2004, HEPATOLOGY, V39, P179, DOI 10.1002/hep.20023; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Delbini P, 2010, BRIT J HAEMATOL, V151, P281, DOI 10.1111/j.1365-2141.2010.08349.x; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Fargion S, 2001, AM J GASTROENTEROL, V96, P2448, DOI 10.1111/j.1572-0241.2001.04052.x; Finberg KE, 2011, BLOOD, V117, P4590, DOI 10.1182/blood-2010-10-315507; Finberg KE, 2009, SEMIN HEMATOL, V46, P378, DOI 10.1053/j.seminhematol.2009.06.006; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Haap M, 2011, J CLIN ENDOCR METAB, V96, pE958, DOI 10.1210/jc.2010-2682; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Martinelli N, 2012, PLOS ONE IN PRESS; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nai A, 2011, BLOOD, V118, P4459, DOI 10.1182/blood-2011-06-364034; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; NELSON JE, 2009, 2009 INT BIOIRON SOC, P185; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Saeed O, 2012, ARTERIOSCL THROM VAS, V32, P299, DOI 10.1161/ATVBAHA.111.240101; Shah SV, 2011, DIABETES CARE, V34, P1676, DOI 10.2337/dc11-0700; Shi ZM, 2006, DIABETES CARE, V29, P1878, DOI 10.2337/dc06-0327; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Sullivan JL, 2007, EXP BIOL MED, V232, P1014, DOI 10.3181/0703-MR-54; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tanaka T, 2009, BLOOD; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; Valenti L, 2011, NUTR METAB CARDIOVAS, V21, P568, DOI 10.1016/j.numecd.2010.01.003; Valenti L, 2003, DIGEST LIVER DIS, V35, P172, DOI 10.1016/S1590-8658(03)00025-2; Valenti L, 2012, J HEPATOL IN PRESS; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Valenti L, 2006, HEPATOLOGY, V44, P857, DOI 10.1002/hep.21329; Valenti L, 2012, WORLD J GASTROENTERO, V18, P3782, DOI 10.3748/wjg.v18.i29.3782; Valenti L, 2011, ARTERIOSCL THROM VAS, V31, P683, DOI 10.1161/ATVBAHA.110.214858; Valenti L, 2010, J HEPATOL, V53, P927, DOI 10.1016/j.jhep.2010.05.023; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Zheng X, 2011, AM J CLIN NUTR, V94, P1012, DOI 10.3945/ajcn.111.015743	52	39	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48804	10.1371/journal.pone.0048804	http://dx.doi.org/10.1371/journal.pone.0048804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144979	gold, Green Submitted, Green Published			2022-12-25	WOS:000310741400062
J	Nagy, A; Takagi, Y; Billington, N; Sun, SA; Hong, DKT; Homsher, E; Wang, AB; Sellers, JR				Nagy, Attila; Takagi, Yasuharu; Billington, Neil; Sun, Sara A.; Hong, Davin K. T.; Homsher, Earl; Wang, Aibing; Sellers, James R.			Kinetic Characterization of Nonmuscle Myosin IIB at the Single Molecule Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOAD-DEPENDENT KINETICS; NATIVE THICK FILAMENTS; MUSCLE-CONTRACTION; OPTICAL TWEEZERS; ACTIN-FILAMENTS; CELL-ADHESION; LIGHT-CHAIN; IN-VITRO; MECHANISM; MOTOR	Nonmuscle myosin IIB (NMIIB) is a cytoplasmic myosin, which plays an important role in cell motility by maintaining cortical tension. It forms bipolar thick filaments with similar to 14 myosin molecule dimers on each side of the bare zone. Our previous studies showed that the NMIIB is a moderately high duty ratio (similar to 20-25%) motor. The ADP release step (similar to 0.35 s(-1)) of NMIIB is only similar to 3 times faster than the rate-limiting phosphate release (0.13 +/- 0.01 s(-1)). The aim of this study was to relate the known in vitro kinetic parameters to the results of single molecule experiments and to compare the kinetic and mechanical properties of single-and double-headed myosin fragments and nonmuscle IIB thick filaments. Examination of the kinetics of NMIIB interaction with actin at the single molecule level was accomplished using total internal reflection fluorescence (TIRF) with fluorescence imaging with 1-nm accuracy (FIONA) and dual-beam optical trapping. At a physiological ATP concentration (1 mM), the rate of detachment of the single-headed and double-headed molecules was similar (similar to 0.4 s(-1)). Using optical tweezers we found that the power stroke sizes of single-and double-headed heavy meromyosin (HMM) were each similar to 6 nm. No signs of processive stepping at the single molecule level were observed in the case of NMIIB-HMM in optical tweezers or TIRF/in vitro motility experiments. In contrast, robust motility of individual fluorescently labeled thick filaments of full-length NMIIB was observed on actin filaments. Our results are in good agreement with the previous steady-state and transient kinetic studies and show that the individual nonprocessive nonmuscle myosin IIB molecules form a highly processive unit when polymerized into filaments.	[Nagy, Attila; Takagi, Yasuharu; Billington, Neil; Sun, Sara A.; Hong, Davin K. T.; Homsher, Earl; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Wang, Aibing] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; [Homsher, Earl] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3523, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov	Sun, Sara A./T-4334-2019	Billington, Neil/0000-0003-2306-0228; Sun, Sara/0000-0002-1456-2528	National Institutes of Health intramural funds from the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004216, ZIAHL001786] Funding Source: NIH RePORTER	National Institutes of Health intramural funds from the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or part, by National Institutes of Health intramural funds from the NHLBI.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Batters C, 2004, PHILOS T R SOC B, V359, P1895, DOI 10.1098/rstb.2004.1559; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; BRENNER B, 1982, P NATL ACAD SCI-BIOL, V79, P7288, DOI 10.1073/pnas.79.23.7288; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; de la Fuente H, 2005, MOL BIOL CELL, V16, P3314, DOI 10.1091/mbc.E05-01-0005; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Greenberg MJ, 2012, P NATL ACAD SCI USA, V109, pE2433, DOI 10.1073/pnas.1207811109; GREENE LE, 1987, J BIOL CHEM, V262, P4177; GREENE LE, 1981, BIOCHEMISTRY-US, V20, P2120, DOI 10.1021/bi00511a008; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kengyel A, 2010, J MUSCLE RES CELL M, V31, P163, DOI 10.1007/s10974-010-9220-y; Knight AE, 2001, PROG BIOPHYS MOL BIO, V77, P45, DOI 10.1016/S0079-6107(01)00010-4; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kural C, 2005, J PHYS-CONDENS MAT, V17, pS3979, DOI 10.1088/0953-8984/17/47/023; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; MARGOSSIAN SS, 1973, J MOL BIOL, V74, P301, DOI 10.1016/0022-2836(73)90375-6; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MAUPIN P, 1994, J CELL SCI, V107, P3077; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Norstrom MF, 2010, J BIOL CHEM, V285, P26326, DOI 10.1074/jbc.M110.123851; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; SELLERS JR, 1990, SCIENCE, V249, P406, DOI 10.1126/science.2377894; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Smith DA, 2004, J MUSCLE RES CELL M, V25, P215, DOI 10.1023/B:JURE.0000038171.22680.2e; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Vicente-Manzanares M, 2003, J IMMUNOL, V171, P1023, DOI 10.4049/jimmunol.171.2.1023; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; West JM, 1996, J MUSCLE RES CELL M, V17, P637, DOI 10.1007/BF00154058; Yanagida T, 2000, CURR OPIN CELL BIOL, V12, P20, DOI 10.1016/S0955-0674(99)00052-6; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s	67	51	51	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					709	722		10.1074/jbc.M112.424671	http://dx.doi.org/10.1074/jbc.M112.424671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148220	hybrid, Green Published			2022-12-25	WOS:000313197200071
J	Valdes, R; Shinde, U; Landfear, SM				Valdes, Raquel; Shinde, Ujwal; Landfear, Scott M.			Cysteine Cross-linking Defines the Extracellular Gate for the Leishmania donovani Nucleoside Transporter 1.1 (LdNT1.1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; NUCLEOBASE TRANSPORTER; GLUTAMATE TRANSPORTER; CHIMERIC CONSTRUCTS; MUTATIONAL ANALYSIS; P-GLYCOPROTEIN; ENT FAMILY; SENSITIVITY; GENE; NITROBENZYLTHIOINOSINE	Equilibrative nucleoside transporters are a unique family of proteins that enable uptake of nucleosides-nucleobases into a wide range of eukaryotes and internalize a myriad of drugs used in the treatment of cancer, heart disease, AIDs, and parasitic infections. In previous work we generated a structural model for such a transporter, the LdNT1.1 nucleoside permease from the parasitic protozoan Leishmania donovani, using ab initio computation. The model suggested that aromatic residues present in transmembrane helices 1, 2, and 7 interact to form an extracellular gate that closes the permeation pathway in the inward-open conformation. Mutation of residues Phe-48(TM1) and Trp-75(TM2) abrogated transport activity, consistent with such prediction. In this study cysteine mutagenesis and oxidative cross-linking were combined to analyze proximity relationships of helices 1, 2, and 7 in LdNT1.1. Disulfide bond formation between introduced paired cysteines at the interface of such helices (A61C(TM1)/F74C(TM2), A61C(TM1)/G350C(TM7), and F74C(TM2)/ G350C(TM7)) was analyzed by transport measurement and gel mobility shifts upon oxidation with Cu (II)-(1,10-phenanthroline)(3). In all cases cross-linking inhibited transport. However, if LdNT1.1 ligands were included during cross-linking, inhibition of transport was reduced, suggesting that ligands moved the three gating helices apart. Moreover, all paired cysteine mutants exhibited a mobility shift upon oxidation, corroborating the formation of a disulfide bond. These data support the notion that helices 1, 2, and 7 constitute the extracellular gate of LdNT1.1, thus further validating the computational model and the previously demonstrated importance of F48(TM1) and Trp-75(TM2) in tethering together helices that are part of the gate.	[Valdes, Raquel; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), OR Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu		Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI44138]; National Science Foundation [0746589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44138 (to S. M. L.). This work was also supported by National Science Foundation Grant 0746589 (to U. S.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Carter NS, 2000, J BIOL CHEM, V275, P20935, DOI 10.1074/jbc.M002418200; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Detke S, 2007, EXP CELL RES, V313, P1963, DOI 10.1016/j.yexcr.2007.02.027; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kavanaugh MP, 1998, P NATL ACAD SCI USA, V95, P12737, DOI 10.1073/pnas.95.22.12737; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Kubo Y, 2000, J BIOL CHEM, V275, P5270, DOI 10.1074/jbc.275.8.5270; LEBOWITZ JH, 1994, METHOD CELL BIOL, V45, P65; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Ortiz D, 2010, MOL MICROBIOL, V78, P108, DOI 10.1111/j.1365-2958.2010.07328.x; Ortiz D, 2009, J BIOL CHEM, V284, P16164, DOI 10.1074/jbc.M109.006718; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Paproski RJ, 2008, BIOCHEM J, V414, P291, DOI 10.1042/BJ20080074; Qiu ZY, 2001, J BIOL CHEM, V276, P194, DOI 10.1074/jbc.M005571200; Rose JB, 2008, PHYSIOLOGY, V23, P41, DOI 10.1152/physiol.00036.2007; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; Stroud RM, 2007, P NATL ACAD SCI USA, V104, P1445, DOI 10.1073/pnas.0610349104; Sundaram M, 1998, J BIOL CHEM, V273, P21519, DOI 10.1074/jbc.273.34.21519; Sundaram M, 2001, BIOCHEMISTRY-US, V40, P8146, DOI 10.1021/bi0101805; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2005, MOL PHARMACOL, V67, P1291, DOI 10.1124/mol.104.005884; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zhang XP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021288; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	59	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44036	44045		10.1074/jbc.M112.414433	http://dx.doi.org/10.1074/jbc.M112.414433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150661	hybrid, Green Published			2022-12-25	WOS:000312938600003
J	Sato, N; Okochi, M; Shinohara, M; Thinakaran, G; Takeda, S; Fukumori, A; Shinohara-Noma, M; Mori-Ueda, M; Hamada, H; Takeda, M; Rakugi, H; Morishita, R				Sato, Naoyuki; Okochi, Masayasu; Shinohara, Mitsuru; Thinakaran, Gopal; Takeda, Shuko; Fukumori, Akio; Shinohara-Noma, Motoko; Mori-Ueda, Mari; Hamada, Hizuki; Takeda, Masatoshi; Rakugi, Hiromi; Morishita, Ryuichi			Differential Regulation of Amyloid Precursor Protein/Presenilin 1 Interaction during Ab40/42 Production Detected Using Fusion Constructs	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; TRANSMEMBRANE DOMAIN; MISSENSE MUTATIONS; BETA-PROTEIN; A-BETA; PRESENILIN-1; GENE; CLEAVAGE; ENDOPROTEOLYSIS	Beta amyloid peptides (A beta) play a key role in the pathogenesis of Alzheimer disease (AD). Presenilins (PS) function as the catalytic subunits of gamma-secretase, the enzyme that releases A beta from ectodomain cleaved amyloid precursor protein (APP) by intramembrane proteolysis. Familial Alzheimer disease (FAD)-linked PSEN mutations alter APP processing in a manner that increases the relative abundance of longer A beta 42 peptides to that of A beta 40 peptides. The mechanisms by which A beta 40 and A beta 42 peptides are produced in a ratio of ten to one by wild type presenilin (PS) and by which A beta 42 is overproduced by FAD-linked PS variants are not completely understood. We generated chimeras of the amyloid precursor protein C-terminal fragment (C99) and PS to address this issue. We found a chimeric protein where C99 is fused to the PS1 N-terminus undergoes in cis processing to produce A beta and that a fusion protein harboring FAD-linked PS1 mutations overproduced A beta 42. To change the molecular interactions within the C99-PS1 fusion protein, we made sequential deletions of the junction between C99 and PS1. We found differential effects of deletion in C99-PS1 on A beta 40 and 42 production. Deletion of the junction between APP CTF and PS1 in the fusion protein decreased A beta 40, while it did not decrease A beta 42 production in the presence or absence of FAD-linked PS1 mutation. These results are consistent with the idea that the APP/PS interaction is differentially regulated during A beta 40 and 42 production.	[Sato, Naoyuki; Shinohara, Mitsuru; Takeda, Shuko; Shinohara-Noma, Motoko; Mori-Ueda, Mari; Hamada, Hizuki; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Sato, Naoyuki; Shinohara, Mitsuru; Takeda, Shuko; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka, Japan; [Okochi, Masayasu; Fukumori, Akio; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat & Behav Prote, Suita, Osaka, Japan; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Osaka University; Osaka University; Osaka University; University of Chicago	Sato, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan.	nsato@cgt.med.osaka-u.ac.jp		Okochi, Masayasu/0000-0002-2318-7651; Rakugi, Hiromi/0000-0001-6508-4338	Japan Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency; Novartis Gerontological Research Grant, Chiyoda; Kanae Foundation; Grants-in-Aid for Scientific Research [23590874] Funding Source: KAKEN	Japan Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Novartis Gerontological Research Grant, Chiyoda; Kanae Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from Japan Promotion of Science, the Japanese Ministry of Education, Culture, Sports, Science and Technology (to NS, RM), the Japan Science and Technology Agency (to NS), a Novartis Gerontological Research Grant, Chiyoda, and Kanae Foundation (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Guerreiro RJ, 2010, NEUROBIOL AGING, V31, P725, DOI 10.1016/j.neurobiolaging.2008.06.012; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	33	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48551	10.1371/journal.pone.0048551	http://dx.doi.org/10.1371/journal.pone.0048551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152781	gold, Green Submitted, Green Published			2022-12-25	WOS:000311234000020
J	Schwartz, AG; Pasteris, JD; Genin, GM; Daulton, TL; Thomopoulos, S				Schwartz, Andrea G.; Pasteris, Jill D.; Genin, Guy M.; Daulton, Tyrone L.; Thomopoulos, Stavros			Mineral Distributions at the Developing Tendon Enthesis	PLOS ONE			English	Article							BONE INSERTION; ROTATOR CUFF; COMPOSITIONAL PROPERTIES; LOCALIZED EXPRESSION; EXTRACELLULAR-MATRIX; COLLAGEN; TISSUE; LIGAMENT; ATTACHMENT; CARTILAGE	Tendon attaches to bone across a functionally graded interface, "the enthesis''. A gradient of mineral content is believed to play an important role for dissipation of stress concentrations at mature fibrocartilaginous interfaces. Surgical repair of injured tendon to bone often fails, suggesting that the enthesis does not regenerate in a healing setting. Understanding the development and the micro/nano-meter structure of this unique interface may provide novel insights for the improvement of repair strategies. This study monitored the development of transitional tissue at the murine supraspinatus tendon enthesis, which begins postnatally and is completed by postnatal day 28. The micrometer-scale distribution of mineral across the developing enthesis was studied by X-ray micro-computed tomography and Raman microprobe spectroscopy. Analyzed regions were identified and further studied by histomorphometry. The nanometer-scale distribution of mineral and collagen fibrils at the developing interface was studied using transmission electron microscopy (TEM). A zone (similar to 20 mu m) exhibiting a gradient in mineral relative to collagen was detected at the leading edge of the hard-soft tissue interface as early as postnatal day 7. Nanocharacterization by TEM suggested that this mineral gradient arose from intrinsic surface roughness on the scale of tens of nanometers at the mineralized front. Microcomputed tomography measurements indicated increases in bone mineral density with time. Raman spectroscopy measurements revealed that the mineral-to-collagen ratio on the mineralized side of the interface was constant throughout postnatal development. An increase in the carbonate concentration of the apatite mineral phase over time suggested possible matrix remodeling during postnatal development. Comparison of Raman-based observations of localized mineral content with histomorphological features indicated that development of the graded mineralized interface is linked to endochondral bone formation near the tendon insertion. These conserved and time-varying aspects of interface composition may have important implications for the growth and mechanical stability of the tendon-to-bone attachment throughout development. Citation: Schwartz AG, Pasteris JD, Genin GM, Daulton TL, Thomopoulos S (2012) Mineral Distributions at the Developing Tendon Enthesis. PLoS ONE 7(11): e48630. doi:10.1371/journal.pone.0048630	[Schwartz, Andrea G.; Thomopoulos, Stavros] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Pasteris, Jill D.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Genin, Guy M.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Daulton, Tyrone L.] Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA; [Daulton, Tyrone L.] Washington Univ, Dept Phys, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Thomopoulos, S (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.	ThomopoulosS@wudosis.wustl.edu		Pasteris, Jill/0000-0001-7041-6966	National Institutes of Health [R01 AR055580]; National Science Foundation [CAREER 844607]; Center for Materials Innovation at Washington University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055580, P30AR057235, T32AR060719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Center for Materials Innovation at Washington University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The studies were funded by the National Institutes of Health (R01 AR055580), the National Science Foundation (CAREER 844607), and the Center for Materials Innovation at Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2012, J ROYAL SOC INTERFAC; Amizuka Norio, 2012, Front Biosci (Elite Ed), V4, P2085; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Awonusi A, 2007, CALCIFIED TISSUE INT, V81, P46, DOI 10.1007/s00223-007-9034-0; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Benjamin M, 2001, J ANAT, V199, P503, DOI 10.1046/j.1469-7580.2001.19950503.x; Bland YS, 1997, J ANAT, V190, P327, DOI 10.1046/j.1469-7580.1997.19030327.x; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; BOOTHROYD B, 1964, J CELL BIOL, V20, P165, DOI 10.1083/jcb.20.1.165; BREUR GJ, 1991, J ORTHOPAED RES, V9, P348, DOI 10.1002/jor.1100090306; Burket J, 2011, J BIOMECH, V44, P277, DOI 10.1016/j.jbiomech.2010.10.018; Claudepierre P, 2005, JOINT BONE SPINE, V72, P32, DOI 10.1016/j.jbspin.2004.02.010; COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1; Dong RX, 2004, SPECTROCHIM ACTA A, V60, P557, DOI 10.1016/S1386-1425(03)00262-2; Donnelly E, 2010, CALCIFIED TISSUE INT, V87, P450, DOI 10.1007/s00223-010-9404-x; Donnelly E, 2010, J BIOMED MATER RES A, V92A, P1048, DOI 10.1002/jbm.a.32442; Doschak M. R., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P35; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Farnum CE, 2008, CELLS TISSUES ORGANS, V187, P48, DOI 10.1159/000109963; Fujioka H, 1997, J ORTHOPAED RES, V15, P675, DOI 10.1002/jor.1100150508; Galatz L, 2007, J ORTHOP RES, V25, P1621, DOI 10.1002/jor.20441; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Gamsjaeger S, 2010, BONE, V47, P392, DOI 10.1016/j.bone.2010.04.608; Gao J, 1996, ANAT EMBRYOL, V194, P399; Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043; Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1271, DOI [10.1359/JBMR.090201, 10.1359/jbmr.090201]; Gupta HS, 2005, J STRUCT BIOL, V149, P138, DOI 10.1016/j.jsb.2004.10.010; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982, DOI 10.2106/00004623-199173070-00004; Hauch KN, 2009, J MECH BEHAV BIOMED, V2, P339, DOI 10.1016/j.jmbbm.2008.10.005; Keene DR, 2010, METHOD CELL BIOL, V96, P443, DOI 10.1016/S0091-679X(10)96019-6; Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452; LANDIS WJ, 1977, J ULTRA MOL STRUCT R, V59, P185, DOI 10.1016/S0022-5320(77)80079-8; Liu YX, 2012, MECH MATER, V44, P83, DOI 10.1016/j.mechmat.2011.08.005; Liu YX, 2011, J ENG MATER-T ASME, V133, DOI 10.1115/1.4002641; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; McCreadie BR, 2006, BONE, V39, P1190, DOI 10.1016/j.bone.2006.06.008; McElderry JDP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3574525; Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402; Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105; Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y; Nowlan NC, 2010, BIRTH DEFECTS RES C, V90, P203, DOI 10.1002/bdrc.20184; Pasteris JD, 2008, 8 WORLD BIOM C AMST; Silva MJ, 2006, J BONE MINER RES, V21, P78, DOI 10.1359/JBMR.050909; Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118; Thomopoulos S, 2003, J BIOMECH ENG-T ASME, V125, P106, DOI 10.1115/1.1536660; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Thomopoulos S, 2006, J BIOMECH, V39, P1842, DOI 10.1016/j.jbiomech.2005.05.021; Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021; Wang INE, 2006, J ORTHOP RES, V24, P1745, DOI 10.1002/jor.20149; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179	53	117	119	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48630	10.1371/journal.pone.0048630	http://dx.doi.org/10.1371/journal.pone.0048630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152788	Green Published, gold, Green Submitted			2022-12-25	WOS:000312272600015
J	Blatteau, JE; Barre, S; Pascual, A; Castagna, O; Abraini, JH; Risso, JJ; Vallee, N				Blatteau, Jean-Eric; Barre, Sandrine; Pascual, Aurelie; Castagna, Olivier; Abraini, Jacques H.; Risso, Jean-Jacques; Vallee, Nicolas			Protective Effects of Fluoxetine on Decompression Sickness in Mice	PLOS ONE			English	Article							SEROTONIN TRANSPORTER; AIR-EMBOLISM; ENDOTHELIAL DAMAGE; MAJOR DEPRESSION; ANION CHANNELS; WHOLE-BLOOD; IN-VITRO; BRAIN; ACTIVATION; RAT	Massive bubble formation after diving can lead to decompression sickness (DCS) that can result in central nervous system disorders or even death. Bubbles alter the vascular endothelium and activate blood cells and inflammatory pathways, leading to a systemic pathophysiological process that promotes ischemic damage. Fluoxetine, a well-known antidepressant, is recognized as having anti-inflammatory properties at the systemic level, as well as in the setting of cerebral ischemia. We report a beneficial clinical effect associated with fluoxetine in experimental DCS. 91 mice were subjected to a simulated dive at 90 msw for 45 min before rapid decompression. The experimental group received 50 mg/kg of fluoxetine 18 hours before hyperbaric exposure (n = 46) while controls were not treated (n = 45). Clinical assessment took place over a period of 30 min after surfacing. At the end, blood samples were collected for blood cells counts and cytokine IL-6 detection. There were significantly fewer manifestations of DCS in the fluoxetine group than in the controls (43.5% versus 75.5%, respectively; p = 0.004). Survivors showed a better and significant neurological recovery with fluoxetine. Platelets and red cells were significantly decreased after decompression in controls but not in the treated mice. Fluoxetine reduced circulating IL-6, a relevant marker of systemic inflammation in DCS. We concluded that fluoxetine decreased the incidence of DCS and improved motor recovery, by limiting inflammation processes. Citation: Blatteau J-E, Barre S, Pascual A, Castagna O, Abraini JH, et al. (2012) Protective Effects of Fluoxetine on Decompression Sickness in Mice. PLoS ONE 7(11): e49069. doi: 10.1371/journal.pone.0049069	[Blatteau, Jean-Eric; Barre, Sandrine; Pascual, Aurelie; Castagna, Olivier; Risso, Jean-Jacques; Vallee, Nicolas] Inst Rech Biomed Armees Toulon, Equipe Residante Rech Subaquat Operat, Dept Environm Operat, Unite Environm Extremes, Toulon, France; [Abraini, Jacques H.] Univ Caen Basse Normandie, Caen, France; [Abraini, Jacques H.] Univ Laval, Hotel Dieu Levis, Ctr Hosp Affilie, Levis, PQ, Canada	Universite de Caen Normandie; Laval University	Blatteau, JE (corresponding author), Inst Rech Biomed Armees Toulon, Equipe Residante Rech Subaquat Operat, Dept Environm Operat, Unite Environm Extremes, Toulon, France.	je.blatteau@infonie.fr						BERGHAGE TE, 1979, UNDERSEA BIOMED RES, V6, P1; Bert P., 1978, BAROMETRIC PRESSURE; Bigley NJ, 2008, J INTERF CYTOK RES, V28, P55, DOI 10.1089/jir.2007.0084; Blatteau JE, 2011, NEUROCRIT CARE, V15, P120, DOI 10.1007/s12028-010-9370-1; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Broussolle B, 2006, PHYSL MED PLONGEE; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; DEGIROLAMI U, 1982, J NEUROPATH EXP NEUR, V41, P129, DOI 10.1097/00005072-198203000-00004; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; DUTKA AJ, 1989, STROKE, V20, P390, DOI 10.1161/01.STR.20.3.390; Ersson A, 1998, UNDERSEA HYPERBAR M, V25, P217; FARAJ BA, 1994, INT J IMMUNOPHARMACO, V16, P561, DOI 10.1016/0192-0561(94)90107-4; Francis T. J. R., 2003, BENNETT ELLIOTTS PHY, P530; Gempp E, 2008, AVIAT SPACE ENVIR MD, V79, P1112, DOI 10.3357/ASEM.2376.2008; GIRY PBL, 1977, UNDERSEA BIOMED RES, V4, P147; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALLENBECK JM, 1973, AEROSPACE MED, V44, P712; Halperin Demian, 2007, Dialogues Clin Neurosci, V9, P47; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; HELPS SC, 1991, STROKE, V22, P351, DOI 10.1161/01.STR.22.3.351; Jin Y, 2009, BRAIN RES, V1281, P108, DOI 10.1016/j.brainres.2009.04.053; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; Kubera M, 2004, INT IMMUNOPHARMACOL, V4, P185, DOI 10.1016/j.intimp.2003.11.006; Kubera N, 2001, J CLIN PSYCHOPHARM, V21, P199, DOI 10.1097/00004714-200104000-00012; LABORIT. H., 1961, AGRESSOLOGIE, V2, P229; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; Lim CM, 2009, J NEUROSCI RES, V87, P1037, DOI 10.1002/jnr.21899; Lima L, 2002, CELL MOL NEUROBIOL, V22, P797, DOI 10.1023/A:1021869310702; Maertens C, 1999, BRIT J PHARMACOL, V126, P508, DOI 10.1038/sj.bjp.0702314; Montcalm-Smith EA, 2008, AVIAT SPACE ENVIR MD, V79, P7, DOI 10.3357/ASEM.2071.2008; Nossum V, 1999, UNDERSEA HYPERBAR M, V26, P1; Nyquist PA, 2004, AVIAT SPACE ENVIR MD, V 75, P211; Pariente J, 2001, ANN NEUROL, V50, P718, DOI 10.1002/ana.1257; PERSSON LI, 1978, ACTA NEUROPATHOL, V44, P53, DOI 10.1007/BF00691639; PHILP R B, 1974, Undersea Biomedical Research, V1, P117; Pontier JM, 2008, AVIAT SPACE ENVIR MD, V79, P1096, DOI 10.3357/ASEM.2352.2008; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Taguchi N, 2012, RESUSCITATION, V83, P652, DOI 10.1016/j.resuscitation.2011.11.004; THORSEN T, 1987, UNDERSEA BIOMED RES, V14, P45; Vallee N, 2012, J APPL PHYSIOL, V112, P1191, DOI 10.1152/japplphysiol.01100.2011; WARREN BA, 1973, BRIT J EXP PATHOL, V54, P163; Wong ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002350; Yang GB, 2007, CELL IMMUNOL, V248, P69, DOI 10.1016/j.cellimm.2007.09.001	44	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49069	10.1371/journal.pone.0049069	http://dx.doi.org/10.1371/journal.pone.0049069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145072	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500071
J	Cossu, A; Posadino, AM; Giordo, R; Emanueli, C; Sanguinetti, AM; Piscopo, A; Poiana, M; Capobianco, G; Piga, A; Pintus, G				Cossu, Annalisa; Posadino, Anna Maria; Giordo, Roberta; Emanueli, Costanza; Sanguinetti, Anna Maria; Piscopo, Amalia; Poiana, Marco; Capobianco, Giampiero; Piga, Antonio; Pintus, Gianfranco			Apricot Melanoidins Prevent Oxidative Endothelial Cell Death by Counteracting Mitochondrial Oxidation and Membrane Depolarization	PLOS ONE			English	Article							REDOX-SENSITIVE GFP; ANTIOXIDANT ACTIVITY; POLYPHENOLIC CONTENT; COFFEE MELANOIDINS; MAILLARD REACTION; HEPG2 CELLS; STRESS; APOPTOSIS; CAPACITY; DAMAGE	The cardiovascular benefits associated with diets rich in fruit and vegetables are thought to be due to phytochemicals contained in fresh plant material. However, whether processed plant foods provide the same benefits as unprocessed ones is an open question. Melanoidins from heat-processed apricots were isolated and their presence confirmed by colorimetric analysis and browning index. Oxidative injury of endothelial cells (ECs) is the key step for the onset and progression of cardiovascular diseases (CVD), therefore the potential protective effect of apricot melanoidins on hydrogen peroxide-induced oxidative mitochondrial damage and cell death was explored in human ECs. The redox state of cytoplasmic and mitochondrial compartments was detected by using the redox-sensitive, fluorescent protein (roGFP), while the mitochondrial membrane potential (MMP) was assessed with the fluorescent dye, JC-1. ECs exposure to hydrogen peroxide, dose-dependently induced mitochondrial and cytoplasmic oxidation. Additionally detected hydrogen peroxide-induced phenomena were MMP dissipation and ECs death. Pretreatment of ECs with apricot melanoidins, significantly counteracted and ultimately abolished hydrogen peroxide-induced intracellular oxidation, mitochondrial depolarization and cell death. In this regard, our current results clearly indicate that melanoidins derived from heat-processed apricots, protect human ECs against oxidative stress. Citation: Cossu A, Posadino AM, Giordo R, Emanueli C, Sanguinetti AM, et al. (2012) Apricot Melanoidins Prevent Oxidative Endothelial Cell Death by Counteracting Mitochondrial Oxidation and Membrane Depolarization. PLoS ONE 7(11): e48817. doi: 10.1371/journal.pone.0048817	[Sanguinetti, Anna Maria; Piga, Antonio] Univ Sassari, Dept Agr, I-07100 Sassari, Italy; [Cossu, Annalisa; Posadino, Anna Maria; Giordo, Roberta; Pintus, Gianfranco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Pintus, Gianfranco] Univ Sassari, Ctr Excellence Biotechnol Dev & Biodivers Res, I-07100 Sassari, Italy; [Piscopo, Amalia; Poiana, Marco] Mediterranean Univ Reggio Calabria, Dept Biotechnol Agr Food & Environm Monitoring, Reggio Di Calabria, Italy; [Emanueli, Costanza] Univ Bristol, Bristol Heart Inst, Sch Clin Sci, Lab Vasc Pathol & Regenerat,Regenerat Med Sect, Bristol, Avon, England; [Capobianco, Giampiero] Univ Sassari, Gynecol & Obstet Clin, I-07100 Sassari, Italy	University of Sassari; University of Sassari; University of Sassari; Universita Mediterranea di Reggio Calabria; University of Bristol; University of Sassari	Piga, A (corresponding author), Univ Sassari, Dept Agr, I-07100 Sassari, Italy.	pigaa@uniss.it; gpintus@uniss.it	Piga, Antonio/A-1679-2009; Piscopo, Amalia/U-4205-2019; Capobianco, Giampiero/AAF-1364-2019; Pintus, Gianfranco/C-2975-2009; Poiana, Marco/V-9690-2019	Piga, Antonio/0000-0002-0309-5936; Pintus, Gianfranco/0000-0002-3031-7733; Poiana, Marco/0000-0001-6117-0482; Piscopo, Amalia/0000-0001-7151-5843; Posadino, Anna Maria/0000-0002-6155-159X; CAPOBIANCO, GIAMPIERO/0000-0002-5523-8943; Emanueli, Costanza/0000-0002-2392-0702	Italian Ministry of Education, Universities and Research "PRIN 05/08", Regione Sardegna LR [7 - 2007]; Banco di Sardegna Foundation	Italian Ministry of Education, Universities and Research "PRIN 05/08", Regione Sardegna LR; Banco di Sardegna Foundation(Fondazione Banco di Sardegna)	The work was supported by grants from the Italian Ministry of Education, Universities and Research "PRIN 05/08", Regione Sardegna LR n.7 - 2007 and Banco di Sardegna Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2009, J AGR FOOD CHEM, V57, P7250, DOI 10.1021/jf9006032; Bichler J, 2007, FOOD CHEM TOXICOL, V45, P1428, DOI 10.1016/j.fct.2007.02.001; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cines DB, 1998, BLOOD, V91, P3527; CLYDESDALE FM, 1993, CRIT REV FOOD SCI, V33, P83, DOI 10.1080/10408399309527614; Crivelli G., 1997, Italus Hortus, V4, P48; Del Caro A, 2004, J AGR FOOD CHEM, V52, P4780, DOI 10.1021/jf049889j; Dittrich R, 2009, FOOD RES INT, V42, P1315, DOI 10.1016/j.foodres.2009.04.007; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Dragovic-Uzelac V, 2007, FOOD CHEM, V102, P966, DOI 10.1016/j.foodchem.2006.04.001; Esposito F, 2003, ALIMENT PHARM THER, V17, P595, DOI 10.1046/j.1365-2036.2003.01429.x; Goya L, 2007, MOL NUTR FOOD RES, V51, P536, DOI 10.1002/mnfr.200600228; Guo CJ, 2003, NUTR RES, V23, P1719, DOI 10.1016/j.nutres.2003.08.005; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Inagi Reiko, 2006, Recent Pat Cardiovasc Drug Discov, V1, P151, DOI 10.2174/157489006777442450; Ishiwata K, 2004, FOOD SCI TECHNOL RES, V10, P152, DOI 10.3136/fstr.10.152; KANEKO I, 1995, J NEUROCHEM, V65, P2585; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Lerici Carlo R., 1996, Advances in Food Sciences, V18, P229; Lindenmeier M, 2002, J AGR FOOD CHEM, V50, P6997, DOI 10.1021/jf020618n; LITTLE AC, 1975, J FOOD SCI, V40, P410, DOI 10.1111/j.1365-2621.1975.tb02213.x; Madrau MA, 2009, EUR FOOD RES TECHNOL, V228, P441, DOI 10.1007/s00217-008-0951-6; Madrau MA, 2010, J FOOD QUALITY, V33, P155, DOI 10.1111/j.1745-4557.2010.00328.x; Manzocco L, 2000, TRENDS FOOD SCI TECH, V11, P340, DOI 10.1016/S0924-2244(01)00014-0; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X; MASTROCOLA D, 1991, Italian Journal of Food Science, V3, P219; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1; Nicoli MC, 1997, CANCER LETT, V114, P71, DOI 10.1016/S0304-3835(97)04628-4; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Parlakpinar H, 2009, FOOD CHEM TOXICOL, V47, P802, DOI 10.1016/j.fct.2009.01.014; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Pereira C, 1998, J NEUROSCI RES, V51, P360, DOI 10.1002/(SICI)1097-4547(19980201)51:3<360::AID-JNR9>3.3.CO;2-7; Piga A, 2004, INT J FOOD SCI TECH, V39, P793, DOI 10.1111/j.1365-2621.2004.00845.x; Piga A, 2003, J AGR FOOD CHEM, V51, P3675, DOI 10.1021/jf021207+; Posadino Anna Maria, 2011, Front Biosci (Elite Ed), V3, P1034; Rosenwasser S, 2010, PHYSIOL PLANTARUM, V138, P493, DOI 10.1111/j.1399-3054.2009.01334.x; Rufian-Henares JA, 2007, J AGR FOOD CHEM, V55, P1480, DOI 10.1021/jf062604d; Rufian-Henares JA, 2009, J AGR FOOD CHEM, V57, P432, DOI 10.1021/jf8027842; Ruiz D, 2005, J AGR FOOD CHEM, V53, P6368, DOI 10.1021/jf0480703; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sanna B, 2002, ARCH BIOCHEM BIOPHYS, V403, P209, DOI 10.1016/S0003-9861(02)00218-7; Sass-Kiss A, 2005, FOOD RES INT, V38, P1023, DOI 10.1016/j.foodres.2005.03.014; Scalzo J, 2005, NUTRITION, V21, P207, DOI 10.1016/j.nut.2004.03.025; Severini C, 2003, LEBENSM-WISS TECHNOL, V36, P657, DOI 10.1016/S0023-6438(03)00085-9; She MR, 2007, ACTA PHARMACOL SIN, V28, P1037, DOI 10.1111/j.1745-7254.2007.00604.x; Tagliazucchi D, 2010, J FOOD BIOCHEM, V34, P1061, DOI 10.1111/j.1745-4514.2010.00349.x; Yurt B, 2011, FOOD CHEM TOXICOL, V49, P508, DOI 10.1016/j.fct.2010.11.035; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]	50	36	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48817	10.1371/journal.pone.0048817	http://dx.doi.org/10.1371/journal.pone.0048817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144984	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500036
J	Gao, S; Wang, ZX				Gao, Shen; Wang, Zhengxin			Subcellular Localization of p44/WDR77 Determines Proliferation and Differentiation of Prostate Epithelial Cells	PLOS ONE			English	Article							RECEPTOR COFACTOR P44; INTRAEPITHELIAL NEOPLASIA; UROGENITAL SINUS; EXPRESSION; IDENTIFICATION; COMPLEX; MICE; HYPERPLASIA; METHYLATION; METHYLOSOME	The molecular mechanism that controls the proliferation and differentiation of prostate epithelial cells is currently unknown. We previously identified a 44-kDa protein (p44/wdr77) as an androgen receptor-interacting protein that regulates a set of androgen receptor target genes in prostate epithelial cells and prostate cancer. In this study, we found that p44 localizes in the cytoplasm of prostate epithelial cells at the early stage of prostate development when cells are proliferating, and its nuclear translocation is associated with cellular and functional differentiation in adult prostate tissue. We further demonstrated that cytoplasmic p44 protein is essential for proliferation of prostate epithelial cells, whereas nuclear p44 is required for cell differentiation and prostate-specific protein secretion. These studies suggest a novel mechanism by which proliferation and differentiation of prostate epithelial cells are controlled by p44's location in the cell.	[Gao, Shen; Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wang, ZX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	zhenwang@mdanderson.org			National Institutes of Health through MD Anderson's Cancer Center Support Grant [CA016672]; Institutional Research Grant Programs from MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research Grant Programs from MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant (CA016672) and the Institutional Research Grant Programs from MD Anderson Cancer Center. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; BOSTWICK DG, 1987, CANCER, V59, P788, DOI 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I; Conlon I, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-36; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; COOKE PS, 1991, ENDOCRINOLOGY, V128, P2867, DOI 10.1210/endo-128-6-2867; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; CUNHA GR, 1975, ENDOCRINOLOGY, V97, P665, DOI 10.1210/endo-97-3-665; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Fujimoto N, 2006, J ENDOCRINOL, V190, P793, DOI 10.1677/joe.1.06733; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; GLYNN RJ, 1985, AM J EPIDEMIOL, V121, P78; Gu Z., 2012, ONCOGENE; Gu Z, 2012, PLOS ONE, V6; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hayward SW, 1996, ACTA ANAT, V155, P81; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Joshua AM, 2008, BBA-REV CANCER, V1785, P156, DOI 10.1016/j.bbcan.2007.12.001; KELLOKUMPULEHTINEN P, 1985, BIOL NEONATE, V48, P157; Konishi N, 2005, PATHOL INT, V55, P531, DOI 10.1111/j.1440-1827.2005.01865.x; Langley RR, 2003, CANCER RES, V63, P2971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meeks JJ, 2011, J ANDROL, V32, P210, DOI 10.2164/jandrol.110.011577; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Montironi R, 2007, NAT CLIN PRACT UROL, V4, P321, DOI 10.1038/ncpuro0815; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Shackney SE, 1999, CYTOMETRY, V35, P97, DOI 10.1002/(SICI)1097-0320(19990201)35:2<97::AID-CYTO1>3.3.CO;2-X; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Swerdloff RS, 2004, BEST PRACT RES CL EN, V18, P349, DOI 10.1016/j.beem.2004.03.011; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; Xue Y, 1998, PROSTATE, V34, P292, DOI 10.1002/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49173	10.1371/journal.pone.0049173	http://dx.doi.org/10.1371/journal.pone.0049173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145110	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500081
J	Hernandez-Guerra, M; Gonzalez-Mendez, Y; de Molina, P; Gimeno-Garcia, AZ; Carrillo, M; Casanova, C; Pumarola, T; Jimenez, A; Hernandez-Porto, M; Torres, A; Quintero, E				Hernandez-Guerra, Manuel; Gonzalez-Mendez, Yanira; de Molina, Patricia; Gimeno-Garcia, Antonio Z.; Carrillo, Marta; Casanova, Carlos; Pumarola, Tomas; Jimenez, Alejandro; Hernandez-Porto, Miriam; Torres, Alvaro; Quintero, Enrique			Immunogenicity and Acceptance of Influenza A (H1N1) Vaccine in a Cohort of Chronic Hepatitis C Patients Receiving Pegylated-Interferon Treatment	PLOS ONE			English	Article							HEALTH-CARE WORKERS; SIMPLE NONINVASIVE INDEX; COMBINATION TREATMENT; SIGNIFICANT FIBROSIS; IMMUNE-RESPONSE; PLUS RIBAVIRIN; INFECTION; NEUTROPENIA; THERAPY; ALPHA	Background & Aims: Individuals at risk of (H1N1) influenza A infection are recommended to receive vaccination. Chronic hepatitis C (CHC) patients receiving treatment might be at a higher risk of respiratory bacterial infections after influenza infection. However, there are no observational studies evaluating the immunogenicity, tolerance and acceptance of 2009 influenza A vaccine in CHC patients. Methods: We evaluated the immunogenicity of influenza A vaccine (Pandemrix (R)) by using the hemagglutination inhibition (HI) titers method in a well defined cohort of CHC patients receiving or not receiving pegylated-interferon and ribavirin, and compared it with healthy subjects (controls). A group of patients with inflammatory bowel disease (IBD) under immunosuppression, thought to have a lower immune response to seasonal influenza vaccine, were also included as a negative control group. In addition, tolerance to injection site reactions and acceptance was assessed by a validated questionnaire (Vaccinees' perception of injection-VAPI-questionnaire). Results: Of 114 subjects invited to participate, 68% accepted and, after exclusions, 72 were included. Post-vaccination geometric mean titers and seroprotection/seroconversion rates were optimal in CHC patients with ongoing treatment (n = 15; 232, CI95% 46-1166; 93%; 93%), without treatment (n = 10; 226, CI95% 69-743: 100%; 100%) and controls (n = 15; 168, CI95% 42-680; 93%; 86%) with no differences between groups (P = 0.8). In contrast, IBD patients had a significantly lower immunogenic response (n = 27; 60, CI95% 42-680; 66%; 66%; P = 0.006). All the groups showed a satisfactory tolerance although CHC patients with ongoing treatment showed more local discomfort after vaccine injection. Conclusion: There appeared to be no differences between CHC patients and healthy controls in serological response and acceptance of (H1N1) influenza vaccination.	[Hernandez-Guerra, Manuel; Gonzalez-Mendez, Yanira; Gimeno-Garcia, Antonio Z.; Carrillo, Marta; Casanova, Carlos; Quintero, Enrique] Univ Hosp Canary Isl, Liver Unit, Tenerife, Spain; [Hernandez-Guerra, Manuel; Jimenez, Alejandro; Quintero, Enrique] Univ Hosp Canary Isl, Res Unit, Tenerife, Spain; [de Molina, Patricia; Pumarola, Tomas] Univ Barcelona, Hosp Clin Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Pumarola, Tomas] Univ Barcelona, Sch Med, Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain; [Torres, Alvaro] Univ La Laguna, Prevent Med & Publ Hlth Dept, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Universidad de la Laguna	Hernandez-Guerra, M (corresponding author), Univ Hosp Canary Isl, Liver Unit, Tenerife, Spain.	mhernandezguerra@gmail.com	Suñe, Tomàs Pumarola/F-7583-2017; Pumarola, Tomàs/AAB-5532-2019; Quintero, Enrique/C-3841-2017	Suñe, Tomàs Pumarola/0000-0002-5171-7461; Pumarola, Tomàs/0000-0002-5171-7461; Quintero, Enrique/0000-0002-7244-8125; Hernandez-Guerra, Manuel/0000-0002-3478-9981; Jimenez-Sosa, Alejandro/0000-0001-8732-2616; Gimeno-Garcia, Antonio Z/0000-0003-0670-6883; Carrillo-Palau, Marta/0000-0002-1056-8711	Fonds Europeen de Developpement Regional (FEDER); Instituto de Salud Carlos III [538/07]; Programa de Intensificacion de Actividad Investigadora [INT07/173]	Fonds Europeen de Developpement Regional (FEDER)(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Programa de Intensificacion de Actividad Investigadora	This study has been supported in part by grants from Fonds Europeen de Developpement Regional (FEDER). Dr. M. Hernandez-Guerra is the recipient of a grant from Instituto de Salud Carlos III (538/07) and Programa de Intensificacion de Actividad Investigadora (INT07/173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P301; Antonini MG, 2008, INFECTION, V36, P250, DOI 10.1007/s15010-007-7132-6; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Beck CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029249; Bracci L, 2006, VACCINE, V24, pS56, DOI 10.1016/j.vaccine.2005.01.121; Cheong HJ, 2006, VACCINE, V24, P2417, DOI 10.1016/j.vaccine.2005.11.064; Chevat C, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-21; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Committee for Proprietary Medicinal Products, 1996, CPMBBWP21496 COMM PR, P1; Cooper CL, 2006, CLIN INFECT DIS, V42, P1674, DOI 10.1086/504386; Cullen G, 2012, GUT, V61, P385, DOI 10.1136/gutjnl-2011-300256; deBruyn JCC, 2012, INFLAMM BOWEL DIS, V18, P25, DOI 10.1002/ibd.21706; Duchini A, 2001, LIVER TRANSPLANT, V7, P311, DOI 10.1053/jlts.2001.23010; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Gaeta GB, 2002, VACCINE, V20, pB33, DOI 10.1016/S0264-410X(02)00510-8; Gaeta GB, 2009, VACCINE, V27, P3373, DOI 10.1016/j.vaccine.2009.01.077; Gallagher KME, 2009, J IMMUNOL, V183, P2915, DOI 10.4049/jimmunol.0801607; Giorgini A, 2009, ANN NY ACAD SCI, V1173, P847, DOI 10.1111/j.1749-6632.2009.04623.x; Greenbaum E, 2004, J CLIN VIROL, V29, P23, DOI 10.1016/S1386-6532(03)00194-X; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Mamula P, 2007, CLIN GASTROENTEROL H, V5, P851, DOI 10.1016/j.cgh.2007.02.035; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Puoti M, 2004, ANTIVIR THER, V9, P627; Rahier JF, 2011, GUT, V60, P456, DOI 10.1136/gut.2010.233981; Rehermann B, 1996, J CLIN INVEST, V98, P1432, DOI 10.1172/JCI118931; Roomer R, 2010, HEPATOLOGY, V52, P1225, DOI 10.1002/hep.23842; Soza A, 2002, HEPATOLOGY, V36, P1273, DOI 10.1053/jhep.2002.36502; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; STIVER HG, 1978, CAN MED ASSOC J, V119, P733; Tanguy M, 2011, VACCINE, V29, P4190, DOI 10.1016/j.vaccine.2011.03.107; Tovey MG, 2006, VACCINE, V24, pS46, DOI 10.1016/j.vaccine.2005.01.117; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yang JF, 2009, ALIMENT PHARM THER, V29, P1000, DOI 10.1111/j.1365-2036.2009.03957.x; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48610	10.1371/journal.pone.0048610	http://dx.doi.org/10.1371/journal.pone.0048610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144908	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500028
J	Jo, HJ; Saad, ZS; Gotts, SJ; Martin, A; Cox, RW				Jo, Hang Joon; Saad, Ziad S.; Gotts, Stephen J.; Martin, Alex; Cox, Robert W.			Quantifying Agreement between Anatomical and Functional Interhemispheric Correspondences in the Resting Brain	PLOS ONE			English	Article							SPONTANEOUS FLUCTUATIONS; VISUAL-CORTEX; DEFAULT-MODE; STATE FMRI; CALLOSAL PROJECTIONS; CORTICAL NETWORK; NEURAL BASIS; CONNECTIVITY; ARCHITECTURE; ORGANIZATION	The human brain is composed of two broadly symmetric cerebral hemispheres, with an abundance of reciprocal anatomical connections between homotopic locations. However, to date, studies of hemispheric symmetries have not identified correspondency precisely due to variable cortical folding patterns. Here we present a method to establish accurate correspondency using position on the unfolded cortical surface relative to gyral and sulcal landmarks. The landmark method is shown to outperform the method of reversing standard volume coordinates, and it is used to quantify the functional symmetry in resting fMRI data throughout the cortex. Resting brain activity was found to be maximally correlated with locations less than 1 cm away on the cortical surface from the corresponding anatomical location in nearly half of the cortex. While select locations exhibited asymmetric patterns, precise symmetric relationships were found to be the norm, with fine-grained symmetric functional maps demonstrated in motor, occipital, and inferior frontal cortex. Citation: Jo HJ, Saad ZS, Gotts SJ, Martin A, Cox RW (2012) Quantifying Agreement between Anatomical and Functional Interhemispheric Correspondences in the Resting Brain. PLoS ONE 7(11): e48847. doi: 10.1371/journal.pone.0048847	[Jo, Hang Joon; Saad, Ziad S.; Cox, Robert W.] NIMH, Sci & Stat Comp Core, NIH, Bethesda, MD 20892 USA; [Gotts, Stephen J.; Martin, Alex] NIMH, Cognit Neuropsychol Sect, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Jo, HJ (corresponding author), NIMH, Sci & Stat Comp Core, NIH, Bethesda, MD 20892 USA.	hangjoon.jo@nih.gov	JO, HANG JOON/D-1775-2011; Gotts, Stephen/J-4842-2012; martin, alex/B-6176-2009	JO, HANG JOON/0000-0002-9180-3831; Cox, Robert/0000-0002-0031-1568	NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002888, ZIAMH002588] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anderson JS, 2011, BRAIN CONNECT, V1, P147, DOI 10.1089/brain.2011.0007; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Binder JR, 2012, NEUROIMAGE, V62, P1086, DOI 10.1016/j.neuroimage.2011.09.026; Binder JR, 2010, EPILEPSIA, V51, P618, DOI 10.1111/j.1528-1167.2009.02340.x; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CUSICK CG, 1984, J COMP NEUROL, V230, P311, DOI 10.1002/cne.902300302; Damasio AR, 1984, ANNU REV NEUROSCI, V7, P127, DOI 10.1146/annurev.ne.07.030184.001015; Derrfuss J, 2009, HUM BRAIN MAPP, V30, P299, DOI 10.1002/hbm.20501; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2009, PEDIATR RES, V66, P301, DOI 10.1203/PDR.0b013e3181b1bd84; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HEDREEN JC, 1981, J COMP NEUROL, V197, P605, DOI 10.1002/cne.901970405; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; JACOBSON S, 1977, BRAIN RES, V132, P235, DOI 10.1016/0006-8993(77)90418-8; Jo HJ, 2008, NEUROIMAGE, V40, P1077, DOI 10.1016/j.neuroimage.2007.12.036; Jo HJ, 2007, NEUROIMAGE, V34, P550, DOI 10.1016/j.neuroimage.2006.09.047; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Jo HJ, 2009, MAGN RESON IMAGING, V27, P691, DOI 10.1016/j.mri.2008.09.002; Ke M, 2010, PSYCHIAT RES-NEUROIM, V182, P30, DOI 10.1016/j.pscychresns.2009.11.004; KENNEDY H, 1988, BEHAV BRAIN RES, V29, P225, DOI 10.1016/0166-4328(88)90027-7; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; MANZONI T, 1986, J COMP NEUROL, V252, P245, DOI 10.1002/cne.902520208; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mezer A, 2009, NEUROIMAGE, V45, P1117, DOI 10.1016/j.neuroimage.2008.12.015; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Saad ZS, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1510; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; van den Heuvel MP, 2010, HUM BRAIN MAPP, V31, P631, DOI 10.1002/hbm.20893; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012	69	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48847	10.1371/journal.pone.0048847	http://dx.doi.org/10.1371/journal.pone.0048847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144995	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500038
J	Oliveira, A; Singh, S; Bidon-Chanal, A; Forti, F; Marti, MA; Boechi, L; Estrin, DA; Dikshit, KL; Luque, FJ				Oliveira, Ana; Singh, Sandeep; Bidon-Chanal, Axel; Forti, Flavio; Marti, Marcelo A.; Boechi, Leonardo; Estrin, Dario A.; Dikshit, Kanak L.; Luque, F. Javier			Role of PheE15 Gate in Ligand Entry and Nitric Oxide Detoxification Function of Mycobacterium tuberculosis Truncated Hemoglobin N	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; OXYGEN-BINDING; HBN; HEME; PROTEINS; KINETICS	The truncated hemoglobin N, HbN, of Mycobacterium tuberculosis is endowed with a potent nitric oxide dioxygenase (NOD) activity that allows it to relieve nitrosative stress and enhance in vivo survival of its host. Despite its small size, the protein matrix of HbN hosts a two-branched tunnel, consisting of orthogonal short and long channels, that connects the heme active site to the protein surface. A novel dual-path mechanism has been suggested to drive migration of O-2 and NO to the distal heme cavity. While oxygen migrates mainly by the short path, a ligand-induced conformational change regulates opening of the long tunnel branch for NO, via a phenylalanine (PheE15) residue that acts as a gate. Site-directed mutagenesis and molecular simulations have been used to examine the gating role played by PheE15 in modulating the NOD function of HbN. Mutants carrying replacement of PheE15 with alanine, isoleucine, tyrosine and tryptophan have similar O-2/CO association kinetics, but display significant reduction in their NOD function. Molecular simulations substantiated that mutation at the PheE15 gate confers significant changes in the long tunnel, and therefore may affect the migration of ligands. These results support the pivotal role of PheE15 gate in modulating the diffusion of NO via the long tunnel branch in the oxygenated protein, and hence the NOD function of HbN. Citation: Oliveira A, Singh S, Bidon-Chanal A, Forti F, Marti MA, et al. (2012) Role of PheE15 Gate in Ligand Entry and Nitric Oxide Detoxification Function of Mycobacterium tuberculosis Truncated Hemoglobin N. PLoS ONE 7(11): e49291. doi: 10.1371/journal.pone.0049291	[Singh, Sandeep; Dikshit, Kanak L.] CSIR Inst Microbial Technol, Chandigarh, India; [Oliveira, Ana; Bidon-Chanal, Axel; Forti, Flavio; Luque, F. Javier] Univ Barcelona Recinte Torribera, Fac Pharm, Dept Phys Chem, Santa Coloma De Gramenet, Spain; [Oliveira, Ana; Bidon-Chanal, Axel; Forti, Flavio; Luque, F. Javier] Univ Barcelona Recinte Torribera, Fac Pharm, Inst Biomed IBUB, Santa Coloma De Gramenet, Spain; [Marti, Marcelo A.; Boechi, Leonardo; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, Inst Quim Fis Mat Medioambiente & Energia INQUIMA, Buenos Aires, DF, Argentina	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Buenos Aires	Dikshit, KL (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	kanak@imtech.res.in; fjluque@ub.edu	Bidon-Chanal, Axel/C-4536-2017; Estrin, Dario/AAY-7549-2020; Luque, F. Javier/L-9652-2014	Bidon-Chanal, Axel/0000-0002-1666-1490; Luque, F. Javier/0000-0002-8049-3567; Estrin, Dario/0000-0002-5006-7225; Oliveira, Ana/0000-0001-6594-6022; Singh, Sandeep/0000-0001-9322-2929; Marti, Marcelo/0000-0002-7911-9340	Spanish Ministerio de Innovacion y Ciencia [SAF2011-27642]; Generalitat de Catalunya [2009SGR298]; Xarxa de Recerca en Quimica Teorica i Computacional (XRQTC); University of Buenos Aires [X074]; CONICET [PIP 2508]	Spanish Ministerio de Innovacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Xarxa de Recerca en Quimica Teorica i Computacional (XRQTC); University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors thank the Department of Biotechnology for providing research fellowship to SS, the Spanish Ministerio de Innovacion y Ciencia (SAF2011-27642), Generalitat de Catalunya (2009SGR298), Xarxa de Recerca en Quimica Teorica i Computacional (XRQTC), University of Buenos Aires (X074) and CONICET (PIP 2508) for financial support, and the Barcelona Supercomputation Center for computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Appleby C A, 1978, Methods Enzymol, V52, P157; Ascenzi P, 2007, GENE, V398, P42, DOI 10.1016/j.gene.2007.02.043; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; Case D.A., 2008, AMBER VERSION 10; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; Daigle R, 2009, BIOPHYS J, V97, P2967, DOI 10.1016/j.bpj.2009.09.006; Daigle R, 2009, PROTEINS, V75, P735, DOI 10.1002/prot.22283; Dantsker D, 2004, J BIOL CHEM, V279, P38844, DOI 10.1074/jbc.M401513200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Giardina B, 1981, Methods Enzymol, V76, P417; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaur R, 2002, APPL ENVIRON MICROB, V68, P152, DOI 10.1128/AEM.68.1.152-160.2002; Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037; Lama A, 2009, J BIOL CHEM, V284, P14457, DOI 10.1074/jbc.M807436200; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Mukai M, 2004, BIOCHEMISTRY-US, V43, P2764, DOI 10.1021/bi035798o; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Perez A, 2005, J CHEM THEORY COMPUT, V1, P790, DOI 10.1021/ct050051s; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Savard PY, 2011, BIOCHEMISTRY-US, V50, P11121, DOI 10.1021/bi201059a; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550	34	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49291	10.1371/journal.pone.0049291	http://dx.doi.org/10.1371/journal.pone.0049291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145144	Green Published, gold			2022-12-25	WOS:000312269500098
J	Acosta-Cabronero, J; Alley, S; Williams, GB; Pengas, G; Nestor, PJ				Acosta-Cabronero, Julio; Alley, Stephanie; Williams, Guy B.; Pengas, George; Nestor, Peter J.			Diffusion Tensor Metrics as Biomarkers in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER DEGENERATION; HUMAN CORPUS-CALLOSUM; FIBER TRACTS; HIPPOCAMPAL; DEMENTIA; REDUCTION; VOLUME	Background: Although diffusion tensor imaging has been a major research focus for Alzheimer's disease in recent years, it remains unclear whether it has sufficient stability to have biomarker potential. To date, frequently inconsistent results have been reported, though lack of standardisation in acquisition and analysis make such discrepancies difficult to interpret. There is also, at present, little knowledge of how the biometric properties of diffusion tensor imaging might evolve in the course of Alzheimer's disease. Methods: The biomarker question was addressed in this study by adopting a standardised protocol both for the whole brain (tract-based spatial statistics), and for a region of interest: the midline corpus callosum. In order to study the evolution of tensor changes, cross-sectional data from very mild (N = 21) and mild (N = 22) Alzheimer's disease patients were examined as well as a longitudinal cohort (N = 16) that had been rescanned at 12 months. Findings and Significance: The results revealed that increased axial and mean diffusivity are the first abnormalities to occur and that the first region to develop such significant differences was mesial parietal/splenial white matter; these metrics, however, remained relatively static with advancing disease indicating they are suitable as 'state-specific' markers. In contrast, increased radial diffusivity, and therefore decreased fractional anisotropy-though less detectable early-became increasingly abnormal with disease progression, and, in the splenium of the corpus callosum, correlated significantly with dementia severity; these metrics therefore appear 'stage-specific' and would be ideal for monitoring disease progression. In addition, the cross-sectional and longitudinal analyses showed that the progressive abnormalities in radial diffusivity and fractional anisotropy always occurred in areas that had first shown an increase in axial and mean diffusivity. Given that the former two metrics correlate with dementia severity, but the latter two did not, it would appear that increased axial diffusivity represents an upstream event that precedes neuronal loss.	[Acosta-Cabronero, Julio; Pengas, George; Nestor, Peter J.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cognit Memory & Language Grp,Neurol Unit, Cambridge, England; [Alley, Stephanie] Univ Cambridge, Dept Appl Math & Theoret Phys, Ctr Math Sci, Cambridge CB3 9EW, England; [Williams, Guy B.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Nestor, Peter J.] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Acosta-Cabronero, J (corresponding author), Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cognit Memory & Language Grp,Neurol Unit, Cambridge, England.	jac@cantab.net	Nestor, Peter/Y-6106-2018; Acosta-Cabronero, Julio/C-8225-2014	Nestor, Peter/0000-0002-5860-5921; Acosta-Cabronero, Julio/0000-0003-1174-5983; Williams, Guy/0000-0001-5223-6654	Medical Research Council, UK; National Institute for Health Research, Cambridge Biomedical Research Centre, UK; Alzheimer's Research UK; MRC [G108/653] Funding Source: UKRI; Alzheimers Research UK [ART-RF2010-1, ART-CRF2007-1] Funding Source: researchfish; Medical Research Council [G108/653] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, Cambridge Biomedical Research Centre, UK(National Institute for Health Research (NIHR)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council, UK (to PJN); National Institute for Health Research, Cambridge Biomedical Research Centre, UK (to PJN); and Alzheimer's Research UK (to JAC and GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; CHASE TN, 1984, ANN NEUROL, V15, pS170; Correia MM, 2009, MAGN RESON IMAGING, V27, P163, DOI 10.1016/j.mri.2008.06.011; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hanyu H, 1999, J NEUROL SCI, V167, P37, DOI 10.1016/S0022-510X(99)00135-5; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Huang H, 2012, NEUROBIOL AGING, V33, P2029, DOI 10.1016/j.neurobiolaging.2011.06.027; Huang JB, 2007, ANN NY ACAD SCI, V1097, P259, DOI 10.1196/annals.1379.021; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Oishi Kenichi, 2011, Front Neurol, V2, P54, DOI 10.3389/fneur.2011.00054; Pearson K, 1896, PHILOS T R SOC A, V187, P253, DOI [10.1098/rsta.1896.0007, DOI 10.1098/RSTA.1896.0007]; Pengas G, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00017; Pengas G, 2009, J NEUROIMAGING, V19, P37, DOI 10.1111/j.1552-6569.2008.00246.x; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Shu N, 2011, J ALZHEIMERS DIS, V26, P275, DOI 10.3233/JAD-2011-0024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Takao H, 2012, HUM BRAIN MAPP, V33, P466, DOI 10.1002/hbm.21225; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	46	86	91	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49072	10.1371/journal.pone.0049072	http://dx.doi.org/10.1371/journal.pone.0049072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145075	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800198
J	Albert, J; Rooman, M				Albert, Jaroslav; Rooman, Marianne			Design Principles of a Genetic Alarm Clock	PLOS ONE			English	Article							POSITIVE-FEEDBACK; NETWORKS; EXPRESSION; NOISE; AUTOREGULATION; CONSTRUCTION; SYSTEMS; MODULE	Turning genes on and off is a mechanism by which cells and tissues make phenotypic decisions. Gene network motifs capable of supporting two or more steady states and thereby providing cells with a plurality of possible phenotypes are referred to as genetic switches. Modeled on the bases of naturally occurring genetic networks, synthetic biologists have successfully constructed artificial switches, thus opening a door to new possibilities for improvement of the known, but also the design of new synthetic genetic circuits. One of many obstacles to overcome in such efforts is to understand and hence control intrinsic noise which is inherent in all biological systems. For some motifs the noise is negligible; for others, fluctuations in the particle number can be comparable to its average. Due to their slowed dynamics, motifs with positive autoregulation tend to be highly sensitive to fluctuations of their chemical environment and are in general very noisy, especially during transition (switching). In this article we use stochastic simulations (Gillespie algorithm) to model such a system, in particular a simple bistable motif consisting of a single gene with positive autoregulation. Due to cooperativety, the dynamical behavior of this kind of motif is reminiscent of an alarm clock - the gene is (nearly) silent for some time after it is turned on and becomes active very suddenly. We investigate how these sudden transitions are affected by noise and show that under certain conditions accurate timing can be achieved. We also examine how promoter complexity influences the accuracy of this timing mechanism.	[Albert, Jaroslav; Rooman, Marianne] Univ Libre Brussels, BioModeling BioInformat & BioProc Dept, Brussels, Belgium	Universite Libre de Bruxelles	Albert, J (corresponding author), Univ Libre Brussels, BioModeling BioInformat & BioProc Dept, Brussels, Belgium.	jalbert@ulb.ac.be			Belgian Fund for Scientific Research	Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	This work was supported by a grant from the Belgian Fund for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Fang X, 2008, BIOPHYS J, V95, P3137, DOI 10.1529/biophysj.107.127175; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gardner TS, 2000, NATURE, V405, P520, DOI 10.1038/35014708; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Sayut DJ, 2007, MOL BIOSYST, V3, P835, DOI 10.1039/b700547d; Sayut DJ, 2006, ACS CHEM BIOL, V1, P692, DOI 10.1021/cb6004245; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	22	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47256	10.1371/journal.pone.0047256	http://dx.doi.org/10.1371/journal.pone.0047256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144809	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800016
J	Cass, J; Johnson, A; Bex, PJ; Alais, D				Cass, John; Johnson, Ameika; Bex, Peter J.; Alais, David			Orientation-Specificity of Adaptation: Isotropic Adaptation Is Purely Monocular	PLOS ONE			English	Article							CONTRAST FOLLOWING ADAPTATION; RECEPTIVE-FIELDS; INTEROCULAR SUPPRESSION; FUNCTIONAL ARCHITECTURE; PSYCHOPHYSICAL EVIDENCE; BINOCULAR ORGANIZATION; SIMPLE CELLS; SELECTIVITY; CAT; MECHANISMS	Numerous studies have found that prolonged exposure to grating stimuli reduces sensitivity to subsequently presented gratings, most evidently when the orientations of the adapting and test patterns are similar. The rate of sensitivity loss varies with angular difference indicating both the presence and bandwidths of psychophysical 'orientation channels'. Here we study the orientation dependency of contrast adaptation measured both monoptically and dichoptically. Earlier psychophysical reports show that orientation bandwidths are broader at lower spatial frequencies, and we confirm this with a simple von Mises model using 0.25 vs. 2 c.p.d. gratings. When a single isotropic (orientation invariant) parameter is added to this model, however, we find no evidence for any difference in bandwidth with spatial frequency. Consistent with cross-orientation masking effects, we find isotropic adaptation to be strongly low spatial frequency-biased. Surprisingly, unlike masking, we find that the effects of interocular adaptation are purely orientation-tuned, with no evidence of isotropic threshold elevation. This dissociation points to isotropic (or 'cross-orientation') adaptation being an earlier and more magnocellular-like process than that which supports orientation-tuned adaptation and suggests that isotropic masking and adaptation are likely mediated by separate mechanisms.	[Cass, John] Univ Western Sydney, Sch Psychol, Penrith, NSW 1797, Australia; [Johnson, Ameika; Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Bex, Peter J.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Cambridge, MA 02138 USA	Western Sydney University; University of Sydney; Harvard University; Schepens Eye Research Institute	Cass, J (corresponding author), Univ Western Sydney, Sch Psychol, Penrith, NSW 1797, Australia.	j.cass@uws.edu.au	Cass, John/AAC-7505-2021		Australian Research Council [DP0774697]	Australian Research Council(Australian Research Council)	This research was funded by a Discovery Project Awarded to author JC by the Australian Research Council (DP0774697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Allison JD, 2001, VISUAL NEUROSCI, V18, P941, DOI 10.1017/S0952523801186116; ANDERSON SJ, 1985, VISION RES, V25, P1147, DOI 10.1016/0042-6989(85)90104-X; Baker DH, 2007, NEUROSCIENCE, V146, P435, DOI 10.1016/j.neuroscience.2007.01.030; Baker DH, 2007, VISION RES, V47, P3096, DOI 10.1016/j.visres.2007.08.013; BAKER DJ, 2012, OPERA NEWS, V76, P63; Barrett BT, 2002, SPATIAL VISION, V16, P5, DOI 10.1163/15685680260433878; BAUMAN LA, 1991, VISION RES, V31, P933, DOI 10.1016/0042-6989(91)90201-F; Bex P J, 2007, J VISION, V7, P386, DOI [DOI 10.1167/7.9.386, 10.1167/7.9.386]; BLAKE R, 1985, VISION RES, V25, P1459, DOI 10.1016/0042-6989(85)90224-X; BLAKEMORE C, 1971, J PHYSIOL-LONDON, V213, P157, DOI 10.1113/jphysiol.1971.sp009374; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Boynton GM, 2005, NAT NEUROSCI, V8, P541, DOI 10.1038/nn0505-541; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; Carandini M, 1997, J NEUROSCI, V17, P8621; Cass JR, 2010, PERCEPTION, V39, P60; Cass J, 2006, VISION RES, V46, P2859, DOI 10.1016/j.visres.2006.02.015; Cass J, 2009, J VISION, V9, DOI 10.1167/9.12.17; Cass J, 2009, J VISION, V9, DOI 10.1167/9.10.12; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Essock EA, 2009, J VISION, V9, DOI 10.1167/9.1.35; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; FOSTER DH, 1991, PSYCHOL BULL, V109, P152, DOI 10.1037/0033-2909.109.1.152; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KELLY DH, 1987, VISION RES, V27, P1527, DOI 10.1016/0042-6989(87)90161-1; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; Langley K, 2007, J EXP PSYCHOL HUMAN, V33, P1283, DOI 10.1037/0096-1523.33.6.1283; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; Ling S, 2009, PSYCHOL SCI, V20, P1348, DOI 10.1111/j.1467-9280.2009.02446.x; Lunghi C, 2011, CURR BIOL, V21, pR538, DOI 10.1016/j.cub.2011.06.004; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; McLoughlin N, 2006, NEUROIMAGE, V31, P76, DOI 10.1016/j.neuroimage.2005.12.054; Meese TS, 2011, I-PERCEPTION, V2, P159, DOI 10.1068/i0416; Meese TS, 2010, J VISION, V10, DOI 10.1167/10.12.9; Meese TS, 2009, J VISION, V9, DOI 10.1167/9.4.7; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; MOVSHON JA, 1973, PERCEPTION, V2, P53, DOI 10.1068/p020053; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; PHILLIPS GC, 1984, J OPT SOC AM A, V1, P226, DOI 10.1364/JOSAA.1.000226; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Ringach DL, 2002, J NEUROSCI, V22, P5639; Roeber U, 2008, J VISION, V8, DOI 10.1167/8.3.15; ROSS J, 1991, P ROY SOC B-BIOL SCI, V246, P61, DOI 10.1098/rspb.1991.0125; ROSS J, 1993, VISION RES, V33, P2051, DOI 10.1016/0042-6989(93)90003-F; Ross J, 1996, VISION RES, V36, P1811, DOI 10.1016/0042-6989(95)00240-5; Sengpiel F, 2005, J NEUROSCI, V25, P6394, DOI 10.1523/JNEUROSCI.0862-05.2005; SENGPIEL F, 1995, NEUROREPORT, V6, P2235, DOI 10.1097/00001756-199511000-00032; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; SNOWDEN RJ, 1992, VISION RES, V32, P1965, DOI 10.1016/0042-6989(92)90056-O; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; TOLHURST DJ, 1973, VISION RES, V13, P2545, DOI 10.1016/0042-6989(73)90251-4; TOLHURST DJ, 1973, J PHYSIOL-LONDON, V231, P385, DOI 10.1113/jphysiol.1973.sp010239; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; Walker GA, 1998, J NEUROPHYSIOL, V79, P227, DOI 10.1152/jn.1998.79.1.227; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066	67	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47425	10.1371/journal.pone.0047425	http://dx.doi.org/10.1371/journal.pone.0047425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144820	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800021
J	Dezzutti, CS; Brown, ER; Moncla, B; Russo, J; Cost, M; Wang, L; Uranker, K; Ayudhya, RPKN; Pryke, K; Pickett, J; LeBlanc, MA; Rohan, LC				Dezzutti, Charlene S.; Brown, Elizabeth R.; Moncla, Bernard; Russo, Julie; Cost, Marilyn; Wang, Lin; Uranker, Kevin; Ayudhya, Ratiya P. Kunjara Na; Pryke, Kara; Pickett, Jim; LeBlanc, Marc-Andre; Rohan, Lisa C.			Is Wetter Better? An Evaluation of Over-the-Counter Personal Lubricants for Safety and Anti-HIV-1 Activity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PHASE-I SAFETY; CANDIDATE TOPICAL MICROBICIDES; CELLULOSE SULFATE GEL; HERPES-SIMPLEX-VIRUS; VAGINAL MICROBICIDE; SEXUAL TRANSMISSION; HIV-INFECTION; EPIGALLOCATECHIN GALLATE; SODIUM-SALICYLATE	Because lubricants may decrease trauma during coitus, it is hypothesized that they could aid in the prevention of HIV acquisition. Therefore, safety and anti-HIV-1 activity of over-the-counter (OTC) aqueous-(n = 10), lipid-(n = 2), and silicone-based (n = 2) products were tested. The rheological properties of the lipid-based lubricants precluded testing with the exception of explant safety testing. Six aqueous-based gels were hyperosmolar, two were nearly iso-osmolar, and two were hypo-osmolar. Evaluation of the panel of products showed Gynol II (a spermicidal gel containing 2% nonoxynol-9), KY Jelly, and Replens were toxic to Lactobacillus. Two nearly iso-osmolar aqueous-and both silicone-based gels were not toxic toward epithelial cell lines or ectocervical or colorectal explant tissues. Hyperosmolar lubricants demonstrated reduction of tissue viability and epithelial fracture/sloughing while the nearly iso-osmolar and silicon-based lubricants showed no significant changes in tissue viability or epithelial modifications. While most of the lubricants had no measurable anti-HIV-1 activity, three lubricants which retained cell viability did demonstrate modest anti-HIV-1 activity in vitro. To determine if this would result in protection of mucosal tissue or conversely determine if the epithelial damage associated with the hyperosmolar lubricants increased HIV-1 infection ex vivo, ectocervical tissue was exposed to selected lubricants and then challenged with HIV-1. None of the lubricants that had a moderate to high therapeutic index protected the mucosal tissue. These results show hyperosmolar lubricant gels were associated with cellular toxicity and epithelial damage while showing no anti-viral activity. The two iso-osmolar lubricants, Good Clean Love and PRE, and both silicone-based lubricants, Female Condom 2 lubricant and Wet Platinum, were the safest in our testing algorithm.	[Dezzutti, Charlene S.; Moncla, Bernard; Russo, Julie; Cost, Marilyn; Wang, Lin; Uranker, Kevin; Ayudhya, Ratiya P. Kunjara Na; Pryke, Kara; Rohan, Lisa C.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Pickett, Jim; LeBlanc, Marc-Andre] Int Rectal Microbicide Advocates, Chicago, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Fred Hutchinson Cancer Center	Dezzutti, CS (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	cdezzutti@mwri.magee.edu		Dezzutti, Charlene/0000-0001-5902-5841	National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health [UM1 AI068633, UM1 AI068615]; National Institute of Child Health and Development of the U.S. National Institutes of Health; National Institute of Mental Health of the U.S. National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068615, UM1AI068633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Development of the U.S. National Institutes of Health; National Institute of Mental Health of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Microbicide Trials Network is funded by the National Institute of Allergy and Infectious Diseases (UM1 AI068633 and UM1 AI068615), the National Institute of Child Health and Development, and the National Institute of Mental Health, all of the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Adriaens E, 2008, SEX TRANSM DIS, V35, P512, DOI 10.1097/OLQ.0b013e3181644669; [Anonymous], 2003, FED REGISTER, V)., P75585; [Anonymous], 2011, DEC DISC US TEN GEL; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Baron S, 2001, AIDS RES HUM RETROV, V17, P997, DOI 10.1089/088922201300343672; Basrani Bettina, 2005, Aust Endod J, V31, P48; Bayer AM, 2010, CULT HEALTH SEX, V12, P771, DOI [10.1080/13691058.2010.488299, 10.1080/13691051003728599]; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Begay O, 2011, AIDS RES HUM RETROV, V27, P1019, DOI [10.1089/aid.2010.0252, 10.1089/AID.2010.0252]; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Carballo-Dieguez A, 2000, AM J PUBLIC HEALTH, V90, P1117, DOI 10.2105/AJPH.90.7.1117; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Coplan PM, 1996, AM J EPIDEMIOL, V144, P817, DOI 10.1093/oxfordjournals.aje.a009016; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Digison Mary Beth, 2007, Plast Surg Nurs, V27, P185, DOI 10.1097/01.PSN.0000306182.50071.e2; Doh AS, 2007, CONTRACEPTION, V76, P245, DOI 10.1016/j.contraception.2007.05.083; El-Sadr WM, 2006, AIDS, V20, P1109, DOI 10.1097/01.aids.0000226950.72223.5f; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; Fuchs EJ, 2008, MICR 2008 NEW DELH I; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Gorbach PM, 2012, SEX TRANSM DIS, V39, P59, DOI 10.1097/OLQ.0b013e318235502b; Guenthner PC, 2005, INFECT IMMUN, V73, P4155, DOI 10.1128/IAI.73.7.4155-4160.2005; Guimaraes MDC, 1997, ARCH INTERN MED, V157, P1362, DOI 10.1001/archinte.157.12.1362; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07; Jamieson DJ, 1996, OBSTET GYNECOL, V87, P55, DOI 10.1016/0029-7844(95)00360-6; Jones DL, 2008, AIDS PATIENT CARE ST, V22, P1015, DOI 10.1089/apc.2007.0212; Jones DL, 2008, SEX TRANSM DIS, V35, P147, DOI 10.1097/OLQ.0b013e3181574dbf; Jones HE, 2009, J WOMENS HEALTH, V18, P1003, DOI 10.1089/jwh.2008.0862; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; KURAMOTO H, 1972, Acta Obstetrica et Gynaecologica Japonica (English Edition), V19, P47; Leyva F, 2011, 18 C RETR OPP INF BO; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Malonza IM, 2005, AIDS, V19, P2157, DOI 10.1097/01.aids.0000194797.59046.8f; Martin S, 2010, J WOMENS HEALTH, V19, P1561, DOI 10.1089/jwh.2009.1362; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Moench TR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-331; Moncla BJ, 2008, ANTIMICROB AGENTS CH, V52, P1577, DOI 10.1128/AAC.01023-07; Moncla BJ, 2005, SEX TRANSM DIS, V32, P491, DOI 10.1097/01.olq.0000170444.13666.e9; Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024; Nguyen D, 2004, J BIOL REG HOMEOS AG, V18, P268; NISHIHATA T, 1985, J PHARM PHARMACOL, V37, P159, DOI 10.1111/j.2042-7158.1985.tb05032.x; NISHIHATA T, 1987, J PHARM PHARMACOL, V39, P180, DOI 10.1111/j.2042-7158.1987.tb06245.x; NORVELL MK, 1984, J REPROD MED, V29, P269; OKADA H, 2001, VAGINAL DRUG DELIVER; PADIAN NS, 1995, J INFECT DIS, V172, P1084, DOI 10.1093/infdis/172.4.1084; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Qjha P, 2003, CONTRACEPTION, V68, P135, DOI 10.1016/S0010-7824(03)00138-0; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Schwartz JL, 2006, CONTRACEPTION, V74, P133, DOI 10.1016/j.contraception.2006.02.008; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Short MB, 2010, SEX TRANSM INFECT, V86, P71, DOI 10.1136/sti.2009.038158; Sudol KM, 2004, SEX TRANSM DIS, V31, P346, DOI 10.1097/00007435-200406000-00005; Tabet SR, 2003, JAIDS-J ACQ IMM DEF, V33, P476, DOI 10.1097/00126334-200308010-00008; Tanner A, 2009, J SEX RES, V46, P15, DOI 10.1080/00224490802398407; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Van Damme L, 2000, AIDS, V14, P85, DOI 10.1097/00002030-200001070-00010; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wang L, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-12; Watts DH, 1999, J INFECT DIS, V180, P426, DOI 10.1086/314881; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Williams DL, 2007, SEX TRANSM DIS, V34, P977, DOI 10.1097/OLQ.0b013e31813347e9; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x	69	79	84	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48328	10.1371/journal.pone.0048328	http://dx.doi.org/10.1371/journal.pone.0048328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23144863	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800044
J	Kao, DP; Wagner, BD; Robertson, AD; Bristow, MR; Lowes, BD				Kao, David P.; Wagner, Brandie D.; Robertson, Alastair D.; Bristow, Michael R.; Lowes, Brian D.			A Personalized BEST: Characterization of Latent Clinical Classes of Nonischemic Heart Failure That Predict Outcomes and Response to Bucindolol	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LOW PULSE PRESSURE; PROGNOSTIC VALUE; CONTROLLED-TRIAL; BLOOD-PRESSURE; MORTALITY; SURVIVAL; MORBIDITY; CARVEDILOL; CRITERIA	Background: Heart failure patients with reduced ejection fraction (HFREF) are heterogenous, and our ability to identify patients likely to respond to therapy is limited. We present a method of identifying disease subtypes using high-dimensional clinical phenotyping and latent class analysis that may be useful in personalizing prognosis and treatment in HFREF. Methods: A total of 1121 patients with nonischemic HFREF from the beta-blocker Evaluation of Survival Trial were categorized according to 27 clinical features. Latent class analysis was used to generate two latent class models, LCM A and B, to identify HFREF subtypes. LCM A consisted of features associated with HF pathogenesis, whereas LCM B consisted of markers of HF progression and severity. The Seattle Heart Failure Model (SHFM) Score was also calculated for all patients. Mortality, improvement in left ventricular ejection fraction (LVEF) defined as an increase in LVEF >= 5% and a final LVEF of 35% after 12 months, and effect of bucindolol on both outcomes were compared across HFREF subtypes. Performance of models that included a combination of LCM subtypes and SHFM scores towards predicting mortality and LVEF response was estimated and subsequently validated using leave-one-out cross-validation and data from the Multicenter Oral Carvedilol Heart Failure Assessment Trial. Results: A total of 6 subtypes were identified using LCM A and 5 subtypes using LCM B. Several subtypes resembled familiar clinical phenotypes. Prognosis, improvement in LVEF, and the effect of bucindolol treatment differed significantly between subtypes. Prediction improved with addition of both latent class models to SHFM for both 1-year mortality and LVEF response outcomes. Conclusions: The combination of high-dimensional phenotyping and latent class analysis identifies subtypes of HFREF with implications for prognosis and response to specific therapies that may provide insight into mechanisms of disease. These subtypes may facilitate development of personalized treatment plans.	[Kao, David P.; Robertson, Alastair D.; Bristow, Michael R.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA; [Wagner, Brandie D.] Colorado Sch Publ Hlth, Aurora, CO USA; [Lowes, Brian D.] Univ Nebraska Med Ctr, Div Cardiol, Omaha, NE USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Nebraska System; University of Nebraska Medical Center	Kao, DP (corresponding author), Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA.	David.Kao@ucdenver.edu	Kao, David P/K-3288-2013; Lowes, Brian/M-9020-2017	Kao, David P/0000-0002-2832-9348; Lowes, Brian/0000-0002-5919-2540	United States National Institutes of Health [NHLBI 2T32 NHL007822-12, NHLBI 5 P20 HL101438-01]; Veteran's Administration; National Heart, Lung, and Blood Institute; Intercardia Pharmaceutical Company; Arca Biopharma, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822, P20HL101438] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intercardia Pharmaceutical Company; Arca Biopharma, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work in this manuscript was supported by the following United States National Institutes of Health Grants. Kao: NHLBI 2T32 NHL007822-12 (PI: P. Buttrick). Wagner, Robertson, Lowes: NHLBI 5 P20 HL101438-01 (PI: Brian Lowes). The original BEST Study was funded by the Veteran's Administration Cooperative Studies Program, the National Heart, Lung, and Blood Institute, Intercardia Pharmaceutical Company and Arca Biopharma, Inc. The funders of this work had no role in the design, analysis, preparation of the manuscript, or decision to publish.	Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; [Anonymous], 1995, AM J CARDIOL, V75, P1220; Bahrami H, 2008, J AM COLL CARDIOL, V51, P1775, DOI 10.1016/j.jacc.2007.12.048; Baldasseroni S, 2011, J CARDIOVASC MED, V12, P723, DOI 10.2459/JCM.0b013e32834ae87e; Banach M, 2011, AM J CARDIOL, V107, P1208, DOI 10.1016/j.amjcard.2010.12.020; Batin P, 1995, EUR HEART J, V16, P1613, DOI 10.1093/oxfordjournals.eurheartj.a060785; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Cassidy F, 2001, NEUROPSYCHOPHARMACOL, V25, P373, DOI 10.1016/S0893-133X(01)00223-8; Chen CY, 2012, CIRC J, V76, P2372, DOI 10.1253/circj.CJ-12-0040; Cheng RK, 2008, AM J CARDIOL, V102, P1698, DOI 10.1016/j.amjcard.2008.07.058; Crow SJ, 2012, J ABNORM PSYCHOL, V121, P225, DOI 10.1037/a0024455; De Keulenaer GW, 2011, CIRCULATION, V123, P1996, DOI 10.1161/CIRCULATIONAHA.110.981431; Dini FL, 2012, EUR J HEART FAIL, V14, P287, DOI 10.1093/eurjhf/hfr176; Domanski M, 2003, J AM COLL CARDIOL, V42, P914, DOI 10.1016/S0735-1097(03)00856-8; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Formann A K, 1996, Stat Methods Med Res, V5, P179, DOI 10.1177/096228029600500205; Fudim Marat, 2011, Curr Heart Fail Rep, V8, P147, DOI 10.1007/s11897-011-0049-5; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Grayson PC, 2012, ANN RHEUM DIS, V71, P1329, DOI 10.1136/annrheumdis-2011-200795; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Jaeger S, 2012, PSYCHIAT RES; Kao DP, 2008, 2008 SUMM TRANSL BIO; Kazory A, 2009, J AM COLL CARDIOL, V53, P639, DOI 10.1016/j.jacc.2008.10.046; Kim J, 2006, AM J EPIDEMIOL, V164, P184, DOI 10.1093/aje/kwj168; Kupari M, 1997, J INTERN MED, V241, P387, DOI 10.1046/j.1365-2796.1997.129150000.x; Lanza ST, 2011, PREV SCI; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Linzer D., 2010, POLCA POLYTOMOUS VAR; Liu L, 2009, SAS GLOB FOR 2009; Maggioni AP, 2005, J CARD FAIL, V11, P91, DOI 10.1016/j.cardfail.2004.05.004; Nagarakanti Rangadham, 2007, Cardiol Rev, V15, P178, DOI 10.1097/CRD.0b013e31804c98b1; O'Connor CM, 2012, CIRC-HEART FAIL, V5, P63, DOI 10.1161/CIRCHEARTFAILURE.111.963462; Ogden LG, 2012, OBESITY, V20, P2039, DOI 10.1038/oby.2012.79; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Petrie CJ, 2009, INT J CARDIOL, V131, P336, DOI 10.1016/j.ijcard.2007.10.023; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rindskopf D, 2002, P ANN M AM STAT ASS, P2912; Shiba N, 2011, J CARDIOL, V57, P8, DOI 10.1016/j.jjcc.2010.09.004; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Singh G, 2012, J CARDIOVASC MED, V13, P246, DOI 10.2459/JCM.0b013e3283516767; Starkstein S, 2011, MOVEMENT DISORD, V26, P2239, DOI 10.1002/mds.23836; Team RDC, 2010, R LANG ENV STAT COMP; Therneau T, 2010, SURVIVAL SURVIVAL AN; Witteles RM, 2008, J AM COLL CARDIOL, V51, P93, DOI 10.1016/j.jacc.2007.10.021; Wong LSM, 2010, HEART FAIL REV, V15, P479, DOI 10.1007/s10741-010-9173-7; Yildiran T, 2010, TEX HEART I J, V37, P284; Zannad F, 2007, EUR J HEART FAIL, V9, P7, DOI 10.1016/j.ejheart.2006.04.011	52	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48184	10.1371/journal.pone.0048184	http://dx.doi.org/10.1371/journal.pone.0048184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144856	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800040
J	Takami, T; Fang, Y; Zhou, X; Jaiseng, W; Ma, Y; Kuno, T				Takami, Tomonori; Fang, Yue; Zhou, Xin; Jaiseng, Wurentuya; Ma, Yan; Kuno, Takayoshi			A Genetic and Pharmacological Analysis of Isoprenoid Pathway by LC-MS/MS in Fission Yeast	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; HMG-COA REDUCTASE; SACCHAROMYCES-CEREVISIAE; DIPHOSPHATE SYNTHASE; PROTEIN; FARNESYL; HETEROMER; STATINS; BINDING	Currently, statins are the only drugs acting on the mammalian isoprenoid pathway. The mammalian genes in this pathway are not easily amenable to genetic manipulation. Thus, it is difficult to study the effects of the inhibition of various enzymes on the intermediate and final products in the isoprenoid pathway. In fission yeast, antifungal compounds such as azoles and terbinafine are available as inhibitors of the pathway in addition to statins, and various isoprenoid pathway mutants are also available. Here in these mutants, treated with statins or antifungals, we quantified the final and intermediate products of the fission yeast isoprenoid pathway using liquid chromatography-mass spectrometry/mass spectrometry. In hmg1-1, a mutant of the gene encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR), ergosterol (a final sterol product), and squalene (an intermediate pathway product), were decreased to approximately 80% and 10%, respectively, compared with that of wild-type cells. Consistently in wild-type cells, pravastatin, an HMGR inhibitor decreased ergosterol and squalene, and the effect was more pronounced on squalene. In hmg1-1 mutant and in wild-type cells treated with pravastatin, the decrease in the levels of farnesyl pyrophosphate and geranylgeranyl pyrophosphate respectively was larger than that of ergosterol but was smaller than that of squalene. In Delta erg6 or Delta sts1 cells, mutants of the genes involved in the last step of the pathway, ergosterol was not detected, and the changes of intermediate product levels were distinct from that of hmg1-1 mutant. Notably, in wild-type cells miconazole and terbinafine only slightly decreased ergosterol level. Altogether, these studies suggest that the pleiotropic phenotypes caused by the hmg1-1 mutation and pravastatin might be due to decreased levels of isoprenoid pyrophosphates or other isoprenoid pathway intermediate products rather than due to a decreased ergosterol level.	[Takami, Tomonori; Fang, Yue; Zhou, Xin; Jaiseng, Wurentuya; Ma, Yan; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan; [Takami, Tomonori] JCL Bioassay Corp, Chem Anal Sect, Nishiwaki, Japan; [Fang, Yue; Kuno, Takayoshi] China Med Univ, Sch Pharmaceut Sci, Dept Pharmacol, Shenyang, Peoples R China; [Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Jinzhou, Peoples R China	Kobe University; China Medical University; Jinzhou Medical University	Fang, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan.	fangyue@mail.cmu.edu.cn			Ministry of Education, Culture, Sports, Science and Technology of Japan; National Natural Science Foundation of China [30900795, 31071094]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Takayoshi Kuno. This work was also financially supported by the National Natural Science Foundation of China to Yue Fang (No. 30900795 and No. 31071094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrdwell WC, 2001, LIPIDS, V36, P327, DOI 10.1007/s11745-001-0725-5; Ceglarek U, 2009, CLIN CHIM ACTA, V401, P114, DOI 10.1016/j.cca.2008.11.022; Fang Y, 2009, GENES CELLS, V14, P759, DOI 10.1111/j.1365-2443.2009.01308.x; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Henneman L, 2008, ANAL BIOCHEM, V383, P18, DOI 10.1016/j.ab.2008.08.023; Henneman L, 2011, BBA-MOL CELL BIOL L, V1811, P227, DOI 10.1016/j.bbalip.2011.01.002; Waki T, 2008, MICROBIOL-SGM, V154, P830, DOI 10.1099/mic.0.2007/011155-0; KOBAYASHI Y, 1993, BIOL PHARM BULL, V16, P1175; Kuranda K, 2010, FEMS YEAST RES, V10, P14, DOI 10.1111/j.1567-1364.2009.00560.x; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORETON RS, 1989, APPL ENVIRON MICROB, V55, P3009, DOI 10.1128/AEM.55.11.3009-3011.1989; Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943; Nowosieski M, 2011, J CHEM INF MODEL, V51, P455, DOI 10.1021/ci100403b; Shackleton C, 2010, J STEROID BIOCHEM, V121, P481, DOI 10.1016/j.jsbmb.2010.02.017; Toda T, 1996, MOL CELL BIOL, V16, P6752; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Tong H, 2008, ANAL BIOCHEM, V378, P138, DOI 10.1016/j.ab.2008.04.021; Tong HX, 2005, ANAL BIOCHEM, V336, P51, DOI 10.1016/j.ab.2004.09.024; Ye YF, 2007, MOL BIOL CELL, V18, P3568, DOI 10.1091/mbc.e07-02-0112; Zhang M, 2008, FEBS J, V275, P3653, DOI 10.1111/j.1742-4658.2008.06510.x	25	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49004	10.1371/journal.pone.0049004	http://dx.doi.org/10.1371/journal.pone.0049004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145048	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800184
J	Xia, XY; Cai, H; Qin, SX; Xu, C				Xia, Xiaoyu; Cai, Heng; Qin, Shixiao; Xu, Chen			Histone Acetylase Inhibitor Curcumin Impairs Mouse Spermiogenesis-An In Vitro Study	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION PROGRAM; SPERMATOGENIC CELLS; TRICHOSTATIN-A; RAT TESTIS; MICE; SPERM; NANOPARTICLES; PROTEINS; ACETYLTRANSFERASE	In the previous study, we unraveled the unique "erasure strategy'' during the mouse spermiogenesis. Chromatin associated proteins sequentially disassociated from the spermatid chromosome, which led to the termination of transcription in elongating spermatids. By this process, a relatively naive paternal chromatin was generated, which might be essential for the zygotic development. We supposed the regulation of histone acetylation played an important role throughout this "erasure'' process. In order to verify this hypothesis, we treated mouse spermatids in vitro by histone acetylase (HAT) inhibitor Curcumin. Our results showed an inhibiting effect of Curcumin on the growth of germ cell line in a dose-dependent manner. Accordingly, the apoptosis of primary haploid spermtids was increased by Curcumin treatment. As expected, the acetylated histone level was downregulated. Furthermore, we found the transcription in spermatids ceased in advance, the dynamics of chromatin associated factors was disturbed by Curcumin treatment. The regulation of histone acetylation should be one of the core reprogramming mechanisms during the spermiogenesis. The reproductive toxicity of Curcumin needs to be thoroughly investigated, which is crucial for its further clinical application.	[Xia, Xiaoyu; Cai, Heng; Qin, Shixiao; Xu, Chen] Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China; [Xia, Xiaoyu; Cai, Heng; Qin, Shixiao; Xu, Chen] Shanghai Key Lab Reprod Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China.	chenx@shsmu.edu.cn			Ministry of Education of P.R. China [20110073120083]; Science and Technology Commission of Shanghai Municipality [10DZ2270600]; Shanghai Leading Academic Discipline Project [S30201]; Shanghai Municipal Education Commission [JDY10141]	Ministry of Education of P.R. China(Ministry of Education, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from the Ministry of Education of P.R. China (20110073120083), http://www.moe.edu.cn/; Science and Technology Commission of Shanghai Municipality (10DZ2270600), http://www.stcsm.gov.cn/; Shanghai Leading Academic Discipline Project (S30201) and Shanghai Municipal Education Commission (JDY10141), http://www.shmec.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2007, ADV EXPT MED BIOL, V595; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bisht Savita, 2009, Curr Drug Discov Technol, V6, P192; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Cheng, 2008, MOL MECH SPERMATOGEN; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Fenic I, 2004, J ANDROL, V25, P811; Fenic I, 2008, J ANDROL, V29, P172, DOI 10.2164/jandrol.107.003848; Feuring-Buske M, 2001, BLOOD, V97, P3882, DOI 10.1182/blood.V97.12.3882; Garner DL, 2009, THERIOGENOLOGY, V71, P11, DOI 10.1016/j.theriogenology.2008.09.023; Giannessi F, 2008, MED SCI MONITOR, V14, pBR237; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Hofmann MC, 2005, STEM CELLS, V23, P200, DOI 10.1634/stemcells.2003-0036; Ilbey YO, 2009, HUM REPROD, V24, P1717, DOI 10.1093/humrep/dep058; Jeyaraj DA, 2002, BIOL REPROD, V66, P877, DOI 10.1095/biolreprod66.4.877; Kang JH, 2005, BIOCHEM PHARMACOL, V69, P1205, DOI 10.1016/j.bcp.2005.01.014; Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kwon JT, 2008, J OCCUP HEALTH, V50, P1, DOI 10.1539/joh.50.1; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; McGraw S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-123; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; Mudrak O, 2005, J CELL SCI, V118, P4541, DOI 10.1242/jcs.02581; Naz RK, 2011, MOL REPROD DEV, V78, P116, DOI 10.1002/mrd.21276; Pradeepa MM, 2009, J BIOL CHEM, V284, P29956, DOI 10.1074/jbc.M109.052043; Rithaporn T, 2003, CONTRACEPTION, V68, P219, DOI 10.1016/S0010-7824(03)00163-X; Shamila Y, 2000, MOL REPROD DEV, V56, P289, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;289::AID-MRD17&gt;3.0.CO;2-Y; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Szasz F, 2000, MOL REPROD DEV, V55, P289, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;289::AID-MRD7&gt;3.0.CO;2-K; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Verma RJ, 2009, FERTIL STERIL, V91, P597, DOI 10.1016/j.fertnstert.2007.11.053; Wei SM, 2009, FERTIL STERIL, V91, P271, DOI 10.1016/j.fertnstert.2007.10.082; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yoshida S, 2009, INT J ANDROL, V32, P337, DOI 10.1111/j.1365-2605.2007.00865.x; Yoshida S, 2010, FERTIL STERIL, V93, P1695, DOI 10.1016/j.fertnstert.2009.03.094; Zheng JK, 2008, DEV DYNAM, V237, P1463, DOI 10.1002/dvdy.21499	40	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48673	10.1371/journal.pone.0048673	http://dx.doi.org/10.1371/journal.pone.0048673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144926	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800096
J	Wilson, RR; Prichard, AK; Parrett, LS; Person, BT; Carroll, GM; Smith, MA; Rea, CL; Yokel, DA				Wilson, Ryan R.; Prichard, Alexander K.; Parrett, Lincoln S.; Person, Brian T.; Carroll, Geoffry M.; Smith, Melanie A.; Rea, Caryn L.; Yokel, David A.			Summer Resource Selection and Identification of Important Habitat Prior to Industrial Development for the Teshekpuk Caribou Herd in Northern Alaska	PLOS ONE			English	Article							RANGIFER-TARANDUS; MIGRATORY CARIBOU; SPATIAL SCALES; TRADE-OFFS; WILDLIFE; PRODUCTIVITY; OIL; AVAILABILITY; CONSERVATION; RUGGEDNESS	Many caribou (Rangifer tarandus) populations are declining worldwide in part due to disturbance from human development. Prior to human development, important areas of habitat should be identified to help managers minimize adverse effects. Resource selection functions can help identify these areas by providing a link between space use and landscape attributes. We estimated resource selection during five summer periods at two spatial scales for the Teshekpuk Caribou Herd in northern Alaska prior to industrial development to identify areas of high predicted use for the herd. Additionally, given the strong influence parturition and insect harassment have on space use, we determined how selection differed between parturient and non-parturient females, and between periods with and without insect harassment. We used location data acquired between 2004-2010 for 41 female caribou to estimate resource selection functions. Patterns of selection varied through summer but caribou consistently avoided patches of flooded vegetation and selected areas with a high density of sedge-grass meadow. Predicted use by parturient females during calving was almost entirely restricted to the area surrounding Teshekpuk Lake presumably due to high concentration of sedge-grass meadows, whereas selection for this area by non-parturient females was less strong. When insect harassment was low, caribou primarily selected the areas around Teshekpuk Lake but when it was high, caribou used areas having climates where insect abundance would be lower (i.e., coastal margins, gravel bars). Areas with a high probability of use were predominately restricted to the area surrounding Teshekpuk Lake except during late summer when high use areas were less aggregated because of more general patterns of resource selection. Planning is currently underway for establishing where oil and gas development can occur in the herd's range, so our results provide land managers with information that can help predict and minimize impacts of development on the herd.	[Wilson, Ryan R.] Wilderness Soc, Anchorage, AK USA; [Prichard, Alexander K.] ABR Inc, Environm Res & Serv, Fairbanks, AK USA; [Parrett, Lincoln S.] Alaska Dept Fish & Game, Fairbanks, AK USA; [Person, Brian T.] N Slope Borough Dept Wildlife Management, Barrow, AK USA; [Carroll, Geoffry M.] Alaska Dept Fish & Game, Barrow, AK USA; [Smith, Melanie A.] Audubon Alaska, Anchorage, AK USA; [Rea, Caryn L.] ConocoPhillips Alaska Inc, Anchorage, AK USA; [Yokel, David A.] US Bur Land Management, Fairbanks, AK USA	Alaska Department of Fish & Game; Alaska Department of Fish & Game; ConocoPhillips	Wilson, RR (corresponding author), Wilderness Soc, Anchorage, AK USA.	ryan_wilson@tws.org		Prichard, Alexander/0000-0002-1172-7059; Smith, Melanie/0000-0001-7397-5018	Alaska Department of Commerce, Community, and Economic Development; Wilburforce Foundation	Alaska Department of Commerce, Community, and Economic Development; Wilburforce Foundation	The study was funded by the Alaska Department of Commerce, Community, and Economic Development and by the The Wilburforce Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2; Bates D, 2011, LME4 LINEAR MIXED EF; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Boelman NT, 2003, OECOLOGIA, V135, P414, DOI 10.1007/s00442-003-1198-3; Boulanger J, 2012, WILDLIFE BIOL, V18, P164, DOI 10.2981/11-045; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Bureau of Land Management Ducks Unlimited Inc, 2002, 40 BUR LAND MAN DUCK; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cameron RD, 2005, ARCTIC, V58, P1; Carroll Geoff M., 2005, Rangifer, P27; Cebrian MR, 2008, ARCT ANTARCT ALP RES, V40, P48, DOI 10.1657/1523-0430(06-073)[CEBRIAN]2.0.CO;2; Colman JE, 2003, J WILDLIFE MANAGE, V67, P11, DOI 10.2307/3803056; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Couturier S, 2009, J MAMMAL, V90, P442, DOI 10.1644/07-MAMM-A-279.1; Dale MRT, 2000, LANDSCAPE ECOL, V15, P467, DOI 10.1023/A:1008176601940; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; FANCY SG, 1991, CAN J ZOOL, V69, P1736, DOI 10.1139/z91-242; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; FINSTAD G., 2008, THESIS U ALASKA FAIR; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Harju SM, 2011, ANIM CONSERV, V14, P502, DOI 10.1111/j.1469-1795.2011.00456.x; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; HELLE T, 1984, Rangifer, V4, P24; Hughes J, 2009, PARASITOLOGY, V136, P253, DOI 10.1017/S0031182008005246; Johnson CJ, 2005, WILDLIFE MONOGR, P1; Johnson CJ, 2004, LANDSCAPE ECOL, V19, P869, DOI 10.1007/s10980-004-0246-7; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnstone J, 2002, RANGIFER, V22, P65; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Manly B.F.J., 2002, RESOURCE SELECTION A; Marell A, 2006, ARCT ANTARCT ALP RES, V38, P413, DOI 10.1657/1523-0430(2006)38[413:SHAHFH]2.0.CO;2; Mayor SJ, 2009, ACTA OECOL, V35, P253, DOI 10.1016/j.actao.2008.11.004; McCabe, 2002, ARCTIC REFUGE COASTA, P8; Montgomery RA, 2011, J WILDLIFE MANAGE, V75, P702, DOI 10.1002/jwmg.96; Murphy Stephen M., 2000, P59, DOI 10.1016/B978-012701235-3/50006-4; Nellemann C, 2003, BIOL CONSERV, V113, P307, DOI 10.1016/S0006-3207(03)00048-X; NELLEMANN C, 1994, ARCTIC, V47, P361; Noel LE, 2004, WILDLIFE SOC B, V32, P757, DOI 10.2193/0091-7648(2004)032[0757:CDNAOR]2.0.CO;2; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parrett L. S., 2007, THESIS U ALASKA FAIR; Person BT, 2007, ARCTIC, V60, P238; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Russell Don E., 1993, Rangifer, V13, P1; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schaefer JA, 1995, ECOGRAPHY, V18, P333, DOI 10.1111/j.1600-0587.1995.tb00136.x; SKOGLAND T, 1984, HOLARCTIC ECOL, V7, P345; Taillon J, 2012, BIOL CONSERV, V147, P163, DOI 10.1016/j.biocon.2011.12.027; Tamstorf MP, 2005, POLAR BIOL, V28, P714, DOI 10.1007/s00300-005-0731-8; Therneau T, 2009, SURVIVAL SURVIVAL AN; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; WALSH NE, 1992, J WILDLIFE MANAGE, V56, P465, DOI 10.2307/3808860; Weladji RB, 2003, J ZOOL, V260, P79, DOI 10.1017/S0952836903003510; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; WHITTEN KR, 1992, J WILDLIFE MANAGE, V56, P201, DOI 10.2307/3808814; Witter LA, 2012, J ANIM ECOL, V81, P284, DOI 10.1111/j.1365-2656.2011.01905.x; WOLFE SA, 2000, THESIS U ALASKA FAIR; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yokel D. A., 2009, ALASKA PARK SCI, V8, P64; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zuur Alain F., 2009, P1	63	24	25	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48697	10.1371/journal.pone.0048697	http://dx.doi.org/10.1371/journal.pone.0048697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144932	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400059
J	Barbolina, MV; Liu, YY; Gurler, H; Kim, M; Kajdacsy-Balla, AA; Rooper, L; Shepard, J; Weiss, M; Shea, LD; Penzes, P; Ravosa, MJ; Stack, MS				Barbolina, Maria V.; Liu, Yiuying; Gurler, Hilal; Kim, Mijung; Kajdacsy-Balla, Andre A.; Rooper, Lisa; Shepard, Jaclyn; Weiss, Michael; Shea, Lonnie D.; Penzes, Peter; Ravosa, Matthew J.; Stack, M. Sharon			Matrix Rigidity Activates Wnt Signaling through Down-regulation of Dickkopf-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER METASTASIS; BETA-CATENIN EXPRESSION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CELL INVASION; MICROENVIRONMENTAL REGULATION; CLINICOPATHOLOGICAL FEATURES; METALLOPROTEINASE EXPRESSION; AMINOTERMINAL PROPEPTIDE; PERICELLULAR PROTEOLYSIS	Cells respond to changes in the physical properties of the extracellular matrix with altered behavior and gene expression, highlighting the important role of the microenvironment in the regulation of cell function. In the current study, culture of epithelial ovarian cancer cells on three-dimensional collagen I gels led to a dramatic down-regulation of the Wnt signaling inhibitor dickkopf-1 with a concomitant increase in nuclear beta-catenin and enhanced beta-catenin/Tcf/Lef transcriptional activity. Increased three-dimensional collagen gel invasion was accompanied by transcriptional up-regulation of the membrane-tethered collagenase membrane type 1 matrix metalloproteinase, and an inverse relationship between dickkopf-1 and membrane type 1 matrix metalloproteinase was observed in human epithelial ovarian cancer specimens. Similar results were obtained in other tissue-invasive cells such as vascular endothelial cells, suggesting a novel mechanism for functional coupling of matrix adhesion with Wnt signaling.	[Barbolina, Maria V.; Gurler, Hilal; Kim, Mijung] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60622 USA; [Kajdacsy-Balla, Andre A.; Rooper, Lisa] Univ Illinois, Dept Pathol, Chicago, IL 60622 USA; [Ravosa, Matthew J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Liu, Yiuying; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, Harper Canc Res Inst, Notre Dame, IN 46556 USA; [Shepard, Jaclyn; Weiss, Michael; Shea, Lonnie D.; Penzes, Peter] Northwestern Univ, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Notre Dame; University of Notre Dame; Northwestern University	Barbolina, MV (corresponding author), Univ Illinois, Dept Biopharmaceut Sci, PHARM 453, 833 S Wood St, Chicago, IL 60612 USA.	mvb@uic.edu	Penzes, Peter/L-3987-2016; Shea, Lonnie D/B-7615-2009	Penzes, Peter/0000-0001-5449-1640; Rooper, Lisa/0000-0001-5636-9753	National Institutes of Health [CA086984, CA109545]; Ovarian Cancer Research Foundation Program of Excellence; Illinois Department of Public Health; NATIONAL CANCER INSTITUTE [R01CA109545, R01CA086984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Foundation Program of Excellence; Illinois Department of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA086984 and CA109545 (to M. S. S.). This work was also supported by the Ovarian Cancer Research Foundation Program of Excellence (to M. V. B.) and the Illinois Department of Public Health (to M. V. B.).	Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Barbolina MV, 2008, CANCER-AM CANCER SOC, V112, P1632, DOI 10.1002/cncr.23341; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; BISSELL MJ, 1987, J CELL SCI, P327; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Fishman DA, 1997, GYNECOL ONCOL, V67, P193, DOI 10.1006/gyno.1997.4850; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hlubek F, 2004, INT J CANCER, V108, P321, DOI 10.1002/ijc.11522; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Kildal W, 2005, EUR J CANCER, V41, P1127, DOI 10.1016/j.ejca.2005.01.022; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; LABATROBERT J, 1990, FEBS LETT, V268, P386, DOI 10.1016/0014-5793(90)81291-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CM, 2003, GYNECOL ONCOL, V88, P363, DOI 10.1016/S0090-8258(02)00015-X; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Marchenko GN, 2002, BIOCHEM J, V363, P253, DOI 10.1042/0264-6021:3630253; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Moser TL, 1996, INT J CANCER, V67, P695, DOI 10.1002/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.3.CO;2-2; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PUISTOLA U, 1990, AM J OBSTET GYNECOL, V163, P1276, DOI 10.1016/0002-9378(90)90707-E; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; RISTELI L, 1988, INT J CANCER, V41, P409, DOI 10.1002/ijc.2910410316; RISTELI L, 1992, ACTA OBSTET GYN SCAN, V71, P99, DOI 10.1111/j.1600-0412.1992.tb00014.x; Roskelley CD, 2002, SEMIN CANCER BIOL, V12, P97, DOI 10.1006/scbi.2001.0417; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Schambony A, 2004, DIFFERENTIATION, V72, P307, DOI 10.1111/j.1432-0436.2004.07207002.x; Shedden KA, 2005, CLIN CANCER RES, V11, P2123, DOI 10.1158/1078-0432.CCR-04-2061; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tsukatani T, 2003, NEUROREPORT, V14, P1135, DOI 10.1097/00001756-200306110-00007; Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; ZHU GG, 1993, CANCER RES, V53, P5028; Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564	64	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					141	151		10.1074/jbc.M112.431411	http://dx.doi.org/10.1074/jbc.M112.431411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23152495	hybrid, Green Published			2022-12-25	WOS:000313197200014
J	Houben, AJS; van Wijk, XMR; van Meeteren, LA; van Zeijl, L; van de Westerlo, EMA; Hausmann, J; Fish, A; Perrakis, A; van Kuppevelt, TH; Moolenaar, WH				Houben, Anna J. S.; van Wijk, Xander M. R.; van Meeteren, Laurens A.; van Zeijl, Leonie; van de Westerlo, Els M. A.; Hausmann, Jens; Fish, Alexander; Perrakis, Anastassis; van Kuppevelt, Toin H.; Moolenaar, Wouter H.			The Polybasic Insertion in Autotaxin alpha Confers Specific Binding to Heparin and Cell Surface Heparan Sulfate Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; MOTILITY-STIMULATING PROTEIN; GROWTH-FACTOR BINDING; LYSOPHOSPHOLIPASE-D; BIOCHEMICAL-CHARACTERIZATION; EXPRESSION; CANCER; FURIN; LPA; IDENTIFICATION	Autotaxin (ATX) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), playing a key role in diverse physiological and pathological processes. ATX exists in distinct splice variants, but isoform-specific functions remain elusive. Here we characterize the ATX alpha isoform, which differs from the canonical form (ATX beta) in having a 52-residue polybasic insertion of unknown function in the catalytic domain. We find that the ATX alpha insertion is susceptible to cleavage by extracellular furin-like endoproteases, but cleaved ATX alpha remains structurally and functionally intact due to strong interactions within the catalytic domain. Through ELISA and surface plasmon resonance assays, we show that ATX alpha binds specifically to heparin with high affinity (K-d similar to 10(-8) M), whereas ATX beta does not; furthermore, heparin moderately enhanced the lysophospholipase D activity of ATX alpha. We further show that ATX alpha, but not ATX beta, binds abundantly to SKOV3 carcinoma cells. ATX alpha binding was abolished after treating the cells with heparinase III, but not after chondroitinase treatment. Thus, the ATX alpha insertion constitutes a cleavable heparin-binding domain that mediates interaction with heparan sulfate proteoglycans, thereby targeting LPA production to the plasma membrane.	[Houben, Anna J. S.; van Meeteren, Laurens A.; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [van Wijk, Xander M. R.; van de Westerlo, Els M. A.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [van Zeijl, Leonie; Hausmann, Jens; Fish, Alexander; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Radboud University Nijmegen; Netherlands Cancer Institute	van Kuppevelt, TH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	a.vankuppevelt@ncmls.ru.nl; w.moolenaar@nki.nl	Van Meeteren, Laurens A./AGQ-6139-2022; Perrakis, Anastassis/E-8704-2013; van Kuppevelt, A.H.M.S.M./L-4463-2015; van Meeteren, Laurens/A-9890-2008	Perrakis, Anastassis/0000-0002-1151-6227; van Meeteren, Laurens/0000-0001-9885-0668; Hausmann, Jens/0000-0001-8960-6225	Dutch Cancer Society; Netherlands Organisation for Scientific Research	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch Cancer Society and The Netherlands Organisation for Scientific Research.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Clair T, 2003, CANCER RES, V63, P5446; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Fuss B, 1997, J NEUROSCI, V17, P9095; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hashimoto T, 2012, J BIOCHEM, V151, P89, DOI 10.1093/jb/mvr126; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hausmann J, 2010, ACTA CRYSTALLOGR F, V66, P1130, DOI 10.1107/S1744309110032938; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kawagoe H, 1997, CANCER RES, V57, P2516; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai SL, 2012, DEVELOPMENT, V139, P4439, DOI 10.1242/dev.081745; Lee HY, 1996, BIOCHEM BIOPH RES CO, V218, P714, DOI 10.1006/bbrc.1996.0127; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sun T, 2010, INT J BIOL SCI, V6, P89; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; van Wijk XMR, 2010, EXP CELL RES, V316, P2504, DOI 10.1016/j.yexcr.2010.04.025; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	51	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					510	519		10.1074/jbc.M112.358416	http://dx.doi.org/10.1074/jbc.M112.358416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150666	hybrid, Green Published			2022-12-25	WOS:000313197200051
J	Mosier, PD; Krishnasamy, C; Kellogg, GE; Desai, UR				Mosier, Philip D.; Krishnasamy, Chandravel; Kellogg, Glen E.; Desai, Umesh R.			On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; HEPARIN-BINDING; WATER-MOLECULES; NONSPECIFIC-BINDING; TERNARY COMPLEX; LIGAND-BINDING; REVEALS; ACTIVATION; MECHANISM; OCTASACCHARIDE	Background: The antithrombin-heparin/heparan sulfate (H/HS) and thrombin-H/HS interactions are recognized as prototypic specific and non-specific glycosaminoglycan (GAG)-protein interactions, respectively. The fundamental structural basis for the origin of specificity, or lack thereof, in these interactions remains unclear. The availability of multiple co-crystal structures facilitates a structural analysis that challenges the long-held belief that the GAG binding sites in antithrombin and thrombin are essentially similar with high solvent exposure and shallow surface characteristics. Methodology: Analyses of solvent accessibility and exposed surface areas, gyrational mobility, symmetry, cavity shape/size, conserved water molecules and crystallographic parameters were performed for 12 X-ray structures, which include 12 thrombin and 16 antithrombin chains. Novel calculations are described for gyrational mobility and prediction of water loci and conservation. Results: The solvent accessibilities and gyrational mobilities of arginines and lysines in the binding sites of the two proteins reveal sharp contrasts. The distribution of positive charges shows considerable asymmetry in antithrombin, but substantial symmetry for thrombin. Cavity analyses suggest the presence of a reasonably sized bifurcated cavity in antithrombin that facilitates a firm 'hand-shake' with H/HS, but with thrombin, a weaker 'high-five'. Tightly bound water molecules were predicted to be localized in the pentasaccharide binding pocket of antithrombin, but absent in thrombin. Together, these differences in the binding sites explain the major H/HS recognition characteristics of the two prototypic proteins, thus affording an explanation of the specificity of binding. This provides a foundation for understanding specificity of interaction at an atomic level, which will greatly aid the design of natural or synthetic H/HS sequences that target proteins in a specific manner.	[Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA.	urdesai@vcu.edu	Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Kellogg, Glen/0000-0002-6282-6794	National Institutes of Health [HL099420, HL090586, HL107152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099420, P01HL107152, R01HL090586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL099420, HL090586 and HL107152 from the National Institutes of Health to URD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abzalimov RR, 2007, ANAL CHEM, V79, P6055, DOI 10.1021/ac0710432; Amadasi A, 2008, J MED CHEM, V51, P1063, DOI 10.1021/jm701023h; An Jianghong, 2004, Genome Inform, V15, P31; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t; Cozzini P, 2004, CURR MED CHEM, V11, P3093, DOI 10.2174/0929867043363929; de Paz JL, 2006, J AM CHEM SOC, V128, P2766, DOI 10.1021/ja057584v; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Desai BJ, 2011, BIOCHEMISTRY-US, V50, P6973, DOI 10.1021/bi2004526; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2009, ESSENTIALS GLYCOBIOL, P501; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gandhi NS, 2011, J CHEM INF MODEL, V51, P335, DOI 10.1021/ci1003366; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2006, J BIOL CHEM, V281, P35478, DOI 10.1074/jbc.M607204200; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Kayitmazer AB, 2010, BIOMACROMOLECULES, V11, P3325, DOI 10.1021/bm1008074; Kellogg G.E., 2005, INTERNET ELECT J MOL, V4, P194; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Kellogg GE, 2004, CHEM BIODIVERS, V1, P98, DOI 10.1002/cbdv.200490016; KRISHNASWAMY S, 1990, J MOL BIOL, V211, P803, DOI 10.1016/0022-2836(90)90077-Y; Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028; LEVITT M, 1993, STRUCTURE, V1, P223, DOI 10.1016/0969-2126(93)90011-5; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Munro PD, 2000, J THEOR BIOL, V203, P407, DOI 10.1006/jtbi.2000.1099; Naimy H, 2010, BIOCHEMISTRY-US, V49, P3743, DOI 10.1021/bi100135d; Nimjee SM, 2009, RNA, V15, P2105, DOI 10.1261/rna.1240109; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; Park TJ, 2008, ANAL BIOCHEM, V383, P116, DOI 10.1016/j.ab.2008.07.037; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Richardson JL, 2000, EMBO J, V19, P5650, DOI 10.1093/emboj/19.21.5650; Sapay N, 2011, GLYCOBIOLOGY, V21, P1181, DOI 10.1093/glycob/cwr052; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P12369, DOI 10.1021/bi020406j; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Torrent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042692; Tripathi A, 2010, PROTEINS, V78, P825, DOI 10.1002/prot.22608; YE J, 1994, J BIOL CHEM, V269, P17965; Zhang FM, 2009, BIOCHEMISTRY-US, V48, P8379, DOI 10.1021/bi9006379; Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9	59	38	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48632	10.1371/journal.pone.0048632	http://dx.doi.org/10.1371/journal.pone.0048632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152789	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000023
J	Serena, E; Cimetta, E; Zatti, S; Zaglia, T; Zagallo, M; Keller, G; Elvassore, N				Serena, Elena; Cimetta, Elisa; Zatti, Susi; Zaglia, Tania; Zagallo, Monica; Keller, Gordon; Elvassore, Nicola			Micro-Arrayed Human Embryonic Stem Cells-Derived Cardiomyocytes for In Vitro Functional Assay	PLOS ONE			English	Article							ENGINEERED HEART-TISSUE; CARDIAC TISSUE; ELECTRICAL-STIMULATION; SYSTEMS; MUSCLE; CONTRACTION; MYOCARDIUM; MYOCYTES; CULTURE; MATRIX	Introduction: The heart is one of the least regenerative organs in the body and any major insult can result in a significant loss of heart cells. The development of an in vitro-based cardiac tissue could be of paramount importance for many aspects of the cardiology research. In this context, we developed an in vitro assay based on human cardiomyocytes (hCMs) and ad hoc micro-technologies, suitable for several applications: from pharmacological analysis to physio-phatological studies on transplantable hCMs. We focused on the development of an assay able to analyze not only hCMs viability, but also their functionality. Methods: hCMs were cultured onto a poly-acrylamide hydrogel with tunable tissue-like mechanical properties and organized through micropatterning in a 20620 array. Arrayed hCMs were characterized by immunofluorescence, GAP-FRAP analyses and live and dead assay. Their functionality was evaluated monitoring the excitation-contraction coupling. Results: Micropatterned hCMs maintained the expression of the major cardiac markers (cTnT, cTnI, Cx43, Nkx2.5, alpha-actinin) and functional properties. The spontaneous contraction frequency was (0.83 +/- 0.2) Hz, while exogenous electrical stimulation lead to an increase up to 2 Hz. As proof of concept that our device can be used for screening the effects of pathological conditions, hCMs were exposed to increasing levels of H2O2. Remarkably, hCMs viability was not compromised with exposure to 0.1 mM H2O2, but hCMs contractility was dramatically suppressed. As proof of concept, we also developed a microfluidic platform to selectively treat areas of the cell array, in the perspective of performing multi-parametric assay. Conclusions: Such system could be a useful tool for testing the effects of multiple conditions on an in vitro cell model representative of human heart physiology, thus potentially helping the processes of therapy and drug development.	[Serena, Elena; Cimetta, Elisa; Zatti, Susi; Zagallo, Monica; Elvassore, Nicola] Univ Padua, Dept Ind Engn, Padua, Italy; [Serena, Elena; Cimetta, Elisa; Zatti, Susi; Zaglia, Tania; Zagallo, Monica; Elvassore, Nicola] Venetian Inst Mol Med, Padua, Italy; [Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada	University of Padua; Veneto Institute Molecular Medicine; University of Toronto; University Health Network Toronto	Elvassore, N (corresponding author), Univ Padua, Dept Ind Engn, Padua, Italy.	nicola.elvassore@unipd.it	Cimetta, Elisa/AAC-5981-2022	Serena, Elena/0000-0001-7990-8852; Keller, Gordon/0000-0001-9309-9297; CIMETTA, Elisa/0000-0002-8632-3999	Progetti Di Eccellenza Ca.Ri.Pa.Ro, Fondo Sociale Europeo [2105/1/10/1268/2008]; Universita degli Studi di Padova; Fondo Sociale Europeo; Progetto Giovani Studiosi; University of Padova	Progetti Di Eccellenza Ca.Ri.Pa.Ro, Fondo Sociale Europeo; Universita degli Studi di Padova; Fondo Sociale Europeo; Progetto Giovani Studiosi; University of Padova	This work was supported by Progetti Di Eccellenza Ca.Ri.Pa.Ro, Fondo Sociale Europeo (grant code 2105/1/10/1268/2008) and the Universita degli Studi di Padova. ES and EC were supported by "Fondo Sociale Europeo'', ES and TZ by the Progetto Giovani Studiosi 2010, University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001; Au HTH, 2009, LAB CHIP, V9, P564, DOI 10.1039/b810034a; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Cannizzaro Christopher, 2007, V140, P291; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Cimetta E, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4723853; Cimetta E, 2009, BIOMED MICRODEVICES, V11, P389, DOI 10.1007/s10544-008-9245-9; Cook SA, 1999, CIRC RES, V85, P940; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Freund C, 2009, J CELL BIOCHEM, V107, P592, DOI 10.1002/jcb.22164; Giaume C, 2001, CONNEXIN METHODS PRO; Greensmith DJ, 2010, CELL CALCIUM, V48, P341, DOI 10.1016/j.ceca.2010.10.007; Grosberg A, 2011, LAB CHIP; Habib M, 2008, J MOL CELL CARDIOL, V45, P462, DOI 10.1016/j.yjmcc.2008.08.008; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Hong J, 2009, DRUG DISCOV TODAY, V14, P134, DOI 10.1016/j.drudis.2008.10.001; Jonsson MKB, 2010, STEM CELL RES, V4, P189, DOI 10.1016/j.scr.2010.02.001; Katare RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009275; Kim SB, 2011, LAB CHIP, V11, P1801, DOI [10.1039/c1lc20098d, 10.1039/c11c20098d]; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lamb GD, 2011, J PHYSIOL-LONDON, V589, P2119, DOI 10.1113/jphysiol.2010.199059; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Moller C, 2010, DRUG DISCOV TODAY, V15, P384, DOI 10.1016/j.drudis.2010.02.010; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003; Radisic M, 2009, TISSUE ENG PT A, V15, P851, DOI 10.1089/ten.tea.2008.0223; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; SAGGIN L, 1988, J BIOL CHEM, V263, P18488; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Serena E, 2008, NEUROL RES, V30, P207, DOI 10.1179/174313208X281109; Serena E, 2010, INTEGR BIOL-UK, V2, P193, DOI 10.1039/b921401a; Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018; Shin DD, 2007, AM J CARDIOL, V99, p4A, DOI 10.1016/j.amjcard.2006.11.025; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zatti S, 2012, LANGMUIR, V28, P2718, DOI 10.1021/la204776e	46	27	27	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48483	10.1371/journal.pone.0048483	http://dx.doi.org/10.1371/journal.pone.0048483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152776	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000017
J	Solovieva, S; Pehkonen, I; Kausto, J; Miranda, H; Shiri, R; Kauppinen, T; Heliovaara, M; Burdorf, A; Husgafvel-Pursiainen, K; Viikari-Juntura, E				Solovieva, Svetlana; Pehkonen, Irmeli; Kausto, Johanna; Miranda, Helena; Shiri, Rahman; Kauppinen, Timo; Heliovaara, Markku; Burdorf, Alex; Husgafvel-Pursiainen, Kirsti; Viikari-Juntura, Eira			Development and Validation of a Job Exposure Matrix for Physical Risk Factors in Low Back Pain	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; EPIDEMIOLOGIC EVIDENCE; WORK LOAD; VALIDITY; POPULATION; PREVALENCE; AGREEMENT; PERFORMANCE; DISORDERS; DISEASE	Objectives: The aim was to construct and validate a gender-specific job exposure matrix (JEM) for physical exposures to be used in epidemiological studies of low back pain (LBP). Materials and Methods: We utilized two large Finnish population surveys, one to construct the JEM and another to test matrix validity. The exposure axis of the matrix included exposures relevant to LBP (heavy physical work, heavy lifting, awkward trunk posture and whole body vibration) and exposures that increase the biomechanical load on the low back (arm elevation) or those that in combination with other known risk factors could be related to LBP (kneeling or squatting). Job titles with similar work tasks and exposures were grouped. Exposure information was based on face-to-face interviews. Validity of the matrix was explored by comparing the JEM (group-based) binary measures with individual-based measures. The predictive validity of the matrix against LBP was evaluated by comparing the associations of the group-based (JEM) exposures with those of individual-based exposures. Results: The matrix includes 348 job titles, representing 81% of all Finnish job titles in the early 2000s. The specificity of the constructed matrix was good, especially in women. The validity measured with kappa-statistic ranged from good to poor, being fair for most exposures. In men, all group-based (JEM) exposures were statistically significantly associated with one-month prevalence of LBP. In women, four out of six group-based exposures showed an association with LBP. Conclusions: The gender-specific JEM for physical exposures showed relatively high specificity without compromising sensitivity. The matrix can therefore be considered as a valid instrument for exposure assessment in large-scale epidemiological studies, when more precise but more labour-intensive methods are not feasible. Although the matrix was based on Finnish data we foresee that it could be applicable, with some modifications, in other countries with a similar level of technology.	[Solovieva, Svetlana; Kausto, Johanna; Shiri, Rahman; Husgafvel-Pursiainen, Kirsti] Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Solovieva, Svetlana; Kausto, Johanna; Shiri, Rahman; Husgafvel-Pursiainen, Kirsti; Viikari-Juntura, Eira] Finnish Inst Occupat Hlth, Disabil Prevent Ctr, Helsinki, Finland; [Pehkonen, Irmeli] Finnish Inst Occupat Hlth, Ctr Expertise Human Factors Work, Helsinki, Finland; [Miranda, Helena] OP Pohjola Grp, Occupat Hlth Serv, Helsinki, Finland; [Miranda, Helena] Univ Tampere, Dept Hlth Sci, FIN-33101 Tampere, Finland; [Kauppinen, Timo] Finnish Inst Occupat Hlth, Surveillance & Reviews Ctr, Helsinki, Finland; [Heliovaara, Markku] Natl Inst Hlth & Welf, Helsinki, Finland; [Burdorf, Alex] Univ Rotterdam, Rotterdam, Netherlands	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Tampere University; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; Erasmus University Rotterdam	Solovieva, S (corresponding author), Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland.	svetlana.solovieva@ttl.fi	Shiri, Rahman/ABB-1780-2021; Burdorf, Alex/A-2226-2008	Shiri, Rahman/0000-0002-9312-3100; Burdorf, Alex/0000-0003-3129-2862; Kausto, Johanna/0000-0002-2898-0018	Finnish Work Environment Fund [109364]; Academy of Finland [129364]	Finnish Work Environment Fund; Academy of Finland(Academy of Finland)	This study was funded by the Finnish Work Environment Fund (project number 109364) and Academy of Finland (project number 129364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aromaa A, 2004, BASELINE RESULT HLTH, P11; Barrero LH, 2009, SCAND J WORK ENV HEA, V35, P245, DOI 10.5271/sjweh.1335; Benke G, 2001, Appl Occup Environ Hyg, V16, P84; Burdorf A, 1997, AM J IND MED, V32, P142, DOI 10.1002/(SICI)1097-0274(199708)32:2<142::AID-AJIM5>3.0.CO;2-0; Burdorf A, 1997, SCAND J WORK ENV HEA, V23, P243, DOI 10.5271/sjweh.217; Cifuentes M, 2010, AM J IND MED, V53, P898, DOI 10.1002/ajim.20846; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohidon C, 2004, SCAND J WORK ENV HEA, V30, P379, DOI 10.5271/sjweh.826; Costa-Black KM, 2010, BEST PRACT RES CL RH, V24, P227, DOI 10.1016/j.berh.2009.11.007; de Vocht F, 2005, AM J IND MED, V47, P434, DOI 10.1002/ajim.20154; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gardner BT, 2010, OCCUP ENVIRON MED, V67, P538, DOI 10.1136/oem.2008.044339; Guo HR, 2002, OCCUP ENVIRON MED, V59, P680, DOI 10.1136/oem.59.10.680; Heistaro S, 2007, MUSCULOSKELETAL DI B, VB25, P8; HILDEBRANDT VH, 1995, ERGONOMICS, V38, P1283, DOI 10.1080/00140139508925188; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Kauppinen T, 1998, AM J IND MED, V33, P409, DOI 10.1002/(SICI)1097-0274(199804)33:4<409::AID-AJIM12>3.0.CO;2-2; KROMHOUT H, 1992, AM J EPIDEMIOL, V136, P698, DOI 10.1093/oxfordjournals.aje.a116549; KROMHOUT H, 1987, AM J IND MED, V12, P551, DOI 10.1002/ajim.4700120509; Kuiper JI, 1999, INT J IND ERGONOM, V24, P389, DOI 10.1016/S0169-8141(99)00006-2; Laiho J, 2008, METHODOLOGY REPORT H, VB26, P13; Le Moual N, 2000, OCCUP ENVIRON MED, V57, P126, DOI 10.1136/oem.57.2.126; Lotters F, 2003, SCAND J WORK ENV HEA, V29, P431; Niedhammer I, 2008, INT ARCH OCC ENV HEA, V82, P87, DOI 10.1007/s00420-008-0311-7; Parent-Thiron A FE, 2007, 4 EUROPEAN WORKING C; Perkio-Makela M, 2010, TYO JA TERVEYS HAAST; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Roffey DM, 2010, SPINE J, V10, P89, DOI 10.1016/j.spinee.2009.09.003; Schlaefer K, 2009, EUR J EPIDEMIOL, V24, P469, DOI 10.1007/s10654-009-9357-4; Seidler A, 2001, OCCUP ENVIRON MED, V58, P735, DOI 10.1136/oem.58.11.735; Shiri R, 2008, AM J EPIDEMIOL, V167, P1110, DOI 10.1093/aje/kwn007; Silverstein B, 2009, SCAND J WORK ENV HEA, V35, P113, DOI 10.5271/sjweh.1309; Stock SR, 2005, SCAND J WORK ENV HEA, V31, P409, DOI 10.5271/sjweh.947; 't Mannetje A, 2003, INT J EPIDEMIOL, V32, P419, DOI 10.1093/ije/dyg080; Teschke K, 2002, OCCUP ENVIRON MED, V59, P575, DOI 10.1136/oem.59.9.575; Tielemans E, 1998, ANN OCCUP HYG, V42, P115, DOI 10.1093/annhyg/42.2.115; Tielemans E, 1999, OCCUP ENVIRON MED, V56, P145, DOI 10.1136/oem.56.3.145; ViikariJuntura E, 1996, SCAND J WORK ENV HEA, V22, P251, DOI 10.5271/sjweh.139; Wai EK, 2010, SPINE J, V10, P554, DOI 10.1016/j.spinee.2010.03.033	40	51	52	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48680	10.1371/journal.pone.0048680	http://dx.doi.org/10.1371/journal.pone.0048680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152793	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000026
J	Broos, S; Malisoux, L; Theisen, D; Francaux, M; Deldicque, L; Thomis, MA				Broos, Siacia; Malisoux, Laurent; Theisen, Daniel; Francaux, Marc; Deldicque, Louise; Thomis, Martine A.			Role of Alpha-actinin-3 in Contractile Properties of Human Single Muscle Fibers: A Case Series Study in Paraplegics	PLOS ONE			English	Article							SPINAL-CORD-INJURY; SKELETAL-MUSCLE; ACTN3 GENOTYPE; ATHLETIC PERFORMANCE; KNOCKOUT MOUSE; GIANT PROTEINS; DEFICIENCY; GENE; POLYMORPHISM; ASSOCIATION	A common nonsense polymorphism in the ACTN3 gene results in the absence of alpha-actinin-3 in XX individuals. The wild type allele has been associated with power athlete status and an increased force output in numeral studies, though the mechanisms by which these effects occur are unclear. Recent findings in the Actn3(-/-) (KO) mouse suggest a shift towards 'slow' metabolic and contractile characteristics of fast muscle fibers lacking alpha-actinin-3. Skinned single fibers from the quadriceps muscle of three men with spinal cord injury (SCI) were tested regarding peak force, unloaded shortening velocity, force-velocity relationship, passive tension and calcium sensitivity. The SCI condition induces an 'equal environment condition' what makes these subjects ideal to study the role of alpha-actinin-3 on fiber type expression and single muscle fiber contractile properties. Genotyping for ACTN3 revealed that the three subjects were XX, RX and RR carriers, respectively. The XX carrier's biopsy was the only one that presented type I fibers with a complete lack of type IIx fibers. Properties of hybrid type IIa/IIx fibers were compared between the three subjects. Absence of alpha-actinin-3 resulted in less stiff type IIa/IIx fibers. The heterozygote (RX) exhibited the highest fiber diameter (0.121 +/- 0.005 mm) and CSA (0.012 +/- 0.001 mm(2)) and, as a consequence, the highest peak force (2.11 +/- 0.14 mN). Normalized peak force was similar in all three subjects (P = 0.75). Unloaded shortening velocity was highest in R-allele carriers (P<0.001). No difference was found in calcium sensitivity. The preservation of type I fibers and the absence of type IIx fibers in the XX individual indicate a restricted transformation of the muscle fiber composition to type II fibers in response to long-term muscle disuse. Lack of alpha-actinin-3 may decrease unloaded shortening velocity and increase fiber elasticity. Citation: Broos S, Malisoux L, Theisen D, Francaux M, Deldicque L, et al. (2012) Role of Alpha-actinin-3 in Contractile Properties of Human Single Muscle Fibers: A Case Series Study in Paraplegics. PLoS ONE 7(11): e49281. doi:10.1371/journal.pone.0049281	[Thomis, Martine A.] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Kinesiol, Phys Act Sports & Hlth Res Grp, Heverlee, Belgium; [Broos, Siacia; Deldicque, Louise] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Kinesiol, Exercise Physiol Res Grp, Heverlee, Belgium; [Francaux, Marc] Catholic Univ Louvain, Fac Med, Fac Educ Phys & Readapt, B-1348 Louvain, Belgium; [Malisoux, Laurent; Theisen, Daniel] Grand Duchy Luxembourg, Publ Res Ctr Hlth, Sports Med Res Lab, Luxembourg, Luxembourg	KU Leuven; KU Leuven; Universite Catholique Louvain; Luxembourg Institute of Health	Thomis, MA (corresponding author), Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Kinesiol, Phys Act Sports & Hlth Res Grp, Heverlee, Belgium.	Martine.Thomis@faber.kuleuven.be	Malisoux, Laurent/AAE-6423-2020	Malisoux, Laurent/0000-0002-6601-5630; Deldicque, Louise/0000-0003-3393-5278; Thomis, Martine/0000-0001-9093-2191; Theisen, Daniel/0000-0002-9699-3013; Francaux, Marc/0000-0001-8182-1588	Research Foundation Flanders [KAN 1.5.100.10]	Research Foundation Flanders(FWO)	The project was supported by a grant to MT by the Research Foundation Flanders KAN 1.5.100.10. (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfred T, 2011, HUM MUTAT, V32, P1008, DOI 10.1002/humu.21526; Bamman MM, 1999, ELECTROPHORESIS, V20, P466, DOI 10.1002/(SICI)1522-2683(19990301)20:3<466::AID-ELPS466>3.0.CO;2-7; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Berman Y, 2010, PHYSIOLOGY, V25, P250, DOI 10.1152/physiol.00008.2010; Biering-Sorensen B, 2009, MUSCLE NERVE, V40, P499, DOI 10.1002/mus.21391; Burnham R, 1997, SPINAL CORD, V35, P86, DOI 10.1038/sj.sc.3100364; Chan S, 2008, AM J PHYSIOL-CELL PH, V295, pC897, DOI 10.1152/ajpcell.00179.2008; Chan S, 2011, MUSCLE NERVE, V43, P37, DOI 10.1002/mus.21778; Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Gerrits HL, 2003, PFLUG ARCH EUR J PHY, V445, P734, DOI 10.1007/s00424-002-0997-4; Gerrits KH, 2005, MUSCLE NERVE, V32, P73, DOI 10.1002/mus.20328; GIULIAN GG, 1983, ANAL BIOCHEM, V129, P277, DOI 10.1016/0003-2697(83)90551-1; HOROWITS R, 1986, NATURE, V323, P160, DOI 10.1038/323160a0; Huygens W, 2004, CAN J APPL PHYSIOL, V29, P186, DOI 10.1139/h04-014; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; LIEBER RL, 1988, ACTA PHYSIOL SCAND, V133, P587, DOI 10.1111/j.1748-1716.1988.tb08446.x; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Maciejewska A, 2011, J SCI MED SPORT, V14, P58, DOI 10.1016/j.jsams.2010.05.006; Malisoux L, 2007, J APPL PHYSIOL, V102, P340, DOI 10.1152/japplphysiol.00609.2006; Malisoux L, 2006, MED SCI SPORT EXER, V38, P1901, DOI 10.1249/01.mss.0000232022.21361.47; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Neagoe C, 2003, J MUSCLE RES CELL M, V24, P175, DOI 10.1023/A:1026053530766; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; Roth SM, 2008, EUR J HUM GENET, V16, P391, DOI 10.1038/sj.ejhg.5201964; Seto JT, 2011, HUM MOL GENET, V20, P2914, DOI 10.1093/hmg/ddr196; Thomas CK, 1997, MUSCLE NERVE, V20, P788, DOI 10.1002/(SICI)1097-4598(199707)20:7<788::AID-MUS2>3.0.CO;2-3; Toursel T, 2002, J APPL PHYSIOL, V92, P1465, DOI 10.1152/japplphysiol.00621.2001; Tskhovrebova L, 2002, J APPL PHYSIOL, V92, P1465; Vincent B, 2012, ACTA PHYSIOL, V204, P555, DOI 10.1111/j.1748-1716.2011.02366.x; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Vincent B, 2010, J APPL PHYSIOL, V109, P564, DOI 10.1152/japplphysiol.01007.2009; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zempo H, 2010, INT J SPORTS MED, V31, P138, DOI 10.1055/s-0029-1242808	38	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49281	10.1371/journal.pone.0049281	http://dx.doi.org/10.1371/journal.pone.0049281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145141	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500095
J	Jung, UJ; Park, YB; Kim, SR; Choi, MS				Jung, Un Ju; Park, Yong Bok; Kim, Sang Ryong; Choi, Myung-Sook			Supplementation of Persimmon Leaf Ameliorates Hyperglycemia, Dyslipidemia and Hepatic Fat Accumulation in Type 2 Diabetic Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PHOSPHOENOLPYRUVATE-CARBOXYKINASE; INSULIN-RESISTANCE; DIOSPYROS-KAKI; PPAR-GAMMA; RAT-LIVER; OXIDATIVE STRESS; RESPONSE ELEMENT; GENE-EXPRESSION; ADIPOSE-TISSUE	Persimmon Leaf (PL), commonly consumed as herbal tea and traditional medicines, contains a variety of compounds that exert antioxidant, alpha-amylase and alpha-glucosidase inhibitory activity. However, little is known about the in vivo effects and underlying mechanisms of PL on hyperglycemia, hyperlipidemia and hepatic steatosis in type 2 diabetes. Powered PL (5%, w/w) was supplemented with a normal diet to C57BL/KsJ-db/db mice for 5 weeks. PL decreased blood glucose, HOMA-IR, plasma triglyceride and total cholesterol levels, as well as liver weight, hepatic lipid droplets, triglycerides and cholesterol contents, while increasing plasma HDL-cholesterol and adiponectin levels. The anti-hyperglycemic effect was linked to decreased activity of gluconeogenic enzymes as well as increased glycogen content, glucokinase activity and its mRNA level in the liver. PL also led to a decrease in lipogenic transcriptional factor PPAR gamma as well as gene expression and activity of enzymes involved in lipogenesis, with a simultaneous increase in fecal lipids, which are seemingly attributable to the improved hyperlipidemia and hepatic steatosis and decreased hepatic fatty acid oxidation. Furthermore, PL ameliorated plasma and hepatic oxidative stress. Supplementation with PL may be an effective dietary strategy to improve type 2 diabetes accompanied by dyslipidemia and hepatic steatosis by partly modulating the activity or gene expression of enzymes related to antioxidant, glucose and lipid homeostasis. Citation: Jung UJ, Park YB, Kim SR, Choi M-S (2012) Supplementation of Persimmon Leaf Ameliorates Hyperglycemia, Dyslipidemia and Hepatic Fat Accumulation in Type 2 Diabetic Mice. PLoS ONE 7(11): e49030. doi:10.1371/journal.pone.0049030	[Jung, Un Ju; Choi, Myung-Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu, South Korea; [Park, Yong Bok; Kim, Sang Ryong] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu, South Korea; [Kim, Sang Ryong] Kyungpook Natl Univ, Brain Sci & Engn Inst, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Choi, MS (corresponding author), Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu, South Korea.	mschoi@knu.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2011-0000920, 2011-0022387]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (No. 2011-0000920 and No. 2011-0022387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT CA, 1995, ARTERIOSCL THROM VAS, V15, P1812, DOI 10.1161/01.ATV.15.11.1812; Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Aebi H., 1974, CATALASE METHODS ENZ, V2, P673; ALEGRE M, 1988, ANAL BIOCHEM, V173, P185, DOI 10.1016/0003-2697(88)90176-5; *AM I NUTR, 1980, J NUTR, V110, P1717; Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; BENTLE LA, 1976, J BIOL CHEM, V251, P2916; BIERI JG, 1977, J NUTR, V107, P1394; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadoudal T, 2007, DIABETOLOGIA, V50, P666, DOI 10.1007/s00125-006-0560-5; Chakravarthy MV, 2011, P NATL ACAD SCI USA, V108, P5378; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cleasby ME, 2004, DIABETES, V53, P3258, DOI 10.2337/diabetes.53.12.3258; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; Davies GF, 2001, BIOCHEM PHARMACOL, V62, P1071, DOI 10.1016/S0006-2952(01)00764-X; Davis RC, 2010, DIABETES, V59, P1616, DOI 10.2337/db09-0878; Devine JH, 1999, J BIOL CHEM, V274, P13604, DOI 10.1074/jbc.274.19.13604; ERICKSON SK, 1980, J LIPID RES, V21, P930; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001; GIRALT M, 1991, J BIOL CHEM, V266, P21991; Glorian M, 2001, BIOCHIMIE, V83, P933, DOI 10.1016/S0300-9084(01)01343-8; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; HULCHER FH, 1973, J LIPID RES, V14, P625; KAMEDA K, 1987, J NAT PROD, V50, P680, DOI 10.1021/np50052a017; Kawakami K, 2011, BIOSCI BIOTECH BIOCH, V75, P1435, DOI 10.1271/bbb.100926; Kawakami K, 2010, BIOSCI BIOTECH BIOCH, V74, P1380, DOI 10.1271/bbb.100056; Kotani M, 2000, J ALLERGY CLIN IMMUN, V106, P159, DOI 10.1067/mai.2000.107194; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Lazarow P B, 1981, Methods Enzymol, V72, P315; Lee JS, 2006, FOOD CHEM TOXICOL, V44, P1875, DOI 10.1016/j.fct.2006.06.014; LEE SC, 1992, J AOAC INT, V75, P395; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MARKWELL MA, 1973, J BIOL CHEM, V248, P3426; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mithieux G, 2002, DIABETES, V51, P139, DOI 10.2337/diabetes.51.1.139; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Moreno MIN, 2000, J ETHNOPHARMACOL, V71, P109, DOI 10.1016/S0378-8741(99)00189-0; Nakamura A, 2011, J DIABETES INVEST, V2, P276, DOI 10.1111/j.2040-1124.2011.00104.x; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nepokroeff C M, 1975, Methods Enzymol, V35, P37, DOI 10.1016/0076-6879(75)35136-7; NEWGARD CB, 1983, J BIOL CHEM, V258, P8046; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pal M, 2009, DRUG DISCOV TODAY, V14, P784, DOI 10.1016/j.drudis.2009.05.013; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rosenblat M, 2009, BIOFACTORS, V35, P98, DOI 10.1002/biof.16; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; SHAFRIR E, 1992, DIABETES METAB REV, V8, P179, DOI 10.1002/dmr.5610080302; SHAPIRO DJ, 1974, BIOCHIM BIOPHYS ACTA, V370, P369, DOI 10.1016/0005-2744(74)90098-9; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Suh YH, 2005, J MOL ENDOCRINOL, V34, P299, DOI 10.1677/jme.1.01679; Sun LJ, 2011, FOOD CHEM TOXICOL, V49, P2689, DOI 10.1016/j.fct.2011.07.042; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Thuong PT, 2008, J NAT PROD, V71, P1775, DOI 10.1021/np800298w; Torres TP, 2009, DIABETES, V58, P78, DOI 10.2337/db08-1119; Valentova K, 2007, J AGR FOOD CHEM, V55, P7726, DOI 10.1021/jf0712447; WALTON PA, 1984, BIOCHIM BIOPHYS ACTA, V796, P364, DOI 10.1016/0005-2760(84)90139-5; Wang L, 2011, CARBOHYD RES, V346, P1212, DOI 10.1016/j.carres.2011.04.021; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108	74	42	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49030	10.1371/journal.pone.0049030	http://dx.doi.org/10.1371/journal.pone.0049030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145054	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500062
J	Meyer, KM; Vos, M; Mooij, WM; Hol, WHG; Termorshuizen, AJ; van der Putten, WH				Meyer, Katrin M.; Vos, Matthijs; Mooij, Wolf M.; Hol, W. H. Gera; Termorshuizen, Aad J.; van der Putten, Wim H.			Testing the Paradox of Enrichment along a Land Use Gradient in a Multitrophic Aboveground and Belowground Community	PLOS ONE			English	Article							PLANT-MEDIATED INTERACTIONS; INDUCIBLE DEFENSES; BIOLOGICAL-CONTROL; SHOOT HERBIVORES; INSECT HERBIVORY; ROOT; PERFORMANCE; BIODIVERSITY; COMPETITION; ECOSYSTEMS	In the light of ongoing land use changes, it is important to understand how multitrophic communities perform at different land use intensities. The paradox of enrichment predicts that fertilization leads to destabilization and extinction of predator-prey systems. We tested this prediction for a land use intensity gradient from natural to highly fertilized agricultural ecosystems. We included multiple aboveground and belowground trophic levels and land use-dependent searching efficiencies of insects. To overcome logistic constraints of field experiments, we used a successfully validated simulation model to investigate plant responses to removal of herbivores and their enemies. Consistent with our predictions, instability measured by herbivore-induced plant mortality increased with increasing land use intensity. Simultaneously, the balance between herbivores and natural enemies turned increasingly towards herbivore dominance and natural enemy failure. Under natural conditions, there were more frequently significant effects of belowground herbivores and their natural enemies on plant performance, whereas there were more aboveground effects in agroecosystems. This result was partly due to the "boom-bust'' behavior of the shoot herbivore population. Plant responses to herbivore or natural enemy removal were much more abrupt than the imposed smooth land use intensity gradient. This may be due to the presence of multiple trophic levels aboveground and belowground. Our model suggests that destabilization and extinction are more likely to occur in agroecosystems than in natural communities, but the shape of the relationship is nonlinear under the influence of multiple trophic interactions. Citation: Meyer KM, Vos M, Mooij WM, Hol WHG, Termorshuizen AJ, et al. (2012) Testing the Paradox of Enrichment along a Land Use Gradient in a Multitrophic Aboveground and Belowground Community. PLoS ONE 7(11): e49034. doi:10.1371/journal.pone.0049034	[Meyer, Katrin M.; Hol, W. H. Gera; van der Putten, Wim H.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Meyer, Katrin M.] Univ Goettingen, Fac Forest Sci & Forest Ecol, Gottingen, Germany; [Vos, Matthijs] Univ Potsdam, Inst Biochem & Biol, Dept Ecol & Ecosyst Modeling, Potsdam, Germany; [Vos, Matthijs; Mooij, Wolf M.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Mooij, Wolf M.] Wageningen Univ, Dept Environm Sci Grp, Wageningen, Netherlands; [Termorshuizen, Aad J.] BLGG Res, Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Gottingen; University of Potsdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Wageningen University & Research	Meyer, KM (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.	kmeyer5@uni-goettingen.de	van der Putten, Wim H/C-3707-2011; Mooij, Wolf M/C-2677-2008; Hol, Gera W. H./B-4490-2008; Vos, Matthijs/B-3802-2009; Meyer, Katrin M/E-6839-2013; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; Mooij, Wolf M/0000-0001-5586-8200; Hol, Gera W. H./0000-0002-1256-495X; Meyer, Katrin M/0000-0002-9990-4047; Termorshuizen, Aad/0000-0003-3058-0088; KNAW, NIOO-KNAW/0000-0002-3835-159X	ALW-biodiversity programme of the NWO [ALWPB/05-02]; State of Lower Saxony (Ministry of Science and Culture; Cluster of Excellence "Functional Biodiversity Research'')	ALW-biodiversity programme of the NWO; State of Lower Saxony (Ministry of Science and Culture; Cluster of Excellence "Functional Biodiversity Research'')	This work was supported by the ALW-biodiversity programme of the NWO (Project ALWPB/05-02) and by the State of Lower Saxony (Ministry of Science and Culture; Cluster of Excellence "Functional Biodiversity Research''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Erb M, 2011, J ECOL, V99, P7, DOI 10.1111/j.1365-2745.2010.01757.x; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Gerber E, 2007, ECOL ENTOMOL, V32, P357, DOI 10.1111/j.1365-2311.2007.00875.x; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Hoehn P, 2009, AGROFOREST SYST, V76, P163, DOI 10.1007/s10457-008-9154-1; Hufbauer RA, 2002, AM MIDL NAT, V147, P204, DOI 10.1674/0003-0031(2002)147[0204:IEODTO]2.0.CO;2; Hunt-Joshi TR, 2004, ECOL APPL, V14, P1574, DOI 10.1890/03-5181; Klein AM, 2002, BIODIVERS CONSERV, V11, P683, DOI 10.1023/A:1015548426672; Maron JL, 1998, ECOLOGY, V79, P1281, DOI 10.1890/0012-9658(1998)079[1281:IHAABI]2.0.CO;2; MASTERS GJ, 1995, ECOL RES, V10, P125, DOI 10.1007/BF02347934; McClean CJ, 2011, GLOBAL CHANGE BIOL, V17, P2882, DOI 10.1111/j.1365-2486.2011.02462.x; Meyer KM, 2009, ECOL MODEL, V220, P2594, DOI 10.1016/j.ecolmodel.2009.06.001; Meyer KM, 2009, OIKOS, V118, P981, DOI 10.1111/j.1600-0706.2009.17220.x; MORAN NA, 1990, ECOLOGY, V71, P1050, DOI 10.2307/1937373; Morrien E, 2011, ECOLOGY, V92, P1344, DOI 10.1890/10-1937.1; Mueller-Schaerer H., 1995, Oikos, V72, P36; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Royer L, 1999, ENTOMOL EXP APPL, V90, P199, DOI 10.1023/A:1003568832109; Rudgers JA, 2003, PLANT ECOL, V169, P105, DOI 10.1023/A:1026221602968; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schadler M, 2004, OECOLOGIA, V138, P242, DOI 10.1007/s00442-003-1425-y; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; Steele AE, 1986, COMPENDIUM BEET DIS, P33; Sunding KN, 2005, PNAS, V102, P4387; Sylvain ZA, 2011, AM J BOT, V98, P517, DOI 10.3732/ajb.1000305; TEMPERTON V. M., 2004, ASSEMBLY RULES RESTO; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; VANDERMEER J, 1993, AM NAT, V141, P687, DOI 10.1086/285500; Verschoor AM, 2004, ECOL LETT, V7, P1143, DOI 10.1111/j.1461-0248.2004.00675.x; Verschoor BC, 2002, J ECOL, V90, P753, DOI 10.1046/j.1365-2745.2002.00710.x; Vos M, 2004, OIKOS, V105, P471, DOI 10.1111/j.0030-1299.2004.12930.x; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Wurst S, 2007, BASIC APPL ECOL, V8, P491, DOI 10.1016/j.baae.2006.09.015	42	11	12	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49034	10.1371/journal.pone.0049034	http://dx.doi.org/10.1371/journal.pone.0049034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145055	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500063
J	Budworth, H; Snijders, AM; Marchetti, F; Mannion, B; Bhatnagar, S; Kwoh, E; Tan, YD; Wang, SX; Blakely, WF; Coleman, M; Peterson, L; Wyrobek, AJ				Budworth, Helen; Snijders, Antoine M.; Marchetti, Francesco; Mannion, Brandon; Bhatnagar, Sandhya; Kwoh, Ely; Tan, Yuande; Wang, Shan X.; Blakely, William F.; Coleman, Matthew; Peterson, Leif; Wyrobek, Andrew J.			DNA Repair and Cell Cycle Biomarkers of Radiation Exposure and Inflammation Stress in Human Blood	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; NUCLEOTIDE EXCISION-REPAIR; HUMAN LYMPHOBLASTOID-CELLS; IONIZING-RADIATION; MESSENGER-RNA; P53; INDUCTION; APOPTOSIS; BIODOSIMETRY; KINASE	DNA damage and repair are hallmarks of cellular responses to ionizing radiation. We hypothesized that monitoring the expression of DNA repair-associated genes would enhance the detection of individuals exposed to radiation versus other forms of physiological stress. We employed the human blood ex vivo radiation model to investigate the expression responses of DNA repair genes in repeated blood samples from healthy, non-smoking men and women exposed to 2 Gy of X-rays in the context of inflammation stress mimicked by the bacterial endotoxin lipopolysaccharide (LPS). Radiation exposure significantly modulated the transcript expression of 12 genes of 40 tested (2.2E-06<p<0.03), of which 8 showed no overlap between unirradiated and irradiated samples (CDKN1A, FDXR, BBC3, PCNA, GADD45a, XPC, POLH and DDB2). This panel demonstrated excellent dose response discrimination (0.5 to 8 Gy) in an independent human blood ex vivo dataset, and 100% accuracy for discriminating patients who received total body radiation. Three genes of this panel (CDKN1A, FDXR and BBC3) were also highly sensitive to LPS treatment in the absence of radiation exposure, and LPS co-treatment significantly affected their radiation responses. At the protein level, BAX and pCHK2-thr68 were elevated after radiation exposure, but the pCHK2-thr68 response was significantly decreased in the presence of LPS. Our combined panel yields an estimated 4-group accuracy of similar to 90% to discriminate between radiation alone, inflammation alone, or combined exposures. Our findings suggest that DNA repair gene expression may be helpful to identify biodosimeters of exposure to radiation, especially within high-complexity exposure scenarios.	[Budworth, Helen; Snijders, Antoine M.; Marchetti, Francesco; Mannion, Brandon; Bhatnagar, Sandhya; Kwoh, Ely; Wyrobek, Andrew J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Tan, Yuande; Peterson, Leif] Methodist Hosp, Ctr Biostat, Res Inst, Houston, TX 77030 USA; [Wang, Shan X.] Stanford Univ, Dept Elect Engn, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Blakely, William F.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA; [Coleman, Matthew] Univ Calif Davis, UC Davis Sch Med, Davis, CA 95616 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; The Methodist Hospital System; The Methodist Hospital - Houston; Stanford University; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; University of California System; University of California Davis	Wyrobek, AJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ajwyrobek@lbl.gov		Wyrobek, Andrew/0000-0002-5921-5298; Coleman, Matthew/0000-0003-1389-4018; Marchetti, Francesco/0000-0002-9435-4867; Mannion, Brandon/0000-0002-1149-3790; Peterson, Leif/0000-0002-1187-0883	U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory under DOE [DE-AC02-05CH11231]; Federal funds from the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services [HHSO100201000006C]; Armed Forces Radiobiology Research Institute (AFRRI) [RBB4AR, RAB4AU]	U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory under DOE(United States Department of Energy (DOE)); Federal funds from the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services; Armed Forces Radiobiology Research Institute (AFRRI)	This work was performed under the auspices of the U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory under DOE contract No. DE-AC02-05CH11231. This project has been funded in whole or in part by Federal funds from the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, under Contract No. HHSO100201000006C. The Armed Forces Radiobiology Research Institute (AFRRI) supported the involvement of WFB in this research under AFRRI work units RBB4AR and RAB4AU; views presented in this manuscript are those of the authors; no endorsement by the Department of Defense has been given or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2000, CANCER RES, V60, P5934; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 1999, RADIAT RES, V152, P225, DOI 10.2307/3580321; Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Amundson SA, 2002, CANCER BIOL THER, V1, P145, DOI 10.4161/cbt.59; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bessho T, 1999, NUCLEIC ACIDS RES, V27, P979, DOI 10.1093/nar/27.4.979; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Brengues M, 2010, HEALTH PHYS, V98, P179, DOI 10.1097/01.HP.0000346706.44253.5c; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; Daino K, 2002, RADIAT RES, V157, P478, DOI 10.1667/0033-7587(2002)157[0478:EIOCPA]2.0.CO;2; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Eslick J, 2004, INFLAMMATION, V28, P139, DOI 10.1023/B:IFLA.0000039560.00231.cd; Falt S, 2003, CARCINOGENESIS, V24, P1837, DOI 10.1093/carcin/bgg134; Fenech M, 2011, RADIAT MEAS, V46, P737, DOI 10.1016/j.radmeas.2011.01.016; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Inoue M, 2004, RADIAT RES, V161, P409, DOI 10.1667/3163; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kang CM, 2003, RADIAT RES, V159, P312, DOI 10.1667/0033-7587(2003)159[0312:PBFIRE]2.0.CO;2; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; LAVNIKOVA N, 1995, J LEUKOCYTE BIOL, V58, P451, DOI 10.1002/jlb.58.4.451; Li MJ, 2011, MED SCI MONITOR, V17, pBR290, DOI 10.12659/MSM.881976; Marchetti F, 2006, INT J RADIAT BIOL, V82, P605, DOI 10.1080/09553000600930103; Mayer C, 2011, CANCER LETT, V302, P20, DOI 10.1016/j.canlet.2010.12.006; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Paul S, 2011, INT J RADIAT BIOL, V87, P791, DOI 10.3109/09553002.2011.568574; Paul S, 2011, RADIAT RES, V175, P257, DOI 10.1667/RR2420.1; Pinto MMPD, 2010, RADIAT ENVIRON BIOPH, V49, P567, DOI 10.1007/s00411-010-0311-3; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Riecke A, 2012, RADIAT RES, V178, P234, DOI 10.1667/RR2738.1; Ring RH, 2003, NEUROSCI LETT, V350, P73, DOI 10.1016/S0304-3940(03)00883-8; Russell JS, 2003, CANCER RES, V63, P7377; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shimizu Y, 2003, EMBO J, V22, P164, DOI 10.1093/emboj/cdg016; Shimizu Y, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/805698; Tichy A, 2007, ACTA BIOCHIM POL, V54, P281; Tucker JD, 2012, RADIAT RES, V177, P209, DOI 10.1667/RR2749.1; Turtoi A, 2010, INT J RADIAT BIOL, V86, P888, DOI 10.3109/09553002.2010.486016; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang Y, 2007, TOXICOL LETT, V171, P50, DOI 10.1016/j.toxlet.2007.04.006; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443; Zschenker O, 2006, RADIOTHER ONCOL, V80, P236, DOI 10.1016/j.radonc.2006.07.019	47	61	63	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48619	10.1371/journal.pone.0048619	http://dx.doi.org/10.1371/journal.pone.0048619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144912	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800084
J	Galan, M; Pages, M; Cosson, JF				Galan, Maxime; Pages, Marie; Cosson, Jean-Francois			Next-Generation Sequencing for Rodent Barcoding: Species Identification from Fresh, Degraded and Environmental Samples	PLOS ONE			English	Article							CYTOCHROME-B; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; MOLECULAR-IDENTIFICATION; GENE-SEQUENCES; PHYLOGENY; NUCLEAR; SYSTEMATICS; PSEUDOGENES; TAXONOMY	Rodentia is the most diverse order among mammals, with more than 2,000 species currently described. Most of the time, species assignation is so difficult based on morphological data solely that identifying rodents at the specific level corresponds to a real challenge. In this study, we compared the applicability of 100 bp mini-barcodes from cytochrome b and cytochrome c oxidase 1 genes to enable rodent species identification. Based on GenBank sequence datasets of 115 rodent species, a 136 bp fragment of cytochrome b was selected as the most discriminatory mini-barcode, and rodent universal primers surrounding this fragment were designed. The efficacy of this new molecular tool was assessed on 946 samples including rodent tissues, feces, museum samples and feces/pellets from predators known to ingest rodents. Utilizing next-generation sequencing technologies able to sequence mixes of DNA, 1,140 amplicons were tagged, multiplexed and sequenced together in one single 454 GS-FLX run. Our method was initially validated on a reference sample set including 265 clearly identified rodent tissues, corresponding to 103 different species. Following validation, 85.6% of 555 rodent samples from Europe, Asia and Africa whose species identity was unknown were able to be identified using the BLASTN program and GenBank reference sequences. In addition, our method proved effective even on degraded rodent DNA samples: 91.8% and 75.9% of samples from feces and museum specimens respectively were correctly identified. Finally, we succeeded in determining the diet of 66.7% of the investigated carnivores from their feces and 81.8% of owls from their pellets. Non-rodent species were also identified, suggesting that our method is sensitive enough to investigate complete predator diets. This study demonstrates how this molecular identification method combined with high-throughput sequencing can open new realms of possibilities in achieving fast, accurate and inexpensive species identification.	[Galan, Maxime; Pages, Marie; Cosson, Jean-Francois] INRA IRD Cirad Montpellier SupAgro, Joint Res Unit Ctr Biol Gest Populat, INRA, Montferrier Sur Lez, France; [Pages, Marie] Univ Liege, Lab Genet Microorganismes, Inst Bot, Liege, Belgium	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); University of Liege	Galan, M (corresponding author), INRA IRD Cirad Montpellier SupAgro, Joint Res Unit Ctr Biol Gest Populat, INRA, Campus Int Baillarguet, Montferrier Sur Lez, France.	galan@supagro.inra.fr	Galan, Maxime/AAB-9511-2019	Galan, Maxime/0000-0001-6981-5732; Cosson, Jean Francois/0000-0003-0863-5871	Institut National de la Recherche Agronomique [Projet innovant du departement EFPA]; French National Agency for Research [CERoPath/ANR 07 BDIV 012]; Fonds de la Recherche Scientifique-FNRS	Institut National de la Recherche Agronomique [Projet innovant du departement EFPA]; French National Agency for Research(French National Research Agency (ANR)); Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Institut National de la Recherche Agronomique [Projet innovant du departement EFPA 2011 - www4.inra.fr/efpa/] and the French National Agency for Research [CERoPath/ANR 07 BDIV 012 - www.ceropath.org/]. MP is currently funded by a Fonds de la Recherche Scientifique-FNRS fellowship (Belgian Fund for Scientific Research - www2.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Bacher S, 2012, TRENDS ECOL EVOL, V27, P65, DOI 10.1016/j.tree.2011.11.003; Balakrishnan R, 2005, SYST BIOL, V54, P689, DOI 10.1080/10635150590950308; Ben Faleh A, 2010, BIOL J LINN SOC, V99, P673; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Chevret P, 2005, MOL PHYLOGENET EVOL, V35, P674, DOI 10.1016/j.ympev.2005.01.001; Colangelo P, 2007, MOL PHYLOGENET EVOL, V42, P797, DOI 10.1016/j.ympev.2006.10.001; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; DeWoody JA, 1999, J MOL EVOL, V48, P380, DOI 10.1007/PL00013154; Dobigny G, 2008, J ZOOL, V276, P368, DOI 10.1111/j.1469-7998.2008.00500.x; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Ducroz JF, 1998, MOL PHYLOGENET EVOL, V10, P104, DOI 10.1006/mpev.1997.0477; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Galewski T, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-80; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Granjon L, 2002, J ZOOL, V256, P181, DOI 10.1017/S0952836902000213; Granjon L, 2002, AFR J ECOL, V40, P10, DOI 10.1046/j.0141-6707.2001.00353.x; Granjon L, 2009, COLLECTION FAUNE FLO, V43; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Haynes S, 2003, MOL ECOL, V12, P951, DOI 10.1046/j.1365-294X.2003.01795.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helgen KM, 2005, MAMM BIOL, V70, P61, DOI 10.1078/1616-5047-00176; Hey J, 2009, NATURE ED, V2; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hsieh HM, 2003, FORENSIC SCI INT, V136, P1, DOI 10.1016/S0379-0738(03)00251-2; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; Jenkins PD, 2004, SYST BIODIVERS, V2, P419, DOI DOI 10.1017/S1477200004001549; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Latinne A, 2011, CONSERV GENET, V12, P1495, DOI 10.1007/s10592-011-0248-3; Lecompte E, 2005, BIOCHEM SYST ECOL, V33, P681, DOI 10.1016/j.bse.2004.12.015; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lecompte F, 2005, MOL PHYLOGENET EVOL, V37, P899, DOI 10.1016/j.ympev.2005.06.018; Lefort MC, 2012, MOL ECOL RESOUR, V12, P389, DOI 10.1111/j.1755-0998.2011.03103.x; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Meglecz E, 2011, BIOINFORMATICS, V27, P277, DOI 10.1093/bioinformatics/btq641; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; Miraldo A, 2012, MOL ECOL, V21, P1005, DOI 10.1111/j.1365-294X.2011.05422.x; Murphy MA, 2000, WILDLIFE SOC B, V28, P951; Musser GG, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)497[0001:DOANGA]2.0.CO;2; MUSSER GG, 2005, MAMMAL SPECIES WORLD, V2, P894; Musser GG, 2006, AM MUS NOVIT, pCOVER1, DOI 10.1206/0003-0082(2006)3517[1:DOANGA]2.0.CO;2; Nagoshi RN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.15401; Ndiaye A, 2012, ZOOL SCR, V41, P11, DOI 10.1111/j.1463-6409.2011.00501.x; Nicolas V, 2009, BIOL J LINN SOC, V98, P29, DOI 10.1111/j.1095-8312.2009.01273.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pages M, PLOS ONE IN PRESS, V7; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Palumbi SR, 1998, J HERED, V89, P459; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Piry S, 2012, MOL ECOL RESOUR, V12, P1151, DOI 10.1111/j.1755-0998.2012.03171.x; Quere JP, 2011, COLLECTION GUIDE PRA; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Robins JH, 2008, MOL PHYLOGENET EVOL, V49, P460, DOI 10.1016/j.ympev.2008.08.001; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Rosentreter R, 2004, USDA FOREST SERVICE, P1; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teletchea F, 2008, J APPL ECOL, V45, P967, DOI 10.1111/j.1365-2664.2007.01415.x; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; Thiam M, 2008, AFR ZOOL, V43, P135, DOI 10.3377/1562-7020-43.2.135; Triant DA, 2008, GENETICA, V132, P21, DOI 10.1007/s10709-007-9145-6; Triant DA, 2009, J MAMMAL, V90, P561, DOI 10.1644/08-MAMM-A-149R1.1; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	89	76	79	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48374	10.1371/journal.pone.0048374	http://dx.doi.org/10.1371/journal.pone.0048374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144869	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800048
J	Gera, N; Hill, AB; White, DP; Carbonell, RG; Rao, BM				Gera, Nimish; Hill, Andrew B.; White, Dalon P.; Carbonell, Ruben G.; Rao, Balaji M.			Design of pH Sensitive Binding Proteins from the Hyperthermophilic Sso7d Scaffold	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; NEONATAL FC-RECEPTOR; AFFINITY-CHROMATOGRAPHY; RANDOM MUTAGENESIS; ANTIBODY; ELUTION; IGG; SWITCHES; ENGINEER; FINE	We have engineered pH sensitive binding proteins for the Fc portion of human immunoglobulin G (hIgG) (hFc) using two different strategies - histidine scanning and random mutagenesis. We obtained an hFc-binding protein, Sso7d-hFc, through mutagenesis of the Sso7d protein from the hyperthermophilic archaeon Sulfolobus solfataricus; Sso7d-hFc was isolated from a combinatorial library of Sso7d mutants using yeast surface display. Subsequently, we identified a pH sensitive mutant, Sso7d-his-hFc, through systematic evaluation of Sso7d-hFc mutants containing single histidine substitutions. In parallel, we also developed a yeast display screening strategy to isolate a different pH sensitive hFc binder, Sso7d-ev-hFc, from a library of mutants obtained by random mutagenesis of a pool of hFc binders. In contrast to Sso7d-hFc, both Sso7d-his-hFc and Sso7d-ev-hFc have a higher binding affinity for hFc at pH 7.4 than at pH 4.5. The Sso7d-mutant hFc binders can be recombinantly expressed at high yield in E. coli and are monomeric in solution. They bind an epitope in the CH3 domain of hFc that has high sequence homology in all four hIgG isotypes (hIgG(1-4)), and recognize hIgG(1-4) as well as deglycosylated hIgG in western blotting assays. pH sensitive hFc binders are attractive candidates for use in chromatography, to achieve elution of IgG under milder pH conditions. However, the surface density of immobilized hFc binders, as well as the avidity effect arising from the multivalent interaction of dimeric hFc with the capture surface, influences the pH dependence of dissociation from the capture surface. Therefore, further studies are needed to evaluate if the Sso7d mutants identified in this study are indeed useful as affinity ligands in chromatography.	[Gera, Nimish; Hill, Andrew B.; White, Dalon P.; Carbonell, Ruben G.; Rao, Balaji M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Rao, BM (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	bmrao@ncsu.edu	White, Dalon/AAF-9507-2019	White, Dalon/0000-0003-2960-7466; Gera, Nimish/0000-0003-2453-9468; Rao, Balaji/0000-0001-5695-8953	National Science Foundation (NSF) [CBET-0853771]; Defense Threat Reduction Agency (DTRA) [HDTRA1-10-1-0024]	National Science Foundation (NSF)(National Science Foundation (NSF)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by grants from the National Science Foundation (NSF; grant CBET-0853771) and the Defense Threat Reduction Agency (DTRA; grant HDTRA1-10-1-0024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; BOTTOMLEY SP, 1995, J IMMUNOL METHODS, V182, P185, DOI 10.1016/0022-1759(95)00049-G; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chaparro-Riggers J., 2012, J BIOL CHEM; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Gera N., 2012, METHODS, DOI 10.1016/j.ymeth.2012.03.014; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Gulich S, 2000, J BIOTECHNOL, V76, P233, DOI 10.1016/S0168-1656(99)00197-2; Hussain M, 2012, ACS SYNTHETIC BIOL; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Liu Z, 2011, J CHROMATOGR A, V1218, P8344, DOI 10.1016/j.chroma.2011.09.038; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Rao BM, 2003, PROTEIN ENG, V16, P1081, DOI 10.1093/protein/gzg111; Sagermann M, 2009, PROTEIN SCI, V18, P217, DOI 10.1002/pro.23; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Schmidt-Dannert Claudia, 1999, Trends in Biotechnology, V17, P135, DOI 10.1016/S0167-7799(98)01283-9; Shukla AA, 2007, J CHROMATOGR A, V1171, P22, DOI 10.1016/j.chroma.2007.09.040; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Watanabe H, 2009, J BIOL CHEM, V284, P12373, DOI 10.1074/jbc.M809236200; Zaccolo M, 1999, J MOL BIOL, V285, P775, DOI 10.1006/jmbi.1998.2262; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	24	41	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48928	10.1371/journal.pone.0048928	http://dx.doi.org/10.1371/journal.pone.0048928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145025	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800173
J	Siu, MKY; Kong, DSH; Chan, HY; Wong, ESY; Ip, PPC; Jiang, LL; Ngan, HYS; Le, XF; Cheung, ANY				Siu, Michelle K. Y.; Kong, Daniel S. H.; Chan, Hoi Yan; Wong, Esther S. Y.; Ip, Philip P. C.; Jiang, LiLi; Ngan, Hextan Y. S.; Le, Xiao-Feng; Cheung, Annie N. Y.			Paradoxical Impact of Two Folate Receptors, FR alpha and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome	PLOS ONE			English	Article							FOLIC-ACID; BINDING-PROTEIN; E-CADHERIN; DIFFERENTIAL EXPRESSION; DIETARY-FOLATE; CARRIER GENE; IN-VIVO; METHOTREXATE; METHYLATION; TRANSPORT	Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced by reports on overexpression of folate receptor alpha (FR alpha) in carcinomas. The role of another folate transporter, reduced folate carrier (RFC), is largely unknown. This study investigated the roles of folate, FR alpha and RFC in ovarian cancers. We demonstrated FR alpha mRNA and protein overexpression and reduced RFC expression in association with FR alpha gene amplification and RFC promoter hypermethylation, respectively. FRa overexpression was associated with tumor progression while RFC expression incurred a favorable clinical outcome. Such reciprocal expression pattern was also observed in ovarian cancer cell lines. Folate was shown to promote cancer cell proliferation, migration and invasion in vitro, and down-regulate E-cadherin expression. This effect was blocked after either stable knockdown of FR alpha or ectopic overexpression of RFC. This hitherto unreported phenomenon suggests that, RFC can serve as a balancing partner of FR alpha and confer a protective effect in patients with high FR alpha-expressing ovarian carcinomas, as evidenced by their prolonged overall and disease-free survivals. In conclusion, we report on the paradoxical impact of FR alpha (putative oncogenic) and RFC (putative tumor suppressive) in human malignancies. FR alpha and RFC may potentially be explored as therapeutic target or prognostic marker respectively. We recommend caution and additional research on folate supplements in cancer patients.	[Siu, Michelle K. Y.; Kong, Daniel S. H.; Chan, Hoi Yan; Wong, Esther S. Y.; Ip, Philip P. C.; Jiang, LiLi; Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Le, Xiao-Feng] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Expt Therapeut, Houston, TX 77030 USA	University of Hong Kong; University of Hong Kong; University of Texas System; UTMD Anderson Cancer Center	Siu, MKY (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	mkysiu@hkucc.hku.hk; anycheun@hkucc.hku.hk	Ip, Philip/AAV-5995-2021; Cheung, Annie Nga Yin/C-4231-2009	Ip, Philip/0000-0002-0493-9838; Ngan, Hextan Y S/0000-0003-3945-159X; Cheung, Annie Nga Yin/0000-0002-1584-7568	American Institute for Cancer Research; University of Hong Kong	American Institute for Cancer Research; University of Hong Kong(University of Hong Kong)	This study was supported by funding from the American Institute for Cancer Research Post-doctoral Award and the University of Hong Kong Seed Funding, and the Conference and Research Grant from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetstra S, 2005, CARCINOGENESIS; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; BOTTERO F, 1993, CANCER RES, V53, P5791; CAMPBELL IG, 1991, CANCER RES, V51, P5329; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; Ferreri AJM, 2004, BRIT J HAEMATOL, V126, P657, DOI 10.1111/j.1365-2141.2004.05109.x; Figini M, 2003, GENE THER, V10, P1018, DOI 10.1038/sj.gt.3301962; Goodman MT, 2003, CANCER, V97, P2676, DOI 10.1002/cncr.11349; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kalli KR, 2008, GYNECOL ONCOL, V108, P619, DOI 10.1016/j.ygyno.2007.11.020; Kelemen LE, 2004, CANCER CAUSE CONTROL, V15, P1085, DOI 10.1007/s10552-004-1546-6; Kelemen LE, 2005, CANCER EPIDEM BIOMAR, V14, P2168, DOI 10.1158/1055-9965.EPI-05-0260; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Kim YI, 2008, CANCER EPIDEM BIOMAR, V17, P2220, DOI 10.1158/1055-9965.EPI-07-2557; Kimura M, 2004, J NUTR, V134, P48, DOI 10.1093/jn/134.1.48; Larsson SC, 2004, JNCI-J NATL CANCER I, V96, P396, DOI 10.1093/jnci/djh061; Ma DWL, 2005, CANCER RES, V65, P887; Marugame T, 2007, JPN J CLIN ONCOL, V37, P802, DOI 10.1093/jjco/hym141; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; Miotti S, 2005, AM J PATHOL, V167, P1411, DOI 10.1016/S0002-9440(10)61228-X; Nakashima-Matsushita N, 1999, ARTHRITIS RHEUM-US, V42, P1609, DOI 10.1002/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Pelucchi C, 2005, CANCER EPIDEM BIOMAR, V14, P2056, DOI 10.1158/1055-9965.EPI-05-0192; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Shen DH, 2005, CARCINOGENESIS, V26, P855, DOI 10.1093/carcin/bgi011; Siu MKY, 2008, AM J PATHOL, V173, P1165, DOI 10.2353/ajpath.2008.080288; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Smith AD, 2008, AM J CLIN NUTR, V87, P517; The Hong Kong Cancer Registry, 2007, DEP HLTH ANN REP; Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P2226, DOI 10.1158/1055-9965.EPI-07-2952; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Woenckhaus J, 2007, VIRCHOWS ARCH, V450, P387, DOI 10.1007/s00428-006-0358-3; Woodside JV, 2005, P NUTR SOC, V64, P543, DOI 10.1079/PNS2005464; Worm J, 2001, J BIOL CHEM, V276, P39990, DOI 10.1074/jbc.M103181200; Yang R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-124	41	58	62	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47201	10.1371/journal.pone.0047201	http://dx.doi.org/10.1371/journal.pone.0047201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100UH	23144806	gold, Green Published, Green Submitted			2022-12-25	WOS:000315728900001
J	Zhao, W; Varghese, M; Vempati, P; Dzhun, A; Cheng, A; Wang, J; Lange, D; Bilski, A; Faravelli, I; Pasinetti, GM				Zhao, Wei; Varghese, Merina; Vempati, Prashant; Dzhun, Anastasiya; Cheng, Alice; Wang, Jun; Lange, Dale; Bilski, Amanda; Faravelli, Irene; Pasinetti, Giulio Maria			Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MEDIUM-CHAIN TRIGLYCERIDES; SUPEROXIDE-DISMUTASE GENE; TRAUMATIC BRAIN-INJURY; KETOGENIC DIET; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; SKELETAL-MUSCLE; TRANSGENIC MICE; SPINAL-CORD	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons causing progressive muscle weakness, paralysis, and finally death. ALS patients suffer from asthenia and their progressive weakness negatively impacts quality of life, limiting their daily activities. They have impaired energy balance linked to lower activity of mitochondrial electron transport chain enzymes in ALS spinal cord, suggesting that improving mitochondrial function may present a therapeutic approach for ALS. When fed a ketogenic diet, the G93A ALS mouse shows a significant increase in serum ketones as well as a significantly slower progression of weakness and lower mortality rate. In this study, we treated SOD1-G93A mice with caprylic triglyceride, a medium chain triglyceride that is metabolized into ketone bodies and can serve as an alternate energy substrate for neuronal metabolism. Treatment with caprylic triglyceride attenuated progression of weakness and protected spinal cord motor neuron loss in SOD1-G93A transgenic animals, significantly improving their performance even though there was no significant benefit regarding the survival of the ALS transgenic animals. We found that caprylic triglyceride significantly promoted the mitochondrial oxygen consumption rate in vivo. Our results demonstrated that caprylic triglyceride alleviates ALS-type motor impairment through restoration of energy metabolism in SOD1-G93A ALS mice, especially during the overt stage of the disease. These data indicate the feasibility of using caprylic acid as an easily administered treatment with a high impact on the quality of life of ALS patients.	[Zhao, Wei; Varghese, Merina; Vempati, Prashant; Dzhun, Anastasiya; Cheng, Alice; Wang, Jun; Bilski, Amanda; Faravelli, Irene; Pasinetti, Giulio Maria] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Zhao, Wei; Wang, Jun; Pasinetti, Giulio Maria] James J Peters Vet Affairs Med Ctr, GRECC, New York, NY USA; [Lange, Dale] Hosp Special Surg, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	Giulio.Pasinetti@mssm.edu	Zhao, Wei/A-2206-2010; Varghese, Merina/H-5472-2019; Faravelli, Irene/AAP-6300-2020	Varghese, Merina/0000-0002-1517-3903; Faravelli, Irene/0000-0001-8126-7353; Pasinetti, Giulio/0000-0002-1524-5196; Zhao, Wei/0000-0002-3449-2395	NIH-NCI [5R24 CA095823-04]; NSF Major Research Instrumentation [DBI-9724504]; NIH [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF Major Research Instrumentation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funding from: NIH-NCI shared resources grant (5R24 CA095823-04), http://www.nih.gov/; NSF Major Research Instrumentation grant (DBI-9724504), http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5260; and NIH shared instrumentation grant (1 S10 RR0 9145-01); http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2012, BRAIN RES, V1446, P1, DOI 10.1016/j.brainres.2012.01.046; Andreassen OA, 2001, J NEUROCHEM, V77, P383, DOI 10.1046/j.1471-4159.2001.00188.x; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Beal MF, 2002, FREE RADICAL RES, V36, P455, DOI 10.1080/10715760290021315; BJUGN R, 1993, BRAIN RES, V627, P25, DOI 10.1016/0006-8993(93)90744-8; Browne SE, 1998, J NEUROCHEM, V71, P281; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cheng BH, 2009, BRAIN RES, V1286, P25, DOI 10.1016/j.brainres.2009.06.060; CHIU AY, 1995, MOL CELL NEUROSCI, V6, P349, DOI 10.1006/mcne.1995.1027; Ciavarro GL, 2003, J NEUROSCI METH, V129, P61, DOI 10.1016/S0165-0270(03)00201-2; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Douglas RM, 2010, AM J PHYSIOL-CELL PH, V298, pC1594, DOI 10.1152/ajpcell.00298.2009; Fidler JA, 2011, FASEB J, V25, P4369, DOI 10.1096/fj.11-190819; Fujita K, 1996, J NEUROSCI RES, V45, P276, DOI 10.1002/(SICI)1097-4547(19960801)45:3<276::AID-JNR9>3.0.CO;2-A; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; HUTTENLOCHER PR, 1971, NEUROLOGY, V21, P1097, DOI 10.1212/WNL.21.11.1097; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Kaal ECA, 2000, J NEUROCHEM, V74, P1158; Kong JM, 1998, J NEUROSCI, V18, P3241; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; PERLMAN BJ, 1984, MOL PHARMACOL, V26, P83; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Roman Marian W, 2010, Issues Ment Health Nurs, V31, P435, DOI 10.3109/01612841003768231; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rothstein JD, 2003, ANN NEUROL, V53, P423, DOI 10.1002/ana.10561; Ruskin DN, 2011, PHYSIOL BEHAV, V103, P501, DOI 10.1016/j.physbeh.2011.04.001; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; Sasaki S, 1996, NEUROSCI LETT, V204, P53, DOI 10.1016/0304-3940(96)12314-4; SILLS MA, 1986, ARCH DIS CHILD, V61, P1168, DOI 10.1136/adc.61.12.1168; SPECTOR R, 1988, J NEUROCHEM, V50, P639, DOI 10.1111/j.1471-4159.1988.tb02958.x; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Strong M, 2003, AMYOTROPH LATERAL SC, V4, P136, DOI 10.1080/14660820310011250; Tu PH, 1997, LAB INVEST, V76, P441; Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339; Vining EPG, 1998, ARCH NEUROL-CHICAGO, V55, P1433, DOI 10.1001/archneur.55.11.1433; Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2; Wlaz P, 2012, NEUROPHARMACOLOGY, V62, P1882, DOI 10.1016/j.neuropharm.2011.12.015; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	53	74	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49191	10.1371/journal.pone.0049191	http://dx.doi.org/10.1371/journal.pone.0049191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145119	Green Published, gold			2022-12-25	WOS:000311935800228
J	Neuditschko, M; Khatkar, MS; Raadsma, HW				Neuditschko, Markus; Khatkar, Mehar S.; Raadsma, Herman W.			NETVIEW: A High-Definition Network-Visualization Approach to Detect Fine-Scale Population Structures from Genome-Wide Patterns of Variation	PLOS ONE			English	Article							GENETIC-STRUCTURE; INFERENCE; SNP; ADMIXTURE; STRATIFICATION; INDIVIDUALS; DIVERSITY; SOFTWARE; DISTANCE; REVEALS	High-throughput sequencing and single nucleotide polymorphism (SNP) genotyping can be used to infer complex population structures. Fine-scale population structure analysis tracing individual ancestry remains one of the major challenges. Based on network theory and recent advances in SNP chip technology, we investigated an unsupervised network clustering method called Super Paramagnetic Clustering (SPC). When applied to whole-genome marker data it identifies the natural divisions of groups of individuals into population clusters without use of prior ancestry information. Furthermore, we optimised an analysis pipeline called NETVIEW, a high-definition network visualization, starting with computation of genetic distance, followed clustering using SPC and finally visualization of clusters with CYTOSCAPE. We compared NETVIEW against commonly used methodologies including Principal Component Analyses (PCA) and a model-based algorithm, ADMIXTURE, on whole-genome-wide SNP data derived from three previously described data sets: simulated (2.5 million SNPs, 5 populations), human (1.4 million SNPs, 11 populations) and cattle (32,653 SNPs, 19 populations). We demonstrate that individuals can be effectively allocated to their correct population whilst simultaneously revealing fine-scale structure within the populations. Analyzing the human HapMap populations, we identified unexpected genetic relatedness among individuals, and population stratification within the Indian, African and Mexican samples. In the cattle data set, we correctly assigned all individuals to their respective breeds and detected fine-scale population sub-structures reflecting different sample origins and phenotypes. The NETVIEW pipeline is computationally extremely efficient and can be easily applied on large-scale genome-wide data sets to assign individuals to particular populations and to reproduce fine-scale population structures without prior knowledge of individual ancestry. NETVIEW can be used on any data from which a genetic relationship/ distance between individuals can be calculated.	[Neuditschko, Markus; Khatkar, Mehar S.; Raadsma, Herman W.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia	University of Sydney	Neuditschko, M (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	markus.neuditschko@sydney.edu.au						Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bagrow JP, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046108; Barad O, 2003, THESIS WEIZMANN I IS; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bowden R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002504; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Brohee S, 2008, NAT PROTOC, V3, P1616, DOI 10.1038/nprot.2008.100; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Falush D, 2003, GENETICS, V164, P1567; Fraley C, 2012, J STAT SOFTW, V18, P1; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao XY, 2009, HUM HERED, V68, P182, DOI 10.1159/000224638; Gao XY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-77; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; Gompert Z, 2010, MOL ECOL, V19, P2455, DOI 10.1111/j.1365-294X.2010.04666.x; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Intarapanich A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-382; Johnson JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014042; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kim JJ, 2005, HUM GENET, V117, P511, DOI 10.1007/s00439-005-1334-8; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lawson DJ, 2012, ANN REV GEN IN PRESS; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu Nianjun, 2006, Human Genomics, V2, P353; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Neuditschko M, 2010, P 9 WORLD C GEN APPL; Parsons L., 2004, SIGKDD EXPLOR NEWSL, V6, P90, DOI DOI 10.1145/1007730.1007731; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reeves PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004269; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serre D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001382; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shriver Mark D., 2005, Human Genomics, V2, P81; Simon-Sanchez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028787; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Tetko IV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-82; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Wu F, 2004, EUR PHYS J B, V38, P331, DOI 10.1140/epjb/e2004-00125-x	73	75	76	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48375	10.1371/journal.pone.0048375	http://dx.doi.org/10.1371/journal.pone.0048375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23152744	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500116
J	Berger, T; Ueda, T; Arpaia, E; Chio, IIC; Shirdel, EA; Jurisica, I; Hamada, K; You-Ten, A; Haight, J; Wakeham, A; Cheung, CC; Mak, TW				Berger, T.; Ueda, T.; Arpaia, E.; Chio, I. I. C.; Shirdel, E. A.; Jurisica, I.; Hamada, K.; You-Ten, A.; Haight, J.; Wakeham, A.; Cheung, C. C.; Mak, T. W.			Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model	ONCOGENE			English	Article						breast cancer; metastasis; MMTV-PyMT; flotillin-1; reggie1/2	SIGNAL-TRANSDUCTION; UP-REGULATION; LIPID RAFTS; CELL-LINES; MICROARRAY; EXPRESSION; PROTEINS; DISEASE; GENOME; CYTOSKELETON	Flotillin microdomains, specialized lipid raft domains in cell membranes, serve as physical platforms for many different molecules important in crucial intracellular signaling pathways. Flotillin-2 (Flot2), together with flotillin-1, is a marker for lipid raft microdomains distinct from caveolar lipid rafts, and has been implicated in the progression of cancer and metastasis formation. Based largely on studies in xenograft models, flotillin-2 has been implicated in the progression of multiple types of human tumors, including breast cancer. In our studies, we identified flotillin-2 as highly amplified in a high-throughput comparative genomic hybridization screen of human breast cancer cell lines and breast tumor samples. Short hairpin RNA-mediated reduction of flotillin-2 protein levels significantly reduced the tumorigenicity and metastatic capability of a human breast cancer cell line in vivo. We generated mice deficient for flotillin-2 and also found a reduction of flotillin-1 protein levels and complete absence of flotillin-specific membrane microdomains in these mice. To examine the role of Flot2 in mammary tumorigenesis and lung metastasis, we used an in vivo molecular genetics approach, crossing a well-characterized transgenic mouse model of breast cancer, the MMTV-PyMT (mouse mammary tumor virus-polyoma middle T antigen) mouse, with gene-targeted Flot2(-/-) mice. Flotillin-2 deficiency lead to a striking reduction in the number of lung metastasis observed, but had no influence on primary tumor formation in this model. Our results indicate, using a novel in vivo animal model approach, that Flot2 is an important regulator of mammary tumor-derived lung metastasis.	[Berger, T.; Ueda, T.; Arpaia, E.; Chio, I. I. C.; Shirdel, E. A.; You-Ten, A.; Haight, J.; Wakeham, A.; Mak, T. W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; [Ueda, T.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan; [Shirdel, E. A.; Jurisica, I.] Univ Hlth Network, Techna Inst, Toronto, ON, Canada; [Shirdel, E. A.; Jurisica, I.] IBM Life Sci Discovery Ctr, Toronto, ON, Canada; [Jurisica, I.; Mak, T. W.] Univ Toronto, Dept Med Phys, Toronto, ON, Canada; [Jurisica, I.; Mak, T. W.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Jurisica, I.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Hamada, K.] Kumamoto Univ, Ctr AIDS Res, Okada Projects, Kumamoto, Japan; [Cheung, C. C.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Mak, T. W.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Hiroshima University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Kumamoto University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mak, TW (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, 620 Univ Ave,Suite 706, Toronto, ON M5G 2M9, Canada.	tmak@uhnresearch.ca	Berger, Thorsten/J-7632-2012	Ueda, Takeshi/0000-0001-9823-6764	Ontario Research Fund [GL2-01-030]; Canada Research Chair Program; Canadian Institutes of Health Research [179815]	Ontario Research Fund; Canada Research Chair Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Lily Zhou for expert technical assistance, and Dr Mary Saunders for insightful scientific editing. This work was supported by grant no. 179815 from the Canadian Institutes of Health Research to TWM. This research was funded in part by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC. ES is in part supported by Ontario Research Fund (GL2-01-030) to IJ, and IJ was in part supported by Canada Research Chair Program.	Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Boyle P, 2008, WORLD CANC REPORT 20; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; de Laurentiis Angela, 2007, Open Biochem J, V1, P12, DOI 10.2174/1874091X00701010012; de Leeuw RJ, 2004, HUM MOL GENET, V13, P1827, DOI 10.1093/hmg/ddh195; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; LEMOYEC L, 1992, BRIT J CANCER, V66, P623, DOI 10.1038/bjc.1992.327; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Maglione JE, 2001, CANCER RES, V61, P8298; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Nohara K, 1998, BREAST CANCER RES TR, V48, P149, DOI 10.1023/A:1005986606010; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Qiu TH, 2004, CANCER RES, V64, P5973, DOI 10.1158/0008-5472.CAN-04-0242; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schulte T, 1997, DEVELOPMENT, V124, P577; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Watson SK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-6; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P551, DOI 10.1083/jcb.1.6.551; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305	28	40	44	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4989	4994		10.1038/onc.2012.499	http://dx.doi.org/10.1038/onc.2012.499			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23146906				2022-12-25	WOS:000325717800015
J	Liu, CH; Yang, JS; Ren, JQ; Liu, CM; You, ZR; Liu, PK				Liu, Christina H.; Yang, Jinsheng; Ren, Jia Q.; Liu, Charng-Ming; You, Zerong; Liu, Philip K.			MRI reveals differential effects of amphetamine exposure on neuroglia in vivo	FASEB JOURNAL			English	Article						drug delivery; molecular MR imaging; nanomedicine; gliogenesis	BLOOD-BRAIN-BARRIER; FIBRILLARY ACIDIC PROTEIN; GENE-EXPRESSION; SEROTONIN NEUROTOXICITY; MESSENGER-RNA; STEM-CELLS; METHAMPHETAMINE; PROBES; LIVE; DELIVERY	How amphetamine affects the neuroglia in living brains is not well understood. In an effort to elucidate this effect, we investigated neuroglia in response to amphetamine exposure using antisense (AS) or sense (S) phosphorothioate-modified oligodeoxynucleotide (sODN) sequences that correspond to glial fibrillary acidic protein (GFAP) mRNA (AS-gfap or S-gfap, respectively) expression. The control is a random-sequence sODN (Ran). Using cyanine 5.5-super-paramagnetic iron oxide nanoparticle (Cy5.5-SPION) labeling and fluorescent microscopy, we demonstrated that living neural progenitor cells (PC-12.1), as well as the cells in fresh brain slices and intact brains of male C57BL6 mice, exhibited universal uptake of all of the sODNs but rapidly excluded all sODN-Ran and most S-gfap. Moreover, transmission electron microscopy revealed electron-dense nanoparticles only in the neuroglia of normal or transgenic mice [B6;DBA-Tg(Fos-tTA, Fos-EGFP*)1MmayTg(tetO-lacZ,tTA*)1Mmay/J] that had been administered AS-gfap or Cy5.5-SPION-gfap. Subtraction R2* maps from mice with acute and chronic amphetamine exposure demonstrated, validated by postmortem immunohistochemistry, a reduction in striatal neuroglia, with gliogenesis in the subventricular zone and the somatosensory cortex in vivo. The sensitivity of our unique gene transcript targeted MRI was illustrated by a positive linear correlation (r(2) = 1.0) between in vivo MRI signal changes and GFAP mRNA copy numbers determined by ex vivo quantitative RTPCR. The study provides direct evidence for targeting neuroglia by antisense DNA-based SPION-gfap that enables in vivo MRI of inaccessible tissue with PCR sensitivity. The results enable us to conclude that amphetamine induces toxicity to neuroglia in vivo, which may cause remodeling or reconnectivity of neuroglia.-Liu, C. H., Yang, J., Ren, J. Q., Liu, C.-M., You, Z., Liu, P. K. MRI reveals differential effects of amphetamine exposure on neuroglia in vivo. FASEB J. 27, 712-724 (2013). www.fasebj.org	[Liu, Christina H.; Yang, Jinsheng; Ren, Jia Q.; Liu, Charng-Ming; Liu, Philip K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [You, Zerong] Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Liu, PK (corresponding author), CNY149 2301 13th St, Charlestown, MA 02129 USA.	philipl@nmr.mgh.harvard.edu		Liu, Christina/0000-0002-5723-177X	American Heart Association [2060416]; U.S. National Institutes of Health (NIH) [AT004974, DA026108, DA029889, EB013768, NS045776]; NIH [DK43351, DK57521]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026108, R01DA029889] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Ms. N. Eusemann for help with editing. This project was supported by grants from the American Heart Association (09Grant2060416) and the U.S. National Institutes of Health (NIH; AT004974 to J.Q.R.; DA026108, DA029889, and EB013768 to P. K. L.; and NS045776 to the Massachusetts General Hospital Neuroscience Center). The 9.4-T MR system used for this work was funded in part by an NIH Shared Instrumentation grant awarded to the Athinoula A. Martinos Center for Biomedical Imaging. The authors appreciate the help of M. McKee with TEM, and the availability of the Microscopy Core (which is supported by NIH DK43351 and DK57521). Author contributions: C. H. L. contributed to MRI acquisition and data analysis and wrote the initial draft of the manuscript; J.Y. contributed to qRT-PCR and TaqMan analysis; J.Q.R. established brain slice cultures, delivered SPION-gfap, and contributed to histology and TEM; C.-M. L. synthesized and modified sODN and carried out PC-12.1 culture studies; Z.Y. contributed to immunohistology; P. K. L. coordinated and provided overall oversight for the project, designed and prepared SPION-sODN, carried out time-lapse microscopy, and supervised the various phases of revision of the manuscript.	Armstrong V, 2004, EUR J PHARMACOL, V488, P111, DOI 10.1016/j.ejphar.2004.02.001; BELTINGER C, 1995, J CLIN INVEST, V95, P1814, DOI 10.1172/JCI117860; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Bowyer JF, 2006, SYNAPSE, V60, P521, DOI 10.1002/syn.20324; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Chadi G, 2009, J MOL HISTOL, V40, P241, DOI 10.1007/s10735-009-9235-0; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Fornai F, 2004, PSYCHOPHARMACOLOGY, V173, P353, DOI 10.1007/s00213-003-1708-3; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Frey BN, 2006, PROG NEURO-PSYCHOPH, V30, P1231, DOI 10.1016/j.pnpbp.2006.03.016; GYURKO R, 1993, REGUL PEPTIDES, V49, P167, DOI 10.1016/0167-0115(93)90438-E; Huang YN, 2009, TOXICOL APPL PHARM, V240, P315, DOI 10.1016/j.taap.2009.06.021; Ichikawa T, 2002, NEOPLASIA, V4, P523, DOI 10.1038/sj.neo.7900266; Kita T, 2009, INT REV NEUROBIOL, V88, P43, DOI 10.1016/S0074-7742(09)88003-3; Kitamura O, 2010, LEGAL MED-TOKYO, V12, P57, DOI 10.1016/j.legalmed.2009.11.001; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Krasnova IN, 2005, FASEB J, V19, P851, DOI 10.1096/fj.04-2881fje; Ladenheim B, 2000, MOL PHARMACOL, V58, P1247, DOI 10.1124/mol.58.6.1247; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; Liu CH, 2008, FASEB J, V22, P1193, DOI 10.1096/fj.07-9557com; Liu CH, 2007, FASEB J, V21, P3004, DOI 10.1096/fj.07-8203com; Liu CH, 2007, J NEUROSCI, V27, P713, DOI 10.1523/JNEUROSCI.4660-06.2007; Liu CH, 2012, FASEB J, V26, P1652, DOI 10.1096/fj.11-199547; Liu CH, 2009, J NEUROSCI, V29, P10663, DOI 10.1523/JNEUROSCI.2167-09.2009; Liu CH, 2009, J NEUROSCI, V29, P3508, DOI 10.1523/JNEUROSCI.5332-08.2009; Liu PK, 2011, METHODS MOL BIOL, V711, P363, DOI 10.1007/978-1-61737-992-5_18; LIU PK, 1994, ANN NEUROL, V36, P566, DOI 10.1002/ana.410360405; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Malaplate-Armand C, 2005, TOXICOL LETT, V159, P203, DOI 10.1016/j.toxlet.2005.04.005; Malberg JE, 1998, J NEUROSCI, V18, P5086; Mao LM, 2001, DEV BRAIN RES, V130, P41, DOI 10.1016/S0165-3806(01)00195-X; MCCANN UD, 1994, NEUROPSYCHOPHARMACOL, V10, P129, DOI 10.1038/npp.1994.15; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Messing A, 1998, AM J PATHOL, V152, P391; MULDOON LL, 1995, AM J PATHOL, V147, P1840; Narita M, 2008, ANN NY ACAD SCI, V1141, P96, DOI 10.1196/annals.1441.032; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; ODAWARA T, 1995, NEUROSCI LETT, V192, P145, DOI 10.1016/0304-3940(95)11595-N; PARDRIDGE WM, 1995, P NATL ACAD SCI USA, V92, P5592, DOI 10.1073/pnas.92.12.5592; Paxinos G., 2001, THE MOUSE BRAIN IN S, DOI DOI 10.1084/JEM.20081588; Peleg-Raibstein D, 2008, BEHAV BRAIN RES, V191, P190, DOI 10.1016/j.bbr.2008.03.037; RICAURTE G, 1985, SCIENCE, V229, P986, DOI 10.1126/science.4023719; ROLLAND B, 1990, DEV BRAIN RES, V56, P144, DOI 10.1016/0165-3806(90)90175-X; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shi NY, 2001, P NATL ACAD SCI USA, V98, P12754, DOI 10.1073/pnas.221450098; Shi NY, 2000, P NATL ACAD SCI USA, V97, P14709, DOI 10.1073/pnas.250332397; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; Smith MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-409; Strauch RC, 2011, J AM CHEM SOC, V133, P16346, DOI 10.1021/ja206134b; Tanibuchi Y., 2010, GEN HOSP PSYCHIAT, V32; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; Tocharus J, 2010, J PINEAL RES, V48, P347, DOI 10.1111/j.1600-079X.2010.00761.x; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; Winkler J, 2010, CHEMMEDCHEM, V5, P1344, DOI 10.1002/cmdc.201000156	61	10	10	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					712	724		10.1096/fj.12-220061	http://dx.doi.org/10.1096/fj.12-220061			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23150521	Green Published			2022-12-25	WOS:000314358000030
J	An, CJ; Hiromasa, Y; Zhang, X; Lovell, S; Zolkiewski, M; Tomich, JM; Michel, K				An, Chunju; Hiromasa, Yasuaki; Zhang, Xin; Lovell, Scott; Zolkiewski, Michal; Tomich, John M.; Michel, Kristin			Biochemical Characterization of Anopheles gambiae SRPN6, a Malaria Parasite Invasion Marker in Mosquitoes	PLOS ONE			English	Article							IMMUNE-RESPONSIVE SERPIN; MANDUCA-SEXTA HEMOLYMPH; MELANIZATION CASCADE; SALIVARY-GLANDS; GENE FAMILY; I-TASSER; ACTIVATION; PLASMODIUM; DEFENSE; PROTEINASES	Serine proteinase inhibitors of the serpin family are well known as negative regulators of hemostasis, thrombolysis and innate immune responses. Additionally, non-inhibitory serpins serve functions as chaperones, hormone transporters, or anti-angiogenic factors. In the African malaria mosquito, Anopheles gambiae s.s., at least three serpins (SRPNs) are implicated in the innate immune response against malaria parasites. Based on reverse genetic and cell biological analyses, AgSRPN6 limits parasite numbers and transmission and has been postulated to control melanization and complement function in mosquitoes. This study aimed to characterize AgSRPN6 biophysically and determine its biochemical mode of action. The structure model of AgSRPN6, as predicted by I-Tasser showed the protein in the native serpin fold, with three central beta-sheets, nine surrounding alpha-helices, and a protruding reactive center loop. This structure is in agreement with biophysical and functional data obtained from recombinant (r) AgSRPN6, produced in Escherichia coli. The physical properties of purified rAgSRPN6 were investigated by means of analytical ultracentrifugation, circular dichroism, and differential scanning calorimetry tools. The recombinant protein exists predominantly as a monomer in solution, is composed of a mixture of alpha-helices and beta-sheets, and has a mid-point unfolding temperature of 56 degrees C. Recombinant AgSRPN6 strongly inhibited porcine pancreatic kallikrein and to a lesser extent bovine pancreatic trypsin in vitro. Furthermore, rAgSRPN6 formed inhibitory, SDS-stable, higher molecular weight complexes with prophenoloxidase-activating proteinase (PAP) 1, PAP3, and Hemolymph protein (HP) 6, which are required for melanization in the lepidopteran model organism, Manduca sexta. Taken together, our results strongly suggest that AgSRPN6 takes on a native serpin fold and is an inhibitor of trypsin-like serine proteinases. Citation: An C, Hiromasa Y, Zhang X, Lovell S, Zolkiewski M, et al. (2012) Biochemical Characterization of Anopheles gambiae SRPN6, a Malaria Parasite Invasion Marker in Mosquitoes. PLoS ONE 7(11): e48689. doi:10.1371/journal.pone.0048689	[An, Chunju; Zhang, Xin; Michel, Kristin] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [An, Chunju] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Hiromasa, Yasuaki; Zolkiewski, Michal; Tomich, John M.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Lovell, Scott] Univ Kansas, Prot Struct Lab, Lawrence, KS 66045 USA	Kansas State University; China Agricultural University; Kansas State University; University of Kansas	Michel, K (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	kmichel@ksu.edu		TOMICH, JOHN/0000-0001-7848-8307	National Institutes of Health [3P20RR017708-07S1, P20RR017686, 1R01AI095842]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health through 3P20RR017708-07S1 and P20RR017686 sub-awards and 1R01AI095842 to K.M. This is contribution 12-098-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; An C, 2010, CELL MOL LIFE SCI; An CJ, 2011, PROTEINS, V79, P1999, DOI 10.1002/prot.23002; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Calvo E, 2011, J BIOL CHEM, V286, P27998, DOI 10.1074/jbc.M111.247924; Danielli A, 2005, CELL MICROBIOL, V7, P181, DOI 10.1111/j.1462-5822.2004.00445.x; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dissanayake SN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-116; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gouagna LC, 1998, TROP MED INT HEALTH, V3, P21, DOI 10.1046/j.1365-3156.1998.00156.x; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huff CG, 1927, AM J HYG, V7, P706, DOI 10.1093/oxfordjournals.aje.a120440; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Iwanaga S, 1998, J BIOCHEM, V123, P1; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li JP, 1999, STRUCTURE, V7, P103, DOI 10.1016/S0969-2126(99)80013-6; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Mulenga A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-217; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; PARK SH, 2010, J BIOL CHEM; Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p; Pelte N, 2006, INSECT BIOCHEM MOLEC, V36, P37, DOI 10.1016/j.ibmb.2005.10.004; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; Rodrigues J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035210; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SAKLATVALA J, 1976, BIOCHEM J, V157, P339, DOI 10.1042/bj1570339; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; Stark KR, 1995, EXP PARASITOL, V81, P321, DOI 10.1006/expr.1995.1123; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; TAKAHARA H, 1984, TOHOKU J EXP MED, V142, P261, DOI 10.1620/tjem.142.261; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011	64	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48689	10.1371/journal.pone.0048689	http://dx.doi.org/10.1371/journal.pone.0048689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152794	gold, Green Published			2022-12-25	WOS:000312272600017
J	Cabrera-Benitez, NE; Perez-Roth, E; Casula, M; Ramos-Nuez, A; Rios-Luci, C; Rodriguez-Gallego, C; Sologuren, I; Jakubkiene, V; Slutsky, AS; Padron, JM; Villar, J				Cabrera-Benitez, Nuria E.; Perez-Roth, Eduardo; Casula, Milena; Ramos-Nuez, Angela; Rios-Luci, Carla; Rodriguez-Gallego, Carlos; Sologuren, Ithaisa; Jakubkiene, Virginija; Slutsky, Arthur S.; Padron, Jose M.; Villar, Jesus			Anti-Inflammatory Activity of a Novel Family of Aryl Ureas Compounds in an Endotoxin-Induced Airway Epithelial Cell Injury Model	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED LUNG INJURY; TOLL-LIKE RECEPTOR; INFLAMMATORY CYTOKINES; SEVERE SEPSIS; ACTIVATION; IDENTIFICATION; EPIDEMIOLOGY; INHIBITORS; EXPRESSION	Background: Despite our increased understanding of the mechanisms involved in acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS), there is no specific pharmacological treatment of proven benefit. We used a novel screening methodology to examine potential anti-inflammatory effects of a small structure-focused library of synthetic carbamate and urea derivatives in a well established cell model of lipopolysaccharide (LPS)-induced ALI/ARDS. Methodology/Principal Findings: After a pilot study to develop an in vitro LPS-induced airway epithelial cell injury model, a library of synthetic carbamate and urea derivates was screened against representative panels of human solid tumor cell lines and bacterial and fungal strains. Molecules that were non-cytotoxic and were inactive in terms of antiproliferative and antimicrobial activities were selected to study the effects on LPS-induced inflammatory response in an in vitro cell culture model using A549 human alveolar and BEAS-2B human bronchial cells. These cells were exposed for 18 h to LPS obtained from Escherichia coli, either alone or in combination with the test compounds. The LPS antagonists rhein and emodin were used as reference compounds. The most active compound (CKT0103) was selected as the lead compound and the impact of CKT0103 on pro-inflammatory IL-6 and IL-8 cytokine levels, expression of toll-like receptor-4 (TLR4) and nuclear factor kappa B inhibitor alpha (I kappa B alpha) was measured. CKT0103 significantly inhibited the synthesis and release of IL-6 and IL-8 induced by LPS. This suppression was associated with inhibition of TLR4 up-regulation and I kappa B alpha down-regulation. Immunocytochemical staining for TLR4 and I kappa B alpha supported these findings. Conclusions/Significance: Using a novel screening methodology, we identified a compound - CKT0103 - with potent anti-inflammatory effects. These findings suggest that CKT0103 is a potential target for the treatment of the acute phase of sepsis and sepsis-induced ALI/ARDS.	[Cabrera-Benitez, Nuria E.; Casula, Milena; Ramos-Nuez, Angela; Villar, Jesus] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Cabrera-Benitez, Nuria E.; Casula, Milena; Ramos-Nuez, Angela; Villar, Jesus] Hosp Univ Dr Negrin, Res Unit, Multidisciplinary Organ Dysfunct Evaluat Res Netw, Las Palmas Gran Canaria, Spain; [Perez-Roth, Eduardo; Padron, Jose M.] Univ La Laguna, Inst Univ Bioorgan Antonio Gonzalez IUBO AG, BioLab, E-38207 San Cristobal la Laguna, Spain; [Rodriguez-Gallego, Carlos; Sologuren, Ithaisa] Hosp Univ Dr Negrin, Dept Immunol, Las Palmas Gran Canaria, Spain; [Jakubkiene, Virginija] Vilnius Univ, Fac Chem, Dept Organ Chem, Vilnius, Lithuania; [Slutsky, Arthur S.; Villar, Jesus] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; Vilnius University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Villar, J (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	jesus.villar54@gmail.com	Luci, Carla Rios/H-6863-2015; Padron, Jose M/H-5240-2011; RODRIGUEZ-GALLEGO, CARLOS/AAB-7516-2022; Villar, Jesús/R-4526-2019; Casula, Milena/AAA-7461-2019; Slutsky, Arthur/M-3325-2019; Padron, Jose M/H-5240-2011; Sologuren, Ithaisa/C-9278-2019	Luci, Carla Rios/0000-0001-8636-1509; Padron, Jose M/0000-0001-6268-6552; Villar, Jesús/0000-0001-5687-3562; Rodriguez-Gallego, Carlos/0000-0002-4344-8644; Perez-Roth, Eduardo/0000-0002-5655-9407; Padron, Jose M/0000-0002-7488-1774; Sologuren, Ithaisa/0000-0001-7989-7671; CASULA, Milena/0000-0002-5079-9864	CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain [CB06/06/1088]; Ministry of Science of Spain [CTQ2008-06806-C02-01/BQU]; Ministry of Health, Spain [RTICC RD06/0020/1046]; ACIISI, Canary Islands, Spain [PI 2007/021]; FUNCIS [PI 43/09]	CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain; Ministry of Science of Spain(Spanish Government); Ministry of Health, Spain(Spanish Government); ACIISI, Canary Islands, Spain; FUNCIS	This work was supported by grants from CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain (CB06/06/1088), Ministry of Science of Spain (CTQ2008-06806-C02-01/BQU); Ministry of Health, Spain (RTICC RD06/0020/1046); ACIISI, Canary Islands, Spain (PI 2007/021); FUNCIS (PI 43/09). EPR holds a "Sara Borrel'' contract from Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bachofen M, 1997, AM REV RESPIR DIS, V116, P589; Boots AW, 2012, BBA-MOL CELL RES, V1823, P1151, DOI 10.1016/j.bbamcr.2012.04.012; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Fortis S, 2012, INTENS CARE MED, V38, P1548, DOI 10.1007/s00134-012-2610-4; Herrera MT, 2003, INTENS CARE MED, V29, P1345, DOI 10.1007/s00134-003-1756-5; Hoyle GW, 2010, AM J PHYSIOL-LUNG C, V298, pL830, DOI 10.1152/ajplung.00014.2010; Jakubkiene V, 2010, ARKIVOC, P39, DOI 10.3998/ark.5550190.0011.b04; Koyama S, 1999, EUR RESPIR J, V14, P545, DOI 10.1034/j.1399-3003.1999.14c11.x; Larsson BM, 1999, INFLAMMATION, V23, P217; Leon LG, 2010, J MED CHEM, V53, P3835, DOI 10.1021/jm100155y; Leon LG, 2008, CHEMMEDCHEM, V3, P1740, DOI 10.1002/cmdc.200800212; Li HL, 2005, INT J MOL MED, V16, P41; Li XM, 2009, EXPERT OPIN INV DRUG, V18, P1047, DOI 10.1517/13543780903018880; Liaudet L, 2002, ANN SURG, V235, P568, DOI 10.1097/00000658-200204000-00016; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Liu X, 2009, INT IMMUNOPHARMACOL, V9, P1021, DOI 10.1016/j.intimp.2009.03.023; Ma SF, 2005, AM J PHYSIOL-LUNG C, V289, pL468, DOI 10.1152/ajplung.00109.2005; MacRedmond R, 2009, EUR RESPIR J, V33, P1403, DOI 10.1183/09031936.00084608; Magalhaes CB, 2010, J APPL PHYSIOL, V108, P845, DOI 10.1152/japplphysiol.00560.2009; Martin G, 2003, INFLAMMATION, V27, P233, DOI 10.1023/A:1025040631514; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Mittal N, 2011, J IMMUNOTOXICOL, V8, P274, DOI 10.3109/1547691X.2011.591294; Muroya M, 2012, BIOSCI TRENDS, V6, P70, DOI 10.5582/bst.2012.v6.2.70; Nan YH, 2009, PEPTIDES, V30, P832, DOI 10.1016/j.peptides.2009.01.015; Park GY, 2006, CURR DRUG TARGETS, V7, P661, DOI 10.2174/138945006777435317; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Shoemaker Robert H., 2002, Current Topics in Medicinal Chemistry, V2, P229, DOI 10.2174/1568026023394317; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Tazi EM, 2011, N AM J MED SCI, V3, P167, DOI 10.4297/najms.2011.3167; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Villar J, 2010, INTENS CARE MED, V36, P1049, DOI 10.1007/s00134-010-1799-3; Villar J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-27; Vincent JL, 2002, CLIN INFECT DIS, V34, P1084, DOI 10.1086/339549; Wang YL, 2011, J IMMUNOL, V186, P3180, DOI 10.4049/jimmunol.1001252; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; Yeh CH, 2011, BRIT J ANAESTH, V106, P590, DOI 10.1093/bja/aer005; Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85; Zheng XC, 2010, INT IMMUNOPHARMACOL, V10, P1209, DOI 10.1016/j.intimp.2010.07.001	55	22	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48468	10.1371/journal.pone.0048468	http://dx.doi.org/10.1371/journal.pone.0048468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144889	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500023
J	Corniola, R; Zou, YN; Leu, D; Fike, JR; Huang, TT				Corniola, Rikki; Zou, Yani; Leu, David; Fike, John R.; Huang, Ting-Ting			Paradoxical Relationship between Mn Superoxide Dismutase Deficiency and Radiation-Induced Cognitive Defects	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; LONG-TERM POTENTIATION; PRECURSOR CELL-FUNCTION; TOTAL-BODY IRRADIATION; NITRIC-OXIDE; PLASMID/LIPOSOMES PROTECTS; DILATED CARDIOMYOPATHY; ALZHEIMERS-DISEASE; DENDRITIC SPINES; OXIDATIVE STRESS	Radiation therapy of the CNS, even at low doses, can lead to deficits in neurocognitive functions. Reduction in hippocampal neurogenesis is usually, but not always, associated with cognitive deficits resulting from radiation therapy. Generation of reactive oxygen species is considered the main cause of radiation-induced tissue injuries, and elevated levels of oxidative stress persist long after the initial cranial irradiation. Consequently, mutant mice with reduced levels of the mitochondrial antioxidant enzyme, Mn superoxide dismutase (MnSOD or Sod2), are expected to be more sensitive to radiation-induced changes in hippocampal neurogenesis and the related functions. In this study, we showed that MnSOD deficiency led to reduced generation of immature neurons in Sod2-/+ mice even though progenitor cell proliferation was not affected. Compared to irradiated Sod2+/+ mice, which showed cognitive defects and reduced differentiation of newborn cells towards the neuronal lineage, irradiated Sod2-/+ mice showed normal hippocampal-dependent cognitive functions and normal differentiation pattern for newborn neurons and astroglia. However, we also observed a disproportional decrease in newborn neurons in irradiated Sod2-/+ following behavioral studies, suggesting that MnSOD deficiency may render newborn neurons more sensitive to stress from behavioral trainings following cranial irradiation. A positive correlation between normal cognitive functions and normal dendritic spine densities in dentate granule cells was observed. The data suggest that maintenance of synaptic connections, via maintenance of dendritic spines, may be important for normal cognitive functions following cranial irradiation. Citation: Corniola R, Zou Y, Leu D, Fike JR, Huang T-T (2012) Paradoxical Relationship between Mn Superoxide Dismutase Deficiency and Radiation-Induced Cognitive Defects. PLoS ONE 7(11): e49367. doi:10.1371/journal.pone.0049367	[Corniola, Rikki; Zou, Yani; Huang, Ting-Ting] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Leu, David] Palo Alto Inst Res & Educ, Palo Alto, CA USA; [Fike, John R.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Leu, David; Huang, Ting-Ting] VA Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Huang, TT (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	tthuang@stanford.edu			National Institutes of Health [NS046051, AG24400]; VA Merit review; Department of Neurology and Neurological Sciences; Palo Alto Institute for Research and Education; resources and facilities at the VA Palo Alto Health Care System; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit review(US Department of Veterans Affairs); Department of Neurology and Neurological Sciences; Palo Alto Institute for Research and Education; resources and facilities at the VA Palo Alto Health Care System; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the National Institutes of Health (NS046051 and AG24400) (JRF and TTH), VA Merit review (TTH), Department of Neurology and Neurological Sciences start-up fund (TTH), Palo Alto Institute for Research and Education residual fund (TTH), and by the resources and facilities at the VA Palo Alto Health Care System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; BALOYANNIS SJ, 1979, NEUROSCI LETT, V12, P283, DOI 10.1016/0304-3940(79)96076-2; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Caito SW, 2011, BRAIN RES, V1398, P1, DOI 10.1016/j.brainres.2011.04.046; Carpenter M, 2005, GENE THER, V12, P685, DOI 10.1038/sj.gt.3302468; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Epperly M, 1998, GENE THER, V5, P196, DOI 10.1038/sj.gt.3300580; Epperly MW, 2011, GENE THER, V18, P579, DOI 10.1038/gt.2010.178; Epperly MW, 2011, RADIAT RES, V175, P759, DOI 10.1667/RR2398.1; Epperly MW, 2000, GENE THER, V7, P1011, DOI 10.1038/sj.gt.3301207; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; Fishman K, 2009, FREE RADICAL BIO MED, V47, P1459, DOI 10.1016/j.freeradbiomed.2009.08.016; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gauter-Fleckenstein B, 2008, FREE RADICAL BIO MED, V44, P982, DOI 10.1016/j.freeradbiomed.2007.10.058; Gauter-Fleckenstein B, 2010, FREE RADICAL BIO MED, V48, P1034, DOI 10.1016/j.freeradbiomed.2010.01.020; Gondi V, 2010, RADIOTHER ONCOL, V97, P370, DOI 10.1016/j.radonc.2010.09.013; Greenberger J S, 2000, Clin Lung Cancer, V1, P302, DOI 10.3816/CLC.2000.n.013; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; Guo HL, 2003, J GASTROINTEST SURG, V7, P229, DOI 10.1016/S1091-255X(02)00186-5; Guo HL, 2003, RADIAT RES, V159, P361, DOI 10.1667/0033-7587(2003)159[0361:PORIOC]2.0.CO;2; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hood JE, 2010, NEUROTOXICOLOGY, V31, P518, DOI 10.1016/j.neuro.2010.05.005; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Kalen AL, 2006, ANTIOXID REDOX SIGN, V8, P1273, DOI 10.1089/ars.2006.8.1273; Kamsler A, 2003, J NEUROSCI, V23, P269; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kim A, 2004, ANTIOXID REDOX SIGN, V6, P489, DOI 10.1089/152308604773934251; Kim A, 2010, FREE RADICAL BIO MED, V48, P1501, DOI 10.1016/j.freeradbiomed.2010.02.028; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Laack NN, 2004, SEMIN ONCOL, V31, P702, DOI 10.1053/j.seminoncol.2004.07.013; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Limoli CL, 1998, CANCER RES, V58, P3712; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Maalouf M, 2008, J NEUROSCI RES, V86, P3322, DOI 10.1002/jnr.21782; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Middei S, 2010, LEARN MEMORY, V17, P236, DOI 10.1101/lm.1748310; Mizumatsu S, 2003, CANCER RES, V63, P4021; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Noble M, 2005, ANTIOXID REDOX SIGN, V7, P1456, DOI 10.1089/ars.2005.7.1456; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Paul V, 2011, INDIAN J MED RES, V133, P471; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; Quiros-Gonzalez I, 2011, FREE RADICAL BIO MED, V50, P525, DOI 10.1016/j.freeradbiomed.2010.10.715; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rosi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031094; Sarkissian V, 2005, NEUROSCI LETT, V382, P118, DOI 10.1016/j.neulet.2005.02.068; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Suzuki S, 2007, J COMP NEUROL, V503, P605, DOI 10.1002/cne.21424; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zaja-Milatovic S, 2008, NEUROTOXICOLOGY, V29, P621, DOI 10.1016/j.neuro.2008.04.009	80	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49367	10.1371/journal.pone.0049367	http://dx.doi.org/10.1371/journal.pone.0049367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145165	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500104
J	Bastard, M; Pinoges, L; Balkan, S; Szumilin, E; Ferreyra, C; Pujades-Rodriguez, M				Bastard, Mathieu; Pinoges, Loretxu; Balkan, Suna; Szumilin, Elisabeth; Ferreyra, Cecilia; Pujades-Rodriguez, Mar			Timeliness of Clinic Attendance Is a Good Predictor of Virological Response and Resistance to Antiretroviral Drugs in HIV-Infected Patients	PLOS ONE			English	Article							RESOURCE-POOR SETTINGS; SUB-SAHARAN AFRICA; PUBLISHED LITERATURE; THERAPY; ADHERENCE; MORTALITY; FAILURE; UGANDA; HAART; METAANALYSIS	Background: Ensuring long-term adherence to therapy is essential for the success of HIV treatment. As access to viral load monitoring and genotyping is poor in resource-limited settings, a simple tool to monitor adherence is needed. We assessed the relationship between an indicator based on timeliness of clinic attendance and virological response and HIV drug resistance. Methods: Data from 7 virological cross-sectional studies were pooled. An adherence indicator was calculated as the number of appointments attended with delay divided by the number of months between antiretroviral treatment (ART) initiation and date of virological testing and multiplying this by 100. Delays of 1 or more to 5 or more days were considered in turn. Multivariate random-intercept logistic regression was fitted to examine the effect on outcomes, separately for adults and children. Results: A total of 3580 adults and 253 children were included. Adults were followed for a median of 26.0 months (IQR 12.8-45.0) and attended a median of 24 visits (IQR 13-34). The 1-day delay adherence indicator was strongly associated with viral load suppression (OR 0.96, 95% CI 0.95-0.97 per unit increase), virological failure (OR 1.05, 95% CI 1.03-1.06) and HIV drug resistance (OR 1.03, 95% CI 1.01-1.05) after adjusting for initial age and CD4 count, previous ART experience, type of regimen and Tuberculosis diagnosis at start of therapy. Similar results were observed in children. Conclusion: An adherence indicator based on timeliness of clinic attendance predicts strongly both virological response and drug resistance, and could help to timely identify non-adherent patients in settings where viral load monitoring is not available.	[Bastard, Mathieu; Pinoges, Loretxu; Pujades-Rodriguez, Mar] Epictr, Paris, France; [Balkan, Suna; Szumilin, Elisabeth] Med Sans Frontieres, Paris, France; [Ferreyra, Cecilia] Med Sans Frontieres, Barcelona, Spain	Doctors Without Borders; Doctors Without Borders	Bastard, M (corresponding author), Epictr, Paris, France.	mathieu.bastard@geneva.msf.org; mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/T-1129-2018; Pujades-Rodriguez, Mar/G-4388-2014	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Pujades-Rodriguez, Mar/0000-0002-7778-3520; FERREYRA, CECILIA/0000-0001-5480-7940	Medecins Sans Frontieres, a medical humanitarian organization	Medecins Sans Frontieres, a medical humanitarian organization	This study was funded by Medecins Sans Frontieres, a medical humanitarian organization. Authors affiliated to MSF and Epicentre, a non-profit organisation linked to MSF-F, participated in the study design, data collection, analysis, decision to publish and the preparation of the manuscript.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Ahoua L, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-67; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bastard M, 2011, JAIDS-J ACQ IMM DEF, V57, P55, DOI 10.1097/QAI.0b013e318211b43b; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Costagliola D., 2001, OBSERVANCE TRAITEMEN, P33; El-Khatib Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017518; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Maman D, 2011, REACHING 500 CD4 CEL; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Pujades-Rodriguez M, 2011, FAILURE 1 LINE THERA; Pujades-Rodriguez M, 2011, TROP MED INT HEALTH, V16, P205, DOI 10.1111/j.1365-3156.2010.02689.x; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Ross-Degnan D, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-42; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2003, ADHERENCE LONG TERM; World Health Organization, 2010, HIV DRUG RES EARL WA	32	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49091	10.1371/journal.pone.0049091	http://dx.doi.org/10.1371/journal.pone.0049091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145079	Green Published, gold			2022-12-25	WOS:000311935800200
J	Fellous, S; Duncan, A; Coulon, A; Kaltz, O				Fellous, Simon; Duncan, Alison; Coulon, Aurelie; Kaltz, Oliver			Quorum Sensing and Density-Dependent Dispersal in an Aquatic Model System	PLOS ONE			English	Article							SOCIAL INFORMATION; EVOLUTION; EMIGRATION; STRATEGIES; DYNAMICS; LIZARD; RATES	Many organisms use cues to decide whether to disperse or not, especially those related to the composition of their environment. Dispersal hence sometimes depends on population density, which can be important for the dynamics and evolution of sub-divided populations. But very little is known about the factors that organisms use to inform their dispersal decision. We investigated the cues underlying density-dependent dispersal in inter-connected microcosms of the freshwater protozoan Paramecium caudatum. In two experiments, we manipulated (i) the number of cells per microcosm and (ii) the origin of their culture medium (supernatant from high- or low-density populations). We found a negative relationship between population density and rates of dispersal, suggesting the use of physical cues. There was no significant effect of culture medium origin on dispersal and thus no support for chemical cues usage. These results suggest that the perception of density - and as a result, the decision to disperse - in this organism can be based on physical factors. This type of quorum sensing may be an adaptation optimizing small scale monitoring of the environment and swarm formation in open water.	[Fellous, Simon; Duncan, Alison; Kaltz, Oliver] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Fellous, Simon] INRA, Ctr Biol Gest Populat, Montferrier Sur Lez, France; [Coulon, Aurelie] Museum Natl Hist Nat, Conservat Especes Restaurat & Suivi Populat UMR 7, Brunoy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Fellous, S (corresponding author), Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France.	simonfellous@free.fr			French Agence Nationale de la Recherche [ANR-09-BLAN-0099, ANR-09-PEXT-011, ANR-10-BLAN-1715-02]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was financed by the French Agence Nationale de la Recherche (ANR-09-BLAN-0099, S. F and A. B. D.; ANR-09-PEXT-011, S. F; ANR-10-BLAN-1715-02, S. F.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2012, ECOLOGY IN PRESS; Barth D, 2006, J EUKARYOT MICROBIOL, V53, P20, DOI 10.1111/j.1550-7408.2005.00068.x; Bocedi G, 2012, AM NAT, V179, P606, DOI 10.1086/665004; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cote J, 2007, ECOL LETT, V10, P411, DOI 10.1111/j.1461-0248.2007.01032.x; Cote J, 2008, BEHAV ECOL, V19, P163, DOI 10.1093/beheco/arm119; Fellous S, 2011, BIOL LETTERS, V7, P327, DOI 10.1098/rsbl.2010.0862; Fels D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005086; Fjerdingstad EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-133; Gortz H -D, 1988, PARAMECIUM; Hauzy C, 2007, J ANIM ECOL, V76, P552, DOI 10.1111/j.1365-2656.2007.01227.x; Ishikawa T, 2006, J EXP BIOL, V209, P4452, DOI 10.1242/jeb.02537; Kim SY, 2009, ECOLOGY, V90, P230, DOI 10.1890/08-0133.1; KUHLMANN HW, 1994, ARCH PROTISTENKD, V144, P163, DOI 10.1016/S0003-9365(11)80121-1; KUSCH J, 1993, OECOLOGIA, V96, P354, DOI 10.1007/BF00317505; Le Galliard JF, 2003, P ROY SOC B-BIOL SCI, V270, P1163, DOI 10.1098/rspb.2003.2360; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Ogata M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011917; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173; Wichterman R., 1986, BIOL PARAMECIUM; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020	26	23	23	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48436	10.1371/journal.pone.0048436	http://dx.doi.org/10.1371/journal.pone.0048436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144882	Green Published, gold			2022-12-25	WOS:000311935800062
J	Ganzinger, M; He, S; Breuhahn, K; Knaup, P				Ganzinger, Matthias; He, Shan; Breuhahn, Kai; Knaup, Petra			On the Ontology Based Representation of Cell Lines	PLOS ONE			English	Article							SERVICE	Cell lines are frequently used as highly standardized and reproducible in vitro models for biomedical analyses and assays. Cell lines are distributed by cell banks that operate databases describing their products. However, the description of the cell lines' properties are not standardized across different cell banks. Existing cell line-related ontologies mostly focus on the description of the cell lines' names, but do not cover aspects like the origin or optimal growth conditions. The objective of this work is to develop an ontology that allows for a more comprehensive description of cell lines and their metadata, which should cover the data elements provided by cell banks. This will provide the basis for the standardized annotation of cell lines and corresponding assays in biomedical research. In addition, the ontology will be the foundation for automated evaluation of such assays and their respective protocols in the future. To accomplish this, a broad range of cell bank databases as well as existing ontologies were analyzed in a comprehensive manner. We identified existing ontologies capable of covering different aspects of the cell line domain. However, not all data fields derived from the cell banks' databases could be mapped to existing ontologies. As a result, we created a new ontology called cell culture ontology (CCONT) integrating existing ontologies where possible. CCONT provides classes from the areas of cell line identification, origin, cell line properties, propagation and tests performed.	[Ganzinger, Matthias; He, Shan; Knaup, Petra] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [He, Shan] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Breuhahn, Kai] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Utah System of Higher Education; University of Utah; Ruprecht Karls University Heidelberg	Ganzinger, M (corresponding author), Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany.	matthias.ganzinger@med.uni-heidelberg.de		Ganzinger, Matthias/0000-0002-2716-5425; Knaup, Petra/0000-0002-1104-0628; Breuhahn, Kai/0000-0002-2462-1229	Deutsche Forschungsgemeinschaft (DFG) [SFB/TRR 77]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the SFB/TRR 77 "Liver Cancer. From Molecular Pathogenesis to Targeted Therapies'' of the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, OWL 2 WEB ONT LANG D; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Budowle B, 1998, CODIS PCR BASED SHOR; Cimino JJ, 1998, METHOD INFORM MED, V37, P394; Cote RG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-97; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Department of Health and Human Services, 2011, NIH GUID RES INV REC; Ganzinger M, 2011, STUD HEALTH TECHNOL, V169, P867, DOI 10.3233/978-1-60750-806-9-867; Gomez-Perez A, 2001, INT J INTELL SYST, V16, P391, DOI 10.1002/1098-111X(200103)16:3<391::AID-INT1014>3.0.CO;2-2; Grenon P, 2004, STUD HEALTH TECHNOL, V102, P20; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hoffman M, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P139; Kogut P, 2002, KNOWL ENG REV, V17, P61, DOI 10.1017/S0269888902000358; Kunz I, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S4; Kushida Tatsuya, 2006, Pac Symp Biocomput, P152; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Malone J, 2010, BIOINFORMATICS, V26, P1112, DOI 10.1093/bioinformatics/btq099; Maojo V, 2011, METHOD INFORM MED, V50, P203, DOI 10.3414/ME10-05-0004; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Molecular Connections, ONT MOL CONN; Motik B, 2009, J ARTIF INTELL RES, V36, P165, DOI 10.1613/jair.2811; Nims RW, 2010, IN VITRO CELL DEV-AN, V46, P811, DOI 10.1007/s11626-010-9352-9; Noy N. F., 2001, ONTOLOGY DEV, DOI DOI 10.1016/J.ARTMED.2004.01.014; Noy Natalya F, 2003, AMIA Annu Symp Proc, P953; Noy NF, 2009, NUCLEIC ACIDS RES, V37, pW170, DOI 10.1093/nar/gkp440; Object Management Group, 2009, ONT DEF MET; Obrst L, 2007, SEMANTIC WEB, P139; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; RDF Primer, 2004, RDF PRIM; Rogers JE, 2006, METHOD INFORM MED, V45, P267; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Sarntivijai S, 2008, BIOINFORMATICS, V24, P2760, DOI 10.1093/bioinformatics/btn502; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Soldatova LN, 2008, BIOINFORMATICS, V24, pI295, DOI 10.1093/bioinformatics/btn156; Soldatova LN, 2005, NAT BIOTECHNOL, V23, P1095, DOI 10.1038/nbt0905-1095; Tsarkov D, 2006, LECT NOTES ARTIF INT, V4130, P292; Visser U, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-257; Vrandeci D., 2009, HDB ONTOLOGIES, P293, DOI [10.1007/978-3-540-92673-313, DOI 10.1007/978-3-540-92673-313, DOI 10.1007/978-3-540-92673-3_13]	41	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48584	10.1371/journal.pone.0048584	http://dx.doi.org/10.1371/journal.pone.0048584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144907	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800080
J	Hajnal, A; Zharikov, A; Polston, JE; Fields, MR; Tomasko, J; Rogers, AM; Volkow, ND; Thanos, PK				Hajnal, Andras; Zharikov, Alevtina; Polston, James E.; Fields, Maxine R.; Tomasko, Jonathan; Rogers, Ann M.; Volkow, Nora D.; Thanos, Panayotis K.			Alcohol Reward Is Increased after Roux-en-Y Gastric Bypass in Dietary Obese Rats with Differential Effects following Ghrelin Antagonism	PLOS ONE			English	Article							STIMULATES LOCOMOTOR-ACTIVITY; BARIATRIC SURGERY; NUCLEUS-ACCUMBENS; GUT HORMONE; GASTROINTESTINAL HORMONES; INSULIN SENSITIVITY; RECEPTOR ANTAGONISM; DEFICIENT MICE; FOOD REWARD; SWEET TASTE	Roux-en-Y gastric bypass (RYGB) is one of the most successful treatments for severe obesity and associated comorbidities. One potential adverse outcome, however, is increased risk for alcohol use. As such, we tested whether RYGB alters motivation to self-administer alcohol in outbred dietary obese rats, and investigated the involvement of the ghrelin system as a potential underlying mechanism. High fat (60% kcal from fat) diet-induced obese, non-diabetic male Sprague Dawley rats underwent RYGB (n = 9) or sham operation (Sham, n = 9) and were tested 4 months after surgery on a progressive ratio-10 (PR10) schedule of reinforcement operant task for 2, 4, and 8% ethanol. In addition, the effects of the ghrelin-1a-receptor antagonist D-[Lys3]-GHRP-6 (50, 100 nmol/kg, IP) were tested on PR10 responding for 4% ethanol. Compared to Sham, RYGB rats made significantly more active spout responses to earn reward, more consummatory licks on the ethanol spout, and achieved higher breakpoints. Pretreatment with a single peripheral injection of D-[Lys3]-GHRP-6 at either dose was ineffective in altering appetitive or consummatory responses to 4% ethanol in the Sham group. In contrast, RYGB rats demonstrated reduced operant performance to earn alcohol reward on the test day and reduced consummatory responses for two subsequent days following the drug. Sensitivity to threshold doses of D-[LYS3]-GHRP-6 suggests that an augmented ghrelin system may contribute to increased alcohol reward in RYGB. Further research is warranted to confirm applicability of these findings to humans and to explore ghrelin-receptor targets for treatment of alcohol-related disorders in RYGB patients.	[Hajnal, Andras; Zharikov, Alevtina; Polston, James E.; Fields, Maxine R.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; [Hajnal, Andras; Tomasko, Jonathan; Rogers, Ann M.] Penn State Univ, Coll Med, Dept Surg, Hershey, PA USA; [Volkow, Nora D.; Thanos, Panayotis K.] NIAAA, Lab Neuroimaging, Intramural Program, NIH, Bethesda, MD 90034 USA; [Thanos, Panayotis K.] Brookhaven Natl Lab, Behav Neuropharmacol & Neuroimaging Lab, Upton, NY 11973 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory	Hajnal, A (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA.	ahajnal@psu.edu		Hajnal, Andras/0000-0001-7297-7134	National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK080899]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000551] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK080899 (to AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2011, NEUROSCIENCE, V192, P500, DOI 10.1016/j.neuroscience.2011.06.001; Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Abizaid A, 2009, J NEUROENDOCRINOL, V21, P787, DOI 10.1111/j.1365-2826.2009.01896.x; Beckman LM, 2011, JPEN-PARENTER ENTER, V35, P169, DOI 10.1177/0148607110381403; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; BROWN EK, 1982, J AM DIET ASSOC, V80, P437; Bueter M, 2011, PHYSIOL BEHAV, V104, P709, DOI 10.1016/j.physbeh.2011.07.025; Bueter M, 2011, INT J OBESITY, V35, pS35, DOI 10.1038/ijo.2011.146; Carrillo J, 2008, ALCOHOL, V42, P171, DOI 10.1016/j.alcohol.2008.01.005; Davis J. F., 2012, BIOL PSYCHIAT; DeMaria J, 2002, ANN SURG, V235, P640, DOI 10.1097/00000658-200205000-00005; Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017; Dunn JP, 2012, DIABETES CARE, V35, P1105, DOI 10.2337/dc11-2250; Dunn JP, 2010, BRAIN RES, V1350, P123, DOI 10.1016/j.brainres.2010.03.064; Edholm D, 2012, SURG OBES RELAT DIS; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ertelt TW, 2008, SURG OBES RELAT DIS, V4, P647, DOI 10.1016/j.soard.2008.01.004; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Hagedorn JC, 2007, SURG OBES RELAT DIS, V3, P543, DOI 10.1016/j.soard.2007.07.003; Hajnal A, 2007, AM J PHYSIOL-REG I, V293, pR1846, DOI 10.1152/ajpregu.00461.2007; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; HALMI KA, 1981, INT J OBESITY, V5, P457; Holt PR, 2011, LANCET, V378, P767, DOI 10.1016/S0140-6736(11)61372-X; Hsu LKG, 1998, PSYCHOSOM MED, V60, P338, DOI 10.1097/00006842-199805000-00021; Jacobsen SH, 2012, OBES SURG, V22, P1084, DOI 10.1007/s11695-012-0621-4; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, ALCOHOL, V45, P341, DOI 10.1016/j.alcohol.2010.10.002; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; King WC, 2012, JAMA-J AM MED ASSOC, V307, P2516, DOI 10.1001/jama.2012.6147; Klockhoff H, 2002, BRIT J CLIN PHARMACO, V54, P587, DOI 10.1046/j.1365-2125.2002.01698.x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Korner J, 2009, INT J OBESITY, V33, P786, DOI 10.1038/ijo.2009.79; Korner J, 2006, OBESITY, V14, P1553, DOI 10.1038/oby.2006.179; Landgren S., 2011, ADDICT BIOL; Le Roux CW, 2011, AM J PHYSL IN PRESS; LOCKE W, 1995, LIFE SCI, V56, P1347, DOI 10.1016/0024-3205(95)00087-9; Marcus MD, 2009, AM J PSYCHIAT, V166, P285, DOI 10.1176/appi.ajp.2008.08091327; Matzko ME, 2012, OBES SURG, V22, P783, DOI 10.1007/s11695-012-0631-2; Morinigo R, 2006, J CLIN ENDOCR METAB, V91, P1735, DOI 10.1210/jc.2005-0904; Mottin CC, 2005, OBES SURG, V15, P788, DOI 10.1381/0960892054222830; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Padwal R, 2011, J GEN INTERN MED, V26, P1183, DOI 10.1007/s11606-011-1721-x; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Prachand VN, 2011, WORLD J SURG, V35, P1464, DOI 10.1007/s00268-011-1033-7; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; Saules KK, 2010, SURG OBES RELAT DIS, V6, P615, DOI 10.1016/j.soard.2009.12.008; Sclafani A, 2003, PHYSIOL BEHAV, V79, P663, DOI 10.1016/S0031-9384(03)00143-4; Sears D, 2008, OBES SURG, V18, P1522, DOI 10.1007/s11695-008-9604-x; Shin AC, 2010, INT J OBES; Shin AC, 2010, ENDOCRINOLOGY, V151, P1588, DOI 10.1210/en.2009-1332; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2012, ENDOCRINOLOGY, V153, P1194, DOI 10.1210/en.2011-1606; Steele KE, 2010, OBES SURG, V20, P369, DOI 10.1007/s11695-009-0015-4; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2011, CURR TOP BEHAV NEURO, V6, P81, DOI 10.1007/7854_2010_89; Suzuki J, 2010, OBES SURG; Suzuki J, 2012, OBES SURG, V22, P201, DOI 10.1007/s11695-010-0346-1; Tam CS, 2011, OBESITY REV IN PRESS; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Thanos PK, 2005, LIFE SCI, V77, P130, DOI 10.1016/j.lfs.2004.10.061; Thanos PK, 2004, ALCOHOL CLIN EXP RES, V28, P720, DOI 10.1097/01.ALC.0000125270.30501.08; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Thanos PK, 2012, OBES SURG IN PRESS; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Woodard GA, 2011, J AM COLL SURGEONS, V212, P209, DOI 10.1016/j.jamcollsurg.2010.09.020; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wurst FM, 2007, ALCOHOL CLIN EXP RES, V31, P1963, DOI 10.1111/j.1530-0277.2007.00531.x	72	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49121	10.1371/journal.pone.0049121	http://dx.doi.org/10.1371/journal.pone.0049121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145091	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800211
J	Majumder, S; Bhattacharjee, S; Chowdhury, BP; Majumdar, S				Majumder, Saikat; Bhattacharjee, Surajit; Chowdhury, Bidisha Paul; Majumdar, Subrata			CXCL10 Is Critical for the Generation of Protective CD8 T Cell Response Induced by Antigen Pulsed CpG-ODN Activated Dendritic Cells	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; LEISHMANIA-AMAZONENSIS INFECTION; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; CROSS-PRESENTATION; MOUSE MODEL; IMMUNITY; MICE; INTERFERON; RECEPTOR	The visceral form of leishmaniasis is the most severe form of the disease and of particular concern due to the emerging problem of HIV/visceral leishmaniasis (VL) co-infection in the tropics. Till date miltefosine, amphotericin B and pentavalent antimony compounds remain the main treatment regimens for leishmaniasis. However, because of severe side effects, there is an urgent need for alternative improved therapies to combat this dreaded disease. In the present study, we have used the murine model of leishmaniasis to evaluate the potential role played by soluble leishmanial antigen (SLA) pulsed-CpG-ODN stimulated dendritic cells (SLA-CpG-DCs) in restricting the intracellular leishmanial growth. We found that mice vaccinated with a single dose of SLA-pulsed DC stimulated by CpG-ODN were protected against a subsequent leishmanial challenge and had a dramatic reduction in parasite burden along with the generation of parasite specific cytotoxic T lymphocytes. Moreover, we demonstrate that the induction of protective immunity conferred by SLA-CpG-DCs depends entirely on the CXC chemokine IFN-gamma-inducible protein 10 (CXCL10; IP-10). CXCL10 is directly involved in the generation of a parasite specific CD8(+) T cell-mediated immune response. We observed significant reduction of CD8(+) T cells in mice depleted of CXCL10 suggesting a direct role of CXCL10 in the generation of CD8(+) T cells in SLA-CpG-DCs vaccinated mice. CXCL10 also contributed towards the generation of perforin and granzyme B, two important cytolytic mediators of CD8(+) T cells, following SLA-CpG-DCs vaccination. Together, these findings strongly demonstrate that CXCL10 is critical for rendering a protective cellular immunity during SLA-CpG-DC vaccination that confers protection against Leishmania donovani infection.	[Majumder, Saikat; Bhattacharjee, Surajit; Chowdhury, Bidisha Paul; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, P1-12,CIT Scheme 7-M, Kolkata, India.	subrata@bic.boseinst.ernet	Bhattacharjee, Surajit/B-5979-2012; Majumder, Saikat/ABC-2194-2020	Bhattacharjee, Surajit/0000-0001-9233-4777; Majumder, Saikat/0000-0002-6591-9515	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi, provided fellowship to Saikat Majumder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SS, 1999, J IMMUNOL, V163, P3890; Amati L, 2006, CURR PHARM DESIGN, V12, P4247, DOI 10.2174/138161206778743583; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Colmenares M, 2003, INFECT IMMUN, V71, P3172, DOI 10.1128/IAI.71.6.3172-3182.2003; Dar WA, 2007, IMMUNOLOGY, V120, P467, DOI 10.1111/j.1365-2567.2006.02534.x; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Enderlin M, 2009, CANCER GENE THER, V16, P149, DOI 10.1038/cgt.2008.62; Flohe SB, 1998, EUR J IMMUNOL, V28, P3800, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3800::AID-IMMU3800&gt;3.0.CO;2-0; GRIFFITHS GM, 1992, P NATL ACAD SCI USA, V89, P549, DOI 10.1073/pnas.89.2.549; Gupta G, 2011, MED MICROBIOL IMMUN, V200, P241, DOI 10.1007/s00430-011-0197-y; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Hernandez-Ruiz J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000871; Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jakob T, 1998, J IMMUNOL, V161, P3042; Kim TG, 2004, IMMUNOLOGY, V112, P117, DOI 10.1111/j.1365-2567.2004.01851.x; Martin S, 2010, J IMMUNOL, V184, P5510, DOI 10.4049/jimmunol.0902762; Moll H, 2001, IMMUNOBIOLOGY, V204, P659, DOI 10.1078/0171-2985-00105; MORRIS L, 1993, INFECT IMMUN, V61, P3459, DOI 10.1128/IAI.61.8.3459-3465.1993; Muller K, 2001, MED MICROBIOL IMMUN, V190, P73; MURRAY HW, 1993, J IMMUNOL, V151, P929; Palucka K, 1999, J CLIN IMMUNOL, V19, P12, DOI 10.1023/A:1020558317162; Pertl U, 2001, J IMMUNOL, V166, P6944, DOI 10.4049/jimmunol.166.11.6944; Rostami MN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000845; Russo DM, 1999, EXP PARASITOL, V93, P161, DOI 10.1006/expr.1999.4452; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taub DD, 1996, BLOOD, V87, P1423, DOI 10.1182/blood.V87.4.1423.bloodjournal8741423; Thapa M, 2009, J VIROL, V83, P9486, DOI 10.1128/JVI.00854-09; Uicker WC, 2005, MED MYCOL, V43, P27, DOI 10.1080/13693780410001731510; Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172; Vasquez RE, 2006, INFECT IMMUN, V74, P6769, DOI 10.1128/IAI.01073-06; Vollmer J, 2004, J ENDOTOXIN RES, V10, P431, DOI 10.1179/096805104225006534; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339; Warren TL, 2000, J IMMUNOL, V165, P6244, DOI 10.4049/jimmunol.165.11.6244; Weinzierl AO, 2008, J VIROL, V82, P8149, DOI 10.1128/JVI.00047-08	43	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48727	10.1371/journal.pone.0048727	http://dx.doi.org/10.1371/journal.pone.0048727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144947	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800113
J	Nesterenko, I; Wanningen, S; Bagci-Onder, T; Anderegg, M; Shah, K				Nesterenko, Irina; Wanningen, Simone; Bagci-Onder, Tugba; Anderegg, Maarten; Shah, Khalid			Evaluating the Effect of Therapeutic Stem Cells on TRAIL Resistant and Sensitive Medulloblastomas	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; HISTONE DEACETYLASE INHIBITORS; GLIOBLASTOMA-MULTIFORME CELLS; HUMAN GLIOMA-CELLS; CANCER-THERAPY; ANTITUMOR-ACTIVITY; TUMOR-THERAPY; BRAIN-TUMORS; GENE-THERAPY; IN-VIVO	Mesenchymal stem cells (MSC) are emerging as novel cell-based delivery agents; however, a thorough investigation addressing their therapeutic potential in medulloblastomas (MB) has not been explored to date. In this study, we engineered human MSC to express a potent and secretable variant of a tumor specific agent, tumor necrosis factor-apoptosis-inducing ligand (S-TRAIL) and assessed the ability of MSC-S-TRAIL mediated MB killing alone or in combination with a small molecule inhibitor of histone-deacetylase, MS-275, in TRAIL-sensitive and -resistant MB in vitro and in vivo. We show that TRAIL sensitivity/resistance correlates with the expression of its cognate death receptor (DR) 5 and MSC-S-TRAIL induces caspase-3 mediated apoptosis in TRAIL-sensitive MB lines. In TRAIL-resistant MB, we show upregulation of DR4/5 levels when pre-treated with MS-275 and a subsequent sensitization to MSC-S-TRAIL mediated apoptosis. Using intracranially implanted MB and MSC lines engineered with different combinations of fluorescent and bioluminescent proteins, we show that MSC-S-TRAIL has significant anti-tumor effects in mice bearing TRAIL-sensitive and MS-275 pretreated TRAIL-resistant MBs. To our knowledge, this is the first study that explores the use of human MSC as MB-targeting therapeutic-vehicles in vivo in TRAIL-sensitive and resistant tumors, and has implications for developing effective therapies for patients with medulloblastomas.	[Nesterenko, Irina; Wanningen, Simone; Bagci-Onder, Tugba; Anderegg, Maarten; Shah, Khalid] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA; [Nesterenko, Irina; Wanningen, Simone; Bagci-Onder, Tugba; Anderegg, Maarten; Shah, Khalid] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Shah, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA.	kshah@mgh.harvard.edu	Onder, Tugba Bagci/AAN-1392-2021	Bagci Onder, Tugba/0000-0003-3646-2613	American Cancer Society [NIH-CA138922, NIH-NS071197]; James McDonnell Foundation; NATIONAL CANCER INSTITUTE [R01CA138922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071197] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); James McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Cancer Society (K.S.), NIH-CA138922, NIH-NS071197 (K.S.) and the James McDonnell Foundation (K.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aguilera DG, 2009, J NEURO-ONCOL, V93, P303, DOI 10.1007/s11060-008-9788-x; Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Bagci-Onder T, 2012, ONCOGENE; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chen PL, 2010, BIOCHEM BIOPH RES CO, V391, P936, DOI 10.1016/j.bbrc.2009.11.168; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Griffith TS, 2000, J IMMUNOL, V165, P2886, DOI 10.4049/jimmunol.165.5.2886; Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816; Gurney JG, 2001, CURR OPIN ONCOL, V13, P160, DOI 10.1097/00001622-200105000-00005; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; Hacker SDA, 2009, ONCOGENE, P1; Hatten ME, 2011, TRENDS NEUROSCI, V34, P134, DOI 10.1016/j.tins.2011.01.002; Heese O, 2005, NEURO-ONCOLOGY, V7, P476, DOI 10.1215/S1152851704000754; Hingtgen SDRX, 2008, MOL CANCER THER, V10, P3573; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kagawa S, 2001, CANCER RES, V61, P3330; Knight MJ, 2001, ONCOGENE, V20, P5789, DOI 10.1038/sj.onc.1204810; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Lee K, 2001, MOL THER, V3, P857, DOI 10.1006/mthe.2001.0327; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Momin EN, 2010, CURR STEM CELL RES T, V5, P326; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Raffel C, 2004, NEOPLASIA, V6, P310, DOI 10.1593/neo.03454; Rieger J, 2007, CELL PHYSIOL BIOCHEM, V20, P23, DOI 10.1159/000104150; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Saito R, 2004, CANCER RES, V64, P6858, DOI 10.1158/0008-5472.CAN-04-1683; Saito R, 2004, J NEURO-ONCOL, V67, P273, DOI 10.1023/B:NEON.0000024217.68738.11; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Sekulic A, 2008, MAYO CLIN PROC, V83, P825, DOI 10.4065/83.7.825; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shah K, 2004, CANCER RES, V64, P3236, DOI 10.1158/0008-5472.CAN-03-3516; Shah K., 2011, ADV DRUG DELIV REV; Siegelin MD, 2009, NEUROBIOL DIS, V33, P243, DOI 10.1016/j.nbd.2008.10.005; Simonini MV, 2006, P NATL ACAD SCI USA, V103, P1587, DOI 10.1073/pnas.0510341103; Sonabend AM, 2008, STEM CELLS, V26, P831, DOI 10.1634/stemcells.2007-0758; Sonnemann J, 2006, INT J ONCOL, V28, P755; Stagg J, 2004, HUM GENE THER, V15, P597, DOI 10.1089/104303404323142042; Tamayo P, 2011, J CLIN ONCOL, V29, P1415, DOI 10.1200/JCO.2010.28.1675; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; Tsurushima H, 2007, CANCER GENE THER, V14, P706, DOI 10.1038/sj.cgt.7701065; VM R, 2006, BRIT J CANC, V95, P2; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yock TI, 2004, NAT CLIN PRACT ONCOL, V1, P97, DOI 10.1038/ncponc0090; Zhou LM, 2010, CANCER RES, V70, P8199, DOI 10.1158/0008-5472.CAN-09-4562	58	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49219	10.1371/journal.pone.0049219	http://dx.doi.org/10.1371/journal.pone.0049219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145127	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800233
J	Ramos-Castro, SE; Castaneda-Zarate, M; Solano-Gomez, R; Salazar, GA				Ramos-Castro, Sergio E.; Castaneda-Zarate, Miguel; Solano-Gomez, Rodolfo; Salazar, Gerardo A.			Stelis zootrophionoides (Orchidaceae: Pleurothallidinae), a New Species from Mexico	PLOS ONE			English	Article							FLORAL CONVERGENCE	Background: Stelis (Orchidaceae) encompasses approximately 1100 species of epiphytic orchids distributed throughout the Neotropics, with the highest diversity in Andean South America. Sixty-two species were recorded previously in Mexico. Methods: We formally describe here Stelis zootrophionoides as a new species from Chiapas, Mexico. To determine its systematic position, we conducted a morphological comparison with other members of Pleurothallidinae and a phylogenetic analysis of nucleotide sequences from the plastid matK/trnK and trnL/trnF regions, as well as the nuclear ribosomal ITS region for 52 species of Pleurothallidinae. Sequences of 49 species were downloaded from GenBank and those of three species, including the new taxon, were newly generated for this work. The new species is described and illustrated; notes on its ecological preferences and a comparison with closely related species are presented. Conclusions: The new species, known only from one location and apparently restricted to the cloud forest in the central highlands of Chiapas, Mexico, is considered a rare species. This small epiphyte is unique among the Mexican species of Stelis by the combination of dark purple flowers with the distal third of the dorsal sepal adhered to the apices of the lateral sepals, which are partially united into a bifid synsepal, leaving two lateral window-like openings, and sagittate labellum. Stelis jalapensis, known from southern Mexico and Guatemala, also has the apices of the sepals adhered to each other, but it is distinguished by its larger flowers with lanceolate, acute dorsal sepal, completely fused lateral sepals (i.e. the synsepal is not bifid), and oblong-elliptic labellum. The phylogenetic analysis shows that S. zootrophionoides is closely related to other Mexican Stelis and corroborates previous suggestions that fused sepal apices have arisen independently in different lineages of Pleurothallidinae.	[Ramos-Castro, Sergio E.] Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico; [Castaneda-Zarate, Miguel; Salazar, Gerardo A.] Univ Nacl Autonoma Mexico, Dept Bot, Inst Biol, Mexico City 04510, DF, Mexico; [Solano-Gomez, Rodolfo] Inst Politecn Nacl, Ctt Interdisciplinario Invest Desarrollo Integral, Unidad Oaxaca, Oaxaca, Mexico; [Ramos-Castro, Sergio E.; Castaneda-Zarate, Miguel] Asociaci Conservac Orquideas Silvestres, Fac Biol, Xalapa, Veracruz, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Ramos-Castro, SE (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico.	s.ramos.castro@gmail.com	Solano, Rodolfo/F-1183-2018; Ramos, Sergio/W-5482-2019; Salazar, Gerardo/AAV-2575-2021	Solano, Rodolfo/0000-0002-0355-5496; Ramos, Sergio/0000-0003-4734-839X; Salazar, Gerardo/0000-0002-5203-5374; Castaneda-Zarate, Miguel/0000-0002-3179-358X	Instituto de Biologia, Universidad Nacional Autonoma de Mexico	Instituto de Biologia, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This study received support from Instituto de Biologia, Universidad Nacional Autonoma de Mexico to G. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albores-Ortiz Octavio, 2006, Act. Bot. Mex, P155; Cameron K. M., 2007, ORCHID BIOL REV PERS, V9, P163; Chase MW, 2009, ANN BOT-LONDON, V104, P387, DOI 10.1093/aob/mcp067; Christensen D.E., 1992, Lindleyana, V7, P28; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Enriquez-Rocha P.L., 2009, BIODIVERSISTAS, V85, P6; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Luer C.A., 1986, MONOGRAPHS SYSTEMATI, V20, P1; Luer CA, 2004, MONOGR SYST BOT MO B, V95, P211; Luer CA, 2007, MONOGRAPHS SYSTEMATI, V112, P1; Luer CA, 2009, MONOGR SYST BOT MISS, V115, P31; Pellmyr Olle, 2002, P157; Pridgeon Alec M., 2001, Lindleyana, V16, P235; Pridgeon AM, 2001, AM J BOT, V88, P2286, DOI 10.2307/3558390; Pridgeon AM, 2005, GENERA ORCHIDACEARUM, V4; Salazar GA, 2011, BOT J LINN SOC, V167, P1, DOI 10.1111/j.1095-8339.2011.01161.x; Gomez RS, 2011, BRITTONIA, V63, P325, DOI 10.1007/s12228-010-9171-z; Solano R, 2003, ICONES ORCHIDACEARUM, V2-3, P683; Solano R, 2008, ICONES ORCHIDACEARUM, V4, P1098; Solano-Gomez R., 2010, LANKESTERIANA, V9, P447, DOI DOI 10.15517/LANK.V0I0.12106; Solano-Gomez R, 2007, REV MEX BIODIVERS, V78, P253; Soto Arenas MA, 2007, ORCHIDS MEXICO DIGIT; Swofford DL, 2001, PAUP PHYLOGENETIC AN	25	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48822	10.1371/journal.pone.0048822	http://dx.doi.org/10.1371/journal.pone.0048822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144987	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800146
J	Rhee, JW; Kim, D; Park, BK; Kwon, S; Cho, S; Lee, I; Park, MS; Seo, JN; Kim, YS; Choi, HS; Lee, Y; Kwon, HJ				Rhee, Jae Won; Kim, Dongbum; Park, Byung Kwon; Kwon, Sanghoon; Cho, Sunhee; Lee, Ilseob; Park, Man-Seong; Seo, Jae-Nam; Kim, Yong-Sun; Choi, Hong Seok; Lee, Younghee; Kwon, Hyung-Joo			Immunization with a Hemagglutinin-Derived Synthetic Peptide Formulated with a CpG-DNA-Liposome Complex Induced Protection against Lethal Influenza Virus Infection in Mice	PLOS ONE			English	Article							A VIRUS; MONOCLONAL-ANTIBODIES; GENOME-WIDE; VACCINE; H5N1; EPITOPE; ACTIVATION; FUSION; IMMUNOGENICITY; PREDICTION	Whole-virus vaccines, including inactivated or live-attenuated influenza vaccines, have been conventionally developed and supported as a prophylaxis. These currently available virus-based influenza vaccines are widely used in the clinic, but the vaccine production takes a long time and a huge number of embryonated chicken eggs. To overcome the imperfection of egg-based influenza vaccines, epitope-based peptide vaccines have been studied as an alternative approach. Here, we formulated an efficacious peptide vaccine without carriers using phosphodiester CpG-DNA and a special liposome complex. Potential epitope peptides predicted from the hemagglutinin (HA) protein of the H5N1 A/Viet Nam/1203/2004 strain (NCBI database, AAW80717) were used to immunize mice along with phosphodiester CpG-DNA co-encapsulated in a phosphatidyl-beta-oleoyl-c-palmitoyl ethanolamine (DOPE): cholesterol hemisuccinate (CHEMS) complex (Lipoplex(O)) without carriers. We identified a B cell epitope peptide (hH5N1 HA233 epitope, 14 amino acids) that can potently induce epitope-specific antibodies. Furthermore, immunization with a complex of the B cell epitope and Lipoplex(O) completely protects mice challenged with a lethal dose of recombinant H5N1 virus. These results suggest that our improved peptide vaccine technology can be promptly applied to vaccine development against pandemic influenza. Furthermore our results suggest that potent epitopes, which cannot be easily found using proteins or a virus as an antigen, can be screened when we use a complex of peptide epitopes and Lipoplex(O).	[Rhee, Jae Won; Kwon, Sanghoon; Kwon, Hyung-Joo] Hallym Univ, Coll Med, Ctr Med Sci Res, Gangwon Do, South Korea; [Kim, Dongbum; Park, Byung Kwon; Cho, Sunhee; Lee, Ilseob; Park, Man-Seong; Kim, Yong-Sun; Choi, Hong Seok; Kwon, Hyung-Joo] Hallym Univ, Coll Med, Dept Microbiol, Gangwon Do, South Korea; [Seo, Jae-Nam] Hallym Univ, Coll Med, Dept Pathol, Gangwon Do, South Korea; [Lee, Younghee] Chungbuk Natl Univ, Dept Biochem, Coll Nat Sci, Chungbuk, South Korea	Hallym University; Hallym University; Hallym University; Chungbuk National University	Kwon, HJ (corresponding author), Hallym Univ, Coll Med, Ctr Med Sci Res, Gangwon Do, South Korea.	hjookwon@hallym.ac.kr	Park, Man-Seong/AAF-1207-2020		Korea Healthcare Technology R&D Project of the Korean Ministry for Health, Welfare and Family Affairs [A08-4411-BB2004-08N1-00030B]; National Research Foundation [20090081761, 20090083296]; Korean Ministry of Education, Science and Technology	Korea Healthcare Technology R&D Project of the Korean Ministry for Health, Welfare and Family Affairs; National Research Foundation; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant from the Korea Healthcare Technology R&D Project of the Korean Ministry for Health, Welfare and Family Affairs (A08-4411-BB2004-08N1-00030B) and grants from the National Research Foundation (20090081761, 20090083296), which is funded by the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Ben-Yedidia T, 2007, EXPERT REV VACCINES, V6, P939, DOI 10.1586/14760584.6.6.939; BenYedidia T, 1997, CURR OPIN BIOTECH, V8, P442, DOI 10.1016/S0958-1669(97)80066-3; Bijker MS, 2007, EXPERT REV VACCINES, V6, P591, DOI 10.1586/14760584.6.4.591; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Castilow EM, 2007, IMMUNOL RES, V39, P225, DOI 10.1007/s12026-007-0071-6; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COHEN A, 1963, VIROLOGY, V20, P518, DOI 10.1016/0042-6822(63)90102-8; Deng GM, 1999, NAT MED, V5, P702, DOI 10.1038/9554; Edwards MJ, 2001, J GEN VIROL, V82, P1387, DOI 10.1099/0022-1317-82-6-1387; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghendon YZ, 2005, VACCINE, V23, P4678, DOI 10.1016/j.vaccine.2005.04.039; Gregoriadis G, 1996, J DRUG TARGET, V3, P469, DOI 10.3109/10611869609015966; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Imai M, 1998, VIRUS RES, V53, P129, DOI 10.1016/S0168-1702(97)00143-3; Jeon SH, 2002, VACCINE, V20, P2772, DOI 10.1016/S0264-410X(02)00187-1; Jiang T, 2011, ANTIVIR RES, V89, P124, DOI 10.1016/j.antiviral.2010.11.013; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; KIDA H, 1982, VIROLOGY, V122, P38, DOI 10.1016/0042-6822(82)90375-0; Kim D, 2011, BMB REP, V44, P607, DOI 10.5483/BMBRep.2011.44.9.607; Kim D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-29; Kim D, 2009, BIOCHEM BIOPH RES CO, V379, P362, DOI 10.1016/j.bbrc.2008.12.063; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Kwon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033121; Lee KW, 2006, MOL IMMUNOL, V43, P2107, DOI 10.1016/j.molimm.2005.12.004; Liang H, 1996, J CLIN INVEST, V98, P1119, DOI 10.1172/JCI118894; Maassab HF, 1999, REV MED VIROL, V9, P237, DOI 10.1002/(SICI)1099-1654(199910/12)9:4&lt;237::AID-RMV252&gt;3.0.CO;2-G; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; Nagata T, 2007, VACCINE, V25, P4914, DOI 10.1016/j.vaccine.2007.04.010; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; REED L. J., 1938, AMER JOUR HYG, V27, P493; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; STEIN CA, 1988, NUCLEIC ACIDS RES, V16, P3209, DOI 10.1093/nar/16.8.3209; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; WHO, 2021, CUM NUMB CONF HUM CA; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048; ZHAO QY, 1994, BLOOD, V84, P3660, DOI 10.1182/blood.V84.11.3660.bloodjournal84113660	60	30	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48750	10.1371/journal.pone.0048750	http://dx.doi.org/10.1371/journal.pone.0048750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144954	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800119
J	Song, CH; Lee, HJ; Park, E; Lee, K				Song, Chin-Hee; Lee, Hyun Joo; Park, Eunsook; Lee, Keesook			The Chicken Ovalbumin Upstream Promoter-Transcription Factor II Negatively Regulates the Transactivation of Androgen Receptor in Prostate Cancer Cells	PLOS ONE			English	Article							RETINOIC ACID RECEPTORS; FACTOR COUP-TF; NUCLEAR RECEPTOR; THYROID-HORMONE; HISTONE ACETYLTRANSFERASES; MOLECULAR-MECHANISMS; ACTIVE REPRESSION; RESPONSE ELEMENTS; EXPRESSION; BINDING	Androgen receptor (AR) is involved in the development and progression of prostate cancers. However, the mechanisms by which this occurs remain incompletely understood. In previous reports, chicken ovalbumin upstream promoter-transcription factor II (COUP-TF II) has been suggested to play a role in the development of cancers. In the present study, we explored a putative role of COUP-TF II in prostate cancers by investigating its effect on cell proliferation and a cross-talk between COUP-TF II and AR. Overexpression of COUP-TF II results in the inhibition of androgen-dependent proliferation of prostate cancer cells. Further studies show that COUP-TF II functions as a corepressor of AR. It represses AR transactivation on target promoters containing the androgen response element (ARE) in a dose-dependent manner. In addition, COUP-TF II interacts physically with AR in vitro and in vivo. It binds to both the DNA binding domain (DBD) and the ligand-binding domain (LBD) of AR and disrupts the N/C terminal interaction of AR. Furthermore, COUP-TF II competes with coactivators such as ARA70, SRC-1, and GRIP1 to modulate AR transactivation as well as inhibiting the recruitment of AR to its ARE-containing target promoter. Taken together, our findings suggest that COUP-TF II is a novel corepressor of AR, and provide an insight into the role of COUP-TF II in prostate cancers.	[Song, Chin-Hee; Lee, Hyun Joo; Park, Eunsook; Lee, Keesook] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea	Chonnam National University	Lee, K (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea.	klee@chonnam.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012 0085]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012 0085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BROTHMAN AR, 1989, CANCER GENET CYTOGEN, V37, P241, DOI 10.1016/0165-4608(89)90055-1; Burd CJ, 2006, ENDOCR-RELAT CANCER, V13, P979, DOI 10.1677/erc.1.01115; Chen GQ, 2002, INT J CANCER, V99, P171, DOI 10.1002/ijc.10304; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DAVIES P, 1991, J ENDOCRINOL, V131, P5, DOI 10.1677/joe.0.1310005; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Dubbink HJ, 2006, MOL ENDOCRINOL, V20, P1742, DOI 10.1210/me.2005-0348; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Fujimoto N, 2001, UROLOGY, V58, P289, DOI 10.1016/S0090-4295(01)01117-7; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Jeong BC, 2004, MOL ENDOCRINOL, V18, P13, DOI 10.1210/me.2003-0065; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Klinge CM, 1997, J BIOL CHEM, V272, P31465, DOI 10.1074/jbc.272.50.31465; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V367, P481, DOI 10.1016/j.bbrc.2007.12.162; Lee SY, 2009, FREE RADICAL BIO MED, V47, P1591, DOI 10.1016/j.freeradbiomed.2009.09.004; Leng X, 1996, MOL CELL BIOL, V16, P2332; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; Litchfield LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038278; Liu XB, 2003, CIRC RES, V92, P1033, DOI 10.1161/01.RES.0000071355.82009.43; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; More E, 2003, J ENDOCRINOL, V176, P83, DOI 10.1677/joe.0.1760083; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Navab R, 2004, CANCER RES, V64, P5097, DOI 10.1158/0008-5472.CAN-03-1185; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; Powell SM, 2004, ENDOCR-RELAT CANCER, V11, P117, DOI 10.1677/erc.0.0110117; Qamar I, 2009, J BIOL CHEM, V284, P18021, DOI 10.1074/jbc.M900896200; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; Riggs KA, 2006, CANCER RES, V66, P10188, DOI 10.1158/0008-5472.CAN-05-3937; Shen HC, 2005, BIOL CHEM, V386, P69, DOI 10.1515/BC.2005.009; Shibata H, 2000, ENDOCR RES, V26, P1039, DOI 10.3109/07435800009048636; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; WONG CI, 1993, J BIOL CHEM, V268, P19004	56	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49026	10.1371/journal.pone.0049026	http://dx.doi.org/10.1371/journal.pone.0049026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145053	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800187
J	Subbiah, M; Shah, DH; Besser, TE; Ullman, JL; Call, DR				Subbiah, Murugan; Shah, Devendra H.; Besser, Thomas E.; Ullman, Jeffrey L.; Call, Douglas R.			Urine from Treated Cattle Drives Selection for Cephalosporin Resistant Escherichia coli in Soil	PLOS ONE			English	Article							SALMONELLA-ENTERICA; REDUCED SUSCEPTIBILITY; MULTIDRUG-RESISTANT; FECAL SAMPLES; CEFTIOFUR; ANTIBIOTICS; O157-H7; MANURE; CEFTRIAXONE; PLASMIDS	The U.S. Food and Drug Administration recently issued new rules for using ceftiofur in food animals in part because of an increasing prevalence of enteric bacteria that are resistant to 3rd-generation cephalosporins. Parenteral ceftiofur treatment, however, has limited effects on enteric bacteria so we tested the hypothesis that excreted ceftiofur metabolites exert significant selection pressure for ceftiofur-resistant Escherichia coli in soil. Test matrices were prepared by mixing soil with bovine feces and adding urine containing ceftiofur metabolites (CFM) (0 ppm, similar to 50 ppm and similar to 100 ppm). Matrices were incubated at 23 degrees C or 4 degrees C for variable periods of time after which residual CFM was quantified using a bioassay. Bla(CMY-2) plasmid-bearing ceftiofur resistant (cef(R)) E. coli and one-month old calves were used to study the selection effects of CFM and transmission of cef(R) bacteria from the environment back to animals. Our studies showed that urinary CFM (similar to 13 ppm final concentration) is biologically degraded in soil within 2.7 days at 23 degrees C, but persists up to 23.3 days at 4 degrees C. Even short-term persistence in soil provides a >1 log(10) advantage to resistant E. coli populations, resulting in significantly prolonged persistence of these bacteria in the soil (similar to two months). We further show that resistant strains readily colonize calves by contact with contaminated bedding and without antibiotic selection pressure. Ceftiofur metabolites in urine amplify resistant E. coli populations and, if applicable to field conditions, this effect is far more compelling than reported selection in vivo after parenteral administration of ceftiofur. Because ceftiofur degradation is temperature dependent, these compounds may accumulate during colder months and this could further enhance selection as seasonal temperatures increase. If cost-effective engineered solutions can be developed to limit ex vivo selection, this may limit proliferation for ceftiofur resistant enteric bacteria while preserving the ability to use this important antibiotic in food animal production.	[Shah, Devendra H.; Besser, Thomas E.; Call, Douglas R.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Shah, Devendra H.; Besser, Thomas E.; Call, Douglas R.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Ullman, Jeffrey L.] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Washington State University; Washington State University; State University System of Florida; University of Florida	Call, DR (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	drcall@wsu.edu	Shah, Devendra H./S-4965-2016	Shah, Devendra H./0000-0001-6365-7868	National Institutes of Health, United States Department of Health and Human Services [No1-AI-30055]; Agricultural Animal Health Program, College of Veterinary Medicine; Agricultural Research Center, Washington State University; Poncin Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030055] Funding Source: NIH RePORTER	National Institutes of Health, United States Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agricultural Animal Health Program, College of Veterinary Medicine; Agricultural Research Center, Washington State University; Poncin Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partial project support came from the National Institutes of Health, United States Department of Health and Human Services, under contract number No1-AI-30055, the Agricultural Animal Health Program, College of Veterinary Medicine, and the Agricultural Research Center, Washington State University. MS received financial support from the Poncin Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Caroff N, 2000, J ANTIMICROB CHEMOTH, V45, P783, DOI 10.1093/jac/45.6.783; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Davis MA, 2005, APPL ENVIRON MICROB, V71, P6816, DOI 10.1128/AEM.71.11.6816-6822.2005; Davis MA, 2007, VET MICROBIOL, V119, P221, DOI 10.1016/j.vetmic.2006.08.028; Department of Human and Health Services, 2012, FED REGISTER, V77, P735; Donaldson SC, 2006, APPL ENVIRON MICROB, V72, P3940, DOI 10.1128/AEM.02770-05; El-Gendy AAM., 2007, BS VET MED, V17, P69, DOI [10.21608/jvmr.2007.77896, DOI 10.21608/JVMR.2007.77896]; GILBERTSON TJ, 1990, J AGR FOOD CHEM, V38, P890, DOI 10.1021/jf00093a064; Giles WP, 2004, ANTIMICROB AGENTS CH, V48, P2845, DOI 10.1128/AAC.48.8.2845-2852.2004; Hammesfahr U, 2011, EUR J SOIL BIOL, V47, P61, DOI 10.1016/j.ejsobi.2010.10.004; Heider LC, 2009, AM J VET RES, V70, P389, DOI 10.2460/ajvr.70.3.389; Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679; JAGLAN PS, 1989, J AGR FOOD CHEM, V37, P1112, DOI 10.1021/jf00088a066; Jiang MX, 2010, CHEMOSPHERE, V80, P1399, DOI 10.1016/j.chemosphere.2010.05.048; Jiang XP, 2006, FOODBORNE PATHOG DIS, V3, P355, DOI 10.1089/fpd.2006.3.355; Jiang XP, 2002, APPL ENVIRON MICROB, V68, P2605, DOI 10.1128/AEM.68.5.2605-2609.2002; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; Rafii F, 2009, VET MICROBIOL, V139, P89, DOI 10.1016/j.vetmic.2009.04.023; Rasmussen MA, 2001, CRIT REV MICROBIOL, V27, P57, DOI 10.1080/20014091096701; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Schmitt H, 2005, SOIL BIOL BIOCHEM, V37, P1882, DOI 10.1016/j.soilbio.2005.02.022; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; Stanford K, 2011, J ANIM SCI, V89, P237, DOI 10.2527/jas.2010-3088; Subbiah M, 2011, APPL ENVIRON MICROB, V77, P7255, DOI 10.1128/AEM.05352-11; Subbiah M, 2011, APPL ENVIRON MICROB, V77, P4486, DOI 10.1128/AEM.02788-10; Tragesser LA, 2006, AM J VET RES, V67, P1696, DOI 10.2460/ajvr.67.10.1696; USDA, 2007, FINAL REPORT; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; You YW, 2006, APPL ENVIRON MICROB, V72, P5777, DOI 10.1128/AEM.00791-06	31	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48919	10.1371/journal.pone.0048919	http://dx.doi.org/10.1371/journal.pone.0048919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145021	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800170
J	Zhang, Y; Lou, JZ				Zhang, Yong; Lou, Jizhong			The Ca2+ Influence on Calmodulin Unfolding Pathway: A Steered Molecular Dynamics Simulation Study	PLOS ONE			English	Article							EF-HAND PROTEINS; CALCIUM-BINDING; APO-CALMODULIN; INHERENT FLEXIBILITY; MULTIDOMAIN PROTEIN; TARGET RECOGNITION; DOMAIN; TRANSITION; STABILITY; SPECTROSCOPY	The force-induced unfolding of calmodulin (CaM) was investigated at atomistic details with steered molecular dynamics. The two isolated CaM domains as well as the full-length CaM were simulated in N-C-terminal pulling scheme, and the isolated N-lobe of CaM was studied specially in two other pulling schemes to test the effect of pulling direction and compare with relevant experiments. Both Ca2+-loaded CaM and Ca2+-free CaM were considered in order to define the Ca2+ influence to the CaM unfolding. The results reveal that the Ca2+ significantly affects the stability and unfolding behaviors of both the isolated CaM domains and the full-length CaM. In Ca2+-loaded CaM, N-terminal domain unfolds in priori to the C-terminal domain. But in Ca2+-free CaM, the unfolding order changes, and C-terminal domain unfolds first. The force-extension curves of CaM unfolding indicate that the major unfolding barrier comes from conquering the interaction of two EF-hand motifs in both N- and C-terminal domains. Our results provide the atomistic-level insights in the force-induced CaM unfolding and explain the observation in recent AFM experiments.	[Zhang, Yong; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNAs, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Lou, JZ (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Noncoding RNAs, Beijing 100080, Peoples R China.	jlou@ibp.ac.cn			Natural Science Foundations of China [31070827]; Chinese Academy of Sciences	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from Natural Science Foundations of China (31070827) and by the Knowledge Innovation Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche D, 1999, J MOL BIOL, V285, P857, DOI 10.1006/jmbi.1998.2329; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Barton NP, 2002, J PHYS CHEM B, V106, P11036, DOI 10.1021/jp026692q; Biekofsky RR, 2002, BIOCHEMISTRY-US, V41, P6850, DOI 10.1021/bi012187s; Browne JP, 1997, BIOCHEMISTRY-US, V36, P9550, DOI 10.1021/bi970460d; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chen YG, 2007, J AM CHEM SOC, V129, P2414, DOI 10.1021/ja067791a; Cohen P, 1988, CALMODULIN; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fefeu S, 2000, BIOCHEMISTRY-US, V39, P15920, DOI 10.1021/bi001772a; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Hertadi R, 2002, PROTEIN SCI, V11, P1532, DOI 10.1110/ps.3600102; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Junker JP, 2010, ANGEW CHEM INT EDIT, V49, P3306, DOI 10.1002/anie.200905747; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kim T, 2006, J AM CHEM SOC, V128, P5330, DOI 10.1021/ja0607382; Kleinjung J, 2003, PROTEINS, V50, P648, DOI 10.1002/prot.10331; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lu H, 2000, ADV EXP MED BIOL, V481, P143; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Messerschmidt A, 2004, HDB METALLOPROTEINS; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Slaughter BD, 2005, J AM CHEM SOC, V127, P12107, DOI 10.1021/ja0526315; Tripathi S, 2009, P NATL ACAD SCI USA, V106, P2104, DOI 10.1073/pnas.0806872106; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yokouchi T, 2003, FEBS LETT, V551, P119, DOI 10.1016/S0014-5793(03)00907-4; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang Y, 2008, FEBS LETT, V582, P1355, DOI 10.1016/j.febslet.2008.03.010; Zhang Y, 2010, J MOL RECOGNIT, V23, P360, DOI 10.1002/jmr.1002	40	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49013	10.1371/journal.pone.0049013	http://dx.doi.org/10.1371/journal.pone.0049013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145050	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800186
J	Davis, AS; Hill, JD; Chase, CA; Johanns, AM; Liebman, M				Davis, Adam S.; Hill, Jason D.; Chase, Craig A.; Johanns, Ann M.; Liebman, Matt			Increasing Cropping System Diversity Balances Productivity, Profitability and Environmental Health	PLOS ONE			English	Article							IMPACT; HERBICIDES; BIODIVERSITY; CHALLENGE; MATTER	Balancing productivity, profitability, and environmental health is a key challenge for agricultural sustainability. Most crop production systems in the United States are characterized by low species and management diversity, high use of fossil energy and agrichemicals, and large negative impacts on the environment. We hypothesized that cropping system diversification would promote ecosystem services that would supplement, and eventually displace, synthetic external inputs used to maintain crop productivity. To test this, we conducted a field study from 2003-2011 in Iowa that included three contrasting systems varying in length of crop sequence and inputs. We compared a conventionally managed 2-yr rotation (maize-soybean) that received fertilizers and herbicides at rates comparable to those used on nearby farms with two more diverse cropping systems: a 3-yr rotation (maize-soybean-small grain + red clover) and a 4-yr rotation (maize-soybean-small grain + alfalfa-alfalfa) managed with lower synthetic N fertilizer and herbicide inputs and periodic applications of cattle manure. Grain yields, mass of harvested products, and profit in the more diverse systems were similar to, or greater than, those in the conventional system, despite reductions of agrichemical inputs. Weeds were suppressed effectively in all systems, but freshwater toxicity of the more diverse systems was two orders of magnitude lower than in the conventional system. Results of our study indicate that more diverse cropping systems can use small amounts of synthetic agrichemical inputs as powerful tools with which to tune, rather than drive, agroecosystem performance, while meeting or exceeding the performance of less diverse systems.	[Davis, Adam S.] ARS, USDA, Global Change & Photosynth Res Unit, Urbana, IL USA; [Hill, Jason D.] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA; [Chase, Craig A.] Iowa State Univ, Leopold Ctr Sustainable Agr, Ames, IA USA; [Johanns, Ann M.] Iowa State Univ Extens & Outreach, Dept Econ, Osage, IA USA; [Liebman, Matt] Iowa State Univ, Dept Agron, Ames, IA USA	United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Iowa State University; Iowa State University	Davis, AS (corresponding author), ARS, USDA, Global Change & Photosynth Res Unit, Urbana, IL USA.	adam.davis@ars.usda.gov	Gole, Tadesse/AAE-5470-2021; Hill, Jason/A-8919-2008	Hill, Jason/0000-0001-7609-6713; Moat, Justin/0000-0002-5513-3615	US Department of Agriculture National Research Initiative [2002-35320-12175, 2006-3532016548]; Leopold Center for Sustainable Agriculture [2004-E06, 2007-E09, 2010-E02]; Iowa Soybean Association; Organic Center	US Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); Leopold Center for Sustainable Agriculture; Iowa Soybean Association; Organic Center	Funding for the study was provided by the US Department of Agriculture National Research Initiative (Projects 2002-35320-12175 and 2006-3532016548), the Leopold Center for Sustainable Agriculture (Projects 2004-E06, 2007-E09, and 2010-E02), the Iowa Soybean Association, and the Organic Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 1291 US GEOL SURV; [Anonymous], 2011, PEST IND SAL US 2006; Bennett AJ, 2012, BIOL REV, V87, P52, DOI 10.1111/j.1469-185X.2011.00184.x; Berthoud A, 2011, INT J LIFE CYCLE ASS, V16, P841, DOI 10.1007/s11367-011-0321-7; Burow K.R., 2010, 1350 US GEOL SURV; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Cornell PMEP, 2008, PESTICIDE MANAGEMENT; Crawley MJ., 2007, R BOOK; Egan JF, 2012, ENVIRON TOXICOL CHEM, V31, P1023, DOI 10.1002/etc.1778; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; FOX R H, 1988, Journal of Production Agriculture, V1, P313; FREEMARK K, 1995, AGR ECOSYST ENVIRON, V52, P67, DOI 10.1016/0167-8809(94)00534-L; Grigg D., 1989, ENGLISH AGR HIST PER; Grigg DB., 1974, AGR SYSTEMS WORLD EV, DOI 10.1017/CBO9780511665882; Hauschild MZ, 2008, ENVIRON SCI TECHNOL, V42, P7032, DOI 10.1021/es703145t; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; HEICHEL GH, 1985, CROP SCI, V25, P101, DOI 10.2135/cropsci1985.0011183X002500010026x; HEICHEL GH, 1984, CROP SCI, V24, P811; Jackson LL, 2000, J SOIL WATER CONSERV, V55, P205; Jordan N, 2010, BIOSCIENCE, V60, P60, DOI 10.1525/bio.2010.60.1.10; KARLEN DL, 1994, ADV AGRON, V53, P1, DOI 10.1016/S0065-2113(08)60611-2; Liebman M, 2009, AGRONOMY MONOGRAPH, V54, P173, DOI DOI 10.2134/AGR0NM0N0GR54.C8; Liebman M., 2001, ECOLOGICAL MANAGEMEN, P322; Liebman M, 2008, AGRON J, V100, P600, DOI 10.2134/agronj2007.0222; Magdoff F, 1997, ADV AGRON, V60, P1, DOI 10.1016/S0065-2113(08)60600-8; Mortensen DA, 2012, BIOSCIENCE, V62, P75, DOI 10.1525/bio.2012.62.1.12; Naylor R, 2005, SCIENCE, V310, P1621, DOI 10.1126/science.1117856; Olmstead J., 2011, FEEDING WORLD 12 YEA; Orton F, 2009, ENVIRON SCI TECHNOL, V43, P2144, DOI 10.1021/es8028928; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; R Development Core Team, 2009, R FDN STAT COMP; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Robertson GP, 2005, FRONT ECOL ENVIRON, V3, P38, DOI 10.2307/3868443; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Smith RG, 2010, WEED RES, V50, P185, DOI 10.1111/j.1365-3180.2010.00775.x; Smith RG, 2008, ECOSYSTEMS, V11, P355, DOI 10.1007/s10021-008-9124-5; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tranel PJ, 2011, J AGR FOOD CHEM, V59, P5808, DOI 10.1021/jf103797n; [No title captured]	45	242	252	1	241	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47149	10.1371/journal.pone.0047149	http://dx.doi.org/10.1371/journal.pone.0047149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23144840	Green Published, gold			2022-12-25	WOS:000312385200085
J	Banerjee, R; Nath, S; Ranjan, A; Khamrui, S; Pani, B; Sen, R; Sen, U				Banerjee, Ramanuj; Nath, Seema; Ranjan, Amitabh; Khamrui, Susmita; Pani, Bibhusita; Sen, Ranjan; Sen, Udayaditya			The First Structure of Polarity Suppression Protein, Psu from Enterobacteria Phage P4, Reveals a Novel Fold and a Knotted Dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-P4; INTERFACE; MECHANISM	Psu is a capsid decoration protein of bacteriophage P4 and acts as an antiterminator of Rho-dependent transcription termination in bacteria. So far, no structures have been reported for the Psu protein or its homologues. Here, we report the first structure of Psu solved by the Hg2+ single wavelength anomalous dispersion method, which reveals that Psu exists as a knotted homodimer and is first of its kind in nature. Each monomer of Psu attains a novel fold around a tight coiled-coil motif. CD spectroscopy and the structure of an engineered disulfide-bridged Psu derivative reveal that the protein folds reversibly and reassembles by itself into the knotted dimeric conformation without the requirement of any chaperone. This structure would help to explain the functional properties of the protein and can be used as a template to design a minimal peptide fragment that can be used as a drug against Rho-dependent transcription termination in bacteria.	[Banerjee, Ramanuj; Nath, Seema; Khamrui, Susmita; Sen, Udayaditya] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata 700064, India; [Ranjan, Amitabh; Pani, Bibhusita; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Lab Transcript Biol, Hyderabad 500001, Andhra Pradesh, India	Saha Institute of Nuclear Physics; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Sen, U (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1-AF, Kolkata 700064, India.	udayaditya.sen@saha.ac.in	RANJAN, AMITABH/AAB-9856-2022; Sen, Ranjan/AAP-7075-2021	Pani, Bibhusita/0000-0003-1513-5189; Sen, Udayaditya/0000-0001-5742-2907; Banerjee, Ramanuj/0000-0002-7751-2317	SPGHGD project, DAE, India, Saha Institute of Nuclear Physics; Department of Biotechnology, India	SPGHGD project, DAE, India, Saha Institute of Nuclear Physics; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported in part by the SPGHGD project, DAE, India, Saha Institute of Nuclear Physics (to U. S.). This work was also supported by the Department of Biotechnology, India (to R. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOKLAND T, 1993, VIROLOGY, V194, P682, DOI 10.1006/viro.1993.1308; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; ISAKSEN ML, 1992, VIROLOGY, V188, P831, DOI 10.1016/0042-6822(92)90538-Z; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; LINDEROTH NA, 1991, J BACTERIOL, V173, P6722, DOI 10.1128/jb.173.21.6722-6731.1991; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; Pani B, 2009, J MOL BIOL, V389, P647, DOI 10.1016/j.jmb.2009.04.052; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Saitta AM, 1999, NATURE, V399, P46, DOI 10.1038/19935	24	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44667	44675		10.1074/jbc.M112.423202	http://dx.doi.org/10.1074/jbc.M112.423202			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150672	Green Published, hybrid			2022-12-25	WOS:000312938600062
J	Pichu, S; Krishnamoorthy, S; Shishkov, A; Zhang, B; McCue, P; Ponnappa, BC				Pichu, Sivakamasundari; Krishnamoorthy, Swapna; Shishkov, Andrei; Zhang, Bi; McCue, Peter; Ponnappa, Biddanda C.			Knockdown of Ki-67 by Dicer-Substrate Small Interfering RNA Sensitizes Bladder Cancer Cells to Curcumin-Induced Tumor Inhibition	PLOS ONE			English	Article							FACTOR-KAPPA-B; IN-VIVO; CLINICAL-TRIALS; DOWN-REGULATION; CHEMOTHERAPY; APOPTOSIS; PROLIFERATION; EXPRESSION; MODEL; SIRNA	Transitional cell carcinoma (TCC) of the urinary bladder is the most common cancer of the urinary tract. Most of the TCC cases are of the superficial type and are treated with transurethral resection (TUR). However, the recurrence rate is high and the current treatments have the drawback of inducing strong systemic toxicity or cause painful cystitis. Therefore, it would be of therapeutic value to develop novel concepts and identify novel drugs for the treatment of bladder cancer. Ki-67 is a large nucleolar phosphoprotein whose expression is tightly linked to cell proliferation, and curcumin, a phytochemical derived from the rhizome Curcuma longa, has been shown to possess powerful anticancer properties. In this study, we evaluated the combined efficacy of curcumin and a siRNA against Ki-67 mRNA (Ki-67-7) in rat (AY-27) and human (T-24) bladder cancer cells. The anticancer effects were assessed by the determination of cell viability, apoptosis and cell cycle analysis. Ki-67-7 (10 mu M) and curcumin (10 mM), when treated independently, were moderately effective. However, in their combined presence, proliferation of bladder cancer cells was profoundly (>85%) inhibited; the rate of apoptosis in the combined presence of curcumin and Ki-67-7 (36%) was greater than that due to Ki-67-7 (14%) or curcumin (13%) alone. A similar synergy between curcumin and Ki-67-7 in inducing cell cycle arrest was also observed. Western blot analysis suggested that pretreatment with Ki-67-7 sensitized bladder cancer cells to curcumin-mediated apoptosis and cell cycle arrest by p53- and p21-independent mechanisms. These data suggest that a combination of anti-Ki-67 siRNA and curcumin could be a viable treatment against the proliferation of bladder cancer cells.	[Pichu, Sivakamasundari; Krishnamoorthy, Swapna; Shishkov, Andrei; Zhang, Bi; McCue, Peter; Ponnappa, Biddanda C.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Ponnappa, BC (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	Biddanda.Ponnappa@jefferson.edu			National Institutes of Health [AA016551]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was partly supported by National Institutes of Health grant AA016551. The funding agency had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2007, BIOCHEM PHARMACOL, V73, P1024, DOI 10.1016/j.bcp.2006.12.010; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Blietz CE, 2009, IN VIVO, V23, P13; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GERDES J, 1984, J IMMUNOL, V133, P1710; Gondi CS, 2009, J CELL PHYSIOL, V220, P285, DOI 10.1002/jcp.21790; GuhaSarkar S, 2010, J CONTROL RELEASE, V148, P147, DOI 10.1016/j.jconrel.2010.08.031; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Herr HW, 2007, J UROLOGY, V178, P1201, DOI 10.1016/j.juro.2007.05.148; Jing YW, 2008, BBA-GEN SUBJECTS, V1780, P34, DOI 10.1016/j.bbagen.2007.09.015; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Kausch I, 2003, INT J CANCER, V105, P710, DOI 10.1002/ijc.11111; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; LAMM DL, 1995, J UROLOGY, V153, P1444, DOI 10.1016/S0022-5347(01)67427-5; Lingnau A, 2010, DEBATES BLADDER CANC, V2, P1; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; MacCallum DE, 1999, EXP CELL RES, V252, P186, DOI 10.1006/excr.1999.4600; Parker SL, 1996, CA-CANCER J CLIN, V46, P5, DOI 10.3322/canjclin.46.1.5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Plumb LA, 2004, METH MOLEC MED, V88, P165; Ponnappa BC, 2009, CURR OPIN INVEST DR, V10, P418; Raghavan D, 2002, SURG ONCOL, V11, P55, DOI 10.1016/S0960-7404(02)00007-5; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Reis LO, 2009, WORLD J UROL, V27, P353, DOI 10.1007/s00345-009-0374-4; Sethi G., 2009, HERBAL DRUGS ETHNOME, P97, DOI 10.1007/978-3-540-79116-4_7; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Sylvester RJ, 2004, J UROLOGY, V171, P2186, DOI 10.1097/01.ju.0000125486.92260.b2; Tang H, 1998, J BIOL CHEM, V273, P29156, DOI 10.1074/jbc.273.44.29156; Tharakan ST, 2009, BIOCHEM PHARMACOL, V79, P218; Tian BQ, 2008, CANCER LETT, V264, P299, DOI 10.1016/j.canlet.2008.01.041; Vaishnaw A.K., 2010, SILENCE, V1, P1, DOI DOI 10.1186/1758-907X-1-14; Xiao Z, 1999, BRIT J CANCER, V81, P638, DOI 10.1038/sj.bjc.6690741; Yao RS, 2007, NEOPLASIA, V9, P207, DOI 10.1593/neo.06814; Zheng JN, 2006, LIFE SCI, V78, P724, DOI 10.1016/j.lfs.2005.05.064	40	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48567	10.1371/journal.pone.0048567	http://dx.doi.org/10.1371/journal.pone.0048567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152782	gold, Green Published, Green Submitted			2022-12-25	WOS:000311234000021
J	de Lucas, M; Ferrer, M; Janss, GFE				de Lucas, Manuela; Ferrer, Miguel; Janss, Guyonne F. E.			Using Wind Tunnels to Predict Bird Mortality in Wind Farms: The Case of Griffon Vultures	PLOS ONE			English	Article							EAGLE AQUILA-CHRYSAETOS; BUFFALO RIDGE; TURBINES; IMPACTS; MINNESOTA; BEHAVIOR; PROJECT; RAPTORS; SPAIN	Background: Wind farms have shown a spectacular growth during the last 15 years. Avian mortality through collision with moving rotor blades is well-known as one of the main adverse impacts of wind farms. In Spain, the griffon vulture incurs the highest mortality rates in wind farms. Methodology/Principal Findings: As far as we know, this study is the first attempt to predict flight trajectories of birds in order to foresee potentially dangerous areas for wind farm development. We analyse topography and wind flows in relation to flight paths of griffon vultures, using a scaled model of the wind farm area in an aerodynamic wind tunnel, and test the difference between the observed flight paths of griffon vultures and the predominant wind flows. Different wind currents for each wind direction in the aerodynamic model were observed. Simulations of wind flows in a wind tunnel were compared with observed flight paths of griffon vultures. No statistical differences were detected between the observed flight trajectories of griffon vultures and the wind passages observed in our wind tunnel model. A significant correlation was found between dead vultures predicted proportion of vultures crossing those cells according to the aerodynamic model. Conclusions: Griffon vulture flight routes matched the predominant wind flows in the area (i.e. they followed the routes where less flight effort was needed). We suggest using these kinds of simulations to predict flight paths over complex terrains can inform the location of wind turbines and thereby reduce soaring bird mortality. Citation: de Lucas M, Ferrer M, Janss GFE (2012) Using Wind Tunnels to Predict Bird Mortality in Wind Farms: The Case of Griffon Vultures. PLoS ONE 7(11): e48092. doi:10.1371/journal.pone.0048092	[de Lucas, Manuela; Ferrer, Miguel; Janss, Guyonne F. E.] CSIC, Estn Biol Donana, Dept Ethol & Biodivers Conservat, E-41080 Seville, Spain; [de Lucas, Manuela] Fdn Migres, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	de Lucas, M (corresponding author), CSIC, Estn Biol Donana, Dept Ethol & Biodivers Conservat, E-41080 Seville, Spain.	manuela@ebd.csic.es	Ferrer, Miguel/G-3519-2015; Ferrer, Miguel/AFU-8286-2022; de Lucas, Manuela/C-9290-2015; Janss, Guyonne F E/C-4157-2011	Ferrer, Miguel/0000-0003-0092-8450; de Lucas, Manuela/0000-0001-8733-1002; Janss, Guyonne F E/0000-0003-4318-6602	ENDESA; Cogeneracion y Renovables S.A.; Aerogeneradores del Sur S.A.; Microcentrales de Andalucia S.A.; WIGEP Andalucia S.A.; Wind Iberica Espana S.A.; PEESA; Alabe la Ahumada S.L.; Donana Biological Station (CSIC)	ENDESA; Cogeneracion y Renovables S.A.; Aerogeneradores del Sur S.A.; Microcentrales de Andalucia S.A.; WIGEP Andalucia S.A.; Wind Iberica Espana S.A.; PEESA; Alabe la Ahumada S.L.; Donana Biological Station (CSIC)	The funders of this study were the Donana Biological Station (CSIC). MdL was supported through a grant from seven Spanish wind developers (ENDESA, Cogeneracion y Renovables S.A., Aerogeneradores del Sur S.A., Microcentrales de Andalucia S.A., WIGEP Andalucia S.A., Wind Iberica Espana S.A., PEESA, Alabe la Ahumada S.L.) and from Donana Biological Station (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by: ENDESA, Cogeneracion y Renovables S.A., Aerogeneradores del Sur S.A., Microcentrales de Andalucia S.A., WIGEP Andalucia S.A., Wind Iberica Espana S.A., PEESA and Alabe la Ahumada S.L. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bernis F., 1980, MIGRACION AVES ESTRE; Bildstein K, IBIS IN PRESS; BILDSTEIN K, 2000, RAPTOR WATCH GLOBAL; Bildstein KL, 2009, IBIS, V151, P382, DOI 10.1111/j.1474-919X.2009.00919.x; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Erickson WP, 2001, AVIAN COLLISIONS WIN; Everaert J, 2007, BIODIVERS CONSERV, V16, P3345, DOI 10.1007/s10531-006-9082-1; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Finlayson C., 1992, BIRDS STRAIT GIBRALT; Hoover SL, 2005, J WILDLIFE MANAGE, V69, P150, DOI 10.2193/0022-541X(2005)069<0150:BORHIA>2.0.CO;2; Hotker H., 2006, IMPACTS BIODIVERSITY; HUNT G., 2002, GOLDEN EAGLES PERILO; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; IDAE, 1996, MAN EN REN, V2; Johnson GD, 2002, WILDLIFE SOC B, V30, P879; Langston R.W.H., 2003, WIND FARMS BIRDS ANA; Telleria JL, 2009, BIODIVERS CONSERV, V18, P1781, DOI 10.1007/s10531-008-9558-2; Mabee TJ, 2006, WILDLIFE SOC B, V34, P682, DOI 10.2193/0091-7648(2006)34[682:NBMOAA]2.0.CO;2; Madders M, 2006, IBIS, V148, P43, DOI 10.1111/j.1474-919X.2006.00506.x; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; McLeod DRA, 2002, J RAPTOR RES, V36, P70; Musters CJM, 1996, BIRD STUDY, V43, P124, DOI 10.1080/00063659609461003; Orloff S., 1992, WIND TURBINE EFFECTS; Osborn RG, 2000, AM MIDL NAT, V143, P41, DOI 10.1674/0003-0031(2000)143[0041:BMAWWT]2.0.CO;2; Pennycuick CJ, 1998, J AVIAN BIOL, V29, P449, DOI 10.2307/3677164; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Percival Steve, 2005, British Birds, V98, P194; Pullen A., 2008, GLOBAL WIND 2008 REP; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Smallwood KS, 2004, DEV METHODS REDUCE B; Tapia L, 2009, BIODIVERS CONSERV, V18, P2033, DOI 10.1007/s10531-008-9571-5; Thelander Carl G., 2007, P25	37	29	31	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48092	10.1371/journal.pone.0048092	http://dx.doi.org/10.1371/journal.pone.0048092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152764	Green Published, Green Submitted, gold			2022-12-25	WOS:000312272600010
J	Dominguez, JA; Xie, Y; Dunne, WM; Yoseph, BP; Burd, EM; Coopersmith, CM; Davidson, NO				Dominguez, Jessica A.; Xie, Yan; Dunne, W. Michael; Yoseph, Benyam P.; Burd, Eileen M.; Coopersmith, Craig M.; Davidson, Nicholas O.			Intestine-Specific Mttp Deletion Decreases Mortality and Prevents Sepsis-Induced Intestinal Injury in a Murine Model of Pseudomonas aeruginosa Pneumonia	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; CRITICAL-CARE MEDICINE; GUT-LYMPH HYPOTHESIS; EPITHELIAL APOPTOSIS; IMPROVES SURVIVAL; SEPTIC SHOCK; ORGAN DYSFUNCTION; DEFICIENT MICE; HOST-DEFENSE; IN-VIVO	Background: The small intestine plays a crucial role in the pathophysiology of sepsis and has been referred to as the "motor'' of the systemic inflammatory response. One proposed mechanism is that toxic gut-derived lipid factors, transported in mesenteric lymph, induce systemic injury and distant organ failure. However, the pathways involved are yet to be defined and the role of intestinal chylomicron assembly and secretion in transporting these lipid factors is unknown. Here we studied the outcome of sepsis in mice with conditional, intestine-specific deletion of microsomal triglyceride transfer protein (Mttp-IKO), which exhibit a block in chylomicron assembly together with lipid malabsorption. Methodology/Principal Findings: Mttp-IKO mice and controls underwent intratracheal injection with either Pseudomonas aeruginosa or sterile saline. Mttp-IKO mice exhibited decreased seven-day mortality, with 0/20 (0%) dying compared to 5/17 (29%) control mice (p<0.05). This survival advantage in Mttp-IKO mice, however, was not associated with improvements in pulmonary bacterial clearance or neutrophil infiltration. Rather, Mttp-IKO mice exhibited protection against sepsis-associated decreases in villus length and intestinal proliferation and were also protected against increased intestinal apoptosis, both central features in control septic mice. Serum IL-6 levels, a major predictor of mortality in human and mouse models of sepsis, were elevated 8-fold in septic control mice but remained unaltered in septic Mttp-IKO mice. Serum high density lipoprotein (HDL) levels were reduced in septic control mice but were increased in septic Mttp-IKO mice. The decreased levels of HDL were associated with decreased hepatic expression of apolipoprotein A1 in septic control mice. Conclusions/Significance: These studies suggest that strategies directed at blocking intestinal chylomicron secretion may attenuate the progression and improve the outcome of sepsis through effects mediated by metabolic and physiological adaptations in both intestinal and hepatic lipid flux. Citation: Dominguez JA, Xie Y, Dunne WM, Yoseph BP, Burd EM, et al. (2012) Intestine-Specific Mttp Deletion Decreases Mortality and Prevents Sepsis-Induced Intestinal Injury in a Murine Model of Pseudomonas aeruginosa Pneumonia. PLoS ONE 7(11): e49159. doi:10.1371/journal.pone.0049159	[Xie, Yan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Dominguez, Jessica A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Dunne, W. Michael] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Yoseph, Benyam P.; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA USA; [Yoseph, Benyam P.; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Burd, Eileen M.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Emory University; Emory University; Emory University	Davidson, NO (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	nod@wustl.edu		Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health [GM66202, GM072808, GM095442, GM082008, HL38180, DK56260, P30 DK52574]; Shock Society Early Career Investigator Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, R01GM066202, T32GM095442, F32GM082008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shock Society Early Career Investigator Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (GM66202 supplement collaborative grant to CMC for work with NOD, GM072808, GM095442 CMC, GM082008 JAD, and HL38180, DK56260, P30 DK52574 to NOD and a Shock Society Early Career Investigator Fellowship to JAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2008, J EUKARYOT MICROBIOL, V55, P235, DOI 10.1111/j.1550-7408.2008.00311.x; [Anonymous], 1992, CRIT CARE MED, V20, P864; Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Bilbault P, 2007, CRIT CARE MED, V35, P69, DOI 10.1097/01.CCM.0000251133.26979.F4; Brunham LR, 2006, CIRC RES, V99, P672, DOI 10.1161/01.RES.0000244014.19589.8e; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; De-Souza DA, 2005, CRIT CARE MED, V33, P1125, DOI 10.1097/01.CCM.0000162680.52397.97; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Ganeshan K, 2012, J IMMUNOL, V188, P594, DOI 10.4049/jimmunol.1102389; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Gonzalez RJ, 2000, SHOCK, V14, P404, DOI 10.1097/00024382-200014030-00028; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Kaplan JM, 2012, OBESITY SILVER SPRIN; Kasravi B, 2008, J SURG RES, V146, P96, DOI 10.1016/j.jss.2007.06.013; Kim E, 2011, J PHARMACOL EXP THER, V337, P775, DOI 10.1124/jpet.110.177527; Lanza-Jacoby S, 2003, J ENDOTOXIN RES, V9, P341, DOI 10.1179/096805103225002782; MAINOUS MR, 1995, SHOCK, V4, P193, DOI 10.1097/00024382-199509000-00007; Mancuso P, 2006, AM J RESP CRIT CARE, V173, P212, DOI 10.1164/rccm.200506-909OC; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; McConnell KW, 2010, CRIT CARE MED, V38, P223, DOI 10.1097/CCM.0b013e3181b4a76b; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Ott J, 2011, PROSTAG LEUKOTR ESS, V85, P267, DOI 10.1016/j.plefa.2011.04.011; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Wenzel RP, 2012, NEW ENGL J MED, V366, P2122, DOI 10.1056/NEJMe1203412; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2012, ARTERIOSCL THROM VAS, V32, P1624, DOI 10.1161/ATVBAHA.112.246066; Zhang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH866, DOI 10.1152/ajpheart.01232.2008	51	17	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49159	10.1371/journal.pone.0049159	http://dx.doi.org/10.1371/journal.pone.0049159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145105	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500079
J	Fu, J; Chen, D; Zhao, B; Zhao, ZH; Zhou, JH; Xu, YM; Xin, YQ; Liu, C; Luo, L; Yin, ZM				Fu, Jin; Chen, Dan; Zhao, Bo; Zhao, Zhihui; Zhou, Jiahong; Xu, Yimiao; Xin, Yinqiang; Liu, Chang; Luo, Lan; Yin, Zhimin			Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3	PLOS ONE			English	Article							HUMAN OSTEOSARCOMA CELLS; X-LINKED INHIBITOR; KAPPA-B PATHWAY; SIGNALING PATHWAY; UP-REGULATION; CANCER-CELLS; FLAVONOIDS; PROTEIN; HEAT-SHOCK-PROTEIN-90; CHAPERONE	Background: Abnormal activity of STAT3 is associated with a number of human malignancies. Hsp90 plays a central role in stabilizing newly synthesized proteins and participates in maintaining the functional competency of a number of signaling transducers involved in cell growth, survival and oncogenesis, such as STAT3. Hsp90 interacts with STAT3 and stabilizes Tyr-phosphorylated STAT3. It has been reported that luteolin possesses anticancer activity through degradation of Tyr(705)-phosphorylated STAT3. Methodology/Principal Findings: We found that overexpression of Hsp90 inhibited luteolin-induced degradation of Tyr(705)-phosphorylated STAT3 and luteolin also reduced the levels of some other Hsp90 interacting proteins. Results from co-immunoprecipitation and immunoblot analysis demonstrated that luteolin prevented the association between Hsp90 and STAT3 and induced both Tyr(705)- and Ser(727)-phosphorylated STAT3 degradation through proteasome-dependent pathway. The molecular modeling analysis with CHARMm-Discovery Studio 2.1(DS 2.1) indicated that luteolin could bind to the ATP-binding pocket of Hsp90. SPR technology-based binding assay confirmed the association between luteolin and Hsp90. ATP-sepharose binding assay displayed that luteolin inhibited Hsp90-ATP binding. Conclusions/Significance: Luteolin promoted the degradation of Tyr(705)- and Ser(727)-phosphorylated STAT3 through interacting with Hsp90 and induced apoptosis of cancer cells. This study indicated that luteolin may act as a potent HSP90 inhibitor in antitumor strategies.	[Chen, Dan; Luo, Lan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Fu, Jin; Zhao, Zhihui; Xu, Yimiao; Xin, Yinqiang; Liu, Chang; Yin, Zhimin] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhao, Bo] Nanjing Normal Univ, Coll Chem & Mat Sci, Nanjing, Jiangsu, Peoples R China; [Zhou, Jiahong] Nanjing Normal Univ, Ctr Anal & Test, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Normal University; Nanjing Normal University; Nanjing Normal University	Luo, L (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	lanluo@nju.edu.cn; yinzhimin@njnu.edu.cn		Multhoff, Gabriele/0000-0002-2616-3137	National Nature Science Foundation of China [81172798, 81072433, 31071000]; Priority Academic Program Development of Jiangsu Higher Education Institutions [164320H106]; Jiangsu Major Nature Science Foundation of High Education [12KJA180006]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Major Nature Science Foundation of High Education	This work was supported by grants from the National Nature Science Foundation of China (Nos. 81172798, 81072433 and 31071000), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 164320H106), and Jiangsu Major Nature Science Foundation of High Education (No. 12KJA180006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin E, 2001, CANCER RES, V61, P1862; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chen CYC, 2008, J CHIN CHEM SOC-TAIP, V55, P297, DOI 10.1002/jccs.200800044; Cheng JQ, 2002, DRUG RESIST UPDATE, V5, P131, DOI 10.1016/S1368-7646(02)00003-1; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Ferry DR, 1996, CLIN CANCER RES, V2, P659; Fujiwara H, 2004, J PHARMACOL EXP THER, V310, P1288, DOI 10.1124/jpet.104.065979; Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horinaka M, 2005, ONCOGENE, V24, P7180, DOI 10.1038/sj.onc.1208874; Horinaka M, 2005, BIOCHEM BIOPH RES CO, V333, P833, DOI 10.1016/j.bbrc.2005.05.179; Jang HS, 2005, BBA-GEN SUBJECTS, V1726, P309, DOI 10.1016/j.bbagen.2005.08.010; Janin YL, 2005, J MED CHEM, V48, P7503, DOI 10.1021/jm050759r; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kim SH, 2003, BIOCHEM PHARMACOL, V66, P955, DOI 10.1016/S0006-2952(03)00465-9; Kook SH, 2007, APOPTOSIS, V12, P1289, DOI 10.1007/s10495-007-0056-x; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Mandler R, 2000, J NATL CANCER I, V92, P1573, DOI 10.1093/jnci/92.19.1573; Manna SK, 2007, CLIN CANCER RES, V13, P2290, DOI 10.1158/1078-0432.CCR-06-2394; Matsuo M, 2005, BIOL PHARM BULL, V28, P253, DOI 10.1248/bpb.28.253; Miyagi Y, 2000, NUTR CANCER, V36, P224, DOI 10.1207/S15327914NC3602_12; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sato N, 2003, BIOCHEM BIOPH RES CO, V300, P847, DOI 10.1016/S0006-291X(02)02941-8; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Selvendiran K, 2006, CANCER RES, V66, P4826, DOI 10.1158/0008-5472.CAN-05-4062; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Ueda H, 2002, BIOL PHARM BULL, V25, P1197, DOI 10.1248/bpb.25.1197; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhao YX, 2011, MOL BIOL REP, V38, P1115, DOI 10.1007/s11033-010-0208-x	47	32	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49194	10.1371/journal.pone.0049194	http://dx.doi.org/10.1371/journal.pone.0049194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145121	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500087
J	Jasinski, S; Lecureuil, A; Miquel, M; Loudet, O; Raffaele, S; Froissard, M; Guerche, P				Jasinski, Sophie; Lecureuil, Alain; Miquel, Martine; Loudet, Olivier; Raffaele, Sylvain; Froissard, Marine; Guerche, Philippe			Natural Variation in Seed Very Long Chain Fatty Acid Content Is Controlled by a New Isoform of KCS18 in Arabidopsis thaliana	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; KETOACYL-COA SYNTHASE; HETEROGENEOUS INBRED FAMILY; BRASSICA-NAPUS; ERUCIC-ACID; OIL CONTENT; HETEROLOGOUS EXPRESSION; FUNCTIONAL GENOMICS; TRANSGENIC PLANTS; QTL ANALYSIS	Oil from oleaginous seeds is mainly composed of triacylglycerols. Very long chain fatty acids (VLCFAs) are major constituents of triacylglycerols in many seed oils and represent valuable feedstock for industrial purposes. To identify genetic factors governing natural variability in VLCFA biosynthesis, a quantitative trait loci (QTL) analysis using a recombinant inbred line population derived from a cross between accessions Bay-0 and Shahdara was performed in Arabidopsis thaliana. Two fatty acid chain length ratio (CLR) QTL were identified, with one major locus, CLR. 2, accounting for 77% of the observed phenotypic variation. A fine mapping and candidate gene approach showed that a key enzyme of the fatty acid elongation pathway, the beta-ketoacyl-CoA synthase 18 (KCS18), was responsible for the CLR. 2 QTL detected between Bay-0 and Shahdara. Association genetics and heterologous expression in yeast cells identified a single point mutation associated with an alteration of KCS18 activity, uncovering the molecular bases for the modulation of VLCFA content in these two natural populations of Arabidopsis. Identification of this kcs18 mutant with altered activity opens new perspectives for the modulation of oil composition in crop plants. Citation: Jasinski S, Lecureuil A, Miquel M, Loudet O, Raffaele S, et al. (2012) Natural Variation in Seed Very Long Chain Fatty Acid Content Is Controlled by a New Isoform of KCS18 in Arabidopsis thaliana. PLoS ONE 7(11): e49261. doi:10.1371/journal.pone.0049261	[Jasinski, Sophie; Lecureuil, Alain; Miquel, Martine; Loudet, Olivier; Froissard, Marine; Guerche, Philippe] INRA, UMR1318, Inst Jean Pierre Bourgin, RD10, F-78026 Versailles, France; [Jasinski, Sophie; Lecureuil, Alain; Miquel, Martine; Loudet, Olivier; Froissard, Marine; Guerche, Philippe] AgroParisTech, Inst Jean Pierre Bourgin, RD10, Versailles, France; [Raffaele, Sylvain] Sainsbury Lab, Norwich, Norfolk, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Jasinski, S (corresponding author), INRA, UMR1318, Inst Jean Pierre Bourgin, RD10, F-78026 Versailles, France.	sophie.jasinski@versailles.inra.fr	Raffaele, Sylvain/F-7187-2012; Loudet, Olivier/CAF-7559-2022; Loudet, Olivier/K-8266-2012; Raffaele, Sylvain/K-6673-2019	Raffaele, Sylvain/0000-0002-2442-9632; Loudet, Olivier/0000-0003-3717-0137; Raffaele, Sylvain/0000-0002-2442-9632; Jasinski, Sophie/0000-0003-1806-2747	"Genetique et Amelioration des Plantes'' department of INRA; "Biologie Vegetale'' department of INRA	"Genetique et Amelioration des Plantes'' department of INRA; "Biologie Vegetale'' department of INRA	This work was supported by the "Genetique et Amelioration des Plantes'' and "Biologie Vegetale'' departments of INRA. M.M. is a Charge de Recherche at CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Allison Mallory, Sebastien Baud and Vincent Arondel for critical reading of the manuscript. We thank Ljerka Kunst for fae1-1 seeds and Guillaume Barthole for sharing results on kcs mutants. We also thank Lilian Dahuron and Philippe Marechal for plant care. This work was supported by the "Genetique et Amelioration des Plantes'' and "Biologie Vegetale'' departments of INRA. M.M. is a Charge de Recherche at CNRS.	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; ALREFAI R, 1995, GENOME, V38, P894, DOI 10.1139/g95-118; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bach L, 2010, CR BIOL, V333, P361, DOI 10.1016/j.crvi.2010.01.014; Barret P, 1998, THEOR APPL GENET, V96, P177, DOI 10.1007/s001220050725; Basten CJ, 2000, QTL CARTOGRAPHER VER; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Baud S, 2009, PLANT PHYSIOL BIOCH, V47, P448, DOI 10.1016/j.plaphy.2008.12.006; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Burns MJ, 2003, HEREDITY, V90, P39, DOI 10.1038/sj.hdy.6800176; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; CHURCHILL GA, 1994, GENETICS, V138, P963; Costaglioli P, 2005, BBA-MOL CELL BIOL L, V1734, P247, DOI 10.1016/j.bbalip.2005.04.002; Csanadi G, 2001, THEOR APPL GENET, V103, P912, DOI 10.1007/s001220100621; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; ECKE W, 1995, THEOR APPL GENET, V91, P972, DOI 10.1007/BF00223908; FEHLING E, 1991, BIOCHIM BIOPHYS ACTA, V1082, P239, DOI 10.1016/0005-2760(91)90198-Q; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Froissard Marine, 2006, Biotechnology Journal, V1, P308, DOI 10.1002/biot.200500034; Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x; Ghanevati M, 2002, EUR J BIOCHEM, V269, P3531, DOI 10.1046/j.1432-1033.2002.03039.x; Ghanevati M, 2001, BBA-MOL CELL BIOL L, V1530, P77, DOI 10.1016/S1388-1981(00)00168-2; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hobbs DH, 2004, PLANT PHYSIOL, V136, P3341, DOI 10.1104/pp.104.049486; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; JAMES DW, 1990, THEOR APPL GENET, V80, P241, DOI 10.1007/BF00224393; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Katavic V, 2004, FEBS LETT, V562, P118, DOI 10.1016/S0014-5793(04)00198-X; Katavic V, 2002, EUR J BIOCHEM, V269, P5625, DOI 10.1046/j.1432-1033.2002.03270.x; KUNST L, 1992, PLANT PHYSIOL BIOCH, V30, P425; Kunst L, 2009, CURR OPIN PLANT BIOL, V12, P721, DOI 10.1016/j.pbi.2009.09.009; LANDER ES, 1989, GENETICS, V121, P185; Lassner MW, 1996, PLANT CELL, V8, P281, DOI 10.1105/tpc.8.2.281; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; Liu P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-132; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Loudet O, 2003, PLANT PHYSIOL, V131, P345, DOI 10.1104/pp.102.010785; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Loudet O, 2008, P NATL ACAD SCI USA, V105, P17193, DOI 10.1073/pnas.0807264105; Mackay TFC, 2004, NAT GENET, V36, P1145, DOI 10.1038/ng1104-1145; Millar AA, 1999, PHYTOCHEMISTRY, V52, P1029, DOI 10.1016/S0031-9422(99)00403-3; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Napier JA, 2007, ANNU REV PLANT BIOL, V58, P295, DOI 10.1146/annurev.arplant.58.032806.103811; Napier JA, 2010, CURR OPIN PLANT BIOL, V13, P330, DOI 10.1016/j.pbi.2010.01.008; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; O'Neill CM, 2003, PHYTOCHEMISTRY, V64, P1077, DOI 10.1016/S0031-9422(03)00351-0; O'Neill CM, 2011, HEREDITY; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Roscoe TJ, 2001, FEBS LETT, V492, P107, DOI 10.1016/S0014-5793(01)02243-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wallis JG, 2010, PLANT J, V61, P1092, DOI 10.1111/j.1365-313X.2010.04125.x; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; Ying JZ, 2012, MOL PLANT, V5, P865, DOI 10.1093/mp/ssr100; Zhao JY, 2008, MOL BREEDING, V21, P115, DOI 10.1007/s11032-007-9113-y; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	70	16	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49261	10.1371/journal.pone.0049261	http://dx.doi.org/10.1371/journal.pone.0049261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145136	Green Published, gold			2022-12-25	WOS:000312269500093
J	Liu, F; Wei, YG; Wang, WT; Chen, KF; Yan, LN; Wen, TF; Zhao, JC; Xu, MQ; Li, B				Liu, Fei; Wei, Yonggang; Wang, Wentao; Chen, Kefei; Yan, Lvnan; Wen, Tianfu; Zhao, Jichun; Xu, Mingqing; Li, Bo			Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection	PLOS ONE			English	Article							MICROVASCULAR INVASION; CIRRHOTIC-PATIENTS; SURGICAL-TREATMENT; MILAN CRITERIA; SINGLE-CENTER; RISK-FACTORS; SURVIVAL; EXPERIENCE; IMPACT; STRATEGY	Background: Salvage liver transplantation (SLT) is restricted to patients who develop hepatocellular carcinoma (HCC) recurrence within Milan criteria (MC). Little is known about outcomes for SLT in patients with recurrent HCC within University of California San Francisco (UCSF) criteria after liver resection (LR). Methods: Between January 2001 and December 2011, 380 patients with HCC meeting UCSF criteria, 200 of which were resected (LR group) from a perspective of SLT in case of recurrence, and 180 directly underwent LT (PLT). We compared patient characteristics, perioperative and long-term outcomes between SLT and PLT groups. We also assessed the outcome of LR and PLT groups. Results: Among the 200 patients in LR group, 86 (43%) developed HCC recurrence and 15/86 (17%) of these patients presented HCC recurrence outside UCSF criteria. Only 39 of the 86 patients underwent SLT, a transplantation rate of 45% of patients with HCC recurrence. Compared with PLT group, LR group showed lower overall survival rate (P = 0.005) and higher recurrence rate (P = 0.006). Although intraoperative blood loss and required blood transfusion were more frequent in SLT group, the perioperative mortality and posttransplant complications were similar in SLT and PLT groups. The overall survival and recurrence rates did not significantly differ between the two groups. When stratifying by graft type in the SLT group, overall survival and recurrence rates did not significantly differ between deceased donor LT (DDLT) and living donor LT (LDLT) groups. In the subgroup analysis by MC, similar results were observed between patients with recurrent HCC meeting MC and patients with recurrent HCC beyond MC but within UCSF criteria. Conclusion: Our single institution experience demonstrated that prior hepatectomy and SLT for recurrent HCC within UCSF criteria was feasible and SLT could achieve the same outcome as PLT.	[Liu, Fei; Wei, Yonggang; Wang, Wentao; Chen, Kefei; Yan, Lvnan; Wen, Tianfu; Zhao, Jichun; Xu, Mingqing; Li, Bo] Sichuan Univ, W China Hosp, Dept Liver & Vasc Surg, Div Liver Transplantat, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Li, B (corresponding author), Sichuan Univ, W China Hosp, Dept Liver & Vasc Surg, Div Liver Transplantat, Chengdu 610064, Sichuan Provinc, Peoples R China.	cdlibo688@163.com	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888	National Natural Science Foundation of China [81172372]; National Science and Technology Major Project of China [2008 ZX 100 02 -026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81172372) and the National Science and Technology Major Project of China (2008 ZX 100 02 -026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44; Beighiti J, 2003, ANN SURG, V238, P885, DOI 10.1097/01.sla.0000098621.74851.65; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Del Gaudio M, 2008, AM J TRANSPLANT, V8, P1177, DOI 10.1111/j.1600-6143.2008.02229.x; Di Sandro S, 2009, TRANSPL P, V41, P1283, DOI 10.1016/j.transproceed.2009.03.022; Duffy JP, 2007, ANN SURG, V246, P502, DOI 10.1097/SLA.0b013e318148c704; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Facciuto ME, 2008, ANN SURG ONCOL, V15, P1383, DOI 10.1245/s10434-008-9851-z; Feng X, 2009, CHINESE MED J-PEKING, V122, P781, DOI 10.3760/cma.j.issn.0366-6999.2009.07.004; Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Gondolesi GE, 2004, ANN SURG, V239, P142, DOI 10.1097/01.sla.0000109022.32391.eb; Hwang S, 2007, LIVER TRANSPLANT, V13, P741, DOI 10.1002/lt.21157; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kaido T, 2012, SURGERY, V151, P55, DOI 10.1016/j.surg.2011.06.032; Klintmalm GB, 1998, ANN SURG, V228, P479, DOI 10.1097/00000658-199810000-00005; Liu F, 2009, WORLD J GASTROENTERO, V15, P3931, DOI 10.3748/wjg.15.3931; Lu DSK, 2005, HEPATOLOGY, V41, P1130, DOI 10.1002/hep.20688; Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763; Margarit C, 2005, LIVER TRANSPLANT, V11, P1242, DOI 10.1002/lt.20398; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Moon JI, 2012, TRANSPL P, V44, P487, DOI 10.1016/j.transproceed.2011.11.009; Onaca N, 2007, LIVER TRANSPLANT, V13, P391, DOI 10.1002/lt.21095; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Regimbeau JM, 2002, SURGERY, V131, P311, DOI 10.1067/msy.2002.121892; Roayaie S, 2004, LIVER TRANSPLANT, V10, P534, DOI 10.1002/lt.20128; Roayaie S, 2002, ANN SURG, V235, P533, DOI 10.1097/00000658-200204000-00012; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Shi M, 2007, ANN SURG, V245, P36, DOI 10.1097/01.sla.0000231758.07868.71; Sotiropoulos GC, 2006, EUR J MED RES, V11, P467; Wong LL, 2002, AM J SURG, V183, P309, DOI 10.1016/S0002-9610(02)00785-7; Yao FY, 2005, LIVER TRANSPLANT, V11, P1505, DOI 10.1002/lt.20526; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Yao FY, 2002, LIVER TRANSPLANT, V8, P765, DOI 10.1053/jlts.2002.34892; Yuan D, 2009, POSTGRAD MED J, V85, P119, DOI 10.1136/pgmj.2008.075176; Zavaglia C, 2005, AM J GASTROENTEROL, V100, P2708, DOI 10.1111/j.1572-0241.2005.00289.x	40	37	45	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48932	10.1371/journal.pone.0048932	http://dx.doi.org/10.1371/journal.pone.0048932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145027	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500048
J	Yadav, D; Paliwal, S; Yadav, R; Pal, M; Pandey, A				Yadav, Divya; Paliwal, Sarvesh; Yadav, Rakesh; Pal, Mahima; Pandey, Anubhuti			Identification of Novel HIV 1-Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening	PLOS ONE			English	Article							CHEMICALLY DIVERSE SERIES; PROTEASE INHIBITORS; CYCLIC UREAS; DRUG DISCOVERY; DESIGN; ANTAGONISTS; GENERATION; RESISTANCE; POTENT; MODELS	A combined ligand and structure-based drug design approach provides a synergistic advantage over either methods performed individually. Present work bestows a good assembly of ligand and structure-based pharmacophore generation concept. Ligand-oriented study was accomplished by employing the HypoGen module of Catalyst in which we have translated the experimental findings into 3-D pharmacophore models by identifying key features (four point pharmacophore) necessary for interaction of the inhibitors with the active site of HIV-1 protease enzyme using a training set of 33 compounds belonging to the cyclic cyanoguanidines and cyclic urea derivatives. The most predictive pharmacophore model (hypothesis 1), consisting of four features, namely, two hydrogen bond acceptors and two hydrophobic, showed a correlation (r) of 0.90 and a root mean square of 0.71 and cost difference of 56.59 bits between null cost and fixed cost. The model was validated using CatScramble technique, internal and external test set prediction. In the second phase of our study, a structure-based five feature pharmacophore hypothesis was generated which signifies the importance of hydrogen bond donor, hydrogen bond acceptors and hydrophobic interaction between the HIV-1 protease enzyme and its inhibitors. This work has taken a significant step towards the full integration of ligand and structure-based drug design methodologies as pharmacophoric features retrieved from structure-based strategy complemented the features from ligand-based study hence proving the accuracy of the developed models. The ligand-based pharmacophore model was used in virtual screening of Maybridge and NCI compound database resulting in the identification of four structurally diverse druggable compounds with nM activities. Citation: Yadav D, Paliwal S, Yadav R, Pal M, Pandey A (2012) Identification of Novel HIV 1-Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening. PLoS ONE 7(11): e48942. doi:10.1371/journal.pone.0048942	[Yadav, Divya; Paliwal, Sarvesh; Yadav, Rakesh; Pal, Mahima; Pandey, Anubhuti] Banasthali Univ, Dept Pharm, Banasthali, Rajasthan, India	Banasthali Vidyapith	Paliwal, S (corresponding author), Banasthali Univ, Dept Pharm, Banasthali, Rajasthan, India.	paliwalsarvesh@yahoo.com	Paliwal, Sarvesh/GQQ-1555-2022; Yadav, Rakesh/A-8679-2012	Yadav, Rakesh/0000-0002-8932-5076; Pandey, Anubhuti/0000-0003-1945-8073; Yadav, Dr Divya/0000-0002-4157-6618				Adamson CS, 2012, MOL BIOL INT, DOI [10.1155/2012/604261, DOI 10.1155/2012/604261]; Ali A, 2010, VIRUSES-BASEL, V2, P2509, DOI 10.3390/v2112509; Andreoni M, 2012, EUR REV MED PHARMACO, V16, P10; [Anonymous], CAT SOFTW PACK VERS; BONE R, 1991, J AM CHEM SOC, V113, P9382, DOI 10.1021/ja00024a061; Briant L., 2011, WORLD J AIDS, V1, P111, DOI [10.4236/wja.2011.14017, DOI 10.4236/WJA.2011.14017]; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Chopra M, 2005, J CHEM INF MODEL, V45, P1934, DOI 10.1021/ci050257m; Chopra M, 2008, J MOL MODEL, V14, P1087, DOI 10.1007/s00894-008-0350-8; De Lucca GV, 1998, J MED CHEM, V41, P2411, DOI 10.1021/jm980103g; Debnath AK, 2003, J MED CHEM, V46, P4501, DOI 10.1021/jm030265z; Doyon L, 2005, ANTIVIR RES, V68, P27, DOI 10.1016/j.antiviral.2005.07.003; Estebanez M, 2012, CURR HIV-AIDS REP, V9, P179, DOI 10.1007/s11904-012-0112-1; Ganguly AK, 2011, J MED CHEM, V54, P7176, DOI 10.1021/jm200778q; Garg R, 2004, BIOORGAN MED CHEM, V12, P5819, DOI 10.1016/j.bmc.2004.08.036; Ghosh AK, 2008, ACCOUNTS CHEM RES, V41, P78, DOI 10.1021/ar7001232; Ghosh AK, 2011, J MED CHEM, V54, P622, DOI 10.1021/jm1012787; Gunner OA, 2000, PHARMACOPHORE PERCEP; Jadhav PK, 1998, J MED CHEM, V41, P1446, DOI 10.1021/jm970524i; Klabe RM, 1998, BIOCHEMISTRY-US, V37, P8735, DOI 10.1021/bi972555l; Kristam R, 2005, J CHEM INF MODEL, V45, P461, DOI 10.1021/ci049731z; Kurogi Y, 2001, CURR MED CHEM, V8, P1035, DOI 10.2174/0929867013372481; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; Li D, 2012, J MOL MODEL, V18, P1841, DOI 10.1007/s00894-011-1205-2; Li H, 1999, PHARMACOPHORE PERCEP, P171; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Mannhold R, 2006, METHODS PRINCIPLES M, P31; Mehellou Y, 2010, J MED CHEM, V53, P521, DOI 10.1021/jm900492g; Oloff S, 2005, J MED CHEM, V48, P7322, DOI 10.1021/jm049116m; Osvaldo A, 2006, J CHEM INF MODEL, V46, P345; Paliwal S, 2012, MED CHEM RES, V21, P2307, DOI 10.1007/s00044-011-9756-4; Paliwal S, 2011, MED CHEM RES, V20, P656, DOI 10.1007/s00044-010-9370-x; Paliwal SK, 2011, MONATSH CHEM, V142, P1069, DOI 10.1007/s00706-011-0509-3; Pandit D, 2006, J CHEM INF MODEL, V46, P1236, DOI 10.1021/ci050511a; Patel M, 1998, BIOORG MED CHEM LETT, V8, P1077, DOI 10.1016/S0960-894X(98)00175-9; Patel M, 1998, BIOORG MED CHEM LETT, V8, P823, DOI 10.1016/S0960-894X(98)00119-X; Periard D, 1999, CIRCULATION, V100, P700, DOI 10.1161/01.CIR.100.7.700; Reddy GSKK, 2007, J MED CHEM, V50, P4316, DOI 10.1021/jm070284z; Rodgers JD, 1998, BIOORG MED CHEM LETT, V8, P715, DOI 10.1016/S0960-894X(98)00118-8; Sakuragi J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00242; Sivan SK, 2012, J MOL MODEL, V18, P569, DOI 10.1007/s00894-011-1048-x; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tomasselli AG, 2000, BBA-PROTEIN STRUCT M, V1477, P189, DOI 10.1016/S0167-4838(99)00273-3; Wei J, 2007, J CHEM INF MODEL, V47, P613, DOI 10.1021/ci600410m; Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003; Wilkerson WW, 1997, J MED CHEM, V40, P4079, DOI 10.1021/jm970288b; Xiao ZY, 2004, J MOL GRAPH MODEL, V23, P129, DOI 10.1016/j.jmgm.2004.05.001; Yazal JE, 2001, TOXICOL SCI, V63, P223, DOI 10.1093/toxsci/63.2.223	49	9	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48942	10.1371/journal.pone.0048942	http://dx.doi.org/10.1371/journal.pone.0048942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145032	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500053
J	Althomsons, SP; Kammerer, JS; Shang, N; Navin, TR				Althomsons, Sandy P.; Kammerer, J. Steven; Shang, Nong; Navin, Thomas R.			Using Routinely Reported Tuberculosis Genotyping and Surveillance Data to Predict Tuberculosis Outbreaks	PLOS ONE			English	Article							CONTACT INVESTIGATIONS; CLASSIFICATION; TRANSMISSION; TREE	We combined routinely reported tuberculosis (TB) patient characteristics with genotyping data and measures of geospatial concentration to predict which small clusters (i.e., consisting of only 3 TB patients) in the United States were most likely to become outbreaks of at least 6 TB cases. Of 146 clusters analyzed, 16 (11.0%) grew into outbreaks. Clusters most likely to become outbreaks were those in which at least 1 of the first 3 patients reported homelessness or excess alcohol or illicit drug use or was incarcerated at the time of TB diagnosis and in which the cluster grew rapidly (i.e., the third case was diagnosed within 5.3 months of the first case). Of 17 clusters with these characteristics and therefore considered high risk, 9 (53%) became outbreaks. This retrospective cohort analysis of clusters in the United States suggests that routinely reported data may identify small clusters that are likely to become outbreaks and which are therefore candidates for intensified contact investigations.	[Althomsons, Sandy P.; Shang, Nong; Navin, Thomas R.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Kammerer, J. Steven] Northrop Grumman Corp, Ctr Dis Control Program, Atlanta, GA USA; [Kammerer, J. Steven] Northrop Grumman Corp, Ctr Prevent Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Northrop Grumman Corporation; Northrop Grumman Corporation	Althomsons, SP (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA.	Salthomsons@cdc.gov			Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention (CDC) provides funding to state and local health departments to conduct surveillance of TB disease in accordance with their own disease reporting regulations. CDC provides technical guidance for the collection of data by the state and local health departments and data are sent to CDC for national-level analyses. The analysis methods for this manuscript were developed by CDC. CDC makes all decisions regarding the publication of national surveillance data as a means to describe the TB epidemic. Northrop Grumman Corporation, Atlanta, Georgia, United States of America, employs JSK and provided scientific analysis services as directed by CDC through a contract with CDC.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Anger HA, 2012, CLIN INFECT DIS, V54, P1287, DOI 10.1093/cid/cis029; Bur S, 2003, INT J TUBERC LUNG D, V7, pS417; [CDC Division of TB Elimination], TB NOTES NEWSLETTER; *CDCP, 2000, MMWR, V49; Centers for Disease Control and Prevention, 2011, REP TUB US 2010; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P181; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cronin WA, 2002, EMERG INFECT DIS, V8, P1271; Dobbins Claire, 2012, Morbidity and Mortality Weekly Report, V61, P186; Driver CR, 2006, AM J EPIDEMIOL, V164, P21, DOI 10.1093/aje/kwj153; Funk EA, 2003, INT J TUBERC LUNG D, V7, pS349; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gerald LB, 2002, AM J RESP CRIT CARE, V166, P1122, DOI 10.1164/rccm.200202-124OC; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Lowther SA, 2011, PUBLIC HEALTH REP, V126, P726, DOI 10.1177/003335491112600515; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Mitruka K, 2011, EMERG INFECT DIS, V17, P425, DOI 10.3201/eid1703.101550; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Sall J., 2002, MONTE CARLO CALIBRAT; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sprinson JE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-217; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1	32	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48754	10.1371/journal.pone.0048754	http://dx.doi.org/10.1371/journal.pone.0048754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144956	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800121
J	Bajaj, A; Li, QF; Zheng, QX; Pumiglia, K				Bajaj, Anshika; Li, Qing-fen; Zheng, Qingxia; Pumiglia, Kevin			Loss of NF1 Expression in Human Endothelial Cells Promotes Autonomous Proliferation and Altered Vascular Morphogenesis	PLOS ONE			English	Article							NEUROFIBROMATOSIS-1 HETEROZYGOSITY; SIGNALING NETWORK; MAMMALIAN TARGET; RASA1 MUTATIONS; MTOR; SENESCENCE; MANNER; GROWTH; HYPERACTIVATION; ANGIOGENESIS	Neurofibromatosis is a well known familial tumor syndrome, however these patients also suffer from a number of vascular anomalies. The loss of NF1 from the endothelium is embryonically lethal in mouse developmental models, however little is known regarding the molecular regulation by NF1 in endothelium. We investigated the consequences of losing NF1 expression on the function of endothelial cells using shRNA. The loss of NF1 was sufficient to elevate levels of active Ras under non-stimulated conditions. These elevations in Ras activity were associated with activation of downstream signaling including activation of ERK, AKT and mTOR. Cells knocked down in NF1 expression exhibited no cellular senescence. Rather, they demonstrated augmented proliferation and autonomous entry into the cell cycle. These proliferative changes were accompanied by enhanced expression of cyclin D, phosphorylation of p27(KIP), and decreases in total p27(KIP) levels, even under growth factor free conditions. In addition, NF1-deficient cells failed to undergo normal branching morphogenesis in a co-culture assay, instead forming planar islands with few tubules and branches. We find the changes induced by the loss of NF1 could be mitigated by co-expression of the GAP-related domain of NF1 implicating Ras regulation in these effects. Using doxycycline-inducible shRNA, targeting NF1, we find that the morphogenic changes are reversible. Similarly, in fully differentiated and stable vascular-like structures, the silencing of NF1 results in the appearance of abnormal vascular structures. Finally, the proliferative changes and the abnormal vascular morphogenesis are normalized by low-dose rapamycin treatment. These data provide a detailed analysis of the molecular and functional consequences of NF1 loss in human endothelial cells. These insights may provide new approaches to therapeutically addressing vascular abnormalities in these patients while underscoring a critical role for normal Ras regulation in maintaining the health and function of the vasculature.	[Bajaj, Anshika; Li, Qing-fen; Zheng, Qingxia; Pumiglia, Kevin] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	Pumiglia, K (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	pumiglk@mail.amc.edu		Pumiglia, Kevin/0000-0003-4655-0334	Neurofibromatosis Research Program of CDMRP [W81XWH-09-1-0432]	Neurofibromatosis Research Program of CDMRP	Funding was provided by award W81XWH-09-1-0432 from the Neurofibromatosis Research Program of CDMRP (http://cdmrp.army.mil/nfrp/default.shtml) and by the generosity of the David E. Bryant Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj A, 2010, CANCER RES, V70, P3803, DOI 10.1158/0008-5472.CAN-09-2648; Banerjee S, 2011, P NATL ACAD SCI USA, V108, P15996, DOI 10.1073/pnas.1019012108; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Brown JA, 2012, MOL CELL NEUROSCI, V49, P13, DOI 10.1016/j.mcn.2011.08.008; Brown JA, 2010, J NEUROSCI, V30, P5579, DOI 10.1523/JNEUROSCI.3994-09.2010; Bryant P, 2006, MOL CELL BIOL, V26, P4201, DOI 10.1128/MCB.01612-05; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; Dasgupta B, 2003, J NEUROSCI, V23, P8949; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Endres M, 2004, STROKE, V35, P2708, DOI 10.1161/01.STR.0000143319.73503.38; Ewart MA, 2011, PHARMACOL THERAPEUT, V131, P242, DOI 10.1016/j.pharmthera.2010.11.002; Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Hayward SW, 2001, CANCER RES, V61, P8135; Ismat FA, 2006, J CLIN INVEST, V116, P2378, DOI 10.1172/JCI28341; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lapinski PE, 2012, J CLIN INVEST, V122, P733, DOI 10.1172/JCI46116; Lasater EA, 2010, J CLIN INVEST, V120, P859, DOI 10.1172/JCI41443; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Ma JR, 2012, J ORTHOP RES, V30, P144, DOI 10.1002/jor.21497; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; McClatchey AI, 2007, ANNU REV PATHOL-MECH, V2, P191, DOI 10.1146/annurev.pathol.2.010506.091940; Meadows KN, 2004, ONCOGENE, V23, P192, DOI 10.1038/sj.onc.1206921; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Munchhof AM, 2006, HUM MOL GENET, V15, P1858, DOI 10.1093/hmg/ddl108; Prinz V, 2011, CURR OPIN NEUROL, V24, P75, DOI 10.1097/WCO.0b013e3283424c53; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shirazi Farheen, 2007, Lymphatic Research and Biology, V5, P233, DOI 10.1089/lrb.2007.1012; Wu M, 2006, ONCOGENE, V25, P2297, DOI 10.1038/sj.onc.1209264; Xu J, 2007, CIRCULATION, V116, P2148, DOI 10.1161/CIRCULATIONAHA.107.707752	37	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49222	10.1371/journal.pone.0049222	http://dx.doi.org/10.1371/journal.pone.0049222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145129	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800235
J	Hong, BX; Lee, SH; Song, XT; Jones, L; Machida, K; Huang, XF; Chen, SY				Hong, Bangxing; Lee, Sung-Hyung; Song, Xiao-Tong; Jones, Lindsey; Machida, Keigo; Huang, Xue F.; Chen, Si-Yi			A Super TLR Agonist to Improve Efficacy of Dendritic Cell Vaccine in Induction of Anti-HCV Immunity	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; TNF-ALPHA PROMOTER; TOLL-LIKE RECEPTOR-5; BACTERIAL FLAGELLIN; T-CELLS; THERAPEUTIC VACCINES; ANTITUMOR IMMUNITY; FUSION PROTEINS; INNATE IMMUNITY; EXPRESSION	Persistent infections caused by pathogens such as hepatitis C virus are major human diseases with limited or suboptimal prophylactic and therapeutic options. Given the critical role of dendritic cell (DC) in inducing immune responses, DC vaccination is an attractive means to prevent and control the occurrence and persistence of the infections. However, DCs are built-in with inherent negative regulation mechanisms which attenuate their immune stimulatory activity and lead to their ineffectiveness in clinical application. In this study, we developed a super DC stimulant that consists of a modified, secretory Toll-like Receptor (TLR)-5 ligand and an inhibitor of the negative regulator, suppressor of cytokine sinaling-1 (SOCS1). We found that expressing the super stimulant in DCs is drastically more potent and persistent than using the commonly used DC stimuli to enhance the level and duration of inflammatory cytokine production by both murine and human DCs. Moreover, the DCs expressing the super stimulant are more potent to provoke both cellular and humoral immune responses against hepatitis C virus (HCV) antigen in vivo. Thus, the strategy capable of triggering and sustaining proinflammatory status of DCs may be used to boost efficiency of DC vaccine in preventing and combating the persistent infection of HCV or other chronic viruses.	[Hong, Bangxing; Lee, Sung-Hyung; Jones, Lindsey; Machida, Keigo; Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Song, Xiao-Tong] Baylor Coll Med, Dept Pediat, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	University of Southern California; Baylor College of Medicine	Huang, XF (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	xuefhuan@usc.edu; siyichen@usc.edu	Huang, Xuefei/G-3371-2014; Song, Xiao-Tong/AAI-8424-2020	Huang, Xuefei/0000-0002-6468-5526; Machida, Keigo/0000-0002-9721-8553	United States National Institutes of Health [R01CA100841, R21AI087185, R01CA90427, R0148480, R01AI48711]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA100841, R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084811, R21AI087185, R01AI048711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018857] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported by the United States National Institutes of Health research grants R01CA100841 and R21AI087185 to XH; R01CA90427, R0148480, and R01AI48711 to SYC; and the research grant from Leukemia and Lymphoma Society to SYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Applequist SE, 2005, J IMMUNOL, V175, P3882, DOI 10.4049/jimmunol.175.6.3882; Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Breckpot K, 2009, J IMMUNOL, V182, P860, DOI 10.4049/jimmunol.182.2.860; Cooper ZA, 2010, CELL STRESS CHAPERON, V15, P665, DOI 10.1007/s12192-010-0179-9; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Garrett S, 2008, J IMMUNOL, V180, P5257, DOI 10.4049/jimmunol.180.8.5257; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hong BX, 2009, CANCER RES, V69, P8076, DOI 10.1158/0008-5472.CAN-09-1507; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee JY, 2003, J LEUKOCYTE BIOL, V73, P862, DOI 10.1189/jlb.1202618; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Moingeon P, 2003, CURR OPIN MICROBIOL, V6, P462, DOI 10.1016/j.mib.2003.08.002; Mossoba ME, 2006, EXPERT REV VACCINES, V5, P717, DOI 10.1586/14760584.5.5.717; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; Sandoval J, 2010, CELL MOL LIFE SCI, V67, P1687, DOI 10.1007/s00018-010-0272-3; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Yang TC, 2007, EXPERT REV VACCINES, V6, P347, DOI 10.1586/14760584.6.3.347; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	43	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48614	10.1371/journal.pone.0048614	http://dx.doi.org/10.1371/journal.pone.0048614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144910	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800082
J	Kobayashi, J; Fujimoto, H; Sato, J; Hayashi, I; Burma, S; Matsuura, S; Chen, DJ; Komatsu, K				Kobayashi, Junya; Fujimoto, Hiroko; Sato, Jun; Hayashi, Ikue; Burma, Sandeep; Matsuura, Shinya; Chen, David J.; Komatsu, Kenshi			Nucleolin Participates in DNA Double-Strand Break-Induced Damage Response through MDC1-Dependent Pathway	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEXES; HOMOLOGOUS RECOMBINATION; HISTONE ACETYLATION; GENOMIC STABILITY; REPAIR; ATM; MDC1; H2AX; AMPLIFICATION; RECRUITMENT	H2AX is an important factor for chromatin remodeling to facilitate accumulation of DNA damage-related proteins at DNA double-strand break (DSB) sites. In order to further understand the role of H2AX in the DNA damage response (DDR), we attempted to identify H2AX-interacting proteins by proteomics analysis. As a result, we identified nucleolin as one of candidates. Here, we show a novel role of a major nucleolar protein, nucleolin, in DDR. Nucleolin interacted with gamma-H2AX and accumulated to laser micro-irradiated DSB damage sites. Chromatin Immunoprecipitation assay also displayed the accumulation of nucleolin around DSB sites. Nucleolin-depleted cells exhibited repression of both ATM-dependent phosphorylation following exposure to c-ray and subsequent cell cycle checkpoint activation. Furthermore, nucleolin-knockdown reduced HR and NHEJ activity and showed decrease in IR-induced chromatin accumulation of HR/NHEJ factors, agreeing with the delayed kinetics of gamma-H2AX focus. Moreover, nucleolin-knockdown decreased MDC1-related events such as focus formation of 53 BP1, RNF168, phosphorylated ATM, and H2A ubiquitination. Nucleolin also showed FACT-like activity for DSB damage-induced histone eviction from chromatin. Taken together, nucleolin could promote both ATM-dependent cell cycle checkpoint and DSB repair by functioning in an MDC1-related pathway through its FACT-like function.	[Kobayashi, Junya; Fujimoto, Hiroko; Sato, Jun; Komatsu, Kenshi] Kyoto Univ, Ctr Radiat Biol, Dept Genome Repair Dynam, Kyoto 606, Japan; [Hayashi, Ikue] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Burma, Sandeep; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Matsuura, Shinya] Hiroshima Univ, Dept Genet & Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan	Kyoto University; Hiroshima University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hiroshima University	Kobayashi, J (corresponding author), Kyoto Univ, Ctr Radiat Biol, Dept Genome Repair Dynam, Kyoto 606, Japan.	jkobayashi@house.rbc.kyoto-u.ac.jp	Matsuura, Shinya/U-4182-2017; Kobayashi, Junya/AAX-6390-2021	Matsuura, Shinya/0000-0001-5294-081X; Kobayashi, Junya/0000-0003-4645-7500; Sato, Jun/0000-0001-5159-2390	Ministry of Education, Culture, Sports, Science and Technology of Japan [21310035, 18101002]; National Institutes of Health [RO1 CA149461]; National Aeronautics and Space Administration [NNX10AE08G]; Cancer Prevention and Research Institute of Texas [RP100644]; NATIONAL CANCER INSTITUTE [R01CA149461] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to JK (21310035) and KK (18101002). SB is supported by grants from the National Institutes of Health (RO1 CA149461), National Aeronautics and Space Administration (NNX10AE08G) and the Cancer Prevention and Research Institute of Texas (RP100644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; De AY, 2006, BIOCHEM BIOPH RES CO, V344, P206, DOI 10.1016/j.bbrc.2006.03.113; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Farin K, 2011, CANCER RES, V71, P2140, DOI 10.1158/0008-5472.CAN-10-2887; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kobayashi J, 2010, MECH AGEING DEV, V131, P436, DOI 10.1016/j.mad.2010.06.005; Kobayashi J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-34; Kobayashi J, 2009, BIOCHEM BIOPH RES CO, V380, P752, DOI 10.1016/j.bbrc.2009.01.109; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Pierce AJ, 2005, METH MOL B, V291, P373; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Yogev O, 2008, CANCER RES, V68, P1398, DOI 10.1158/0008-5472.CAN-07-2865	49	53	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49245	10.1371/journal.pone.0049245	http://dx.doi.org/10.1371/journal.pone.0049245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145133	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800236
J	Lin, QQ; London, E				Lin, Qingqing; London, Erwin			Altering Hydrophobic Sequence Lengths Shows That Hydrophobic Mismatch Controls Affinity for Ordered Lipid Domains (Rafts) in the Multitransmembrane Strand Protein Perfringolysin O	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; CALCIUM ADENOSINE-TRIPHOSPHATASE; INDEPENDENT-MUTAGENESIS SLIM; BILAYER THICKNESS; MODEL MEMBRANES; PORE FORMATION; PEPTIDES; BINDING; CHAIN; PENETRATION	The hypothesis that mismatch between transmembrane (TM) length and bilayer width controls TM protein affinity for ordered lipid domains (rafts) was tested using perfringolysin O (PFO), a pore-forming cholesterol-dependent cytolysin. PFO forms a multimeric barrel with many TM segments. The properties of PFO mutants with lengthened or shortened TM segments were compared with that of PFO with wild type TM sequences. Both mutant and wild type length PFO exhibited cholesterol-dependent membrane insertion. Maximal PFO-induced pore formation occurred in vesicles with wider bilayers for lengthened TM segments and in thinner bilayers for shortened TM segments. In diC(18:0) phosphatidylcholine (PC)/diC(14:1) PC/cholesterol vesicles, which form ordered domains with a relatively thick bilayer and disordered domains with a relatively thin bilayer, affinity for ordered domains was greatest with lengthened TM segments and least with shortened TM segments as judged by FRET. Similar results were observed by microscopy in giant vesicles containing sphingomyelin in place of diC(18:0) PC. In contrast, in diC(16:0) PC/diC(14:0) PC/diC(20:1) PC/cholesterol vesicles, which should form ordered domains with a relatively thin bilayer and disordered domains with a relatively thick bilayer, relative affinity for ordered domains was greatest with shortened TM segments and least with lengthened TM segments. The inability of multi-TM segment proteins (unlike single TM segment proteins) to adapt to mismatch by tilting may explain the sensitivity of raft affinity to mismatch. The difference in width sensitivity for single and multi-TM helix proteins may link raft affinity to multimeric state and thus control the assembly of multimeric TM complexes in rafts.	[Lin, Qingqing; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Science Foundation [MCB 1019986]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 1019986.	Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Caffrey M, 1981, Biochem Soc Trans, V9, P155; CAFFREY M, 1981, BIOCHEMISTRY-US, V20, P1949, DOI 10.1021/bi00510a034; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Chiantia S, 2007, LANGMUIR, V23, P7659, DOI 10.1021/la7010919; Chiantia S, 2011, BIOPHYS J, V100, pLO1, DOI 10.1016/j.bpj.2010.11.051; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; Dumas F, 2000, BIOCHEMISTRY-US, V39, P4846, DOI 10.1021/bi992634s; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; FLORINE KI, 1987, BIOCHEMISTRY-US, V26, P2978, DOI 10.1021/bi00385a004; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; JOHANNSSON A, 1981, J BIOL CHEM, V256, P1643; JOHANNSSON A, 1981, BIOCHIM BIOPHYS ACTA, V641, P416, DOI 10.1016/0005-2736(81)90498-3; JOHNSON ID, 1991, ANAL BIOCHEM, V198, P228, DOI 10.1016/0003-2697(91)90418-S; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1939, DOI 10.1021/bi00510a033; Marsh D, 2004, BBA-BIOMEMBRANES, V1666, P118, DOI 10.1016/j.bbamem.2004.08.006; MONTECUCCO C, 1982, FEBS LETT, V144, P145, DOI 10.1016/0014-5793(82)80588-7; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Nicol F, 1999, BIOPHYS J, V76, P2121, DOI 10.1016/S0006-3495(99)77368-6; Nir S, 1999, MOL MEMBR BIOL, V16, P95, DOI 10.1080/096876899294814; O'Keeffe AH, 2000, BIOPHYS J, V79, P2066, DOI 10.1016/S0006-3495(00)76454-X; Pathak P, 2011, BIOPHYS J, V101, P2417, DOI 10.1016/j.bpj.2011.08.059; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; Ridder ANJA, 2002, BIOCHEMISTRY-US, V41, P4946, DOI 10.1021/bi0158674; Sachs JN, 2006, ANNU REV BIOCHEM, V75, P707, DOI 10.1146/annurev.biochem.75.110105.142336; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stopar D, 2009, BIOPHYS J, V96, P1408, DOI 10.1016/j.bpj.2008.11.029; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; van Duyl BY, 2002, FEBS LETT, V523, P79, DOI 10.1016/S0014-5793(02)02939-3; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vidal A, 2005, BIOPHYS J, V89, P1102, DOI 10.1529/biophysj.105.062380; Wang J, 2006, BIOCHEMISTRY-US, V45, P8124, DOI 10.1021/bi060587f; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	54	49	49	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1340	1352		10.1074/jbc.M112.415596	http://dx.doi.org/10.1074/jbc.M112.415596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23150664	hybrid, Green Published			2022-12-25	WOS:000313570300055
J	Andrew, AJ; Berndsen, CE; Kao, S; Strebel, K				Andrew, Amy J.; Berndsen, Christopher E.; Kao, Sandra; Strebel, Klaus			The Size and Conservation of a Coiled-coil Structure in the Ectodomain of Human BST-2/Tetherin Is Dispensable for Inhibition of HIV-1 Virion Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ANTI-TETHERIN ACTIVITIES; CELL-SURFACE; OLIGOMERIZATION STATE; MOLECULAR-CLONING; DOWN-MODULATION; VIRUS RELEASE; VPU; PROTEIN; BST-2	BST-2/CD317/tetherin is a host factor that inhibits HIV-1 release and is counteracted by HIV-1 Vpu. Structural studies indicate that the BST-2 ectodomain assumes a coiled-coil conformation. Here we studied the role of the BST-2 ectodomain for tethering function. First, we addressed the importance of the length and structure of the ectodomain by adding or substituting heterologous coiled-coil or non-coiled-coil sequences. We found that extending or replacing the BST-2 ectodomain using non-coiled-coil sequences resulted in loss of BST-2 function. Doubling the size of the BST-2 ectodomain by insertion of a heterologous coiled-coil motif or substituting the BST-2 coiled-coil domain with a heterologous coiled-coil motif maintained tethering function. Reductions in the size of the BST-2 coiled-coil domain were tolerated as well. In fact, deletion of the C-terminal half of the BST-2 ectodomain, including a series of seven consecutive heptad motifs did not abolish tethering function. However, slight changes in the positioning of deletions affecting the relative placing of charged or hydrophobic residues on the helix severely impacted the functional properties of BST-2. Overall, we conclude that the size of the BST-2 ectodomain is highly flexible and can be reduced or extended as long as the positioning of residues important for the stability of the dimer interface is maintained.	[Andrew, Amy J.; Kao, Sandra; Strebel, Klaus] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Berndsen, Christopher E.] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA 22807 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); James Madison University	Strebel, K (corresponding author), NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 310,4 Ctr Dr MSC 0460, Bethesda, MD 20892 USA.	kstrebel@nih.gov		Berndsen, Christopher/0000-0002-4285-4341	Intramural Research Program of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000669] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIAID, National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Bartoli L, 2009, BIOINFORMATICS, V25, P2757, DOI 10.1093/bioinformatics/btp539; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; FISCHETTI VA, 1993, INFORM PROCESS LETT, V45, P11, DOI 10.1016/0020-0190(93)90245-5; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Fritz JV, 2012, VIROLOGY, V424, P33, DOI 10.1016/j.virol.2011.12.008; GOTO T, 1994, BLOOD, V84, P1922; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-10; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Kwok SC, 2004, BIOPOLYMERS, V76, P378, DOI 10.1002/bip.20141; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Lu SM, 2004, PROTEIN SCI, V13, P714, DOI 10.1110/ps.03443204; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Miyagi E, 2011, J VIROL, V85, P11981, DOI 10.1128/JVI.05176-11; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Vigan R, 2011, J VIROL, V85, P9737, DOI 10.1128/JVI.00479-11; Wagschal K, 1999, PROTEIN SCI, V8, P2312; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; Yang SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-13; Yoshida T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00035; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008; Zhou JM, 2012, BIOCHEMISTRY-US, V51, P1288, DOI 10.1021/bi2015986	58	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44278	44288		10.1074/jbc.M112.418822	http://dx.doi.org/10.1074/jbc.M112.418822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152502	Green Published, hybrid			2022-12-25	WOS:000312938600026
J	Alto, BW; Malicoate, J; Elliott, SM; Taylor, J				Alto, Barry W.; Malicoate, Jolene; Elliott, Scott M.; Taylor, Jacqueline			Demographic Consequences of Predators on Prey: Trait and Density Mediated Effects on Mosquito Larvae in Containers	PLOS ONE			English	Article							INDUCED MORPHOLOGICAL DEFENSES; AEDES-TRISERIATUS DIPTERA; BEHAVIORAL-RESPONSES; SPECIES INTERACTIONS; DEPENDENT PREDATION; INVASIVE MOSQUITOS; HABITAT COMPLEXITY; COMPETITION; SIZE; ALBOPICTUS	Predators may affect prey population growth and community diversity through density mediated lethal and trait mediated non-lethal effects that influence phenotypic traits of prey. We tested experimentally the roles of thinning the density of prey (lethality) in the absence of predator cues and density and trait mediated effects (lethality + intimidation) of predatory midge Corethrella appendiculata on competing native and invasive mosquito prey. Predator-mediated reductions in prey and density reductions in the absence of C. appendiculata resulted in lower percent survivorship to adulthood and estimates of the finite rate of increase (lambda') for invasive mosquito Aedes albopictus relative to that of controls. In most instances, thinning the density of prey in the absence, but not in the presence, of C. appendiculata cues resulted in lower survivorship to adulthood and lambda' for native mosquito Aedes triseriatus relative to that of controls. Together, these results suggested trait mediated effects of C. appendiculata specific to each species of mosquito prey. Release from intraspecific competition attributable to density reductions in the absence, but not in the presence, of C. appendiculata enhanced growth and lengthened adult lifespan relative to that of controls for A. albopictus but not A. triseriatus. These results show the importance of predator-mediated density and trait mediated effects on phenotypic traits and populations of invasive and native mosquitoes. Species-specific differences in the phenotypic responses of prey may be due, in part, to longer evolutionary history of C. appendiculata with A. triseriatus than A. albopictus.	[Alto, Barry W.; Malicoate, Jolene; Elliott, Scott M.; Taylor, Jacqueline] Univ Florida, Florida Med Entomol Lab, Dept Entomol & Nematol, Vero Beach, FL USA	State University System of Florida; University of Florida	Alto, BW (corresponding author), Univ Florida, Florida Med Entomol Lab, Dept Entomol & Nematol, Vero Beach, FL USA.	bwalto@ufl.edu			Institute of Food and Agricultural Sciences, University of Florida; University of Florida Open-Access Publishing Fund	Institute of Food and Agricultural Sciences, University of Florida(University of Florida); University of Florida Open-Access Publishing Fund	This study was supported by funds from the Institute of Food and Agricultural Sciences, University of Florida. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Alto BW, 2009, J ANIM ECOL, V78, P928, DOI 10.1111/j.1365-2656.2009.01558.x; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Babbitt KJ, 1998, OECOLOGIA, V114, P258, DOI 10.1007/s004420050444; BARRY MJ, 1994, OECOLOGIA, V97, P278, DOI 10.1007/BF00323161; Beketov MA, 2007, ECOL ENTOMOL, V32, P405, DOI 10.1111/j.1365-2311.2007.00889.x; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; BENCE JR, 1986, ECOLOGY, V67, P324, DOI 10.2307/1938576; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; Bevins SN, 2007, J VECTOR ECOL, V32, P252, DOI 10.3376/1081-1710(2007)32[252:TORIAL]2.0.CO;2; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Costanzo KS, 2011, ECOL ENTOMOL, V36, P605, DOI 10.1111/j.1365-2311.2011.01302.x; Craig JK, 2006, ECOLOGY, V87, P2366, DOI 10.1890/0012-9658(2006)87[2366:PGASPI]2.0.CO;2; Dahl J, 2002, ECOLOGY, V83, P1620, DOI 10.1890/0012-9658(2002)083[1620:IMDITW]2.0.CO;2; Day T, 2002, EVOLUTION, V56, P877; Fill A, 2012, ECOL ENTOMOL, V37, P43, DOI 10.1111/j.1365-2311.2011.01333.x; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grill CP, 1996, J ANIM ECOL, V65, P63, DOI 10.2307/5700; Griswold MW, 2005, ANN ENTOMOL SOC AM, V98, P673, DOI 10.1603/0013-8746(2005)098[0673:COOACD]2.0.CO;2; Griswold MW, 2005, ECOL ENTOMOL, V30, P122, DOI 10.1111/j.0307-6946.2005.00671.x; Hechtel LJ, 1997, ECOLOGY, V78, P838, DOI 10.1890/0012-9658(1997)078[0838:EOAPOP]2.0.CO;2; Hoverman JT, 2009, FUNCT ECOL, V23, P1179, DOI 10.1111/j.1365-2435.2009.01586.x; Johansson F, 2002, CAN J ZOOL, V80, P944, DOI 10.1139/Z02-073; Johnson DW, 2006, ECOLOGY, V87, P1179, DOI 10.1890/0012-9658(2006)87[1179:PHCAVI]2.0.CO;2; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; JULIANO SA, 1992, OIKOS, V63, P465, DOI 10.2307/3544974; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Juliano SA, 2010, OECOLOGIA, V162, P709, DOI 10.1007/s00442-009-1475-x; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z; Kesavaraju B, 2004, ANN ENTOMOL SOC AM, V97, P194, DOI 10.1603/0013-8746(2004)097[0194:DBRTWC]2.0.CO;2; Kesavaraju B, 2008, ANN ENTOMOL SOC AM, V101, P1150, DOI 10.1603/0013-8746-101.6.1150; Kesavaraju B, 2008, OECOLOGIA, V155, P631, DOI 10.1007/s00442-007-0935-4; Kesavaraju B, 2007, ECOL ENTOMOL, V32, P262, DOI 10.1111/j.1365-2311.2006.00846.x; Kesavaraju B, 2010, ANN ENTOMOL SOC AM, V103, P1038, DOI 10.1603/AN10007; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204; Lounibos LP, 2008, J INSECT BEHAV, V21, P47, DOI 10.1007/s10905-007-9103-2; Lounibos L. P., 2001, Biological Invasions, V3, P151, DOI 10.1023/A:1014519919099; LOUNIBOS LP, 1993, OIKOS, V66, P114, DOI 10.2307/3545203; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Mowles SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023068; Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x; Nannini MA, 1998, ANN ENTOMOL SOC AM, V91, P33, DOI 10.1093/aesa/91.1.33; NOVAK MG, 1993, ENVIRON ENTOMOL, V22, P311, DOI 10.1093/ee/22.2.311; Peckarsky BL, 2001, ECOLOGY, V82, P740, DOI 10.1890/0012-9658(2001)082[0740:VIMSAM]2.0.CO;2; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Relyea RA, 2003, ECOL APPL, V13, P1515, DOI 10.1890/02-5298; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Relyea RA, 2008, OIKOS, V117, P1647, DOI 10.1111/j.1600-0706.2008.16933.x; Relyea RA, 2012, ECOL APPL, V22, P634, DOI 10.1890/11-0189.1; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; Sanders NJ, 2003, ECOLOGY, V84, P1024, DOI 10.1890/0012-9658(2003)084[1024:RIATOO]2.0.CO;2; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SIH A, 1986, ECOLOGY, V67, P434, DOI 10.2307/1938587; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Tilman D., 1982, Monographs in Population Biology, pi; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; WERNER EE, 1974, J FISH RES BOARD CAN, V31, P1531, DOI 10.1139/f74-186; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227; Yee DA, 2007, J ANIM ECOL, V76, P1105, DOI 10.1111/j.1365-2656.2007.01297.x	68	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e45785	10.1371/journal.pone.0045785	http://dx.doi.org/10.1371/journal.pone.0045785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152748	Green Published, gold, Green Submitted			2022-12-25	WOS:000311234000002
J	Franca, M; Turella, L; Canto, R; Brunelli, N; Allione, L; Andreasi, NG; Desantis, M; Marzoli, D; Fadiga, L				Franca, Michele; Turella, Luca; Canto, Rosario; Brunelli, Nicola; Allione, Luisa; Andreasi, Nico Golfre; Desantis, Marianna; Marzoli, Daniele; Fadiga, Luciano			Corticospinal Facilitation during Observation of Graspable Objects: A Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; GRASPING-RELATED NEURONS; MOTOR CORTEX; AREA F5; FUNCTIONAL-ORGANIZATION; CORTICAL MECHANISMS; COIL STIMULATION; DORSAL PREMOTOR; MACAQUE MONKEY; TIME-COURSE	In 1979, Gibson first advanced the idea that the sight of graspable objects automatically activates in the observer the repertoire of actions necessary to interact with them, even in the absence of any intention to act ("affordance effect''). The neurophysiological substrate of this effect was later identified in a class of bimodal neurons, the so-called "canonical" neurons, located within monkey premotor cortex. In humans, even if different behavioral studies supported the existence of affordance effect, neurophysiological investigations exploring its neural substrates showed contradictory results. Here, by means of Transcranial Magnetic Stimulation (TMS), we explored the time-course of the "affordance effect'' elicited by the observation of everyday-life graspable objects on motor cortex of resting observers. We recorded motor evoked potentials (MEP) from three intrinsic hand muscles (two "synergic" for grasping, OP and FDI and one "neutral", ADM). We found that objects' vision determined an increased excitability at 120 milliseconds after their presentation. Moreover, this modulation was proved to be specific to the cortical representations of synergic muscles. From an evolutionary perspective, this timing perfectly fits with a fast recruitment of the motor system aimed at rapidly and accurately choosing the appropriate motor plans in a competitive environment filled with different opportunities. Citation: Franca M, Turella L, Canto R, Brunelli N, Allione L, et al. (2012) Corticospinal Facilitation during Observation of Graspable Objects: A Transcranial Magnetic Stimulation Study. PLoS ONE 7(11): e49025. doi:10.1371/journal.pone.0049025	[Franca, Michele; Turella, Luca; Canto, Rosario; Brunelli, Nicola; Allione, Luisa; Andreasi, Nico Golfre; Desantis, Marianna; Marzoli, Daniele; Fadiga, Luciano] Univ Ferrara, Sect Human Physiol, Dept Biomed Sci & Adv Therapies, I-44100 Ferrara, Italy; [Turella, Luca; Canto, Rosario; Fadiga, Luciano] Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy	University of Ferrara; Istituto Italiano di Tecnologia - IIT	Franca, M (corresponding author), Univ Ferrara, Sect Human Physiol, Dept Biomed Sci & Adv Therapies, I-44100 Ferrara, Italy.	michele.tfr@gmail.com	França, Michele/GQA-6034-2022; Andreasi, Nico Golfrè/AAC-2306-2019; Fadiga, Luciano/AAC-7404-2022; Turella, Luca/AAB-2327-2019	Andreasi, Nico Golfrè/0000-0003-3555-5367; Turella, Luca/0000-0003-1096-2150; fadiga, luciano/0000-0001-5691-5080	E.C. project POETICON; E.C. project POETICON++; project Regione Emilia Romagna Universita	E.C. project POETICON; E.C. project POETICON++; project Regione Emilia Romagna Universita	This research was supported by E.C. projects POETICON and POETICON++ and by the project Regione Emilia Romagna Universita through financial grants to Luciano Fadiga. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amassian VE, 2003, SUPPL CLIN NEUROPHYS, V56, P119; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Anderson SJ, 2002, P ROY SOC B-BIOL SCI, V269, P1225, DOI 10.1098/rspb.2002.1998; Brochier T, 2007, CURR OPIN NEUROBIOL, V17, P637, DOI 10.1016/j.conb.2007.12.002; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; Canto R, 2011, BEHAV RES METHODS, V43, P292, DOI 10.3758/s13428-010-0022-3; Cattaneo L, 2005, P NATL ACAD SCI USA, V102, P898, DOI 10.1073/pnas.0409182102; Cerri G, 2003, J NEUROPHYSIOL, V90, P832, DOI 10.1152/jn.01026.2002; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Davare M, 2010, CURR BIOL, V20, P176, DOI 10.1016/j.cub.2009.11.063; Di Lazzaro V, 1999, EXP BRAIN RES, V129, P494, DOI 10.1007/s002210050919; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Ellis R, 2000, BRIT J PSYCHOL, V91, P451, DOI 10.1348/000712600161934; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gibson JJ, 1979, ECOLOGICAL APPROACH; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hohlefeld FU, 2011, BRAIN RES, V1368, P185, DOI 10.1016/j.brainres.2010.10.035; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Koch G, 2010, NEUROPSYCHOLOGIA, V48, P3513, DOI 10.1016/j.neuropsychologia.2010.07.037; Lago A, 2010, NEUROPSYCHOLOGIA, V48, P1802, DOI 10.1016/j.neuropsychologia.2010.02.030; MACCABEE PJ, 1991, ELECTROEN CLIN NEURO, P111; Makris S, 2011, BRAIN COGNITION, V77, P257, DOI 10.1016/j.bandc.2011.08.002; Matelli M, 2000, ADV NEUROL, V84, P51; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips JC, 2002, VIS COGN, V9, P540, DOI 10.1080/13506280143000575; Prabhu G, 2007, J PHYSIOL-LONDON, V581, P189, DOI 10.1113/jphysiol.2006.123356; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, NOVART FDN SYMP, V218, P81; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Vainio L, 2007, EXP BRAIN RES, V179, P583, DOI 10.1007/s00221-006-0813-z; Vainio L, 2006, EXP BRAIN RES, V173, P395, DOI 10.1007/s00221-006-0378-x; Valyear KF, 2007, NEUROIMAGE, V36, pT94, DOI 10.1016/j.neuroimage.2007.03.031; Vingerhoets G, 2009, BRAIN COGNITION, V69, P481, DOI 10.1016/j.bandc.2008.10.003; Walsh V, 2003, BRADFORD BOOKS, P1	55	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49025	10.1371/journal.pone.0049025	http://dx.doi.org/10.1371/journal.pone.0049025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145052	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500061
J	Schmidt, JM; Sebastian, P; Wilder, SM; Rypstra, AL				Schmidt, Jason M.; Sebastian, Peter; Wilder, Shawn M.; Rypstra, Ann L.			The Nutritional Content of Prey Affects the Foraging of a Generalist Arthropod Predator	PLOS ONE			English	Article							WOLF SPIDERS ARANEAE; PARDOSA-MILVINA ARANEAE; FUNCTIONAL-RESPONSE; ELEMENTAL STOICHIOMETRY; NUTRIENT IMBALANCE; FEEDING-BEHAVIOR; TROPHIC CASCADES; LYCOSIDAE; ECOLOGY; CANNIBALISM	While foraging theory predicts that predatory responses should be determined by the energy content and size of prey, it is becoming increasingly clear that carnivores regulate their intake of specific nutrients. We tested the hypothesis that prey nutrient composition and predator nutritional history affects foraging intensity, consumption, and prey selection by the wolf spider, Pardosa milvina. By altering the rearing environment for fruit flies, Drosophila melanogaster, we produced high quality flies containing more nitrogen and protein and less lipid than low quality fruit flies. In one experiment, we quantified the proportion of flies taken and consumption across a range of densities of either high or low quality flies and, in a second experiment, we determined the prey capture and consumption of spiders that had been maintained on contrasting diets prior to testing. In both cases, the proportion of prey captured declined with increasing prey density, which characterizes the Type II functional response that is typical of wolf spiders. Spiders with similar nutritional histories killed similar numbers of each prey type but consumed more of the low quality prey. Spiders provided high quality prey in the weeks prior to testing killed more prey than those on the low quality diet but there was no effect of prior diet on consumption. In the third experiment, spiders were maintained on contrasting diets for three weeks and then allowed to select from a mixture of high and low quality prey. Interestingly, feeding history affected prey preferences: spiders that had been on a low quality diet showed no preference but those on the high quality diet selected high quality flies from the mixture. Our results suggest that, even when prey size and species identity are controlled, the nutritional experience of the predator as well as the specific content of the prey shapes predator-prey interactions.	[Rypstra, Ann L.] Miami Univ, Dept Zool, Hamilton, OH 45011 USA; [Schmidt, Jason M.; Sebastian, Peter; Wilder, Shawn M.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University; University System of Ohio; Miami University	Rypstra, AL (corresponding author), Miami Univ, Dept Zool, Hamilton, OH 45011 USA.	rypstral@muohio.edu		M. Schmidt, Jason/0000-0002-8119-856X; Wilder, Shawn/0000-0003-0359-7220	US National Science Foundation Research Experience for Undergraduates Program, REU [DBI 0353915]; Miami University's Graduate School, Department of Zoology; Div Of Biological Infrastructure [1156703] Funding Source: National Science Foundation	US National Science Foundation Research Experience for Undergraduates Program, REU; Miami University's Graduate School, Department of Zoology; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Peter Sebastian's participation in this research was funded by the US National Science Foundation Research Experience for Undergraduates Program, REU (DBI 0353915). Additional funding was provided by Miami University's Graduate School, Department of Zoology (from both the Oxford and Hamilton Campuses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1987, THEOR POPUL BIOL, V32, P262, DOI 10.1016/0040-5809(87)90050-5; Abrams PA, 2010, FUNCT ECOL, V24, P7, DOI 10.1111/j.1365-2435.2009.01621.x; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Bell RD, 2006, ETHOLOGY, V112, P903, DOI 10.1111/j.1439-0310.2006.01244.x; Birkhofer K, 2010, BASIC APPL ECOL, V11, P486, DOI 10.1016/j.baae.2010.06.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bressendorff BB, 2011, BIOL LETTERS, V7, P517, DOI 10.1098/rsbl.2011.0103; Chen BR, 1999, ECOLOGY, V80, P761, DOI 10.1890/0012-9658(1999)080[0761:BULOPA]2.0.CO;2; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; DeVito J, 2004, CAN J ZOOL, V82, P1119, DOI 10.1139/Z04-090; Elser J, 2006, AM NAT, V168, pS25, DOI 10.1086/509048; GREENSTONE MH, 1979, NATURE, V282, P501, DOI 10.1038/282501a0; Griffen BD, 2007, ECOLOGY, V88, P3012, DOI 10.1890/07-0172.1; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Halaj J, 2001, AM NAT, V157, P262, DOI 10.1086/319190; Harwood JD, 2003, J ANIM ECOL, V72, P745, DOI 10.1046/j.1365-2656.2003.00746.x; Hoefler CD, 2002, J ARACHNOL, V30, P155, DOI 10.1636/0161-8202(2002)030[0155:CRTPIP]2.0.CO;2; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; HOROWITZ H, 2002, OFFICIAL METHODS ANA; Jaenike J, 2003, FUNCT ECOL, V17, P115, DOI 10.1046/j.1365-2435.2003.00701.x; Jensen K, 2012, P ROY SOC B-BIOL SCI, V279, P2212, DOI 10.1098/rspb.2011.2410; Jensen K, 2011, ANIM BEHAV, V81, P993, DOI 10.1016/j.anbehav.2011.01.035; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Jespersen LB, 2003, FUNCT ECOL, V17, P737, DOI 10.1111/j.1365-2435.2003.00788.x; Juliano S., 2001, DESIGN ANAL ECOLOGIC, P179; JULIANO SA, 1987, J ANIM ECOL, V56, P641, DOI 10.2307/5074; Lomborg JP, 2009, BEHAV ECOL, V20, P700, DOI 10.1093/beheco/arp044; MANLY BFJ, 1972, AM NAT, V106, P719, DOI 10.1086/282808; Markow TA, 1999, FUNCT ECOL, V13, P78, DOI 10.1046/j.1365-2435.1999.00285.x; Maupin JL, 2001, BEHAV ECOL, V12, P569, DOI 10.1093/beheco/12.5.569; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2006, J ANIM ECOL, V75, P288, DOI 10.1111/j.1365-2656.2006.01046.x; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; NENTWIG W, 1986, OECOLOGIA, V69, P571, DOI 10.1007/BF00410365; Nyffeler M, 2003, AGR ECOSYST ENVIRON, V95, P579, DOI 10.1016/S0167-8809(02)00181-0; NYFFELER M, 1988, J APPL ENTOMOL, V106, P123, DOI 10.1111/j.1439-0418.1988.tb00575.x; Persons MH, 1997, J INSECT BEHAV, V10, P737, DOI 10.1007/BF02765390; Persons MH, 2002, BEHAV ECOL, V13, P386, DOI 10.1093/beheco/13.3.386; Raubenheimer D, 2007, ECOLOGY, V88, P2598, DOI 10.1890/07-0012.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Rypstra AL, 2005, J ARACHNOL, V33, P390, DOI 10.1636/CT05-10.1; Rypstra AL, 2003, ETHOLOGY, V109, P315, DOI 10.1046/j.1439-0310.2003.00874.x; Rypstra AL, 2007, OIKOS, V116, P853, DOI [10.1111/j.2007.0030-1299.15622.x, 10.1111/j.0030-1299.2007.15622.x]; SAMU F, 1993, EUR J ENTOMOL, V90, P471; Schmidt JM, 2012, OIKOS, V121, P1715, DOI 10.1111/j.1600-0706.2011.20366.x; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schonewolf KW, 2006, J CHEM ECOL, V32, P1565, DOI 10.1007/s10886-006-9070-7; Searcy LE, 1999, J CHEM ECOL, V25, P2527, DOI 10.1023/A:1020878225553; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TREXLER JC, 1993, ECOLOGY, V74, P1629, DOI 10.2307/1939921; Trubl P, 2011, ETHOLOGY, V117, P236, DOI 10.1111/j.1439-0310.2010.01870.x; Walker SE, 2002, CAN J ZOOL, V80, P679, DOI 10.1139/Z02-037; Whelan Christopher J., 2007, P141; Wilder SM, 2008, ANIM BEHAV, V76, P439, DOI 10.1016/j.anbehav.2008.01.023; Wilder SM, 2011, ADV INSECT PHYSIOL, V40, P87, DOI 10.1016/B978-0-12-387668-3.00002-7; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x	64	65	67	4	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49223	10.1371/journal.pone.0049223	http://dx.doi.org/10.1371/journal.pone.0049223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145130	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500089
J	Arata, H; Komatsu, H; Hosokawa, K; Maeda, M				Arata, Hideyuki; Komatsu, Hiroshi; Hosokawa, Kazuo; Maeda, Mizuo			Rapid and Sensitive MicroRNA Detection with Laminar Flow-Assisted Dendritic Amplification on Power-Free Microfluidic Chip	PLOS ONE			English	Article							ROLLING CIRCLE AMPLIFICATION; TOTAL ANALYSIS SYSTEMS; CIRCULATING MICRORNAS; GENE-EXPRESSION; FREE MICROCHIP; HUMAN CANCERS; DNA; HYBRIDIZATION; DEVICES; POLY(DIMETHYLSILOXANE)	Detection of microRNAs, small noncoding single-stranded RNAs, is one of the key topics in the new generation of cancer research because cancer in the human body can be detected or even classified by microRNA detection. This report shows rapid and sensitive microRNA detection using a power-free microfluidic device, which is driven by degassed poly(dimethylsiloxane), thus eliminating the need for an external power supply. MicroRNA is detected by sandwich hybridization, and the signal is amplified by laminar flow-assisted dendritic amplification. This method allows us to detect microRNA of specific sequences at a limit of detection of 0.5 pM from a 0.5 mu L sample solution with a detection time of 20 min. Together with the advantages of self-reliance of this device, this method might contribute substantially to future point-of-care early-stage cancer diagnosis.	[Arata, Hideyuki; Komatsu, Hiroshi; Hosokawa, Kazuo; Maeda, Mizuo] RIKEN, Bioengn Lab, Wako, Saitama, Japan	RIKEN	Hosokawa, K (corresponding author), RIKEN, Bioengn Lab, Wako, Saitama, Japan.	k-hoso@riken.go.jp	Arata, Hideyuki/N-4092-2017; Maeda, Mizuo/I-3498-2014	Arata, Hideyuki/0000-0002-6310-6078; 	KAKENHI [22500448]; Funding Program for World-Leading Innovative R&D on Science and Technology; Grants-in-Aid for Scientific Research [22500448] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Funding Program for World-Leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (22500448) and the Funding Program for World-Leading Innovative R&D on Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arata HF, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177374; Arata H, 2012, ANALYST, V137, P3234, DOI 10.1039/c2an16154k; Arata HF, 2009, INTEGR BIOL-UK, V1, P363, DOI 10.1039/b901902b; Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Cai S, 2010, ANAL CHEM, V82, P7178, DOI 10.1021/ac101892t; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Castoldi M, 2008, NAT PROTOC, V3, P321, DOI 10.1038/nprot.2008.4; Chapin SC, 2011, ANAL CHEM, V83, P7179, DOI 10.1021/ac201618k; Cissell A.K., 2007, ANAL CHEM, V79, P4755; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; Diamandis P., 1996, IMMUNOASSAY; Duan DM, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr774; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao W, 2011, CLIN LUNG CANCER, V12, P14, DOI 10.3816/CLC.2011.n.001; GLASER RW, 1993, ANAL BIOCHEM, V213, P152, DOI 10.1006/abio.1993.1399; Hisamoto H, 2001, CHEM COMMUN, P2662, DOI 10.1039/b106494k; Hosokawa K, 2006, LAB CHIP, V6, P236, DOI 10.1039/b513424b; Hosokawa K, 2004, LAB CHIP, V4, P181, DOI 10.1039/b403930k; Hosokawa K, 2007, ANAL CHEM, V79, P6000, DOI 10.1021/ac070659o; Hosokawa K, 2010, ANAL SCI, V26, P1053, DOI 10.2116/analsci.26.1053; Hosokawa K, 2009, LAB CHIP, V9, P464, DOI 10.1039/b810814e; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Jeffrey SS, 2008, NAT BIOTECHNOL, V26, P400, DOI 10.1038/nbt0408-400; Judy JW, 2001, SMART MATER STRUCT, V10, P1115, DOI 10.1088/0964-1726/10/6/301; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Li W, 2009, ANAL BIOANAL CHEM, V394, P1117, DOI 10.1007/s00216-008-2570-2; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072; Sato K, 2003, ADV DRUG DELIVER REV, V55, P379, DOI 10.1016/S0169-409X(02)00225-9; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; TRIMMER WS, 1997, MICROMECHANICS MEMS; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yuan BF, 2008, CHEM COMMUN, P6600, DOI 10.1039/b812929k; Zhou YT, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq556; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a	44	57	57	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48329	10.1371/journal.pone.0048329	http://dx.doi.org/10.1371/journal.pone.0048329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144864	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800045
J	Comyn, SA; Pilgrim, D				Comyn, Sophie A.; Pilgrim, David			Lack of Developmental Redundancy between Unc45 Proteins in Zebrafish Muscle Development	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CO-CHAPERONE; EMBRYONIC-DEVELOPMENT; SKELETAL-MUSCLES; UNC-45 GENE; MYOSIN; OVEREXPRESSION; PRESERVATION; COLOCALIZES; CARTILAGE	Since the majority of protein-coding genes in vertebrates have intra-genomic homologues, it has been difficult to eliminate the potential of functional redundancy from analyses of mutant phenotypes, whether produced by genetic lesion or transient knockdown. Further complicating these analyses, not all gene products have activities that can be assayed in vitro, where the efficiency of the various family members can be compared against constant substrates. Two vertebrate UNC-45 homologues, unc45a and unc45b, affect distinct stages of muscle differentiation when knocked down in cell culture and are functionally redundant in vitro. UNC-45 proteins are members of the UCS (UNC-45/CRO1/She4p) protein family that has been shown to regulate myosin-dependent functions from fungi to vertebrates through direct interaction with the myosin motor domain. To test whether the same functional relationship exists between these unc45 paralogs in vivo, we examined the developmental phenotypes of doubly homozygous unc45b(-/-); unc45a(-/-) mutant zebrafish embryos. We focused specifically on the combined effects on morphology and gene expression resulting from the zygotic lack of both paralogs. We found that unc45b(-/-) and unc45b(-/-); unc45a(-/-) embryos were phenotypically indistinguishable with both mutants displaying identical cardiac, skeletal muscle, and jaw defects. We also found no evidence to support a role for zygotic Unc45a function in myoblast differentiation. In contrast to previous in vitro work, this rules out a model of functional redundancy between Unc45a and Unc45b in vivo. Instead, our phylogenetic and phenotypic analyses provide evidence for the role of functional divergence in the evolution of the UCS protein family.	[Comyn, Sophie A.; Pilgrim, David] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Pilgrim, D (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dave.pilgrim@ualberta.ca	Pilgrim, David/A-2676-2014	Pilgrim, David/0000-0001-7820-7915	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC; NICHS; Alberta Ingenuity Fund	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NICHS; Alberta Ingenuity Fund	This work was supported by a Discovery Grant to DP from the Natural Sciences and Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). SC was supported in part by an NSERC Graduate Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for the development of the University of Alberta's zebrafish facility was provided by Alberta Ingenuity Fund via Dr. Andrew Waskiewicz. Aleah McCorry assisted in maintaining zebrafish stocks, and Layne Myhre commented on the manuscript. The MF20 monoclonal antibody (developed by Stockdale and Fischman) was obtained from the Developmental Studies Hybridoma Bank, under the auspices of the NICHS and maintained by the University of Iowa, Department of Biological Sciences.	Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL, V171, P1640, DOI 10.2353/ajpath.2007.070325; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chadli A, 2008, J BIOL CHEM, V283, P9509, DOI 10.1074/jbc.C800017200; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Epping MT, 2009, MOL CANCER RES, V7, P1861, DOI 10.1158/1541-7786.MCR-09-0187; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Force A, 1999, GENETICS, V151, P1531; French CR, 2009, DEV BIOL, V333, P37, DOI 10.1016/j.ydbio.2009.06.018; Geach TJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-75; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Hoppe PE, 1996, J CELL BIOL, V135, P371, DOI 10.1083/jcb.135.2.371; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kim J, 2008, TRENDS CELL BIOL, V18, P264, DOI 10.1016/j.tcb.2008.03.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krone PH, 1997, CELL MOL LIFE SCI, V53, P122, DOI 10.1007/PL00000574; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Lele Z, 1999, DEV BIOL, V210, P56, DOI 10.1006/dbio.1999.9262; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Lynch M, 2000, GENETICS, V154, P459; MARUYAMA IN, 1989, MOL GEN GENET, V219, P113, DOI 10.1007/BF00261165; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Schilling TF, 1996, DEVELOPMENT, V123, P329; Shi H, 2010, P NATL ACAD SCI US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Walker Michael G., 2001, Mini-Reviews in Medicinal Chemistry, V1, P197, DOI 10.2174/1389557013407034; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wong KCY, 2000, J CELL SCI, V113, P2421; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0	52	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48861	10.1371/journal.pone.0048861	http://dx.doi.org/10.1371/journal.pone.0048861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144999	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800155
J	Dias, MP; Granadeiro, JP; Catry, P				Dias, Maria P.; Granadeiro, Jose P.; Catry, Paulo			Do Seabirds Differ from Other Migrants in Their Travel Arrangements? On Route Strategies of Cory's Shearwater during Its Trans-Equatorial Journey	PLOS ONE			English	Article							DISTANCE MIGRATION; SOOTY SHEARWATERS; FORAGING BEHAVIOR; PELAGIC SEABIRD; HABITAT USE; OCEAN; TIME; MORPHOLOGY; MOVEMENTS; PATTERNS	Long-distance migrants have developed diverse strategies to deal with the challenges imposed by their annual journeys. These are relatively well studied in some avian groups, such as passerines, shorebirds and raptors. In contrast, few studies have addressed the migratory behaviour of pelagic birds in the light of current theories of optimal migration. Using a dataset of 100 complete migratory tracks gathered along four years, we performed a detailed study on the migratory strategy of a pelagic trans-equatorial migrant, the Cory's shearwater Calonectris diomedea. We analysed daily routines, stopover ecology and travel speed, as well as the influence of the moon on several behavioural patterns. Cory's shearwaters adopted a "fly-and-forage'' strategy when migrating, similarly to what has been observed in some raptors. However, by flying by dynamic soaring, shearwaters attained high overall migration speeds, and were able to travel thousands of kilometres without making major stopovers and, apparently, without a noticeable pre-migratory fattening period. Other major findings of this study include the ability to adapt daily schedules when crossing major ecological barriers, and the constant adjustment of migration speed implying higher rates of travel in the pre-breeding movement, with a final sprint to the nesting colony. The present study also highlights a preference of Cory's shearwaters for starting travel at twilight and documents a strong relationship between their migratory activity and the moon phase.	[Dias, Maria P.; Catry, Paulo] Inst Univ Ciencias Psicol Sociais & Vida, Ecoethol Res Unit, Lisbon, Portugal; [Dias, Maria P.; Catry, Paulo] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, Lisbon, Portugal; [Granadeiro, Jose P.] Museu Nacl Hist Nat & Ciencia, Ctr Estudos Ambiente & Mar, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade de Lisboa	Dias, MP (corresponding author), Inst Univ Ciencias Psicol Sociais & Vida, Ecoethol Res Unit, Lisbon, Portugal.	madias@fc.ul.pt	Catry, Paulo/I-5408-2013; Granadeiro, José Pedro/E-8060-2011; Dias, Maria/AAK-1171-2021	Catry, Paulo/0000-0003-3000-0522; Granadeiro, José Pedro/0000-0002-7207-3474; Dias, Maria/0000-0002-7281-4391	Fundacao para a Ciencia e a Tecnologia (FCT - Portugal); FEDER [PTDC/MAR/71927/2006, PEst-OE/MAR/UI0331/2011]; FCT-BPD/46827/08	Fundacao para a Ciencia e a Tecnologia (FCT - Portugal)(Portuguese Foundation for Science and Technology); FEDER(European Commission); FCT-BPD/46827/08	This research was funded by Fundacao para a Ciencia e a Tecnologia (FCT - Portugal; http://www. fct.pt/index.phtml.en) and FEDER through PTDC/MAR/71927/2006 and PEst-OE/MAR/UI0331/2011 projects and a postdoctoral fellowship (FCT-BPD/46827/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE KP, 1989, J EXP BIOL, V141, P241; Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T., 1990, P331; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2006, ARDEA, V94, P347; Alerstam T, 2009, J THEOR BIOL, V258, P530, DOI 10.1016/j.jtbi.2009.01.020; [Anonymous], 2010, R LANG ENV STAT COMP; Awkerman JA, 2005, MAR ECOL PROG SER, V291, P289, DOI 10.3354/meps291289; Bestley S, 2008, J ANIM ECOL, V77, P1223, DOI 10.1111/j.1365-2656.2008.01437.x; Bulyuk VN, 2009, J ORNITHOL, V150, P339, DOI 10.1007/s10336-008-0352-4; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Catry P, 2004, MAR ECOL PROG SER, V280, P261, DOI 10.3354/meps280261; Catry P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026079; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; Fusani L, 2009, BIOL LETTERS, V5, P302, DOI 10.1098/rsbl.2008.0755; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hedenstrom A, 1998, J AVIAN BIOL, V29, P424, DOI 10.2307/3677161; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; Hedenstrom A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000362; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; James D, 2000, CR ACAD SCI III-VIE, V323, P215, DOI 10.1016/S0764-4469(00)00121-9; Klaassen RHG, 2008, BEHAV ECOL SOCIOBIOL, V62, P1427, DOI 10.1007/s00265-008-0572-x; Kopp M, 2011, MAR ECOL PROG SER, V435, P263, DOI 10.3354/meps09229; Lindstrom A, 2011, CONDOR, V113, P129, DOI 10.1525/cond.2011.090171; Luque SP, 2007, BEHAVIOUR, V144, P1315, DOI 10.1163/156853907782418213; Mackley EK, 2011, MAR BIOL, V158, P429, DOI 10.1007/s00227-010-1570-x; Monteiro LR, 1996, COLON WATERBIRD, V19, P82, DOI 10.2307/1521810; MOORE FR, 1987, ETHOLOGY, V75, P155; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; NORRIS KS, 1980, FISH B-NOAA, V77, P821; Pennycuik Colin J., 2002, Avian Science, V2, P1; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Ramos JA, 2009, CONDOR, V111, P424, DOI 10.1525/cond.2009.090008; Richardson PL, 2011, PROG OCEANOGR, V88, P46, DOI 10.1016/j.pocean.2010.08.001; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; SIBLY RM, 1990, ANIM BEHAV, V39, P63, DOI 10.1016/S0003-3472(05)80726-2; Sittler B, 2011, J ORNITHOL, V152, P375, DOI 10.1007/s10336-010-0597-6; Spear LB, 1999, CONDOR, V101, P205, DOI 10.2307/1369984; Strandberg R, 2007, BEHAV ECOL SOCIOBIOL, V61, P1865, DOI 10.1007/s00265-007-0426-y; Strandberg R, 2009, ARDEA, V97, P287, DOI 10.5253/078.097.0304; Strandberg R, 2009, IBIS, V151, P200, DOI 10.1111/j.1474-919X.2008.00890.x; Vedernikov VI, 2007, OCEANOLOGY+, V47, P386, DOI 10.1134/S0001437007030113; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019; Yamamoto T, 2010, AUK, V127, P871, DOI 10.1525/auk.2010.10029; ZWARTS L, 1990, ARDEA, V78, P237; [No title captured]	58	44	44	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49376	10.1371/journal.pone.0049376	http://dx.doi.org/10.1371/journal.pone.0049376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145168	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800256
J	Garufi, A; Pistritto, G; Ceci, C; Di Renzo, L; Santarelli, R; Faggioni, A; Cirone, M; D'Orazi, G				Garufi, Alessia; Pistritto, Giuseppa; Ceci, Claudia; Di Renzo, Livia; Santarelli, Roberta; Faggioni, Alberto; Cirone, Mara; D'Orazi, Gabriella			Targeting COX-2/PGE(2) Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE 2; IMMUNE-RESPONSES; GENE-EXPRESSION; UP-REGULATION; BETA-CATENIN; P53 ACTIVITY; HYPOXIA; CYCLOOXYGENASE; SUPPRESSION	Background: Homeodomain-interacting protein kinase 2 (HIPK2) is a multifunctional protein that exploits its kinase activity to modulate key molecular pathways in cancer to restrain tumor growth and induce response to therapies. For instance, HIPK2 knockdown induces upregulation of oncogenic hypoxia-inducible factor-1 (HIF-1) activity leading to a constitutive hypoxic and angiogenic phenotype with increased tumor growth in vivo. HIPK2 inhibition, therefore, releases pathways leading to production of pro-inflammatory molecules such as vascular endothelial growth factor (VEGF) or prostaglandin E2 (PGE(2)). Tumor-produced inflammatory mediators other than promote tumour growth and vascular development may permit evasion of anti-tumour immune responses. Thus, dendritic cells (DCs) dysfunction induced by tumor-produced molecules, may allow tumor cells to escape immunosurveillance. Here we evaluated the molecular mechanism of PGE(2) production after HIPK2 depletion and how to modulate it. Methodology/Principal findings: We show that HIPK2 knockdown in colon cancer cells resulted in cyclooxygenase-2 (COX-2) upregulation and COX-2-derived PGE(2) generation. At molecular level, COX-2 upregulation depended on HIF-1 activity. We previously reported that zinc treatment inhibits HIF-1 activity. Here, zinc supplementation to HIPK2 depleted cells inhibited HIF-1-induced COX-2 expression and PGE(2)/VEGF production. At translational level, while conditioned media of both siRNA control and HIPK2 depleted cells inhibited DCs maturation, conditioned media of only zinc-treated HIPK2 depleted cells efficiently restored DCs maturation, seen as the expression of co-stimulatory molecules CD80 and CD86, cytokine IL-10 release, and STAT3 phosphorylation. Conclusion/Significance: These findings show that: 1) HIPK2 knockdown induced COX-2 upregulation, mostly depending on HIF-1 activity; 2) zinc treatment downregulated HIF-1-induced COX-2 and inhibited PGE(2)/VEGF production; and 3) zinc treatment of HIPK2 depleted cells restored DCs maturation.	[Di Renzo, Livia; Santarelli, Roberta; Faggioni, Alberto; Cirone, Mara] Univ Roma La Sapienza, Dept Expt Med, Inst Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Garufi, Alessia] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Pistritto, Giuseppa; Ceci, Claudia] Univ Roma Tor Vergata, Dept Neurosci, Pharmacol Sect, Rome, Italy; [D'Orazi, Gabriella] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara	Cirone, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Inst Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy.	mara.cirone@uniroma1.it; gdorazi@unich.it	D'Orazi, Gabriella/T-2792-2019; Ceci, Claudia/GQP-1347-2022; Garufi, Alessia/AAT-3363-2020; Di Renzo, Livia/D-1143-2013; Ceci, Claudia/AHE-8839-2022; Santarelli, Roberta/K-5434-2015	D'Orazi, Gabriella/0000-0001-6876-9105; Di Renzo, Livia/0000-0003-3807-0760; Ceci, Claudia/0000-0002-5958-7497; Santarelli, Roberta/0000-0002-9416-7594; Garufi, Alessia/0000-0001-9354-993X	Italian Association for Cancer Research (AIRC) [11377, 10265]	Italian Association for Cancer Research (AIRC)	This study was supported by Grants from The Italian Association for Cancer Research (AIRC) to GDO (no. 11377) and to AF (n. 10265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chan TA, 2006, TRENDS MOL MED, V12, P240, DOI 10.1016/j.molmed.2006.04.006; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cirone M, 2010, INT J IMMUNOPATH PH, V23, P1079, DOI 10.1177/039463201002300412; Cirone M, 2008, IMMUNOL LETT, V120, P37, DOI 10.1016/j.imlet.2008.06.011; Cirone M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031732; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; D'Orazi G, 2006, CLIN CANCER RES, V12, P735, DOI 10.1158/1078-0432.CCR-05-1557; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Fong LYY, 2005, J NATL CANCER I, V97, P40, DOI 10.1093/jnci/dji006; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Rodriguez LAG, 2006, LANCET, V368, P1745, DOI 10.1016/S0140-6736(06)69667-0; Gottfried E, 2008, CYTOKINE GROWTH F R, V19, P65, DOI 10.1016/j.cytogfr.2007.10.008; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim EA, 2010, BIOCHEM BIOPH RES CO, V394, P966, DOI 10.1016/j.bbrc.2010.03.099; Lavra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020665; Lee CT, 2010, INT J HYPERTHER, V26, P232, DOI 10.3109/02656731003601745; Mao JH, 2012, ONCOGENE, V31, P1176, DOI 10.1038/onc.2011.306; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Nardinocchi L, 2010, CELL CYCLE, V9, P1270, DOI 10.4161/cc.9.7.11125; Nardinocchi L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006819; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Nefedova Y, 2005, J IMMUNOL, V175, P4338, DOI 10.4049/jimmunol.175.7.4338; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Puca R, 2009, EXP CELL RES, V315, P67, DOI 10.1016/j.yexcr.2008.10.018; Puca R, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-22; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ristimaki A, 1997, CANCER RES, V57, P1276; Saukkonen K, 2003, APMIS, V111, P915, DOI 10.1034/j.1600-0463.2003.1111001.x; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V94, P1021; Sheffer M, 2011, ONCOTARGET, V2, P1191; Sheng KC, 2011, CURR MED CHEM, V18, P5507; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhong XS, 2007, BIOCHEM BIOPH RES CO, V358, P92, DOI 10.1016/j.bbrc.2007.04.083	57	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48342	10.1371/journal.pone.0048342	http://dx.doi.org/10.1371/journal.pone.0048342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144866	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800046
J	Huang, SH; Wu, CH; Chang, YC; Kwon-Chung, KJ; Brown, RJ; Jong, A				Huang, Sheng-He; Wu, Chun-Hua; Chang, Yun C.; Kwon-Chung, Kyung J.; Brown, Robert J.; Jong, Ambrose			Cryptococcus neoformans-Derived Microvesicles Enhance the Pathogenesis of Fungal Brain Infection	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; CAPSULE-ASSOCIATED GENE; EXTRACELLULAR VESICLES; MEMBRANE-VESICLES; EXOSOMES; VIRULENCE; INVASION; POLYSACCHARIDE; MACROPHAGES; LEISHMANIA	Cryptococcal meningoencephalitis is the most common fungal disease in the central nervous system. The mechanisms by which Cryptococcus neoformans invades the brain are largely unknown. In this study, we found that C. neoformans-derived microvesicles (CnMVs) can enhance the traversal of the blood-brain barrier (BBB) by C. neoformans in vitro. The immunofluorescence imaging demonstrates that CnMVs can fuse with human brain microvascular endothelial cells (HBMECs), the constituents of the BBB. This activity is presumably due to the ability of the CnMVs to activate HBMEC membrane rafts and induce cell fusogenic activity. CnMVs also enhanced C. neoformans infection of the brain, found in both infected brains and cerebrospinal fluid. In infected mouse brains, CnMVs are distributed inside and around C. neoformans-induced cystic lesions. GFAP (glial fibrillary acidic protein)-positive astrocytes were found surrounding the cystic lesions, overlapping with the 14-3-3-GFP (14-3-3-green fluorescence protein fusion) signals. Substantial changes could be observed in areas that have a high density of CnMV staining. This is the first demonstration that C. neoformans-derived microvesicles can facilitate cryptococcal traversal across the BBB and accumulate at lesion sites of C. neoformans-infected brains. Results of this study suggested that CnMVs play an important role in the pathogenesis of cryptococcal meningoencephalitis.	[Wu, Chun-Hua; Brown, Robert J.; Jong, Ambrose] Univ So Calif, Keck Sch Med, Div Hematol Oncol, Saban Res Inst,Childrens Hosp Los Angeles,Dept Pe, Los Angeles, CA 90033 USA; [Huang, Sheng-He] Univ So Calif, Keck Sch Med, Div Infect Dis, Saban Res Inst,Childrens Hosp Los Angeles,Dept Pe, Los Angeles, CA 90033 USA; [Chang, Yun C.; Kwon-Chung, Kyung J.] NIAID, Lab Clin Infect Dis, Bethesda, MD 20892 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jong, A (corresponding author), Univ So Calif, Keck Sch Med, Div Hematol Oncol, Saban Res Inst,Childrens Hosp Los Angeles,Dept Pe, Los Angeles, CA 90033 USA.	ajong@chla.usc.edu			Public Health Service grants from National Institutes of Health [R01-NS047599, R01-AI40635]; intramural program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040635, ZIAAI000057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	Public Health Service grants from National Institutes of Health; intramural program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was financially supported by Public Health Service grants R01-NS047599 (A.J.) and R01-AI40635 (S. H. H.) from the National Institutes of Health. The work of Kyung J. Kwon-Chung and Yun C. Chang was supported by funds from the intramural program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HC, 2010, LAB INVEST, V90, P1549, DOI 10.1038/labinvest.2010.152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Chang YC, 1996, INFECT IMMUN, V64, P1977, DOI 10.1128/IAI.64.6.1977-1983.1996; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; De Jesus M, 2009, EUKARYOT CELL, V8, P96, DOI 10.1128/EC.00331-08; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Huang SH, 2011, BIOCHEM J, V438, P457, DOI 10.1042/BJ20110218; Jong A, 2012, J BIOL CHEM; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Long M, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-19; Oliveira DL, 2009, FUNGAL GENET BIOL, V46, P956, DOI 10.1016/j.fgb.2009.09.001; Panepinto J, 2009, MOL MICROBIOL, V71, P1165, DOI 10.1111/j.1365-2958.2008.06588.x; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Silverman JM, 2011, CELL MICROBIOL, V13, P1, DOI 10.1111/j.1462-5822.2010.01537.x; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wang LI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019162; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	32	69	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48570	10.1371/journal.pone.0048570	http://dx.doi.org/10.1371/journal.pone.0048570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144903	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800077
J	Kresse, SH; Rydbeck, H; Skarn, M; Namlos, HM; Barragan-Polania, AH; Cleton-Jansen, AM; Serra, M; Liestol, K; Hogendoorn, PCW; Hovig, E; Myklebost, O; Meza-Zepeda, LA				Kresse, Stine H.; Rydbeck, Halfdan; Skarn, Magne; Namlos, Heidi M.; Barragan-Polania, Ana H.; Cleton-Jansen, Anne-Marie; Serra, Massimo; Liestol, Knut; Hogendoorn, Pancras C. W.; Hovig, Eivind; Myklebost, Ola; Meza-Zepeda, Leonardo A.			Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CELL-LINES; BREAST-CANCER; COPY-NUMBER; EXPRESSION; IDENTIFICATION; DISEASE; BONE; BIOINFORMATICS; OVEREXPRESSION	Background: Osteosarcomas are the most common non-haematological primary malignant tumours of bone, and all conventional osteosarcomas are high-grade tumours showing complex genomic aberrations. We have integrated genome-wide genetic and epigenetic profiles from the EuroBoNeT panel of 19 human osteosarcoma cell lines based on microarray technologies. Principal Findings: The cell lines showed complex patterns of DNA copy number changes, where genomic copy number gains were significantly associated with gene-rich regions and losses with gene-poor regions. By integrating the datasets, 350 genes were identified as having two types of aberrations (gain/over-expression, hypo-methylation/over-expression, loss/under-expression or hyper-methylation/under-expression) using a recurrence threshold of 6/19 (>30%) cell lines. The genes showed in general alterations in either DNA copy number or DNA methylation, both within individual samples and across the sample panel. These 350 genes are involved in embryonic skeletal system development and morphogenesis, as well as remodelling of extracellular matrix. The aberrations of three selected genes, CXCL5, DLX5 and RUNX2, were validated in five cell lines and five tumour samples using PCR techniques. Several genes were hyper-methylated and under-expressed compared to normal osteoblasts, and expression could be reactivated by demethylation using 5-Aza-2'-deoxycytidine treatment for four genes tested; AKAP12, CXCL5, EFEMP1 and IL11RA. Globally, there was as expected a significant positive association between gain and over-expression, loss and under-expression as well as hyper-methylation and under-expression, but gain was also associated with hyper-methylation and under-expression, suggesting that hyper-methylation may oppose the effects of increased copy number for detrimental genes. Conclusions: Integrative analysis of genome-wide genetic and epigenetic alterations identified dependencies and relationships between DNA copy number, DNA methylation and mRNA expression in osteosarcomas, contributing to better understanding of osteosarcoma biology.	[Kresse, Stine H.; Rydbeck, Halfdan; Skarn, Magne; Namlos, Heidi M.; Barragan-Polania, Ana H.; Hovig, Eivind; Myklebost, Ola; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway; [Rydbeck, Halfdan; Liestol, Knut; Hovig, Eivind] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Barragan-Polania, Ana H.; Myklebost, Ola; Meza-Zepeda, Leonardo A.] Univ Oslo, Norwegian Microarray Consortium, Dept Mol Biosci, Oslo, Norway; [Cleton-Jansen, Anne-Marie; Hogendoorn, Pancras C. W.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Serra, Massimo] Ist Ortoped Rizzoli, Expt Oncol Lab, Bologna, Italy	University of Oslo; University of Oslo; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; IRCCS Istituto Ortopedico Rizzoli	Meza-Zepeda, LA (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway.	leonardm@rr-research.no	Meza-Zepeda, Leonardo Andres/CAG-5229-2022; Hogendoorn, Pancras/O-6494-2019; Serra, Massimo/J-4878-2016; Hovig, Eivind/H-2474-2011; Hogendoorn, Pancras C.W./H-5859-2015; Namløs, Heidi Maria/AAB-2843-2021; Myklebost, Ola/E-9335-2010	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X; Hogendoorn, Pancras/0000-0002-1513-8104; Serra, Massimo/0000-0003-0742-1177; Hovig, Eivind/0000-0002-9103-1077; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Myklebost, Ola/0000-0002-2866-3223; rydbeck, halfdan/0000-0003-1606-3842	European Network to Promote Research into Uncommon Cancers in Adults and Children: Pathology, Biology and Genetics of Bone Tumours (EuroBoNeT); Norwegian Cancer Society (Ragnvarda F. Sorvik and Hakon Starheim's legacy); Norwegian Research Council	European Network to Promote Research into Uncommon Cancers in Adults and Children: Pathology, Biology and Genetics of Bone Tumours (EuroBoNeT); Norwegian Cancer Society (Ragnvarda F. Sorvik and Hakon Starheim's legacy); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the European Network to Promote Research into Uncommon Cancers in Adults and Children: Pathology, Biology and Genetics of Bone Tumours (EuroBoNeT), the Norwegian Cancer Society (Ragnvarda F. Sorvik and Hakon Starheim's legacy) and the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes LH, 2006, ACTA ONCOL, V45, P38, DOI 10.1080/02841860500466624; Bacci G, 2003, ANN ONCOL, V14, P1126, DOI 10.1093/annonc/mdg286; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Toledo SRC, 2011, J ORTHOP SCI, V16, P458, DOI 10.1007/s00776-011-0106-7; Chari R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-67; Cui JC, 2011, B CANCER, V98, pE62, DOI 10.1684/bdc.2011.1400; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Epping MT, 2006, CANCER RES, V66, P10639, DOI 10.1158/0008-5472.CAN-06-2522; Flanagan JM, 2010, AM J HUM GENET, V86, P420, DOI 10.1016/j.ajhg.2010.02.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hattinger CM, 2010, EXPERT OPIN EMERG DR, V15, P615, DOI 10.1517/14728214.2010.505603; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kawamura M, 2011, EUR J CANC IN PRESS; Kresse Stine H, 2010, BMC Res Notes, V3, P223, DOI 10.1186/1756-0500-3-223; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Kuijjer ML, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-66; Lau CC, 2004, GENE CHROMOSOME CANC, V39, P11, DOI 10.1002/gcc.10291; Lauss M, 2012, EPIGENETICS, V7; Lee MH, 2009, ANN NY ACAD SCI, V1171, P87, DOI 10.1111/j.1749-6632.2009.04909.x; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058; Li Y, 2008, EXP MOL PATHOL, V84, P234, DOI 10.1016/j.yexmp.2008.03.013; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lockwood WW, 2011, J MOL DIAGN, V13, P289, DOI 10.1016/j.jmoldx.2010.11.020; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Ozaki T, 2002, INT J CANCER, V102, P355, DOI 10.1002/ijc.10709; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; PosthumaDeBoer J, 2011, CLIN EXP METASTAS, V28, P493, DOI 10.1007/s10585-011-9384-x; Rao-Bindal Krithi, 2011, Sarcoma, V2011, P679457, DOI 10.1155/2011/679457; Raymond AK., 2002, WHO CLASSIFICATION T; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Schenk T, 2007, GENE CHROMOSOME CANC, V46, P796, DOI 10.1002/gcc.20465; Schulz A, 1993, CALCIFIED TISSUE INT, V52, P30; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Smida J, 2010, CLIN CANCER RES, V16, P4256, DOI 10.1158/1078-0432.CCR-10-0284; Speetjens FM, 2008, CLIN CANCER RES, V14, P2276, DOI 10.1158/1078-0432.CCR-07-4045; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Yen CC, 2009, INT J ONCOL, V35, P775, DOI 10.3892/ijo_00000390; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zou C, 2011, CANCER, V118, P1845, DOI 10.1101/531210	57	73	73	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48262	10.1371/journal.pone.0048262	http://dx.doi.org/10.1371/journal.pone.0048262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144859	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800042
J	McManus, H; O'Connor, CC; Boyd, M; Broom, J; Russell, D; Watson, K; Roth, N; Read, PJ; Petoumenos, K; Law, MG				McManus, Hamish; O'Connor, Catherine C.; Boyd, Mark; Broom, Jennifer; Russell, Darren; Watson, Kerrie; Roth, Norman; Read, Phillip J.; Petoumenos, Kathy; Law, Matthew G.		Australian HIV Observational Datab	Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy	PLOS ONE			English	Article							LIFE EXPECTANCY; CONTROLLED-TRIAL; CELL COUNTS; MORTALITY; COHORT; INFECTION; DIAGNOSIS; PEOPLE; IMPACT	Background: Life expectancy has increased for newly diagnosed HIV patients since the inception of combination antiretroviral treatment (cART), but there remains a need to better understand the characteristics of long-term survival in HIV-positive patients. We examined long-term survival in HIV-positive patients receiving cART in the Australian HIV Observational Database (AHOD), to describe changes in mortality compared to the general population and to develop longer-term survival models. Methods: Data were examined from 2,675 HIV-positive participants in AHOD who started cART. Standardised mortality ratios (SMR) were calculated by age, sex and calendar year across prognostic characteristics using Australian Bureau of Statistics national data as reference. SMRs were examined by years of duration of cART by CD4 and similarly by viral load. Survival was analysed using Cox-proportional hazards and parametric survival models. Results: The overall SMR for all-cause mortality was 3.5 (95% CI: 3.0-4.0). SMRs by CD4 count were 8.6 (95% CI: 7.2-10.2) for CD4<350 cells/mu l; 2.1 (95% CI: 1.5-2.9) for CD4 = 350-499 cells/mu l; and 1.5 (95% CI: 1.1-2.0) for CD4 >= 500 cells/mu l. SMRs for patients with CD4 counts<350 cells/mu l were much higher than for patients with higher CD4 counts across all durations of cART. SMRs for patients with viral loads greater than 400 copies/ml were much higher across all durations of cART. Multivariate models demonstrated improved survival associated with increased recent CD4, reduced recent viral load, younger patients, absence of HBVsAg-positive ever, year of HIV diagnosis and incidence of ADI. Parametric models showed a fairly constant mortality risk by year of cART up to 15 years of treatment. Conclusion: Observed mortality remained fairly constant by duration of cART and was modelled accurately by accepted prognostic factors. These rates did not vary much by duration of treatment. Changes in mortality with age were similar to those in the Australian general population.	[McManus, Hamish; Boyd, Mark; Petoumenos, Kathy; Law, Matthew G.] UNSW, Kirby Inst, Sydney, NSW, Australia; [O'Connor, Catherine C.] Royal Prince Alfred Hosp, RPA Sexual Hlth, Sydney, NSW, Australia; [O'Connor, Catherine C.] UNSW, S Western Clin Sch, Sydney, NSW, Australia; [O'Connor, Catherine C.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Broom, Jennifer] Nambour Gen Hosp, Dept Infect Dis, Nambour, Qld, Australia; [Russell, Darren] Cairns Sexual Hlth Serv, Cairns, Qld, Australia; [Watson, Kerrie] Alfred Hosp, Melbourne, Vic, Australia; [Roth, Norman] Prahran Market Clin, Prahran, Vic, Australia; [Read, Phillip J.] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; University of Sydney; University of New South Wales Sydney; University of Sydney; Florey Institute of Neuroscience & Mental Health	McManus, H (corresponding author), UNSW, Kirby Inst, Sydney, NSW, Australia.	hmcmanus@kirby.unsw.edu.au	Broom, Jennifer/I-1414-2013	Boyd, Mark/0000-0002-6848-3307; Broom, Jennifer/0000-0003-3513-3412; Law, Matthew/0000-0002-3540-8837; McManus, Hamish/0000-0002-7264-8848; Templeton, David/0000-0003-2157-9587	Asia Pacific HIV Observational Database, a program of The Foundation for AIDS Research, amfAR; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI069907]; Merck Sharp Dohme; Gilead; Bristol-Myers Squibb; Boehringer Ingelheim; Roche; Pfizer; GlaxoSmithKline; Janssen-Cilag; Australian Government Department of Health and Ageing; Johnson Johnson; CSL Ltd.; Merck; BMS; Abbott; ViiV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	Asia Pacific HIV Observational Database, a program of The Foundation for AIDS Research, amfAR; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); CSL Ltd.; Merck(Merck & Company); BMS(Bristol-Myers Squibb); Abbott(Abbott Laboratories); ViiV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Australian HIV Observational Database is funded as part of the Asia Pacific HIV Observational Database, a program of The Foundation for AIDS Research, amfAR, and is supported in part by a grant from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) (Grant No. U01-AI069907) and by unconditional grants from Merck Sharp & Dohme; Gilead; Bristol-Myers Squibb; Boehringer Ingelheim; Roche; Pfizer; GlaxoSmithKline; Janssen-Cilag. The Kirby Institute is funded by The Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Matthew Law has received research grants, consultancy and/or travel grants from: Boehringer Ingelheim; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Janssen-Cilag; Johnson & Johnson; Merck Sharp & Dohme; Pfizer; Roche; and CSL Ltd. Mark Boyd has been a board member for Merck and BMS received research grants, consultancy and/or travel grants from: Merck Sharp & Dohme; Abbott; Gilead; Janssen-Cilag; and from Boehringer Ingelheim. Darren Russell has received research grants, consultancy and/or travel grants from: Janssen-Cilag; Merck Sharp & Dohme; Abbott; and Gilead. Norman Roth has received research grants, consultancy and/or travel grants from Boehringer Ingelheim; ViiV; Merck Sharp & Dohme; and Janssen-Cilag. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2011, TABL 1 LIF TABL AUST; [Anonymous], 2011, TABL 5 9 EST RES POP; [Anonymous], 2010, TABL 1 9 DEATHS SUMM; Australian Bureau of Statistics, 2011, NAT HLTH SURV SUMM R; Australian HIV Observational Database, 2002, HIV Med, V3, P28; Baillargeon J, 1999, INT J STD AIDS, V10, P22, DOI 10.1258/0956462991913033; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Denholm JT, 2009, AUST FAM PHYSICIAN, V38, P574; Falster K, 2009, AIDS, V23, P2323, DOI 10.1097/QAD.0b013e328331910c; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hughes RA, 2011, HIV MED, V12, P583, DOI 10.1111/j.1468-1293.2011.00929.x; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Lewden C, MORTALITY WORKING GR; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Li XH, 2011, JAIDS-J ACQ IMM DEF, V57, P421, DOI 10.1097/QAI.0b013e31821e9f21; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Mahy M, 2010, SEX TRANSM INFECT, V86, pI67, DOI 10.1136/sti.2010.046060; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; Monforte AD, 2005, ARCH INTERN MED, V165, P416; Ouhoummane N, 2009, DIABETIC MED, V26, P609, DOI 10.1111/j.1464-5491.2009.02740.x; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Secrest AM, 2010, DIABETES, V59, P3216, DOI 10.2337/db10-0862; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946; Wright ST, 2011, JAIDS-J ACQ IMM DEF, V58, P72, DOI 10.1097/QAI.0b013e318225ba62; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	29	60	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48839	10.1371/journal.pone.0048839	http://dx.doi.org/10.1371/journal.pone.0048839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144991	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800150
J	Menzies, NA; Berruti, AA; Blandford, JM				Menzies, Nicolas A.; Berruti, Andres A.; Blandford, John M.			The Determinants of HIV Treatment Costs in Resource Limited Settings	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; MODELS; HEALTH; PREVENTION; EFFICIENCY; DELIVERY; OUTCOMES; IMPROVE	Background: Governments and international donors have partnered to provide free HIV treatment to over 6 million individuals in low and middle-income countries. Understanding the determinants of HIV treatment costs will help improve efficiency and provide greater certainty about future resource needs. Methods and Findings: We collected data on HIV treatment costs from 54 clinical sites in Botswana, Ethiopia, Mozambique, Nigeria, Uganda, and Vietnam. Sites provided free HIV treatment funded by the U. S. President's Emergency Plan for AIDS Relief (PEPFAR), national governments, and other partners. Service delivery costs were categorized into successive six-month periods from the date when each site began HIV treatment scale-up. A generalized linear mixed model was used to investigate relationships between site characteristics and per-patient costs, excluding ARV expenses. With predictors at their mean values, average annual per-patient costs were $177 (95% CI: 127-235) for pre-ART patients, $353 (255-468) for adult patients in the first 6 months of ART, and $222 (161-296) for adult patients on ART for >6 months (excludes ARV costs). Patient volume (no. patients receiving treatment) and site maturity (months since clinic began providing treatment services) were both strong independent predictors of per-patient costs. Controlling for other factors, costs declined by 43% (18-63) as patient volume increased from 500 to 5,000 patients, and by 28% (6-47) from 5,000 to 10,000 patients. For site maturity, costs dropped 41% (28-52) between months 0-12 and 25% (15-35) between months 12-24. Price levels (proxied by per-capita GDP) were also influential, with costs increasing by 22% (4-41) for each doubling in per-capita GDP. Additionally, the frequency of clinical follow-up, frequency of laboratory monitoring, and clinician-patient ratio were significant independent predictors of per-patient costs. Conclusions: Substantial reductions in per-patient service delivery costs occur as sites mature and patient cohorts increase in size. Other predictors suggest possible strategies to reduce per-patient costs.	[Menzies, Nicolas A.; Berruti, Andres A.; Blandford, John M.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Menzies, Nicolas A.] ICF Macro Inc, Atlanta, GA USA; [Menzies, Nicolas A.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Harvard University; Harvard T.H. Chan School of Public Health	Menzies, NA (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA USA.	nick.menzies@gmail.com	Berruti, Andrés/AAA-7936-2019; Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984	PEPFAR	PEPFAR	The PEPFAR ART Costing Project is a PEPFAR-funded public health evaluation (PHE) study led by the U.S. Centers for Disease Control and Prevention (CDC) and implemented with ICF Macro, in collaboration with the U.S. Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Cleary SM, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327621.24232.71; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Filler SJ, 2011, JAIDS-J ACQ IMM DEF, V57, pE1, DOI 10.1097/QAI.0b013e3182158980; Fleishman JA, 2005, MED CARE, V43, P40; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Holmes CB, 2011, JAIDS-J ACQ IMM DEF, V57, pS104, DOI 10.1097/QAI.0b013e31821fa12d; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Medicins Sans Frontieres, 2011, UNT WEB ANT PRIC RED; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Meyer-Rath G, 2012, J ACQUIR IMMUNE DEFI; Meyer-Rath G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001247; Oliva-Moreno J, 2010, EUR J HEALTH ECON, V11, P405, DOI 10.1007/s10198-009-0212-z; Perez-Casas Carmen, 2001, ACCESSING ARVS UNTAN, V10; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Pitter C, 2007, JAIDS-J ACQ IMM DEF, V44, P336, DOI 10.1097/QAI.0b013e31802f12b5; R Development Core Team, 2008, R LANG ENV STAT COMP; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Walker DG, 2011, AIDS, V25, P1795, DOI 10.1097/QAD.0b013e32834a1f77; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WHO, 2010, ANT THER HIV INF AD; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Health Organization, 2011, GLOB PRIC REP MECH	35	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48726	10.1371/journal.pone.0048726	http://dx.doi.org/10.1371/journal.pone.0048726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144946	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800112
J	Norgaard, T; Gagnon, YL; Warrant, EJ				Norgaard, Thomas; Gagnon, Yakir L.; Warrant, Eric J.			Nocturnal Homing: Learning Walks in a Wandering Spider?	PLOS ONE			English	Article							LEUCORCHESTRIS-ARENICOLA ARANEAE; ANTERIOR LATERAL EYES; LYCOSA-TARENTULA ARANEAE; ORIENTATION FLIGHTS; PATH-INTEGRATION; NAVIGATION; VISION; BEES; MOVEMENTS; MEMORY	Homing by the nocturnal Namib Desert spider Leucorchestris arenicola (Araneae: Sparassidae) is comparable to homing in diurnal bees, wasps and ants in terms of path length and layout. The spiders' homing is based on vision but their basic navigational strategy is unclear. Diurnal homing insects use memorised views of their home in snapshot matching strategies. The insects learn the visual scenery identifying their nest location during learning flights (e. g. bees and wasps) or walks (ants). These learning flights and walks are stereotyped movement patterns clearly different from other movement behaviours. If the visual homing of L. arenicola is also based on an image matching strategy they are likely to exhibit learning walks similar to diurnal insects. To explore this possibility we recorded departures of spiders from a new burrow in an unfamiliar area with infrared cameras and analysed their paths using computer tracking techniques. We found that L. arenicola performs distinct stereotyped movement patterns during the first part of their departures in an unfamiliar area and that they seem to learn the appearance of their home during these movement patterns. We conclude that the spiders perform learning walks and this strongly suggests that L. arenicola uses a visual memory of the burrow location when homing.	[Norgaard, Thomas; Gagnon, Yakir L.; Warrant, Eric J.] Lund Univ, Dept Biol, Lund, Sweden; [Gagnon, Yakir L.] Duke Univ, Dept Biol, Durham, NC USA	Lund University; Duke University	Norgaard, T (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	thomas.norgaard@biol.lu.se	Gagnon, Yakir/C-2665-2008	Gagnon, Yakir/0000-0003-2512-4520; Warrant, Eric/0000-0001-7480-7016	Carlsberg Foundation; Carl Tryggers Foundation; Swedish Research Council; Royal Physiographic Society in Lund	Carlsberg Foundation(Carlsberg Foundation); Carl Tryggers Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund	The authors wish to thank the Carlsberg Foundation, the Carl Tryggers Foundation, the Swedish Research Council, and the Royal Physiographic Society in Lund for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2011, LANGUAGER DATA SETS; Bates D, 2012, LME4 LINEAR MIXED EF; BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; BENHAMOU S, 1990, J THEOR BIOL, V145, P1, DOI 10.1016/S0022-5193(05)80531-4; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; Bouguet J. Y., 2008, CAMERA CALIBRATION T; Capaldi EA, 1999, J EXP BIOL, V202, P1655; Collett TS, 1996, CURR DIR PSYCHOL SCI, V5, P149, DOI 10.1111/1467-8721.ep11512352; COLLETT TS, 1993, P ROY SOC B-BIOL SCI, V252, P129, DOI 10.1098/rspb.1993.0056; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; de Ibarra NH, 2009, J EXP BIOL, V212, P3193, DOI 10.1242/jeb.029751; Dittmar L, 2011, COMM INT BIOL, V4, p17v20; Foelix R. F., 2011, BIOL SPIDERS; Giurfa M, 1999, TRENDS NEUROSCI, V22, P237, DOI 10.1016/S0166-2236(99)01406-X; Henschel J.R., 1990, NAMIB ECOLOGY 25 YEA, P115; Henschel JR, 2002, J ARACHNOL, V30, P321, DOI 10.1636/0161-8202(2002)030[0321:LDWAMB]2.0.CO;2; Kovoor J, 2005, ITAL J ZOOL, V72, P205, DOI 10.1080/11250000509356673; Kral K, 2003, BEHAV PROCESS, V64, P1, DOI 10.1016/S0376-6357(03)00054-8; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; LEHRER M, 1993, J COMP PHYSIOL A, V172, P549, DOI 10.1007/BF00213678; LEHRER M, 1991, NATURWISSENSCHAFTEN, V78, P274, DOI 10.1007/BF01134357; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; Norgaard T, 2006, J COMP PHYSIOL A, V192, P365, DOI 10.1007/s00359-005-0072-7; Norgaard T, 2005, J ARACHNOL, V33, P533, DOI 10.1636/04-113.1; Norgaard T, 2003, J COMP PHYSIOL A, V189, P801, DOI 10.1007/s00359-003-0455-6; Norgaard T, 2008, J EXP BIOL, V211, P816, DOI 10.1242/jeb.010546; Norgaard Thomas, 2006, Senckenbergiana Biologica, V86, P211; Norgaard T, 2007, J COMP PHYSIOL A, V193, P217, DOI 10.1007/s00359-006-0178-6; Ortega-Escobar J, 2006, J ARACHNOL, V34, P51, DOI 10.1636/S04-103.1; Ortega-Escobar J, 2011, J EXP BIOL, V214, P2375, DOI 10.1242/jeb.055988; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Seyfarth E.-A., 1985, P230; SEYFARTH EA, 1972, J COMP PHYSIOL, V78, P176, DOI 10.1007/BF00693611; SEYFARTH EA, 1982, BEHAV ECOL SOCIOBIOL, V11, P139, DOI 10.1007/BF00300103; Tinbergen N., 1932, Zeitschrift fuer Vergleichende Physiologie Berlin, V16, P305; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Warrant E, 2010, BRAIN BEHAV EVOLUT, V75, P156, DOI 10.1159/000314277; WEHNER R, 1986, MONIT ZOOL ITAL, V20, P309; Wehner R., 1992, P45; Wehner R, 1981, COMP PHYS EVOLUTION, VVII/ 6C, P287, DOI DOI 10.1007/978-3642-67868-4; Wehner Ruediger, 2003, P9; Zeil J, 1996, J EXP BIOL, V199, P245; ZEIL J, 1993, J COMP PHYSIOL A, V172, P189, DOI 10.1007/BF00189396; Zeil J, 2008, CURR BIOL, V18, pR320, DOI 10.1016/j.cub.2008.02.017; Zeil J, 2009, FLYING INSECTS AND ROBOTS, P87, DOI 10.1007/978-3-540-89393-6_7; ZHANG SW, 1995, P NATL ACAD SCI USA, V92, P3029, DOI 10.1073/pnas.92.7.3029; ZOLLIKOFER CPE, 1995, J EXP BIOL, V198, P1637; Zurek DB, 2010, J EXP BIOL, V213, P2372, DOI 10.1242/jeb.042382	48	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49263	10.1371/journal.pone.0049263	http://dx.doi.org/10.1371/journal.pone.0049263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145137	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800238
J	Pimentel, IAS; Paladi, CD; Katz, S; Judice, WAD; Cunha, RLOR; Barbieri, CL				Salerno Pimentel, Isabella Aparecida; Paladi, Carolina de Siqueira; Katz, Simone; de Souza Judice, Wagner Alves; Cunha, Rodrigo L. O. R.; Barbieri, Clara Lucia			In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; CYSTEINE PROTEASES; DRUG-RESISTANCE; MILTEFOSINE; INHIBITION	Tellurium compounds have shown several biological properties and recently the leishmanicidal effect of one organotellurane was demonstrated. These findings led us to test the effect of the organotellurium compound RF07 on Leishmania (Leishmania) chagasi, the agent of visceral leishmaniasis in Latin America. In vitro assays were performed in L. (L.) chagasi-infected bone marrow derived macrophages treated with different concentrations of RF07. In in vivo experiments Golden hamsters were infected with L. (L.) chagasi and injected intraperitoneally with RF07 whereas control animals received either Glucantime or PBS. The effect of RF07 on cathepsin B activity of L. (L.) chagasi amastigotes was assayed spectrofluorometrically using fluorogenic substrates. The main findings were: 1) RF07 showed significant leishmanicidal activity against intracellular parasites at submicromolar concentrations (IC50 of 529.7+/-26.5 nM), and the drug displayed 10-fold less toxicity to macrophages (CC50 of 5,426+/-272.8 nM); 2) kinetics assays showed an increasing leishmanicidal action of RF07 at longer periods of treatment; 3) one month after intraperitoneal injection of RF07 L. (L.) chagasi-infected hamsters showed a reduction of 99.6% of parasite burden when compared to controls that received PBS; 4) RF07 inhibited the cathepsin B activity of L. (L.) chagasi amastigotes. The present results demonstrated that the tellurium compound RF07 is able to destroy L. (L.) chagasi in vitro and in vivo at concentrations that are non toxic to the host. We believe these findings support further study of the potential of RF07 as a possible alternative for the chemotherapy of visceral leishmaniasis.	[Salerno Pimentel, Isabella Aparecida; Paladi, Carolina de Siqueira; Katz, Simone; Barbieri, Clara Lucia] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [de Souza Judice, Wagner Alves] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Sao Paulo, Brazil; [Cunha, Rodrigo L. O. R.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Mogi das Cruzes; Universidade Federal do ABC (UFABC)	Barbieri, CL (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	barbieri.clara@unifesp.br	Cunha, Rodrigo L. O. R./A-5589-2008; DE SOUZA JUDICE, WAGNER ALVES/AAG-3225-2020; DE SOUZ A S JUDICE, WAGNER ALVES/O-1050-2013; Barbiéri, Clara L./E-1505-2012	Cunha, Rodrigo L. O. R./0000-0002-0203-3143; DE SOUZ A S JUDICE, WAGNER ALVES/0000-0002-1608-9105; Barbiéri, Clara L./0000-0001-9426-2308	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto de Pesquisa, Informacao e Tecnologia da Amazonia (IPITAM)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto de Pesquisa, Informacao e Tecnologia da Amazonia (IPITAM)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Instituto de Pesquisa, Informacao e Tecnologia da Amazonia (IPITAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abondanza TS, 2008, FOOD CHEM TOXICOL, V46, P2540, DOI 10.1016/j.fct.2008.04.010; Albeck A, 1998, INORG CHEM, V37, P1704, DOI 10.1021/ic971456t; Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213; Ba LA, 2010, ORG BIOMOL CHEM, V8, P4203, DOI 10.1039/c0Ob00086h; BARBIERI CL, 1990, EXP PARASITOL, V71, P218, DOI 10.1016/0014-4894(90)90024-7; Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684; Campbell TW, 2004, VETERINARY HEMATOLOGY AND CLINICAL CHEMISTRY, P463; Lima CBC, 2009, KOREAN J PARASITOL, V47, P213, DOI 10.3347/kjp.2009.47.3.213; Cotrin SS, 2004, ANAL BIOCHEM, V335, P244, DOI 10.1016/j.ab.2004.09.012; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cunha RLOR, 2005, BIOORG MED CHEM LETT, V15, P755, DOI 10.1016/j.bmcl.2004.11.012; Cunha RLOR, 2009, BIOL CHEM, V390, P1205, DOI 10.1515/BC.2009.125; Cunha RLOR, 2009, AN ACAD BRAS CIENC, V81, P393, DOI 10.1590/S0001-37652009000300006; De Muylder G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001253; Dutta A, 2005, PARASITOL INT, V54, P119, DOI 10.1016/j.parint.2005.01.001; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2; Miguel DC, 2009, J ANTIMICROB CHEMOTH, V63, P365, DOI 10.1093/jac/dkn509; Mundodi V, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-3; Murray HW, 2001, ANTIMICROB AGENTS CH, V45, P2185, DOI 10.1128/AAC.45.8.2185-2197.2001; Nascimento ELT, 2008, CAD SAUDE PUBLICA, V24, P2964, DOI 10.1590/S0102-311X2008001200028; Persike DS, 2008, NEUROBIOL DIS, V31, P120, DOI 10.1016/j.nbd.2008.04.001; Polonio T, 2008, INT J MOL MED, V22, P277, DOI 10.3892/ijmm_00000020; Seifert Karin, 2011, Open Med Chem J, V5, P31, DOI 10.2174/1874104501105010031; Sen R, 2011, PHYTOMEDICINE, V18, P1056, DOI 10.1016/j.phymed.2011.03.004; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Sredni B, 2012, SEMIN CANCER BIOL, V22, P60, DOI 10.1016/j.semcancer.2011.12.003; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sunduru N, 2009, EUR J MED CHEM, V44, P2473, DOI 10.1016/j.ejmech.2009.01.016; Tempone AG, 2011, PLANTA MED, V77, P572, DOI 10.1055/s-0030-1250663; Tiekink ERT, 2012, DALTON T, V41, P6390, DOI 10.1039/c2dt12225a; Tiuman TS, 2011, INT J INFECT DIS, V15, pE525, DOI 10.1016/j.ijid.2011.03.021; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; WHO, 2010, WHO TECH REP SER, V949, P1; Wieslander E, 1998, BIOCHEM PHARMACOL, V55, P573, DOI 10.1016/S0006-2952(97)00517-0; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003; Zeni G, 1999, ORGANOMETALLICS, V18, P803, DOI 10.1021/om980738d	39	34	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48780	10.1371/journal.pone.0048780	http://dx.doi.org/10.1371/journal.pone.0048780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144968	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800130
J	Simcha, D; Price, ND; Geman, D				Simcha, David; Price, Nathan D.; Geman, Donald			The Limits of De Novo DNA Motif Discovery	PLOS ONE			English	Article							FACTOR-BINDING SITES; GENE-EXPRESSION; HUMAN GENOME; SEQUENCES; PROMOTERS; PROFILES; ELEMENTS; DATABASE; TOOLS; WIDE	A major challenge in molecular biology is reverse-engineering the cis-regulatory logic that plays a major role in the control of gene expression. This program includes searching through DNA sequences to identify "motifs" that serve as the binding sites for transcription factors or, more generally, are predictive of gene expression across cellular conditions. Several approaches have been proposed for de novo motif discovery-searching sequences without prior knowledge of binding sites or nucleotide patterns. However, unbiased validation is not straightforward. We consider two approaches to unbiased validation of discovered motifs: testing the statistical significance of a motif using a DNA "background" sequence model to represent the null hypothesis and measuring performance in predicting membership in gene clusters. We demonstrate that the background models typically used are "too null," resulting in overly optimistic assessments of significance, and argue that performance in predicting TF binding or expression patterns from DNA motifs should be assessed by held-out data, as in predictive learning. Applying this criterion to common motif discovery methods resulted in universally poor performance, although there is a marked improvement when motifs are statistically significant against real background sequences. Moreover, on synthetic data where "ground truth" is known, discriminative performance of all algorithms is far below the theoretical upper bound, with pronounced "over-fitting" in training. A key conclusion from this work is that the failure of de novo discovery approaches to accurately identify motifs is basically due to statistical intractability resulting from the fixed size of co-regulated gene clusters, and thus such failures do not necessarily provide evidence that unfound motifs are not active biologically. Consequently, the use of prior knowledge to enhance motif discovery is not just advantageous but necessary. An implementation of the LR and ALR algorithms is available at http://code.google.com/p/likelihood-ratio-motifs/.	[Simcha, David] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Price, Nathan D.] Inst Syst Biol, Seattle, WA USA; [Geman, Donald] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA	Johns Hopkins University; Institute for Systems Biology (ISB); Johns Hopkins University	Simcha, D (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	dsimcha1@jhmi.edu	Geman, Donald/A-3325-2010	Price, Nathan/0000-0002-4157-0267	National Institutes of Health National Center for Research Resources [UL1 RR 025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health National Center for Research Resources [UL1 RR 025005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chen K, 2010, GENOME BIOL EVOL, V2, P697, DOI 10.1093/gbe/evq054; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Fauteux F, 2008, BIOINFORMATICS, V24, P2303, DOI 10.1093/bioinformatics/btn444; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; LESLIE C, 2002, PAC S BIOCOMPUT, V7, P564, DOI DOI 10.1142/9789812799623_0053; Liu X, 2001, Pac Symp Biocomput, P127; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Mandel M, 1968, NUCL ACIDS B, V12, P195; Marschall T, 2009, BIOINFORMATICS, V25, pI356, DOI 10.1093/bioinformatics/btp188; Narlikar L, 2007, LECT NOTES COMPUT SC, V4453, P107; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Salem AH, 2003, P NATL ACAD SCI USA, V100, P12787, DOI 10.1073/pnas.2133766100; Sandve GK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-193; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sinha S, 2003, J COMPUT BIOL, V10, P599, DOI 10.1089/10665270360688219; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; VERT JP, 2005, P 19 ANN C NEUR INF; Wilczynski B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.35; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Workman C T, 2000, Pac Symp Biocomput, P467	40	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47836	10.1371/journal.pone.0047836	http://dx.doi.org/10.1371/journal.pone.0047836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144830	Green Published, gold			2022-12-25	WOS:000311935800027
J	Takasu, NN; Kurosawa, G; Tokuda, IT; Mochizuki, A; Todo, T; Nakamura, W				Takasu, Nana N.; Kurosawa, Gen; Tokuda, Isao T.; Mochizuki, Atsushi; Todo, Takeshi; Nakamura, Wataru			Circadian Regulation of Food-Anticipatory Activity in Molecular Clock-Deficient Mice	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; FEEDING SCHEDULES; RHYTHMS; PERIOD; OSCILLATORS; MUTATION; SYSTEM; ENTRAINMENT; COMPONENT; LESIONS	In the mammalian brain, the suprachiasmatic nucleus (SCN) of the anterior hypothalamus is considered to be the principal circadian pacemaker, keeping the rhythm of most physiological and behavioral processes on the basis of light/dark cycles. Because restriction of food availability to a certain time of day elicits anticipatory behavior even after ablation of the SCN, such behavior has been assumed to be under the control of another circadian oscillator. According to recent studies, however, mutant mice lacking circadian clock function exhibit normal food-anticipatory activity (FAA), a daily increase in locomotor activity preceding periodic feeding, suggesting that FAA is independent of the known circadian oscillator. To investigate the molecular basis of FAA, we examined oscillatory properties in mice lacking molecular clock components. Mice with SCN lesions or with mutant circadian periods were exposed to restricted feeding schedules at periods within and outside circadian range. Periodic feeding led to the entrainment of FAA rhythms only within a limited circadian range. Cry1(-/-) mice, which are known to be a "short-period mutant," entrained to a shorter period of feeding cycles than did Cry2(-/-) mice. This result indicated that the intrinsic periods of FAA rhythms are also affected by Cry deficiency. Bmal1(-/-) mice, deficient in another essential element of the molecular clock machinery, exhibited a pre-feeding increase of activity far from circadian range, indicating a deficit in circadian oscillation. We propose that mice possess a food-entrainable pacemaker outside the SCN in which canonical clock genes such as Cry1, Cry2 and Bmal1 play essential roles in regulating FAA in a circadian oscillatory manner.	[Takasu, Nana N.; Nakamura, Wataru] Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Osaka, Japan; [Kurosawa, Gen; Mochizuki, Atsushi] RIKEN Adv Sci Inst, Theoret Biol Lab, Wako, Saitama, Japan; [Tokuda, Isao T.] Ritsumeikan Univ, Dept Micro Syst Technol, Kyoto, Shiga, Japan; [Todo, Takeshi] Osaka Univ, Dept Radiat Biol & Med Genet, Grad Sch Med, Osaka, Japan; [Nakamura, Wataru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan	Osaka University; RIKEN; Ritsumeikan University; Osaka University; Japan Science & Technology Agency (JST)	Nakamura, W (corresponding author), Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Osaka, Japan.	wataru@dent.osaka-u.ac.jp	Kurosawa, Gen/AAC-9390-2022; Mochizuki, Atsushi/A-7917-2015	Mochizuki, Atsushi/0000-0002-7714-1755; Kurosawa, Gen/0000-0002-2151-783X; Tokuda, Isao/0000-0001-6212-0022	Japan Science and Technology Agency PRESTO; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Science; Grants-in-Aid for Scientific Research [23560446, 23241023, 23360047] Funding Source: KAKEN	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Science and Technology Agency PRESTO program and the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to WN), and a Japan Society for Promotion of Science postdoctoral fellowship (to NNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, AM J PHYSIOL-REG I, V292, pR607, DOI 10.1152/ajpregu.00331.2006; Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Batschelet E, 1981, CIRCULAR STAT BIOL; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Brown S, 2005, AM POETRY REV, V34, P3; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; COLEMAN GJ, 1982, PHYSIOL BEHAV, V29, P107, DOI 10.1016/0031-9384(82)90373-0; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Halberg F, 1967, CIRCADIAN SYSTEM PHA; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; HONMA KI, 1983, AM J PHYSIOL, V245, pR339, DOI 10.1152/ajpregu.1983.245.3.R339; Iijima M, 2005, NEUROSCI RES, V52, P166, DOI 10.1016/j.neures.2005.03.003; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamont EW, 2005, NEUROSCIENCE, V132, P245, DOI 10.1016/j.neuroscience.2005.01.029; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Mendoza J, 2010, GENES BRAIN BEHAV, V9, P467, DOI 10.1111/j.1601-183X.2010.00576.x; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mieda M, 2011, J NEUROSCI, V31, P15391, DOI 10.1523/JNEUROSCI.2801-11.2011; Mistlberger RE, 2008, SCIENCE, V322, DOI 10.1126/science.1161284; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; MISTLBERGER RE, 1995, BEHAV NEUROSCI, V109, P790, DOI 10.1037/0735-7044.109.4.790; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ripperger JA, 2011, FEBS LETT, V585, P1384, DOI 10.1016/j.febslet.2011.02.027; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Silver R, 2011, PHYSIOL BEHAV, V104, P562, DOI 10.1016/j.physbeh.2011.05.034; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; STEPHAN FK, 1981, J COMP PHYSIOL, V143, P401, DOI 10.1007/BF00609906; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	31	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48892	10.1371/journal.pone.0048892	http://dx.doi.org/10.1371/journal.pone.0048892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145013	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800164
J	Wich, SA; Gaveau, D; Abram, N; Ancrenaz, M; Baccini, A; Brend, S; Curran, L; Delgado, RA; Erman, A; Fredriksson, GM; Goossens, B; Husson, SJ; Lackman, I; Marshall, AJ; Naomi, A; Molidena, E; Nardiyono; Nurcahyo, A; Odom, K; Panda, A; Purnomo; Rafiastanto, A; Ratnasari, D; Santana, AH; Sapari, I; van Schaik, CP; Sihite, J; Spehar, S; Santoso, E; Suyoko, A; Tiju, A; Usher, G; Atmoko, SSU; Willems, EP; Meijaard, E				Wich, Serge A.; Gaveau, David; Abram, Nicola; Ancrenaz, Marc; Baccini, Alessandro; Brend, Stephen; Curran, Lisa; Delgado, Roberto A.; Erman, Andi; Fredriksson, Gabriella M.; Goossens, Benoit; Husson, Simon J.; Lackman, Isabelle; Marshall, Andrew J.; Naomi, Anita; Molidena, Elis; Nardiyono; Nurcahyo, Anton; Odom, Kisar; Panda, Adventus; Purnomo; Rafiastanto, Andjar; Ratnasari, Dessy; Santana, Adi H.; Sapari, Imam; van Schaik, Carel P.; Sihite, Jamartin; Spehar, Stephanie; Santoso, Eddy; Suyoko, Amat; Tiju, Albertus; Usher, Graham; Atmoko, Sri Suci Utami; Willems, Erik P.; Meijaard, Erik			Understanding the Impacts of Land-Use Policies on a Threatened Species: Is There a Future for the Bornean Orang-utan?	PLOS ONE			English	Article							TROPICAL FORESTS; CLIMATE-CHANGE; POPULATION; SUMATRA; DEFORESTATION; KINABATANGAN; DENSITY; SABAH	The geographic distribution of Bornean orang-utans and its overlap with existing land-use categories (protected areas, logging and plantation concessions) is a necessary foundation to prioritize conservation planning. Based on an extensive orang-utan survey dataset and a number of environmental variables, we modelled an orang-utan distribution map. The modelled orang-utan distribution map covers 155,106 km(2) (21% of Borneo's landmass) and reveals four distinct distribution areas. The most important environmental predictors are annual rainfall and land cover. The overlap of the orang-utan distribution with land-use categories reveals that only 22% of the distribution lies in protected areas, but that 29% lies in natural forest concessions. A further 19% and 6% occurs in largely undeveloped oil palm and tree plantation concessions, respectively. The remaining 24% of the orang-utan distribution range occurs outside of protected areas and outside of concessions. An estimated 49% of the orang-utan distribution will be lost if all forest outside of protected areas and logging concessions is lost. To avoid this potential decline plantation development in orang-utan habitats must be halted because it infringes on national laws of species protection. Further growth of the plantation sector should be achieved through increasing yields in existing plantations and expansion of new plantations into areas that have already been deforested. To reach this goal a large scale island-wide land-use masterplan is needed that clarifies which possible land uses and managements are allowed in the landscape and provides new standardized strategic conservation policies. Such a process should make much better use of non-market values of ecosystem services of forests such as water provision, flood control, carbon sequestration, and sources of livelihood for rural communities. Presently land use planning is more driven by vested interests and direct and immediate economic gains, rather than by approaches that take into consideration social equity and environmental sustainability.	[Wich, Serge A.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England; [Gaveau, David; Molidena, Elis] Ctr Int Forestry Res, Bogor Barat, West Java, Indonesia; [Abram, Nicola] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Ancrenaz, Marc; Lackman, Isabelle] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc; Lackman, Isabelle] HUTAN, Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] N England Zool Soc, Chester, Cheshire, England; [Baccini, Alessandro] Woods Hole Res Ctr, Falmouth, MA USA; [Brend, Stephen] Orangutan Fdn, London, England; [Curran, Lisa] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Curran, Lisa] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Delgado, Roberto A.] Univ So Calif, Program Integrat & Evolutionary Biol IEB, Dept Anthropol, Los Angeles, CA USA; [Delgado, Roberto A.] Univ So Calif, Dept Biol Sci, Program Integrat & Evolutionary Biol IEB, Los Angeles, CA 90089 USA; [Erman, Andi] GFA KWF, Kapuas Hulu Program, W Kalimantan, Indonesia; [Fredriksson, Gabriella M.; Naomi, Anita; Usher, Graham] Sumatran Orangutan Conservat Programme PanEco YEL, Medan, Sumatra, Indonesia; [Fredriksson, Gabriella M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Zool Museum, Amsterdam, Netherlands; [Goossens, Benoit] Danau Girang Field Ctr, Sabah Willife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [Husson, Simon J.] Univ Palangka Raya, Ctr Int Cooperat Sustainable Management Trop Peat, Orangutan Trop Peatland Project, Cent Kalimantan, Indonesia; [Marshall, Andrew J.] Univ Calif Davis, Anim Behav Grad Grp, Grad Grp Ecol, Dept Anthropol, Davis, CA 95616 USA; [Nardiyono; Nurcahyo, Anton; Rafiastanto, Andjar; Sapari, Imam; Sihite, Jamartin; Tiju, Albertus; Atmoko, Sri Suci Utami] Forum Orangutan Indonesia FORINA, Bogor, West Java, Indonesia; [Nardiyono; Purnomo] TNC, Jakarta, Indonesia; [Nurcahyo, Anton; Odom, Kisar; Suyoko, Amat] BOSF, Nyaru Menteng, Central Kaliman, Indonesia; [Panda, Adventus] Univ Palangkaraya, Sebangau Conservat Program, World Wide Fund Nat Indonesia WWF Indonesia, Cent Kalimantan, Indonesia; [Rafiastanto, Andjar] Flora & Fauna Int Indonesia, Jakarta, Indonesia; [Ratnasari, Dessy] Lembaga Living Landscapes Indonesia LLI, Pontianak, West Kalimantan, Indonesia; [Santana, Adi H.; Atmoko, Sri Suci Utami] Univ Nas UNAS, Fac Biol, Jakarta, Indonesia; [Sapari, Imam; Santoso, Eddy] Yayasan Orangutan Indonesia YAYORIN, Pangkalan Bun, Central Kaliman, Indonesia; [van Schaik, Carel P.; Willems, Erik P.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Sihite, Jamartin] RHOI, Bogor, West Java, Indonesia; [Spehar, Stephanie] Univ Wisconsin Oshkosh, Dept Religious Studies & Anthropol, Anthropol Program, Oshkosh, WI USA; [Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia	Liverpool John Moores University; CGIAR; Center for International Forestry Research (CIFOR); University of Kent; Woods Hole Research Center; Stanford University; Stanford University; University of Southern California; University of Southern California; University of Amsterdam; Cardiff University; Universitas Palangka Raya (UPR); University of California System; University of California Davis; Universitas Palangka Raya (UPR); University of Zurich; University of Wisconsin System; University of Wisconsin Oshkosh; People & Nature Consulting International; University of Queensland; Australian National University	Wich, SA (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England.	s.a.wich@ljmu.ac.uk	Goossens, Benoit R/E-8812-2010; Panda, Adventus/ABA-4283-2020; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Meijaard, Erik/A-2687-2016; Abram, Nicola/K-2060-2014	Panda, Adventus/0000-0003-3565-9545; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Meijaard, Erik/0000-0001-8685-3685; Curran, Lisa M./0000-0002-2813-5578; Abram, Nicola/0000-0003-1886-7297; Wich, Serge/0000-0003-3954-5174	Arcus Foundation; Government of Malaysia; Government of Indonesia	Arcus Foundation; Government of Malaysia; Government of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	The authors thank the Arcus Foundation for providing financial support for the mapping workshop and write-up. The Arcus Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Governments of Malaysia and Indonesia with all the respective forest and wildlife departments and other agencies for supporting our research. All fieldwork was conducted with permits from the Governments of Indonesia and Malaysia. We also thank AidEnvironment en Sarawak Dayak Iban Association [SADIA). We thank Herry Djoko Susuilo (FORINA) for his support of the study. The maps used in the paper are available on request from Serge Wich (; sergewich1@yahoo.com). This paper has been produced as part of a larger set of studies on land use optimization, conservation planning and management, and species ecology ("The Borneo Futures Project'') that we would like to contribute to key actors: governments, major businesses, and political decision makers in Indonesia and Malaysia. We hope that these efforts will allow these countries to develop their economies, provide welfare to their people, and maintain some of the highest biological diversity found anywhere on the planet.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, 2008, PONGO PYGMAEUS IUCN; Ancrenaz M, 2007, ORANGUTAN AERIAL SUR; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/nclimate1354, 10.1038/NCLIMATE1354]; Bachelard M, 2012, FORMER ACEH CHIEF DE; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; BPS, 2009, PEND ANGK KERJ POP L; BPS, 2007, POP AG GROUP KAL BAR; Brandon K, 1998, PARKS PERIL PEOPLE P, Vxv; Bruford Michael W., 2010, Endangered Species Research, V12, P249, DOI 10.3354/esr00295; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Campbell-Smith G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020962; Campbell-Smith G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017210; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Central Kalimantan Plantation Department, 2007, CENTR KAL PLANT CO E; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Dennis RA, 2008, ECOL SOC, V13; Dunbar RIM, 2009, BIOL REV, V84, P413, DOI 10.1111/j.1469-185X.2009.00080.x; EIA Telepak, 1999, FIN CUT ILL LOGG IND; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Faeh D, 2011, DEV GLOBAL TIMBER TY; Franklin J, 2009, MAPPING SPECIES DIST; Gaveau DLA, 2012, CONSERV LETT, V5, P142, DOI 10.1111/j.1755-263X.2011.00220.x; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gaveau DLA, 2009, BIOL CONSERV, V142, P597, DOI 10.1016/j.biocon.2008.11.024; Gaveau DL, 2009, ENVIRON RES LETT, V4, P1; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Hosmer DW, 2000, APPL LOGISITC REGRES; Husson Simon J., 2009, P77; Jenness J, 2012, DEM SURFACE TOOLS; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2007, BIODIVERS CONSERV, V16, P3935, DOI 10.1007/s10531-007-9177-3; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P97; Meijaard E, 2008, NATURE, V454, P159, DOI 10.1038/454159b; Meijaard E, 2007, CURR BIOL, V17, pR540, DOI 10.1016/j.cub.2007.05.016; Meijaard E, 2012, ANN NY ACAD SCI, V1249, P29, DOI 10.1111/j.1749-6632.2011.06288.x; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Nellemann, 2007, LAST STAND ORANGUTAN; Obidzinski K, 2009, INT FOREST REV, V11, P79, DOI 10.1505/ifor.11.1.79; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Rijksen HD, 1999, OUR VANISHING RELATI; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; RSPO (Roundtable on Sustainable Palm Oil), 2007, RSPO PRINC CRIT SUST; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Sabah Wildlife Department, 2011, OR ACT PLAN; Sasaki N, 2009, CONSERV LETT, V2, P226, DOI 10.1111/j.1755-263X.2009.00067.x; Schiller D.M., 1994, P P IND PETR ASS CON, V23, P189; Schmidt-Vogt D, 2009, HUM ECOL, V37, P269, DOI 10.1007/s10745-009-9239-0; Singleton I., 2004, ORANGUTAN POPULATION; Soehartono T, 2001, TROP BIODIVERS, V7, P83; Soehartono T, 2007, STRATEGI RENCANA ASK; South Kalimantan Forestry Department (Dinas Kehutanan), 2005, S KAL OIL PALM PLANT; South Kalimantan Forestry Department (Dinas Kehutanan), 2005, REG PLANN DEV DAT; UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Van Schaik C, 2004, ORANGUTANS RED APES; van Schaik CP, 1997, LAST STAND PROTECTED; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Verissimo A, 2011, AREAS PROTEGIDAS AMA; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; West Kalimantan National Land Body (BPN), 2008, PLANT TRANSM FISH IN; Wich SA, 2012, BIOL CONSERV, V146, P163, DOI 10.1016/j.biocon.2011.12.006; Wich S. A., 2011, ORANGUTANS EC SUSTAI; Wich S. A., 2009, ORANGUTANS GEOGRAPHI; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wich SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021278; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Wollenberg E, 2009, ECOL SOC, V14; World Bank, 2006, SUST IND FOR STRAT W; Zagt R, 2010, BIODIVERS CONSERV, pV	81	67	70	2	254	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49142	10.1371/journal.pone.0049142	http://dx.doi.org/10.1371/journal.pone.0049142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145100	Green Published, Green Accepted, gold			2022-12-25	WOS:000311935800218
J	Pandolfi, S; Montagnani, V; Penachioni, JY; Vinci, MC; Olivito, B; Borgognoni, L; Stecca, B				Pandolfi, S.; Montagnani, V.; Penachioni, J. Y.; Vinci, M. C.; Olivito, B.; Borgognoni, L.; Stecca, B.			WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function	ONCOGENE			English	Article						Hedgehog; GLI1; WIP1; melanoma; xenograft; self-renewal; cancer stem cells	BASAL-CELL CARCINOMA; STEM-CELL; WILD-TYPE; PROTEIN PHOSPHATASE; SELF-RENEWAL; IN-VITRO; WIP1-DEPENDENT REGULATION; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; HUMAN HOMOLOG	The Hedgehog-GLI (HH-GLI) signaling plays a critical role in controlling growth and tissue patterning during embryogenesis and is implicated in a variety of human malignancies, including those of the skin. Phosphorylation events have been shown to regulate the activity of the GLI transcription factors, the final effectors of the HH-GLI signaling pathway. Here, we show that WIP1 (or PPM1D), an oncogenic phosphatase amplified/overexpressed in several types of human cancer, is a positive modulator of the HH signaling. Mechanistically, WIP1 enhances the function of GLI1 by increasing its transcriptional activity, nuclear localization and protein stability, but not of GLI2 nor GLI3. We also find that WIP1 and GLI1 are in a complex. Modulation of the transcriptional activity of GLI1 by WIP1 depends on the latter's phosphatase activity and, remarkably, does not require p53, a known WIP1 target. Functionally, we find that WIP1 is required for melanoma and breast cancer cell proliferation and self-renewal in vitro and melanoma xenograft growth induced by activation of the HH signaling. Pharmacological blockade of the HH pathway with the SMOOTHENED antagonist cyclopamine acts synergistically with inhibition of WIP1 in reducing growth of melanoma and breast cancer cells in vitro. Overall, our data uncover a role for WIP1 in modulating the activity of GLI1 and in sustaining cancer cell growth and cancer stem cell self-renewal induced by activation of the HH pathway. These findings open a novel therapeutic approach for human melanomas and, possibly, other cancer types expressing WIP1 and with activated HH pathway.	[Pandolfi, S.; Montagnani, V.; Penachioni, J. Y.; Vinci, M. C.; Stecca, B.] Ist Toscani Tumori CRL ITT, Core Res Lab, Tumor Cell Biol Lab, I-50134 Florence, Italy; [Olivito, B.] Anna Meyer Childrens Hosp, Dept Pediat, Immunol Unit, Florence, Italy; [Borgognoni, L.] Ist Toscani Tumori, SM Annunziata Hosp, Reg Melanoma Referral Ctr, Plast Surg Unit, Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Stecca, B (corresponding author), Ist Toscani Tumori CRL ITT, Core Res Lab, Tumor Cell Biol Lab, Vle Morgagni 50, I-50134 Florence, Italy.	barbara.stecca@ittumori.it	Vinci, Maria Cristina/E-7401-2016; Borgognoni, Lorenzo/X-1981-2019; Stecca, Barbara/J-7209-2016	Vinci, Maria Cristina/0000-0001-6323-147X; Borgognoni, Lorenzo/0000-0002-3571-0366; Stecca, Barbara/0000-0003-1197-1622; OLIVITO, BIAGIO/0000-0002-4479-0708	Associazione Italiana per la Ricerca sul Cancro (AIRC) [9566]; Regional Health Research Program; Fondazione Cassa di Risparmio di Firenze; AIRC fellowship	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regional Health Research Program; Fondazione Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); AIRC fellowship(Fondazione AIRC per la ricerca sul cancro)	We thank G Del Sal, A Ruiz i Altaba, L Luzzatto for helpful comments on the paper and discussion. We are grateful to G Del Sal (Laboratorio Nazionale CIB, Padriciano, Italy) for HCT116 p53wt and p53ko cells, A Ruiz i Altaba (University of Geneva, Geneva, Switzerland), H Sasaki (NCCRI, Tokyo, Japan), RH Medema (University of Utrecht, Utrecht, The Netherlands) for plasmids, G Gerlini (S Maria Annunziata Hospital, Florence, Italy) for help in obtaining samples, E Rovida (University of Florence, Florence, Italy) for assistance with confocal microscopy. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC, 9566), Regional Health Research Program 2009 and Fondazione Cassa di Risparmio di Firenze to BS. SP was supported by AIRC fellowship.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; Cha H, 2010, CANCER RES, V70, P4112, DOI 10.1158/0008-5472.CAN-09-4244; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Doucette TA, 2012, NEUROSURGERY, V70, P1003, DOI 10.1227/NEU.0b013e31823e5332; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hayashi R, 2011, BIOCHEMISTRY-US, V50, P4537, DOI 10.1021/bi101949t; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jin ZG, 2011, J BIOL CHEM, V286, P36171, DOI 10.1074/jbc.M111.274761; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Krauss S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007471; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Le Guezennec X, 2012, CELL METAB, V16, P68, DOI 10.1016/j.cmet.2012.06.003; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Liang CH, 2012, BRAIN RES, V1444, P65, DOI 10.1016/j.brainres.2011.12.052; Lindqvist A, 2009, EMBO J, V28, P3196, DOI 10.1038/emboj.2009.246; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Parssinen J, 2008, CANCER GENET CYTOGEN, V182, P33, DOI 10.1016/j.cancergencyto.2007.12.013; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697; Zhu YH, 2009, STEM CELLS, V27, P1433, DOI 10.1002/stem.65	75	38	39	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4737	4747		10.1038/onc.2012.502	http://dx.doi.org/10.1038/onc.2012.502			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23146903				2022-12-25	WOS:000325274700002
J	Doppler, H; Bastea, LI; Eiseler, T; Storz, P				Doeppler, Heike; Bastea, Ligia I.; Eiseler, Tim; Storz, Peter			Neuregulin Mediates F-actin-driven Cell Migration through Inhibition of Protein Kinase D1 via Rac1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; COFILIN-PHOSPHATASE SLINGSHOT; NF-KAPPA-B; REGULATES COFILIN; SIGNALING PATHWAYS; ESTROGEN-RECEPTOR; MAMMARY-GLAND; TUMOR CELLS; HEREGULIN; ACTIVATION	Neuregulin (NRG; heregulin) is overexpressed in similar to 30% of breast cancers and mediates various processes involved in tumor progression, including tumor cell migration and invasion. Here, we show that NRG mediates its effects on tumor cell migration via PKD1. Downstream of RhoA, PKD1 can prevent directed cell migration through phosphorylation of its substrate SSH1L. NRG exerts its inhibitory effects on PKD1 through Rac1/NADPH oxidase, leading to decreased PKD1 activation loop phosphorylation and decreased activity toward SSH1L. The consequence of PKD1 inhibition by NRG is decreased binding of 14-3-3 to SSH1L, localization of SSH1L to F-actin at the leading edge, and increased cofilin activity, resulting in increased reorganization of the actin cytoskeleton and cell motility. Our data provide a mechanism through which the Rho GTPase Rac1 cross-talks with PKD1 signaling pathways to facilitate directed cell migration.	[Doeppler, Heike; Bastea, Ligia I.; Eiseler, Tim; Storz, Peter] Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Griffin Bldg,Rm 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			National Institutes of Health [GM086435, CA140182]; Florida Department of Health [10BG11]; NATIONAL CANCER INSTITUTE [R01CA140182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086435 and CA140182. This work was also supported by Bank-head-Coley Program Grant 10BG11 from the Florida Department of Health (to P.S.).	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Atlas E, 2003, MOL CANCER RES, V1, P165; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bastea LI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030459; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Daly JM, 1997, CANCER RES, V57, P3804; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GRUNT TW, 1995, INT J CANCER, V63, P560, DOI 10.1002/ijc.2910630417; Guerra-Vladusic FK, 1999, INT J ONCOL, V15, P883; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P1217, DOI 10.1091/mbc.4.11.1217; Hijazi MM, 2000, INT J ONCOL, V17, P629; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Karam M, 2012, EXP CELL RES, V318, P558, DOI 10.1016/j.yexcr.2012.01.001; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Kligys K, 2009, BIOCHEM BIOPH RES CO, V383, P450, DOI 10.1016/j.bbrc.2009.04.031; Krane IM, 1996, ONCOGENE, V12, P1781; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Li QF, 2004, CANCER RES, V64, P7078, DOI 10.1158/0008-5472.CAN-04-1152; Marshall C, 2006, BREAST CANCER RES TR, V96, P163, DOI 10.1007/s10549-005-9073-z; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schelfhout VRJ, 2000, JNCI-J NATL CANCER I, V92, P622, DOI 10.1093/jnci/92.8.622; Schmitt M, 2006, MOL CARCINOGEN, V45, P490, DOI 10.1002/mc.20180; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Tan M, 1999, CANCER RES, V59, P1620; Tang CK, 1996, CANCER RES, V56, P3350; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200	47	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					455	465		10.1074/jbc.M112.397448	http://dx.doi.org/10.1074/jbc.M112.397448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148218	Green Published, hybrid			2022-12-25	WOS:000313197200046
J	Yang, Y; Wang, CJ; Zhang, PZ; Gao, K; Wang, DJ; Yu, HX; Zhang, T; Jiang, SR; Hexige, S; Hong, ZH; Yasui, A; Liu, JO; Huang, HJ; Yu, L				Yang, Yang; Wang, Chenji; Zhang, Pingzhao; Gao, Kun; Wang, Dejie; Yu, Hongxiu; Zhang, Ting; Jiang, Sirui; Hexige, Saiyin; Hong, Zehui; Yasui, Akira; Liu, Jun O.; Huang, Haojie; Yu, Long			Polycomb Group Protein PHF1 Regulates p53-dependent Cell Growth Arrest and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL STROMAL SARCOMA; P53; METHYLATION; DEGRADATION; JAZF1/PHF1	Polycomb group protein PHF1 is well known as a component of a novel EED-EZH2.Polycomb repressive complex 2 complex and plays important roles in H3K27 methylation and Hox gene silencing. PHF1 is also involved in the response to DNA double-strand breaks in human cells, promotes nonhomologous end-joining processes through interaction with Ku70/Ku80. Here, we identified another function of PHF1 as a potential p53 pathway activator in a pathway screen using luminescence reporter assay. Subsequent studies showed PHF1 directly interacts with p53 proteins both in vivo and in vitro and co-localized in nucleus. PHF1 binds to the C-terminal regulatory domain of p53. Overexpression of PHF1 elevated p53 protein level and prolonged its turnover. Knockdown of PHF1 reduced p53 protein level and its target gene expression both in normal state and DNA damage response. Mechanically, PHF1 protects p53 proteins from MDM2-mediated ubiquitination and degradation. Furthermore, we showed that PHF1 regulates cell growth arrest and etoposide-induced apoptosis in a p53-dependent manner. Finally, PHF1 expression was significantly down-regulated in human breast cancer samples. Taken together, we establish PHF1 as a novel positive regulator of the p53 pathway. These data shed light on the potential roles of PHF1 in tumorigenesis and/or tumor progression.	[Yang, Yang; Wang, Chenji; Zhang, Pingzhao; Gao, Kun; Wang, Dejie; Zhang, Ting; Jiang, Sirui; Hexige, Saiyin; Yu, Long] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Pingzhao; Yu, Hongxiu; Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Hong, Zehui] Southeast Univ, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China; [Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Hong, Zehui] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hong, Zehui] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Huang, Haojie] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Fudan University; Fudan University; Southeast University - China; Tohoku University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic	Yu, L (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Wang, Dejie/AAJ-9461-2020		National Key Sci-Tech Special Project of China [2008ZX10002-020]; National Natural Science Foundation of China [30872947, 31071193, 81171964]	National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Sci-Tech Special Project of China Grants 2008ZX10002-020) and National Natural Science Foundation of China Grants 30872947, 31071193, and 81171964.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chiang S, 2011, AM J SURG PATHOL, V35, P1364, DOI 10.1097/PAS.0b013e3182262743; Hainaut P, 2000, ADV CANCER RES, V77, P81; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Micci F, 2006, CANCER RES, V66, P107, DOI 10.1158/0008-5472.CAN-05-2485; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; Panagopoulos I, 2008, CANCER GENET CYTOGEN, V185, P74, DOI 10.1016/J.cancergencyto.2008.04.020; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004	19	25	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					529	539		10.1074/jbc.M111.338996	http://dx.doi.org/10.1074/jbc.M111.338996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150668	Green Published, hybrid			2022-12-25	WOS:000313197200053
J	Cohen, J; Fink, G; Berg, K; Aber, F; Jordan, M; Maloney, K; Dickens, W				Cohen, Jessica; Fink, Guenther; Berg, Katrina; Aber, Flavia; Jordan, Matthew; Maloney, Kathleen; Dickens, William			Feasibility of Distributing Rapid Diagnostic Tests for Malaria in the Retail Sector: Evidence from an Implementation Study in Uganda	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; FEBRILE ILLNESS; MANAGEMENT; MICROSCOPY; PNEUMONIA; CHILDREN; ACT	Background: Despite the benefits of malaria diagnosis, most presumed malaria episodes are never tested. A primary reason is the absence of diagnostic tests in retail establishments, where many patients seek care. Malaria rapid diagnostic tests (RDTs) in drug shops hold promise for guiding appropriate treatment. However, retail providers generally lack awareness of RDTs and training to administer them. Further, unsubsidized RDTs may be unaffordable to patients and unattractive to retailers. This paper reports results from an intervention study testing the feasibility of RDT distribution in Ugandan drug shops. Methods and Findings: 92 drug shops in 58 villages were offered subsidized RDTs for sale after completing training. Data on RDT purchases, storage, administration and disposal were collected, and samples were sent for quality testing. Household surveys were conducted to capture treatment outcomes. Estimated daily RDT sales varied substantially across shops, from zero to 8.46 RDTs per days. Overall compliance with storage, treatment and disposal guidelines was excellent. All RDTs (100%) collected from shops passed quality testing. The median price charged for RDTs was 1000USH ($0.40), corresponding to a 100% markup, and the same price as blood slides in local health clinics. RDTs affected treatment decisions. RDT-positive patients were 23 percentage points more likely to buy Artemisinin Combination Therapies (ACTs) (p = .005) and 33.1 percentage points more likely to buy other antimalarials (p<.001) than RDT-negative patients, and were 5.6 percentage points more likely to buy ACTs (p = .05) and 31.4 percentage points more likely to buy other antimalarials (p<.001) than those not tested at all. Conclusions: Despite some heterogeneity, shops demonstrated a desire to stock RDTs and use them to guide treatment recommendations. Most shops stored, administered and disposed of RDTs properly and charged mark-ups similar to those charged on common medicines. Results from this study suggest that distributing RDTs through the retail sector is feasible and can reduce inappropriate treatment for suspected malaria.	[Cohen, Jessica; Fink, Guenther] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Dickens, William] Northeastern Univ, Dept Econ, Boston, MA 02115 USA; [Cohen, Jessica; Jordan, Matthew; Dickens, William] Brookings Inst, Washington, DC 20036 USA; [Berg, Katrina] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; [Aber, Flavia; Maloney, Kathleen] Clinton Hlth Access Initiat, Kampala, Uganda	Harvard University; Harvard T.H. Chan School of Public Health; Northeastern University; Brookings Institution; Johns Hopkins University	Cohen, J (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	cohenj@hsph.harvard.edu			Clinton Health Access Initiative; Bill and Melinda Gates Foundation; Ugandan Ministry of Health	Clinton Health Access Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ugandan Ministry of Health	Funding for the study was provided by the Clinton Health Access Initiative and the Bill and Melinda Gates Foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Innovations for Poverty Action-Uganda for the smooth implementation of the study and data entry and cleaning. We thank the Ugandan Ministry of Health for their support of this research and members of the Foundation for Innovative New Diagnostics Kampala office for input into shop training procedures. The authors thank Abacus for their partnership in distributing RDTs.; FA and KM are employees of, and JC receives research funding from, the Clinton Health Access Initiative, which is engaged in efforts to expand access to malaria diagnostics. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; Baiden F, 2011, TROP MED INT HEALTH, V16, P142, DOI 10.1111/j.1365-3156.2010.02692.x; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-373; Batwala V, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-377, 10.1186/1475-2875-10-373]; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; Bloland P. B., 2001, DRUG RESISTANCE IN M; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Chanda P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-158; Cohen J, THE VALUE OF INFORMA; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; Endeshaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033014; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Friedman J, 2011, SUBSIDIZED ACTS AND; Global Fund to Fight AIDS TB and Malaria and the World Health Organization, 2010, CONSULTATION ON THE; Hansen KS, 2012, WILLINGNESS TO PAY F; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Hawkes M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-308; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Mbonye AK, 2008, J BIOSOC SCI, V40, P283, DOI 10.1017/S0021932007002398; Mbonye AK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-367; Mosha JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008707; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; National Malaria Control Program, 2010, NATIONAL MALARIA CON; Nuwaha F, 2002, TROP MED INT HEALTH, V7, P462, DOI 10.1046/j.1365-3156.2002.00877.x; Oliveira AMd, 2009, AMERICAN JOURNAL OF; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; The USAID Quality Assurance Project (QAP) University Research Co. World Health Organization, 2010, HOW TO USE A RAPID D; Uganda Bureau of Statistics, 2010, UGANDA MALARIA INDIC; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Whitty C, 2008, OPPORTUNITIES AND TH; WHO, 2010, GUIDELINES FOR THE T; World Health Organization, 2011, MALARIA RAPID DIAGNO; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	41	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48296	10.1371/journal.pone.0048296	http://dx.doi.org/10.1371/journal.pone.0048296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152766	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000009
J	Stie, J; Fox, D				Stie, Jamal; Fox, Deborah			Induction of Brain Microvascular Endothelial Cell Urokinase Expression by Cryptococcus neoformans Facilitates Blood-Brain Barrier Invasion	PLOS ONE			English	Article							PROTEIN-KINASE-C; PLASMINOGEN-ACTIVATOR INHIBITOR-1; FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA; EPIDEMIOLOGIC DIFFERENCES; HELICOBACTER-PYLORI; GENE-EXPRESSION; CANCER CELLS; RECEPTOR	The invasive ability of the blood-borne fungal pathogen Cryptococcus neoformans can be enhanced through interactions with host plasma components, such as plasminogen. Previously we showed by in vitro studies that plasminogen coats the surface of C. neoformans and is converted to the active serine protease, plasmin, by host plasminogen activators. Viable, but not formaldehyde-or sodium azide-killed, cryptococcal strains undergo brain microvascular endothelial cell-dependent plasminogen-to-plasmin activation, which results in enhanced, plasmin-dependent cryptococcal invasion of primary bovine brain microvascular endothelial cells and fungal ability to degrade plasmin substrates. In the present work, brain microvascular endothelial cells cultured with viable, but not killed, cryptococcal strains led to significant increases in both urokinase mRNA transcription and cell-associated urokinase protein expression. Soluble urokinase was also detected in conditioned medium from brain microvascular endothelial cells cultured with viable, but not killed, C. neoformans. Exposure of plasminogen pre-coated viable C. neoformans to conditioned medium from strain-matched brain microvascular endothelial cell-fungal co-cultures resulted in plasminogen-to-plasmin activation and plasmin-dependent cryptococcal invasion. siRNA-mediated silencing of urokinase gene expression or the use of specific inhibitors of urokinase activity abrogated both plasminogen-to-plasmin activation on C. neoformans and cryptococcal-brain microvascular endothelial cell invasion. Our results suggest that pathogen exploitation of the host urokinase-plasmin(ogen) system may contribute to C. neoformans virulence during invasive cryptococcosis. Citation: Stie J, Fox D (2012) Induction of Brain Microvascular Endothelial Cell Urokinase Expression by Cryptococcus neoformans Facilitates Blood-Brain Barrier Invasion. PLoS ONE 7(11): e49402. doi:10.1371/journal.pone.0049402	[Stie, Jamal; Fox, Deborah] Louisiana State Univ, Hlth Sci Ctr, Res Inst Children, New Orleans, LA 70112 USA; [Fox, Deborah] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fox, D (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Res Inst Children, New Orleans, LA 70112 USA.	dfox@chnola-research.org			Research Institute for Children; K22 Career Development Award [AI055302]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI055302] Funding Source: NIH RePORTER	Research Institute for Children; K22 Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Research Institute for Children and a K22 Career Development Award AI055302 (NIAID) to D.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J RESP CELL MOL, V22, P401, DOI 10.1165/ajrcmb.22.4.f184; ALTUS MS, 1991, J BIOL CHEM, V266, P21190; Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298; Bastaki M, 1997, ARTERIOSCL THROM VAS, V17, P454, DOI 10.1161/01.ATV.17.3.454; BENNETT JE, 1977, AM J EPIDEMIOL, V105, P582, DOI 10.1093/oxfordjournals.aje.a112423; Bezerra LML, 2004, BLOOD, V103, P2143, DOI 10.1182/blood-2003-06-2186; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Casadevall A, 2010, J CLIN INVEST, V120, P1389, DOI 10.1172/JCI42949; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Chavakis T, 2001, THROMB HAEMOSTASIS, V86, P686, DOI 10.1055/s-0037-1616105; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Cho JY, 1997, CANCER, V79, P878, DOI 10.1002/(SICI)1097-0142(19970301)79:5<878::AID-CNCR2>3.3.CO;2-N; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Faisal A, 2004, J BIOL CHEM, V279, P3202, DOI 10.1074/jbc.M310010200; Gotz JM, 1996, DIGEST DIS SCI, V41, P1577, DOI 10.1007/BF02087903; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Gyetko MR, 1996, J CLIN INVEST, V97, P1818, DOI 10.1172/JCI118611; Gyetko MR, 2002, J IMMUNOL, V168, P801, DOI 10.4049/jimmunol.168.2.801; Hall CJ, 2010, MYCOLOGIA, V102, P546, DOI 10.3852/08-110; HENDERSON BR, 1992, CANCER RES, V52, P2489; Herren T, 2003, FRONT BIOSCI-LANDMRK, V8, pD1, DOI 10.2741/916; Horton MR, 2000, AM J PHYSIOL-LUNG C, V279, pL707, DOI 10.1152/ajplung.2000.279.4.L707; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; IBRAHIM AS, 1995, INFECT IMMUN, V63, P4368, DOI 10.1128/IAI.63.11.4368-4374.1995; IOZZO RV, 1985, LAB INVEST, V53, P373; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Iwamoto JI, 2005, SCAND J GASTROENTERO, V40, P783, DOI 10.1080/00365520510015665; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong A, 2007, EUKARYOT CELL, V6, P1486, DOI 10.1128/EC.00120-07; Jong A, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/375620; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; KASAI S, 1985, J BIOL CHEM, V260, P2377; Kenny S, 2008, AM J PHYSIOL-GASTR L, V295, pG431, DOI 10.1152/ajpgi.90283.2008; Kim TS, 2009, ANIM REPROD SCI, V114, P228, DOI 10.1016/j.anireprosci.2008.09.021; Kim TS, 2010, CRYOBIOLOGY, V60, P211, DOI 10.1016/j.cryobiol.2009.12.002; Kobayashi H, 2002, INT J CANCER, V102, P379, DOI 10.1002/ijc.10710; Kornblau SM, 2005, LEUKEMIA, V19, P1550, DOI 10.1038/sj.leu.2403845; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lee KH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-73; Lee KH, 2009, EXP MOL MED, V41, P180, DOI 10.3858/emm.2009.41.3.021; Li T, 2010, PHARM BIOL, V48, P161, DOI 10.3109/13880200903062630; LIJNEN HR, 1995, BAILLIERE CLIN HAEM, V8, P277, DOI 10.1016/S0950-3536(05)80268-9; Litvintseva AP, 2009, INFECT IMMUN, V77, P3188, DOI 10.1128/IAI.00296-09; Long M, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-19; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Mahanivong C, 2008, ONCOGENE, V27, P1273, DOI 10.1038/sj.onc.1210746; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MUTHUKRISHNAN L, 1991, J CELL PHYSIOL, V148, P1, DOI 10.1002/jcp.1041480102; Nagamine Y, 2005, THROMB HAEMOSTASIS, V93, P661, DOI 10.1160/TH04-12-0814; Nanbu R, 1997, EUR J BIOCHEM, V247, P169, DOI 10.1111/j.1432-1033.1997.00169.x; NANBU R, 1994, MOL CELL BIOL, V14, P4920, DOI 10.1128/MCB.14.7.4920; NIEDBALA MJ, 1992, BIOL CHEM H-S, V373, P555, DOI 10.1515/bchm3.1992.373.2.555; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Ohta S, 2000, THROMB RES, V97, P343, DOI 10.1016/S0049-3848(99)00174-7; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Pai MP, 2009, J CEREBR BLOOD F MET, V29, P545, DOI 10.1038/jcbfm.2008.144; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pedersen CD, 2009, SCAND J IMMUNOL, V70, P447, DOI 10.1111/j.1365-3083.2009.02320.x; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; POWDERLY WG, 1993, CLIN INFECT DIS, V17, P837, DOI 10.1093/clinids/17.5.837; Qureshi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015587; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; Schiller HB, 2009, MOL BIOL CELL, V20, P745, DOI 10.1091/mbc.E08-06-0569; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Shetty S, 2005, MOL CELL BIOCHEM, V271, P13, DOI 10.1007/s11010-005-3453-x; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; SIER CFM, 1993, GUT, V34, P80, DOI 10.1136/gut.34.1.80; Stepanova VV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P109, DOI 10.1023/A:1013912500373; Stie J, 2012, MICROBIOL-SGM, V158, P240, DOI 10.1099/mic.0.051524-0; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sweeney NV, 2005, BIOCHEM BIOPH RES CO, V329, P573, DOI 10.1016/j.bbrc.2005.02.013; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Wu SQ, 2005, AM J PHYSIOL-HEART C, V289, pH873, DOI 10.1152/ajpheart.00993.2004	87	8	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49402	10.1371/journal.pone.0049402	http://dx.doi.org/10.1371/journal.pone.0049402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145170	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500108
J	Bey, A; Leue, S; Wienbruch, C				Bey, Alina; Leue, Stefan; Wienbruch, Christian			A Neuronal Network Model for Simulating the Effects of Repetitive Transcranial Magnetic Stimulation on Local Field Potential Power Spectra	PLOS ONE			English	Article							LOW-FREQUENCY; PREFRONTAL CORTEX; MOTOR CORTEX; EXCITABILITY; FACILITATION; DEPRESSION; RTMS	Repetitive transcranial magnetic stimulation (rTMS) holds promise as a non-invasive therapy for the treatment of neurological disorders such as depression, schizophrenia, tinnitus, and epilepsy. Complex interdependencies between stimulus duration, frequency and intensity obscure the exact effects of rTMS stimulation on neural activity in the cortex, making evaluation of and comparison between rTMS studies difficult. To explain the influence of rTMS on neural activity (e.g. in the motor cortex), we use a neuronal network model. The results demonstrate that the model adequately explains experimentally observed short term effects of rTMS on the band power in common frequency bands used in electroencephalography (EEG). We show that the equivalent local field potential (eLFP) band power depends on stimulation intensity rather than on stimulation frequency. Additionally, our model resolves contradictions in experiments.	[Bey, Alina; Leue, Stefan] Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany; [Wienbruch, Christian] Univ Konstanz, Dept Psychol, Constance, Germany	University of Konstanz; University of Konstanz	Bey, A (corresponding author), Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany.	alina.bey@uni-konstanz.de						Barr MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022627; Barr MS, 2009, NEUROPSYCHOPHARMACOL, V34, P2359, DOI 10.1038/npp.2009.79; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buzsaki G., 2006, RHYTHMS BRAIN; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Gangitano M, 2001, J CLIN NEUROPHYSIOLO, P18; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Graf T, 2001, PSYCHIAT RES-NEUROIM, V107, P1, DOI 10.1016/S0925-4927(01)00083-X; Griskova I, 2007, NEUROSCI LETT, V419, P162, DOI 10.1016/j.neulet.2007.04.030; Hamidi M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.014.2009; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Houdayer E, 2008, EXP BRAIN RES, V187, P207, DOI 10.1007/s00221-008-1294-z; Husain FT, 2002, NEUROIMAGE, V15, P58, DOI 10.1006/nimg.2001.0966; Kandel E.R., 2000, PRINCIPLES NEURAL SC, VXLI; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Langguth B, 2010, NEUROPHYSIOL CLIN, V40, P45, DOI 10.1016/j.neucli.2009.03.001; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; Miyawaki Y, 2004, ADV NEUR IN, V16, P1295; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Okamura H, 2001, J CLIN NEUROPHYSIOL, V18, P318, DOI 10.1097/00004691-200107000-00003; Pascual-Leone A., 2002, HDB TRANSCRANIAL MAG; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Romero JR, 2002, CLIN NEUROPHYSIOL, V113, P101, DOI 10.1016/S1388-2457(01)00693-9; Simpson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020039; Wallace E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014804	30	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49097	10.1371/journal.pone.0049097	http://dx.doi.org/10.1371/journal.pone.0049097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145082	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800203
J	le Roex, N; Noyes, H; Brass, A; Bradley, DG; Kemp, SJ; Kay, S; van Helden, PD; Hoal, EG				le Roex, Nikki; Noyes, Harry; Brass, Andrew; Bradley, Daniel G.; Kemp, Steven J.; Kay, Suzanne; van Helden, Paul D.; Hoal, Eileen G.			Novel SNP Discovery in African Buffalo, Syncerus caffer, Using High-Throughput Sequencing	PLOS ONE			English	Article							GENERATION; MITOCHONDRIAL; POLYMORPHISMS; FRAMEWORK; LOCI	The African buffalo, Syncerus caffer, is one of the most abundant and ecologically important species of megafauna in the savannah ecosystem. It is an important prey species, as well as a host for a vast array of nematodes, pathogens and infectious diseases, such as bovine tuberculosis and corridor disease. Large-scale SNP discovery in this species would greatly facilitate further research into the area of host genetics and disease susceptibility, as well as provide a wealth of sequence information for other conservation and genomics studies. We sequenced pools of Cape buffalo DNA from a total of 9 animals, on an ABI SOLiD4 sequencer. The resulting short reads were mapped to the UMD3.1 Bos taurus genome assembly using both BWA and Bowtie software packages. A mean depth of 2.7x coverage over the mapped regions was obtained. Btau4 gene annotation was added to all SNPs identified within gene regions. Bowtie and BWA identified a maximum of 2,222,665 and 276,847 SNPs within the buffalo respectively, depending on analysis method. A panel of 173 SNPs was validated by fluorescent genotyping in 87 individuals. 27 SNPs failed to amplify, and of the remaining 146 SNPs, 43-54% of the Bowtie SNPs and 57-58% of the BWA SNPs were confirmed as polymorphic. dN/dS ratios found no evidence of positive selection, and although there were genes that appeared to be under negative selection, these were more likely to be slowly evolving house-keeping genes.	[le Roex, Nikki; van Helden, Paul D.; Hoal, Eileen G.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Research, MRC Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet,Fac Hlth Sci, Cape Town, South Africa; [Noyes, Harry; Kemp, Steven J.; Kay, Suzanne] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Brass, Andrew] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Kemp, Steven J.] Int Livestock Res Inst, Nairobi, Kenya	National Research Foundation - South Africa; Stellenbosch University; University of Liverpool; University of Manchester; Trinity College Dublin; CGIAR; International Livestock Research Institute (ILRI)	Hoal, EG (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Research, MRC Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet,Fac Hlth Sci, Cape Town, South Africa.	egvh@sun.ac.za	Noyes, Harry A/B-1151-2010	Noyes, Harry A/0000-0002-0656-200X; Brass, Andrew/0000-0002-0389-7058; Hoal, Eileen/0000-0002-6444-5688; Bradley, Daniel G/0000-0001-7335-7092	Wellcome Trust [GR066764MA]; WOTRO [W01.65.321.00]	Wellcome Trust(Wellcome TrustEuropean Commission); WOTRO	Funding for sequencing was provided by the Wellcome Trust (GR066764MA to SJK). Financial support was provided by WOTRO (W01.65.321.00; http://www.nwo.nl/wotro/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Applied Biosystems, 2010, APPL BIOS SOLID4 SYS; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Grobler JP, 1996, BIOCHEM SYST ECOL, V24, P757, DOI 10.1016/S0305-1978(97)81214-8; Heller R, 2008, MOL ECOL, V17, P4845, DOI 10.1111/j.1365-294X.2008.03961.x; Imelfort M, 2009, PLANT BIOTECHNOL J, V7, P312, DOI 10.1111/j.1467-7652.2009.00406.x; Jolles AE, 2007, AFR J ECOL, V45, P398, DOI 10.1111/j.1365-2028.2006.00726.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-177; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Noyes H, 2011, CAPE BUFFALO SNP; Rios D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-238; Rozen S, 2000, Methods Mol Biol, V132, P365; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; van Hooft WF, 2003, CONSERV GENET, V4, P467, DOI 10.1023/A:1024719231545; Van Hooft WF, 2002, MOL ECOL, V11, P267, DOI 10.1046/j.1365-294X.2002.01429.x; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	33	11	11	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48792	10.1371/journal.pone.0048792	http://dx.doi.org/10.1371/journal.pone.0048792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144973	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800135
J	Waldmeier, L; Meyer-Schaller, N; Diepenbruck, M; Christofori, G				Waldmeier, Lorenz; Meyer-Schaller, Nathalie; Diepenbruck, Maren; Christofori, Gerhard			Py2T Murine Breast Cancer Cells, a Versatile Model of TGF beta-Induced EMT In Vitro and In Vivo	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; MAMMARY EPITHELIUM; TUMOR PROGRESSION; TRANSGENIC MICE; CLAUDIN-LOW; E-CADHERIN; BASAL-LIKE; EXPRESSION; DISEASE	Introduction: Increasing evidence supports a role of an epithelial to mesenchymal transition (EMT) process in endowing subsets of tumor cells with properties driving malignant tumor progression and resistance to cancer therapy. To advance our understanding of the underlying mechanisms, we sought to generate a transplantable cellular model system that allows defined experimental manipulation and analysis of EMT in vitro and at the same time recapitulates oncogenic EMT in vivo. Methodology/Results: We have established a stable murine breast cancer cell line (Py2T) from a breast tumor of an MMTV-PyMT transgenic mouse. Py2T cells display a metastable epithelial phenotype characterized by concomitant expression of luminal and basal cytokeratins and sheet migration. Exposure of Py2T cells to transforming growth factor beta (TGF beta) in vitro induces reversible EMT accompanied by downregulation of E-cadherin and upregulation of mesenchymal markers, including EMT transcription factors, and a gain in single cell motility and invasiveness. Py2T cells give rise to tumors after orthotopic injection into syngeneic FVB/N mice. Notably, transplantation of epithelial Py2T cells results in the formation of invasive primary tumors with low to absent E-cadherin expression, indicating that the cells undergo EMT-like changes in vivo. This process appears to at least in part depend on TGF beta signaling, since tumors formed by Py2T cells expressing a dominant-negative version of TGF beta receptor widely maintain their epithelial differentiation status. Conclusions/Significance: Together, the data demonstrate that the Py2T cell line represents a versatile model system to study the EMT process in vitro and in vivo. The observation that Py2T cells give rise to tumors and collectively undergo EMT-like changes in vivo highlights the suitability of the Py2T model system as a tool to study tumor-related EMT. In particular, Py2T cells may serve to corroborate recent findings relating EMT to cancer cell stemness, to therapy resistance and to tumor recurrence.	[Waldmeier, Lorenz; Meyer-Schaller, Nathalie; Diepenbruck, Maren; Christofori, Gerhard] Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland	University of Basel	Christofori, G (corresponding author), Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland.	Gerhard.Christofori@unibas.ch			Swiss National Science Foundation; SystemsX.ch RTD project Cellplasticity; Krebsliga Beider Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch RTD project Cellplasticity; Krebsliga Beider Basel	This work was supported by the Swiss National Science Foundation, the SystemsX.ch RTD project Cellplasticity, and the Krebsliga Beider Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Andrechek ER, 2005, ONCOGENE, V24, P932, DOI 10.1038/sj.onc.1208230; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bakin AV, 2002, J CELL SCI, V115, P3193; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Cardiff RD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2887; Cardiff RD, 2010, J MAMMARY GLAND BIOL, V15, P225, DOI 10.1007/s10911-010-9184-y; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Maglione JE, 2001, CANCER RES, V61, P8298; Mahler-Araujo B, 2008, J CLIN PATHOL, V61, P615, DOI 10.1136/jcp.2007.053991; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Santibanez JF, 2006, FEBS LETT, V580, P5385, DOI 10.1016/j.febslet.2006.09.003; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	68	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48651	10.1371/journal.pone.0048651	http://dx.doi.org/10.1371/journal.pone.0048651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144919	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800089
J	Wu, Y; Tao, Y; Chen, YC; Xu, WR				Wu, Yan; Tao, Yan; Chen, Yongchang; Xu, Wenrong			RhoC Regulates the Proliferation of Gastric Cancer Cells through Interaction with IQGAP1	PLOS ONE			English	Article							LUNG-CANCER; IN-VITRO; GTPASES; METASTASIS; EXPRESSION; CARCINOMA; INVASION; INVASIVENESS; MIGRATION; ADHESION	Our previous research results showed that both Ras homolog family member C (RhoC) and IQ-domain GTPase-activating protein 1 (IQGAP1) were over-expressed in gastric cancer tissues and cells, but their role in tumorigenensis has not been addressed clearly. Herein we reported the proliferation stimulating effect of RhoC and IQGAP1 on gastric cancer cells and the interaction between two proteins in regulating the proliferation of gastric cancer cells. Plasmids and viral constructs encoding target siRNA and DNA were used to alter the expression of RhoC and IQGAP1. MTT method and BrdU incorporation assay were used for analyzing the effect of RhoC and different structures of IQGAP1 on proliferation. Protein levels of IQGAP1 and RhoC in cell lines were detected by Western blotting. Immunofluorescence and Co-Immunoprecipitation assays were applied to investigate the localization and binding between RhoC and IQGAP1. The results showed that RhoC, IQGAP1 and the C-terminal fragment of IQGAP1 significantly stimulated the proliferation of gastric cancer cells, and enhanced the expression of cyclin E and cyclin D1. By contrast, reduction of endogenous IQGAP1 or RhoC by siRNA attenuated cell proliferation. The depletion of IQGAP1 expression by siRNA significantly blocked the proliferative activity of constitutively active RhoC, while RhoC silencing by siRNA had no effect on IQGAP1-induced proliferation in gastric cancer cells. Co-immunoprecipitation and Immunofluorescence assays showed that RhoC and IQGAP1 bound each other. In conclusion, our results suggest that RhoC stimulates the proliferation of gastric cancer cells through recruiting IQGAP1 as an effector.	[Wu, Yan; Tao, Yan; Chen, Yongchang; Xu, Wenrong] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Wu, Y (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China.	wuyan81@ujs.edu.cn			Specialized Research Fund for Senior Personnel Program of Jiangsu University [11JDG114]; National Natural Science Foundation of China [31040002]	Specialized Research Fund for Senior Personnel Program of Jiangsu University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Specialized Research Fund for Senior Personnel Program of Jiangsu University(No. 11JDG114) and the National Natural Science Foundation of China(No. 31040002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Boye E, 2003, EMBO REP, V4, P757, DOI 10.1038/sj.embor.embor895; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brown N S, 2001, Methods Mol Med, V58, P47, DOI 10.1385/1-59259-137-X:047; Cai YH, 1986, J BEIJING MED U, V18, P136; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Faried A, 2006, EUR J CANCER, V42, P1455, DOI 10.1016/j.ejca.2006.02.012; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Srivastava S, 2010, BRIT J CANCER, V102, P196, DOI 10.1038/sj.bjc.6605451; Sun HW, 2007, WORLD J GASTROENTERO, V13, P3517, DOI 10.3748/wjg.v13.i25.3517; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Wu Y, 2011, MOL MED REP, V4, P697, DOI 10.3892/mmr.2011.482; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676	32	23	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48917	10.1371/journal.pone.0048917	http://dx.doi.org/10.1371/journal.pone.0048917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145020	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800169
J	Zhang, WC; Tsuda, M; Yang, GX; Tsuneyama, K; He, XS; Ansari, AA; Ridgway, WM; Coppel, RL; Lian, ZX; Leung, PSC; Gershwin, ME				Zhang, Weici; Tsuda, Masanobu; Yang, Guo-Xiang; Tsuneyama, Koichi; He, Xiao-Song; Ansari, Aftab A.; Ridgway, William M.; Coppel, Ross L.; Lian, Zhe-Xiong; Leung, Patrick S. C.; Gershwin, M. Eric			Lymphoma-Like T Cell Infiltration in Liver Is Associated with Increased Copy Number of Dominant Negative Form of TGF beta Receptor II	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PRIMARY BILIARY-CIRRHOSIS; SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON GENE; AUTOIMMUNE CHOLANGITIS; INTERLEUKIN-6; MICE; PROGRESSION; HOMEOSTASIS; MECHANISMS	Hepatosplenic T cell lymphoma (HSTCL) is a distinct and lethal subtype of peripheral T cell lymphoma with an aggressive course and poor outcome despite multiagent chemotherapy. Contradictory literature, an unknown etiology, and poor response to treatment highlight the need to define the malignant process and identify molecular targets with potential for successful therapeutic interventions. Herein, we report that mice homozygously expressing a dominant negative TGF beta RII (dnTGF beta RII) under the control of the CD4 promoter spontaneously develop lymphoma-like T cell infiltration involving both spleen and liver. Splenomegaly, hepatomegaly and liver dysfunction were observed in homozygous dnTGFbRII mice between 10 weeks and 10 months of age associated with a predominant infiltration of CD4(-)CD8(-)TCR beta(+)NK1.1(+) or CD8(+)TCR beta(+)NK1.1(-) T cell subsets. Notch 1 and c-Myc expression at the mRNA levels were significantly increased and positively correlated with the cell number of lymphoid infiltrates in the liver of dnTGFbRII homozygous compared to hemizygous mice. Further, 2 x 10(4) isolated lymphoma-like cells transplant disease by adoptive cell transfers. Collectively, our data demonstrate that increased copy number of dnTGF beta RII is critical for development of lymphoma-like T cell infiltration.	[Zhang, Weici; Tsuda, Masanobu; Yang, Guo-Xiang; He, Xiao-Song; Leung, Patrick S. C.; Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Ridgway, William M.] Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Coppel, Ross L.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Lian, Zhe-Xiong] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Inst Immunol, Hefei 230026, Peoples R China; [Lian, Zhe-Xiong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	University of California System; University of California Davis; University of Toyama; Emory University; University System of Ohio; University of Cincinnati; Monash University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gershwin, ME (corresponding author), Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.	megershwin@ucdavis.edu	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124; Tsuneyama, Koichi/0000-0002-0670-9868	National Institutes of Health grant [DK090019]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090019] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support provided by National Institutes of Health grant DK090019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellam N, 2010, CANCER TREAT RES, V155, P85, DOI 10.1007/978-1-4419-6033-7_5; Brattain Michael G., 1996, Current Opinion in Oncology, V8, P49, DOI 10.1097/00001622-199601000-00009; CAPOCASALE RJ, 1995, P NATL ACAD SCI USA, V92, P5501, DOI 10.1073/pnas.92.12.5501; Cozzio A, 2008, J INVEST DERMATOL, V128, P771, DOI 10.1038/jid.2008.49; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; Ferreri AJ, 2011, CRIT REV ONCOL HEMAT; Foss FM, 2011, BLOOD, V117, P6756, DOI 10.1182/blood-2010-05-231548; Gomez G, 2000, INT IMMUNOL, V12, P263, DOI 10.1093/intimm/12.3.263; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Inman GJ, 2000, J GEN VIROL, V81, P1567, DOI 10.1099/0022-1317-81-6-1567; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222; KADIN ME, 1994, P NATL ACAD SCI USA, V91, P6002, DOI 10.1073/pnas.91.13.6002; Kawano R, 2005, HAEMATOLOGICA, V90, P1192; Knaus PI, 1996, MOL CELL BIOL, V16, P3480; Kumar S, 2001, AM J SURG PATHOL, V25, P970, DOI 10.1097/00000478-200107000-00020; Li J, 2010, BLOOD, V116, P5615, DOI 10.1182/blood-2010-03-274506; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lucas PJ, 2004, CANCER RES, V64, P6524, DOI 10.1158/0008-5472.CAN-04-0896; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Macon WR, 2001, AM J SURG PATHOL, V25, P285, DOI 10.1097/00000478-200103000-00002; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mitha N, 2000, METH MOLEC MED, V49, P189, DOI 10.1385/1-59259-081-0:189; Monteiro M, 2010, J IMMUNOL, V185, P2157, DOI 10.4049/jimmunol.1000359; Mraz-Gernhard S, 2001, J CLIN ONCOL, V19, P2179, DOI 10.1200/JCO.2001.19.8.2179; Nagai Y, 2010, INT J CLIN ONCOL, V15, P215, DOI 10.1007/s10147-010-0028-y; Newrzela S, 2012, LEUKEMIA; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Ponti R, 2008, J INVEST DERMATOL, V128, P1030, DOI 10.1038/sj.jid.5701109; Preti HA, 1997, ANN INTERN MED, V127, P186, DOI 10.7326/0003-4819-127-3-199708010-00002; Przybylski GK, 2000, J MOL DIAGN, V2, P11, DOI 10.1016/S1525-1578(10)60610-1; Rook AH, 2003, HEMATOL ONCOL CLIN N, V17, P1435, DOI 10.1016/S0889-8588(03)00109-6; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Suarez F, 2000, AM J SURG PATHOL, V24, P1027, DOI 10.1097/00000478-200007000-00016; Takeshita M, 2004, AM J CLIN PATHOL, V121, P408, DOI 10.1309/TYRGT196N2APLLR9; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yamamura M, 1998, BRIT J HAEMATOL, V100, P129, DOI 10.1046/j.1365-2141.1998.00538.x; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Yashiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-303; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022; Yoshida K, 2009, HEPATOLOGY, V50, P1494, DOI 10.1002/hep.23132; Zhang WC, 2011, J AUTOIMMUN, V37, P71, DOI 10.1016/j.jaut.2011.05.009; Zhang WC, 2010, HEPATOLOGY, V52, P215, DOI 10.1002/hep.23664	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49413	10.1371/journal.pone.0049413	http://dx.doi.org/10.1371/journal.pone.0049413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145171	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800257
J	Gogada, R; Yadav, N; Liu, JW; Tang, SH; Zhang, DM; Schneider, A; Seshadri, A; Sun, LM; Aldaz, CM; Tang, DG; Chandra, D				Gogada, Raghu; Yadav, Neelu; Liu, Junwei; Tang, Shaohua; Zhang, Dianmu; Schneider, Andrea; Seshadri, Athul; Sun, Leimin; Aldaz, C. Marcelo; Tang, Dean G.; Chandra, Dhyan			Bim, a Proapoptotic Protein, Up-regulated via Transcription Factor E2F1-dependent Mechanism, Functions as a Prosurvival Molecule in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER BIM; NF-KAPPA-B; BCL-2 FAMILY; INDUCED APOPTOSIS; STRUCTURAL BASIS; GENE-EXPRESSION; ACTIVATION; BAX; IDENTIFICATION; INHIBITION	Proapoptotic Bcl-2 homology 3-only protein Bim plays an important role in Bax/Bak-mediated cytochrome c release and apoptosis. Here, we provide evidence for a novel prosurvival function of Bim in cancer cells. Bim was constitutively overexpressed in multiple prostate and breast cancer cells as well as in primary tumor cells. Quantitative real time PCR analysis showed that Bim was transcriptionally up-regulated. We have identified eight endogenous E2F1-binding sites on the Bim promoter using in silico analysis. Luciferase assay demonstrated that Bim expression was E2F1-dependent as mutation of the E2F1-binding sites on the Bim promoter inhibited luciferase activities. In support, E2F1 silencing led to the loss of Bim expression in cancer cells. Bim primarily localized to mitochondrial and cytoskeleton-associated fractions. Bim silencing or microinjection of anti-Bim antibodies into the cell cytoplasm resulted in cell rounding, detachment, and subsequent apoptosis. We observed up-regulation of prosurvival proteins Bcl-xL and Mcl-1, which sequester Bim in cancer cells. In addition, a phosphorylated form of Bim was also elevated in cancer cells. These findings suggest that the constitutively overexpressed Bim may function as a prosurvival molecule in epithelial cancer cells, and phosphorylation and association with Bcl-xL/Mcl-1 block its proapoptotic functions.	[Gogada, Raghu; Yadav, Neelu; Zhang, Dianmu; Schneider, Andrea; Seshadri, Athul; Sun, Leimin; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Liu, Junwei; Tang, Shaohua; Aldaz, C. Marcelo; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center	Chandra, D (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Elm & Carlton Sts, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org	Aldaz, C. Marcelo/E-7868-2011; Gogada, Raghu/AAG-6624-2019; Tang, Dean/AAI-3457-2020	Aldaz, C. Marcelo/0000-0002-2453-2939; Tang, Dean/0000-0001-5029-1174; Chandra, Dhyan/0000-0001-7272-9384; Gogada, Raghu/0000-0003-0933-7999	National Institutes of Health [CA123142, R1-ES015888, 1R21CA 150009]; NCI [P30 CA016056]; Department of Defense [W81XWH-11-1-0331]; American Cancer Society [RSG-12-214-01 CCG]; NATIONAL CANCER INSTITUTE [P30CA016056, K01CA123142, R21CA150009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health K01 Award CA123142 (to D. C.) and Grants R1-ES015888 and 1R21CA 150009 (to D. G. T.) and Support Grant P30 CA016056 from NCI (to Roswell Park Cancer Institute). This work was also supported by Department of Defense Grant W81XWH-11-1-0331 (to D.G.T.).; Supported by a Research Scholar Grant RSG-12-214-01 CCG from the American Cancer Society. To whom correspondence should be addressed: Dept. of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Sts., Buffalo, NY 14263. Tel.: 716-845-4882; Fax: 716-845-8857; E-mail: dhyan.chandra@roswellpark.org.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Cheng EH, 2012, NAT MED, V18, P494, DOI 10.1038/nm.2725; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gogada R, 2011, CELL CYCLE, V10, P4128, DOI 10.4161/cc.10.23.18292; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Kerr DA, 2002, J VIROL, V76, P10393, DOI 10.1128/JVI.76.20.10393-10400.2002; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; King SM, 2000, J CELL SCI, V113, P2521; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Liu JW, 2003, ONCOGENE, V22, P1475, DOI 10.1038/sj.onc.1206196; Liu JW, 2002, CANCER RES, V62, P2976; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Madden DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028530; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Moore PS, 2004, BBA-MOL CELL RES, V1693, P167, DOI 10.1016/j.bbamcr.2004.07.001; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Paterson A, 2012, BLOOD, V119, P1726, DOI 10.1182/blood-2011-07-367417; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Seo SY, 2004, J BIOL CHEM, V279, P42240, DOI 10.1074/jbc.M406775200; Seward RJ, 2003, MOL IMMUNOL, V39, P983, DOI 10.1016/S0161-5890(03)00047-6; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tang DG, 1998, CANCER RES, V58, P3466; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zhang HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016379; Zhang SY, 2000, CANCER EPIDEM BIOMAR, V9, P395; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	76	54	57	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					368	381		10.1074/jbc.M112.386102	http://dx.doi.org/10.1074/jbc.M112.386102			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23152504	Green Published, hybrid			2022-12-25	WOS:000313197200038
J	Ramirez, GIJ; Logan, JG; Loza-Reyes, E; Stashenko, E; Moores, GD				Jaramillo Ramirez, Gloria Isabel; Logan, James G.; Loza-Reyes, Elisa; Stashenko, Elena; Moores, Graham D.			Repellents Inhibit P450 Enzymes in Stegomyia (Aedes) aegypti	PLOS ONE			English	Article							BITING MIDGE; BIOTRANSFORMATION ENZYMES; DROSOPHILA-MELANOGASTER; CULICOIDES-IMPUNCTATUS; VOLATILE CHEMICALS; MOSQUITO; IDENTIFICATION; 1-OCTEN-3-OL; RESPONSES; MONOTERPENES	The primary defence against mosquitoes and other disease vectors is often the application of a repellent. Despite their common use, the mechanism(s) underlying the activity of repellents is not fully understood, with even the mode of action of DEET having been reported to be via different mechanisms; e.g. interference with olfactory receptor neurones or actively detected by olfactory receptor neurones on the antennae or maxillary palps. In this study, we discuss a novel mechanism for repellence, one of P450 inhibition. Thirteen essential oil extracts from Colombian plants were assayed for potency as P450 inhibitors, using a kinetic fluorometric assay, and for repellency using a modified World Health Organisation Pesticide Evaluations Scheme (WHOPES) arm-in cage assay with Stegomyia (Aedes) aegypti mosquitoes. Bootstrap analysis on the inhibition analysis revealed a significant correlation between P450-inhibition and repellent activity of the oils.	[Jaramillo Ramirez, Gloria Isabel; Moores, Graham D.] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England; [Jaramillo Ramirez, Gloria Isabel] Ctr Int Entrenamiento & Invest Med, Cali, Colombia; [Logan, James G.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Loza-Reyes, Elisa] Rothamsted Res, Dept Computat & Syst Biol, Harpenden, Herts, England; [Stashenko, Elena] Ctr Nacl Invest Agroind Especies Vegetales Aromat, Bucaramanga, Colombia; [Moores, Graham D.] Rothamsted Res, ApresLabs Ltd, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of London; London School of Hygiene & Tropical Medicine; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Moores, GD (corresponding author), Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England.	Graham.moores@apreslabs.co.uk	Stashenko, Elena/AAS-2877-2021; Jaramillo, Gloria Isabel/HCH-3263-2022	Stashenko, Elena/0000-0001-7052-932X; Jaramillo, Gloria Isabel/0000-0002-7597-3873	Rothamsted International; Rothamsted Research Ltd.; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005107] Funding Source: researchfish; BBSRC [BBS/E/C/00005107] Funding Source: UKRI	Rothamsted International(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rothamsted Research Ltd.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Rothamsted International; Rothamsted Research Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhasin A, 2000, MED VET ENTOMOL, V14, P300, DOI 10.1046/j.1365-2915.2000.00247.x; Blackwell A, 1996, PHYSIOL ENTOMOL, V21, P15, DOI 10.1111/j.1365-3032.1996.tb00830.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bonnet J, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-17; Choi WS, 2002, J AM MOSQUITO CONTR, V18, P348; Curtis C., 1989, APPROPRIATE TECHNOLO, P76; Das N. G., 2003, Journal of Vector Borne Diseases, V40, P49; DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052; de Paula JP, 2003, J ETHNOPHARMACOL, V88, P253, DOI 10.1016/S0378-8741(03)00233-2; Dekker T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-183; DESOUSA G, 1995, ANAL BIOCHEM, V229, P86, DOI 10.1006/abio.1995.1382; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Drapeau J, 2011, CR CHIM, V14, P629, DOI 10.1016/j.crci.2011.02.008; Frances S. P., 2007, INSECT REPELLENTS PR, P311; GABRIEL KR, 1962, ANN MATH STAT, V33, P201, DOI 10.1214/aoms/1177704724; Hansson BS, 2010, CHEMOECOLOGY, V20, P51, DOI 10.1007/s00049-009-0033-7; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; KLINE DL, 1994, MED VET ENTOMOL, V8, P25, DOI 10.1111/j.1365-2915.1994.tb00379.x; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2009, J MED ENTOMOL, V46, P208, DOI 10.1603/033.046.0205; Maibeche-Coisne M, 2002, INSECT MOL BIOL, V11, P273, DOI 10.1046/j.1365-2583.2002.00335.x; Park BS, 2005, J AM MOSQUITO CONTR, V21, P80, DOI 10.2987/8756-971X(2005)21[80:MFTTVA]2.0.CO;2; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Payne R.W., 2010, INTRO GENSTAT WINDOW; R Development Core Team, 2012, R LANG ENV STAT COMP; Rogers ME, 1999, J EXP BIOL, V202, P1625; Ross G.J.S., 1990, NONLINEAR ESTIMATION; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Stashenko EE, 2004, J CHROMATOGR A, V1025, P93, DOI 10.1016/j.chroma.2003.10.058; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Strickman D., 2007, INSECT REPELLENTS PR, P361; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Traboulsi AF, 2005, PEST MANAG SCI, V61, P597, DOI 10.1002/ps.1017; ULLRICH V, 1972, H-S Z PHYSIOL CHEM, V353, P1171, DOI 10.1515/bchm2.1972.353.2.1171; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; WHO, 2009, GUID EFF TEST MOSQ R; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Zhu JJ, 2009, MED VET ENTOMOL, V23, P209, DOI 10.1111/j.1365-2915.2009.00809.x	40	24	27	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48698	10.1371/journal.pone.0048698	http://dx.doi.org/10.1371/journal.pone.0048698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152795	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000311234600009
J	Gonzalez, S; Kilpatrick, ES; Atkin, SL				Gonzalez, Susana; Kilpatrick, Eric S.; Atkin, Stephen L.			The Biological Variation of N-Terminal Pro-Brain Natriuretic Peptide in Postmenopausal Women with Type 2 Diabetes: A Case Control Study	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; POLYCYSTIC OVARIAN SYNDROME; INSULIN-RESISTANCE; BNP; PERFORMANCE; HEMOGLOBIN; PHYSIOLOGY; PREDICTOR; MORBIDITY; MORTALITY	Background: The incidence of heart failure in type 2 diabetes is high and it has poorer prognosis when compared with patients without diabetes. Access to echocardiography is limited and alternative methods to identify early heart failure such as the measurement of natriuretic peptides levels have been proposed. However, their wide biological variation could limit their clinical utility. Our aim was to determine if the intrinsic biological variation of one of these peptides, N-terminal proBNP, is as wide in type 2 diabetes as it is in health and to calculate the critical difference values that could be utilised in clinical practice to ensure changes observed between two samples are due to intervention rather than to its biological variability. Methodology/Principal Findings: 12 postmenopausal women with diet controlled type 2 diabetes and without heart failure were compared with 11 control postmenopausal women without diabetes. N-terminal proBNP levels were measured on 10 occasions. The biological variation was calculated according to Fraser's methods. The mean NT-proBNP level was similar in both groups (mean +/- standard deviation; type 2 diabetes, 10.7 pmol/L +/- 8.5 versus 8.49 +/- 6.0 pmol/L, p = 0.42). The biological variation was also similarly wide. The critical difference in patients with type 2 diabetes was between -70% and +/- 236%. Conclusions: Type 2 diabetes does not appear to significantly influence the marked biological variation of N-terminal proBNP in postmenopausal women. The critical difference values reported in this study could be used to titrate therapy or monitor response to interventions although the change required in between samples is wide and this might limit its utility. Citation: Gonzalez S, Kilpatrick ES, Atkin SL (2012) The Biological Variation of N-Terminal Pro-Brain Natriuretic Peptide in Postmenopausal Women with Type 2 Diabetes: A Case Control Study. PLoS ONE 7(11): e47191. doi: 10.1371/journal.pone.0047191	[Gonzalez, Susana] Bradford Teaching Hosp NHS Fdn Trust, Dept Diabet, Bradford, W Yorkshire, England; [Kilpatrick, Eric S.] Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, East Riding Of, England; [Atkin, Stephen L.] Univ Hull, Dept Med, Kingston Upon Hull HU6 7RX, East Riding Of, England	University of Hull; University of Hull	Gonzalez, S (corresponding author), Bradford Teaching Hosp NHS Fdn Trust, Dept Diabet, Bradford, W Yorkshire, England.	ucm_sg@hotmail.com	Gonzalez, Susana/GSD-7811-2022; Atkin, stephen/ABE-7047-2020; atkin, stephen/D-7400-2014	atkin, stephen/0000-0002-5887-7257	Department of Medicine research fund	Department of Medicine research fund	This work was supported by the Department of Medicine research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Balion CM, 2008, CLIN BIOCHEM, V41, P266, DOI 10.1016/j.clinbiochem.2007.10.006; Barrett-Connor E, 2003, J CLIN ENDOCR METAB, V88, P4031, DOI 10.1210/jc.2003-030876; Boomsma F, 2001, CARDIOVASC RES, V51, P442, DOI 10.1016/S0008-6363(01)00195-X; Browne RW, 2008, BIOMARKERS, V13, P160, DOI [10.1080/13547500701775563, 10.1080/13547500701775563 ]; Bruins S, 2004, CLIN CHEM, V50, P2052, DOI 10.1373/clinchem.2004.038752; Cho LW, 2009, ANN CLIN BIOCHEM, V46, P218, DOI 10.1258/acb.2008.008146; Cho LW, 2005, CLIN CHEM, V51, P1905, DOI 10.1373/clinchem.2005.052753; d'Eril GVM, 2003, CLIN CHEM, V49, P1554; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409; Fraser CG, 2001, BIOL VARIATION PRINC; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; Hartmann F, 2004, EUR J HEART FAIL, V6, P343, DOI 10.1016/j.ejheart.2004.01.009; Jayagopal V, 2002, DIABETES CARE, V25, P2022, DOI 10.2337/diacare.25.11.2022; Jayagopal V, 2003, J CLIN ENDOCR METAB, V88, P1528, DOI 10.1210/jc.2002-020557; Jayagopal V, 2002, J CLIN ENDOCR METAB, V87, P1560, DOI 10.1210/jc.87.4.1560; Jourdain P, 2003, EUR J HEART FAIL, V5, P155, DOI 10.1016/S1388-9842(02)00247-7; Keevil BG, 1998, CLIN CHEM, V44, P1535; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Knudsen CW, 2005, J AM COLL CARDIOL, V46, P838, DOI 10.1016/j.jacc.2005.05.057; Knudsen CW, 2005, CLIN SCI, V109, P69, DOI 10.1042/CS20040349; Koglin J, 2001, J AM COLL CARDIOL, V38, P1934, DOI 10.1016/S0735-1097(01)01672-2; Magnusson M, 2004, DIABETES CARE, V27, P1929, DOI 10.2337/diacare.27.8.1929; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; O'Hanlon R, 2007, J CARD FAIL, V13, P50, DOI 10.1016/j.cardfail.2006.09.003; Raymond I, 2003, HEART, V89, P745, DOI 10.1136/heart.89.7.745; Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1; Silver Marc A, 2004, Congest Heart Fail, V10, P1, DOI 10.1111/j.1527-5299.2004.03271.x; Sokoll LJ, 2004, CLIN CHEM LAB MED, V42, P965, DOI 10.1515/CCLM.2004.157; Song Bong Geun, 2005, Korean Journal of Internal Medicine, V20, P26; surveillance Doncd, 1999, SURV DONCD; Troughton RW, 2008, AM J CARDIOL, V101, p72A, DOI 10.1016/j.amjcard.2007.11.027; Willis MS, 2005, CLIN CHIM ACTA, V358, P175, DOI 10.1016/j.cccn.2005.03.009; Wu AHB, 2004, DIABETES CARE, V27, P2398, DOI 10.2337/diacare.27.10.2398; Wu AHB, 2004, EUR J HEART FAIL, V6, P355, DOI 10.1016/j.ejheart.2003.12.011; Wu AHB, 2003, AM J CARDIOL, V92, P628, DOI 10.1016/S0002-9149(03)00741-0; Yano Y, 1999, J CLIN ENDOCR METAB, V84, P2353, DOI 10.1210/jc.84.7.2353	39	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e47191	10.1371/journal.pone.0047191	http://dx.doi.org/10.1371/journal.pone.0047191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152754	Green Submitted, Green Published, gold			2022-12-25	WOS:000312272600003
J	Crowther, NJ; Norris, SA				Crowther, Nigel J.; Norris, Shane A.			The Current Waist Circumference Cut Point Used for the Diagnosis of Metabolic Syndrome in Sub-Saharan African Women Is Not Appropriate	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; CARDIOVASCULAR RISK; SOUTH-AFRICA; BODY-FAT; POPULATION; OBESITY; NUTRITION; HEALTH; PREVALENCE; TRANSITION	The waist circumference cut point for diagnosing the metabolic syndrome in sub-Saharan African subjects is based on that obtained from studies in European populations. The aim of this study was to measure the prevalence of obesity and related metabolic disorders in an urban population of African females, a group at high risk for such diseases, and to determine the appropriate waist cut point for diagnosing the metabolic syndrome. Anthropometry and fasting lipid, glucose and insulin levels were measured in a cohort of 1251 African females participating in the Birth to Twenty cohort study in Soweto, Johannesburg. The waist circumference cut points for diagnosing metabolic syndrome (as defined using the new harmonised guidelines), insulin resistance, dysglycaemia, hypertension and dyslipidaemia were obtained using receiver operator characteristic curve analysis. The prevalence of obesity, type 2 diabetes and metabolic syndrome were 50.1%, 14.3% and 42.1%, respectively. The appropriate waist cut point for diagnosing metabolic syndrome was found to be 91.5 cm and was similar to the cuts points obtained for detecting increased risk of insulin resistance (89.0 cm), dysglycaemia (88.4 cm), hypertension (90.1 cm), hypo-high density lipoproteinaemia (87.6 cm) and hyper-low density lipoproteinaemia (90.5 cm). The present data demonstrates that urban, African females have a high prevalence of obesity and related disorders and the waist cut point currently recommended for the diagnosis of the metabolic syndrome (80.0 cm) in this population should be increased to 91.5 cm. This latter finding demonstrates a clear ethnic difference in the relationship between abdominal adiposity and metabolic disease risk. The similar waist cut points identified for the detection of the individual components of the metabolic syndrome and related cardiovascular risk factors demonstrates that the risk for different metabolic diseases increases at the same level of abdominal adiposity suggesting a common aetiological pathway. Citation: Crowther NJ, Norris SA (2012) The Current Waist Circumference Cut Point Used for the Diagnosis of Metabolic Syndrome in Sub-Saharan African Women Is Not Appropriate. PLoS ONE 7(11): e48883. doi:10.1371/journal.pone.0048883	[Crowther, Nigel J.] Univ Witwatersrand, Dept Chem Pathol, Fac Hlth Sci, Natl Hlth Lab Serv, Johannesburg, South Africa; [Norris, Shane A.] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, MRC Univ Witwatersrand Dev Pathways Hlth Res Unit, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand	Crowther, NJ (corresponding author), Univ Witwatersrand, Dept Chem Pathol, Fac Hlth Sci, Natl Hlth Lab Serv, Johannesburg, South Africa.	nigel.crowther@nhls.ac.za	Norris, Shane/C-4664-2014	Norris, Shane/0000-0001-7124-3788; Crowther, Nigel/0000-0002-5766-1745	Wellcome Trust of the United Kingdom; Medical Research Council of South Africa; Medical Research Council [G1001333] Funding Source: researchfish; MRC [G1001333] Funding Source: UKRI	Wellcome Trust of the United Kingdom(Wellcome Trust); Medical Research Council of South Africa(South African Medical Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust of the United Kingdom and the Medical Research Council of South Africa funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Akinboboye O, 2003, J HUM HYPERTENS, V17, P381, DOI 10.1038/sj.jhh.1001562; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ali AT, 2011, HORM METAB RES, V43, P77, DOI 10.1055/s-0030-1269851; Amer Coll Endocrinologists Board T, 2010, ENDOCR PRACT, V16, P155; Balkau B, 1999, DIABETIC MED, V16, P442; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ferris WF, 2005, HORM METAB RES, V37, P695, DOI 10.1055/s-2005-870580; Fezeu L, 2007, ATHEROSCLEROSIS, V193, P70, DOI 10.1016/j.atherosclerosis.2006.08.037; Fourie CMT, 2010, LIPIDS, V45, P73, DOI 10.1007/s11745-009-3369-4; George JA, 2009, AIDS RES HUM RETROV, V25, P771, DOI 10.1089/aid.2008.0308; Han TS, 1996, OBES RES, V4, P533, DOI 10.1002/j.1550-8528.1996.tb00267.x; Hara K, 2006, DIABETES CARE, V29, P1123, DOI 10.2337/dc05-2540; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lear SA, 2010, EUR J CLIN NUTR, V64, P42, DOI 10.1038/ejcn.2009.70; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mokhtar N, 2001, J NUTR, V131, p887S, DOI 10.1093/jn/131.3.887S; Motala AA, 2011, DIABETES CARE, V34, P1032, DOI 10.2337/dc10-1921; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; Norris SA, 2007, J INT DEV, V19, P1143, DOI DOI 10.1002/JID.1390; Obuchowski NA, 2004, CLIN CHEM, V50, P1118, DOI 10.1373/clinchem.2004.031823; Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Prinsloo J, 2011, EXP CLIN ENDOCR DIAB, V119, P599, DOI 10.1055/s-0031-1280801; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Richter LM, 2007, INT J EPIDEMIOL, V36, P1; Seidell Jacob C, 2005, Semin Vasc Med, V5, P3, DOI 10.1055/s-2005-871737; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sumner AE, 2011, OBESITY, V19, P671, DOI 10.1038/oby.2010.201; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Vorster HH, 2005, PUBLIC HEALTH NUTR, V8, P480, DOI 10.1079/PHN2005784; Williams MJ, 1996, INT J OBESITY, V20, P613; Yach D, 1991, Paediatr Perinat Epidemiol, V5, P211, DOI 10.1111/j.1365-3016.1991.tb00702.x; Zemlin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022558; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	45	76	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48883	10.1371/journal.pone.0048883	http://dx.doi.org/10.1371/journal.pone.0048883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145009	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500044
J	Pang, MD; Lin, XQ; Hu, M; Li, J; Lu, CP; Liu, YJ				Pang, Mao-Da; Lin, Xiao-Qin; Hu, Meng; Li, Jing; Lu, Cheng-Ping; Liu, Yong-Jie			Tetrahymena: An Alternative Model Host for Evaluating Virulence of Aeromonas Strains	PLOS ONE			English	Article							SHIGA TOXIN; THERMOPHILA; PYRIFORMIS; PROTOZOAN; EVOLUTION; PREDATOR	An easier assessment model would be helpful for high-throughput screening of Aeromonas virulence. The previous study indicated the potential of Tetrahymena as a permissive model to examine virulence of Aeromonas hydrophila. Here our aim was to assess virulence of Aeromonas spp. using two model hosts, a zebrafish assay and Tetrahymena-Aeromonas co-culture, and to examine whether data from the Tetrahymena thermophila model reflects infections in the well-established animal model. First, virulence of 39 Aeromonas strains was assessed by determining the 50% lethal dose (LD50) in zebrafish. LD50 values ranging from 1.3x10(2) to 3.0x10(7) indicated that these strains represent a high to moderate degree of virulence and could be useful to assess virulence in the Tetrahymena model. In Tetrahymena-Aeromonas co-culture, we evaluated the virulence of Aeromonas by detecting relative survival of Aeromonas and Tetrahymena. An Aeromonas isolate was considered virulent when its relative survival was greater than 60%, while the Aeromonas isolate was considered avirulent if its relative survival was below 40%. When relative survival of T. thermophila was lower than 40% after co-culture with an Aeromonas isolate, the bacterial strain was regarded as virulent. In contrast, the strain was classified as avirulent if relative survival of T. thermophila was greater than 50%. Encouragingly, data from the 39 Aeromonas strains showed good correlation in zebrafish and Tetrahymena-Aeromonas co-culture models. The results provide sufficient data to demonstrate that Tetrahymena can be a comparable alternative to zebrafish for determining the virulence of Aeromonas isolates.	[Pang, Mao-Da; Lin, Xiao-Qin; Hu, Meng; Li, Jing; Lu, Cheng-Ping; Liu, Yong-Jie] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	liuyongjie@njau.edu.cn			National Nature Science Foundation [31072151]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The study was funded by National Nature Science Foundation (31072151) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benghezal M, 2007, CELL MICROBIOL, V9, P1336, DOI 10.1111/j.1462-5822.2006.00877.x; Bi ZX, 2007, RES VET SCI, V83, P150, DOI 10.1016/j.rvsc.2007.01.003; Bonnet JL, 2008, ARCH ENVIRON CON TOX, V55, P576, DOI 10.1007/s00244-008-9145-2; Breneva N. V., 2008, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P39; Bukharin O V, 2008, Mikrobiologiia, V77, P219; Coehran WG, 1977, SAMPLING TECHNIQUES; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Froquet R, 2007, APPL ENVIRON MICROB, V73, P5657, DOI 10.1128/AEM.00908-07; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Hayes SL, 2007, J APPL MICROBIOL, V103, P811, DOI 10.1111/j.1365-2672.2007.03318.x; Jacobs ME, 2006, EUKARYOT CELL, V5, P1990, DOI 10.1128/EC.00195-06; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Kingombe CIB, 2004, INT J FOOD MICROBIOL, V94, P113, DOI 10.1016/S0168-1605(03)00105-3; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; Li J, 2011, FEMS MICROBIOL LETT, V316, P160, DOI 10.1111/j.1574-6968.2010.02208.x; LY TMC, 1990, J MED MICROBIOL, V33, P51, DOI 10.1099/00222615-33-1-51; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Munro BH, 1993, STAT METHODS HLTH CA, P81; Ni XD, 2010, FEMS IMMUNOL MED MIC, V58, P363, DOI 10.1111/j.1574-695X.2009.00646.x; Orias E, 1998, GENOME RES, V8, P91, DOI 10.1101/gr.8.2.91; Orias E, 2011, RES MICROBIOL, V162, P578, DOI 10.1016/j.resmic.2011.05.001; Ottaviani D, 2006, FOOD MICROBIOL, V23, P418, DOI 10.1016/j.fm.2005.08.001; Pradel E, 2004, ANNU REV GENET, V38, P347, DOI 10.1146/annurev.genet.38.072902.092528; Pu JunYi, 2007, Scientia Agricultura Sinica, V40, P2655; Pushkareva V. I., 2003, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P40; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez I, 2008, FISH SHELLFISH IMMUN, V25, P239, DOI 10.1016/j.fsi.2008.05.002; Rodriguez I, 2009, FISH SHELLFISH IMMUN, V27, P369, DOI 10.1016/j.fsi.2009.02.007; STELMA GN, 1992, APPL ENVIRON MICROB, V58, P2776, DOI 10.1128/AEM.58.9.2776-2782.1992; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; Stover NA, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas007	32	23	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48922	10.1371/journal.pone.0048922	http://dx.doi.org/10.1371/journal.pone.0048922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145022	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500047
J	Widagdo, J; Taylor, KM; Gunning, PW; Hardeman, EC; Palmer, SJ				Widagdo, Jocelyn; Taylor, Kylie M.; Gunning, Peter W.; Hardeman, Edna C.; Palmer, Stephen J.			SUMOylation of GTF2IRD1 Regulates Protein Partner Interactions and Ubiquitin-Mediated Degradation	PLOS ONE			English	Article							WILLIAMS-BEUREN-SYNDROME; BROAD-SPECTRUM IDENTIFICATION; TFII-I; HISTONE DEACETYLASE-3; MENTAL-RETARDATION; SUMO CONJUGATION; FAMILY PROTEINS; PIAS PROTEINS; ZINC FINGERS; GENE FAMILY	GTF2IRD1 is one of the genes implicated in Williams-Beuren syndrome, a disease caused by haploinsufficiency of certain dosage-sensitive genes within a hemizygous microdeletion of chromosome 7. GTF2IRD1 is a prime candidate for some of the major features of the disease, presumably caused by abnormally reduced abundance of this putative transcriptional repressor protein. GTF2IRD1 has been shown to interact with the E3 SUMO ligase PIASx beta, but the significance of this relationship is largely unexplored. Here, we demonstrate that GTF2IRD1 can be SUMOylated by the SUMO E2 ligase UBC9 and the level of SUMOylation is enhanced by PIASxb. A major SUMOylation site was mapped to lysine 495 within a conserved SUMO consensus motif. SUMOylation of GTF2IRD1 alters the affinity of the protein for binding partners that contain SUMO-interacting motifs, including a novel family member of the HDAC repressor complex, ZMYM5, and PIASxb itself. In addition, we show that GTF2IRD1 is targeted for ubiquitination and proteasomal degradation. Cross regulation by SUMOylation modulates this process, thus potentially regulating the level of GTF2IRD1 protein in the cell. These findings, concerning post-translational control over the activity and stability of GTF2IRD1, together with previous work showing how GTF2IRD1 directly regulates its own transcription levels suggest an evolutionary requirement for fine control over GTF2IRD1 activity in the cell. Citation: Widagdo J, Taylor KM, Gunning PW, Hardeman EC, Palmer SJ (2012) SUMOylation of GTF2IRD1 Regulates Protein Partner Interactions and Ubiquitin-Mediated Degradation. PLoS ONE 7(11): e49283. doi: 10.1371/journal.pone.0049283	[Widagdo, Jocelyn; Taylor, Kylie M.; Hardeman, Edna C.; Palmer, Stephen J.] Univ New S Wales, Sch Med Sci, Neuromuscular & Regenerat Med Unit, Sydney, NSW, Australia; [Gunning, Peter W.] Univ New S Wales, Sch Med Sci, Oncol Res Unit, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Palmer, SJ (corresponding author), Univ New S Wales, Sch Med Sci, Neuromuscular & Regenerat Med Unit, Sydney, NSW, Australia.	s.palmer@unsw.edu.au	Widagdo, Jocelyn/J-6316-2013; Gunning, Peter W/E-9058-2010; Palmer, Stephen/F-2822-2013	Widagdo, Jocelyn/0000-0001-9667-9203; Palmer, Stephen/0000-0002-4907-4719; Gunning, Peter/0000-0003-0833-3128; Hardeman, Edna/0000-0003-1649-7712	Australian National Health and Medical Research Council [423401]; University of New South Wales Postgraduate Award	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales Postgraduate Award	This work was supported by a Project Grant (423401) from the Australian National Health and Medical Research Council. JW held a University of New South Wales Postgraduate Award scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ganesan AK, 2007, PROTEOMICS, V7, P2216, DOI 10.1002/pmic.200600971; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Greeberg F, 1990, AM J MED GENET S, V6, P85; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Howard ML, 2012, NEUROBIOL DIS, V45, P913, DOI 10.1016/j.nbd.2011.12.010; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Karmiloff-Smith A, 2003, J MED GENET, V40, P136, DOI 10.1136/jmg.40.2.136; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Ouyang J, 2009, EPIGENETICS, V4, P1; Palmer SJ, 2010, J BIOL CHEM, V285, P4715, DOI 10.1074/jbc.M109.086660; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Sohal J, 2000, CYTOGENET CELL GENET, V89, P24, DOI 10.1159/000015584; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tay ESE, 2003, BIOCHEM J, V374, P359, DOI 10.1042/BJ20030189; Tussie-Luna MI, 2002, J BIOL CHEM, V277, P43185, DOI 10.1074/jbc.M207635200; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Vullhorst D, 2003, J BIOL CHEM, V278, P8370, DOI 10.1074/jbc.M209361200; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wen YD, 2003, J BIOL CHEM, V278, P1841, DOI 10.1074/jbc.M206528200; Young EJ, 2008, GENES BRAIN BEHAV, V7, P224, DOI 10.1111/j.1601-183X.2007.00343.x; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49283	10.1371/journal.pone.0049283	http://dx.doi.org/10.1371/journal.pone.0049283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145142	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500096
J	Yang, CY; Xiao, JH; Niu, LM; Ma, GC; Cook, JM; Bian, SN; Fu, YG; Huang, DW				Yang, Chun-Yan; Xiao, Jin-Hua; Niu, Li-Ming; Ma, Guang-Chang; Cook, James M.; Bian, Sheng-Nan; Fu, Yue-Guan; Huang, Da-Wei			Chaos of Wolbachia Sequences Inside the Compact Fig Syconia of Ficus benjamina (Ficus: Moraceae)	PLOS ONE			English	Article							HORIZONTAL TRANSFER; CYTOPLASMIC INCOMPATIBILITY; WASP COMMUNITIES; INFECTION; TRANSMISSION; PHYLOGENY; RECOMBINATION; HYMENOPTERA; EVOLUTION; DYNAMICS	Figs and fig wasps form a peculiar closed community in which the Ficus tree provides a compact syconium (inflorescence) habitat for the lives of a complex assemblage of Chalcidoid insects. These diverse fig wasp species have intimate ecological relationships within the closed world of the fig syconia. Previous surveys of Wolbachia, maternally inherited endosymbiotic bacteria that infect vast numbers of arthropod hosts, showed that fig wasps have some of the highest known incidences of Wolbachia amongst all insects. We ask whether the evolutionary patterns of Wolbachia sequences in this closed syconium community are different from those in the outside world. In the present study, we sampled all 17 fig wasp species living on Ficus benjamina, covering 4 families, 6 subfamilies, and 8 genera of wasps. We made a thorough survey of Wolbachia infection patterns and studied evolutionary patterns in wsp (Wolbachia Surface Protein) sequences. We find evidence for high infection incidences, frequent recombination between Wolbachia strains, and considerable horizontal transfer, suggesting rapid evolution of Wolbachia sequences within the syconium community. Though the fig wasps have relatively limited contact with outside world, Wolbachia may be introduced to the syconium community via horizontal transmission by fig wasps species that have winged males and visit the syconia earlier. Citation: Yang C-Y, Xiao J-H, Niu L-M, Ma G-C, Cook JM, et al. (2012) Chaos of Wolbachia Sequences Inside the Compact Fig Syconia of Ficus benjamina (Ficus: Moraceae). PLoS ONE 7(11): e48882. doi:10.1371/journal.pone.0048882	[Yang, Chun-Yan; Bian, Sheng-Nan; Huang, Da-Wei] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Xiao, Jin-Hua; Niu, Li-Ming; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Niu, Li-Ming; Ma, Guang-Chang; Fu, Yue-Guan] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Danzhou, Hainan, Peoples R China; [Cook, James M.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Cook, James M.] Univ Western Sydney, Hawkesbury Inst Environm, Sydney, NSW, Australia	Shandong Agricultural University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Tropical Agricultural Sciences; University of Reading; Western Sydney University	Huang, DW (corresponding author), Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China.	huangdw@ioz.ac.cn	Cook, James/S-2128-2019; Cook, James M/D-6423-2011	Cook, James/0000-0001-8447-6126; Cook, James M/0000-0001-8447-6126	National Natural Science Foundation of China (NSFC) [31090253, 31172072]; Major Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-2]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy) [NSFC-J0930004]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Innovation Program of Chinese Academy of Sciences; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy)	This project was supported by the National Natural Science Foundation of China (NSFC grant no. 31090253, 31172072), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2), a grant (No. O529YX5105) from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences and National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy, NSFC-J0930004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Baldo L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-48; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Charlat S, 2002, EVOLUTION, V56, P1735, DOI 10.1111/j.0014-3820.2002.tb00187.x; Chen LL, 2010, INSECT SCI, V17, P101, DOI 10.1111/j.1744-7917.2009.01291.x; Chen Ying-Ru, 1999, Journal of Taiwan Museum, V52, P39; Compton S. G., 1993, African Entomology, V1, P123; Compton Stephen G., 1994, P343; Cook JM, 1996, J BIOGEOGR, V23, P487, DOI 10.1111/j.1365-2699.1996.tb00010.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Floate KD, 2008, BIOCONTROL SCI TECHN, V18, P733, DOI 10.1080/09583150802155274; Frost CL, 2010, MOL ECOL, V19, P4077, DOI 10.1111/j.1365-294X.2010.04764.x; Gibernau M, 2002, INT J PLANT SCI, V163, P1017, DOI 10.1086/342628; Grenier S, 1998, P ROY SOC B-BIOL SCI, V265, P1441, DOI 10.1098/rspb.1998.0455; Haine ER, 2005, P ROY SOC B-BIOL SCI, V272, P421, DOI 10.1098/rspb.2004.2956; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HANSON P, 1992, J NAT HIST, V26, P1333, DOI 10.1080/00222939200770761; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 1999, PARASITOLOGY, V118, P125, DOI 10.1017/S0031182098003655; Jiggins FM, 2002, MOL BIOL EVOL, V19, P1640, DOI 10.1093/oxfordjournals.molbev.a004228; Kerdelhue C, 2000, ECOLOGY, V81, P2832, DOI 10.1890/0012-9658(2000)081[2832:CCESOO]2.0.CO;2; Kerdelhue C, 1996, OIKOS, V77, P163, DOI 10.2307/3545597; Kittayapong P, 2003, MOL ECOL, V12, P1049, DOI 10.1046/j.1365-294X.2003.01793.x; Kuttamathiatu J. J., 1959, P662; Kyei-Poku GK, 2005, MOL ECOL, V14, P285, DOI 10.1111/j.1365-294X.2004.02409.x; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Melika G, 2007, J ENTOMOLOGICAL RES, V9; Mercot H, 2004, GENETICA, V120, P51, DOI 10.1023/B:GENE.0000017629.31383.8f; Miller WJ, 2006, APPL ENVIRON MICROB, V72, P826, DOI 10.1128/AEM.72.1.826-835.2006; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Parrish C, 2010, PLOS PATHOG, V6; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; Rokas A, 2002, MOL ECOL, V11, P1815, DOI 10.1046/j.1365-294X.2002.01556.x; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; SCHIFFLER GUSTAVO, 2002, Neotrop. entomol., V31, P653, DOI 10.1590/S1519-566X2002000400022; Shoemaker DD, 2002, P ROY SOC B-BIOL SCI, V269, P2257, DOI 10.1098/rspb.2002.2100; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Stahlhut JK, 2010, MOL ECOL, V19, P1940, DOI 10.1111/j.1365-294X.2010.04572.x; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Tamura K, 2011, MOL BIOL EVOLUTION; Tzeng HY, 2008, SYMBIOSIS, V45, P129; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Viljakainen L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-55; Wang ZJ, 2010, SYMBIOSIS, V51, P181, DOI 10.1007/s13199-010-0072-4; Weiblen GD, 2002, MOL ECOL, V11, P1573, DOI 10.1046/j.1365-294X.2002.01529.x; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xiao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015067; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	64	8	8	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48882	10.1371/journal.pone.0048882	http://dx.doi.org/10.1371/journal.pone.0048882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145008	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500043
J	Zullo, L; Chiappalone, M; Martinoia, S; Benfenati, F				Zullo, Letizia; Chiappalone, Michela; Martinoia, Sergio; Benfenati, Fabio			A "Spike-Based" Grammar Underlies Directional Modification in Network Connectivity: Effect on Bursting Activity and Implications for Bio-Hybrids Systems	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; CULTURED CORTICAL-NEURONS; ACTIVITY PATTERNS; MULTIELECTRODE ARRAYS; INFORMATION; DYNAMICS; TRANSMISSION; STIMULATION; ENHANCEMENT; RELIABILITY	Developed biological systems are endowed with the ability of interacting with the environment; they sense the external state and react to it by changing their own internal state. Many attempts have been made to build 'hybrids' with the ability of perceiving, modifying and reacting to external modifications. Investigation of the rules that govern network changes in a hybrid system may lead to finding effective methods for 'programming' the neural tissue toward a desired task. Here we show a new perspective in the use of cortical neuronal cultures from embryonic mouse as a working platform to study targeted synaptic modifications. Differently from the common timing-based methods applied in bio-hybrids robotics, here we evaluated the importance of endogenous spike timing in the information processing. We characterized the influence of a spike-patterned stimulus in determining changes in neuronal synchronization (connectivity strength and precision) of the evoked spiking and bursting activity in the network. We show that tailoring the stimulation pattern upon a neuronal spike timing induces the network to respond stronger and more precisely to the stimulation. Interestingly, the induced modifications are conveyed more consistently in the burst timing. This increase in strength and precision may be a key in the interaction of the network with the external world and may be used to induce directional changes in bio-hybrid systems. Citation: Zullo L, Chiappalone M, Martinoia S, Benfenati F (2012) A "Spike-Based" Grammar Underlies Directional Modification in Network Connectivity: Effect on Bursting Activity and Implications for Bio-Hybrids Systems. PLoS ONE 7(11): e49299. doi:10.1371/journal.pone.0049299	[Zullo, Letizia; Chiappalone, Michela; Martinoia, Sergio; Benfenati, Fabio] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Martinoia, Sergio] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy; [Benfenati, Fabio] Univ Genoa, Dept Expt Med, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa; University of Genoa	Zullo, L (corresponding author), Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	letizia.zullo@iit.it	Zullo, Letizia/G-5269-2018; martinoia, sergio/H-1863-2011	Zullo, Letizia/0000-0003-0503-6312; martinoia, sergio/0000-0002-0058-9519; Chiappalone, Michela/0000-0003-1427-5147	Compagnia di San Paolo, Torino; Telethon-Italy [GGP09134]	Compagnia di San Paolo, Torino(Compagnia di San Paolo); Telethon-Italy(Fondazione Telethon)	This work has been supported by the Compagnia di San Paolo, Torino and by the Telethon-Italy (Grant GGP09134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Banker CaGK, 1998, CULTURING NERVE CELL; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bologna LL, 2010, NEURAL NETWORKS, V23, P685, DOI 10.1016/j.neunet.2010.05.002; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Clark K, 2008, EUR J NEUROSCI, V28, P279, DOI 10.1111/j.1460-9568.2008.06337.x; Cozzi L, 2006, BIOL CYBERN, V94, P335, DOI 10.1007/s00422-006-0051-2; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Eytan D, 2004, J NEUROPHYSIOL, V92, P1817, DOI 10.1152/jn.00202.2004; Eytan D, 2003, J NEUROSCI, V23, P9349; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; Gjorgjieva J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000618; Harnett MT, 2009, NEURON, V62, P826, DOI 10.1016/j.neuron.2009.05.011; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kallenberg O., 1997, FDN MODERN PROBABILI; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; MAEDA E, 1995, J NEUROSCI, V15, P6834; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Martinoia S, 2004, NEUROCOMPUTING, V58, P1065, DOI 10.1016/j.neucom.2004.01.167; Mussa-Ivaldi F. A., 2010, FRONTIERS NEUROSCIEN; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Pine J., 2006, ADV NETWORK ELECTROP, P3, DOI DOI 10.1007/0-387-25858-2_1; Potter S M, 2001, Prog Brain Res, V130, P49; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rieke F., 1997, SPIKES EXPLORING NEU; SEGEV R, 2004, PHYS REV LETT, V92; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Tateno T, 1999, BIOL CYBERN, V80, P45, DOI 10.1007/s004220050503; Tiesinga PHE, 2005, J COMPUT NEUROSCI, V18, P275, DOI 10.1007/s10827-005-0330-2; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005	46	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49299	10.1371/journal.pone.0049299	http://dx.doi.org/10.1371/journal.pone.0049299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145147	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500100
J	Bracewell, SA; Spencer, M; Marrs, RH; Iles, M; Robinson, LA				Bracewell, Sally A.; Spencer, Matthew; Marrs, Rob H.; Iles, Matthew; Robinson, Leonie A.			Cleft, Crevice, or the Inner Thigh: 'Another Place' for the Establishment of the Invasive Barnacle Austrominius modestus (Darwin, 1854)	PLOS ONE			English	Article							FRAGILE SSP TOMENTOSOIDES; ELMINIUS-MODESTUS; BIOLOGICAL INVASIONS; SETTLEMENT RATE; SPECIES TRAITS; MARINE; RECRUITMENT; HABITAT; SPREAD; WATER	The proliferation of anthropogenic infrastructure in the marine environment has aided the establishment and spread of invasive species. These structures can create novel habitats in areas normally characterised as void of suitable settlement sites. The habitat requirements of the invasive acorn barnacle Austrominius modestus (Darwin, 1854) were assessed using a novel sampling site at Crosby Beach, Liverpool. Austrominius modestus has spread rapidly around the UK since its initial introduction, becoming locally dominant in many estuarine areas including the Antony Gormley art installation, 'Another Place', at Crosby Beach. The installation consists of 100 replicate solid cast-iron life-size human figures, located at a range of heights on the shore. We recorded the distribution and abundance of A. modestus present on all of the statues at various positions during the summer of 2006. The positions varied in location, exposure, direction, and rugosity. Although parameters such as rugosity and exposure did influence patterns of recruitment, they were less important than interactions between shore height and direction, and specific location on the beach. The addition of a suitable substrate to a sheltered and estuarine region of Liverpool Bay has facilitated the establishment of A. modestus. Understanding the habitat requirements of invasive species is important if we are to make predictions about their spread and the likelihood of invasion success. Austrominius modestus has already become locally dominant in some regions of the UK and, with projections of favourable warming conditions and the global expansion of artificial structures, the continued spread of this species can be expected. The implications of this on the balance between native and invasive species dominance should be considered.	[Bracewell, Sally A.; Spencer, Matthew; Marrs, Rob H.; Iles, Matthew; Robinson, Leonie A.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Bracewell, SA (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England.	sally_bracewell@hotmail.com		Iles, Mark/0000-0002-2603-6509	Esmee Fairbairn Foundation under the URBANE project (Urban Research on Biodiversity on Artificial and Natural coastal Environments); British Ecological Society	Esmee Fairbairn Foundation under the URBANE project (Urban Research on Biodiversity on Artificial and Natural coastal Environments); British Ecological Society	This work was partly funded by the Esmee Fairbairn Foundation (www.esmeefairbairn.org.uk/) under the URBANE project (Urban Research on Biodiversity on Artificial and Natural coastal Environments) and the British Ecological Society (www.britishecologicalsociety.org) through a Small Ecological Project Grant to LA Robinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; Allen Brendan M., 2006, Biology and Environment, V106B, P155, DOI 10.3318/BIOE.2006.106.2.155; Allen JR, 1995, AQUAT CONSERV, V5, P299, DOI 10.1002/aqc.3270050405; Allred BW, 2010, BIOL INVASIONS, V12, P739, DOI 10.1007/s10530-009-9476-6; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bracewell SA, 2011, THESIS U LIVERPOOL L; Briggs JC, 2012, MAR ECOL PROG SER, V449, P297, DOI 10.3354/meps09553; Broitman BR, 2008, ECOLOGY, V89, pS81, DOI 10.1890/08-0635.1; Bulleri F, 2006, HYDROBIOLOGIA, V555, P263, DOI 10.1007/s10750-005-1122-4; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Burrows MT, 2008, MAR ECOL PROG SER, V353, P1, DOI 10.3354/meps07284; Chun YJ, 2010, ECOL LETT, V13, P937, DOI 10.1111/j.1461-0248.2010.01498.x; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Clark GF, 2005, MAR ECOL PROG SER, V298, P9, DOI 10.3354/meps298009; Connell J.H., 1972, Annual Rev Ecol Syst, V3, P169, DOI 10.1146/annurev.es.03.110172.001125; CONNELL JH, 1970, ECOL MONOGR, V40, P49, DOI 10.2307/1942441; CRISP DJ, 1948, NATURE, V161, P64, DOI 10.1038/161064a0; CRISP DJ, 1958, J MAR BIOL ASSOC UK, V37, P483, DOI 10.1017/S0025315400023833; CRISP DJ, 1959, J MAR BIOL ASSOC UK, V38, P429, DOI 10.1017/S0025315400006846; CRISP DJ, 1954, J ANIM ECOL, V23, P142, DOI 10.2307/1664; Darwin C., 1854, MONOGRAPH SUBCLASS C; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Edwards RA, 2005, MAR FRESHWATER RES, V56, P133, DOI 10.1071/MF04202; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Forrest BM, 2009, J APPL ECOL, V46, P46, DOI 10.1111/j.1365-2664.2008.01544.x; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Gomes-Filho J. G. F., 2010, MAR BIODIVERS REC, V3, P1; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Jeschke J. M., 2012, NeoBiota, P1; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Lawson J, 2004, ESTUAR COAST SHELF S, V60, P729, DOI 10.1016/j.ecss.2004.03.011; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; Mills David J.L., 1998, P315; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Munroe DM, 2010, MAR ECOL PROG SER, V412, P151, DOI 10.3354/meps08712; Munroe DM, 2010, J EXP MAR BIOL ECOL, V392, P188, DOI 10.1016/j.jembe.2010.04.019; Muxagata E, 2004, ICES J MAR SCI, V61, P585, DOI 10.1016/j.icesjms.2004.03.015; PINEDA J, 1994, MAR ECOL PROG SER, V107, P125, DOI 10.3354/meps107125; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Polton JA, 2011, OCEAN DYNAM, V61, P1421, DOI 10.1007/s10236-011-0431-6; Pope Elizabeth C., 1945, REC AUSTRALIAN MUS, V21, P351; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAIMONDI PT, 1990, ECOL MONOGR, V60, P283, DOI 10.2307/1943059; Rajakaruna H, 2012, BIOL INVASIONS, V14, P633, DOI 10.1007/s10530-011-0104-x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rittschof D, 1998, BIOFOULING, V12, P31, DOI 10.1080/08927019809378344; RUSSELL G, 1983, J APPL ECOL, V20, P43, DOI 10.2307/2403375; Strayer DL, 2012, ECOL LETT, V15, P1199, DOI 10.1111/j.1461-0248.2012.01817.x; Svane I, 2001, MAR ECOL-P S Z N I, V22, P169, DOI 10.1046/j.1439-0485.2001.01729.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Wilkinson SB, 1996, MAR ECOL-P S Z N I, V17, P197, DOI 10.1111/j.1439-0485.1996.tb00501.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Witte S, 2010, BIOL INVASIONS, V12, P3579, DOI 10.1007/s10530-010-9752-5; Wright JR, 1999, MAR ECOL PROG SER, V183, P179, DOI 10.3354/meps183179	61	18	18	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48863	10.1371/journal.pone.0048863	http://dx.doi.org/10.1371/journal.pone.0048863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145000	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800156
J	Silva, KAD; Luiz, RDS; Rampaso, RR; de Abreu, NP; Moreira, ED; Mostarda, CT; De Angelis, K; Teixeira, VDC; Irigoyen, MC; Schor, N				dos Santos Silva, Kleiton Augusto; Luiz, Rafael da Silva; Rampaso, Rodolfo Rosseto; de Abreu, Nayda Parisio; Moreira, Edson Dias; Mostarda, Cristiano Teixeira; De Angelis, Katia; Castro Teixeira, Vicente de Paulo; Irigoyen, Maria Claudia; Schor, Nestor			Previous Exercise Training Has a Beneficial Effect on Renal and Cardiovascular Function in a Model of Diabetes	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SPONTANEOUSLY HYPERTENSIVE-RATS; SYMPATHETIC-NERVE ACTIVITY; CHRONIC KIDNEY-DISEASE; BAROREFLEX SENSITIVITY; SKELETAL-MUSCLE; ANGIOTENSIN-II; MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; GLUCOSE-TRANSPORT	Exercise training (ET) is an important intervention for chronic diseases such as diabetes mellitus (DM). However, it is not known whether previous exercise training intervention alters the physiological and medical complications of these diseases. We investigated the effects of previous ET on the progression of renal disease and cardiovascular autonomic control in rats with streptozotocin (STZ)-induced DM. Male Wistar rats were divided into five groups. All groups were followed for 15 weeks. Trained control and trained diabetic rats underwent 10 weeks of exercise training, whereas previously trained diabetic rats underwent 14 weeks of exercise training. Renal function, proteinuria, renal sympathetic nerve activity (RSNA) and the echocardiographic parameters autonomic modulation and baroreflex sensitivity (BRS) were evaluated. In the previously trained group, the urinary albumin/creatinine ratio was reduced compared with the sedentary diabetic and trained diabetic groups (p < 0.05). Additionally, RSNA was normalized in the trained diabetic and previously trained diabetic animals (p < 0.05). The ejection fraction was increased in the previously trained diabetic animals compared with the diabetic and trained diabetic groups (p < 0.05), and the myocardial performance index was improved in the previously trained diabetic group compared with the diabetic and trained diabetic groups (p < 0.05). In addition, the previously trained rats had improved heart rate variability and BRS in the tachycardic response and bradycardic response in relation to the diabetic group (p < 0.05). This study demonstrates that previous ET improves the functional damage that affects DM. Additionally, our findings suggest that the development of renal and cardiac dysfunction can be minimized by 4 weeks of ET before the induction of DM by STZ.	[dos Santos Silva, Kleiton Augusto; Luiz, Rafael da Silva; Rampaso, Rodolfo Rosseto; de Abreu, Nayda Parisio; Castro Teixeira, Vicente de Paulo; Schor, Nestor] Fed Univ Sao Paulo UNIFESP EPM, Div Nephrol, Dept Med, Sao Paulo, Brazil; [Moreira, Edson Dias; Mostarda, Cristiano Teixeira; Irigoyen, Maria Claudia] Univ Sao Paulo, Sch Med, Hypertens Unit, Heart Inst InCor, Sao Paulo, Brazil; [De Angelis, Katia] Nove Julho Univ, Lab Translat Physiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Nove de Julho	Silva, KAD (corresponding author), Fed Univ Sao Paulo UNIFESP EPM, Div Nephrol, Dept Med, Sao Paulo, Brazil.	ksilva@unifesp.br	DE ANGELIS, KATIA/I-6098-2016; IRIGOYEN, MARIA CLAUDIA C/N-6880-2014; Batista, Marcelo/K-4305-2013; Mostarda, Cristiano/AAG-4087-2019; Schor, Nestor/K-4364-2013	DE ANGELIS, KATIA/0000-0002-3640-9049; IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662; Mostarda, Cristiano Teixeira/0000-0002-1305-1697; Silva, Kleiton/0000-0001-8230-0012	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Oswaldo Ramos; CNPq-Bolsa de Produtividade em pesquisa (BPQ)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Ramos; CNPq-Bolsa de Produtividade em pesquisa (BPQ)	The present study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Oswaldo Ramos. K. De Angelis, M. C. Irigoyen and N. Schor were recipients of CNPq-Bolsa de Produtividade em pesquisa (BPQ) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Akula A, 2003, PHARMACOL RES, V48, P429, DOI 10.1016/S1043-6618(03)00191-9; ALBRIGHT AL, 1995, MED SCI SPORT EXER, V27, P1270; Farah VDA, 2007, CLINICS, V62, P477, DOI 10.1590/S1807-59322007000400015; Bai SZ, 2012, DIABETES RES CLIN PR, V95, P378, DOI 10.1016/j.diabres.2011.11.007; Bardoux P, 1999, P NATL ACAD SCI USA, V96, P10397, DOI 10.1073/pnas.96.18.10397; Bell TD, 2006, J AM SOC NEPHROL, V17, P2184, DOI 10.1681/ASN.2006030216; Bergamaschi CT, 1997, MED SCI SPORT EXER, V29, P169, DOI 10.1097/00005768-199702000-00001; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Brotman DJ, 2010, J AM SOC NEPHROL, V21, P1560, DOI 10.1681/ASN.2009111112; Chandra P, 2012, NEPHROL DIAL TRANSPL, V27, P700, DOI 10.1093/ndt/gfr340; Cheng SM, 2012, INT J CARDIOL, DOI 10.1016/j.ijcard.2012.01.031; CIANFLOCCO AJ, 1992, CLIN SPORT MED, V11, P437; d'Avila KDL, 1999, HYPERTENSION, V34, P768, DOI 10.1161/01.HYP.34.4.768; Dall'Ago P, 2007, AUTON NEUROSCI-BASIC, V131, P28, DOI 10.1016/j.autneu.2006.06.005; De Angelis KLD, 2000, BRAZ J MED BIOL RES, V33, P635, DOI 10.1590/S0100-879X2000000600004; DiCarlo SE, 2002, CLIN EXP HYPERTENS, V24, P221, DOI 10.1081/CEH-120003202; Dinh W, DIABET MED; elMidaoui A, 1996, METABOLISM, V45, P810, DOI 10.1016/S0026-0495(96)90151-1; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Gu H, 2009, NEUROSCIENCE, V161, P78, DOI 10.1016/j.neuroscience.2009.02.083; Gunduz F, 2003, J APPL PHYSIOL, V95, P1867, DOI 10.1152/japplphysiol.00599.2003; Harthmann AD, 2007, AUTON NEUROSCI-BASIC, V133, P115, DOI 10.1016/j.autneu.2006.10.004; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Johansen KL, 2005, SPORTS MED, V35, P485, DOI 10.2165/00007256-200535060-00003; Jorge L, 2012, EXP DIABETES RES, DOI 10.1155/2012/108680; Jorge L, 2011, EUR HEART J, V32, P904, DOI 10.1093/eurheartj/ehq244; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; La Rovere MT, 1998, LANCET, V351, P478; Lohmeier TE, 2003, CIRC RES, V92, P1282, DOI 10.1161/01.RES.0000080784.15419.5A; Luippold G, 2004, NEPHROL DIAL TRANSPL, V19, P342, DOI 10.1093/ndt/gfg584; LUNDIN S, 1984, ACTA PHYSIOL SCAND, V120, P265, DOI 10.1111/j.1748-1716.1984.tb00133.x; Malfitano C, 2012, J CARDIOVASC PHARM, V59, P58, DOI 10.1097/FJC.0b013e3182354776; Matsuoka H, 1993, Diabetes Res, V23, P19; Mihm MJ, 2001, LIFE SCI, V69, P527, DOI 10.1016/S0024-3205(01)01141-9; Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x; Mostarda C, 2011, J CARD FAIL, V17, P519, DOI 10.1016/j.cardfail.2011.02.007; Mostarda C, 2009, AUTON NEUROSCI-BASIC, V145, P11, DOI 10.1016/j.autneu.2008.10.010; Mousa TM, 2008, J APPL PHYSIOL, V104, P616, DOI 10.1152/japplphysiol.00601.2007; Nakai N, 2002, ENDOCR J, V49, P547, DOI 10.1507/endocrj.49.547; Niebauer J, 1999, AM J PHYSIOL-HEART C, V276, pH1346; Ramires PR, 1997, J APPL PHYSIOL, V83, P608, DOI 10.1152/jappl.1997.83.2.608; Rodrigues AM, 2011, EXP BIOL MED, V236, P1180, DOI 10.1258/ebm.2011.011005; Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38; Schaan BD, 2005, AUTON NEUROSCI-BASIC, V117, P54, DOI 10.1016/j.autneu.2004.11.001; Schaan Beatriz D'Agord, 2005, Nephron Physiology, V100, P43; Sigal RJ, DIABETES CARE, V33, pe147; Silva GJJ, 1997, HYPERTENSION, V30, P714, DOI 10.1161/01.HYP.30.3.714; Soares PPDA, 2004, AUTON NEUROSCI-BASIC, V113, P24, DOI 10.1016/j.autneu.2004.05.002; Souza SBC, 2007, HYPERTENSION, V50, P786, DOI 10.1161/HYPERTENSIONAHA.107.095000; Weston PJ, 1996, CLIN SCI, V91, P59, DOI 10.1042/cs0910059; Wichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40; Zheng H, 2006, AM J PHYSIOL-RENAL, V291, pF1148, DOI 10.1152/ajprenal.00501.2005; Zimmet PZ, 1997, J DIABETES COMPLICAT, V11, P60, DOI 10.1016/S1056-8727(96)00090-6	56	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48826	10.1371/journal.pone.0048826	http://dx.doi.org/10.1371/journal.pone.0048826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144989	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800148
J	Gassman, NR; Stefanick, DF; Kedar, PS; Horton, JK; Wilson, SH				Gassman, Natalie R.; Stefanick, Donna F.; Kedar, Padmini S.; Horton, Julie K.; Wilson, Samuel H.			Hyperactivation of PARP Triggers Nonhomologous End-Joining in Repair-Deficient Mouse Fibroblasts	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-POLYMERASE-BETA; DEPENDENT PROTEIN-KINASE; CELL-DEATH PARTHANATOS; POLY(ADP-RIBOSE) POLYMERASE; MAMMALIAN-CELLS; DAMAGE; KU; IDENTIFICATION; PATHWAY	Regulation of poly(ADP-ribose) (PAR) synthesis and turnover is critical to determining cell fate after genotoxic stress. Hyperactivation of PAR synthesis by poly(ADP-ribose) polymerase-1 (PARP-1) occurs when cells deficient in DNA repair are exposed to genotoxic agents; however, the function of this hyperactivation has not been adequately explained. Here, we examine PAR synthesis in mouse fibroblasts deficient in the base excision repair enzyme DNA polymerase beta (pol beta). The extent and duration of PARP-1 activation was measured after exposure to either the DNA alkylating agent, methyl methanesulfonate (MMS), or to low energy laser-induced DNA damage. There was strong DNA damage-induced hyperactivation of PARP-1 in pol beta null cells, but not in wild-type cells. In the case of MMS treatment, PAR synthesis did not lead to cell death in the pol b null cells, but instead resulted in increased PARylation of the nonhomologous end-joining (NHEJ) protein Ku70 and increased association of Ku70 with PARP-1. Inhibition of the NHEJ factor DNA-PK, under conditions of MMS-induced PARP-1 hyperactivation, enhanced necrotic cell death. These data suggest that PARP-1 hyperactivation is a protective mechanism triggering the classical-NHEJ DNA repair pathway when the primary alkylated base damage repair pathway is compromised.	[Gassman, Natalie R.; Stefanick, Donna F.; Kedar, Padmini S.; Horton, Julie K.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Gassman, Natalie/0000-0002-8488-2332	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-ES050158, Z01-ES050159]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, Z01ES050158, ZIAES050158, Z01ES050159] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Research Project Numbers Z01-ES050158 and Z01-ES050159 in the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Audebert M, 2008, BIOCHEM BIOPH RES CO, V369, P982, DOI 10.1016/j.bbrc.2007.11.132; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Cheng Q, 2011, NUCLEIC ACIDS RES, V39, P9605, DOI 10.1093/nar/gkr656; Chiarugi A, 2005, NEUROTOXICOLOGY, V26, P847, DOI 10.1016/j.neuro.2005.01.012; Couto CAM, 2011, J CELL BIOL, V194, P367, DOI 10.1083/jcb.201012132; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Heacock ML, 2010, DNA REPAIR, V9, P929, DOI 10.1016/j.dnarep.2010.05.007; Horton JK, 2005, DNA REPAIR, V4, P1111, DOI 10.1016/j.dnarep.2005.05.011; Horton JK, 2005, J BIOL CHEM, V280, P15773, DOI 10.1074/jbc.M413841200; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Hu HY, 2004, J BIOL CHEM, V279, P39736, DOI 10.1074/jbc.M402842200; Jelezcova E, 2010, MUTAT RES-FUND MOL M, V686, P57, DOI 10.1016/j.mrfmmm.2010.01.016; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lan L, 2004, DNA REPAIR, V3, P135, DOI 10.1016/j.dnarep.2003.10.005; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Masaoka A, 2012, J BIOL CHEM, V287, P27648, DOI 10.1074/jbc.M112.370759; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Okano S, 2005, NUCLEIC ACIDS RES, V33, P422, DOI 10.1093/nar/gki190; Pachkowski BF, 2009, MUTAT RES-FUND MOL M, V671, P93, DOI 10.1016/j.mrfmmm.2009.09.006; Paddock MN, 2011, DNA REPAIR, V10, P338, DOI 10.1016/j.dnarep.2010.12.005; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Strande N, 2012, J BIOL CHEM, V287, P13686, DOI 10.1074/jbc.M111.329730; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; Wang Lian-Bang, 2010, Yichuan, V32, P881, DOI 10.3724/SP.J.1005.2010.00881; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Wilson DM, 1999, J HISTOCHEM CYTOCHEM, V47, P1095, DOI 10.1177/002215549904700814	58	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49301	10.1371/journal.pone.0049301	http://dx.doi.org/10.1371/journal.pone.0049301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145148	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800242
J	Jeong, W; Kim, J; Ahn, SE; Lee, SI; Bazer, FW; Han, JY; Song, G				Jeong, Wooyoung; Kim, Jinyoung; Ahn, Suzie E.; Lee, Sang In; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa			AHCYL1 Is Mediated by Estrogen-Induced ERK1/2 MAPK Cell Signaling and MicroRNA Regulation to Effect Functional Aspects of the Avian Oviduct	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR-BINDING PROTEIN; HYDROLASE-LIKE PROTEIN-1; ADENOSYL-L-HOMOCYSTEINE; CHICK OVIDUCT; GENE-EXPRESSION; IP3 RECEPTOR; EPITHELIAL-CELLS; DIFFERENTIATION; IRBIT	S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1), also known as IP3 receptor-binding protein released with IP3 (IRBIT), regulates IP3-induced Ca2+ release into the cytoplasm of cells. AHCYL1 is a critical regulator of early developmental stages in zebrafish, but little is known about the function of AHCYL1 or hormonal regulation of expression of the AHCYL1 gene in avian species. Therefore, we investigated differential expression profiles of the AHCYL1 gene in various adult organs and in oviducts from estrogen-treated chickens. Chicken AHCYL1 encodes for a protein of 540 amino acids that is highly conserved and has considerable homology to mammalian AHCYL1 proteins (. 94% identity). AHCYL1 mRNA was expressed abundantly in various organs of chickens. Further, the synthetic estrogen agonist induced AHCYL1 mRNA and protein predominantly in luminal and glandular epithelial cells of the chick oviduct. In addition, estrogen activated AHCYL1 through the ERK1/2 signal transduction cascade and that activated expression of AHCYL1 regulated genes affecting oviduct development in chicks as well as calcium release in epithelial cells of the oviduct. Also, microRNAs, miR-124a, miR-1669, miR-1710 and miR-1782 influenced AHCYL1 expression in vitro via its 3'-UTR which suggests that post-transcriptional events are involved in the regulation of AHCYL1 expression in the chick oviduct. In conclusion, these results indicate that AHCYL1 is a novel estrogen-stimulated gene expressed in epithelial cells of the chicken oviduct that likely affects growth, development and calcium metabolism of the mature oviduct of hens via an estrogen-mediated ERK1/2 MAPK cell signaling pathway.	[Jeong, Wooyoung; Kim, Jinyoung; Ahn, Suzie E.; Lee, Sang In; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX USA	Seoul National University (SNU); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Song, G (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	ghsong@snu.ac.kr	Bazer, Fuller/AAF-4317-2021; Song, Gwonhwa/H-3647-2015; Lim, Whasun/F-2060-2013; gwonhwa, song/H-3208-2015	Bazer, Fuller/0000-0002-5823-5086; 	World Class University (WCU) program [R31-10056]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2010-0013078]; Ministry of Education, Science, and Technology; Next-Generation BioGreen 21 Program [PJ008142]; Rural Development Administration, Republic of Korea	World Class University (WCU) program; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was funded by the World Class University (WCU) program (R31-10056) and by Basic Science Research Program (2010-0013078) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Ando H, 2009, J NEUROCHEM, V109, P539, DOI 10.1111/j.1471-4159.2009.05979.x; Bar A, 2009, J POULT SCI, V46, P267, DOI 10.2141/jpsa.46.267; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Buhi WC, 1997, J REPROD FERTIL, P285; Bujnicki JM, 2003, PROTEINS, V52, P624, DOI 10.1002/prot.10446; Chousalkar KK, 2008, CELL TISSUE RES, V332, P349, DOI 10.1007/s00441-007-0567-3; Cooper BJ, 2006, J BIOL CHEM, V281, P22471, DOI 10.1074/jbc.M602520200; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Dekker JW, 2002, IMMUNOGENETICS, V53, P993, DOI 10.1007/s00251-001-0402-z; DELAHABA G, 1959, J BIOL CHEM, V234, P603; Devogelaere B, 2006, BIOCHEM BIOPH RES CO, V343, P49, DOI 10.1016/j.bbrc.2006.02.119; Dougherty DC, 2005, TRENDS ENDOCRIN MET, V16, P414, DOI 10.1016/j.tem.2005.09.001; Drummond A.J., 2010, GENEIOUS V5 04; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Serra M, 2004, DEV BIOL, V268, P384, DOI 10.1016/j.ydbio.2003.12.029; Gomi T, 2008, BBA-PROTEINS PROTEOM, V1784, P1786, DOI 10.1016/j.bbapap.2008.08.016; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hincke MT, 2010, J POULT SCI, V47, P208, DOI 10.2141/jpsa.009122; Jung JG, 2011, BIOL REPROD, V85, P798, DOI 10.1095/biolreprod.111.092023; Kim JY, 2008, ENDOCRINOLOGY, V149, P3085, DOI 10.1210/en.2007-1367; KOHLER PO, 1968, SCIENCE, V160, P86, DOI 10.1126/science.160.3823.86; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Lee SI, 2009, POULTRY SCI, V88, P1003, DOI 10.3382/ps.2008-00197; Lim W, 2011, EXPT BIOL M IN PRESS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Monroe DG, 2000, MOL CELL BIOL, V20, P4626, DOI 10.1128/MCB.20.13.4626-4634.2000; Monroe DG, 2002, MOL ENDOCRINOL, V16, P1322, DOI 10.1210/me.16.6.1322; Munro S. S., 1943, POULTRY SCI, V22, P330, DOI 10.3382/ps.0220330; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Okada Akinobu, 2005, Journal of Toxicological Sciences, V30, P75, DOI 10.2131/jts.30.75; PALMITER RD, 1971, J CELL BIOL, V50, P598, DOI 10.1083/jcb.50.3.598; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDERS MM, 1988, BIOCHEMISTRY-US, V27, P6550, DOI 10.1021/bi00417a053; Seo Bee Won, 2009, Journal of Animal Science and Technology, V51, P485; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SOCHER SH, 1973, DEV BIOL, V30, P411, DOI 10.1016/0012-1606(73)90098-5; Song G, 2011, BIOL REPROD IN PRESS; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Wang YC, 2004, DEV DYNAM, V231, P72, DOI 10.1002/dvdy.20114; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	50	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49204	10.1371/journal.pone.0049204	http://dx.doi.org/10.1371/journal.pone.0049204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145124	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800230
J	Li, XH; Ha, CT; Fu, DD; Xiao, M				Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang			Micro-RNA30c Negatively Regulates REDD1 Expression in Human Hematopoietic and Osteoblast Cells after Gamma-Irradiation	PLOS ONE			English	Article							MIR-30 FAMILY; RADIATION-THERAPY; KAPPA-B; MICRORNAS; PROGENITORS; GENE; RNA; DIFFERENTIATION; TARGET; MODEL	We recently demonstrated that a novel cell stress response gene REDD1 protects human fetal osteoblast cell line (hFOB) cells from c-radiation-induced premature senescence. Here we show that levels of endogenous REDD1 are very low in human hematopoietic progenitor CD34+ cells regardless of radiation, but highly expressed in differentiated hematopoietic cells (14 day cultured CD34+ cells) in response to radiation, which might be associated with radiation tolerance of the latter cells. To further understand the mechanisms of radiation-induced damage in different cells, microRNA (miRNA)-arrays were performed using purified miRNAs from CD34+ and hFOB cells before and post-irradiation and real-time reverse transcription (RT)-PCR was used to validate the expression profiles of miRNAs in the radiation-damaged cells. The results indicate that gamma-radiation downregulated 16 miRNAs in CD34+ cells and 14 in hFOB cells. Radiation-induced upregulation was observed for 15 miRNAs in CD34+ cells and 18 miRNAs in hFOB cells. The profiles of radiation-induced miRNA expression were completely different in CD34+ vs. hFOB cells. Radiation up-regulated miRNA (miR)-30b, miR-30c and miR-30d in CD34+ cells, whereas it inhibited miR-30c expression in hFOB cells. Since miR-30 has potential target sites located in the 3'untranslated region (UTR) of the REDD1 gene and radiation regulated miR-30c expression in both CD34+ and hFOB cells, we further explored the effects of miR-30c on REDD1 expression using miR-30c inhibitor and precursor (pre-miR-30c). The results show that pre-miR-30c transfection suppressed REDD1 expression in 14 day cultured CD34+ cells and hFOB cells and resulted in hFOB cell death. In contrast, inhibition of miR-30c expression significantly enhanced clonogenicity in CD34+ cells. Our data suggest that CD34+ and hFOB cells have different miRNA expression patterns after irradiation and miR-30c plays a key role in radiation-induced cell damage which might be through regulation of REDD1 expression.	[Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Xiao, M (corresponding author), Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	mang.xiao@usuhs.edu			Armed Forces Radiobiology Research Institute intramural grant [RAB2EI]; American Congressional Grant [G1B2EP]	Armed Forces Radiobiology Research Institute intramural grant; American Congressional Grant	This study was supported by Armed Forces Radiobiology Research Institute intramural grant (RAB2EI) to MX and American Congressional Grant (G1B2EP) to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Chaudhry MA, 2010, INT J RADIAT BIOL, V86, P569, DOI 10.3109/09553001003734568; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li XH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039690, 10.1371/journal.pone.0036604]; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Ozcan S, 2009, ISLETS, V1, P283, DOI 10.4161/isl.1.3.9968; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Xiao M, 2009, EXP HEMATOL, V37, P52, DOI 10.1016/j.exphem.2008.09.001; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121	29	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48700	10.1371/journal.pone.0048700	http://dx.doi.org/10.1371/journal.pone.0048700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144934	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800102
J	Pers, BM; Krishna, S; Chakraborty, S; Pigolotti, S; Sekara, V; Semsey, S; Jensen, MH				Pers, Benedicte Mengel; Krishna, Sandeep; Chakraborty, Sagar; Pigolotti, Simone; Sekara, Vedran; Semsey, Szabolcs; Jensen, Mogens H.			Effects of Growth and Mutation on Pattern Formation in Tissues	PLOS ONE			English	Article							CELL-PROLIFERATION; LATERAL INHIBITION; RECEPTORS; NOTCH	In many developing tissues, neighboring cells enter different developmental pathways, resulting in a fine-grained pattern of different cell states. The most common mechanism that generates such patterns is lateral inhibition, for example through Delta-Notch coupling. In this work, we simulate growth of tissues consisting of a hexagonal arrangement of cells laterally inhibiting their neighbors. We find that tissue growth by cell division and cell migration tends to produce ordered patterns, whereas lateral growth leads to disordered, patchy patterns. Ordered patterns are very robust to mutations (gene silencing or activation) in single cells. In contrast, mutation in a cell of a disordered tissue can produce a larger and more widespread perturbation of the pattern. In tissues where ordered and disordered patches coexist, the perturbations spread mostly at boundaries between patches. If cell division occurs on time scales faster than the degradation time, disordered patches will appear. Our work suggests that careful experimental characterization of the disorder in tissues could pinpoint where and how the tissue is susceptible to large-scale damage even from single cell mutations.	[Pers, Benedicte Mengel; Chakraborty, Sagar; Pigolotti, Simone; Sekara, Vedran; Semsey, Szabolcs; Jensen, Mogens H.] Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark; [Krishna, Sandeep] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	University of Copenhagen; Niels Bohr Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Jensen, MH (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	mhjensen@nbi.dk	Semsey, Szabolcs/L-6329-2013; Pigolotti, Simone/AAU-2395-2021; Jensen, Mogens H./U-5510-2017	Pigolotti, Simone/0000-0002-6157-6906; Jensen, Mogens H./0000-0001-8104-4299; Semsey, Szabolcs/0000-0002-4522-5495; Chakraborty, Sagar/0000-0001-7568-0598; Sekara, Vedran/0000-0003-4490-3757; Mengel Pers, Anne Benedicte/0000-0003-4601-3002	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This study was funded by The Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKLESARIA P, 1990, P NATL ACAD SCI USA, V87, P3289, DOI 10.1073/pnas.87.9.3289; Barad O, 2010, SCI SIGNAL, V129, P1; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Cowin SC, 2004, ANNU REV BIOMED ENG, V6, P77, DOI 10.1146/annurev.bioeng.6.040803.140250; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eglen SJ, 2002, DEVELOPMENT, V129, P5399, DOI 10.1242/dev.00118; Gilbert S.F., DEV BIOL DEV BIOL; Honda H, 1996, J INVEST DERMATOL, V106, P312, DOI 10.1111/1523-1747.ep12342964; Honda H, 2002, DEV DYNAM, V223, P180, DOI 10.1002/dvdy.10042; Hunziker A, 2010, P NATL ACAD SCI USA, V107, P12998, DOI 10.1073/pnas.0915003107; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jensen MH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.118101; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Martens H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-87; Plahte E, 2001, J MATH BIOL, V43, P411, DOI 10.1007/s002850100105; PYSHNOV MB, 1980, J THEOR BIOL, V87, P189, DOI 10.1016/0022-5193(80)90227-1; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; TANEMURA M, 1991, J THEOR BIOL, V153, P287, DOI 10.1016/S0022-5193(05)80571-5; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Yaron A, 2012, TRENDS NEUROSCI, V35, P230, DOI 10.1016/j.tins.2011.12.003	21	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48772	10.1371/journal.pone.0048772	http://dx.doi.org/10.1371/journal.pone.0048772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144963	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800127
J	Tseng, WK; Chieh, JJ; Yang, YF; Chiang, CK; Chen, YL; Yang, SY; Horng, HE; Yang, HC; Wu, CC				Tseng, Wei-Kung; Chieh, Jen-Jie; Yang, Yi-Fan; Chiang, Chih-Kang; Chen, Yuh-Lien; Yang, Shieh Yueh; Horng, Herng-Er; Yang, Hong-Chang; Wu, Chau-Chung			A Noninvasive Method to Determine the Fate of Fe3O4 Nanoparticles following Intravenous Injection Using Scanning SQUID Biosusceptometry	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; MAGNETIC NANOPARTICLES	Magnetic nanoparticles (MNPs) of Fe3O4 have been widely applied in many medical fields, but few studies have clearly shown the outcome of particles following intravenous injection. We performed a magnetic examination using scanning SQUID biosusceptometry (SSB). Based on the results of SSB analysis and those of established in vitro nonmagnetic bioassays, this study proposes a model of MNP metabolism consisting of an acute metabolic phase with an 8 h duration that is followed by a chronic metabolic phase that continues for 28 d following MNP injection. The major features included the delivery of the MNPs to the heart and other organs, the biodegradation of the MNPs in organs rich with macrophages, the excretion of iron metabolites in the urine, and the recovery of the iron load from the liver and the spleen. Increases in serum iron levels following MNP injection were accompanied by increases in the level of transferrin in the serum and the number of circulating red blood cells. Correlations between the in vivo and in vitro test results indicate the feasibility of using SSB examination for the measurement of MNP concentrations, implying future clinical applications of SSB for monitoring the hematological effects of MNP injection.	[Tseng, Wei-Kung; Chieh, Jen-Jie; Yang, Shieh Yueh; Horng, Herng-Er] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan; [Tseng, Wei-Kung] E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Tseng, Wei-Kung] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Yang, Yi-Fan; Chiang, Chih-Kang; Wu, Chau-Chung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Yuh-Lien] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Yang, Hong-Chang] Kun Shan Univ, Dept Electroopt Engn, Tainan, Taiwan; [Wu, Chau-Chung] Natl Taiwan Univ, Coll Med, Dept Primary Care Med, Taipei 10764, Taiwan	National Taiwan Normal University; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Kun Shan University; National Taiwan University	Horng, HE (corresponding author), Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan.	phyfv001@ntnu.edu.tw; chauchungwu@ntu.edu.tw		CHIANG, CHIH-KANG/0000-0001-9021-4616; Chieh, Jen-Jie/0000-0002-7144-2637; Chen, Yuh-Lien/0000-0002-6498-4008	National Science Council of Taiwan [NSC100-2221-E003-013, NSC100-2112-M003-010, NSC 100-2120-M-002-015, NSC101-2120-M168-001, NSC 101-2221-E003-005]; Department of Health [DOH99-TD-N-111-008, DOH100-TD-N-111-008, DOH101-TD-N-111-004]; National Taiwan Normal University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health; National Taiwan Normal University	This work was supported by the National Science Council of Taiwan under grant numbers NSC100-2221-E003-013, NSC100-2112-M003-010, NSC 100-2120-M-002-015, NSC101-2120-M168-001, and NSC 101-2221-E003-005; the Department of Health under grant numbers DOH99-TD-N-111-008, DOH100-TD-N-111-008, DOH101-TD-N-111-004, and National Taiwan Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1; Briley-Saebo K, 2004, CELL TISSUE RES, V316, P315, DOI 10.1007/s00441-004-0884-8; Chieh JJ, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3623795; Chieh JJ, 2010, J APPL PHYS, V107, DOI 10.1063/1.3340861; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Hong CY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2536127; Issa N, 2008, CLEV CLIN J MED, V75, P95, DOI 10.3949/ccjm.75.2.95; Jiang WQ, 2004, J MAGN MAGN MATER, V283, P210, DOI 10.1016/j.jmmm.2004.05.022; Kuckelhaus S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1852311; Lopez A, 2007, PHYS MED BIOL, V52, P5043, DOI 10.1088/0031-9155/52/16/022; Moghimi SM, 2011, NANOMED-NANOTECHNOL, V7, P515, DOI 10.1016/j.nano.2011.05.001; Muller S, 2009, NANOMED-NANOTECHNOL, V5, P387, DOI 10.1016/j.nano.2009.01.011; Oghabian MA, 2010, NANOMED-NANOTECHNOL, V6, P496, DOI 10.1016/j.nano.2009.11.005; PERSSON LI, 1981, SCAND J IMMUNOL, V14, P359, DOI 10.1111/j.1365-3083.1981.tb00576.x; Rahimi M, 2010, NANOMED-NANOTECHNOL, V6, P672, DOI 10.1016/j.nano.2010.01.012; Sarkar J, 2003, J BIOL CHEM, V278, P44018, DOI 10.1074/jbc.M304926200; Schlachter EK, 2011, INT J NANOMED, V6, P1793, DOI 10.2147/IJN.S23638; Silva AC, 2011, INT J NANOMED, V6, P591, DOI 10.2147/IJN.S14737; Tseng WK, 2011, IEEE T APPL SUPERCON, V21, P2250, DOI 10.1109/TASC.2011.2107871; Tsuchiya K, 2011, INT J NANOMED, V6, P1, DOI 10.2147/IJN.S22189; Van Beers BE, 2001, J MAGN RESON IMAGING, V13, P594, DOI 10.1002/jmri.1083; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; Wang J, 2010, INT J NANOMED, V5, P861, DOI 10.2147/IJN.S13662; Wang ZY, 2011, INT J NANOMED, V6, P871, DOI 10.2147/IJN.S16485; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Xu R, 2010, INT J NANOMED, V5, P707	27	18	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48510	10.1371/journal.pone.0048510	http://dx.doi.org/10.1371/journal.pone.0048510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152779	Green Submitted, Green Published, gold			2022-12-25	WOS:000311234000019
J	Wu, Y; Zhou, HJ; Wang, J; Li, LQ; Li, WG; Cui, ZG; Chen, X; Cen, RQ; Lu, JX; Cheng, Y				Wu, Yuan; Zhou, Haijian; Wang, Jing; Li, Lianqing; Li, Wenge; Cui, Zhigang; Chen, Xia; Cen, Ruiqi; Lu, Jinxing; Cheng, Ying			Analysis of the Clonality of Candida tropicalis Strains from a General Hospital in Beijing Using Multilocus Sequence Typing	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; FIELD GEL-ELECTROPHORESIS; ANTIFUNGAL SUSCEPTIBILITIES; FUNGAL-INFECTION; UNITED-STATES; EPIDEMIOLOGY; SURVEILLANCE; ALBICANS; MULTICENTER; POPULATION	Multilocus sequence typing (MLST) based on six loci was used to analyze the relationship of 58 Candida tropicalis isolates from individual patients in a general hospital in Beijing, China. A total of 52 diploid sequence types (DSTs) were generated by the MLST, all of which were new to the central database. Unweighted Pair Group Method with Arithmetic Mean (UPGMA) dendrograms were constructed, which showed that the 58 isolates were distributed robustly and 6 main groups were clustered regardless of the specimen source and medical department. The minimum spanning tree (MST) of the 58 isolates (52 DSTs) and all 401 isolates (268 DSTs) in the C. tropicalis central database (http://pubmlst.org/ctropicalis/) indicated that the isolates in this study clustered in three relative pure clonal complexes, and 2 clustered with isolates from Taiwan, Belgium, Brazil, and the US. This study presents the first MLST analysis of C. tropicalis isolates from Mainland China, which may be useful for further studies on the similarity, genetic relationship, and molecular epidemiology of C. tropicalis strains worldwide. Citation: Wu Y, Zhou H, Wang J, Li L, Li W, et al. (2012) Analysis of the Clonality of Candida tropicalis Strains from a General Hospital in Beijing Using Multilocus Sequence Typing. PLoS ONE 7(11): e47767. doi:10.1371/journal.pone.0047767	[Wu, Yuan; Zhou, Haijian; Li, Wenge; Cui, Zhigang; Cen, Ruiqi; Lu, Jinxing; Cheng, Ying] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Jing] China Japan Friendship Hosp, Beijing, Peoples R China; [Li, Lianqing] Shanxi Ctr Clin Labs, Taiyuan, Shanxi, Peoples R China; [Chen, Xia] Capital Med Univ, Fu Xing Hosp, Dept Crit Care Med, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; China-Japan Friendship Hospital; Capital Medical University	Lu, JX (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	lujinxing@icdc.cn; chengying@icdc.cn			Young Scholar Scientific Research Foundation of China CDC [2012A107]; National Sci-Tech Key Project [2012ZX10004-201]	Young Scholar Scientific Research Foundation of China CDC; National Sci-Tech Key Project	This work was supported by Project Sponsored by the Young Scholar Scientific Research Foundation of China CDC (2012A107) and National Sci-Tech Key Project (2012ZX10004-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Bedini A, 2006, CLIN MICROBIOL INFEC, V12, P75, DOI 10.1111/j.1469-0691.2005.01310.x; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chalmers C, 2011, MYCOSES, V54, pE795, DOI 10.1111/j.1439-0507.2011.02027.x; Chan MS, 2001, BIOINFORMATICS, V17, P1077, DOI 10.1093/bioinformatics/17.11.1077; Chen CY, 2003, ANN HEMATOL, V82, P93, DOI 10.1007/s00277-002-0588-7; Chen KW, 2006, J CLIN MICROBIOL, V44, P2172, DOI 10.1128/JCM.00320-06; Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011; Chou HH, 2007, DIAGN MICR INFEC DIS, V58, P427, DOI 10.1016/j.diagmicrobio.2007.03.014; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Desnos-Ollivier M, 2008, EMERG INFECT DIS, V14, P557, DOI 10.3201/eid1404.071083; Doczi I, 2012, ACTA MICROBIOL IMM H, V59, P29, DOI 10.1556/AMicr.59.2012.1.4; Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003; Falagas ME, 2010, INT J INFECT DIS, V14, pE954, DOI 10.1016/j.ijid.2010.04.006; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fridkin SK, 2006, PEDIATRICS, V117, P1680, DOI 10.1542/peds.2005-1996; Hajjeh RA, 2004, J CLIN MICROBIOL, V42, P1519, DOI 10.1128/JCM.42.4.1519-1527.2004; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; Issa SY, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-79; Jacobsen MD, 2008, FUNGAL GENET BIOL, V45, P1040, DOI 10.1016/j.fgb.2008.03.011; Jayatilake JAMS, 2011, MYCOPATHOLOGIA, V171, P235, DOI 10.1007/s11046-010-9373-7; Jung SI, 2010, MED MYCOL, V48, P669, DOI 10.3109/13693780903410386; Lai HP, 2005, J FORMOS MED ASSOC, V104, P174; Lewis RE, 2009, CURR MED RES OPIN, V25, P1732, DOI 10.1185/03007990902990817; Lin CY, 2007, J CLIN MICROBIOL, V45, P2452, DOI 10.1128/JCM.00699-07; Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08; Pfaller MA, 2006, CLIN INFECT DIS, V42, pS153, DOI 10.1086/500662; Pfaller MA, 1998, J CLIN MICROBIOL, V36, P1886, DOI 10.1128/JCM.36.7.1886-1889.1998; Shimizu Kazue, 2011, Med Mycol J, V52, P129, DOI 10.3314/jjmm.52.129; St-Germain G, 2008, CAN J INFECT DIS MED, V19, P55, DOI 10.1155/2008/634046; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	36	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e47767	10.1371/journal.pone.0047767	http://dx.doi.org/10.1371/journal.pone.0047767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152759	gold, Green Published, Green Submitted			2022-12-25	WOS:000312272600007
J	Anwar, SL; Krech, T; Hasemeier, B; Schipper, E; Schweitzer, N; Vogel, A; Kreipe, H; Lehmann, U				Anwar, Sumadi Lukman; Krech, Till; Hasemeier, Britta; Schipper, Elisa; Schweitzer, Nora; Vogel, Arndt; Kreipe, Hans; Lehmann, Ulrich			Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							FACTOR 2 GENE; TUMOR-SUPPRESSOR; NONCODING RNA; EXPRESSION; CANCER; METHYLATION; MEG3; IGF2; HYPERMETHYLATION; CONTRIBUTE	Deregulation of imprinted genes is an important molecular mechanism contributing to the development of cancer in humans. However, knowledge about imprinting defects in human hepatocellular carcinoma (HCC), the third leading cause of cancer mortality worldwide, is still limited. Therefore, a systematic meta-analysis of the expression of 223 imprinted loci in human HCC was initiated. This screen revealed that the DLK1-MEG3 locus is frequently deregulated in HCC. Deregulation of DLK1 and MEG3 expression accompanied by extensive aberrations in DNA methylation could be confirmed experimentally in an independent series of human HCC (n = 40) in more than 80% of cases. Loss of methylation at the DLK1-MEG3 locus correlates linearly with global loss of DNA methylation in HCC (r(2) = 0.63, p<0.0001). Inhibition of DNMT1 in HCC cells using siRNA led to a reduction in MEG3-DMR methylation and concomitant increase in MEG3 RNA expression. Allele-specific expression analysis identified loss of imprinting in 10 out of 31 informative samples (32%), rendering it one of the most frequent molecular defects in human HCC. In 2 cases unequivocal gain of bi-allelic expression accompanied by substantial loss of methylation at the IG-DMR could be demonstrated. In 8 cases the tumour cells displayed allelic switching by mono-allelic expression of the normally imprinted allele. Allelic switching was accompanied by gains or losses of DNA methylation primarily at IG-DMR1. Analysis of 10 hepatocellular adenomas (HCA) and 5 cases of focal nodular hyperplasia (FNH) confirmed that this epigenetic instability is specifically associated with the process of malignant transformation and not linked to increased proliferation per se. This widespread imprint instability in human HCC has to be considered in order to minimize unwanted side-effects of therapeutic approaches targeting the DNA methylation machinery. It might also serve in the future as predictive biomarker and for monitoring response to epigenetic therapy. Citation: Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, et al. (2012) Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma. PLoS ONE 7(11): e49462. doi:10.1371/journal.pone.0049462	[Anwar, Sumadi Lukman; Krech, Till; Hasemeier, Britta; Schipper, Elisa; Kreipe, Hans; Lehmann, Ulrich] Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany; [Schweitzer, Nora; Vogel, Arndt] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30623 Hannover, Germany	Hannover Medical School; Hannover Medical School	Lehmann, U (corresponding author), Hannover Med Sch, Inst Pathol, D-30623 Hannover, Germany.	Lehmann.Ulrich@MH-Hannover.de	Vogel, Arndt/A-8437-2012	anwar, sumadi lukman/0000-0002-2607-6682; Vogel, Arndt/0000-0003-0560-5538	German Research Council within the Hannover-Heidelberg "Liver cancer'' (Project B1) [Transregio-SFB TRR 77]	German Research Council within the Hannover-Heidelberg "Liver cancer'' (Project B1)	This work was supported by a grant from the German Research Council within the Hannover-Heidelberg Transregio-SFB TRR 77 "Liver cancer'' (Project B1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; BENETATOS L, 2009, LEUKEMIA RES, V34, P148; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Engel JR, 2000, J MED GENET, V37, P921, DOI 10.1136/jmg.37.12.921; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; IACOBUZIODONAHU.CA, 2008, ANN REV PATHOL; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Khoury H, 2010, BLOOD, V115, P2260, DOI 10.1182/blood-2009-03-212746; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; Knudson AG, 2002, AM J MED GENET, V111, P96, DOI 10.1002/ajmg.10320; Lehmann U, 2001, LAB INVEST, V81, P635, DOI 10.1038/labinvest.3780272; Li XR, 1997, CANCER RES, V57, P2048; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; Mai M, 1998, CANCER RES, V58, P2347; Mai M, 1998, ONCOGENE, V17, P1739, DOI 10.1038/sj.onc.1202099; Midorikawa Y, 2006, ONCOGENE, V25, P5581, DOI 10.1038/sj.onc.1209537; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morison IM, 1996, NAT MED, V2, P311, DOI 10.1038/nm0396-311; Nahm CB, 2011, J GASTROINTEST SURG, V15, P2275, DOI 10.1007/s11605-011-1680-x; Park YN, 2011, ARCH PATHOL LAB MED, V135, P704, DOI 10.1043/2010-0524-RA.1; Poirier K, 2003, J PATHOL, V201, P473, DOI 10.1002/path.1477; Potapova A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-6; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Royo JL, 2009, METHODS MOL BIOL, V578, P123, DOI 10.1007/978-1-60327-411-1_7; Scelfo RAM, 2002, ONCOGENE, V21, P2564, DOI 10.1038/sj.onc.1205336; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Schwienbacher C, 2000, P NATL ACAD SCI USA, V97, P5445, DOI 10.1073/pnas.090087497; Stoot JHMB, 2010, HPB, V12, P509, DOI 10.1111/j.1477-2574.2010.00222.x; Takeda S, 1996, ONCOGENE, V12, P1589; Tessema M, 2005, INT J ONCOL, V26, P499; Trankenschuh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013688; Uchida K, 1997, MOL CARCINOGEN, V18, P193, DOI 10.1002/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.3.CO;2-2; VARMUZA S, 1994, TRENDS GENET, V10, P118, DOI 10.1016/0168-9525(94)90212-7; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; WILKINS RJ, 1988, LANCET, V1, P329; Wu J, 2008, GENOMICS, V91, P443, DOI 10.1016/j.ygeno.2008.01.007; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	48	106	114	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49462	10.1371/journal.pone.0049462	http://dx.doi.org/10.1371/journal.pone.0049462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145177	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500112
J	Cozzi, R; Prigozhin, D; Rosini, R; Abate, F; Bottomley, MJ; Grandi, G; Telford, JL; Rinaudo, CD; Maione, D; Alber, T				Cozzi, Roberta; Prigozhin, Daniil; Rosini, Roberto; Abate, Francesca; Bottomley, Matthew J.; Grandi, Guido; Telford, John L.; Rinaudo, C. Daniela; Maione, Domenico; Alber, Tom			Structural Basis for Group B Streptococcus Pilus 1 Sortases C Regulation and Specificity	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CORYNEBACTERIUM-DIPHTHERIAE; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; CELL-WALL; PNEUMONIAE; PROTEINS; MODEL; IDENTIFICATION; INVOLVEMENT	Gram-positive bacteria assemble pili through class C sortase enzymes specialized in polymerizing pilin subunits into covalently linked, high-molecular-weight, elongated structures. Here we report the crystal structures of two class C sortases (SrtC1 and SrtC2) from Group B Streptococcus (GBS) Pilus Island 1. The structures show that both sortases are comprised of two domains: an 8-stranded beta-barrel catalytic core conserved among all sortase family members and a flexible N-terminal region made of two alpha-helices followed by a loop, known as the lid, which acts as a pseudo-substrate. In vitro experiments performed with recombinant SrtC enzymes lacking the N-terminal portion demonstrate that this region of the enzyme is dispensable for catalysis but may have key roles in substrate specificity and regulation. Moreover, in vitro FRET-based assays show that the LPXTG motif common to many sortase substrates is not the sole determinant of sortase C specificity during pilin protein recognition.	[Cozzi, Roberta; Rosini, Roberto; Abate, Francesca; Bottomley, Matthew J.; Grandi, Guido; Telford, John L.; Rinaudo, C. Daniela; Maione, Domenico] Novartis Vaccines & Diagnost, Siena, Italy; [Prigozhin, Daniil; Alber, Tom] Univ Calif Berkeley, Berkeley, CA 94720 USA	Novartis; University of California System; University of California Berkeley	Maione, D (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020	Prigozhin, Daniil M/0000-0003-2075-0231; Grandi, Guido/0000-0001-9724-2185	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by internal funding from Novartis Vaccines and Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILGIN N, 1990, EMBO J, V9, P2717, DOI 10.1002/j.1460-2075.1990.tb07458.x; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cozzi R, 2012, FASEB J; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Khare B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022995; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Lu GW, 2011, PROTEINS, V79, P2764, DOI 10.1002/prot.23093; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Necchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025300; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson K, 2011, ACTA CRYSTALLOGR D, V67, P212, DOI 10.1107/S0907444911004215; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Wang TF, 1998, J BIOL CHEM, V273, P24814, DOI 10.1074/jbc.273.38.24814; Wu CG, 2012, J BACTERIOL, V194, P2531, DOI 10.1128/JB.00093-12; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	46	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49048	10.1371/journal.pone.0049048	http://dx.doi.org/10.1371/journal.pone.0049048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145064	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500068
J	Nishihara, D; Yajima, I; Tabata, H; Nakai, M; Tsukiji, N; Katahira, T; Takeda, K; Shibahara, S; Nakamura, H; Yamamoto, H				Nishihara, Daisuke; Yajima, Ichiro; Tabata, Hiromasa; Nakai, Masato; Tsukiji, Nagaharu; Katahira, Tatsuya; Takeda, Kazuhisa; Shibahara, Shigeki; Nakamura, Harukazu; Yamamoto, Hiroaki			Otx2 Is Involved in the Regional Specification of the Developing Retinal Pigment Epithelium by Preventing the Expression of Sox2 and Fgf8, Factors That Induce Neural Retina Differentiation	PLOS ONE			English	Article							OPTIC VESICLE; EYE DEVELOPMENT; CHICK-EMBRYO; ANTERIOR NEUROECTODERM; CELL-DIFFERENTIATION; MULTIPLE FUNCTIONS; PROGENITOR CELLS; DOWN-REGULATION; UP-REGULATION; BETA-CATENIN	The retinal pigment epithelium (RPE) shares its developmental origin with the neural retina (NR). When RPE development is disrupted, cells in the presumptive RPE region abnormally differentiate into NR-like cells. Therefore, the prevention of NR differentiation in the presumptive RPE area seems to be essential for regionalizing the RPE during eye development. However, its molecular mechanisms are not fully understood. In this study, we conducted a functional inhibition of a transcription factor Otx2, which is required for RPE development, using early chick embryos. The functional inhibition of Otx2 in chick eyes, using a recombinant gene encoding a dominant negative form of Otx2, caused the outer layer of the optic cup ( the region forming the RPE, when embryos normally develop) to abnormally form an ectopic NR. In that ectopic NR, the characteristics of the RPE did not appear and NR markers were ectopically expressed. Intriguingly, the repression of Otx2 function also caused the ectopic expression of Fgf8 and Sox2 in the outer layer of the optic cup ( the presumptive RPE region of normally developing eyes). These two factors are known to be capable of inducing NR cell differentiation in the presumptive RPE region, and are not expressed in the normally developing RPE region. Here, we suggest that Otx2 prevents the presumptive RPE region from forming the NR by repressing the expression of both Fgf8 and Sox2 which induce the NR cell fate. Citation: Nishihara D, Yajima I, Tabata H, Nakai M, Tsukiji N, et al. (2012) Otx2 Is Involved in the Regional Specification of the Developing Retinal Pigment Epithelium by Preventing the Expression of Sox2 and Fgf8, Factors That Induce Neural Retina Differentiation. PLoS ONE 7(11): e48879. doi:10.1371/journal.pone.0048879	[Nishihara, Daisuke; Tabata, Hiromasa; Nakai, Masato; Yamamoto, Hiroaki] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama, Shiga, Japan; [Nishihara, Daisuke; Tsukiji, Nagaharu; Nakamura, Harukazu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Yajima, Ichiro] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Katahira, Tatsuya] Doshisha Univ, Grad Sch Brain Sci, Dev Neurobiol Lab, Kyotanabe, Kyoto, Japan; [Takeda, Kazuhisa; Shibahara, Shigeki] Tohoku Univ, Sch Med, Dept Mol Biol & Appl Physiol, Sendai, Miyagi 980, Japan; [Nakamura, Harukazu] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nakamura, Harukazu] Tohoku Univ, Dept Mol Neurobiol, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Tohoku University; Chubu University; Doshisha University; Tohoku University; Tohoku University; Tohoku University	Yamamoto, H (corresponding author), Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama, Shiga, Japan.	h_yamamoto@nagahama-i-bio.ac.jp	YAJIMA, Ichiro/I-7467-2014; Shibahara, Shigeki/M-3644-2014		Japan Society for the Promotion of Science (JSPS) [10J07029]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [22570199, 10J07029] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Japan Society for the Promotion of Science (JSPS) to DN (10J07029, http://www.jsps.go.jp/) and to IY, and a Grant-in Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Acampora D, 1999, DEVELOPMENT, V126, P1417; Azuma N, 2005, HUM MOL GENET, V14, P1059, DOI 10.1093/hmg/ddi098; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Bell E, 2001, DEV BIOL, V236, P76, DOI 10.1006/dbio.2001.0301; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Carl M, 2002, DEVELOPMENT, V129, P4057; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; GalliResta L, 1997, J NEUROSCI, V17, P7831; Galy A, 2002, DEV BIOL, V248, P251, DOI 10.1006/dbio.2002.0736; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hirashima M, 2008, DEV BIOL, V317, P620, DOI 10.1016/j.ydbio.2008.03.010; Hyer J, 1998, DEVELOPMENT, V125, P869; Ishii Y, 2009, DEVELOPMENT, V136, P2579, DOI 10.1242/dev.031344; Kagiyama Y, 2005, DEV GROWTH DIFFER, V47, P523; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kobayashi T, 2010, DEV GROWTH DIFFER, V52, P351, DOI 10.1111/j.1440-169X.2010.01170.x; Kobayashi T, 2009, DEV GROWTH DIFFER, V51, P723, DOI 10.1111/j.1440-169X.2009.01132.x; LI HS, 1994, DEV BIOL, V162, P181, DOI 10.1006/dbio.1994.1077; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Pera EM, 1998, DEV GENES EVOL, V208, P168, DOI 10.1007/s004270050170; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; PITTACK C, 1991, DEVELOPMENT, V113, P577; Pittack C, 1997, DEVELOPMENT, V124, P805; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Schwarz M, 2000, DEVELOPMENT, V127, P4325; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Spence JR, 2007, MOL VIS, V13, P57; Takeda K, 2003, BIOCHEM BIOPH RES CO, V300, P908, DOI 10.1016/S0006-291X(02)02934-0; Tetreault N, 2008, DEV BIOL; Torres MA, 1996, DEVELOPMENT, V122, P3381; Tsukiji N, 2009, DEV BIOL, V326, P335, DOI 10.1016/j.ydbio.2008.11.029; Uemonsa T, 2002, DEV BIOL, V248, P319, DOI 10.1006/dbio.2002.0737; Viringipurampeer IA, 2012, HUM MOL GENET, V21, P2357, DOI 10.1093/hmg/dds056; Vogel-Hopker A, 2000, MECH DEVELOP, V94, P25, DOI 10.1016/S0925-4773(00)00320-8; Vugler A, 2008, EXP NEUROL; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Westenskow PD, 2010, INVEST OPHTH VIS SCI, V51, P5328, DOI 10.1167/iovs.09-5015; Yun S, 2009, DEVELOPMENT, V136, P3895, DOI 10.1242/dev.041202; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	57	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48879	10.1371/journal.pone.0048879	http://dx.doi.org/10.1371/journal.pone.0048879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145006	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500041
J	Thueng-in, K; Thanongsaksrikul, J; Srimanote, P; Bangphoomi, K; Poungpair, O; Maneewatch, S; Choowongkomon, K; Chaicumpa, W				Thueng-in, Kanyarat; Thanongsaksrikul, Jeeraphong; Srimanote, Potjanee; Bangphoomi, Kunan; Poungpair, Ornnuthchar; Maneewatch, Santi; Choowongkomon, Kiattawee; Chaicumpa, Wanpen			Cell Penetrable Humanized-VH/VHH That Inhibit RNA Dependent RNA Polymerase (NS5B) of HCV	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CRYSTAL-STRUCTURE; NAJA-KAOUTHIA; THAI COBRA; DOMAIN; REPLICATION; INITIATION; SEQUENCE; THERAPY	NS5B is pivotal RNA dependent RNA polymerase (RdRp) of HCV and NS5B function interfering halts the virus infective cycle. This work aimed to produce cell penetrable humanized single domain antibodies (SdAb; VH/VHH) that interfere with the RdRp activity. Recombinant NS5B Delta 55 of genotype 3a HCV with de novo RNA synthetic activity was produced and used in phage biopanning for selecting phage clones that displayed NS5B Delta 55 bound VH/VHH from a humanized-camel VH/VHH display library. VH/VHH from E. coli transfected with four selected phage clones inhibited RdRp activity when tested by ELISA inhibition using 3'di-cytidylate 25 nucleotide directed in vitro RNA synthesis. Deduced amino acid sequences of two clones showed VHH hallmark and were designated V(H)H6 and V(H)H24; other clones were conventional VH, designated VH9 and VH13. All VH/VHH were linked molecularly to a cell penetrating peptide, penetratin. The cell penetrable VH9, VH13, V(H)H6 and V(H)H24 added to culture of Huh7 cells transfected with JHF-1 RNA of genotype 2a HCV reduced the amounts of RNA intracellularly and in culture medium implying that they inhibited the virus replication. VH/VHH mimotopes matched with residues scattered on the polymerase fingers, palm and thumb which were likely juxtaposed to form conformational epitopes. Molecular docking revealed that the antibodies covered the RdRp catalytic groove. The transbodies await further studies for in vivo role in inhibiting HCV replication. Citation: Thueng-in K, Thanongsaksrikul J, Srimanote P, Bangphoomi K, Poungpair O, et al. (2012) Cell Penetrable Humanized-VH/VHH That Inhibit RNA Dependent RNA Polymerase (NS5B) of HCV. PLoS ONE 7(11): e49254. doi:10.1371/journal.pone.0049254	[Chaicumpa, Wanpen] Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok, Thailand; [Thueng-in, Kanyarat] Kasetsart Univ, Fac Sci, Fac Vet Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Thanongsaksrikul, Jeeraphong; Srimanote, Potjanee] Thammasat Univ, Fac Allied Hlth Sci, Grad Program, Pathum Thani, Thailand; [Bangphoomi, Kunan; Choowongkomon, Kiattawee] Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Poungpair, Ornnuthchar] Siriraj Hosp, Fac Med, Dept Res & Dev, Bangkok, Thailand; [Maneewatch, Santi] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand	Mahidol University; Kasetsart University; Thammasat University; Kasetsart University; Mahidol University; Mahidol University	Chaicumpa, W (corresponding author), Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok, Thailand.	wanpen.cha@mahidol.ac.th	Srimanote, Potjanee/W-2221-2019; maneewatchararangsri, santi/K-7898-2015; Thanongsaksrikul, Jeeraphong/AAF-5267-2020; choowongkomon, kiattawee/M-6528-2014	choowongkomon, kiattawee/0000-0002-2421-7859; Thanongsaksrikul, Jeeraphong/0000-0002-7238-9591	Thailand Research Fund [DPG5380001]; National Research University Project, Office of Commission on Higer Education, Ministry of Education, Thailand	Thailand Research Fund(Thailand Research Fund (TRF)); National Research University Project, Office of Commission on Higer Education, Ministry of Education, Thailand	This work was supported by the Thailand Research Fund (DPG5380001) and the National Research University Project, Office of Commission on Higer Education, Ministry of Education, Thailand. The funders had no role in study design, data collection and data analysis, dicision to publish, or preparation of the manuscript.	Adachi T, 2002, BBA-PROTEINS PROTEOM, V1601, P38, DOI 10.1016/S1570-9639(02)00433-8; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Carreno V, 2006, J INFECT DIS, V194, P53, DOI 10.1086/504692; Chavanayarn C, 2012, TOXINS, V4, P554, DOI 10.3390/toxins4070554; Chinnaswamy S., 2010, VIRUS ADAP TREAT, V2, P73, DOI DOI 10.2147/VAAT.S9641; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Gastaminza P, 2011, J VIROL, V85, P5513, DOI 10.1128/JVI.02116-10; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Herlihy KJ, 2008, ANTIMICROB AGENTS CH, V52, P3523, DOI 10.1128/AAC.00533-08; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Kulkeaw K, 2009, J PROTEOMICS, V72, P270, DOI 10.1016/j.jprot.2008.12.007; Kulkeaw K, 2007, TOXICON, V49, P1026, DOI 10.1016/j.toxicon.2007.01.019; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Park C, 2002, J VIROL METHODS, V101, P211, DOI 10.1016/S0166-0934(01)00443-8; Poungpair O, 2010, BIOCONJUGATE CHEM, V21, P1134, DOI 10.1021/bc900251u; Ranjith-Kumar C.T., 2006, HEPATITIS C VIRUSES, P293; RASMUSSEN SR, 1991, ANAL BIOCHEM, V198, P138, DOI 10.1016/0003-2697(91)90518-X; Tavis JE, 2011, GENOME MED, V3, DOI 10.1186/gm222; Thanongsaksrikul J, 2011, TOXINS, V3, P469, DOI 10.3390/toxins3050469; Thanongsaksrikul J, 2010, J BIOL CHEM, V285, P9657, DOI 10.1074/jbc.M109.073163; Troke PJF, 2012, ANTIMICROB AGENTS CH, V56, P1331, DOI 10.1128/AAC.05611-11; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	34	43	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49254	10.1371/journal.pone.0049254	http://dx.doi.org/10.1371/journal.pone.0049254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145135	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500092
J	Wolf, BJ; Hill, EG; Slate, EH; Neumann, CA; Kistner-Griffin, E				Wolf, Bethany J.; Hill, Elizabeth G.; Slate, Elizabeth H.; Neumann, Carola A.; Kistner-Griffin, Emily			LBoost: A Boosting Algorithm with Application for Epistasis Discovery	PLOS ONE			English	Article							POSTMENOPAUSAL BREAST-CANCER; LOGIC REGRESSION; PEROXIREDOXIN-II; GENE-EXPRESSION; PROSTATE-CANCER; MODELS; DISEASE; RISK; CLASSIFICATION; ASSOCIATION	Many human diseases are attributable to complex interactions among genetic and environmental factors. Statistical tools capable of modeling such complex interactions are necessary to improve identification of genetic factors that increase a patient's risk of disease. Logic Forest (LF), a bagging ensemble algorithm based on logic regression (LR), is able to discover interactions among binary variables predictive of response such as the biologic interactions that predispose individuals to disease. However, LF's ability to recover interactions degrades for more infrequently occurring interactions. A rare genetic interaction may occur if, for example, the interaction increases disease risk in a patient subpopulation that represents only a small proportion of the overall patient population. We present an alternative ensemble adaptation of LR based on boosting rather than bagging called LBoost. We compare the ability of LBoost and LF to identify variable interactions in simulation studies. Results indicate that LBoost is superior to LF for identifying genetic interactions associated with disease that are infrequent in the population. We apply LBoost to a subset of single nucleotide polymorphisms on the PRDX genes from the Cancer Genetic Markers of Susceptibility Breast Cancer Scan to investigate genetic risk for breast cancer. LBoost is publicly available on CRAN as part of the LogicForest package, http://cran.r-project.org/. Citation: Wolf BJ, Hill EG, Slate EH, Neumann CA, Kistner-Griffin E (2012) LBoost: A Boosting Algorithm with Application for Epistasis Discovery. PLoS ONE 7(11): e47281. doi:10.1371/journal.pone.0047281	[Wolf, Bethany J.; Hill, Elizabeth G.; Kistner-Griffin, Emily] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Slate, Elizabeth H.] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Neumann, Carola A.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	Medical University of South Carolina; State University System of Florida; Florida State University; Medical University of South Carolina	Wolf, BJ (corresponding author), Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA.	wolfb@musc.edu		Neumann, Carola/0000-0003-2801-9531; Wolf, Bethany/0000-0002-7124-5158	American Cancer Society Institutional Research Grant; National Institutes of Health/National Institute of Dental and Craniofacial Research Grant [K25DE016863]; South Carolina Clinical and Translational Research Institute, Medical University of South Carolina's CTSA, National Institutes of Health/National Center for Research Resources grant [UL1RR029882]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K25DE016863] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health/National Institute of Dental and Craniofacial Research Grant; South Carolina Clinical and Translational Research Institute, Medical University of South Carolina's CTSA, National Institutes of Health/National Center for Research Resources grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported in part by pilot funding from an American Cancer Society Institutional Research Grant awarded to the Hollings Cancer Center, Medical University of South Carolina, by National Institutes of Health/National Institute of Dental and Craniofacial Research Grant K25DE016863, and by the South Carolina Clinical and Translational Research Institute, Medical University of South Carolina's CTSA, National Institutes of Health/National Center for Research Resources grant UL1RR029882. The contents are solely the responsibility of the authors and do not necessarily represent the official views of Natitional Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; Bae JY, 2007, J CELL BIOCHEM, V101, P1038, DOI 10.1002/jcb.21241; Baird AE, 2010, J AM COLL CARDIOL, V56, P245, DOI 10.1016/j.jacc.2010.02.051; Breiman L, 1994, 421 U CAL DEP STAT, P1; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; DEMPSTER ER, 1950, GENETICS, V35, P212; Dietterich TG, 2000, MACH LEARN, V40, P139, DOI 10.1023/A:1007607513941; Ertel A, 2010, CANCER INFORM, V9, P11; Etzioni R, 2004, CANCER EPIDEM BIOMAR, V13, P1640; Etzioni R, 2003, BIOSTATISTICS, V4, P523, DOI 10.1093/biostatistics/4.4.523; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Hallgrimsdottir IB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-17; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Janes H, 2005, STAT MED, V24, P1321, DOI 10.1002/sim.2021; Kaklamani Virginia G, 2006, Curr Treat Options Oncol, V7, P123, DOI 10.1007/s11864-006-0047-0; Kooperberg C, 2007, AM J EPIDEMIOL, V165, P334, DOI 10.1093/aje/kwk006; Kotti S, 2007, HUM HERED, V63, P85, DOI 10.1159/000099180; Kumar S, 2006, BIOMARKERS, V11, P385, DOI 10.1080/13547500600775011; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; National Cancer Institute, 2005, CANC GEN MARK SUSC C; Noh DY, 2001, ANTICANCER RES, V21, P2085; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; R Development Core Team, 2009, R FDN STAT COMP; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; SCHWENDER H, 2007, LOGICFS IDENTIFYING; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; VanderWeele TJ, 2011, ANN HUM GENET, V75, P146, DOI 10.1111/j.1469-1809.2010.00600.x; Wang TL, 2005, CANCER RES, V65, P10338, DOI 10.1158/0008-5472.CAN-04-4614; Wolf BJ, 2010, BIOINFORMATICS, V26, P2183, DOI 10.1093/bioinformatics/btq354; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131	33	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e47281	10.1371/journal.pone.0047281	http://dx.doi.org/10.1371/journal.pone.0047281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144812	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500006
J	Bao, RY; Christova, T; Song, SY; Angers, S; Yan, XJ; Attisano, L				Bao, Renyue; Christova, Tania; Song, Siyuan; Angers, Stephane; Yan, Xiaojun; Attisano, Liliana			Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; STRUCTURAL BASIS; PATHWAY; ACTIVATION; MAMMARY; APC; EXPRESSION; MECHANISM; TARGET; TUMORIGENESIS	Constitutive Wnt signalling is characterized by excessive levels of beta-catenin protein and is a frequent occurrence in cancer. APC and Axin are key components of the beta-catenin destruction complex that acts to promote beta-catenin degradation. The levels of Axin are in turn controlled by tankyrases, members of the PARP-family of poly-ADP-ribosylation enzymes. In colorectal cancer cells, which typically harbor APC mutations, inhibition of tankyrase activity promotes Axin stabilization and attenuates Wnt signalling. Here, we examined the effect of inhibiting tankyrases in breast cancer cells with normal APC. We show that application of the small molecule tankyrase inhibitor, XAV939 or siRNA-mediated abrogation of tankyrase expression increases Axin1 and Axin2 protein levels and attenuates Wnt-induced transcriptional responses in several breast cancer lines. In MDA-MB-231 cells, inhibiton of tankyrase activity also attenuate Wnt3a induced cell migration. Moreover, in both MDA-MB-231 and colorectal cancer cells, XAV939 inhibits cell growth under conditions of serum-deprivation. However, the presence of serum prevents this growth inhibitory effect, although inhibition of Wnt-induced transcriptional and migratory responses was maintained. These results indicate that stabilization of Axin by inhibition of tankyrases alone, may not be an effective means to block tumor cell growth and that combinatorial therapeutic approaches should be considered.	[Bao, Renyue; Yan, Xiaojun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Bao, Renyue; Christova, Tania; Song, Siyuan; Angers, Stephane; Attisano, Liliana] Univ Toronto, Dept Biochem, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Angers, Stephane] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON, Canada	Zhejiang University; University of Toronto; University of Toronto	Yan, XJ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yanxiaojun@nbu.edu.cn; liliana.attisano@utoronto.ca	Angers, Stephane/E-1432-2014	Angers, Stephane/0000-0001-7241-9044	Canadian Institute for Health Research [246295]; Canadian Breast Cancer Foundation, Ontario Chapter; China Scholarship Council (CSC)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation, Ontario Chapter; China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by grants to L. A. from the Canadian Institute for Health Research (Grant #246295) and to S. A. from Canadian Breast Cancer Foundation, Ontario Chapter. L. A. holds a Canada Research Chair and R. B., a studentship from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collu GM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2336; Curtin JC, 2010, ONCOTARGET, V1, P563, DOI 10.18632/oncotarget.191; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fearon ER, 2009, CANCER CELL, V16, P366, DOI 10.1016/j.ccr.2009.10.007; Gorczynski RM, 2010, BREAST CANCER RES TR, V123, P405, DOI 10.1007/s10549-009-0667-8; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Gunaydin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033740; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karner CM, 2010, DEV DYNAM, V239, P2014, DOI 10.1002/dvdy.22340; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Laezza C, 2012, EUR J CANC; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Liu CM, 2010, J MOL CELL BIOL, V2, P70, DOI 10.1093/jmcb/mjp040; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Michaelson JS, 2001, ONCOGENE, V20, P5093, DOI 10.1038/sj.onc.1204586; Miller BW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.72; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Polakis P, 2012, COLD SPRING HARB PER, V4; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Shultz MD, 2012, J MED CHEM, V55, P1127, DOI 10.1021/jm2011222; Song S, 2011, CANCER RES, V71, P7628, DOI 10.1158/0008-5472.CAN-11-2745; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Vaira S, 2012, J CELL PHYSIOL, V227, P578, DOI 10.1002/jcp.22757; van de Wetering M, 2001, CANCER RES, V61, P278; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Waaler J, 2012, CANC RES; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	55	116	120	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48670	10.1371/journal.pone.0048670	http://dx.doi.org/10.1371/journal.pone.0048670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144924	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800094
J	Dandekar, S; Ding, J; Privitera, C; Carney, T; Klein, SA				Dandekar, Sangita; Ding, Jian; Privitera, Claudio; Carney, Thom; Klein, Stanley A.			The Fixation and Saccade P3	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; HUMAN PARIETAL; RESPONSES; TIME; EEG; SUPPRESSION; TARGET	Although most instances of object recognition during natural viewing occur in the presence of saccades, the neural correlates of objection recognition have almost exclusively been examined during fixation. Recent studies have indicated that there are post-saccadic modulations of neural activity immediately following eye movement landing; however, whether post-saccadic modulations affect relatively late occurring cognitive components such as the P3 has not been explored. The P3 as conventionally measured at fixation is commonly used in brain computer interfaces, hence characterizing the post-saccadic P3 could aid in the development of improved brain computer interfaces that allow for eye movements. In this study, the P3 observed after saccadic landing was compared to the P3 measured at fixation. No significant differences in P3 start time, temporal persistence, or amplitude were found between fixation and saccade trials. Importantly, sensory neural responses canceled in the target minus distracter comparisons used to identify the P3. Our results indicate that relatively late occurring cognitive neural components such as the P3 are likely less sensitive to post saccadic modulations than sensory neural components and other neural activity occurring shortly after eye movement landing. Furthermore, due to the similarity of the fixation and saccade P3, we conclude that the P3 following saccadic landing could possibly be used as a viable signal in brain computer interfaces allowing for eye movements.	[Dandekar, Sangita; Carney, Thom; Klein, Stanley A.] Univ Calif Berkeley, Vis Sci Grad Program, Berkeley, CA 94720 USA; [Klein, Stanley A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Ding, Jian; Privitera, Claudio; Carney, Thom; Klein, Stanley A.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Klein, Stanley A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dandekar, S (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	sd93@nyu.edu			DARPA [B8U556562]; NIH [RO1 EY04776]; NATIONAL EYE INSTITUTE [R01EY004776] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this research was provided by DARPA grant B8U556562 and NIH grant RO1 EY04776. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Cloherty SL, 2010, VISION RES, V50, P2683, DOI 10.1016/j.visres.2010.08.020; COOPER R, 1977, SCIENCE, V196, P74, DOI 10.1126/science.841343; Dandekar S, 2012, J NEUROPHYSIOL, V107, P1776, DOI 10.1152/jn.00237.2011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dimigen O, 2011, J EXP PSYCHOL GEN; Dimigen O, 2009, J NEUROSCI, V29, P12321, DOI 10.1523/JNEUROSCI.0911-09.2009; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; GAARDER K, 1964, SCIENCE, V146, P1481, DOI 10.1126/science.146.3650.1481; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Hooge ITC, 1999, VISION RES, V39, P1567, DOI 10.1016/S0042-6989(98)00213-2; Ibbotson M, 2011, CURR OPIN NEUROBIOL, V21, P553, DOI 10.1016/j.conb.2011.05.012; Ibbotson MR, 2008, J NEUROSCI, V28, P10952, DOI 10.1523/JNEUROSCI.3950-08.2008; Ibbotson MR, 2006, CURR BIOL, V16, pR834, DOI 10.1016/j.cub.2006.08.081; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Kamienkowski JE, 2012, J VISION, V12, DOI 10.1167/12.7.4; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MARTON M, 1985, DOC OPHTHALMOL, V59, P199, DOI 10.1007/BF00160616; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Polich J, 1998, J CLIN NEUROPHYSIOL, V15, P14, DOI 10.1097/00004691-199801000-00004; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rajkai C, 2008, CEREB CORTEX, V18, P200, DOI 10.1093/cercor/bhm046; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Sylvester R, 2005, CURR BIOL, V15, P37, DOI 10.1016/j.cub.2004.12.061; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	38	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48761	10.1371/journal.pone.0048761	http://dx.doi.org/10.1371/journal.pone.0048761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144959	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800124
J	Jorgensen, LV; Sigh, J; Kania, PW; Holten-Andersen, L; Buchmann, K; Clark, T; Rasmussen, JS; Einer-Jensen, K; Lorenzen, N				Jorgensen, Louise von Gersdorff; Sigh, Jens; Kania, Per Walter; Holten-Andersen, Lars; Buchmann, Kurt; Clark, Theodore; Rasmussen, Jesper Skou; Einer-Jensen, Katja; Lorenzen, Niels			Approaches towards DNA Vaccination against a Skin Ciliate Parasite in Fish	PLOS ONE			English	Article							ICHTHYOPHTHIRIUS-MULTIFILIIS FOUQUET; HEMATOPOIETIC NECROSIS VIRUS; CARP CYPRINUS-CARPIO; ICTALURUS-PUNCTATUS RAFINESQUE; HEMORRHAGIC SEPTICEMIA VIRUS; ONCORHYNCHUS-MYKISS WALBAUM; IMMUNE-RELEVANT GENES; RAINBOW-TROUT; CHANNEL CATFISH; PROTECTIVE IMMUNITY	Rainbow trout (Oncorhynchus mykiss) were immunized with plasmid DNA vaccine constructs encoding selected antigens from the parasite Ichthyophthirius multifiliis. Two immobilization antigens (I-ags) and one cysteine protease were tested as genetic vaccine antigen candidates. Antigenicity was evaluated by immunostaining of transfected fish cells using I-ag specific mono-and polyclonal antibodies. I. multifiliis specific antibody production, regulation of immune-relevant genes and/or protection in terms of parasite burden or mortality was measured to evaluate the induced immune response in vaccinated fish. Apart from intramuscular injection, needle free injection and gene gun delivery were tested as alternative administration techniques. For the I-ags the complement protein fragment C3d and the termini of the viral haemorrhagic septicaemia virus glyco(G) protein (VHSV G) were tested as opsonisation and cellular localisation mediators, respectively, while the full length viral G protein was tested as molecular adjuvant. Expression of I-ags in transfected fish cells was demonstrated for several constructs and by immunohistochemistry it was possible to detect expression of a secreted form of the Iag52B in the muscle cells of injected fish. Up-regulations of mRNA coding for IgM, MHC I, MHC II and TCR beta, respectively, were observed in muscle tissue at the injection site in selected trials. In the spleen up-regulations were found for IFN-gamma and IL-10. The highest up-regulations were seen following co-administration of I-ag and cysteine protease plasmid constructs. This correlated with a slight elevation of an I. multifiliis specific antibody response. However, in spite of detectable antigen expression and immune reactions, none of the tested vaccination strategies provided significant protection. This might suggest an insufficiency of DNA vaccination alone to trigger protective mechanisms against I. multifiliis or that other or additional parasite antigens are required for such a vaccine to be successful.	[Jorgensen, Louise von Gersdorff; Sigh, Jens; Kania, Per Walter; Holten-Andersen, Lars; Buchmann, Kurt] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Clark, Theodore] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY USA; [Rasmussen, Jesper Skou; Einer-Jensen, Katja; Lorenzen, Niels] Tech Univ Denmark, Natl Vet Lab, Aarhus, Denmark	University of Copenhagen; Cornell University; Technical University of Denmark	Jorgensen, LV (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	lvgj@sund.ku.dk	; Lorenzen, Niels/L-3967-2017	Jorgensen, Louise von Gersdorff/0000-0002-6005-3249; Lorenzen, Niels/0000-0002-6946-3252; Buchmann, Kurt/0000-0002-2747-237X	FP6 project IMAQUANIM; EU-commision; Danish Fish Immunology Research Centre and Network	FP6 project IMAQUANIM; EU-commision; Danish Fish Immunology Research Centre and Network	This study was funded by the FP6 project IMAQUANIM funded by the EU-commision and by the Danish Fish Immunology Research Centre and Network www.dafinet.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ED, 1996, MOL MAR BIOL BIOTECH, V5, P114; BAUER ON, 1953, DOKL AKAD NAUK SSSR+, V93, P377; Boudinot P, 1998, VIROLOGY, V249, P297, DOI 10.1006/viro.1998.9322; BURKART MA, 1990, J FISH DIS, V13, P401, DOI 10.1111/j.1365-2761.1990.tb00799.x; Carvalho JA, 2010, EXPERT REV VACCINES, V9, P175, DOI [10.1586/erv.09.158, 10.1586/ERV.09.158]; Clark TG, 1997, PARASITOL TODAY, V13, P477, DOI 10.1016/S0169-4758(97)01152-6; Clark TG, 1996, P NATL ACAD SCI USA, V93, P6825, DOI 10.1073/pnas.93.13.6825; CLARK TG, 1987, J FISH BIOL, V31, P203, DOI 10.1111/j.1095-8649.1987.tb05314.x; Clark Theodore G., 1995, Annual Review of Fish Diseases, V5, P113, DOI 10.1016/0959-8030(95)00005-4; Corbeil S, 2000, FISH SHELLFISH IMMUN, V10, P711, DOI 10.1006/fsim.2000.0286; CROSS ML, 1992, J FISH DIS, V15, P497, DOI 10.1111/j.1365-2761.1992.tb00681.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fernandez-Alonso M, 1998, DIS AQUAT ORGAN, V34, P167, DOI 10.3354/dao034167; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Gonzalez SF, 2007, VET IMMUNOL IMMUNOP, V115, P172, DOI 10.1016/j.vetimm.2006.09.007; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; He JY, 1997, AQUACULTURE, V158, P1, DOI 10.1016/S0044-8486(97)00074-4; Heppell J, 1998, FISH SHELLFISH IMMUN, V8, P271, DOI 10.1006/fsim.1997.0133; Heppell J, 2000, ADV DRUG DELIVER REV, V43, P29, DOI 10.1016/S0169-409X(00)00075-2; HINES RS, 1974, J FISH BIOL, V6, P373, DOI 10.1111/j.1095-8649.1974.tb04554.x; Holten-Andersen L, 2012, DETERMINING IN PRESS; HOUGHTON G, 1990, J FISH DIS, V13, P269, DOI 10.1111/j.1365-2761.1990.tb00783.x; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Ivory Catherine, 2004, Genet Vaccines Ther, V2, P17, DOI 10.1186/1479-0556-2-17; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Jorgensen LV, 2008, DIS AQUAT ORGAN, V80, P189, DOI 10.3354/dao01935; Jousson O, 2007, FEMS MICROBIOL LETT, V269, P77, DOI 10.1111/j.1574-6968.2006.00611.x; Kamstrup S, 2004, VACCINE, V22, P1358, DOI 10.1016/j.vaccine.2004.01.032; Kurath G., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072048; Lin TL, 1996, INFECT IMMUN, V64, P4085, DOI 10.1128/IAI.64.10.4085-4090.1996; LIN TL, 1992, J PROTOZOOL, V39, P457, DOI 10.1111/j.1550-7408.1992.tb04832.x; Lin YK, 2002, MOL BIOCHEM PARASIT, V120, P93, DOI 10.1016/S0166-6851(01)00436-4; Lin YK, 2002, GENE, V288, P85, DOI 10.1016/S0378-1119(02)00433-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen E, 2009, VACCINE, V27, P3870, DOI 10.1016/j.vaccine.2009.04.012; Lorenzen N, 2005, REV SCI TECH OIE, V24, P201, DOI 10.20506/rst.24.1.1565; LORENZEN N, 1988, DIS AQUAT ORGAN, V4, P35, DOI 10.3354/dao004035; LORENZEN N, 1993, FISH SHELLFISH IMMUN, V3, P461, DOI 10.1006/fsim.1993.1045; Lorenzen N, 2002, FISH SHELLFISH IMMUN, V12, P439, DOI 10.1006/fsim.2002.0422; LORENZEN N, 1990, J GEN VIROL, V71, P561, DOI 10.1099/0022-1317-71-3-561; Lorenzen N, 1998, FISH SHELLFISH IMMUN, V8, P261, DOI 10.1006/fsim.1997.0134; Lorenzen N, 2002, DEV COMP IMMUNOL, V26, P173, DOI 10.1016/S0145-305X(01)00059-3; Lorenzen N, 2001, FISH SHELLFISH IMMUN, V11, P585, DOI 10.1006/fsim.2001.0337; LORENZEN N, 1993, J GEN VIROL, V74, P623, DOI 10.1099/0022-1317-74-4-623; Maki JL, 2003, CLIN DIAGN LAB IMMUN, V10, P876, DOI 10.1128/CDLI.10.5.876-881.2003; Matthews RA, 2005, ADV PARASIT, V59, P159, DOI 10.1016/S0065-308X(05)59003-1; Mohamed RM, 2003, VACCINE, V21, P2852, DOI [10.1016/S0264-410X(03)00157-9, 10.1016/s0264-410X(03)00157-9]; OLESEN NJ, 1992, DIS AQUAT ORGAN, V12, P235, DOI 10.3354/dao012235; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Rafati S, 2001, VACCINE, V19, P3369, DOI 10.1016/S0264-410X(01)00081-0; Raida MK, 2007, DIS AQUAT ORGAN, V77, P41, DOI 10.3354/dao01808; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sigh J, 2001, J FISH DIS, V24, P49, DOI 10.1046/j.1365-2761.2001.00258.x; Swan CM, 2008, J FISH DIS, V31, P383, DOI 10.1111/j.1365-2761.2008.00918.x; Wahli T, 1999, DIS AQUAT ORGAN, V36, P201, DOI 10.3354/dao036201; Wang XT, 2002, CLIN DIAGN LAB IMMUN, V9, P176, DOI 10.1128/CDLI.9.1.176-181.2002; Xu DH, 2009, FISH SHELLFISH IMMUN, V26, P614, DOI 10.1016/j.fsi.2008.09.015; Xu DH, 2004, J FISH DIS, V27, P135, DOI 10.1111/j.1365-2761.2004.00523.x; Zarkadis IK, 2001, DEV COMP IMMUNOL, V25, P11, DOI 10.1016/S0145-305X(00)00039-2; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 2003, IMMUNOGENETICS, V55, P325, DOI 10.1007/s00251-003-0580-y	65	25	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48129	10.1371/journal.pone.0048129	http://dx.doi.org/10.1371/journal.pone.0048129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144852	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800036
J	Selimoglu-Buet, D; Gallais, I; Denis, N; Guillouf, C; Moreau-Gachelin, F				Selimoglu-Buet, Dorothee; Gallais, Isabelle; Denis, Nicole; Guillouf, Christel; Moreau-Gachelin, Francoise			Oncogenic Kit Triggers Shp2/Erk1/2 Pathway to Down-Regulate the Pro-Apoptotic Protein Bim and to Promote Apoptosis Resistance in Leukemic Cells	PLOS ONE			English	Article							BH3 MIMETIC ABT-737; BCL-2 FAMILY; HEMATOLOGIC MALIGNANCIES; SIGNALING PATHWAYS; WILD-TYPE; C-KIT; INHIBITOR; PHOSPHORYLATION; MUTATIONS; ERK1/2	Oncogenic mutations leading to persistent kinase activities are implicated in various human malignancies. Thereby, signaling pathway-targeted therapies are powerful customized treatment to eradicate cancer cells. In murine and human leukemia cells harboring mutations in Kit, we previously showed that distinct and independent pathways controlled resistance to apoptosis or cell cycle. A treatment with PI3Kinase inhibitors to reduce cell proliferation combined with inhibitors of Erk1/2 activity to promote apoptosis had synergistic effects allowing eradication of leukemia cell growth. We reported here that Bim(EL), a pro-apoptotic member of the Bcl2 family proteins, is the target of Erk1/2 signaling and that its down-regulation is responsible for the apoptosis resistance of murine and human leukemic cells. Downstream of Kit mutant, the tyrosine phosphatase Shp2 maintains Bim(EL) expression at a low level, through Erk/2 activation and proteosomal Bim(EL) degradation. This process is controlled by Shp2 independently of other signaling pathways activated downstream of oncogenic Kit, demonstrating that Shp2 is a key regulator of Bim expression in the context of an oncogenic signaling. The increase in Bim(EL) expression is associated to an increased apoptosis. Moreover, the depletion of Bim overcomes apoptosis associated with Erk1/2 inactivation in UO126-treated leukemic cells, thereby establishing the contribution of Bim to drug-induced apoptosis. These data provide a molecular rationale for using BH3 mimetics in combination with PI3K inhibitors to treat leukemia, especially in the case of an oncogenic signaling refractory to Tyrosine Kinase inhibitors.	[Selimoglu-Buet, Dorothee; Gallais, Isabelle; Denis, Nicole; Guillouf, Christel; Moreau-Gachelin, Francoise] Inst Curie, Inserm U830, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Moreau-Gachelin, F (corresponding author), Inst Curie, Inserm U830, Paris, France.	framoreau@curie.fr		Selimoglu-Buet, Dorothee/0000-0002-3565-2709	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Curie; Association pour la Recherche sur le Cancer [3822]; Association Christelle Bouillot	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association Christelle Bouillot	The work was supported by Institut National de la Sante et de la Recherche Medicale (Inserm) and Institut Curie, and by grants from Association pour la Recherche sur le Cancer (grant 3822), and Association Christelle Bouillot. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Akin C, 2003, EXP HEMATOL, V31, P686, DOI 10.1016/S0301-472X(03)00112-7; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Barnache S, 2001, BLOOD, V98, P2372, DOI 10.1182/blood.V98.8.2372; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Buet D, 2012, BLOOD, V119, P4228, DOI 10.1182/blood-2011-07-368316; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kosmider O, 2005, CANCER CELL, V8, P467, DOI 10.1016/j.ccr.2005.11.009; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Ma YS, 2002, BLOOD, V99, P1741, DOI 10.1182/blood.V99.5.1741; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Schimmer AD, 2008, CLIN CANCER RES, V14, P8295, DOI 10.1158/1078-0432.CCR-08-0999; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49052	10.1371/journal.pone.0049052	http://dx.doi.org/10.1371/journal.pone.0049052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145067	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800193
J	Wang, J; Zhou, N; Xu, B; Hao, HJ; Kang, L; Zheng, YL; Jiang, YQ; Jiang, H				Wang, Jie; Zhou, Na; Xu, Bin; Hao, Huaijie; Kang, Lin; Zheng, Yuling; Jiang, Yongqiang; Jiang, Hua			Identification and Cluster Analysis of Streptococcus pyogenes by MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; INVASIVE INFECTIONS; VACCINE DEVELOPMENT; GENETIC DIVERSITY; TIME; STRAINS; EMM	Background: Whole-cell matrix-assisted laser desorption ionization time-of-flight ( MALDI-TOF) mass spectrometry ( MS) has been successfully applied for bacterial identification and typing of many pathogens. The fast and reliable qualities of MALDI-TOF MS make it suitable for clinical diagnostics. MALDI-TOF MS for the identification and cluster analysis of Streptococcus pyogenes, however, has not been reported. The goal of our study was to evaluate this approach for the rapid identification and typing of S. pyogenes. Methods: 65 S. pyogenes isolates were obtained from the hospital. The samples were prepared and MALDI-TOF MS measurements were conducted as previously reported. Identification of unknown spectra was performed via a pattern recognition algorithm with a reference spectra and a dendrogram was constructed using the statistical toolbox in Matlab 7.1 integrated in the MALDI Biotyper 2.0 software. Results: For identification, 61 of 65 S. pyogenes isolates could be identified correctly by MALDI-TOF MS with BioType 2.0 when compared to biochemical identification (API Strep), with an accuracy of 93.85%. In clustering analysis, 44 of 65 isolates were in accordance with those established by M typing, with a matching rate of 67.69%. When only the M type prevalence in China was considered, 41 of 45 isolates were in agreement with M typing, with a matching rate of 91.1%. Conclusions: It was here shown that MALDI-TOF MS with Soft Biotype 2.0 and its database could facilitate rapid identification of S. pyogenes. It may present an attractive alternative to traditional biochemical methods of identification. However, for classification, more isolates and advances in the MALDI-TOF MS technology are needed to improve accuracy.	[Hao, Huaijie; Kang, Lin; Zheng, Yuling; Jiang, Yongqiang; Jiang, Hua] Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Jie; Zhou, Na; Xu, Bin] Natl Ctr Biomed Anal, Beijing, Peoples R China; [Zhou, Na] Jilin Univ, Dept Pharm, Hosp Stomatol, Changchun 130023, Peoples R China	Academy of Military Medical Sciences - China; Jilin University	Jiang, YQ (corresponding author), Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	jiangyq@nic.bmi.ac.cn; jhua76@126.com	Hao, Huaijie/D-3861-2017	Hao, Huaijie/0000-0002-1928-4205	Chinese State Key Project Specialized for Infectious Disease [2009ZX10004-103, 2011ZX10004-001, 2013ZX10004-101, 2012YQ180117]	Chinese State Key Project Specialized for Infectious Disease	This work was supported by grants from Chinese State Key Project Specialized for Infectious Disease (2009ZX10004-103, 2011ZX10004-001, 2013ZX10004-101, 2012YQ180117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dubois D, 2010, J CLIN MICROBIOL, V48, P941, DOI 10.1128/JCM.00413-09; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Green NM, 2005, J CLIN MICROBIOL, V43, P4083, DOI 10.1128/JCM.43.8.4083-4091.2005; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Ilina EN, 2010, RAPID COMMUN MASS SP, V24, P328, DOI 10.1002/rcm.4394; Jing HB, 2006, J MED MICROBIOL, V55, P1101, DOI 10.1099/jmm.0.46243-0; Nagy E, 2009, CLIN MICROBIOL INFEC, V15, P796, DOI 10.1111/j.1469-0691.2009.02788.x; Neal S, 2007, J CLIN MICROBIOL, V45, P1175, DOI 10.1128/JCM.02146-06; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Smeesters PR, 2010, VACCINE, V28, P883, DOI 10.1016/j.vaccine.2009.10.137; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Steer AC, 2009, J CLIN MICROBIOL, V47, P2502, DOI 10.1128/JCM.00312-09; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013	16	33	35	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47152	10.1371/journal.pone.0047152	http://dx.doi.org/10.1371/journal.pone.0047152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144803	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800015
J	Worsaae, K; Sterrer, W; Kaul-Strehlow, S; Hay-Schmidt, A; Giribet, G				Worsaae, Katrine; Sterrer, Wolfgang; Kaul-Strehlow, Sabrina; Hay-Schmidt, Anders; Giribet, Gonzalo			An Anatomical Description of a Miniaturized Acorn Worm (Hemichordata, Enteropneusta) with Asexual Reproduction by Paratomy	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DEUTEROSTOME PHYLOGENY; SPOLIA BERMUDIANA; ACOEL FLATWORMS; BASAL POSITION; EVOLUTION; ANNELIDA; POLYCHAETA; PHYLUM; OPTIMIZATION	The interstitial environment of marine sandy bottoms is a nutrient-rich, sheltered habitat whilst at the same time also often a turbulent, space-limited, and ecologically challenging environment dominated by meiofauna. The interstitial fauna is one of the most diverse on earth and accommodates miniaturized representatives from many macrofaunal groups as well as several exclusively meiofaunal phyla. The colonization process of this environment, with the restrictions imposed by limited space and low Reynolds numbers, has selected for great morphological and behavioral changes as well as new life history strategies. Here we describe a new enteropneust species inhabiting the interstices among sand grains in shallow tropical waters of the West Atlantic. With a maximum body length of 0.6 mm, it is the first microscopic adult enteropneust known, a group otherwise ranging from 2 cm to 250 cm in adult size. Asexual reproduction by paratomy has been observed in this new species, a reproductive mode not previously reported among enteropneusts. Morphologically, Meioglossus psammophilus gen. et sp. nov. shows closest resemblance to an early juvenile stage of the acorn worm family Harrimaniidae, a result congruent with its phylogenetic placement based on molecular data. Its position, clearly nested within the larger macrofaunal hemichordates, suggests that this represents an extreme case of miniaturization. The evolutionary pathway to this simple or juvenile appearance, as chiefly demonstrated by its small size, dense ciliation, and single pair of gill pores, may be explained by progenesis. The finding of M. psammophilus gen. et sp. nov. underscores the notion that meiofauna may constitute a rich source of undiscovered metazoan diversity, possibly disguised as juveniles of other species.	[Worsaae, Katrine] Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark; [Sterrer, Wolfgang] Bermuda Nat Hist Museum, Flatts, Bermuda; [Kaul-Strehlow, Sabrina] Univ Vienna, Dept Mol Evolut & Dev, Vienna, Austria; [Hay-Schmidt, Anders] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Giribet, Gonzalo] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Copenhagen; University of Vienna; University of Copenhagen; Harvard University	Worsaae, K (corresponding author), Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark.	kworsaae@bio.ku.dk	Worsaae, Katrine/L-8739-2014; Giribet, Gonzalo/P-1086-2015; Worsaae, Katrine/AEX-9585-2022	Worsaae, Katrine/0000-0003-0443-4298; Giribet, Gonzalo/0000-0002-5467-8429; 	Carlsberg Foundation; Danish Council for independent research (FNU) [272-06-0260]; US National Science Foundation [DEB-0918499]; Smithsonian Marine Science network	Carlsberg Foundation(Carlsberg Foundation); Danish Council for independent research (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); US National Science Foundation(National Science Foundation (NSF)); Smithsonian Marine Science network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network)	The study was funded by The Carlsberg Foundation (grant to K. Worsaae; www.carlsbergfondet.dk/) and The Danish Council for independent research (FNU grant # 272-06-0260 to K. Worsaae; www.en.fi.dk/councils-commissions/the-danish-council-for-independent-research). Partial funding of collecting trip to Belize came from an award to Dr. Rick Hochberg from the US National Science Foundation (DEB-0918499; www.nsf.gov) and to Dr. Jon Norenburg from the Smithsonian Marine Science network (www.si.edu/marinescience/msn_cfps.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson B, 2001, ACTA ZOOL-STOCKHOLM, V82, P231, DOI 10.1046/j.1463-6395.2001.00084.x; AX P, 1996, MULTICELLULAR ANIMAL, V1; Ax P., 1956, ABH AKAD WISS LIT MN, V8, P1; Benito J, 1997, MICROSCOPICAL ANATOM, V15, P15; Bleidorn C, 2007, J ZOOL SYST EVOL RES, V45, P299, DOI 10.1111/j.1439-0469.2007.00425.x; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; BURDONJONES C, 1952, PHILOS T ROY SOC B, V236, P553, DOI 10.1098/rstb.1952.0010; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cameron CB, 2002, BIOL BULL, V202, P182, DOI 10.2307/1543654; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Casu M, 2006, BIOL J LINN SOC, V87, P553, DOI 10.1111/j.1095-8312.2006.00588.x; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Curini-Galletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033801; D Fontaneto, 2011, BIOGEOGRAPHY MICROSC; Deland C, 2010, ZOOTAXA, P1; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; DILLY PN, 1985, J ZOOL, V207, P223; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Egger B, 2007, DEV GENES EVOL, V217, P89, DOI 10.1007/s00427-006-0120-5; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Garstang W, 1939, Q J MICROSC SCI, V81, P321; Garstang W, 1939, Q J MICROSC SCI, V81, P347; Giere, 2009, MEIOBENTHOLOGY THE M; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Hadfield M.G., 1975, P185; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Higgins R. P., 1988, INTRO STUDY MEIOFAUN; Holland ND, 2005, NATURE, V434, P374, DOI 10.1038/nature03382; Holland ND, 2009, ZOOSYSTEMA, V31, P333, DOI 10.5252/z2009n2a6; Kaul S, 2010, J MORPHOL, V271, P1240, DOI 10.1002/jmor.10868; Kharin A. V., 2006, Russian Journal of Developmental Biology, V37, P354, DOI 10.1134/S1062360406060038; KRISTENSEN RM, 1983, Z ZOOL SYST EVOL, V21, P163; Kristensen RM, 2000, J MORPHOL, V246, P1; LESTER SM, 1988, ACTA ZOOL-STOCKHOLM, V69, P95, DOI 10.1111/j.1463-6395.1988.tb00906.x; Lowe CJ, 2011, CURR BIOL, V21, pR151, DOI 10.1016/j.cub.2010.12.017; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; Miyamoto N, 2010, DEV GROWTH DIFFER, V52, P615, DOI 10.1111/j.1440-169X.2010.01197.x; Monniot C., 1978, Oceanography and Marine Biology an Annual Review, V16, P181; Monniot C., 1975, Archives Zool exp gen, V116, P77; MONNIOT C, 1990, ZOOL J LINN SOC-LOND, V99, P239, DOI 10.1111/j.1096-3642.1990.tb00562.x; MONNIOT F, 1962, CR HEBD ACAD SCI, V255, P2820; Monniot F, 1966, ASCIDIES INTERSTITIE, P161; MONNIOT FRANCOISE, 1965, MEM MUS NAT HIST NATUR PARIS SER A ZOOL, V35, P1; Nielsen C, 2007, J MORPHOL, V268, P551, DOI 10.1002/jmor.10533; Nielsen C, 2010, J MORPHOL, V271, P1094, DOI 10.1002/jmor.10856; Osborn KJ, 2012, P ROY SOC B-BIOL SCI, V279, P1646, DOI 10.1098/rspb.2011.1916; PACKARD A, 1968, PROC R SOC SER B-BIO, V171, P261, DOI 10.1098/rspb.1968.0068; PETERSEN JA, 1971, MAR BIOL, V9, P78, DOI 10.1007/BF00348821; Petersen JA, 1994, ASEXUAL PROPAGATIO B, V6, P385; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Quast B, 2012, 13 ANN M GFBS 2012 B; RAO GC, 1968, P INDIAN ACAD SCI B, V67, P201; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Rundell RJ, 2010, BIOESSAYS, V32, P430, DOI 10.1002/bies.200900116; Rutzler K, 1982, ATLANTIC BARRIER REE; Rychel AL, 2009, STEM CELLS IN MARINE ORGANISMS, P245, DOI 10.1007/978-90-481-2767-2_10; SALVINI-PLAWEN L V, 1972, Zoologischer Anzeiger, V188, P301; SCHAEFFER B, 1987, EVOL BIOL, V21, P179; Sempere LF, 2007, EVOL DEV, V9, P409, DOI 10.1111/j.1525-142X.2007.00180.x; Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x; Sorensen MV, 2003, J MORPHOL, V255, P131, DOI 10.1002/jmor.10038; Spengel J.W., 1893, FAUNA FLORA GOLF, P1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEBBING AR, 1970, MAR BIOL, V5, P205, DOI 10.1007/BF00346908; STERRER W, 1986, MARINE FAUNA FLORA B; Struck TH, 2002, MOL PHYLOGENET EVOL, V25, P190, DOI 10.1016/S1055-7903(02)00231-2; Struck TH, 2006, INTEGR COMP BIOL, V46, P558, DOI 10.1093/icb/icj055; SWEDMARK B, 1971, Smithsonian Contributions to Zoology, V76, P41; Tyler Seth, 2001, Systematics Association Special Volume Series, V60, P3; Varon A, 2012, POY VERSION 5 0 0 SO; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; WARNER RR, 1975, AM NAT, V109, P61, DOI 10.1086/282974; WESTHEIDE W, 1987, J NAT HIST, V21, P843, DOI 10.1080/00222938700770501; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Willems W. R., 2009, Meiofauna Marina, V17, P1; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Worsaae K, 2005, HYDROBIOLOGIA, V535, P319, DOI 10.1007/s10750-004-4417-y; Worsaae K, 2005, ZOOL SCR, V34, P313, DOI 10.1111/j.1463-6409.2005.00190.x; Worsaae K, 2010, J MORPHOL, V271, P127, DOI 10.1002/jmor.10786; Worsaae K, 2008, J MORPHOL, V269, P1426, DOI 10.1002/jmor.10686	87	42	43	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48529	10.1371/journal.pone.0048529	http://dx.doi.org/10.1371/journal.pone.0048529			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144898	gold, Green Published			2022-12-25	WOS:000311935800073
J	Rodriguez, AE; Hernandez, JA; Benito, R; Gutierrez, NC; Garcia, JL; Hernadez-Sanchez, M; Risueno, A; Sarasquete, ME; Ferminan, E; Fisac, R; de Coca, AG; Martin-Nunez, G; de las Heras, N; Recio, I; Gutierrez, O; De Las Rivas, J; Gonzalez, M; Hernandez-Rivas, JM				Eugenia Rodriguez, Ana; Angel Hernandez, Jose; Benito, Rocio; Gutierrez, Norma C.; Luis Garcia, Juan; Hernadez-Sanchez, Maria; Risueno, Alberto; Eugenia Sarasquete, M.; Ferminan, Encarna; Fisac, Rosa; Garcia de Coca, Alfonso; Martin-Nunez, Guillermo; de las Heras, Natalia; Recio, Isabel; Gutierrez, Oliver; De Las Rivas, Javier; Gonzalez, Marcos; Hernandez-Rivas, Jesus M.			Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14	PLOS ONE			English	Article							B-CELL-RECEPTOR; GENE MUTATIONAL STATUS; CD38 EXPRESSION; GENOMIC ABERRATIONS; ACTIVATION; SURVIVAL; CLL; PROLIFERATION; PROGNOSIS; BIOLOGY	Background: Patients with chronic lymphocytic leukemia and 13q deletion as their only FISH abnormality could have a different outcome depending on the number of cells displaying this aberration. Thus, cases with a high number of 13q- cells (13q-H) had both shorter overall survival and time to first therapy. The goal of the study was to analyze the genetic profile of 13q-H patients. Design and Methods:: A total of 102 samples were studied, 32 of which served as a validation cohort and five were healthy donors. Results: Chronic lymphocytic leukemia patients with higher percentages of 13q-cells (>80%) showed a different level of gene expression as compared to patients with lower percentages (<80%, 13q-L). This deregulation affected genes involved in apoptosis and proliferation (BCR and NF kappa B signaling), leading to increased proliferation and decreased apoptosis in 13q-H patients. Deregulation of several microRNAs, such as miR-15a, miR-155, miR-29a and miR-223, was also observed in these patients. In addition, our study also suggests that the gene expression pattern of 13q-H cases could be similar to the patients with 11q- or 17p-. Conclusions: This study provides new evidence regarding the heterogeneity of 13q deletion in chronic lymphocytic leukemia patients, showing that apoptosis, proliferation as well as miRNA regulation are involved in cases with higher percentages of 13q- cells.	[Eugenia Rodriguez, Ana; Benito, Rocio; Hernadez-Sanchez, Maria; Gonzalez, Marcos; Hernandez-Rivas, Jesus M.] Univ Salamanca, CSIC, Ctr Invest Canc, IBSAL,IBMCC, E-37008 Salamanca, Spain; [Angel Hernandez, Jose] Hosp Univ Infanta Leonor, Serv Hematol, Madrid, Spain; [Gutierrez, Norma C.; Eugenia Sarasquete, M.; Gonzalez, Marcos; Hernandez-Rivas, Jesus M.] Univ Salamanca, Hosp Clin, Serv Hematol, E-37008 Salamanca, Spain; [Luis Garcia, Juan] IECSCYL HUSAL, Inst Estudios Ciencias Salud Castilla & Leon, Castilla Y Leon, Spain; [Risueno, Alberto; De Las Rivas, Javier] Univ Salamanca, CSIC, Ctr Invest Canc, Grp Bioinformat & Genom Funct,IBMCC, E-37008 Salamanca, Spain; [Risueno, Alberto] Celgene Inst Translat Res Europe CITRE, Seville, Spain; [Ferminan, Encarna] Univ Salamanca, CSIC, Ctr Invest Canc, Unidad Genom,IBMCC, E-37008 Salamanca, Spain; [Fisac, Rosa] Hosp Gen Segovia, Serv Hematol, Segovia, Spain; [Garcia de Coca, Alfonso] Hosp Clin Univ, Serv Hematol, Valladolid, Spain; [Martin-Nunez, Guillermo] Hosp Virgen del Puerto, Serv Hematol, Plasencia, Spain; [de las Heras, Natalia] Hosp Virgen Blanca, Serv Hematol, Leon, Spain; [Recio, Isabel] Hosp Nuestra Senora Sonsoles, Serv Hematol, Avila, Spain; [Gutierrez, Oliver] Hosp del Rio Hortega, Serv Hematol, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Hospital Universitario Infanta Leonor; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Hospital del Rio Hortega	Hernandez-Rivas, JM (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, IBSAL,IBMCC, E-37008 Salamanca, Spain.	jmhr@usal.es	Rodríguez-Vicente, Ana E/AAP-5504-2021; Garcia-Sanz, Ramon/B-7986-2017; Hernández, Jesus M/B-5459-2017; De Las Rivas, Javier/G-5936-2014; Rodriguez, Ana E/B-5462-2017; BENITO, ROCIO/B-4271-2017; Hernandez-Rivas, Jose-Angel/ADF-6441-2022; sarasquete, Maria E/U-8063-2018; Hernández-Sánchez, María/I-9045-2016; garcia, Juan/B-4617-2017	Rodríguez-Vicente, Ana E/0000-0001-6516-2172; Garcia-Sanz, Ramon/0000-0003-4120-2787; Hernández, Jesus M/0000-0002-9661-9371; De Las Rivas, Javier/0000-0002-0984-9946; Rodriguez, Ana E/0000-0001-6516-2172; BENITO, ROCIO/0000-0001-9781-4198; Hernandez-Rivas, Jose-Angel/0000-0003-4550-757X; sarasquete, Maria E/0000-0001-7335-3657; Hernández-Sánchez, María/0000-0001-9968-2782; garcia, Juan/0000-0002-2146-5726; Gutierrez, Norma/0000-0001-5834-9510; , Alberto/0000-0002-5544-0762; Ferminan, Encarna/0000-0001-8111-068X; Garcia de Coca, Alfonso/0000-0002-4942-060X	Spanish Fondo de Investigaciones Sanitarias [02/1041, FIS 09/01543]; Caja de Burgos-Banca Civica, Proyectos de Investigacion del SACYL [106/A/06]; Accion Transversal del Cancer project; Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Science and Innovation; Cancer Research Foundation of Salamanca University; Redes de Investigacion RTIIC (FIS); Ayuda Predoctoral FIS de Formacion en Investigacion by the Spanish Fondo de Investigaciones Sanitarias	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Caja de Burgos-Banca Civica, Proyectos de Investigacion del SACYL; Accion Transversal del Cancer project; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cancer Research Foundation of Salamanca University; Redes de Investigacion RTIIC (FIS)(Instituto de Salud Carlos III); Ayuda Predoctoral FIS de Formacion en Investigacion by the Spanish Fondo de Investigaciones Sanitarias	The study was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias 02/1041 and FIS 09/01543; Caja de Burgos-Banca Civica, Proyectos de Investigacion del SACYL 106/A/06 and by the Accion Transversal del Cancer project, through an agreement between the Instituto de Salud Carlos III (ISCIII), the Spanish Ministry of Science and Innovation, the Cancer Research Foundation of Salamanca University and the Redes de Investigacion RTIIC (FIS). AR is fully supported by an Ayuda Predoctoral FIS de Formacion en Investigacion by the Spanish Fondo de Investigaciones Sanitarias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Binet JL, 2006, BLOOD, V107, P859, DOI 10.1182/blood-2005-04-1677; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chiorazzi N, 2007, BEST PRACT RES CL HA, V20, P399, DOI 10.1016/j.beha.2007.03.007; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dal Bo M, 2011, GENE CHROMOSOME CANC, V50, P633, DOI 10.1002/gcc.20885; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dighiero G, 2003, LEUKEMIA, V17, P2385, DOI 10.1038/sj.leu.2403154; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Guarini A, 2008, BLOOD, V112, P782, DOI 10.1182/blood-2007-12-127688; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Hernandez JA, 2009, HAEMATOL-HEMATOL J, V94, P364, DOI 10.3324/haematol.13862; Keating MJ, 1999, SEMIN ONCOL, V26, P107; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Li S, 2011, PLOS ONE, V6; Lin K, 2002, BLOOD, V100, P1404, DOI 10.1182/blood-2001-11-0066; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Mehes G, 2005, PATHOL ONCOL RES, V11, P205, DOI 10.1007/BF02893852; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Rodriguez A, 2007, LEUKEMIA, V21, P1984, DOI 10.1038/sj.leu.2404831; Sanchez ML, 2003, BLOOD, V102, P2994, DOI 10.1182/blood-2003-01-0045; Stamatopoulos B, 2009, BLOOD, V113, P5237, DOI 10.1182/blood-2008-11-189407; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Dyke DL, 2010, BRIT J HAEMATOL, V148, P544, DOI 10.1111/j.1365-2141.2009.07982.x; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	46	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48485	10.1371/journal.pone.0048485	http://dx.doi.org/10.1371/journal.pone.0048485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152777	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234600006
J	Becker, LE; Lu, ZX; Chen, WQ; Xiong, W; Kong, MY; Li, Y				Becker, Lindsey E.; Lu, Zhongxin; Chen, Weiqun; Xiong, Wei; Kong, Maiying; Li, Yong			A Systematic Screen Reveals MicroRNA Clusters That Significantly Regulate Four Major Signaling Pathways	PLOS ONE			English	Article							KAPPA-B; CELL-PROLIFERATION; GROWTH RESTRICTION; TARGET GENES; CANCER; P53; EXPRESSION; APOPTOSIS; MYC; COMPLEX	MicroRNAs (miRNAs) are encoded in the genome as individual miRNA genes or as gene clusters transcribed as polycistronic units. About 50% of all miRNAs are estimated to be co-expressed with neighboring miRNAs. Recent studies have begun to illuminate the importance of the clustering of miRNAs from an evolutionary, as well as a functional standpoint. Many miRNA clusters coordinately regulate multiple members of cellular signaling pathways or protein interaction networks. This cooperative method of targeting could produce effects on an overall process that are much more dramatic than the smaller effects often associated with regulation by an individual miRNA. In this study, we screened 366 human miRNA minigenes to determine their effects on the major signaling pathways culminating in AP-1, NF-kappa B, c-Myc, or p53 transcriptional activity. By stratifying these data into miRNA clusters, this systematic screen provides experimental evidence for the combined effects of clustered miRNAs on these signaling pathways. We also verify p53 as a direct target of miR-200a. This study is the first to provide a panoramic view of miRNA clusters' effects on cellular pathways.	[Becker, Lindsey E.; Li, Yong] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Lu, Zhongxin; Chen, Weiqun] Cent Hosp Wuhan, Dept Med Lab, Wuhan, Hubei, Peoples R China; [Lu, Zhongxin; Chen, Weiqun] Cent Hosp Wuhan, Cent Lab, Wuhan, Hubei, Peoples R China; [Xiong, Wei] Cent S Univ, Canc Res Inst, Changsha, Hunan, Peoples R China; [Kong, Maiying] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA	University of Louisville; Central South University; University of Louisville	Li, Y (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	yong.li@louisville.edu			National Cancer Institute/National Institutes of Health (NIH) [R01 CA138688]; Center for Environmental Genomics and Integrated Biology (National Institute of Environmental Health Sciences/NIH) [P30 ES014443]; Diabetes and Obesity Center (National Center for Research Resources/NIH) [P20 RR024489]; NATIONAL CANCER INSTITUTE [R01CA138688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Environmental Genomics and Integrated Biology (National Institute of Environmental Health Sciences/NIH); Diabetes and Obesity Center (National Center for Research Resources/NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by an National Cancer Institute/National Institutes of Health (NIH) project research grant (R01 CA138688), the Center for Environmental Genomics and Integrated Biology (National Institute of Environmental Health Sciences/NIH; P30 ES014443), and Diabetes and Obesity Center (National Center for Research Resources/NIH; P20 RR024489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bryant A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-8; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Faraway J., 2004, LINEAR MODELS R; Fries KL, 1996, J VIROL, V70, P8653, DOI 10.1128/JVI.70.12.8653-8659.1996; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kagawa S, 1997, ONCOGENE, V15, P1903, DOI 10.1038/sj.onc.1201362; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Kurashige J, 2012, ANN SURG ONCOL; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Ohuchida K, 2012, ANN SURG ONCOL; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Takwi A, 2012, EMBO MOL ME IN PRESS; Takwi A, 2009, CURR GENOMICS, V10, P194, DOI 10.2174/138920209788185270; Teleman AA, 2010, CELL METAB, V11, P8, DOI 10.1016/j.cmet.2009.12.004; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yuan XY, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-65	61	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48474	10.1371/journal.pone.0048474	http://dx.doi.org/10.1371/journal.pone.0048474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144891	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500024
J	Park, Y; Kim, BS; Choi, KH; Shin, DH; Lee, MJ; Cho, Y; Kim, HS				Park, Yongjung; Kim, Beom Seok; Choi, Kyu Hun; Shin, Dong Ho; Lee, Mi Jung; Cho, Yonggeun; Kim, Hyon-Suk			A Novel Multiplex Real-Time PCR Assay for the Concurrent Detection of Hepatitis A, B and C Viruses in Patients with Acute Hepatitis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 RNA; SURFACE-ANTIGEN; UNITED-STATES; RT-PCR; INFECTION; DNA; SERUM; PREVALENCE; FULMINANT	A novel multiplex real-time PCR assay for concurrent detection of hepatitis viruses was evaluated for its clinical performance in screening patients with acute hepatitis. A total of 648 serum samples were collected from patients with acute symptoms of hepatitis. Concurrent detection of nucleic acids of HAV, HBV and HCV was performed using the Magicplex (TM) HepaTrio Real-time Detection test. Serum nucleic acid levels of HBV and HCV were also quantified by the Cobas (R) AmpliPrep/Cobas (R) TaqMan (R) (CAP/CTM) HBV and HCV tests. Patients' medical records were also reviewed. Concordance rates between the results from the HepaTrio and the CAP/CTM tests for the detection of HBV and HCV were 94.9% (k = 0.88) and 99.2% (k = 0.98), respectively. The cycle threshold values with the HepaTrio test were also correlated well with the levels of HBV DNA (r = -0.9230) and HCV RNA (r = -0.8458). The sensitivity and specificity of the HepaTrio test were 93.8% and 98.2%, respectively, for detecting HBV infection, and 99.1% and 100.0%, respectively, for HCV infection. For the HepaTrio test, 21 (3.2%) cases were positive for both HBV and HCV. Among the positive cases, 6 (0.9%) were true coinfections. This test also detected 18 (2.8%) HAV positives. The HepaTrio test demonstrated good clinical performance and produced results that agreed well with those of the CAP/CTM assays, especially for the detection of HCV. This assay was also able to detect HAV RNA from anti-HAV IgM-positive individuals. Therefore, this new multiplex PCR assay could be useful for the concurrent detection of the three hepatitis viruses. Citation: Park Y, Kim BS, Choi KH, Shin DH, Lee MJ, et al. (2012) A Novel Multiplex Real-Time PCR Assay for the Concurrent Detection of Hepatitis A, B and C Viruses in Patients with Acute Hepatitis. PLoS ONE 7(11): e49106. doi: 10.1371/journal.pone.0049106	[Park, Yongjung; Cho, Yonggeun; Kim, Hyon-Suk] Yonsei Univ, Coll Med, Severance Hosp, Dept Lab Med, Seoul 120749, South Korea; [Kim, Beom Seok; Choi, Kyu Hun; Shin, Dong Ho; Lee, Mi Jung] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Lab Med, Seoul 120749, South Korea.	kimhs54@yuhs.ac	Kim, Hyon-Suk/R-4113-2017	Kim, Hyon-Suk/0000-0001-5662-7740; Park, Yongjung/0000-0001-5668-4120; Kim, Beom Seok/0000-0002-5732-2583; Choi, Kyu Hun/0000-0003-0095-9011; Lee, Mi Jung/0000-0001-8888-029X; Cho, Yonggeun/0000-0003-1946-4318				Adami V, 2004, CLIN MICROBIOL INFEC, V10, P1075, DOI 10.1111/j.1469-0691.2004.01025.x; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Candotti D, 2004, J VIROL METHODS, V118, P39, DOI 10.1016/j.jviromet.2004.01.017; Cho Ji-Hyun, 2009, Korean J Hepatol, V15, P140, DOI 10.3350/kjhep.2009.15.2.140; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Clinical Laboratory Standards Institute, 2008, EP12A2 CLSI; Defoort JP, 2000, J CLIN MICROBIOL, V38, P1066, DOI 10.1128/JCM.38.3.1066-1071.2000; FERAY C, 1993, GASTROENTEROLOGY, V104, P549, DOI 10.1016/0016-5085(93)90425-C; Gaeta GB, 2003, J HEPATOL, V39, P1036, DOI 10.1016/S0168-8278(03)00470-7; Gasim GI, 2012, J MED VIROL, V84, P52, DOI 10.1002/jmv.22256; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; LIAW YF, 1995, HEPATOLOGY, V22, P1101, DOI 10.1016/0270-9139(95)90615-0; Liaw YF, 2011, HEPATOLOGY, V54, pE1, DOI 10.1002/hep.24473; Lim Young Suk, 2009, Korean J Hepatol, V15 Suppl 6, pS25, DOI 10.3350/kjhep.2009.15.S6.S25; McCormick MK, 2006, J CLIN VIROL, V36, P166, DOI 10.1016/j.jcv.2005.12.003; Meng Q, 2001, J CLIN MICROBIOL, V39, P2937, DOI 10.1128/JCM.39.8.2937-2945.2001; Ohishi W, 2012, HEPATOL RES, V42, P219, DOI 10.1111/j.1872-034X.2011.00921.x; Park Y, 2010, J CLIN MICROBIOL, V48, P2253, DOI 10.1128/JCM.01856-09; Semnani S, 2007, TURK J GASTROENTEROL, V18, P20; Shin A, 2011, ANN ONCOL, V22, P1435, DOI 10.1093/annonc/mdq592; Suh DJ, 2005, INTERVIROLOGY, V49, P70, DOI 10.1159/000087266; Suzuki F, 2009, J MED VIROL, V81, P27, DOI 10.1002/jmv.21339; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Wen JK, 2004, BIOSENS BIOELECTRON, V19, P685, DOI 10.1016/S0956-5663(03)00264-1; Woo HY, 2008, ARCH VIROL, V153, P2019, DOI 10.1007/s00705-008-0218-3; WU JC, 1994, HEPATOLOGY, V19, P836, DOI 10.1002/hep.1840190406	27	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49106	10.1371/journal.pone.0049106	http://dx.doi.org/10.1371/journal.pone.0049106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145085	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500075
J	Benachour, H; Bastogne, T; Toussaint, M; Chemli, Y; Seve, A; Frochot, C; Lux, F; Tillement, O; Vanderesse, R; Barberi-Heyob, M				Benachour, Hamanou; Bastogne, Thierry; Toussaint, Magali; Chemli, Yosra; Seve, Aymeric; Frochot, Celine; Lux, Francois; Tillement, Olivier; Vanderesse, Regis; Barberi-Heyob, Muriel			Real-Time Monitoring of Photocytotoxicity in Nanoparticles-Based Photodynamic Therapy: A Model-Based Approach	PLOS ONE			English	Article							IN-VIVO; POLYMERIC NANOPARTICLES; MAGNETIC NANOPARTICLES; INTEGRIN EXPRESSION; DRUG-DELIVERY; CANCER CELLS; TUMOR; NANOTECHNOLOGY; CYTOTOXICITY; PARTICLES	Nanoparticles are widely suggested as targeted drug-delivery systems. In photodynamic therapy (PDT), the use of multifunctional nanoparticles as photoactivatable drug carriers is a promising approach for improving treatment efficiency and selectivity. However, the conventional cytotoxicity assays are not well adapted to characterize nanoparticles cytotoxic effects and to discriminate early and late cell responses. In this work, we evaluated a real-time label-free cell analysis system as a tool to investigate in vitro cyto- and photocyto-toxicity of nanoparticles-based photosensitizers compared with classical metabolic assays. To do so, we introduced a dynamic approach based on real-time cell impedance monitoring and a mathematical model-based analysis to characterize the measured dynamic cell response. Analysis of real-time cell responses requires indeed new modeling approaches able to describe suited use of dynamic models. In a first step, a multivariate analysis of variance associated with a canonical analysis of the obtained normalized cell index (NCI) values allowed us to identify different relevant time periods following nanoparticles exposure. After light irradiation, we evidenced discriminant profiles of cell index (CI) kinetics in a concentration-and light dose-dependent manner. In a second step, we proposed a full factorial design of experiments associated with a mixed effect kinetic model of the CI time responses. The estimated model parameters led to a new characterization of the dynamic cell responses such as the magnitude and the time constant of the transient phase in response to the photo-induced dynamic effects. These parameters allowed us to characterize totally the in vitro photodynamic response according to nanoparticle-grafted photosensitizer concentration and light dose. They also let us estimate the strength of the synergic photodynamic effect. This dynamic approach based on statistical modeling furnishes new insights for in vitro characterization of nanoparticles-mediated effects on cell proliferation with or without light irradiation.	[Benachour, Hamanou; Bastogne, Thierry; Toussaint, Magali; Chemli, Yosra; Barberi-Heyob, Muriel] Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Benachour, Hamanou; Bastogne, Thierry; Toussaint, Magali; Chemli, Yosra; Barberi-Heyob, Muriel] CRAN, CNRS, UMR 7039, Vandoeuvre Les Nancy, France; [Bastogne, Thierry] IECN, Biol Genet & Stat BIGS, Inria, UMR 7502, Vandoeuvre Les Nancy, France; [Seve, Aymeric; Frochot, Celine] CNRS, LRGP, UPR 3349, Nancy, France; [Frochot, Celine; Barberi-Heyob, Muriel] CNRS, GdR Medicaments Photoactivables Photochimiotherap, F-75700 Paris, France; [Lux, Francois; Tillement, Olivier] Univ Lyon 1, LPCML, UMR 5620, F-69365 Lyon, France; [Lux, Francois; Tillement, Olivier] CNRS, LPCML, UMR 5620, Lyon, France; [Vanderesse, Regis] Univ Lorraine, LCPM, UMR 7568, Nancy, France; [Vanderesse, Regis] CNRS, LCPM, UMR 7568, Nancy, France; [Barberi-Heyob, Muriel] CRLCC, Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Inria; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL)	Barberi-Heyob, M (corresponding author), Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France.	m.barberi@nancy.unicancer.fr			French Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche [08-PCV1-0021-01]	French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the research funds of the French Ligue Nationale Contre le Cancer and the Agence Nationale de la Recherche project no. 08-PCV1-0021-01-entitled "NanoVTP''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbu E, 2009, EXPERT OPIN DRUG DEL, V6, P553, DOI [10.1517/17425240902939143 , 10.1517/17425240902939143]; Bastogne T, 2010, J THEOR BIOL, V262, P544, DOI 10.1016/j.jtbi.2009.10.008; Bazzi R, 2004, J COLLOID INTERF SCI, V273, P191, DOI 10.1016/j.jcis.2003.10.031; Bazzi R, 2003, J LUMIN, V102, P445, DOI 10.1016/S0022-2313(02)00588-4; Bechet D, 2008, TRENDS BIOTECHNOL, V26, P612, DOI 10.1016/j.tibtech.2008.07.007; Benachour H, 2012, THERANOSTIC IN PRESS; Brevet D, 2009, CHEM COMMUN, P1475, DOI 10.1039/b900427k; Caruso G, 2011, NANOMED-NANOTECHNOL, V7, P744, DOI 10.1016/j.nano.2011.02.008; Chatterjee DK, 2008, ADV DRUG DELIVER REV, V60, P1627, DOI 10.1016/j.addr.2008.08.003; Chen SW, 2012, BIOSENS BIOELECTRON, V33, P196, DOI 10.1016/j.bios.2011.12.052; Chouikrat R, 2012, CURR MED CHEM, V19, P781, DOI 10.2174/092986712799034897; Couleaud P, 2011, NANOMEDICINE-UK, V6, P995, DOI [10.2217/nnm.11.31, 10.2217/NNM.11.31]; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Elisia I, 2008, PHYTOCHEM ANALYSIS, V19, P479, DOI 10.1002/pca.1069; Faure AC, 2009, SMALL, V5, P2565, DOI 10.1002/smll.200900563; Fingar V H, 1996, J Clin Laser Med Surg, V14, P323; Gupta S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-43; Hanusova V, 2010, XENOBIOTICA, V40, P681, DOI 10.3109/00498254.2010.508821; Heng BC, 2010, BIOINTERPHASES, V5, pFA88, DOI 10.1116/1.3494617; Hong H, 2009, NANO TODAY, V4, P399, DOI 10.1016/j.nantod.2009.07.001; Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y; Kirstein SL, 2006, ASSAY DRUG DEV TECHN, V4, P545, DOI 10.1089/adt.2006.4.545; Koo H, 2011, ACCOUNTS CHEM RES, V44, P1018, DOI 10.1021/ar2000138; Li JY, 2010, NANOSCALE RES LETT, V5, P1063, DOI 10.1007/s11671-010-9603-4; Liu YJ, 2011, BIOMATERIALS, V32, P5167, DOI 10.1016/j.biomaterials.2011.03.077; Louis C, 2005, CHEM MATER, V17, P1673, DOI 10.1021/cm0480162; Lux F, 2011, ANGEW CHEM INT EDIT, V50, P12299, DOI 10.1002/anie.201104104; Margaron P, 1997, BBA-MOL CELL RES, V1359, P200, DOI 10.1016/S0167-4889(97)00115-8; Mariani V, 2012, NANOTOXICOLOGY, V6, P272, DOI 10.3109/17435390.2011.572302; McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014; McGowan EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020623; Mohs AM, 2010, NEUROIMAG CLIN N AM, V20, P283, DOI 10.1016/j.nic.2010.04.002; Pazos MDC, 2007, BRAZ J MED BIOL RES, V40, P1025, DOI 10.1590/S0100-879X2006005000142; Praetorius Natalie P, 2007, Recent Pat Drug Deliv Formul, V1, P37, DOI 10.2174/187221107779814104; Quereda JJ, 2010, TRANSPL P, V42, P3239, DOI 10.1016/j.transproceed.2010.05.059; Runnels JM, 1999, BRIT J CANCER, V80, P946, DOI 10.1038/sj.bjc.6690448; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Soenen SJH, 2009, CONTRAST MEDIA MOL I, V4, P207, DOI 10.1002/cmmi.282; Soenen SJH, 2009, BIOMATERIALS, V30, P3691, DOI 10.1016/j.biomaterials.2009.03.040; Solomon M, 2011, CURR OPIN PEDIATR, V23, P215, DOI 10.1097/MOP.0b013e32834456a5; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Tassa C, 2011, ACCOUNTS CHEM RES, V44, P842, DOI 10.1021/ar200084x; Thomas N, 2010, BIOCHEM PHARMACOL, V80, P226, DOI 10.1016/j.bcp.2010.03.036; Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007; Verma S, 2007, PHOTOCHEM PHOTOBIOL, V83, P996, DOI 10.1111/j.1751-1097.2007.00166.x; Vistejnova L, 2009, NEUROENDOCRINOL LETT, V30, P121; Volanti C, 2004, ONCOGENE, V23, P8649, DOI 10.1038/sj.onc.1207871; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; WINTHER J, 1989, BRIT J CANCER, V59, P869, DOI 10.1038/bjc.1989.184; Yang TH, 2007, ORAL ONCOL, V43, P358, DOI 10.1016/j.oraloncology.2006.04.007	51	16	17	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48617	10.1371/journal.pone.0048617	http://dx.doi.org/10.1371/journal.pone.0048617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144911	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800083
J	Fujimoto, Y; Salam, KA; Furuta, A; Matsuda, Y; Fujita, O; Tani, H; Ikeda, M; Kato, N; Sakamoto, N; Maekawa, S; Enomoto, N; de Voogd, NJ; Nakakoshi, M; Tsubuki, M; Sekiguchi, Y; Tsuneda, S; Akimitsu, N; Noda, N; Yamashita, A; Tanaka, J; Moriishi, K				Fujimoto, Yuusuke; Salam, Kazi Abdus; Furuta, Atsushi; Matsuda, Yasuyoshi; Fujita, Osamu; Tani, Hidenori; Ikeda, Masanori; Kato, Nobuyuki; Sakamoto, Naoya; Maekawa, Shinya; Enomoto, Nobuyuki; de Voogd, Nicole J.; Nakakoshi, Masamichi; Tsubuki, Masayoshi; Sekiguchi, Yuji; Tsuneda, Satoshi; Akimitsu, Nobuyoshi; Noda, Naohiro; Yamashita, Atsuya; Tanaka, Junichi; Moriishi, Kohji			Inhibition of Both Protease and Helicase Activities of Hepatitis C Virus NS3 by an Ethyl Acetate Extract of Marine Sponge Amphimedon sp.	PLOS ONE			English	Article							TARGETED ANTIVIRAL THERAPY; RNA HELICASE; NATURAL-PRODUCTS; DRUG DISCOVERY; ALPHA-INTERFERON; HCV INFECTION; CELL-CULTURE; IN-VITRO; REPLICATION; BINDING	Combination therapy with ribavirin, interferon, and viral protease inhibitors could be expected to elicit a high level of sustained virologic response in patients infected with hepatitis C virus (HCV). However, several severe side effects of this combination therapy have been encountered in clinical trials. In order to develop more effective and safer anti-HCV compounds, we employed the replicon systems derived from several strains of HCV to screen 84 extracts from 54 organisms that were gathered from the sea surrounding Okinawa Prefecture, Japan. The ethyl acetate-soluble extract that was prepared from marine sponge Amphimedon sp. showed the highest inhibitory effect on viral replication, with EC50 values of 1.5 and 24.9 mu g/ml in sub-genomic replicon cell lines derived from genotypes 1b and 2a, respectively. But the extract had no effect on interferon-inducing signaling or cytotoxicity. Treatment with the extract inhibited virus production by 30% relative to the control in the JFH1-Huh7 cell culture system. The in vitro enzymological assays revealed that treatment with the extract suppressed both helicase and protease activities of NS3 with IC50 values of 18.9 and 10.9 mu g/ml, respectively. Treatment with the extract of Amphimedon sp. inhibited RNA-binding ability but not ATPase activity. These results suggest that the novel compound(s) included in Amphimedon sp. can target the protease and helicase activities of HCV NS3.	[Fujimoto, Yuusuke; Yamashita, Atsuya; Moriishi, Kohji] Univ Yamanashi, Dept Microbiol, Div Med, Grad Sch Med & Engn, Yamanashi, Japan; [Salam, Kazi Abdus; Akimitsu, Nobuyoshi] Univ Tokyo, Radioisotope Ctr, Tokyo, Japan; [Furuta, Atsushi; Matsuda, Yasuyoshi; Fujita, Osamu; Sekiguchi, Yuji; Noda, Naohiro] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Japan; [Furuta, Atsushi; Matsuda, Yasuyoshi; Fujita, Osamu; Tsuneda, Satoshi; Noda, Naohiro] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Tani, Hidenori] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Japan; [Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama, Japan; [Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Maekawa, Shinya; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Yamanashi, Japan; [de Voogd, Nicole J.] Netherlands Ctr Biodivers Nat, Leiden, Netherlands; [Nakakoshi, Masamichi; Tsubuki, Masayoshi] Hoshi Univ, Inst Med Chem, Tokyo 142, Japan; [Tanaka, Junichi] Univ Ryukyus, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 90301, Japan	University of Yamanashi; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Waseda University; National Institute of Advanced Industrial Science & Technology (AIST); Okayama University; Hokkaido University; University of Yamanashi; Naturalis Biodiversity Center; Hoshi University; University of the Ryukyus	Yamashita, A (corresponding author), Univ Yamanashi, Dept Microbiol, Div Med, Grad Sch Med & Engn, Yamanashi, Japan.	atsuyay@yamanashi.ac.jp; jtanaka@sci.u-ryukyu.ac.jp; kmoriishi@yamanashi.ac.jp	Moriishi, Kohji/I-4173-2019; Tani, Hidenori/A-7175-2017; Sekiguchi, Yuji/M-3362-2018; Tani, Hidenori/F-2042-2010; Maekawa, Shinya/AAF-1349-2019; de Voogd, Nicole/I-9280-2012; NODA, Naohiro/M-2383-2018	Moriishi, Kohji/0000-0002-9542-5188; Tani, Hidenori/0000-0001-6390-4136; Sekiguchi, Yuji/0000-0002-1264-0617; Tani, Hidenori/0000-0001-6390-4136; de Voogd, Nicole/0000-0002-7985-5604; NODA, Naohiro/0000-0001-7592-5495; Tanaka, Junichi/0000-0002-8672-7379	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22603007, 24659204, 24390185] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare (http://www.mhlw.go.jp/) and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Aratake S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030410; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Baldo V, 2008, CURR PHARM DESIGN, V14, P1646, DOI 10.2174/138161208784746770; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Belon CA, 2010, BIOCHEMISTRY-US, V49, P1822, DOI 10.1021/bi901974a; Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Chen ST, 2012, J HEPATOL, V57, P470, DOI 10.1016/j.jhep.2012.02.004; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Cummings MD, 2010, ANGEW CHEM INT EDIT, V49, P1652, DOI 10.1002/anie.200906696; Donia M, 2003, LANCET INFECT DIS, V3, P338, DOI 10.1016/S1473-3099(03)00655-8; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jazwinski Alison B, 2011, Gastroenterol Hepatol (N Y), V7, P154; Jin H, 2008, HEPATOL RES, V38, P909, DOI 10.1111/j.1872-034X.2008.00352.x; KANAI A, 1995, FEBS LETT, V376, P221, DOI 10.1016/0014-5793(95)01283-X; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lange CM, 2010, ALIMENT PHARM THER, V32, P14, DOI 10.1111/j.1365-2036.2010.04317.x; Leu GZ, 2004, BIOCHEM BIOPH RES CO, V318, P275, DOI 10.1016/j.bbrc.2004.04.019; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Maga G, 2005, BIOCHEMISTRY-US, V44, P9637, DOI 10.1021/bi047437u; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Mayer AMS, 2010, TRENDS PHARMACOL SCI, V31, P255, DOI 10.1016/j.tips.2010.02.005; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Moriishi K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00054; Moriishi K, 2010, HEPATOLOGY, V52, P411, DOI 10.1002/hep.23680; Nishikawa F, 2004, OLIGONUCLEOTIDES, V14, P114, DOI 10.1089/1545457041526335; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Salam KA, 2012, J NAT PROD, V75, P650, DOI 10.1021/np200883s; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schiering N, 2011, P NATL ACAD SCI USA, V108, P21052, DOI 10.1073/pnas.1110534108; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Tani H, 2009, BIOCHEM BIOPH RES CO, V379, P1054, DOI 10.1016/j.bbrc.2009.01.020; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yamashita A, 2012, MAR DRUGS, V10, P744, DOI 10.3390/md10040744; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]	60	3	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48685	10.1371/journal.pone.0048685	http://dx.doi.org/10.1371/journal.pone.0048685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144928	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800098
J	Jin, L; Xu, L; Song, XC; Wei, QY; Sturgis, EM; Li, GJ				Jin, Lei; Xu, Li; Song, Xicheng; Wei, Qingyi; Sturgis, Erich M.; Li, Guojun			Genetic Variation in MDM2 and p14(ARF) and Susceptibility to Salivary Gland Carcinoma	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; P53 PATHWAY; CANCER; RISK; ASSOCIATION; PROMOTER; NECK; HEAD; SMOKING	Background: The p14(ARF)/MDM2/p53 pathway plays an important role in modulation of DNA damage and oxidative stress responses. The aim of this study was to determine whether genetic variants in MDM2 and p14(ARF) are associated with risk of salivary gland carcinoma (SGC). Methods: Four single nucleotide polymorphisms (SNPs) in MDM2 and p14(ARF) (MDM2-rs2279744, MDM2-rs937283, p14(ARF)-rs3731217, and p14(ARF)-rs3088440) were genotyped in 156 patients with SGC and 511 cancer-free controls. Multivariate logistic regression analysis was performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Results: MDM2-rs2279744 was significantly associated with a moderately increased risk of SGC (OR, 1.5, 95% CI, 1.1-2.2). There was a trend toward significantly increased SGC risk with increasing number of risk genotypes of the four polymorphisms (P-trend = 0.004). Individuals carrying 3-4 risk genotypes in MDM2 and p14(ARF) were at increased SGC risk (OR, 2.0, 95% CI, 1.1-2.7) compared with individuals carrying 0-2 risk genotypes. Moreover, the combined effect of risk genotypes of MDM2 and p14(ARF) was more pronounced among young subjects (<= 45 years), female subjects, subjects with race/ethnicity other than non-Hispanic white, ever-smokers, and ever-drinkers. Conclusion: Our results support the involvement of SNPs of MDM2 and p14(ARF), either alone or more likely in combination, in susceptibility to SGC. Larger studies are needed to validate our findings.	[Jin, Lei; Xu, Li; Song, Xicheng; Sturgis, Erich M.; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Jin, Lei] So Med Univ, Sch Med, Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Yantai, Peoples R China; [Wei, Qingyi; Sturgis, Erich M.; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Southern Medical University - China; Qingdao University; University of Texas System; UTMD Anderson Cancer Center	Li, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	gli@mdanderson.org	Xu, Li/B-9535-2012		University of Texas MD Anderson Cancer Center start-up funds; National Institutes of Health grant [U01 DE019765-01]; National Institute of Environmental Health Sciences [R01 ES-11740]; Cancer Center Support Grant [CA016672]; Halliburton Employees Fellow in Cancer Prevention funds; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE019765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center start-up funds; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Center Support Grant; Halliburton Employees Fellow in Cancer Prevention funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by The University of Texas MD Anderson Cancer Center start-up funds (to EMS); National Institutes of Health grant U01 DE019765-01 (to Dr. Adel K. El-Naggar; EMS is project 2 leader); National Institute of Environmental Health Sciences grant R01 ES-11740 (to QW); Cancer Center Support Grant CA016672 to The University of Texas MD Anderson Cancer Center (to Dr. John Mendelsohn); and a cancer prevention fellowship (to LX) supported by Halliburton Employees Fellow in Cancer Prevention funds (Shine Chang, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104; Eischen CM, 2004, ONCOGENE, V23, P8931, DOI 10.1038/sj.onc.1208052; FIELD JK, 1992, LANCET, V339, P502, DOI 10.1016/0140-6736(92)91122-O; Forrest J, 2008, NUTR CANCER, V60, P469, DOI 10.1080/01635580802143851; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Kibel AS, 2008, PROSTATE, V68, P1179, DOI 10.1002/pros.20784; Li GJ, 2006, CARCINOGENESIS, V27, P2028, DOI 10.1093/carcin/bgl047; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Saku T, 1997, CANCER-AM CANCER SOC, V79, P1465, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.3.CO;2-7; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang ML, 2008, CLIN CANCER RES, V14, P3633, DOI 10.1158/1078-0432.CCR-07-5155; Wo XM, 2011, J GENET GENOMICS, V38, P341, DOI 10.1016/j.jgg.2011.07.005; Xu L, 2012, ORAL ONCOL, V48, P842, DOI 10.1016/j.oraloncology.2012.03.012; Zhang Y, 2011, CANCER-AM CANCER SOC, V117, P1227, DOI 10.1002/cncr.25605	21	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49361	10.1371/journal.pone.0049361	http://dx.doi.org/10.1371/journal.pone.0049361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145162	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800253
J	Klumpp, S; Dong, JJ; Hwa, T				Klumpp, Stefan; Dong, Jiajia; Hwa, Terence			On Ribosome Load, Codon Bias and Protein Abundance	PLOS ONE			English	Article							COLI TRANSFER-RNAS; ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSLATION EFFICIENCY; RESPECTIVE CODONS; ADAPTATION INDEX; USAGE BIAS; SELECTION; SEQUENCE; GROWTH	Different codons encoding the same amino acid are not used equally in protein-coding sequences. In bacteria, there is a bias towards codons with high translation rates. This bias is most pronounced in highly expressed proteins, but a recent study of synthetic GFP-coding sequences did not find a correlation between codon usage and GFP expression, suggesting that such correlation in natural sequences is not a simple property of translational mechanisms. Here, we investigate the effect of evolutionary forces on codon usage. The relation between codon bias and protein abundance is quantitatively analyzed based on the hypothesis that codon bias evolved to ensure the efficient usage of ribosomes, a precious commodity for fast growing cells. An explicit fitness landscape is formulated based on bacterial growth laws to relate protein abundance and ribosomal load. The model leads to a quantitative relation between codon bias and protein abundance, which accounts for a substantial part of the observed bias for E. coli. Moreover, by providing an evolutionary link, the ribosome load model resolves the apparent conflict between the observed relation of protein abundance and codon bias in natural sequences and the lack of such dependence in a synthetic gfp library. Finally, we show that the relation between codon usage and protein abundance can be used to predict protein abundance from genomic sequence data alone without adjustable parameters.	[Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany; [Dong, Jiajia] Bucknell Univ, Dept Phys & Astron, Lewisburg, PA 17837 USA; [Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Max Planck Society; Bucknell University; University of California System; University of California San Diego	Klumpp, S (corresponding author), Max Planck Inst Colloids & Interfaces, Potsdam, Germany.	klumpp@mpikg.mpg.de	Hwa, Terence/J-4012-2013; Dong, JiaJia/E-3154-2012; Klumpp, Stefan/AAC-3936-2019; Hwa, Terry/GOJ-9904-2022; Klumpp, Stefan/C-2966-2008	Hwa, Terence/0000-0003-1837-6842; Dong, JiaJia/0000-0001-9908-2699; Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146	NSF through the Center for Theoretical Biological Physics [PHY-0822283]; NIH [R01GM95903]; Deutsche Forschungsgemeinschaft [KL818/1-1, KL818/1-2]; NSF through IGERT [DGE-0504196]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095903] Funding Source: NIH RePORTER	NSF through the Center for Theoretical Biological Physics(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF through IGERT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NSF through the Center for Theoretical Biological Physics (grant PHY-0822283) and by the NIH through grant R01GM95903 (to TH) with additional support during the initial phase of the project from Deutsche Forschungsgemeinschaft (fellowship KL818/1-1 and KL818/1-2, to SK) and from the NSF through IGERT (grant DGE-0504196, to JJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, NUCLEIC ACIDS RES, V37, pD163, DOI 10.1093/nar/gkn692; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Ardell DH, 2005, PLOS COMPUT BIOL, V1, P86, DOI 10.1371/journal.pcbi.0010012; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bremer H, 1996, ESCHERICHIA COLI SAL; BULMER M, 1988, J THEOR BIOL, V133, P67, DOI 10.1016/S0022-5193(88)80024-9; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BULMER M, 1991, GENETICS, V129, P897; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chu D, 2011, NUCLEIC ACIDS RES, V39, P6705, DOI 10.1093/nar/gkr300; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Gerland U, 2002, J MOL EVOL, V55, P386, DOI 10.1007/s00239-002-2335-z; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Karlin S, 2001, J BACTERIOL, V183, P5025, DOI 10.1128/JB.183.17.5025-5040.2001; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; Lopez-Campistrous A, 2005, MOL CELL PROTEOMICS, V4, P1205, DOI 10.1074/mcp.D500006-MCP200; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Maaloe O., 1979, BIOL REGUL DEV, P487; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; NATH K, 1970, J BIOL CHEM, V245, P2889; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; POST LE, 1979, P NATL ACAD SCI USA, V76, P1697, DOI 10.1073/pnas.76.4.1697; REEH S, 1979, MOL GEN GENET, V173, P183, DOI 10.1007/BF00330309; Savageau MA, 1998, GENETICS, V149, P1677; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; VANBOGELEN RA, 1992, ELECTROPHORESIS, V13, P1014, DOI 10.1002/elps.11501301203; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; Woodcock G, 1996, J THEOR BIOL, V179, P61, DOI 10.1006/jtbi.1996.0049; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	63	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48542	10.1371/journal.pone.0048542	http://dx.doi.org/10.1371/journal.pone.0048542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144899	Green Published, gold			2022-12-25	WOS:000311935800074
J	Leiria, LO; Sollon, C; Calixto, MC; Lintomen, L; Monica, FZ; Anhe, GF; De Nucci, G; Zanesco, A; Grant, AD; Antunes, E				Leiria, Luiz O.; Sollon, Carolina; Calixto, Marina C.; Lintomen, Leticia; Monica, Fabiola Z.; Anhe, Gabriel F.; De Nucci, Gilberto; Zanesco, Angelina; Grant, Andrew D.; Antunes, Edson			Role of PKC and CaV1.2 in Detrusor Overactivity in a Model of Obesity Associated with Insulin Resistance in Mice	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; PROTEIN-KINASE-C; NITRIC-OXIDE SYNTHASE; METABOLIC SYNDROME; MUSCARINIC RECEPTORS; CA2+ RELEASE; BLADDER; CONTRACTION; MUSCLE; DYSFUNCTION	Obesity/metabolic syndrome are common risk factors for overactive bladder. This study aimed to investigate the functional and molecular changes of detrusor smooth muscle (DSM) in high-fat insulin resistant obese mice, focusing on the role of protein kinase C (PKC) and Ca(v)1.2 in causing bladder dysfunction. Male C57BL/6 mice were fed with high-fat diet for 10 weeks. In vitro functional responses and cystometry, as well as PKC and Ca(v)1.2 expression in bladder were evaluated. Obese mice exhibited higher body weight, epididymal fat mass, fasting glucose and insulin resistance. Carbachol (0.001-100 mu M), alpha,beta-methylene ATP (1-10 mu M), KCl (1-300 mM), extracellular Ca2+ (0.01-100 mM) and phorbol-12,13-dibutyrate (PDBu; 0.001-3 mu M) all produced greater DSM contractions in obese mice, which were fully reversed by the Ca(v)1.2 blocker amlodipine. Cystometry evidenced augmented frequency, non-void contractions and post-void pressure in obese mice that were also prevented by amlodipine. Metformin treatment improved the insulin sensitivity, and normalized the in vitro bladder hypercontractility and cystometric dysfunction in obese mice. The PKC inhibitor GF109203X (1 mu M) also reduced the carbachol induced contractions. PKC protein expression was markedly higher in bladder tissues from obese mice, which was normalized by metformin treatment. The Ca(v)1.2 channel protein expression was not modified in any experimental group. Our findings show that Ca(v)1.2 blockade and improvement of insulin sensitization restores the enhanced PKC protein expression in bladder tissues and normalizes the overactive detrusor. It is likely that insulin resistance importantly contributes for the pathophysiology of this urological disorder in obese mice.	[Leiria, Luiz O.; Sollon, Carolina; Calixto, Marina C.; Lintomen, Leticia; Monica, Fabiola Z.; Anhe, Gabriel F.; De Nucci, Gilberto; Antunes, Edson] Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Sao Paulo, Brazil; [Zanesco, Angelina] Univ Sao Paulo State UNESP, Dept Phys Educ, Inst Biosci, Sao Paulo, Brazil; [Grant, Andrew D.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	Universidade Estadual de Campinas; Universidade Estadual Paulista; University of London; King's College London	Antunes, E (corresponding author), Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Sao Paulo, Brazil.	edson.antunes@uol.com.br	Zanesco, Angelina/V-6154-2019; Zanesco, Angelina/N-3632-2013; Monica, Fabiola Zakia/B-4191-2013; De Nucci, Gilberto/ABB-7380-2021; Anhe, Gabriel F/C-1980-2012; ANTUNES, EDSON/F-6731-2012; Grant, Andrew/A-8819-2008; De Nucci, Gilberto/J-5990-2012; Mónica, Fabiola/L-2198-2014; Zanesco, Angelina/AAF-6370-2019; Lintomen, Leticia/C-4643-2015	Zanesco, Angelina/0000-0002-2515-1871; Monica, Fabiola Zakia/0000-0002-8449-6677; De Nucci, Gilberto/0000-0002-4346-7941; ANTUNES, EDSON/0000-0003-2201-8247; Grant, Andrew/0000-0002-7032-3716; De Nucci, Gilberto/0000-0002-4346-7941; Mónica, Fabiola/0000-0003-2312-1019; Lintomen, Leticia/0000-0002-2110-367X; Anhe, Gabriel/0000-0002-7694-8397	State of Sao Paulo Research Foundation [FAPESP 2010/01452-4]; BBSRC [BB/E527098/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E527098/1] Funding Source: researchfish	State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the State of Sao Paulo Research Foundation, Grant Number: FAPESP 2010/01452-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2006, BRIT J PHARMACOL, V148, P565, DOI 10.1038/sj.bjp.0706780; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Anhe GF, 2007, AM J PHYSIOL-REG I, V292, pR2225, DOI 10.1152/ajpregu.00902.2006; Barton M, 2012, BRIT J PHARMACOL, V165, P591, DOI 10.1111/j.1476-5381.2011.01472.x; Calixto MC, 2010, BRIT J PHARMACOL, V159, P617, DOI 10.1111/j.1476-5381.2009.00560.x; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Daneshgari F, 2009, J UROLOGY, V182, pS18, DOI 10.1016/j.juro.2009.08.070; de Oliveira CF, 1999, EUR J PHARMACOL, V373, P195, DOI 10.1016/S0014-2999(99)00267-8; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Gasbarro G, 2010, AM J PHYSIOL-RENAL, V298, pF72, DOI 10.1152/ajprenal.00309.2009; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hanley AJG, 2003, DIABETES, V52, P2740, DOI 10.2337/diabetes.52.11.2740; Huster M, 2010, FASEB J, V24, P2651, DOI 10.1096/fj.09-149856; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kennedy C, 2007, J NEUROSCI, V27, P845, DOI 10.1523/JNEUROSCI.3115-06.2007; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Lagaud GJL, 1999, AM J PHYSIOL-HEART C, V276, pH300, DOI 10.1152/ajpheart.1999.276.1.H300; Laven BA, 2008, J UROLOGY, V179, P1891, DOI 10.1016/j.juro.2008.01.029; Lee M, 2007, AM J CARDIOL, V99, p68B, DOI 10.1016/j.amjcard.2006.11.007; Lee WC, 2008, J UROLOGY, V179, P2470, DOI 10.1016/j.juro.2008.01.086; Leiria LOS, 2011, BRIT J PHARMACOL, V163, P1276, DOI 10.1111/j.1476-5381.2011.01311.x; Lenasi H, 2003, CARDIOVASC RES, V59, P844, DOI 10.1016/S0008-6363(03)00505-4; Lu X, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-48; Masters JG, 1999, BRIT J PHARMACOL, V127, P996, DOI 10.1038/sj.bjp.0702640; Michel MC, 2008, PHARMACOL THERAPEUT, V117, P297, DOI 10.1016/j.pharmthera.2007.12.001; Moul S, 2010, CURR OPIN UROL, V20, P7, DOI 10.1097/MOU.0b013e3283336f3f; Naruse K, 2006, DIABETES, V55, P691, DOI 10.2337/diabetes.55.03.06.db05-0771; Nobe K, 2009, J PHARMACOL EXP THER, V328, P940, DOI 10.1124/jpet.108.144907; Opie LH, 2007, CIRCULATION, V115, pE32, DOI 10.1161/CIRCULATIONAHA.106.671057; Parsons JK, 2009, J UROLOGY, V182, pS27, DOI 10.1016/j.juro.2009.07.086; Pinna C, 2006, LIFE SCI, V79, P1301, DOI 10.1016/j.lfs.2006.03.035; Rahman NU, 2007, BJU INT, V100, P658, DOI 10.1111/j.1464-410X.2007.07069.x; Richter HE, 2005, AM J OBSTET GYNECOL, V193, P2088, DOI 10.1016/j.ajog.2005.07.068; Richter HE, 2010, J UROLOGY, V183, P622, DOI 10.1016/j.juro.2009.09.083; Rohrmann S, 2005, INT J OBESITY, V29, P310, DOI 10.1038/sj.ijo.0802881; Sena CM, 2011, BRIT J PHARMACOL, V163, P424, DOI 10.1111/j.1476-5381.2011.01230.x; Shore SA, 2008, J APPL PHYSIOL, V105, P1127, DOI 10.1152/japplphysiol.00117.2008; Stretton C, 2010, AM J PHYSIOL-ENDOC M, V299, pE402, DOI 10.1152/ajpendo.00171.2010; Tong YC, 2007, J UROLOGY, V178, P1537, DOI 10.1016/j.juro.2007.05.114; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; UCHIDA W, 1994, N-S ARCH PHARMACOL, V350, P398; Vikram A, 2010, BRIT J PHARMACOL, V161, P1708, DOI 10.1111/j.1476-5381.2010.00994.x; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Wuest M, 2007, EUR J PHARMACOL, V565, P180, DOI 10.1016/j.ejphar.2007.02.046; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	51	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48507	10.1371/journal.pone.0048507	http://dx.doi.org/10.1371/journal.pone.0048507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144896	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800071
J	Price, H; Bansi, L; Sabin, CA; Bhagani, S; Burroughs, A; Chadwick, D; Dunn, D; Fisher, M; Main, J; Nelson, M; Pillay, D; Rodger, A; Taylor, C; Gilson, R				Price, Huw; Bansi, Loveleen; Sabin, Caroline A.; Bhagani, Sanjay; Burroughs, Andrew; Chadwick, David; Dunn, David; Fisher, Martin; Main, Janice; Nelson, Mark; Pillay, Deenan; Rodger, Alison; Taylor, Chris; Gilson, Richard		UK Collaborative HIV Cohort Hepati; Steering Comm	Hepatitis B Virus Infection in HIV-Positive Individuals in the UK Collaborative HIV Cohort (UK CHIC) Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; HOMOSEXUAL-MEN; MORTALITY; PROGRESSION; ANTIGEN; AIDS	Background: Hepatitis B virus (HBV) infection is an increasingly important cause of morbidity and mortality in HIV-infected adults. This study aimed to determine the prevalence and incidence of HBV in the UK CHIC Study, a multicentre observational cohort. Methods and Findings: 12 HIV treatment centres were included. Of 37,331 patients, 27,450 had at least one test (HBsAg, anti-HBs or anti-HBc) result post-1996 available. 16,043 were white, 8,130 black and 3,277 other ethnicity. Route of exposure was homosexual sex 15,223 males, heterosexual sex 3,258 males and 5,384 females, injecting drug use 862 and other 2,723. The main outcome measures used were the cumulative prevalence and the incidence of HBV coinfection. HBV susceptible patients were followed up until HBsAg and/or anti-HBc seroconversion incident infection, evidence of vaccination or last visit. Poisson regression was used to determine associated factors. 25,973 had at least one HBsAg test result. Participants with HBsAg results were typically MSM (57%) and white (59%) (similar to the cohort as a whole). The cumulative prevalence of detectable HBsAg was 6.9% (6.6 to 7.2%). Among the 3,379 initially HBV-susceptible patients, the incidence of HBV infection was 1.7 (1.5 to 1.9)/100 person-years. Factors associated with incident infection were older age and IDU. The main limitation of the study was that 30% of participants did not have any HBsAg results available. However baseline characteristics of those with results did not differ from those of the whole cohort. Efforts are on-going to improve data collection. Conclusions: The prevalence of HBV in UK CHIC is in line with estimates from other studies and low by international standards. Incident infection continued to occur even after entry to the cohort, emphasising the need to ensure early vaccination.	[Price, Huw; Gilson, Richard] UCL, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England; [Bansi, Loveleen; Sabin, Caroline A.] UCL, Res Dept Infect & Populat Hlth, HIV Epidemiol & Biostat Grp, London, England; [Bhagani, Sanjay] Royal Free Hosp, Dept Infect Dis & HIV Med, London NW3 2QG, England; [Chadwick, David] James Cook Univ Hosp, Dept Infect & Travel Med, Middlesbrough, Cleveland, England; [Dunn, David] MRC, Clin Trials Unit, London, England; [Fisher, Martin] Royal Sussex Cty Hosp, Dept Sexual Hlth & HIV, Brighton BN2 5BE, E Sussex, England; [Main, Janice] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Nelson, Mark] Chelsea & Westminster Hosp, HIV & Sexual Hlth Serv, London, England; [Pillay, Deenan] UCL, Res Dept Infect, London, England; [Taylor, Chris] Kings Coll Hosp, Caldecot Ctr, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; James Cook University Hospital; Medical Research Council Clinical Trials Unit; University of Brighton; Imperial College London; Imperial College London; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Price, H (corresponding author), UCL, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England.	huw.price@ucl.ac.uk	Burroughs, Andrew K/C-5645-2009; Sabin, Caroline/C-2464-2008	Burroughs, Andrew K/0000-0001-6527-457X; Sabin, Caroline/0000-0001-5173-2760; Dunn, David/0000-0003-1836-4446; Bhagani, Sanjay/0000-0003-2557-4337; Anderson, Jane/0000-0001-5294-8707; Leen, Clifford/0000-0001-8439-7719; delpech, valerie/0000-0002-9952-8109	Medical Research Council (MRC); MRC fellowship; MRC [G0900274] Funding Source: UKRI; Medical Research Council [G0900274] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK CHIC Study has received project grant support from the Medical Research Council (MRC). Huw Price is funded by an MRC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, THE WORLD HEALTH REP; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138; Brook G, 2010, HIV MED, V11, P1, DOI 10.1111/j.1468-1293.2009.00781.x; Gilson RJC, 1997, AIDS, V11, P597, DOI 10.1097/00002030-199705000-00007; HADLER SC, 1991, J INFECT DIS, V163, P454, DOI 10.1093/infdis/163.3.454; Hakeem L, 2010, J CLIN MED RES, V2, P34; Health Protection Agency, 2010, HLTH PROTECTION REPO, V4, P6; Health Protection Agency, 2012, UNITED KINGDOM NEW H; Health Protection Agency, 2009, HLTH PROTECTION REPO, V3, P16; Hoffmann CJ, 2009, AIDS, V23, P1881, DOI 10.1097/QAD.0b013e32832e463a; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Psevdos G, 2010, WORLD J GASTROENTERO, V16, P1093, DOI 10.3748/wjg.v16.i9.1093; SHULMAN NR, 1969, SCIENCE, V165, P304, DOI 10.1126/science.165.3890.304; Steedman NM, 2008, INT J STD AIDS, V19, P83, DOI 10.1258/ijsa.2007.007144; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; UNAIDS, 2010, GLOBAL REPORT UNAIDS; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	20	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49314	10.1371/journal.pone.0049314	http://dx.doi.org/10.1371/journal.pone.0049314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145150	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000311935800243
J	Schiliro, E; Ferrara, M; Nigro, F; Mercado-Blanco, J				Schiliro, Elisabetta; Ferrara, Massimo; Nigro, Franco; Mercado-Blanco, Jesus			Genetic Responses Induced in Olive Roots upon Colonization by the Biocontrol Endophytic Bacterium Pseudomonas fluorescens PICF7	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; FUNCTIONAL GENOMICS; DEFENSE; INDUCTION; PLANTS; STIMULATION; SUPPRESSION; PROTEINS; TISSUES; TOMATO	Knowledge on the genetic basis underlying interactions between beneficial bacteria and woody plants is still very limited, and totally absent in the case of olive. We aimed to elucidate genetic responses taking place during the colonization of olive roots by the native endophyte Pseudomonas fluorescens PICF7, an effective biocontrol agent against Verticillium wilt of olive. Roots of olive plants grown under non-gnotobiotic conditions were collected at different time points after PICF7 inoculation. A Suppression Subtractive Hybridization cDNA library enriched in induced genes was generated. Quantitative real time PCR (qRT-PCR) analysis validated the induction of selected olive genes. Computational analysis of 445 olive ESTs showed that plant defence and response to different stresses represented nearly 45% of genes induced in PICF7-colonized olive roots. Moreover, quantitative real-time PCR (qRT-PCR) analysis confirmed induction of lipoxygenase, phenylpropanoid, terpenoids and plant hormones biosynthesis transcripts. Different classes of transcription factors (i.e., bHLH, WRKYs, GRAS1) were also induced. This work highlights for the first time the ability of an endophytic Pseudomonas spp. strain to mount a wide array of defence responses in an economically-relevant woody crop such as olive, helping to explain its biocontrol activity.	[Schiliro, Elisabetta; Mercado-Blanco, Jesus] CSIC, Inst Agr Sostenible, Dept Protecc Cult, Cordoba, Spain; [Ferrara, Massimo; Nigro, Franco] Univ Bari Aldo Moro, Dipartimento Biol & Chim Agroforestale & Ambienta, Bari, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universita degli Studi di Bari Aldo Moro	Mercado-Blanco, J (corresponding author), CSIC, Inst Agr Sostenible, Dept Protecc Cult, Cordoba, Spain.	jesus.mercado@ias.csic.es	Ferrara, Massimo/B-8394-2015; Mercado-Blanco, Jesús/F-3385-2011; Nigro, Franco/AAG-5755-2020; Trilety, Roman/I-8225-2014; Nigro, Franco/J-1499-2012	Ferrara, Massimo/0000-0002-4751-8478; Mercado-Blanco, Jesús/0000-0003-1895-5895; Trilety, Roman/0000-0002-3778-0368; Nigro, Franco/0000-0002-8273-0052	Junta de Andalucia (Spain) [P07-CVI-02624]; Spanish MICINN [AGL2009-07275]; ERDF of the EU	Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ERDF of the EU	Financial support for this research was provided by grants P07-CVI-02624 from Junta de Andalucia (Spain) and AGL2009-07275 from Spanish MICINN, both co-financed by ERDF of the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda S, 2011, PLANT SOIL, V343, P329, DOI 10.1007/s11104-011-0721-2; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Bakker PAHM, 2003, CAN J PLANT PATHOL, V25, P5; Bakker PAHM, 2007, PHYTOPATHOLOGY, V97, P239, DOI 10.1094/PHYTO-97-2-0239; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barranco D., 2008, CULTIVO OLIVO; Benhamou N, 1996, PLANT PHYSIOL, V112, P919, DOI 10.1104/pp.112.3.919; Benhamou N, 1996, PHYTOPATHOLOGY, V86, P1174, DOI 10.1094/Phyto-86-1174; Berg G, 2006, FEMS MICROBIOL ECOL, V56, P250, DOI 10.1111/j.1574-6941.2005.00025.x; Choudhary Devendra K., 2007, Indian Journal of Microbiology, V47, P289, DOI 10.1007/s12088-007-0054-2; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Lopez-Escudero FJ, 2011, PLANT SOIL, V344, P1, DOI 10.1007/s11104-010-0629-2; Kim JH, 2008, INT J FOOD MICROBIOL, V122, P49, DOI 10.1016/j.ijfoodmicro.2007.11.058; Kloepper JW, 2006, MICROBIAL ROOT ENDOP, P33, DOI DOI 10.1007/3-540-33526-9_3; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Escudero FJ, 2004, EUR J PLANT PATHOL, V110, P79, DOI 10.1023/B:EJPP.0000010150.08098.2d; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mariutto M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-29; Mark GL, 2006, FEMS MICROBIOL ECOL, V56, P167, DOI 10.1111/j.1574-6941.2006.00056.x; Mercado-Blanco J, 2004, BIOL CONTROL, V30, P474, DOI 10.1016/j.biocontrol.2004.02.002; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Mercado-Blanco J, 2012, PLANT SOIL, V355, P17, DOI 10.1007/s11104-011-1091-5; Ongena M, 2004, MOL PLANT MICROBE IN, V17, P1009, DOI 10.1094/MPMI.2004.17.9.1009; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Prieto P, 2008, FEMS MICROBIOL ECOL, V64, P297, DOI 10.1111/j.1574-6941.2008.00450.x; Prieto P, 2011, MICROB ECOL, V62, P435, DOI 10.1007/s00248-011-9827-6; Prieto P, 2009, MICROB BIOTECHNOL, V2, P499, DOI 10.1111/j.1751-7915.2009.00105.x; Ramamoorthy V, 2002, PLANT SOIL, V239, P55, DOI 10.1023/A:1014904815352; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sun XL, 2012, BIOCHEM J, V442, P1, DOI 10.1042/BJ20111766; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Van Verk MC, 2009, ADV BOT RES, V51, P397, DOI 10.1016/S0065-2296(09)51010-5; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	46	48	48	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48646	10.1371/journal.pone.0048646	http://dx.doi.org/10.1371/journal.pone.0048646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144916	Green Published, gold			2022-12-25	WOS:000311935800086
J	Testa, JS; Shetty, V; Hafner, J; Nickens, Z; Kamal, S; Sinnathamby, G; Philip, R				Testa, James S.; Shetty, Vivekananda; Hafner, Julie; Nickens, Zacharie; Kamal, Shivali; Sinnathamby, Gomathinayagam; Philip, Ramila			MHC Class I-Presented T Cell Epitopes Identified by Immunoproteomics Analysis Are Targets for a Cross Reactive Influenza-Specific T Cell Response	PLOS ONE			English	Article							A-VIRUS; MASS-SPECTROMETRY; PROTECTIVE IMMUNITY; PEPTIDE VACCINE; TRANSGENIC MICE; INFECTION; LYMPHOCYTES; ANTIBODIES; ASSAY; HEMAGGLUTININ	Influenza virus infection and the resulting complications are a significant global public health problem. Improving humoral immunity to influenza is the target of current conventional influenza vaccines, however, these are generally not cross-protective. On the contrary, cell-mediated immunity generated by primary influenza infection provides substantial protection against serologically distinct viruses due to recognition of cross-reactive T cell epitopes, often from internal viral proteins conserved between viral subtypes. Efforts are underway to develop a universal flu vaccine that would stimulate both the humoral and cellular immune responses leading to long-lived memory. Such a universal vaccine should target conserved influenza virus antibody and T cell epitopes that do not vary from strain to strain. In the last decade, immunoproteomics, or the direct identification of HLA class I presented epitopes, has emerged as an alternative to the motif prediction method for the identification of T cell epitopes. In this study, we used this method to uncover several cross-specific MHC class I specific T cell epitopes naturally presented by influenza A-infected cells. These conserved T cell epitopes, when combined with a cross-reactive antibody epitope from the ectodomain of influenza M2, generate cross-strain specific cell mediated and humoral immunity. Overall, we have demonstrated that conserved epitope-specific CTLs could recognize multiple influenza strain infected target cells and, when combined with a universal antibody epitope, could generate virus specific humoral and T cell responses, a step toward a universal vaccine concept. These epitopes also have potential as new tools to characterize T cell immunity in influenza infection, and may serve as part of a universal vaccine candidate complementary to current vaccines.	[Testa, James S.; Shetty, Vivekananda; Hafner, Julie; Nickens, Zacharie; Kamal, Shivali; Sinnathamby, Gomathinayagam; Philip, Ramila] Immunotope Inc, Doylestown, PA USA		Philip, R (corresponding author), Immunotope Inc, Doylestown, PA USA.	rphilip@immunotope.com			National Institutes of Health SBIR [1 R43 AI091232-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI091232] Funding Source: NIH RePORTER	National Institutes of Health SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health SBIR grant 1 R43 AI091232-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WHO INFLUENZA SEASON; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BURLINGTON DB, 1983, INFECT IMMUN, V41, P540, DOI 10.1128/IAI.41.2.540-545.1983; Chen JZ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-30; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Epstein SL, 1998, J IMMUNOL, V160, P322; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Greenbaum J, 2009, KNOWLEDGEBASE AND FO; Hickman HD, 2003, J IMMUNOL, V171, P22, DOI 10.4049/jimmunol.171.1.22; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Kang SM, 2011, VIRUS RES, V162, P31, DOI 10.1016/j.virusres.2011.09.037; Lamb R.A., 1983, GENETICS INFLUENZA V, P21; Lemmel C, 2004, NAT BIOTECHNOL, V22, P450, DOI 10.1038/nbt947; Li CG, 2010, NAT PROTOC, V5, P14, DOI 10.1038/nprot.2009.200; MAN S, 1994, J IMMUNOL, V153, P4458; MAN S, 1995, INT IMMUNOL, V7, P597, DOI 10.1093/intimm/7.4.597; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Mittendorf EA, 2005, BREAST CANCER RES TR, V92, P85, DOI 10.1007/s10549-005-0988-1; Motomura Y, 2008, INT J ONCOL, V32, P985; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; MURPHY BR, 1982, INFECT IMMUN, V36, P1102, DOI 10.1128/IAI.36.3.1102-1108.1982; PARKER KC, 1994, J IMMUNOL, V152, P163; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Purcell AW, 2004, MOL CELL PROTEOMICS, V3, P193, DOI 10.1074/mcp.R300013-MCP200; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; RIMMELZWAAN GF, 1995, VACCINE, V13, P703; Schild GC, 1975, THE INFLUENZA VIRUSE, P315; Shetty V, 2011, J PROTEOMICS, V74, P728, DOI 10.1016/j.jprot.2011.02.020; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Tan PT, 2011, HUM VACCINES, V7, P402, DOI 10.4161/hv.7.4.13845; Testa JS, 2012, J INFECT DIS, V205, P647, DOI 10.1093/infdis/jir814; Thomas PG, 2007, J IMMUNOL, V178, P3091, DOI 10.4049/jimmunol.178.5.3091; van Els CACM, 2000, EUR J IMMUNOL, V30, P1172, DOI 10.1002/(SICI)1521-4141(200004)30:4<1172::AID-IMMU1172>3.0.CO;2-J; Veronese FD, 1996, J EXP MED, V183, P2509, DOI 10.1084/jem.183.6.2509; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Wiesmuller KH, 2001, BIOL CHEM, V382, P571, DOI 10.1515/BC.2001.070; YAP KL, 1979, CELL IMMUNOL, V43, P341, DOI 10.1016/0008-8749(79)90178-3; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	52	26	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48484	10.1371/journal.pone.0048484	http://dx.doi.org/10.1371/journal.pone.0048484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144892	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800068
J	Tolf, C; Bengtsson, D; Rodrigues, D; Latorre-Margalef, N; Wille, M; Figueiredo, ME; Jankowska-Hjortaas, M; Germundsson, A; Duby, PY; Lebarbenchon, C; Gauthier-Clerc, M; Olsen, B; Waldenstrom, J				Tolf, Conny; Bengtsson, Daniel; Rodrigues, David; Latorre-Margalef, Neus; Wille, Michelle; Figueiredo, Maria Ester; Jankowska-Hjortaas, Monika; Germundsson, Anna; Duby, Pierre-Yves; Lebarbenchon, Camille; Gauthier-Clerc, Michel; Olsen, Bjorn; Waldenstrom, Jonas			Birds and Viruses at a Crossroad - Surveillance of Influenza A Virus in Portuguese Waterfowl	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; WILD BIRDS; H5N1 OUTBREAKS; MIGRATORY WATERFOWL; NORTHERN EUROPE; HUMAN INFECTION; AQUATIC BIRDS; HONG-KONG; DUCKS; H9N2	During recent years, extensive amounts of data have become available regarding influenza A virus (IAV) in wild birds in northern Europe, while information from southern Europe is more limited. Here, we present an IAV surveillance study conducted in western Portugal 2008-2009, analyzing 1653 samples from six different species of waterfowl, with the majority of samples taken from Mallards (Anas platyrhynchos). Overall 4.4% of sampled birds were infected. The sampling results revealed a significant temporal variation in the IAV prevalence, including a pronounced peak among predominantly young birds in June, indicating that IAV circulate within breeding populations in the wetlands of western Portugal. The H10N7 and H9N2 subtypes were predominant among isolated viruses. Phylogenetic analyses of the hemagglutinin and neuraminidase sequences of H10N7, H9N2 and H11N3 virus showed that sequences from Portugal were closely related to viral sequences from Central Europe as well as to IAVs isolated in the southern parts of Africa, reflecting Portugal's position on the European-African bird migratory flyway. This study highlights the importance of Portugal as a migratory crossroad for IAV, connecting breeding stationary waterfowl with birds migrating between continents which enable transmission and spread of IAV.	[Tolf, Conny; Bengtsson, Daniel; Latorre-Margalef, Neus; Wille, Michelle; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Rodrigues, David; Figueiredo, Maria Ester; Duby, Pierre-Yves] Inst Politecn Coimbra, Escola Super Agr, Dept Recursos Florestais, Coimbra, Portugal; [Jankowska-Hjortaas, Monika; Germundsson, Anna] Norwegian Vet Inst, Dept Anim Hlth, Oslo, Norway; [Lebarbenchon, Camille] Univ La Reunion, St Denis, Reunion, France; [Gauthier-Clerc, Michel] Ctr Rech Tour Valat, Arles, France; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Linnaeus University; Instituto Politecnico de Coimbra (IPC); Norwegian Veterinary Institute; University of La Reunion; Uppsala University	Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden.	jonas.waldenstrom@lnu.se	Lebarbenchon, Camille/H-7245-2013; Waldenström, Jonas/E-4460-2013; Lebarbenchon, Camille/GLQ-7287-2022; Wille, Michelle/F-4819-2013	Lebarbenchon, Camille/0000-0002-0922-7573; Waldenström, Jonas/0000-0002-1152-4235; Lebarbenchon, Camille/0000-0002-0922-7573; Wille, Michelle/0000-0002-5629-0196; Rodrigues, David/0000-0002-3855-7686; Olsen, Bjorn/0000-0002-4646-691X	Instituto de Financiamento e Apoio ao Desenvolvimento da Agricultura e Pescas [2006.09.001199.7]; NEW - FLUBIRD project (EU) [FP6/SSP/8.1]; Swedish Research Council Formas [2009-1220]	Instituto de Financiamento e Apoio ao Desenvolvimento da Agricultura e Pescas; NEW - FLUBIRD project (EU); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Field work expenses were covered by Instituto de Financiamento e Apoio ao Desenvolvimento da Agricultura e Pescas projects 2006.09.001199.7 and AIV analysis by the NEW - FLUBIRD project (EU, FP6/SSP/8.1) and the Swedish Research Council Formas (grant 2009-1220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2010, AVIAN DIS, V54, P313, DOI 10.1637/8781-040109-Reg.1; Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2010, AVIAN DIS, V54, P194, DOI 10.1637/8833-040209-Reg.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Alexander DJ, 2003, AVIAN DIS, V47, P792, DOI 10.1637/0005-2086-47.s3.792; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; ARENAS A, 1990, AVIAN PATHOL, V19, P539, DOI 10.1080/03079459008418706; Bennett G., 2001, DEV APPL ECOLOGICAL; Bouscambert-Duchamp M, 2009, ARCH PEDIATRIE, V16, pS101, DOI 10.1016/S0929-693X(09)75311-4; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Busquets N, 2010, VIRUS RES, V149, P10, DOI 10.1016/j.virusres.2009.12.005; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cattoli G, 2007, J WILDLIFE DIS, V43, pS35; Cramp S., 1994, HDB BIRDS EUROPE MID; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; De Marco MA, 2003, VET RES COMMUN, V27, P107, DOI 10.1023/B:VERC.0000014126.72654.22; Drummond A. J., 2010, GENEIOUS V 5 3; Ekong PS, 2012, PREV VET MED, V103, P170, DOI 10.1016/j.prevetmed.2011.10.001; Enserink M, 2006, SCIENCE, V311, P932; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Germundsson A, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-28; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; Henriques AM, 2011, AVIAN PATHOL, V40, P597, DOI 10.1080/03079457.2011.618943; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kim HR, 2012, EMERG INFECT DIS, V18, P480, DOI [10.3201/eid1803.111490, 10.3201/1803.111490]; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Le Gall-Recule G, 2008, AVIAN PATHOL, V37, P15, DOI 10.1080/03079450701774835; Lebarbenchon C, 2007, INFECT GENET EVOL, V7, P604, DOI 10.1016/j.meegid.2007.05.009; Lebarbenchon Camille, 2008, J Mol Genet Med, V3, P121; Lebarbenchon C, 2010, AVIAN DIS, V54, P446, DOI 10.1637/8665-022509-ResNote.1; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2010, J VIROL METHODS, V170, P94, DOI 10.1016/j.jviromet.2010.09.006; OTSUKI K, 1987, JPN J VET SCI, V49, P721; Pappaioanou M, 2009, COMP IMMUNOL MICROB, V32, P287, DOI 10.1016/j.cimid.2008.01.003; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rodrigues D., 1997, ITE Symposium, V30, P127; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simulundu E, 2011, J GEN VIROL, V92, P1416, DOI 10.1099/vir.0.030403-0; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2002, WHOCDSCSRNCS20025199, P1	58	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49002	10.1371/journal.pone.0049002	http://dx.doi.org/10.1371/journal.pone.0049002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145046	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800183
J	Williams, DM; Quinn, AD; Porter, WF				Williams, David M.; Quinn, Amy Dechen; Porter, William F.			Impact of Habitat-Specific GPS Positional Error on Detection of Movement Scales by First-Passage Time Analysis	PLOS ONE			English	Article							WILDLIFE RESOURCE USE; WHITE-TAILED DEER; COLLAR PERFORMANCE; TELEMETRY COLLARS; SYSTEM COLLARS; LOCATION ERROR; BIAS; ACCURACY; ANIMALS; FOREST	Advances in animal tracking technologies have reduced but not eliminated positional error. While aware of such inherent error, scientists often proceed with analyses that assume exact locations. The results of such analyses then represent one realization in a distribution of possible outcomes. Evaluating results within the context of that distribution can strengthen or weaken our confidence in conclusions drawn from the analysis in question. We evaluated the habitat-specific positional error of stationary GPS collars placed under a range of vegetation conditions that produced a gradient of canopy cover. We explored how variation of positional error in different vegetation cover types affects a researcher's ability to discern scales of movement in analyses of first-passage time for white-tailed deer (Odocoileus virginianus). We placed 11 GPS collars in 4 different vegetative canopy cover types classified as the proportion of cover above the collar (0-25%, 26-50%, 51-75%, and 76-100%). We simulated the effect of positional error on individual movement paths using cover-specific error distributions at each location. The different cover classes did not introduce any directional bias in positional observations (1 m <= mean <= 6.51 m, 0.24 <= p <= 0.47), but the standard deviation of positional error of fixes increased significantly with increasing canopy cover class for the 0-25%, 26-50%, 51-75% classes (SD = 2.18 m, 3.07 m, and 4.61 m, respectively) and then leveled off in the 76-100% cover class (SD = 4.43 m). We then added cover-specific positional errors to individual deer movement paths and conducted first-passage time analyses on the noisy and original paths. First-passage time analyses were robust to habitat-specific error in a forest-agriculture landscape. For deer in a fragmented forest-agriculture environment, and species that move across similar geographic extents, we suggest that first-passage time analysis is robust with regard to positional errors.	[Williams, David M.; Quinn, Amy Dechen; Porter, William F.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Williams, DM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	dmwill@msu.edu			New York State Department of Environmental Conservation (NYSDEC); United States Federal Aid in Wildlife Restoration Project [W-173-G]; United States Geological Survey; McIntire-Stennis Foundation at SUNY-ESF	New York State Department of Environmental Conservation (NYSDEC); United States Federal Aid in Wildlife Restoration Project; United States Geological Survey(United States Geological Survey); McIntire-Stennis Foundation at SUNY-ESF	Funding for this project was provided by the New York State Department of Environmental Conservation (NYSDEC) with partial support from the United States Federal Aid in Wildlife Restoration Project W-173-G. Additional support was provided by the United States Geological Survey and the McIntire-Stennis Foundation at SUNY-ESF. The NYSDEC assisted in the selection of the study areas and provided technicians to assist in deer-trapping efforts. The NYSDEC had no role in additional data collection, analysis, decision to publish, or preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JL, 2000, WILDLIFE SOC B, V28, P141; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Gau RJ, 2004, WILDLIFE SOC B, V32, P693, DOI 10.2193/0091-7648(2004)032[0693:UFPOTG]2.0.CO;2; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Jerde CL, 2005, ECOL APPL, V15, P806, DOI 10.1890/04-0895; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Montgomery RA, 2011, J WILDLIFE MANAGE, V75, P702, DOI 10.1002/jwmg.96; Montgomery RA, 2010, J WILDLIFE MANAGE, V74, P1917, DOI 10.2193/2010-019; Moser BW, 2007, J WILDLIFE MANAGE, V71, P2421, DOI 10.2193/2007-003; NYS Streets-Public, NYS STREETS PUBL; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Quinn A., 2010, INFLUENCES MOVEMENT; R Development Core Team, 2009, R FDN STAT COMP; Sager-Fradkin KA, 2007, J WILDLIFE MANAGE, V71, P1298, DOI 10.2193/2006-367; United States Monthly Surface Data, US MONTHL SURF DAT; Williams DM, 2012, LANDSCAPE ECOL, V27, P45, DOI 10.1007/s10980-011-9664-5	31	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48439	10.1371/journal.pone.0048439	http://dx.doi.org/10.1371/journal.pone.0048439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144884	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800064
J	Zhu, XQ; Chen, HJ; Wang, Y; Cui, Y; Teng, GJ				Zhu, Xi-Qi; Chen, Hua-Jun; Wang, Yu; Cui, Ying; Teng, Gao-Jun			Aberrant Resting-State Corticostriatal Functional Connectivity in Cirrhotic Patients with Hyperintense Globus Pallidus on T1-Weighted MR Imaging	PLOS ONE			English	Article							ACQUIRED HEPATOCEREBRAL DEGENERATION; MAGNETIC-RESONANCE IMAGES; CEREBRAL-BLOOD-FLOW; HEPATIC-ENCEPHALOPATHY; LIVER-CIRRHOSIS; MANGANESE NEUROTOXICITY; RECEPTOR DENSITY; BASAL GANGLIA; BRAIN; DISEASE	Neurobiological and neuroimaging studies have emphasized the structural and functional alterations in the striatum of cirrhotic patients, but alterations in the functional connections between the striatum and other brain regions have not yet been explored. Of note, manganese accumulation in the nervous system, frequently reflected by hyperintensity at the bilateral globus pallidus (GP) on T1-weighted imaging, has been considered a factor affecting the striatal and cortical functions in hepatic decompensation. We employed resting-state functional magnetic resonance imaging to analyze the temporal correlation between the striatum and the remaining brain regions using seed-based correlation analyses. The two-sample t-test was conducted to detect the differences in corticostriatal connectivity between 44 cirrhotic patients with hyperintensity at the bilateral GP and 20 healthy controls. Decreased connectivity of the caudate was detected in the anterior/middle cingulate gyrus, and increased connectivity of the caudate was found in the left motor cortex. A reduction in functional connectivity was found between the putamen and several regions, including the anterior cingulate gyrus, right insular lobe, inferior frontal gyrus, left parahippocampal gyrus, and anterior lobe of the right cerebellum; increased connectivity was detected between the putamen and right middle temporal gyrus. There were significant correlations between the corticostriatal connectivity and neuropsychological performances in the patient group, but not between the striatal connectivity and GP signal intensity. These alterations in the corticostriatal functional connectivity suggested the abnormalities in the intrinsic brain functional organiztion among the cirrhotic patients with manganese deposition, and may be associated with development of metabolic encephalopathy. The manganese deposition in nervous system, however, can not be an independent factor predicting the resting-state brain dysfunction in real time.	[Zhu, Xi-Qi; Chen, Hua-Jun; Wang, Yu; Cui, Ying; Teng, Gao-Jun] Southeast Univ, Sch Med, Zhongda Hosp, Jiangsu Key Lab Mol & Funct Imaging,Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhu, Xi-Qi] Southeast Univ, Sch Med, Hosp Nanjing 2, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Teng, GJ (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Jiangsu Key Lab Mol & Funct Imaging,Dept Radiol, Nanjing, Jiangsu, Peoples R China.	gjteng@vip.sina.com	xiqi, zhu/GLU-8790-2022					Ahl B, 2004, HEPATOLOGY, V40, P73, DOI 10.1002/hep.20290; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; BARTHAUER L, 1992, ALCOHOL CLIN EXP RES, V16, P982, DOI 10.1111/j.1530-0277.1992.tb01905.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burkhard PR, 2003, ARCH NEUROL-CHICAGO, V60, P521, DOI 10.1001/archneur.60.4.521; Butterworth RF, 1995, METAB BRAIN DIS, V10, P259, DOI 10.1007/BF02109357; Cagnin A, 2006, GUT, V55, P547, DOI 10.1136/gut.2005.075051; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Cordoba J, 2011, J HEPATOL, V54, P1030, DOI 10.1016/j.jhep.2010.11.015; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; FINLAYSON MH, 1981, BRAIN, V104, P79, DOI 10.1093/brain/104.1.79; Fukuzawa T, 2006, J GASTROEN HEPATOL, V21, P902, DOI 10.1111/j.1440-1746.2006.04226.x; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hazell AS, 2002, NEUROCHEM INT, V41, P271, DOI 10.1016/S0197-0186(02)00013-X; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iwasa M, 2005, METAB BRAIN DIS, V20, P7, DOI 10.1007/s11011-005-2472-3; Jog MS, 1995, MOVEMENT DISORD, V10, P714, DOI 10.1002/mds.870100604; Josephs KA, 2005, NEUROLOGY, V64, P2033, DOI 10.1212/01.WNL.0000167411.93483.A1; Krieger S, 1996, GASTROENTEROLOGY, V111, P147, DOI 10.1053/gast.1996.v111.pm8698193; KULISEVSKY J, 1992, HEPATOLOGY, V16, P1382, DOI 10.1002/hep.1840160613; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MOUSSEAU DD, 1993, NEUROSCI LETT, V162, P192, DOI 10.1016/0304-3940(93)90593-A; Naegele T, 2000, RADIOLOGY, V216, P683, DOI 10.1148/radiology.216.3.r00se27683; Normandin L, 2002, METAB BRAIN DIS, V17, P375, DOI 10.1023/A:1021970120965; POMIERLAYRARGUES G, 1995, LANCET, V345, P735, DOI 10.1016/S0140-6736(95)90909-5; PUJOL A, 1993, NEUROLOGY, V43, P65, DOI 10.1212/WNL.43.1_Part_1.65; Rovira A, 2008, AM J NEURORADIOL, V29, P1612, DOI 10.3174/ajnr.A1139; Seger CA, 2010, NEUROIMAGE, V50, P644, DOI 10.1016/j.neuroimage.2009.11.083; TaylorRobinson SD, 1996, METAB BRAIN DIS, V11, P249, DOI 10.1007/BF02237962; VICTOR M, 1965, MEDICINE, V44, P345, DOI 10.1097/00005792-196509000-00001; Weissenborn K, 1998, METAB BRAIN DIS, V13, P261, DOI 10.1023/A:1020628607245; Weissenborn K, 2004, METAB BRAIN DIS, V19, P269, DOI 10.1023/B:MEBR.0000043976.17500.8e; Weissenborn K, 2000, METAB BRAIN DIS, V15, P173; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295	49	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48886	10.1371/journal.pone.0048886	http://dx.doi.org/10.1371/journal.pone.0048886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145011	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800162
J	Li, JP; Yang, SG; Lu, SH; Zhao, H; Feng, JM; Li, WQ; Ma, FX; Ren, Q; Liu, B; Zhang, L; Zheng, YZ; Han, ZC				Li, Jianping; Yang, Shaoguang; Lu, Shihong; Zhao, Hui; Feng, Jianming; Li, Wenqian; Ma, Fengxia; Ren, Qian; Liu, Bin; Zhang, Lei; Zheng, Yizhou; Han, Zhong Chao			Differential Gene Expression Profile Associated with the Abnormality of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia	PLOS ONE			English	Article							HEMATOPOIETIC SUPPRESSION; INTERFERON-GAMMA; T-CELLS; APOPTOSIS; DISEASE; PATIENT	Aplastic anemia (AA) is generally considered as an immune-mediated bone marrow failure syndrome with defective hematopoietic stem cells (HSCs) and marrow microenvironment. Previous studies have demonstrated the defective HSCs and aberrant T cellular-immunity in AA using a microarray approach. However, little is known about the overall specialty of bone marrow mesenchymal stem cells (BM-MSCs). In the present study, we comprehensively compared the biological features and gene expression profile of BM-MSCs between AA patients and healthy volunteers. In comparison with healthy controls, BM-MSCs from AA patients showed aberrant morphology, decreased proliferation and clonogenic potential and increased apoptosis. BM-MSCs from AA patients were susceptible to be induced to differentiate into adipocytes but more difficult to differentiate into osteoblasts. Consistent with abnormal biological features, a large number of genes implicated in cell cycle, cell division, proliferation, chemotaxis and hematopoietic cell lineage showed markedly decreased expression in BM-MSCs from AA patients. Conversely, more related genes with apoptosis, adipogenesis and immune response showed increased expression in BM-MSCs from AA patients. The gene expression profile of BM-MSCs further confirmed the abnormal biological properties and provided significant evidence for the possible mechanism of the destruction of the bone marrow microenvironment in AA.	[Li, Jianping; Yang, Shaoguang; Lu, Shihong; Ma, Fengxia; Ren, Qian; Liu, Bin; Zhang, Lei; Zheng, Yizhou; Han, Zhong Chao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Li, Jianping; Yang, Shaoguang; Lu, Shihong; Ma, Fengxia; Ren, Qian; Liu, Bin; Zhang, Lei; Zheng, Yizhou; Han, Zhong Chao] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin, Peoples R China; [Li, Jianping; Yang, Shaoguang; Lu, Shihong; Ma, Fengxia; Ren, Qian; Liu, Bin; Zhang, Lei; Zheng, Yizhou; Han, Zhong Chao] Peking Union Med Coll, Tianjin, Peoples R China; [Li, Jianping; Feng, Jianming; Li, Wenqian] Qinghai Prov Peoples Hosp, Dept Hematol, Xining, Qinghai, Peoples R China; [Zhao, Hui] Tianjin Univ Commerce, Sch Biotechnol & Food Sci, Tianjin Key Lab Food & Biotechnol, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tianjin University of Commerce	Han, ZC (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.	hanzhongchao@hotmail.com	Han, Zhong Chao/D-7157-2016; Zhao, Hui/AAB-2163-2019; Li, Jianping/Q-1618-2019; Li, Jianping/U-6806-2017	Han, Zhong Chao/0000-0002-2687-7682; Zhao, Hui/0000-0002-3710-3607; Li, Jianping/0000-0002-3972-1652; Zhang, Lei/0000-0001-7769-7377	National Basic Research Program of China [2011CB964800 (2011CB964802)]; Ministry of Science and Technology of China [2011AA020118]; National Natural Science Foundation of China [30872330, 81160071]; Tianjin Research Program of Application Foundation and Advanced Technology [12JCZDJC25000]; West Light Foundation of The Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology; West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Basic Research Program of China 2011CB964800 (2011CB964802), the 863 project (Grant no. 2011AA020118) from the Ministry of Science and Technology of China, the National Natural Science Foundation of China (30872330 and 81160071), the Tianjin Research Program of Application Foundation and Advanced Technology (12JCZDJC25000) and the West Light Foundation of The Chinese Academy of Sciences (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacigalupo A, 2005, EXP HEMATOL, V33, P819, DOI 10.1016/j.exphem.2005.05.006; Callera F, 1997, BRIT J HAEMATOL, V98, P18, DOI 10.1046/j.1365-2141.1997.1532971.x; Chao YH, 2010, ANN HEMATOL, V89, P715, DOI 10.1007/s00277-009-0892-6; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Jaganathan BG, 2010, LEUKEMIA, V24, P1791, DOI 10.1038/leu.2010.164; Killick SB, 2000, BRIT J HAEMATOL, V111, P1164, DOI 10.1046/j.1365-2141.2000.02485.x; Li JP, 2010, CRIT REV ONCOL HEMAT, V75, P79, DOI 10.1016/j.critrevonc.2009.12.001; Li Jianping, 2012, Results Immunol, V2, P142, DOI 10.1016/j.rinim.2012.07.002; Li JP, 2011, BRIT J HAEMATOL, V153, P764, DOI 10.1111/j.1365-2141.2010.08431.x; Maciejewski JP, 1996, BLOOD, V88, P1983, DOI 10.1182/blood.V88.6.1983.bloodjournal8861983; Manz CY, 1996, AM J HEMATOL, V52, P264, DOI 10.1002/(SICI)1096-8652(199608)52:4<264::AID-AJH5>3.3.CO;2-3; Marsh JCW, 2009, BRIT J HAEMATOL, V147, P43, DOI 10.1111/j.1365-2141.2009.07842.x; NEGENDANK W, 1991, BLOOD, V78, P2872; Philpott NJ, 1995, EXP HEMATOL, V23, P1642; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Rizzo Sian, 2002, Hematol J, V3, P230, DOI 10.1038/sj.thj.6200187; Schrezenmeier H, 1996, BLOOD, V88, P4474, DOI 10.1182/blood.V88.12.4474.bloodjournal88124474; Sloand E, 2002, BLOOD, V100, P1185, DOI 10.1182/blood-2002-01-0035; STEINER R M, 1990, Magnetic Resonance Quarterly, V6, P17; Timeus F, 2005, EXP HEMATOL, V33, P597, DOI 10.1016/j.exphem.2005.02.005; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wang HX, 2010, CYTOTHERAPY, V12, P563, DOI 10.3109/14653241003695059; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777; Zeng WH, 2004, EXP HEMATOL, V32, P806, DOI 10.1016/j.exphem.2004.06.004; Zeng WH, 2004, BLOOD, V103, P325, DOI 10.1182/blood-2003-02-0490; ZOUMBOS NC, 1985, P NATL ACAD SCI USA, V82, P188, DOI 10.1073/pnas.82.1.188	27	11	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47764	10.1371/journal.pone.0047764	http://dx.doi.org/10.1371/journal.pone.0047764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144828	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400029
J	Wen, J; Cerosaletti, K; Schultz, KJ; Wright, JA; Concannon, P				Wen, J.; Cerosaletti, K.; Schultz, K. J.; Wright, J. A.; Concannon, P.			NBN Phosphorylation regulates the accumulation of MRN and ATM at sites of DNA double-strand breaks	ONCOGENE			English	Article						MRN; ATM; nibrin (NBN); I-PpoI and DNA double-strand breaks	DISTINCT FUNCTIONAL DOMAINS; CELL-PENETRATING PEPTIDES; S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; DEPENDENT PHOSPHORYLATION; CHROMOSOMAL INSTABILITY; SYNDROME PROTEIN; DAMAGE RESPONSE; REPAIR	In response to ionizing radiation, the MRE11/RAD50/NBN complex re-distributes to the sites of DNA double-strand breaks (DSBs) where each of its individual components is phosphorylated by the serine-threonine kinase, ATM. ATM phosphorylation of NBN is required for the activation of the S-phase checkpoint, but the mechanism whereby these phosphorylation events signal the checkpoint machinery remains unexplained. Here, we describe the use of direct protein transduction of the homing endonuclease, I-PpoI, into human cells to generate site-specific DSBs. Direct transduction of I-PpoI protein results in rapid accumulation and turnover of the endonuclease in live cells, facilitating comparisons across multiple cell lines. We demonstrate the utility of this system by introducing I-PpoI into isogenic cell lines carrying mutations at the ATM phosphorylation sites in NBN and assaying the effects of these mutations on the spatial distribution and temporal accumulation of NBN and ATM at DSBs by chromatin immunoprecipitation, as well as timing and extent of DSB repair. Although the spatial distribution of NBN and ATM recruited to the sites of DSBs was comparable between control cells and those expressing phosphorylation mutants of NBN, the timing of accumulation of NBN and ATM was altered. Serine-to-alanine mutations that blocked phosphorylation resulted in delayed recruitment of both NBN and ATM to DSBs. Serine-to-glutamic acid substitutions that mimicked the phosphorylation event resulted in both increased and prolonged accumulation of both NBN and ATM at DSBs. The repair of DSBs in cells lacking full-length NBN was significantly delayed compared with control cells, whereas blocking phosphorylation of NBN resulted in a more modest delay in repair. These data indicate that following the induction of DSBs, phosphorylation of NBN regulates its accumulation, and that of ATM, at sites of DNA DSB as well as the timing of the repair of these sites.	[Wen, J.; Wright, J. A.; Concannon, P.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Cerosaletti, K.] Benaroya Res Inst, Translat Res Program, Seattle, WA USA; [Schultz, K. J.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Concannon, P.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	University of Virginia; Benaroya Research Institute; University of New Mexico; University of Virginia	Concannon, P (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Dept Biochem & Mol Genet, POB 800717, Charlottesville, VA 22908 USA.	pjc6n@virginia.edu		Concannon, Patrick/0000-0002-5801-1859	NCI [CA57569]; NATIONAL CANCER INSTITUTE [R01CA057569] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the NCI (CA57569).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; DERZWET MK, 1999, MUTAT RES, V434, P17; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Di VM, 2009, DNA REPAIR, V8, P1311; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dong ZW, 1999, J BIOL CHEM, V274, P19513, DOI 10.1074/jbc.274.28.19513; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Gatei M, 2011, J BIOL CHEM, V286, P31542, DOI 10.1074/jbc.M111.258152; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lindgren M, 2011, METHODS MOL BIOL, V683, P3, DOI 10.1007/978-1-60761-919-2_1; Lins S, 2009, GENE, V447, P12, DOI 10.1016/j.gene.2009.07.013; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; TAALMAN RDFM, 1983, MUTAT RES, V112, P23, DOI 10.1016/0167-8817(83)90021-4; TAALMAN RDFM, 1989, AM J MED GENET, V32, P425, DOI 10.1002/ajmg.1320320332; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vissinga CS, 2009, MOL CELL BIOL, V29, P1000, DOI 10.1128/MCB.01131-08; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	50	16	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 12	2013	32	37					4448	4456		10.1038/onc.2012.443	http://dx.doi.org/10.1038/onc.2012.443			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23146902	Green Accepted			2022-12-25	WOS:000324404200013
J	Muili, KA; Wang, D; Orabi, AI; Sarwar, S; Luo, YH; Javed, TA; Eisses, JF; Mahmood, SM; Jin, SQ; Singh, VP; Ananthanaravanan, M; Perides, G; Williams, JA; Molkentin, JD; Husain, SZ				Muili, Kamaldeen A.; Wang, Dong; Orabi, Abrahim I.; Sarwar, Sheharyar; Luo, Yuhuan; Javed, Tanveer A.; Eisses, John F.; Mahmood, Syeda M.; Jin, Shunqian; Singh, Vijay P.; Ananthanaravanan, Meena; Perides, George; Williams, John A.; Molkentin, Jeffery D.; Husain, Sohail Z.			Bile Acids Induce Pancreatic Acinar Cell Injury and Pancreatitis by Activating Calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE-C; TRYPSINOGEN ACTIVATION; ZYMOGEN ACTIVATION; BILIARY PANCREATITIS; ENZYME ACTIVATION; TACROLIMUS FK-506; TISSUE-DAMAGE; CALCIUM; FK506	Biliary pancreatitis is the leading cause of acute pancreatitis in both children and adults. A proposed mechanism is the reflux of bile into the pancreatic duct. Bile acid exposure causes pancreatic acinar cell injury through a sustained rise in cytosolic Ca2+. Thus, it would be clinically relevant to know the targets of this aberrant Ca2+ signal. We hypothesized that the Ca2+-activated phosphatase calcineurin is such a Ca2+ target. To examine calcineurin activation, we infected primary acinar cells from mice with an adenovirus expressing the promoter for a downstream calcineurin effector, nuclear factor of activated T-cells (NFAT). The bile acid taurolithocholic acid-3-sulfate (TLCS) was primarily used to examine bile acid responses. TLCS caused calcineurin activation only at concentrations that cause acinar cell injury. The activation of calcineurin by TLCS was abolished by chelating intracellular Ca2+. Pretreatment with 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid (acetoxymethyl ester) (BAPTA-AM) or the three specific calcineurin inhibitors FK506, cyclosporine A, or calcineurin inhibitory peptide prevented bile acid-induced acinar cell injury as measured by lactate dehydrogenase leakage and propidium iodide uptake. The calcineurin inhibitors reduced the intra-acinar activation of chymotrypsinogen within 30 min of TLCS administration, and they also prevented NF-kappa B activation. In vivo, mice that received FK506 or were deficient in the calcineurin isoform A beta (CnA beta) subunit had reduced pancreatitis severity after infusion of TLCS or taurocholic acid into the pancreatic duct. In summary, we demonstrate that acinar cell calcineurin is activated in response to Ca2+ generated by bile acid exposure, bile acid-induced pancreatic injury is dependent on calcineurin activation, and calcineurin inhibitors may provide an adjunctive therapy for biliary pancreatitis.	[Muili, Kamaldeen A.; Wang, Dong; Orabi, Abrahim I.; Sarwar, Sheharyar; Luo, Yuhuan; Javed, Tanveer A.; Eisses, John F.; Mahmood, Syeda M.; Jin, Shunqian; Husain, Sohail Z.] UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, Dept Pediat, Pittsburgh, PA 15224 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA; [Wang, Dong] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Wang, Dong] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Ananthanaravanan, Meena] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06519 USA; [Perides, George] Tufts Univ, Med Ctr, Dept Surg, Boston, MA 02111 USA; [Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; Fudan University; Yale University; Tufts University; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati	Husain, SZ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, Dept Pediat, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sohail.husain@chp.edu	Wang, Dong/A-6518-2018	Husain, Sohail Z/0000-0003-3012-1308; Molkentin, Jeffery/0000-0002-3558-6529; Williams, John/0000-0002-6063-7615; Singh, Vijay/0000-0001-6611-1908	National Institutes of Health [DK083327, DK093491, DK091327, DK092460, DK041122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091327, R01DK092460, R37DK041122, R01DK083327, T32DK007017, T32DK071492, R01DK093491, R01DK041122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083327 and DK093491 (to S. Z. H.), DK091327 (to Michael L. Steer), DK092460 (to V. P. S.), and DK041122 (to J. A. W.).	Abdulla A, 2011, J LEUKOCYTE BIOL, V90, P975, DOI 10.1189/jlb.0411195; Awla D, 2012, GASTROENTEROLOGY, V143, P1352, DOI 10.1053/j.gastro.2012.07.098; Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Biswas A, 2011, J BIOL CHEM, V286, P3129, DOI 10.1074/jbc.M110.188565; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; D Frank C, 2006, NAT CLIN PRACT GASTR, V3, P680, DOI 10.1038/ncpgasthep0654; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; ECHIGO Y, 1995, ARCH SURG-CHICAGO, V130, P64; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FISHER MM, 1973, CAN MED ASSOC J, V109, P190; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gukovskaya AS, 2004, AM J PHYSIOL-GASTR L, V286, pG204, DOI 10.1152/ajpgi.00088.2003; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gurda GT, 2008, MOL BIOL CELL, V19, P198, DOI 10.1091/mbc.E07-05-0430; Gurda GT, 2010, GASTROENTEROLOGY, V139, P609, DOI 10.1053/j.gastro.2010.04.050; Hackert T, 2006, PANCREAS, V32, P145, DOI 10.1097/01.mpa.0000194610.62723.18; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Husain SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG1594, DOI 10.1152/ajpgi.00500.2006; Husain SZ, 2012, AM J PHYSIOL-GASTR L, V302, pG1423, DOI 10.1152/ajpgi.00546.2011; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; ITO T, 1994, J GASTROENTEROL, V29, P305, DOI 10.1007/BF02358370; Ji BA, 2009, J BIOL CHEM, V284, P17488, DOI 10.1074/jbc.M109.005520; JONES BA, 1987, ANN SURG, V205, P123, DOI 10.1097/00000658-198702000-00003; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; Kim MS, 2011, GASTROENTEROLOGY, V140, P2107, DOI 10.1053/j.gastro.2011.02.052; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lowenfels Albert B, 2005, Curr Gastroenterol Rep, V7, P90, DOI 10.1007/s11894-005-0045-6; Ma MH, 2012, J PEDIATR GASTR NUTR, V54, P651, DOI 10.1097/MPG.0b013e31823a897d; Maleth J, 2011, GUT, V60, P136, DOI 10.1136/gut.2009.192153; Mayer JM, 2000, EUR J SURG, V166, P734; MCDIARMID SV, 1991, TRANSPLANT P, V23, P2996; Muili K., 2011, PANCREAPEDIA EXOCRIN, DOI [10.3998/panc.2011.4, DOI 10.3998/PANC.2011.4]; Muili KA, 2012, AM J PHYSIOL-GASTR L, V302, pG898, DOI 10.1152/ajpgi.00545.2011; Nieto Y, 2000, BONE MARROW TRANSPL, V26, P109, DOI 10.1038/sj.bmt.1702471; Ogunseinde BA, 2003, TRANSPLANTATION, V76, P448, DOI 10.1097/01.TP.0000070434.73865.7A; Oliveria SF, 2012, J NEUROSCI, V32, P15328, DOI 10.1523/JNEUROSCI.2302-12.2012; Opie EL, 1909, J EXP MED, V11, P561, DOI 10.1084/jem.11.4.561; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Perides G, 2010, GASTROENTEROLOGY, V138, P715, DOI 10.1053/j.gastro.2009.10.052; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Sastry J, 2004, BONE MARROW TRANSPL, V33, P867, DOI 10.1038/sj.bmt.1704429; Sendler M., 2012, GUT IN PRESS; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Tantral L., 2004, CELL BIOCHEM FUNCT, V22, P35; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Udina E, 2003, J PERIPHER NERV SYST, V8, P145, DOI 10.1046/j.1529-8027.2003.03020.x; UEMOTO S, 1993, TRANSPLANTATION, V55, P288, DOI 10.1097/00007890-199302000-00011; van Geenen EJM, 2010, NAT REV GASTRO HEPAT, V7, P495, DOI 10.1038/nrgastro.2010.114; Venglovecz V, 2008, GUT, V57, P1102, DOI 10.1136/gut.2007.134361; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Weinman SA, 2008, TXB GASTROENTEROLOGY, P401; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yamada T, 2001, AM J PHYSIOL-GASTR L, V281, pG1397, DOI 10.1152/ajpgi.2001.281.6.G1397	76	64	67	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					570	580		10.1074/jbc.M112.428896	http://dx.doi.org/10.1074/jbc.M112.428896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148215	Green Published, hybrid			2022-12-25	WOS:000313197200057
J	Yu, JJ; He, XM; Chen, YG; Hao, Y; Yang, S; Wang, L; Pan, L; Tang, H				Yu, Junjing; He, Xiaomeng; Chen, Ye-Guang; Hao, Yan; Yang, Shuo; Wang, Lei; Pan, Lei; Tang, Hong			Myotubularin- related Protein 4 (MTMR4) Attenuates BMP/Dpp Signaling by Dephosphorylation of Smad Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; TGF-BETA SUPERFAMILY; DPP RECEPTORS; SELF-RENEWAL; DROSOPHILA; GENE; PATHWAY; PHOSPHATASES; FAMILY; IDENTIFICATION	Bone morphogenetic proteins (BMPs) signaling essentially regulates a wide range of biological responses. Although multiple regulators at different layers of the receptor-effectors axis have been identified, the mechanisms of homeostatic BMP signaling remain vague. Herein we demonstrated that myotubularin-related protein 4 (MTMR4), a FYVE domain-containing dual-specificity protein phosphatase (DUSP), preferentially associated with and dephosphorylated the activated R-Smads in cytoplasm, which is a critical checkpoint in BMP signal transduction. Therefore, transcriptional activation by BMPs was tightly controlled by the expression level and the intrinsic phosphatase activity of MTMR4. More profoundly, ectopic expression of MTMR4 or its Drosophila homolog CG3632 genetically interacted with BMP/Dppsignaling axis in regulation of the vein development of Drosophila wings. By doing so, MTMR4 could interact with and dephosphorylate Mothers against Decapentaplegic (Mad), the sole R-Smad in Drosophila BMP pathway, and hence affected the target genes expression of Mad. In conclusion, this study has suggested that MTMR4 is a necessary negative modulator for the homeostasis of BMP/Dpp signaling.	[Yu, Junjing; He, Xiaomeng; Hao, Yan; Yang, Shuo; Pan, Lei; Tang, Hong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun CASKLII, Beijing 100101, Peoples R China; [Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Lei; Tang, Hong] Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China; [Wang, Lei; Tang, Hong] Chinese Acad Sci, State Key Lab Virol, Wuhan 430071, Peoples R China; [Yu, Junjing; Pan, Lei; Tang, Hong] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China; [He, Xiaomeng; Hao, Yan; Yang, Shuo; Wang, Lei] Univ Chinese Acad Sci, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pan, L (corresponding author), 15 Da Tun Rd, Beijing 10010, Peoples R China.	panlei@moon.ibp.ac.cn; tanghong@moon.ibp.ac.cn	Chen, Ye-Guang/L-6998-2019; Wang, Li/E-4222-2014; Yang, Shuo/ABH-8550-2020	Wang, Li/0000-0002-9615-1879; Yang, Shuo/0000-0002-7929-0244; Pan, Lei/0000-0002-0500-8904	National Natural Science Foundation of China [31000403, 31200685]; Ministry of Science and Technology of China [2011CB946104, 2011DFG32790, 2012CB518900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by funding from the National Natural Science Foundation of China (31000403) (to L. P.) and (31200685) (to J. Y.) and from the Ministry of Science and Technology of China (2011CB946104 and 2011DFG32790) (to H. T.) and (2012CB518900) (to L. P.).	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Burke R, 1996, DEVELOPMENT, V122, P2261; Chauvet C, 2012, J HYPERTENS, V30, P81, DOI 10.1097/HJH.0b013e32834dddb1; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Eivers E, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002034; Green J, 2002, DEV DYNAM, V225, P392, DOI 10.1002/dvdy.10170; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Khalsa O, 1998, DEVELOPMENT, V125, P2723; KHERADMAND F, 1994, AM J PHYSIOL-LUNG C, V267, pL728, DOI 10.1152/ajplung.1994.267.6.L728; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; MIYAZONO K, 2002, SCI STKE, pPE40; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Naughtin MJ, 2010, J CELL SCI, V123, P3071, DOI 10.1242/jcs.060103; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; RAFTERY LA, 1995, GENETICS, V139, P241; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shi WB, 2007, J CELL SCI, V120, P1216, DOI 10.1242/jcs.03400; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SIMMONDS AJ, 1995, NATURE, V376, P424, DOI 10.1038/376424a0; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JJ, 2010, J BIOL CHEM, V285, P8454, DOI 10.1074/jbc.M109.075036	44	15	16	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					79	88		10.1074/jbc.M112.413856	http://dx.doi.org/10.1074/jbc.M112.413856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150675	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000313197200008
J	Zheng, M; Kang, YM; Liu, W; Zang, WJ; Bao, CY; Qin, DN				Zheng, Min; Kang, Yu-Ming; Liu, Wei; Zang, Wei-Jin; Bao, Cui-Yu; Qin, Da-Nian			Inhibition of Cyclooxygenase-2 Reduces Hypothalamic Excitation in Rats with Adriamycin-Induced Heart Failure	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; FACTOR-KAPPA-B; PARAVENTRICULAR NUCLEUS; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; BRAIN ANGIOTENSIN; OXIDATIVE STRESS; NERVE DISCHARGE; AT(1) RECEPTOR; ACTIVATION	Background: The paraventricular nucleus (PVN) of the hypothalamus plays an important role in the progression of heart failure (HF). We investigated whether cyclooxygenase-2 (COX-2) inhibition in the PVN attenuates the activities of sympathetic nervous system (SNS) and renin-angiotensin system (RAS) in rats with adriamycin-induced heart failure. Methodology/Principal Finding: Heart failure was induced by intraperitoneal injection of adriamycin over a period of 2 weeks (cumulative dose of 15 mg/kg). On day 19, rats received intragastric administration daily with either COX-2 inhibitor celecoxib (CLB) or normal saline. Treatment with CLB reduced mortality and attenuated both myocardial atrophy and pulmonary congestion in HF rats. Compared with the HF rats, ventricle to body weight (VW/BW) and lung to body weight (LW/BW) ratios, heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular peak systolic pressure (LVPSP) and maximum rate of change in left ventricular pressure (LV +/- dp/dtmax) were improved in HF+CLB rats. Angiotensin II (ANG II), norepinephrine (NE), COX-2 and glutamate (Glu) in the PVN were increased in HF rats. HF rats had higher levels of ANG II and NE in plasma, higher level of ANG II in myocardium, and lower levels of ANP in plasma and myocardium. Treatment with CLB attenuated these HF-induced changes. HF rats had more COX-2-positive neurons and more corticotropin releasing hormone (CRH) positive neurons in the PVN than did control rats. Treatment with CLB decreased COX-2-positive neurons and CRH positive neurons in the PVN of HF rats. Conclusions: These results suggest that PVN COX-2 may be an intermediary step for PVN neuronal activation and excitatory neurotransmitter release, which further contributes to sympathoexcitation and RAS activation in adriamycin-induced heart failure. Treatment with COX-2 inhibitor attenuates sympathoexcitation and RAS activation in adriamycin-induced heart failure.	[Kang, Yu-Ming] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Cardiovasc Res Ctr, Xian 710049, Peoples R China; [Zheng, Min; Liu, Wei; Qin, Da-Nian] Shantou Univ, Dept Physiol, Coll Med, Shantou, Peoples R China; [Zheng, Min; Bao, Cui-Yu] Hubei Univ Sci & Techonol, Dept Biomed Engn, Xianning, Peoples R China; [Zang, Wei-Jin] Xi An Jiao Tong Univ, Dept Pharmacol, Sch Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; Shantou University; Hubei University of Science & Technology; Xi'an Jiaotong University	Kang, YM (corresponding author), Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Cardiovasc Res Ctr, Xian 710049, Peoples R China.	ykang@mail.xjtu.edu.cn; dnqin@stu.edu.cn			National Basic Research Program of China [2012CB517805]; National Natural Science Foundation of China [81170248, 81070199]; foundation of Hubei Provincial Department of Education [Z20092801]; Shantou University Medical College Grant	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation of Hubei Provincial Department of Education; Shantou University Medical College Grant	This work was supported by National Basic Research Program of China (No. 2012CB517805), National Natural Science Foundation of China (Nos. 81170248, 81070199), foundation of Hubei Provincial Department of Education (No. Z20092801) and Shantou University Medical College Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONACCIO MJ, 1978, NEUROPHARMACOLOGY, V17, P783, DOI 10.1016/0028-3908(78)90065-5; Arabia AM, 2002, NEUROSCIENCE, V114, P591, DOI 10.1016/S0306-4522(02)00337-8; Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Boudaba C, 1996, J NEUROSCI, V16, P7151; Braunwald E, 2000, CIRCULATION, V102, P14; BRENNAN TJ, 1983, LIFE SCI, V33, P701, DOI 10.1016/0024-3205(83)90774-9; CATT KJ, 1987, ADV BIOCHEM PSYCHOPH, V43, P51; Delgado RM, 2004, CIRCULATION, V109, P1428, DOI 10.1161/01.CIR.0000121354.34067.48; Dieterich H A, 2005, Fiziol Cheloveka, V31, P97; Ericsson A, 1997, J NEUROSCI, V17, P7166; Francis J, 2004, AM J PHYSIOL-HEART C, V287, pH2138, DOI 10.1152/ajpheart.00112.2004; Francis J, 2004, AM J PHYSIOL-HEART C, V287, pH791, DOI 10.1152/ajpheart.00099.2004; Helwig BG, 2007, AM J PHYSIOL-REG I, V292, pR1165, DOI 10.1152/ajpregu.00507.2006; HOFFMAN WE, 1979, J PHYSIOL-LONDON, V288, P159; Huang JH, 1999, BRAIN RES, V845, P77, DOI 10.1016/S0006-8993(99)01937-X; Jaimes EA, 2005, KIDNEY INT, V68, P2143, DOI 10.1111/j.1523-1755.2005.00670.x; Johnson AK, 1997, FRONT NEUROENDOCRIN, V18, P292, DOI 10.1006/frne.1997.0153; Kang YM, 2008, CARDIOVASC RES, V79, P671, DOI 10.1093/cvr/cvn119; Kang YM, 2008, AM J PHYSIOL-HEART C, V295, pH227, DOI 10.1152/ajpheart.01157.2007; Kang YM, 2006, CIRC RES, V99, P758, DOI 10.1161/01.RES.0000244092.95152.86; Kang YM, 2009, CARDIOVASC RES, V83, P737, DOI 10.1093/cvr/cvp160; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Liang CS, 2007, ACTA PHARMACOL SIN, V28, P921, DOI 10.1111/j.1745-7254.2007.00585.x; Lindley TE, 2004, CIRC RES, V94, P402, DOI 10.1161/01.RES.0000112964.40701.93; McKinley MJ, 2001, JPN J PHYSIOL, V51, P281, DOI 10.2170/jjphysiol.51.281; McKinley MJ, 1996, CLIN EXP PHARMACOL P, V23, pS99, DOI 10.1111/j.1440-1681.1996.tb02821.x; MohanKumar SMJ, 1998, BRAIN RES BULL, V47, P29, DOI 10.1016/S0361-9230(98)00037-9; Oldfield BJ, 2001, J NEUROENDOCRINOL, V13, P139, DOI 10.1046/j.1365-2826.2001.00597.x; Ouyang CH, 2007, NEUROSCI LETT, V420, P174, DOI 10.1016/j.neulet.2007.05.004; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; Pieske B, 2000, Ther Umsch, V57, P284, DOI 10.1024/0040-5930.57.5.284; Raasch W, 2006, ENDOCRINOLOGY, V147, P3539, DOI 10.1210/en.2006-0198; Rabelo E, 2001, HYPERTENSION, V38, P576, DOI 10.1161/hy09t1.096185; Saavedra JM, 2005, REGUL PEPTIDES, V128, P227, DOI 10.1016/j.regpep.2004.12.015; SIVESKIILISKOVIC N, 1994, CIRCULATION, V89, P2829, DOI 10.1161/01.CIR.89.6.2829; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tan JH, 2004, AM J PHYSIOL-HEART C, V286, pH1665, DOI 10.1152/ajpheart.00858.2003; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; vanAcker SABE, 1996, CANCER CHEMOTH PHARM, V38, P95, DOI 10.1007/s002800050453; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281; Yu Y, 2007, HYPERTENSION, V49, P511, DOI 10.1161/01.HYP.0000257356.20527.c5; Zanzinger J, 2000, PFLUG ARCH EUR J PHY, V439, P489, DOI 10.1007/s004240050968; Zhang K, 2002, AM J PHYSIOL-REG I, V282, pR1006, DOI 10.1152/ajpregu.00241.2001; Zhang ZH, 2003, AM J PHYSIOL-REG I, V284, pR916, DOI 10.1152/ajpregu.00406.2002; Zucker IH, 2006, HYPERTENSION, V48, P1005, DOI 10.1161/01.HYP.0000246614.47231.25	45	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48771	10.1371/journal.pone.0048771	http://dx.doi.org/10.1371/journal.pone.0048771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152801	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234600011
J	Lira-Silva, E; Santiago-Martinez, MG; Hernandez-Juarez, V; Garcia-Contreras, R; Moreno-Sanchez, R; Jasso-Chavez, R				Lira-Silva, Elizabeth; Geovanni Santiago-Martinez, M.; Hernandez-Juarez, Viridiana; Garcia-Contreras, Rodolfo; Moreno-Sanchez, Rafael; Jasso-Chavez, Ricardo			Activation of Methanogenesis by Cadmium in the Marine Archaeon Methanosarcina acetivorans	PLOS ONE			English	Article							ANAEROBIC GRANULAR SLUDGE; HEAVY-METALS; CARBONIC-ANHYDRASE; EUGLENA-GRACILIS; ACETATE KINASE; THERMOPHILA; TOXICITY; COBALT; PURIFICATION; INHIBITION	Methanosarcina acetivorans was cultured in the presence of CdCl2 to determine the metal effect on cell growth and biogas production. With methanol as substrate, cell growth and methane synthesis were not altered by cadmium, whereas with acetate, cadmium slightly increased both, growth and methane rate synthesis. In cultures metabolically active, incubations for short-term (minutes) with 10 mu M total cadmium increased the methanogenesis rate by 6 and 9 folds in methanol- and acetate-grown cells, respectively. Cobalt and zinc but not copper or iron also activated the methane production rate. Methanogenic carbonic anhydrase and acetate kinase were directly activated by cadmium. Indeed, cells cultured in 100 mu M total cadmium removed 41-69% of the heavy metal from the culture and accumulated 231-539 nmol Cd/mg cell protein. This is the first report showing that (i) Cd2+ has an activating effect on methanogenesis, a biotechnological relevant process in the bio-fuels field; and (ii) a methanogenic archaea is able to remove a heavy metal from aquatic environments.	[Lira-Silva, Elizabeth; Geovanni Santiago-Martinez, M.; Hernandez-Juarez, Viridiana; Garcia-Contreras, Rodolfo; Moreno-Sanchez, Rafael; Jasso-Chavez, Ricardo] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico	Jasso-Chavez, R (corresponding author), Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico.	rjass_cardiol@yahoo.com.mx	Garcia-Contreras, Rodolfo/AAI-3548-2020; lira-silva, elizabeth/GQH-9313-2022; Moreno-Sanchez, Rafael/A-3158-2011	Lira-Silva, Elizabeth/0000-0001-8261-0010; Moreno-Sanchez, Rafael/0000-0002-9587-7184; Santiago Martinez, Michel Geovanni/0000-0002-9872-7894	CONACyT, Mexico [90619, 80534, 123636, 156969]; ICyTDF, Mexico [PICS08-5]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ICyTDF, Mexico	The funding of the grants described in the manuscript (90619, 80534, 123636 and 156969 from CONACyT and # PICS08-5 from ICyTDF, Mexico) were used for acquisition of lab materials, chemicals and small equipmnet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBANAT DR, 1990, J BACTERIOL, V172, P7145, DOI 10.1128/jb.172.12.7145-7150.1990; ACETI DJ, 1988, J BIOL CHEM, V263, P15444; ALBER BE, 1994, P NATL ACAD SCI USA, V91, P6909, DOI 10.1073/pnas.91.15.6909; Altas L, 2009, J HAZARD MATER, V162, P1551, DOI 10.1016/j.jhazmat.2008.06.048; [Anonymous], 1992, REV INT CONTAM AMB; Cesar A, 2009, ECOTOX ENVIRON SAFE, V72, P1832, DOI 10.1016/j.ecoenv.2008.12.001; Fermoso FG, 2010, BIORESOURCE TECHNOL, V101, P9429, DOI 10.1016/j.biortech.2010.07.053; Ferry JG, 2007, ARCHAEA MOL CELLULAR, P100; FLORENCIO L, 1994, APPL ENVIRON MICROB, V60, P227, DOI 10.1128/AEM.60.1.227-234.1994; Gillan DC, 2005, APPL ENVIRON MICROB, V71, P679, DOI 10.1128/AEM.71.2.679-690.2005; HICKEY RF, 1989, WATER RES, V23, P207, DOI 10.1016/0043-1354(89)90045-6; Ingram-Smith C, 2005, J BACTERIOL, V187, P2386, DOI 10.1128/JB.187.7.2386-2394.2005; Innocenti A, 2004, BIOORG MED CHEM LETT, V14, P3327, DOI 10.1016/j.bmcl.2004.03.101; JARRELL KF, 1987, CAN J MICROBIOL, V33, P551, DOI 10.1139/m87-093; Karri S, 2006, CHEMOSPHERE, V62, P121, DOI 10.1016/j.chemosphere.2005.04.016; Kim BK, 1996, APPL ENVIRON MICROB, V62, P2629, DOI 10.1128/AEM.62.7.2629-2635.1996; KING TE, 1967, METHOD ENZYMOL, V10, P634; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Lira-Silva E, 2011, J HAZARD MATER, V193, P216, DOI 10.1016/j.jhazmat.2011.07.056; LUNDIE LL, 1989, J BIOL CHEM, V264, P18392; MacAuley SR, 2009, BIOCHEMISTRY-US, V48, P817, DOI 10.1021/bi802246s; Madoni P, 2006, ENVIRON POLLUT, V141, P1, DOI 10.1016/j.envpol.2005.08.025; Mendoza-Cozatl DG, 2006, FEBS J, V273, P5703, DOI 10.1111/j.1742-4658.2006.05558.x; Mori K, 2000, J BIOSCI BIOENG, V90, P260, DOI 10.1263/jbb.90.260; PEPI M, 1992, BIOMETALS, V5, P179, DOI 10.1007/BF01061326; Rohlin L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-62; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Sillen L, 1964, STABILITY CONSTANTS; SILVER S, 1989, BIOL TRACE ELEM RES, V21, P145, DOI 10.1007/BF02917247; SIMPSON W R, 1981, Progress in Oceanography, V10, P1, DOI 10.1016/0079-6611(81)90007-0; SOWERS KR, 1984, APPL ENVIRON MICROB, V47, P971, DOI 10.1128/AEM.47.5.971-978.1984; Sowers KR, 1995, ARCHAEA LAB MANUAL, P200; Toes ACM, 2008, ARCH ENVIRON CON TOX, V55, P372, DOI 10.1007/s00244-008-9135-4; Tripp BC, 2004, J BIOL CHEM, V279, P6683, DOI 10.1074/jbc.M311648200; Wang MJ, 2011, AQUAT TOXICOL, V101, P387, DOI 10.1016/j.aquatox.2010.11.012	36	13	13	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48779	10.1371/journal.pone.0048779	http://dx.doi.org/10.1371/journal.pone.0048779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152802	gold, Green Published, Green Submitted			2022-12-25	WOS:000311234000029
J	van Lierop, MJC; Alkema, W; Laskewitz, AJ; Dijkema, R; van der Maaden, HM; Smit, MJ; Plate, R; Conti, PGM; Jans, CGJM; Timmers, CM; van Boeckel, CAA; Lusher, SJ; McGuire, R; van Schaik, RC; de Vlieg, J; Smeets, RL; Hofstra, CL; Boots, AMH; van Duin, M; Ingelse, BA; Schoonen, WGEJ; Grefhorst, A; van Dijk, TH; Kuipers, F; Dokter, WHA				van Lierop, Marie-Jose C.; Alkema, Wynand; Laskewitz, Anke J.; Dijkema, Rein; van der Maaden, Hans M.; Smit, Martin J.; Plate, Ralf; Conti, Paolo G. M.; Jans, Christan G. J. M.; Timmers, C. Marco; van Boeckel, Constant A. A.; Lusher, Scott J.; McGuire, Ross; van Schaik, Rene C.; de Vlieg, Jacob; Smeets, Ruben L.; Hofstra, Claudia L.; Boots, Annemieke M. H.; van Duin, Marcel; Ingelse, Benno A.; Schoonen, Willem G. E. J.; Grefhorst, Aldo; van Dijk, Theo H.; Kuipers, Folkert; Dokter, Wim H. A.			Org 214007-0: A Novel Non-Steroidal Selective Glucocorticoid Receptor Modulator with Full Anti-Inflammatory Properties and Improved Therapeutic Index	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; INDUCED ARTHRITIS; HEALTHY-SUBJECTS; GENE-EXPRESSION; BIOMAP ANALYSIS; TRANSREPRESSION; AGONIST; TRANSACTIVATION; REPRESSION	Glucocorticoids (GCs) such as prednisolone are potent immunosuppressive drugs but suffer from severe adverse effects, including the induction of insulin resistance. Therefore, development of so-called Selective Glucocorticoid Receptor Modulators (SGRM) is highly desirable. Here we describe a non-steroidal Glucocorticoid Receptor (GR)-selective compound (Org 214007-0) with a binding affinity to GR similar to that of prednisolone. Structural modelling of the GR-Org 214007-0 binding site shows disturbance of the loop between helix 11 and helix 12 of GR, confirmed by partial recruitment of the TIF2-3 peptide. Using various cell lines and primary human cells, we show here that Org 214007-0 acts as a partial GC agonist, since it repressed inflammatory genes and was less effective in induction of metabolic genes. More importantly, in vivo studies in mice indicated that Org 214007-0 retained full efficacy in acute inflammation models as well as in a chronic collagen-induced arthritis (CIA) model. Gene expression profiling of muscle tissue derived from arthritic mice showed a partial activity of Org 214007-0 at an equi-efficacious dosage of prednisolone, with an increased ratio in repression versus induction of genes. Finally, in mice Org 214007-0 did not induce elevated fasting glucose nor the shift in glucose/glycogen balance in the liver seen with an equi-efficacious dose of prednisolone. All together, our data demonstrate that Org 214007-0 is a novel SGRMs with an improved therapeutic index compared to prednisolone. This class of SGRMs can contribute to effective anti-inflammatory therapy with a lower risk for metabolic side effects.	[van Lierop, Marie-Jose C.; Smeets, Ruben L.; Hofstra, Claudia L.; Dokter, Wim H. A.] MSD, Dept Immune Therapeut, Oss, Netherlands; [Alkema, Wynand; Lusher, Scott J.; McGuire, Ross; van Schaik, Rene C.; de Vlieg, Jacob] MSD, Dept Mol Design & Informat, Oss, Netherlands; [Laskewitz, Anke J.; Grefhorst, Aldo; van Dijk, Theo H.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 AV Groningen, Netherlands; [Dijkema, Rein; van der Maaden, Hans M.; Smit, Martin J.] MSD, Dept Mol Pharmacol, Oss, Netherlands; [Plate, Ralf; Conti, Paolo G. M.; Jans, Christan G. J. M.; van Boeckel, Constant A. A.] MSD, Dept Med Chem, Oss, Netherlands; [Timmers, C. Marco; van Duin, Marcel] MSD, Womens Hlth Dept, Oss, Netherlands; [Boots, Annemieke M. H.] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands; [Kuipers, Folkert] Univ Med Ctr Groningen, Dept Lab Med, NL-9713 AV Groningen, Netherlands	Merck & Company; Merck & Company; University of Groningen; Merck & Company; Merck & Company; Merck & Company; University of Groningen; University of Groningen	van Lierop, MJC (corresponding author), MSD, Dept Immune Therapeut, Oss, Netherlands.	mariejose.vanlierop@merck.com	Boots, Annemieke M/D-7266-2011; Alkema, Wynand/G-5826-2018; McGuire, Ross/P-8855-2015; Smeets, Ruben L/M-9478-2015	Alkema, Wynand/0000-0002-5523-9217; McGuire, Ross/0000-0003-3404-6456; Smeets, Ruben L/0000-0002-2862-1058; Kuipers, Folkert/0000-0003-2518-737X; Schoonen, Willem/0000-0001-6321-504X	Top Institute Pharma (TIPharma) [TI-106]	Top Institute Pharma (TIPharma)	The work presented in this manuscript was financially supported by Top Institute Pharma (TIPharma), a nonprofit organization that catalyzes medicine development by founding partnerships between academia and industry, and was known under projectnumber TI-106. TIPharma had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The following co-authors are or were employees at Merck at the time the work described in this manuscript was performed: M.J.C. van Lierop, W. Alkema, R. Dijkema, H. van der Maaden, M.J. Smit, R. Plate, P.G.M. Conti, C.G.J.M. Jans, C.M. Timmers, C.A.A. van Boeckel, S.J. Lusher, R. McGuire, R.C. van Schaik, J. de Vlieg, R. Smeets, C.L. Hofstra, A.M.H. Boots, M. van Duin, B.A. Ingelse, W.G.J.E. Schoonen and W. Dokter. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The research described in this manuscript was funded by Top Institute Pharma (TIPharma), a nonprofit organization that catalyzes medicine development by founding partnerships between academia and industry. The co-author A.J. Laskewitz was employed by TIPharma. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.	an RA, 1993, MOL ENDOCRINOL, V7, P47; Bandsma RHJ, 2004, DIABETOLOGIA, V47, P2022, DOI 10.1007/s00125-004-1571-8; Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Biggadike K, 2008, J MED CHEM, V51, P3349, DOI 10.1021/jm800279t; Biggadike K, 2009, P NATL ACAD SCI USA, V106, P18114, DOI 10.1073/pnas.0909125106; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; de Groot DM, 2009, J IMMUNOL, V183, P4127, DOI 10.4049/jimmunol.0901253; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; Henningsen J, 2011, MOL BIOSYST, V7, P311, DOI 10.1039/c0mb00209g; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; Kroe RR, 2007, BIOPHYS CHEM, V128, P156, DOI 10.1016/j.bpc.2007.03.013; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; Laskewitz AJ, 2012, ENDOCRINOLOGY, V153, P3713, DOI 10.1210/en.2011-1891; Laskewitz AJ, 2010, ENDOCRINOLOGY, V151, P2171, DOI 10.1210/en.2009-1374; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; Lusher SJ, 2011, STEROIDS BASIC SCI, P221; Miner JN, 2007, P NATL ACAD SCI USA, V104, P19244, DOI 10.1073/pnas.0705517104; Nabuurs SB, 2007, J MED CHEM, V50, P6507, DOI 10.1021/jm070593p; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; ng BV, 2010, J MED CHEM, V53, P8241; Nielsen MF, 2004, AM J PHYSIOL-ENDOC M, V286, pE102, DOI 10.1152/ajpendo.00566.2002; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; PLATE R, 2007, Patent No. 2007025938; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Riether D, 2010, J MED CHEM, V53, P6681, DOI 10.1021/jm100751q; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Sun YG, 2008, MOL CELL ENDOCRINOL, V295, P59, DOI 10.1016/j.mce.2008.05.008; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Toonen EJM, 2011, PHARMACOGENOMICS, V12, P985, DOI [10.2217/pgs.11.34, 10.2217/PGS.11.34]; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Raalte DH, 2010, EUR J ENDOCRINOL, V162, P729, DOI 10.1530/EJE-09-1034; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; WAJNGOT A, 1990, AM J PHYSIOL, V259, pE626, DOI 10.1152/ajpendo.1990.259.5.E626; Wu J, 2004, MOL ENDOCRINOL, V18, P53, DOI 10.1210/me.2002-0373	54	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48385	10.1371/journal.pone.0048385	http://dx.doi.org/10.1371/journal.pone.0048385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152771	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000012
J	Abbott, GW; Ramesh, B; Srai, SK				Abbott, Geoffrey W.; Ramesh, Bala; Srai, Surjit K.			Interaction between Soluble and Membrane-Embedded Potassium Channel Peptides Monitored by Fourier Transform Infrared Spectroscopy	PLOS ONE			English	Article							VOLTAGE-SENSOR; SECONDARY STRUCTURE; INACTIVATION GATE; PUTATIVE RECEPTOR; DOMAIN; INFORMATION; TEMPERATURE; REGION; MODEL	Recent studies have explored the utility of Fourier transform infrared spectroscopy (FTIR) in dynamic monitoring of soluble protein-protein interactions. Here, we investigated the applicability of FTIR to detect interaction between synthetic soluble and phospholipid-embedded peptides corresponding to, respectively, a voltage-gated potassium (Kv) channel inactivation domain (ID) and S4-S6 of the Shaker Kv channel (KV1; including the S4-S5 linker "pre-inactivation" ID binding site). KV1 was predominantly alpha-helical at 30 degrees C when incorporated into dimyristoyl-L-alpha-phosphatidylcholine (DMPC) bilayers. Cooling to induce a shift in DMPC from liquid crystalline to gel phase reversibly decreased KV1 helicity, and was previously shown to partially extrude a synthetic S4 peptide. While no interaction was detected in liquid crystalline DMPC, upon cooling to induce the DMPC gel phase a reversible amide I peak (1633 cm(-1)) consistent with novel hydrogen bond formation was detected. This spectral shift was not observed for KV1 in the absence of ID (or vice versa), nor when the non-inactivating mutant V7E ID was applied to KV1 under similar conditions. Alteration of salt or redox conditions affected KV1-ID hydrogen bonding in a manner suggesting electrostatic KV1-ID interaction favored by a hairpin conformation for the ID and requiring extrusion of one or more KV1 domains from DMPC, consistent with ID binding to S4-S5. These findings support the utility of FTIR in detecting reversible interactions between soluble and membrane-embedded proteins, with lipid state-sensitivity of the conformation of the latter facilitating control of the interaction. Citation: Abbott GW, Ramesh B, Srai SK (2012) Interaction between Soluble and Membrane-Embedded Potassium Channel Peptides Monitored by Fourier Transform Infrared Spectroscopy. PLoS ONE 7(11): e49070. doi: 10.1371/journal.pone.0049070	[Abbott, Geoffrey W.] Univ Calif Irvine, Dept Pharmacol, Dept Physiol & Biophys, Sch Med, Irvine, CA 92717 USA; [Ramesh, Bala; Srai, Surjit K.] UCL, Dept Biochem & Mol Biol, London, England	University of California System; University of California Irvine; University of London; University College London	Abbott, GW (corresponding author), Univ Calif Irvine, Dept Pharmacol, Dept Physiol & Biophys, Sch Med, Irvine, CA 92717 USA.	abbottg@uci.edu	Srai, Kaila/AAE-7039-2021	Abbott, Geoffrey/0000-0003-4552-496X	Peter Samuels Royal Free Fund; University of California, Irvine	Peter Samuels Royal Free Fund; University of California, Irvine(University of California System)	The authors are grateful for financial support from the Peter Samuels Royal Free Fund and University of California, Irvine setup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1998, BIOCHEMISTRY-US, V37, P1640, DOI 10.1021/bi972350c; Antz C, 1999, NAT STRUCT BIOL, V6, P146; Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; Brazier SP, 1998, BIOCHEM J, V335, P375, DOI 10.1042/bj3350375; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; Chen YR, 2003, BIOCHEMISTRY-US, V42, P6310, DOI 10.1021/bi0340752; Encinar JA, 1998, BIOCHEM J, V331, P497, DOI 10.1042/bj3310497; Encinar JA, 1996, BIOPHYS J, V71, P1313, DOI 10.1016/S0006-3495(96)79331-1; FERNANDEZBALLESTER G, 1995, BIOPHYS J, V68, P858, DOI 10.1016/S0006-3495(95)80262-6; Haris PI, 2010, BIOCHEM SOC T, V38, P940, DOI 10.1042/BST0380940; HARIS PI, 1992, TRENDS BIOCHEM SCI, V17, P328, DOI 10.1016/0968-0004(92)90305-S; HARIS PI, 1994, FEBS LETT, V349, P371, DOI 10.1016/0014-5793(94)00704-7; Helluin O, 1996, BBA-BIOMEMBRANES, V1279, P1, DOI 10.1016/0005-2736(95)00270-7; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; JANIAK MJ, 1979, J BIOL CHEM, V254, P6068; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Lombardi SJ, 1998, J BIOL CHEM, V273, P30092, DOI 10.1074/jbc.273.46.30092; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O; Mercer EAJ, 1997, BIOCHEM J, V325, P475, DOI 10.1042/bj3250475; MERRIFIELD RB, 1965, ENDEAVOUR, V24, P3, DOI 10.1016/0160-9327(65)90090-6; MULVEY D, 1989, FEBS LETT, V257, P113, DOI 10.1016/0014-5793(89)81799-5; Park MT, 2001, BIOTECHNOL BIOENG, V72, P434, DOI 10.1002/1097-0290(20000220)72:4<434::AID-BIT1005>3.0.CO;2-6; Perl D, 2001, J MOL BIOL, V313, P343, DOI 10.1006/jmbi.2001.5050; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Ugwu S.O., 2004, PHARM TECHNOL, V28, P86, DOI DOI 10.1016/J.SAA.2011.06.021; VANSTOKKUM IHM, 1995, BIOCHEMISTRY-US, V34, P10508, DOI 10.1021/bi00033a024; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	38	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49070	10.1371/journal.pone.0049070	http://dx.doi.org/10.1371/journal.pone.0049070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145073	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500072
J	Rubelt, MS; Amasheh, S; Grobosch, T; Stein, C				Rubelt, Miriam S.; Amasheh, Salah; Grobosch, Thomas; Stein, Christoph			Liquid Chromatography-Tandem Mass Spectrometry for Analysis of Intestinal Permeability of Loperamide in Physiological Buffer	PLOS ONE			English	Article							P-GLYCOPROTEIN; IN-VITRO; OPIOID ANTINOCICEPTION; BARRIER PROPERTIES; HUMAN PLASMA; PAIN; CACO-2; MODEL; RAT; PHARMACOKINETICS	Analysis of in vitro samples with high salt concentrations represents a major challenge for fast and specific quantification with liquid chromatography-tandem mass spectrometry (LC-MS/MS). To investigate the intestinal permeability of opioids in vitro employing the Ussing chamber technique, we developed and validated a fast, sensitive and selective method based on LC-MS/MS for the determination of loperamide in HEPES-buffered Ringer's solution. Chromatographic separation was achieved with an Atlantis dC18 column, 2.1 mm x 20 mm, 3 mu m particle size and a gradient consisting of methanol/0.1% formic acid and ammonium acetate. The flow rate was 0.7 ml/min, and the total run time was 3 min. For quantification, two mass transitions for loperamide and a deuterated internal standard (methadone-d(3)) were used. The lower limit of loperamide quantification was 0.2 ng/ml. This new LC-MS/MS method can be used for the detection of loperamide in any experimental setup using HEPES-buffered Ringer's solution as a matrix compound.	[Rubelt, Miriam S.; Stein, Christoph] Charite, Dept Anesthesiol, Berlin, Germany; [Amasheh, Salah] Charite, Inst Clin Physiol, Berlin, Germany; [Grobosch, Thomas] Labor Berlin Charite Vivantes GmbH, Lab Med & Toxikol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rubelt, MS (corresponding author), Charite, Dept Anesthesiol, Berlin, Germany.	miriam.heydt@charite.de	Amasheh, Salah/AAG-4035-2021	Stein, Christoph/0000-0001-5240-6836	Deutsche Forschungsgemeinschaft (DFG); Freie Universitat Berlin (focus area NanoScale)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Freie Universitat Berlin (focus area NanoScale)	This project was supported by the Deutsche Forschungsgemeinschaft (DFG) and the Freie Universitat Berlin (focus area NanoScale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh S, 2005, CELL TISSUE RES, V321, P89, DOI 10.1007/s00441-005-1101-0; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; [Anonymous], 2002, LINEARE KALIBRATIONS, P9; Craft RM, 1995, J PHARMACOL EXP THER, V275, P1535; Crowe A, 2004, DRUG DEV IND PHARM, V30, P449, DOI 10.1081/DDC-120037471; Crowe A, 2003, TOXICOL APPL PHARM, V193, P127, DOI 10.1016/S0041-008X(03)00372-7; Elkiweri IA, 2009, ANESTH ANALG, V108, P149, DOI 10.1213/ane.0b013e31818e0bd1; Faupel-Badger JM, 2010, CANCER EPIDEM BIOMAR, V19, P292, DOI 10.1158/1055-9965.EPI-09-0643; Furst S, 2005, J PHARMACOL EXP THER, V312, P609, DOI 10.1124/jpet.104.075176; Gaveriaux-Ruff C, 2011, PAIN; Go3R, GO3R SEM SEARCH AV A; Grune B, 2004, ALTEX-ALTERN TIEREXP, V21, P115; He HB, 2000, J CHROMATOGR B, V744, P323, DOI 10.1016/S0378-4347(00)00253-X; Hernandez-Covarrubias C, 2012, EUR J MED CHEM, V52, P193, DOI 10.1016/j.ejmech.2012.03.014; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Jessome L. L., 2006, ION SUPPRESSION MAJO; Kalvass JC, 2007, J PHARMACOL EXP THER, V323, P346, DOI 10.1124/jpet.107.119560; Kalvass JC, 2004, PHARM RES-DORDR, V21, P1867, DOI 10.1023/B:PHAM.0000045241.26925.8b; Kataoka M, 2011, INT J PHARMACEUT, V414, P69, DOI 10.1016/j.ijpharm.2011.05.016; Kohler C, 2011, ANAL BIOANAL CHEM, V400, P17, DOI 10.1007/s00216-010-4466-1; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Li Hongyu, 2004, J Cyst Fibros, V3 Suppl 2, P123, DOI 10.1016/j.jcf.2004.05.026; Markov AG, 2010, J COMP PHYSIOL B, V180, P591, DOI 10.1007/s00360-009-0440-7; Mercer SL, 2011, CURR TOP MED CHEM, V11, P1157; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; NIEMEGEERS CJE, 1981, DRUG DEVELOP RES, V1, P1, DOI 10.1002/ddr.430010102; Peters FT, 2007, FORENSIC SCI INT, V165, P216, DOI 10.1016/j.forsciint.2006.05.021; Reichert JA, 2001, PAIN, V89, P221, DOI 10.1016/S0304-3959(00)00365-1; Russell WMS., 1959, MED J AUSTRALIA; Shannon HE, 2002, NEUROPHARMACOLOGY, V42, P253, DOI 10.1016/S0028-3908(01)00173-3; Shin YG, 2011, ARCH PHARM RES, V34, P1983, DOI 10.1007/s12272-011-1119-7; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Streel B, 2005, J CHROMATOGR B, V814, P263, DOI 10.1016/j.jchromb.2004.10.050; Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI [10.1517/17425255.4.4.395, 10.1517/17425255.4.4.395 ]; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Tseong L. F., 1995, PHARM OPIOID PEPTIDE; USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x; van Dorp ELA, 2008, EXPERT OPIN PHARMACO, V9, P1955, DOI [10.1517/14656566.9.11.1955, 10.1517/14656566.9.11.1955 ]; Xu X, 2005, ANAL CHEM, V77, P6646, DOI 10.1021/ac050697c; Yamashita S, 2002, J PHARM SCI, V91, P669, DOI 10.1002/jps.10050	41	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48502	10.1371/journal.pone.0048502	http://dx.doi.org/10.1371/journal.pone.0048502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144895	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500025
J	Andras, P				Andras, Peter			A Bayesian Interpretation of the Particle Swarm Optimization and Its Kernel Extension	PLOS ONE			English	Article							ALGORITHM	Particle swarm optimization is a popular method for solving difficult optimization problems. There have been attempts to formulate the method in formal probabilistic or stochastic terms (e. g. bare bones particle swarm) with the aim to achieve more generality and explain the practical behavior of the method. Here we present a Bayesian interpretation of the particle swarm optimization. This interpretation provides a formal framework for incorporation of prior knowledge about the problem that is being solved. Furthermore, it also allows to extend the particle optimization method through the use of kernel functions that represent the intermediary transformation of the data into a different space where the optimization problem is expected to be easier to be resolved-such transformation can be seen as a form of prior knowledge about the nature of the optimization problem. We derive from the general Bayesian formulation the commonly used particle swarm methods as particular cases.	Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Andras, P (corresponding author), Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	peter.andras@ncl.ac.uk	Andras, Peter/AAV-1194-2020	Andras, Peter/0000-0002-9321-3296	School of Computing Science of Newcastle University	School of Computing Science of Newcastle University	There was no specific funding provided for this research beyond the support from the School of Computing Science of Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai TJ, 2009, COMPUT OPER RES, V36, P1693, DOI 10.1016/j.cor.2008.04.003; AlRashidi MR, 2009, IEEE T EVOLUT COMPUT, V13, P913, DOI 10.1109/TEVC.2006.880326; Banks Alec, 2007, Natural Computing, V6, P467, DOI 10.1007/s11047-007-9049-5; Banks Alec, 2008, Natural Computing, V7, P109, DOI 10.1007/s11047-007-9050-z; Blackwell Tim, 2008, P193, DOI 10.1007/978-3-540-74089-6_6; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; Eberhart RC, 2000, IEEE C EVOL COMPUTAT, P84, DOI 10.1109/CEC.2000.870279; Haykin S. O., 2008, NEURAL NETWORKS LEAR; Kennedy J, 2003, PROCEEDINGS OF THE 2003 IEEE SWARM INTELLIGENCE SYMPOSIUM (SIS 03), P80, DOI 10.1109/SIS.2003.1202251; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Krohling RA, 2009, IEEE C EVOL COMPUTAT, P3285, DOI 10.1109/CEC.2009.4983361; Liu HB, 2010, FUTURE GENER COMP SY, V26, P1336, DOI 10.1016/j.future.2009.05.022; Monson CK, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P193; Monson CK, 2004, LECT NOTES COMPUT SC, V3102, P140; Montes de Oca MA, 2009, TRIRIDIA2009002; Pan QK, 2008, COMPUT OPER RES, V35, P2807, DOI 10.1016/j.cor.2006.12.030; Poli Riccardo, 2007, Swarm Intelligence, V1, P33, DOI 10.1007/s11721-007-0002-0; Poli R, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P142; Richer T, 2006, P IEEE C EV COMP, P3150; Schabeck R, 2009, DOLOMITES RES NOTES; Scholkopf B., 1998, ADV KERNEL METHODS; Schwaab M, 2008, CHEM ENG SCI, V63, P1542, DOI 10.1016/j.ces.2007.11.024; Zhang GH, 2009, COMPUT IND ENG, V56, P1309, DOI 10.1016/j.cie.2008.07.021	24	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48710	10.1371/journal.pone.0048710	http://dx.doi.org/10.1371/journal.pone.0048710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144937	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000311935800104
J	Lee, MJ; Shin, DH; Kim, SJ; Oh, HJ; Yoo, DE; Ko, KI; Koo, HM; Kim, CH; Doh, FM; Park, JT; Han, SH; Yoo, TH; Choi, KH; Kang, SW				Lee, Mi Jung; Shin, Dong Ho; Kim, Seung Jun; Oh, Hyung Jung; Yoo, Dong Eun; Ko, Kwang Il; Koo, Hyang Mo; Kim, Chan Ho; Doh, Fa Mee; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook			Progression of Aortic Arch Calcification Over 1 Year Is an Independent Predictor of Mortality in Incident Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC-KIDNEY-DISEASE; STAGE RENAL-DISEASE; CORONARY-ARTERY CALCIFICATION; CHEST-X-RAY; VASCULAR CALCIFICATION; HEMODIALYSIS-PATIENTS; MAINTENANCE HEMODIALYSIS; CARDIOVASCULAR-DISEASE; MINERAL METABOLISM; RISK-FACTORS	Backgrounds and Aims: The presence and progression of vascular calcification have been demonstrated as important risk factors for mortality in dialysis patients. However, since the majority of subjects included in most previous studies were hemodialysis patients, limited information was available in peritoneal dialysis (PD) patients. Therefore, the aim of this study was to investigate the prevalence of aortic arch calcification (AoAC) and prognostic value of AoAC progression in PD patients. Methods: We prospectively determined AoAC by chest X-ray at PD start and after 12 months, and evaluated the impact of AoAC progression on mortality in 415 incident PD patients. Results: Of 415 patients, 169 patients (40.7%) had AoAC at baseline with a mean of 18.1+/-11.2%. The presence of baseline AoAC was an independent predictor of all-cause [Hazard ratio (HR): 2.181, 95% confidence interval (CI): 1.336-3.561, P = 0.002] and cardiovascular mortality (HR: 3.582, 95% CI: 1.577-8.132, P = 0.002). Among 363 patients with follow-up chest X-rays at 12 months after PD start, the proportion of patients with AoAC progression was significantly higher in patients with baseline AoAC (64.2 vs. 5.3%, P<0.001). Moreover, all-cause and cardiovascular death rates were significantly higher in the progression groups than in the non-progression group (P<0.001). Multivariate Cox analysis revealed that AoAC progression was an independent predictor for all-cause (HR: 2.625, 95% CI: 1.150-5.991, P = 0.022) and cardiovascular mortality (HR: 4.008, 95% CI: 1.079-14.890, P = 0.038) in patients with AoAC at baseline. Conclusions: The presence and progression of AoAC assessed by chest X-ray were independently associated with unfavorable outcomes in incident PD patients. Regular follow-up by chest X-ray could be a simple and useful method to stratify mortality risk in these patients.	[Lee, Mi Jung; Shin, Dong Ho; Kim, Seung Jun; Oh, Hyung Jung; Yoo, Dong Eun; Ko, Kwang Il; Koo, Hyang Mo; Kim, Chan Ho; Doh, Fa Mee; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yoo, Tae-Hyun; Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Kang, SW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kswkidney@yumc.yonsei.ac.kr	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018; Kim, Seung Jun/N-5248-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kim, Seung Jun/0000-0002-6913-6358; Kang, Shin-Wook/0000-0002-5677-4756; Choi, Kyu Hun/0000-0003-0095-9011; Yoo, Tae-Hyun/0000-0002-9183-4507; doh, fa mee/0000-0002-4780-6728; Lee, Mi Jung/0000-0001-8888-029X; Park, Jung Tak/0000-0002-2325-8982	Brain Korea 21 Project for Medical Science, Yonsei University; National Research Foundation of Korea; Korea government (MEST) [2011-0030711]; Korea Healthcare Technology Research & Development project, Ministry of Health and Welfare, Republic of Korea [A102065]	Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology Research & Development project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea grant funded by the Korea government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology Research & Development project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirati AL, 2007, PERITON DIALYSIS INT, V27, P340; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Drueke TB, 2010, NAT REV NEPHROL, V6, P723, DOI 10.1038/nrneph.2010.143; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Garland JS, 2008, AM J KIDNEY DIS, V52, P849, DOI 10.1053/j.ajkd.2008.04.012; Hashimoto H, 2009, J ATHEROSCLER THROMB, V16, P256, DOI 10.5551/jat.E570; Inoue T, 2011, HEART VESSELS, DOI 10,1007/S00380-011-0129-1; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Jiang CQ, 2009, ATHEROSCLEROSIS, V202, P529, DOI 10.1016/j.atherosclerosis.2008.03.004; Jung HH, 2006, NEPHROL DIAL TRANSPL, V21, P1915, DOI 10.1093/ndt/gfl118; Karohl C, 2011, NAT REV NEPHROL, V7, P567, DOI 10.1038/nrneph.2011.110; Kim HG, 2011, HEMODIAL INT, V15, P460, DOI 10.1111/j.1542-4758.2011.00571.x; Klassen PS, 2002, JAMA-J AM MED ASSOC, V287, P1548, DOI 10.1001/jama.287.12.1548; Koo HM, 2011, ATHEROSCLEROSIS, V219, P925, DOI 10.1016/j.atherosclerosis.2011.09.025; Kurita N, 2011, NEPHROL DIAL TRANSPL, V26, P1747, DOI 10.1093/ndt/gfr087; Leskinen Y, 2009, J HEART VALVE DIS, V18, P429; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Momiyama Y, 2010, ATHEROSCLEROSIS, V210, P668, DOI 10.1016/j.atherosclerosis.2009.12.024; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Noordzij M, 2011, NEPHROL DIAL TRANSPL, V26, P1662, DOI 10.1093/ndt/gfq582; Ogawa T, 2010, INT UROL NEPHROL, V42, P187, DOI 10.1007/s11255-009-9574-5; Ogawa T, 2009, HEMODIAL INT, V13, P301, DOI 10.1111/j.1542-4758.2009.00366.x; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Rana JS, 2012, AM J CARDIOL; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Sigrist M, 2006, NEPHROL DIAL TRANSPL, V21, P707, DOI 10.1093/ndt/gfi236; Sigrist MK, 2007, CLIN J AM SOC NEPHRO, V2, P1241, DOI 10.2215/CJN.02190507; Taniwaki H, 2005, NEPHROL DIAL TRANSPL, V20, P2472, DOI 10.1093/ndt/gfi039; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; Turkmen K, 2011, CLIN J AM SOC NEPHRO, V6, P1920, DOI 10.2215/CJN.00890111; TWARDOWSKI ZJ, 1989, BLOOD PURIFICAT, V7, P95, DOI 10.1159/000169582; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; WITTEMAN JCM, 1986, LANCET, V2, P1120; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; Yamada K, 2007, NEPHROL DIAL TRANSPL, V22, P2032, DOI 10.1093/ndt/gfm031	39	5	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48793	10.1371/journal.pone.0048793	http://dx.doi.org/10.1371/journal.pone.0048793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144974	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800136
J	Louarn, J; Carbonne, F; Delavault, P; Becard, G; Rochange, S				Louarn, Johann; Carbonne, Francis; Delavault, Philippe; Becard, Guillaume; Rochange, Soizic			Reduced Germination of Orobanche cumana Seeds in the Presence of Arbuscular Mycorrhizal Fungi or Their Exudates	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; PHELIPANCHE; RESISTANCE; STRIGA; STRIGOLACTONES; COLONIZATION; METABOLITES; BIOCONTROL; HELIANTHUS; SYMBIOSIS	Broomrapes (Orobanche and Phelipanche spp) are parasitic plants responsible for important crop losses, and efficient procedures to control these pests are scarce. Biological control is one of the possible strategies to tackle these pests. Arbuscular Mycorrhizal (AM) fungi are widespread soil microorganisms that live symbiotically with the roots of most plant species, and they have already been tested on sorghum for their ability to reduce infestation by witchweeds, another kind of parasitic plants. In this work AM fungi were evaluated as potential biocontrol agents against Orobanche cumana, a broomrape species that specifically attacks sunflower. When inoculated simultaneously with O. cumana seeds, AM fungi could offer a moderate level of protection against the broomrape. Interestingly, this protection did not only rely on a reduced production of parasitic seed germination stimulants, as was proposed in previous studies. Rather, mycorrhizal root exudates had a negative impact on the germination of O. cumana induced by germination stimulants. A similar effect could be obtained with AM spore exudates, establishing the fungal origin of at least part of the active compounds. Together, our results demonstrate that AM fungi themselves can lead to a reduced rate of parasitic seed germination, in addition to possible effects mediated by the mycorrhizal plant. Combined with the other benefits of AM symbiosis, these effects make AM fungi an attractive option for biological control of O. cumana.	[Louarn, Johann; Carbonne, Francis; Becard, Guillaume; Rochange, Soizic] Univ Toulouse, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Louarn, Johann; Carbonne, Francis; Becard, Guillaume; Rochange, Soizic] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Delavault, Philippe] LUNAM Univ, SFR QUASAV 4207, Lab Biol & Pathol Vegetales, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rochange, S (corresponding author), Univ Toulouse, UPS, UMR 5546, Lab Rech Sci Vegetales, BP 42617 Auzeville, F-31326 Castanet Tolosan, France.	rochange@scsv.ups-tlse.fr			Association Nationale de la Recherche et de la Technologie (France); Syngenta Seeds; Soltis through a CIFRE grant [300/2009]; Soltis; Syngenta	Association Nationale de la Recherche et de la Technologie (France); Syngenta Seeds(Syngenta); Soltis through a CIFRE grant; Soltis; Syngenta(Syngenta)	JL was funded by the Association Nationale de la Recherche et de la Technologie (France), Syngenta Seeds and Soltis through a CIFRE grant (number 300/2009). The authors wish to declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by 'Soltis' and 'Syngenta'. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Amsellem Z, 2001, BIOCONTROL, V46, P211, DOI 10.1023/A:1011496114707; Andolfi A, 2005, J AGR FOOD CHEM, V53, P1598, DOI 10.1021/jf048339i; Auger B, 2012, MOL PLANT MICROBE IN, V25, P993, DOI 10.1094/MPMI-01-12-0006-R; Balzergue C, 2011, J EXP BOT, V62, P1049, DOI 10.1093/jxb/erq335; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Bouizgarne B, 2006, MOL PLANT MICROBE IN, V19, P550, DOI 10.1094/MPMI-19-0550; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; Brachmann A, 2006, PLOS BIOL, V4, P1111, DOI 10.1371/journal.pbio.0040239; Cardoso C, 2011, PLANT SCI, V180, P414, DOI 10.1016/j.plantsci.2010.11.007; Castellan NJ, 1988, NONPARAMETRIC STAT B; de Luque AP, 2000, PHYTOCHEMISTRY, V53, P45, DOI 10.1016/S0031-9422(99)00485-9; de Zelicourt A, 2009, PLANTA, V230, P1047, DOI 10.1007/s00425-009-1008-1; Dominguez J, 1996, PLANT BREEDING, V115, P203, DOI 10.1111/j.1439-0523.1996.tb00904.x; Draie R, 2011, MOL PLANT PATHOL, V12, P638, DOI 10.1111/J.1364-3703.2010.00702.X; Fernandez-Aparicio M, 2010, WEED RES, V50, P262, DOI 10.1111/j.1365-3180.2010.00771.x; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; Joel DM, 2011, PHYTOCHEMISTRY, V72, P624, DOI 10.1016/j.phytochem.2011.01.037; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Labrousse P, 2001, ANN BOT-LONDON, V88, P859, DOI 10.1006/anbo.2001.1520; Lendzemo VW, 2007, PLANT SIGNAL BEHAV, V2, P58, DOI 10.4161/psb.2.1.3884; Lendzemo VW, 2001, AGR ECOSYST ENVIRON, V87, P29, DOI 10.1016/S0167-8809(00)00293-0; Lopez-Granados F, 1999, WEED SCI, V47, P161, DOI 10.1017/S0043174500091578; Lopez-Raez JA, 2011, J PLANT PHYSIOL, V168, P294, DOI 10.1016/j.jplph.2010.08.011; MUSSELMAN LJ, 1980, ANNU REV PHYTOPATHOL, V18, P463, DOI 10.1146/annurev.py.18.090180.002335; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Perez-De-Luque A, 2009, WEED RES, V49, P8, DOI 10.1111/j.1365-3180.2009.00738.x; Pujadas-Salva AJ, 2000, BOT J LINN SOC, V134, P513, DOI 10.1111/j.1095-8339.2000.tb00548.x; Rubiales D, 2006, EUPHYTICA, V147, P187, DOI 10.1007/s10681-006-7399-1; Sauerborn J, 2007, CROP PROT, V26, P246, DOI 10.1016/j.cropro.2005.12.012; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; Serghini K, 2001, J EXP BOT, V52, P2227, DOI 10.1093/jexbot/52.364.2227; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Sun Z, 2008, PLANTA, V228, P789, DOI 10.1007/s00425-008-0781-6; Thomas H, 1998, BIOL CONTROL, V13, P41, DOI 10.1006/bcon.1998.0642; Thorogood CJ, 2009, WEED RES, V49, P461, DOI 10.1111/j.1365-3180.2009.00716.x; Tosi L, 2000, EUR J PLANT PATHOL, V106, P735, DOI 10.1023/A:1026543126341; Velasco L, 2007, PLANT BREEDING, V126, P67, DOI 10.1111/j.1439-0523.2006.01278.x; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Vurro M, 2009, PEST MANAG SCI, V65, P566, DOI 10.1002/ps.1742; Yoder JI, 2010, CURR OPIN PLANT BIOL, V13, P478, DOI 10.1016/j.pbi.2010.04.011; Yoneyama K, 2011, PLANT GROWTH REGUL, V65, P495, DOI 10.1007/s10725-011-9620-z	46	29	36	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49273	10.1371/journal.pone.0049273	http://dx.doi.org/10.1371/journal.pone.0049273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145139	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800239
J	Ramdya, P; Schaffter, T; Floreano, D; Benton, R				Ramdya, Pavan; Schaffter, Thomas; Floreano, Dario; Benton, Richard			Fluorescence Behavioral Imaging (FBI) Tracks Identity in Heterogeneous Groups of Drosophila	PLOS ONE			English	Article							MALE COURTSHIP; MELANOGASTER; EXPRESSION	Distinguishing subpopulations in group behavioral experiments can reveal the impact of differences in genetic, pharmacological and life-histories on social interactions and decision-making. Here we describe Fluorescence Behavioral Imaging (FBI), a toolkit that uses transgenic fluorescence to discriminate subpopulations, imaging hardware that simultaneously records behavior and fluorescence expression, and open-source software for automated, high-accuracy determination of genetic identity. Using FBI, we measure courtship partner choice in genetically mixed groups of Drosophila.	[Ramdya, Pavan; Benton, Richard] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Lausanne, Switzerland; [Ramdya, Pavan; Schaffter, Thomas; Floreano, Dario] Ecole Polytech Fed Lausanne, Lab Intelligent Syst, Inst Microengn, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Ramdya, P (corresponding author), Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Lausanne, Switzerland.	pavan.ramdya@epfl.ch			Human Frontier Science Program Long-Term Fellowship; SystemsX.ch Initiative; European Research Council	Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); SystemsX.ch Initiative; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Human Frontier Science Program Long-Term Fellowship (www.hfsp.org); SystemsX.ch Initiative (http://www.systemsx.ch/); and a European Research Council Starting Independent Researcher Grant (http://erc.europa.eu/starting-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; GAILEY DA, 1989, GENETICS, V121, P773; GEYER PK, 1986, MOL CELL BIOL, V6, P3388, DOI 10.1128/MCB.6.10.3388; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Grover D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-93; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/NMETH.1800, 10.1038/nmeth.1800]; Schaefer AT, 2012, CURR OPIN NEUROBIOL, V22, P170, DOI 10.1016/j.conb.2011.11.004; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; The MathWorks Inc, 2011, MATLAB VERS 7 13 0	22	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48381	10.1371/journal.pone.0048381	http://dx.doi.org/10.1371/journal.pone.0048381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144871	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800050
J	Ryan, PE; Kales, SC; Yadavalli, R; Nau, MM; Zhang, H; Lipkowitz, S				Ryan, Philip E.; Kales, Stephen C.; Yadavalli, Rajgopal; Nau, Marion M.; Zhang, Han; Lipkowitz, Stanley			Cbl-c Ubiquitin Ligase Activity Is Increased via the Interaction of Its RING Finger Domain with a LIM Domain of the Paxillin Homolog, Hic 5	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CONFORMATIONAL-CHANGE; POSSIBLE INVOLVEMENT; CONJUGATING ENZYME; ADHESION KINASE; FOCAL ADHESIONS; PROTEIN HIC-5; ACTIVATION; SENESCENCE; COMPLEX	Cbl proteins (Cbl, Cbl-b and Cbl-c) are ubiquitin ligases that are critical regulators of tyrosine kinase signaling. In this study we identify a new Cbl-c interacting protein, Hydrogen peroxide Induced Construct 5 (Hic-5). The two proteins interact through a novel interaction mediated by the RING finger of Cbl-c and the LIM2 domain of Hic-5. Further, this interaction is mediated and dependent on specific zinc coordinating complexes within the RING finger and LIM domain. Binding of Hic-5 to Cbl-c leads to an increase in the ubiquitin ligase activity of Cbl-c once Cbl-c has been activated by Src phosphorylation or through an activating phosphomimetic mutation. In addition, co-transfection of Hic-5 with Cbl-c leads to an increase in Cblc mediated ubiquitination of the EGFR. These data suggest that Hic-5 enhances Cbl-c ubiquitin ligase activity once Cbl-c has been phosphorylated and activated. Interactions between heterologous RING fingers have been shown to activate E3s. This is the first demonstration of enhancement of ubiquitin ligase activity of a RING finger ubiquitin ligase by the direct interaction of a LIM zinc coordinating domain.	[Ryan, Philip E.; Kales, Stephen C.; Yadavalli, Rajgopal; Nau, Marion M.; Zhang, Han; Lipkowitz, Stanley] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ryan, Philip E.] George Washington Univ, Inst Biomed Sci, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University	Lipkowitz, S (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lipkowis@mail.nih.gov			Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010977] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraamides C, 2007, AM J PHYSIOL-HEART C, V293, pH193, DOI 10.1152/ajpheart.00728.2006; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BORDEN KLB, 1995, EMBO J, V14, P5947, DOI 10.1002/j.1460-2075.1995.tb00283.x; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Ettenberg S A, 1999, Mol Cell Biol Res Commun, V2, P111, DOI 10.1006/mcbr.1999.0157; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Gao ZL, 2007, EXP CELL RES, V313, P4000, DOI 10.1016/j.yexcr.2007.05.023; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Hagmann J, 1998, J CELL SCI, V111, P2181; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; LANGDON WY, 1990, CURR TOP MICROBIOL, V166, P159; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lill NL, 2000, J BIOL CHEM, V275, P367, DOI 10.1074/jbc.275.1.367; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Mori K, 2006, J BIOL CHEM, V281, P22048, DOI 10.1074/jbc.M513111200; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nau MM, 2008, CBL PROTEINS, P3; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Park HJ, 2008, BIOCHEMISTRY-US, V47, P13887, DOI 10.1021/bi801904q; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Shibanuma M, 1997, MOL CELL BIOL, V17, P1224, DOI 10.1128/MCB.17.3.1224; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Shibanuma M, 2002, CELL STRUCT FUNCT, V27, P21, DOI 10.1247/csf.27.21; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Yang XA, 2004, PROTEIN EXPRES PURIF, V33, P332, DOI 10.1016/j.pep.2003.10.006; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	48	10	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49428	10.1371/journal.pone.0049428	http://dx.doi.org/10.1371/journal.pone.0049428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145173	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800258
J	Uuskula, L; Mannik, J; Rull, K; Minajeva, A; Koks, S; Vaas, P; Teesalu, P; Reimand, J; Laan, M				Uuskuela, Liis; Maennik, Jaana; Rull, Kristiina; Minajeva, Ave; Koks, Sulev; Vaas, Pille; Teesalu, Pille; Reimand, Jueri; Laan, Maris			Mid-Gestational Gene Expression Profile in Placenta and Link to Pregnancy Complications	PLOS ONE			English	Article							CREATINE SYNTHESIS; STANNIOCALCIN 1; IMPRINTED GENE; PROTEIN; IDENTIFICATION; TRANSCRIPTION; FOLLISTATIN; REVEALS; NETWORK; ZAC1	Despite the importance of placenta in mediating rapid physiological changes in pregnancy, data on temporal dynamics of placental gene expression are limited. We completed the first transcriptome profiling of human placental gene expression dynamics (GeneChips, Affymetrix (R); similar to 47,000 transcripts) from early to mid-gestation (n = 10; gestational weeks 5-18) and report 154 genes with significant transcriptional changes (ANOVA, FDR P < 0.1). TaqMan RT-qPCR analysis (n = 43; gestational weeks 5-41) confirmed a significant (ANOVA and t-test, FDR P < 0.05) mid-gestational peak of placental gene expression for BMP5, CCNG2, CDH11, FST, GATM, GPR183, ITGBL1, PLAGL1, SLC16A10 and STC1, followed by sharp decrease in mRNA levels at term (t-test, FDR P < 0.05). We hypothesized that normal course of late pregnancy may be affected when genes characteristic to mid-gestation placenta remain highly expressed until term, and analyzed their expression in term placentas from normal and complicated pregnancies [preeclampsia (PE), n = 12; gestational diabetes mellitus (GDM), n = 12; small- and large-for-gestational-age newborns (SGA, LGA), n = 12+ 12]. STC1 (stanniocalcin 1) exhibited increased mRNA levels in all studied complications, with the most significant effect in PE- and SGA-groups (t-test, FDR P, 0.05). In post-partum maternal plasma, the highest STC1 hormone levels (ELISA, n = 129) were found in women who had developed PE and delivered a SGA newborn (median 731 vs 418 pg/ml in controls; ANCOVA, P = 0.00048). Significantly higher expression (t-test, FDR P < 0.05) of CCNG2 and LYPD6 accompanied with enhanced immunostaining of the protein was detected in placental sections of PE and GDM cases (n = 15). Our study demonstrates the importance of temporal dynamics of placental transcriptional regulation across three trimesters of gestation. Interestingly, many genes with high expression in mid-gestation placenta have also been implicated in adult complex disease, promoting the discussion on the role of placenta in developmental programming. The discovery of elevated maternal plasma STC1 in pregnancy complications warrants further investigations of its potential as a biomarker.	[Reimand, Jueri] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Uuskuela, Liis; Maennik, Jaana; Rull, Kristiina; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Grp, EE-50090 Tartu, Estonia; [Maennik, Jaana] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN USA; [Rull, Kristiina; Vaas, Pille; Teesalu, Pille] Tartu Univ Hosp, Dept Obstet & Gynecol, Tartu, Estonia; [Minajeva, Ave] Tartu Univ Hosp, Dept Pathol, Tartu, Estonia; [Koks, Sulev] Univ Tartu, Dept Physiol, Ctr Translat Med, EE-50090 Tartu, Estonia	University of Toronto; University of Tartu; University of Tennessee System; University of Tennessee Knoxville; University of Tartu	Reimand, J (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.	Juri.Reimand@utoronto.ca; maris.laan@ut.ee	Rull, Kristiina/H-9555-2013; Reimand, Jüri/U-9264-2019; Laan, Maris/A-4100-2011; Koks, Sulev/H-3655-2015; Minajeva, Ave/F-6977-2017	Rull, Kristiina/0000-0002-3396-0716; Reimand, Jüri/0000-0002-2299-2309; Laan, Maris/0000-0002-8519-243X; Koks, Sulev/0000-0001-6087-6643; Minajeva, Ave/0000-0003-0256-1410; Mannik, Jaana/0000-0002-0777-7846	Wellcome Trust International Senior Research Fellowship in Biomedical Science in Central Europe [070191/Z/03/A]; Estonian Science Foundation [ETF7471, ETF9030]; Estonian Ministry of Education and Science core grant [SF0180022s12]; Howard Hughes Medical Institute International Scholarship Grant [55005617]; Seitsmes Sammas Stipend; Tartu University Foundation	Wellcome Trust International Senior Research Fellowship in Biomedical Science in Central Europe; Estonian Science Foundation; Estonian Ministry of Education and Science core grant; Howard Hughes Medical Institute International Scholarship Grant; Seitsmes Sammas Stipend; Tartu University Foundation	This work was supported by grants to M.L.: Wellcome Trust International Senior Research Fellowship in Biomedical Science in Central Europe [070191/Z/03/A], Estonian Science Foundation grants [ETF7471, ETF9030], Estonian Ministry of Education and Science core grant [SF0180022s12], Howard Hughes Medical Institute International Scholarship Grant [#55005617]. L.U. was the recipient of the Seitsmes Sammas Stipend provided by Tartu University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra A, 2009, HUM REPROD, V24, P2549, DOI 10.1093/humrep/dep222; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Bamberger AM, 2004, MOL HUM REPROD, V10, P223, DOI 10.1093/molehr/gah011; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bates S, 1996, ONCOGENE, V13, P1103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Bramlage CP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1923; Chapuis J, 2008, HUM MOL GENET, V17, P2863, DOI 10.1093/hmg/ddn183; Chung BHY, 2012, EUR J HUM GENET, V20, P398, DOI 10.1038/ejhg.2011.199; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; Cullen ME, 2006, CIRCULATION, V114, pI16, DOI 10.1161/CIRCULATIONAHA.105.000448; Deol HK, 2000, ENDOCRINOLOGY, V141, P3412, DOI 10.1210/en.141.9.3412; Du XY, 2011, J MOL HISTOL, V42, P129, DOI 10.1007/s10735-011-9315-9; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Farber CR, 2011, J BONE MINER RES, V26, P2174, DOI 10.1002/jbmr.436; Gajos-Michniewicz A, 2010, BIOMARKERS, V15, P563, DOI 10.3109/1354750X.2010.495786; Guenther C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000308; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Huppertz B, 2011, THROMB RES, V127, pS96, DOI 10.1016/S0049-3848(11)70026-3; Jellinek DA, 2000, BIOCHEM J, V350, P453, DOI 10.1042/0264-6021:3500453; Johnston J, 2010, TRANSGENIC RES, V19, P1017, DOI 10.1007/s11248-010-9376-7; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Karro H, 1997, EESTI ARST, V4, P299; Khan M A, 2010, Indian J Physiol Pharmacol, V54, P299; Kim SJ, 2006, GYNECOL ONCOL, V103, P654, DOI 10.1016/j.ygyno.2006.05.015; Kino T, 2011, CLIN EXP RHEUMATOL, V29, pS32; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YH, 2008, HUM MOL GENET, V17, P759, DOI 10.1093/hmg/ddm348; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Marui T, 2009, INT J NEUROPSYCHOPH, V12, P1, DOI 10.1017/S1461145708009127; Marzioni D, 2010, PLACENTA, V31, P919, DOI 10.1016/j.placenta.2010.08.001; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McKay R, 2011, NATURE, V472, P298, DOI 10.1038/472298a; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nevo O, 2008, J CLIN ENDOCR METAB, V93, P285, DOI 10.1210/jc.2007-1042; Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rull K, 2008, MOL HUM REPROD, V14, P23, DOI 10.1093/molehr/gam082; Sagawa N, 2002, ENDOCRINE, V19, P65, DOI 10.1385/ENDO:19:1:65; Sandell LL, 2003, P NATL ACAD SCI USA, V100, P4622, DOI 10.1073/pnas.0230424100; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Sitras V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033294; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song G, 2006, BIOL REPROD, V74, P913, DOI 10.1095/biolreprod.106.050807; Song G, 2009, ENDOCRINOLOGY, V150, P936, DOI 10.1210/en.2008-1026; Struwe E, 2010, CLIN ENDOCRINOL, V72, P241, DOI 10.1111/j.1365-2265.2009.03659.x; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Tardif G, 2004, ARTHRITIS RHEUM-US, V50, P2521, DOI 10.1002/art.20441; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Valente T, 2005, DEV DYNAM, V233, P667, DOI 10.1002/dvdy.20373; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Yuasa S, 2010, CIRC RES, V106, P1083, DOI 10.1161/CIRCRESAHA.109.214130; Yue LM, 2005, ENDOCRINOLOGY, V146, P2424, DOI 10.1210/en.2004-1605; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	73	53	53	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49248	10.1371/journal.pone.0049248	http://dx.doi.org/10.1371/journal.pone.0049248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145134	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800237
J	Stringari, C; Nourse, JL; Flanagan, LA; Gratton, E				Stringari, Chiara; Nourse, Jamison L.; Flanagan, Lisa A.; Gratton, Enrico			Phasor Fluorescence Lifetime Microscopy of Free and Protein-Bound NADH Reveals Neural Stem Cell Differentiation Potential	PLOS ONE			English	Article							OXIDATIVE STRESS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; REDOX REGULATION; GENE-EXPRESSION; IMAGING REVEALS; SINGLE CELLS; SELF-RENEWAL; METABOLISM; MARKERS	In the stem cell field there is a lack of non invasive and fast methods to identify stem cell's metabolic state, differentiation state and cell-lineage commitment. Here we describe a label-free method that uses NADH as an intrinsic biomarker and the Phasor approach to Fluorescence Lifetime microscopy to measure the metabolic fingerprint of cells. We show that different metabolic states are related to different cell differentiation stages and to stem cell bias to neuronal and glial fate, prior the expression of lineage markers. Our data demonstrate that the NADH FLIM signature distinguishes non-invasively neurons from undifferentiated neural progenitor and stem cells (NPSCs) at two different developmental stages (E12 and E16). NPSCs follow a metabolic trajectory from a glycolytic phenotype to an oxidative phosphorylation phenotype through different stages of differentiation. NSPCs are characterized by high free/bound NADH ratio, while differentiated neurons are characterized by low free/bound NADH ratio. We demonstrate that the metabolic signature of NPSCs correlates with their differentiation potential, showing that neuronal progenitors and glial progenitors have a different free/bound NADH ratio. Reducing conditions in NPSCs correlates with their neurogenic potential, while oxidative conditions correlate with glial potential. For the first time we show that FLIM NADH metabolic fingerprint provides a novel, and quantitative measure of stem cell potential and a label-free and non-invasive means to identify neuron-or glial-biased progenitors.	[Stringari, Chiara; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92717 USA; [Nourse, Jamison L.; Flanagan, Lisa A.] Univ Calif Irvine, Dept Neurol, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Gratton, E (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92717 USA.	egratton22@yahoo.com		Stringari, Chiara/0000-0002-0550-7463	National Institutes of Health [P41 P41-RRO3155, P41 GM103540, P50-GM076516, CIRM RT1-01074]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, P41GM103540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health-P41 P41-RRO3155, P41 GM103540, P50-GM076516, CIRM RT1-01074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; BANERJEE S, 1989, Indian Journal of Cancer, V26, P21; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Bonnert TP, 2006, EUR J NEUROSCI, V24, P661, DOI 10.1111/j.1460-9568.2006.04912.x; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Chan JW, 2009, ANAL CHEM, V81, P1324, DOI 10.1021/ac801665m; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Flanagan LA, 2008, STEM CELLS, V26, P656, DOI 10.1634/stemcells.2007-0810; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; GROVE EA, 1993, DEVELOPMENT, V117, P553; Guo HW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2990752; Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Johnson KW, 2007, CURR PHARM BIOTECHNO, V8, P133; Karsten SL, 2003, DEV BIOL, V261, P165, DOI 10.1016/S0012-1606(03)00274-4; Konig K, 2011, MICROSC RES TECHNIQ, V74, P9, DOI 10.1002/jemt.20866; Labeed FH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025458; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Li D, 2008, OPT LETT, V33, P2365, DOI 10.1364/OL.33.002365; Libert S, 2008, NAT CELL BIOL, V2008, P4; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; McGraw TE, 2010, NAT CHEM BIOL, V6, P176, DOI 10.1038/nchembio.324; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Nicholas CR, 2007, STEM CELLS DEV, V16, P109, DOI 10.1089/scd.2006.0059; Noble M, 2005, ANTIOXID REDOX SIGN, V7, P1456, DOI 10.1089/ars.2005.7.1456; Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI [10.1089/ars.2008.2308, 10.1089/ARS.2008.2308]; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Pascut FC, 2011, BIOPHYS J, V100, P251, DOI 10.1016/j.bpj.2010.11.043; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rao Raj R., 2007, V407, P51, DOI 10.1007/978-1-59745-536-7_5; Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075; Sidhu KS, 2006, STEM CELLS DEV, V15, P61, DOI 10.1089/scd.2006.15.61; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Stringari C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00568; Stringari C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046012; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Uchugonova A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3002370; Wachsmann-Hogiu S, 2009, CURR OPIN BIOTECH, V20, P63, DOI 10.1016/j.copbio.2009.02.006; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wright B, 2012, BIOPHYS J, V3, P1; Wu YC, 2006, OPT LETT, V31, P3122, DOI 10.1364/OL.31.003122; Yu QR, 2009, J PHOTOCH PHOTOBIO B, V95, P46, DOI 10.1016/j.jphotobiol.2008.12.010; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	61	123	123	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48014	10.1371/journal.pone.0048014	http://dx.doi.org/10.1371/journal.pone.0048014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144844	Green Published, gold			2022-12-25	WOS:000310741400035
J	Yang, HF; Zhang, ZH; Xiang, LB; Tang, KL; Luo, F; Liu, CY; Zhou, JB; Li, JQ; Xu, JZ				Yang, Hui-feng; Zhang, Ze-hua; Xiang, Liang-bi; Tang, Kang-lai; Luo, Fei; Liu, Chun-yu; Zhou, Jian-bo; Li, Jin-qing; Xu, Jian-zhong			25(OH)D-3 Affects the Maturation and Function of Mouse Bone Marrow-Derived Dendritic Cells Stimulated by Mycobacterium Bovis BCG	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; TUBERCULOSIS PATIENTS; ACTIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; CONTROLLED-TRIAL; IMMUNE-SYSTEM; DOUBLE-BLIND; D-RECEPTOR; INFECTION; DIFFERENTIATION	It has been shown that vitamin D deficiency increases an individual's susceptibility to tuberculosis (TB). However, very little is known about the effect of vitamin D on the immune response to Mycobacterium tuberculosis (M. tb) in dendritic cells (DCs). Because DCs play an important role in TB infection, we investigated the phenotypic characteristics and functional capabilities of mouse bone marrow-derived dendritic cells (BMDCs) after stimulation with Bacillus Calmette-Guerin (BCG) in the presence or absence of 25(OH)D-3(100 nM). Bone marrow cells from mice were cultured with GM-CSF (20 ng/ml) and were then treated with 25(OH)D-3 for 7 days. On day 6, 5 mu g/ml of BCG (>= 1.0 x 10(6) CFU/mg) was added to the cells for 24 hours, and on day 7, the non-adherent cells were harvested for phenotypic and functional analyses. After incubation with 25(OH)D-3, the expression levels of MHC-II and CD86 on the surface of the dendritic cells (DCs) and the ability of the DCs to stimulate proliferation of allogeneic mixed lymphocytes were lower than control cells (p<0.05). Furthermore, the level of Interleukin (IL) -4 secreted by the BMDCs in the 25(OH)D-3 culture was lower than that in the control culture (p<0.01). However, the BMDCs cultured with 25(OH)D-3 produced significantly higher levels of IL-2, IL-6, IL-10 and interferon gamma(IFN-gamma) than those in the control culture (p<0.05). These findings suggest that 25(OH)D-3 modulates the immune response during mycobacterial infection by affecting the maturation and function of DCs.	[Yang, Hui-feng; Zhang, Ze-hua; Tang, Kang-lai; Luo, Fei; Liu, Chun-yu; Zhou, Jian-bo; Li, Jin-qing; Xu, Jian-zhong] Third Mil Med Univ, Southwest Hosp, Dept Orthoped Surg, Chongqing, Peoples R China; [Xiang, Liang-bi] Gen Hosp Shenyang Mil Command, Dept Orthoped Surg, Shenyang, Peoples R China	Army Medical University	Xu, JZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthoped Surg, Chongqing, Peoples R China.	xujianzhong2011@hotmail.com		Xu, Jianzhong/0000-0003-0434-5148	National Natural Science Foundation of China [30901174/H2601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (30901174/H2601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2011; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bai XY, 2004, TUBERCULOSIS, V84, P375, DOI 10.1016/j.tube.2004.05.001; Bikle DD, 2008, CURR OPIN NEPHROL HY, V17, P348, DOI 10.1097/MNH.0b013e3282ff64a3; Chang JM, 2004, J LAB CLIN MED, V143, P14, DOI 10.1016/j.lab.2003.08.002; Chocano-Bedoya P, 2009, NUTR REV, V67, P289, DOI 10.1111/j.1753-4887.2009.00195.x; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Dlugovitzky D, 1997, FEMS IMMUNOL MED MIC, V18, P203, DOI 10.1016/S0928-8244(97)00040-0; Dominguez J, 2009, DIAGN MICR INFEC DIS, V63, P43, DOI 10.1016/j.diagmicrobio.2008.09.010; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; FLYNN JL, 1995, J IMMUNOL, V155, P2515; Gorman S, 2010, J STEROID BIOCHEM, V121, P247, DOI 10.1016/j.jsbmb.2010.02.034; Goswami R, 2008, INDIAN J MED RES, V127, P229; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; He XY, 2010, EUR J CLIN MICROBIOL, V29, P643, DOI 10.1007/s10096-010-0908-0; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Infante-Duarte C, 1999, SPRINGER SEMIN IMMUN, V21, P317, DOI 10.1007/s002810050070; Koo HK, 2012, RESPIROLOGY, V17, P808, DOI 10.1111/j.1440-1843.2012.02172.x; Lichtner M, 2006, CLIN EXP IMMUNOL, V143, P329, DOI 10.1111/j.1365-2249.2005.02994.x; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Morcos M M, 1998, Boll Chim Farm, V137, P157; Nemeth J, 2011, CLIN IMMUNOL, V138, P50, DOI 10.1016/j.clim.2010.09.005; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Rajashree R, 2009, TUBERCULOSIS, V89, P77, DOI 10.1016/j.tube.2008.07.006; Sano K, 1999, AM J RESP CELL MOL, V20, P1260, DOI 10.1165/ajrcmb.20.6.3546; Sato S, 2012, RESPIR INVESTIG, V50, P40, DOI 10.1016/j.resinv.2012.05.002; Selvaraj P, 2011, VITAM HORM, V86, P307, DOI 10.1016/B978-0-12-386960-9.00013-7; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; Tan Q, 2011, EUR J CLIN MICROBIOL; TOOSSI Z, 1995, J IMMUNOL, V154, P465; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48062	10.1371/journal.pone.0048062	http://dx.doi.org/10.1371/journal.pone.0048062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144845	gold, Green Published, Green Submitted			2022-12-25	WOS:000310741400036
J	da Silva, DV; Nordholm, J; Madjo, U; Pfeiffer, A; Daniels, R				da Silva, Diogo V.; Nordholm, Johan; Madjo, Ursula; Pfeiffer, Annika; Daniels, Robert			Assembly of Subtype 1 Influenza Neuraminidase Is Driven by Both the Transmembrane and Head Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A VIRUS NEURAMINIDASE; CYTOPLASMIC TAIL; PROTEIN; STALK; GENES; HEMAGGLUTININ; REPLICATION; MATURATION; SIGNAL; NA	Neuraminidase (NA) is one of the two major influenza surface antigens and the main influenza drug target. Although NA has been well characterized and thought to function as a tetramer, the role of the transmembrane domain (TMD) in promoting proper NA assembly has not been systematically studied. Here, we demonstrate that in the absence of the TMD, NA is synthesized and transported in a predominantly inactive state. Substantial activity was rescued by progressive truncations of the stalk domain, suggesting the TMD contributes to NA maturation by tethering the stalk to the membrane. To analyze how the TMD supports NA assembly, the TMD was examined by itself. The NA TMD formed a homotetramer and efficiently trafficked to the plasma membrane, indicating the TMD and enzymatic head domain drive assembly together through matching oligomeric states. In support of this, an unrelated strong oligomeric TMD rescued almost full NA activity, whereas the weak oligomeric mutant of this TMD restored only half of wild type activity. These data illustrate that a large soluble domain can force assembly with a poorly compatible TMD; however, optimal assembly requires coordinated oligomerization between the TMD and the soluble domain.	[da Silva, Diogo V.; Nordholm, Johan; Madjo, Ursula; Pfeiffer, Annika; Daniels, Robert] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Daniels, R (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	robertd@dbb.su.se		daniels, Robert/0000-0002-5988-2920; Pfeiffer, Annika/0000-0002-0340-5797; nordholm, johan/0000-0002-5864-8489	Swedish Research Council; Swedish Foundation for Strategic Research; Carl Trygger Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Trygger Foundation	This work was supported by grants from the Swedish Research Council, Swedish Foundation for Strategic Research, and the Carl Trygger Foundation (to R. D.).	Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BLOK J, 1982, BIOCHEMISTRY-US, V21, P4001, DOI 10.1021/bi00260a015; BLOK J, 1982, VIROLOGY, V118, P229, DOI 10.1016/0042-6822(82)90337-3; BOS TJ, 1984, P NATL ACAD SCI-BIOL, V81, P2327, DOI 10.1073/pnas.81.8.2327; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Daniels R, 2004, CELL BIOCHEM BIOPHYS, V41, P113, DOI 10.1385/CBB:41:1:113; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Hoffmann TW, 2012, J VIROL, V86, P584, DOI 10.1128/JVI.05474-11; HOGUE BG, 1992, VIROLOGY, V188, P510, DOI 10.1016/0042-6822(92)90505-J; Jejcic A, 2009, J VIROL, V83, P10075, DOI 10.1128/JVI.01700-08; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; KUNDU A, 1991, MOL CELL BIOL, V11, P2675, DOI 10.1128/MCB.11.5.2675; LAVER WG, 1978, VIROLOGY, V86, P78, DOI 10.1016/0042-6822(78)90009-0; LAVER WG, 1969, VIROLOGY, V38, P105, DOI 10.1016/0042-6822(69)90132-9; Lew W, 2000, CURR MED CHEM, V7, P663, DOI 10.2174/0929867003374886; Li JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014722; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; LUO GX, 1993, VIRUS RES, V29, P141; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mellroth P, 2012, J BIOL CHEM, V287, P11018, DOI 10.1074/jbc.M111.318584; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mitnaul LJ, 1996, J VIROL, V70, P873, DOI 10.1128/JVI.70.2.873-879.1996; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; PATERSON RG, 1990, J CELL BIOL, V110, P999, DOI 10.1083/jcb.110.4.999; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; SAITO T, 1995, J VIROL, V69, P5011, DOI 10.1128/JVI.69.8.5011-5017.1995; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; SIVASUBRAMANIAN N, 1987, P NATL ACAD SCI USA, V84, P1, DOI 10.1073/pnas.84.1.1; Sorrell EM, 2010, J VIROL, V84, P11831, DOI 10.1128/JVI.01460-10; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang N, 2008, J BIOL CHEM, V283, P33826, DOI 10.1074/jbc.M806897200; WEBSTER RG, 1967, J IMMUNOL, V99, P49; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	50	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					644	653		10.1074/jbc.M112.424150	http://dx.doi.org/10.1074/jbc.M112.424150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150659	hybrid, Green Published			2022-12-25	WOS:000313197200065
J	Harding, HP; Zyryanova, AF; Ron, D				Harding, Heather P.; Zyryanova, Alisa F.; Ron, David			Uncoupling Proteostasis and Development in Vitro with a Small Molecule Inhibitor of the Pancreatic Endoplasmic Reticulum Kinase, PERK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATED STRESS-RESPONSE; MESSENGER-RNA TRANSLATION; UNFOLDED PROTEIN RESPONSE; GENE-EXPRESSION; ALPHA-SUBUNIT; INITIATION; PHOSPHORYLATION; EIF2AK3; REINITIATION; MAINTAINS	Loss-of-function mutations in EIF2AK3, encoding the pancreatic endoplasmic reticulum (ER) kinase, PERK, are associated with dysfunction of the endocrine pancreas and diabetes. However, to date it has not been possible to uncouple the long term developmental effects of PERK deficiency from sensitization to physiological levels of ER unfolded protein stress upon interruption of PERK modulation of protein synthesis rates. Here, we report that a selective PERK inhibitor acutely deregulates protein synthesis in freshly isolated islets of Langerhans, across a range of glucose concentrations. Acute loss of the PERK-mediated strand of the unfolded protein response leads to rapid accumulation of misfolded pro-insulin in cultured beta cells and is associated with a kinetic defect in pro-insulin processing. These in vitro observations uncouple the latent role of PERK in beta cell development from the regulation of unfolded protein flux through the ER and attest to the importance of the latter in beta cell proteostasis.	[Harding, Heather P.] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; Addenbrookes Hosp, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Harding, HP (corresponding author), Univ Cambridge, Metab Res Labs, Hills Rd, Cambridge CB2 0QQ, England.	hph23@medschl.cam.ac.uk; dr360@medschl.cam.ac.uk		Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974	Wellcome Trust Principal Research Fellowship [084812/Z/08/Z]; European Union [277713]; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust Principal Research Fellowship(Wellcome Trust); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Principal Research Fellowship 084812/Z/08/Z and by European Union FP7 BetaBat Grant 277713.	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MATTS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2559, DOI 10.1073/pnas.80.9.2559; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	31	81	81	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44338	44344		10.1074/jbc.M112.428987	http://dx.doi.org/10.1074/jbc.M112.428987			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148209	hybrid, Green Published			2022-12-25	WOS:000312938600031
J	Chen, YL; Duan, YJ; Kang, YH; Yang, XX; Jiang, MX; Zhang, L; Li, GL; Yin, ZN; Hu, WQ; Dong, PZ; Li, XJ; Hajjar, DP; Han, JH				Chen, Yuanli; Duan, Yajun; Kang, Yanhua; Yang, Xiaoxiao; Jiang, Meixiu; Zhang, Ling; Li, Guangliang; Yin, Zhinan; Hu, Wenquan; Dong, Pengzhi; Li, Xiaoju; Hajjar, David P.; Han, Jihong			Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; OXIDIZED LDL; DEFICIENT MICE; MONOCLONAL AUTOANTIBODIES; ATHEROSCLEROTIC LESIONS; PROTECTIVE IMMUNITY; NATURAL ANTIBODIES; T-LYMPHOCYTES; LXR	IL-5 stimulates production of T15/EO6 IgM antibodies that can block the uptake of oxidized low density lipoprotein by macrophages, whereas a deficiency in macrophage IL-5 expression accelerates development of atherosclerosis. Liver X receptors (LXRs) are ligand-activated transcription factors that can induce macrophage ABCA1 expression and cholesterol efflux, thereby inhibiting the development of atherosclerosis. However, it remains unknown whether additional mechanisms, such as the regulation of macrophage IL-5 expression, are related to the anti-atherogenic properties of LXR. We initially defined IL-5 expression in macrophages where the LXR ligand (T0901317) induced macrophage IL-5 protein expression and secretion. The overexpression of LXR increased, whereas its knockdown inhibited IL-5 expression. Furthermore, we found that LXR activation increased IL-5 transcripts, promoter activity, formation of an LXR.LXR-responsive element complex, and IL-5 protein stability. In vivo, we found that T0901317 increased IL-5 and total IgM levels in plasma and IL-5 expression in multiple tissues in wild type mice. In LDL receptor knock-out (LDLR-/-) mice, T0901317 increased IL-5 expression in the aortic root area. Taken together, our studies demonstrate that macrophage IL-5 is a target gene for LXR activation, and the induction of macrophage IL-5 expression can be related to LXR-inhibited atherosclerosis.	[Chen, Yuanli; Duan, Yajun; Kang, Yanhua; Yang, Xiaoxiao; Jiang, Meixiu; Zhang, Ling; Li, Guangliang; Yin, Zhinan; Hu, Wenquan; Dong, Pengzhi; Li, Xiaoju; Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Chen, Yuanli; Duan, Yajun; Kang, Yanhua; Yang, Xiaoxiao; Jiang, Meixiu; Zhang, Ling; Li, Guangliang; Yin, Zhinan; Hu, Wenquan; Dong, Pengzhi; Li, Xiaoju; Han, Jihong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Hajjar, David P.] Cornell Univ, Weill Med Coll, New York, NY 10067 USA	Nankai University; Nankai University; Cornell University	Duan, YJ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yajunduan@nankai.edu.cn; jihonghan2008@nankai.edu.cn			Ministry of Science and Technology of China [2010CB945003]; National Science Foundation of China (NSFC) [30971271, 81272460, 81000128]; Tianjin Municipal Science and Technology Commission of China [08ZCKFSH04400, 11JCYBJC10600]; J & S Gross Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China; J & S Gross Foundation	This work was supported by the Ministry of Science and Technology of China Grant 2010CB945003 to JH; the National Science Foundation of China (NSFC) Grants 30971271 and 81272460 to JH and 81000128 to YD; Tianjin Municipal Science and Technology Commission of China Grants 08ZCKFSH04400 and 11JCYBJC10600 to JH, and funds from the J & S Gross Foundation awarded to DH.	APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Binder CJ, 2008, CURR DRUG TARGETS, V9, P190; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Duan YJ, 2012, J BIOL CHEM, V287, P23667, DOI 10.1074/jbc.M112.350181; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Frostegard Johan, 2002, Autoimmunity Reviews, V1, P233, DOI 10.1016/S1568-9972(02)00059-9; Hogan SP, 1997, IMMUNOL CELL BIOL, V75, P284, DOI 10.1038/icb.1997.43; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Hulthe J, 2004, CLIN CHIM ACTA, V348, P1, DOI 10.1016/j.cccn.2004.05.021; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Karlen S, 1998, Int Rev Immunol, V16, P227, DOI 10.3109/08830189809042996; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; LASSER EC, 1987, ALLERGY, V42, P549, DOI 10.1111/j.1398-9995.1987.tb00381.x; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Linton MF, 2001, CURR OPIN LIPIDOL, V12, P489, DOI 10.1097/00041433-200110000-00003; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Mitra S, 2011, AM J MED SCI, V342, P135, DOI 10.1097/MAJ.0b013e318224a147; NAORA H, 1994, J IMMUNOL, V153, P3466; PALINSKI W, 1995, ARTERIOSCL THROM VAS, V15, P1569, DOI 10.1161/01.ATV.15.10.1569; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Parikh N, 2010, CARDIOL REV, V18, P269, DOI 10.1097/CRD.0b013e3181e8067a; Sampi M, 2008, J AM COLL CARDIOL, V52, P1370, DOI 10.1016/j.jacc.2008.06.047; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Tsimikas S, 2001, ARTERIOSCL THROM VAS, V21, P95, DOI 10.1161/01.ATV.21.1.95; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601	42	37	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43340	43350		10.1074/jbc.M112.403394	http://dx.doi.org/10.1074/jbc.M112.403394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23150660	Green Published, hybrid			2022-12-25	WOS:000312940800015
J	Sela, I; Izzetoglu, M; Izzetoglu, K; Onaral, B				Sela, Itamar; Izzetoglu, Meltem; Izzetoglu, Kurtulus; Onaral, Banu			A Working Memory Deficit among Dyslexic Readers with No Phonological Impairment as Measured Using the N-Back Task: An fNIR Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN; CHILDREN; ORGANIZATION; RECOGNITION; OXYGENATION; ACTIVATION; RESPONSES; COMPONENT; BLOOD	Data indicated that dyslexic individuals exhibited difficulties on tasks involving Working Memory (WM). Previous studies have suggested that these deficits stem from impaired processing in the Phonological Loop (PL). The PL impairment was connected to poor phonological processing. However, recent data has pointed to the Central Executive (CE) system as another source of WM deficit in dyslexic readers. This opened a debate whether the WM deficit stems solely from PL or can also be seen as an outcome of poor CE processing. In an attempt to verify this question, the current study compared adult skilled and compensated dyslexic readers with no impairment of phonological skills. The participants' PL and CE processing were tested by using the fNIR device attached to the frontal lobe and measured the changes in brain oxygen values when performing N-back task. As it was previously suggested, the N = 0 represented PL and N = 1 to 3 represent CE processing. It was hypothesized that dyslexic readers who show non-impaired phonological skills will exhibit deficits mainly in the CE subsystem and to a lesser extent in the PL. Results indicated that the two reading level groups did not differ in their accuracy and reaction times in any of the N-Back conditions. However, the dyslexic readers demonstrated significant lower maximum oxyHb values in the upper left frontal lobe, mainly caused due to a significant lower activity under the N = 1 condition. Significant task effects were found in the medial left hemisphere, and the high medial right hemisphere. In addition, significant correlations between fNIR-features, reading performance and speed of processing were found. The higher oxyHb values, the better reading and speed of processing performance obtained. The results of the current study support the hypothesis that at least for the group of dyslexics with non-impaired PL, WM deficit stems from poor CE activity.	[Sela, Itamar; Izzetoglu, Meltem; Izzetoglu, Kurtulus; Onaral, Banu] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Sela, Itamar] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel	Drexel University; University of Haifa	Sela, I (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	isela01@campus.haifa.ac.il	Izzetoglu, Kurtulus/AAB-6402-2020	Izzetoglu, Kurtulus/0000-0001-5304-7361	Edmond J. Safra Philanthropic Foundation	Edmond J. Safra Philanthropic Foundation	This research was funded by the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN PT, 1993, J LEARN DISABIL, V26, P597, DOI 10.1177/002221949302600910; Aletti F, 2012, COMPUT BIOL MED, V42, P282, DOI 10.1016/j.compbiomed.2011.06.001; Asbjornsen AE, 1998, NEUROPSYCHOLOGIA, V36, P143, DOI 10.1016/S0028-3932(97)00090-0; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Beneventi H, 2010, INT J NEUROSCI, V120, P51, DOI 10.3109/00207450903275129; BENTIN S, 1989, LANG SPEECH, V32, P205, DOI 10.1177/002383098903200302; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BREZNITZ Z, 1992, J EDUC PSYCHOL, V84, P193, DOI 10.1037/0022-0663.84.2.193; Breznitz Z., 2006, FLUENCY READING SYNC; Brickenkamp R., 1981, TEST D2 AUFMERK SANK; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; CASEY BJ, 1995, NEUROIMAGE, V2, P221, DOI 10.1006/nimg.1995.1029; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Elbro C, 2005, SCAND J PSYCHOL, V46, P375, DOI 10.1111/j.1467-9450.2005.00468.x; Gathercole SE, 2001, Q J EXP PSYCHOL-A, V54, P1, DOI 10.1080/02724980042000002; GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P505, DOI 10.1111/j.1469-8986.1995.tb02102.x; Heekeren HR, 1997, PHILOS T ROY SOC B, V352, P743, DOI 10.1098/rstb.1997.0057; Helland T, 2004, J CLIN EXP NEUROPSYC, V26, P31, DOI 10.1076/jcen.26.1.31.23935; Hofmann MJ, 2008, NEUROIMAGE, V40, P1340, DOI 10.1016/j.neuroimage.2007.12.037; HULME C, 1992, COGNITIVE NEUROPSYCH, V9, P47, DOI 10.1080/02643299208252052; Izzetoglu K, 2004, INT J HUM-COMPUT INT, V17, P211, DOI 10.1207/s15327590ijhc1702_6; Izzetoglu M, 2005, INT CONF ACOUST SPEE, P633; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; MATAL, 2007, DIAGN BATT ASS LEARN; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palmer S, 2000, MEMORY, V8, P179, DOI 10.1080/096582100387597; Palmer S., 2000, J RES READ, V23, P28, DOI DOI 10.1111/1467-9817.00100; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Raven J.C., 1960, GUIDE STANDARD PROGR; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Rolfe P, 2000, ANNU REV BIOMED ENG, V2, P715, DOI 10.1146/annurev.bioeng.2.1.715; Sakatani K, 1999, J Stroke Cerebrovasc Dis, V8, P398, DOI 10.1016/S1052-3057(99)80047-0; Sela I, 2012, J LEARNING DISABILIT; Sela I, 2011, LECT NOTES ARTIF INT, V6780, P231, DOI 10.1007/978-3-642-21852-1_29; Shatil, 1995, ONE MINUTE TES UNPUB; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Siegel L., 2008, SAGE HDB DYSLEXIA, P11; Smith-Spark JH, 2003, EUR J COGN PSYCHOL, V15, P567, DOI 10.1080/09541440340000024; Snowling M., 2000, DYSLEXIA; Snowling M., 1997, J RES READ, V20, P31, DOI [10.1111/1467-9817.00018, DOI 10.1111/1467-9817.00018, 10.1111/1467-9817.00018.]; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Suto T, 2002, INT C SERIES, V1232, P383; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P307, DOI 10.1007/978-0-387-85998-9_46; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wechsler D., 1997, WECHSLER ADULT INTEL	60	5	5	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e46527	10.1371/journal.pone.0046527	http://dx.doi.org/10.1371/journal.pone.0046527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152750	Green Published, gold, Green Submitted			2022-12-25	WOS:000311234600003
J	Tomar, D; Sripada, L; Prajapati, P; Singh, R; Singh, AK; Singh, R				Tomar, Dhanendra; Sripada, Lakshmi; Prajapati, Paresh; Singh, Rochika; Singh, Arun Kumar; Singh, Rajesh			Nucleo-Cytoplasmic Trafficking of TRIM8, a Novel Oncogene, Is Involved in Positive Regulation of TNF Induced NF-kappa B Pathway	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CELL-MIGRATION; IN-VITRO; PIAS3; ACTIVATION; EXPRESSION; DISEASE; DEATH; ASSAY; GENE	TNF induced nuclear factor kappa B (NF-kappa B) is one of the central signaling pathways that plays a critical role in carcinogenesis and inflammatory diseases. Post-translational modification through ubiquitin plays important role in the regulation of this pathway. In the current study, we investigated the role of TRIM8, member of RING family ubiquitin ligase in regulation of NF-kappa B pathway. We observed that TRIM8 positively regulates TNF induced NF-kappa B pathway. Different domains of TRIM8 showed discrete functions at the different steps in regulation of TNF induced NF-kappa B pathway. Ubiquitin ligase activity of TRIM8 is essential for regulation of NF-kappa B activation in both cytoplasm as well as nucleus. TRIM8 negates PIAS3 mediated negative repression of NF-kappa B at p65 by inducing translocation of PIAS3 from nucleus to cytoplasm as well as its turnover. TNF induces translocation of TRIM8 from nucleus to cytoplasm, which positively regulates NF-kappa B. The cytoplasmic translocation of TRIM8 is essential for TNF induced NF-kappa B but not for p65 mediated NF-kappa B regulation. TRIM8 also enhanced the clonogenic and migration ability of cells by modulating NF-kappa B. The further study will help to understand the role of TRIM8 in inflammation and cancer.	[Tomar, Dhanendra; Sripada, Lakshmi; Prajapati, Paresh; Singh, Rochika; Singh, Arun Kumar; Singh, Rajesh] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, India		Singh, R (corresponding author), Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, India.	rsingh@iiar.res.in	Tomar, Dhanendra/A-1050-2012; Tomar, Dhanendra/H-3358-2019; Prajapati, Paresh/P-1058-2019	Tomar, Dhanendra/0000-0002-3144-7257; Tomar, Dhanendra/0000-0002-3144-7257; Prajapati, Paresh/0000-0002-3734-4662	Indian Institute of Advanced Research (IIAR); Department of Biotechnology (DBT), Govt. of India; Council of Scientific and Industrial Research (CSIR), Govt. of India; University Grant Commission (UGC), Govt. of India	Indian Institute of Advanced Research (IIAR); Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission (UGC), Govt. of India(University Grants Commission, India)	This study was supported by the Program Support to Indian Institute of Advanced Research (IIAR) sponsored by Department of Biotechnology (DBT), Govt. of India. Dhanendra Tomar received Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), Govt. of India. Lakshmi Sripada received Junior Research Fellowship from University Grant Commission (UGC), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Baud V, 2011, CURR TOP MICROBIOL, V349, P97, DOI 10.1007/82_2010_101; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kingston Robert E, 2003, Curr Protoc Cell Biol, VChapter 20, DOI 10.1002/0471143030.cb2003s19; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Levy C, 2003, MOL CELL BIOL, V23, P9073, DOI 10.1128/MCB.23.24.9073-9080.2003; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Li X, 2011, J BIOL CHEM, V286, P27959, DOI 10.1074/jbc.M111.260406; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu LM, 2011, CLIN RES HEPATOL GAS, V35, P393, DOI 10.1016/j.clinre.2010.12.002; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Liu Xin-lei, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P60; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Okumura F, 2010, J CELL SCI, V123, P2238, DOI 10.1242/jcs.068981; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Tomar D, 2012, BBA-MOL CELL RES, V1823, P316, DOI 10.1016/j.bbamcr.2011.11.015; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Yu SS, 2011, BIOCHEM BIOPH RES CO, V410, P247, DOI 10.1016/j.bbrc.2011.05.124	41	41	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48662	10.1371/journal.pone.0048662	http://dx.doi.org/10.1371/journal.pone.0048662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152791	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000024
J	Cunha, RL; Coscia, I; Madeira, C; Mariani, S; Stefanni, S; Castilho, R				Cunha, Regina L.; Coscia, Ilaria; Madeira, Celine; Mariani, Stefano; Stefanni, Sergio; Castilho, Rita			Ancient Divergence in the Trans-Oceanic Deep-Sea Shark Centroscymnus crepidater	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; ATLANTIC BIGEYE TUNA; FALSE DISCOVERY RATE; GLOBAL PHYLOGEOGRAPHY; THUNNUS-OBESUS; F-ST; MOLECULAR SYSTEMATICS; WESTERN ATLANTIC; RHINCODON-TYPUS; WHALE SHARK	Unravelling the genetic structure and phylogeographic patterns of deep-sea sharks is particularly challenging given the inherent difficulty in obtaining samples. The deep-sea shark Centroscymnus crepidater is a medium-sized benthopelagic species that exhibits a circumglobal distribution occurring both in the Atlantic and Indo-Pacific Oceans. Contrary to the wealth of phylogeographic studies focused on coastal sharks, the genetic structure of bathyal species remains largely unexplored. We used a fragment of the mitochondrial DNA control region, and microsatellite data, to examine genetic structure in C. crepidater collected from the Atlantic Ocean, Tasman Sea, and southern Pacific Ocean (Chatham Rise). Two deeply divergent (3.1%) mtDNA clades were recovered, with one clade including both Atlantic and Pacific specimens, and the other composed of Atlantic samples with a single specimen from the Pacific (Chatham Rise). Bayesian analyses estimated this splitting in the Miocene at about 15 million years ago. The ancestral C. crepidater lineage was probably widely distributed in the Atlantic and Indo-Pacific Oceans. The oceanic cooling observed during the Miocene due to an Antarctic glaciation and the Tethys closure caused changes in environmental conditions that presumably restricted gene flow between basins. Fluctuations in food resources in the Southern Ocean might have promoted the dispersal of C. crepidater throughout the northern Atlantic where habitat conditions were more suitable during the Miocene. The significant genetic structure revealed by microsatellite data suggests the existence of present-day barriers to gene flow between the Atlantic and Pacific populations most likely due to the influence of the Agulhas Current retroflection on prey movements.	[Cunha, Regina L.; Madeira, Celine; Castilho, Rita] Univ Algarve, CCMAR CIMAR, Faro, Portugal; [Coscia, Ilaria] Aberystwyth Univ, IBERS, Aberystwyth, Ceredigion, Wales; [Mariani, Stefano] Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England; [Stefanni, Sergio] Univ Azores, Dept Oceanog & Fisheries, IMAR DOP, Horta, Azores, Portugal	Universidade do Algarve; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Manchester; University of Salford; Universidade dos Acores	Cunha, RL (corresponding author), Univ Algarve, CCMAR CIMAR, Faro, Portugal.	rcunha@ualg.pt	Mariani, Stefano/A-2964-2012; Cunha, Regina L/M-3463-2013; Castilho, Rita/B-6185-2008	Mariani, Stefano/0000-0002-5329-0553; Cunha, Regina L/0000-0002-4275-9723; Castilho, Rita/0000-0003-0727-3688; Stefanni, Sergio/0000-0001-9477-0062; Coscia, Ilaria/0000-0001-5768-4675	DEECON "Unravelling population connectivity for sustainable fisheries in the Deep Sea''; Foundation for Science and Technology, Portugal (FCT); FCT; IMAR/DOP;  [SFRH/BPD/33613 2009]	DEECON "Unravelling population connectivity for sustainable fisheries in the Deep Sea''; Foundation for Science and Technology, Portugal (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); IMAR/DOP; 	This work was funded by DEECON "Unravelling population connectivity for sustainable fisheries in the Deep Sea'' project approved by the European Science Foundation (ESF) under the EUROCORES programme (proposal No 06-EuroDEEP-FP-008 and SFRH-EuroDEEP/0002/2007). R.L.C. was supported by a Postdoctoral fellowship (SFRH/BPD/33613 2009) funded by Foundation for Science and Technology, Portugal (FCT). S.S. is a researcher contracted by IMAR/DOP under the 'Ciencia 2007' recruitment program funded by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnet S, 2001, LETHAIA, V34, P234; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alberto F., 2006, STANDARICH V1 00 R P; Allen MB, 2008, PALAEOGEOGR PALAEOCL, V265, P52, DOI 10.1016/j.palaeo.2008.04.021; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Avise John C., 1994, pi; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bremer JRA, 1998, MAR BIOL, V132, P547, DOI 10.1007/s002270050420; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Dabney A., 2006, QVALUE Q VALUE ESTIM; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feldheim KA, 2001, MOL ECOL, V10, P295, DOI 10.1046/j.1365-294x.2001.01182.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grant SW, 2012, MOL PHYLOGENETICS EV; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Helyar S, 2011, CONSERV GENET RESOUR, V3, P173, DOI 10.1007/s12686-010-9316-0; Hueter Robert E., 1998, Shark News, V12, P1; Irvine SB, 2006, CAN J FISH AQUAT SCI, V63, P617, DOI 10.1139/f05-237; Ivanova EV, 2009, GLOB THERM PAL; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Klug S, 2010, ZOOL SCR, V39, P331, DOI 10.1111/j.1463-6409.2010.00427.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Lutjeharms J.O.R.E.L., 2006, SEA, V14, P783; MARTIN AK, 1981, S AFR J SCI, V77, P547; Martinez P, 2006, MOL PHYLOGENET EVOL, V39, P404, DOI 10.1016/j.ympev.2005.07.022; MAUCHLINE J, 1983, MAR BIOL, V75, P269, DOI 10.1007/BF00406012; MCNEIL DH, 1990, ARCTIC, V43, P301; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Musick JA, 2004, CRC MAR BIOL SER, P33; Nei M., 1987, MOL EVOLUTIONARY GEN; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Pennings PS, 2011, J EVOLUTION BIOL, V24, P871, DOI 10.1111/j.1420-9101.2010.02223.x; Pereyra S, 2010, FISH RES, V106, P468, DOI 10.1016/j.fishres.2010.09.022; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D., 2004, COLLAPSE 1 2; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RICOU LE, 1987, GEODIN ACTA, V1, P225, DOI 10.1080/09853111.1987.11105141; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Rutschmann F., 2005, BAYESIAN MOL DATING; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smart CW, 2007, MICROPALEONTOLOGY, V53, P73, DOI 10.2113/gsmicropal.53.1-2.73; Stelbrink B, 2010, MOL PHYLOGENET EVOL, V54, P395, DOI 10.1016/j.ympev.2009.07.029; Stoner DS, 2003, CONSERV GENET, V4, P805, DOI 10.1023/B:COGE.0000006122.47004.c2; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Suzuki Hideshi, 2008, Journal of the Geological Society of Japan, V114, P536; Thies Detlev, 1993, Palaeontologische Zeitschrift, V67, P89; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; THUNELL R, 1982, MICROPALEONTOLOGY, V28, P381, DOI 10.2307/1485451; Verissimo A, 2011, ICES J MAR SCI, V68, P555, DOI 10.1093/icesjms/fsr003; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; White TA, 2009, MOL ECOL, V18, P2563, DOI 10.1111/j.1365-294X.2009.04218.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Williams ST, 2004, EVOLUTION, V58, P2227; Wilson GA, 2003, GENETICS, V163, P1177; Woodruff F, 1989, PALEOCEANOGRAPHY, V4, P87, DOI 10.1029/PA004i001p00087; Zardi GI, 2011, OECOLOGIA, V165, P947, DOI 10.1007/s00442-010-1788-9	84	15	15	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49196	10.1371/journal.pone.0049196	http://dx.doi.org/10.1371/journal.pone.0049196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145122	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500088
J	Banack, SA; Metcalf, JS; Jiang, LY; Craighead, D; Ilag, LL; Cox, PA				Banack, Sandra Anne; Metcalf, James S.; Jiang, Liying; Craighead, Derek; Ilag, Leopold L.; Cox, Paul Alan			Cyanobacteria Produce N-(2-Aminoethyl)Glycine, a Backbone for Peptide Nucleic Acids Which May Have Been the First Genetic Molecules for Life on Earth	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASE; PNA; THYMINE; RNA; RECOGNITION; NEUROTOXINS; ANTIQUITY; EVOLUTION; SEQUENCE; CYTOSINE	Prior to the evolution of DNA-based organisms on earth over 3.5 billion years ago it is hypothesized that RNA was the primary genetic molecule. Before RNA-based organisms arose, peptide nucleic acids may have been used to transmit genetic information by the earliest forms of life on earth. We discovered that cyanobacteria produce N-(2-aminoethyl) glycine (AEG), a backbone for peptide nucleic acids. We detected AEG in axenic strains of cyanobacteria with an average concentration of 1 mu g/g. We also detected AEG in environmental samples of cyanobacteria as both a free or weakly bound molecule and a tightly bound form released by acid hydrolysis, at concentrations ranging from not detected to 34 mu g/g. The production of AEG by diverse taxa of cyanobacteria suggests that AEG may be a primitive feature which arose early in the evolution of life on earth.	[Banack, Sandra Anne; Metcalf, James S.; Cox, Paul Alan] Inst Ethnomed, Jackson, WY USA; [Jiang, Liying; Ilag, Leopold L.] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden; [Craighead, Derek] Craighead Beringia S, Kelly, WY USA	Stockholm University	Cox, PA (corresponding author), Inst Ethnomed, Jackson, WY USA.	paul@ethnomedicine.org		metcalf, james/0000-0003-3011-3973; Cox, Paul/0000-0001-6401-2981; Ilag, Leopold/0000-0003-3678-7100				Banack SA, 2011, TOXICON, V57, P730, DOI 10.1016/j.toxicon.2011.02.005; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; Christensen L, 1995, J Pept Sci, V1, P175; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; DUEHOLM KL, 1994, J ORG CHEM, V59, P5767, DOI 10.1021/jo00098a042; EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062; EGHOLM M, 1992, J AM CHEM SOC, V114, P9677, DOI 10.1021/ja00050a068; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Jiang LY, 2012, ANAL BIOANAL CHEM, V403, P1719, DOI 10.1007/s00216-012-5966-y; Joyce GF, 2012, SCIENCE, V336, P307, DOI 10.1126/science.1221724; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; Nelson KE, 2000, P NATL ACAD SCI USA, V97, P3868, DOI 10.1073/pnas.97.8.3868; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; NIELSEN PE, 1993, ORIGINS LIFE EVOL B, V23, P323, DOI 10.1007/BF01582083; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Ray A, 2000, FASEB J, V14, P1041, DOI 10.1096/fasebj.14.9.1041; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Wagner E, 2008, PHARM RES-DORD, V25, P2920, DOI 10.1007/s11095-008-9689-x	24	51	53	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49043	10.1371/journal.pone.0049043	http://dx.doi.org/10.1371/journal.pone.0049043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145061	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800191
J	Breidenstein, EBM; Janot, L; Strehmel, J; Fernandez, L; Taylor, PK; Kukavica-Ibrulj, I; Gellatly, SL; Levesque, RC; Overhage, J; Hancock, REW				Breidenstein, Elena B. M.; Janot, Laure; Strehmel, Janine; Fernandez, Lucia; Taylor, Patrick K.; Kukavica-Ibrulj, Irena; Gellatly, Shaan L.; Levesque, Roger C.; Overhage, Joerg; Hancock, Robert E. W.			The Lon Protease Is Essential for Full Virulence in Pseudomonas aeruginosa	PLOS ONE			English	Article							III SECRETION SYSTEM; CYSTIC-FIBROSIS PATIENTS; ATP-DEPENDENT PROTEASE; CHRONIC LUNG INFECTION; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; MUTANT LIBRARY	Pseudomonas aeruginosa PAO1 lon mutants are supersusceptible to ciprofloxacin, and exhibit a defect in cell division and in virulence-related properties, such as swarming, twitching and biofilm formation, despite the fact that the lon protease is not a traditional regulator. Here we set out to investigate the influence of a lon mutation in a series of infection models. It was demonstrated that the lon mutant had a defect in cytotoxicity towards epithelial cells, was less virulent in an amoeba model as well as a mouse acute lung infection model, and impacted on in vivo survival in a rat model of chronic infection. Using qRT-PCR it was demonstrated that the Ion mutation led to a down-regulation of Type III secretion genes. The Lon protease also influenced motility and biofilm formation in a mucin-rich environment. Thus alterations in several virulence-related processes in vitro in a lon mutant were reflected by defective virulence in vivo.	[Breidenstein, Elena B. M.; Janot, Laure; Fernandez, Lucia; Taylor, Patrick K.; Gellatly, Shaan L.; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Strehmel, Janine; Overhage, Joerg] KIT, Inst Funct Interfaces, Karlsruhe, Germany; [Kukavica-Ibrulj, Irena; Levesque, Roger C.] Univ Laval, IBIS, Quebec City, PQ, Canada	University of British Columbia; Helmholtz Association; Karlsruhe Institute of Technology; Laval University	Hancock, REW (corresponding author), Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada.	bob@hancocklab.com	Levesque, Roger C./ABD-8407-2021; Fernández, Lucía/ADE-1414-2022; Gellatly, Shaan/AAT-1638-2021; Overhage, Joerg/H-2033-2013; Fernández, Lucía/F-9858-2016; Hancock, Robert E. W./E-1145-2013	Fernández, Lucía/0000-0002-7383-7595; Gellatly, Shaan/0000-0002-7361-2337; Overhage, Joerg/0000-0001-5278-2479; Hancock, Robert E. W./0000-0001-5989-8503; Levesque, Roger/0000-0001-8315-5937	Canadian Institute of Health Research and Cystic Fibrosis Canada; CFC; German Excellence Initiative and the BioInterface (BIF) Programme of the Karlsruher Institute of Technology (KIT) in the Helmholtz Association; Canadian Institute of Health Research	Canadian Institute of Health Research and Cystic Fibrosis Canada(Canadian Institutes of Health Research (CIHR)); CFC; German Excellence Initiative and the BioInterface (BIF) Programme of the Karlsruher Institute of Technology (KIT) in the Helmholtz Association; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institute of Health Research and Cystic Fibrosis Canada. E.B.M.B. was a recipient of a scholarship from CFC. R.E.W.H. holds a Canada Research Chair. The group of J.O. is supported within the German Excellence Initiative and the BioInterface (BIF) Programme of the Karlsruher Institute of Technology (KIT) in the Helmholtz Association. The research group of R.C.L. was funded by the Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027615; Alibaud L, 2008, CELL MICROBIOL, V10, P729, DOI 10.1111/j.1462-5822.2007.01080.x; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boddicker JD, 2004, INFECT IMMUN, V72, P2002, DOI 10.1128/IAI.72.4.2002-2013.2004; Botos I, 2004, J STRUCT BIOL, V146, P113, DOI 10.1016/j.jsb.2003.09.003; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Brazas MD, 2007, ANTIMICROB AGENTS CH, V51, P4276, DOI 10.1128/AAC.00830-07; Breidenstein EBM, 2008, ANTIMICROB AGENTS CH, V52, P4486, DOI 10.1128/AAC.00222-08; Breidenstein EBM, 2012, ANTIMICROB AGENTS CH, V56, P2879, DOI 10.1128/AAC.06014-11; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Bretz J, 2002, MOL MICROBIOL, V45, P397, DOI 10.1046/j.1365-2958.2002.03008.x; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cohn MT, 2007, APPL ENVIRON MICROB, V73, P7803, DOI 10.1128/AEM.00698-07; Fernandez L, 2012, ANTIMICROB AGENTS CH, V56, P1128, DOI 10.1128/AAC.05336-11; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; GOVAN JRW, 1978, J ANTIMICROB CHEMOTH, V4, P233, DOI 10.1093/jac/4.3.233; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Jackson MW, 2004, MOL MICROBIOL, V54, P1364, DOI 10.1111/j.1365-2958.2004.04353.x; JENSEN ET, 1990, INFECT IMMUN, V58, P2383, DOI 10.1128/IAI.58.7.2383-2385.1990; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lehoux DE, 2000, FEMS MICROBIOL LETT, V190, P141, DOI 10.1016/S0378-1097(00)00314-1; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Li M, 2005, PROTEIN SCI, V14, P2895, DOI 10.1110/ps.051736805; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Marr AK, 2007, MICROBIOL-SGM, V153, P474, DOI 10.1099/mic.0.2006/002519-0; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; MELULENI GJ, 1995, J IMMUNOL, V155, P2029; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rotanova TV, 2006, PROTEIN SCI, V15, P1815, DOI 10.1110/ps.052069306; Spinner JL, 2008, INFECT IMMUN, V76, P3754, DOI 10.1128/IAI.00385-08; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Takaya A, 2003, INFECT IMMUN, V71, P690, DOI 10.1128/IAI.71.2.690-696.2003; Takaya A, 2008, J BACTERIOL, V190, P4181, DOI 10.1128/JB.01873-07; Yeung ATY, 2012, MBIO, V3, DOI 10.1128/mBio.00073-12; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10	43	54	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49123	10.1371/journal.pone.0049123	http://dx.doi.org/10.1371/journal.pone.0049123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145092	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800212
J	Coslovsky, M; Richner, H				Coslovsky, Michael; Richner, Heinz			Preparing Offspring for a Dangerous World: Potential Costs of Being Wrong	PLOS ONE			English	Article							DEVELOPMENTAL PLASTICITY; CORTICOSTERONE LEVELS; GROWTH STRATEGIES; PREDATORS; STRESS; RATES; PHENOTYPE; GREAT; EGGS; RISK	Adaptive maternal responses to stressful environments before young are born can follow two non-exclusive pathways: either the mother reduces current investment in favor of future investment, or influences offspring growth and development in order to fit offspring phenotype to the stressful environment. Inducing such developmental cues, however, may be risky if the environment changes meanwhile, resulting in maladapted offspring. Here we test the effects of a predator-induced maternal effect in a predator-free postnatal environment. We manipulated perceived predation-risk for breeding female great tits by exposing them to stuffed models of either a predatory bird or a non-predatory control. Offspring were raised either in an environment matching the maternal one by exchanging whole broods within a maternal treatment group, or in a mismatching environment by exchanging broods among the maternal treatments. Offspring growth depended on the matching of the two environments. While for offspring originating from control treated mothers environmental mismatch did not significantly change growth, offspring of mothers under increased perceived predation risk grew faster and larger in matching conditions. Offspring of predator treated mothers fledged about one day later when growing under mismatching conditions. This suggests costs paid by the offspring if mothers predict environmental conditions wrongly.	[Coslovsky, Michael; Richner, Heinz] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	University of Bern	Coslovsky, M (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	mcoslov@gmail.com	Richner, Heinz/B-1659-2008	Richner, Heinz/0000-0001-7390-0526	Swiss National Science Foundation [3100A0-102017]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was financially supported by a Swiss National Science Foundation grant (3100A0-102017) to HR. (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2008, LME4 LINEAR MIXED EF; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Berthouly A, 2007, FUNCT ECOL, V21, P335, DOI 10.1111/j.1365-2435.2006.01236.x; Bize P, 2003, J ANIM ECOL, V72, P633, DOI 10.1046/j.1365-2656.2003.00734.x; Bize P, 2006, FUNCT ECOL, V20, P857, DOI 10.1111/j.1365-2435.2006.01157.x; Caro Tim, 2005, pXIII; Chin EH, 2009, P ROY SOC B-BIOL SCI, V276, P499, DOI 10.1098/rspb.2008.1294; Coslovsky M, 2012, OIKOS IN PRESS; Coslovsky M, 2012, GEN COMP ENDOCRINOLO; Coslovsky M, 2011, FUNCT ECOL, V25, P878, DOI 10.1111/j.1365-2435.2011.01834.x; EMLEN ST, 1991, CONDOR, V93, P591, DOI 10.2307/1368191; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Gosler A, 1993, GREAT TIT; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kovarik P, 2011, ETHOLOGY, V117, P181, DOI 10.1111/j.1439-0310.2010.01865.x; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Love OP, 2008, AM NAT, V172, pE135, DOI 10.1086/590959; Love OP, 2008, HORM BEHAV, V54, P496, DOI 10.1016/j.yhbeh.2008.01.006; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nilsson JA, 1996, J ANIM ECOL, V65, P825, DOI 10.2307/5680; Perrins C.M., 1979, BRIT TITS; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DC, 2010, R LANG ENV STAT COMP; Remes V, 2002, EVOLUTION, V56, P2505; RICKLEFS RE, 1969, NATURE, V223, P922, DOI 10.1038/223922a0; Rubolini D, 2005, HORM BEHAV, V47, P592, DOI 10.1016/j.yhbeh.2005.01.006; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Sarkar D., 2019, NLME LINEAR NONLINEA; Storm JJ, 2010, AM NAT, V175, P382, DOI 10.1086/650443; Tarwater CE, 2009, ANIM BEHAV, V78, P1239, DOI 10.1016/j.anbehav.2009.07.040; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Wells JCK, 2007, ENV QUALITY DEV PLAS, V2007; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227	46	9	9	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48840	10.1371/journal.pone.0048840	http://dx.doi.org/10.1371/journal.pone.0048840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144992	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800151
J	Feng, YM; Schouteden, S; Geenens, R; Van Duppen, V; Herijgers, P; Holvoet, P; Van Veldhoven, PP; Verfaillie, CM				Feng, Yingmei; Schouteden, Sarah; Geenens, Rachel; Van Duppen, Vik; Herijgers, Paul; Holvoet, Paul; Van Veldhoven, Paul P.; Verfaillie, Catherine M.			Hematopoietic Stem/Progenitor Cell Proliferation and Differentiation Is Differentially Regulated by High-Density and Low-Density Lipoproteins in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; APOLIPOPROTEIN-A-I; BONE-MARROW; SCAVENGER RECEPTOR; STEM-CELLS; MOBILIZATION; HYPERCHOLESTEROLEMIA; CHOLESTEROL; GRANULOCYTE; ATHEROSCLEROSIS	Rationale: Hematopoietic stem/progenitor cells (HSPC) are responsible for maintaining the blood system as a result of their self-renewal and multilineage differentiation capacity. Recently, studies have suggested that HDL cholesterol may inhibit and impaired cholesterol efflux may increase HSPC proliferation and differentiation. Objectives: We hypothesized that LDL may enhance HSPC proliferation and differentiation while HDL might have the opposing effect which might influence the size of the pool of inflammatory cells. Methods and Results: HSPC number and function were studied in hypercholesterolemic LDL receptor knockout (LDLr-/-) mice on high fat diet. Hypercholesterolemia was associated with increased frequency of HSPC, monocytes and granulocytes in the peripheral blood (PB). In addition, an increased proportion of BM HSPC was in G(2)M of the cell cycle, and the percentage of HSPC and granulocyte-macrophage progenitors (GMP) increased in BM of LDLr-/- mice. When BM Lin-Sca-1+cKit+ (i.e. "LSK'') cells were cultured in the presence of LDL in vitro we also found enhanced differentiation towards monocytes and granulocytes. Furthermore, LDL promoted lineage negative (Lin-) cells motility. The modulation by LDL on HSPC differentiation into granulocytes and motility was inhibited by inhibiting ERK phosphorylation. By contrast, when mice were infused with human apoA-I (the major apolipoprotein of HDL) or reconstituted HDL (rHDL), the frequency and proliferation of HSPC was reduced in BM in vivo. HDL also reversed the LDL-induced monocyte and granulocyte differentiation in vitro. Conclusion: Our data suggest that LDL and HDL have opposing effects on HSPC proliferation and differentiation. It will be of interest to determine if breakdown of HSPC homeostasis by hypercholesterolemia contributes to inflammation and atherosclerosis progression.	[Feng, Yingmei; Schouteden, Sarah; Van Duppen, Vik; Verfaillie, Catherine M.] Katholieke Univ Leuven, Interdept Stem Cell Inst, Louvain, Belgium; [Geenens, Rachel; Herijgers, Paul] Katholieke Univ Leuven, Div Cardiac Surg, Louvain, Belgium; [Holvoet, Paul] Katholieke Univ Leuven, Dept Cardiovasc Dis, Atherosclerosis & Metab Unit, Louvain, Belgium; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Lipid Biochem & Prot Interact, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Feng, YM (corresponding author), Katholieke Univ Leuven, Interdept Stem Cell Inst, Louvain, Belgium.	yingmei.feng@med.kuleuven.be; Catherine.verfaillie@med.kuleuven.be	, Van Veldhoven Paul/U-6359-2019; Herijgers, Paul/B-8064-2013; HOLVOET, PAUL/T-8434-2017	, Van Veldhoven Paul/0000-0002-4478-2564; Herijgers, Paul/0000-0003-0951-8132; HOLVOET, PAUL/0000-0001-9201-0772	Vanwayenberghe fonds; Fonds Westenschappelijk Onderzork founding [G085111N]; Odysseus;  [NIH-PO1-CA-65493-06]	Vanwayenberghe fonds; Fonds Westenschappelijk Onderzork founding; Odysseus; 	This work was supported by the Vanwayenberghe fonds, Fonds Westenschappelijk Onderzork founding (G085111N), NIH-PO1-CA-65493-06, Odysseus funding to CMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Anzinger JJ, 2010, ARTERIOSCL THROM VAS, V30, P2022, DOI 10.1161/ATVBAHA.110.210849; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Carlo-Stella C, 2004, BLOOD, V103, P3287, DOI 10.1182/blood-2003-07-2428; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cho KH, 2009, EXP MOL MED, V41, P417, DOI 10.3858/emm.2009.41.6.047; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Crysandt M, 2011, BONE MARROW TRANSPL, V46, P1426, DOI 10.1038/bmt.2010.327; Feng Y, 2008, ARTERIOSCL THROM VAS, V28, P278, DOI 10.1161/ATVBAHA.107.158741; Feng YM, 2011, ATHEROSCLEROSIS, V214, P271, DOI 10.1016/j.atherosclerosis.2010.09.024; Feng YM, 2009, J MOL MED, V87, P287, DOI 10.1007/s00109-008-0427-y; Feng YM, 2009, BLOOD, V113, P755, DOI 10.1182/blood-2008-06-161794; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gomes AL, 2010, BLOOD, V115, P3886, DOI 10.1182/blood-2009-08-240580; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Hohensinner PJ, 2007, J THROMB HAEMOST, V5, P2520, DOI 10.1111/j.1538-7836.2007.02784.x; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Murphy AJ, 2011, ARTERIOSCL THROM VAS, V31, P1333, DOI 10.1161/ATVBAHA.111.226258; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; NEBEN S, 1993, BLOOD, V81, P1960; Patel S, 2010, ATHEROSCLEROSIS, V212, P392, DOI 10.1016/j.atherosclerosis.2010.05.035; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Reimers GJ, 2011, CARDIOVASC RES, V91, P37, DOI 10.1093/cvr/cvr057; Saitoh T, 2000, J AM COLL CARDIOL, V35, P655, DOI 10.1016/S0735-1097(99)00583-5; Singh P, 2012, LEUKEMIA, V26, P2375, DOI 10.1038/leu.2012.117; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Strawn WB, 2008, ATHEROSCLEROSIS, V196, P624, DOI 10.1016/j.atherosclerosis.2007.06.024; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tabet F, 2011, ARTERIOSCL THROM VAS, V31, P1192, DOI 10.1161/ATVBAHA.110.222000; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866	48	46	48	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47286	10.1371/journal.pone.0047286	http://dx.doi.org/10.1371/journal.pone.0047286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144813	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800017
J	Fukano, Y; Yahara, T				Fukano, Yuya; Yahara, Tetsukazu			Changes in Defense of an Alien Plant Ambrosia artemisiifolia before and after the Invasion of a Native Specialist Enemy Ophraella communa	PLOS ONE			English	Article							INCREASED COMPETITIVE ABILITY; GENETIC DIFFERENTIATION; LESAGE COLEOPTERA; EICA HYPOTHESIS; EVOLUTION; RELEASE; GENERALIST; HERBIVORES; ESCAPE; GROWTH	The evolution of increased competitive ability hypothesis (EICA) predicts that when alien plants are free from their natural enemies they evolve lower allocation to defense in order to achieve a higher growth rate. If this hypothesis is true, the converse implication would be that the defense against herbivory could be restored if a natural enemy also becomes present in the introduced range. We tested this scenario in the case of Ambrosia artemisiifolia (common ragweed) - a species that invaded Japan from North America. We collected seeds from five North American populations, three populations in enemy free areas of Japan and four populations in Japan where the specialist herbivore Ophraella communa naturalized recently. Using plants grown in a common garden in Japan, we compared performance of O. communa with a bioassay experiment. Consistent with the EICA hypothesis, invasive Japanese populations of A. artemisiifolia exhibited a weakened defense against the specialist herbivores and higher growth rate than native populations. Conversely, in locations where the herbivore O. communa appeared during the past decade, populations of A. artemisiifolia exhibited stronger defensive capabilities. These results strengthen the case for EICA and suggest that defense levels of alien populations can be recuperated rapidly after the native specialist becomes present in the introduced range. Our study implies that the plant defense is evolutionary labile depending on plant-herbivore interactions.	[Fukano, Yuya; Yahara, Tetsukazu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Kyushu University	Fukano, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	ragweed.beetle@gmail.com		Yahara, Tetsukazu/0000-0001-5105-7152	Sumitomo Foundation [083356]	Sumitomo Foundation	This work was supported by the Sumitomo Foundation, No. 083356. (http://www.sumitomo.or.jp/html/kankyo/kankyou.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Koichi Tanaka for providing ragweed seeds from Tsukuba and valuable research suggestion, Yusuke Onoda and Steve Franks for their critical comments on our draft, Atsushi Shiota, Yoshinobu Takizaki, and Konami Kinoshita for their kind help in sampling plant and insect materials, Chris Wood and Marko Jusup for editing the manuscript and members of ecology group in Kyushu University for helpful discussion. This work was carried out with a support from Sumitomo Foundation No. 083356.	Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1995, PLANT INVADERS; Atwood J. P., 2011, NeoBiota, P7, DOI 10.3897/neobiota.10.954; BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Buschmann H, 2005, J ECOL, V93, P322, DOI 10.1111/j.1365-2745.2005.00991.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cripps MG, 2009, BASIC APPL ECOL, V10, P103, DOI 10.1016/j.baae.2008.03.001; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Doorduin LJ, 2011, PHYTOCHEM REV, V10, P99, DOI 10.1007/s11101-010-9195-8; Elton C. S., 1958, ECOLOGY INVASIONS AN; Franks SJ, 2008, BIOSCIENCE, V58, P870, DOI 10.1641/B580913; Franks SJ, 2010, J PLANT BIOL, V53, P1, DOI 10.1007/s12374-009-9086-y; FUTUYMA DJ, 1990, J NEW YORK ENTOMOL S, V98, P163; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Genton BJ, 2005, OECOLOGIA, V146, P404, DOI 10.1007/s00442-005-0234-x; Hendry AP, 1999, EVOLUTION, V1999, P6; Hisauchi K., 1950, NATURALIZED PLANTS; Hodgins KA, 2011, J EVOLUTION BIOL, V24, P2731, DOI 10.1111/j.1420-9101.2011.02404.x; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Hull-Sanders HM, 2007, J CHEM ECOL, V33, P781, DOI 10.1007/s10886-007-9252-y; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Julien M. H., 1998, BIOL CONTROL WEEDS W; Kato Atsushi, 2008, Japanese Journal of Environmental Entomology and Zoology, V19, P125; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kiss L, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P80, DOI 10.1079/9781845932657.0080; Liu H, 2007, BIOL INVASIONS, V9, P773, DOI 10.1007/s10530-006-9074-9; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; MacDonald AAM, 2010, OECOLOGIA, V162, P977, DOI 10.1007/s00442-009-1557-9; MacKay J, 2008, J ECOL, V96, P1152, DOI 10.1111/j.1365-2745.2008.01426.x; Maron JL, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P280; Meggs WJ, 1996, ARCH ENVIRON HEALTH, V51, P275, DOI 10.1080/00039896.1996.9936026; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moloney KA, 2009, PERSPECT PLANT ECOL, V11, P311, DOI 10.1016/j.ppees.2009.05.002; Moriya Seiichi, 2001, Japanese Journal of Entomology New Series, V4, P99; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; PALMER WA, 1991, COLEOPTS BULL, V45, P115; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Siemann E, 2003, ECOL APPL, V13, P1503, DOI 10.1890/03-5022; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Takizawa Haruo, 1999, Gekkan-Mushi, V338, P26; van Kleunen M, 2009, J ECOL, V97, P385, DOI 10.1111/j.1365-2745.2009.01483.x; Williamson M, 1996, POPULATION AND COMMU; Wolfe LM, 2002, AM NAT, V160, P705, DOI 10.1086/343872; Yamazaki K, 2000, APPL ENTOMOL ZOOL, V35, P215, DOI 10.1303/aez.2000.215; Zangerl AR, 2008, P NATL ACAD SCI USA, V105, P4547, DOI 10.1073/pnas.0710280105; Zangerl AR, 2005, P NATL ACAD SCI USA, V102, P15529, DOI 10.1073/pnas.0507805102	54	28	30	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49114	10.1371/journal.pone.0049114	http://dx.doi.org/10.1371/journal.pone.0049114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145089	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800209
J	Hall, JA; Jewell, DE				Hall, Jean A.; Jewell, Dennis E.			Feeding Healthy Beagles Medium-Chain Triglycerides, Fish Oil, and Carnitine Offsets Age-Related Changes in Serum Fatty Acids and Carnitine Metabolites	PLOS ONE			English	Article							IMMUNE-RESPONSE; DIETARY N-6; VITAMIN-E; DOGS; RATS; CLEARANCE; EMULSIONS; PROFILE	The purpose of this study was to determine if feeding dogs medium-chain triglycerides (MCT), fish oil, and L-carnitine enriched foods offsets age-associated changes in serum fatty acids (FA) and carnitine metabolites. Forty-one healthy Beagles, mean age 9.9 years (range 3.1 to 14.8), were fed control or one of two treatment foods for 6 months. All foods were complete and balanced and met the nutrient requirements for adult dogs, and had similar concentrations of moisture, protein, and fat (approx. 7.4%, 14.0%, and 18.1%, respectively). The treatment diets both contained added L-carnitine (300 mg/kg) and 0.6% (treatment food 1) or 1.5% (treatment food 2) added fish oil. Treatment food 2 also had increased MCT from coconut oil, added corn oil, and reduced animal fat. Composition of serum FA was determined by gas chromatography of FA methyl esters. Metabolomic profiles of serum samples were determined from extracted supernatants that were split and run on GC/MS and LC/MS/MS platforms, for identification and relative quantification of small metabolites. Body composition was determined by dual energy x-ray absorptiometry. Among dog groups, there was no change in total-lean-body weight, or in serum total protein and serum albumin concentrations, based on time or dietary treatment. Serum concentrations of carnitine metabolites were decreased in geriatric (>7 years) vs. mature adult (<= 7 years) dogs, and supplementation with L-carnitine attenuated the effects of aging. The ratio of PUFA to SFA was significantly greater in mature dogs at baseline (P <= 0.05). Serum concentrations of eicosapentaenoic and docosahexaenoic FA increased in a dose-dependent manner. Dogs consuming treatment food 2 also had increased serum concentrations of lauric and myristic FA, and decreased concentrations of SFA, MUFA, and arachidonate (all P <= 0.05) and their PUFA to SFA ratio increased. In summary, dietary MCT, fish oil, and L-carnitine counterbalanced the effects of aging on circulating concentrations of these compounds.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS. http://www.hillspet. com/our-company.html. The funding decision makers had no role in study design, data collection and analysis, or preparation of the manuscript.	Block RC, 2010, PROSTAG LEUKOTR ESS, V82, P87, DOI 10.1016/j.plefa.2009.12.005; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Carpentier YA, 2010, AM J CLIN NUTR, V91, P875, DOI 10.3945/ajcn.2009.27951; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guarnieri G, 2007, J RENAL NUTR, V17, P23, DOI 10.1053/j.jrn.2006.10.006; Hall JA, 2005, PROSTAG LEUKOTR ESS, V73, P335, DOI 10.1016/j.plefa.2005.07.006; Hall JA, 2003, AM J VET RES, V64, P762, DOI 10.2460/ajvr.2003.64.762; Hall JA, 2006, J NUTR, V136, P2338, DOI 10.1093/jn/136.9.2338; Hall JA, 2011, VET IMMUNOL IMMUNOP, V144, P355, DOI 10.1016/j.vetimm.2011.08.007; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; Huang LS, 2010, LIPIDS, V45, P225, DOI 10.1007/s11745-010-3392-5; Jacob F, 2002, J AM VET MED ASSOC, V220, P1163, DOI 10.2460/javma.2002.220.1163; Juliet PAR, 2003, J GERONTOL A-BIOL, V58, P970; Kono H, 2010, TRANSL RES, V156, P282, DOI 10.1016/j.trsl.2010.07.012; LANDS WEM, 1995, AM J CLIN NUTR, V61, p721S, DOI 10.1093/ajcn/61.3.721S; Matera M, 2003, J RENAL NUTR, V13, P2, DOI 10.1053/jren.2003.50010; Murphy WJA, 2012, NEPHROL DIAL TRANSPL, V27, P304, DOI 10.1093/ndt/gfr334; Nelson R.W., 2012, SMALL ANIMAL CLIN DI, V5th ed., P156; Hung DN, 2011, INFLAMMATION, V34, P147, DOI 10.1007/s10753-010-9218-z; Owen L, 2011, NUTRIENTS, V3, P735, DOI 10.3390/nu3080735; Pan YL, 2010, BRIT J NUTR, V103, P1746, DOI 10.1017/S0007114510000097; Picq M, 2010, MOL NEUROBIOL, V42, P48, DOI 10.1007/s12035-010-8131-7; Qi KM, 2006, J NUTR, V136, P2766, DOI 10.1093/jn/136.11.2766; Roush JK, 2010, JAVMA-J AM VET MED A, V236, P59, DOI 10.2460/javma.236.1.59; Simoens CM, 2008, AM J CLIN NUTR, V88, P282, DOI 10.1093/ajcn/88.2.282; Studzinski CM, 2008, BRAIN RES, V1226, P209, DOI 10.1016/j.brainres.2008.06.005; Taha AY, 2009, NEUROCHEM RES, V34, P1619, DOI 10.1007/s11064-009-9952-5; Thangasamy T, 2008, CLIN CHIM ACTA, V389, P19, DOI 10.1016/j.cca.2007.11.013; Wander RC, 1997, J NUTR, V127, P1198, DOI 10.1093/jn/127.6.1198; Zhao YT, 2009, CELL SIGNAL, V21, P367, DOI 10.1016/j.cellsig.2008.10.010	34	25	27	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49510	10.1371/journal.pone.0049510	http://dx.doi.org/10.1371/journal.pone.0049510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145181	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800262
J	Iwanaga, S; Kaneko, I; Kato, T; Yuda, M				Iwanaga, Shiroh; Kaneko, Izumi; Kato, Tomomi; Yuda, Masao			Identification of an AP2-family Protein That Is Critical for Malaria Liver Stage Development	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PLASMODIUM-BERGHEI; T-CELLS; PARASITES; SPOROZOITES; IMMUNITY; INFECTIVITY; PROTECTION; SAP1	Liver-stage malaria parasites are a promising target for drugs and vaccines against malaria infection. However, little is currently known about gene regulation in this stage. In this study, we used the rodent malaria parasite Plasmodium berghei and showed that an AP2-family transcription factor, designated AP2-L, plays a critical role in the liver-stage development of the parasite. AP2-L-depleted parasites proliferated normally in blood and in mosquitoes. However, the ability of these parasites to infect the liver was approximately 10,000 times lower than that of wild-type parasites. In vitro assays showed that the sporozoites of these parasites invaded hepatocytes normally but that their development stopped in the middle of the liver schizont stage. Expression profiling using transgenic P. berghei showed that fluorescent protein-tagged AP2-L increased rapidly during the liver schizont stage but suddenly disappeared with the formation of the mature liver schizont. DNA microarray analysis showed that the expression of several genes, including those of parasitophorous vacuole membrane proteins, was significantly decreased in the early liver stage of AP2-L-depleted parasites. Investigation of the targets of this transcription factor should greatly promote the exploration of liver-stage antigens and the elucidation of the mechanisms of hepatocyte infection by malaria parasites.	[Iwanaga, Shiroh; Kaneko, Izumi; Kato, Tomomi; Yuda, Masao] Mie Univ, Sch Med, Dept Med Zool, Tsu, Mie 514, Japan	Mie University	Yuda, M (corresponding author), Mie Univ, Sch Med, Dept Med Zool, Tsu, Mie 514, Japan.	m-yuda@doc.medic.mie-u.ac.jp		Iwanaga, Shiroh/0000-0002-4394-7267	Ministry of Education, Science, Culture, and Sports of Japan [21022019]	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Science, Culture, and Sports of Japan (grant 21022019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Aly ASI, 2011, MOL MICROBIOL, V79, P929, DOI 10.1111/j.1365-2958.2010.07497.x; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; White KL, 1996, J IMMUNOL, V156, P3374; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	20	72	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47557	10.1371/journal.pone.0047557	http://dx.doi.org/10.1371/journal.pone.0047557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144823	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800023
J	Jones, MEH; Werneburg, I; Curtis, N; Penrose, R; O'Higgins, P; Fagan, MJ; Evans, SE				Jones, Marc E. H.; Werneburg, Ingmar; Curtis, Neil; Penrose, Rod; O'Higgins, Paul; Fagan, Michael J.; Evans, Susan E.			The Head and Neck Anatomy of Sea Turtles (Cryptodira: Chelonioidea) and Skull Shape in Testudines	PLOS ONE			English	Article							JUVENILE KEMPS RIDLEY; CARETTA-CARETTA; FEEDING ECOLOGY; MUSCULOSKELETAL SYSTEM; MOLECULAR PHYLOGENY; MARINE TURTLES; GREEN TURTLE; MORPHOLOGY; ORIGIN; MITOCHONDRIAL	Background: Sea turtles (Chelonoidea) are a charismatic group of marine reptiles that occupy a range of important ecological roles. However, the diversity and evolution of their feeding anatomy remain incompletely known. Methodology/Principal Findings: Using computed tomography and classical comparative anatomy we describe the cranial anatomy in two sea turtles, the loggerhead (Caretta caretta) and Kemp's ridley (Lepidochelys kempii), for a better understanding of sea turtle functional anatomy and morphological variation. In both taxa the temporal region of the skull is enclosed by bone and the jaw joint structure and muscle arrangement indicate that palinal jaw movement is possible. The tongue is relatively small, and the hyoid apparatus is not as conspicuous as in some freshwater aquatic turtles. We find several similarities between the muscles of C. caretta and L. kempii, but comparison with other turtles suggests only one of these characters may be derived: connection of the m. adductor mandibulae internus into the Pars intramandibularis via the Zwischensehne. The large fleshy origin of the m. adductor mandibulae externus Pars superficialis from the jugal seems to be a characteristic feature of sea turtles. Conclusions/Significance: In C. caretta and L. kempii the ability to suction feed does not seem to be as well developed as that found in some freshwater aquatic turtles. Instead both have skulls suited to forceful biting. This is consistent with the observation that both taxa tend to feed on relatively slow moving but sometimes armoured prey. The broad fleshy origin of the m. adductor mandibulae externus Pars superficialis may be linked to thecheek region being almost fully enclosed in bone but the relationship is complex.	[Jones, Marc E. H.; Evans, Susan E.] UCL, Res Dept Cell & Dev Biol, UCL, London, England; [Werneburg, Ingmar] Univ Tubingen, Fachbereich Geowissensch, Tubingen, Germany; [Werneburg, Ingmar] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan; [Werneburg, Ingmar] Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland; [Curtis, Neil; Fagan, Michael J.] Univ Hull, Dept Engn, Kingston Upon Hull HU6 7RX, N Humberside, England; [Penrose, Rod] Marine Environm Monitoring, United Kingdom Cetacean Strandings Invest Program, Caredigion, Cymru, Wales; [O'Higgins, Paul] Univ York, Hull York Med Sch, Ctr Anat & Human Sci, York YO10 5DD, N Yorkshire, England	University of London; University College London; Eberhard Karls University of Tubingen; RIKEN; University of Zurich; University of Hull; University of Hull; University of York - UK	Jones, MEH (corresponding author), UCL, Res Dept Cell & Dev Biol, UCL, London, England.	marc.jones@ucl.ac.uk	Huw, Emyr/C-1516-2010; Evans, Susan/C-1888-2008; Evans, Susan/C-1888-2008	Huw, Emyr/0000-0002-0146-9623; Evans, Susan/0000-0002-1633-158X; Werneburg, Ingmar/0000-0003-1359-2036; Evans, Susan/0000-0002-0799-4154; O'Higgins, Paul/0000-0002-9797-0809	Defra; Devolved Administration in Scotland; Devolved Administration in Wales; Biotechnology and Biological Sciences Research Council [BB/E007465/1, BB/E009204/1, BB/E007813/1]; UCL; Synthesys [DE-TAF-3859]; Japan Society for the Promotion of Science [11027]; Deutsche Forschungsgemeinschaft [JO 928/1-1]; Swiss National Science Foundation [3100A0-116013, 31003A_133032/1]; BBSRC [BB/E007465/1, BB/E007813/1, BB/E009204/1] Funding Source: UKRI	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Devolved Administration in Scotland; Devolved Administration in Wales; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UCL; Synthesys; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The sea turtle specimens, three Caretta caretta and two Lepidochelys kempii, were provided by the UK Cetacean Strandings Investigation Programme (CSIP) which is funded by Defra and the Devolved Administrations in Scotland and Wales. The animals were found on beaches around the UK between 2007 and 2010, recovered by the CSIP, and given postmortem examinations. Transfer of the material (which represent Annex IV listed species) to SEE and MEHJ was carried out by R. Deaville (UK Cetacean Strandings Investigation Programme, Institute of Zoology, Zoological Society of London) under licences issued by Countryside Council for Wales (CCW) and Natural England (NE) (WML-CL01 (01/12)). We thank S. Taft (University of Hull, UK) for helping us to micro-CT scan the turtle specimens and L. Clarke for bisecting specimen XT043/08. For access to skeletal material, we thank M. Lowe (University Museum of Zoology Cambridge), N. Camacho (Los Angeles County Natural History Museum), and E-L. B. Nicholls (Grant Museum of Zoology, UCL). MEHJ thanks Kris A. Lappin (Cal Poly Pomona) for hosting a visit to California which provided the opportunity to visit the Los Angeles County Natural History Museum and also to Johannes Muller for hosting a visit to Museum fur Naturkunde to examine Proganochelys specimen MB 1910.45.2. We also thank Juan Daza, Andrew Farke, and Casey Holliday for their constructive feedback on an earlier version of this manuscript.; MEHJ and NC were funded by Biotechnology and Biological Sciences Research Council grants (BB/E007465/1, BB/E009204/1 and BB/E007813/1) awarded to SEE (UCL), MJF (University of Hull), and PO (Hull York Medical School and University of Hull) respectively. MEHJ also received funding for visiting specimen collections from the UCL Bogue Fellowship (2009) and Synthesys (grant DE-TAF-3859). IW was supported by a Japan Society for the Promotion of Science-grant (PE 11027), a Deutsche Forschungsgemeinschaft-grant (JO 928/1-1 awarded to Walter G. Joyce), and by Swiss National Science Foundation-grants (No. 3100A0-116013, No. 31003A_133032/1; awarded to Marcelo R. Sanchez-Villagra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L. A., 1919, Annals New York Academy Science, V28; Arencibia A, 2006, RES VET SCI, V81, P165, DOI 10.1016/j.rvsc.2005.12.009; BARGHUSEN HR, 1973, J PALEONTOL, V47, P823; Baur G., 1889, J MORPHOL, V3, P467; Bellairs A.d'A., 1981, Biology of Reptilia, V11, P1; Bels Vincent, 2008, P187; Benson RBJ, 2011, PALEOBIOLOGY, V37, P547, DOI 10.1666/10052.1; Bhullar Bhart-Anjan S., 2009, Breviora, V518, P1, DOI 10.3099/0006-9698-518.1.1; BJORNDAL K.A., 2003, LOGGERHEAD SEA TURTL, P235; Bjorndal KA, 2003, CRC MAR BIOL SER, P259; Bjorndal Karen A., 1997, P199; BLANEY SPA, 1989, ANAT REC, V224, P550, DOI 10.1002/ar.1092240413; Bolten AB, 2003, CRC MAR BIOL SER, P243; Bolten AB, 2003, LOGGERHEAD SEA TURTL; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; Boulenger GA, 1918, COMPTES RENDUS A ACA, V169, P605; BOWEN B, 1993, CONSERV BIOL, V7, P834, DOI 10.1046/j.1523-1739.1993.740834.x; BOWEN B.W., 2003, LOGGERHEAD SEA TURTL, P7; Boyle MC, 2008, MAR BIOL, V155, P233, DOI 10.1007/s00227-008-1022-z; Boyle MC, 2009, P R SOC B, V276, P1993, DOI 10.1098/rspb.2008.1931; Bramble D.M., 1985, P230; Brinkman Donald B., 1999, Paludicola, V2, P134; Broom R, 1924, B AM MUS NAT HIST, V51, P39; Broom R, 1921, P ZOOL SOC LOND, V1921, P143; BURKE VJ, 1993, COPEIA, P1176; Burne RH, 1905, P ZOOL SOC LOND, V1905, P291; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Bustard H. R., 1972, SEA TURTLES NATURAL; Cao Y, 2000, GENE, V259, P139, DOI 10.1016/S0378-1119(00)00425-X; Carr A, 1952, HDB TURTLES TURTLES; CARROLL RL, 1969, BIOL REV, V44, P393, DOI 10.1111/j.1469-185X.1969.tb01218.x; Case E. C., 1924, Contributions from the Museum of Geology University of Michigan, V2, P1; Claude J, 2004, SYST BIOL, V53, P933, DOI 10.1080/10635150490889498; COX CB, 1969, B BRIT MUS NAT HIST, V18, P165; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Crowder L, 2011, SOLUTIONS, V2, P67; Curtis N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029804; Curtis N, 2010, J R SOC INTERFACE, V7, P153, DOI 10.1098/rsif.2009.0139; DAVENPORT J, 1984, PROC R SOC SER B-BIO, V220, P447, DOI 10.1098/rspb.1984.0013; de Beer G., 1937, DEV VERTEBRATE SKULL; de Lapparent de Broin F., 2000, TREBALLS MUS GEOL, V9, P43; deBraga M, 1997, ZOOL J LINN SOC-LOND, V120, P281, DOI 10.1111/j.1096-3642.1997.tb01280.x; DODD CK, 1992, J HERPETOL, V26, P1, DOI 10.2307/1565014; Dodd CK., 1988, 88 US FISH WILDL SER, V88, P1, DOI DOI 10.2307/1445468; Duchene S, 2012, MOL PHY EVOL; Dutton PH, 1996, MOL PHYLOGENET EVOL, V5, P511, DOI 10.1006/mpev.1996.0046; EERNISSE DJ, 1993, MOL BIOL EVOL, V10, P1170; Fox R. C., 1966, Paleontological Contributions University of Kansas, V11, P1; FRAZIER J, 1985, J HERPETOL, V19, P1, DOI 10.2307/1564414; FRAZZETTA TH, 1968, J MORPHOL, V125, P145, DOI 10.1002/jmor.1051250203; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; FURBRINGER M, 1922, ABHANDLUNGEN HEIDE B, V11, P1; Gaffney E.S., 1972, American Museum Novitates, VNo. 2486, P1; GAFFNEY E S, 1990, Bulletin of the American Museum of Natural History, P1; Gaffney E.S., 1988, Systematics Association Special Volume Series, P157; GAFFNEY E S, 1977, American Museum Novitates, P1; Gaffney E.S., 1979, Bulletin of the American Museum of Natural History, V164, P67; GAFFNEY E. S., 1985, AM MUS NOVIT, V2805, P1; Gaffney ES, 2011, B AM MUS NAT HIST, P1; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; George J. C., 1955, J ANIMAL MORPHOLOGY, V1, P1; Gnanamuthu CP, 1937, P ZOOL SOC LOND B-SY, V107, P1; Goodrich ES, 1916, P R SOC LOND B-CONTA, V89, P261, DOI 10.1098/rspb.1916.0012; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; Gregory WK, 1915, SCIENCE, V41, P763, DOI 10.1126/science.41.1064.763; GREGORY WK, 1946, B AM MUS NAT HIST, V86, P281; Hay OP., 1908, FOSSIL TURTLES N AM, DOI DOI 10.5962/BHL.TITLE.12500; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Henderson DM, 2002, J VERTEBR PALEONTOL, V22, P766, DOI 10.1671/0272-4634(2002)022[0766:TEHITS]2.0.CO;2; HENDRICKSON JR, 1980, AM ZOOL, V20, P597; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel Anthony, 2008, P163; Hill RV, 2005, SYST BIOL, V54, P530, DOI 10.1080/10635150590950326; Hirayama R, 1998, NATURE, V392, P705, DOI 10.1038/33669; Hirayama Ren, 1994, Island Arc, V3, P270, DOI 10.1111/j.1440-1738.1994.tb00116.x; Hoffstetter R., 1969, P201; Hunt N, 1998, CLIN ORAL SCI, P120; Iordansky N.N., 1994, Russian Journal of Herpetology, V1, P13; Iordansky N.N., 1996, Russian Journal of Herpetology, V3, P49; Iverson John B., 2007, Chelonian Research Monographs, V4, P85; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Johnson SA, 1996, CONSERV BIOL, V10, P570, DOI 10.1046/j.1523-1739.1996.10020570.x; Johnston P, 2011, J MORPHOL, V272, P1492, DOI 10.1002/jmor.10998; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2012, ANAT REC, V295, P1075, DOI 10.1002/ar.22487; Jones MEH, 2011, PALAEONTOL ELECTRON, V14; Jones MEH, 2009, PALAEONTOL ELECT, V12, P1; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2004, J PALEONTOL, V78, P989, DOI 10.1666/0022-3360(2004)078<0989:DAPFTC>2.0.CO;2; Joyce WG, 2004, P ROY SOC B-BIOL SCI, V271, P1, DOI 10.1098/rspb.2003.2523; KAMEZAKI N, 1995, J HERPETOL, V29, P51, DOI 10.2307/1565085; Kamezaki N., 2003, LOGGERHEAD SEA TURTL, P28; Kesteven, 1910, J P ROY SOC NS WALES, V44, P368; Kilias R., 1957, Mitteilungen aus dem Zoologischen Museum in Berlin, V33, P307; KRAUSE DW, 1982, PALEOBIOLOGY, V8, P265, DOI 10.1017/S0094837300006989; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; LAKE JL, 1994, MAR ENVIRON RES, V38, P313, DOI 10.1016/0141-1136(94)90031-0; Lakjer T., 1926, STUDIEN TRIGEMINUS V; Lauder G.V., 1985, P210; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; Lee MSY, 1997, ZOOL J LINN SOC-LOND, V120, P197; Lee MSY, 2001, CONTRIB ZOOL, V70, P1; Lemell P, 2000, J MORPHOL, V244, P127, DOI 10.1002/(SICI)1097-4687(200005)244:2<127::AID-JMOR3>3.0.CO;2-U; Lemell P, 2010, AMPHIBIA-REPTILIA, V31, P97, DOI 10.1163/156853810790457803; Leon YM, 2002, MAR ECOL PROG SER, V245, P249, DOI 10.3354/meps245249; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Limpus C., 2007, BIOLOGICAL REV AUSTR; Limpus C.J., 1973, Herpetologica, V29, P42; LOVTRUP S, 1985, SYST ZOOL, V34, P463, DOI 10.2307/2413210; Lutcavage Molly E., 1997, P387; Lutz P.L., 1997, BIOL SEA TURTLES; Lyson TR, 2012, BIOL LETTERS, V8, P1028, DOI 10.1098/rsbl.2012.0462; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; Marshall CD, J EXP BIOL IN PRESS, DOI 10.1242jeb.074385; Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0; Matzke AT, 2009, PALAEONTOGR ABT A, V288, P93; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Meylan P. A., 1989, AM MUS NOVIT, V2941, P1; MOORE W. J., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P123; MOSS ML, 1960, AM J PHYS ANTHROPOL, V18, P281, DOI 10.1002/ajpa.1330180406; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Naro-Maciel E, 2008, MOL PHYLOGENET EVOL, V49, P659, DOI 10.1016/j.ympev.2008.08.004; Nick Ludwig, 1912, Zoologische Jahrbuecher Jena Abteilungen fur Anatomie, V33; Nishizawa Hideaki, 2010, Current Herpetology, V29, P97, DOI 10.3105/018.029.0205; Ogushi K., 1913, Morphologisches Jahrbuch Leipzig, V46; OLSON EC, 1961, AM ZOOL, V1, P205; Olson Everett Claire, 1947, FIELDIANA GEOL, V11, P1; Oxnard CE, 1995, BONE STRUCTURE REMOD, V2, P105; Parham James F., 1997, Chelonian Conservation and Biology, V2, P548; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Parham JF, 1997, B MAR SCI, V61, P287; PLOTKIN PT, 1993, MAR BIOL, V115, P1, DOI 10.1007/BF00349379; Poglayen-Neuwall I., 1953, Anatomischer Anzeiger, V99, P257; POGLAYEN-NEUWALL IVO, 1953, ACTA ZOOL [STOCKHOLM], V34, P241; Preuschoft Holger, 2002, Senckenbergiana Lethaea, V82, P207; Pritchard P. C. H, 1997, BIOL SEA TURTLES, P1; Pritchard PCH., 1984, S ZOOL SOC LOND, V52, P87; Ray C. E., 1959, Anatomischer Anzeiger, V107, P85; Renous Sabine, 2008, P97; Rieppel O, 2000, ZOOL SCR, V29, P199, DOI 10.1046/j.1463-6409.2000.00039.x; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; RIEPPEL O, 1990, ZOOL J LINN SOC-LOND, V98, P27, DOI 10.1111/j.1096-3642.1990.tb01218.x; Robinson P, 1975, C INT C N R S, V218, P461; Romer A, 1956, OSTEOLOGY REPTILES; Salmon M, 2004, J HERPETOL, V38, P36, DOI 10.1670/228-01A; Scheyer TM, 2007, P ROY SOC B-BIOL SCI, V274, P1885, DOI 10.1098/rspb.2007.0499; SCHUMACHER G. H., 1956, ANAT ANZ, V103, P1; Schumacher G. H., 1973, P101; Schumacher G. H., 1956, Zoologischer Anzeiger, V156, P35; SCHUMACHER G. H., 1956, ACTA ZOOL [STOCKHOLM], V37, P1; Schumacher G.H., 1972, KOPF HALSREGION LEDE; SCHUMACHER G. H., 1954, WISS Z ERNST MORITZ, V4, P501; SCHUMACHER G. H., 1954, WISSENSCHAFTLICHE Z, V4, P559; Schumacher GH, 1953, WISS Z ERNST MORITZ, V3, P457; Shaffer H. Bradley, 2009, P398; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; SHAH R. V., 1963, BULL MUS COMP ZOOL HARVARD UNIV, V129, P343; SHAVER DJ, 1991, J HERPETOL, V25, P327, DOI 10.2307/1564592; SHOOP CR, 1982, BIOL CONSERV, V23, P213; Spotila JR, 2004, SEA TURTLES COMPLETE; Sterli J, 2008, BIOL LETTERS, V4, P286, DOI 10.1098/rsbl.2008.0022; Sterli J, 2007, ACTA PALAEONTOL POL, V52, P675; Sterli J, 2010, J VERTEBR PALEONTOL, V30, P351, DOI 10.1080/02724631003617597; Sverdlova NS, 2010, J BIOMECH, V43, P387, DOI 10.1016/j.jbiomech.2009.09.049; TAYLOR MA, 1987, ZOOL J LINN SOC-LOND, V91, P171, DOI 10.1111/j.1096-3642.1987.tb01727.x; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Tomas J, 2001, J ZOOL, V255, P525, DOI 10.1017/S0952836901001613; Tsai HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024935; Vallois H., 1922, ARCH MORPHOL GEN EXP, V13, P1; VanDamme J, 1997, J MORPHOL, V233, P113, DOI 10.1002/(SICI)1097-4687(199708)233:2<113::AID-JMOR3>3.0.CO;2-7; Von Hofsten N, 1941, ZOOL BIDR UPPS, V20, P501; Watson DMS, 1914, P ZOOL SOC LOND, V1914, P1011; Werneburg I, 2010, EVOLUTION DEV TURTLE; Werneburg I, 2013, ORG DIVERS EVOL, V13, P225, DOI 10.1007/s13127-012-0103-5; Werneburg I, 2012, J EXP ZOOL PART B, V318B, P235, DOI 10.1002/jez.b.22450; Werneburg I, 2011, PALAEONTOL ELECTRON, V14; Werneburg I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-82; WILLIAMS ERNEST E., 1959, BREVIORA MUS COMP ZOOL [HARVARD], V101, P1; WILLIAMS ERNEST EDWARD, 1950, BULL AMER MUS NAT HIST, V94, P505; Williston SW, 1904, BIOL BULL-US, V7, P175, DOI 10.2307/1535794; Williston SW, 1914, J GEOL, V22, P364, DOI 10.1086/622158; Williston SW, 1917, CONTRIBUTIONS WALKER, V2, P61; WITHERINGTON BE, 1992, J HERPETOL, V26, P226, DOI 10.2307/1564869; Witzel U, 2005, ANAT REC PART A, V283A, P391, DOI 10.1002/ar.a.20174; Witzell WN, 2005, B MAR SCI, V77, P191; Wyneken, 2003, BIOL SEA TURTLES, VII; Wyneken J, 2003, CRC MAR BIOL SER, P39; Wyneken J., 2001, NMFSSEFSC470 NOAA US; Wyneken Jeanette, 1997, P165; Zangerl R., 1971, Memoires Inst r Sci nat Belg (Ser 1), VNo. 169, P1; ZANGERL R, 1948, EVOLUTION, V2, P351, DOI 10.2307/2405524; ZANGERL R, 1980, AM ZOOL, V20, P585; ZANGERL R., 1953, FIELDIANA GEOLOGY ME, P137, DOI DOI 10.5962/BHL.TITLE.7198; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zdansky O, 1923, B GEOLOG INSTIT U UP, V19, P89; [No title captured]	201	47	49	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47852	10.1371/journal.pone.0047852	http://dx.doi.org/10.1371/journal.pone.0047852			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144831	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000311935800028
J	Prakash, V; Bishwakarma, MC; Chaudhary, A; Cuthbert, R; Dave, R; Kulkarni, M; Kumar, S; Paudel, K; Ranade, S; Shringarpure, R; Green, RE				Prakash, Vibhu; Bishwakarma, Mohan Chandra; Chaudhary, Anand; Cuthbert, Richard; Dave, Ruchi; Kulkarni, Mandar; Kumar, Sashi; Paudel, Khadananda; Ranade, Sachin; Shringarpure, Rohan; Green, Rhys E.			The Population Decline of Gyps Vultures in India and Nepal Has Slowed since Veterinary Use of Diclofenac was Banned	PLOS ONE			English	Article							BENGALENSIS; RESIDUES; EXPOSURE	Populations of oriental white-backed vulture (Gyps bengalensis), long-billed vulture (Gyps indicus) and slender-billed vulture (Gyps tenuirostris) crashed during the mid-1990s throughout the Indian subcontinent. Surveys in India, initially conducted in 1991-1993 and repeated in 2000, 2002, 2003 and 2007, revealed that the population of Gyps bengalensis had fallen by 2007 to 0.1% of its numbers in the early 1990s, with the population of Gyps indicus and G. tenuirostris combined having fallen to 3.2% of its earlier level. A survey of G. bengalensis in western Nepal indicated that the size of the population in 2009 was 25% of that in 2002. In this paper, repeat surveys conducted in 2011 were analysed to estimate recent population trends. Populations of all three species of vulture remained at a low level, but the decline had slowed and may even have reversed for G. bengalensis, both in India and Nepal. However, estimates of the most recent population trends are imprecise, so it is possible that declines may be continuing, though at a significantly slower rate. The degree to which the decline of G. bengalensis in India has slowed is consistent with the expected effects on population trend of a measured change in the level of contamination of ungulate carcasses with the drug diclofenac, which is toxic to vultures, following a ban on its veterinary use in 2006. The most recent available information indicates that the elimination of diclofenac from the vultures' food supply is incomplete, so further efforts are required to fully implement the ban.	[Cuthbert, Richard; Green, Rhys E.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Prakash, Vibhu; Dave, Ruchi; Kulkarni, Mandar; Kumar, Sashi; Ranade, Sachin; Shringarpure, Rohan] Bombay Nat Hist Soc, Bombay, Maharashtra, India; [Bishwakarma, Mohan Chandra; Chaudhary, Anand; Paudel, Khadananda] Bird Conservat Nepal, Kathmandu, Nepal; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Royal Society for Protection of Birds; University of Cambridge	Green, RE (corresponding author), Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England.	reg29@hermes.cam.ac.uk	Kulkarni, Mandar/AAG-1429-2020	Kulkarni, Mandar/0000-0002-2694-9826; Chaudhary, Anand/0000-0002-3914-6942	Darwin Initiative of the United Kingdom government; Royal Society for the Protection of Birds (RSPB); Ministry of the Environment and Forests (MoEF) of the Government of India; Department of National Parks and Wildlife Conservation (DNPWC) of the Government of Nepal	Darwin Initiative of the United Kingdom government; Royal Society for the Protection of Birds (RSPB); Ministry of the Environment and Forests (MoEF) of the Government of India; Department of National Parks and Wildlife Conservation (DNPWC) of the Government of Nepal	This project was funded by the Darwin Initiative of the United Kingdom government (http://darwin.defra.gov.uk/) and the Royal Society for the Protection of Birds (RSPB) (http://www.rspb.org.uk). RC and REG are authors of the paper and members of the research staff of the Conservation Science Department of RSPB. Beyond this, the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the Ministry of the Environment and Forests (MoEF) of the Government of India and the Department of National Parks and Wildlife Conservation (DNPWC) of the Government of Nepal, for their support. We are grateful to Ian Newton and an anonymous referee for critical comments on previous versions.	Baral Hem Sagar, 2004, P215; Chaudhary A, 2012, BIRD CONSERV INT, V22, P270, DOI 10.1017/S0959270911000426; Cuthbert R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019069; Cuthbert RJ, 2011, ORYX, V45, P420, DOI 10.1017/S0030605311000135; Ferriere R, 1996, ACTA OECOL, V17, P629; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Gilbert Martin, 2004, P221; Gilbert M, 2006, ORYX, V40, P388, DOI 10.1017/S0030605306001347; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Green RE, 2002, CONSERV BIOL SER, V7, P139; Green RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000686; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Mateo-Tomas P, 2012, J APPL ECOL, V49, P376, DOI 10.1111/j.1365-2664.2012.02119.x; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; Prakash V., 2007, J BOMBAY NAT HIST SO, V104, P129; Rasmussen Pamela C., 2001, Vulture News, V44, P18; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Swan GE, 2006, PLOS BIOL, V4, P1, DOI DOI 10.1371/JOURNAL.PBIO.0040066; Swarup D, 2007, ANIM CONSERV, V10, P192, DOI 10.1111/j.1469-1795.2006.00086.x	23	80	89	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49118	10.1371/journal.pone.0049118	http://dx.doi.org/10.1371/journal.pone.0049118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145090	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800210
J	Scozzari, R; Massaia, A; D'Atanasio, E; Myres, NM; Perego, UA; Trombetta, B; Cruciani, F				Scozzari, Rosaria; Massaia, Andrea; D'Atanasio, Eugenia; Myres, Natalie M.; Perego, Ugo A.; Trombetta, Beniamino; Cruciani, Fulvio			Molecular Dissection of the Basal Clades in the Human Y Chromosome Phylogenetic Tree	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; GENE CONVERSION; HUMAN-POPULATIONS; HAPLOGROUP TREE; MTDNA VARIATION; DIVERSITY; LINEAGES; HISTORY; ORIGIN; PHYLOGEOGRAPHY	One hundred and forty-six previously detected mutations were more precisely positioned in the human Y chromosome phylogeny by the analysis of 51 representative Y chromosome haplogroups and the use of 59 mutations from literature. Twenty-two new mutations were also described and incorporated in the revised phylogeny. This analysis made it possible to identify new haplogroups and to resolve a deep trifurcation within haplogroup B2. Our data provide a highly resolved branching in the African-specific portion of the Y tree and support the hypothesis of an origin in the north-western quadrant of the African continent for the human MSY diversity.	[Scozzari, Rosaria; Massaia, Andrea; D'Atanasio, Eugenia; Trombetta, Beniamino; Cruciani, Fulvio] Sapienza Univ Roma, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy; [Myres, Natalie M.; Perego, Ugo A.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Myres, Natalie M.] AncestryDNA, Provo, UT USA; [Perego, Ugo A.] Univ Pavia, Dipartimento Biol & Biotecnol Lazzaro Spallanzani, I-27100 Pavia, Italy	Sapienza University Rome; University of Pavia	Cruciani, F (corresponding author), Sapienza Univ Roma, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy.	fulvio.cruciani@uniroma1.it	Perego, Ugo/AAG-9327-2019; D'ATANASIO, EUGENIA/AAX-8157-2020	D'ATANASIO, EUGENIA/0000-0002-4965-246X; Trombetta, Beniamino/0000-0001-8245-9437; Cruciani, Fulvio/0000-0002-6900-024X	Italian Ministry of Education, University and Research [2009P2CNKK]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of Education, University and Research (grant "Progetti di Ricerca di Interesse Nazionale", n. 2009P2CNKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Batini C, 2011, MOL BIOL EVOL, V28, P2603, DOI 10.1093/molbev/msr089; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Butler JM, 2005, FORENSIC DNA TYPING; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Cruciani F, 2010, AM J HUM GENET, V86, P495, DOI 10.1016/j.ajhg.2010.01.033; Gomes V, 2010, HUM GENET, V127, P603, DOI 10.1007/s00439-010-0808-5; Goncalves R, 2003, HUM GENET, V113, P467, DOI 10.1007/s00439-003-1007-4; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hassan HY, 2008, AM J PHYS ANTHROPOL, V137, P316, DOI 10.1002/ajpa.20876; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M., 2007, BIOTECHNIQUES, V43, pS16; King TE, 2007, EUR J HUM GENET, V15, P288, DOI 10.1038/sj.ejhg.5201771; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Myres NM, 2009, CROAT MED J, V50, P239, DOI 10.3325/cmj.2009.50.239; Naidoo Thijessen, 2010, Investig Genet, V1, P6, DOI 10.1186/2041-2223-1-6; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2004, AM J HUM GENET, V75, P514, DOI 10.1086/423394; Rosa A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-124; Rosser ZH, 2009, AM J HUM GENET, V85, P130, DOI 10.1016/j.ajhg.2009.06.009; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Simms TM, 2012, AM J PHYS ANTHROPOL, V148, P618, DOI 10.1002/ajpa.22090; Simms TM, 2011, AM J PHYS ANTHROPOL, V146, P594, DOI 10.1002/ajpa.21616; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	42	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49170	10.1371/journal.pone.0049170	http://dx.doi.org/10.1371/journal.pone.0049170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145109	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800223
J	Stepanenko, OV; Stepanenko, OV; Kuznetsova, IM; Shcherbakova, DM; Verkhusha, VV; Turoverov, KK				Stepanenko, Olesya V.; Stepanenko, Olga V.; Kuznetsova, Irina M.; Shcherbakova, Daria M.; Verkhusha, Vladislav V.; Turoverov, Konstantin K.			Distinct Effects of Guanidine Thiocyanate on the Structure of Superfolder GFP	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; INTRINSIC FLUORESCENCE; CHROMOPHORE; BINDING; STABILITY; ACTIN; LANDSCAPE; EMISSION; AZURIN; STATES	Having a high folding efficiency and a low tendency to aggregate, the superfolder GFP (sfGFP) offers a unique opportunity to study the folding of proteins that have a beta-barrel topology. Here, we studied the unfolding-refolding of sfGFP that was induced by guanidine thiocyanate (GTC), which is a stronger denaturing agent than GdnHCl or urea. Structural perturbations of sfGFP were studied by spectroscopic methods (absorbance, fluorescence, and circular dichroism), by acrylamide quenching of tryptophan and green chromophore fluorescence, and by size-exclusion chromatography. Low concentrations of GTC (up to 0.1 M) induce subtle changes in the sfGFP structure. The pronounced changes in the visible absorption spectrum of sfGFP which are accompanied by a dramatic decrease in tryptophan and green chromophore fluorescence was recorded in the range 0-0.7 M GNC. These alterations of sfGFP characteristics that erroneously can be mixed up with appearance of intermediate state in fact have pure spectroscopic but not structural nature. Higher concentrations of GTC (from 0.7 to 1.7 M), induce a disruption of the sfGFP structure, that is manifested in simultaneous changes of all of the detected parameters. Full recovery of native properties of denaturated sfGFP was observed after denaturant removal. The refolding of sfGFP passes through the accumulation of the off-pathway intermediate state, in which inner alpha-helix and hence green chromophore and Trp57 are still not tuned up to (properly integrated into) the already formed b-barrel scaffold of protein. Incorporation of the chromophore in the b-barrel in the pathway of refolding and restoration of its ability to fluoresce occur in a narrow range of GTC concentrations from 1.0 to 0.7 M, and a correct insertion of Trp 57 occurs at concentrations ranging from 0.7 to 0 M GTC. These two processes determine the hysteresis of protein unfolding and refolding.	[Stepanenko, Olesya V.; Stepanenko, Olga V.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Shcherbakova, Daria M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Yeshiva University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@incras.ru	Kuznetsova, Irina M./R-9844-2017; Verkhusha, Vladislav/AAU-7784-2020; Stepanenko, Olesya V/S-3433-2017; Stepanenko, Olga/S-3427-2017; Turoverov, Konstantin/S-2079-2016	Kuznetsova, Irina M./0000-0002-3336-4834; Verkhusha, Vladislav/0000-0002-2083-8121; Turoverov, Konstantin/0000-0002-6977-1896; Stepanenko, Olesya/0000-0003-3779-6711; Stepanenko, Olga/0000-0002-9145-3480	Russian Academy of Sciences; Russian Foundation of basic research [12-04-31469]; SPb Government	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of basic research(Russian Foundation for Basic Research (RFBR)); SPb Government	This work was supported by the Program "Molecular and Cell Biology" of the Russian Academy of Sciences (KKT), Russian Foundation of basic research (grant 12-04-31469, OVS) and grant from SPb Government (OVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbyad P, 2007, P NATL ACAD SCI USA, V104, P20189, DOI 10.1073/pnas.0706185104; Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Andrews BT, 2008, P NATL ACAD SCI USA, V105, P12283, DOI 10.1073/pnas.0804039105; Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Andrews BT, 2009, J MOL BIOL, V392, P218, DOI 10.1016/j.jmb.2009.06.072; Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bizzarri R, 2009, ANAL BIOANAL CHEM, V393, P1107, DOI 10.1007/s00216-008-2515-9; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Enoki S, 2006, J MOL BIOL, V361, P969, DOI 10.1016/j.jmb.2006.07.009; Follenius-Wund A, 2003, BIOPHYS J, V85, P1839, DOI 10.1016/S0006-3495(03)74612-8; Frommer WB, 2009, CHEM SOC REV, V38, P2833, DOI 10.1039/b907749a; Fuentes L, 2004, BIOPHYS J, V87, P1873, DOI 10.1529/biophysj.104.042580; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Hsin J, 2008, CURR PROTOC BIOINFOR; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Ibraheem A, 2010, CURR OPIN CHEM BIOL, V14, P30, DOI 10.1016/j.cbpa.2009.09.033; Kutrowska B. W., 2007, J PHYS CONDENS MATT, V19; Kuznetsova I M, 1998, Tsitologiia, V40, P747; Kuznetsova IM, 2005, J PROTEOME RES, V4, P417, DOI 10.1021/pr0498077; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Kuznetsova IM, 2002, BIOCHEMISTRY-US, V41, P13127, DOI 10.1021/bi026412x; Kuznetsova IM, 1999, FEBS LETT, V452, P205, DOI 10.1016/S0014-5793(99)00574-8; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mishin AS, 2008, BIOCHEMISTRY-US, V47, P4666, DOI 10.1021/bi702130s; Mizuno T, 2007, J AM CHEM SOC, V129, P11378, DOI 10.1021/ja0685102; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Nolting B., 1999, BIOPHYSICAL METHODS; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; PARKER CA, 1962, ANALYST, V87, P83, DOI 10.1039/an9628700083; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Piatkevich KD, 2010, J AM CHEM SOC, V132, P10762, DOI 10.1021/ja101974k; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Royant A, 2011, J STRUCT BIOL, V174, P385, DOI 10.1016/j.jsb.2011.02.004; Seifert MH, 2002, J AM CHEM SOC, V124, P7932, DOI 10.1021/ja0257725; Seward HE, 2009, CHEM SOC REV, V38, P2842, DOI 10.1039/b901355p; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shu XK, 2009, PROTEIN SCI, V18, P460, DOI 10.1002/pro.66; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Stepanenko OV, 2011, BIOTECHNIQUES, V51, P313, DOI 10.2144/000113765; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Stepartenko OV, 2008, PROTEINS, V73, P539, DOI 10.1002/prot.22089; Sulatskaya Anna I, 2012, Methods Mol Biol, V895, P441, DOI 10.1007/978-1-61779-927-3_26; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Turoverov K K, 1998, Tsitologiia, V40, P806; TUROVEROV KK, 1985, BIOPHYS CHEM, V23, P79, DOI 10.1016/0301-4622(85)80066-1; Turoverov KK, 2003, J FLUORESC, V13, P41, DOI 10.1023/A:1022366816812; Turoverov KK, 2002, BIOCHEMISTRY-US, V41, P1014, DOI 10.1021/bi015548c; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Weber W, 1999, P NATL ACAD SCI USA, V96, P6177, DOI 10.1073/pnas.96.11.6177; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004	70	17	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48809	10.1371/journal.pone.0048809	http://dx.doi.org/10.1371/journal.pone.0048809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144981	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800141
J	Wang, LF; Hong, BX; Jiang, XX; Jones, L; Chen, SY; Huang, XF				Wang, Lifeng; Hong, Bangxing; Jiang, Xiaoxia; Jones, Lindsey; Chen, Si-Yi; Huang, Xue F.			A20 Controls Macrophage to Elicit Potent Cytotoxic CD4(+) T Cell Response	PLOS ONE			English	Article							NF-KAPPA-B; LARGE ESTABLISHED MELANOMA; DENDRITIC CELLS; ANTIGEN PRESENTATION; ALTERNATIVE ACTIVATION; ANTITUMOR IMMUNITY; EFFECTOR FUNCTIONS; IFN-GAMMA; IN-VIVO; LYMPHOMA	Emerging evidence indicates that CD4(+) T cells possess cytotoxic potential for tumor eradication and perforin/granzyme-mediated cytotoxicity functions as one of the important mechanisms for CD4(+) T cell-triggered cell killing. However, the critical issue is how the cytotoxic CD4(+) T cells are developed. During the course of our work that aims at promoting immunostimulation of APCs by inhibition of negative regulators, we found that A20-silenced M drastically induced granzyme B expression in CD4(+) T cells. As a consequence, the granzyme-highly expressing CD4(+) T cells exhibited a strong cytotoxic activity that restricted tumor development. We found that A20-silenced M Phi activated cytotoxic CD4(+) T cells by MHC class-II restricted mechanism and the activation was largely dependent on enhanced production of IFN-gamma.	[Wang, Lifeng; Hong, Bangxing; Jiang, Xiaoxia; Jones, Lindsey; Chen, Si-Yi; Huang, Xue F.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Huang, XF (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	xuefhuan@usc.edu		Wang, Lifeng/0000-0001-5095-6842	National Institutes of Health [R01CA100841, R21AI087185, R01CA90427, R0148480, R01AI48711]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA100841, R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087185, R01AI048711, R01AI084811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institutes of Health research grants (R01CA100841 and R21AI087185 to XFH, R01CA90427, R0148480 and R01AI48711 to SYC), and the research grant from Leukemia and Lymphoma Society (to SYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutner U, 1998, INT IMMUNOL, V10, P305, DOI 10.1093/intimm/10.3.305; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dobrzanski MJ, 2004, J IMMUNOL, V172, P1380, DOI 10.4049/jimmunol.172.3.1380; Echchakir H, 2000, J INVEST DERMATOL, V115, P74, DOI 10.1046/j.1523-1747.2000.00995.x; Esser MT, 1998, J EXP MED, V187, P1057, DOI 10.1084/jem.187.7.1057; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guillot B, 2005, BRIT J DERMATOL, V152, P690, DOI 10.1111/j.1365-2133.2005.06512.x; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; MAN S, 1990, EUR J IMMUNOL, V20, P847, DOI 10.1002/eji.1830200420; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MCCARTHY SA, 1986, J IMMUNOL, V137, P3087; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Norris PJ, 2001, J VIROL, V75, P9771, DOI 10.1128/JVI.75.20.9771-9779.2001; Paludan C, 2002, J IMMUNOL, V169, P1593, DOI 10.4049/jimmunol.169.3.1593; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Song XT, 2006, PLOS MED, V3, P76, DOI 10.1371/journal.pmed.0030011; Sun Q, 2002, BLOOD, V99, P3302, DOI 10.1182/blood.V99.9.3302; VARIN A, 2009, IMMUNOBIOLOGY; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Williams NS, 1996, J IMMUNOL, V156, P153; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yasukawa M, 2000, BLOOD, V95, P2352, DOI 10.1182/blood.V95.7.2352.007k40_2352_2355; Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48930	10.1371/journal.pone.0048930	http://dx.doi.org/10.1371/journal.pone.0048930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145026	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800174
J	Pietruszka, M; Lipowczan, M; Geitmann, A				Pietruszka, Mariusz; Lipowczan, Marcin; Geitmann, Anja			Persistent Symmetry Frustration in Pollen Tubes	PLOS ONE			English	Article							CELL-WALL; TIP-GROWTH; MODEL; ENDOCYTOSIS; EXPANSION; DYNAMICS; CALCIUM; ACTIN; FLOW	Pollen tubes are extremely rapidly growing plant cells whose morphogenesis is determined by spatial gradients in the biochemical composition of the cell wall. We investigate the hypothesis (MP) that the distribution of the local mechanical properties of the wall, corresponding to the change of the radial symmetry along the axial direction, may lead to growth oscillations in pollen tubes. We claim that the experimentally observed oscillations originate from the symmetry change at the transition zone, where both intervening symmetries (cylindrical and spherical) meet. The characteristic oscillations between resonating symmetries at a given (constant) turgor pressure and a gradient of wall material constants may be identified with the observed growth-cycles in pollen tubes.	[Pietruszka, Mariusz] Univ Silesia, Lab Plant Physiol, Fac Biol & Environm Protect, Katowice, Poland; [Lipowczan, Marcin] Univ Silesia, Dept Biophys & Morphogenesis Plants, Fac Biol & Environm Protect, Katowice, Poland; [Geitmann, Anja] Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ H1X 2B2, Canada	University of Silesia in Katowice; University of Silesia in Katowice; Universite de Montreal	Pietruszka, M (corresponding author), Univ Silesia, Lab Plant Physiol, Fac Biol & Environm Protect, Katowice, Poland.	mariusz.pietruszka@us.edu.pl	Lipowczan, Marcin/ABF-6842-2020; Geitmann, Anja/D-4696-2012	Lipowczan, Marcin/0000-0002-2508-3354; Geitmann, Anja/0000-0003-0390-0517; Pietruszka, Mariusz/0000-0001-5852-9095	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Research in the Geitmann lab is funded by a grant from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Chavarria-Krauser A, 2011, J THEOR BIOL, V285, P10, DOI 10.1016/j.jtbi.2011.06.008; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Daher FB, 2011, TRAFFIC, V12, P1537, DOI 10.1111/j.1600-0854.2011.01256.x; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Eggen E, 2011, J THEOR BIOL, V283, P113, DOI 10.1016/j.jtbi.2011.05.034; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Geitmann A, 2004, SEX PLANT REPROD, V17, P9, DOI 10.1007/s00497-004-0210-3; Geitmann A, 2010, CURR OPIN PLANT BIOL, V13, P693, DOI 10.1016/j.pbi.2010.09.017; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Geitmann A, 2009, PLANT SIGNAL BEHAV, V4, P136, DOI 10.4161/psb.4.2.7633; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Hill AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036585; Kost B, 2008, TRENDS CELL BIOL, V18, P119, DOI 10.1016/j.tcb.2008.01.003; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; Kroeger JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018549; Kroeger JH, 2012, MECH RES COMMUN, V42, P32, DOI 10.1016/j.mechrescom.2011.11.005; Kroeger JH, 2009, BIOPHYS J, V97, P1822, DOI 10.1016/j.bpj.2009.07.038; Landau L. D., 1986, COURSE THEORETICAL P, V7; LI YQ, 1995, P K NED AKAD WETENSC, V98, P39; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; Lovy-Wheeler A, 2005, PLANTA, V221, P95, DOI 10.1007/s00425-004-1423-2; ORTEGA JKE, 1985, PLANT PHYSIOL, V79, P318, DOI 10.1104/pp.79.1.318; Proseus TE, 2006, J EXP BOT, V57, P3231, DOI 10.1093/jxb/erl087; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; Winship LJ, 2011, TRENDS PLANT SCI, V16, P353, DOI 10.1016/j.tplants.2011.03.010; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zonia L, 2004, PLANT PHYSIOL, V134, P813, DOI 10.1104/pp.103.029454; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007; Zonia L, 2007, TRENDS PLANT SCI, V12, P90, DOI 10.1016/j.tplants.2007.01.006; Zonia L, 2011, TRENDS PLANT SCI, V16, P347, DOI 10.1016/j.tplants.2011.03.009; Zonia L, 2010, J EXP BOT, V61, P1939, DOI 10.1093/jxb/erq073; Zonia L, 2009, TRENDS PLANT SCI, V14, P318, DOI 10.1016/j.tplants.2009.03.008	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48087	10.1371/journal.pone.0048087	http://dx.doi.org/10.1371/journal.pone.0048087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144847	gold, Green Published, Green Submitted			2022-12-25	WOS:000310741400037
J	Hagenbuchner, J; Kuznetsov, AV; Obexer, P; Ausserlechner, MJ				Hagenbuchner, J.; Kuznetsov, A. V.; Obexer, P.; Ausserlechner, M. J.			BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery	ONCOGENE			English	Article						chemotherapy; FOXO3; mitochondrial respiration; reactive oxygen species; Warburg effect	OXIDATIVE STRESS; HUMAN NEUROBLASTOMA; CELL-PROLIFERATION; CYTOCHROME-C; EXPRESSION; APOPTOSIS; SURVIVIN; PROTEIN; CANCER; FISSION	Gain of chromosome 17q correlates with high-stage disease, an adverse clinical outcome and leads to the overexpression of the antiapoptotic protein BIRC5/Survivin in neuroblastoma (NB). We have shown before that Survivin defines a threshold for the sensitivity of NB cells to DNA-damaging chemotherapeutic agents that require FOXO3 activation for apoptosis induction. To investigate the molecular basis of apoptosis inhibition we analyzed the function of Survivin at mitochondria and uncovered that Survivin induces mitochondrial fragmentation, reduces mitochondrial respiration and represses BCL2L11/Bim. Mitochondrial fission depends on Survivin-induced recruitment of the fission regulator DNM1L/Drp1 to mitochondria. In parallel, Survivin expression inhibits the respiratory complex-I, thereby preventing reactive oxygen species accumulation and, as a consequence, FOXO3-induced apoptosis. The loss of energy production via oxidative phosphorylation is compensated by increased glycolysis in Survivin-overexpressing NB tumor cells. Glycolysis inhibitors neutralize the antiapoptotic effect of Survivin and sensitize high-stage NB to DNA-damaging drugs. This suggests that glycolysis inhibitors target an 'archilles heel' of Survivin-overexpressing NB and may be highly useful as chemosensitizers in the treatment of high-stage NB.	[Hagenbuchner, J.; Obexer, P.] Med Univ Innsbruck, Dept Pediat 2, A-6020 Innsbruck, Austria; [Hagenbuchner, J.; Obexer, P.; Ausserlechner, M. J.] Tyrolean Canc Res Inst, Innsbruck, Austria; [Kuznetsov, A. V.] Med Univ Innsbruck, Dept Cardiac Surg, Cardiac Surg Res Lab, A-6020 Innsbruck, Austria; [Ausserlechner, M. J.] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Obexer, P (corresponding author), Med Univ Innsbruck, Dept Pediat 2, Innrain 66, A-6020 Innsbruck, Austria.	Petra.Obexer@i-med.ac.at; Michael.J.Ausserlechner@i-med.ac.at		Ausserlechner, Michael/0000-0002-1015-2302; Hagenbuchner, Judith/0000-0003-1396-3407	COMET Center ONCOTYROL; Austrian Federal Ministries BMVIT/BMWFJ (via FFG); Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT); 'Kinderkrebshilfe Tirol und Vorarlberg'; 'Krebshilfe Sudtirol'; 'SVP-Frauen-Initiative'; 'Kinderkrebshilfe Sudtirol-Regenbogen'; Austrian Science Fund [P22080-B20]; Medical University Innsbruck for young scientists MUI-START [P2012032014]; OeNB Anniversary Fund [P12582]; 'Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK)'; 'Tyrolean Cancer Society'; Austrian Science Fund (FWF) [P 22080] Funding Source: researchfish	COMET Center ONCOTYROL; Austrian Federal Ministries BMVIT/BMWFJ (via FFG); Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT); 'Kinderkrebshilfe Tirol und Vorarlberg'; 'Krebshilfe Sudtirol'; 'SVP-Frauen-Initiative'; 'Kinderkrebshilfe Sudtirol-Regenbogen'; Austrian Science Fund(Austrian Science Fund (FWF)); Medical University Innsbruck for young scientists MUI-START; OeNB Anniversary Fund; 'Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK)'; 'Tyrolean Cancer Society'; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Dr Martin Hermann und Dr Albert Amberger (Medical University Innsbruck) for valuable discussion. This work was supported by the COMET Center ONCOTYROL, which is funded by the Austrian Federal Ministries BMVIT/BMWFJ (via FFG) and the Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT) and by grants from 'Kinderkrebshilfe Tirol und Vorarlberg', the 'Krebshilfe Sudtirol', the 'SVP-Frauen-Initiative', the 'Kinderkrebshilfe Sudtirol-Regenbogen', the Austrian Science Fund (P22080-B20), by the intramural funding program of the Medical University Innsbruck for young scientists MUI-START (P2012032014) and by the OeNB Anniversary Fund (P12582). The Tyrolean Cancer Research Institute and this study are supported by the 'Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK)' and the 'Tyrolean Cancer Society'.	Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen K, 2003, J BIOL CHEM, V278, P39527, DOI 10.1074/jbc.M304423200; Chen QR, 2010, J PROTEOME RES, V9, P373, DOI 10.1021/pr900701v; Connell CM, 2008, J BIOL CHEM, V283, P3289, DOI 10.1074/jbc.M704461200; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; De Lena M, 2001, EUR J CANCER, V37, P364, DOI 10.1016/S0959-8049(00)00400-7; Di Cosimo S, 2003, DRUGS TODAY, V39, P157, DOI 10.1358/dot.2003.39.3.799451; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Geiger K, 2012, MOL BIOL CELL, V23, P2226, DOI 10.1091/mbc.E11-06-0535; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Grignani F, 1998, CANCER RES, V58, P14; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Kang BH, 2011, J BIOL CHEM, V286, P16758, DOI 10.1074/jbc.M110.210120; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Obexer P, 2009, MOL BIOL CELL, V20, P2041, DOI 10.1091/mbc.E08-07-0699; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Smith DJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-259; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x	40	99	103	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 3	2013	32	40					4748	4757		10.1038/onc.2012.500	http://dx.doi.org/10.1038/onc.2012.500			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23146905				2022-12-25	WOS:000325274700003
J	Maingat, FG; Polyak, MJ; Paul, AM; Vivithanaporn, P; Noorbakhsh, F; Ahboucha, S; Baker, GB; Pearson, K; Power, C				Maingat, Ferdinand G.; Polyak, Maria J.; Paul, Amber M.; Vivithanaporn, Pornpun; Noorbakhsh, Farshid; Ahboucha, Samir; Baker, Glen B.; Pearson, Keir; Power, Christopher			Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence	FASEB JOURNAL			English	Article						FIV; inflammation; glia; neuron	FELINE-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; NEUROACTIVE STEROIDS; LENTIVIRUS INFECTION; NEURONAL INJURY; NEUROCOGNITIVE IMPAIRMENT; DEHYDROEPIANDROSTERONE; RECEPTOR; ACTIVATION; HORMONE	Neurosteroids are cholesterol-derived molecules synthesized within the brain, which exert trophic and protective actions. Infection by human and feline immunodeficiency viruses (HIV and FIV, respectively) causes neuroinflammation and neurodegeneration, leading to neurological deficits. Secretion of neuroinflammatory host and viral factors by glia and infiltrating leukocytes mediates the principal neuropathogenic mechanisms during lentivirus infections, although the effect of neurosteroids on these processes is unknown. We investigated the interactions between neurosteroid-mediated effects and lentivirus infection outcomes. Analyses of HIV-infected (HIV+) and uninfected human brains disclosed a reduction in neurosteroid synthesis enzyme expression. Human neurons exposed to supernatants from HIV+ macrophages exhibited suppressed enzyme expression without reduced cellular viability. HIV+ human macrophages treated with sulfated dehydroepiandrosterone (DHEA-S) showed suppression of inflammatory gene (IL-1 beta, IL-6, TNF-alpha) expression. FIV-infected (FIV+) animals treated daily with 15 mg/kg body weight. DHEA-S treatment reduced inflammatory gene transcripts (IL-1 beta, TNF-alpha, CD3 epsilon, GFAP) in brain compared to vehicle-(beta-cyclodextrin)-treated FIV+ animals similar to levels found in vehicle-treated FIV- animals. DHEA-S treatment also increased CD4(+) T-cell levels and prevented neurobehavioral deficits and neuronal loss among FIV+ animals, compared to vehicle-treated FIV+ animals. Reduced neuronal neurosteroid synthesis was evident in lentivirus infections, but treatment with DHEA-S limited neuroinflammation and prevented neurobehavioral deficits. Neurosteroid-derived therapies could be effective in the treatment of virus-or inflammation-mediated neurodegeneration.-Maingat, F. G., Polyak, M. J., Paul, A. M., Vivithanaporn, P., Noorbakhsh, F., Ahboucha S., Baker, G. B., Pearson, K., Power, C. Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence. FASEB J. 27, 725-737 (2013). www.fasebj.org	[Maingat, Ferdinand G.; Polyak, Maria J.; Paul, Amber M.; Vivithanaporn, Pornpun; Noorbakhsh, Farshid; Power, Christopher] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Baker, Glen B.; Power, Christopher] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2S2, Canada; [Pearson, Keir] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada; [Vivithanaporn, Pornpun] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Ahboucha, Samir] Univ Cadi Ayyad, Fac Sci, Dept Pharmacol & Environm, Marrakech, Morocco	University of Alberta; University of Alberta; University of Alberta; Mahidol University; Cadi Ayyad University of Marrakech	Power, C (corresponding author), Univ Alberta, Dept Med, Heritage Med Res Ctr 6 11, Edmonton, AB T6G 2S2, Canada.	chris.power@ualberta.ca	AHBOUCHA, Samir/AAE-4294-2020	Power, Christopher/0000-0002-5131-9711; Paul, Amber/0000-0002-1657-3618	Alberta Innovates-Health Solutions; Canadian Institutes of Health Research	Alberta Innovates-Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	C.P. holds a Canada Research Chair (CRC; tier 1) in Neurological Infection and Immunity and is an Alberta Innovates-Health Solutions Senior Scholar. P. V. holds a fellowship from Alberta Innovates-Health Solutions. These studies were supported by the Canadian Institutes of Health Research (C. P., G. B. B.). The authors thank Dr. Synthia Mellon (University of California, San Francisco, CA, USA) for generously providing antibodies for these studies and helpful discussions. The authors are grateful to Ms. Gail Rauw for her expert technical assistance in assaying levels of the neurosteroids. The authors declare no conflicts of interest.	Abrams DI, 2007, AIDS RES HUM RETROV, V23, P77, DOI [10.1089/aid.2006.0107, 10.1089/aid.2006.0170]; Afkhami-Goli A, 2007, J IMMUNOL, V179, P5493, DOI 10.4049/jimmunol.179.8.5493; Ahboucha S, 2008, NEUROGASTROENT MOTIL, V20, P671, DOI 10.1111/j.1365-2982.2007.01080.x; Ahboucha S, 2007, METAB BRAIN DIS, V22, P291, DOI 10.1007/s11011-007-9065-2; Barger SW, 2000, J NEUROSCI RES, V62, P503, DOI 10.1002/1097-4547(20001115)62:4<503::AID-JNR4>3.0.CO;2-A; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; BLACK SM, 1993, ENDOCRINOLOGY, V132, P539, DOI 10.1210/en.132.2.539; BOLOGA L, 1987, J NEUROSCI RES, V17, P225, DOI 10.1002/jnr.490170305; Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213; Boven LA, 2007, J NEUROVIROL, V13, P173, DOI 10.1080/13550280701258399; Charalampopoulos I, 2008, TRENDS ENDOCRIN MET, V19, P300, DOI 10.1016/j.tem.2008.07.004; Dong LY, 2009, J PHARMACOL EXP THER, V330, P494, DOI 10.1124/jpet.109.154294; Dubrovsky B, 2006, PHARMACOL BIOCHEM BE, V84, P644, DOI 10.1016/j.pbb.2006.06.016; Dubrovsky BO, 2005, PROG NEURO-PSYCHOPH, V29, P169, DOI 10.1016/j.pnpbp.2004.11.001; Epstein LG, 1999, J LEUKOCYTE BIOL, V65, P453, DOI 10.1002/jlb.65.4.453; Eser D, 2006, PHARMACOL BIOCHEM BE, V84, P656, DOI 10.1016/j.pbb.2006.05.020; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Johnston J, 1999, J VIROL, V73, P2491, DOI 10.1128/JVI.73.3.2491-2498.1999; Johnston JB, 2002, J NEUROVIROL, V8, P420, DOI 10.1080/13550280260422721; KALIMI M, 1994, MOL CELL BIOCHEM, V131, P99, DOI 10.1007/BF00925945; Kennedy JM, 2004, AIDS, V18, P1241, DOI 10.1097/00002030-200406180-00002; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; Le Melledo JM, 2002, J PSYCHIATR NEUROSCI, V27, P161; LEVINE MS, 1987, NEUROBIOL AGING, V8, P253, DOI 10.1016/0197-4580(87)90010-8; Lombardi G, 2001, BRIT J PHARMACOL, V133, P936, DOI 10.1038/sj.bjp.0704134; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Luchetti S, 2011, NEUROSCIENCE, V191, P6, DOI 10.1016/j.neuroscience.2011.04.010; MacKenzie EM, 2007, CELL MOL NEUROBIOL, V27, P541, DOI 10.1007/s10571-006-9086-0; Maingat F, 2011, FASEB J, V25, P2211, DOI 10.1096/fj.10-175992; Maingat F, 2009, J NEUROSCI, V29, P8429, DOI 10.1523/JNEUROSCI.5818-08.2009; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Marx CE, 2011, NEUROSCIENCE, V191, P78, DOI 10.1016/j.neuroscience.2011.06.076; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McVea DA, 2006, J NEUROSCI, V26, P1175, DOI 10.1523/JNEUROSCI.4458-05.2006; Mellon SH, 2002, ENDOCR RES, V28, P463, DOI 10.1081/ERC-120016823; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Mellon SH, 2007, PHARMACOL THERAPEUT, V116, P107, DOI 10.1016/j.pharmthera.2007.04.011; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Nigam R, 2010, ARCH DERMATOL RES, V302, P507, DOI 10.1007/s00403-010-1052-5; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Noorbakhsh F, 2006, VIROLOGY, V348, P260, DOI 10.1016/j.virol.2005.10.044; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; PARKCHUNG MJ, 1994, MOL PHARMACOL, V46, P146; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Pedersen NC, 2003, VET IMMUNOL IMMUNOP, V94, P133, DOI 10.1016/S0165-2427(03)00081-3; Piketty C, 2001, CLIN ENDOCRINOL, V55, P325, DOI 10.1046/j.1365-2265.2001.01310.x; Poli A, 1999, J NEUROVIROL, V5, P465, DOI 10.3109/13550289909045375; Power C, 1997, NEUROSCIENCE, V77, P1175, DOI 10.1016/S0306-4522(96)00531-3; Power C, 1998, J VIROL, V72, P9109, DOI 10.1128/JVI.72.11.9109-9115.1998; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Power C, 2009, CAN J NEUROL SCI, V36, P285, DOI 10.1017/S0317167100007009; Rackstraw S, 2011, PSYCHOL HEALTH MED, V16, P548, DOI 10.1080/13548506.2011.579992; Ritsner MS, 2011, NEUROSCIENCE, V191, P91, DOI 10.1016/j.neuroscience.2011.04.017; Ritsner MS, 2010, J PSYCHIATR RES, V44, P75, DOI 10.1016/j.jpsychires.2009.07.002; Roy A, 2007, J VIROL, V81, P7993, DOI 10.1128/JVI.00710-07; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Schule C, 2011, NEUROSCIENCE, V191, P55, DOI 10.1016/j.neuroscience.2011.03.025; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Scott-Sheldon L. A., 2008, HEALTH PSYCHOL, V27, P129; Strous RD, 2006, EUR NEUROPSYCHOPHARM, V16, P155, DOI 10.1016/j.euroneuro.2005.09.005; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Tsutsui S, 2008, FASEB J, V22, P786, DOI 10.1096/fj.07-9002com; van Marle G, 2005, J NEUROVIROL, V11, P107, DOI 10.1080/13550280590922838; WARNER M, 1995, FRONT NEUROENDOCRIN, V16, P224, DOI 10.1006/frne.1995.1008; Weaver CE, 1997, P NATL ACAD SCI USA, V94, P10450, DOI 10.1073/pnas.94.19.10450; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; Wetzel CHR, 1998, MOL ENDOCRINOL, V12, P1441, DOI 10.1210/me.12.9.1441; Wright E, 2011, CURR OPIN HIV AIDS, V6, P303, DOI 10.1097/COH.0b013e3283477c46; WU FS, 1991, MOL PHARMACOL, V40, P333; Zhu Y, 2005, J IMMUNOL, V175, P1118, DOI 10.4049/jimmunol.175.2.1118; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819; Zink MC, 2006, CURR HIV RES, V4, P293	82	28	28	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					725	737		10.1096/fj.12-215079	http://dx.doi.org/10.1096/fj.12-215079			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23150523				2022-12-25	WOS:000314358000031
J	Ortega, F; Stott, J; Visser, SAG; Bendtsen, C				Ortega, Fernando; Stott, Jonathan; Visser, Sandra A. G.; Bendtsen, Claus			Interplay between alpha-, beta-, and gamma-Secretases Determines Biphasic Amyloid-beta Protein Level in the Presence of a gamma-Secretase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; IN-VIVO; CLEAVAGE; ADAM10; PHARMACODYNAMICS; METABOLISM; MODULATION; PLASMA	Amyloid-beta (A beta) is produced by the consecutive cleavage of amyloid precursor protein (APP) first by beta-secretase, generating C99, and then by gamma-secretase. APP is also cleaved by alpha-secretase. It is hypothesized that reducing the production of A beta in the brain may slow the progression of Alzheimer disease. Therefore, different gamma-secretase inhibitors have been developed to reduce A beta production. Paradoxically, it has been shown that low to moderate inhibitor concentrations cause a rise in A beta production in different cell lines, in different animal models, and also in humans. A mechanistic understanding of the A beta rise remains elusive. Here, a minimal mathematical model has been developed that quantitatively describes the A beta dynamics in cell lines that exhibit the rise as well as in cell lines that do not. The model includes steps of APP processing through both the so-called amyloidogenic pathway and the so-called non-amyloidogenic pathway. It is shown that the cross-talk between these two pathways accounts for the increase in A beta production in response to inhibitor, i.e. an increase in C99 will inhibit the non-amyloidogenic pathway, redirecting APP to be cleaved by beta-secretase, leading to an additional increase in C99 that overcomes the loss in gamma-secretase activity. With a minor extension, the model also describes plasma A beta profiles observed in humans upon dosing with a gamma-secretase inhibitor. In conclusion, this mechanistic model rationalizes a series of experimental results that spans from in vitro to in vivo and to humans. This has important implications for the development of drugs targeting A beta production in Alzheimer disease.	[Ortega, Fernando; Stott, Jonathan; Bendtsen, Claus] AstraZeneca, Discovery Sci, Computat Biol, Macclesfield SK10 4TG, Cheshire, England; [Visser, Sandra A. G.] AstraZeneca Sodertalje, Innovat Med, Global Drug Metab Pharmacokinet Ctr Excellence, SE-15185 Sodertalje, Sweden	AstraZeneca; AstraZeneca	Bendtsen, C (corresponding author), AstraZeneca, Discovery Sci, Computat Biol, Mereside 50S21,Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	claus.bendtsen@astrazeneca.com	Ortega, Fernando/G-2129-2015	Ortega, Fernando/0000-0002-3172-2095; Bendtsen, Claus/0000-0002-8338-987X				Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Cirrito JR, 2003, J NEUROSCI, V23, P8844; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook JJ, 2010, J NEUROSCI, V30, P6743, DOI 10.1523/JNEUROSCI.1381-10.2010; Das R, 2011, B MATH BIOL, V73, P230, DOI 10.1007/s11538-010-9540-5; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Dockens R, 2012, CLIN PHARMACOKINET, V51, P681, DOI 10.1007/s40262-012-0005-x; Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Hone E, 2003, J ALZHEIMERS DIS, V5, P1, DOI 10.3233/JAD-2003-5101; Hook V, 2008, BIOL CHEM, V389, P993, DOI 10.1515/BC.2008.124; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jamsa A, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-76; Korczyn AD, 2008, ALZHEIMERS DEMENT, V4, P176, DOI 10.1016/j.jalz.2007.11.008; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; KUMAMOTO M, 2008, ALZHEIMERS DEMENT, V4, pT785; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lu YS, 2011, J PHARMACOL EXP THER, V339, P922, DOI 10.1124/jpet.111.186791; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; McLendon C, 2000, FASEB J, V14, P2383; Niva C., 2012, EUR J CLIN IN PRESS; Ortega F, 2002, P NATL ACAD SCI USA, V99, P1170, DOI 10.1073/pnas.022267399; Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Prasad CVC, 2007, BIOORG MED CHEM LETT, V17, P4006, DOI 10.1016/j.bmcl.2007.04.082; Prox J, 2012, EXP BRAIN RES, V217, P331, DOI 10.1007/s00221-011-2952-0; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Siemers ER, 2007, CLIN NEUROPHARMACOL, V30, P317, DOI 10.1097/WNF.0b013e31805b7660; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800	41	29	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					785	792		10.1074/jbc.M112.419135	http://dx.doi.org/10.1074/jbc.M112.419135			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23152503	hybrid, Green Published			2022-12-25	WOS:000313570300004
J	Wang, P; Li, ZW; Wei, JS; Zhao, ZL; Sun, DY; Cui, SJ				Wang, Peng; Li, Zhaowei; Wei, Jingshuang; Zhao, Zenglin; Sun, Daye; Cui, Sujuan			ANa(+)/Ca2+ Exchanger-like Protein (AtNCL) Involved in Salt Stress in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; SIGNAL-TRANSDUCTION; FUNCTIONAL EXPRESSION; NA+/CA2+ EXCHANGER; MOLECULAR-CLONING; PLANT-CELLS; MEMBRANE; IDENTIFICATION; CA2+; TEMPERATURE	Calcium ions (Ca2+) play a crucial role in many key physiological processes; thus, the maintenance of Ca2+ homeostasis is of primary importance. Na+/Ca2+ exchangers (NCXs) play an important role in Ca2+ homeostasis in animal excitable cells. Bioinformatic analysis of the Arabidopsis genome suggested the existence of a putative NCX gene, Arabidopsis NCX-like (AtNCL), encoding a protein with an NCX-like structure and different from Ca2+/H+ exchangers and Na+/H+ exchangers previously identified in plant. AtNCL was identified to localize in the Arabidopsis cell membrane fraction, have the ability of binding Ca2+, and possess NCX-like activity in a heterologous expression system of cultured mammalian CHO-K1 cells. AtNCL is broadly expressed in Arabidopsis, and abiotic stresses stimulated its transcript expression. Loss-of-function atncl mutants were less sensitive to salt stress than wild-type or AtNCL transgenic overexpression lines. In addition, the total calcium content in whole atncl mutant seedlings was higher than that in wild type by atomic absorption spectroscopy. The level of free Ca2+ in the cytosol and Ca2+ flux at the root tips of atncl mutant plants, as detected using transgenic aequorin and a scanning ion-selective electrode, required a longer recovery time following NaCl stress compared with that in wild type. All of these data suggest that AtNCL encodes a Na+/Ca2+ exchanger-like protein that participates in the maintenance of Ca2+ homeostasis in Arabidopsis. AtNCL may represent a new type of Ca2+ transporter in higher plants.	[Wang, Peng; Li, Zhaowei; Zhao, Zenglin; Sun, Daye; Cui, Sujuan] Hebei Normal Univ, Coll Life Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050024, Peoples R China; [Li, Zhaowei] Hebei Univ Sci & Technol, Coll Biol Sci & Engn, Shijiazhuang 050018, Hebei, Peoples R China; [Wei, Jingshuang] N China Pharmaceutical Grp Corp, State Key Lab Dev Antibody Drugs, New Drug R&D Ctr, Shijiazhuang 050015, Peoples R China	Hebei Normal University; Hebei University of Science & Technology	Cui, SJ (corresponding author), Hebei Normal Univ, Coll Life Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050024, Peoples R China.	cuisujuan@mail.hebtu.edu.cn	WANG, PENG/E-4804-2013	Wang, Peng/0000-0002-7521-5925	National Basic Research Program of China [2006CB100101, 2006CB910600]; Research Program of the Ministry of Agriculture, China [2008ZX08009-003]; National Science Foundation of Hebei Province, China [C2009001516]; New Century Excellent Teacher Project of Education Department, China [NCET-06- 0256]	National Basic Research Program of China(National Basic Research Program of China); Research Program of the Ministry of Agriculture, China; National Science Foundation of Hebei Province, China; New Century Excellent Teacher Project of Education Department, China	This work was supported by National Basic Research Program of China Grant 2006CB100101 and Research Program of the Ministry of Agriculture, China, Grant 2008ZX08009-003 (to D. S.); National Science Foundation of Hebei Province, China, Grant C2009001516, New Century Excellent Teacher Project of Education Department, China, Grant NCET-06-0256, and National Basic Research Program of China Grant 2006CB910600 (to S. C.).	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; Baczyk D, 2011, CELL CALCIUM, V49, P350, DOI 10.1016/j.ceca.2010.12.003; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BRISKIN DP, 1990, PLANT PHYSIOL, V94, P397, DOI 10.1104/pp.94.2.397; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Eisner DA, 2004, CIRC RES, V95, P549, DOI 10.1161/01.RES.0000143419.87518.9e; Ferrol N, 1996, PLANT CELL, V8, P1159, DOI 10.2307/3870359; He ZP, 1998, J GEN PHYSIOL, V111, P857, DOI 10.1085/jgp.111.6.857; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hong BM, 1999, PLANT PHYSIOL, V119, P1165, DOI 10.1104/pp.119.4.1165; HUANG LQ, 1993, P NATL ACAD SCI USA, V90, P10066, DOI 10.1073/pnas.90.21.10066; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kimura J, 1996, ANN NY ACAD SCI, V779, P515, DOI 10.1111/j.1749-6632.1996.tb44825.x; KIMURA J, 1987, J PHYSIOL-LONDON, V384, P199, DOI 10.1113/jphysiol.1987.sp016450; Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; KUHTREIBER WM, 1990, J CELL BIOL, V110, P1565, DOI 10.1083/jcb.110.5.1565; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Manohar M, 2011, PLANT BIOLOGY, V13, P561, DOI 10.1111/j.1438-8677.2011.00466.x; Calderon-Sanchez EM, 2011, CELL CALCIUM, V50, P84, DOI 10.1016/j.ceca.2011.05.010; Marshall CR, 2005, J BIOL CHEM, V280, P28903, DOI 10.1074/jbc.M504807200; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Mitra SK, 2007, J PROTEOME RES, V6, P1933, DOI 10.1021/pr060525b; MONROY AF, 1995, PLANT CELL, V7, P321, DOI 10.1105/tpc.7.3.321; NAKASAKI Y, 1993, J BIOCHEM-TOKYO, V114, P528, DOI 10.1093/oxfordjournals.jbchem.a124211; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Paredes-Gamero Edgar Julian, 2012, Front Biosci (Elite Ed), V4, P1375; PFEIFFER W, 1993, PLANTA, V191, P377, DOI 10.1007/BF00195696; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Pineros M, 1997, J EXP BOT, V48, P551, DOI 10.1093/jxb/48.Special_Issue.551; Pittman JK, 2002, J BIOL CHEM, V277, P26452, DOI 10.1074/jbc.M202563200; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; POOVAIAH BW, 1993, CRIT REV PLANT SCI, V12, P185, DOI 10.1080/713608046; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; REUTER H, 1968, J PHYSIOL-LONDON, V195, P451, DOI 10.1113/jphysiol.1968.sp008467; Ruknudin A, 1997, AM J PHYSIOL-CELL PH, V273, pC257, DOI 10.1152/ajpcell.1997.273.1.C257; Sambrook J., 2006, CONDENSED PROTOCOLS, P599; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Shabala S, 2000, ANN BOT-LONDON, V85, P681, DOI 10.1006/anbo.2000.1131; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Spalding EP, 2011, CURR OPIN PLANT BIOL, V14, P715, DOI 10.1016/j.pbi.2011.08.001; Srikanth S, 2006, CELL CALCIUM, V39, P187, DOI 10.1016/j.ceca.2005.10.013; Szponarski W, 2004, PROTEOMICS, V4, P397, DOI 10.1002/pmic.200300607; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; TSURUYA Y, 1994, BBA-BIOMEMBRANES, V1196, P97, DOI 10.1016/0005-2736(94)90301-8; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wang Z., 1994, J WUHAN U NAT SCI ED, V5, P111; Weber CR, 2002, CIRC RES, V90, P182, DOI 10.1161/hh0202.103940; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yang YC, 2010, J BIOL CHEM, V285, P28275, DOI 10.1074/jbc.M110.141424; Yin D, 2000, CHEM RES TOXICOL, V13, P103, DOI 10.1021/tx990142a; Zhao J, 2009, J BIOL CHEM, V284, P34075, DOI 10.1074/jbc.M109.070235; Zheng SZ, 2012, PLANT J, V69, P689, DOI 10.1111/j.1365-313X.2011.04823.x	67	55	55	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44062	44070		10.1074/jbc.M112.351643	http://dx.doi.org/10.1074/jbc.M112.351643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148213	hybrid, Green Published			2022-12-25	WOS:000312938600005
J	Prigent, S; Ballesta, A; Charles, F; Lenuzza, N; Gabriel, P; Tine, LM; Rezaei, H; Doumic, M				Prigent, Stephanie; Ballesta, Annabelle; Charles, Frederique; Lenuzza, Natacha; Gabriel, Pierre; Tine, Leon Matar; Rezaei, Human; Doumic, Marie			An Efficient Kinetic Model for Assemblies of Amyloid Fibrils and Its Application to Polyglutamine Aggregation	PLOS ONE			English	Article							PROTEIN AGGREGATION; POLYMERIZATION; DYNAMICS; DISCRETE; DISEASE; EQUATIONS; LIMIT	Protein polymerization consists in the aggregation of single monomers into polymers that may fragment. Fibrils assembly is a key process in amyloid diseases. Up to now, protein aggregation was commonly mathematically simulated by a polymer size-structured ordinary differential equations (ODE) system, which is infinite by definition and therefore leads to high computational costs. Moreover, this Ordinary Differential Equation-based modeling approach implies biological assumptions that may be difficult to justify in the general case. For example, whereas several ordinary differential equation models use the assumption that polymerization would occur at a constant rate independently of polymer size, it cannot be applied to certain protein aggregation mechanisms. Here, we propose a novel and efficient analytical method, capable of modelling and simulating amyloid aggregation processes. This alternative approach consists of an integro-Partial Differential Equation (PDE) model of coalescence-fragmentation type that was mathematically derived from the infinite differential system by asymptotic analysis. To illustrate the efficiency of our approach, we applied it to aggregation experiments on polyglutamine polymers that are involved in Huntington's disease. Our model demonstrates the existence of a monomeric structural intermediate (c) over tilde (1) acting as a nucleus and deriving from a non polymerizing monomer (c(1)). Furthermore, we compared our model to previously published works carried out in different contexts and proved its accuracy to describe other amyloid aggregation processes.	[Ballesta, Annabelle; Doumic, Marie] Inst Natl Rech Informat & Automat, Rocquencourt, France; [Charles, Frederique] Univ Paris 06, Paris, France; [Prigent, Stephanie; Rezaei, Human] INRA, Jouy En Josas, France; [Lenuzza, Natacha] Commissariat Energie Atom, Gif Sur Yvette, France; [Gabriel, Pierre] Inst Natl Rech Informat & Automat Rhones Alpes, Lyon, France; [Tine, Leon Matar] Univ Gaston Berger, St Louis, Senegal	UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Doumic, M (corresponding author), Inst Natl Rech Informat & Automat, Rocquencourt, France.	marie.doumic@inria.fr	Doumic, Marie/AAC-5766-2020	GABRIEL, Pierre/0000-0001-6867-1386; Doumic, Marie/0000-0002-3183-8215	French Agence Nationale de la Recherche, ANR grant [09-BLAN-0218-01]	French Agence Nationale de la Recherche, ANR grant(French National Research Agency (ANR))	The work was partially financed by the French Agence Nationale de la Recherche, ANR grant 09-BLAN-0218-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ackleh AS, 1997, J MATH BIOL, V35, P480, DOI 10.1007/s002850050062; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Banks HT, 2011, B MATH BIOL, V73, P116, DOI 10.1007/s11538-010-9524-5; Bernacki JP, 2009, BIOPHYS J, V96, P2871, DOI 10.1016/j.bpj.2008.12.3903; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bortz DM, 2008, B MATH BIOL, V70, P745, DOI 10.1007/s11538-007-9277-y; Calvez V, 2009, MATH BIOSCI, V217, P88, DOI 10.1016/j.mbs.2008.10.007; Collet JF, 2002, SIAM J APPL MATH, V62, P1488, DOI 10.1137/S0036139900378852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dicko C, 2006, ADV PROTEIN CHEM, V73, P17, DOI 10.1016/S0065-3233(06)73002-9; Doumic M, 2010, ACTA BIOTHEOR, V58, P405, DOI 10.1007/s10441-010-9114-9; Doumic M, 2009, COMMUN MATH SCI, V7, P839, DOI 10.4310/CMS.2009.v7.n4.a3; Doumic M, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/4/045008; Gabriel P., 2010, ESAIM P, V30, P54; Hansen N, 2006, STUD FUZZ SOFT COMP, V192, P75; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Laurencot P, 2002, P ROY SOC EDINB A, V132, P1219, DOI 10.1017/S0308210500002080; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Oosawa F., 1975, THERMODYNAMICS POLYM; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wulkow M, 1996, MACROMOL THEOR SIMUL, V5, P393, DOI 10.1002/mats.1996.040050303; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, PROTEIN ENG DES SEL, V22, P489, DOI 10.1093/protein/gzp026	29	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e43273	10.1371/journal.pone.0043273	http://dx.doi.org/10.1371/journal.pone.0043273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152746	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234600001
J	Gallion, SL				Gallion, Steven L.			Modeling Amyloid-Beta as Homogeneous Dodecamers and in Complex with Cellular Prion Protein	PLOS ONE			English	Article							OLIGOMERIC A-BETA; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; SH3 DOMAIN; PEPTIDE; CONFORMATION; DYNAMICS; SHEET; NMR	Soluble amyloid beta (A beta) peptide has been linked to the pathology of Alzheimer's disease. A variety of soluble oligomers have been observed to be toxic, ranging from dimers to protofibrils. No tertiary structure has been identified as a single biologically relevant form, though many models are comprised of highly ordered beta-sheets. Evidence exists for much less ordered toxic oligomers. The mechanism of toxicity remains highly debated and probably involves multiple pathways. Interaction of A beta oligomers with the N-terminus of the cellular form of the prion protein (PrPc) has recently been proposed. The intrinsically disordered nature of this protein and the highly polymorphic nature of A beta oligomers make structural resolution of the complex exceptionally challenging. In this study, molecular dynamics simulations are performed for dodecameric assemblies of A beta comprised of monomers having a single, short antiparallel beta-hairpin at the C-terminus. The resulting models, devoid of any intermolecular hydrogen bonds, are shown to correlate well with experimental data and are found to be quite stable within the hydrophobic core, whereas the alpha-helical N-termini transform to a random coil state. This indicates that highly ordered assemblies are not required for stability and less ordered oligomers are a viable component in the population of soluble oligomers. In addition, a tentative model is proposed for the association of A beta dimers with a double deletion mutant of the intrinsically disordered N-terminus of PrPc. This may be useful as a conceptual working model for the binding of higher order oligomers and in the design of further experiments. Citation: Gallion SL (2012) Modeling Amyloid-Beta as Homogeneous Dodecamers and in Complex with Cellular Prion Protein. PLoS ONE 7(11): e49375. doi:10.1371/journal.pone.0049375				sgallion@comcast.net			Chemical Computing Group Inc.	Chemical Computing Group Inc.	The author received funding from Chemical Computing Group Inc. There are no patents, products in development or marketed products to declare. This does not alter the author's adherence to all the PLOS ONE policies on sharing data and materials.	Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Altman R.B., 1994, PROTEIN PEPTIDE LETT, V1, P120; [Anonymous], 2010, MOL OP ENV MOE 2010; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034345; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cote S, 2012, J PHYS CHEM B, V116, P4043, DOI 10.1021/jp2126366; De Simone A, 2007, BIOPHYS J, V93, P1284, DOI 10.1529/biophysj.107.108613; DeMarco ML, 2007, BIOCHEMISTRY-US, V46, P3045, DOI 10.1021/bi0619066; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Hirschberger T, 2006, BIOPHYS J, V90, P3908, DOI 10.1529/biophysj.105.075341; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li HY, 2010, BIOCHEMISTRY-US, V49, P1259, DOI 10.1021/bi902075h; Luginbuhl B, 2006, J MOL BIOL, V363, P75, DOI 10.1016/j.jmb.2006.07.027; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Ma BY, 2011, J BIOL CHEM, V286, P34244, DOI 10.1074/jbc.M111.241141; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Ngo S, 2011, BIOCHEM BIOPH RES CO, V414, P512, DOI 10.1016/j.bbrc.2011.09.097; O'Nuallain B, 2011, J NEUROCHEM, V119, P189, DOI 10.1111/j.1471-4159.2011.07389.x; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Rajadas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021776; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rother K, 2009, NUCLEIC ACIDS RES, V37, pD393, DOI 10.1093/nar/gkn769; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Santini S, 2003, PROTEINS, V51, P258, DOI 10.1002/prot.10348; Sarroukh R, 2011, CELL MOL LIFE SCI, V68, P1429, DOI 10.1007/s00018-010-0529-x; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith LJ, 2002, PROTEINS, V48, P487, DOI 10.1002/prot.10144; Spinner DS, 2007, J LEUKOCYTE BIOL, V81, P1374, DOI 10.1189/jlb.1106665; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Sturgeon JB, 2000, J CHEM PHYS, V112, P3474, DOI 10.1063/1.480502; Takeda T, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22406; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tsai J, 1999, J MOL BIOL, V291, P215, DOI 10.1006/jmbi.1999.2949; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; van der Kamp MW, 2010, BIOPHYS J, V99, P2289, DOI 10.1016/j.bpj.2010.07.063; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Yang LW, 2007, STRUCTURE, V15, P741, DOI 10.1016/j.str.2007.04.014; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Yoshida H, 2000, J BIOCHEM-TOKYO, V128, P271, DOI 10.1093/oxfordjournals.jbchem.a022750; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003235; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]; Yun SJ, 2007, BIOPHYS J, V92, P4064, DOI 10.1529/biophysj.106.097766; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859	83	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49375	10.1371/journal.pone.0049375	http://dx.doi.org/10.1371/journal.pone.0049375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145167	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500106
J	Waldert, S; Tushaus, L; Kaller, CP; Aertsen, A; Mehring, C				Waldert, Stephan; Tueshaus, Laura; Kaller, Christoph P.; Aertsen, Ad; Mehring, Carsten			fNIRS Exhibits Weak Tuning to Hand Movement Direction	PLOS ONE			English	Article							INFRARED SPECTROSCOPY SIGNALS; MOTOR CORTEX; ARM MOVEMENTS; OXYGENATION; CLASSIFICATION; ORGANIZATION; PERFORMANCE; SELECTIVITY; HEMOGLOBIN; INTERFACE	Functional near-infrared spectroscopy (fNIRS) has become an established tool to investigate brain function and is, due to its portability and resistance to electromagnetic noise, an interesting modality for brain-machine interfaces (BMIs). BMIs have been successfully realized using the decoding of movement kinematics from intra-cortical recordings in monkey and human. Recently, it has been shown that hemodynamic brain responses as measured by fMRI are modulated by the direction of hand movements. However, quantitative data on the decoding of movement direction from hemodynamic responses is still lacking and it remains unclear whether this can be achieved with fNIRS, which records signals at a lower spatial resolution but with the advantage of being portable. Here, we recorded brain activity with fNIRS above different cortical areas while subjects performed hand movements in two different directions. We found that hemodynamic signals in contralateral sensorimotor areas vary with the direction of movements, though only weakly. Using these signals, movement direction could be inferred on a single-trial basis with an accuracy of similar to 65% on average across subjects. The temporal evolution of decoding accuracy resembled that of typical hemodynamic responses observed in motor experiments. Simultaneous recordings with a head tracking system showed that head movements, at least up to some extent, do not influence the decoding of fNIRS signals. Due to the low accuracy, fNIRS is not a viable alternative for BMIs utilizing decoding of movement direction. However, due to its relative resistance to head movements, it is promising for studies investigating brain activity during motor experiments. Citation: Waldert S, Tushaus L, Kaller CP, Aertsen A, Mehring C (2012) fNIRS Exhibits Weak Tuning to Hand Movement Direction. PLoS ONE 7(11): e49266. doi:10.1371/journal.pone.0049266	[Waldert, Stephan; Tueshaus, Laura; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Fac Biol, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; [Waldert, Stephan; Tueshaus, Laura; Mehring, Carsten] Univ Freiburg, Fac Biol, Inst Biol 1, D-79106 Freiburg, Germany; [Waldert, Stephan] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Kaller, Christoph P.] Univ Freiburg, Univ Med Ctr Freiburg, Dept Neurol, D-79106 Freiburg, Germany; [Aertsen, Ad] Univ Freiburg, Fac Biol, Inst Biol 3, D-79106 Freiburg, Germany; [Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England	University of Freiburg; University of Freiburg; University of London; University College London; University of Freiburg; University of Freiburg; Imperial College London; Imperial College London	Waldert, S (corresponding author), Univ Freiburg, Fac Biol, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	s.waldert@ucl.ac.uk	Mehring, Carsten/R-8986-2019	Mehring, Carsten/0000-0001-8125-5205; Kaller, Christoph/0000-0003-1206-889X; Tushaus, Laura/0000-0002-1961-688X	German Federal Ministry of Education and Research [01GQ0420, 01GQ0761, 01GQ0762, 01GQ0830]; German National Academic Foundation; German Academic Exchange Service; German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German National Academic Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by the German Federal Ministry of Education and Research grants 01GQ0420, 01GQ0761, 01GQ0762, and 01GQ0830, a PhD fellowship (SW) of the German National Academic Foundation and a PostDoc fellowship (SW) of the German Academic Exchange Service. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing. The funders had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirikian B, 2003, P NATL ACAD SCI USA, V100, P12474, DOI 10.1073/pnas.2037719100; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; chung Chang C., 2001, SOFTWARE; Cowper-Smith CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013330; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Eisenberg M, 2010, J NEUROSCI, V30, P8897, DOI 10.1523/JNEUROSCI.0007-10.2010; Fabbri S, 2010, J NEUROSCI, V30, P13488, DOI 10.1523/JNEUROSCI.2571-10.2010; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Hatakenaka M, 2007, NEUROIMAGE, V34, P109, DOI 10.1016/j.neuroimage.2006.08.014; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holper L, 2009, NEUROIMAGE, V46, P1105, DOI 10.1016/j.neuroimage.2009.03.027; Hu XS, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026012; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; Kanoh S, 2009, 31 ANN C IEEE EMBS M; Kuboyama Naomi, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P201, DOI 10.2114/jpa.24.201; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; MATSUNAMI K, 1981, BRAIN RES, V204, P29, DOI 10.1016/0006-8993(81)90649-1; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046003; Nambu I, 2009, NEUROIMAGE, V47, P628, DOI 10.1016/j.neuroimage.2009.04.050; Obrig H, 1996, J APPL PHYSIOL, V81, P1174, DOI 10.1152/jappl.1996.81.3.1174; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Prahl S., 1998, TABULATED MOLAR EXTI; Sato T, 2009, 31 ANN INT C IEEE EM; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Shibuya K, 2008, BRAIN RES, V1210, P142, DOI 10.1016/j.brainres.2008.03.009; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Tsubone T, 2007, 29 ANN C IEEE EMBS L; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Waldert S, 2009, J PHYSIOL-PARIS, V103, P244, DOI 10.1016/j.jphysparis.2009.08.007; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Winter D, 2005, BIOMECHANICS MOTOR C; WITTE M, 2010, 4 INT BCI M MONT CA; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Wriessnegger SC, 2008, INT J PSYCHOPHYSIOL, V67, P54, DOI 10.1016/j.ijpsycho.2007.10.004; Yamashita Y, 2001, MED PHYS, V28, P1108, DOI 10.1118/1.1373401	46	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49266	10.1371/journal.pone.0049266	http://dx.doi.org/10.1371/journal.pone.0049266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145138	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500094
J	Oomizu, S; Arikawa, T; Niki, T; Kadowaki, T; Ueno, M; Nishi, N; Yamauchi, A; Hattori, T; Masaki, T; Hirashima, M				Oomizu, Souichi; Arikawa, Tomohiro; Niki, Toshiro; Kadowaki, Takeshi; Ueno, Masaki; Nishi, Nozomu; Yamauchi, Akira; Hattori, Toshio; Masaki, Tsutomu; Hirashima, Mitsuomi			Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3(+) Treg Development by Galectin-9 Secretion	PLOS ONE			English	Article							DENDRITIC CELLS; MACROPHAGES; SUPPRESSES; INDUCTION; IMMUNITY; TIM-3; DIFFERENTIATION; INFLAMMATION; PROMOTION; ARTHRITIS	Galectin-9 (Gal-9), a beta-galactoside binding mammalian lectin, regulates immune responses by reducing pro-inflammatory IL-17-producing Th cells (Th17) and increasing anti-inflammatory Foxp3(+) regulatory T cells (Treg) in vitro and in vivo. These functions of Gal-9 are thought to be exerted by binding to receptor molecules on the cell surface. However, Gal-9 lacks a signal peptide for secretion and is predominantly located in the cytoplasm, which raises questions regarding how and which cells secrete Gal-9 in vivo. Since Gal-9 expression does not necessarily correlate with its secretion, Gal-9-secreting cells in vivo have been elusive. We report here that CD4 T cells expressing Gal-9 on the cell surface (Gal-9(+) Th cells) secrete Gal-9 upon T cell receptor (TCR) stimulation, but other CD4 T cells do not, although they express an equivalent amount of intracellular Gal-9. Gal-9(+) Th cells expressed interleukin (IL)-10 and transforming growth factor (TGF)-beta but did not express Foxp3. In a co-culture experiment, Gal-9(+) Th cells regulated Th17/Treg development in a manner similar to that by exogenous Gal-9, during which the regulation by Gal-9(+) Th cells was shown to be sensitive to a Gal-9 antagonist but insensitive to IL-10 and TGF-beta blockades. Further elucidation of Gal-9(+) Th cells in humans indicates a conserved role of these cells through evolution and implies the possible utility of these cells for diagnosis or treatment of immunological diseases.	[Oomizu, Souichi; Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa 760, Japan; [Arikawa, Tomohiro] Kanazawa Med Univ, Dept Biol, Kanazawa, Ishikawa, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] GalPharma Co Ltd, Kagawa, Japan; [Kadowaki, Takeshi] Kagawa Univ, Dept Holist Immunol, Takamatsu, Kagawa 760, Japan; [Ueno, Masaki] Kagawa Univ, Dept Inflammat Pathol, Fac Med, Takamatsu, Kagawa 760, Japan; [Nishi, Nozomu] Kagawa Univ, Life Sci Res Ctr, Takamatsu, Kagawa 760, Japan; [Yamauchi, Akira] Kitano Hosp, Dept Breast Surg, Osaka, Japan; [Hattori, Toshio] Tohoku Univ, Lab Disaster Related Infect Dis, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan	Kagawa University; Kanazawa Medical University; Kagawa University; Kagawa University; Kagawa University; Kitano Hospital; Tohoku University; Kagawa University	Niki, T (corresponding author), Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa 760, Japan.	niki.t@galpharma.com	Hattori, Toshio/AAI-4599-2020	Hattori, Toshio/0000-0003-0947-7625; Nishi, Nozomu/0000-0001-7050-3226	Japan Society for Promotion of Science (JSPS) [20790570, 22590360, 23591438, 23256004]; Grants-in-Aid for Scientific Research [22590958, 23256004] Funding Source: KAKEN	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-In-Aid for young scientists (B) 2008-2009 (20790570) from the Japan Society for Promotion of Science (JSPS), Scientific Research (C) 2010- (22590360) from JSPS, Scientific Research (C) 2011- (23591438) from JSPS, Scientific Research (A) 2011- (23256004) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (JSPS HP: http://www.jsps.go.jp/). No additional external funding was received for this study.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Asseman C, 1998, GUT, V42, P157, DOI 10.1136/gut.42.2.157; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Kadowaki T, 2012, CLIN IMMUNOL, V142, P296, DOI 10.1016/j.clim.2011.11.006; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kojima K, 2011, AM J RESP CRIT CARE, V184, P328, DOI 10.1164/rccm.201010-1566OC; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Matsuura A, 2009, GENES CELLS, V14, P511, DOI 10.1111/j.1365-2443.2009.01287.x; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	28	78	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48574	10.1371/journal.pone.0048574	http://dx.doi.org/10.1371/journal.pone.0048574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144904	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800078
J	Seidel, D; Krinke, D; Jahnke, HG; Hirche, A; Kloss, D; Mack, TGA; Striggow, F; Robitzki, A				Seidel, Diana; Krinke, Dana; Jahnke, Heinz-Georg; Hirche, Anika; Kloss, Daniel; Mack, Till G. A.; Striggow, Frank; Robitzki, Andrea			Induced Tauopathy in a Novel 3D-Culture Model Mediates Neurodegenerative Processes: A Real-Time Study on Biochips	PLOS ONE			English	Article							TRANSGENIC MOUSE MODELS; ALZHEIMERS-DISEASE; SH-SY5Y CELLS; NEUROBLASTOMA-CELLS; KINASE INHIBITOR; INSOLUBLE TAU; LABEL-FREE; PHOSPHORYLATION; 3D; STAUROSPORINE	Tauopathies including Alzheimer's disease represent one of the major health problems of aging population worldwide. Therefore, a better understanding of tau-dependent pathologies and consequently, tau-related intervention strategies is highly demanded. In recent years, several tau-focused therapies have been proposed with the aim to stop disease progression. However, to develop efficient active pharmaceutical ingredients for the broad treatment of Alzheimer's disease patients, further improvements are necessary for understanding the detailed neurodegenerative processes as well as the mechanism and side effects of potential active pharmaceutical ingredients (API) in the neuronal system. In this context, there is a lack of suitable complex in vitro cell culture models recapitulating major aspects of taupathological degenerative processes in sufficient time and reproducible manner. Herewith, we describe a novel 3D SH-SY5Y cell-based, tauopathy model that shows advanced characteristics of matured neurons in comparison to monolayer cultures without the need of artificial differentiation promoting agents. Moreover, the recombinant expression of a novel highly pathologic fourfold mutated human tau variant lead to a fast and emphasized degeneration of neuritic processes. The neurodegenerative effects could be analyzed in real time and with high sensitivity using our unique microcavity array-based impedance spectroscopy measurement system. We were able to quantify a time- and concentration-dependent relative impedance decrease when Alzheimer's disease-like tau pathology was induced in the neuronal 3D cell culture model. In combination with the collected optical information, the degenerative processes within each 3D-culture could be monitored and analyzed. More strikingly, tau-specific regenerative effects caused by tau-focused active pharmaceutical ingredients could be quantitatively monitored by impedance spectroscopy. Bringing together our novel complex 3D cell culture taupathology model and our microcavity array-based impedimetric measurement system, we provide a powerful tool for the label-free investigation of tau-related pathology processes as well as the high content analysis of potential active pharmaceutical ingredient candidates.	[Seidel, Diana; Krinke, Dana; Jahnke, Heinz-Georg; Kloss, Daniel; Robitzki, Andrea] Univ Leipzig, Ctr Biotechnol & Biomed BBZ, Div Mol Biol Biochem Proc Technol, Leipzig, Germany; [Hirche, Anika] Univ Leipzig, Translat Ctr Regenerat Med, Leipzig, Germany; [Mack, Till G. A.; Striggow, Frank] KeyNeurotek Pharmaceut AG, Magdeburg, Germany; [Mack, Till G. A.; Striggow, Frank] German Ctr Neurodegenerat Dis DZNE, Dept Neurodegenerat & Intervent Strategies, Magdeburg, Germany	Leipzig University; Leipzig University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Robitzki, A (corresponding author), Univ Leipzig, Ctr Biotechnol & Biomed BBZ, Div Mol Biol Biochem Proc Technol, Leipzig, Germany.	andrea.robitzki@bbz.uni-leipzig.de		Jahnke, Heinz-Georg/0000-0001-6615-7092	German Research Foundation (DFG) [SFB610, T1 Rob.]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG; SFB610, T1 Rob.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Avila J, 2010, NAT REV NEUROL, V6, P587, DOI 10.1038/nrneurol.2010.157; Bose A, 2011, BRAIN PATHOL, V21, P189, DOI 10.1111/j.1750-3639.2010.00437.x; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brunden KR, 2010, EXP NEUROL, V223, P304, DOI 10.1016/j.expneurol.2009.08.031; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gotz J, 2010, BBA-MOL BASIS DIS, V1802, P860, DOI 10.1016/j.bbadis.2009.09.008; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hinners I, 2008, MOL CELL NEUROSCI, V37, P559, DOI 10.1016/j.mcn.2007.12.004; Hubinger G, 2008, J ALZHEIMERS DIS, V13, P281; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jahnke HG, 2009, LAB CHIP, V9, P1422, DOI 10.1039/b819754g; Jahnke HG, 2011, BIOSENS BIOELECTRON; JALAVA A, 1993, J CELL PHYSIOL, V155, P301, DOI 10.1002/jcp.1041550211; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Julien C, 2012, METHODS MOL BIOL, V849, P473, DOI 10.1007/978-1-61779-551-0_32; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kloss D, 2008, BIOSENS BIOELECTRON, V23, P1473, DOI 10.1016/j.bios.2008.01.003; Krinke D, 2010, BIOSENS BIOELECTRON, V26, P162, DOI 10.1016/j.bios.2010.06.002; Krinke D, 2009, BIOSENS BIOELECTRON, V24, P2798, DOI 10.1016/j.bios.2009.02.006; Leuba G, 2008, NEUROBIOL DIS, V30, P408, DOI 10.1016/j.nbd.2008.02.012; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Loffler T, 2012, J MOL NEUROSCI, V47, P192, DOI 10.1007/s12031-012-9716-6; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Mikami M, 2008, EUR J PHARMACOL, V589, P14, DOI 10.1016/j.ejphar.2008.04.045; Mondragon-Rodriguez S., 2012, INT J ALZHEIMERS DIS; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Rodgers AB, 2008, ALZHEIMERS DISEASE U, P79; Rothermel A, 2005, TISSUE ENG, V11, P1749, DOI 10.1089/ten.2005.11.1749; Silveyra MX, 2012, NEUROBIOL AGING, V33, p[624, e623]; Sinha G, 2011, NAT BIOTECHNOL, V29, P384, DOI 10.1038/nbt.1863; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhang Z, 2010, BRAIN RES, V1359, P233, DOI 10.1016/j.brainres.2010.08.077; Zhao HP, 2012, ADV PHARMACOL, V64, P1, DOI 10.1016/B978-0-12-394816-8.00001-5	43	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49150	10.1371/journal.pone.0049150	http://dx.doi.org/10.1371/journal.pone.0049150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145103	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800220
J	Donovan, GM; Sneyd, J; Tawhai, MH				Donovan, Graham M.; Sneyd, James; Tawhai, Merryn H.			The Importance of Synergy between Deep Inspirations and Fluidization in Reversing Airway Closure	PLOS ONE			English	Article							SMOOTH-MUSCLE; PHYSIOLOGY HUMAN; ASTHMA; HYPERRESPONSIVENESS; MODEL; MECHANICS; CANINE; LUNG; RESPONSIVENESS; HETEROGENEITY	Deep inspirations (DIs) and airway smooth muscle fluidization are two widely studied phenomena in asthma research, particularly for their ability (or inability) to counteract severe airway constriction. For example, DIs have been shown effectively to reverse airway constriction in normal subjects, but this is impaired in asthmatics. Fluidization is a connected phenomenon, wherein the ability of airway smooth muscle (ASM, which surrounds and constricts the airways) to exert force is decreased by applied strain. A maneuver which sufficiently strains the ASM, then, such as a DI, is thought to reduce the force generating capacity of the muscle via fluidization and hence reverse or prevent airway constriction. Understanding these two phenomena is considered key to understanding the pathophysiology of asthma and airway hyper-responsiveness, and while both have been extensively studied, the mechanism by which DIs fail in asthmatics remains elusive. Here we show for the first time the synergistic interaction between DIs and fluidization which allows the combination to provide near complete reversal of airway closure where neither is effective alone. This relies not just on the traditional model of airway bistability between open and closed states, but also the critical addition of previously-unknown oscillatory and chaotic dynamics. It also allows us to explore the types of subtle change which can cause this interaction to fail, and thus could provide the missing link to explain DI failure in asthmatics.	[Donovan, Graham M.; Sneyd, James] Univ Auckland, Dept Math, Auckland 1, New Zealand; [Tawhai, Merryn H.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand	University of Auckland; University of Auckland	Donovan, GM (corresponding author), Univ Auckland, Dept Math, Auckland 1, New Zealand.	g.donovan@auckland.ac.nz	Sneyd, James/C-8995-2009; Donovan, Graham/AAC-7445-2020; Donovan, Graham M/O-4469-2016	Sneyd, James/0000-0001-7305-2862; Donovan, Graham/0000-0001-5903-5484; Donovan, Graham M/0000-0001-5903-5484; Tawhai, Merryn/0000-0002-3211-6337	National Institutes of Health (NIH) [HL103405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the support of the National Institutes of Health (NIH) under grant HL103405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affonce DA, 2006, J APPL PHYSIOL, V101, P1710, DOI 10.1152/japplphysiol.00344.2006; Allgower E., 2003, INTRO NUMERICAL CONT, V45; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Anafi RC, 2001, J APPL PHYSIOL, V91, P1185, DOI 10.1152/jappl.2001.91.3.1185; Bai TR, 2004, J APPL PHYSIOL, V97, P2029, DOI 10.1152/japplphysiol.00884.2004; Bates JHT, 2009, AM J PHYSIOL-LUNG C, V297, pL362, DOI 10.1152/ajplung.00095.2009; Chapman DG, 2011, J APPL PHYSIOL, V110, P1400, DOI 10.1152/japplphysiol.00855.2010; Chapman DG, 2010, RESP PHYSIOL NEUROBI, V173, P157, DOI 10.1016/j.resp.2010.07.011; Chin LYM, 2012, EUR RESPIR J, V40, P45, DOI 10.1183/09031936.00065411; Donovan GM, 2010, BIOPHYS J, V99, P3164, DOI 10.1016/j.bpj.2010.09.031; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; FEIGENBAUM MJ, 1983, PHYSICA D, V7, P16, DOI 10.1016/0167-2789(83)90112-4; FISH JE, 1981, J APPL PHYSIOL, V50, P1079, DOI 10.1152/jappl.1981.50.5.1079; GUNST SJ, 1988, J APPL PHYSIOL, V64, P2522, DOI 10.1152/jappl.1988.64.6.2522; Kapsali T, 2000, J APPL PHYSIOL, V89, P711, DOI 10.1152/jappl.2000.89.2.711; LAIFOOK SJ, 1979, J APPL PHYSIOL, V46, P419, DOI 10.1152/jappl.1979.46.3.419; LAMBERT RK, 1982, J APPL PHYSIOL, V52, P44, DOI 10.1152/jappl.1982.52.1.44; Lambert RK, 1997, J APPL PHYSIOL, V83, P140, DOI 10.1152/jappl.1997.83.1.140; LAMBERT RK, 1993, J APPL PHYSIOL, V74, P2771, DOI 10.1152/jappl.1993.74.6.2771; LaPrad AS, 2010, J APPL PHYSIOL, V109, P940, DOI 10.1152/japplphysiol.00688.2010; LaPrad AS, 2010, J APPL PHYSIOL, V109, P295, DOI 10.1152/japplphysiol.00107.2010; Latourelle J, 2002, J APPL PHYSIOL, V92, P771, DOI 10.1152/japplphysiol.01090.2000; Macklem PT, 1996, AM J RESP CRIT CARE, V153, P83, DOI 10.1164/ajrccm.153.1.8542167; Mijailovich SM, 2000, BIOPHYS J, V79, P2667, DOI 10.1016/S0006-3495(00)76505-2; MORENO RH, 1986, AM REV RESPIR DIS, V133, P1171; Murray J, 2002, MATH BIOL NUMBER V 2; Noble PB, 2010, J APPL PHYSIOL, V109, P938, DOI 10.1152/japplphysiol.00631.2010; Oliver MN, 2007, AM J RESP CELL MOL, V37, P264, DOI 10.1165/rcmb.2006-0418OC; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; Salome CM, 2003, EUR RESPIR J, V22, P62, DOI 10.1183/09031936.03.00117502; Scichilone N, 2001, AM J RESP CRIT CARE, V163, P413, DOI 10.1164/ajrccm.163.2.2003119; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tsuda A, 2011, J THEOR BIOL, V286, P57, DOI 10.1016/j.jtbi.2011.06.038; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Wang I, 2008, BIOPHYS J, V94, P2053, DOI 10.1529/biophysj.107.113977; Wang L, 2001, J APPL PHYSIOL, V90, P734, DOI 10.1152/jappl.2001.90.2.734; WIGGS BR, 1990, J APPL PHYSIOL, V69, P849, DOI 10.1152/jappl.1990.69.3.849; Winkler T, 2011, J APPL PHYSIOL, V110, P1482, DOI 10.1152/japplphysiol.01163.2010	40	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48552	10.1371/journal.pone.0048552	http://dx.doi.org/10.1371/journal.pone.0048552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144901	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500026
J	Li, RJ; Strykowski, R; Meyer, M; Mulcrone, P; Krakora, D; Suzuki, M				Li, Ruojia; Strykowski, Rachel; Meyer, Michael; Mulcrone, Patrick; Krakora, Dan; Suzuki, Masatoshi			Male-Specific Differences in Proliferation, Neurogenesis, and Sensitivity to Oxidative Stress in Neural Progenitor Cells Derived from a Rat Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MODULATE DISEASE PROGRESSION; STEM-CELLS; DEHYDROEPIANDROSTERONE DHEA; NATURAL-HISTORY; FETAL CORTEX; MOUSE MODEL; CULTURES; ONSET; SOD1	Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor dysfunction and the loss of large motor neurons in the spinal cord and brain stem. A clear genetic link to point mutations in the superoxide dismutase 1 (SOD1) gene has been shown in a small group of familial ALS patients. The exact etiology of ALS is still uncertain, but males have consistently been shown to be at a higher risk for the disease than females. Here we present male-specific effects of the mutant SOD1 transgene on proliferation, neurogenesis, and sensitivity to oxidative stress in rat neural progenitor cells (rNPCs). E14 pups were bred using SOD1(G93A) transgenic male rats and wild-type female rats. The spinal cord and cortex tissues were collected, genotyped by PCR using primers for the SOD1(G93A) transgene or the male-specific Sry gene, and cultured as neurospheres. The number of dividing cells was higher in male rNPCs compared to female rNPCs. However, SOD1(G93A) over-expression significantly reduced cell proliferation in male cells but not female cells. Similarly, male rNPCs produced more neurons compared to female rNPCs, but SOD1(G93A) over-expression significantly reduced the number of neurons produced in male cells. Finally we asked whether sex and SOD1(G93A) transgenes affected sensitivity to oxidative stress. There was no sex-based difference in cell viability after treatment with hydrogen peroxide or 3-morpholinosydnonimine, a free radical-generating agent. However, increased cytotoxicity by SOD1(G93A) over-expression occurred, especially in male rNPCs. These results provide essential information on how the mutant SOD1 gene and sexual dimorphism are involved in ALS disease progression.	[Li, Ruojia; Strykowski, Rachel; Meyer, Michael; Mulcrone, Patrick; Krakora, Dan; Suzuki, Masatoshi] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Suzuki, Masatoshi] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Suzuki, M (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.	msuzuki@svm.vetmed.wisc.edu			Amyotrophic lateral sclerosis (ALS) Association, National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke [R21NS06104]; University of Wisconsin Foundation; Les Turner ALS foundation; NIH/National Center for Advancing Translational Sciences [9U54TR000021]; UW Stem Cell and Regenerative Medicine Center Pilot Grant Program	Amyotrophic lateral sclerosis (ALS) Association, National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke; University of Wisconsin Foundation; Les Turner ALS foundation; NIH/National Center for Advancing Translational Sciences; UW Stem Cell and Regenerative Medicine Center Pilot Grant Program	This work was supported by grants from the Amyotrophic lateral sclerosis (ALS) Association, National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (R21NS06104 to MS), the University of Wisconsin Foundation, and the Les Turner ALS foundation. The project was also supported in part by grant 9U54TR000021 to the University of Wisconsin (UW) Institute for Clinical and Translational Research from NIH/National Center for Advancing Translational Sciences and funds from the UW Stem Cell and Regenerative Medicine Center Pilot Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre T, 1998, ANN NEUROL, V43, P452, DOI 10.1002/ana.410430407; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Bradley LJ, 2009, EXP NEUROL, V218, P92, DOI 10.1016/j.expneurol.2009.04.007; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; CHIO A, 1991, NEUROEPIDEMIOLOGY, V10, P174, DOI 10.1159/000110267; Cho GW, 2011, NEUROSCI LETT, V504, P107, DOI 10.1016/j.neulet.2011.09.008; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Deasy BM, 2008, CRIT REV EUKAR GENE, V18, P173, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.60; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Groeneveld GJ, 2004, BRAIN RES, V1021, P128, DOI 10.1016/j.brainres.2004.06.024; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hayes-Punzo A, 2012, AMYOTROPH LATERAL SC, V13, P311, DOI 10.3109/17482968.2012.654393; Herrmann JL, 2010, J CARDIOVASC TRANSL, V3, P103, DOI 10.1007/s12265-009-9149-y; Hossaini M, 2011, J NEUROPATH EXP NEUR, V70, P662, DOI 10.1097/NEN.0b013e31822581ac; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kim HJ, 2007, EXP NEUROL, V203, P394, DOI 10.1016/j.expneurol.2006.08.029; Liu ZP, 2006, J COMP NEUROL, V497, P468, DOI 10.1002/cne.21012; McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Nelson AD, 2008, STEM CELLS, V26, P348, DOI 10.1634/stemcells.2007-0299; NORRIS F, 1993, J NEUROL SCI, V118, P48, DOI 10.1016/0022-510X(93)90245-T; Ostenfeld T, 2003, ADV TECH STAND NEUR, V28, P3; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sekido R, 2010, INT J BIOCHEM CELL B, V42, P417, DOI 10.1016/j.biocel.2009.12.005; Stephens B, 2006, J NEUROL SCI, V244, P41, DOI 10.1016/j.jns.2005.12.003; Suzuki M, 2004, P NATL ACAD SCI USA, V101, P3202, DOI 10.1073/pnas.0307325101; Suzuki M, 2007, AMYOTROPH LATERAL SC, V8, P20, DOI 10.1080/17482960600982447; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Svendsen CN, 1997, DEV BRAIN RES, V99, P253, DOI 10.1016/S0165-3806(97)00002-3; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Ticozzi N, 2011, ARCH ITAL BIOL, V149, P65, DOI 10.4449/aib.v149i1.1262; Turner MR, 2012, AMYOTROPH LATERAL SC, V13, P245, DOI 10.3109/17482968.2011.636050; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4; Waldron J, 2010, STEM CELLS CLONING, V3, P175, DOI 10.2147/SCCAA.S15200; Waldron J, 2010, STEM CELLS CLONING, V3, P119, DOI 10.2147/SCCAA.S13035; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Yuan J, 2010, BIOCHEM BIOPH RES CO, V396, P394, DOI 10.1016/j.bbrc.2010.04.103	42	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48581	10.1371/journal.pone.0048581	http://dx.doi.org/10.1371/journal.pone.0048581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144905	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500027
J	McEwan, MV; Eccles, MR; Horsfield, JA				McEwan, Miranda V.; Eccles, Michael R.; Horsfield, Julia A.			Cohesin Is Required for Activation of MYC by Estradiol	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LONG-RANGE INTERACTION; C-MYC; COLORECTAL-CANCER; GENE-EXPRESSION; CHROMOSOME 8Q24; ONCOGENE EXPRESSION; CELL-PROLIFERATION; PROSTATE-CANCER; TRANSCRIPTIONAL REGULATION	Cohesin is best known as a multi-subunit protein complex that holds together replicated sister chromatids from S phase until G2. Cohesin also has an important role in the regulation of gene expression. We previously demonstrated that the cohesin complex positively regulates expression of the oncogene MYC. Cell proliferation driven by MYC contributes to many cancers, including breast cancer. The MYC oncogene is estrogen-responsive and a transcriptional target of estrogen receptor alpha (ER alpha). Estrogen-induced cohesin binding sites coincide with ERa binding at the MYC locus, raising the possibility that cohesin and ERa combine actions to regulate MYC transcription. The objective of this study was to investigate a putative role for cohesin in estrogen induction of MYC expression. We found that siRNA-targeted depletion of a cohesin subunit, RAD21, decreased MYC expression in ER-positive (MCF7 and T47D) and ER-negative (MDA-MB-231) breast cancer cell lines. In addition, RAD21 depletion blocked estradiol-mediated activation of MYC in ER-positive cell lines, and decreased ERa binding to estrogen response elements (EREs) upstream of MYC, without affecting total ERa levels. Treatment of MCF7 cells with estradiol caused enrichment of RAD21 binding at upstream enhancers and at the P2 promoter of MYC. Enriched binding at all sites, except the P2 promoter, was dependent on ERa. Since RAD21 depletion did not affect transcription driven by an exogenous reporter construct containing a naked ERE, chromatin-based mechanisms are likely to be involved in cohesin-dependent MYC transcription. This study demonstrates that ERa activation of MYC can be modulated by cohesin. Together, these results demonstrate a novel role for cohesin in estrogen-mediated regulation of MYC and the first evidence that cohesin plays a role in ERa binding. Citation: McEwan MV, Eccles MR, Horsfield JA (2012) Cohesin Is Required for Activation of MYC by Estradiol. PLoS ONE 7(11): e49160. doi:10.1371/journal.pone.0049160	[McEwan, Miranda V.; Eccles, Michael R.; Horsfield, Julia A.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand	University of Otago	Horsfield, JA (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand.	julia.horsfield@otago.ac.nz	Horsfield, Julia A/B-5091-2012	Horsfield, Julia A/0000-0002-9536-7790	Breast Cancer Research Trust; Genesis Oncology Trust; Health Research Council of New Zealand; Cancer Society of New Zealand	Breast Cancer Research Trust; Genesis Oncology Trust; Health Research Council of New Zealand(Health Research Council of New Zealand); Cancer Society of New Zealand	This research was supported by the Breast Cancer Research Trust (http://www.breastcancercure.org.nz/), Genesis Oncology Trust (http://genesisoncology.org.nz/oncology/), Health Research Council of New Zealand (http://www.hrc.govt.nz/), and the Cancer Society of New Zealand (http://www.cancernz.org.nz/). Dr McEwan's research was conducted during tenure of a Health Sciences Career Development Award of the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2010, GASTROENTEROLOGY, V139, P788, DOI 10.1053/j.gastro.2010.05.072; Acevedo ML, 2003, MOL CELL BIOL, V23, P335, DOI 10.1128/MCB.23.1.335-348.2003; Aguda BD, 2011, BIOPHYS J, V101, P2082, DOI 10.1016/j.bpj.2011.09.052; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; Almeida MI, 2010, CELL RES, V20, P603, DOI 10.1038/cr.2010.70; Atienza JM, 2005, MOL CANCER THER, V4, P361; Bangert A, 2012, ONCOGENE; Batliner J, 2012, BRIT J HAEMATOL, V157, P270, DOI 10.1111/j.1365-2141.2011.08964.x; Beebe-Dimmer JL, 2008, INT J CANCER, V122, P2876, DOI 10.1002/ijc.23471; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Carroll JS, 2002, CANCER RES, V62, P3126; Castellvi-Bel S, 2012, MUTAGENESIS, V27, P153, DOI 10.1093/mutage/ger047; Chen YH, 2008, EXPERT REV ANTICANC, V8, P1689, DOI 10.1586/14737140.8.10.1689; Chien R, 2011, J BIOL CHEM, V286, P17870, DOI 10.1074/jbc.M110.207365; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; DUBIK D, 1987, CANCER RES, V47, P6517; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fletcher O, 2008, CANCER EPIDEM BIOMAR, V17, P702, DOI 10.1158/1055-9965.EPI-07-2564; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Guo Y, 2011, WORLD J GASTROENTERO, V17, P1759, DOI 10.3748/wjg.v17.i13.1759; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hogstrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031366; Hoffman B, 1998, ONCOGENE, V17, P3351, DOI 10.1038/sj.onc.1202592; Hoffman B, 1996, CURR TOP MICROBIOL, V211, P17; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Huang R, 2011, FASEB J, V25, P4138, DOI 10.1096/fj.11-185033; Hynes NE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2406; Jarvinen K, 2011, EXP CELL RES, V317, P2602, DOI 10.1016/j.yexcr.2011.08.014; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; KELLY K, 1985, J CLIN IMMUNOL, V5, P65, DOI 10.1007/BF00915003; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Laubstein H, 1985, Dermatol Monatsschr, V171, P2; Leoni BD, 2012, DIFFERENTIATION, V83, P116, DOI 10.1016/j.diff.2011.10.005; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Liu Q, 2011, CURR PROTEIN PEPT SC, V12, P631, DOI 10.2174/1389203711109070631; Mendes-Pereira AM, 2011, P NATL ACAD SCI US; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; MILLER TL, 1993, MOL CELL ENDOCRINOL, V91, P83, DOI 10.1016/0303-7207(93)90258-L; Miller TW, 2011, CLIN CANCER RES, V17, P2024, DOI 10.1158/1078-0432.CCR-10-2567; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Musgrove EA, 2008, ADV EXP MED BIOL, V617, P445, DOI 10.1007/978-0-387-69080-3_43; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Neta G, 2012, LARYNGOSCOPE, V122, P1040, DOI 10.1002/lary.23209; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Okobia MN, 2011, PROSTATE, V71, P1054, DOI 10.1002/pros.21320; Papanikolopoulou A, 2012, CLIN CHEM LAB MED, V50, P379, DOI [10.1515/CCLM.2011.778, 10.1515/cclm.2011.778]; Pauli A, 2010, CURR BIOL, V20, P1787, DOI 10.1016/j.cub.2010.09.006; Peiro-Jordan R, 2012, EUR J CANCER PREV, V21, P413, DOI 10.1097/CEJ.0b013e32834ef16f; Perera PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3039; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Prenzel T, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-13; Prokunina-Olsson L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-96; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Reid G, 2009, INT J BIOCHEM CELL B, V41, P155, DOI 10.1016/j.biocel.2008.08.028; Remeseiro S, 2012, EMBO J, V31, P2090, DOI 10.1038/emboj.2012.60; Rhodes JM, 2011, MOL CANCER RES, V9, P1587, DOI 10.1158/1541-7786.MCR-11-0382; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; SANTOS GF, 1988, J BIOL CHEM, V263, P9565; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sehl ME, 2009, CLIN CANCER RES, V15, P2192, DOI 10.1158/1078-0432.CCR-08-1417; Sofueva S., 2012, BRIEF FUNCT GENOMICS; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Stoelzle T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-63; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Tuupanen S, 2012, CANCER GENET-NY, V205, P25, DOI 10.1016/j.cancergen.2012.01.005; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; van Agthoven T, 2010, ENDOCR-RELAT CANCER, V17, P215, DOI 10.1677/ERC-09-0062; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venditti M, 2002, INT J CANCER, V99, P35, DOI 10.1002/ijc.10269; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; WYLLIE AH, 1987, BRIT J CANCER, V56, P251, DOI 10.1038/bjc.1987.186; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814; Xu HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012112; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029	109	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49160	10.1371/journal.pone.0049160	http://dx.doi.org/10.1371/journal.pone.0049160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145106	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500080
J	Zanin, S; Borgo, C; Girardi, C; O'Brien, SE; Miyata, Y; Pinna, LA; Donella-Deana, A; Ruzzene, M				Zanin, Sofia; Borgo, Christian; Girardi, Cristina; O'Brien, Sean E.; Miyata, Yoshihiko; Pinna, Lorenzo A.; Donella-Deana, Arianna; Ruzzene, Maria			Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells	PLOS ONE			English	Article							PROTEIN-KINASE CK2; CANCER-CELLS; MULTIDRUG-RESISTANCE; INDUCED APOPTOSIS; CONSTITUTIVE ACTIVITY; P-GLYCOPROTEIN; COMBINATION; SURVIVAL; PHOSPHORYLATES; AUGMENTS	CK2 is a pleiotropic protein kinase, which regulates many survival pathways and plays a global anti-apoptotic function. It is highly expressed in tumor cells, and is presently considered a promising therapeutic target. Among the many inhibitors available for this kinase, the recently developed CX-4945 and CX-5011 have proved to be very potent, selective and effective in inducing cell death in tumor cells; CX-4945 has recently entered clinical trials. However, no data are available on the efficacy of these compounds to overcome drug resistance, a major reasons of cancer therapy failure. Here we address this point, by studying their effects in several tumor cell lines, each available as variant R resistant to drug-induced apoptosis, and normal-sensitive variant S. We found that the inhibition of endogenous CK2 was very similar in S and R treated cells, with more than 50% CK2 activity reduction at sub-micromolar concentrations of CX-4945 and CX-5011. A consequent apoptotic response was induced both in S and R variants of each pairs. Moreover, the combined treatment of CX-4945 plus vinblastine was able to sensitize to vinblastine R cells that are otherwise almost insensitive to this conventional antitumor drug. Consistently, doxorubicin accumulation in multidrug resistant (MDR) cells was greatly increased by CX-4945. In summary, we demonstrated that all the R variants are sensitive to CX-4945 and CX-5011; since some of the treated R lines express the extrusion pump Pgp, often responsible of the MDR phenotype, we can also conclude that the two inhibitors can successfully overcome the MDR phenomenon.	[Zanin, Sofia; Borgo, Christian; Girardi, Cristina; Pinna, Lorenzo A.; Donella-Deana, Arianna; Ruzzene, Maria] Univ Padua, Inst Neurosci, Dept Biomed Sci, Padua, Italy; [Zanin, Sofia; Borgo, Christian; Girardi, Cristina; Pinna, Lorenzo A.; Donella-Deana, Arianna; Ruzzene, Maria] Univ Padua, Natl Res Council, Inst Neurosci, Padua, Italy; [O'Brien, Sean E.] Cylene Pharmaceut, San Diego, CA USA; [Miyata, Yoshihiko] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Kyoto, Japan; [Pinna, Lorenzo A.; Ruzzene, Maria] Venetian Inst Mol Med, Padua, Italy	University of Padua; University of Padua; Kyoto University; Veneto Institute Molecular Medicine	Ruzzene, M (corresponding author), Univ Padua, Inst Neurosci, Dept Biomed Sci, Padua, Italy.	maria.ruzzene@unipd.it	Borgo, Christian/AAB-2712-2020; Miyata, Y/X-7111-2019; ZANIN, SOFIA/AAJ-5529-2020; Zanin, Sofia/ABA-3509-2021	BORGO, CHRISTIAN/0000-0001-9540-8145; Ruzzene, Maria/0000-0001-8712-8151; Zanin, Sofia/0000-0002-9421-8793; Pinna, Lorenzo A./0000-0002-8856-4956	University of Padova; Associazione Italiana per la Ricerca sul Cancro Project [IG 10312]; Italian Miur	University of Padova; Associazione Italiana per la Ricerca sul Cancro Project(Fondazione AIRC per la ricerca sul cancro); Italian Miur(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from University of Padova (Progetto Ateneo 2011) to MR, from Associazione Italiana per la Ricerca sul Cancro Project IG 10312 to LAP, and from Italian Miur PRIN 2008 to LAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Battistutta R, 2009, CELL MOL LIFE SCI, V66, P1868, DOI 10.1007/s00018-009-9155-x; Battistutta R, 2011, BIOCHEMISTRY-US, V50, P8478, DOI 10.1021/bi2008382; Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Bliesath J, 2012, CANCER LETT, V322, P113, DOI 10.1016/j.canlet.2012.02.032; Cenni V, 2004, INT J ONCOL, V25, P1599; Di Maira G, 2007, ONCOGENE, V26, P6915, DOI 10.1038/sj.onc.1210495; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Di Maira G, 2008, MOL CELL BIOCHEM, V316, P155, DOI 10.1007/s11010-008-9813-6; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Fukuda Y, 2012, BIOCHEM PHARMACOL, V83, P1073, DOI 10.1016/j.bcp.2011.12.042; Giovannetti E, 2004, CLIN CANCER RES, V10, P2936, DOI 10.1158/1078-0432.CCR-03-0520; Glavy JS, 1997, J BIOL CHEM, V272, P5909, DOI 10.1074/jbc.272.9.5909; Goda K, 2009, CURR CANCER DRUG TAR, V9, P281, DOI 10.2174/156800909788166493; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Ljubimov AV, 2004, INVEST OPHTH VIS SCI, V45, P4583, DOI 10.1167/iovs.04-0686; Manni S, 2012, CLIN CANCER RES, V18, P1888, DOI 10.1158/1078-0432.CCR-11-1789; Marzano C, 2007, FREE RADICAL BIO MED, V42, P872, DOI 10.1016/j.freeradbiomed.2006.12.021; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Mishra S, 2007, LEUKEMIA, V21, P178, DOI 10.1038/sj.leu.2404460; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Prudent R, 2010, CANCER RES, V70, P9865, DOI 10.1158/0008-5472.CAN-10-0917; Redaelli S, 2010, LEUKEMIA, V24, P1223, DOI 10.1038/leu.2010.79; Rosenzweig SA, 2012, BIOCHEM PHARMACOL, V83, P1041, DOI 10.1016/j.bcp.2011.12.025; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Ruzzene M, 2011, MOL CELL BIOCHEM, V356, P5, DOI 10.1007/s11010-011-0959-2; Ruzzene M, 2010, METHOD ENZYMOL, V484, P495, DOI [10.1016/S0076-6879(10)84024-8, 10.1016/B978-0-12-381298-8.00024-1]; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; Sarno S, 2002, J BIOL CHEM, V277, P22509, DOI 10.1074/jbc.M200486200; Sawicka M, 2004, J PHARM PHARMACOL, V56, P1067, DOI 10.1211/0022357044265; Siddiqui-Jain A, 2008, AACR M, V2008, P4875; Siddiqui-Jain A, 2012, MOL CANCER THER, V11, P994, DOI 10.1158/1535-7163.MCT-11-0613; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Stolarczyk EI, 2012, MOL PHARM; Tew KD, 2012, BIOCHEM PHARMACOL, V83, P985, DOI 10.1016/j.bcp.2011.11.023; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96	44	42	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49193	10.1371/journal.pone.0049193	http://dx.doi.org/10.1371/journal.pone.0049193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145120	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500086
J	Asakura, H; Bruggemann, H; Sheppard, SK; Ekawa, T; Meyer, TF; Yamamoto, S; Igimi, S				Asakura, Hiroshi; Bruggemann, Holger; Sheppard, Samuel K.; Ekawa, Tomoya; Meyer, Thomas F.; Yamamoto, Shigeki; Igimi, Shizunobu			Molecular Evidence for the Thriving of Campylobacter jejuni ST-4526 in Japan	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MULTILOCUS SEQUENCE TYPES; ANTIMICROBIAL RESISTANCE; GENETIC DIVERSITY; NATURAL TRANSFORMATION; BIOFILM FORMATION; BROILER FLOCKS; POULTRY MEAT; COLI; PREVALENCE	Campylobacter jejuni is a leading cause of human gastroenteritis worldwide. This study aimed at a better understanding of the genetic diversity of this pathogen disseminated in Japan. We performed multilocus sequence typing (MLST) of Campylobacter jejuni isolated from different sources (100 human, 61 poultry, and 51 cattle isolates) in Japan between 2005 and 2006. This approach identified 62 sequence types (STs) and 19 clonal complexes (CCs), including 11 novel STs. These 62 STs were phylogenetically divided into 6 clusters, partially exhibiting host association. We identified a novel ST (ST-4526) that has never been reported in other countries; a phylogenetic analysis showed that ST-4526 and related STs showed distant lineage from the founder ST, ST-21 within CC-21. Comparative genome analysis was performed to investigate which properties could be responsible for the successful dissemination of ST-4526 in Japan. Results revealed that three representative ST-4526 isolates contained a putative island comprising the region from Cj0737 to Cj0744, which differed between the ST-4526 isolates and the reference strain NCTC11168 (ST-43/CC-21). Amino acid sequence alignment analyses showed that two of three ST-4526 isolates expressed 693aa-filamentous hemagglutination domain protein (FHA), while most of other C. jejuni strains whose genome were sequenced exhibited its truncation. Correspondingly, host cell binding of FHA-positive C. jejuni was greater than that of FHA-truncated strains, and exogenous administration of rFHA protein reduced cell adhesion of FHA-positive bacteria. Biochemical assays showed that this putative protein exhibited a dose-dependent binding affinity to heparan sulfate, indicating its adhesin activity. Moreover, ST-4526 showed increased antibiotic-resistance (nalidixic acid and fluoroquinolones) and a reduced ability for DNA uptake. Taken together, our data suggested that these combined features contributed to the clonal thriving of ST-4526 in Japan.	[Asakura, Hiroshi; Ekawa, Tomoya; Yamamoto, Shigeki; Igimi, Shizunobu] Natl Inst Hlth Sci, Div Biomed Food Res, Tokyo, Japan; [Bruggemann, Holger] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Sheppard, Samuel K.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Igimi, Shizunobu] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	National Institute of Health Sciences - Japan; Aarhus University; University of Oxford; Max Planck Society	Asakura, H (corresponding author), Natl Inst Hlth Sci, Div Biomed Food Res, Tokyo, Japan.	hasakura@nihs.go.jp	Asakura, Hiroshi/AAK-6592-2021; Meyer, Thomas F. F/J-2485-2013	Asakura, Hiroshi/0000-0002-4890-037X; Meyer, Thomas F. F/0000-0002-6120-8679; Bruggemann, Holger/0000-0001-7433-0190; Sheppard, Samuel/0000-0001-6901-3203	Japan Society for Promotion of Science (JSPS) [22780275]; Ministry of Health, Labor and Welfare in Japan [H24-shokuhin-ippan-009, H22-shokuhin-ippan-012]; BBSRC [BB/I02464X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02464X/1] Funding Source: researchfish	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part through funding from a Grant-in-Aid of Scientific Research (22780275) from the Japan Society for Promotion of Science (JSPS) and grants from the Ministry of Health, Labor and Welfare in Japan (H24-shokuhin-ippan-009, H22-shokuhin-ippan-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 2012, FOODBORNE PATHOG DIS, V9, P375, DOI 10.1089/fpd.2011.0988; Asakura H, 2007, FEMS MICROBIOL LETT, V275, P278, DOI 10.1111/j.1574-6968.2007.00893.x; Atanassova V, 1999, INT J FOOD MICROBIOL, V51, P187, DOI 10.1016/S0168-1605(99)00120-8; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chatre P, 2010, J FOOD PROTECT, V73, P825, DOI 10.4315/0362-028X-73.5.825; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; de Haan CPA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-200; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Friedman C.R., 2000, CAMPYLOBACTER, P121; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Habib I, 2009, APPL ENVIRON MICROB, V75, P4277, DOI 10.1128/AEM.02269-08; Hanel I, 2009, VET MICROBIOL, V136, P121, DOI 10.1016/j.vetmic.2008.10.018; Hanel I, 2004, VET MICROBIOL, V101, P75, DOI 10.1016/j.vetmic.2004.04.004; Hanninen ML, 2007, J ANTIMICROB CHEMOTH, V60, P1251, DOI 10.1093/jac/dkm345; Harada K, 2009, MICROBIOL IMMUNOL, V53, P107, DOI 10.1111/j.1348-0421.2008.00092.x; Haruna M, 2012, ZOONOSES PUBLIC HLTH, V59, P241, DOI 10.1111/j.1863-2378.2011.01441.x; Ishihara K, 2006, J APPL MICROBIOL, V100, P153, DOI 10.1111/j.1365-2672.2005.02769.x; Jesse TW, 2006, J APPL MICROBIOL, V100, P682, DOI 10.1111/j.1365-2672.2005.02796.x; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jorgensen F, 2011, APPL ENVIRON MICROB, V77, P3741, DOI 10.1128/AEM.02444-10; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; Keller J, 2006, VET MICROBIOL, V113, P103, DOI 10.1016/j.vetmic.2005.10.019; Koene MGJ, 2009, VET MICROBIOL, V133, P199, DOI 10.1016/j.vetmic.2008.06.022; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; Kwan PSL, 2008, APPL ENVIRON MICROB, V74, P3626, DOI 10.1128/AEM.01669-07; Lang P, 2010, APPL ENVIRON MICROB, V76, P1913, DOI 10.1128/AEM.01753-09; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Muller J, 2007, J MED MICROBIOL, V56, P1589, DOI 10.1099/jmm.0.47305-0; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; NACHAMKIN I, 1993, APPL ENVIRON MICROB, V59, P1269, DOI 10.1128/AEM.59.5.1269-1273.1993; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Oporto B, 2011, ZOONOSES PUBLIC HLTH, V58, P365, DOI 10.1111/j.1863-2378.2010.01373.x; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Piddock LJV, 2003, J ANTIMICROB CHEMOTH, V51, P19, DOI 10.1093/jac/dkg033; Ragimbeau C, 2008, APPL ENVIRON MICROB, V74, P7715, DOI 10.1128/AEM.00865-08; Ribot EM, 2001, J CLIN MICROBIOL, V39, P1889, DOI 10.1128/JCM.39.5.1889-1894.2001; Sails AD, 2003, J CLIN MICROBIOL, V41, P4733, DOI 10.1128/JCM.41.10.4733-4739.2003; Saito S, 2005, FEMS IMMUNOL MED MIC, V45, P311, DOI 10.1016/j.femsim.2005.05.006; Sanad YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025778; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Soncini G, 2006, J FOOD PROTECT, V69, P3021, DOI 10.4315/0362-028X-69.12.3021; Sopwith W, 2006, EMERG INFECT DIS, V12, P1500, DOI 10.3201/eid1210.060048; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Japanese Ministry of Health Labour and Welfare, FOOD POIS STAT; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Wiesner RS, 2003, J BACTERIOL, V185, P5408, DOI 10.1128/JB.185.18.5408-5418.2003; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Yabe S, 2010, MICROBIOL IMMUNOL, V54, P362, DOI 10.1111/j.1348-0421.2010.00222.x; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	66	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48394	10.1371/journal.pone.0048394	http://dx.doi.org/10.1371/journal.pone.0048394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144873	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800053
J	Cooke, GM; Chao, NL; Beheregaray, LB				Cooke, Georgina M.; Chao, Ning L.; Beheregaray, Luciano B.			Five Cryptic Species in the Amazonian Catfish Centromochlus existimatus Identified Based on Biogeographic Predictions and Genetic Data	PLOS ONE			English	Article							ENVIRONMENTAL GRADIENTS; MORPHOLOGICAL EVOLUTION; NATURAL-SELECTION; FISH ASSEMBLAGES; PHYLOGEOGRAPHY; MITOCHONDRIAL; BIODIVERSITY; DIVERSITY; DIVERSIFICATION; HISTORY	Accurately quantifying biodiversity is fundamental for both evolutionary theory and conservation strategies. DNA-based studies are exposing high cryptic diversity irrespective of taxonomic group or environmental setting, and increasing the ever-growing estimates of global biodiversity. This has severe implications for under-sampled and species-rich tropical regions, such as the Amazon Basin. We used biogeographic predictions derived from geomorphological history and contemporary hydrochemical and genetic data to examine cryptic diversity in the Amazonian driftwood catfish Centromochlus existimatus. Using both nuclear and mitochondrial DNA markers, five deeply divergent cryptic lineages are reported, for which at least three are sympatric in distribution. These lineages appear relatively old, with divergence times dating back to middle Miocene. Diversification events appear to be chronologically associated with the formation of the modern Amazon River system, and perhaps influenced by hydrochemical gradients between tributaries. The cause of apparent morphological stasis in the C. existimatus species complex is speculated within the context of hydrochemistry and non-visual mating cues and a full taxonomic revision is recommended. Our findings suggest that the diversity of Amazonian ichthyofauna is vastly underestimated and highlight the relevance of biogeographic predictions to guide sampling efforts in ecologically complex and under-studied ecosystems.	[Cooke, Georgina M.; Beheregaray, Luciano B.] Macquarie Univ, Mol Ecol Lab, Dept Biol Sci, Sydney, NSW 2109, Australia; [Chao, Ning L.] Bioamazonia Conservat Int, Baltimore, MD USA; [Beheregaray, Luciano B.] Flinders Univ S Australia, Sch Biol Sci, Mol Ecol Lab, Adelaide, SA 5001, Australia	Macquarie University; Flinders University South Australia	Beheregaray, LB (corresponding author), Macquarie Univ, Mol Ecol Lab, Dept Biol Sci, Sydney, NSW 2109, Australia.	luciano.beheregaray@flinders.edu.au	Beheregaray, Luciano/AAY-6384-2021; Beheregaray, Luciano B/A-8621-2008	Beheregaray, Luciano/0000-0003-0944-3003; Beheregaray, Luciano B/0000-0003-0944-3003	Australian Research Council (ARC) [DP0556496]; Macquarie University	Australian Research Council (ARC)(Australian Research Council); Macquarie University	This study was funded by the Discovery Program of the Australian Research Council (ARC grant DP0556496 to L. Beheregaray) (http://www.arc.gov.au/ncgp/dp/dp_default.htm) and by Macquarie University through a postgraduate travel grant and student award to G. Cooke (http://www.mq.edu.au/). Logistics and local arrangements were supported in part through the Brazilian National Council of Research and Technology (CNPq-SEAP No. 408782/2006-4 to N. Chao Universidade Federal do Amazonas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE J C, 1985, Philosophical Transactions of the Royal Society of London B Biological Sciences, V312, P325; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bates John M., 2001, Diversity and Distributions, V7, P249, DOI 10.1046/j.1366-9516.2001.00112.x; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Burns JR, 2002, COPEIA, P173; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Carcraft J, 1989, SPECIATION ITS CONSE, P28; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colborn J, 2001, EVOLUTION, V55, P807, DOI 10.1554/0014-3820(2001)055[0807:TEEOBA]2.0.CO;2; Cooke GM, 2012, J EVOLUTION BIOL, V25, P1305, DOI 10.1111/j.1420-9101.2012.02514.x; Cooke GM, 2012, MOL ECOL, V21, P2410, DOI 10.1111/j.1365-294X.2012.05540.x; Cooke GM, 2012, J BIOGEOGR, V39, P724, DOI 10.1111/j.1365-2699.2011.02635.x; Cooke GM, ELECT SPECIES UNPUB; Coyne JA, 2004, SPECIATION, V37; DOBZHANSKY T, 1950, AM NAT, V84, P401, DOI 10.1086/281638; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Fernandes FMC, 2005, ZOOTAXA, P1; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Henderson PA, 1997, J TROP ECOL, V13, P175, DOI 10.1017/S0266467400010403; Hewitt GM, 2001, NOVA ACTA LEOPOLDINA, V88, P205; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson PA, 1996, EVOL ECOL, V10, P187, DOI 10.1007/BF01241784; JUNK W J, 1983, Amazoniana, V7, P397; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Laurance William F., 2002, Trends in Ecology and Evolution, V17, P251, DOI 10.1016/S0169-5347(02)02484-9; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Littmann MW, 2001, P ACAD NAT SCI PHILA, V151, P87, DOI 10.1635/0097-3157(2001)151[0087:ANCSOS]2.0.CO;2; Lopez JA, 2004, COPEIA, P449, DOI 10.1643/CG-03-087R1; Lopez-Osorio F, 2010, CONSERV BIOL, V24, P1359, DOI 10.1111/j.1523-1739.2010.01482.x; Lundberg John G., 1998, P13; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Mayr E., 1942, P1; Mees G.F., 1974, Zoologische Verh Leiden, VNo. 132, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagamachi CY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-28; Nakayama C, 2001, COPEIA, P866; Nelson G., 1981, SYSTEMATICS BIOGEORA; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nylander J. A. A., 2004, MRMODELTEST V2; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; Petry P, 2003, J FISH BIOL, V63, P547, DOI 10.1046/j.1095-8649.2003.00169.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Piggott MP, 2011, BIOL J LINN SOC, V102, P391, DOI 10.1111/j.1095-8312.2010.01571.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; Rambaut A, 2006, TRACER; Reis R. E., 2003, CHECKLIST FRESHWATER; Rocha-Olivares A, 2001, MOL BIOL EVOL, V18, P1088, DOI 10.1093/oxfordjournals.molbev.a003880; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez MA, 1997, ECOL MONOGR, V67, P109, DOI 10.1890/0012-9615(1997)067[0109:SOFAAE]2.0.CO;2; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Saint-Paul U, 2000, ENVIRON BIOL FISH, V57, P235, DOI 10.1023/A:1007699130333; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Silva DD, 2008, MICRON, V39, P1251, DOI 10.1016/j.micron.2008.04.001; Sioli H., 1984, AMAZON LIMNOLOGY LAN, DOI [10.1007/978-94-009-6542-3_5, DOI 10.1007/978-94-009-6542-3_5]; Siqueira S, 2009, HEREDITAS, V146, P141, DOI 10.1111/j.1601-5223.2009.02104.x; Sistrom MJ, 2009, J ZOOL, V278, P287, DOI 10.1111/j.1469-7998.2009.00576.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Teugels GG, 1996, AQUAT LIVING RESOUR, V9, P9, DOI 10.1051/alr:1996039; Vari Richard P., 1998, P1; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	88	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48800	10.1371/journal.pone.0048800	http://dx.doi.org/10.1371/journal.pone.0048800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144977	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800139
J	Farkash-Amar, S; Eden, E; Cohen, A; Geva-Zatorsky, N; Cohen, L; Milo, R; Sigal, A; Danon, T; Alon, U				Farkash-Amar, Shlomit; Eden, Eran; Cohen, Ariel; Geva-Zatorsky, Naama; Cohen, Lydia; Milo, Ron; Sigal, Alex; Danon, Tamar; Alon, Uri			Dynamic Proteomics of Human Protein Level and Localization across the Cell Cycle	PLOS ONE			English	Article							WIDE TRANSCRIPTIONAL ANALYSIS; LIVING HUMAN-CELLS; DNA-REPLICATION; CANCER-CELLS; GENOME; GENES; IDENTIFICATION; CYTOKINESIS; YEAST; CLASSIFICATION	Regulation of proteins across the cell cycle is a basic process in cell biology. It has been difficult to study this globally in human cells due to lack of methods to accurately follow protein levels and localizations over time. Estimates based on global mRNA measurements suggest that only a few percent of human genes have cell-cycle dependent mRNA levels. Here, we used dynamic proteomics to study the cell-cycle dependence of proteins. We used 495 clones of a human cell line, each with a different protein tagged fluorescently at its endogenous locus. Protein level and localization was quantified in individual cells over 24h of growth using time-lapse microscopy. Instead of standard chemical or mechanical methods for cell synchronization, we employed in-silico synchronization to place protein levels and localization on a time axis between two cell divisions. This non-perturbative synchronization approach, together with the high accuracy of the measurements, allowed a sensitive assay of cell-cycle dependence. We further developed a computational approach that uses texture features to evaluate changes in protein localizations. We find that 40% of the proteins showed cell cycle dependence, of which 11% showed changes in protein level and 35% in localization. This suggests that a broader range of cell-cycle dependent proteins exists in human cells than was previously appreciated. Most of the cell-cycle dependent proteins exhibit changes in cellular localization. Such changes can be a useful tool in the regulation of the cell-cycle being fast and efficient.	[Farkash-Amar, Shlomit; Eden, Eran; Cohen, Ariel; Geva-Zatorsky, Naama; Cohen, Lydia; Milo, Ron; Sigal, Alex; Danon, Tamar; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Milo, Hilla/C-8767-2016; Geva-Zatorsky, Naama/AAP-9176-2021; Sigal, Alex/GWC-7488-2022	Geva-Zatorsky, Naama/0000-0002-7303-854X; Sigal, Alex/0000-0001-8571-2004; Milo, Ron/0000-0003-1641-2299	European Union's Seventh Framework Programme [258068]; EU-FP7-Systems Microscopy NoE	European Union's Seventh Framework Programme; EU-FP7-Systems Microscopy NoE	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no258068; EU-FP7-Systems Microscopy NoE." (Annex II to the Grant Agreement, II.30.4). Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026272; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Chebira A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-210; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004901; Cooper S, 2007, J THEOR BIOL, V249, P574, DOI 10.1016/j.jtbi.2007.08.019; Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Geva-Zatorsky N, 2012, NAT PROTOC, V7, P801, DOI 10.1038/nprot.2012.028; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Santos SDM, 2012, CELL, V149, P1500, DOI 10.1016/j.cell.2012.05.028; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Tully GH, 2009, MOL BIOL CELL, V20, P1201, DOI 10.1091/mbc.E08-08-0822; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	38	13	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48722	10.1371/journal.pone.0048722	http://dx.doi.org/10.1371/journal.pone.0048722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144944	Green Published, gold			2022-12-25	WOS:000311935800110
J	Golkar, A; Lonsdorf, TB; Olsson, A; Lindstrom, KM; Berrebi, J; Fransson, P; Schalling, M; Ingvar, M; Ohman, A				Golkar, Armita; Lonsdorf, Tina B.; Olsson, Andreas; Lindstrom, Kara M.; Berrebi, Jonathan; Fransson, Peter; Schalling, Martin; Ingvar, Martin; Ohman, Arne			Distinct Contributions of the Dorsolateral Prefrontal and Orbitofrontal Cortex during Emotion Regulation	PLOS ONE			English	Article							COGNITIVE CONTROL; VOLUNTARY SUPPRESSION; NEGATIVE AFFECT; WORKING-MEMORY; AMYGDALA; RESPONSES; ANXIETY; PATHWAYS; FEELINGS; REGIONS	The lateral prefrontal and orbitofrontal cortices have both been implicated in emotion regulation, but their distinct roles in regulation of negative emotion remain poorly understood. To address this issue we enrolled 58 participants in an fMRI study in which participants were instructed to reappraise both negative and neutral stimuli. This design allowed us to separately study activations reflecting cognitive processes associated with reappraisal in general and activations specifically related to reappraisal of negative emotion. Our results confirmed that both the dorsolateral prefrontal cortex (DLPFC) and the lateral orbitofrontal cortex (OFC) contribute to emotion regulation through reappraisal. However, activity in the DLPFC was related to reappraisal independently of whether negative or neutral stimuli were reappraised, whereas the lateral OFC was uniquely related to reappraisal of negative stimuli. We suggest that relative to the lateral OFC, the DLPFC serves a more general role in emotion regulation, perhaps by reflecting the cognitive demand that is inherent to the regulation task.	[Golkar, Armita; Lonsdorf, Tina B.; Olsson, Andreas; Lindstrom, Kara M.; Berrebi, Jonathan; Fransson, Peter; Ingvar, Martin; Ohman, Arne] Karolinska Inst, Stockholm Brain Inst, Dept Clin Neurosci, Solna, Sweden; [Golkar, Armita; Lonsdorf, Tina B.; Olsson, Andreas; Ingvar, Martin; Ohman, Arne] Nord Ctr Excellence Cognit Control, Stockholm, Sweden; [Lonsdorf, Tina B.] Univ Hosp Hamburg Eppendorf, Inst Syst Neurosci, Hamburg, Germany; [Lindstrom, Kara M.] NIMH, Mood & Anxiety Program, Bethesda, MD 20892 USA; [Schalling, Martin] Karolinska Inst, Ctr Mol Med & Surg, Solna, Sweden; [Ingvar, Martin] Osher Ctr Integrat Med, Stockholm, Sweden; [Ohman, Arne] NIH, Ctr Study Emot & Attent, Gainesville, FL USA	Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Karolinska Institutet; National Institutes of Health (NIH) - USA	Golkar, A (corresponding author), Karolinska Inst, Stockholm Brain Inst, Dept Clin Neurosci, Solna, Sweden.	armita.golkar@ki.se	Schalling, Martin/F-1518-2015; Fransson, Peter/M-5679-2014; Lonsdorf, Tina/K-8657-2017	Schalling, Martin/0000-0001-5011-2922; Fransson, Peter/0000-0002-1305-9875; Ingvar, Martin/0000-0002-9041-5714; Golkar, Armita/0000-0003-3077-0391; Lonsdorf, Tina/0000-0003-1501-4846	Swedish Research Council; Nordic Research Council for the Humanities and Social Sciences (NOS-HS); National Institute of Mental Health, Center for the Study of Emotion and Attention; Barbro and Bernard Osher Foundation; Swedish Governmental Agency for Innovation Systems (VINNOVA); Swedish Foundation for Strategic Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Nordic Research Council for the Humanities and Social Sciences (NOS-HS); National Institute of Mental Health, Center for the Study of Emotion and Attention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Barbro and Bernard Osher Foundation; Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Research Council (to A.O., M.S., M.I.), the Nordic Research Council for the Humanities and Social Sciences (NOS-HS, to A.O.), the National Institute of Mental Health, Center for the Study of Emotion and Attention (to A.O.), the Barbro and Bernard Osher Foundation (M.I.), The Swedish Governmental Agency for Innovation Systems (VINNOVA) and The Swedish Foundation for Strategic Research (A.O., M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bunge SA, 2004, BRAIN COGNITION, V56, P141, DOI 10.1016/j.bandc.2003.08.001; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Cunningham WA, 2007, TRENDS COGN SCI, V11, P97, DOI 10.1016/j.tics.2006.12.005; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Friston KJ., 1994, FUNCTIONAL NEUROIMAG, P79; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Jackson DC, 2000, PSYCHOPHYSIOLOGY, V37, P515, DOI 10.1111/1469-8986.3740515; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Munafo, 2009, BIOL PSYCHIAT, V66, P302, DOI 10.1016/j.biopsych.2009.06.007; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Petrovic P, 2008, J NEUROSCI, V28, P10509, DOI 10.1523/JNEUROSCI.2807-08.2008; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Walter H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006726	46	126	126	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48107	10.1371/journal.pone.0048107	http://dx.doi.org/10.1371/journal.pone.0048107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144849	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800035
J	Li, AQ; Wei, GF; Wang, YF; Zhou, Y; Zhang, XE; Bi, LJ; Chen, RS				Li, Aqian; Wei, Guifeng; Wang, Yunfei; Zhou, Ying; Zhang, Xian-en; Bi, Lijun; Chen, Runsheng			Identification of Intermediate-Size Non-Coding RNAs Involved in the UV-Induced DNA Damage Response in C. elegans	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CAENORHABDITIS-ELEGANS; CELL-DEATH; TRANSCRIPTOME; FEATURES; EXPRESSION; APOPTOSIS; HOMOLOG; REVEALS; PROTEIN	Background: A network of DNA damage response (DDR) mechanisms functions coordinately to maintain genome integrity and prevent disease. The Nucleotide Excision Repair (NER) pathway is known to function in the response to UV-induced DNA damage. Although numbers of coding genes and miRNAs have been identified and reported to participate in UV-induced DNA damage response (UV-DDR), the precise role of non-coding RNAs (ncRNAs) in UV-DDR remains largely unknown. Methodology/Principal Findings: We used high-throughput RNA-sequencing (RNA-Seq) to discover intermediate-size (70-500 nt) ncRNAs (is-ncRNAs) in C. elegans, using the strains of L4 larvae of wild-type (N2), UV-irradiated (N2/UV100) and NER-deficient mutant (xpa-1), and 450 novel non-coding transcripts were initially identified. A customized microarray assay was then applied to examine the expression profiles of both novel transcripts and known is-ncRNAs, and 57 UV-DDR-related is-ncRNA candidates showed expression variations at different levels between UV irradiated strains and non-irradiated strains. The top ranked is-ncRNA candidates with expression differences were further validated by qRT-PCR analysis, of them, 8 novel is-ncRNAs were significantly up-regulated after UV irradiation. Knockdown of two novel is-ncRNAs, ncRNA317 and ncRNA415, by RNA interference, resulted in higher UV sensitivity and significantly decreased expression of NER-related genes in C. elegans. Conclusions/Significance: The discovery of above two novel is-ncRNAs in this study indicated the functional roles of is-ncRNAs in the regulation of UV-DDR network, and aided our understanding of the significance of ncRNA involvement in the UV-induced DNA damage response.	[Li, Aqian; Wei, Guifeng; Wang, Yunfei; Zhou, Ying; Bi, Lijun; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100080, Peoples R China; [Li, Aqian; Wei, Guifeng] Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China; [Zhang, Xian-en] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Bi, LJ (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100080, Peoples R China.	blj@sun5.ibp.ac.cn; crs@sun5.ibp.ac.cn	Wei, Guifeng/A-2184-2013; ZHANG, Xian-En/AAJ-5579-2021; Chen, Runsheng/S-9834-2017	Chen, Runsheng/0000-0001-6049-8347; Wei, Guifeng/0000-0002-5698-426X	National Natural Science Foundation of China [31170132]; National Basic Research Program of China [2009CB825401, 2009CB825402, 2011CB910302]; Chinese Academy of Science [KSCX2-EW-R-01-02]; Beijing Institute of Life Science [2010-Biols-CAS-0302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Beijing Institute of Life Science	This work was supported by the National Natural Science Foundation of China (31170132), the National Basic Research Program of China (2009CB825401, 2009CB825402 and 2011CB910302), the Chinese Academy of Science Knowledge Innovation Project (KSCX2-EW-R-01-02), and Innovation Program of Beijing Institute of Life Science (2010-Biols-CAS-0302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J., 2006, WORMBOOK, P1; Astin JW, 2008, DNA REPAIR, V7, P267, DOI 10.1016/j.dnarep.2007.10.004; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206; Denver DR, 2005, GENETICS, V170, P107, DOI 10.1534/genetics.104.038521; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He HS, 2007, GENOME RES, V17, P1471, DOI 10.1101/gr.6611807; He HS, 2006, NUCLEIC ACIDS RES, V34, P2976, DOI 10.1093/nar/gkl371; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee MH, 2002, FEBS LETT, V522, P47, DOI 10.1016/S0014-5793(02)02880-6; Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x; Li TT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-71; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Nehme R, 2008, ONCOGENE, V27, pS30, DOI 10.1038/onc.2009.41; O'Neil Nigel, 2006, WormBook, P1; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Park HK, 2004, DNA REPAIR, V3, P1375, DOI 10.1016/j.dnarep.2004.04.008; Park HK, 2002, MOL CELLS, V14, P50; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Scharer OD, 2003, ANGEW CHEM INT EDIT, V42, P2946, DOI 10.1002/anie.200200523; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Vella Monica C, 2005, WormBook, P1; Wan GH, 2011, TRENDS BIOCHEM SCI, V36, P478, DOI 10.1016/j.tibs.2011.06.002; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wang YF, 2011, NUCLEIC ACIDS RES, V39, P5203, DOI 10.1093/nar/gkr102; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yan DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021652	48	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48066	10.1371/journal.pone.0048066	http://dx.doi.org/10.1371/journal.pone.0048066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144846	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800033
J	Madigan, DJ; Litvin, SY; Popp, BN; Carlisle, AB; Farwell, CJ; Block, BA				Madigan, Daniel J.; Litvin, Steven Y.; Popp, Brian N.; Carlisle, Aaron B.; Farwell, Charles J.; Block, Barbara A.			Tissue Turnover Rates and Isotopic Trophic Discrimination Factors in the Endothermic Teleost, Pacific Bluefin Tuna (Thunnus orientalis)	PLOS ONE			English	Article							NITROGEN STABLE-ISOTOPES; CENTRAL CALIFORNIA; PROTEIN-TURNOVER; MARINE PREDATOR; FEEDING ECOLOGY; METABOLIC-RATE; FISH-TISSUES; CARBON; DIET; FRACTIONATION	Stable isotope analysis (SIA) of highly migratory marine pelagic animals can improve understanding of their migratory patterns and trophic ecology. However, accurate interpretation of isotopic analyses relies on knowledge of isotope turnover rates and tissue-diet isotope discrimination factors. Laboratory-derived turnover rates and discrimination factors have been difficult to obtain due to the challenges of maintaining these species in captivity. We conducted a study to determine tissue-(white muscle and liver) and isotope-(nitrogen and carbon) specific turnover rates and trophic discrimination factors (TDFs) using archived tissues from captive Pacific bluefin tuna (PBFT), Thunnus orientalis, 1-2914 days after a diet shift in captivity. Half-life values for N-15 turnover in white muscle and liver were 167 and 86 days, and for C-13 were 255 and 162 days, respectively. TDFs for white muscle and liver were 1.9 and 1.1% for delta N-15 and 1.8 and 1.2% for delta C-13, respectively. Our results demonstrate that turnover of N-15 and C-13 in bluefin tuna tissues is well described by a single compartment first-order kinetics model. We report variability in turnover rates between tissue types and their isotope dynamics, and hypothesize that metabolic processes play a large role in turnover of nitrogen and carbon in PBFT white muscle and liver tissues. N-15 in white muscle tissue showed the most predictable change with diet over time, suggesting that white muscle delta N-15 data may provide the most reliable inferences for diet and migration studies using stable isotopes in wild fish. These results allow more accurate interpretation of field data and dramatically improve our ability to use stable isotope data from wild tunas to better understand their migration patterns and trophic ecology.	[Madigan, Daniel J.; Carlisle, Aaron B.; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; [Popp, Brian N.] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Farwell, Charles J.] Monterey Bay Aquarium, Monterey, CA USA	Stanford University; University of Hawaii System; University of Hawaii Manoa; Monterey Bay Aquarium Research Institute	Madigan, DJ (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	dmadigan@stanford.edu		Popp, Brian/0000-0001-7021-5478; Carlisle, Aaron/0000-0003-0796-6564	Tuna Research and Conservation Center; Monterey Bay Aquarium; Lerner-Grey fund of the American Natural History Museum; Directorate For Geosciences [1040810] Funding Source: National Science Foundation; Division Of Ocean Sciences [1041329] Funding Source: National Science Foundation	Tuna Research and Conservation Center; Monterey Bay Aquarium; Lerner-Grey fund of the American Natural History Museum; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the Tuna Research and Conservation Center, Monterey Bay Aquarium, and Lerner-Grey fund of the American Natural History Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIFF W H, 1991, Inter-American Tropical Tuna Commission Bulletin, V20, P3; Bayliff WM, 1994, FAO FISHERIES TECHNI, V336, P244; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bestley S, 2008, J ANIM ECOL, V77, P1223, DOI 10.1111/j.1365-2656.2008.01437.x; Blank JM, 2007, J EXP BIOL, V210, P4254, DOI 10.1242/jeb.005835; Blank JM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P167, DOI 10.1086/510637; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bosley KL, 2002, MAR ECOL PROG SER, V236, P233, DOI 10.3354/meps236233; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Brett JR., 1979, FISH PHYSIOL, P677, DOI [10.1016/S1546-5098(08)60034-5, DOI 10.1016/S1546-5098(08)60034-5]; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Cailliet GM, 1977, P 1 PAC NW TECHN WOR, P1; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; CAREY FG, 1971, AM ZOOL, V11, P137; CAREY FG, 1984, J EXP BIOL, V109, P1; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Childers J, 2011, FISH OCEANOGR, V20, P157, DOI 10.1111/j.1365-2419.2011.00575.x; de la Higuera M, 1999, AQUACULTURE, V179, P203, DOI 10.1016/S0044-8486(99)00163-5; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Deriso R, 1991, WORLD MEETING ON STO; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Farwell Charles J., 2001, Fish Physiology, V19, P391; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Fry B., 2006, STABLE ISOTOPE ECOLO; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 2008, TERR ECOL SER, V2, P1; HOULIHAN DF, 1988, CAN J FISH AQUAT SCI, V45, P951, DOI 10.1139/f88-117; Hsu CC, 2000, FISHERIES SCI, V66, P485, DOI 10.1046/j.1444-2906.2000.00078.x; Katz SL, 2002, J EXP BIOL, V205, P2251; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; Klaassen M, 2010, FUNCT ECOL, V24, P796, DOI 10.1111/j.1365-2435.2010.01689.x; Korsmeyer K.E., 2001, TUNA PHYSL ECOLOGY E, P35, DOI DOI 10.1016/S1546-5098(01)19003-5; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Kurle CM, 2001, OECOLOGIA, V126, P254, DOI 10.1007/s004420000518; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Logan J, 2006, OECOLOGIA, V147, P391, DOI 10.1007/s00442-005-0277-z; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; MacAvoy SE, 2005, CAN J ZOOL, V83, P631, DOI 10.1139/Z05-038; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Madigan DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00654; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Madigan DJ, INSIGHTS INTO PACIFI; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Ohman MD, 2012, DEEP-SEA RES PT I, V60, P46, DOI 10.1016/j.dsr.2011.11.003; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pinkas L., 1971, Fish Bull California, V152, P47; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rundel P.W., 1989, STABLE ISOTOPES ECOL; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Sepulveda CA, 2004, MAR BIOL, V145, P191, DOI 10.1007/s00227-004-1356-0; SMITH MAK, 1981, J FISH BIOL, V19, P213, DOI 10.1111/j.1095-8649.1981.tb05825.x; Sweeting CJ, 2005, FUNCT ECOL, V19, P777, DOI 10.1111/j.1365-2435.2005.01019.x; Sydeman WJ, 1997, CONDOR, V99, P327, DOI 10.2307/1369938; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Varela JL, 2011, J EXP MAR BIOL ECOL, V406, P21, DOI 10.1016/j.jembe.2011.06.010; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4	82	112	113	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49220	10.1371/journal.pone.0049220	http://dx.doi.org/10.1371/journal.pone.0049220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145128	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800234
J	Martinez-Gil, L; Ayllon, J; Ortigoza, MB; Garcia-Sastre, A; Shaw, ML; Palese, P				Martinez-Gil, Luis; Ayllon, Juan; Ortigoza, Mila Brum; Garcia-Sastre, Adolfo; Shaw, Megan L.; Palese, Peter			Identification of Small Molecules with Type I Interferon Inducing Properties by High-Throughput Screening	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; RIG-I; ANTIVIRAL ACTIVITY; NUCLEIC-ACIDS; SENDAI-VIRUS; IFN-BETA; INDUCTION; CELLS; RECOGNITION; ACTIVATION	The continuous emergence of virus that are resistant to current anti-viral drugs, combined with the introduction of new viral pathogens for which no therapeutics are available, creates an urgent need for the development of novel broad spectrum antivirals. Type I interferon (IFN) can, by modulating the cellular expression profile, stimulate a non-specific antiviral state. The antiviral and adjuvant properties of IFN have been extensively demonstrated; however, its clinical application has been so far limited. We have developed a human cell-based assay that monitors IFN-beta production for use in a high throughput screen. Using this assay we screened 94,398 small molecules and identified 18 compounds with IFN-inducing properties. Among these, 3 small molecules (C3, E51 and L56) showed activity not only in human but also in murine and canine derived cells. We further characterized C3 and showed that this molecule is capable of stimulating an anti-viral state in human-derived lung epithelial cells. Furthermore, the IFN-induction by C3 is not diminished by the presence of influenza A virus NS1 protein or hepatitis C virus NS3/4A protease, which make this molecule an interesting candidate for the development of a new type of broad-spectrum antiviral. In addition, the IFN-inducing properties of C3 also suggest its potential use as vaccine adjuvant.	[Martinez-Gil, Luis; Ayllon, Juan; Ortigoza, Mila Brum; Garcia-Sastre, Adolfo; Shaw, Megan L.; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Inst Global Hlth & Emerging Pathogens, New York, NY USA; [Garcia-Sastre, Adolfo; Palese, Peter] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	Peter.palese@mssm.edu	Barasoain, Juan Ayllón/AAA-3899-2019; Martinez-Gil, Luis/M-7422-2014	Barasoain, Juan Ayllón/0000-0002-7556-8106; Martinez-Gil, Luis/0000-0002-9076-7760; Brum Ortigoza, Mila/0000-0002-4522-0184; Shaw, Megan/0000-0002-1267-0891; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Ortigoza, Mila/0000-0002-9428-1469; Palese, Peter/0000-0002-0337-5823	National Institutes of Health [HHSN272200900032C, U54308 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants: HHSN272200900032C and U54308 AI057159. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bedard KM, 2012, J VIROL, V86, P7334, DOI 10.1128/JVI.06867-11; Bergman SJ, 2011, INFECT DIS CLIN N AM, V25, P819, DOI 10.1016/j.idc.2011.07.008; Burel SA, 2012, J PHARM EXP THER; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Cheng BK, 2007, J ANTIMICROB CHEMOTH, V59, P640, DOI 10.1093/jac/dkl556; Cheng YS, 2010, CANCER BIOL THER, V10, P1219, DOI 10.4161/cbt.10.12.13450; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; FALCOFF E, 1973, ANTIMICROB AGENTS CH, V3, P590, DOI 10.1128/AAC.3.5.590; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; HERNIMAN KA, 1972, ARCH GES VIRUSFORSCH, V37, P97, DOI 10.1007/BF01241155; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Inao T, 2012, BREAST CANCER RES TR, V134, P89, DOI 10.1007/s10549-011-1930-3; Keam SJ, 2008, DRUGS, V68, P1273, DOI 10.2165/00003495-200868090-00006; Kim T, 1999, J BIOL CHEM, V274, P30686, DOI 10.1074/jbc.274.43.30686; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kuznik A, 2010, CURR MED CHEM, V17, P1899, DOI 10.2174/092986710791163957; Liu F, 2011, PROTEIN CELL, V2, P351, DOI 10.1007/s13238-011-1045-y; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Martinez-Martin Nadia, 2010, Front Biosci (Schol Ed), V2, P718; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; MILLER DK, 1982, J GEN VIROL, V60, P327, DOI 10.1099/0022-1317-60-2-327; Miller RL, 2008, DRUG NEWS PERSPECT, V21, P69, DOI 10.1358/dnp.2008.21.2.1188193; Nagarajan UM, 2011, CRIT REV IMMUNOL, V31, P459, DOI 10.1615/CritRevImmunol.v31.i6.20; Nguyen DN, 2009, BIOTECHNOL BIOENG, V103, P664, DOI 10.1002/bit.22312; Ortigoza MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002668; Panter G, 2009, CURR OPIN MOL THER, V11, P133; Patel DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036594; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rizza P, 2011, EXPERT REV VACCINES, V10, P487, DOI [10.1586/erv.11.9, 10.1586/ERV.11.9]; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Tagawa M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/479013; Tang SC, 2010, ANTIMICROB AGENTS CH, V54, P620, DOI 10.1128/AAC.01025-09; Toporovski R, 2010, EXPERT OPIN BIOL TH, V10, P1489, DOI 10.1517/14712598.2010.521495; Tovey MG, 2010, METHODS MOL BIOL, V626, P287, DOI 10.1007/978-1-60761-585-9_19; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; WHEELER HR, 1990, INT J CANCER, V46, P626, DOI 10.1002/ijc.2910460413; WONG JP, 1995, ANTIMICROB AGENTS CH, V39, P2574, DOI 10.1128/AAC.39.11.2574; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49049	10.1371/journal.pone.0049049	http://dx.doi.org/10.1371/journal.pone.0049049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145065	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800192
J	Shao, CB; Tan, M; Bishop, JA; Liu, J; Bai, WL; Gaykalova, DA; Ogawa, T; Vikani, AR; Agrawal, Y; Li, RJ; Kim, MS; Westra, WH; Sidransky, D; Califano, JA; Ha, PK				Shao, Chunbo; Tan, Marietta; Bishop, Justin A.; Liu, Jia; Bai, Weiliang; Gaykalova, Daria A.; Ogawa, Takenori; Vikani, Ami R.; Agrawal, Yuri; Li, Ryan J.; Kim, Myoung Sook; Westra, William H.; Sidransky, David; Califano, Joseph A.; Ha, Patrick K.			Suprabasin Is Hypomethylated and Associated with Metastasis in Salivary Adenoid Cystic Carcinoma	PLOS ONE			English	Article							PROMOTER METHYLATION; CANCER; EXPRESSION; GENE; HYPERMETHYLATION; INVASION; PATTERNS; FREQUENT; REVEALS; CTCF	Background: Salivary gland adenoid cystic carcinoma (ACC) is a rare cancer, accounting for only 1% of all head and neck malignancies. ACC is well known for perineural invasion and distant metastasis, but its underlying molecular mechanisms of carcinogenesis are still unclear. Principal Findings: Here, we show that a novel oncogenic candidate, suprabasin (SBSN), plays important roles in maintaining the anchorage-independent and anchorage-dependent cell proliferation in ACC by using SBSN shRNA stably transfected ACC cell line clones. SBSN is also important in maintaining the invasive/metastatic capability in ACC by Matrigel invasion assay. More interestingly, SBSN transcription is significantly upregulated by DNA demethylation induced by 5-aza-2'-deoxycytidine plus trichostatin A treatment and the DNA methylation levels of the SBSN CpG island located in the second intron were validated to be significantly hypomethylated in primary ACC samples versus normal salivary gland tissues. Conclusions/Significance: Taken together, these results support SBSN as novel oncogene candidate in ACC, and the methylation changes could be a promising biomarker for ACC.	[Shao, Chunbo; Tan, Marietta; Gaykalova, Daria A.; Agrawal, Yuri; Li, Ryan J.; Kim, Myoung Sook; Sidransky, David; Califano, Joseph A.; Ha, Patrick K.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Bishop, Justin A.; Westra, William H.] Johns Hopkins Med Inst, Dept Surg Pathol, Baltimore, MD 21205 USA; [Liu, Jia] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Bai, Weiliang] China Med Univ, Shengjing Hosp, Dept Otorhinolaryngol, Shenyang, Peoples R China; [Ogawa, Takenori] Tohoku Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan; [Vikani, Ami R.] George Washington Univ, Sch Med, Washington, DC USA; [Califano, Joseph A.; Ha, Patrick K.] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; China Medical University; Tohoku University; George Washington University; Greater Baltimore Medical Center	Ha, PK (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	pha1@jhmi.edu			United States National Institutes of Health/National Institute of Dental and Craniofacial Research (NIDCR) [K08-018463]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER	United States National Institutes of Health/National Institute of Dental and Craniofacial Research (NIDCR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the United States National Institutes of Health/National Institute of Dental and Craniofacial Research (NIDCR) grant (K08-018463) (to P. H,). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett AW, 2009, ORAL ONCOL, V45, P936, DOI 10.1016/j.oraloncology.2009.07.001; Bazzi H, 2007, DEV DYNAM, V236, P961, DOI 10.1002/dvdy.21099; Bell A, 2011, CANCER-AM CANCER SOC, V117, P2898, DOI 10.1002/cncr.25818; Cai Y, 2010, PATHOL RES PRACT, V206, P793, DOI 10.1016/j.prp.2010.08.001; Daa T, 2008, APMIS, V116, P21, DOI 10.1111/j.1600-0463.2008.00773.x; Ding LC, 2010, ONCOL REP, V24, P363, DOI 10.3892/or_00000868; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dong L, 2011, J DENT RES, V90, P804, DOI 10.1177/0022034511401407; Durr ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010828; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Fan XP, 2010, MOL MED REP, V3, P775, DOI 10.3892/mmr.2010.337; Formolo CA, 2011, J PROTEOME RES, V10, P3149, DOI 10.1021/pr200210w; Gaykalova D, 2012, PLOS ONE IN PRESS; Glazer CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008189; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Li J, 2005, CANCER-AM CANCER SOC, V104, P771, DOI 10.1002/cncr.21215; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Maruya S, 2004, MODERN PATHOL, V17, P637, DOI 10.1038/modpathol.3800104; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200; Phuchareon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006040; Shao C, 2011, CLIN CANC RES; Shao C, 2011, ORAL ONCOL; SPIRO RH, 1974, AM J SURG, V128, P512, DOI 10.1016/0002-9610(74)90265-7; Sun WY, 2012, CLIN CANCER RES, V18, P1082, DOI 10.1158/1078-0432.CCR-11-2392; Tang QL, 2011, ORAL ONCOL, V47, P365, DOI 10.1016/j.oraloncology.2011.02.022; Tang YL, 2010, ORAL ONCOL, V46, P311, DOI 10.1016/j.oraloncology.2010.02.001; Uchida D, 2004, BRIT J CANCER, V91, P1131, DOI 10.1038/sj.bjc.6602004; Wang JF, 2011, ONCOL REP, V26, P101, DOI 10.3892/or.2011.1286; Williams MD, 2006, CLIN CANCER RES, V12, P7353, DOI 10.1158/1078-0432.CCR-06-1272; Xu Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-136; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang XJ, 2010, ORAL ONCOL, V46, P755, DOI 10.1016/j.oraloncology.2010.08.008; Zhou C, 2011, J ORAL PATHOL MED	36	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48582	10.1371/journal.pone.0048582	http://dx.doi.org/10.1371/journal.pone.0048582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144906	gold, Green Published			2022-12-25	WOS:000311935800079
J	Silva, ART; Grinberg, LT; Farfel, JM; Diniz, BS; Lima, LA; Silva, PJS; Ferretti, REL; Rocha, RM; Jacob, W; Carraro, DM; Brentani, H				Silva, Aderbal R. T.; Grinberg, Lea T.; Farfel, Jose M.; Diniz, Breno S.; Lima, Leandro A.; Silva, Paulo J. S.; Ferretti, Renata E. L.; Rocha, Rafael M.; Jacob Filho, Wilson; Carraro, Dirce M.; Brentani, Helena			Transcriptional Alterations Related to Neuropathology and Clinical Manifestation of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MOLECULAR INTERACTION DATABASE; GENE-EXPRESSION; AMYLOID DEPOSITION; NONDEMENTED INDIVIDUALS; UP-REGULATION; DNA-DAMAGE; PROTEIN; BRAIN; MICROARRAY	Alzheimer's disease (AD) is the most common cause of dementia in the human population, characterized by a spectrum of neuropathological abnormalities that results in memory impairment and loss of other cognitive processes as well as the presence of non-cognitive symptoms. Transcriptomic analyses provide an important approach to elucidating the pathogenesis of complex diseases like AD, helping to figure out both pre-clinical markers to identify susceptible patients and the early pathogenic mechanisms to serve as therapeutic targets. This study provides the gene expression profile of postmortem brain tissue from subjects with clinic-pathological AD (Braak IV, V, or V and CERAD B or C; and CDR >= 1), preclinical AD (Braak IV, V, or VI and CERAD B or C; and CDR = 0), and healthy older individuals (Braak <= II and CERAD 0 or A; and CDR = 0) in order to establish genes related to both AD neuropathology and clinical emergence of dementia. Based on differential gene expression, hierarchical clustering and network analysis, genes involved in energy metabolism, oxidative stress, DNA damage/repair, senescence, and transcriptional regulation were implicated with the neuropathology of AD; a transcriptional profile related to clinical manifestation of AD could not be detected with reliability using differential gene expression analysis, although genes involved in synaptic plasticity, and cell cycle seems to have a role revealed by gene classifier. In conclusion, the present data suggest gene expression profile changes secondary to the development of AD-related pathology and some genes that appear to be related to the clinical manifestation of dementia in subjects with significant AD pathology, making necessary further investigations to better understand these transcriptional findings on the pathogenesis and clinical emergence of AD.	[Brentani, Helena] Univ Sao Paulo, Sch Med, Clin Pathol Lab, LIM 23,Dept & Inst Psychiat, Sao Paulo, Brazil; [Silva, Aderbal R. T.; Lima, Leandro A.; Rocha, Rafael M.; Carraro, Dirce M.] AC Camargo Hosp, Res Ctr CIPE, Sao Paulo, Brazil; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Silva, Aderbal R. T.; Grinberg, Lea T.; Farfel, Jose M.; Ferretti, Renata E. L.; Jacob Filho, Wilson] Brazilian Brain Bank, Aging Brain Study Grp, LIM 22, Sao Paulo, Brazil; [Farfel, Jose M.; Ferretti, Renata E. L.; Jacob Filho, Wilson] Univ Sao Paulo, Sch Med, Div Geriatr, Sao Paulo, Brazil; [Diniz, Breno S.] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, LIM 27,Neurosci Lab, Sao Paulo, Brazil; [Silva, Paulo J. S.] Univ Sao Paulo, Dept Comp Sci, Inst Math & Stat, Sao Paulo, Brazil	Universidade de Sao Paulo; A.C.Camargo Cancer Center; University of California System; University of California San Francisco; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Brentani, H (corresponding author), Univ Sao Paulo, Sch Med, Clin Pathol Lab, LIM 23,Dept & Inst Psychiat, Sao Paulo, Brazil.	helena.brentani@gmail.com	Silva, Paulo JS/D-1938-2012; de Lucena Ferretti-Rebustini, Renata Eloah/C-8126-2012; Jacob-Filho, Wilson WJF/H-5837-2012; Brentani, Helena/G-6839-2011; de Lucena Ferretti-Rebustini, Renata Eloah/ABF-5144-2020; Diniz, Breno/H-8381-2019; Farfel, Jose/C-8936-2012; Rocha, Rafael M/A-7302-2010; carraro, dirce/C-9179-2009; Ruy T. Silva, Aderbal/K-6503-2012	Silva, Paulo JS/0000-0003-1340-965X; de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; Brentani, Helena/0000-0001-5192-4682; de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; Diniz, Breno/0000-0003-0653-1905; Farfel, Jose/0000-0003-2057-3669; Rocha, Rafael M/0000-0002-4782-626X; carraro, dirce/0000-0001-5667-1418; grinberg, lea/0000-0002-6809-0618; Ruy T. Silva, Aderbal/0000-0003-1158-5617	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/04151-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research is supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - www.fapesp.br) grant 2005/04151-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2006, J NEUROCHEM, V96, P1322, DOI 10.1111/j.1471-4159.2005.03647.x; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braga-Neto U, 2004, PATTERN RECOGN, V37, P1267, DOI 10.1016/j.patcog.2003.08.017; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Buchhave P, 2010, NEUROBIOL AGING, V31, P1877, DOI 10.1016/j.neurobiolaging.2008.10.012; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Cenini G, 2008, J CELL MOL MED, V12, P987, DOI 10.1111/j.1582-4934.2008.00163.x; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Coppede F, 2009, CURR ALZHEIMER RES, V6, P36, DOI 10.2174/156720509787313970; Counts SE, 2007, ARCH NEUROL-CHICAGO, V64, P1771, DOI 10.1001/archneur.64.12.1771; DELBO R, 1995, NEUROSCI LETT, V188, P70, DOI 10.1016/0304-3940(95)11384-9; Diniz BS, 2010, J ALZHEIMERS DIS, V22, P1305, DOI 10.3233/JAD-2010-100921; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011; Forlenza OV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-89; Forlenza OV, 2010, WORLD J BIOL PSYCHIA, V11, P774, DOI 10.3109/15622971003797241; Galindo MF, 2010, J NEUROCHEM, V114, P933, DOI 10.1111/j.1471-4159.2010.06814.x; Gattaz WF, 2004, J NEURAL TRANSM, V111, P591, DOI 10.1007/s00702-004-0142-y; Gomes LI, 2003, ANAL BIOCHEM, V321, P244, DOI 10.1016/S0003-2697(03)00466-4; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hoyer S, 2004, ADV EXP MED BIOL, V541, P135; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim S, 2002, J COMPUT BIOL, V9, P127, DOI 10.1089/10665270252833226; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lee W, 2004, MOL CELL NEUROSCI, V26, P222, DOI 10.1016/j.mcn.2003.10.020; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:1:001; Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nagasaka Y, 2005, P NATL ACAD SCI USA, V102, P14854, DOI 10.1073/pnas.0504178102; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Pollack J, 2003, DNA MICROARRAYS MOL, P168; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaub RT, 2002, AM J PSYCHIAT, V159, P1227, DOI 10.1176/appi.ajp.159.7.1227; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Silva PJS, 2005, PATTERN RECOGN LETT, V26, P1444, DOI 10.1016/j.patrec.2004.11.017; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomida J, 2008, J BIOL CHEM, V283, P9071, DOI 10.1074/jbc.M709835200; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Yang Y, 2003, J NEUROSCI, V23, P2557; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8; Zhu GF, 2001, BIOCHEM BIOPH RES CO, V285, P997, DOI 10.1006/bbrc.2001.5273	83	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48751	10.1371/journal.pone.0048751	http://dx.doi.org/10.1371/journal.pone.0048751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144955	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800120
J	Wang, ZX; Deng, RP; Jiang, HW; Guo, SJ; Le, HY; Zhao, XD; Chen, CS; Zhang, JB; Tao, SC				Wang, Zong-xiu; Deng, Rui-ping; Jiang, He-wei; Guo, Shu-Juan; Le, Huang-ying; Zhao, Xiao-dong; Chen, Chien-Sheng; Zhang, Ji-bin; Tao, Sheng-ce			Global Identification of Prokaryotic Glycoproteins Based on an Escherichia coli Proteome Microarray	PLOS ONE			English	Article							SIGNAL PEPTIDES; GLYCOSYLATION; PROTEINS; EXPRESSION; ADHERENCE; REVEALS; BIOSYNTHESIS; ACETYLATION; PREDICTION; DATABASE	Glycosylation is one of the most abundant protein posttranslational modifications. Protein glycosylation plays important roles not only in eukaryotes but also in prokaryotes. To further understand the roles of protein glycosylation in prokaryotes, we developed a lectin binding assay to screen glycoproteins on an Escherichia coli proteome microarray containing 4,256 affinity-purified E. coli proteins. Twenty-three E. coli proteins that bound Wheat-Germ Agglutinin (WGA) were identified. PANTHER protein classification analysis showed that these glycoprotein candidates were highly enriched in metabolic process and catalytic activity classes. One sub-network centered on deoxyribonuclease I (sbcB) was identified. Bioinformatics analysis suggests that prokaryotic protein glycosylation may play roles in nucleotide and nucleic acid metabolism. Fifteen of the 23 glycoprotein candidates were validated by lectin (WGA) staining, thereby increasing the number of validated E. coli glycoproteins from 3 to 18. By cataloguing glycoproteins in E. coli, our study greatly extends our understanding of protein glycosylation in prokaryotes.	[Wang, Zong-xiu; Deng, Rui-ping; Jiang, He-wei; Guo, Shu-Juan; Le, Huang-ying; Zhao, Xiao-dong; Tao, Sheng-ce] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Zong-xiu; Zhang, Ji-bin] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Wang, Zong-xiu; Deng, Rui-ping; Jiang, He-wei; Guo, Shu-Juan; Tao, Sheng-ce] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Huazhong Agricultural University; Shanghai Jiao Tong University	Zhang, JB (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China.	zhangjb@mail.hzau.edu.cn; taosc@sjtu.edu.cn	Chen, Chien-Sheng/ACO-7414-2022; Tao, Sheng-ce/A-5833-2012	Tao, Sheng-ce/0000-0002-9210-1823	National Natural Science Foundation of China [31000388, 30971884]; National High Technology Research and Development Program of China [2012AA020103, 2012AA020203]; State Key Development Program for Basic Research in China [2010CB529205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Development Program for Basic Research in China	This work was supported by the National Natural Science Foundation of China (No. 31000388 and 30971884), the National High Technology Research and Development Program of China (No. 2012AA020103 and 2012AA020203), the State Key Development Program for Basic Research in China (No. 2010CB529205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bartels KM, 2011, J BACTERIOL, V193, P1107, DOI 10.1128/JB.01507-10; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; DIDERICHSEN B, 1980, J BACTERIOL, V141, P858, DOI 10.1128/JB.141.2.858-867.1980; ELSINGHORST EA, 1994, INFECT IMMUN, V62, P3463, DOI 10.1128/IAI.62.8.3463-3471.1994; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Foster MW, 2009, P NATL ACAD SCI USA, V106, P18948, DOI 10.1073/pnas.0900729106; Fruh K, 2010, FUTURE MICROBIOL, V5, P131, DOI [10.2217/fmb.09.130, 10.2217/FMB.09.130]; GALLY DL, 1994, J BACTERIOL, V176, P5665, DOI 10.1128/JB.176.18.5665-5672.1994; Hasman H, 1999, J BACTERIOL, V181, P4834, DOI 10.1128/JB.181.16.4834-4841.1999; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Jeong JS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016253; Jeong JS, 2011, METHODS MOL BIOL, V723, P213, DOI 10.1007/978-1-61779-043-0_14; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Kung LA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.64; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lindenthal C, 2001, INFECT IMMUN, V69, P52, DOI 10.1128/IAI.69.1.52-57.2001; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Muir EM, 2010, J BIOTECHNOL, V145, P103, DOI 10.1016/j.jbiotec.2009.11.002; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Neuberger A, 1938, BIOCHEM J, V32, P1435, DOI 10.1042/bj0321435; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rambaruth NDS, 2012, GLYCOBIOLOGY, V22, P839, DOI 10.1093/glycob/cws051; Ramos C.L., 2012, EUKARYOT CELL; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Yang LN, 2011, ACTA BIOCH BIOPH SIN, V43, P161, DOI 10.1093/abbs/gmq127; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	55	4	4	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49080	10.1371/journal.pone.0049080	http://dx.doi.org/10.1371/journal.pone.0049080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145077	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800199
J	Hayes, KE; Walk, EL; Ammer, AG; Kelley, LC; Martin, KH; Weed, SA				Hayes, K. E.; Walk, E. L.; Ammer, A. G.; Kelley, L. C.; Martin, K. H.; Weed, S. A.			Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop	ONCOGENE			English	Article						abl; imatinib mesylate; invadopodia; invasion; head and neck cancer; cortactin	SRC FAMILY KINASES; PHASE-II TRIAL; GROWTH-FACTOR; C-ABL; BREAST-CANCER; TYROSINE PHOSPHORYLATION; LUNG-CANCER; MATRIX-METALLOPROTEINASE; SARACATINIB AZD0530; IMATINIB MESYLATE	Head and neck squamous cell carcinoma (HNSCC) has a proclivity for locoregional invasion. HNSCC mediates invasion in part through invadopodia-based proteolysis of the extracellular matrix (ECM). Activation of Src, Erk1/2, Abl and Arg downstream of epidermal growth factor receptor (EGFR) modulates invadopodia activity through phosphorylation of the actin regulatory protein cortactin. In MDA-MB-231 breast cancer cells, Abl and Arg function downstream of Src to phosphorylate cortactin, promoting invadopodia ECM degradation activity and thus assigning a pro-invasive role for Ableson kinases. We report that Abl kinases have an opposite, negative regulatory role in HNSCC where they suppress invadopodia and tumor invasion. Impairment of Abl expression or Abl kinase activity with imatinib mesylate enhanced HNSCC matrix degradation and 3D collagen invasion, functions that were impaired in MDA-MB-231. HNSCC lines with elevated EGFR and Src activation did not contain increased Abl or Arg kinase activity, suggesting that Src could bypass Abl/Arg to phosphorylate cortactin and promote invadopodia ECM degradation. Src-transformed Abl(-/-)/Arg(-/-) fibroblasts produced ECM degrading invadopodia containing pY421 cortactin, indicating that Abl/Arg are dispensable for invadopodia function in this system. Imatinib-treated HNSCC cells had increased EGFR, Erk1/2 and Src activation, enhancing cortactin pY421 and pS405/418 required for invadopodia function. Imatinib stimulated shedding of the EGFR ligand heparin-binding EGF-like growth factor (HB-EGF) from HNSCC cells, where soluble HB-EGF enhanced invadopodia ECM degradation in HNSCC but not in MDA-MB-231. HNSCC cells treated with inhibitors of the EGFR-invadopodia pathway indicated that EGFR and Src are required for invadopodia function. Collectively, our results indicate that Abl kinases negatively regulate HNSCC invasive processes through suppression of an HB-EGF autocrine loop responsible for activating a EGFR-Src-cortactin cascade, in contrast to the invasion promoting functions of Abl kinases in breast and other cancer types. Our results provide mechanistic support for recent failed HNSCC clinical trials utilizing imatinib.	[Hayes, K. E.; Walk, E. L.; Ammer, A. G.; Kelley, L. C.; Martin, K. H.; Weed, S. A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Program Canc Cell Biol, Dept Neurobiol & Anat, Morgantown, WV 26506 USA	West Virginia University	Weed, SA (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr Morgantown, Morgantown, WV 26506 USA.	scweed@hsc.wvu.edu		Martin, Karen/0000-0001-8916-4092; Weed, Scott/0000-0001-7033-9999	NIH [R01 DE014578, P20 RR16440]; West Virginia University Mary Babb Randolph Cancer Center; Mary Babb Randolph Cancer, NIH [P20 RR16440, P30 RR032138/GM103488]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032138, P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia University Mary Babb Randolph Cancer Center; Mary Babb Randolph Cancer, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bruce Mayer (University of Connecticut) for Abl constructs, Anthony Koleske (Yale University) for Abl<SUP>-/-</SUP>/Arg<SUP>-/-</SUP> fibroblasts, Silja Wessler (Paul-Ehrlich Institute) for the Abl shRNA construct, Elena Pugacheva (West Virginia University) for MDA-MB-231LN cells, Jim Bear (University of North Carolina) for pLL5.0 and advice on spheroid assay development. We thank Mark Auble and Barbara Frederick for technical assistance. Saracatinib and gefitinib were provided by AstraZeneca. This study was supported by NIH Grants R01 DE014578, P20 RR16440 (to SAW) and the West Virginia University Mary Babb Randolph Cancer Center. The West Virginia University Microscopy Imaging Facility (supported by the Mary Babb Randolph Cancer, NIH Grants P20 RR16440 and P30 RR032138/GM103488) is gratefully acknowledged.	Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Ammer Amanda Gatesman, 2009, J Cancer Sci Ther, V1, P52; Antoku S, 2008, J CELL SCI, V121, P3071, DOI 10.1242/jcs.031575; Araujo JC, 2012, CANCER-AM CANCER SOC, V118, P63, DOI 10.1002/cncr.26204; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brooks HD, 2011, CANCER-AM CANCER SOC, V117, P2112, DOI 10.1002/cncr.25769; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Ernst T, 2012, SEMIN ONCOL, V39, P58, DOI 10.1053/j.seminoncol.2011.11.002; Frasca F, 2001, ONCOGENE, V20, P3845, DOI 10.1038/sj.onc.1204531; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Furlan A, 2011, CELL DEATH DIFFER, V18, P1608, DOI 10.1038/cdd.2011.23; Fury MG, 2011, ANTICANCER RES, V31, P249; Ganguly SS, 2011, ONCOGENE, P5; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Hama T, 2012, CLIN EXP METASTAS, V29, P19, DOI 10.1007/s10585-011-9425-5; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Hatakeyama H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012702; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang YT, 2002, INT J CANCER, V99, P505, DOI 10.1002/ijc.10373; Johnson FM, 2005, J CELL PHYSIOL, V205, P218, DOI 10.1002/jcp.20383; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kelley LC, 2010, J CELL SCI, V123, P3923, DOI 10.1242/jcs.075200; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Koppikar P, 2008, CLIN CANCER RES, V14, P4284, DOI 10.1158/1078-0432.CCR-07-5226; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lara PN, 2009, ANTI-CANCER DRUG, V20, P179, DOI 10.1097/CAD.0b013e328325a867; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Martin KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4119; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; O-charoenrat P, 2000, CANCER RES, V60, P1121; Ohnishi Y, 2012, ONCOL REP, V27, P954, DOI 10.3892/or.2011.1616; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, CELL CYCLE, V2, P273, DOI 10.4161/cc.2.4.409; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Pryor DI, 2011, ASIA-PAC J CLIN ONCO, V7, P236, DOI 10.1111/j.1743-7563.2011.01420.x; Ren G, 2009, CELL MOTIL CYTOSKEL, V66, P865, DOI 10.1002/cm.20380; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Sen B, 2009, CANCER RES, V69, P1958, DOI 10.1158/0008-5472.CAN-08-2944; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Sibony-Benyamini H, 2012, EUR J CELL BIOL, V91, P896, DOI 10.1016/j.ejcb.2012.04.001; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tsao AS, 2011, J THORAC ONCOL, V6, P2104, DOI 10.1097/JTO.0b013e31822e7256; Uribe P, 2011, PATHOL RES PRACT, V207, P337, DOI 10.1016/j.prp.2011.03.002; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Wang Y, 2011, INT J HEMATOL, V94, P552, DOI 10.1007/s12185-011-0953-1; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; Wheeler DL, 2009, CANCER BIOL THER, V8, P696, DOI 10.4161/cbt.8.8.7903; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yanagawa T, 2000, ORAL ONCOL, V36, P89, DOI 10.1016/S1368-8375(99)00067-6; Yang JL, 2005, CANCER LETT, V225, P61, DOI 10.1016/j.canlet.2004.11.041; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	87	35	35	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4766	4777		10.1038/onc.2012.513	http://dx.doi.org/10.1038/onc.2012.513			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23146907	Green Accepted			2022-12-25	WOS:000325274700005
J	Maciejewska, AM; Poznanski, J; Kaczmarska, Z; Krowisz, B; Nieminuszczy, J; Polkowska-Nowakowska, A; Grzesiuk, E; Kusmierek, JT				Maciejewska, Agnieszka M.; Poznanski, Jaroslaw; Kaczmarska, Zuzanna; Krowisz, Beata; Nieminuszczy, Jadwiga; Polkowska-Nowakowska, Agnieszka; Grzesiuk, Elzbieta; Kusmierek, Jaroslaw T.			AlkB Dioxygenase Preferentially Repairs Protonated Substrates SPECIFICITY AGAINST EXOCYCLIC ADDUCTS AND MOLECULAR MECHANISM OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URACIL-DNA GLYCOSYLASE; ESCHERICHIA-COLI; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; ADAPTIVE RESPONSE; IN-VIVO; PROTEINS; BACTERIAL; MISMATCH; 1,N-6-ETHENOADENINE	Efficient repair by Escherichia coli AlkB dioxygenase of exo-cyclic DNA adducts 3, N-4-ethenocytosine, 1, N-6-ethenoadenine, 3, N-4-alpha-hydroxyethanocytosine, and reported here for the first time 3, N-4-alpha-hydroxypropanocytosine requires higher Fe(II) concentration than the reference 3-methylcytosine. The pH optimum for the repair follows the order of pK(a) values for protonation of the adduct, suggesting that positively charged substrates favorably interact with the negatively charged carboxylic group of Asp-135 side chain in the enzyme active center. This interaction is supported by molecular modeling, indicating that 1, N-6-ethenoadenine and 3, N-4-ethenocytosine are bound to AlkB more favorably in their protonated cationic forms. An analysis of the pattern of intermolecular interactions that stabilize the location of the ligand points to a role of Asp-135 in recognition of the adduct in its protonated form. Moreover, ab initio calculations also underline the role of substrate protonation in lowering the free energy barrier of the transition state of epoxidation of the etheno adducts studied. The observed time courses of repair of mixtures of stereoisomers of 3, N-4-alpha-hydroxyethanocytosine or 3, N-4-alpha-hydroxypropanocytosine are unequivocally two-exponential curves, indicating that the respective isomers are repaired by AlkB with different efficiencies. Molecular modeling of these adducts bound by AlkB allowed evaluation of the participation of their possible conformational states in the enzymatic reaction.	[Maciejewska, Agnieszka M.; Poznanski, Jaroslaw; Kaczmarska, Zuzanna; Krowisz, Beata; Nieminuszczy, Jadwiga; Polkowska-Nowakowska, Agnieszka; Grzesiuk, Elzbieta; Kusmierek, Jaroslaw T.] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Maciejewska, AM (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A St, PL-02106 Warsaw, Poland.	agniesza@ibb.waw.pl	Maciejewska, Agnieszka M/B-2287-2012; poznanski, jarek/G-7064-2013; Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Grzesiuk, Elzbieta/0000-0002-7833-7602; Kaczmarska, Zuzanna/0000-0002-7668-1442; Maciejewska, Agnieszka M./0000-0002-1268-2606	Polish-Norwegian Research Fund [PNRF-143-AI-1/07]; National Science Centre [UMO-2012/04/M/NZ1/00068]; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy [CRP/08/011]	Polish-Norwegian Research Fund; National Science Centre(National Science Centre, Poland); International Centre for Genetic Engineering and Biotechnology, Trieste, Italy	This work was supported by Polish-Norwegian Research Fund Grant PNRF-143-AI-1/07 and partially by National Science Centre Grant UMO-2012/04/M/NZ1/00068. Molecular modeling performed by J. P. was partially supported by International Centre for Genetic Engineering and Biotechnology, Trieste, Italy Grant CRP/08/011.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ARAVIND L, 2001, GENOME BIOL, V2; Bartsch H, 1999, IARC SCI PUBL, P1; BORYS E, 1994, MUTAGENESIS, V9, P407, DOI 10.1093/mutage/9.5.407; Borys-Brzywczy E, 2005, ACTA BIOCHIM POL, V52, P149; Chen H, 2006, CHEM BIOL, V13, P849, DOI 10.1016/j.chembiol.2006.06.009; CHENNA A, 1993, CHEM RES TOXICOL, V6, P261, DOI 10.1021/tx00033a003; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Frick LE, 2007, P NATL ACAD SCI USA, V104, P755, DOI 10.1073/pnas.0607377104; Gozdek A, 2008, ACTA BIOCHIM POL, V55, P57, DOI 10.18388/abp.2008_3201; Hang B, 2004, BIOESSAYS, V26, P1195, DOI 10.1002/bies.20130; Hertwig RH, 1997, CHEM PHYS LETT, V268, P345, DOI 10.1016/S0009-2614(97)00207-8; Ho RYN, 2001, J AM CHEM SOC, V123, P5022, DOI 10.1021/ja0041775; Jurado J, 2004, DNA REPAIR, V3, P1579, DOI 10.1016/j.dnarep.2004.06.012; Kim MY, 2007, CHEM RES TOXICOL, V20, P1075, DOI 10.1021/tx700167v; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krwawicz J, 2007, ACTA BIOCHIM POL, V54, P413, DOI 10.18388/abp.2007_3219; KUSMIEREK JT, 1982, BIOCHEMISTRY-US, V21, P5717, DOI 10.1021/bi00265a050; Leiros I, 2007, EMBO J, V26, P2206, DOI 10.1038/sj.emboj.7601662; LEONARD NJ, 1984, CRC CR REV BIOCH MOL, V15, P125, DOI 10.3109/10409238409102299; Maciejewska AM, 2011, MUTAGENESIS, V26, P401, DOI 10.1093/mutage/geq107; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; NILGES M, 1991, NATO ADV SCI I A-LIF, V225, P451; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Poznanski J, 2004, THERMOCHIM ACTA, V409, P25, DOI 10.1016/S0040-6031(03)00329-0; Poznanski J, 2007, J PHYS CHEM A, V111, P6501, DOI 10.1021/jp071611h; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SMITH RA, 1989, CHEM RES TOXICOL, V2, P267, DOI 10.1021/tx00010a009; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wasik R, 2010, J PHYS CHEM B, V114, P10601, DOI 10.1021/jp102848y; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wiewi?rowski M, 1979, POL J CHEM, V53, P243; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106; Zielenkiewicz W, 2005, J MOL LIQ, V121, P8, DOI 10.1016/j.molliq.2004.08.031	52	28	28	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					432	441		10.1074/jbc.M112.353342	http://dx.doi.org/10.1074/jbc.M112.353342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148216	Green Published, hybrid			2022-12-25	WOS:000313197200044
J	Bruel, N; Castanie-Cornet, MP; Cirinesi, AM; Koningstein, G; Georgopoulos, C; Luirink, J; Genevaux, P				Bruel, Nicolas; Castanie-Cornet, Marie-Pierre; Cirinesi, Anne-Marie; Koningstein, Gregory; Georgopoulos, Costa; Luirink, Joen; Genevaux, Pierre			Hsp33 Controls Elongation Factor-Tu Stability and Allows Escherichia coli Growth in the Absence of the Major DnaK and Trigger Factor Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK GENES; MULTIDRUG TOLERANCE; QUALITY-CONTROL; PROTEIN; IDENTIFICATION; DEGRADATION; RECOGNITION; SECB; ACTIVATION; DISSECTION	Intracellular de novo protein folding is assisted by cellular networks of molecular chaperones. In Escherichia coli, cooperation between the chaperones trigger factor (TF) and DnaK is central to this process. Accordingly, the simultaneous deletion of both chaperone-encoding genes leads to severe growth and protein folding defects. Herein, we took advantage of such defective phenotypes to further elucidate the interactions of chaperone networks in vivo. We show that disruption of the TF/DnaK chaperone pathway is efficiently rescued by overexpression of the redox-regulated chaperone Hsp33. Consistent with this observation, the deletion of hslO, the Hsp33 structural gene, is no longer tolerated in the absence of the TF/DnaK pathway. However, in contrast with other chaperones like GroEL or SecB, suppression by Hsp33 was not attributed to its potential overlapping general chaperone function(s). Instead, we show that overexpressed Hsp33 specifically binds to elongation factor-Tu (EF-Tu) and targets it for degradation by the protease Lon. This synergistic action of Hsp33 and Lon was responsible for the rescue of bacterial growth in the absence of TF and DnaK, by presumably restoring the coupling between translation and the downstream folding capacity of the cell. In support of this hypothesis, we show that overexpression of the stress-responsive toxin HipA, which inhibits EF-Tu, also rescues bacterial growth and protein folding in the absence of TF and DnaK. The relevance for such a convergence of networks of chaperones and proteases acting directly on EF-Tu to modulate the intracellular rate of protein synthesis in response to protein aggregation is discussed.	[Bruel, Nicolas; Castanie-Cornet, Marie-Pierre; Cirinesi, Anne-Marie; Genevaux, Pierre] CNRS, LMGM, F-31062 Toulouse 9, France; [Bruel, Nicolas; Castanie-Cornet, Marie-Pierre; Cirinesi, Anne-Marie; Genevaux, Pierre] Univ Toulouse 3, F-31062 Toulouse, France; [Koningstein, Gregory; Luirink, Joen] Vrije Univ Amsterdam, Dept Mol Microbiol, Amsterdam, Netherlands; [Georgopoulos, Costa] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Vrije Universiteit Amsterdam; Utah System of Higher Education; University of Utah	Genevaux, P (corresponding author), CNRS, LMGM, 118 Route Narbonne, F-31062 Toulouse 9, France.	pierre.genevaux@ibcg.biotoul.fr	Castanie-Cornet, Marie-Pierre/AAC-6857-2022; Luirink, Joen/AAB-8658-2021; Genevaux, Pierre/A-4851-2015	Luirink, J./0000-0001-8431-0804; GENEVAUX, Pierre/0000-0001-7539-3126; Castanie-Cornet, Marie-Pierre/0000-0001-9889-1101	National Institutes of Health [5R01GM088207]; CNRS-ATIP Microbiology program; joint Region Midi-Pyrenees/CNRS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS-ATIP Microbiology program; joint Region Midi-Pyrenees/CNRS grant(Region Occitanie); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM088207 (to C.G.), a grant from the CNRS-ATIP Microbiology program (to P.G), and a joint Region Midi-Pyrenees/CNRS grant (to N.B.).	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BUKAU B, 1989, J BACTERIOL, V171, P6030, DOI 10.1128/jb.171.11.6030-6038.1989; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chi SW, 2011, FEBS LETT, V585, P664, DOI 10.1016/j.febslet.2011.01.029; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Cremers CM, 2010, J BIOL CHEM, V285, P11243, DOI 10.1074/jbc.M109.084350; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jong WSP, 2004, EUR J BIOCHEM, V271, P4779, DOI 10.1111/j.1432-1033.2004.04442.x; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; Meriin AB, 2012, J BIOL CHEM, V287, P34264, DOI 10.1074/jbc.M112.397307; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Moll I, 2012, TRENDS BIOCHEM SCI, V37, P493, DOI 10.1016/j.tibs.2012.07.007; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; THOMPSON RC, 1986, J BIOL CHEM, V261, P4868; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tomoyasu T, 2001, J BACTERIOL, V183, P5911, DOI 10.1128/JB.183.20.5911-5917.2001; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Wholey WY, 2012, MOL MICROBIOL, V83, P981, DOI 10.1111/j.1365-2958.2012.07982.x; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Yamaguchi Y, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-16; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	65	24	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44435	44446		10.1074/jbc.M112.418525	http://dx.doi.org/10.1074/jbc.M112.418525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148222	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000312938600040
J	Shih, HH; Tu, C; Cao, W; Klein, A; Ramsey, R; Fennell, BJ; Lambert, M; Shuilleabhain, DN; Autin, B; Kouranova, E; Laxmanan, S; Braithwaite, S; Wu, L; Ait-Zahra, M; Milici, AJ; Dumin, JA; LaVallie, ER; Arai, M; Corcoran, C; Paulsen, JE; Gill, D; Cunningham, O; Bard, J; Mosyak, L; Finlay, WJJ				Shih, Heather H.; Tu, Chao; Cao, Wei; Klein, Anne; Ramsey, Renee; Fennell, Brian J.; Lambert, Matthew; Shuilleabhain, Deirdre Ni; Autin, Benedicte; Kouranova, Eugenia; Laxmanan, Sri; Braithwaite, Steven; Wu, Leeying; Ait-Zahra, Mostafa; Milici, Anthony J.; Dumin, Jo Ann; LaVallie, Edward R.; Arai, Maya; Corcoran, Christopher; Paulsen, Janet E.; Gill, Davinder; Cunningham, Orla; Bard, Joel; Mosyak, Lydia; Finlay, William J. J.			An Ultra-specific Avian Antibody to Phosphorylated Tau Protein Reveals a Unique Mechanism for Phosphoepitope Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; V-H REPERTOIRE; ABNORMAL PHOSPHORYLATION; HIGH-AFFINITY; PHAGE-DISPLAY; IN-VITRO; RECOMBINANT ANTIBODIES; CHICKEN; GENERATION; CHAIN	Highly specific antibodies to phosphoepitopes are valuable tools to study phosphorylation in disease states, but their discovery is largely empirical, and the molecular mechanisms mediating phosphospecific binding are poorly understood. Here, we report the generation and characterization of extremely specific recombinant chicken antibodies to three phosphoepitopes on the Alzheimer disease-associated protein tau. Each antibody shows full specificity for a single phosphopeptide. The chimeric IgG pT231/pS235_1 exhibits a K-D of 0.35 nM in 1:1 binding to its cognate phosphopeptide. This IgG is murine ortholog-cross-reactive, specifically recognizing the pathological form of tau in brain samples from Alzheimer patients and a mouse model of tauopathy. To better understand the underlying binding mechanisms allowing such remarkable specificity, we determined the structure of pT231/pS235_1 Fab in complex with its cognate phosphopeptide at 1.9 angstrom resolution. The Fab fragment exhibits novel complementarity determining region (CDR) structures with a "bowl-like" conformation in CDR-H2 that tightly and specifically interacts with the phospho-Thr-231 phosphate group, as well as a long, disulfide-constrained CDR-H3 that mediates peptide recognition. This binding mechanism differs distinctly from either peptide-or hapten-specific antibodies described to date. Surface plasmon resonance analyses showed that pT231/pS235_1 binds a truly compound epitope, as neither phosphorylated Ser-235 nor free peptide shows any measurable binding affinity.	[Shih, Heather H.; Tu, Chao; Cao, Wei; Ramsey, Renee; Laxmanan, Sri; Wu, Leeying; Ait-Zahra, Mostafa; LaVallie, Edward R.; Arai, Maya; Corcoran, Christopher; Paulsen, Janet E.; Gill, Davinder; Bard, Joel; Mosyak, Lydia] Pfizer Global Res & Dev, Global Biotherapeut Technol, Cambridge, MA 02140 USA; [Fennell, Brian J.; Lambert, Matthew; Shuilleabhain, Deirdre Ni; Autin, Benedicte; Cunningham, Orla; Finlay, William J. J.] Pfizer Global Res & Dev, Global Biotherapeut Technol, Dublin D22, Ireland; [Klein, Anne; Kouranova, Eugenia; Braithwaite, Steven; Milici, Anthony J.; Dumin, Jo Ann] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Finlay, WJJ (corresponding author), Pfizer R&D, Global Biotherapeut Technol, Grange Castle Business Pk, Dublin D22, Ireland.	william.finlay@pfizer.com			Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank John Dunlop for support and encouragement on this project. Use of Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Abraha A, 2000, J CELL SCI, V113, P3737; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Almagro JC, 2006, J MOL RECOGNIT, V19, P413, DOI 10.1002/jmr.796; Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Alonso AD, 2001, J BIOL CHEM, V276, P37967; Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Andris-Widhopf J, 2000, J IMMUNOL METHODS, V242, P159, DOI 10.1016/S0022-1759(00)00221-0; Blanc E., 2011, BUSTER VERSION 2 11; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; Brumbaugh K, 2011, METHODS MOL BIOL, V717, P3, DOI 10.1007/978-1-61779-024-9_1; Chailyan A, 2011, PROTEINS, V79, P1513, DOI 10.1002/prot.22979; Cobaugh CW, 2008, J MOL BIOL, V378, P622, DOI 10.1016/j.jmb.2008.02.037; Cummins E, 2008, J IMMUNOL METHODS, V339, P38, DOI 10.1016/j.jim.2008.07.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fennell BJ, 2010, J MOL BIOL, V400, P155, DOI 10.1016/j.jmb.2010.04.061; Finlay WJ, 2009, J MOL BIOL, V388, P541, DOI 10.1016/j.jmb.2009.03.019; Finlay WJJ, 2006, APPL ENVIRON MICROB, V72, P3343, DOI 10.1128/AEM.72.5.3343-3349.2006; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P87, DOI 10.1007/978-1-60761-913-0_6; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P383, DOI 10.1007/978-1-60761-913-0_21; Finlay WJJ, 2005, CLIN EXP ALLERGY, V35, P1040, DOI 10.1111/j.1365-2222.2005.02307.x; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI 10.1586/ERN.09.104; Hof D, 2008, CLIN EXP IMMUNOL, V151, P367, DOI 10.1111/j.1365-2249.2007.03569.x; Iwamoto S, 2009, MABS-AUSTIN, V1, P357, DOI 10.4161/mabs.1.4.8919; Kabat EA, 1991, SEQUENCES PROTEINS I; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Lu PJ, 1999, NATURE, V399, P784; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NAIRN AC, 1982, NATURE, V299, P734, DOI 10.1038/299734a0; Nishibori N, 2006, MOL IMMUNOL, V43, P634, DOI 10.1016/j.molimm.2005.04.002; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARVARI R, 1990, P NATL ACAD SCI USA, V87, P3072, DOI 10.1073/pnas.87.8.3072; Persson H, 2006, J MOL BIOL, V357, P607, DOI 10.1016/j.jmb.2006.01.004; REYNAUD CA, 1991, EUR J IMMUNOL, V21, P2661, DOI 10.1002/eji.1830211104; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROSS AH, 1981, NATURE, V294, P654, DOI 10.1038/294654a0; RUFFJAMISON S, 1991, J BIOL CHEM, V266, P6607; RUFFJAMISON S, 1993, J IMMUNOL, V150, P3389; RUFFJAMISON S, 1993, PROTEIN ENG, V6, P661, DOI 10.1093/protein/6.6.661; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; Tan CSH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002093; Tars K, 2012, J MOL BIOL, V415, P118, DOI 10.1016/j.jmb.2011.10.042; Valler MJ, 2000, DRUG DISCOV TODAY, V5, P286, DOI 10.1016/S1359-6446(00)01517-8; Vielemeyer O, 2009, J BIOL CHEM, V284, P20791, DOI 10.1074/jbc.M109.008730; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WEILL JC, 1992, CURR OPIN IMMUNOL, V4, P177, DOI 10.1016/0952-7915(92)90009-4; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Yamanaka HI, 1996, J IMMUNOL, V157, P1156; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	69	44	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44425	44434		10.1074/jbc.M112.415935	http://dx.doi.org/10.1074/jbc.M112.415935			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148212	hybrid, Green Published			2022-12-25	WOS:000312938600039
J	Emanuele, VA; Panicker, G; Gurbaxani, BM; Lin, JMS; Unger, ER				Emanuele, Vincent A., II; Panicker, Gitika; Gurbaxani, Brian M.; Lin, Jin-Mann S.; Unger, Elizabeth R.			Sensitive and Specific Peak Detection for SELDI-TOF Mass Spectrometry Using a Wavelet/Neural-Network Based Approach	PLOS ONE			English	Article							SERUM BIOMARKERS; BREAST-CANCER; VALIDATION; MS	SELDI-TOF mass spectrometer's compact size and automated, high throughput design have been attractive to clinical researchers, and the platform has seen steady-use in biomarker studies. Despite new algorithms and preprocessing pipelines that have been developed to address reproducibility issues, visual inspection of the results of SELDI spectra preprocessing by the best algorithms still shows miscalled peaks and systematic sources of error. This suggests that there continues to be problems with SELDI preprocessing. In this work, we study the preprocessing of SELDI in detail and introduce improvements. While many algorithms, including the vendor supplied software, can identify peak clusters of specific mass (or m/z) in groups of spectra with high specificity and low false discover rate (FDR), the algorithms tend to underperform estimating the exact prevalence and intensity of peaks in those clusters. Thus group differences that at first appear very strong are shown, after careful and laborious hand inspection of the spectra, to be less than significant. Here we introduce a wavelet/neural network based algorithm which mimics what a team of expert, human users would call for peaks in each of several hundred spectra in a typical SELDI clinical study. The wavelet denoising part of the algorithm optimally smoothes the signal in each spectrum according to an improved suite of signal processing algorithms previously reported (the LibSELDI toolbox under development). The neural network part of the algorithm combines those results with the raw signal and a training dataset of expertly called peaks, to call peaks in a test set of spectra with approximately 95% accuracy. The new method was applied to data collected from a study of cervical mucus for the early detection of cervical cancer in HPV infected women. The method shows promise in addressing the ongoing SELDI reproducibility issues.	[Emanuele, Vincent A., II; Panicker, Gitika; Gurbaxani, Brian M.; Lin, Jin-Mann S.; Unger, Elizabeth R.] Ctr Dis Control & Prevent, Chron & Viral Dis Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Emanuele, VA (corresponding author), Ctr Dis Control & Prevent, Chron & Viral Dis Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.	VEmanueleII@cdc.gov		Unger, Elizabeth/0000-0002-2925-5635	National Cancer Institute's (NCI) Early Detection Research Network [IAA Y1-CN-5005-01, Y1-CN-0101-01]; Oak Ridge Institute for Science and Education through U.S. Department of Energy; Oak Ridge Institute for Science and Education through Centers for Disease Control and Prevention (CDC); DIVISION OF CANCER PREVENTION AND CONTROL [N43CN005005, Z01CN000101] Funding Source: NIH RePORTER	National Cancer Institute's (NCI) Early Detection Research Network; Oak Ridge Institute for Science and Education through U.S. Department of Energy; Oak Ridge Institute for Science and Education through Centers for Disease Control and Prevention (CDC); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute's (NCI) Early Detection Research Network through IAA Y1-CN-5005-01 and Y1-CN-0101-01. This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an inter-agency agreement between the U.S. Department of Energy and the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besbeas P, 2004, INT STAT REV, V72, P209; Callesen AK, 2008, J PROTEOME RES, V7, P8; Coifman RR, 1995, 475 STANF U, P1; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Cruz-Marcelo A, 2008, BIOINFORMATICS, V24, P2129, DOI 10.1093/bioinformatics/btn398; Emanuele VA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-512; Emanuele VA, 2009, PROTEOMICS, V9, P1754, DOI 10.1002/pmic.200701171; Gast MC, 2009, BREAST CANC RES TREA, V116, P9; Gustafsson F, 1996, IEEE T SIGNAL PROCES, V44, P988, DOI 10.1109/78.492552; Hastie T., 2009, UNSUPERVISED LEARNIN; Li JN, 2005, CLIN CHEM, V51, P2229, DOI 10.1373/clinchem.2005.052878; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; OPPENHEIM AV, 1999, PRENTICEHALL SIGNAL, P775; Panicker G, 2007, CYTOKINE, V37, P176, DOI 10.1016/j.cyto.2007.03.006; Panicker Gitika, 2010, Clin Proteomics, V6, P18; Panicker G, 2009, J PROTEOMICS, V71, P637, DOI 10.1016/j.jprot.2008.11.004; Rajeevan MS, 2005, INT J CANCER, V115, P114, DOI 10.1002/ijc.20894; Rollin D, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-9; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; van Winden AWJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-4	20	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48103	10.1371/journal.pone.0048103	http://dx.doi.org/10.1371/journal.pone.0048103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152765	gold, Green Submitted, Green Published			2022-12-25	WOS:000311234000007
J	Ahn, JM; You, SJ; Lee, YM; Oh, SW; Ahn, SY; Kim, S; Chin, HJ; Chae, DW; Na, KY				Ahn, Jeong-Myung; You, Sun Jin; Lee, Yun-Mi; Oh, Se-Won; Ahn, Shin-young; Kim, Sejoong; Chin, Ho Jun; Chae, Dong-Wan; Na, Ki Young			Hypoxia-Inducible Factor Activation Protects the Kidney from Gentamicin-Induced Acute Injury	PLOS ONE			English	Article							INDUCED NEPHROTOXICITY; INDUCED APOPTOSIS; GENE-EXPRESSION; RENAL INJURY; HIF-ALPHA; FACTOR-I; COBALT; INFLAMMATION; INDUCTION; TETRAMETHYLPYRAZINE	Gentamicin nephrotoxicity is one of the most common causes of acute kidney injury (AKI). Hypoxia-inducible factor (HIF) is effective in protecting the kidney from ischemic and toxic injury. Increased expression of HIF-1 alpha mRNA has been reported in rats with gentamicin-induced renal injury. We hypothesizd that we could study the role of HIF in gentamicin-induced AKI by modulating HIF activity. In this study, we investigated whether HIF activation had protective effects on gentamicin-induced renal tubule cell injury. Gentamicin-induced AKI was established in male Sprague-Dawley rats. Cobalt was continuously infused into the rats to activate HIF. HK-2 cells were pre-treated with cobalt or dimethyloxalylglycine (DMOG) to activate HIF and were then exposed to gentamicin. Cobalt or DMOG significantly increased HIF-1 alpha expression in rat kidneys and HK-2 cells. In HK-2 cells, HIF inhibited gentamicin-induced reactive oxygen species (ROS) formation. HIF also protected these cells from apoptosis by reducing caspase-3 activity and the amount of cleaved caspase-3, and -9 proteins. Increased expression of HIF-1 alpha reduced the number of gentamicin-induced apoptotic cells in rat kidneys and HK-2 cells. HIF activation improved the creatinine clearance and proteinuria in gentamicin-induced AKI. HIF activation also ameliorated the extent of histologic injury and reduced macrophage infiltration into the tubulointerstitium. In gentamicin-induced AKI, the activation of HIF by cobalt or DMOG attenuated renal dysfunction, proteinuria, and structural damage through a reduction of oxidative stress, inflammation, and apoptosis in renal tubular epithelial cells. Citation: Ahn J-m, You SJ, Lee Y-M, Oh S-W, Ahn S-y, et al. (2012) Hypoxia-Inducible Factor Activation Protects the Kidney from Gentamicin-Induced Acute Injury. PLoS ONE 7(11): e48952. doi:10.1371/journal.pone.0048952	[You, Sun Jin; Lee, Yun-Mi; Ahn, Shin-young; Kim, Sejoong; Chin, Ho Jun; Chae, Dong-Wan; Na, Ki Young] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Ahn, Jeong-Myung] Maryknoll Hosp, Dept Internal Med, Pusan, South Korea; [Oh, Se-Won] Eulji Gen Hosp, Dept Internal Med, Songnam, South Korea; [Kim, Sejoong; Chin, Ho Jun; Chae, Dong-Wan; Na, Ki Young] Seoul Natl Univ, Coll Med, Seoul, South Korea	Seoul National University (SNU); Eulji University; Seoul National University (SNU)	Na, KY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	kyna@snubh.org	Chin, Ho Jun/J-5678-2012; Na, Ki Young/J-5456-2012; Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962	Seoul National University Bundang Hospital [03-2010-010, 02-2011-013]	Seoul National University Bundang Hospital	This work was supported by the Seoul National University Bundang Hospital [Grant 03-2010-010 and 02-2011-013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2006, TRENDS BIOCHEM SCI, V31, P243, DOI 10.1016/j.tibs.2006.03.004; Ali BH, 2003, FOOD CHEM TOXICOL, V41, P1447, DOI 10.1016/S0278-6915(03)00186-8; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cuzzocrea S, 2002, EUR J PHARMACOL, V450, P67, DOI 10.1016/S0014-2999(02)01749-1; El Mouedden M, 2000, TOXICOL SCI, V56, P229, DOI 10.1093/toxsci/56.1.229; El Mouedden M, 2000, ANTIMICROB AGENTS CH, V44, P665, DOI 10.1128/AAC.44.3.665-675.2000; Geleilete TJ, 2002, J NEPHROL, V15, P633; Hardman J, 2006, AMINOGLYCOSIDES GOOD, V11; HOUGHTON DC, 1978, AM J PATHOL, V93, P137; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Juan SH, 2007, NEPHROL DIAL TRANSPL, V22, P732, DOI 10.1093/ndt/gfl699; Kalayarasan S, 2009, EUR J PHARMACOL, V606, P162, DOI 10.1016/j.ejphar.2008.12.055; Karatas Y, 2004, FUND CLIN PHARMACOL, V18, P79, DOI 10.1046/j.0767-3981.2003.00211.x; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Koyner JL, 2008, NEPHRON EXP NEPHROL, V109, pE109, DOI 10.1159/000142935; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; LEEHEY DJ, 1993, J AM SOC NEPHROL, V4, P81; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Martinez-Salgado C, 2004, KIDNEY INT, V65, P2161, DOI 10.1111/j.1523-1755.2004.00642.x; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Morales AI, 2002, ANTIOXID REDOX SIGN, V4, P893, DOI 10.1089/152308602762197434; Morales AI, 2010, KIDNEY INT, V77, P861, DOI 10.1038/ki.2010.11; Muchnik E, 2011, EXPERT OPIN INV DRUG, V20, P645, DOI 10.1517/13543784.2011.566861; Oh SW, 2012, TOHOKU J EXP MED, V226, P197, DOI 10.1620/tjem.226.197; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Servais H, 2008, APOPTOSIS, V13, P11, DOI 10.1007/s10495-007-0151-z; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Sue YM, 2009, NEPHROL DIAL TRANSPL, V24, P769, DOI 10.1093/ndt/gfn545; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Xu EY, 2008, CHEM RES TOXICOL, V21, P1548, DOI 10.1021/tx800061w	42	41	47	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48952	10.1371/journal.pone.0048952	http://dx.doi.org/10.1371/journal.pone.0048952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145036	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500055
J	Guo, SQ; Garnham, CP; Whitney, JC; Graham, LA; Davies, PL				Guo, Shuaiqi; Garnham, Christopher P.; Whitney, John C.; Graham, Laurie A.; Davies, Peter L.			Re-Evaluation of a Bacterial Antifreeze Protein as an Adhesin with Ice-Binding Activity	PLOS ONE			English	Article							FREEZING RESISTANCE; PSEUDOMONAS-PUTIDA; SECRETION; HYDRATION; FISHES; FOLD; RECRYSTALLIZATION; MECHANISMS; ADSORPTION; SEQUENCES	A novel role for antifreeze proteins (AFPs) may reside in an exceptionally large 1.5-MDa adhesin isolated from an Antarctic Gram-negative bacterium, Marinomonas primoryensis. MpAFP was purified from bacterial lysates by ice adsorption and gel electrophoresis. We have previously reported that two highly repetitive sequences, region II (RII) and region IV (RIV), divide MpAFP into five distinct regions, all of which require mM Ca2+ levels for correct folding. Also, the antifreeze activity is confined to the 322-residue RIV, which forms a Ca2+-bound beta-helix containing thirteen Repeats-In-Toxin (RTX)-like repeats. RII accounts for approximately 90% of the mass of MpAFP and is made up of similar to 120 tandem 104-residue repeats. Because these repeats are identical in DNA sequence, their number was estimated here by pulsed-field gel electrophoresis. Structural homology analysis by the Protein Homology/analogY Recognition Engine (Phyre2) server indicates that the 104-residue RII repeat adopts an immunoglobulin beta-sandwich fold that is typical of many secreted adhesion proteins. Additional RTX-like repeats in RV may serve as a non-cleavable signal sequence for the type I secretion pathway. Immunodetection shows both repeated regions are uniformly distributed over the cell surface. We suggest that the development of an AFP-like domain within this adhesin attached to the bacterial outer surface serves to transiently bind the host bacteria to ice. This association would keep the bacteria within the upper reaches of the water column where oxygen and nutrients are potentially more abundant. This novel envirotactic role would give AFPs a third function, after freeze avoidance and freeze tolerance: that of transiently binding an organism to ice.	[Davies, Peter L.] Queens Univ, Prot Funct Discovery Grp, Kingston, ON, Canada; Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Prot Funct Discovery Grp, Kingston, ON, Canada.	peter.davies@queensu.ca			Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council-PGSD3 scholarship; R. Samuel McLaughlin fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council-PGSD3 scholarship; R. Samuel McLaughlin fellowship	This work was funded by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to PLD. CPG was the recipient of an Natural Sciences and Engineering Research Council-PGSD3 scholarship (http://www.nserc-crsng.gc.ca/index_eng.asp) and an R. Samuel McLaughlin fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; DeLuca CI, 1998, BIOPHYS J, V74, P1502, DOI 10.1016/S0006-3495(98)77862-2; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Gallagher KR, 2003, BIOPHYS CHEM, V105, P195, DOI 10.1016/S0301-4622(03)00087-5; Garnham CP, 2008, BIOCHEM J, V411, P171, DOI 10.1042/BJ20071372; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Gilbert JA, 2005, FEMS MICROBIOL LETT, V245, P67, DOI 10.1016/j.femsle.2005.02.022; Gilbert JA, 2004, MICROBIOL-SGM, V150, P171, DOI 10.1099/mic.0.26610-0; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; HIXSON JE, 1990, AM J HUM BIOL, V2, P172, DOI 10.1002/ajhb.1310020211; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0; Kuiper MJ, 2003, BIOCHEM BIOPH RES CO, V300, P645, DOI 10.1016/S0006-291X(02)02900-5; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; ORKIN S, 1990, NATURE, V343, P604, DOI 10.1038/343604a0; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Romanenko LA, 2003, INT J SYST EVOL MICR, V53, P829, DOI 10.1099/ijs.0.02280-0; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sidebottom C, 2000, NATURE, V406, P256, DOI 10.1038/35018639; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Takamatsu H, 2006, CRYOBIOLOGY, V53, P1, DOI 10.1016/j.cryobiol.2006.03.005; WEBB MS, 1994, PLANT PHYSIOL, V104, P467, DOI 10.1104/pp.104.2.467; WETZEL RG, 1993, CC/AGR BIOL ENVIRON, P8; Wooldridge KG, 2005, INFECT IMMUN, V73, P5554, DOI 10.1128/IAI.73.9.5554-5567.2005; Worrall D, 1998, SCIENCE, V282, P115, DOI 10.1126/science.282.5386.115; Yang C, 2005, PROTEINS, V59, P266, DOI 10.1002/prot.20429; Yang C, 2004, BIOPHYS CHEM, V109, P137, DOI 10.1016/j.bpc.2003.10.024	42	44	45	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48805	10.1371/journal.pone.0048805	http://dx.doi.org/10.1371/journal.pone.0048805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144980	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800140
J	Martin-Manso, G; Navarathna, DHMLP; Galli, S; Soto-Pantoja, DR; Kuznetsova, SA; Tsokos, M; Roberts, DD				Martin-Manso, Gema; Navarathna, Dhammika H. M. L. P.; Galli, Susana; Soto-Pantoja, David R.; Kuznetsova, Svetlana A.; Tsokos, Maria; Roberts, David D.			Endogenous Thrombospondin-1 Regulates Leukocyte Recruitment and Activation and Accelerates Death from Systemic Candidiasis	PLOS ONE			English	Article							HUMAN-NEUTROPHILS; MACROPHAGE ACTIVATION; EXTRACELLULAR-MATRIX; IMMUNE-RESPONSE; IN-VIVO; EXPRESSION; CELL; CHEMOKINE; ALBICANS; PROMOTES	Disseminated Candida albicans infection results in high morbidity and mortality despite treatment with existing antifungal drugs. Recent studies suggest that modulating the host immune response can improve survival, but specific host targets for accomplishing this goal remain to be identified. The extracellular matrix protein thrombospondin-1 is released at sites of tissue injury and modulates several immune functions, but its role in C. albicans pathogenesis has not been investigated. Here, we show that mice lacking thrombospondin-1 have an advantage in surviving disseminated candidiasis and more efficiently clear the initial colonization from kidneys despite exhibiting fewer infiltrating leukocytes. By examining local and systemic cytokine responses to C. albicans and other standard inflammatory stimuli, we identify a crucial function of phagocytes in this enhanced resistance. Subcutaneous air pouch and systemic candidiasis models demonstrated that endogenous thrombospondin-1 enhances the early innate immune response against C. albicans and promotes activation of inflammatory macrophages (inducible nitric oxide synthase(+), IL-6(high), TNF-alpha(high), IL-10(low)), release of the chemokines MIP-2, JE, MIP-1 alpha, and RANTES, and CXCR2-driven polymorphonuclear leukocytes recruitment. However, thrombospondin-1 inhibited the phagocytic capacity of inflammatory leukocytes in vivo and in vitro, resulting in increased fungal burden in the kidney and increased mortality in wild type mice. Thus, thrombospondin-1 enhances the pathogenesis of disseminated candidiasis by creating an imbalance in the host immune response that ultimately leads to reduced phagocytic function, impaired fungal clearance, and increased mortality. Conversely, inhibitors of thrombospondin-1 may be useful drugs to improve patient recovery from disseminated candidiasis.	[Martin-Manso, Gema; Navarathna, Dhammika H. M. L. P.; Galli, Susana; Soto-Pantoja, David R.; Kuznetsova, Svetlana A.; Tsokos, Maria; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Martin Manso, Maria Gema/D-4612-2013; Roberts, David D./A-9699-2008; Pantoja, David Soto/ABB-3764-2020; Navarathna, Dhammika/GXM-8674-2022	Roberts, David D./0000-0002-2481-2981; 	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; grant BEFI from Instituto de Salud Carlos III; NATIONAL CANCER INSTITUTE [ZIASC009173, ZIASC009172] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); grant BEFI from Instituto de Salud Carlos III; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (DDR, MT). GMM was recipient of a grant BEFI from Instituto de Salud Carlos III (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; Brechot N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003950; Cao F, 2005, J HUAZHONG U SCI TEC, V25, P184; Cao Fei, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P141; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; da Silva FP, 2009, FRONT BIOSCI-LANDMRK, V14, P4464, DOI 10.2741/3542; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DAWSON J, 1991, INT J TISSUE REACT, V13, P171; DiPietro LA, 1996, AM J PATHOL, V148, P1851; Fulurija A, 1996, MICROBIOL-SGM, V142, P3487, DOI 10.1099/13500872-142-12-3487; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; GODYNA S, 1995, J CELL BIOL, V129, P1403, DOI 10.1083/jcb.129.5.1403; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P1780, DOI 10.1002/art.1780401009; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Haberstroh U, 2002, KIDNEY INT, V62, P1264, DOI 10.1046/j.1523-1755.2002.00572.x; HERRMANN M, 1991, INFECT IMMUN, V59, P279, DOI 10.1128/IAI.59.1.279-288.1991; Houard X, 2009, CARDIOVASC RES, V82, P532, DOI 10.1093/cvr/cvp048; Isenberg JS, 2008, AM J PATHOL, V173, P1100, DOI 10.2353/ajpath.2008.080237; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Johnson CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040614; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; MacCallum DM, 2009, FEMS YEAST RES, V9, P1111, DOI 10.1111/j.1567-1364.2009.00576.x; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Majluf-Cruz A, 2000, J LAB CLIN MED, V136, P292, DOI 10.1067/mlc.2000.109407; MANSFIELD PJ, 1990, J CELL BIOL, V111, P3077, DOI 10.1083/jcb.111.6.3077; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Mantovani A, 2000, J LEUKOCYTE BIOL, V68, P400; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martin-Manso G, 2008, CANCER RES, V68, P7090, DOI 10.1158/0008-5472.CAN-08-0643; McMaken S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019654; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Mittal R, 2010, J IMMUNOL, V185, P2998, DOI 10.4049/jimmunol.1001296; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Murciano C, 2006, J MED MICROBIOL, V55, P1649, DOI 10.1099/jmm.0.46740-0; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Navarathna DHMLP, 2010, FREE RADICAL BIO MED, V49, P1561, DOI 10.1016/j.freeradbiomed.2010.08.020; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; Niemann S, 2009, THROMB HAEMOSTASIS, V102, P735, DOI 10.1160/TH09-01-0049; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658, DOI 10.1152/ajplung.2000.279.4.L658; PARRODI F, 1989, INT J PARASITOL, V19, P567, DOI 10.1016/0020-7519(89)90088-X; Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051; QIAN QF, 1994, J IMMUNOL, V152, P5000; Rangel-Frausto MS, 1999, CLIN INFECT DIS, V29, P253, DOI 10.1086/520194; RAUGI GJ, 1987, J INVEST DERMATOL, V89, P551, DOI 10.1111/1523-1747.ep12461198; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; Simmons KJ, 2006, FEBS LETT, V580, P2365, DOI 10.1016/j.febslet.2006.03.054; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Spellberg Brad, 2002, Curr Infect Dis Rep, V4, P387, DOI 10.1007/s11908-002-0005-3; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; SUCHARD SJ, 1993, BLOOD CELLS, V19, P197; SUCHARD SJ, 1991, J IMMUNOL, V147, P651; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tessier PA, 1997, J IMMUNOL, V159, P3595; Vonk AG, 2006, EXPERT OPIN BIOL TH, V6, P891, DOI 10.1517/14712598.6.9.891; Yamauchi Y, 2002, BIOCHEM BIOPH RES CO, V290, P1551, DOI 10.1006/bbrc.2002.6386; Yanagisawa N, 2001, J MED MICROBIOL, V50, P712, DOI 10.1099/0022-1317-50-8-712	63	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48775	10.1371/journal.pone.0048775	http://dx.doi.org/10.1371/journal.pone.0048775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144964	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800128
J	Micoli, F; Rondini, S; Gavini, M; Lanzilao, L; Medaglini, D; Saul, A; Martin, LB				Micoli, Francesca; Rondini, Simona; Gavini, Massimiliano; Lanzilao, Luisa; Medaglini, Donata; Saul, Allan; Martin, Laura B.			O:2-CRM197 Conjugates against Salmonella Paratyphi A	PLOS ONE			English	Article							O-SPECIFIC POLYSACCHARIDE; SHIGELLA-DYSENTERIAE TYPE-1; ENTERICA SEROVAR PARATYPHI; EMERGING PROBLEM; TYPHOID-FEVER; VACCINES; LIPOPOLYSACCHARIDE; IMMUNOGENICITY; PROTECTION; PROTEIN	Enteric fevers remain a common and serious disease, affecting mainly children and adolescents in developing countries. Salmonella enterica serovar Typhi was believed to cause most enteric fever episodes, but several recent reports have shown an increasing incidence of S. Paratyphi A, encouraging the development of a bivalent vaccine to protect against both serovars, especially considering that at present there is no vaccine against S. Paratyphi A. The O-specific polysaccharide (O:2) of S. Paratyphi A is a protective antigen and clinical data have previously demonstrated the potential of using O:2 conjugate vaccines. Here we describe a new conjugation chemistry to link O:2 and the carrier protein CRM197, using the terminus 3-deoxy-D-manno-octulosonic acid (KDO), thus leaving the O:2 chain unmodified. The new conjugates were tested in mice and compared with other O:2-antigen conjugates, synthesized adopting previously described methods that use CRM197 as carrier protein. The newly developed conjugation chemistry yielded immunogenic conjugates with strong serum bactericidal activity against S. Paratyphi A.	[Micoli, Francesca; Rondini, Simona; Gavini, Massimiliano; Lanzilao, Luisa; Saul, Allan; Martin, Laura B.] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Medaglini, Donata] Univ Siena, Dipartimento Biotecnol, Lab Microbiol Mol & Biotecnol LAMMB, I-53100 Siena, Italy	Novartis; University of Siena	Micoli, F (corresponding author), Novartis Vaccines Inst Global Hlth, Siena, Italy.	francesca.micoli@novartis.com	Rondini, Simona/GLN-4357-2022; Martin, Laura/N-1789-2013; Medaglini, Donata/R-1149-2018; Saul, Allan J/I-6968-2013; Saul, Allan/ABH-2091-2020; Rondini, Simona/N-1780-2013	Martin, Laura/0000-0002-4431-4381; Medaglini, Donata/0000-0003-1729-7325; Saul, Allan J/0000-0003-0665-4091; Saul, Allan/0000-0003-0665-4091; Rondini, Simona/0000-0002-7993-9656	Wellcome Trust [089102]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Wellcome Trust grant number 089102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding.	Abucejo P. Erma, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P531; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; Broker M, 2011, BIOLOGICALS, V39, P195, DOI 10.1016/j.biologicals.2011.05.004; CHU CY, 1991, INFECT IMMUN, V59, P4450, DOI 10.1128/IAI.59.12.4450-4458.1991; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dong BQ, 2010, B WORLD HEALTH ORGAN, V88, P689, DOI [10.2471/BLT.09.069310, 10.1590/S0042-96862010000900013]; DUBOIS M, 1956, ANAL CHEM; Ekdahl K, 2005, J TRAVEL MED, V12, P197, DOI 10.2310/7060.2005.12405; Fangtham M, 2008, J TRAVEL MED, V15, P344, DOI 10.1111/j.1708-8305.2008.00237.x; Gat O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001373; HELLERQVIST CG, 1971, ACTA CHEM SCAND, V25, P955, DOI 10.3891/acta.chem.scand.25-0955; Kafeja F, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025398, PONE-D-11-13873[pii], DOI 10.1371/JOURNAL.PONE.0025398]; Khan MI, 2006, B WORLD HEALTH ORGAN, V84, P72, DOI 10.2471/BLT.05.023630; Konadu E, 1996, INFECT IMMUN, V64, P2709, DOI 10.1128/IAI.64.7.2709-2715.1996; Konadu EY, 2000, INFECT IMMUN, V68, P1529, DOI 10.1128/IAI.68.3.1529-1534.2000; Kulkarni SV, 2011, ASIAN J MED SCI, V2, P14; Lane CF, 1975, SYNTHESIS; MACGEE J, 1954, J BIOL CHEM, V210, P617; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Meltzer E, 2005, J TRAVEL MED, V12, P275, DOI 10.2310/7060.2005.12507; Micoli F, 2011, VACCINE, V29, P712, DOI 10.1016/j.vaccine.2010.11.022; MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1; Nohta H, 2003, J CHROMATOGR A, V1010, P37, DOI 10.1016/S0021-9673(03)01028-8; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; PALMER DW, 1969, CLIN CHEM, V15, P891; Podda A, 2010, J INFECT DEV COUNTR, V4, P404, DOI 10.3855/jidc.1048; Roland KL, 2010, VACCINE, V28, P3679, DOI 10.1016/j.vaccine.2010.03.019; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; SATAKE K, 1960, J BIOCHEM-TOKYO, V47, P654, DOI 10.1093/oxfordjournals.jbchem.a127107; SCHWARTZ E, 1990, ARCH INTERN MED, V150, P349, DOI 10.1001/archinte.150.2.349; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; TAYLOR DN, 1993, INFECT IMMUN, V61, P3678, DOI 10.1128/IAI.61.9.3678-3687.1993; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; WATSON DC, 1992, INFECT IMMUN, V60, P4679, DOI 10.1128/IAI.60.11.4679-4686.1992; Whitfield C, 2003, J ENDOTOXIN RES, V9, P244, DOI 10.1179/096805103225001440; Wilde H, 2007, VACCINE, V25, P5246, DOI 10.1016/j.vaccine.2007.04.053	38	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47039	10.1371/journal.pone.0047039	http://dx.doi.org/10.1371/journal.pone.0047039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144798	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800013
J	Ni, G; Li, Q; Kong, LF; Zheng, XD				Ni, Gang; Li, Qi; Kong, Lingfeng; Zheng, Xiaodong			Phylogeography of Bivalve Cyclina sinensis: Testing the Historical Glaciations and Changjiang River Outflow Hypotheses in Northwestern Pacific	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; PLEISTOCENE ISOLATION; POPULATION-STRUCTURE; BAYESIAN-INFERENCE; MARGINAL SEAS; HYBRID ZONES; DISPERSAL; EVOLUTION; DIVERGENCE	Background: The marginal seas of northwestern Pacific are characterized by unique topography and intricate hydrology. Two hypotheses have been proposed to explain genetic patterns of marine species inhabiting the region: the historical glaciations hypothesis suggests population genetic divergence between sea basins, whereas the Changjiang River outflow hypothesis suggests genetic break in line with the Changjiang Estuary. Here the phylogeography of bivalve Cyclina sinensis was investigated to test the validity of these two hypotheses for intertidal species in three marginal seas-the East China Sea (ECS), the South China Sea (SCS), and the Japan Sea (JPS). Methodology/Principal Findings: Fragments of two markers (mitochondrial COI and nuclear ITS-1) were sequenced for 335 individuals collected from 21 populations. Significant pairwise Phi(ST) were observed between different marginal sea populations. Network analyses illustrated restricted distribution of haplogroups/sub-haplogroups to sea basins, with a narrow secondary contact zone between the ECS and SCS. Demographic expansion was inferred for ECS and SCS lineages using mismatch distributions, neutral tests, and extended Bayesian Skyline Plots. Based on a molecular clock method, the divergence times among COI lineages were estimated dating from the Pleistocene. Conclusions: The phylogeographical break revealed for C. sinensis populations is congruent with the historical isolation of sea basins rather than the putative Changjiang River outflow barrier. The large land bridges extending between seas during glaciation allowed accumulation of mutations and subsequently gave rise to deep divergent lineages. The low-dispersal capacity of the clam and coastal oceanography may facilitate the maintenance of the historical patterns as barriers shift. Our study supports the historical glaciations hypothesis for interpreting present-day phylogeographical patterns of C. sinensis, and highlights the importance of historical glaciations for generating genetic structure of marine coastal species especially those with low-dispersal abilities in northwestern Pacific.	[Ni, Gang; Li, Qi; Kong, Lingfeng; Zheng, Xiaodong] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China	Ocean University of China	Li, Q (corresponding author), Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	Scientific and Technical Supporting Program [2011BAD13B03]; 973 Program [2010CB126406]; National Natural Science Foundation of China [31072207, 40906064]	Scientific and Technical Supporting Program; 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from Scientific and Technical Supporting Program (2011BAD13B03), 973 Program (2010CB126406) and the National Natural Science Foundation of China (31072207 and 40906064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; [Anonymous], 2011, POPULATION GENETICS; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baoping Pan, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P737; Calderon I, 2008, MAR BIOL, V154, P137, DOI 10.1007/s00227-008-0908-0; Calderon I, 2006, J EXP MAR BIOL ECOL, V336, P184, DOI 10.1016/j.jembe.2006.05.006; Cheang CC, 2010, MOL ECOL, V19, P2933, DOI 10.1111/j.1365-294X.2010.04685.x; Chen CC, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004891; Chevolot M, 2006, MOL ECOL, V15, P3693, DOI 10.1111/j.1365-294X.2006.03043.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cunha RL, 2008, MOL ECOL, V17, P885, DOI 10.1111/j.1365-294X.2007.03618.x; David DC, 2011, GENET MOL BIOL, V12, P1; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; ECCBR, 1993, CHIN BAY REC; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gaffney PM, 1998, MUTATION ANAL, V2, P329; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hellberg ME, 1999, MOL BIOL EVOL, V16, P839, DOI 10.1093/oxfordjournals.molbev.a026168; Hellberg ME, 2002, B MAR SCI, V70, P273; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hinnov LA, 2010, PALEOCEANOGRAPHY, V25; Hou L, 2006, AQUACULTURE, V261, P865, DOI 10.1016/j.aquaculture.2006.09.011; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Kimura M, 2000, TROPICS, V10, P5, DOI DOI 10.3759/TROPICS.10.5; Kirkendale LA, 2004, MOL ECOL, V13, P2749, DOI 10.1111/j.1365-294X.2004.02284.x; Kong LF, 2009, MAR BIOL, V156, P1507, DOI 10.1007/s00227-009-1190-5; Lee HJ, 2009, MOL ECOL, P182165; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li Q, 2002, J SHELLFISH RES, V21, P811; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu J, 2011, MOL ECOL, V20, P4332, DOI 10.1111/j.1365-294X.2011.05275.x; Marko PB, 2009, J BIOGEOGR, V36, P1861, DOI 10.1111/j.1365-2699.2009.02114.x; Marko PB, 2002, MOL BIOL EVOL, V19, P2005, DOI 10.1093/oxfordjournals.molbev.a004024; Navajas M, 2003, P ROY SOC B-BIOL SCI, V270, pS124, DOI 10.1098/rsbl.2003.0034; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; Pan Bao-Ping, 2005, Acta Hydrobiologica Sinica, V29, P372; Pitts JP, 2010, MOL PHYLOGENET EVOL, V56, P134, DOI 10.1016/j.ympev.2010.03.033; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rato C, 2011, MOL PHYLOGENET EVOL, V58, P365, DOI 10.1016/j.ympev.2010.12.004; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Schneider S, 1999, GENETICS, V152, P1079; Schroder HC, 2003, J ZOOL SYST EVOL RES, V41, P80, DOI 10.1046/j.1439-0469.2003.00199.x; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shen KN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-83; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Sponaugle S, 2002, B MAR SCI, P70341; Su J., 2005, COASTAL HYDROLOGY CH; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang BD, 2003, ESTUAR COAST SHELF S, V58, P127, DOI 10.1016/S0272-7714(03)00067-2; Wang LX, 2001, J NW SCI TECHNOLOGY, V29, P94; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; WANG PX, 1994, CATENA, V23, P341; Wang R, 2008, SCI MARINE SHELLFISH; Wang Xing-qiang, 2006, Fisheries Science (Liaoning), V25, P312; Wares JP, 2002, MOL ECOL, V11, P1131, DOI 10.1046/j.1365-294X.2002.01510.x; Xu F. S., 1997, BIVALVE MOLLUSCA CHI; Xu JW, 2009, MOL PHYLOGENET EVOL, V52, P45, DOI 10.1016/j.ympev.2009.02.007; Yang JM, 2008, BIOCHEM GENET, V46, P539, DOI 10.1007/s10528-008-9168-4; Yao ZL, 2005, MAR FISH, V27, P102; Yu JN, 2010, ZOOL SCI, V27, P375, DOI 10.2108/zsj.27.375; Zeng ZN, 1991, TROPIC OCEANOLOGY, V10, P86; Zhang X, 1963, OCEANOLOGIA LIMNOLOG, V5, P124; Zhao YM, 2007, FISHERIES SCI, V73, P1338, DOI 10.1111/j.1444-2906.2007.01473.x; Zhao YM, 2009, HYDROBIOLOGIA, V635, P227, DOI 10.1007/s10750-009-9916-4; Zheng Wen-juan, 2009, Zoological Research, V30, P17, DOI 10.3724/SP.J.1141.2009.01017	81	53	56	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49487	10.1371/journal.pone.0049487	http://dx.doi.org/10.1371/journal.pone.0049487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145178	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800260
J	Wang, JB; Zeng, LN; Zang, QC; Gong, QF; Li, BC; Zhang, XR; Chu, XH; Zhang, P; Zhao, YL; Xiao, XH				Wang, Jia-bo; Zeng, Ling-na; Zang, Qing-ce; Gong, Qian-feng; Li, Bao-cai; Zhang, Xue-ru; Chu, Xiao-hui; Zhang, Ping; Zhao, Yan-ling; Xiao, Xiao-he			Colorimetric Grading Scale Can Promote the Standardization of Experiential and Sensory Evaluation in Quality Control of Traditional Chinese Medicines	PLOS ONE			English	Article							RHUBARB EXTRACT; COLOR; RATS; SCIENCE	Experiential and sensory evaluation is an ancient method that remains important in the current quality control system of Traditional Chinese Medicines (TCMs). The process is rapid and convenient when evaluating the quality of crude materials in TCM markets. However, sensory evaluation has been met with skepticism because it is mainly based on experience and lacks a scientific basis. In this study, rhubarb was selected to demonstrate how color-based sensory evaluation could differentiate the quality of herbal medicines objectively. The colors of the rhubarb samples, expressed as RGB values, were obtained from different parts and forms of the plant, including the plant's surface, fracture surface color, and a powdered form with or without treatment with a color-developing reagent. We first divided the rhubarb samples into three grades based on the total content of five hydroxyanthraquinone derivatives, the major pharmacological components in rhubarb. Then, a three-layer back-propagation artificial neural network (BP-ANN), calibrated with selected training samples, was used to correlate the quality of the rhubarb with its color. The color of the rhubarb powder after coloration attained the highest accuracy (92.3%) in predicting the quality grade of the test samples with the established artificial neural networks. Finally, a standardized colorimetric grading scale was created based on the spatial distribution of the rhubarb samples in a two-dimensional chromaticity diagram according to the colors of the powdered rhubarb after color enhancement. By comparing the color between the scale and the tested samples, similar to performing a pH test with indicator paper, subjects without sensory evaluation experience could quickly determine the quality grade of rhubarb. This work illustrates the technical feasibility of the color-based grading of rhubarb quality and offers references for quantifying and standardizing the sensory evaluation of TCMs, foods and other products.	[Xiao, Xiao-he] 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China; [Wang, Jia-bo; Zeng, Ling-na; Zang, Qing-ce; Zhang, Xue-ru; Chu, Xiao-hui; Zhang, Ping; Zhao, Yan-ling] 302 Mil Hosp, China Mil Inst Chinese Med, Beijing, Peoples R China; [Zeng, Ling-na; Li, Bao-cai] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Peoples R China; [Zang, Qing-ce; Gong, Qian-feng] Jiangxi Univ Tradit Chinese Med, Coll Pharm, Nanchang, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Kunming University of Science & Technology; Jiangxi University of Traditional Chinese Medicine	Xiao, XH (corresponding author), 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China.	pharmacy302@126.com	Wang, Jiabo/B-6681-2015; xiao, xiang/GWU-6035-2022		Industry Research Program of Traditional Chinese Medicine [200807020, 201207002]; National Key Technology Research and Development Program [2012BAI29B02]; National Science Foundation of China [81274026, 30973947]	Industry Research Program of Traditional Chinese Medicine; National Key Technology Research and Development Program(National Key Technology R&D Program); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the Industry Research Program of Traditional Chinese Medicine (Nos. 200807020 and 201207002), the National Key Technology Research and Development Program (No. 2012BAI29B02), and the National Science Foundation of China (Nos. 81274026 and 30973947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; [Anonymous], 2010, PHARMACOPOEIA PEOPLE, P22; [Anonymous], 2010, Pharmacopoeia of the People's Republic of China, First Div., P22, Patent No. [CN102042978A, 102042978]; Chu XH, 2011, WORLD SCI TECH MODER, V13, P321; Cuellar MJ, 2001, FITOTERAPIA, V72, P221, DOI 10.1016/S0367-326X(00)00305-1; Cunha CR, 2010, FOOD RES INT, V43, P723, DOI 10.1016/j.foodres.2009.11.009; Evin F, 2002, ENERG BUILDINGS, V34, P647, DOI 10.1016/S0378-7788(02)00015-4; Huang YQ, 2007, CRIT REV FOOD SCI, V47, P113, DOI 10.1080/10408390600626453; Li ZL, 2007, ORIGINS MAT MED; Mendoza F, 2006, POSTHARVEST BIOL TEC, V41, P285, DOI 10.1016/j.postharvbio.2006.04.004; Parpinello GP, 2009, FOOD RES INT, V42, P1389, DOI 10.1016/j.foodres.2009.07.005; Parpinello GP, 2006, FOOD RES INT, V39, P47, DOI 10.1016/j.foodres.2005.05.010; Elortondo FJP, 2007, FOOD QUAL PREFER, V18, P425, DOI 10.1016/j.foodqual.2006.05.002; Rossel RAV, 2006, GEODERMA, V133, P320, DOI 10.1016/j.geoderma.2005.07.017; SHAHIDI F, 1986, CRIT REV FOOD SCI, V24, P141, DOI 10.1080/10408398609527435; Wang Jiabo, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2657; Wang JB, 2009, J ETHNOPHARMACOL, V124, P18, DOI 10.1016/j.jep.2009.04.018; World Health Organization, 1999, WHO MONOGRAPHS SELEC, P231; YOKOZAWA T, 1985, CHEM PHARM BULL, V33, P4508; Zhao YL, 2009, BASIC CLIN PHARMACOL, V104, P463, DOI 10.1111/j.1742-7843.2009.00389.x; Zhao ZZ, 2011, J ETHNOPHARMACOL, V134, P556, DOI 10.1016/j.jep.2011.01.018; Zhu SH, 2006, MODERN COMMODITY STU, P113	22	6	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48887	10.1371/journal.pone.0048887	http://dx.doi.org/10.1371/journal.pone.0048887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145012	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800163
J	Cicchillitti, L; Di Stefano, V; Isaia, E; Crimaldi, L; Fasanaro, P; Ambrosino, V; Antonini, A; Capogrossi, MC; Gaetano, C; Piaggio, G; Martelli, F				Cicchillitti, Lucia; Di Stefano, Valeria; Isaia, Eleonora; Crimaldi, Luca; Fasanaro, Pasquale; Ambrosino, Valeria; Antonini, Annalisa; Capogrossi, Maurizio C.; Gaetano, Carlo; Piaggio, Giulia; Martelli, Fabio			Hypoxia-inducible Factor 1-alpha Induces miR-210 in Normoxic Differentiating Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; IN-VITRO; MUSCLE REGENERATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; STEM-CELLS; MICRORNA-210; ANGIOGENESIS; MITOCHONDRIA	MicroRNA-210 (miR-210) induction is a virtually constant feature of the hypoxic response in both normal and transformed cells, regulating several key aspects of cardiovascular diseases and cancer. We found that miR-210 was induced in normoxic myoblasts upon myogenic differentiation both in vitro and in vivo. miR-210 transcription was activated in an hypoxia-inducible factor 1-alpha (Hif1a)-dependent manner, and chromatin immunoprecipitation experiments show that Hif1a bound to the miR-210 promoter only in differentiated myotubes. Accordingly, luciferase reporter assays demonstrated the functional relevance of the Hif1a binding site for miR-210 promoter activation in differentiating myoblasts. To investigate the functional relevance of increased miR-210 levels in differentiated myofibers, we blocked miR-210 with complementary locked nucleic acid oligonucleotides (anti-miR-210). We found that C2C12 myoblast cell line differentiation was largely unaffected by anti-miR-210. Likewise, miR-210 inhibition did not affect skeletal muscle regeneration following cardiotoxin damage. However, we found that miR-210 blockade greatly increased myotube sensitivity to oxidative stress and mitochondrial dysfunction. In conclusion, miR-210 is induced in normoxic myofibers, playing a cytoprotective role.	[Martelli, Fabio] IRCCS Policlin San Donato, Mol Cardiol Lab, I-20097 Milan, Italy; [Di Stefano, Valeria; Fasanaro, Pasquale; Antonini, Annalisa; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, I-00167 Rome, Italy; [Ambrosino, Valeria; Piaggio, Giulia] Ist Nazl Tumori Regina Elena, I-00158 Rome, Italy; [Gaetano, Carlo] Uniklinikum Goethe Univ, D-60590 Frankfurt, Germany	IRCCS Policlinico San Donato; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Martelli, F (corresponding author), IRCCS Policlin San Donato, Mol Cardiol Lab, Via Morandi 30, I-20097 Milan, Italy.	fabio.martelli@grupposandonato.it	Gaetano, Carlo/P-9997-2019; Martelli, Fabio/AAL-3788-2020; Piaggio, Giulia/AAD-7336-2022; Piaggio, Giulia/J-7214-2018	Gaetano, Carlo/0000-0002-5238-1832; Martelli, Fabio/0000-0002-8624-7738; Piaggio, Giulia/0000-0003-2114-1892	Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro Grant [AIRC IG-11436]	Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro Grant AIRC IG-11436.	Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Bloomer RJ, 2004, CAN J APPL PHYSIOL, V29, P245, DOI 10.1139/h04-017; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Du YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-249; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044651; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Gurtner C, 2002, ELECTROPHORESIS, V23, P1543, DOI 10.1002/1522-2683(200205)23:10<1543::AID-ELPS1543>3.0.CO;2-#; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kon M, 2007, APPL PHYSIOL NUTR ME, V32, P273, DOI 10.1139/H06-115; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Lou YL, 2012, MOL CELL BIOCHEM, V370, P45, DOI 10.1007/s11010-012-1396-6; MARTELLI F, 1994, ONCOGENE, V9, P3579; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 2010, CURR OPIN CLIN NUTR, V13, P236, DOI 10.1097/MCO.0b013e3283368188; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; Ono Y, 2006, J CELL BIOCHEM, V98, P642, DOI 10.1002/jcb.20804; Pisani DF, 2005, J GEN PHYSIOL, V126, P173, DOI 10.1085/jgp.200509265; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Quero L, 2011, RADIOTHER ONCOL, V101, P203, DOI 10.1016/j.radonc.2011.05.063; Scatena R, 2012, ADV EXP MED BIOL, V942, P329, DOI 10.1007/978-94-007-2869-1_15; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Travaglione S, 2005, CELL DEATH DIFFER, V12, P78, DOI 10.1038/sj.cdd.4401522; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	53	78	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44761	44771		10.1074/jbc.M112.421255	http://dx.doi.org/10.1074/jbc.M112.421255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148210	hybrid, Green Published			2022-12-25	WOS:000312938600070
J	Zhang, YH; Zhang, MS; Wu, JC; Lei, GH; Li, HL				Zhang, Yinghua; Zhang, Mingsheng; Wu, Jianchun; Lei, Guohua; Li, Honglin			Transcriptional Regulation of the Ufm1 Conjugation System in Response to Disturbance of the Endoplasmic Reticulum Homeostasis and Inhibition of Vesicle Trafficking	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSMEMBRANE PROTEIN; MESSENGER-RNA; FACTOR XBP-1; ER STRESS; KINASE; ATF6; IDENTIFICATION; IRE1-ALPHA; ACTIVATION	Homeostasis of the endoplasmic reticulum (ER) is essential for normal cellular functions. Disturbance of this homeostasis causes ER stress and activates the Unfolded Protein Response (UPR). The Ufm1 conjugation system is a novel Ubiquitin-like (Ubl) system whose physiological target(s) and biological functions remain largely undefined. Genetic study has demonstrated that the Ufm1-activating enzyme Uba5 is indispensible for erythroid differentiation in mice, highlighting the importance of this novel system in animal development. In this report we present the evidence for involvement of RCAD/Ufl1, a putative Ufm1-specific E3 ligase, and its binding partner C53/LZAP protein in ufmylation of endogenous Ufm1 targets. Moreover, we found that the Ufm1 system was transcriptionally up-regulated by disturbance of the ER homeostasis and inhibition of vesicle trafficking. Using luciferase reporter and ChIP assays, we dissected the Ufm1 promoter and found that Ufm1 was a potential target of Xbp-1, one of crucial transcription factors in UPR. We further examined the effect of Xbp-1 deficiency on the expression of the Ufm1 components. Interestingly, the expression of Ufm1, Uba5, RCAD/Ufl1 and C53/LZAP in wild-type mouse embryonic fibroblasts (MEFs) was significantly induced by inhibition of vesicle trafficking, but the induction was negated by Xbp-1 deficiency. Finally, we found that knockdown of the Ufm1 system in U2OS cells triggered UPR and amplification of the ER network. Taken together, our study provided critical insight into the regulatory mechanism of the Ufm1 system and established a direct link between this novel Ubl system and the ER network.	[Zhang, Yinghua; Zhang, Mingsheng; Li, Honglin] Georgia Hlth Sci Univ, Ctr Canc, Dept Biochem & Mol Biol, Augusta, GA USA; [Zhang, Mingsheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430074, Peoples R China; [Wu, Jianchun] Univ Illinois, Ctr Canc, Chicago, IL USA; [Lei, Guohua] So Med Univ, Dept Biophys, Guangzhou, Guangdong, Peoples R China	University System of Georgia; Augusta University; Huazhong University of Science & Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Southern Medical University - China	Li, HL (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, Dept Biochem & Mol Biol, Augusta, GA USA.	hli@georgiahealth.edu	Wu, Jianchun/AAX-3533-2020	Wu, Jianchun/0000-0002-8473-9368	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The financial support for this study is from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; MORI K, 1993, CELL, V74, P743; Neziri D, 2010, BBA-GEN SUBJECTS, V1800, P430, DOI 10.1016/j.bbagen.2009.12.004; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	41	44	48	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48587	10.1371/journal.pone.0048587	http://dx.doi.org/10.1371/journal.pone.0048587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152784	Green Published, gold, Green Submitted			2022-12-25	WOS:000311234600008
J	Agundez, JAG; Ayuso, P; Cornejo-Garcia, JA; Blanca, M; Torres, MJ; Dona, I; Salas, M; Blanca-Lopez, N; Canto, G; Rondon, C; Campo, P; Laguna, JJ; Fernandez, J; Martinez, C; Garcia-Martin, E				Agundez, Jose A. G.; Ayuso, Pedro; Cornejo-Garcia, Jose A.; Blanca, Miguel; Torres, Maria J.; Dona, Inmaculada; Salas, Maria; Blanca-Lopez, Natalia; Canto, Gabriela; Rondon, Carmen; Campo, Paloma; Laguna, Jose J.; Fernandez, Javier; Martinez, Carmen; Garcia-Martin, Elena			The Diamine Oxidase Gene Is Associated with Hypersensitivity Response to Non-Steroidal Anti-Inflammatory Drugs	PLOS ONE			English	Article							ALLERGIC RHINITIS; ENZYME-ACTIVITY; POLYMORPHISM; VARIABILITY; ASPIRIN; ASTHMA; PHARMACOGENOMICS; PATTERNS	Non-steroidal anti-inflammatory drugs (NSAIDs) are the drugs most frequently involved in hypersensitivity drug reactions. Histamine is released in the allergic response to NSAIDs and is responsible for some of the clinical symptoms. The aim of this study is to analyze clinical association of functional polymorphisms in the genes coding for enzymes involved in histamine homeostasis with hypersensitivity response to NSAIDs. We studied a cohort of 442 unrelated Caucasian patients with hypersensitivity to NSAIDs. Patients who experienced three or more episodes with two or more different NSAIDs were included. If this requirement was not met diagnosis was established by challenge. A total of 414 healthy unrelated controls ethnically matched with patients and from the same geographic area were recruited. Analyses of the SNPs rs17740607, rs2073440, rs1801105, rs2052129, rs10156191, rs1049742 and rs1049793 in the HDC, HNMT and DAO genes were carried out by means of TaqMan assays. The detrimental DAO 16 Met allele (rs10156191), which causes decreased metabolic capacity, is overrepresented among patients with crossed-hypersensitivity to NSAIDs with an OR = 1.7 (95% CI = 1.3-2.1; Pc = 0.0003) with a gene-dose effect (P = 0.0001). The association was replicated in two populations from different geographic areas (Pc = 0.008 and Pc = 0.004, respectively). Conclusions and implications: The DAO polymorphism rs10156191 which causes impaired metabolism of circulating histamine is associated with the clinical response in crossed-hypersensitivity to NSAIDs and could be used as a biomarker of response.	[Ayuso, Pedro; Garcia-Martin, Elena] Univ Extremadura, Dept Bioquim & Biol Mol & Genet, Caceres, Spain; [Agundez, Jose A. G.; Martinez, Carmen] Univ Extremadura, Dept Farmacol, Caceres, Spain; [Cornejo-Garcia, Jose A.] Fdn IMABIS, Lab Invest, Malaga, Spain; [Blanca, Miguel; Torres, Maria J.; Dona, Inmaculada; Salas, Maria; Rondon, Carmen; Campo, Paloma] Hosp Carlos Haya, Serv Alergol, Malaga, Spain; [Blanca-Lopez, Natalia; Canto, Gabriela] Hosp Infanta Leonor, Serv Alergol, Madrid, Spain; [Laguna, Jose J.] Hosp Cruz Roja, Serv Alergol, Madrid, Spain; [Fernandez, Javier] Hosp San Juan, Serv Alergol, Alicante, Spain	Universidad de Extremadura; Universidad de Extremadura; FIMABIS; Hospital Carlos Haya; Hospital Universitario Infanta Leonor	Garcia-Martin, E (corresponding author), Univ Extremadura, Dept Bioquim & Biol Mol & Genet, Caceres, Spain.	elenag@unex.es	Torres, Maria/GVU-3391-2022; Torres, María José/T-3518-2017; Agúndez, José A. G./A-5503-2008; García-Martin, Elena/H-9828-2016; Martinez, Jose Julio Laguna/L-6891-2017; Fernandez, Javier/B-6425-2018; Salas, María/D-3898-2018; Cornejo-García, Jose Antonio/S-7726-2016	Torres, María José/0000-0001-5228-471X; Agúndez, José A. G./0000-0001-6895-9160; García-Martin, Elena/0000-0002-8094-046X; Martinez, Jose Julio Laguna/0000-0001-5909-8979; Fernandez, Javier/0000-0003-1065-7199; Cornejo-García, Jose Antonio/0000-0003-3465-8735; RONDON SEGOVIA, CARMEN/0000-0003-0976-3402; Ayuso Parejo, Pedro/0000-0002-9441-4022	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS PS09/00943, PS09/00469, RETICS RD07/0064/ 0016]; Junta de Extremadura, Spain [GR10068]; European Union	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; European Union(European Commission)	FIS PS09/00943, PS09/00469, and RETICS RD07/0064/ 0016 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain, and GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2008, CLIN CHEM, V54, P1390, DOI 10.1373/clinchem.2008.105569; Alfirevic A, 2010, PHARMACOGENOMICS, V11, P497, DOI [10.2217/pgs.10.12, 10.2217/PGS.10.12]; Ayuso P, 2007, PHARMACOGENET GENOM, V17, P687, DOI 10.1097/FPC.0b013e328012b8e4; Casadevall J, 2000, THORAX, V55, P921, DOI 10.1136/thorax.55.11.921; Dona I, 2012, J INVEST ALLERG CLIN, V22, P363; Dona I, 2011, CLIN EXP ALLERGY, V41, P86, DOI 10.1111/j.1365-2222.2010.03651.x; Garcia-Martin E, 2007, CLIN EXP ALLERGY, V37, P1175, DOI 10.1111/j.1365-2222.2007.02769.x; Garcia-Martin E, 2007, CLIN BIOCHEM, V40, P1339, DOI 10.1016/j.clinbiochem.2007.07.019; Garcia-Martin E, 2006, WORLD J GASTROENTERO, V12, P615, DOI 10.3748/wjg.v12.i4.615; Garcia-Martin E, 2009, PHARMACOGENOMICS, V10, P867, DOI 10.2217/PGS.09.26; Gervasini G, 2010, ALLERGY, V65, P1576, DOI 10.1111/j.1398-9995.2010.02425.x; Kennedy MJ, 2008, PHARMACOTHERAPY, V28, P1495, DOI 10.1592/phco.28.12.1495; Khan DA, 2010, J ALLERGY CLIN IMMUN, V125, pS126, DOI 10.1016/j.jaci.2009.10.028; Kim SH, 2009, ALLERGY, V64, P213, DOI 10.1111/j.1398-9995.2008.01795.x; Kowalski ML, 2011, ALLERGY, V66, P818, DOI 10.1111/j.1398-9995.2011.02557.x; Maintz L, 2011, ALLERGY, V66, P893, DOI 10.1111/j.1398-9995.2011.02548.x; Mita H, 2001, ALLERGY, V56, P1061; Naisbitt DJ, 2003, CURR ALLERGY ASTHM R, V3, P22, DOI 10.1007/s11882-003-0006-9; Pirmohamed M, 2006, AAPS J, V8, pE20, DOI 10.1208/aapsj080103; Preuss CV, 1998, MOL PHARMACOL, V53, P708, DOI 10.1124/mol.53.4.708; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rutherford K, 2008, BIOCHEMISTRY-US, V47, P893, DOI 10.1021/bi701737f; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Warrington R., 2011, ALLERGY ASTHMA CL IM, V7, pS10, DOI DOI 10.1186/1710-1492-7-S1-S10	25	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e47571	10.1371/journal.pone.0047571	http://dx.doi.org/10.1371/journal.pone.0047571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152756	Green Published, gold			2022-12-25	WOS:000311234000004
J	Remis, RS; Merid, MF; Palmer, RWH; Whittingham, E; King, SM; Danson, NS; Vernich, L; Swantee, C; Major, C				Remis, Robert S.; Merid, Maraki Fikre; Palmer, Robert W. H.; Whittingham, Elaine; King, Susan M.; Danson, Natasha S.; Vernich, Lee; Swantee, Carol; Major, Carol			High Uptake of HIV Testing in Pregnant Women in Ontario, Canada	PLOS ONE			English	Article							TRANSMISSION	In 1999, Ontario implemented a policy to offer HIV counseling and testing to all pregnant women and undertook measures to increase HIV testing. We evaluated the effectiveness of the new policy by examining HIV test uptake, the number of HIV-infected women identified and, in 2002, the HIV rate in women not tested during prenatal care. We analyzed test uptake among women receiving prenatal care from 1999 to 2010. We examined HIV test uptake and HIV rate by year, age and health region. In an anonymous, unlinked study, we determined the HIV rate in pregnant women not tested. Prenatal HIV test uptake in Ontario increased dramatically, from 33% in the first quarter of 1999 to 96% in 2010. Test uptake was highest in younger women but increased in all age groups. All health regions improved and experienced similar test uptake in recent years. The HIV rate among pregnant women tested in 2010 was 0.13/1,000; in Toronto, the rate was 0.28 per 1,000. In the 2002 unlinked study, the HIV rate was 0.62/1,000 among women not tested in pregnancy compared to 0.31/1,000 among tested women. HIV incidence among women who tested more than once was 0.05/1,000 person-years. In response to the new policy in Ontario, prenatal HIV testing uptake improved dramatically among women in all age groups and health regions. A reminder to physicians who had not ordered a prenatal HIV test appeared to be very effective. In 2002, the HIV rate in women who were not tested was twice that of tested women: though 77% of pregnant women had been tested, only 63% of HIV-infected women were tested. HIV testing uptake was estimated at 98% in 2010. Citation: Remis RS, Merid MF, Palmer RWH, Whittingham E, King SM, et al. (2012) High Uptake of HIV Testing in Pregnant Women in Ontario, Canada. PLoS ONE 7(11): e48077. doi:10.1371/journal.pone.0048077	[Remis, Robert S.; Merid, Maraki Fikre; Palmer, Robert W. H.; Whittingham, Elaine; Danson, Natasha S.; Vernich, Lee] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [King, Susan M.] Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Swantee, Carol; Major, Carol] Publ Hlth Ontario, HIV Lab, Etobicoke, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Remis, RS (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	rs.remis@utoronto.ca			AIDS Bureau; Ontario Ministry of Health and Long-Term Care; Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada	AIDS Bureau; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada	The anonymous, unlinked component of the study was funded in part by the AIDS Bureau, Ontario Ministry of Health and Long-Term Care and the Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada. The ongoing collection of prenatal data was carried out by the Ontario HIV Epidemiology Monitoring Unit which is based at the University of Toronto and funded largely by the AIDS Bureau, Ontario Ministry of Health and Long-Term Care. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitnun A, 2002, CAN MED ASSOC J, V166, P904; Boucher M, 2002, CAN J INFECT DIS SA; Boxall EH, 2004, J PUBLIC HEALTH-UK, V26, P285, DOI 10.1093/pubmed/fdh148; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada & Social Sciences and Humanities Research Council of Canada, 1998, TRIC POL STAT ETH CO; Center for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P8; COATES RA, 1992, CLIN INVEST MED, V15, P1; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; ELMSLIE K, 1992, CAN MED ASSOC J, V146, P1743; Gruslin A, 2001, CAN J PUBLIC HEALTH, V92, P255, DOI 10.1007/BF03404955; Guenter D, 2003, CAN FAM PHYSICIAN, V49, P1334; Guenter D, 2003, CAN J PUBLIC HEALTH, V94, P93, DOI 10.1007/BF03404579; Hughes CA, 2010, AM J PUBLIC HEALTH, V100, P389, DOI 10.2105/AJPH.2009.181925; Jayaraman GC, 2003, CAN MED ASSOC J, V168, P679; MacDonald SE, 2001, CAN FAM PHYSICIAN, V47, P2250; O'Connor KS, 2002, CAN J PUBLIC HEALTH, V93, P31, DOI 10.1007/BF03404414; Ogilvie G, 1997, CAN FAM PHYSICIAN, V43, P1376; Plitt SS, 2007, CLIN INFECT DIS, V45, P1640, DOI 10.1086/523730; Poulin C, 1998, CAN J INFECT DIS; Sansom SL, 2003, OBSTET GYNECOL, V102, P782, DOI 10.1016/S0029-7844(03)00624-0; The Health Protection Agency, 2003, ANN REPORT; Wang FL, 2005, CAN J PUBLIC HEALTH, V96, P60, DOI 10.1007/BF03404020; Yudin MH, 2007, OBSTET GYNECOL, V110, P81, DOI 10.1097/01.AOG.0000267497.39041.06	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48077	10.1371/journal.pone.0048077	http://dx.doi.org/10.1371/journal.pone.0048077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053LI	23152762	Green Published, Green Submitted, gold			2022-12-25	WOS:000312272600009
J	Bolte, C; Zhang, YF; York, A; Kalin, TV; Schultz, JEJ; Molkentin, JD; Kalinichenko, VV				Bolte, Craig; Zhang, Yufang; York, Allen; Kalin, Tanya V.; Schultz, Jo El J.; Molkentin, Jeffery D.; Kalinichenko, Vladimir V.			Postnatal Ablation of Foxm1 from Cardiomyocytes Causes Late Onset Cardiac Hypertrophy and Fibrosis without Exacerbating Pressure Overload-Induced Cardiac Remodeling	PLOS ONE			English	Article							M1 TRANSCRIPTION FACTOR; FACTOR TRIDENT; LUNG INJURY; MOUSE HEART; S PHASE; CARDIOMYOPATHY; EXPRESSION; LIVER; DEFECTS; CELLS	Heart disease remains a leading cause of morbidity and mortality in the industrialized world. Hypertrophic cardiomyopathy is the most common genetic cardiovascular disorder and the most common cause of sudden cardiac death. Foxm1 transcription factor (also known as HFH-11B, Trident, Win or MPP2) plays an important role in the pathogenesis of various cancers and is a critical mediator of post-injury repair in multiple organs. Foxm1 has been previously shown to be essential for heart development and proliferation of embryonic cardiomyocytes. However, the role of Foxm1 in postnatal heart development and in cardiac injury has not been evaluated. To delete Foxm1 in postnatal cardiomyocytes, alpha MHC-Cre/Foxm1(fl/fl) mice were generated. Surprisingly, alpha MHC-Cre/Foxm1(fl/fl) mice exhibited normal cardiomyocyte proliferation at postnatal day seven and had no defects in cardiac structure or function but developed cardiac hypertrophy and fibrosis late in life. The development of cardiomyocyte hypertrophy and cardiac fibrosis in aged Foxm1-deficient mice was associated with reduced expression of Hey2, an important regulator of cardiac homeostasis, and increased expression of genes critical for cardiac remodeling, including MMP9, alpha SMA, fibronectin and vimentin. We also found that following aortic constriction Foxm1 mRNA and protein were induced in cardiomyocytes. However, Foxm1 deletion did not exacerbate cardiac hypertrophy or fibrosis following chronic pressure overload. Our results demonstrate that Foxm1 regulates genes critical for age-induced cardiomyocyte hypertrophy and cardiac fibrosis. Citation: Bolte C, Zhang Y, York A, Kalin TV, Schultz JEJ, et al. (2012) Postnatal Ablation of Foxm1 from Cardiomyocytes Causes Late Onset Cardiac Hypertrophy and Fibrosis without Exacerbating Pressure Overload-Induced Cardiac Remodeling. PLoS ONE 7(11): e48713. doi:10.1371/journal.pone.0048713	[Bolte, Craig; Zhang, Yufang; Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Cincinnati, OH 45229 USA; [Schultz, Jo El J.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Kalinichenko, VV (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Cincinnati, OH 45229 USA.	Craig.Bolte@cchmc.org; Vladimir.Kalinichenko@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529	National Institute of Health grant [RO1HL84151]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by National Institute of Health grant RO1HL84151 (VVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022217; Bowles NE, 1998, CURR OPIN CARDIOL, V13, P179; Gaschen L, 1999, J VET INTERN MED, V13, P346, DOI 10.1892/0891-6640(1999)013&lt;0346:CIDDHF&gt;2.3.CO;2; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kapelko V I, 2001, Exp Clin Cardiol, V6, P41; Kim IM, 2005, J BIOL CHEM, V280, P37908, DOI 10.1074/jbc.M506531200; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kubo T, 2010, GERIATR GERONTOL INT, V10, P9, DOI 10.1111/j.1447-0594.2009.00572.x; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; Murakami H, 2010, CELL CYCLE, V9, P3233, DOI 10.4161/cc.9.16.12599; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Ommen SR, 2011, CURR PROB CARDIOLOGY, V36, P409, DOI 10.1016/j.cpcardiol.2011.06.001; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Raju H, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6966; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; Ren XM, 2010, MOL CELL BIOL, V30, P5381, DOI 10.1128/MCB.00876-10; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Semsarian C, 2011, HEART LUNG CIRC, V20, P688, DOI 10.1016/j.hlc.2011.07.017; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Xue L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009229; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Yu M, 2009, OMICS, V13, P501, DOI 10.1089/omi.2009.0086; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056; Zhang H, 2010, DIABETES, V59, P143, DOI 10.2337/db09-0050; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	42	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48713	10.1371/journal.pone.0048713	http://dx.doi.org/10.1371/journal.pone.0048713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144938	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500031
J	Jung, HJ; Jung, HJ; Ahmed, NU; Park, JI; Kang, KK; Hur, Y; Lim, YP; Nou, IS				Jung, Hee-Jeong; Jung, Hyo-Jin; Ahmed, Nasar Uddin; Park, Jong-In; Kang, Kwon-Kyoo; Hur, Yoonkang; Lim, Yong-Pyo; Nou, Ill-Sup			Development of Self-Compatible B. rapa by RNAi-Mediated S Locus Gene Silencing	PLOS ONE			English	Article							DOMINANCE RELATIONSHIPS; BRASSICA-RAPA; RECEPTOR KINASE; INCOMPATIBILITY; POLLEN; PROTEIN; ALLELES; TRANSFORMATION; DETERMINES; HAPLOTYPES	The self-incompatibility (SI) system is genetically controlled by a single polymorphic locus known as the S-locus in the Brassicaceae. Pollen rejection occurs when the stigma and pollen share the same S-haplotype. Recognition of S-haplotype specificity has recently been shown to involve at least two S-locus genes, S-receptor kinase (SRK) and S-locus protein 11 or S locus Cysteine-rich (SP11/SCR) protein. Here, we examined the function of S-60, one SP11/SCR allele of B. rapa cv. Osome, using a RNAi-mediated gene silencing approach. The transgenic RNAi lines were highly self-compatible, and this trait was stable in subsequent generations, even after crossing with other commercial lines. These findings also suggested that the resultant self-compatibility could be transferred to commercial cultivars with the desired performances in B. rapa. Citation: Jung H-J, Jung H-J, Ahmed NU, Park J-I, Kang K-K et al. (2012) Development of Self-Compatible B. rapa by RNAi-Mediated S Locus Gene Silencing. PLoS ONE 7(11): e49497. doi:10.1371/journal.pone.0049497	[Jung, Hee-Jeong; Ahmed, Nasar Uddin; Park, Jong-In; Nou, Ill-Sup] Sunchon Natl Univ, Dept Hort, Sunchon, South Korea; [Jung, Hyo-Jin] Jeollanam Do Agr Res & Extens Serv, Dept Hort, Najusi, South Korea; [Kang, Kwon-Kyoo] Hankyong Natl Univ, Dept Hort, Ansung, South Korea; [Hur, Yoonkang] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [Lim, Yong-Pyo] Chungnam Natl Univ, Dept Hort, Taejon, South Korea	Sunchon National University; Hankyong National University; Chungnam National University; Chungnam National University	Nou, IS (corresponding author), Sunchon Natl Univ, Dept Hort, Sunchon, South Korea.	nis@sunchon.ac.kr		Hur, Yoonkang/0000-0002-2325-2249	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ009085022012]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ009085022012), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI [10.1104/pp.108.4.1353, 10.1016/j.chiabu.2021.105188]; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Fukuda H, 2011, PLANT CELL PHYSIOL, V52, P1, DOI 10.1093/pcp/pcq193; Goto H, 2011, PLANT CELL PHYSIOL, V52, P49, DOI 10.1093/pcp/pcq191; Hancock CN, 2005, PLANT J, V43, P716, DOI 10.1111/j.1365-313X.2005.02490.x; Hatakeyama K, 1998, HEREDITY, V80, P241, DOI 10.1046/j.1365-2540.1998.00295.x; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Hunter C, 2003, CURR OPIN GENET DEV, V13, P372, DOI 10.1016/S0959-437X(03)00081-9; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; Kakizaki T, 2003, PLANT CELL PHYSIOL, V44, P70, DOI 10.1093/pcp/pcg009; McCubbin AG, 2000, ANNU REV CELL DEV BI, V16, P333, DOI 10.1146/annurev.cellbio.16.1.333; Murase K, 2004, SCIENCE, V303, P1516, DOI 10.1126/science.1093586; Nagamine A, 2011, PLANT CELL PHYSIOL, V52, P1003, DOI 10.1093/pcp/pcr053; NASRALLAH JB, 1993, PLANT CELL, V5, P1325, DOI 10.2307/3869785; NOU IS, 1991, JPN J GENET, V66, P227, DOI 10.1266/jjg.66.227; NOU IS, 1993, SEX PLANT REPROD, V6, P71; NOU IS, 1993, SEX PLANT REPROD, V6, P79, DOI 10.1007/BF00227652; RADKE SE, 1992, PLANT CELL REP, V11, P499, DOI 10.1007/BF00236265; Schopfer CR, 2000, PLANT PHYSIOL, V124, P935, DOI 10.1104/pp.124.3.935; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2006, NAT GENET, V38, P297, DOI 10.1038/ng1734; Shiba H, 2002, PLANT CELL, V14, P491, DOI 10.1105/tpc.010378; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; Shimosato H, 2007, PLANT CELL, V19, P107, DOI 10.1105/tpc.105.038869; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Suwabe K, 2010, GENES GENET SYST, V85, P297, DOI 10.1266/ggs.85.297; Suzuki G, 1999, GENETICS, V153, P391; Suzuki G, 2000, THEOR APPL GENET, V101, P80, DOI 10.1007/s001220051452; Takasaki T, 1997, BREEDING SCI, V47, P127; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Tarutani Y, 2010, NATURE, V466, P983, DOI 10.1038/nature09308; Urayama S, 2010, PLANT CELL PHYSIOL, V51, P58, DOI 10.1093/pcp/pcp167; Wakasa Y, 2011, PLANT CELL PHYSIOL, V52, P2190, DOI 10.1093/pcp/pcr151; Watanabe M., 2008, P151, DOI 10.1007/978-3-540-68486-2_7; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3; WATANABE M, 1994, PLANT CELL PHYSIOL, V35, P1221, DOI 10.1093/oxfordjournals.pcp.a078716; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yadav SR, 2011, PLANT CELL PHYSIOL, V52, P2123, DOI 10.1093/pcp/pcr142; Zhang FL, 2000, PLANT CELL REP, V19, P569, DOI 10.1007/s002990050775; Zhang XG, 2008, MOL BREEDING, V21, P305, DOI 10.1007/s11032-007-9130-x	45	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49497	10.1371/journal.pone.0049497	http://dx.doi.org/10.1371/journal.pone.0049497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145180	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500113
J	Roser, C; Jordan, N; Balfanz, S; Baumann, A; Walz, B; Baumann, O; Blenau, W				Roeser, Claudia; Jordan, Nadine; Balfanz, Sabine; Baumann, Arnd; Walz, Bernd; Baumann, Otto; Blenau, Wolfgang			Molecular and Pharmacological Characterization of Serotonin 5-HT2 alpha and 5-HT7 Receptors in the Salivary Glands of the Blowfly Calliphora vicina	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; V-ATPASE; DROSOPHILA-MELANOGASTER; ADENYLYL-CYCLASE; FLUID SECRETION; CYCLIC-AMP; 5-HYDROXYTRYPTAMINE; CALCIUM; STIMULATION; ACTIVATION	Secretion in blowfly (Calliphora vicina) salivary glands is stimulated by the biogenic amine serotonin (5-hydroxytryptamine, 5-HT), which activates both inositol 1,4,5-trisphosphate (InsP(3))/Ca2+ and cyclic adenosine 3',5'-monophosphate (cAMP) signalling pathways in the secretory cells. In order to characterize the signal-inducing 5-HT receptors, we cloned two cDNAs (Cv5-ht2 alpha, Cv5-ht7) that share high similarity with mammalian 5-HT2 and 5-HT7 receptor genes, respectively. RT-PCR demonstrated that both receptors are expressed in the salivary glands and brain. Stimulation of Cv5-ht2 alpha-transfected mammalian cells with 5-HT elevates cytosolic [Ca2+] in a dose-dependent manner (EC50 = 24 nM). In Cv5-ht7-transfected cells, 5-HT produces a dose-dependent increase in [cAMP](i) (EC50 = 4 nM). We studied the pharmacological profile for both receptors. Substances that appear to act as specific ligands of either Cv5-HT2 alpha or Cv5-HT7 in the heterologous expression system were also tested in intact blowfly salivary gland preparations. We observed that 5-methoxytryptamine (100 nM) activates only the Cv(5)-HT2 alpha receptor, 5-carboxamidotryptamine (300 nM) activates only the Cv5-HT7 receptor, and clozapine (1 mu M) antagonizes the effects of 5-HT via Cv5-HT7 in blowfly salivary glands, providing means for the selective activation of each of the two 5-HT receptor subtypes. This study represents the first comprehensive molecular and pharmacological characterization of two 5-HT receptors in the blowfly and permits the analysis of the physiological role of these receptors, even when co-expressed in cells, and of the modes of interaction between the Ca2+- and cAMP-signalling cascades. Citation: Roser C, Jordan N, Balfanz S, Baumann A, Walz B, et al. (2012) Molecular and Pharmacological Characterization of Serotonin 5-HT2a and 5-HT7 Receptors in the Salivary Glands of the Blowfly Calliphora vicina. PLoS ONE 7(11): e49459. doi:10.1371/journal.pone.0049459	[Roeser, Claudia; Walz, Bernd; Baumann, Otto; Blenau, Wolfgang] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Jordan, Nadine; Balfanz, Sabine; Baumann, Arnd] Res Ctr Julich, ICS 4, Julich, Germany; [Blenau, Wolfgang] Goethe Univ Frankfurt, Inst Bienenkunde, Polytech Gesell, Oberursel, Germany	University of Potsdam; Helmholtz Association; Research Center Julich; Goethe University Frankfurt	Blenau, W (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	Blenau@bio.uni-frankfurt.de	Baumann, Arnd/I-7941-2013; Blenau, Wolfgang/A-4304-2010	Baumann, Arnd/0000-0001-9456-7275; Blenau, Wolfgang/0000-0002-6874-4730; Balfanz, Sabine/0000-0002-7082-3999	German Research Foundation (DFG) [WA 463/9-6]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG, WA 463/9-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann O, 2012, J INSECT PHYSIOL, V58, P450, DOI 10.1016/j.jinsphys.2011.11.015; Baxter GD, 1999, INSECT BIOCHEM MOLEC, V29, P461, DOI 10.1016/S0965-1748(99)00023-5; BERRIDGE MJ, 1980, CELL CALCIUM, V1, P217, DOI 10.1016/0143-4160(80)90045-7; BERRIDGE MJ, 1981, MOL CELL ENDOCRINOL, V23, P91, DOI 10.1016/0303-7207(81)90119-2; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; BERRIDGE MJ, 1981, BRIT J PHARMACOL, V73, P729, DOI 10.1111/j.1476-5381.1981.tb16809.x; BERRIDGE MJ, 1968, SCIENCE, V162, P462, DOI 10.1126/science.162.3852.462; BERRIDGE MJ, 1972, J EXP BIOL, V56, P139; BERRIDGE MJ, 1976, J EXP BIOL, V64, P311; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Colas JF, 1997, ANN NY ACAD SCI, V812, P149, DOI 10.1111/j.1749-6632.1997.tb48157.x; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gerhardt CC, 1996, EUR J PHARMACOL, V311, P249, DOI 10.1016/0014-2999(96)00410-4; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HANSENBAY CM, 1978, J EXP BIOL, V75, P189; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Heindorff K, 2012, CELL CALCIUM, V52, P103, DOI 10.1016/j.ceca.2012.04.016; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; HESLOP JP, 1980, BIOCHEM J, V192, P247, DOI 10.1042/bj1920247; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; HOYER D, 1994, PHARMACOL REV, V46, P157; Knight JA, 2009, MOL PHARMACOL, V75, P374, DOI 10.1124/mol.108.052084; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lee DW, 2003, INSECT MOL BIOL, V12, P561, DOI 10.1046/j.1365-2583.2003.00441.x; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; Marg S, 2004, J INSECT PHYSIOL, V50, P821, DOI 10.1016/j.jinsphys.2004.06.004; NASSEL DR, 1985, NEUROSCIENCE, V15, P293, DOI 10.1016/0306-4522(85)90136-8; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; OSCHMAN J L, 1970, Tissue and Cell, V2, P281, DOI 10.1016/S0040-8166(70)80021-0; Papoucheva E, 2004, J BIOL CHEM, V279, P3280, DOI 10.1074/jbc.M308177200; Pietrantonio PV, 2001, INSECT MOL BIOL, V10, P357, DOI 10.1046/j.0962-1075.2001.00274.x; PRINCE WT, 1973, J EXP BIOL, V58, P367; Prioleau C, 2002, J BIOL CHEM, V277, P36577, DOI 10.1074/jbc.M206223200; RAYMOND JR, 1994, BIOCHEMISTRY-US, V33, P11264, DOI 10.1021/bi00203a023; Rein J, 2006, J EXP BIOL, V209, P1716, DOI 10.1242/jeb.02187; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schaerlinger B, 2007, DEV DYNAM, V236, P991, DOI 10.1002/dvdy.21110; Schlenstedt J, 2006, J NEUROCHEM, V98, P1985, DOI 10.1111/j.1471-4159.2006.04012.x; Schmidt Ruth, 2008, BMC Physiology, V8, P10, DOI 10.1186/1472-6793-8-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thamm M, 2010, CELL MOL LIFE SCI, V67, P2467, DOI 10.1007/s00018-010-0350-6; TRIMMER BA, 1985, J EXP BIOL, V114, P307; Troppmann B, 2010, BRIT J PHARMACOL, V159, P1450, DOI 10.1111/j.1476-5381.2010.00638.x; Vetter I, 2010, BIOCHEM PHARMACOL, V79, P908, DOI 10.1016/j.bcp.2009.10.020; Voss M, 2010, AM J PHYSIOL-CELL PH, V298, pC1047, DOI 10.1152/ajpcell.00328.2009; Wachten S, 2006, J NEUROCHEM, V96, P1580, DOI 10.1111/j.1471-4159.2006.03666.x; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Xie XD, 1999, FEBS LETT, V456, P63, DOI 10.1016/S0014-5793(99)00918-7; Yao Y, 2010, NEUROSCIENCE, V169, P87, DOI 10.1016/j.neuroscience.2010.04.042; Zgombick JM, 1996, N-S ARCH PHARMACOL, V354, P226; Zimmermann B, 1997, J PHYSIOL-LONDON, V500, P17, DOI 10.1113/jphysiol.1997.sp021995	60	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49459	10.1371/journal.pone.0049459	http://dx.doi.org/10.1371/journal.pone.0049459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145175	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500110
J	Schobel, N; Radtke, D; Lubbert, M; Gisselmann, G; Lehmann, R; Cichy, A; Schreiner, BSP; Altmuller, J; Spector, AC; Spehr, J; Hatt, H; Wetzel, CH				Schoebel, Nicole; Radtke, Debbie; Luebbert, Matthias; Gisselmann, Guenter; Lehmann, Ramona; Cichy, Annika; Schreiner, Benjamin S. P.; Altmueller, Janine; Spector, Alan C.; Spehr, Jennifer; Hatt, Hanns; Wetzel, Christian H.			Trigeminal Ganglion Neurons of Mice Show Intracellular Chloride Accumulation and Chloride-Dependent Amplification of Capsaicin-Induced Responses	PLOS ONE			English	Article							OLFACTORY SENSORY NEURONS; CA2+-ACTIVATED CL-CHANNELS; DORSAL-ROOT; NA-K-2CL COTRANSPORTER; IN-VITRO; NA+-K+-2CL(-) COTRANSPORTER; SOMATOSENSORY SYSTEM; NKCC1 COTRANSPORTER; RECEPTOR-CELLS; PAIN PATHWAY	Intracellular Cl- concentrations ([Cl-](i)) of sensory neurons regulate signal transmission and signal amplification. In dorsal root ganglion (DRG) and olfactory sensory neurons (OSNs), Cl- is accumulated by the Na+-K+-2Cl(-) cotransporter 1 (NKCC1), resulting in a [Cl-] i above electrochemical equilibrium and a depolarizing Cl- efflux upon Cl- channel opening. Here, we investigate the [Cl-](i) and function of Cl- in primary sensory neurons of trigeminal ganglia (TG) of wild type (WT) and NKCC1(-/-) mice using pharmacological and imaging approaches, patch-clamping, as well as behavioral testing. The [Cl-](i) of WT TG neurons indicated active NKCC1-dependent Cl- accumulation. Gamma-aminobutyric acid (GABA) A receptor activation induced a reduction of [Cl-](i) as well as Ca2+ transients in a corresponding fraction of TG neurons. Ca2+ transients were sensitive to inhibition of NKCC1 and voltage-gated Ca2+ channels (VGCCs). Ca2+ responses induced by capsaicin, a prototypical stimulus of transient receptor potential vanilloid subfamily member-1 (TRPV1) were diminished in NKCC1(-/-) TG neurons, but elevated under conditions of a lowered [Cl-](o) suggesting a Cl--dependent amplification of capsaicin-induced responses. Using next generation sequencing (NGS), we found expression of different Ca2(+-)activated Cl- channels (CaCCs) in TGs of mice. Pharmacological inhibition of CaCCs reduced the amplitude of capsaicin-induced responses of TG neurons in Ca2+ imaging and electrophysiological recordings. In a behavioral paradigm, NKCC1(-/-) mice showed less avoidance of the aversive stimulus capsaicin. In summary, our results strongly argue for a Ca2+-activated Cl--dependent signal amplification mechanism in TG neurons that requires intracellular Cl- accumulation by NKCC1 and the activation of CaCCs.	[Schoebel, Nicole; Radtke, Debbie; Luebbert, Matthias; Gisselmann, Guenter; Lehmann, Ramona; Schreiner, Benjamin S. P.; Hatt, Hanns; Wetzel, Christian H.] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Schoebel, Nicole; Lehmann, Ramona] Univ Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Cichy, Annika; Spehr, Jennifer] Rheinisch Westfael TH Aachen Univ, Inst Biol 2, Aachen, Germany; [Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Wetzel, Christian H.] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Spector, Alan C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); RWTH Aachen University; University of Cologne; University of Regensburg; State University System of Florida; Florida State University	Schobel, N (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	nicole.schoebel@gmx.de	Wetzel, Christian/C-2501-2009; Spector, Alan/W-2925-2019; Wetzel, Christian/F-1366-2018; Wetzel, Christian H/N-9880-2017	Wetzel, Christian/0000-0002-5762-0003; Wetzel, Christian H/0000-0002-5762-0003; Cichy, Annika/0000-0002-4620-7854; Altmuller, Janine/0000-0003-4372-1521	Deutsche Forschungsgemeinschaft [736]; International Graduate School of Neuroscience - IGSN; Ruhr-University Research School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Neuroscience - IGSN; Ruhr-University Research School	NS was funded by the Deutsche Forschungsgemeinschaft Graduate Programme 736 "Development and Plasticity of the Nervous System'' and the "International Graduate School of Neuroscience - IGSN''. NS, DR and ML received support by the doctorate program of the "Ruhr-University Research School''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAMIRANO AA, 1987, J GEN PHYSIOL, V89, P669, DOI 10.1085/jgp.89.5.669; Alvarez-Leefmans FJ, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P439; ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; BADER CR, 1987, J PHYSIOL-LONDON, V394, P125, DOI 10.1113/jphysiol.1987.sp016863; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cattaert D, 1999, J NEUROSCI, V19, P6079, DOI 10.1523/JNEUROSCI.19-14-06079.1999; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Cho H, 2012, NAT NEUROSCI; CURRIE KPM, 1992, BRIT J PHARMACOL, V106, P593, DOI 10.1111/j.1476-5381.1992.tb14381.x; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Eccles, 2013, PHYSL SYNAPSES; Evans SR, 2004, J BIOL CHEM, V279, P41792, DOI 10.1074/jbc.M408354200; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; French AS, 2006, NEUROSCI RES, V55, P189, DOI 10.1016/j.neures.2006.03.002; Funk K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-32; Galan A, 2005, NEUROSCIENCE, V133, P245, DOI 10.1016/j.neuroscience.2005.02.025; Gilbert D, 2007, INT J DEV NEUROSCI, V25, P479, DOI 10.1016/j.ijdevneu.2007.08.001; Gorman C M, 1990, Curr Opin Biotechnol, V1, P36, DOI 10.1016/0958-1669(90)90008-9; Granados-Soto V, 2005, PAIN, V114, P231, DOI 10.1016/j.pain.2004.12.023; Harr B, 2010, MOL ECOL, V19, P228, DOI 10.1111/j.1365-294X.2009.04490.x; Hayasaki H, 2006, EUR J NEUROSCI, V23, P745, DOI 10.1111/j.1460-9568.2006.04602.x; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Valencia-de Ita S, 2006, J NEUROPHYSIOL, V95, P3553, DOI 10.1152/jn.01091.2005; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kaneko H, 2001, AM J PHYSIOL-CELL PH, V280, pC1387, DOI 10.1152/ajpcell.2001.280.6.C1387; Klasen K, 2012, PFLUG ARCH EUR J PHY, V463, P779, DOI 10.1007/s00424-012-1098-7; Klein JD, 1999, AM J PHYSIOL-CELL PH, V277, pC425, DOI 10.1152/ajpcell.1999.277.3.C425; KONCZ C, 1994, AM J PHYSIOL-HEART C, V267, pH2114, DOI 10.1152/ajpheart.1994.267.6.H2114; KONDO E, 1994, MOL BRAIN RES, V21, P363, DOI 10.1016/0169-328X(94)90269-0; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Leverkoehne I, 2002, HISTOCHEM CELL BIOL, V118, P11, DOI 10.1007/s00418-002-0420-4; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Luebbert M, 2010, PFLUG ARCH EUR J PHY, V459, P737, DOI 10.1007/s00424-009-0782-8; MAYER ML, 1985, J PHYSIOL-LONDON, V364, P217, DOI 10.1113/jphysiol.1985.sp015740; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Nickell WT, 2006, J NEUROPHYSIOL, V95, P2003, DOI 10.1152/jn.00962.2005; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Price TJ, 2006, BRAIN RES, V1112, P146, DOI 10.1016/j.brainres.2006.07.012; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reuter D, 1998, J NEUROSCI, V18, P6623; Rocha-Gonzalez HI, 2008, J NEUROPHYSIOL, V100, P169, DOI 10.1152/jn.01007.2007; Rothermel M, 2007, J NEUROVIROL, V13, P579, DOI 10.1080/13550280701586419; Ruan HZ, 2003, HISTOCHEM CELL BIOL, V120, P415, DOI 10.1007/s00418-003-0579-3; SCHLICHTER R, 1989, NEUROSCIENCE, V30, P585, DOI 10.1016/0306-4522(89)90153-X; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; Spehr J, 2004, EUR J NEUROSCI, V19, P2497, DOI 10.1111/j.0953-816X.2004.03329.x; STAPLETON SR, 1994, BRIT J PHARMACOL, V111, P57, DOI 10.1111/j.1476-5381.1994.tb14023.x; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Sung KW, 2000, J NEUROSCI, V20, P7531; Suzuki M, 2006, EXP PHYSIOL, V91, P141, DOI 10.1113/expphysiol.2005.031773; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Toyoda H, 2005, MOL BRAIN RES, V133, P12, DOI 10.1016/j.molbrainres.2004.09.015; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VERKMAN AS, 1989, ANAL BIOCHEM, V178, P355, DOI 10.1016/0003-2697(89)90652-0; Willis EF, 2004, CLIN EXP ALLERGY, V34, P450, DOI 10.1111/j.1365-2222.2004.01898.x; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	73	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48005	10.1371/journal.pone.0048005	http://dx.doi.org/10.1371/journal.pone.0048005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144843	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500014
J	Wheelhouse, NM; Sait, M; Aitchison, K; Livingstone, M; Wright, F; McLean, K; Inglis, NF; Smith, DGE; Longbottom, D				Wheelhouse, Nick M.; Sait, Michelle; Aitchison, Kevin; Livingstone, Morag; Wright, Frank; McLean, Kevin; Inglis, Neil F.; Smith, David G. E.; Longbottom, David			Processing of Chlamydia abortus Polymorphic Membrane Protein 18D during the Chlamydial Developmental Cycle	PLOS ONE			English	Article							GENOME SEQUENCE; MULTIPLE ALIGNMENTS; MASS-SPECTROMETRY; PSITTACI; TRACHOMATIS; AUTOTRANSPORTER; IDENTIFICATION; EXPRESSION; THROUGHPUT; PATHOGEN	Background: Chlamydia possess a unique family of autotransporter proteins known as the Polymorphic membrane proteins (Pmps). While the total number of pmp genes varies between Chlamydia species, all encode a single pmpD gene. In both Chlamydia trachomatis (C. trachomatis) and C. pneumoniae, the PmpD protein is proteolytically cleaved on the cell surface. The current study was carried out to determine the cleavage patterns of the PmpD protein in the animal pathogen C. abortus (termed Pmp18D). Methodology/Principal Findings: Using antibodies directed against different regions of Pmp18D, proteomic techniques revealed that the mature protein was cleaved on the cell surface, resulting in a100 kDa N-terminal product and a 60 kDa carboxy-terminal protein. The N-terminal protein was further processed into 84, 76 and 73 kDa products. Clustering analysis resolved PmpD proteins into three distinct clades with C. abortus Pmp18D, being most similar to those originating from C. psittaci, C. felis and C. caviae. Conclusions/Significance: This study indicates that C. abortus Pmp18D is proteolytically processed at the cell surface similar to the proteins of C. trachomatis and C. pneumoniae. However, patterns of cleavage are species-specific, with low sequence conservation of PmpD across the genus. The absence of conserved domains indicates that the function of the PmpD molecule in chlamydia remains to be elucidated.	[Wheelhouse, Nick M.; McLean, Kevin; Inglis, Neil F.] Moredun Res Inst, Moredun Prote Facil, Edinburgh EH17 7JH, Midlothian, Scotland; [Wright, Frank] Biomath & Stat Scotland, Dundee, Scotland; [Smith, David G. E.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Moredun Research Institute; James Hutton Institute; University of Glasgow	Wheelhouse, NM (corresponding author), Moredun Res Inst, Moredun Prote Facil, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	nick.wheelhouse@moredun.ac.uk	Longbottom, David/GWZ-8448-2022; Smith, David/N-9743-2018; Wright, Frank/N-3510-2013	Longbottom, David/0000-0003-0086-8443; Smith, David/0000-0002-2484-2603; Sait, Michelle/0000-0001-8782-6128; Wheelhouse, Nick/0000-0002-2803-0055	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Biotechnology and Biological Sciences Research Council [BB/E018939/1]; BBSRC [BB/E018939/1] Funding Source: UKRI	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, http://www.scotland.gov.uk) and by grant no. BB/E018939/1 from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken ID., 2007, DIS SHEEP, V4, P105, DOI [10.1002/9780470753316.ch16, DOI 10.1002/9780470753316.CH16]; Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GRAHAM SP, 1995, J COMP PATHOL, V112, P185, DOI 10.1016/S0021-9975(05)80060-X; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Kiselev AO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000568; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Longbottom D, 1998, INFECT IMMUN, V66, P1317, DOI 10.1128/IAI.66.4.1317-1324.1998; Longbottom D, 1996, FEMS MICROBIOL LETT, V142, P277; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Taylor GK, 2005, RAPID COMMUN MASS SP, V19, P3420, DOI 10.1002/rcm.2225; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Voigt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035097; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wheelhouse N, 2012, VET MICROBIOL; Wheelhouse N, 2009, VET RES, V40, DOI 10.1051/vetres/2009030	28	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49190	10.1371/journal.pone.0049190	http://dx.doi.org/10.1371/journal.pone.0049190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145118	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000312269500085
J	Clark, J; Silvaggi, JM; Kiselak, T; Zheng, KN; Clore, EL; Dai, Y; Bass, CE; Simon, DK				Clark, Joanne; Silvaggi, Jessica M.; Kiselak, Tomas; Zheng, Kangni; Clore, Elizabeth L.; Dai, Ying; Bass, Caroline E.; Simon, David K.			Pgc-1 alpha Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased Bdnf	PLOS ONE			English	Article							COACTIVATOR 1-ALPHA PGC-1-ALPHA; TYROSINE-HYDROXYLASE EXPRESSION; NEUROTROPHIC FACTOR; TRANSCRIPTIONAL COACTIVATOR; DOPAMINERGIC-NEURONS; RAT MODEL; MITOCHONDRIAL DYSFUNCTION; ADENOASSOCIATED VIRUS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA	Multiple mechanisms likely contribute to neuronal death in Parkinson's disease (PD), including mitochondrial dysfunction and oxidative stress. Peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) positively regulates the expression of genes required for mitochondrial biogenesis and the cell's antioxidant responses. Also, expression of PGC-1 alpha-regulated genes is low in substantia nigra (SN) neurons in early PD. Thus upregulation of PGC-1 alpha is a candidate neuroprotective strategy in PD. Here, an adeno-associated virus (AAV) was used to induce unilateral overexpression of Pgc-1 alpha, or a control gene, in the SN of wild-type C57BL/6CR mice. Three weeks after AAV administration, mice were treated with saline or MPTP. Overexpression of Pgc-1 alpha in the SN induced expression of target genes, but unexpectedly it also greatly reduced the expression of tyrosine hydroxylase (Th) and other markers of the dopaminergic phenotype with resultant severe loss of striatal dopamine. Reduced Th expression was associated with loss of Pitx3, a transcription factor that is critical for the development and maintenance of dopaminergic cells. Expression of the neurotrophic factor Bdnf, which also is regulated by Pitx3, similarly was reduced. Overexpression of Pgc-1 alpha also led to increased sensitivity to MPTP-induced death of Th+ neurons. Pgc-1 alpha overexpression alone, in the absence of MPTP treatment, did not lead to cell loss in the SN or to loss of dopaminergic terminals. These data demonstrate that overexpression of Pgc-1 alpha results in dopamine depletion associated with lower levels of Pitx3 and enhances susceptibility to MPTP. These data may have ramifications for neuroprotective strategies targeting overexpression of PGC-1 alpha in PD.	[Clark, Joanne; Kiselak, Tomas; Zheng, Kangni; Clore, Elizabeth L.; Dai, Ying; Simon, David K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Silvaggi, Jessica M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Bass, Caroline E.] SUNY Buffalo, Sch Med & Biosci, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Clark, J (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA.	jclark3@bidmc.harvard.edu		Bass, Caroline/0000-0002-5856-6387	National Parkinson Foundation; National Research Service Award [F32DK075253-02]; Michael J. Fox Foundation; Mentored Research Scientist Development Award [K01DA024763]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK075253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA024763] Funding Source: NIH RePORTER	National Parkinson Foundation; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Mentored Research Scientist Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by a National Parkinson Foundation "Mega-Research Project" Award (DKS), a National Research Service Award (F32DK075253-02, JMS), a Target Validation award from the Michael J. Fox Foundation (DKS) and a Mentored Research Scientist Development Award (K01DA024763, CEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618; CLARK J, 2008, ANTIOXID REDOX SIGNA; Clark J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-69; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; De BP, 2006, MOL THER, V13, P67, DOI 10.1016/j.ymthe.2005.09.003; Doskeland AP, 2002, EUR J BIOCHEM, V269, P1561, DOI 10.1046/j.1432-1033.2002.02808.x; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; FRIM DM, 1994, P NATL ACAD SCI USA, V91, P5104, DOI 10.1073/pnas.91.11.5104; Fukuchi M, 2010, BRAIN RES, V1366, P18, DOI 10.1016/j.brainres.2010.10.034; Galpern WR, 1996, CELL TRANSPLANT, V5, P225, DOI 10.1016/0963-6897(95)02030-6; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Helisalmi S, 2008, J NEUROL, V255, P668, DOI 10.1007/s00415-008-0774-1; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Levivier M, 1995, J NEUROSCI, V15, P7810, DOI 10.1523/jneurosci.15-12-07810.1995; Liang HY, 2011, MUSCLE NERVE, V44, P947, DOI 10.1002/mus.22217; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lindholm D, 2012, CELL MOL LIFE SCI, V69, P2465, DOI 10.1007/s00018-012-1043-0; Loeliger MM, 2008, INVEST OPHTH VIS SCI, V49, P1282, DOI 10.1167/iovs.07-0521; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Messmer K, 2007, INT J DEV NEUROSCI, V25, P29, DOI 10.1016/j.ijdevneu.2006.11.003; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nakashima A, 2011, BIOCHEM BIOPH RES CO, V407, P343, DOI 10.1016/j.bbrc.2011.03.020; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Peng CG, 2011, J NEUROSCI, V31, P12802, DOI 10.1523/JNEUROSCI.0898-11.2011; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schapira AH, 2011, MITOCHONDRIAL CONTRI; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Simon DK, 2001, PARKINSONS DISEASE D; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Soyal SM, 2012, HUM MOL GENET, V21, P3461, DOI 10.1093/hmg/dds177; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; TSUKAHARA T, 1995, NEUROSURGERY, V37, P733, DOI 10.1227/00006123-199510000-00018; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang ZH, 2002, NEUROSCIENCE, V113, P629, DOI 10.1016/S0306-4522(02)00204-X; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Wullner U, 1996, NEUROREPORT, V7, P921; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang DH, 2008, J NEUROSCI RES, V86, P3393, DOI 10.1002/jnr.21774; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	69	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48925	10.1371/journal.pone.0048925	http://dx.doi.org/10.1371/journal.pone.0048925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145024	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800172
J	Colin, SP; Costello, JH; Dabiri, JO; Villanueva, A; Blottman, JB; Gemmell, BJ; Priya, S				Colin, Sean P.; Costello, John H.; Dabiri, John O.; Villanueva, Alex; Blottman, John B.; Gemmell, Brad J.; Priya, Shashank			Biomimetic and Live Medusae Reveal the Mechanistic Advantages of a Flexible Bell Margin	PLOS ONE			English	Article							AERODYNAMIC PERFORMANCE; SWIMMING PERFORMANCE; FLOW PATTERNS; FISH; WAKE; FIN; LOCOMOTION; FLEXIBILITY; MORPHOLOGY; JELLYFISH	Flexible bell margins are characteristic components of rowing medusan morphologies and are expected to contribute towards their high propulsive efficiency. However, the mechanistic basis of thrust augmentation by flexible propulsors remained unresolved, so the impact of bell margin flexibility on medusan swimming has also remained unresolved. We used biomimetic robotic jellyfish vehicles to elucidate that propulsive thrust enhancement by flexible medusan bell margins relies upon fluid dynamic interactions between entrained flows at the inflexion point of the exumbrella and flows expelled from under the bell. Coalescence of flows from these two regions resulted in enhanced fluid circulation and, therefore, thrust augmentation for flexible margins of both medusan vehicles and living medusae. Using particle image velocimetry (PIV) data we estimated pressure fields to demonstrate a mechanistic basis of enhanced flows associated with the flexible bell margin. Performance of vehicles with flexible margins was further enhanced by vortex interactions that occur during bell expansion. Hydrodynamic and performance similarities between robotic vehicles and live animals demonstrated that the propulsive advantages of flexible margins found in nature can be emulated by human-engineered propulsors. Although medusae are simple animal models for description of this process, these results may contribute towards understanding the performance of flexible margins among other animal lineages.	[Colin, Sean P.] Roger Williams Univ, Bristol, RI 02809 USA; [Colin, Sean P.; Costello, John H.; Gemmell, Brad J.] Whitman Ctr, Marine Biol Lab, Woods Hole, MA USA; [Costello, John H.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Dabiri, John O.] CALTECH, Grad Aeronaut Labs & Bioengn, Pasadena, CA 91125 USA; [Villanueva, Alex; Priya, Shashank] Virginia Tech, CEHMS, Blacksburg, VA USA; [Blottman, John B.] USN, Undersea Warfare Ctr, Div Newport, Newport, RI USA	Marine Biological Laboratory - Woods Hole; Providence College; California Institute of Technology; Virginia Polytechnic Institute & State University; United States Department of Defense; United States Navy	Colin, SP (corresponding author), Roger Williams Univ, Bristol, RI 02809 USA.	scolin@rwu.edu	Priya, S/GQH-7176-2022	Priya, Shashank/0000-0003-1367-3434; Colin, Sean/0000-0003-4463-5588	ONR MURI [N000140810654]; National Science Foundation [OCE 0623508]; Directorate For Geosciences [1061353] Funding Source: National Science Foundation; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	ONR MURI(MURIOffice of Naval Research); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by an ONR MURI award to SP (N000140810654) and National Science Foundation grant OCE 0623508 to JHC, SPC, JOD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alben S, 2008, J FLUID MECH, V614, P355, DOI 10.1017/S0022112008003297; Bandyopadhyay PR, 2008, J EXP BIOL, V211, P206, DOI 10.1242/jeb.012161; Blondeaux P, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2131923; Bozkurttas M, 2009, ADV SCI TECH, V58, P193; Colin SP, 2002, J EXP BIOL, V205, P427; Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524; Combes SA, 2001, J EXP BIOL, V204, P2073; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Costello JH, 1995, MAR BIOL, V124, P399, DOI 10.1007/BF00363913; Costello JH, 2008, INVERTEBR BIOL, V127, P265, DOI 10.1111/j.1744-7410.2008.00126.x; Dabiri JO, 2010, J EXP BIOL, V213, P1217, DOI 10.1242/jeb.034660; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Dong H, 2010, J FLUID MECH, V645, P345, DOI 10.1017/S0022112009992941; Drucker EG, 1999, J EXP BIOL, V202, P2393; Eldredge JD, 2009, ADV SCI TECH, V58, P212; Ford MD, 2000, SCI MAR, V64, P47; GREEN S. I., 1995, FLUID VORTICES, P427; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Joshi KB, 2011, MAR TECHNOL SOC J, V45, P165, DOI 10.4031/MTSJ.45.4.13; Lauder GV, 2006, BIOINSPIR BIOMIM, V1, pS25, DOI 10.1088/1748-3182/1/4/S04; Le TQ, 2010, J BIONIC ENG, V7, P87, DOI 10.1016/S1672-6529(09)60196-7; Lehmann FO, 2008, J EXP BIOL, V211, P224, DOI 10.1242/jeb.007575; Liu XF, 2006, EXP FLUIDS, V41, P227, DOI 10.1007/s00348-006-0152-7; Megill WM, 2005, J EXP BIOL, V208, P3819, DOI 10.1242/jeb.01765; Michelin S, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3177356; Mittal R, 2006, BIOINSPIR BIOMIM, V1, pS35, DOI 10.1088/1748-3182/1/4/S05; Muller UK, 2001, J EXP BIOL, V204, P2751; Palmisano J, 2008, BIO-MECHANISMS OF SWIMMING AND FLYING: FLUID DYNAMICS, BIOMIMETIC ROBOTS, AND SPORTS SCIENCE, P283, DOI 10.1007/978-4-431-73380-5_23; Sahin M, 2009, J EXP BIOL, V212, P2656, DOI 10.1242/jeb.025536; Smith C, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/1/012001; Spedding GR, 2009, EXP FLUIDS, V46, P749, DOI 10.1007/s00348-008-0597-y; Tangorra JL, 2010, J EXP BIOL, V213, P4043, DOI 10.1242/jeb.048017; Toomey J, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2956372; Vanella M, 2009, J EXP BIOL, V212, P95, DOI 10.1242/jeb.016428; Villanueva A., 2010, 2010 IEEE International Conference on Robotics and Biomimetics (ROBIO), P1124, DOI 10.1109/ROBIO.2010.5723486; Villanueva AA, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/2/025013; Villanueva A, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/036004; Wang TM, 2010, J BIONIC ENG, V7, P56, DOI 10.1016/S1672-6529(09)60183-9; Wolfgang MJ, 1999, J EXP BIOL, V202, P2303; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928	40	33	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48909	10.1371/journal.pone.0048909	http://dx.doi.org/10.1371/journal.pone.0048909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145016	Green Published, Green Accepted, gold			2022-12-25	WOS:000311935800167
J	Hulcr, J; Latimer, AM; Henley, JB; Rountree, NR; Fierer, N; Lucky, A; Lowman, MD; Dunn, RR				Hulcr, Jiri; Latimer, Andrew M.; Henley, Jessica B.; Rountree, Nina R.; Fierer, Noah; Lucky, Andrea; Lowman, Margaret D.; Dunn, Robert R.			A Jungle in There: Bacteria in Belly Buttons are Highly Diverse, but Predictable	PLOS ONE			English	Article							MICROBIOME; DOMINANCE; SEQUENCES	The belly button is one of the habitats closest to us, and yet it remains relatively unexplored. We analyzed bacteria and arachaea from the belly buttons of humans from two different populations sampled within a nation-wide citizen science project. We examined bacterial and archaeal phylotypes present and their diversity using multiplex pyrosequencing of 16S rDNA libraries. We then tested the oligarchy hypothesis borrowed from tropical macroecology, namely that the frequency of phylotypes in one sample of humans predicts its frequency in another independent sample. We also tested the predictions that frequent phylotypes (the oligarchs) tend to be common when present, and tend to be more phylogenetically clustered than rare phylotypes. Once rarefied to four hundred reads per sample, bacterial communities from belly buttons proved to be at least as diverse as communities known from other skin studies (on average 67 bacterial phylotypes per belly button). However, the belly button communities were strongly dominated by a few taxa: only 6 phylotypes occurred on >80% humans. While these frequent bacterial phylotypes (the archaea were all rare) are a tiny part of the total diversity of bacteria human navels (<0.3% of phylotypes), they constitute a major portion of individual reads (similar to 1/3), and are predictable among independent samples of humans, in terms of both the occurrence and evolutionary relatedness (more closely related than randomly drawn equal sets of phylotypes). Thus, the hypothesis that "oligarchs" dominate diverse assemblages appears to be supported by human-associated bacteria. Although it remains difficult to predict which species of bacteria might be found on a particular human, predicting which species are most frequent (or rare) seems more straightforward, at least for those species living in belly buttons.	[Hulcr, Jiri; Rountree, Nina R.; Lucky, Andrea; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Hulcr, Jiri; Rountree, Nina R.; Lucky, Andrea; Dunn, Robert R.] N Carolina State Univ, Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Hulcr, Jiri; Lowman, Margaret D.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Latimer, Andrew M.] Univ Calif Davis, Dept Plant Sci, Davis, CA USA; [Henley, Jessica B.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Lucky, Andrea] Univ Florida, Dept Entomol, Gainesville, FL USA; [Lowman, Margaret D.] N Carolina Museum Nat Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; State University System of Florida; University of Florida; University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Florida	Dunn, RR (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	rrdunn@ncsu.edu	Dunn, Robert/B-1360-2013; Hulcr, Jiri/AAE-4210-2019	Hulcr, Jiri/0000-0002-8706-4618; FIERER, NOAH/0000-0002-6432-4261; Dunn, Robert/0000-0002-6030-4837; Latimer, Andrew/0000-0001-8098-0448	Howard Hughes Medical Institute; TREE Foundation; NSF; Division Of Environmental Biology [1046328] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); TREE Foundation; NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	JH, RRD, NR and AL were funded by a grant from Howard Hughes Medical Institute. MDL was funded by the TREE Foundation. AML was funded by a grant from NSF. NF and JBH were funded by NSF grants to NF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bojar RA, 2002, WORLD J MICROB BIOT, V18, P889, DOI 10.1023/A:1021271028979; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Fisher B. L., 2007, ANTS N AM GUIDE GENE; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hanski I, 2012, ENV BIODIVERSITY HUM; Hubbell Stephen P., 2001, V32, pi; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Ornithologists UA, 1998, CHECK LIST; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	31	47	47	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47712	10.1371/journal.pone.0047712	http://dx.doi.org/10.1371/journal.pone.0047712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144827	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800026
J	Kanaya, S; Matsushima, Y; Yokosawa, K				Kanaya, Shoko; Matsushima, Yuka; Yokosawa, Kazuhiko			Does Seeing Ice Really Feel Cold? Visual-Thermal Interaction under an Illusory Body-Ownership	PLOS ONE			English	Article							RUBBER HAND ILLUSION; SENSATIONS; INTEGRATION; PERCEPTION; CONTACT; TOUCH	Although visual information seems to affect thermal perception (e. g. red color is associated with heat), previous studies have failed to demonstrate the interaction between visual and thermal senses. However, it has been reported that humans feel an illusory thermal sensation in conjunction with an apparently-thermal visual stimulus placed on a prosthetic hand in the rubber hand illusion (RHI) wherein an individual feels that a prosthetic (rubber) hand belongs to him/her. This study tests the possibility that the ownership of the body surface on which a visual stimulus is placed enhances the likelihood of a visual-thermal interaction. We orthogonally manipulated three variables: induced hand-ownership, visually-presented thermal information, and tactically-presented physical thermal information. Results indicated that the sight of an apparently-thermal object on a rubber hand that is illusorily perceived as one's own hand affects thermal judgments about the object physically touching this hand. This effect was not observed without the RHI. The importance of ownership of a body part that is touched by the visual object on the visual-thermal interaction discussed.	[Kanaya, Shoko; Matsushima, Yuka; Yokosawa, Kazuhiko] Univ Tokyo, Dept Psychol, Tokyo, Japan	University of Tokyo	Kanaya, S (corresponding author), Univ Tokyo, Dept Psychol, Tokyo, Japan.	skanaya@l.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS [23653221]; Grants-in-Aid for Scientific Research [23653221] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Shoko Kanaya is a Research Fellow of the Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/english/). This research was supported by Grant-in-Aid for JSPS Fellows (awarded to Shoko Kanaya) and by Grant-in-Aid for Exploratory Research (awarded to Kazuhiko Yokosawa; http://kaken.nii.ac.jp/ja/p/23653221) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; BENNETT CA, 1972, HUM FACTORS, V14, P149, DOI 10.1177/001872087201400204; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Candas Victor, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P33, DOI 10.2114/jpa.24.33; Durgin FH, 2007, PSYCHOL SCI, V18, P152, DOI 10.1111/j.1467-9280.2007.01865.x; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Green BG, 2009, ATTEN PERCEPT PSYCHO, V71, P1185, DOI 10.3758/APP.71.5.1185; Green BG, 2003, EXP BRAIN RES, V148, P290, DOI 10.1007/s00221-002-1280-9; GREEN BG, 1977, PERCEPT PSYCHOPHYS, V22, P331, DOI 10.3758/BF03199698; Ho HN, 2010, ATTEN PERCEPT PSYCHO, V72, P1666, DOI 10.3758/APP.72.6.1666; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kammers MPM, 2010, CURR BIOL, V20, P1819, DOI 10.1016/j.cub.2010.08.038; Morgan M., 1926, AM J PSYCHOL, V37, P427; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Schutz-Bosbach S, 2009, BRAIN COGNITION, V70, P136, DOI 10.1016/j.bandc.2009.01.006; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Zopf R, 2011, NEUROPSYCHOLOGIA, V49, P1287, DOI 10.1016/j.neuropsychologia.2011.02.012	22	18	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47293	10.1371/journal.pone.0047293	http://dx.doi.org/10.1371/journal.pone.0047293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144814	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800018
J	Kuriakose, S; Muleme, HM; Onyilagha, C; Singh, R; Jia, P; Uzonna, JE				Kuriakose, Shiby; Muleme, Helen M.; Onyilagha, Chukwunonso; Singh, Rani; Jia, Ping; Uzonna, Jude E.			Diminazene Aceturate (Berenil) Modulates the Host Cellular and Inflammatory Responses to Trypanosoma congolense Infection	PLOS ONE			English	Article							EXPERIMENTAL AFRICAN TRYPANOSOMIASIS; T-CELLS; MEDIATED PHAGOCYTOSIS; SUSCEPTIBLE MICE; KINETOPLAST DNA; NITRIC-OXIDE; RESISTANCE; GAMMA; ANTIBODIES; DIFFER	Background: Trypanosoma congolense are extracellular and intravascular blood parasites that cause debilitating acute or chronic disease in cattle and other domestic animals. Diminazene aceturate (Berenil) has been widely used as a chemotherapeutic agent for trypanosomiasis in livestock since 1955. As in livestock, treatment of infected highly susceptible BALB/c mice with Berenil leads to rapid control of parasitemia and survival from an otherwise lethal infection. The molecular and biochemical mechanisms of action of Berenil are still not very well defined and its effect on the host immune system has remained relatively unstudied. Here, we investigated whether Berenil has, in addition to its trypanolytic effect, a modulatory effect on the host immune response to Trypanosoma congolense. Methodology/Principal Findings: BALB/c and C57BL/6 mice were infected intraperitoneally with T. congolense, treated with Berenil and the expression of CD25 and FoxP3 on splenic cells was assessed directly ex vivo. In addition, serum levels and spontaneous and LPS-induced production of pro-inflammatory cytokines by splenic and hepatic CD11b(+) cells were determined by ELISA. Berenil treatment significantly reduced the percentages of CD25(+) cells, a concomitant reduction in the percentage of regulatory (CD4(+)Foxp3(+)) T cells and a striking reduction in serum levels of disease exacerbating pro-inflammatory cytokines including IL-6, IL-12, TNF and IFN-gamma. Furthermore, Berenil treatment significantly suppressed spontaneous and LPS-induced production of inflammatory cytokines by splenic and liver macrophages and significantly ameliorated LPS-induced septic shock and the associated cytokine storm. Conclusions/Significance: Collectively, these results provide evidence that in addition to its direct trypanolytic effect, Berenil also modulates the host immune response to the parasite in a manner that dampen excessive immune activation and production of pathology-promoting pro-inflammatory cytokines, suggesting that this drug may also be beneficial for treatment of disease conditions caused by excessive production of inflammatory cytokines.	[Kuriakose, Shiby; Muleme, Helen M.; Onyilagha, Chukwunonso; Singh, Rani; Jia, Ping; Uzonna, Jude E.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	University of Manitoba	Uzonna, JE (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	uzonna@cc.umanitoba.ca	Onyilagha, Chukwunonso/AAO-9770-2021	Onyilagha, Chukwunonso/0000-0002-5592-7095	Natural Sciences and Engineering Research Council; Manitoba Health Research Council; Manitoba Health Research Council Masters Award	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Council; Manitoba Health Research Council Masters Award	Funding for this study was provided by the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca) and the Manitoba Health Research Council (www.mhrc.mb.ca). Shiby Kuriakose is supported by Manitoba Health Research Council Masters Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRACK C, 1972, J ULTRA MOL STRUCT R, V39, P568, DOI 10.1016/S0022-5320(72)90122-0; DING L, 1993, J IMMUNOL, V151, P1224; Gonzalez VM, 1997, J INORG BIOCHEM, V68, P283, DOI 10.1016/S0162-0134(97)00111-6; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; HOMEIDA AM, 1981, J COMP PATHOL, V91, P355, DOI 10.1016/0021-9975(81)90005-0; Joubert KE, 2003, J S AFR VET ASSOC, V74, P69; Kaushik RS, 2000, CYTOKINE, V12, P1024, DOI 10.1006/cyto.2000.0685; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LUMSDEN WHR, 1965, VET REC, V77, P147; Magez S, 2006, J INFECT DIS, V193, P1575, DOI 10.1086/503808; Magez S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000122; MAHLER HR, 1973, MOL GEN GENET, V121, P285, DOI 10.1007/BF00433228; Naylor D C, 1971, Trop Anim Health Prod, V3, P95, DOI 10.1007/BF02356484; Okwor I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001761; OTESILE EB, 1987, J PARASITOL, V73, P947, DOI 10.2307/3282517; Pan WL, 2006, MICROBES INFECT, V8, P1209, DOI 10.1016/j.micinf.2005.11.009; RIOU G, 1980, BIOCHEM BIOPH RES CO, V96, P350, DOI 10.1016/0006-291X(80)91221-8; RURANGIRWA FR, 1979, INFECT IMMUN, V26, P822, DOI 10.1128/IAI.26.3.822-826.1979; Shi MQ, 2004, J LEUKOCYTE BIOL, V76, P399, DOI 10.1189/jlb.1003500; Shi MQ, 2003, EUR J IMMUNOL, V33, P108, DOI 10.1002/immu.200390013; Tabel H, 2000, MICROBES INFECT, V2, P1619, DOI 10.1016/S1286-4579(00)01318-6; TABEL H, 1982, PARASITE IMMUNOL, V4, P329, DOI 10.1111/j.1365-3024.1982.tb00444.x; Tabel H, 2008, IMMUNOL REV, V225, P128, DOI 10.1111/j.1600-065X.2008.00675.x; Taylor KA, 1996, EXP PARASITOL, V83, P106, DOI 10.1006/expr.1996.0054; Tomlinson S, 1998, PARASITOL TODAY, V14, P354, DOI 10.1016/S0169-4758(98)01295-2; Uzonna JE, 1998, J IMMUNOL, V161, P5507; Uzonna JE, 1999, PARASITE IMMUNOL, V21, P57, DOI 10.1046/j.1365-3024.1999.00202.x; Wei GJ, 2008, J IMMUNOL, V180, P2514, DOI 10.4049/jimmunol.180.4.2514	29	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48696	10.1371/journal.pone.0048696	http://dx.doi.org/10.1371/journal.pone.0048696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144931	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800101
J	Lemos, NB; Angeli, JK; Faria, TD; Ribeiro, RF; Vassallo, DV; Padilha, AS; Stefanon, I				Lemos, Nubia Belem; Angeli, Jhuli Keli; Faria, Thais de Oliveira; Ribeiro Junior, Rogerio Faustino; Vassallo, Dalton Valentim; Padilha, Alessandra Simao; Stefanon, Ivanita			Low Mercury Concentration Produces Vasoconstriction, Decreases Nitric Oxide Bioavailability and Increases Oxidative Stress in Rat Conductance Artery	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SMOOTH-MUSCLE CELLS; ENDOTHELIAL DYSFUNCTION; LIPID-PEROXIDATION; MYOCARDIAL-INFARCTION; VASCULAR REACTIVITY; EASTERN FINLAND; HEAVY-METALS; EXPOSURE; ATHEROSCLEROSIS	Mercury is an environmental pollutant that reduces nitric oxide (NO) bioavailability and increases oxidative stress, having a close link with cardiovascular diseases, as carotid atherosclerosis, myocardial infarction, coronary heart disease and hypertension. One of the main sites affected by oxidative stress, which develops atherosclerosis, is the aorta. Under acute exposure to low mercury concentrations reactive oxygen species (ROS) production were only reported for resistance vessels but if low concentrations of mercury also affect conductance arteries it is still unclear. We investigated the acute effects of 6 nM HgCl2 on endothelial function of aortic rings measuring the reactivity to phenylephrine in rings incubated, or not, with HgCl2 for 45 min, the protein expression for cyclooxygenase 2 (COX-2) and the AT1 receptor. HgCl2 increased Rmax and pD2 to phenylephrine without changing the vasorelaxation induced by acetylcholine and sodium nitroprusside. Endothelial damage abolished the increased reactivity to phenylephrine. The increase of Rmax and pD2 produced by L-NAME was smaller in the presence of HgCl2. Enalapril, losartan, indomethacin, furegrelate, the selective COX-2 inhibitor NS 398, superoxide dismutase and the NADPH oxidase inhibitor apocynin reverted HgCl2 effects on the reactivity to phenylephrine, COX-2 protein expression was increased, and AT1 expression reduced. At low concentration, below the reference values, HgCl2 increased vasoconstrictor activity by reducing NO bioavailability due to increased ROS production by NADPH oxidase activity. Results suggest that this is due to local release of angiotensin II and prostanoid vasoconstrictors. Results also suggest that acute low concentration mercury exposure, occurring time to time could induce vascular injury due to endothelial oxidative stress and contributing to increase peripheral resistance, being a high risk factor for public health.	[Lemos, Nubia Belem; Angeli, Jhuli Keli; Faria, Thais de Oliveira; Ribeiro Junior, Rogerio Faustino; Vassallo, Dalton Valentim; Padilha, Alessandra Simao; Stefanon, Ivanita] Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Espirito Santo, Brazil; [Vassallo, Dalton Valentim] EMESCAM, Escola Ensino Super Santa Casa Misericordia Vitor, Vitoria, Espirito Santo, Brazil	Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	Vassallo, DV (corresponding author), Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Espirito Santo, Brazil.	daltonv2@terra.com.br	Ribeiro, Rogerio/F-7116-2012; Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Ribeiro, Rogerio/0000-0002-9725-3869; Stefanon, Ivanita/0000-0003-2638-5183; Vassallo, Dalton/0000-0002-4463-4174	FAPES/CNPq (Fundacao de Amparo a Pesquisa do Espirito Santo/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [48511935/2009 PRONEX]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPES/CNPq (Fundacao de Amparo a Pesquisa do Espirito Santo/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from No 48511935/2009 PRONEX - FAPES/CNPq (Fundacao de Amparo a Pesquisa do Espirito Santo/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ Y, 2007, PHARM EXP THER, V321, P381, DOI DOI 10.1124/JPET.106.115287; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bernhoft RA, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/460508; Bjorkman L, 1997, TOXICOL APPL PHARM, V144, P156, DOI 10.1006/taap.1997.8128; Chen CY, 2005, CLIN CHEM, V51, P759, DOI 10.1373/clinchem.2004.042093; Choi AL, 2009, ENVIRON HEALTH PERSP, V117, P367, DOI 10.1289/ehp.11608; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Davel AP, 2011, BRAZ J MED BIOL RES, V44, P920, DOI [10.1590/S0100-879X2011007500104, 10.1590/S0100-879X2011000900014]; Eckhardt W, 1999, BIOCHEM J, V338, P695, DOI 10.1042/0264-6021:3380695; Furieri LB, 2011, BRIT J PHARMACOL, V162, P1819, DOI 10.1111/j.1476-5381.2011.01203.x; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Grotto D, 2009, ARCH TOXICOL, V83, P653, DOI 10.1007/s00204-009-0437-8; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Hu ZW, 2002, J PHARMACOL EXP THER, V303, P563, DOI 10.1124/jpet.102.037705; Huang YL, 1996, BIOL TRACE ELEM RES, V52, P193, DOI 10.1007/BF02789461; Kim SH, 2004, TOXICOL APPL PHARM, V196, P47, DOI 10.1016/j.taap.2003.11.020; Kishimoto T, 1995, TOXICOLOGY, V103, P1, DOI 10.1016/0300-483X(95)99370-R; Langworth S, 1997, J DENT RES, V76, P1397, DOI 10.1177/00220345970760071001; Mahboob M, 2001, J ENVIRON SCI HEAL B, V36, P687, DOI 10.1081/PFC-100106195; McKelvey W, 2007, ENVIRON HEALTH PERSP, V115, P1435, DOI 10.1289/ehp.10056; Mitra S, 2011, AM J MED SCI, V342, P135, DOI 10.1097/MAJ.0b013e318224a147; Pecanha FM, 2010, J PHYSIOL PHARMACOL, V61, P29; Pinheiro MCN, 2008, ENVIRON RES, V107, P53, DOI 10.1016/j.envres.2007.08.007; Rooney JPK, 2007, TOXICOLOGY, V234, P145, DOI 10.1016/j.tox.2007.02.016; Roulet M, 1998, SCI TOTAL ENVIRON, V213, P203, DOI 10.1016/S0048-9697(98)00093-X; Salonen JT, 2000, ATHEROSCLEROSIS, V148, P265, DOI 10.1016/S0021-9150(99)00272-5; SALONEN JT, 1995, CIRCULATION, V91, P645, DOI 10.1161/01.CIR.91.3.645; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Vassallo DV, 2011, BRAZ J MED BIOL RES, V44, P939, DOI 10.1590/S0100-879X2011000900016; Vassallo DV, 1999, TOXICOL APPL PHARM, V156, P113, DOI 10.1006/taap.1999.8636; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Wiggers GA, 2008, COMP BIOCHEM PHYS C, V147, P252, DOI 10.1016/j.cbpc.2007.10.003; Wolf MB, 2007, BIOMETALS, V20, P73, DOI 10.1007/s10534-006-9016-0; Wolin MS, 2000, ARTERIOSCL THROM VAS, V20, P1430, DOI 10.1161/01.ATV.20.6.1430; World Health Organization, 1991, AP ENV HLTH CRIT, V118; Zalups RK, 2000, PHARMACOL REV, V52, P113	39	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49005	10.1371/journal.pone.0049005	http://dx.doi.org/10.1371/journal.pone.0049005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145049	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800185
J	Mewis, I; Khan, MAM; Glawischnig, E; Schreiner, M; Ulrichs, C				Mewis, Inga; Khan, Mohammed A. M.; Glawischnig, Erich; Schreiner, Monika; Ulrichs, Christian			Water Stress and Aphid Feeding Differentially Influence Metabolite Composition in Arabidopsis thaliana (L.)	PLOS ONE			English	Article							BREVICORYNE-BRASSICAE; CABBAGE APHID; GLUCOSINOLATE BIOSYNTHESIS; MYZUS-PERSICAE; NITROGEN-METABOLISM; PLANT DEFENSE; PHLOEM-SAP; RESPONSES; CAMALEXIN; ACCUMULATION	Little is known about how drought stress influences plant secondary metabolite accumulation and how this affects plant defense against different aphids. We therefore cultivated Arabidopsis thaliana (L.) plants under well-watered, drought, and water-logged conditions. Two aphid species were selected for this study: the generalist Myzus persicae (Sulzer) and the crucifer specialist Brevicoryne brassicae (L.). Metabolite concentrations in the phloem sap, which influence aphid growth, changed particularly under drought stress. Levels of sucrose and several amino acids, such as glutamic acid, proline, isoleucine, and lysine increased, while concentrations of 4-methoxyindol-3-ylmethyl glucosinolate decreased. M. persicae population growth was highest on plants under drought stress conditions. However, B. brassicae did not profit from improved phloem sap quality under drought stress and performed equally in all water treatments. Water stress and aphids generally had an opposite effect on the accumulation of secondary metabolites in the plant rosettes. Drought stress and water-logging led to increased aliphatic glucosinolate and flavonoid levels. Conversely, aphid feeding, especially of M. persicae, reduced levels of flavonoids and glucosinolates in the plants. Correspondingly, transcript levels of aliphatic biosynthetic genes decreased after feeding of both aphid species. Contrary to M. persicae, drought stress did not promote population growth of B. brassicae on these plants. The specialist aphid induced expression of CYP79B2, CYP79B3, and PAD3 with corresponding accumulation of indolyl glucosinolates and camalexin. This was distinct from M. persicae, which did not elicit similarly strong camalexin accumulation, which led to the hypothesis of a specific defense adaptations against the specialist aphid.	[Mewis, Inga; Schreiner, Monika] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Qual, Grossbeeren, Germany; [Khan, Mohammed A. M.; Ulrichs, Christian] Humboldt Univ, Inst Hort Sci, Div Urban Plant Ecophysiol, D-10099 Berlin, Germany; [Glawischnig, Erich] Tech Univ Munich, Lehrstuhl Genet, Freising Weihenstephan, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Humboldt University of Berlin; Technical University of Munich	Mewis, I (corresponding author), Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Qual, Grossbeeren, Germany.	inga@entomology.de	Ulrichs, Christian/C-6055-2015	Khan, Mohammed Abul Monjur/0000-0003-1750-6318; Ulrichs, Christian/0000-0002-6733-3366; Schreiner, Monika/0000-0002-5629-4429; Glawischnig, Erich/0000-0001-9280-5065	German Academic Exchange Service (DAAD) [A0691368]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the German Academic Exchange Service (DAAD), reference no. A0691368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, AGRON SUSTAIN DEV, V30, P311, DOI 10.1051/agro/2009025; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chandra A, 1998, J AGRON CROP SCI, V181, P45, DOI 10.1111/j.1439-037X.1998.tb00396.x; Cole RA, 2003, ENTOMOLOGIA EXPT APP, V85, P121; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Gabrys B, 1997, J CHEM ECOL, V23, P1661, DOI 10.1023/B:JOEC.0000006442.56544.1a; Garg BK, 2001, BIOL PLANTARUM, V44, P289, DOI 10.1023/A:1010215812791; Geu-Flores F, 2011, PLANT CELL, V23, P2456, DOI 10.1105/tpc.111.083998; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gunduz EA, 2009, P ROY SOC B-BIOL SCI, V276, P987, DOI 10.1098/rspb.2008.1476; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Jensen CR, 1996, FIELD CROP RES, V47, P93, DOI 10.1016/0378-4290(96)00026-3; Joshi V, 2009, PLANT PHYSIOL, V151, P367, DOI 10.1104/pp.109.138651; Karley AJ, 2002, J EXP BIOL, V205, P3009; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Kelly PJ, 1998, PLANTA, V206, P370, DOI 10.1007/s004250050412; Khan MAM, 2011, CHEMOECOLOGY, V21, P235, DOI 10.1007/s00049-011-0084-4; Khan MAM, 2010, ENTOMOL EXP APPL, V137, P229, DOI 10.1111/j.1570-7458.2010.01059.x; Kim JH, 2008, PLANT J, V54, P1015, DOI 10.1111/j.1365-313X.2008.03476.x; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kim KS, 2011, PLANT AN GEN 19 C JA, P398; King C, 2006, AUST J AGR RES, V57, P439, DOI 10.1071/AR05137; KING RW, 1974, PLANT PHYSIOL, V53, P96, DOI 10.1104/pp.53.1.96; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Lattanzio V, 2000, J AGR FOOD CHEM, V48, P5316, DOI 10.1021/jf000229y; Matyssek R, 2002, PLANT BIOLOGY, V4, P133, DOI 10.1055/s-2002-25742; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Mewis I, 2012, PLANT CELL PHYSIOL, V53, P1546, DOI 10.1093/pcp/pcs096; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Pinheiro C, 2001, J EXP BOT, V52, P1063, DOI 10.1093/jexbot/52.358.1063; Pommerrenig B, 2007, PLANT PHYSIOL, V144, P1029, DOI 10.1104/pp.106.089151; Pratt C, 2008, J CHEM ECOL, V34, P323, DOI 10.1007/s10886-007-9421-z; Robbins RJ, 2005, J MED FOOD, V8, P204, DOI 10.1089/jmf.2005.8.204; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Schreiner M, 2005, EUR J NUTR, V44, P85, DOI 10.1007/s00394-004-0498-7; Schreiner M, 2009, J AGR FOOD CHEM, V57, P7259, DOI 10.1021/jf901076h; Schuhegger R, 2007, J PLANT PHYSIOL, V164, P636, DOI 10.1016/j.jplph.2006.04.012; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Sellam A, 2007, PLANT PATHOL, V56, P296, DOI 10.1111/j.1365-3059.2006.01497.x; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P71, DOI 10.1016/0022-1910(94)00073-P; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Streeter JG, 2001, PLANT CELL ENVIRON, V24, P429, DOI 10.1046/j.1365-3040.2001.00690.x; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; WEARING CH, 1972, ENTOMOL EXP APPL, V15, P61, DOI 10.1007/BF00335100; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	68	121	126	2	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48661	10.1371/journal.pone.0048661	http://dx.doi.org/10.1371/journal.pone.0048661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144921	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800091
J	An, Y; Kiang, A; Lopez, JP; Kuo, SZ; Yu, MA; Abhold, EL; Chen, JS; Wang-Rodriguez, J; Ongkeko, WM				An, Yi; Kiang, Alan; Lopez, Jay Patrick; Kuo, Selena Z.; Yu, Michael Andrew; Abhold, Eric L.; Chen, Jocelyn S.; Wang-Rodriguez, Jessica; Ongkeko, Weg M.			Cigarette Smoke Promotes Drug Resistance and Expansion of Cancer Stem Cell-Like Side Population	PLOS ONE			English	Article							CONDENSATE-INDUCED ADHESION; LUNG-CANCER; ABCG2 EXPRESSION; EPITHELIAL-CELLS; KAPPA-B; PHENOTYPE; AKT; CARCINOMA; CESSATION; NICOTINE	It is well known that many patients continue to smoke cigarettes after being diagnosed with cancer. Although smoking cessation has typically been presumed to possess little therapeutic value for cancer, a growing body of evidence suggests that continued smoking is associated with reduced efficacy of treatment and a higher incidence of recurrence. We therefore investigated the effect of cigarette smoke condensate (CSC) on drug resistance in the lung cancer and head and neck cancer cell lines A549 and UMSCC-10B, respectively. Our results showed that CSC significantly increased the cellular efflux of doxorubicin and mitoxantrone. This was accompanied by membrane localization and increased expression of the multidrug transporter ABCG2. The induced efflux of doxorubicin was reversed upon addition of the specific ABCG2 inhibitor Fumitremorgin C, confirming the role of ABCG2. Treatment with CSC increased the concentration of phosphorylated Akt, while addition of the PI3K inhibitor LY294002 blocked doxorubicin extrusion, suggesting that Akt activation is required for CSC-induced drug efflux. In addition, CSC was found to promote resistance to doxorubicin as determined by MTS assays. This CSC-induced doxurbicin-resistance was mitigated by mecamylamine, a nicotinic acetylcholine receptor inhibitor, suggesting that nicotine is at least partially responsible for the effect of CSC. Lastly, CSC increased the size of the side population (SP), which has been linked to a cancer stem cell-like phenotype. In summary, CSC promotes chemoresistance via Akt-mediated regulation of ABCG2 activity, and may also increase the proportion of cancer stem-like cells, contributing to tumor resilience. These findings underscore the importance of smoking cessation following a diagnosis of cancer, and elucidate the mechanisms of continued smoking that may be detrimental to treatment.	[An, Yi; Kiang, Alan; Lopez, Jay Patrick; Kuo, Selena Z.; Yu, Michael Andrew; Abhold, Eric L.; Chen, Jocelyn S.; Ongkeko, Weg M.] Univ Calif San Diego, Dept Surg, Div Head & Neck Surg, San Diego, CA 92103 USA; [Wang-Rodriguez, Jessica] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ongkeko, WM (corresponding author), Univ Calif San Diego, Dept Surg, Div Head & Neck Surg, San Diego, CA 92103 USA.	rongkeko@ucsd.edu		Lopez, Jay/0000-0002-7645-1620	Department of Defense (CDMRP); NCI/NIH [5 U01 CA114810-03]; NATIONAL CANCER INSTITUTE [U01CA114810] Funding Source: NIH RePORTER	Department of Defense (CDMRP)(United States Department of Defense); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Department of Defense (CDMRP) to WO and NCI/NIH 5 U01 CA114810-03 to JWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Askari MDF, 2006, PANCREAS, V33, P53, DOI 10.1097/01.mpa.0000226883.55828.e9; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Cataldo JK, 2010, ONCOLOGY-BASEL, V78, P289, DOI 10.1159/000319937; CHEN AM, 2010, INT J RAD ONCOL BIOL; Chu TS, 2008, ARCH OTOLARYNGOL, V134, P979, DOI 10.1001/archotol.134.9.979; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KALRA VK, 1994, J CELL PHYSIOL, V160, P154, DOI 10.1002/jcp.1041600118; LI F, 2010, MED ONCOL; Litman T, 2000, J CELL SCI, V113, P2011; Lopez JP, 2007, ARCH OTOLARYNGOL, V133, P1022, DOI 10.1001/archotol.133.10.1022; Matsunawa M, 2009, TOXICOL SCI, V109, P50, DOI 10.1093/toxsci/kfp044; Mogi M, 2003, J BIOL CHEM, V278, P39068, DOI 10.1074/jbc.M306362200; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; RICHARDSON GE, 1993, ANN INTERN MED, V119, P383, DOI 10.7326/0003-4819-119-5-199309010-00006; Robinson SN, 2005, BONE MARROW TRANSPL, V35, P807, DOI 10.1038/sj.bmt.1704881; Sadeu JC, 2011, FERTIL STERIL, V95, P2410, DOI 10.1016/j.fertnstert.2011.03.072; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Shen YM, 1996, AM J PHYSIOL-HEART C, V270, pH1624, DOI 10.1152/ajpheart.1996.270.5.H1624; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tan KP, 2010, MOL PHARM; To KKW, 2008, MOL CELL BIOL, V28, P5147, DOI 10.1128/MCB.00331-08; Tsunoda S, 2006, ONCOLOGY-BASEL, V71, P251, DOI 10.1159/000106787; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Xu J, 2007, INT J ORAL MAX SURG, V36, P739, DOI 10.1016/j.ijom.2007.05.016; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	37	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47919	10.1371/journal.pone.0047919	http://dx.doi.org/10.1371/journal.pone.0047919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144836	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400032
J	Pantenburg, B; Sikorski, C; Luppa, M; Schomerus, G; Konig, HH; Werner, P; Riedel-Heller, SG				Pantenburg, Birte; Sikorski, Claudia; Luppa, Melanie; Schomerus, Georg; Koenig, Hans-Helmut; Werner, Perla; Riedel-Heller, Steffi G.			Medical Students' Attitudes towards Overweight and Obesity	PLOS ONE			English	Article							REPRESENTATIVE POPULATION SURVEY; MENTAL-ILLNESS; WEIGHT BIAS; HEALTH-PROFESSIONALS; MAJOR DEPRESSION; SOCIAL DISTANCE; STIGMA; PATIENT; DISCRIMINATION; CANCER	Objective: Studies from the USA have identified medical students as a major source of stigmatizing attitudes towards overweight and obese individuals. As data from Europe is scarce, medical students' attitudes were investigated at the University of Leipzig in Leipzig, Germany. Design: Cross-sectional survey containing an experimental manipulation consisting of a pair of vignettes depicting an obese and a normal weight 42-year-old woman, respectively. Vignettes were followed by the Fat Phobia Scale (FPS), a semantic differential assessing weight related attitudes. In case of the overweight vignette a panel of questions on causal attribution for the overweight preceded administration of the FPS. Subjects: 671 medical students were enrolled at the University of Leipzig from May to June 2011. Results: The overweight vignette was rated significantly more negative than the normal weight vignette (mean FPS score 3.65 +/- 0.45 versus 2.54 +/- 0.38, p<0.001). A higher proportion of students had negative attitudes towards the overweight as compared to the normal weight individual (98.9% versus 53.7%, p<0.001). A "positive energy balance" was perceived as the most relevant cause for the overweight, followed by "negligent personality trait", "societal and social environment" and "biomedical causes". Attributing a "positive energy balance" or "negligent personality trait" as relevant cause for the overweight was positively associated with negative attitudes. Conclusion: The results of this study confirm and complement findings from other countries, mainly the USA, and indicate that weight bias in the health care setting may be a global issue. Stigmatizing attitudes towards overweight and obesity are prevalent among a sample of medical students at the University of Leipzig. Negative attitudes arise on the basis of holding the individual accountable for the excess weight. They call for bringing the topic of overweight and obesity more into the focus of the medical curriculum and for enhancing medical students' awareness of the complex aetiology of this health condition.	[Pantenburg, Birte; Sikorski, Claudia] Univ Leipzig, Integrated Res & Treatment Ctr IFB AdiposityDis, Leipzig, Germany; [Pantenburg, Birte; Sikorski, Claudia; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Schomerus, Georg] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, Stralsund, Germany; [Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol & Hlth Econ, Hamburg, Germany; [Werner, Perla] Univ Haifa, Fac Social Welf & Hlth Sci, IL-31999 Haifa, Israel	Leipzig University; Leipzig University; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Haifa	Pantenburg, B (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr IFB AdiposityDis, Leipzig, Germany.	Birte.Pantenburg@medizin.uni-leipzig.de	König, Hans-Helmut/P-1211-2018; Schomerus, Georg/A-6568-2013; Luppa, Melanie/AAQ-7338-2021; Werner, Perla/G-6008-2012; Riedel-Heller, Steffi/ABG-1537-2021	König, Hans-Helmut/0000-0001-5711-6862; Schomerus, Georg/0000-0002-6752-463X; 	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CH, 1993, WOMEN HEALTH, V20, P45, DOI 10.1300/J013v20n02_04; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Andrade Allen D, 2012, Stud Health Technol Inform, V173, P23; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Angermeyer MC, 2004, SCHIZOPHR RES, V69, P175, DOI 10.1016/S0920-9964(03)00186-5; Ashmore Jamile A, 2008, Eat Behav, V9, P203, DOI 10.1016/j.eatbeh.2007.09.006; Ata RN, 2010, OBESITY FACTS, V3, P41, DOI 10.1159/000276547; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Buckley O, 2009, EUR RADIOL, V19, P298, DOI 10.1007/s00330-008-1154-z; Chen EY, 2005, OBES RES, V13, P1393, DOI 10.1038/oby.2005.168; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Corrigan PW, 2001, PSYCHIAT SERV, V52, P953, DOI 10.1176/appi.ps.52.7.953; CRANDALL CS, 1995, BRIT J SOC PSYCHOL, V34, P67, DOI 10.1111/j.2044-8309.1995.tb01049.x; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 1996, PERS SOC PSYCHOL B, V22, P1165, DOI 10.1177/01461672962211007; CRANDALL CS, 1995, PERS SOC PSYCHOL B, V21, P724, DOI 10.1177/0146167295217007; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; CRANDALL CS, 1991, PERS SOC PSYCHOL B, V17, P606, DOI 10.1177/0146167291176002; DEJONG W, 1980, J HEALTH SOC BEHAV, V21, P75, DOI 10.2307/2136696; Drury Christine Aramburu Alegria, 2002, J Am Acad Nurse Pract, V14, P554; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Ferrante JM, 2006, J WOMENS HEALTH, V15, P531, DOI 10.1089/jwh.2006.15.531; Ferrante JM, 2006, CANCER DETECT PREV, V30, P459, DOI 10.1016/j.cdp.2006.09.003; Friedman KE, 2008, OBESITY, V16, pS69, DOI 10.1038/oby.2008.457; Harkness JA, 2008, ROUND 4 ESS TRANSLAT; Hebl MR, 2001, INT J OBESITY, V25, P1246, DOI 10.1038/sj.ijo.0801681; Heuer CA, 2011, J HEALTH COMMUN, V16, P976, DOI 10.1080/10810730.2011.561915; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Hilbert A, 2009, OBESITY FACTS, V2, P46, DOI 10.1159/000195697; Huizinga MM, 2010, OBESITY, V18, P1932, DOI 10.1038/oby.2010.35; Huizinga MM, 2009, J GEN INTERN MED, V24, P1236, DOI 10.1007/s11606-009-1104-8; Karnehed N, 2006, OBESITY, V14, P1421, DOI 10.1038/oby.2006.161; King DR, 2010, CRIT CARE MED, V38, pS478, DOI 10.1097/CCM.0b013e3181ec54f6; KLEIN D, 1982, J FAM PRACTICE, V14, P881; Latner JD, 2005, OBES RES, V13, P1226, DOI 10.1038/oby.2005.145; Lewis S, 2011, SOC SCI MED, V73, P1349, DOI 10.1016/j.socscimed.2011.08.021; Neary NM, 2004, CLIN ENDOCRINOL, V60, P153, DOI 10.1046/j.1365-2265.2003.01839.x; Patten SB, 2011, J AFFECT DISORDERS, V134, P288, DOI 10.1016/j.jad.2011.06.027; Persky S, 2011, INT J OBESITY, V35, P728, DOI 10.1038/ijo.2010.173; Pinfold V, 2005, INT REV PSYCHIATR, V17, P123, DOI 10.1080/09540260500073638; PINGITORE R, 1994, J APPL PSYCHOL, V79, P909, DOI 10.1037/0021-9010.79.6.909; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl R, 2009, J AM DIET ASSOC, V109, P438, DOI 10.1016/j.jada.2008.11.034; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; ROTHBLUM ED, 1990, J VOCAT BEHAV, V37, P251, DOI 10.1016/0001-8791(90)90044-3; Ruggs EN, 2010, OBESITY FACTS, V3, P60, DOI 10.1159/000273208; Schomerus G, 2009, PSYCHOL MED, V39, P1855, DOI 10.1017/S0033291709005832; Schomerus G, 2010, PSYCHIAT PRAX, V37, P111, DOI 10.1055/s-0029-1223438; Schwartz MB, 2003, OBES RES, V11, P1033, DOI 10.1038/oby.2003.142; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Sikorski C, 2012, SCAND J PUBLIC HEALT, V40, P271, DOI 10.1177/1403494812443604; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; Wear D, 2006, ACAD MED, V81, P454, DOI 10.1097/01.ACM.0000222277.21200.a1; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; Wigton RS, 2001, J GEN INTERN MED, V16, P262, DOI 10.1046/j.1525-1497.2001.016004262.x	57	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48113	10.1371/journal.pone.0048113	http://dx.doi.org/10.1371/journal.pone.0048113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032TG	23144850	Green Submitted, gold, Green Published			2022-12-25	WOS:000310741400038
J	Cai, R; Yu, TT; Huang, C; Xia, XF; Liu, XB; Gu, JM; Xue, S; Yeh, ETH; Cheng, JK				Cai, Rong; Yu, Tingting; Huang, Chao; Xia, Xuefeng; Liu, Xiaobing; Gu, Jianmin; Xue, Song; Yeh, Edward T. H.; Cheng, Jinke			SUMO-specific Protease 1 Regulates Mitochondrial Biogenesis through PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; COACTIVATOR PGC-1-BETA; RECEPTOR-ALPHA; ERR-ALPHA; PHOSPHORYLATION; HOMEOSTASIS; SENP5; AMPK	Peroxisome proliferator-activated receptor gamma (PPAR gamma) coactivator 1 alpha (PGC-1 alpha) is a master regulator of mitochondrial biogenesis in response to changes in the cellular environment, physiological or pathological status of mammals. PGC-1 alpha is known to be modified by SUMO (Small Ubiquitin-like Modifier). However, it is not known whether SUMOylation could affect the function of PGC-1 alpha in mitochondrial biogenesis and that how PGC-1 alpha SUMOylation is regulated. In this study, we have identified the role of Sentrin/SUMO-specific protease 1 (SENP1) as a specific SUMO protease to regulate SUMOylation status of PGC-1 alpha. More importantly, we have also found that SENP1 promotes PGC-1 alpha transcription activity, which is essential for the expression of mitochondrial genes and subsequently mitochondrial biogenesis. Thus, we reveal that the SUMOylation of PGC-1 alpha controlled by SENP1 plays an important role in mitochondrial biogenesis and function.	[Cai, Rong; Yu, Tingting; Huang, Chao; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Liu, Xiaobing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Affiliated 9, Shanghai 200011, Peoples R China; [Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200438, Peoples R China; [Gu, Jianmin; Xue, Song] Shanghai Jiao Tong Univ, Sch Med, Shanghai RenJi Hosp Affiliated, Shanghai 200001, Peoples R China; [Xia, Xuefeng] Methodist Hosp, Res Inst, Weill Cornell Sch Med, Houston, TX 77030 USA; [Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Huang, Chao; Liu, Xiaobing; Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute	Cheng, JK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, 280 Chongqing S Rd, Shanghai 200025, Peoples R China.	jkcheng@shsmu.edu.cn	yu, tingting/HGA-4783-2022	huang, chao/0000-0002-4913-921X	National Natural Science Foundation of China [91019021]; National Basic Research Program of China (973 Program) [2010CB912104]; Shanghai Committee of Science and Technology [11XD1403200, 11DZ2260200]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China (91019021 to J. C.), National Basic Research Program of China (973 Program) (No. 2010CB912104 to J. C.), and Shanghai Committee of Science and Technology (11XD1403200 to J. C., 11DZ2260200).	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Michel S, 2012, J CELL PHYSIOL, V227, P2297, DOI 10.1002/jcp.23021; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	34	30	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44464	44470		10.1074/jbc.M112.422626	http://dx.doi.org/10.1074/jbc.M112.422626			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152500	hybrid, Green Published			2022-12-25	WOS:000312938600042
J	Haddow, LJ; Moosa, MYS; Mosam, A; Moodley, P; Parboosing, R; Easterbrook, PJ				Haddow, Lewis John; Moosa, Mahomed-Yunus Suleman; Mosam, Anisa; Moodley, Pravi; Parboosing, Raveen; Easterbrook, Philippa Jane			Incidence, Clinical Spectrum, Risk Factors and Impact of HIV-Associated Immune Reconstitution Inflammatory Syndrome in South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RESTORATION DISEASE; INFECTED PATIENTS; EARLY MORTALITY; CRYPTOCOCCAL ANTIGENEMIA; CASE-DEFINITION; HERPES-ZOSTER; TUBERCULOSIS; INITIATION; ADULTS	Background: Immune reconstitution inflammatory syndrome (IRIS) is a widely recognised complication of antiretroviral therapy (ART), but there are still limited data from resource-limited settings. Our objective was to characterize the incidence, clinical spectrum, risk factors and contribution to mortality of IRIS in two urban ART clinics in South Africa. Methods and Findings: 498 adults initiating ART in Durban, South Africa were followed prospectively for 24 weeks. IRIS diagnosis was based on consensus expert opinion, and classified by mode of presentation (paradoxical worsening of known opportunistic infection [OI] or unmasking of subclinical disease). 114 patients (22.9%) developed IRIS (36% paradoxical, 64% unmasking). Mucocutaneous conditions accounted for 68% of IRIS events, mainly folliculitis, warts, genital ulcers and herpes zoster. Tuberculosis (TB) accounted for 25% of IRIS events. 18/135 (13.3%) patients with major pre-ART OIs (e.g. TB, cryptococcosis) developed paradoxical IRIS related to the same OI. Risk factors for this type of IRIS were baseline viral load > 5.5 vs. < 4.5 log(10) (adjusted hazard ratio 7.23; 95% confidence interval 1.35-38.76) and <= 30 vs. > 30 days of OI treatment prior to ART (2.66; 1.16-6.09). Unmasking IRIS related to major OIs occurred in 25/498 patients (5.0%), and risk factors for this type of IRIS were baseline C-reactive protein >= 25 vs. <= 25 mg/L (2.77; 1.31-5.85), haemoglobin < 10 vs. > 12 g/dL (3.36; 1.32-8.52), >= 10% vs. < 10% weight loss prior to ART (2.31; 1.05-5.11) and mediastinal lymphadenopathy on pre-ART chest x-ray (9.15; 4.10-20.42). IRIS accounted for 6/25 (24%) deaths, 13/65 (20%) hospitalizations and 10/35 (29%) ART interruptions or discontinuations. Conclusion: IRIS occurred in almost one quarter of patients initiating ART, and accounted for one quarter of deaths in the first 6 months. Priority strategies to reduce IRIS-associated morbidity and mortality in ART programmes include earlier ART initiation before onset of advanced immunodeficiency, improved pre-ART screening for TB and cryptococcal infection, optimization of OI therapy prior to ART initiation, more intensive clinical monitoring in initial weeks of ART, and education of health care workers and patients about IRIS.	[Haddow, Lewis John; Moosa, Mahomed-Yunus Suleman; Easterbrook, Philippa Jane] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Infect Dis, Durban, South Africa; [Haddow, Lewis John] UCL, Ctr Sexual Hlth & HIV Res, Res Dept Infect & Populat Hlth, London, England; [Mosam, Anisa] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Dermatol, Durban, South Africa; [Moodley, Pravi; Parboosing, Raveen] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Virol, Durban, South Africa; [Moodley, Pravi; Parboosing, Raveen] Inkosi Albert Luthuli Cent Hosp, Natl Hlth Lab Serv, Durban, South Africa	University of Kwazulu Natal; University of London; University College London; University of Kwazulu Natal; University of Kwazulu Natal	Easterbrook, PJ (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Infect Dis, Durban, South Africa.	easterbrookp@who.int	Parboosing, Raveen/T-1933-2019	Parboosing, Raveen/0000-0002-5476-1011; Easterbrook, Philippa/0000-0002-2603-5418; Haddow, Lewis/0000-0003-3016-2986; Moodley, Pravi/0000-0002-9946-8783	Doris Duke Charitable Foundation [2006029]; Medical Research Council UK (Clinical Research Training Fellowship) [G0700530]; British Society for Antimicrobial Chemotherapy [GA745]; UK National Institutes of Health Research Senior Investigator Award; MRC [G0700530] Funding Source: UKRI; Medical Research Council [G0700530] Funding Source: researchfish	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Medical Research Council UK (Clinical Research Training Fellowship)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Society for Antimicrobial Chemotherapy; UK National Institutes of Health Research Senior Investigator Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Doris Duke Charitable Foundation (grant number 2006029), the Medical Research Council UK (Clinical Research Training Fellowship number G0700530), and the British Society for Antimicrobial Chemotherapy (Research Grant GA745). PE is a recipient of a UK National Institutes of Health Research Senior Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID INT TUB CAS FIN; [Anonymous], 2004, NAT ANT TREATM GUID; Baalwa J, 2008, AFR HEALTH SCI, V8, P190; Bicanic T, 2009, JAIDS-J ACQ IMM DEF, V51, P130, DOI 10.1097/QAI.0b013e3181a56f2e; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Bouscarat F, 2000, AIDS, V14, P617, DOI 10.1097/00002030-200003310-00019; Bower M, 2005, J CLIN ONCOL, V23, P5224, DOI 10.1200/JCO.2005.14.597; Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Delfos NM, 2004, AIDS, V18, P701, DOI 10.1097/00002030-200403050-00019; Dunic I, 2005, INT J STD AIDS, V16, P475, DOI 10.1258/0956462054308404; Easterbrook PJ, 2008, AIDS, V22, P643, DOI 10.1097/QAD.0b013e3282f4a621; Espinosa E, 2009, HIV MED, V10, P454, DOI 10.1111/j.1468-1293.2009.00700.x; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; French Martyn A, 2007, Curr HIV/AIDS Rep, V4, P16, DOI 10.1007/s11904-007-0003-z; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Haddow LJ, 2010, LANCET INFECT DIS, V10, P791, DOI 10.1016/S1473-3099(10)70170-5; Haddow LJ, 2010, AIDS, V24, P103, DOI 10.1097/QAD.0b013e32832ec1f4; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; Haddow LJ, 2009, AIDS, V23, P1609, DOI 10.1097/QAD.0b013e32832c41f4; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Huruy K, 2008, JPN J INFECT DIS, V61, P205; Jarvis JN, 2011, 6 IAS C HIV PATH TRE; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Jevtovic D, 2005, HIV MED, V6, P140, DOI 10.1111/j.1468-1293.2005.00277.x; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kumarasamy N, 2004, JAIDS-J ACQ IMM DEF, V37, P1574, DOI 10.1097/00126334-200412150-00007; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Letang E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016946; Letang E, 2010, JAIDS-J ACQ IMM DEF, V53, P589, DOI 10.1097/QAI.0b013e3181bc476f; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Manabe YC, 2007, JAIDS-J ACQ IMM DEF, V46, P456, DOI 10.1097/QAI.0b013e3181594c8c; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Michailidis C, 2005, ANTIVIR THER, V10, P417; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Navas E, 2002, ARCH INTERN MED, V162, P97, DOI 10.1001/archinte.162.1.97; Rajendran PM, 2005, ARCH DERMATOL, V141, P1227, DOI 10.1001/archderm.141.10.1227; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Robertson J, 2006, CLIN INFECT DIS, V42, P1639, DOI 10.1086/503903; Sharma SK, 2010, INDIAN J MED RES, V131, P804; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Shelburne SA, 2005, CLIN INFECT DIS, V40, P1049, DOI 10.1086/428618; UNAIDS, 2010, REP GLOB AIDS EP; Valin N, 2010, AIDS, V24, P1519, DOI 10.1097/QAD.0b013e3283396007; Vidal JE, 2008, REV INST MED TROP SP, V50, P209, DOI 10.1590/S0036-46652008000400004; World Health Organization, 2011, RAP ADV DIAGN PREV M; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	67	56	57	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e40623	10.1371/journal.pone.0040623	http://dx.doi.org/10.1371/journal.pone.0040623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152745	Green Submitted, Green Published, gold			2022-12-25	WOS:000311234000001
J	Schor, IE; Lleres, D; Risso, GJ; Pawellek, A; Ule, J; Lamond, AI; Kornblihtt, AR				Schor, Ignacio E.; Lleres, David; Risso, Guillermo J.; Pawellek, Andrea; Ule, Jernej; Lamond, Angus I.; Kornblihtt, Alberto R.			Perturbation of Chromatin Structure Globally Affects Localization and Recruitment of Splicing Factors	PLOS ONE			English	Article							POLYMERASE-II TRANSCRIPTION; IN-VIVO; RNA; GENE; PROTEINS; EXON; ORGANIZATION; PARASPECKLES; SEQUENCE; DYNAMICS	Chromatin structure is an important factor in the functional coupling between transcription and mRNA processing, not only by regulating alternative splicing events, but also by contributing to exon recognition during constitutive splicing. We observed that depolarization of neuroblastoma cell membrane potential, which triggers general histone acetylation and regulates alternative splicing, causes a concentration of SR proteins in nuclear speckles. This prompted us to analyze the effect of chromatin structure on splicing factor distribution and dynamics. Here, we show that induction of histone hyperacetylation results in the accumulation in speckles of multiple splicing factors in different cell types. In addition, a similar effect is observed after depletion of the heterochromatic protein HP1 alpha, associated with repressive chromatin. We used advanced imaging approaches to analyze in detail both the structural organization of the speckle compartment and nuclear distribution of splicing factors, as well as studying direct interactions between splicing factors and their association with chromatin in vivo. The results support a model where perturbation of normal chromatin structure decreases the recruitment efficiency of splicing factors to nascent RNAs, thus causing their accumulation in speckles, which buffer the amount of free molecules in the nucleoplasm. To test this, we analyzed the recruitment of the general splicing factor U2AF65 to nascent RNAs by iCLIP technique, as a way to monitor early spliceosome assembly. We demonstrate that indeed histone hyperacetylation decreases recruitment of U2AF65 to bulk 3' splice sites, coincident with the change in its localization. In addition, prior to the maximum accumulation in speckles, similar to 20% of genes already show a tendency to decreased binding, while U2AF65 seems to increase its binding to the speckle-located ncRNA MALAT1. All together, the combined imaging and biochemical approaches support a model where chromatin structure is essential for efficient co-transcriptional recruitment of general and regulatory splicing factors to pre-mRNA.	[Schor, Ignacio E.; Risso, Guillermo J.; Kornblihtt, Alberto R.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol,Dept Fisiol Biol Mol & Celu, Inst Fisiol Biol Mol & Neurociencias,Consejo Nacl, Buenos Aires, DF, Argentina; [Lleres, David; Pawellek, Andrea; Lamond, Angus I.] Univ Dundee, Dundee Ctr Gene Regulat & Express, Dundee, Scotland; [Ule, Jernej] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Dundee; MRC Laboratory Molecular Biology	Kornblihtt, AR (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol,Dept Fisiol Biol Mol & Celu, Inst Fisiol Biol Mol & Neurociencias,Consejo Nacl, Buenos Aires, DF, Argentina.	ark@fbmc.fcen.uba.ar	Ule, Jernej/C-6315-2013; Llères, David/G-9157-2018; Schor, Ignacio/M-6793-2019	Ule, Jernej/0000-0002-2452-4277; Llères, David/0000-0003-1630-8758; Schor, Ignacio/0000-0002-8566-6471; Lamond, Angus/0000-0001-6204-6045; Kornblihtt, Alberto/0000-0003-4322-0831	University of Buenos Aires [UBACYT-X112]; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET); Howard Hughes Medical Institute; European Alternative Splicing Network (EURASNET, European Union Network of Excellence) [518238]; Medical Research Council [U105185858]; Wellcome Trust [073980/Z/03/B]; European Molecular Biology Organization (EMBO); International Union of Biochemistry and Molecular Biology (IUBMB);  [PICT2010-0202]; Medical Research Council [MC_U105185858] Funding Source: researchfish; MRC [MC_U105185858] Funding Source: UKRI	University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Alternative Splicing Network (EURASNET, European Union Network of Excellence); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); International Union of Biochemistry and Molecular Biology (IUBMB); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Argentina (PICT2010-0202, URL: http://www.agencia.gov.ar/), the University of Buenos Aires (UBACYT-X112, URL: http://www.uba.ar/), Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET) (no number, URL: http://www.conicet.gov.ar/web/conicet/inicio), Howard Hughes Medical Institute (no number, URL: http://www.hhmi.org/) and the European Alternative Splicing Network (EURASNET, European Union Network of Excellence # 518238, URL: http://www.eurasnet.info/). Grants were provided to J.U. by the Medical Research Council (U105185858, URL: http://www.mrc.ac.uk/index.htm). Grants to A.I.L. were provided by Wellcome Trust (073980/Z/03/B, URL: http://www.hhmi.org/). The Scottish Universities Life Sciences Alliance (SULSA, URL: http://www.sulsa.ac.uk/) supports the use of OMX microscope. Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET, URL: http://www.conicet.gov.ar/web/conicet/inicio) funded a post-doctoral fellowship for I.E.S. and funds a doctoral fellowship for G.R. European Molecular Biology Organization (EMBO, URL: http://www.embo.org/) funded a short-term fellowship for I.E.S. International Union of Biochemistry and Molecular Biology (IUBMB, URL: http://www.iubmb.org/) funded a Wood-Whelan fellowhsip for I.E.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI G, 1991, EMBO J, V10, P3457, DOI 10.1002/j.1460-2075.1991.tb04910.x; Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bjork P, 2009, J CELL BIOL, V184, P555, DOI 10.1083/jcb.200806156; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Carmo-Fonseca M, 2011, NAT CELL BIOL, V13, P110, DOI 10.1038/ncb0211-110; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chusainow J, 2005, RNA, V11, P1201, DOI 10.1261/rna.7277705; Cramer P, 2001, FEBS LETT, V498, P179, DOI 10.1016/S0014-5793(01)02485-1; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Ellis JD, 2008, J CELL BIOL, V181, P921, DOI 10.1083/jcb.200710051; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; Huranova M, 2010, J CELL BIOL, V191, P75, DOI 10.1083/jcb.201004030; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Lleres David, 2007, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1210s42; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; Rino J, 2007, PLOS COMPUT BIOL, V3, P2019, DOI 10.1371/journal.pcbi.0030201; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schor IE, 2010, EPIGENETICS, V5; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Serrano A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005118; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Sleeman J, 1998, EXP CELL RES, V243, P290, DOI 10.1006/excr.1998.4135; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; SPECTOR DL, 1983, BIOL CELL, V49, P1; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.3.11319; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	65	42	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48084	10.1371/journal.pone.0048084	http://dx.doi.org/10.1371/journal.pone.0048084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152763	Green Published, gold, Green Submitted			2022-12-25	WOS:000311234000006
J	Zehender, G; Pariani, E; Piralla, A; Lai, A; Gabanelli, E; Ranghiero, A; Ebranati, E; Amendola, A; Campanini, G; Rovida, F; Ciccozzi, M; Galli, M; Baldanti, F; Zanetti, AR				Zehender, Gianguglielmo; Pariani, Elena; Piralla, Antonio; Lai, Alessia; Gabanelli, Elena; Ranghiero, Alberto; Ebranati, Erika; Amendola, Antonella; Campanini, Giulia; Rovida, Francesca; Ciccozzi, Massimo; Galli, Massimo; Baldanti, Fausto; Zanetti, Alessandro Remo			Reconstruction of the Evolutionary Dynamics of the A(H1N1)pdm09 Influenza Virus in Italy during the Pandemic and Post-Pandemic Phases	PLOS ONE			English	Article							POSITIVE SELECTION; HEMAGGLUTININ; ORIGIN; SUBSTITUTION; MODEL; RATES	The aim of this study was to reconstruct the evolutionary dynamics of the A(H1N1)pdm09 influenza virus in Italy during two epidemic seasons (2009/2010 and 2010/2011) in the light of the forces driving the evolution of the virus. Nearly six thousands respiratory specimens were collected from patients with influenza-like illness within the framework of the Italian Influenza Surveillance Network, and the A(H1N1)pdm09 hemagglutinin (HA) gene was amplified and directly sequenced from 227 of these. Phylodynamic and phylogeographical analyses were made using a Bayesian Markov Chain Monte Carlo method, and codon-specific positive selection acting on the HA coding sequence was evaluated. The global and local phylogenetic analyses showed that all of the Italian sequences sampled in the post-pandemic (2010/2011) season grouped into at least four highly significant Italian clades, whereas those of the pandemic season (2009/2010) were interspersed with isolates from other countries at the tree root. The time of the most recent common ancestor of the strains circulating in the pandemic season in Italy was estimated to be between the spring and summer of 2009, whereas the Italian clades of the post-pandemic season originated in the spring of 2010 and showed radiation in the summer/autumn of the same year; this was confirmed by a Bayesian skyline plot showing the biphasic growth of the effective number of infections. The local phylogeography analysis showed that the first season of infection originated in Northern Italian localities with high density populations, whereas the second involved less densely populated localities, in line with a gravity-like model of geographical dispersion. Two HA sites, codons 97 and 222, were under positive selection. In conclusion, the A(H1N1)pdm09 virus was introduced into Italy in the spring of 2009 by means of multiple importations. This was followed by repeated founder effects in the post-pandemic period that originated specific Italian clades. Citation: Zehender G, Pariani E, Piralla A, Lai A, Gabanelli E, et al. (2012) Reconstruction of the Evolutionary Dynamics of the A(H1N1)pdm09 Influenza Virus in Italy during the Pandemic and Post-Pandemic Phases. PLoS ONE 7(11): e47517. doi: 10.1371/journal.pone.0047517	[Zehender, Gianguglielmo; Lai, Alessia; Gabanelli, Elena; Ebranati, Erika; Galli, Massimo] Univ Milan, Sez Malattie Infett, Dipartimento Sci Clin & Biomed Luigi Sacco, Milan, Italy; [Pariani, Elena; Ranghiero, Alberto; Amendola, Antonella; Zanetti, Alessandro Remo] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy; [Piralla, Antonio; Campanini, Giulia; Rovida, Francesca; Baldanti, Fausto] Fdn Ist Ricovero & Cura Carattere Sci Policlin Sa, Pavia, Italy; [Ciccozzi, Massimo] Ist Super Sanita, Dipartimento Malattie Infett, I-00161 Rome, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Istituto Superiore di Sanita (ISS)	Zehender, G (corresponding author), Univ Milan, Sez Malattie Infett, Dipartimento Sci Clin & Biomed Luigi Sacco, Milan, Italy.	gianguglielmo.zehender@unimi.it	Amendola, Antonella/M-8980-2016; Ranghiero, Alberto/AAR-8131-2020; Pariani, Elena/M-3491-2016; Ciccozzi, Massimo/AAC-3271-2022; Baldanti, Fausto/J-4924-2018; CICCOZZI, MASSIMO/C-6484-2016; Campanini, Giulia/J-4889-2018; LAI, ALESSIA/AAR-1300-2021; Piralla, Antonio/K-4756-2018; Rovida, Francesca/K-7984-2016; GALLI, MASSIMO/L-7282-2017	Amendola, Antonella/0000-0002-0499-8977; Pariani, Elena/0000-0001-5681-3455; Ciccozzi, Massimo/0000-0003-3866-9239; Baldanti, Fausto/0000-0002-3358-8969; CICCOZZI, MASSIMO/0000-0003-3866-9239; Campanini, Giulia/0000-0002-3536-2437; LAI, ALESSIA/0000-0002-3174-5721; Piralla, Antonio/0000-0002-6062-2579; Rovida, Francesca/0000-0003-2345-2790; GALLI, MASSIMO/0000-0001-8887-6215	Direzione Generale Sanita, Regione Lombardia [5988, 30/6/2011]; Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente [80622]; Progetto Cariplo, Milan, Italy	Direzione Generale Sanita, Regione Lombardia(Regione Lombardia); Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente(Ministry of Health, Italy); Progetto Cariplo, Milan, Italy	This study was supported by grants from Direzione Generale Sanita, Regione Lombardia (Grant No. 5988, 30/6/2011), Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente (grant no. 80622), Progetto Cariplo 2012, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellis J, 2011, EUROSURVEILLANCE, V16, P2; ELLIS JS, 1995, ARCH VIROL, V140, P1889, DOI 10.1007/BF01322680; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Galiano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023779; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kilander A, 2010, EURO SURVEILL, V15; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Li XH, 2011, INT J ENV RES PUB HE, V8, P3134, DOI 10.3390/ijerph8083134; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Lycett S, 2012, J GEN VIROL, V93, P1253, DOI 10.1099/vir.0.039370-0; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Network WGIS, 2011, MAN LAB DIAGN VIR SU; Piralla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028332; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tse H, 2011, EXP BIOL MED, V236, P915, DOI 10.1258/ebm.2011.010264; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wei Hu, 2010, Journal of Biomedical Science & Engineering, V3, P227, DOI 10.4236/jbise.2010.33031; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236	41	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e47517	10.1371/journal.pone.0047517	http://dx.doi.org/10.1371/journal.pone.0047517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152755	Green Published, gold			2022-12-25	WOS:000312272600004
J	Zhang, PJ; Cao, GL; Sheng, J; Xue, RY; Gong, CL				Zhang, Pengjie; Cao, Guangli; Sheng, Jie; Xue, Renyu; Gong, Chengliang			BmTGIF, a Bombyx mori Homolog of Drosophila DmTGIF, Regulates Progression of Spermatogenesis	PLOS ONE			English	Article							SMAD TRANSCRIPTIONAL COREPRESSOR; MEIOTIC CELL-CYCLE; TERMINAL DIFFERENTIATION GENES; DNA-BINDING SPECIFICITY; HOMEODOMAIN PROTEINS; HOMEOBOX GENES; INTERACTING-FACTOR; MYELOID-LEUKEMIA; TALE SUPERCLASS; TGIF	TG-interacting factor (TGIF) in Drosophila consists of two tandemly-repeated genes, achintya (Dmachi) and vismay (Dmvis), which act as transcriptional activators in Drosophila spermatogenesis. In contrast, TGIF in humans is a transcriptional repressor that binds directly to DNA or interacts with corepressors to repress the transcription of target genes. In this study, we investigated the characteristics and functions of BmTGIF, a Bombyx mori homolog of DmTGIF. Like DmTGIF, BmTGIF is predominantly expressed in the testes and ovaries. Four alternatively spliced isoforms could be isolated from testes, and two isoforms from ovaries. Quantitative polymerase chain reaction indicated BmTGIF was abundantly expressed in the testis of 3rd instar larvae, when the testis is almost full of primary spermatocytes. The results of luciferase assays indicated that BmTGIF contains two adjacent acidic domains that activate the transcription of reporter genes. Immunofluorescence assay in BmN cells showed that the BmTGIF protein was located mainly in the nucleus, and paraffin sections of testis showed BmTGIF was grossly expressed in primary spermatocytes and mature sperms. Consistent with the role of DmVis in Drosophila development, BmTGIF significantly affected spermatid differentiation, as indicated by hematoxylin-eosin staining of paraffin sections of testis from BmTGIF-small interfering RNA (siRNA)-injected male silkworms. Co-immunoprecipitation experiments suggested that BmTGIF interacted with BmAly, and that they may recruit other factors to form a complex to regulate the genes required for meiotic divisions and spermatid differentiation. The results of this analysis of BmTGIF will improve our understanding of the mechanism of spermatid differentiation in B. mori, with potential applications for pest control. Citation: Zhang P, Cao G, Sheng J, Xue R, Gong C (2012) BmTGIF, a Bombyx mori Homolog of Drosophila DmTGIF, Regulates Progression of Spermatogenesis. PLoS ONE 7(11): e47861. doi:10.1371/journal.pone.0047861	[Zhang, Pengjie; Cao, Guangli; Sheng, Jie; Xue, Renyu; Gong, Chengliang] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Cao, Guangli; Xue, Renyu; Gong, Chengliang] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Gong, CL (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China.	gongcl@suda.edu.cn			National Basic Research Program of China (973 Program) [2012CB114600]; Natural Science Foundation of Jiangsu Province [BK2009117]; National Natural Science Foundation of China [31072085]; Key Fostering Project for Application Research of Soochow University [Q3134991]; Specialized Research Fund for the Doctoral Program of Higher Education [20113201130002]; Priority Academic Program of Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Fostering Project for Application Research of Soochow University; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program of Development of Jiangsu Higher Education Institutions	This project is supported by the National Basic Research Program of China (973 Program, 2012CB114600), the Natural Science Foundation of Jiangsu Province (BK2009117), the National Natural Science Foundation of China (31072085), the Key Fostering Project for Application Research of Soochow University (Q3134991), the Specialized Research Fund for the Doctoral Program of Higher Education (20113201130002), and a project funded by the Priority Academic Program of Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara H, 1999, MOL CELL BIOL, V19, P8219; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; Ayyar S, 2003, DEVELOPMENT, V130, P2841, DOI 10.1242/dev.00513; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Fuller Margaret T., 1993, P71; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hamid R, 2008, BBA-GENE REGUL MECH, V1779, P347, DOI 10.1016/j.bbagrm.2008.04.003; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Ho CKM, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-10; Hyman CA, 2003, MOL CELL BIOL, V23, P9262, DOI 10.1128/MCB.23.24.9262-9274.2003; Imoto I, 2000, BIOCHEM BIOPH RES CO, V276, P264, DOI 10.1006/bbrc.2000.3449; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Jiang JQ, 2007, DEVELOPMENT, V134, P1549, DOI 10.1242/dev.000521; Jiang JQ, 2003, DEVELOPMENT, V130, P563, DOI 10.1242/dev.00246; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kawamura N, 2000, J MORPHOL, V246, P53, DOI 10.1002/1097-4687(200011)246:2<53::AID-JMOR1>3.0.CO;2-P; KEMPHUES KJ, 1982, CELL, V31, P655, DOI 10.1016/0092-8674(82)90321-X; Knoepfler PS, 1996, NUCLEIC ACIDS RES, V24, P2288, DOI 10.1093/nar/24.12.2288; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; Lin TY, 1996, DEVELOPMENT, V122, P1331; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Melhuish TA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-2; Melhuish TA, 2001, J BIOL CHEM, V276, P32109, DOI 10.1074/jbc.M103377200; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Miyagawa Y, 2005, INSECT MOL BIOL, V14, P245, DOI 10.1111/j.1365-2583.2005.00553.x; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; OVERHAUSER J, 1995, AM J HUM GENET, V57, P1080; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Perezgasga L, 2004, DEVELOPMENT, V131, P1691, DOI 10.1242/dev.01032; PESCHON JJ, 1987, P NATL ACAD SCI USA, V84, P5316, DOI 10.1073/pnas.84.15.5316; PHILLIPS CL, 1994, BIOCHEMISTRY-US, V33, P9294, DOI 10.1021/bi00197a033; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Polanska MA, 2005, J EXP ZOOL PART A, V303A, P1013, DOI 10.1002/jez.a.227; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHULZ RA, 1990, DEVELOPMENT, V108, P613; Sharma M, 2001, MOL ENDOCRINOL, V15, P1918, DOI 10.1210/me.15.11.1918; Shimoda M, 2007, ZOOL SCI, V24, P1036, DOI 10.2108/zsj.24.1036; Sprules T, 2000, BIOCHEMISTRY-US, V39, P9943, DOI 10.1021/bi0001067; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; TREISMAN J, 1989, CELL, V59, P553; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Wang ZH, 2003, DEVELOPMENT, V130, P2853, DOI 10.1242/dev.00510; White-Cooper H, 2000, DEVELOPMENT, V127, P5463; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wotton D, 2001, CELL GROWTH DIFFER, V12, P457; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamashiki N, 1998, DEV GROWTH DIFFER, V40, P619, DOI 10.1046/j.1440-169X.1998.t01-4-00006.x; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199	64	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e47861	10.1371/journal.pone.0047861	http://dx.doi.org/10.1371/journal.pone.0047861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152760	gold, Green Submitted, Green Published			2022-12-25	WOS:000312272600008
J	Buss, LW; Anderson, C; Westerman, E; Kritzberger, C; Poudyal, M; Moreno, MA; Lakkis, FG				Buss, Leo W.; Anderson, Christopher; Westerman, Erica; Kritzberger, Chad; Poudyal, Monita; Moreno, Maria A.; Lakkis, Fadi G.			Allorecognition Triggers Autophagy and Subsequent Necrosis in the Cnidarian Hydractinia symbiolongicarpus	PLOS ONE			English	Article							ANEMONE ANTHOPLEURA-ELEGANTISSIMA; NECROTIC CELL-DEATH; SEA-ANEMONES; INTRASPECIFIC AGGRESSION; INTERSPECIFIC AGGRESSION; CAENORHABDITIS-ELEGANS; MONITORING AUTOPHAGY; HYDROID HYDRACTINIA; METRIDIUM-SENILE; CATCH TENTACLES	Transitory fusion is an allorecognition phenotype displayed by the colonial hydroid Hydractinia symbiolongicarpus when interacting colonies share some, but not all, loci within the allorecognition gene complex (ARC). The phenotype is characterized by an initial fusion followed by subsequent cell death resulting in separation of the two incompatible colonies. We here characterize this cell death process using scanning electron microscopy (SEM), transmission electron microscopy (TEM), and continuous in vivo digital microscopy. These techniques reveal widespread autophagy and subsequent necrosis in both colony and grafted polyp assays. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays and ultrastructural observations revealed no evidence of apoptosis. Pharmacological inhibition of autophagy using 3-methyladenine (3-MA) completely suppressed transitory fusion in vivo in colony assays. Rapamycin did not have a significant effect in the same assays. These results establish the hydroid allorecognition system as a novel model for the study of cell death.	[Buss, Leo W.; Anderson, Christopher; Westerman, Erica; Kritzberger, Chad; Poudyal, Monita] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Moreno, Maria A.] Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT USA; [Lakkis, Fadi G.] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Dept Surg, Pittsburgh, PA USA; [Lakkis, Fadi G.] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Dept Immunol, Pittsburgh, PA USA	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	leo.buss@yale.edu		Kritzberger, Chad/0000-0002-3997-6938	National Science Foundation [IOS-0818295]	National Science Foundation(National Science Foundation (NSF))	Funding by the National Science Foundation (IOS-0818295), www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rawi S, 2012, AUTOPHAGY, V8, P421, DOI 10.4161/auto.19242; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; BIGGER CH, 1980, BIOL BULL, V159, P117, DOI 10.2307/1541013; BLACKSTONE NW, 1991, BIOL BULL, V180, P394, DOI 10.2307/1542340; BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; BUSS LW, 1990, TRENDS ECOL EVOL, V5, P352, DOI 10.1016/0169-5347(90)90093-S; BUSS LW, 1990, NATURE, V343, P63, DOI 10.1038/343063a0; Cadavid LF, 2004, GENETICS, V167, P357, DOI 10.1534/genetics.167.1.357; Calvo-Garrido J, 2010, AUTOPHAGY, V6, P686, DOI 10.4161/auto.6.6.12513; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Deretic V., 2006, AUTOPHAGY IMMUNITY I; Enari M, 1998, NATURE, V393, P396, DOI 10.1038/30782; FALCIERI E, 1994, SCANNING MICROSCOPY, V8, P653; Fengsrud M, 2004, AUTOPHAGY; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; FRANCIS L, 1976, BIOL BULL, V150, P361, DOI 10.2307/1540678; FRANCIS L, 1973, BIOL BULL, V144, P64, DOI 10.2307/1540147; FRANCIS L, 1973, BIOL BULL, V144, P73, DOI 10.2307/1540148; Giusti C, 2009, BBA-MOL CELL RES, V1793, P1422, DOI 10.1016/j.bbamcr.2008.12.005; Gloria-Soria A, 2012, MOL BIOL EVOLUTION; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hartog J, 1977, P 3 INT COR REEF S, V1, P463; HAUENSCHILD C, 1956, Z NATURFORSCH PT B, V11, P132; Hauenschild C, 1954, Wilhelm Roux Arch Entwickl Mech Org, V147, P1, DOI 10.1007/BF00576821; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HILDEMANN WH, 1977, NATURE, V270, P219, DOI 10.1038/270219a0; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2004, AUTOPHAGY; Kunzel T, 2010, DEV BIOL, V348, P120, DOI 10.1016/j.ydbio.2010.08.017; LANG J, 1973, B MAR SCI, V23, P260; LANGE R, 1989, J EXP ZOOL, V249, P284, DOI 10.1002/jez.1402490307; LANGE RG, 1992, J EXP ZOOL, V262, P307, DOI 10.1002/jez.1402620311; Mokady O, 1996, GENETICS, V143, P823; MULLER AW, 1964, WILHEM ROUX ARCH, V155, P182; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Nicotra ML, 2005, BIOL BULL-US, V208, P157, DOI 10.2307/3593147; Nicotra ML, 2009, CURR BIOL, V19, P1; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Otto G, 2003, J BIOL CHEM, V278; Petiot A, 2000, J BIOL CHEM, V275, P12360; Powell AE, 2007, GENETICS, V177, P2101, DOI 10.1534/genetics.107.075689; Powell AE, 2011, G3-GENES GENOM GENET, V1, P499, DOI 10.1534/g3.111.001149; PURCELL JE, 1982, BIOL BULL, V162, P345, DOI 10.2307/1540988; PURCELL JE, 1977, BIOL BULL, V153, P355, DOI 10.2307/1540441; Rosa SFP, 2010, CURR BIOL, V20, P1122, DOI 10.1016/j.cub.2010.04.050; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Sato M, 2012, AUTOPHAGY, V8, P424, DOI 10.4161/auto.19243; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seipp S, 2001, DEVELOPMENT, V128, P4891; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; SHENK MA, 1991, J EXP ZOOL, V257, P80, DOI 10.1002/jez.1402570111; SHEPPARD CRC, 1979, MAR ECOL PROG SER, V1, P237, DOI 10.3354/meps001237; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Toth ML, 2007, J CELL SCI, V120, P1134, DOI 10.1242/jcs.03401; Vellai T, 2007, AUTOPHAGY, V3, P461, DOI 10.4161/auto.4282; WATSON GM, 1983, BIOL BULL, V164, P506, DOI 10.2307/1541259; WATSON GM, 1983, TISSUE CELL, V15, P939, DOI 10.1016/0040-8166(83)90059-9; WELLINGTON GM, 1980, OECOLOGIA, V47, P340, DOI 10.1007/BF00398527; WILLIAMS RB, 1978, J MAR BIOL ASSOC UK, V58, P787; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Zecher D, 2012, TRANSPL IMMUNOL, V26, P113, DOI 10.1016/j.trim.2011.12.006; Zecher D, 2009, J IMMUNOL, V183, P7810, DOI 10.4049/jimmunol.0902194; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	72	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48914	10.1371/journal.pone.0048914	http://dx.doi.org/10.1371/journal.pone.0048914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145018	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500046
J	Kluber, LA; Carrino-Kyker, SR; Coyle, KP; DeForest, JL; Hewins, CR; Shaw, AN; Smemo, KA; Burke, DJ				Kluber, Laurel A.; Carrino-Kyker, Sarah R.; Coyle, Kaitlin P.; DeForest, Jared L.; Hewins, Charlotte R.; Shaw, Alanna N.; Smemo, Kurt A.; Burke, David J.			Mycorrhizal Response to Experimental pH and P Manipulation in Acidic Hardwood Forests	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGAL COMMUNITIES; SOIL CHEMISTRY; SUGAR MAPLE; PHOSPHORUS; NITROGEN; GROWTH; COLONIZATION; DEPOSITION; DIVERSITY; ROOTS	Many temperate forests of the Northeastern United States and Europe have received significant anthropogenic acid and nitrogen (N) deposition over the last century. Although temperate hardwood forests are generally thought to be N-limited, anthropogenic deposition increases the possibility of phosphorus (P) limiting productivity in these forest ecosystems. Moreover, inorganic P availability is largely controlled by soil pH and biogeochemical theory suggests that forests with acidic soils (i.e., <pH 5) are particularly vulnerable to P limitation. Results from previous studies in these systems are mixed with evidence both for and against P limitation. We hypothesized that shifts in mycorrhizal colonization and community structure help temperate forest ecosystems overcome an underlying P limitation by accessing mineral and organic P sources that are otherwise unavailable for direct plant uptake. We examined arbuscular mycorrhizal (AM) and ectomycorrhizal (EcM) communities and soil microbial activity in an ecosystem- level experiment where soil pH and P availability were manipulated in mixed deciduous forests across eastern Ohio, USA. One year after treatment initiation, AM root biomass was positively correlated with the most available P pool, resin P, while AM colonization was negatively correlated. In total, 15,876 EcM root tips were identified and assigned to 26 genera and 219 operational taxonomic units (97% similarity). Ectomycorrhizal richness and root tip abundance were negatively correlated with the moderately available P pools, while the relative percent of tips colonized by Ascomycetes was positively correlated with soil pH. Canonical correspondence analysis revealed regional, but not treatment, differences in AM communities, while EcM communities had both treatment and regional differences. Our findings highlight the complex interactions between mycorrhizae and the soil environment and further underscore the fact that mycorrhizal communities do not merely reflect the host plant community. Citation: Kluber LA, Carrino-Kyker SR, Coyle KP, DeForest JL, Hewins CR, et al. (2012) Mycorrhizal Response to Experimental pH and P Manipulation in Acidic Hardwood Forests. PLoS ONE 7(11): e48946. doi:10.1371/journal.pone.0048946	[Kluber, Laurel A.; Carrino-Kyker, Sarah R.; Coyle, Kaitlin P.; Burke, David J.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Kluber, Laurel A.; Carrino-Kyker, Sarah R.; Hewins, Charlotte R.; Smemo, Kurt A.; Burke, David J.] Holden Arboretum, Kirtland, OH USA; [DeForest, Jared L.; Shaw, Alanna N.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Smemo, Kurt A.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Case Western Reserve University; University System of Ohio; Ohio University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Kluber, LA (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	laurel.kluber@ars.usda.gov	Shaw, Alanna/J-4385-2019; DeForest, Jared/E-5777-2011	Shaw, Alanna/0000-0002-6405-5225; Kyker, Sarah/0000-0002-4758-5718; Kluber, Laurel/0000-0002-9302-9413; DeForest, Jared/0000-0002-8390-9126	National Science Foundation [DEB 0918581, 0918167]; Holden Arboretum Trust; Corning Institute for Education and Research; Ohio University's Undergraduate Program to Aid Career Exploration (PACE); Division Of Environmental Biology [0918167] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Holden Arboretum Trust; Corning Institute for Education and Research; Ohio University's Undergraduate Program to Aid Career Exploration (PACE); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the National Science Foundation (DEB 0918581 and 0918167), The Holden Arboretum Trust and the Corning Institute for Education and Research provided research funds to DJB and KAS, and Ohio University's Undergraduate Program to Aid Career Exploration (PACE) supported ANS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2002, COLOR ATLAS ECTOMYCO; Aguilera P, 2011, SOIL BIOL BIOCHEM, V43, P2427, DOI 10.1016/j.soilbio.2011.09.001; Alkan N, 2006, APPL ENVIRON MICROB, V72, P4192, DOI 10.1128/AEM.02889-05; Antunes PM, 2007, PEDOBIOLOGIA, V51, P281, DOI 10.1016/j.pedobi.2007.04.007; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Avis PG, 2006, MOL ECOL, V15, P873, DOI 10.1111/j.1365-294X.2005.02842.x; Avis PG, 2005, MOL ECOL NOTES, V5, P969, DOI 10.1111/j.1471-8286.2005.01105.x; Avis PG, 2003, NEW PHYTOL, V160, P239, DOI 10.1046/j.1469-8137.2003.00865.x; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Boerner REJ, 2005, SOIL BIOL BIOCHEM, V37, P1419, DOI 10.1016/j.soilbio.2004.12.012; BOLAN NS, 1991, PLANT SOIL, V134, P189, DOI 10.1007/BF00012037; Burke DJ, 2008, AM J BOT, V95, P1416, DOI 10.3732/ajb.0800184; Burke DJ, 2009, APPL ENVIRON MICROB, V75, P7639, DOI 10.1128/AEM.01648-09; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cairney JWG, 2011, PLANT SOIL, V344, P51, DOI 10.1007/s11104-011-0731-0; Casson NJ, 2012, ENVIRON MONIT ASSESS, V184, P5917, DOI 10.1007/s10661-011-2390-2; Colwell R. K., 2006, ESTIMATES VERSION 8; Coughlan AP, 2000, CAN J FOREST RES, V30, P1543, DOI 10.1139/cjfr-30-10-1543; DeForest JL, 2012, BIOGEOCHEMISTRY, V109, P189, DOI 10.1007/s10533-011-9619-6; DeForest JL, 2011, NORTHEAST NAT, V18, P177, DOI 10.1656/045.018.0204; DeForest JL, 2010, SOIL SCI SOC AM J, V74, P2059, DOI 10.2136/sssaj2009.0426; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Dickie IA, 2009, CAN J FOREST RES, V39, P1069, DOI 10.1139/X09-036; DIGHTON J, 1987, NEW PHYTOL, V107, P191, DOI 10.1111/j.1469-8137.1987.tb04893.x; Drummond A, 2009, GENEIOUS V5 4; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; ERLAND S, 1990, NEW PHYTOL, V115, P675, DOI 10.1111/j.1469-8137.1990.tb00499.x; Finzi AC, 2009, BIOGEOCHEMISTRY, V92, P217, DOI 10.1007/s10533-009-9286-z; Garcia-Montero LG, 2009, SOIL BIOL BIOCHEM, V41, P1227, DOI 10.1016/j.soilbio.2009.03.003; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GRIFFITHS RP, 1994, SOIL BIOL BIOCHEM, V26, P331, DOI 10.1016/0038-0717(94)90282-8; Groffman PM, 2011, SOIL BIOL BIOCHEM, V43, P2441, DOI 10.1016/j.soilbio.2011.08.011; Heijne B, 1996, PLANT SOIL, V179, P197, DOI 10.1007/BF00009329; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; HUNG LL, 1983, MYCOLOGIA, V75, P234, DOI 10.2307/3792807; Isayenkov S, 2004, J PLANT PHYSIOL, V161, P1379, DOI 10.1016/j.jplph.2004.04.012; Jongmans AG, 1997, NATURE, V389, P682, DOI 10.1038/39493; Juice SM, 2006, ECOLOGY, V87, P1267, DOI 10.1890/0012-9658(2006)87[1267:ROSMTC]2.0.CO;2; Kjoller R, 2012, NEW PHYTOL, V194, P278, DOI 10.1111/j.1469-8137.2011.04041.x; Kjoller R, 2009, FOREST ECOL MANAG, V257, P2217, DOI 10.1016/j.foreco.2009.02.038; Kluber LA, 2011, SOIL BIOL BIOCHEM, V43, P1042, DOI 10.1016/j.soilbio.2011.01.022; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; McCune B, 2002, ANAL ECOLOGICAL COMM; MILLER MH, 1995, CRIT REV BIOTECHNOL, V15, P241, DOI 10.3109/07388559509147411; Morris MH, 2008, NEW PHYTOL, V178, P167, DOI 10.1111/j.1469-8137.2007.02348.x; OUIMET R, 1995, CAN J BOT, V73, P1168, DOI 10.1139/b95-126; Qian XM, 1998, PLANT SOIL, V199, P99, DOI 10.1023/A:1004243207414; Rineau F, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009089; Roth DR, 1998, WATER AIR SOIL POLL, V103, P263, DOI 10.1023/A:1004929801839; Rudawska M, 1995, WATER AIR SOIL POLL, V85, P1281, DOI 10.1007/BF00477158; SanClements MD, 2010, SOIL SCI SOC AM J, V74, P2175, DOI 10.2136/sssaj2009.0267; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Sinsabaugh RL, 1999, LT EC RES NETWK SER, V2, P318; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Taylor DL, 2008, MOL ECOL RESOUR, V8, P742, DOI 10.1111/j.1755-0998.2008.02094.x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Tuason MMS, 2009, APPL ENVIRON MICROB, V75, P7079, DOI 10.1128/AEM.00325-09; van Aarle IM, 2002, NEW PHYTOL, V155, P173, DOI 10.1046/j.1469-8137.2002.00439.x; Van Tichelen KK, 2000, PHYSIOL PLANTARUM, V110, P96, DOI 10.1034/j.1399-3054.2000.110113.x; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wallander H, 1997, PLANT SOIL, V195, P329, DOI 10.1023/A:1004280401423; WANG GM, 1993, NEW PHYTOL, V124, P465, DOI 10.1111/j.1469-8137.1993.tb03837.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; WOOD T, 1984, SCIENCE, V223, P391, DOI 10.1126/science.223.4634.391; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	68	52	55	3	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48946	10.1371/journal.pone.0048946	http://dx.doi.org/10.1371/journal.pone.0048946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145035	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500054
J	Li, HP; Geng, QM; Guo, W; Zhuang, DM; Li, L; Liu, YJ; Bao, ZY; Liu, SY; Li, JY				Li, Hanping; Geng, Qingmao; Guo, Wei; Zhuang, Daomin; Li, Lin; Liu, Yongjian; Bao, Zuoyi; Liu, Siyang; Li, Jingyun			Screening for and Verification of Novel Mutations Associated with Drug Resistance in the HIV Type 1subtype B ' in China	PLOS ONE			English	Article							RNASE-H DOMAIN; REVERSE-TRANSCRIPTASE; CONNECTION SUBDOMAIN; SUBTYPE B; MOLECULAR EPIDEMIOLOGY; IN-VITRO; VIRUS; NUCLEOSIDE; NAIVE; RECOMBINANT	Objective: Mutations associated with HIV drug resistance have been extensively characterized at the HIV-1 polymerase domain, but more studies have verified that mutations outside of the polymerase domain also results in resistance to antiviral drugs. In this study, mutations were identified in 354 patients experiencing antiretroviral therapy (ART) failure and in 97 naive-therapy patients. Mutations whose impact on antiviral drugs was unknown were verified by phenotypic testing. Methods: Pol sequences of HIV subtype B' obtained from patients experiencing ART failure and from naive-therapy patients were analyzed for mutations distinct between two groups. Mutations that occurred at a significantly higher frequency in the ART failure than the naive-therapy group were submitted to the Stanford HIV Drug Resistance Database (SHDB) to analyze the correlation between HIV mutations and drug resistance. For mutations whose impact on the antiviral drug response is unknown, the site-directed mutagenesis approach was applied to construct plasmids containing the screened mutations. 50% inhibitory concentration (IC50) to AZT, EFV and NVP was measured to determine the response of the genetically constructed viruses to antiviral drugs. Results: 7 mutations at 6 positions of the RT region, D123E, V292I, K366R, T369A, T369V, A371V and I375V, occurred more frequently in the ART failure group than the naive-therapy group. Phenotypic characterization of these HIV mutants revealed that constructed viruses with mutations A371V and T369V exhibited dual resistance to AZT and EFV respectively, whereas the other 5 mutations showed weak resistance. Although the impact of the other six mutations on response to NVP was minimal, mutation T369V could enhance resistance to NVP. Conclusions: This study demonstrated that mutations at the RT C-terminal in subtype B' could result in resistance to RT inhibitors if the mutations occurred alone, but that some mutations could promote susceptibility to antiviral drugs. Citation: Li H, Geng Q, Guo W, Zhuang D, Li L, et al. (2012) Screening for and Verification of Novel Mutations Associated with Drug Resistance in the HIV Type 1subtype B' in China. PLoS ONE 7(11): e47119. doi:10.1371/journal.pone.0047119	[Li, Hanping; Geng, Qingmao; Guo, Wei; Zhuang, Daomin; Li, Lin; Liu, Yongjian; Bao, Zuoyi; Liu, Siyang; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn		Geng, Qingmao/0000-0001-7478-0730	National Natural Science Foundation [30800938, 30830088]; National Key S&T Special Projects on Major Infectious Disease [2012ZX10001-002, 2008ZX10001-004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key S&T Special Projects on Major Infectious Disease	This work was supported by a National Natural Science Foundation grant, 30800938,30830088 (http://www.nsfc.gov.cn/Portal0/default152.htm), and a National Key S&T Special Projects on Major Infectious Disease grant, 2012ZX10001-002,2008ZX10001-004 (http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancor G, 2010, ANTIMICROB AGENTS CH, V54, P4799, DOI 10.1128/AAC.00716-10; Biondi MJ, 2010, J BIOL CHEM, V285, P26966, DOI 10.1074/jbc.M110.105775; Cane PA, 2007, AIDS, V21, P447, DOI 10.1097/QAD.0b013e3280129964; Chilton DN, 2010, ANTIVIR THER, V15, P985, DOI 10.3851/IMP1658; Delviks-Frankenberry KA, 2010, VIRUSES-BASEL, V2, P1476, DOI 10.3390/v2071476; DELWART EL, 1995, AIDS RES HUM RETROV, V11, P1081, DOI 10.1089/aid.1995.11.1081; Deng XT, 2008, ALGORITHMICA, V52, P1, DOI 10.1007/s00453-007-9001-1; Erali M, 2001, J CLIN MICROBIOL, V39, P2157, DOI 10.1128/JCM.39.6.2157-2165.2001; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Garriga C, 2009, J ANTIMICROB CHEMOTH, V64, P251, DOI 10.1093/jac/dkp200; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; KALISH ML, 1995, AIDS, V9, P851, DOI 10.1097/00002030-199508000-00004; KALISH ML, 1994, AIDS RES HUM RETROV, V10, P1573, DOI 10.1089/aid.1994.10.1573; Lai MT, 2010, ANTIMICROB AGENTS CH, V54, P4812, DOI 10.1128/AAC.00829-10; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; Neogi U, 2010, AIDS RES HUM RETROV, V26, P1097, DOI 10.1089/aid.2010.0092; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Radzio J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-69; Roche M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-89; Roquebert B, 2007, J MED VIROL, V79, P207, DOI 10.1002/jmv.20788; Santos AF, 2011, J CLIN VIROL, V52, P373, DOI 10.1016/j.jcv.2011.09.005; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Tanuma J, 2010, MICROBES INFECT, V12, P1170, DOI 10.1016/j.micinf.2010.08.003; Visco-Comandini U, 2003, SCAND J INFECT DIS, V35, P75, DOI 10.1080/03008870310009777; Westin MR, 2011, AIDS RES HUM RETROV, V27, P981, DOI 10.1089/aid.2010.0260; Xu HT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-80; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945	36	1	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e47119	10.1371/journal.pone.0047119	http://dx.doi.org/10.1371/journal.pone.0047119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144802	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500003
J	Roeseler, DA; Sachdev, S; Buckley, DM; Joshi, T; Wu, DK; Xu, D; Hannink, M; Waters, ST				Roeseler, David A.; Sachdev, Shrikesh; Buckley, Desire M.; Joshi, Trupti; Wu, Doris K.; Xu, Dong; Hannink, Mark; Waters, Samuel T.			Elongation Factor 1 alpha1 and Genes Associated with Usher Syndromes Are Downstream Targets of GBX2	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; IN-VITRO TRANSCRIPTION; CREST CELL-MIGRATION; INNER-EAR; HOMEOBOX GENE; ISTHMIC ORGANIZER; TATA BOX; MID/HINDBRAIN ORGANIZER; INTRON ENHANCER; ZEBRAFISH GBX1	Gbx2 encodes a DNA-binding transcription factor that plays pivotal roles during embryogenesis. Gain-and loss-of-function studies in several vertebrate species have demonstrated a requirement for Gbx2 in development of the anterior hindbrain, spinal cord, inner ear, heart, and neural crest cells. However, the target genes through which GBX2 exerts its effects remain obscure. Using chromatin immunoprecipitation coupled with direct sequencing (ChIP-Seq) analysis in a human prostate cancer cell line, we identified cis-regulatory elements bound by GBX2 to provide insight into its direct downstream targets. The analysis revealed more than 286 highly significant candidate target genes, falling into various functional groups, of which 51% are expressed in the nervous system. Several of the top candidate genes include EEF1A1, ROBO1, PLXNA4, SLIT3, NRP1, and NOTCH2, as well as genes associated with the Usher syndrome, PCDH15 and USH2A, and are plausible candidates contributing to the developmental defects in Gbx2(-/-) mice. We show through gel shift analyses that sequences within the promoter or introns of EEF1A1, ROBO1, PCDH15, USH2A and NOTCH2, are directly bound by GBX2. Consistent with these in vitro results, analyses of Gbx2(-/-) embryos indicate that Gbx2 function is required for migration of Robo1-expressing neural crest cells out of the hindbrain. Furthermore, we show that GBX2 activates transcriptional activity through the promoter of EEF1A1, suggesting that GBX2 could also regulate gene expression indirectly via EEF1A. Taken together, our studies show that GBX2 plays a dynamic role in development and diseases. Citation: Roeseler DA, Sachdev S, Buckley DM, Joshi T, Wu DK, et al. (2012) Elongation Factor 1 alpha1 and Genes Associated with Usher Syndromes Are Downstream Targets of GBX2. PLoS ONE 7(11): e47366. doi:10.1371/journal.pone.0047366	[Roeseler, David A.; Buckley, Desire M.; Waters, Samuel T.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Roeseler, David A.; Sachdev, Shrikesh; Buckley, Desire M.; Joshi, Trupti; Xu, Dong; Hannink, Mark; Waters, Samuel T.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Sachdev, Shrikesh; Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Wu, Doris K.] NIDCD, Mol Biol Lab, NIH, Bethesda, MD USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Inst Informat, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Missouri System; University of Missouri Columbia	Waters, ST (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	waterssa@missouri.edu		Joshi, Trupti/0000-0001-8944-4924	National Science Foundation [NSF 1021288]	National Science Foundation(National Science Foundation (NSF))	This work has been funded by the National Science Foundation, NSF 1021288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Burroughs-Garcia J, 2011, DEV DYNAM, V240, P828, DOI 10.1002/dvdy.22589; Byrd NA, 2005, DEV BIOL, V284, P233, DOI 10.1016/j.ydbio.2005.05.023; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Castro LFC, 2006, DEV BIOL, V295, P40, DOI 10.1016/j.ydbio.2006.03.003; CHAPMAN G, 1995, FEBS LETT, V364, P289, DOI 10.1016/0014-5793(95)00410-B; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Draganescu A, 1998, J MOL BIOL, V276, P529, DOI 10.1006/jmbi.1997.1567; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gao AC, 2000, CLIN CANCER RES, V6, P493; Gao AC, 1996, PROSTATE, V29, P395; Hatch EP, 2007, DEVELOPMENT, V134, P3615, DOI 10.1242/dev.006627; Heimbucher T, 2007, MOL CELL BIOL, V27, P340, DOI 10.1128/MCB.00811-06; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Jia L, 2005, DEV BIOL, V282, P411, DOI 10.1016/j.ydbio.2005.03.021; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Johnson JM, 2010, AJNR, V32, P230; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Kelley MW, 2003, CURR TOP DEV BIOL, V57, P321, DOI 10.1016/S0070-2153(03)57011-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; Kikuta H, 2003, DEV DYNAM, V228, P433, DOI 10.1002/dvdy.10409; KowenzLeutz E, 1997, CELL, V91, P185, DOI 10.1016/S0092-8674(00)80401-8; Lambert M, 1996, EUR J BIOCHEM, V236, P778, DOI 10.1111/j.1432-1033.1996.00778.x; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; Li JYH, 2001, DEVELOPMENT, V128, P4979; Li JYH, 2005, DEVELOPMENT, V132, P1971, DOI 10.1242/dev.01727; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Lin ZS, 2005, DEVELOPMENT, V132, P2309, DOI 10.1242/dev.01804; Liu AM, 2001, DEVELOPMENT, V128, P181; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Luu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020940; Manfre L, 1997, AM J NEURORADIOL, V18, P773; MARGALIT Y, 1993, NUCLEIC ACIDS RES, V21, P4915, DOI 10.1093/nar/21.21.4915; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; McLennan R, 2007, DEV BIOL, V301, P227, DOI 10.1016/j.ydbio.2006.08.019; Miyazaki H, 2006, DEV GROWTH DIFFER, V48, P429, DOI 10.1111/j.1440-169x.2006.00879.x; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Morgan R, 1997, DEVELOPMENT, V124, P2751; Muller U, 2008, CURR OPIN CELL BIOL, V20, P557, DOI 10.1016/j.ceb.2008.06.004; Murcia CL, 2001, MECH DEVELOP, V105, P163, DOI 10.1016/S0925-4773(01)00388-4; Mutoh H, 2010, BIOCHEM J, V427, P423, DOI 10.1042/BJ20091177; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P2289, DOI 10.1073/pnas.87.6.2289; OHKUMA Y, 1990, CELL, V61, P475, DOI 10.1016/0092-8674(90)90529-N; Rhinn M, 2003, MECH DEVELOP, V120, P919, DOI 10.1016/S0925-4773(03)00135-7; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Rhinn M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-12; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Robledo RF, 2006, GENESIS, V44, P425, DOI 10.1002/dvg.20233; Rosenberg T, 1997, CLIN GENET, V51, P314; SCHANKE JT, 1994, NUCLEIC ACIDS RES, V22, P5425, DOI 10.1093/nar/22.24.5425; SCHANKE JT, 1994, J IMMUNOL, V153, P4565; Schwarz Q, 2008, DEVELOPMENT, V135, P1605, DOI 10.1242/dev.015412; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; Steiner LA, 2009, MOL CELL BIOL, V29, P5399, DOI 10.1128/MCB.00777-09; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Waters ST, 2006, DEVELOPMENT, V133, P1991, DOI 10.1242/dev.02364; Waters ST, 2003, GENE EXPR PATTERNS, V3, P313, DOI 10.1016/S1567-133X(03)00041-3; Weinstein DC, 1997, DEVELOPMENT, V124, P4235; White RB, 2008, PHYSIOL GENOMICS, V33, P41, DOI 10.1152/physiolgenomics.00256.2007; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Wu CC, 2005, LARYNGOSCOPE, V115, P132, DOI 10.1097/01.mlg.0000150691.85387.3f; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	83	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e47366	10.1371/journal.pone.0047366	http://dx.doi.org/10.1371/journal.pone.0047366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144817	gold, Green Submitted, Green Published			2022-12-25	WOS:000312269500008
J	Tognazzo, M; Schmid-Hempel, R; Schmid-Hempel, P				Tognazzo, Martina; Schmid-Hempel, Regula; Schmid-Hempel, Paul			Probing Mixed-Genotype Infections II: High Multiplicity in Natural Infections of the Trypanosomatid, Crithidia bombi, in Its Host, Bombus spp	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; SEXUAL RECOMBINATION; GENETIC DIVERSITY; PARASITE; VIRULENCE; PATHOGEN; TOXOPLASMA; TERRESTRIS; TRANSMISSION; EVOLUTION	Mixed-genotype infections have major consequences for many essential elements of host-parasite interactions. With genetic exchange between co-infecting parasite genotypes increased diversity among parasite offspring and the emergence of novel genotypes from infected hosts is possible. We here investigated mixed-genotype infections using the host, Bombus spp. and its trypanosome parasite Crithidia bombi as our study case. The natural infections of C. bombi were genotyped with a novel method for a representative sample of workers and spring queens in Switzerland. We found that around 60% of all infected hosts showed mixed-genotype infections with an average of 2.47 +/- 0.22 (S.E.) and 3.65 +/- 1.02 genotypes per worker or queen, respectively. Queens, however, harboured up to 29 different genotypes. Based on the genotypes of co-infecting strains, these could be putatively assigned to either 'primary' and 'derived' genotypes - the latter resulting from genetic exchange among the primary genotypes. High genetic relatedness among co-infecting derived but not primary genotypes supported this scenario. Co-infection in queens seems to be a major driver for the diversity of genotypes circulating in host populations.Citation: Tognazzo M, Schmid-Hempel R, Schmid-Hempel P (2012) Probing Mixed-Genotype Infections II: High Multiplicity in Natural Infections of the Trypanosomatid, Crithidia bombi, in Its Host, Bombus spp. PLoS ONE 7(11): e49137. doi:10.1371/journal.pone. 0049137	[Tognazzo, Martina; Schmid-Hempel, Regula; Schmid-Hempel, Paul] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	ETH Zurich	Schmid-Hempel, P (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	psh@env.ethz.ch			Swiss National Science Foundation [31003A-116057]; Competence Center Environment and Sustainability-Biochange and GEnetic DIversity Host And Parasite-programs; ERC [26885]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Competence Center Environment and Sustainability-Biochange and GEnetic DIversity Host And Parasite-programs; ERC(European Research Council (ERC)European Commission)	Financed by the Swiss National Science Foundation (nr. 31003A-116057 to PSH), the Competence Center Environment and Sustainability-Biochange and GEnetic DIversity Host And Parasite-programs, and an advanced grant from the ERC (# 26885 RESIST to PSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; [Anonymous], GENALEX V5 GENETIC A; Babiker HA, 1999, T ROY SOC TROP MED H, V93, pS11, DOI 10.1016/S0035-9203(99)90321-8; Balmer O, 2011, LANCET INFECT DIS, V11, P868, DOI 10.1016/S1473-3099(11)70241-9; Balmer O, 2009, ECOLOGY, V90, P3367, DOI 10.1890/08-2291.1; Bogreau H, 2006, AM J TROP MED HYG, V74, P953; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Cui LW, 2003, TRENDS PARASITOL, V19, P220, DOI 10.1016/S1471-4922(03)00085-0; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Gauthier C, 2005, ACTA TROP, V94, P241, DOI 10.1016/j.actatropica.2005.04.001; GORBUNOV PS, 1987, ZOOL ZH, V66, P1775; Gower CM, 2005, EVOLUTION, V59, P544, DOI 10.1111/j.0014-3820.2005.tb01014.x; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Grigg ME, 2009, INT J PARASITOL, V39, P925, DOI 10.1016/j.ijpara.2009.02.005; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; MacLeod A, 2005, MOL BIOCHEM PARASIT, V143, P12, DOI 10.1016/j.molbiopara.2005.04.009; Mallon EB, 2003, EVOLUTION, V57, P1444; Perez-Tris J, 2005, PARASITOLOGY, V131, P15, DOI 10.1017/S003118200500733X; Popp M, 2011, J EUKARYOT MICROBIOL, V58, P7, DOI 10.1111/j.1550-7408.2010.00514.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; R Development Core Team, 2008, LANG ENV STAT COMP; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Ruiz-Gonzalez MX, 2012, EVOLUTION, V66, P3053, DOI 10.1111/j.1558-5646.2012.01655.x; Salathe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049046; Salathe RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022054; Schjorring S, 2003, P ROY SOC B-BIOL SCI, V270, P189, DOI 10.1098/rspb.2002.2233; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel R, 2011, INFECT GENET EVOL, V11, P564, DOI 10.1016/j.meegid.2011.01.002; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; SCHMIDHEMPEL P, 1993, BEHAV ECOL SOCIOBIOL, V33, P319, DOI 10.1007/BF00172930; Sreekumar C, 2005, INT J PARASITOL, V35, P991, DOI 10.1016/j.ijpara.2005.03.017; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Ulrich Y, 2011, J EVOLUTION BIOL, V24, P354, DOI 10.1111/j.1420-9101.2010.02172.x; Ulrich Y, 2012, P ROY SOC B-BIOL SCI, V279, P2982, DOI 10.1098/rspb.2012.0474; Vardo-Zalik AM, 2009, ECOLOGY, V90, P529, DOI 10.1890/07-1866.1; Vizoso DB, 2005, OECOLOGIA, V143, P157, DOI 10.1007/s00442-004-1771-4; Yourth CP, 2006, P ROY SOC B-BIOL SCI, V273, P655, DOI 10.1098/rspb.2005.3371	52	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49137	10.1371/journal.pone.0049137	http://dx.doi.org/10.1371/journal.pone.0049137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145099	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500077
J	Mela, V; Llorente-Berzal, A; Diaz, F; Argente, J; Viveros, MP; Chowen, JA				Mela, Virginia; Llorente-Berzal, Alvaro; Diaz, Francisca; Argente, Jesus; Viveros, Maria-Paz; Chowen, Julie A.			Maternal Deprivation Exacerbates the Response to a High Fat Diet in a Sexually Dimorphic Manner	PLOS ONE			English	Article							METABOLIC SYNDROME; GLUCOCORTICOID METABOLISM; INSULIN SENSITIVITY; GENE-EXPRESSION; INDUCED OBESITY; LEPTIN SURGE; BODY-WEIGHT; FEMALE RATS; FOOD-INTAKE; ADOLESCENT	Maternal deprivation (MD) during neonatal life has diverse long-term effects, including affectation of metabolism. Indeed, MD for 24 hours during the neonatal period reduces body weight throughout life when the animals are maintained on a normal diet. However, little information is available regarding how this early stress affects the response to increased metabolic challenges during postnatal life. We hypothesized that MD modifies the response to a high fat diet (HFD) and that this response differs between males and females. To address this question, both male and female Wistar rats were maternally deprived for 24 hours starting on the morning of postnatal day (PND) 9. Upon weaning on PND22 half of each group received a control diet (CD) and the other half HFD. MD rats of both sexes had significantly reduced accumulated food intake and weight gain compared to controls when raised on the CD. In contrast, when maintained on a HFD energy intake and weight gain did not differ between control and MD rats of either sex. However, high fat intake induced hyperleptinemia in MD rats as early as PND35, but not until PND85 in control males and control females did not become hyperleptinemic on the HFD even at PND102. High fat intake stimulated hypothalamic inflammatory markers in both male and female rats that had been exposed to MD, but not in controls. Reduced insulin sensitivity was observed only in MD males on the HFD. These results indicate that MD modifies the metabolic response to HFD intake, with this response being different between males and females. Thus, the development of obesity and secondary complications in response to high fat intake depends on numerous factors.	[Mela, Virginia; Llorente-Berzal, Alvaro; Viveros, Maria-Paz] Univ Complutense, Fac Biol, Dept Physiol Anim Physiol 2, Inst Invest Sanitaria,Hosp Clin San Carlos, E-28040 Madrid, Spain; [Diaz, Francisca; Argente, Jesus; Chowen, Julie A.] Hosp Infantil Univ Nino Jesus, Dept Endocrinol, Inst Invest Biomed Princesa, Madrid, Spain; [Argente, Jesus] Univ Autonoma Madrid, Dept Pediat, Madrid, Spain; [Diaz, Francisca; Argente, Jesus; Chowen, Julie A.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Viveros, MP (corresponding author), Univ Complutense, Fac Biol, Dept Physiol Anim Physiol 2, Inst Invest Sanitaria,Hosp Clin San Carlos, E-28040 Madrid, Spain.	pazviver@bio.ucm.es; julieann.chowen@madrid.salud.org	Argente, Jesús/K-1167-2014; Chowen, Julie/C-8979-2011; Llorente-Berzal, Alvaro/GLQ-8115-2022; Llorente-Berzal, Alvaro/C-8232-2018; Viveros, Maria-Paz/S-6855-2016; Mela, Virginia/AIE-5893-2022; Mela, Virginia/N-4664-2017; Argente, Jesús/M-5226-2019	Argente, Jesús/0000-0001-5826-0276; Chowen, Julie/0000-0002-4770-2291; Llorente-Berzal, Alvaro/0000-0002-9787-2619; Llorente-Berzal, Alvaro/0000-0002-9787-2619; Viveros, Maria-Paz/0000-0002-4119-4636; Mela, Virginia/0000-0001-7702-0972; Argente, Jesús/0000-0001-5826-0276; Diaz-Gonzalez, Francisca/0000-0003-1364-7586	Fondos de Investigacion Sanitaria [PI10 / 00747]; CIBER Fisiopatologia de Obesidad y Nutricion Instituto de Salud Carlos III; Ministerio de Ciencia e innovacion [BFU2009-10109, BFU2011-27492]; GRUPOS UCM-BSCH [GRUPO UCM951579]; Fundacion de Endocrinologia y Nutricion; Red de Trastornos Adictivos [RD06 / 0001/1013]	Fondos de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBER Fisiopatologia de Obesidad y Nutricion Instituto de Salud Carlos III; Ministerio de Ciencia e innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); GRUPOS UCM-BSCH; Fundacion de Endocrinologia y Nutricion; Red de Trastornos Adictivos(Instituto de Salud Carlos III)	This work was funded by grants from Fondos de Investigacion Sanitaria (PI10 / 00747), CIBER Fisiopatologia de Obesidad y Nutricion Instituto de Salud Carlos III, Ministerio de Ciencia e innovacion: (BFU2009-10109, subprograma BFI and BFU2011-27492), GRUPOS UCM-BSCH (GRUPO UCM951579) and Fundacion de Endocrinologia y Nutricion. VM is supported by Red de Trastornos Adictivos RD06 / 0001/1013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Amengual-Cladera E, 2012, METABOLISM, V61, P1108, DOI 10.1016/j.metabol.2011.12.016; Anderson J W, 2000, Curr Atheroscler Rep, V2, P536, DOI 10.1007/s11883-000-0055-7; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; BASSETT DR, 1988, J APPL PHYSIOL, V64, P1249, DOI 10.1063/1.342505; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Boullu-Ciocca S, 2008, DIABETES, V57, P669, DOI 10.2337/db07-1316; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Branchi A, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/215052; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; Fernandez-Twinn DS, 2010, ANN NY ACAD SCI, V1212, P78, DOI 10.1111/j.1749-6632.2010.05798.x; Frier BC, 2011, AM J PHYSIOL-REG I, V300, pR212, DOI 10.1152/ajpregu.00367.2010; Fuente-Martin E, 2012, METABOLISM, V61, P812, DOI 10.1016/j.metabol.2011.11.003; Garcia-Caceres C, 2010, PSYCHONEUROENDOCRINO, V35, P1525, DOI 10.1016/j.psyneuen.2010.05.006; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Granado M, 2011, ENDOCRINOLOGY, V152, P4116, DOI 10.1210/en.2011-1233; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Hsuchou H, 2009, BRAIN, V132, P889, DOI 10.1093/brain/awp029; Jacobs B, 2004, J NUTR, V134, P1400, DOI 10.1093/jn/134.6.1400; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Landt M, 1998, CLIN CHEM, V44, P565; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Llorente R, 2007, PSYCHONEUROENDOCRINO, V32, P636, DOI 10.1016/j.psyneuen.2007.04.002; Llorente-Berzal A, 2012, NEUROPHARMACOLOGY, V62, P1332, DOI 10.1016/j.neuropharm.2011.07.031; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P1553, DOI 10.1016/j.psyneuen.2010.05.012; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P717, DOI 10.1016/j.psyneuen.2009.10.013; Marco EM, 2009, NEUROSCI BIOBEHAV R, V33, P498, DOI 10.1016/j.neubiorev.2008.03.008; MARGOLIS S, 1989, J AM COLL NUTR, V8, pS33; Maringhini S, 2010, J MATERN-FETAL NEO M, V23, P84, DOI 10.3109/14767058.2010.510245; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; Mela V, 2012, J NEUROENDOCRINOL, V24, P756, DOI 10.1111/j.1365-2826.2012.02279.x; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Nadal-Casellas A, 2012, BIOCHEM CELL BIOL, V90, P164, DOI [10.1139/O11-069, 10.1139/o11-069]; Palou M, 2011, J NUTR BIOCHEM, V22, P574, DOI 10.1016/j.jnutbio.2010.05.001; Patterson CM, 2010, ENDOCRINOLOGY, V151, P4270, DOI 10.1210/en.2010-0401; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Priego T, 2009, HORM BEHAV, V55, P33, DOI 10.1016/j.yhbeh.2008.07.010; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Shin SH, 2012, CHILD ABUSE NEGLECT, V36, P84, DOI 10.1016/j.chiabu.2011.08.007; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Vamosi ME, 2011, OBESITY, V19, P1445, DOI 10.1038/oby.2011.20; Viveros MP, 2010, HORM BEHAV, V58, P808, DOI 10.1016/j.yhbeh.2010.08.003; Viveros MP, 2010, HORM BEHAV, V57, P405, DOI 10.1016/j.yhbeh.2010.01.009; Xu RY, 2008, CLIN CHIM ACTA, V397, P96, DOI 10.1016/j.cca.2008.07.027; Yi CX, 2011, NEUROENDOCRINOLOGY, V93, P143, DOI 10.1159/000324888; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005	53	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48915	10.1371/journal.pone.0048915	http://dx.doi.org/10.1371/journal.pone.0048915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145019	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800168
J	Minamimoto, T; Hori, Y; Richmond, BJ				Minamimoto, Takafumi; Hori, Yukiko; Richmond, Barry J.			Is Working More Costly than Waiting in Monkeys?	PLOS ONE			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; REWARD; DELAY; MOTIVATION; PIGEONS; HUMANS	We studied how value for instrumental action is discounted by predicted effort and delay. The monkeys were trained to perform instrumental trials that required a bar release when a visual target changed from red-to-green. There were two trial conditions. In delay trials, after the monkeys performed one instrumental trial correctly a reward was delivered 0-7 seconds later. In work trials, the monkeys had to perform 0, 1, or 2 additional instrumental trials to obtain a reward. The lengths of trials in delay matched the time it took to complete work trials. The length of delay or number of trials was indicated by a visual cue presented throughout the trial. Our hypothesis was that the monkeys would all show temporal discounting of reward in the delay trials, and that in the work trials the monkeys' performance might reflect an additional cost due to working. The error rate increased linearly as remaining cost increased for all 8 monkeys. For 4 monkeys the error rate was significantly larger in work trials than in delay trials (effort sensitive monkeys). For the other 4 monkeys there was no significant difference in error rate (effort insensitive monkeys). Since the error rate has an inverse relation with value for action, these results suggest that value is discounted hyperbolically by effort as well as by delay. Error rates generally increased as the testing sessions progressed and the total reward accumulated (i.e., effect of reward devaluation). The relative impact of delay and effort on error rates was reasonably stable within subjects. Thus, within the monkey population there seems to be a significant dichotomy in the sensitivity governing whether working is more costly than waiting, possibly arising from a constitutional or genetic trait.	[Minamimoto, Takafumi; Hori, Yukiko] Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Mol Neuroimaging, Chiba 260, Japan; [Minamimoto, Takafumi; Richmond, Barry J.] NIMH, Neuropsychol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Minamimoto, Takafumi] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	National Institutes for Quantum Science & Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Japan Science & Technology Agency (JST)	Minamimoto, T (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Mol Neuroimaging, Chiba 260, Japan.	minamoto@nirs.go.jp	Minamimoto, Takafumi/D-6610-2012; Minamimoto, Takafumi/AAD-8726-2020	Minamimoto, Takafumi/0000-0003-4305-0174; Minamimoto, Takafumi/0000-0003-4305-0174	Ministry of Education, Culture, Sports, Science and Technology, MEXT Japan [KAKENHI 21012005, 23011006]; PRESTO/JST; National Institute of Mental Health; JSPS	Ministry of Education, Culture, Sports, Science and Technology, MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO/JST(Japan Science & Technology Agency (JST)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-Aid for Scientific Research on Priority Areas, from the Ministry of Education, Culture, Sports, Science and Technology, MEXT Japan (KAKENHI 21012005, 23011006 to TM), PRESTO/JST (to TM), and Intramural Research Program of the National Institute of Mental Health (to BJR). TM was partly supported by JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; La Camera G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000131; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; Minamimoto T, 2012, EXP BRAIN RES, V218, P609, DOI 10.1007/s00221-012-3054-3; Minamimoto T, 2009, J NEUROPHYSIOL, V101, P437, DOI 10.1152/jn.90959.2008; Miyazaki K, 2012, MOL NEUROBIOL, V45, P213, DOI 10.1007/s12035-012-8232-6; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Richards JB, 1997, J EXP ANAL BEHAV, V67, P353, DOI 10.1901/jeab.1997.67-353; RODRIGUEZ ML, 1988, J EXP PSYCHOL ANIM B, V14, P105, DOI 10.1037/0097-7403.14.1.105; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; Simmons JM, 2010, J NEUROSCI, V30, P15878, DOI 10.1523/JNEUROSCI.1802-10.2010; Stevens JR, 2005, CURR BIOL, V15, P1855, DOI 10.1016/j.cub.2005.09.016; Tsujimoto S, 2007, NEUROREPORT, V18, P703, DOI 10.1097/WNR.0b013e3280d943a1; Walton ME, 2002, J NEUROSCI, V22, P10996	20	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48434	10.1371/journal.pone.0048434	http://dx.doi.org/10.1371/journal.pone.0048434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144881	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800061
J	Verghese, S; Waghmare, I; Kwon, H; Hanes, K; Kango-Singh, M				Verghese, Shilpi; Waghmare, Indrayani; Kwon, Hailey; Hanes, Katelin; Kango-Singh, Madhuri			Scribble Acts in the Drosophila Fat-Hippo Pathway to Regulate Warts Activity	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; BASAL CELL POLARITY; ORGAN SIZE CONTROL; SIGNALING PATHWAY; GROWTH-CONTROL; YORKIE PHOSPHORYLATION; PROLIFERATION CONTROL; PROMOTES APOPTOSIS; TISSUE OVERGROWTH; TEAD/TEF FAMILY	Epithelial cells are the major cell-type for all organs in multicellular organisms. In order to achieve correct organ size, epithelial tissues need mechanisms that limit their proliferation, and protect tissues from damage caused by defective epithelial cells. Recently, the Hippo signaling pathway has emerged as a major mechanism that orchestrates epithelial development. Hippo signaling is required for cells to stop proliferation as in the absence of Hippo signaling tissues continue to proliferate and produce overgrown organs or tumors. Studies in Drosophila have led the way in providing a framework for how Hippo alters the pattern of gene transcription in target cells, leading to changes in cell proliferation, survival, and other behaviors. Scribble (Scrib) belongs to a class of neoplastic tumor suppressor genes that are required to establish apical-basal cell polarity. The disruption of apical-basal polarity leads to uncontrolled cell proliferation of epithelial cells. The interaction of apical basal polarity genes with the Hippo pathway has been an area of intense investigation. Loss of scrib has been known to affect Hippo pathway targets, however, its functions in the Hippo pathway still remain largely unknown. We investigated the interactions of Scrib with the Hippo pathway. We present data suggesting that Drosophila scrib acts downstream of the Fat (Ft) receptor, and requires Hippo signaling for its growth regulatory functions. We show that Ft requires Scrib to interact with Expanded (Ex) and Dachs (D), and for regulating Warts (Wts) levels and stability, thus placing Scrib in the Hippo pathway network.	[Verghese, Shilpi; Waghmare, Indrayani; Kwon, Hailey; Hanes, Katelin; Kango-Singh, Madhuri] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Kango-Singh, Madhuri] Univ Dayton, Premed Programs, Dayton, OH 45469 USA; [Kango-Singh, Madhuri] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University of Dayton	Kango-Singh, M (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	mkangosingh1@udayton.edu	Verghese, Shilpi/L-1864-2019	Kwon, JiMin/0000-0003-3053-5498	University of Dayton; NICHD	University of Dayton; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work is supported by start-up funds from the University of Dayton to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For flies and reagents the authors would like to thank: Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Center (VDRC), D. Bilder for scrib mutants and anti-guinea pig Scrib antibody; B. Hay for anti-mouse DIAP1 antibody, K. Irvine for anti-rabbit Wts antibody, G. Halder for ex and ft mutants and anti-rabbit Ex antibody, Sang-Chul Nam for eyFLP; UbiGFP FRT40A, and A. Singh for the use of Zeiss Apotome. The m-beta gal (40-1a) antibody developed by Joshua Sanes was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. The authors would also like to thank A. Singh, M. Tare, and O. Roy for comments on the manuscript.	Badouel C, 2009, BBA-BIOMEMBRANES, V1788, P755, DOI 10.1016/j.bbamem.2008.08.026; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Froldi F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-33; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Grzeschik NA, 2007, DEV BIOL, V311, P106, DOI 10.1016/j.ydbio.2007.08.025; Grzeschik NA, 2010, CELL CYCLE, V9, P3202, DOI 10.4161/cc.9.16.12633; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hafezi Y, 2012, DEV BIOL, V368, P358, DOI 10.1016/j.ydbio.2012.06.001; Halder G, 2012, NAT REV MOL CELL BIO; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Katoh Y, 2006, INT J MOL MED, V18, P523; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Lim J, 2011, DEV CELL, V21, P983, DOI 10.1016/j.devcel.2011.11.017; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Mao Y, 2009, DEVELOPMENT, V136, P3223, DOI 10.1242/dev.036152; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Menendez J, 2010, P NATL ACAD SCI USA, V107, P14651, DOI 10.1073/pnas.1009376107; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Oh H, 2009, DEV BIOL; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Schroeder MC, 2012, SEMIN CELL DEV BIOL; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Sopko R, 2009, CURR BIOL, V19, P1112, DOI 10.1016/j.cub.2009.05.049; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; Udan RS, 2003, NAT CELL BIOL; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Vaccari T, 2009, MOL ONCOL, V3, P354, DOI 10.1016/j.molonc.2009.05.005; Viktorinova I, 2009, DEVELOPMENT, V136, P4123, DOI 10.1242/dev.039099; Willecke M, 2006, CURR BIOL; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yue T, 2012, DEV CELL, V22, P255, DOI 10.1016/j.devcel.2011.12.011; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, CURR OPIN CELL BIOL; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao M, 2008, GENETICS, V178, P1947, DOI 10.1534/genetics.108.086983	78	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47173	10.1371/journal.pone.0047173	http://dx.doi.org/10.1371/journal.pone.0047173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144804	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400016
J	Quinzii, CM; Garone, C; Emmanuele, V; Tadesse, S; Krishna, S; Dorado, B; Hirano, M				Quinzii, Catarina M.; Garone, Caterina; Emmanuele, Valentina; Tadesse, Saba; Krishna, Sindu; Dorado, Beatriz; Hirano, Michio			Tissue-specific oxidative stress and loss of mitochondria in CoQ-deficient Pdss2 mutant mice	FASEB JOURNAL			English	Article						ubiquinone; polyprenyl-diphosphate synthase; ATP; ROS	CULTURED SKIN FIBROBLASTS; REACTIVE OXYGEN; COENZYME-Q; KIDNEY-DISEASE; NEPHROPATHY; UBIQUINONE; MUTATIONS; DEPLETION; CORRELATE; DEFECTS	Primary human CoQ(10) deficiencies are clinically heterogeneous diseases caused by mutations in PDSS2 and other genes required for CoQ(10) biosynthesis. Our in vitro studies of PDSS2 mutant fibroblasts, with <20% CoQ(10) of control cells, revealed reduced activity of CoQ(10)-dependent complex II+III and ATP synthesis, without amplification of reactive oxygen species (ROS), markers of oxidative damage, or antioxidant defenses. In contrast, COQ2 and ADCK3 mutant fibroblasts, with 30-50% CoQ(10) of controls, showed milder bioenergetic defects but significantly increased ROS and oxidation of lipids and proteins. We hypothesized that absence of oxidative stress markers and cell death in PDSS2 mutant fibroblasts were due to the extreme severity of CoQ(10) deficiency. Here, we have investigated in vivo effects of Pdss2 deficiency in affected and unaffected organs of CBA/Pdss2(kd/kd) mice at presymptomatic, phenotypic-onset, and end-stages of the disease. Although Pdss2 mutant mice manifest widespread CoQ(9) deficiency and mitochondrial respiratory chain abnormalities, only affected organs show increased ROS production, oxidative stress, mitochondrial DNA depletion, and reduced citrate synthase activity, an index of mitochondrial mass. Our data indicate that kidney-specific loss of mitochondria triggered by oxidative stress may be the cause of renal failure in Pdss2(kd/kd) mice.-Quinzii, C. M., Garone, C., Emmanuele, V., Tadesse, S., Krishna, S., Dorado, B., Hirano, M. Tissue-specific oxidative stress and loss of mitochondria in CoQ-deficient Pdss2 mutant mice. FASEB J. 27, 612-621 (2013). www.fasebj.org	[Quinzii, Catarina M.; Garone, Caterina; Emmanuele, Valentina; Tadesse, Saba; Krishna, Sindu; Dorado, Beatriz; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Garone, Caterina] Univ Bologna & Turin, Human Genet Joint PhD Program, Turin, Italy; [Emmanuele, Valentina] Univ Genoa, Ist Ricovero & Cura Carattere Sci, G Gaslini Inst, Pediat Clin, Genoa, Italy	Columbia University; University of Bologna; University of Genoa; IRCCS Istituto Giannina Gaslini	Hirano, M (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 630 W 168th St,P&S 4-432, New York, NY 10032 USA.	mh29@columbia.edu	Garone, Caterina/AAB-8659-2019	Garone, Caterina/0000-0003-4928-1037; Dorado, Beatriz/0000-0002-1958-4558	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [1R01HD057543, K23HD065871]; U.S. National Institutes of Health [R01HD056103, 1RC1NS070232]; Muscular Dystrophy Association; Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD065871, R01HD057543, R01HD056103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS070232] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors appreciate the kind gift of CBA-Pdss2<SUP>kd</SUP>/J from Dr. David Gasser (University of Pennsylvania, Philadelphia, PA, USA) and helpful advice from Drs. Vernice Jackson-Lewis, Vivette D. D'Agati, and Luis Lopez Garcia. The project described was supported by grants 1R01HD057543 (M. H.) and K23HD065871 (C. M. Q.) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). M. H. is supported by U.S. National Institutes of Health grants R01HD056103 and 1RC1NS070232, by a Muscular Dystrophy Association grant, and by the Marriott Mitochondrial Disorder Clinical Research Fund (MMDCRF).	DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453; Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206; Falk MJ, 2011, EMBO MOL MED, V3, P410, DOI 10.1002/emmm.201100149; Geromel V, 2001, FREE RADICAL RES, V35, P11, DOI 10.1080/10715760100300551; Geromel V, 2002, FREE RADICAL RES, V36, P375, DOI 10.1080/10715760290021216; Hallman TM, 2006, J AUTOIMMUN, V26, P1, DOI 10.1016/j.jaut.2005.10.006; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Liu YH, 2009, KIDNEY INT, V76, P1125, DOI 10.1038/ki.2009.352; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; LYON MF, 1971, J MED GENET, V8, P41, DOI 10.1136/jmg.8.1.41; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Nakai D, 2004, AGING CELL, V3, P273, DOI 10.1111/j.1474-9728.2004.00116.x; Peng M, 2004, KIDNEY INT, V66, P20, DOI 10.1111/j.1523-1755.2004.00702.x; Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; Quinzii CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030606; Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008; Sohal RS, 2007, MITOCHONDRION, V7, pS103, DOI 10.1016/j.mito.2007.03.006; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Ziegler CGK, 2012, MITOCHONDRION, V12, P248, DOI 10.1016/j.mito.2011.09.011	33	46	46	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					612	621		10.1096/fj.12-209361	http://dx.doi.org/10.1096/fj.12-209361			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23150520	Green Published			2022-12-25	WOS:000314358000020
J	Bauer, EM; Shapiro, R; Billiar, TR; Bauer, PM				Bauer, Eileen M.; Shapiro, Richard; Billiar, Timothy R.; Bauer, Philip M.			High Mobility Group Box 1 Inhibits Human Pulmonary Artery Endothelial Cell Migration via a Toll-like Receptor 4- and Interferon Response Factor 3-dependent Mechanism(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR HMGB1; ACUTE LUNG INJURY; GENE-EXPRESSION; LIVER ISCHEMIA; HYPOXIA; ANGIOGENESIS; PROTEIN; IMMUNE; OVEREXPRESSION; HYPERTENSION	In pulmonary hypertension the loss of precapillary arterioles results from vascular injury causing endothelial dysfunction. Endothelial cell migration and proliferation are critical for vascular regeneration. This study focused on the effect of high mobility group box 1 protein (HMGB1) on these critical processes. HMGB1 had no effect on human pulmonary artery endothelial cell (HPAEC) proliferation. In contrast, treatment of HPAECs with HMGB1 dose-dependently inhibited VEGF-stimulated HPAEC migration. The effect of HMGB1 on HPAEC migration was TLR4-dependent because it was reversed by TLR4 siRNA or TLR4-neutralizing antibody. Exposure of HPAECs to hypoxia caused translocation and release of HMGB1 and inhibition of HPAEC migration. The effect of hypoxia on HPAEC migration was mediated by HMGB1 because HMGB1-neutralizing antibody but not control IgG restored HPAEC migration. Likewise, TLR4 siRNA but not control siRNA reversed the inhibitory effect of hypoxia in HPAECs. The canonical TLR4 signaling pathway requires the adaptor protein MyD88 and leads to downstream NF kappa B activation. Interestingly, HMGB1 failed to stimulate NF kappa B translocation to the nucleus, but instead activated an alternative pathway characterized by activation of interferon response factor 3 (IRF3). This was in contrast to human umbilical vein endothelial cells in which HMGB1 stimulated nuclear translocation of NF kappa B but not IRF3. IRF3 siRNA, but not MyD88 siRNA, reversed the inhibitory effect of HMGB1 on HPAEC migration. These data demonstrate that HMGB1 inhibits HPAEC migration, a critical process for vascular regeneration, via TLR4- and IRF3-dependent mechanisms.	[Bauer, Eileen M.; Shapiro, Richard; Billiar, Timothy R.; Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bauer, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St,Starzl Biomed Sci,Tower W1147, Pittsburgh, PA 15261 USA.	bauerpm@upmc.edu			National Institutes of Health [R01-HL085134, R03-HL110794, P50-GM53789, T32-098036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085134, R03HL110794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL085134 and R03-HL110794 (to P. M. B.), P50-GM53789 (to T. R. B.), and T32-098036 (to E. M. B.).	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Chen JL, 2011, KIDNEY INT, V80, P504, DOI 10.1038/ki.2011.140; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Gong Q, 2009, SCAND J IMMUNOL, V69, P29, DOI 10.1111/j.1365-3083.2008.02194.x; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Lin Q, 2011, ARTERIOSCL THROM VAS, V31, P1024, DOI 10.1161/ATVBAHA.111.224048; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ngamkitidechakul C, 2002, BIOTECHNIQUES, V33, P1296, DOI 10.2144/02336pt02; Ogawa EN, 2006, AM J RESP CRIT CARE, V174, P400, DOI 10.1164/rccm.200605-699OC; Ohmori H, 2011, EXPERT OPIN THER TAR, V15, P183, DOI 10.1517/14728222.2011.546785; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Partovian C, 2000, AM J RESP CELL MOL, V23, P762, DOI 10.1165/ajrcmb.23.6.4106; Pascaud MA, 2003, AM J RESP CELL MOL, V29, P449, DOI 10.1165/rcmb.2002-0120OC; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reiss LK, 2012, EUR J CELL BIOL, V91, P590, DOI 10.1016/j.ejcb.2011.11.004; Sachdev U, 2012, J VASC SURG, V55, P180, DOI 10.1016/j.jvs.2011.07.072; Schlueter C, 2005, PATHOL RES PRACT, V201, P101, DOI 10.1016/j.prp.2004.11.010; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tsai TH, 2011, SHOCK, V35, P92, DOI 10.1097/SHK.0b013e3181ea45ca; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Young KC, 2010, EXP LUNG RES, V36, P111, DOI 10.3109/01902140903171610; Zhu XY, 2008, LIFE SCI, V83, P801, DOI 10.1016/j.lfs.2008.09.029	48	43	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1365	1373		10.1074/jbc.M112.434142	http://dx.doi.org/10.1074/jbc.M112.434142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23148224	hybrid, Green Published			2022-12-25	WOS:000313570300057
J	Bitbol, AF; Constantin, D; Fournier, JB				Bitbol, Anne-Florence; Constantin, Doru; Fournier, Jean-Baptiste			Bilayer Elasticity at the Nanoscale: The Need for New Terms	PLOS ONE			English	Article							BICONTINUOUS CUBIC PHASES; LIPID-BILAYERS; PROTEIN INTERACTIONS; THICKNESS FLUCTUATIONS; HYDROPHOBIC MISMATCH; GRAMICIDIN CHANNELS; MEMBRANE-PROTEIN; SINGLE-CHANNEL; CHAIN-LENGTH; ION-CHANNEL	Continuum elastic models that account for membrane thickness variations are especially useful in the description of nanoscale deformations due to the presence of membrane proteins with hydrophobic mismatch. We show that terms involving the gradient and the Laplacian of the area per lipid are significant and must be retained in the effective Hamiltonian of the membrane. We reanalyze recent numerical data, as well as experimental data on gramicidin channels, in light of our model. This analysis yields consistent results for the term stemming from the gradient of the area per molecule. The order of magnitude we find for the associated amplitude, namely 13-60 mN/m, is in good agreement with the 25 mN/m contribution of the interfacial tension between water and the hydrophobic part of the membrane. The presence of this term explains a systematic variation in previously published numerical data.	[Bitbol, Anne-Florence; Fournier, Jean-Baptiste] Univ Paris 07, CNRS, Lab Mat & Syst Complexes MSC, UMR 7057, Paris, France; [Constantin, Doru] Univ Paris 11, CNRS, Phys Solides Lab, UMR 8502, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Fournier, JB (corresponding author), Univ Paris 07, CNRS, Lab Mat & Syst Complexes MSC, UMR 7057, Paris, France.	jean-baptiste.fournier@univ-paris-diderot.fr	Constantin, Doru/H-8495-2013	Constantin, Doru/0000-0001-5623-9633; Bitbol, Anne-Florence/0000-0003-1020-494X; Fournier, Jean-Baptiste/0000-0003-3760-9357				[Anonymous], 1992, INTERMOLECULAR SURFA; ArandaEspinoza H, 1996, BIOPHYS J, V71, P648, DOI 10.1016/S0006-3495(96)79265-2; Bitbol AF, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11053-4; Brannigan G, 2006, BIOPHYS J, V90, P1501, DOI 10.1529/biophysj.105.075838; Brannigan G, 2007, BIOPHYS J, V92, P864, DOI 10.1529/biophysj.106.094953; CHUNG H, 1994, BIOPHYS J, V66, P377, DOI 10.1016/S0006-3495(94)80787-8; CHUNG H, 1994, NATURE, V368, P224, DOI 10.1038/368224a0; DAN N, 1993, LANGMUIR, V9, P2768, DOI 10.1021/la00035a005; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; Fournier JB, 1999, EUR PHYS J B, V11, P261, DOI 10.1007/s100510050937; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; HELFRICH P, 1990, BIOPHYS J, V57, P1075, DOI 10.1016/S0006-3495(90)82625-4; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HLADKY SB, 1982, BIOPHYS J, V38, P251, DOI 10.1016/S0006-3495(82)84556-6; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Kim T, 2012, BIOPHYS J, V102, P1551, DOI 10.1016/j.bpj.2012.03.014; KOLB HA, 1977, BIOCHIM BIOPHYS ACTA, V464, P127, DOI 10.1016/0005-2736(77)90376-5; Leikin S, 1996, BIOPHYS J, V71, P2623, DOI 10.1016/S0006-3495(96)79454-7; Lindahl E, 2000, BIOPHYS J, V79, P426, DOI 10.1016/S0006-3495(00)76304-1; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Marrink SJ, 2001, J PHYS CHEM B, V105, P6122, DOI 10.1021/jp0103474; May ER, 2007, MOL SIMULAT, V33, P787, DOI 10.1080/08927020701308323; May ER, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021913; May S, 1999, BIOPHYS J, V76, P751, DOI 10.1016/S0006-3495(99)77241-3; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; MOURITSEN OG, 1984, BIOPHYS J, V46, P141, DOI 10.1016/S0006-3495(84)84007-2; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; OCONNELL AM, 1990, SCIENCE, V250, P1256, DOI 10.1126/science.1700867; OWICKI JC, 1978, P NATL ACAD SCI USA, V75, P1616, DOI 10.1073/pnas.75.4.1616; OWICKI JC, 1979, P NATL ACAD SCI USA, V76, P4750, DOI 10.1073/pnas.76.10.4750; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; SACKMANN E, 1984, BIOL MEMBRANES, V0005, P00105; Safran S. A., 1994, STAT THERMODYNAMICS; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Szule JA, 2002, BIOPHYS J, V83, P977, DOI 10.1016/S0006-3495(02)75223-5; TEMPLER RH, 1995, J PHYS II, V5, P1053, DOI 10.1051/jp2:1995229; TEMPLER RH, 1995, LANGMUIR, V11, P334, DOI 10.1021/la00001a056; Vacklin HP, 2000, LANGMUIR, V16, P4741, DOI 10.1021/la991408g; Watson MC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.028102; Watson MC, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3660673; West B, 2009, BIOPHYS J, V96, P101, DOI 10.1529/biophysj.108.138677	44	29	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48306	10.1371/journal.pone.0048306	http://dx.doi.org/10.1371/journal.pone.0048306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144862	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500018
J	Bjornstad, LG; Meza, TJ; Otterlei, M; Olafsrud, SM; Meza-Zepeda, LA; Falnes, PO				Bjornstad, Linn G.; Meza, Trine J.; Otterlei, Marit; Olafsrud, Solveig M.; Meza-Zepeda, Leonardo A.; Falnes, Pal O.			Human ALKBH4 Interacts with Proteins Associated with Transcription	PLOS ONE			English	Article							PHD FINGER-BROMODOMAIN; OXIDATIVE DEMETHYLATION; DNA-DAMAGE; H3K79 METHYLATION; YEATS DOMAIN; FAMILY; GENE; RNA; REPAIR; CHROMATIN	The Fe(II)- and 2-oxoglutarate (2OG)-dependent dioxygenase AlkB from E. coli is a demethylase which repairs alkyl lesions in DNA, as well as RNA, through a direct reversal mechanism. Humans possess nine AlkB homologs (ALKBH1-8 and FTO). ALKBH2 and ALKBH3 display demethylase activities corresponding to that of AlkB, and both ALKBH8 and FTO are RNA modification enzymes. The biochemical functions of the rest of the homologs are still unknown. To increase our knowledge on the functions of ALKBH4 and ALKBH7 we have here performed yeast two-hybrid screens to identify interaction partners of the two proteins. While no high-confidence hits were detected in the case of ALKBH7, several proteins associated with chromatin and/or involved in transcription were found to interact with ALKBH4. For all interaction partners, the regions mediating binding to ALKBH4 comprised domains previously reported to be involved in interaction with DNA or chromatin. Furthermore, some of these partners showed nuclear co-localization with ALKBH4. However, the global gene expression pattern was only marginally altered upon ALKBH4 over-expression, and larger effects were observed in the case of ALKBH7. Although the molecular function of both proteins remains to be revealed, our findings suggest a role for ALKBH4 in regulation of gene expression or chromatin state.	[Olafsrud, Solveig M.; Meza-Zepeda, Leonardo A.; Falnes, Pal O.] Univ Oslo, Dept Mol Biosci, Genom Core Facil, Oslo, Norway; [Otterlei, Marit] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Olafsrud, Solveig M.; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo	Falnes, PO (corresponding author), Univ Oslo, Dept Mol Biosci, Genom Core Facil, Oslo, Norway.	pal.falnes@imbv.uio.no	Falnes, Pål Ø./AAA-4581-2020; Meza, Trine Johansen/AAC-5495-2020; Meza-Zepeda, Leonardo Andres/CAG-5229-2022	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X; Otterlei, Marit/0000-0002-5232-1186; Falnes, Pal/0000-0001-8114-6025	Norwegian Cancer Society [PR-2007-0132]; Research Council of Norway [159013/S10]; Polish-Norwegian Research Fund [PNRF-143-AI-1/07]	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Polish-Norwegian Research Fund	This work was supported by the Norwegian Cancer Society (www.kreftforeningen.no, grant number PR-2007-0132), the Research Council of Norway (www.forskningsradet.no, FUGE program grant number 159013/S10) and the Polish-Norwegian Research Fund (www.fbn.opi.org.pl, grant number PNRF-143-AI-1/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Agricola E, 2011, MOL CELL, V43, P85, DOI 10.1016/j.molcel.2011.05.020; ARAVIND L, 2001, GENOME BIOL, V2; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bjornstad LG, 2011, BIOCHEM J, V434, P391, DOI 10.1042/BJ20101667; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dray E, 2006, PLANT PHYSIOL, V140, P1059, DOI 10.1104/pp.105.075838; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frick LE, 2007, P NATL ACAD SCI USA, V104, P755, DOI 10.1073/pnas.0607377104; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; IIDA S, 1993, ONCOGENE, V8, P3085; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Korvald H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025188; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; NAKAMURA T, 1993, P NATL ACAD SCI USA, V90, P4631, DOI 10.1073/pnas.90.10.4631; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Nordstrand LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013827; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; RUBNITZ JE, 1994, BLOOD, V84, P1747; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210	75	25	35	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49045	10.1371/journal.pone.0049045	http://dx.doi.org/10.1371/journal.pone.0049045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145062	gold, Green Published, Green Submitted			2022-12-25	WOS:000312269500066
J	Schuiki, I; Zhang, LL; Volchuk, A				Schuiki, Irmgard; Zhang, Liling; Volchuk, Allen			Endoplasmic Reticulum Redox State Is Not Perturbed by Pharmacological or Pathological Endoplasmic Reticulum Stress in Live Pancreatic beta-Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; APOPTOSIS; HOMEOSTASIS; INHIBITION; EXPRESSION; INDICATORS; PALMITATE; ERO1-BETA; GLUCOSE	Accumulation of unfolded, misfolded and aggregated proteins in the endoplasmic reticulum (ER) causes ER stress. ER stress can result from physiological situations such as acute increases in secretory protein biosynthesis or pathological conditions that perturb ER homeostasis such as alterations in the ER redox state. Here we monitored ER redox together with transcriptional output of the Unfolded Protein Response (UPR) in INS-1 insulinoma cells stably expressing eroGFP (ER-redox-sensor) and mCherry protein driven by a GRP78 promoter (UPR-sensor). Live cell imaging, flow cytometry and biochemical characterization were used to examine these parameters in response to various conditions known to induce ER stress. As expected, treatment of the cells with the reducing agent dithiothreitol caused a decrease in the oxidation state of the ER accompanied by an increase in XBP-1 splicing. Unexpectedly however, other treatments including tunicamycin, thapsigargin, DL-homocysteine, elevated free fatty acids or high glucose had essentially no influence on the ER redox state, despite inducing ER stress. Comparable results were obtained with dispersed rat islet cells expressing eroGFP. Thus, unlike in yeast cells, ER stress in pancreatic beta-cells is not associated with a more reducing ER environment.	[Schuiki, Irmgard; Zhang, Liling; Volchuk, Allen] Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada; [Volchuk, Allen] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Volchuk, Allen] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Volchuk, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada.	avolchuk@uhnres.utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP-114922]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research (CIHR, MOP-114922; http://www.cihr-irsc.gc.ca/e/193.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/509437; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Margittai E, 2010, FEBS LETT, V584, P2995, DOI 10.1016/j.febslet.2010.05.055; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Rieusset J, 2011, INT J BIOCHEM CELL B, V43, P1257, DOI 10.1016/j.biocel.2011.05.006; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Solovyova N, 2002, J NEUROSCI METH, V122, P1, DOI 10.1016/S0165-0270(02)00300-X; van Lith M, 2011, J CELL SCI, V124, P2349, DOI 10.1242/jcs.085530; Vellanki RN, 2010, ENDOCRINOLOGY, V151, P4146, DOI 10.1210/en.2010-0137; Volchuk A, 2010, DIABETES OBES METAB, V12, P48, DOI 10.1111/j.1463-1326.2010.01271.x; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	36	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48626	10.1371/journal.pone.0048626	http://dx.doi.org/10.1371/journal.pone.0048626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144914	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500029
J	Blair, MW; Soler, A; Cortes, AJ				Blair, Matthew W.; Soler, Alvaro; Cortes, Andres J.			Diversification and Population Structure in Common Beans (Phaseolus vulgaris L.)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GENETIC DIVERSITY; MICROSATELLITE MARKERS; CORE COLLECTION; WILD; DOMESTICATION; LANDRACES; ORIGIN; POLYMORPHISMS; INFERENCE	Wild accessions of crops and landraces are valuable genetic resources for plant breeding and for conserving alleles and gene combinations in planta. The primary genepool of cultivated common beans includes wild accessions of Phaseolus vulgaris. These are of the same species as the domesticates and therefore are easily crossable with cultivated accessions. Molecular marker assessment of wild beans and landraces is important for the proper utilization and conservation of these important genetic resources. The goal of this research was to evaluate a collection of wild beans with fluorescent microsatellite or simple sequence repeat markers and to determine the population structure in combination with cultivated beans of all known races. Marker diversity in terms of average number of alleles per marker was high (13) for the combination of 36 markers and 104 wild genotypes that was similar to the average of 14 alleles per marker found for the 606 cultivated genotypes. Diversity in wild beans appears to be somewhat higher than in cultivated beans on a per genotype basis. Five populations or genepools were identified in structure analysis of the wild beans corresponding to segments of the geographical range, including Mesoamerican (Mexican), Guatemalan, Colombian, Ecuadorian-northern Peruvian and Andean (Argentina, Bolivia and Southern Peru). The combined analysis of wild and cultivated accessions showed that the first and last of these genepools were related to the cultivated genepools of the same names and the penultimate was found to be distinct but not ancestral to the others. The Guatemalan genepool was very novel and perhaps related to cultivars of race Guatemala, while the Colombian population was also distinct. Results suggest geographic isolation, founder effects or natural selection could have created the different semi-discrete populations of wild beans and that multiple domestications and introgression were involved in creating the diversity of cultivated beans.	[Blair, Matthew W.; Soler, Alvaro] Univ Nacl Colombia, Dept Ciencias Agr, Palmira, Colombia; [Blair, Matthew W.] Cornell Univ, Dept Plant Breeding, Ithaca, NY USA; [Cortes, Andres J.] Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden	Universidad Nacional de Colombia; Cornell University; Uppsala University	Blair, MW (corresponding author), Univ Nacl Colombia, Dept Ciencias Agr, Palmira, Colombia.	mwb1@cornell.edu; andres.cortes@ebc.uu.se		Cortes, Andres J./0000-0003-4178-0675; Soler-Garzon, Alvaro/0000-0002-7671-3109	ADOC; Genotyping initiatives of the Generation Challenge Program; USAID funds	ADOC; Genotyping initiatives of the Generation Challenge Program; USAID funds(United States Agency for International Development (USAID))	This project was supported by the ADOC and Genotyping initiatives of the Generation Challenge Program and by USAID funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Beebe S, 2000, CROP SCI, V40, P264, DOI 10.2135/cropsci2000.401264x; Beebe S, 2001, CROP SCI, V41, P854, DOI 10.2135/cropsci2001.413854x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blair MW, 2007, THEOR APPL GENET, V116, P29, DOI 10.1007/s00122-007-0644-8; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Chacon S MI, 2007, PLANT SYST EVOL, V266, P175, DOI 10.1007/s00606-007-0536-z; Cortes AJ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-58; Cortes AJ, 2012, THEOR APPL GENET, V125, P1069, DOI 10.1007/s00122-012-1896-5; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; DEBOUCK DG, 1993, ECON BOT, V47, P408, DOI 10.1007/BF02907356; Diaz LM, 2006, THEORETICAL APPL GEN, V114; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Galvan MZ, 2006, GENET RESOUR CROP EV, V53, P891, DOI 10.1007/s10722-004-0981-2; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gepts P., 1991, Common beans: research for crop improvement., P7; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Idury RM, 1997, GENOME RES, V7, P1104, DOI 10.1101/gr.7.11.1104; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KAMI J, 1995, P NATL ACAD SCI USA, V92, P1101, DOI 10.1073/pnas.92.4.1101; KHAIRALLAH MM, 1992, THEOR APPL GENET, V84, P915, DOI 10.1007/BF00227404; KOENIG R, 1989, THEOR APPL GENET, V78, P809, DOI 10.1007/BF00266663; Kwak M, 2009, CROP SCI, V49, P554, DOI 10.2135/cropsci2008.07.0421; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mahuku GS, 2003, EUPHYTICA, V130, P303, DOI 10.1023/A:1023095531683; Metais I, 2002, THEOR APPL GENET, V104, P1346, DOI 10.1007/s00122-002-0901-9; Miklas Phillip N., 2007, V3, P1; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg N.A, 2002, DISTRUCT PROGRAM GRA; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x	39	69	71	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49488	10.1371/journal.pone.0049488	http://dx.doi.org/10.1371/journal.pone.0049488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145179	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800261
J	Quail, DF; Zhang, GH; Walsh, LA; Siegers, GM; Dieters-Castator, DZ; Findlay, SD; Broughton, H; Putman, DM; Hess, DA; Postovit, LM				Quail, Daniela F.; Zhang, Guihua; Walsh, Logan A.; Siegers, Gabrielle M.; Dieters-Castator, Dylan Z.; Findlay, Scott D.; Broughton, Heather; Putman, David M.; Hess, David A.; Postovit, Lynne-Marie			Embryonic Morphogen Nodal Promotes Breast Cancer Growth and Progression	PLOS ONE			English	Article							HIGH ALDEHYDE DEHYDROGENASE; TUMOR-SUPPRESSOR; TGF-BETA; CELLS; EXPRESSION; PROLIFERATION; PATHWAYS; CRIPTO-1; PROVIDES; MODELS	Breast cancers expressing human embryonic stem cell (hESC)-associated genes are more likely to progress than well-differentiated cancers and are thus associated with poor patient prognosis. Elevated proliferation and evasion of growth control are similarly associated with disease progression, and are classical hallmarks of cancer. In the current study we demonstrate that the hESC-associated factor Nodal promotes breast cancer growth. Specifically, we show that Nodal is elevated in aggressive MDA-MB-231, MDA-MB-468 and Hs578t human breast cancer cell lines, compared to poorly aggressive MCF-7 and T47D breast cancer cell lines. Nodal knockdown in aggressive breast cancer cells via shRNA reduces tumour incidence and significantly blunts tumour growth at primary sites. In vitro, using Trypan Blue exclusion assays, Western blot analysis of phosphorylated histone H3 and cleaved caspase-9, and real time RT-PCR analysis of BAX and BCL2 gene expression, we demonstrate that Nodal promotes expansion of breast cancer cells, likely via a combinatorial mechanism involving increased proliferation and decreased apopotosis. In an experimental model of metastasis using beta-glucuronidase (GUSB)-deficient NOD/SCID/mucopolysaccharidosis type VII (MPSVII) mice, we show that although Nodal is not required for the formation of small (<100 cells) micrometastases at secondary sites, it supports an elevated proliferation: apoptosis ratio (Ki67:TUNEL) in micrometastatic lesions. Indeed, at longer time points (8 weeks), we determined that Nodal is necessary for the subsequent development of macrometastatic lesions. Our findings demonstrate that Nodal supports tumour growth at primary and secondary sites by increasing the ratio of proliferation: apoptosis in breast cancer cells. As Nodal expression is relatively limited to embryonic systems and cancer, this study establishes Nodal as a potential tumour-specific target for the treatment of breast cancer.	[Quail, Daniela F.; Zhang, Guihua; Siegers, Gabrielle M.; Dieters-Castator, Dylan Z.; Findlay, Scott D.; Postovit, Lynne-Marie] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Walsh, Logan A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Broughton, Heather; Putman, David M.; Hess, David A.] Dept Physiol & Pharmacol, London, ON, Canada; [Broughton, Heather; Putman, David M.; Hess, David A.] Robarts Res Inst, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Memorial Sloan Kettering Cancer Center; Western University (University of Western Ontario)	Postovit, LM (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.	Lynne.Postovit@schulich.uwo.ca	Siegers, Gabrielle M/M-2042-2017; Findlay, Scott D/AAP-9554-2021; zhang, guihua/GVU-4494-2022; Hess, David A/M-2828-2013	Siegers, Gabrielle M/0000-0003-2154-0279; Findlay, Scott D/0000-0002-0393-1623; Walsh, Logan/0000-0001-8771-2577; Postovit, Lynne-Marie/0000-0002-8088-4197	Canadian Institutes for Health Research [MOP 89714, PLS 95381]; Cancer Research Society; Canadian Breast Cancer Foundation; Canadian Institutes of Health Research (CIHR); CIHR; new investigator award; MacDonald Scholarship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); new investigator award; MacDonald Scholarship	This work was supported by the Canadian Institutes for Health Research (MOP 89714 and PLS 95381) and the Cancer Research Society to L.M.P. D.F.Q. is a recipient of a doctoral fellowship from the Canadian Breast Cancer Foundation and from the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer. L.M.P. is the recipient of the premier new investigator award from the CIHR. D.A.H. is the recipient of a new investigator award and a MacDonald Scholarship for the Canadian Heart and Stroke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Cavallari C, 2013, ONCOGENE, V32, P819, DOI 10.1038/onc.2012.114; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardy KM, 2010, CANCER RES, V70, P10340, DOI 10.1158/0008-5472.CAN-10-0705; Hess DA, 2008, STEM CELLS, V26, P611, DOI 10.1634/stemcells.2007-0429; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hunter Kent W, 2008, Breast Cancer Res, V10 Suppl 1, pS2, DOI 10.1186/bcr1988; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kenney NJ, 2004, J MAMMARY GLAND BIOL, V9, P133, DOI 10.1023/B:JOMG.0000037158.91940.1c; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Postovit LM, 2007, EXPERT OPIN THER TAR, V11, P497, DOI 10.1517/14728222.11.4.497; Quail DF, 2012, CANCER RES, V72, P3851, DOI 10.1158/0008-5472.CAN-11-3951; Quail DF, 2011, MOL BIOL CELL, V22, P4809, DOI 10.1091/mbc.E11-03-0263; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Strizzi L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3185; Strizzi Luigi, 2008, Breast Dis, V29, P91; Strizzi Luigi, 2009, Expert Rev Dermatol, V4, P67, DOI 10.1586/17469872.4.1.67; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vo BT, 2011, PROSTATE, V71, P1084, DOI 10.1002/pros.21326; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zhong Yu, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P83	38	33	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48237	10.1371/journal.pone.0048237	http://dx.doi.org/10.1371/journal.pone.0048237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144858	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800041
J	Tayama, M; Tateno, M; Park, TW; Ukai, W; Hashimoto, E; Saito, T				Tayama, Masaya; Tateno, Masaru; Park, Tae Woo; Ukai, Wataru; Hashimoto, Eri; Saito, Toshikazu			The Study of Cognitive Characteristics in Asperger's Disorder by Using a Modified Prisoner's Dilemma Game with a Variable Payoff Matrix	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; AUTISM SPECTRUM; INFANTILE-AUTISM; COOPERATION; PREVALENCE; EPIDEMIOLOGY; STRATEGY; CHILDREN; ADULTS; JAPAN	Individuals with Asperger's Disorder (ASP) have difficulties in social reciprocity and in providing appropriate cooperative behavior. The Prisoner's Dilemma (PD) is a well-known model in game theory that illustrates the paradoxical disposition of interaction between two individuals with opposing interests, and may be a useful tool in the diagnosis of ASP in early childhood. In this study, we investigated the cognitive characteristics of ASP by using a modified PD game. The subjects were 29 individuals with ASP and 28 age-and IQ-matched controls. In the PD game, each of two players has two cards: card 1 represents cooperation and card 2 betrayal. The score each player obtains is decided according to a 2 x 2 payoff matrix and depends on the combination of their selections. The P-score ("P" for punishment) is defined as the score that is given when they both select betrayal. Comparing the two groups, the mean P-score at the end of the game and the mean total score were significantly higher in the ASP group, while the rate of selection of cooperative choice in both groups did not differ significantly. The classification of the shape of the graph according to fluctuation of the P-score revealed that in the ASP group only 2 cases (6.9%) showed continuous decrease of P-score compared to 8 control cases (28.6%) demonstrating similar results. However, the reasons were thought to be different: ASP subjects presumably selected card 2 because of a preference for the number itself, whereas control subjects preferentially chose this card to enhance their chance of winning the competition. It is often difficult to diagnose ASP in the young especially when they lack the distinctive clinical features of ASD in early childhood. Given the limited number of objective tools to evaluate the cognitive characteristics of ASP subjects, the PD game might be a useful diagnostic support tool for ASP.	[Tayama, Masaya; Tateno, Masaru; Ukai, Wataru; Hashimoto, Eri; Saito, Toshikazu] Sapporo Med Univ, Sch Med, Dept Neuropsychiat, Sapporo, Hokkaido, Japan; [Park, Tae Woo] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Park, Tae Woo] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Sapporo Medical University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Tateno, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Neuropsychiat, Sapporo, Hokkaido, Japan.	tatema@sapmed.ac.jp			 [22791133]		This study was supported by a Grant-in-Aid for Young Scientists (B) for Masaru Tateno (22791133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 1994, DIAGN STAT MAN MENT; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOUCHER J, 1989, BRIT J DISORD COMMUN, V24, P181; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; DEUTSCH M, 1960, J ABNORM SOC PSYCH, V61, P138, DOI 10.1037/h0046501; Deutsch M., 1958, J CONFLICT RESOLUT, V2, P265, DOI [DOI 10.1177/002200275800200401, 10.1177/002200275800200401]; Downs A, 2004, J AUTISM DEV DISORD, V34, P625, DOI 10.1007/s10803-004-5284-0; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; GALLO PS, 1965, J CONFLICT RESOLUT, V9, P68, DOI DOI 10.1177/; GUYER M, 1968, BEHAV SCI, V13, P205, DOI 10.1002/bs.3830130305; Hill EL, 2004, J CONSCIOUSNESS STUD, V11, P144; Kawamura Y, 2008, PSYCHIAT CLIN NEUROS, V62, P152, DOI 10.1111/j.1440-1819.2008.01748.x; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; KRAINES D, 1989, THEOR DECIS, V26, P47, DOI 10.1007/BF00134056; Kurita H, 2006, LANCET, V368, P179, DOI 10.1016/S0140-6736(06)69015-6; Luce RD, 1989, GAMES DECISIONS INTR; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; MATSUISHI T, 1987, J CHILD NEUROL, V2, P268, DOI 10.1177/088307388700200406; MATSUMOTO D, 1986, DEV PSYCHOL, V22, P663, DOI 10.1037/0012-1649.22.5.663; Nakahara J, 1965, HOKKAIDO REPORT PSYC, V67, P1; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Poundstone W., 1993, PRISONERS DILEMMA; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; RABIN M, 1993, AM ECON REV, V83, P1281; RAPOPORT A, 1962, BEHAV SCI, V7, P1; Rapoport A., 1965, PRISONERS DILEMMA ST; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; SUGIYAMA T, 1989, J AUTISM DEV DISORD, V19, P87, DOI 10.1007/BF02212720; TANOUE Y, 1988, J AUTISM DEV DISORD, V18, P155, DOI 10.1007/BF02211943; Tateno Masaru, 2009, Child Adolesc Psychiatry Ment Health, V3, P30, DOI 10.1186/1753-2000-3-30; Yoshida W, 2010, J NEUROSCI, V30, P8815, DOI 10.1523/JNEUROSCI.0400-10.2010	41	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48794	10.1371/journal.pone.0048794	http://dx.doi.org/10.1371/journal.pone.0048794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23144975	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800137
J	Perinpanayagam, MA; Beauchamp, E; Martin, DDO; Sim, JYW; Yap, MC; Berthiaume, LG				Perinpanayagam, Maneka A.; Beauchamp, Erwan; Martin, Dale D. O.; Sim, Jacky Y. W.; Yap, Megan C.; Berthiaume, Luc G.			Regulation of co- and post-translational myristoylation of proteins during apoptosis: interplay of N-myristoyltransferases and caspases	FASEB JOURNAL			English	Article						NMT; programmed cell death; cancer	FATTY-ACYLATION; RAPID DETECTION; CLEAVAGE; ASSAY; PALMITOYLATION; TRANSFERASE; KINASES; ENZYME	Myristoylation occurs cotranslationally on nascent proteins and post-translationally during apoptosis after caspase cleavages expose cryptic myristoylation sites. We demonstrate a drastic change in the myristoylated protein proteome in apoptotic cells, likely as more substrates are revealed by caspases. We show for the first time that both N-myristoyltransferases (NMTs) 1 and 2 are cleaved during apoptosis and that the caspase-3- or -8-mediated cleavage of NMT1 at Asp-72 precedes the cleavage of NMT2 by caspase-3 mainly at Asp-25. The cleavage of NMTs did not significantly affect their activity in apoptotic cells until the 8 h time point. However, the cleavage of the predominantly membrane bound NMT1 (64%) removed a polybasic domain stretch and led to a cytosolic relocalization (>55%), whereas predominantly cytosolic NMT2 (62%) relocalized to membranes when cleaved (>80%) after the removal of a negatively charged domain. The interplay between caspases and NMTs during apoptosis is of particular interest since caspases may not only control the rates of substrate production but also their myristoylation rate by regulating the location and perhaps the specificity of NMTs. Since apoptosis is often suppressed in cancer, the reduced caspase activity seen in cancer cells might also explain the higher NMT levels observed in many cancers.-Perinpanayagam, M. A., Beauchamp, E., Martin, D. D. O., Sim, J. Y. W., Yap, M. C., Berthiaume, L. G. Regulation of co- and post-translational myristoylation of proteins during apoptosis: interplay of N-myristoyltransferases and caspases. FASEB J. 27, 811-821 (2013). www.fasebj.org	[Perinpanayagam, Maneka A.; Beauchamp, Erwan; Martin, Dale D. O.; Sim, Jacky Y. W.; Yap, Megan C.; Berthiaume, Luc G.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Sch Mol & Syst Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Berthiaume, LG (corresponding author), Univ Alberta, Fac Med & Dent, Dept Cell Biol, Sch Mol & Syst Biol, 5-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	luc.berthiaume@ualberta.ca	martel, celine/O-6651-2016; Martin, Dale/L-6351-2015	martel, celine/0000-0002-1800-4558; Berthiaume, Luc/0000-0003-0926-059X	Canadian Institute of Health Research (CIHR) [MOP 81248]; Alberta Cancer Research Institute (ACRI) [24425]; University of Alberta-Faculty of Medicine and Dentistry; CIHR; Alberta Heritage Foundation for Medical Research	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute (ACRI); University of Alberta-Faculty of Medicine and Dentistry(University of Alberta); CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was initiated by Canadian Institute of Health Research (CIHR) grant MOP 81248 and continued with Alberta Cancer Research Institute (ACRI) grant 24425 (to L. G. B). M. A. P. held an ACRI graduate studentship and a University of Alberta-Faculty of Medicine and Dentistry 75th Anniversary Award. D.D.O.M. held a Canada Graduate Scholarships Doctoral Award from CIHR and a Medical Research Studentship Incentive Award from the Alberta Heritage Foundation for Medical Research. The authors thank Alexandra Janowicz and Ryan J. Heit for technical assistance.	Armah DA, 1999, J BIOL CHEM, V274, P5931, DOI 10.1074/jbc.274.9.5931; Bhatnagar RS, 1998, NAT STRUCT BIOL, V5, P1091, DOI 10.1038/4202; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Hang HC, 2011, CHEM REV, V111, P6341, DOI 10.1021/cr2001977; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Heal WP, 2008, CHEM COMMUN, P480, DOI 10.1039/b716115h; Jakobi R, 2004, DRUG RESIST UPDATE, V7, P11, DOI 10.1016/j.drup.2004.01.001; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; KING MJ, 1991, ANAL BIOCHEM, V199, P149, DOI 10.1016/0003-2697(91)90082-5; Kumar Sujeet, 2011, Cancers (Basel), V3, P1372, DOI 10.3390/cancers3011372; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Martin DDO, 2012, FASEB J, V26, P13, DOI 10.1096/fj.11-182360; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Raju RVS, 1999, METH MOL B, V116, P193; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RUDNICK DA, 1992, J BIOL CHEM, V267, P23852; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Selvakumar P, 2006, FEBS LETT, V580, P2021, DOI 10.1016/j.febslet.2006.02.076; Selvakumar P, 2007, PROG LIPID RES, V46, P1, DOI 10.1016/j.plipres.2006.05.002; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Solary E, 1998, CELL BIOL TOXICOL, V14, P121, DOI 10.1023/A:1007481921502; Takamune N, 2010, BIOL PHARM BULL, V33, P2018, DOI 10.1248/bpb.33.2018; TOWLER D, 1986, P NATL ACAD SCI USA, V83, P2812, DOI 10.1073/pnas.83.9.2812; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhao Y, 2000, MOL BIOL CELL, V11, P721, DOI 10.1091/mbc.11.2.721	43	25	26	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					811	821		10.1096/fj.12-214924	http://dx.doi.org/10.1096/fj.12-214924			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23150525				2022-12-25	WOS:000314358000039
J	Benoit, ME; Hernandez, MX; Dinh, ML; Benavente, F; Vasquez, O; Tenner, AJ				Benoit, Marie E.; Hernandez, Michael X.; Dinh, Minhan L.; Benavente, Francisca; Vasquez, Osvaldo; Tenner, Andrea J.			C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-beta Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; ELEMENT-BINDING PROTEIN; A-BETA; PRECURSOR PROTEIN; FIBRILLAR OLIGOMERS; COUPLED RECEPTORS; COMMON MECHANISM; CELL-SURFACE; COMPLEMENT; C1Q	Complement protein C1q is induced in the brain in response to a variety of neuronal injuries, including Alzheimer disease (AD), and blocks fibrillar amyloid-beta (fA beta) neurotoxicity in vitro. Here, we show that C1q protects immature and mature primary neurons against fA beta toxicity, and we report for the first time that C1q prevents toxicity induced by oligomeric forms of amyloid-beta (A beta). Gene expression analysis reveals C1q-activated phosphorylated cAMP-response element-binding protein and AP-1, two transcription factors associated with neuronal survival and neurite outgrowth, and increased LRP1B and G protein-coupled receptor 6(GPR6) expression in fA beta-injured neurons. Silencing of cAMP-response element-binding protein, LRP1B or GPR6 expression inhibited C1q-mediated neuroprotection from fA beta-induced injury. In addition, C1q altered the association of oligomeric A beta and fA beta with neurons. In vivo, increased hippocampal expression of C1q, LRP1B, and GPR6 is observed as early as 2 months of age in the 3 x Tg mouse model of AD, whereas no such induction of LRP1B and GPR6 was seen in C1q-deficient AD mice. In contrast, expression of C1r and C1s, proteases required to activate the classical complement pathway, and C3 showed a significant age-dependent increase only after 10-13 months of age when A beta plaques start to accumulate in this AD model. Thus, our results identify pathways by which C1q, up-regulated in vivo early in response to injury without the coordinate induction of other complement components, can induce a program of gene expression that promotes neuroprotection and thus may provide protection against A beta in preclinical stages of AD and other neurodegenerative processes.	[Benoit, Marie E.; Vasquez, Osvaldo; Tenner, Andrea J.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Hernandez, Michael X.; Tenner, Andrea J.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Dinh, Minhan L.; Benavente, Francisca; Tenner, Andrea J.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Tenner, Andrea J.] Univ Calif Irvine, Inst Memory Impairment & Neurol Disorders, Irvine, CA 92697 USA; [Tenner, Andrea J.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.	atenner@uci.edu		Benavente, Francisca/0000-0001-8245-2673	National Institutes of Health [AI 41090, NS35144, AG 00538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 41090, NS35144, and AG 00538.	Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Benoit ME, 2012, J IMMUNOL, V188, P5682, DOI 10.4049/jimmunol.1103760; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Fan R, 2004, EXP NEUROL, V185, P241, DOI 10.1016/j.expneurol.2003.09.023; Fan R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-1; Fonseca MI, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-4; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fonseca MI, 2004, NEUROBIOL DIS, V15, P40, DOI 10.1016/j.nbd.2003.09.004; Fraser DA, 2007, J BIOL CHEM, V282, P7360, DOI 10.1074/jbc.M605741200; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Harris JA, 2008, J NEUROSCI, V28, P10990, DOI 10.1523/JNEUROSCI.2697-08.2008; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; McCauslin CS, 2006, J BIOL CHEM, V281, P17681, DOI 10.1074/jbc.M600207200; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; Poduslo SE, 2010, AM J MED GENET B, V153B, P114, DOI 10.1002/ajmg.b.30963; Reichwald J, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-35; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Supnet C, 2006, J BIOL CHEM, V281, P38440, DOI 10.1074/jbc.M606736200; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Tchantchou F, 2009, J ALZHEIMERS DIS, V18, P787, DOI 10.3233/JAD-2009-1189; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Webster S, 1996, J NEUROSCI RES, V46, P58, DOI 10.1002/(SICI)1097-4547(19961001)46:1<58::AID-JNR8>3.0.CO;2-E; WEBSTER S, 1994, J NEUROSCI RES, V39, P448, DOI 10.1002/jnr.490390412; YOUNG KR, 1991, J IMMUNOL, V146, P3356	64	85	87	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					654	665		10.1074/jbc.M112.400168	http://dx.doi.org/10.1074/jbc.M112.400168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150673	Green Published, hybrid			2022-12-25	WOS:000313197200066
J	Villar, VM; Jones, JE; Armando, I; Asico, LD; Escano, CS; Lee, H; Wang, XY; Yang, Y; Pascua-Crusan, AM; Palmes-Saloma, CP; Felder, RA; Jose, PA				Villar, Van Anthony M.; Jones, John Edward; Armando, Ines; Asico, Laureano D.; Escano, Crisanto S., Jr.; Lee, Hewang; Wang, Xiaoyan; Yang, Yu; Pascua-Crusan, Annabelle M.; Palmes-Saloma, Cynthia P.; Felder, Robin A.; Jose, Pedro A.			Sorting Nexin 1 Loss Results in D-5 Dopamine Receptor Dysfunction in Human Renal Proximal Tubule Cells and Hypertension in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAFFICKING PROPERTIES; TYPE-1 RECEPTOR; BLOOD-PRESSURE; NADPH OXIDASE; KNOCKOUT MICE; II TYPE-1; DEGRADATION; MEMBRANE; KIDNEY; RATS	The peripheral dopaminergic system plays a crucial role in blood pressure regulation through its actions on renal hemodynamics and epithelial ion transport. The dopamine D5 receptor (D5R) interacts with sorting nexin 1 (SNX1), a protein involved in receptor retrieval from the trans-Golgi network. In this report, we elucidated the spatial, temporal, and functional significance of this interaction in human renal proximal tubule cells and HEK293 cells stably expressing human D5R and in mice. Silencing of SNX1 expression via RNAi resulted in the failure of D5R to internalize and bind GTP, blunting of the agonist-induced increase in cAMP production and decrease in sodium transport, and up-regulation of angiotensin II receptor expression, of which expression was previously shown to be negatively regulated by D5R. Moreover, siRNA-mediated depletion of renal SNX1 in C57BL/6J and BALB/cJ mice resulted in increased blood pressure and blunted natriuretic response to agonist in salt-loaded BALB/cJ mice. These data demonstrate a crucial role for SNX1 in D5R trafficking and that SNX1 depletion results in D5R dysfunction and thus may represent a novel mechanism for the pathogenesis of essential hypertension.	[Villar, Van Anthony M.; Jones, John Edward; Armando, Ines; Asico, Laureano D.; Escano, Crisanto S., Jr.; Lee, Hewang; Wang, Xiaoyan; Yang, Yu; Pascua-Crusan, Annabelle M.; Jose, Pedro A.] Childrens Natl Med Ctr, Childrens Res Inst, Ctr Mol Physiol Res, Washington, DC 20010 USA; [Palmes-Saloma, Cynthia P.] Univ Philippines, Natl Inst Mol Biol & Biotechnol, Quezon City 1101, Philippines; [Felder, Robin A.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	Children's National Health System; University of the Philippines System; University of the Philippines Diliman; University of Virginia	Villar, VM (corresponding author), Univ Maryland, Sch Med, Div Nephrol, Dept Med, 20 Penn St,Suite S003C, Baltimore, MD 21201 USA.	vvillar@medicine.umaryland.edu	Wang, Xiaoyan/GOK-1663-2022; Asico, Laureano/AAM-6321-2020	Wang, Xiaoyan/0000-0001-7406-5008; Lee, Hewang/0000-0003-1338-2573	National Institutes of Health (National Institutes of Health National Center for Research Resources) [HL68686, HL23081, HL074940, HL092196, DK39308, UL1RR031988, KL2 RR031987]; Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource; United States Public Health Service Grant [2P30-CA-51008, 1S10 RR15768-01]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031988, S10RR015768, KL2RR031987] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686, R01HL023081, P01HL074940, R37HL023081, R01HL092196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090918, R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health (National Institutes of Health National Center for Research Resources); Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource; United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL68686, HL23081, HL074940, HL092196, and DK39308 and awards UL1RR031988 and KL2 RR031987 (National Institutes of Health National Center for Research Resources). This work was also supported by the Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource and United States Public Health Service Grants 2P30-CA-51008 and 1S10 RR15768-01.	Banday AA, 2008, CURR HYPERTENS REP, V10, P268, DOI 10.1007/s11906-008-0051-9; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Carey RM, 2001, HYPERTENSION, V38, P297, DOI 10.1161/hy0901.096422; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen Y., 2005, MOL IMAGING FRET MIC, P126; CHRISTIE MI, 1992, BRIT J PHARMACOL, V107, P1008, DOI 10.1111/j.1476-5381.1992.tb13399.x; Clague MJ, 2001, J CELL SCI, V114, P3075; Crowley SD, 2007, CURR HYPERTENS REP, V9, P148, DOI 10.1007/s11906-007-0026-2; Escano CS, 2009, AM J PHYSIOL-REG I, V297, pR1660, DOI 10.1152/ajpregu.00147.2009; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; FELDER RA, 1990, HYPERTENSION, V15, P560, DOI 10.1161/01.HYP.15.6.560; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gildea JJ, 2008, HYPERTENSION, V51, P360, DOI 10.1161/HYPERTENSIONAHA.107.100099; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HAYASHI M, 1991, AM J PHYSIOL, V260, pE675, DOI 10.1152/ajpendo.1991.260.5.E675; He Y, 2009, NEUROSCI BULL, V25, P43, DOI 10.1007/s12264-009-0107-0; Heydorn A, 2004, FEBS LETT, V556, P276, DOI 10.1016/S0014-5793(03)01431-5; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; Jose PA, 1998, PHARMACOL THERAPEUT, V80, P149, DOI 10.1016/S0163-7258(98)00027-8; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Li HW, 2008, J CLIN INVEST, V118, P2180, DOI 10.1172/JCI33637; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nisar S, 2010, TRAFFIC, V11, P508, DOI 10.1111/j.1600-0854.2010.01035.x; Pons V, 2003, J BIOL CHEM, V278, P21155, DOI 10.1074/jbc.M211008200; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Prosser DC, 2010, TRAFFIC, V11, P1347, DOI 10.1111/j.1600-0854.2010.01100.x; Rosskopf D, 2007, N-S ARCH PHARMACOL, V374, P429, DOI 10.1007/s00210-007-0133-2; Schwarz DG, 2002, MOL BIOL CELL, V13, P3588, DOI 10.1091/mbc.E02-03-0145; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SIRAGY HM, 1989, AM J PHYSIOL, V257, pF469, DOI 10.1152/ajprenal.1989.257.3.F469; Thompson D, 2011, TRAFFIC, V12, P644, DOI 10.1111/j.1600-0854.2011.01179.x; TIBERI M, 1994, J BIOL CHEM, V269, P27925; Vieira-Coelho MA, 2000, BRIT J PHARMACOL, V129, P573, DOI 10.1038/sj.bjp.0703065; Wang XY, 2008, PEDIATR NEPHROL, V23, P2131, DOI 10.1007/s00467-008-0901-3; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yang ZW, 2006, AM J PHYSIOL-REG I, V290, pR96, DOI 10.1152/ajpregu.00434.2005; Yang ZW, 2004, J RECEPT SIG TRANSD, V24, P149, DOI 10.1081/LRST-200029971; Yao LP, 1998, HYPERTENSION, V32, P1049, DOI 10.1161/01.HYP.32.6.1049; Yu P, 2006, KIDNEY INT, V70, P1072, DOI 10.1038/sj.ki.5001708; Yu PY, 2000, HYPERTENSION, V36, P1053, DOI 10.1161/01.HYP.36.6.1053; Zeng CY, 2005, HYPERTENSION, V45, P804, DOI 10.1161/01.HYP.0000155212.33212.99; Zeng CY, 2004, PHYSIOL GENOMICS, V19, P233, DOI 10.1152/physiolgenomics.00127.2004	50	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					152	163		10.1074/jbc.M112.428458	http://dx.doi.org/10.1074/jbc.M112.428458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23152498	Green Published, hybrid			2022-12-25	WOS:000313197200015
J	Chauviac, FX; Bommer, M; Yan, J; Parkin, G; Daviter, T; Lowden, P; Raven, EL; Thalassinos, K; Keep, NH				Chauviac, Francois-Xavier; Bommer, Martin; Yan, Jun; Parkin, Gary; Daviter, Tina; Lowden, Philip; Raven, Emma L.; Thalassinos, Konstantinos; Keep, Nicholas H.			Crystal Structure of Reduced MsAcg, a Putative Nitroreductase from Mycobacterium smegmatis and a Close Homologue of Mycobacterium tuberculosis Acg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIC RESPONSE; REDOX PROPERTIES; PROTEIN; FLAVIN; REDUCTION; GENE; VALIDATION; DELETION; SYSTEM; GROWTH	This paper presents the structure of MsAcg (MSMEG_5246), a Mycobacterium smegmatis homologue of Mycobacterium tuberculosis Acg (Rv2032) in its reduced form at 1.6 angstrom resolution using x-ray crystallography. Rv2032 is one of the most induced genes under the hypoxic model of tuberculosis dormancy. The Acg family turns out to be unusual flavin mononucleotide (FMN)-binding proteins that have probably arisen by gene duplication and fusion from a classical homodimeric nitroreductase such that the monomeric protein resembles a classical nitroreductase dimer but with one active site deleted and the other active site covered by a unique lid. The FMN cofactor is not reduced by either NADH or NADPH, but the chemically reduced enzyme is capable of reduction of nitro substrates, albeit at no kinetic advantage over free FMN. The reduced enzyme is rapidly oxidized by oxygen but without any evidence for a radical state commonly seen in oxygen-sensitive nitroreductases. The presence of the unique lid domain, the lack of reduction by NAD(P)H, and the slow rate of reaction of the chemically reduced protein raises a possible alternative function of Acg proteins in FMN storage or sequestration from other biochemical pathways as part of the bacteria's adaptation to a dormancy state.	[Bommer, Martin] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Bommer, Martin] Helmholtz Zentrum Berlin Mat & Energie, Inst Soft Matter & Funct Mat, Macromol Crystallog Grp, D-12489 Berlin, Germany; [Yan, Jun; Thalassinos, Konstantinos] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England; [Parkin, Gary; Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Daviter, Tina; Keep, Nicholas H.] Univ London, Dept Biol Sci, Inst Struct & Mol Biol, Ctr Biophys, London WC1E 7HX, England	Humboldt University of Berlin; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of London; Birkbeck University London; University College London; University of Leicester; University of London; Birkbeck University London	Keep, NH (corresponding author), Univ London, Dept Biol Sci, Inst Struct & Mol Biol, Ctr Biophys, Malet St, London WC1E 7HX, England.	n.keep@mail.cryst.bbk.ac.uk	Keep, N/C-2759-2008; Keep, Nicholas/R-3493-2019	Keep, N/0000-0002-5042-1837; Keep, Nicholas/0000-0002-5042-1837; Thalassinos, Konstantinos/0000-0001-5072-8428; Frederiksen, Jun/0000-0003-0764-1831; Raven, Emma/0000-0002-1643-8694	Bloomsbury Colleges Studentship; Biotechnology and Biological Sciences Research Council [BB/F011148/1] Funding Source: researchfish; BBSRC [BB/F011148/1] Funding Source: UKRI	Bloomsbury Colleges Studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sponsored by a Bloomsbury Colleges Studentship. Present address: Virology Dept., Structural Virology Unit, Institut Pasteur, 28 rue du docteur Roux, 75724 Paris cedex 15, France.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark W. M., 1972, OXIDATION REDUCTION; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Efimov I, 2004, BIOCHEMISTRY-US, V43, P10532, DOI 10.1021/bi049375d; Efimov I, 2007, BIOCHEMISTRY-US, V46, P8017, DOI 10.1021/bi7006492; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hu Y., 2003, DORMANCY LOW GROWTH, P181; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lederer F, 1999, METH MOL B, V131, P149; Lennon BW, 1999, PROTEIN SCI, V8, P2366; Long QX, 2010, CHEM BIOL DRUG DES, V75, P339, DOI 10.1111/j.1747-0285.2010.00946.x; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; MCCALLA DR, 1970, J BACTERIOL, V104, P1126, DOI 10.1128/JB.104.3.1126-1134.1970; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nivinskas H, 2001, ARCH BIOCHEM BIOPHYS, V385, P170, DOI 10.1006/abbi.2000.2127; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Purkayastha A, 2002, INFECT IMMUN, V70, P1518, DOI 10.1128/IAI.70.3.1518-1529.2002; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Sandegren L, 2008, J ANTIMICROB CHEMOTH, V62, P495, DOI 10.1093/jac/dkn222; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tito MA, 2000, J AM CHEM SOC, V122, P3550, DOI 10.1021/ja993740k; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2011, 2011 2012 TUB GLOB F; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	62	16	16	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44372	44383		10.1074/jbc.M112.406264	http://dx.doi.org/10.1074/jbc.M112.406264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148223	Green Published, hybrid			2022-12-25	WOS:000312938600034
J	Ingram, KK; Kutowoi, A; Wurm, Y; Shoemaker, D; Meier, R; Bloch, G				Ingram, Krista K.; Kutowoi, Alexander; Wurm, Yannick; Shoemaker, DeWayne; Meier, Rudolf; Bloch, Guy			The Molecular Clockwork of the Fire Ant Solenopsis invicta	PLOS ONE			English	Article							DIVISION-OF-LABOR; TRANSCRIPTIONAL REPRESSOR; CIRCADIAN-RHYTHMS; PERIOD EXPRESSION; PROTEIN FAMILIES; GENE DUPLICATION; DRAFT GENOME; PLASTICITY; EVOLUTION; ORANGE	The circadian clock is a core molecular mechanism that allows organisms to anticipate daily environmental changes and adapt the timing of behaviors to maximize efficiency. In social insects, the ability to maintain the appropriate temporal order is thought to improve colony efficiency and fitness. We used the newly sequenced fire ant (Solenopsis invicta) genome to characterize the first ant circadian clock. Our results reveal that the fire ant clock is similar to the clock of the honeybee, a social insect with an independent evolutionary origin of sociality. Gene trees for the eight core clock genes, period, cycle, clock, cryptochrome-m, timeout, vrille, par domain protein 1 & clockwork orange, show ant species grouping closely with honeybees and Nasonia wasps as an outgroup to the social Hymenoptera. Expression patterns for these genes suggest that the ant clock functions similar to the honeybee clock, with period and cry-m mRNA levels increasing during the night and cycle and clockwork orange mRNAs cycling approximately anti-phase to period. Gene models for five of these genes also parallel honeybee models. In particular, the single ant cryptochrome is an ortholog of the mammalian-type (cry-m), rather than Drosophila-like protein (cry-d). Additionally, we find a conserved VPIFAL C-tail region in clockwork orange shared by insects but absent in vertebrates. Overall, our characterization of the ant clock demonstrates that two social insect lineages, ants and bees, share a similar, mammalian-like circadian clock. This study represents the first characterization of clock genes in an ant and is a key step towards understanding socially-regulated plasticity in circadian rhythms by facilitating comparative studies on the organization of circadian clockwork.	[Ingram, Krista K.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Kutowoi, Alexander] Hebrew Univ Jerusalem, A Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Wurm, Yannick] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Wurm, Yannick] Univ London, Sch Biol & Chem Sci, London, England; [Shoemaker, DeWayne] USDA, ARS, Gainesville, FL USA; [Meier, Rudolf] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Colgate University; Hebrew University of Jerusalem; University of Lausanne; University of London; United States Department of Agriculture (USDA); National University of Singapore	Ingram, KK (corresponding author), Colgate Univ, Dept Biol, Hamilton, NY 13346 USA.	kingram@colgate.edu	Wurm, Yannick/A-9525-2009; Bloch, Guy/I-5861-2019; Meier, Rudolf/A-7099-2011; Meier, Rudolf/AAB-3848-2021	Wurm, Yannick/0000-0002-3140-2809; Bloch, Guy/0000-0003-1624-4926; Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Shoemaker, DeWayne/0000-0003-3659-8393	Picker Interdisciplinary Science Research Grant; National Science Foundation Integrative Organismal Systems (NSF-IOS) Facilitating Research at Primarily Undergraduate Institutions (RUI) grant [IOS-1021723]; ERC Advanced Grant; Division Of Integrative Organismal Systems [1021723] Funding Source: National Science Foundation	Picker Interdisciplinary Science Research Grant; National Science Foundation Integrative Organismal Systems (NSF-IOS) Facilitating Research at Primarily Undergraduate Institutions (RUI) grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); ERC Advanced Grant(European Research Council (ERC)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Picker Interdisciplinary Science Research Grant to KKI and a National Science Foundation Integrative Organismal Systems (NSF-IOS) Facilitating Research at Primarily Undergraduate Institutions (RUI) grant to KKI (IOS-1021723). YW was supported by an ERC Advanced Grant to L. Keller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bloch G, 2004, INSECT BIOCHEM MOLEC, V34, P879, DOI 10.1016/j.ibmb.2004.05.004; Bloch G, 2001, NATURE, V410, P1048, DOI 10.1038/35074183; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bloch G, 2011, PHILOS T R SOC B, V366, P2155, DOI 10.1098/rstb.2010.0346; Bloch G, 2010, J BIOL RHYTHM, V25, P307, DOI 10.1177/0748730410380149; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cheeseman JF, 2012, P NATL ACAD SCI USA, V109, P7061, DOI 10.1073/pnas.1201734109; Cortes T, 2010, INSECT MOL BIOL, V19, P123, DOI 10.1111/j.1365-2583.2009.00931.x; Duncan EJ, 2010, GENOME RES, V20, P917, DOI 10.1101/gr.104794.109; Eban-Rothschild A, 2011, P ROY SOC B-BIOL SCI, V278, P3510, DOI 10.1098/rspb.2011.0579; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Greene MJ, 2007, AM NAT, V170, P943, DOI 10.1086/522843; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Ingram Krista K., 2009, BMC Ecology, V9, P7, DOI 10.1186/1472-6785-9-7; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Lone SR, 2011, CHRONOBIOL INT, V28, P862, DOI 10.3109/07420528.2011.622676; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; McDonald M, 2006, NEW SCI, V189, P50; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Zas SL, 2012, J BIOL RHYTHM, V27, P12, DOI 10.1177/0748730411431404; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sharkey MJ, 2007, ZOOTAXA, P521, DOI 10.11646/zootaxa.1668.1.25; Shemesh Y, 2007, FASEB J, V21, P2304, DOI 10.1096/fj.06-8032com; Shemesh Y, 2010, J NEUROSCI, V30, P12517, DOI 10.1523/JNEUROSCI.1490-10.2010; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; VINSON SB, 1986, EC IMPACT CONTROL SO; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson E.O., 1971, INSECT SOC; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Xu D, 2000, CURR PROTEIN PEPT SC, V1, P1, DOI 10.2174/1389203003381469; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	58	45	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e45715	10.1371/journal.pone.0045715	http://dx.doi.org/10.1371/journal.pone.0045715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152747	gold, Green Submitted, Green Published			2022-12-25	WOS:000311234600002
J	Long, D; Wang, JW; Xuan, M; Gu, QQ; Xu, XJ; Kong, DX; Zhang, MM				Long, Dan; Wang, Jinwei; Xuan, Min; Gu, Quanquan; Xu, Xiaojun; Kong, Dexing; Zhang, Minming			Automatic Classification of Early Parkinson's Disease with Multi-Modal MR Imaging	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBRAL ATROPHY; RESTING-STATE; FUNCTIONAL CONNECTIVITY; DIFFERENTIAL-DIAGNOSIS; COGNITIVE IMPAIRMENT; BRAIN ATROPHY; PATTERNS; PARCELLATION; MOVEMENTS	Background: In recent years, neuroimaging has been increasingly used as an objective method for the diagnosis of Parkinson's disease (PD). Most previous studies were based on invasive imaging modalities or on a single modality which was not an ideal diagnostic tool. In this study, we developed a non-invasive technology intended for use in the diagnosis of early PD by integrating the advantages of various modals. Materials and Methods: Nineteen early PD patients and twenty-seven normal volunteers participated in this study. For each subject, we collected resting-state functional magnetic resonance imaging (rsfMRI) and structural images. For the rsfMRI images, we extracted the characteristics at three different levels: ALFF (amplitude of low-frequency fluctuations), ReHo (regional homogeneity) and RFCS (regional functional connectivity strength). For the structural images, we extracted the volume characteristics from the gray matter (GM), the white matter (WM) and the cerebrospinal fluid (CSF). A two-sample t-test was used for the feature selection, and then the remaining features were fused for classification. Finally a classifier for early PD patients and normal control subjects was identified from support vector machine training. The performance of the classifier was evaluated using the leave-one-out cross-validation method. Results: Using the proposed methods to classify the data set, good results (accuracy = 86.96%, sensitivity = 78.95%, specificity = 92.59%) were obtained. Conclusions: This method demonstrates a promising diagnosis performance by the integration of information from a variety of imaging modalities, and it shows potential for improving the clinical diagnosis and treatment of PD. Citation: Long D, Wang J, Xuan M, Gu Q, Xu X, et al. (2012) Automatic Classification of Early Parkinson's Disease with Multi-Modal MR Imaging. PLoS ONE 7(11): e47714. doi: 10.1371/journal.pone.0047714	[Kong, Dexing] Zhejiang Univ, Dept Math, Hangzhou 310003, Zhejiang, Peoples R China; [Long, Dan; Xuan, Min; Gu, Quanquan; Xu, Xiaojun; Zhang, Minming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jinwei] Zhejiang Univ, Ctr Math Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhang, MM (corresponding author), Zhejiang Univ, Dept Math, Hangzhou 310003, Zhejiang, Peoples R China.	kong@cms.zju.edu.cn; zhangminming@zju.edu.cn			Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period [2012BAI10B04]; National Natural Science Foundation of China [30570536, 30900358]; Medical Scientific Research Foundation of Zhejiang Province [2009QN005]; Scientific Research Project of Zhejiang Province [2011C37025]	Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Zhejiang Province; Scientific Research Project of Zhejiang Province	This work was supported by the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (grant 2012BAI10B04), National Natural Science Foundation of China (grant 30570536 and 30900358), Medical Scientific Research Foundation of Zhejiang Province (grant 2009QN005) and Scientific Research Project of Zhejiang Province (grant 2011C37025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton PD, 2006, PHYS MED BIOL, V51, P3057, DOI 10.1088/0031-9155/51/12/004; Adler CH, 2011, INT J NEUROSCI, V121, P3, DOI 10.3109/00207454.2011.620192; Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Benjaminsson S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00034; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Cao H, 2011, AM J NEURORADIOL, V32, P1969, DOI 10.3174/ajnr.A2672; Catalan MJ, 1999, BRAIN, V122, P483, DOI 10.1093/brain/122.3.483; Chou KL, 2004, PARKINSONISM RELAT D, V10, P375, DOI 10.1016/j.parkreldis.2004.04.002; Craddock R.C., 2011, HUM BRAIN MAPP; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Hu MTM, 2001, J NEURAL TRANSM, V108, P571, DOI 10.1007/s007020170057; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008247; Kashmere J, 2002, CURR OPIN NEUROL, V15, P461, DOI 10.1097/00019052-200208000-00010; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kloppel S, 2009, NEUROLOGY, V72, P426, DOI 10.1212/01.wnl.0000341768.28646.b6; Kostic VS, 2010, NEUROLOGY, V75, P857, DOI 10.1212/WNL.0b013e3181f11c1d; Lewis MM, 2007, NEUROSCIENCE, V147, P224, DOI 10.1016/j.neuroscience.2007.04.006; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Martin WRW, 2009, MOVEMENT DISORD, V24, P1949, DOI 10.1002/mds.22680; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Palmer SJ, 2010, NEUROSCIENCE, V166, P1110, DOI 10.1016/j.neuroscience.2010.01.012; Palmer SJ, 2009, EUR J NEUROSCI, V29, P2187, DOI 10.1111/j.1460-9568.2009.06753.x; Pan PL, 2012, EUR J NEUROL, V19, P199, DOI 10.1111/j.1468-1331.2011.03474.x; Piccini P, 2004, LANCET NEUROL, V3, P284, DOI 10.1016/S1474-4422(04)00736-7; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; Reetz K, 2008, Open Neuroimag J, V2, P102, DOI 10.2174/1874440000802010102; Rinne JO, 2000, ARCH NEUROL-CHICAGO, V57, P470, DOI 10.1001/archneur.57.4.470; Salas-Gonzalez D, 2010, PHYS MED BIOL, V55, P2807, DOI 10.1088/0031-9155/55/10/002; Skidmore FM, 2011, NEUROIMAGE; Spetsieris PG, 2009, NEUROIMAGE, V45, P1241, DOI 10.1016/j.neuroimage.2008.12.063; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; Tir M, 2009, MOVEMENT DISORD, V24, P863, DOI 10.1002/mds.22463; Turner RS, 2003, NEUROIMAGE, V19, P163, DOI 10.1016/S1053-8119(03)00059-4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; VAPNIK VN, 1998, STAT LEARNING THEORY, pR24; Vu TC, 2012, BR J CLIN PHARM; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151; Wu T, 2010, NEUROIMAGE, V49, P2581, DOI 10.1016/j.neuroimage.2009.10.051; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang WL, 2011, J ALZHEIMERS DIS, V24, P775, DOI 10.3233/JAD-2011-101371; Yeterian EH, 1998, J COMP NEUROL, V399, P384; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	56	64	68	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e47714	10.1371/journal.pone.0047714	http://dx.doi.org/10.1371/journal.pone.0047714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152757	Green Published, Green Submitted, gold			2022-12-25	WOS:000312272600005
J	Yang, Y; Liu, Q; Ji, RR; Gao, Y				Yang, You; Liu, Qiong; Ji, Rongrong; Gao, Yue			Dynamic 3D Scene Depth Reconstruction via Optical Flow Field Rectification	PLOS ONE			English	Article								In this paper, we propose a depth propagation scheme based on optical flow field rectification towards more accurate depth reconstruction. In depth reconstruction, the occlusions and low-textural regions easily result in optical flow field errors, which lead ambiguous depth value or holes without depth in the obtained depth map. In this work, a scheme is proposed to improve the precision of depth propagation and the quality of depth reconstruction for dynamic scene. The proposed scheme first adaptively detects the occlusive or low-textural regions, and the obtained vectors in optical flow field are rectified properly. Subsequently, we process the occluded and ambiguous vectors for more precise depth propagation. We further leverage the boundary enhancement filters as a post-processing to sharpen the object boundaries in obtained depth maps for better quality. Quantitative evaluations show that the proposed scheme can reconstruct depth map with higher accuracy and better quality compared with the state-of-the-art methods. Citation: Yang Y, Liu Q, Ji R, Gao Y (2012) Dynamic 3D Scene Depth Reconstruction via Optical Flow Field Rectification. PLoS ONE 7(11): e47041. doi: 10.1371/journal.pone.0047041	[Ji, Rongrong] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Yang, You; Liu, Qiong] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China; [Yang, You] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Gao, Yue] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	Columbia University; Huazhong University of Science & Technology; Tsinghua University; National University of Singapore	Ji, RR (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	rrji@ee.columbia.edu; kevin.gaoy@gmail.com	Yang, You/A-9497-2019; Yang, You/O-5723-2019	Yang, You/0000-0002-5695-1046; 	National Natural Science Foundation of China (NSFC) [61170194, 61202301]; International S&T Cooperation Program of China (ISTCP) [2012DFG12010]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China (ISTCP)	This work was supported by National Natural Science Foundation of China (NSFC) (No. 61170194 and 61202301) and International S&T Cooperation Program of China (ISTCP) (No. 2012DFG12010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, JTC1SC29WG11 ISOIEC; [Anonymous], 2008, JTC1SC29WG11 ISOIEC; Bertalmio M, 2000, COMP GRAPH, P417, DOI 10.1145/344779.344972; Cao X, 2011, IEEE T BROADCAST, V57, P491, DOI 10.1109/TBC.2011.2127650; Cho JH, 2008, IEEE T CONSUM ELECTR, V54, P1514, DOI 10.1109/TCE.2008.4711195; Choi WS, 2008, OPT LETT, V33, P171, DOI 10.1364/OL.33.000171; Fehn C, 2004, PROC SPIE, V5291, P93, DOI 10.1117/12.524762; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P2269, DOI 10.1109/TIP.2011.2170081; Gao Y, 2011, IEEE T MULTIMEDIA, V13, P1007, DOI 10.1109/TMM.2011.2160619; Gao Y, 2010, PATTERN RECOGN, V43, P1142, DOI 10.1016/j.patcog.2009.07.012; Henry P., 2010, P ADV REAS DEPTH CAM, P1; Ince S, 2008, IEEE T IMAGE PROCESS, V17, P1443, DOI 10.1109/TIP.2008.925381; Jung JH, 2010, OPT EXPRESS, V18, P26373, DOI 10.1364/OE.18.026373; Kolb Andreas, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563159; Lee D. S., 2009, IEDM, P1, DOI [10.1109/IEDM.2009.5424227, DOI 10.1109/IEDM.2009.5424227]; Lee JJ, 2011, APPL OPTICS, V50, P5624, DOI 10.1364/AO.50.005624; Leyvand T, 2011, COMPUTER, V44, P94, DOI 10.1109/MC.2011.114; Liu Q, 2012, IEEE SIGNAL PROC LET, V19, P295, DOI 10.1109/LSP.2012.2190060; Muller K, 2008, EURASIP J IMAGE VIDE, DOI 10.1155/2008/438148; Pavillon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030912; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Smolic A, 2006, INT C MULT EXP; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Varekamp C, 2007, 4 EUR C VIS MED PROD, P1; Wang M, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2333112.2333120; Wang M, 2012, IEEE T MULTIMEDIA, V14, P858, DOI 10.1109/TMM.2012.2187181; Yan X., 2011, 3DTV C TRUE VIS CAPT, P1, DOI DOI 10.1109/3DTV.2011.5877167	28	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e47041	10.1371/journal.pone.0047041	http://dx.doi.org/10.1371/journal.pone.0047041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152753	Green Submitted, Green Published, gold			2022-12-25	WOS:000312272600002
J	Cavazzini, F; Magistroni, R; Furci, L; Lupo, V; Ligabue, G; Granito, M; Leonelli, M; Albertazzi, A; Cappelli, G				Cavazzini, Fabrizio; Magistroni, Riccardo; Furci, Luciana; Lupo, Valentina; Ligabue, Giulia; Granito, Maria; Leonelli, Marco; Albertazzi, Alberto; Cappelli, Gianni			Identification and Characterization of a New Autoimmune Protein in Membranous Nephropathy by Immunoscreening of a Renal cDNA Library	PLOS ONE			English	Article							NEUTRAL ENDOPEPTIDASE ANTIBODIES; HEYMANN NEPHRITIS; GLOMERULAR INJURY; NUCLEOLAR PROTEIN; TREATMENT DILEMMA; GLOMERULONEPHRITIS; ANTIGEN; AUTOANTIGEN; SUBCLASSES; DISEASE	Membranous Nephropathy (MN) represents a large amount of Nephrotic Syndromes in the adult population and its definitive diagnosis is currently carried out through biopsy. An autoimmune condition has been demonstrated in idiopathic MN (iMN) in which some kidney structures are targeted by patient autoantibodies. Some candidate antigens have been described and other likely involved target proteins responsible for the disease are not known yet. In this work our aim is to identify these proteins by screening a lambda-phage library with patients' sera. We enrolled four groups of patients: two MN groups of 12 full iMN patients; one control group of 15 patients suffering from other renal diseases; one control group of 15 healthy individuals. A commercial cDNA phagemide library was screened using the above described sera, in order to detect positive signals due to antigen-antibody bond. We detected one phagemide clone expressing a protein which was shown to be targeted by the antibodies of the iMN sera only. Control sera were negative. The sequence analysis of cDNA matched the Synaptonemal Complex protein 65 (SC65) coding sequence. Further proteomic analyses were carried out to validate our results. We provide evidence of an involvement of SC65 protein as an autoimmune target in iMN. Considering the invasiveness and the resulting risk coming from renal biopsy, our ongoing aim is to set a procedure able to diagnose affected patients through a little- or non-invasive method such as blood sampling rather than biopsy. Citation: Cavazzini F, Magistroni R, Furci L, Lupo V, Ligabue G, et al. (2012) Identification and Characterization of a New Autoimmune Protein in Membranous Nephropathy by Immunoscreening of a Renal cDNA Library. PLoS ONE 7(11): e48845. doi:10.1371/journal.pone.0048845	[Cavazzini, Fabrizio; Magistroni, Riccardo; Lupo, Valentina; Ligabue, Giulia; Granito, Maria; Albertazzi, Alberto; Cappelli, Gianni] Univ Modena & Reggio Emilia, Dept Med Emergency Med & Med Special, Div Nephrol Dialysis & Renal Transplantat, Modena, Italy; [Furci, Luciana; Leonelli, Marco] Modena Univ Hosp, Div Nephrol Dialysis & Renal Transplantat, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Cavazzini, F (corresponding author), Univ Modena & Reggio Emilia, Dept Med Emergency Med & Med Special, Div Nephrol Dialysis & Renal Transplantat, Modena, Italy.	fabrizio.cavazzini@unimore.it	Leonelli, Marco/J-5406-2014; Cappelli, Gianni/N-8812-2019; Magistroni, Riccardo/AAL-8753-2020; Cappelli, Gianni/F-8277-2012	Leonelli, Marco/0000-0001-6568-1984; Cappelli, Gianni/0000-0003-2304-5001; Magistroni, Riccardo/0000-0002-3319-0248; Cappelli, Gianni/0000-0003-2304-5001; Ligabue, Giulia/0000-0002-0043-2300	Italian Ministry of Education, University and Research (MIUR) [2004064212]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grant 2004064212 from the Italian Ministry of Education, University and Research (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1984, KIDNEY INT, V26, P830, DOI 10.1038/ki.1984.225; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bruschi M, 2009, NDT PLUS; Bruschi M, 2011, J PROTEOMICS, V74, P2008, DOI 10.1016/j.jprot.2011.05.021; CAMERON JS, 1982, AM J KIDNEY DIS, V1, P371; CAMERON JS, 1992, NEW ENGL J MED, V327, P638, DOI 10.1056/NEJM199208273270911; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; Debiec H, 2003, J AM SOC NEPHROL, V14, pS27, DOI 10.1097/01.ASN.0000067649.64849.75; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Delunardo F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1940; Fossa A, 2000, BRIT J CANCER, V83, P743, DOI 10.1054/bjoc.2000.1365; Glassock RJ, 2004, AM J KIDNEY DIS, V44, P562, DOI 10.1053/j.ajkd.2004.06.003; Glassock RJ, 2003, SEMIN NEPHROL, V23, P324, DOI 10.1016/S0270-9295(03)00049-4; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; Kerjaschki D, 1996, J AM SOC NEPHROL, V7, P2518; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; NOEL LH, 1988, CLIN IMMUNOL IMMUNOP, V46, P186, DOI 10.1016/0090-1229(88)90181-X; Ochs RL, 1996, MOL BIOL CELL, V7, P1015, DOI 10.1091/mbc.7.7.1015; Ponticelli C, 2007, J NEPHROL, V20, P268; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Ronco P, 2009, AM J KIDNEY DIS; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664; Willats WGT, 2002, PLANT MOL BIOL, V50, P837, DOI 10.1023/A:1021215516430	27	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48845	10.1371/journal.pone.0048845	http://dx.doi.org/10.1371/journal.pone.0048845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144993	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500037
J	Claassen, MAA; de Knegt, RJ; Turgut, D; Groothuismink, ZMA; Janssen, HLA; Boonstra, A				Claassen, Mark A. A.; de Knegt, Robert J.; Turgut, Duygu; Groothuismink, Zwier M. A.; Janssen, Harry L. A.; Boonstra, Andre			Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy	PLOS ONE			English	Article							RAT PRENEOPLASTIC LIVER; IN-VITRO PROLIFERATION; T-CELL RESPONSES; ANTIVIRAL THERAPY; INFECTED PATIENTS; LYMPHOCYTES; APOPTOSIS; EFFECTOR; ALPHA; BETA	Specific inhibitory mechanisms suppress the T-cell response against the hepatitis C virus (HCV) in chronically infected patients. However, the relative importance of suppression by IL-10, TGF-beta and regulatory T-cells and the impact of pegylated interferon-alpha and ribavirin (PegIFN-alpha/ribavirin) therapy on these inhibitory mechanisms are still unclear. We revealed that coregulation of the HCV-specific T-cell responses in blood of 43 chronic HCV patients showed a highly heterogeneous pattern before, during and after PegIFN-alpha/ribavirin. Prior to treatment, IL-10 mediated suppression of HCV-specific IFN-gamma production in therapy-naive chronic HCV patients was associated with higher HCV-RNA loads, which suggests that protective antiviral immunity is controlled by IL-10. In addition, as a consequence of PegIFN-alpha/ribavirin therapy, negative regulation of especially HCV-specific IFN-gamma production by TGF-beta and IL-10 changed dramatically. Our findings emphasize the importance of negative regulation for the dysfunctional HCV-specific immunity, which should be considered in the design of future immunomodulatory therapies. Citation: Claassen MAA, de Knegt RJ, Turgut D, Groothuismink ZMA, Janssen HLA, et al. (2012) Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy. PLoS ONE 7(11): e49389. doi:10.1371/journal.pone.0049389	[Claassen, Mark A. A.; de Knegt, Robert J.; Turgut, Duygu; Groothuismink, Zwier M. A.; Janssen, Harry L. A.; Boonstra, Andre] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Boonstra, A (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.a.boonstra@erasmusmc.nl	De Knegt, Robert/X-4629-2019	De Knegt, Robert/0000-0003-0934-6975; Boonstra, Andre/0000-0001-8607-1616	Foundation for Liver and Gastrointestinal Research (SLO), Rotterdam, the Netherlands; Schering-Plough now MSD; Virgo consortium; Dutch government [FES0908]; Netherlands Genomics Initiative (NGI) [050-060-452]	Foundation for Liver and Gastrointestinal Research (SLO), Rotterdam, the Netherlands(Netherlands Government); Schering-Plough now MSD(Merck & CompanySchering Plough Corporation); Virgo consortium; Dutch government; Netherlands Genomics Initiative (NGI)	This work was funded by the Foundation for Liver and Gastrointestinal Research (SLO), Rotterdam, the Netherlands, and further supported by Schering-Plough now MSD, the Virgo consortium, funded by the Dutch government, project number FES0908, and by the Netherlands Genomics Initiative (NGI), project number 050-060-452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel M, 2006, HEPATOLOGY, V44, P1607, DOI 10.1002/hep.21438; Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Alvarez MD, 2004, HEPATOLOGY, V40, P394, DOI 10.1002/hep.20307; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Birerdinc A, 2010, J VIRAL HEPATITIS, V17, P730, DOI 10.1111/j.1365-2893.2009.01235.x; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bolacchi F, 2006, CLIN EXP IMMUNOL, V144, P188, DOI 10.1111/j.1365-2249.2006.03048.x; Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Burton JR, 2008, J HEPATOL, V49, P329, DOI 10.1016/j.jhep.2008.05.020; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Claassen MAA, 2011, J VIROL, V85, P5323, DOI 10.1128/JVI.02551-10; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Grungreiff K, 1999, CYTOKINE, V11, P1076, DOI 10.1006/cyto.1999.0504; Kaplan DE, 2008, J HEPATOL, V48, P903, DOI 10.1016/j.jhep.2008.01.030; Klenerman P, 2007, HEPATITIS C VIRUS DI, P71; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Liu BS, 2011, J LEUKOCYTE BIOL, V89, P981, DOI 10.1189/jlb.1210680; Manigold T, 2006, BLOOD, V107, P4424, DOI 10.1182/blood-2005-09-3903; Marek B, 2005, J CLIN PHARM THER, V30, P271, DOI 10.1111/j.1365-2710.2005.00644.x; Quiroga AD, 2009, GROWTH FACTORS, V27, P214, DOI 10.1080/08977190902951558; Raziorrouh B, 2011, GASTROENTEROLOGY; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Rushbrook SM, 2005, J VIROL, V79, P7852, DOI 10.1128/JVI.79.12.7852-7859.2005; Schlaphoff V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002045; Stoop JN, 2008, CLIN IMMUNOL, V129, P419, DOI 10.1016/j.clim.2008.07.029; Sturm N, 2010, J HEPATOL, V53, P25, DOI 10.1016/j.jhep.2010.02.024; Suneetha PV, 2009, J IMMUNOL METHODS, V342, P33, DOI 10.1016/j.jim.2008.11.020; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	36	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49389	10.1371/journal.pone.0049389	http://dx.doi.org/10.1371/journal.pone.0049389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145169	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500107
J	Di Pizio, A; Agamennone, M; Aschi, M				Di Pizio, Antonella; Agamennone, Mariangela; Aschi, Massimiliano			An Integrated Computational Approach to Rationalize the Activity of Non-Zinc-Binding MMP-2 Inhibitors	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MOLECULAR-DYNAMICS SIMULATIONS; STRUCTURE-BASED DESIGN; PROTEIN FLEXIBILITY; CATALYTIC DOMAIN; DRUG DISCOVERY; SELECTIVE-INHIBITION; CHELATING INHIBITORS; THERAPEUTIC TARGETS; CRYSTAL-STRUCTURES	Matrix metalloproteinases are a family of Zn-proteases involved in tissue remodeling and in many pathological conditions. Among them MMP-2 is one of the most relevant target in anticancer therapy. Commonly, MMP inhibitors contain a functional group able to bind the zinc ion and responsible for undesired side effects. The discovery of potent and selective MMP inhibitors not bearing a zinc-binding group is arising for some MMP family members and represents a new opportunity to find selective and non toxic inhibitors. In this work we attempted to get more insight on the inhibition process of MMP-2 by two non-zinc-binding inhibitors, applying a general protocol that combines several computational tools (docking, Molecular Dynamics and Quantum Chemical calculations), that all together contribute to rationalize experimental inhibition data. Molecular Dynamics studies showed both structural and mechanical-dynamical effects produced by the ligands not disclosed by docking analysis. Thermodynamic Integration provided relative binding free energies consistent with experimentally observed activity data. Quantum Chemical calculations of the tautomeric equilibrium involving the most active ligand completed the picture of the binding process. Our study highlights the crucial role of the specificity loop and suggests that enthalpic effect predominates over the entropic one.	[Di Pizio, Antonella; Agamennone, Mariangela] Univ G DAnnunzio, Dipartimento Farm, Chieti, Italy; [Aschi, Massimiliano] Univ Aquila, Dipartimento Sci Fis & Chim, I-67100 Laquila, Italy	G d'Annunzio University of Chieti-Pescara; University of L'Aquila	Agamennone, M (corresponding author), Univ G DAnnunzio, Dipartimento Farm, Via Vestini 31, Chieti, Italy.	m.agamennone@unich.it; m.aschi@caspur.it	Di Pizio, Antonella/M-9141-2019; Agamennone, Mariangela/J-2916-2012; Di Pizio, Antonella/ABC-6792-2020	Agamennone, Mariangela/0000-0001-5198-0051; Di Pizio, Antonella/0000-0002-8520-5165; aschi, massimiliano/0000-0003-2959-0158				Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], 2010, MAESTR V 91207 LIGPR; [Anonymous], 2010, CALC PLUG MARV 5 2; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Arza B, 2001, EUR J BIOCHEM, V268, P826, DOI 10.1046/j.1432-1327.2001.01943.x; Aschi M, 2002, J COMPUT AID MOL DES, V16, P213, DOI 10.1023/A:1020178822319; B-Rao C, 2009, DRUG DISCOV TODAY, V14, P394, DOI 10.1016/j.drudis.2009.01.003; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Carlson HA, 2002, CURR PHARM DESIGN, V8, P1571, DOI 10.2174/1381612023394232; Chen JM, 2000, J AM CHEM SOC, V122, P9648, DOI 10.1021/ja001547g; Chen LY, 1999, J MOL BIOL, V293, P545, DOI 10.1006/jmbi.1999.3147; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chipot C., 2007, FREE ENERGY CALCULAT, V86; Clark IM, 2003, EXPERT OPIN THER TAR, V7, P19, DOI 10.1517/14728222.7.1.19; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; de Oliveira CAF, 2007, CURR PHARM DESIGN, V13, P3471, DOI 10.2174/138161207782794211; Dhanaraj V, 1999, CROAT CHEM ACTA, V72, P575; Diaz N, 2007, BIOCHEMISTRY-US, V46, P8943, DOI 10.1021/bi700541p; Drummond AH, 1999, ANN NY ACAD SCI, V878, P228, DOI 10.1111/j.1749-6632.1999.tb07688.x; Dublanchet AC, 2005, BIOORG MED CHEM LETT, V15, P3787, DOI 10.1016/j.bmcl.2005.05.079; Durrant JD, 2011, CHEM BIOL DRUG DES, V78, P191, DOI 10.1111/j.1747-0285.2011.01148.x; Durrant JD, 2010, J MOL RECOGNIT, V23, P173, DOI 10.1002/jmr.989; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Essman V, 1995, J CHEM PHYS, V103, P8577; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frisch M., 2016, GAUSSIAN 16 REVISION; Fujitani H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1999637; Giangreco I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025597; Gooley PR, 1996, J BIOMOL NMR, V7, P8; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Heim-Riether A, 2009, BIOORG MED CHEM LETT, V19, P5321, DOI 10.1016/j.bmcl.2009.07.151; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Johnson LL, 2000, J BIOL CHEM, V275, P11026, DOI 10.1074/jbc.275.15.11026; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lawrenz M, 2009, J CHEM THEORY COMPUT, V5, P1106, DOI 10.1021/ct800559d; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li JJ, 2008, J MED CHEM, V51, P835, DOI 10.1021/jm701274v; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; McCammon JA, 1998, CURR OPIN STRUC BIOL, V8, P245, DOI 10.1016/S0959-440X(98)80046-8; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Moy FJ, 2002, J AM CHEM SOC, V124, P12658, DOI 10.1021/ja027391x; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pirard B, 2007, DRUG DISCOV TODAY, V12, P640, DOI 10.1016/j.drudis.2007.06.003; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030; Schnute ME, 2010, BIOORG MED CHEM LETT, V20, P576, DOI 10.1016/j.bmcl.2009.11.081; Stone MJ, 2001, ACCOUNTS CHEM RES, V34, P379, DOI 10.1021/ar000079c; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Turpeenniemi-Hujanen T, 2005, BIOCHIMIE, V87, P287, DOI 10.1016/j.biochi.2005.01.014; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Zagrovic B, 2007, J CHEM THEORY COMPUT, V3, P301, DOI 10.1021/ct600322d	72	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e47774	10.1371/journal.pone.0047774	http://dx.doi.org/10.1371/journal.pone.0047774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144829	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500011
J	Eiro, N; Gonzalez, L; Gonzalez, LO; Fernandez-Garcia, B; Lamelas, ML; Marin, L; Gonzalez-Reyes, S; del Casar, JM; Vizoso, FJ				Eiro, Noemi; Gonzalez, Lucia; Gonzalez, Luis O.; Fernandez-Garcia, Belen; Luz Lamelas, Maria; Marin, Laura; Gonzalez-Reyes, Salome; Manuel del Casar, Jose; Vizoso, Francisco J.			Relationship between the Inflammatory Molecular Profile of Breast Carcinomas and Distant Metastasis Development	PLOS ONE			English	Article							HUMAN PAPILLOMA-VIRUS; MATRIX METALLOPROTEINASES; GROWTH-FACTOR; TUMOR-GROWTH; PROMOTES ANGIOGENESIS; IN-VIVO; CANCER; CELLS; EXPRESSION; INHIBITORS	Inflammatory conditions may promote tumor progression and aggressiveness. In previous reports, we found a group of breast cancer tumors characterized by metalloprotease-11 (MMP-11) expression by intratumoral mononuclear inflammatory cells (MICs), which was associated with distant metastasis development. Thus, in the present study we evaluated the relationship between MMP-11 expression by MICs, distant metastasis development, and a wide panel of inflammatory factors in breast carcinoma. In an initial approach, we analyzed 65 factors associated with tumor progression and inflammation, in a tumor population classified in good or bad prognosis, based on MMP-11 expression by intratumoral MICs. The most differentially expressed factors were then analyzed in a wider tumor population classified according to MMP-11 expression by MICs and also according to metastasis development. These analyses were carried out by Real-time PCR. The results showed that of the 65 starting factors analyzed, those related with MMP-11 expression by MICs were: IL-1, -5, -6, -8, -17, -18, MMP-1, TIMP-1, ADAM-8, -10, -15, -23, ADAMTS-1, -2, -15, Annexin A2, IFN beta, Claudin-3, CCL-3, MyD88, IRAK-4 and NF kappa B. Of them, factors more differentially expressed between both groups of tumors were IL-1, IL-5, IL-6, IL-17, IFN beta and NF kappa B. Thereafter, we confirmed in the wider tumor population, that there is a higher expression of those factors in tumors infiltrated by MMP-11 positive MICs. Altogether these results indicate that tumors developing worse prognosis and identified by MMP-11 expression by intratumoral MICs, shows an up-regulation of inflammatory-related genes.	[Eiro, Noemi; Gonzalez, Lucia; Gonzalez, Luis O.; Fernandez-Garcia, Belen; Luz Lamelas, Maria; Marin, Laura; Gonzalez-Reyes, Salome; Manuel del Casar, Jose; Vizoso, Francisco J.] Fdn Hosp Jove, Unidad Invest, Gijon, Asturias, Spain; [Gonzalez, Luis O.] Fdn Hosp Jove, Serv Anat Patol, Gijon, Asturias, Spain; [Luz Lamelas, Maria] Fdn Hosp Jove, Serv Ginecol, Gijon, Asturias, Spain; [Manuel del Casar, Jose; Vizoso, Francisco J.] Fdn Hosp Jove, Serv Cirugia Gen, Gijon, Asturias, Spain		Vizoso, FJ (corresponding author), Fdn Hosp Jove, Unidad Invest, Gijon, Asturias, Spain.	investigacion@hospitaldejove.com	Eiro, Noemi/C-9510-2018	Eiro, Noemi/0000-0001-5840-4807; Fernandez-Garcia, Belen/0000-0002-9950-2494	Fundacion para la Investigacion Cientifica y Tecnologica FICYT [EXPTE: IB08-170]; Fondo de Inversion Sanitaria del Instituto de Salud Carlos III [FIS-PI10/02106]; FICEMU	Fundacion para la Investigacion Cientifica y Tecnologica FICYT; Fondo de Inversion Sanitaria del Instituto de Salud Carlos III; FICEMU	This work has been supported by grants from Fundacion para la Investigacion Cientifica y Tecnologica FICYT (EXPTE: IB08-170), Fondo de Inversion Sanitaria del Instituto de Salud Carlos III (FIS-PI10/02106) and FICEMU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Allred DC, 1998, MODERN PATHOL, V11, P155; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Cornelius LA, 1998, J IMMUNOL, V161, P6845; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daniel D, 2005, CANCER RES, V65, P2018, DOI 10.1158/0008-5472.CAN-04-3444; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellis I.O., 2006, HISTOLOGIC GRADE BRE, P225; Gemma A, 2001, EUR J CANCER, V37, P1554, DOI 10.1016/S0959-8049(01)00154-X; Gonzalez LO, 2007, BRIT J CANCER, V97, P957, DOI 10.1038/sj.bjc.6603963; Gonzalez LO, 2009, HUM PATHOL, V40, P1224, DOI 10.1016/j.humpath.2008.12.022; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kan CY, 2005, BRIT J CANCER, V93, P946, DOI 10.1038/sj.bjc.6602778; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; Knupfer H, 2004, BREAST, V13, P28, DOI 10.1016/j.breast.2003.07.002; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Manes S, 1999, J BIOL CHEM, V274, P6935, DOI 10.1074/jbc.274.11.6935; Marrogi AJ, 1997, INT J CANCER, V74, P492, DOI 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z; Noe V, 2001, J CELL SCI, V114, P111; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; Salven P, 2002, FASEB J, V16, P1471, DOI 10.1096/fj.02-0134fje; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wurtz SO, 2005, ENDOCR-RELAT CANCER, V12, P215, DOI 10.1677/erc.1.00719	34	43	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49047	10.1371/journal.pone.0049047	http://dx.doi.org/10.1371/journal.pone.0049047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145063	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500067
J	Parker, MW; Xu, P; Guo, HF; Vander Kooi, CW				Parker, Matthew W.; Xu, Ping; Guo, Hou-Fu; Vander Kooi, Craig W.			Mechanism of Selective VEGF-A Binding by Neuropilin-1 Reveals a Basis for Specific Ligand Inhibition	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SPINAL-CORD; SEMAPHORIN 3A; STRUCTURAL BASIS; RECEPTOR; DOMAIN; EXPRESSION; SYSTEM; CELLS; VEGF(165)	Neuropilin (Nrp) receptors function as essential cell surface receptors for the Vascular Endothelial Growth Factor (VEGF) family of proangiogenic cytokines and the semaphorin 3 (Sema3) family of axon guidance molecules. There are two Nrp homologues, Nrp1 and Nrp2, which bind to both overlapping and distinct members of the VEGF and Sema3 family of molecules. Nrp1 specifically binds the VEGF-A164/5 isoform, which is essential for developmental angiogenesis. We demonstrate that VEGF-A specific binding is governed by Nrp1 residues in the b1 coagulation factor domain surrounding the invariant Nrp C-terminal arginine binding pocket. Further, we show that Sema3F does not display the Nrp-specific binding to the b1 domain seen with VEGF-A. Engineered soluble Nrp receptor fragments that selectively sequester ligands from the active signaling complex are an attractive modality for selectively blocking the angiogenic and chemorepulsive functions of Nrp ligands. Utilizing the information on Nrp ligand binding specificity, we demonstrate Nrp constructs that specifically sequester Sema3 in the presence of VEGF-A. This establishes that unique mechanisms are used by Nrp receptors to mediate specific ligand binding and that these differences can be exploited to engineer soluble Nrp receptors with specificity for Sema3.	[Vander Kooi, Craig W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; Univ Kentucky, Struct Biol Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Vander Kooi, CW (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	craig.vanderkooi@uky.edu	Parker, Matthew/AAW-2444-2020	Parker, Matthew/0000-0001-9845-9108; Guo, Hou-Fu/0000-0002-3659-9399	National Institutes of Health [R01GM094155, P20RR020171, T32HL072743]; Kentucky Lung Cancer Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (R01GM094155) and the Kentucky Lung Cancer Research Program. Core support was provided by National Institutes of Health (P20RR020171). Training grant support was provided by the National Institutes of Health to M.W.P. (T32HL072743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Christinger HW, 1996, PROTEINS, V26, P353, DOI 10.1002/(SICI)1097-0134(199611)26:3<353::AID-PROT9>3.0.CO;2-E; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Geretti E, 2007, J BIOL CHEM, V282, P25698, DOI 10.1074/jbc.M702942200; Geretti E, 2010, MOL CANCER RES, V8, P1063, DOI 10.1158/1541-7786.MCR-10-0157; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Jardin BA, 2008, J BIOTECHNOL, V135, P272, DOI 10.1016/j.jbiotec.2008.04.006; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Kikuchi K, 2003, J BIOL CHEM, V278, P42985, DOI 10.1074/jbc.M302395200; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Niclou SP, 2006, J NEUROTRAUM, V23, P409, DOI 10.1089/neu.2006.23.409; Niclou SP, 2003, MOL CELL NEUROSCI, V24, P902, DOI 10.1016/S1044-7431(03)00243-4; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Parker MW, 2012, J BIOL CHEM; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Stewart MW, 2012, NAT REV DRUG DISCOV, V11, P269, DOI 10.1038/nrd3700; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Zachary IC, 2009, BIOCHEM SOC T, V37, P1171, DOI 10.1042/BST0371171	32	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49177	10.1371/journal.pone.0049177	http://dx.doi.org/10.1371/journal.pone.0049177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145112	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500082
J	Shaik, R; Ramakrishna, W				Shaik, Rafi; Ramakrishna, Wusirika			Bioinformatic Analysis of Epigenetic and MicroRNA Mediated Regulation of Drought Responsive Genes in Rice	PLOS ONE			English	Article							HIGH-SALINITY STRESSES; WILD WATERMELON; DNA METHYLATION; TOLERANCE; EXPRESSION; OVEREXPRESSION; ACCUMULATION; PROTEINS; COLD; SALT	Drought stress response is a complex trait regulated at multiple levels. Changes in the epigenetic and miRNA regulatory landscape can dramatically alter the outcome of a stress response. However, little is known about the scope and extent of these regulatory factors on drought related cellular processes and functions. To this end, we selected a list of 5468 drought responsive genes (DRGs) of rice identified in multiple microarray studies and mapped the DNA methylation regions found in a genome wide methylcytosine immunoprecipitation and sequencing (mCIP-Seq) study to their genic and promoter regions, identified the chromatin remodeling genes and the genes that are targets of miRNAs. We found statistically significant enrichment of DNA methylation reads and miRNA target sequences in DRGs compared to a random set of genes. About 75% of the DRGs annotated to be involved in chromatin remodeling were downregulated. We found one-third of the DRGs are targeted by two-thirds of all known/predicted miRNAs in rice which include many transcription factors targeted by more than five miRNAs. Clustering analysis of the DRGs with epigenetic and miRNA features revealed, upregulated cluster was enriched in drought tolerance mechanisms while the downregulated cluster was enriched in drought resistance mechanisms evident by their unique gene ontologies (GOs), protein-protein interactions (PPIs), specific transcription factors, protein domains and metabolic pathways. Further, we analyzed the proteome of two weeks old young rice plants treated with a global demethylating agent, 5-azacytidine (5-azaC), subjected to drought stress and identified 56 protein spots that are differentially expressed. Out of the 56 spots, 35 were differently expressed in the sample with both demethylation and drought stress treatments and 28 (50%) were part of DRGs considered in the bioinformatic analysis. Citation: Shaik R, Ramakrishna W (2012) Bioinformatic Analysis of Epigenetic and MicroRNA Mediated Regulation of Drought Responsive Genes in Rice. PLoS ONE 7(11): e49331. doi:10.1371/journal.pone.0049331	[Shaik, Rafi; Ramakrishna, Wusirika] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Michigan Technological University	Ramakrishna, W (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.	wusirika@mtu.edu	Ramakrishna, Wusirika/M-6646-2017; Wusirika, Ramakrishna/O-9116-2019	Ramakrishna, Wusirika/0000-0002-8571-5827; 				Akashi K, 2001, FEBS LETT, V508, P438, DOI 10.1016/S0014-5793(01)03123-4; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Capell T, 2004, P NATL ACAD SCI USA, V101, P9909, DOI 10.1073/pnas.0306974101; Choudhary MK, 2009, MOL CELL PROTEOMICS, V8, P1579, DOI 10.1074/mcp.M800601-MCP200; Cooper B, 2003, P NATL ACAD SCI USA, V100, P4945, DOI 10.1073/pnas.0737574100; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; He GM, 2011, ANNU REV PLANT BIOL, V62, P411, DOI 10.1146/annurev-arplant-042110-103806; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Kawasaki S, 2000, PLANT CELL PHYSIOL, V41, P864, DOI 10.1093/pcp/pcd005; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar B, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P263, DOI 10.1007/978-90-481-3112-9_13; Lindow M, 2007, PLOS COMPUT BIOL, V3, P2379, DOI 10.1371/journal.pcbi.0030238; Liu WY, 2009, J INTEGR PLANT BIOL, V51, P825, DOI 10.1111/j.1744-7909.2009.00853.x; Lopez-Gomez M, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P253, DOI 10.1007/978-1-4614-0634-1_14; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Oliveros J. C, 2007, VENNY INTERACTIVE TO, DOI DOI 10.1017/S0266267108002022; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Puhakainen T, 2004, PLANT MOL BIOL, V54, P743, DOI 10.1023/B:PLAN.0000040903.66496.a4; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ray S, 2011, FUNCT INTEGR GENOMIC, V11, P157, DOI 10.1007/s10142-010-0187-y; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Rock CD, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P33, DOI 10.1007/978-90-481-3112-9_3; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Shu LB, 2011, PROTEOMICS, V11, P4122, DOI 10.1002/pmic.201000485; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Smith BD, 1995, EMERGENCE AGR SCI AM; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tarutani Y, 2010, NATURE, V466, P983, DOI 10.1038/nature09308; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Yan H, 2010, PLANT J CELL MOL BIO; Zhang WL, 2012, GENOME RES, V22, P151, DOI 10.1101/gr.131342.111; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhao LF, 2010, ANN BOT-LONDON, V105, P401, DOI 10.1093/aob/mcp303; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	54	33	37	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49331	10.1371/journal.pone.0049331	http://dx.doi.org/10.1371/journal.pone.0049331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145152	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500102
J	Song, N; Liang, AP; Bu, CP				Song, Nan; Liang, Ai-Ping; Bu, Cui-Ping			A Molecular Phylogeny of Hemiptera Inferred from Mitochondrial Genome Sequences	PLOS ONE			English	Article							A+T-RICH REGION; NUCLEOTIDE-SEQUENCE; COMPOSITIONAL HETEROGENEITY; PLANTHOPPERS HEMIPTERA; DELPHACIDAE HEMIPTERA; EVOLUTION; INSECTA; DNA; HOMOPTERA; ORGANIZATION	Classically, Hemiptera is comprised of two suborders: Homoptera and Heteroptera. Homoptera includes Cicadomorpha, Fulgoromorpha and Sternorrhyncha. However, according to previous molecular phylogenetic studies based on 18S rDNA, Fulgoromorpha has a closer relationship to Heteroptera than to other hemipterans, leaving Homoptera as paraphyletic. Therefore, the position of Fulgoromorpha is important for studying phylogenetic structure of Hemiptera. We inferred the evolutionary affiliations of twenty-five superfamilies of Hemiptera using mitochondrial protein-coding genes and rRNAs. We sequenced three mitogenomes, from Pyrops candelaria, Lycorma delicatula and Ricania marginalis, representing two additional families in Fulgoromorpha. Pyrops and Lycorma are representatives of an additional major family Fulgoridae in Fulgoromorpha, whereas Ricania is a second representative of the highly derived clade Ricaniidae. The organization and size of these mitogenomes are similar to those of the sequenced fulgoroid species. Our consensus phylogeny of Hemiptera largely supported the relationships (((Fulgoromorpha, Sternorrhyncha), Cicadomorpha), Heteroptera), and thus supported the classic phylogeny of Hemiptera. Selection of optimal evolutionary models (exclusion and inclusion of two rRNA genes or of third codon positions of protein-coding genes) demonstrated that rapidly evolving and saturated sites should be removed from the analyses. Citation: Song N, Liang A-P, Bu C-P (2012) A Molecular Phylogeny of Hemiptera Inferred from Mitochondrial Genome Sequences. PLoS ONE 7(11): e48778. doi:10.1371/journal.pone.0048778	[Song, Nan; Liang, Ai-Ping; Bu, Cui-Ping] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Song, Nan] Henan Entry Exit Inspect & Quarantine Bur, Zhengzhou, Peoples R China; [Bu, Cui-Ping] Huaiyin Normal Univ, Jiangsu Key Lab Ecoagr Biotechnol, Huaiyin, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Huaiyin Normal University	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	liangap@ioz.ac.cn			National Basic Research Program of China (973 Program) [2007CB411601]; National Natural Science Foundation of China [30530110, 30770269, 30970400]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Science Fund for Fostering Talents in Basic Research, Special subjects in animal taxonomy [NSFCJ0630964/J0109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research, Special subjects in animal taxonomy	This study was supported by grants from the National Basic Research Program of China (973 Program) grant # 2007CB411601, the National Natural Science Foundation of China grants # 30530110, 30770269 and 30970400, the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences grant # O529YX5105, and the National Science Fund for Fostering Talents in Basic Research, Special subjects in animal taxonomy, grant # NSFCJ0630964/J0109, all awarded to APL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Asche M, 1987, P 6 AUCH M TUR IT 7, P47; Bae JS, 2004, MOL PHYLOGENET EVOL, V32, P978, DOI 10.1016/j.ympev.2004.03.009; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Boudreaux H. B., 1979, ARTHROPOD PHYLOGENY; Bourgoin T, 1997, CLADISTICS, V13, P207, DOI 10.1111/j.1096-0031.1997.tb00316.x; BROUGHTON RE, 1994, GENETICS, V138, P179; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; CAMPBELL BC, 1995, SYST ENTOMOL, V20, P175, DOI 10.1111/j.1365-3113.1995.tb00090.x; Campbell Bruce C., 1994, Insect Molecular Biology, V3, P73, DOI 10.1111/j.1365-2583.1994.tb00154.x; Carver M., 1991, P429; Castro LR, 2007, SYST ENTOMOL, V32, P60, DOI 10.1111/j.1365-3113.2006.00356.x; Ceotto P, 2008, MOL PHYLOGENET EVOL, V48, P667, DOI 10.1016/j.ympev.2008.04.026; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; Chou L, 1985, EC INSECT FAUNA CHIN, P1; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; COBBEN RH, 1978, EVOLUTIONARY TRENDS, V2; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Dijkstra E, 2003, SYST ENTOMOL, V28, P89, DOI 10.1046/j.1365-3113.2003.00203.x; Dijkstra Eddy, 2006, Insect Science, V13, P167, DOI 10.1111/j.1744-7917.2006.00079.x; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Douglas DA, 2006, ZOOL SCR, V35, P545, DOI 10.1111/j.1463-6409.2006.00257.x; Dowton M, 2009, MOL PHYLOGENET EVOL, V52, P512, DOI 10.1016/j.ympev.2009.04.001; Dyck VA, 1979, IRRI BROWN PLANTHOPP, p[369, 3]; Emeuanov A. F., 1987, P USSR ENT SOC, V69, P19; EVANS JW, 1963, ANNU REV ENTOMOL, V8, P77, DOI 10.1146/annurev.en.08.010163.000453; FEARNLEY IM, 1987, BIOCHEMISTRY-US, V26, P8247, DOI 10.1021/bi00399a034; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; GOODCHILD AJ, 1966, BIOL REV, V41, P97, DOI 10.1111/j.1469-185X.1966.tb01540.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HAMILTON KGA, 1981, CAN ENTOMOL, V113, P953, DOI 10.4039/Ent113953-11; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Hennig W., 1981, INSECT PHYLOGENY; HILLIS DM, 1994, NATURE, V369, P363, DOI 10.1038/369363a0; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Inohira K, 1997, MOL BIOL EVOL, V14, P814, DOI 10.1093/oxfordjournals.molbev.a025822; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Kaltenpoth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032826; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Kramer S., 1950, ILLINOIS BIOL MONOGR, V20, p[i, 1], DOI DOI 10.5962/BHL.TITLE.50340; KUMAR S, 1996, PHYLTEST PROGRAM TES; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Nylander J, 2004, MR MODELTEST V2 PROG; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ross H., 1965, TXB ENTOMOLOGY, V3rd; Schuh R.T., 1979, SYST ZOOL, V28, P653, DOI DOI 10.2307/2412577; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Song N, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.7601; Song N, 2009, ZOOL SCI, V26, P851, DOI 10.2108/zsj.26.851; Song N, 2009, ACTA BIOCH BIOPH SIN, V41, P206, DOI 10.1093/abbs/gmp003; SORENSEN JT, 1995, PAN-PAC ENTOMOL, V71, P31; Stewart JB, 2006, GENOME, V49, P815, DOI 10.1139/G06-037; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Swofford David L., 1996, P407; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Timmermans MJTN, 2012, MOL PHYLOGENET EVOL, V63, P299, DOI 10.1016/j.ympev.2011.12.021; Urban JM, 2007, MOL PHYLOGENET EVOL, V42, P556, DOI 10.1016/j.ympev.2006.08.009; Urban JM, 2010, SYST ENTOMOL, V35, P678, DOI 10.1111/j.1365-3113.2010.00539.x; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Wilkinson GS, 1997, GENETICS, V146, P1035; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; WOOTTON RJ, 1986, SYST ENTOMOL, V11, P389, DOI 10.1111/j.1365-3113.1986.tb00191.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia X, 2003, FUNDAMENTAL CONCEPTS, P149; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yeh W.B., 1999, CHINESE J ENTOMOLOGY, V11, P87; Yeh WB, 1998, ZOOL STUD, V37, P45; Yeh WB, 2005, ZOOL STUD, V44, P519; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZRZAVY J, 1992, ACTA ENTOMOL BOHEMOS, V89, P77; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	94	75	80	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48778	10.1371/journal.pone.0048778	http://dx.doi.org/10.1371/journal.pone.0048778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144967	Green Published, gold			2022-12-25	WOS:000312269500033
J	Arnold, SEJ; Stevenson, PC; Belmain, SR				Arnold, Sarah E. J.; Stevenson, Philip C.; Belmain, Steven R.			Odour-Mediated Orientation of Beetles Is Influenced by Age, Sex and Morph	PLOS ONE			English	Article							CALLOSOBRUCHUS-MACULATUS F; ORYZAE L. COLEOPTERA; SEED BEETLE; METHYL SALICYLATE; LIFE-HISTORY; SECURIDACA-LONGEPEDUNCULATA; DISPERSAL POLYMORPHISM; RHYZOPERTHA-DOMINICA; PEST-MANAGEMENT; INSECT PESTS	The behaviour of insects is dictated by a combination of factors and may vary considerably between individuals, but small insects are often considered en masse and thus these differences can be overlooked. For example, the cowpea bruchid Callosobruchus maculatus F. exists naturally in two adult forms: the active (flight) form for dispersal, and the inactive (flightless), more fecund but shorter-lived form. Given that these morphs show dissimilar biology, it is possible that they differ in odour-mediated orientation and yet studies of this species frequently neglect to distinguish morph type, or are carried out only on the inactive morph. Along with sex and age of individual, adult morph could be an important variable determining the biology of this and similar species, informing studies on evolution, ecology and pest management. We used an olfactometer with motion-tracking to investigate whether the olfactory behaviour and orientation of C. maculatus towards infested and uninfested cowpeas and a plant-derived repellent compound, methyl salicylate, differed between morphs or sexes. We found significant differences between the behaviour of male and female beetles and beetles of different ages, as well as interactive effects of sex, morph and age, in response to both host and repellent odours. This study demonstrates that behavioural experiments on insects should control for sex and age, while also considering differences between adult morphs where present in insect species. This finding has broad implications for fundamental entomological research, particularly when exploring the relationships between physiology, behaviour and evolutionary biology, and the application of crop protection strategies.	[Arnold, Sarah E. J.; Stevenson, Philip C.; Belmain, Steven R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England; [Stevenson, Philip C.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	University of Greenwich; Royal Botanic Gardens, Kew	Arnold, SEJ (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, Kent, England.	s.e.j.arnold@greenwich.ac.uk	Arnold, Sarah/H-6490-2019; Stevenson, Philip C/E-8822-2013; Belmain, Steven R/F-7758-2012; stevenson, philip c/E-8741-2013	Arnold, Sarah/0000-0001-7345-0529; Stevenson, Philip C/0000-0002-0736-3619; Belmain, Steven R/0000-0002-5590-7545; stevenson, philip c/0000-0002-0736-3619	Higher Education Funding Council for England (via the University of Greenwich); European Union; McKnight Foundation	Higher Education Funding Council for England (via the University of Greenwich)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); European Union(European Commission); McKnight Foundation	The work was supported by the Higher Education Funding Council for England (via the University of Greenwich), the European Union-funded ADAPPT project (www.nri.org/adappt) and the McKnight Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lawati H. T., 2002, Sultan Qaboos University Journal for Scientific Research - Agricultural Sciences, V7, P37; Bashir T, 2001, ENTOMOL EXP APPL, V101, P273, DOI 10.1023/A:1019282901748; Belmain S., 2001, Pesticide Outlook, V12, P233, DOI 10.1039/b110542f; Boeke SJ, 2004, INT J PEST MANAGE, V50, P251, DOI 10.1080/09670870410001702206; Boeke SJ, 2004, J STORED PROD RES, V40, P423, DOI 10.1016/S0022-474X(03)00046-8; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; CASWELL G. H., 1960, BULL ENT RES, V50, P671, DOI 10.1017/S0007485300054705; Dickens Joseph C., 2000, Agricultural and Forest Entomology, V2, P167, DOI 10.1046/j.1461-9563.2000.00065.x; Dobie P, 1991, INSECTS ARACHNIDS TR; Du Yong-Jun, 1994, Acta Entomologica Sinica, V37, P385; Elhag EA, 2000, INT J PEST MANAGE, V46, P109, DOI 10.1080/096708700227462; Fox CW, 2003, FUNCT ECOL, V17, P811, DOI 10.1111/j.1365-2435.2003.00799.x; Gendo JO, 2008, J STORED PROD RES, V44, P328, DOI 10.1016/j.jspr.2008.02.009; Hallsson LR, 2012, J EVOLUTION BIOL, V25, P1564, DOI 10.1111/j.1420-9101.2012.02541.x; Hallsson LR, 2012, ECOL EVOL, V2, P128, DOI 10.1002/ece3.56; HARDIE J, 1994, J CHEM ECOL, V20, P2847, DOI 10.1007/BF02098393; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; Ignacimuthu S, 2000, ENTOMOL EXP APPL, V96, P213, DOI 10.1023/A:1004016127866; Jaba J., 2010, Journal of Biopesticides, V3, P405; Jayasekara TK, 2005, J CHEM ECOL, V31, P303, DOI 10.1007/s10886-005-1342-0; Jayasekara TK, 2002, J MASS SPECTROM, V37, P577, DOI 10.1002/jms.314; Kamanula J, 2011, INT J PEST MANAGE, V57, P41, DOI 10.1080/09670874.2010.522264; Kestenholz C, 2007, J STORED PROD RES, V43, P79, DOI 10.1016/j.jspr.2005.11.003; Lextrait P, 1995, PHYSIOL ENTOMOL, V20, P309, DOI 10.1111/j.1365-3032.1995.tb00820.x; MACKAY PA, 1975, CAN ENTOMOL, V107, P1161, DOI 10.4039/Ent1071161-11; MESSINA FJ, 1991, OECOLOGIA, V85, P447, DOI 10.1007/BF00320624; MESSINA FJ, 1987, ANN ENTOMOL SOC AM, V80, P12, DOI 10.1093/aesa/80.1.12; MESSINA FJ, 1984, ENTOMOL EXP APPL, V35, P241, DOI 10.1007/BF00369139; MESSINA FJ, 1985, ANN ENTOMOL SOC AM, V78, P201, DOI 10.1093/aesa/78.2.201; Messina FJ, 1990, FUJII KEA, P303; Miller LK, 2005, EVOLUTION, V59, P2414; Mossi AJ, 2011, J SCI FOOD AGR, V91, P273, DOI 10.1002/jsfa.4181; Nahdy MS, 1999, J STORED PROD RES, V35, P339, DOI 10.1016/S0022-474X(99)00017-X; Nerio LS, 2009, J STORED PROD RES, V45, P212, DOI 10.1016/j.jspr.2009.01.002; Nguyen DT, 2008, J STORED PROD RES, V44, P90, DOI 10.1016/j.jspr.2007.06.008; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9; R Core Team, 2022, R LANG ENV STAT COMP; Salisbury A, 2012, PHYSIOL ENTOMOL, V37, P97, DOI 10.1111/j.1365-3032.2011.00823.x; SANOFUJII I, 1986, J STORED PROD RES, V22, P115, DOI 10.1016/0022-474X(86)90003-2; SANOFUJII I, 1984, J STORED PROD RES, V20, P153, DOI 10.1016/0022-474X(84)90024-9; SU HCF, 1985, J ECON ENTOMOL, V78, P451, DOI 10.1093/jee/78.2.451; Torr SJ, 2006, B ENTOMOL RES, V96, P71, DOI 10.1079/BER2005404; Trematerra P, 1999, J STORED PROD RES, V35, P265, DOI 10.1016/S0022-474X(99)00010-7; Ukeh DA, 2010, PEST MANAG SCI, V66, P44, DOI 10.1002/ps.1828; UTIDA S, 1972, J STORED PROD RES, V8, P111, DOI 10.1016/0022-474X(72)90028-8; VANDERMEER JM, 1979, J EMBRYOL EXP MORPH, V51, P1; Williamson S, 2008, CROP PROT, V27, P1327, DOI 10.1016/j.cropro.2008.04.006; Zannou ET, 2003, J INSECT PHYSIOL, V49, P575, DOI 10.1016/S0022-1910(03)00029-5; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8	50	8	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49071	10.1371/journal.pone.0049071	http://dx.doi.org/10.1371/journal.pone.0049071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145074	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800197
J	Farkash-Amar, S; David, Y; Polten, A; Hezroni, H; Eldar, YC; Meshorer, E; Yakhini, Z; Simon, I				Farkash-Amar, Shlomit; David, Yaara; Polten, Andreas; Hezroni, Hadas; Eldar, Yonina C.; Meshorer, Eran; Yakhini, Zohar; Simon, Itamar			Systematic Determination of Replication Activity Type Highlights Interconnections between Replication, Chromatin Structure and Nuclear Localization	PLOS ONE			English	Article							BODY-SPECIFIC METHYLATION; HEAVY-CHAIN LOCUS; HUMAN GENOME; HISTONE ACETYLATION; LAMINA INTERACTIONS; NONCODING RNAS; TIME ZONES; CELL-TYPES; REVEALS; ORGANIZATION	DNA replication is a highly regulated process, with each genomic locus replicating at a distinct time of replication (ToR). Advances in ToR measurement technology enabled several genome-wide profiling studies that revealed tight associations between ToR and general genomic features and a remarkable ToR conservation in mammals. Genome wide studies further showed that at the hundreds kb-to-megabase scale the genome can be divided into constant ToR regions (CTRs) in which the replication process propagates at a faster pace due to the activation of multiple origins and temporal transition regions (TTRs) in which the replication process propagates at a slower pace. We developed a computational tool that assigns a ToR to every measured locus and determines its replication activity type (CTR versus TTR). Our algorithm, ARTO (Analysis of Replication Timing and Organization), uses signal processing methods to fit a constant piece-wise linear curve to the measured raw data. We tested our algorithm and provide performance and usability results. A Matlab implementation of ARTO is available at http://bioinfo.cs.technion.ac.il/people/zohar/ARTO/. Applying our algorithm to ToR data measured in multiple mouse and human samples allowed precise genome-wide ToR determination and replication activity type characterization. Analysis of the results highlighted the plasticity of the replication program. For example, we observed significant ToR differences in 10-25% of the genome when comparing different tissue types. Our analyses also provide evidence for activity type differences in up to 30% of the probes. Integration of the ToR data with multiple aspects of chromosome organization characteristics suggests that ToR plays a role in shaping the regional chromatin structure. Namely, repressive chromatin marks, are associated with late ToR both in TTRs and CTRs. Finally, characterization of the differences between TTRs and CTRs, with matching ToR, revealed that TTRs are associated with compact chromatin and are located significantly closer to the nuclear envelope. Supplementary material is available. Raw and processed data were deposited in Geo (GSE17236).	[Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Yakhini, Zohar] Agilent Labs Tel Aviv, Tel Aviv, Israel; [Farkash-Amar, Shlomit; Simon, Itamar] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Sch Med, IMRIC, Jerusalem, Israel; [David, Yaara; Eldar, Yonina C.] Technion Israel Inst Technol, Dept Elect Engn, IL-32000 Haifa, Israel; [Polten, Andreas] Agilent Technol, Waldbronn, Germany; [Hezroni, Hadas; Meshorer, Eran] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Agilent Technologies; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Agilent Technologies; Hebrew University of Jerusalem	Yakhini, Z (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	zohar_yakhini@agilent.com; itamarsi@ekmd.huji.ac.il		Simon, Itamar/0000-0002-8517-1903; Meshorer, Eran/0000-0003-4777-986X; Yakhini, Zohar/0000-0002-0420-5412	Israel Science Foundation [567/10]; Agilent Technologies Foundation; European Research Council [281306]; USAID's American Schools and Hospitals Abroad (ASHA) Program for the upgrading of the Flow Cytometry laboratory	Israel Science Foundation(Israel Science Foundation); Agilent Technologies Foundation(Principality of Asturias); European Research Council(European Research Council (ERC)European Commission); USAID's American Schools and Hospitals Abroad (ASHA) Program for the upgrading of the Flow Cytometry laboratory(United States Agency for International Development (USAID))	This research was supported by the Israel Science Foundation (grant No. 567/10), an Agilent Technologies Foundation Research Gift, the European Research Council Starting Grant (#281306), USAID's American Schools and Hospitals Abroad (ASHA) Program for the upgrading of the Flow Cytometry laboratory. The authors also thank The Edmond J. Safra Foundation and the Sudarsky Center for Computational Biology. YD was also funded by Diane and Leonard Sherman Interdisciplinary Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Baker A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002443; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Desprat R, 2009, GENOME RES, V19, P2288, DOI 10.1101/gr.094060.109; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Ermakova OV, 1999, MOL CELL, V3, P321, DOI 10.1016/S1097-2765(00)80459-1; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Farkash-Amar S, 2010, CHROMOSOME RES, V18, P115, DOI 10.1007/s10577-009-9091-5; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Guan ZQ, 2009, J CELL BIOL, V187, P623, DOI 10.1083/jcb.200905144; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guilbaud G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002322; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hough P.V.C., 1962, METHOD MEANS RECOGNI; ILLINGWORTH J, 1988, COMPUT VISION GRAPH, V44, P87, DOI 10.1016/S0734-189X(88)80033-1; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maya-Mendoza A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000900; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Suzuki M, 2011, GENOME RES, V21, P1833, DOI 10.1101/gr.116509.110; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zhou J, 2002, MOL CELL BIOL, V22, P4876, DOI 10.1128/MCB.22.13.4876-4889.2002; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	49	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48986	10.1371/journal.pone.0048986	http://dx.doi.org/10.1371/journal.pone.0048986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145042	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800180
J	Lara-Gonzalez, P; Taylor, SS				Lara-Gonzalez, Pablo; Taylor, Stephen S.			Cohesion Fatigue Explains Why Pharmacological Inhibition of the APC/C Induces a Spindle Checkpoint-Dependent Mitotic Arrest	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; ASSEMBLY CHECKPOINT; KINETOCHORE LOCALIZATION; AURORA-B; HUMAN-CELLS; CYCLIN B1; CENP-E; COMPLEX; PROTEIN; BUBR1	The Spindle Assembly Checkpoint (SAC) delays the onset of anaphase in response to unattached kinetochores by inhibiting the activity of the Anaphase-Promoting Complex/Cyclosome (APC/C), an E3 ubiquitin ligase. Once all the chromosomes have bioriented, SAC signalling is somehow silenced, which allows progression through mitosis. Recent studies suggest that the APC/C itself participates in SAC silencing by targeting an unknown factor for proteolytic degradation. Key evidence in favour of this model comes from the use of proTAME, a small molecule inhibitor of the APC/C. In cells, proTAME causes a mitotic arrest that is SAC-dependent. Even though this observation comes at odds with the current view that the APC/C acts downstream of the SAC, it was nonetheless argued that these results revealed a role for APC/C activity in SAC silencing. However, we show here that the mitotic arrest induced by proTAME is due to the induction of cohesion fatigue, a phenotype that is caused by the loss of sister chromatid cohesion following a prolonged metaphase. Under these conditions, the SAC is re-activated and APC/C inhibition is maintained independently of proTAME. Therefore, these results provide a simpler explanation for why the proTAME-induced mitotic arrest is also dependent on the SAC. While these observations question the notion that the APC/C is required for SAC silencing, we nevertheless show that APC/C activity does partially contribute to its own release from inhibitory complexes, and importantly, this does not depend on proteasome-mediated degradation.	[Lara-Gonzalez, Pablo; Taylor, Stephen S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Taylor, SS (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	stephen.taylor@manchester.ac.uk	Taylor, Stephen/GZL-6499-2022; Lara-Gonzalez, Pablo/S-3617-2016	Lara-Gonzalez, Pablo/0000-0002-8863-9006; Taylor, Stephen/0000-0003-4621-9326	CONICYT; University of Manchester; Cancer Research UK; Cancer Research UK [11913] Funding Source: researchfish	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); University of Manchester; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	P.L.-G. is funded by CONICYT Chile (http://www.conicyt.cl) and the University of Manchester (http://www.manchester.ac.uk/), and S. S. T. is funded by a Senior Fellowship from Cancer Research UK (http://www.cancerresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Foster S.A., 2012, MOL CELL IN PRESS; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gao YF, 2011, NAT CELL BIOL, V13, P924, DOI 10.1038/ncb2287; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Gurden MDJ, 2010, J CELL SCI, V123, P321, DOI 10.1242/jcs.062075; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Hoermanseder E, 2011, EMBO REP, V12, P436, DOI 10.1038/embor.2011.32; Holland AJ, 2007, J BIOL CHEM, V282, P24623, DOI 10.1074/jbc.M702545200; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Ma HT, 2011, J BIOL CHEM, V286, P13052, DOI 10.1074/jbc.M110.201897; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Miniowitz-Shemtov S, 2010, P NATL ACAD SCI USA, V107, P5351, DOI 10.1073/pnas.1001875107; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2001, J CELL SCI, V114, P4385; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; van Zon W, 2010, BIOCHEM SOC T, V38, P72, DOI 10.1042/BST0380072; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Visconti R, 2010, CELL CYCLE, V9, P564, DOI 10.4161/cc.9.3.10581; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Westhorpe FG, 2010, CHROMOSOMA, V119, P371, DOI 10.1007/s00412-010-0261-1; Zeng X, 2012, NAT CHEM BIOL, V8, P383, DOI [10.1038/nchembio.801, 10.1038/NCHEMBIO.801]; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	51	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49041	10.1371/journal.pone.0049041	http://dx.doi.org/10.1371/journal.pone.0049041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145059	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800190
J	Mander, L; Wesseln, CJ; McElwain, JC; Punyasena, SW				Mander, Luke; Wesseln, Cassandra J.; McElwain, Jennifer C.; Punyasena, Surangi W.			Tracking Taphonomic Regimes Using Chemical and Mechanical Damage of Pollen and Spores: An Example from the Triassic-Jurassic Mass Extinction	PLOS ONE			English	Article							KAP STEWART FORMATION; TRIASSIC/JURASSIC BOUNDARY; TERRESTRIAL; RECORD	The interpretation of biotic changes in the geological past relies on the assumption that samples from different time intervals represent an equivalent suite of natural sampling conditions. As a result, detailed investigations of taphonomic regimes during intervals of major biotic upheaval, such as mass extinctions, are crucial. In this paper, we have used variations in the frequency of chemical and mechanical sporomorph (pollen and spore) damage as a guide to taphonomic regimes across the Triassic-Jurassic mass extinction (Tr-J; -201.3 Ma) at a boundary section at Astartekloft, East Greenland. We find that the frequency of sporomorph damage is extremely variable in samples from this locality. This likely reflects a combination of taxon-specific susceptibility to damage and the mixing of sporomorphs from a mosaic of environments and taphonomic regimes. The stratigraphic interval containing evidence of plant extinction and compositional change in the source vegetation at Astartekloft is not marked by a consistent rise or fall in the frequency of sporomorph damage. This indicates that natural taphonomic regimes did not shift radically during this critical interval. We find no evidence of a consistent relationship between the taxonomic richness of sporomorph assemblages and the frequency of damage among sporomorphs at Astartekloft. This indicates that previously reported patterns of sporomorph richness across the Tr-J at this locality are likely to be robust. Taken together, our results suggest that the patterns of vegetation change at Astartekloft represent a real biological response to environmental change at the Tr-J.	[Mander, Luke; Wesseln, Cassandra J.; Punyasena, Surangi W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [McElwain, Jennifer C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University of Illinois System; University of Illinois Urbana-Champaign; University College Dublin	Mander, L (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	luke.mander@gmail.com	Punyasena, Surangi/C-9134-2011; McElwain, Jennifer/B-1735-2009; McElwain, Jennifer/AAX-1605-2020	McElwain, Jennifer/0000-0002-1729-6755; Punyasena, Surangi/0000-0003-2110-5840	University of Illinois; Undergraduate Research Experience and Knowledge Award from Science Foundation Ireland; Marie Cure Excellence Grant [MEXT-CT-2006-042531]; Science Foundation Ireland [SFI 11/PI/1103]; European Research Council Starting Investigator Grant [279962]; United States National Science Foundation Innovations in Biological Imaging and Visualization program [NSF DBI 1052997]; Direct For Biological Sciences [1052997] Funding Source: National Science Foundation	University of Illinois; Undergraduate Research Experience and Knowledge Award from Science Foundation Ireland(Science Foundation Ireland); Marie Cure Excellence Grant; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council Starting Investigator Grant(European Research Council (ERC)); United States National Science Foundation Innovations in Biological Imaging and Visualization program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	CJW was supported by a Robert H. Davis Undergraduate Research Prize and a School of Integrative Biology Enhancement Fund grant from the University of Illinois and by an Undergraduate Research Experience and Knowledge Award from Science Foundation Ireland (2010). LM and JCM acknowledge funding through a Marie Cure Excellence Grant (MEXT-CT-2006-042531 to JCM). JCM acknowledges support from Science Foundation Ireland (SFI 11/PI/1103) and a European Research Council Starting Investigator Grant (279962). LM, CJW and SWP acknowledge support from the United States National Science Foundation Innovations in Biological Imaging and Visualization program (NSF DBI 1052997 to SWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1937, MEDDELELSER GRONLAND; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bonis NR, 2010, PALAEOGEOGR PALAEOCL, V295, P146, DOI 10.1016/j.palaeo.2010.05.034; Bonis NR, 2009, REV PALAEOBOT PALYNO, V156, P376, DOI 10.1016/j.revpalbo.2009.04.003; Campbell Ian D., 1994, Palynology, V18, P5; Chaloner WG, 1999, FOSSIL PLANTS SPORES; CUSHING E J, 1967, Review of Palaeobotany and Palynology, V4, P87, DOI 10.1016/0034-6667(67)90175-3; DAM G, 1992, GEOLOGY, V20, P749, DOI 10.1130/0091-7613(1992)020<0749:FRIALW>2.3.CO;2; Deenen MHL, 2010, EARTH PLANET SC LETT, V291, P113, DOI 10.1016/j.epsl.2010.01.003; Delcourt P.A., 1980, PALYNOLOGY, V4, P215, DOI DOI 10.1080/01916122.1980.9989209; GASTALDO R A, 1987, Palaios, V2, P229, DOI 10.2307/3514673; Harrington GJ, 2008, PALAEONTOLOGY, V51, P611, DOI 10.1111/j.1475-4983.2008.00768.x; HAVINGA A J, 1967, Review of Palaeobotany and Palynology, V2, P81, DOI 10.1016/0034-6667(67)90138-8; Havinga A.J., 1984, POLLEN SPORES, V26, P541; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hofmann CC, 2002, REV PALAEOBOT PALYNO, V119, P191, DOI 10.1016/S0034-6667(01)00141-5; Holst I, 2007, P NATL ACAD SCI USA, V104, P17608, DOI 10.1073/pnas.0708736104; Jackson ST, 1999, BOT REV, V65, P39, DOI 10.1007/BF02856557; Jones J, 2007, ENVIRON ARCHAEOL, V12, P71, DOI 10.1179/174963107x172769; Katifori E, 2010, P NATL ACAD SCI USA, V107, P7635, DOI 10.1073/pnas.0911223107; KOPPELHUS E.B., 1996, DANMARK GRONLANDS GE, V5, P1; Kuerschner WM, 2007, PALAEOGEOGR PALAEOCL, V244, P257, DOI 10.1016/j.palaeo.2006.06.031; Mander L, 2011, J MICROPALAEONTOL, V30, P107, DOI 10.1144/0262-821X11-012; Mander L, 2010, P NATL ACAD SCI USA, V107, P15351, DOI 10.1073/pnas.1004207107; Mander L, 2008, PALAEONTOLOGY, V51, P1213, DOI 10.1111/j.1475-4983.2008.00821.x; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; McElwain JC, 2009, SCIENCE, V324, P1554, DOI 10.1126/science.1171706; Moore LR, 1963, PALAEONTOLOGY, V6, P349; MULLER JAN, 1959, MICROPALEONTOLOGY, V5, P1, DOI 10.2307/1484153; PEDERSEN KR, 1980, REV PALAEOBOT PALYNO, V31, P1; Potonie R, 1962, PALAEONTOL Z, V36, P46; Ruhl M, 2011, SCIENCE, V333, P430, DOI 10.1126/science.1204255; Schaller MF, 2011, SCIENCE, V331, P1404, DOI 10.1126/science.1199011; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Sluyter Andrew, 1997, Palynology, V21, P35; Steinthorsdottir M, 2011, PALAEOGEOGR PALAEOCL, V308, P418, DOI 10.1016/j.palaeo.2011.05.050; Traverse A., 2007, PALEOPALYNOLOGY; Tweddle JC, 2010, REV PALAEOBOT PALYNO, V161, P59, DOI 10.1016/j.revpalbo.2010.03.004; van de Schootbrugge B, 2009, NAT GEOSCI, V2, P589, DOI 10.1038/NGEO577; Van Mourik JM, 2001, PALAEOBIOLOGY; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107; Wodehouse RP., 1935, POLLEN GRAINS	46	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49153	10.1371/journal.pone.0049153	http://dx.doi.org/10.1371/journal.pone.0049153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145104	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800221
J	Ying, WZ; Aaron, KJ; Sanders, PW				Ying, Wei-Zhong; Aaron, Kristal J.; Sanders, Paul W.			Effect of Aging and Dietary Salt and Potassium Intake on Endothelial PTEN (Phosphatase and Tensin Homolog on Chromosome 10) Function	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR-BETA; TUMOR-SUPPRESSOR; KINASE; DYSFUNCTION; PHOSPHORYLATION; ACTIVATION; RELAXATION; ARTERIAL; DISEASE	Aging promotes endothelial dysfunction, defined as a reduction in bioavailable nitric oxide (NO) produced by the endothelial isoform of nitric oxide synthase (NOS3). This enzyme is critically regulated by phosphorylation by protein kinase B (Akt), which in turn is regulated by the lipid phosphatase, PTEN. The present series of studies demonstrated a reduction in bioavailable NO as the age of rats increased from 1 to 12 months. At 12 months of age, rats no longer demonstrated increases in phosphorylated NOS3 in response to high dietary salt intake. Endothelial cell levels of PTEN increased with age and became refractory to change with increased salt intake. In contrast to the reduction in NO production, endothelial cell production of transforming growth factor-beta (TGF-beta) relative to NO increased progressively with age. In macrovascular endothelial cells, PTEN was regulated in a dose-dependent fashion by TGF-beta, which was further regulated by extracellular [KCl]. When combined with prior studies, the present series of experiments suggested an integral role for PTEN in endothelial cell pathobiology of aging and an important mitigating function of TGF-beta in endothelial PTEN regulation. The findings further supported a role for diet in affecting vascular function through the production of TGF-beta and NO.	[Ying, Wei-Zhong; Aaron, Kristal J.; Sanders, Paul W.] Univ Alabama Birmingham, Dept Med, Div Nephrol, Nephrol Res & Training Ctr,Ctr Free Rad Biol,Ctr, Birmingham, AL 35294 USA; [Ying, Wei-Zhong; Aaron, Kristal J.; Sanders, Paul W.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Sanders, Paul W.] Dept Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanders, PW (corresponding author), Univ Alabama Birmingham, Dept Med, Div Nephrol, Nephrol Res & Training Ctr,Ctr Free Rad Biol,Ctr, Birmingham, AL 35294 USA.	psanders@uab.edu		Sanders, Paul/0000-0002-2915-5714	Office of Research and Development [1 IP1 BX001595]; Medical Research Service; Department of Veterans Affairs; National Institutes of Health [R01 DK046199, P30 DK079337]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046199, P30DK079337] Funding Source: NIH RePORTER	Office of Research and Development; Medical Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A grant (1 IP1 BX001595) from the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, and National Institutes of Health grants (R01 DK046199 and P30 DK079337 (George M. O'Brien Kidney and Urological Research Centers Program)), supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu TAM, 2001, TRENDS ENDOCRIN MET, V12, P257, DOI 10.1016/S1043-2760(01)00425-8; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Blackwell KA, 2004, AM J PHYSIOL-HEART C, V287, pH2448, DOI 10.1152/ajpheart.00248.2004; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Cohen DL, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/407801; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Goligorsky MS, 2005, AM J PHYSIOL-RENAL, V288, pF871, DOI 10.1152/ajprenal.00333.2004; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Hill C, 1997, AM J PHYSIOL-REG I, V272, pR1747, DOI 10.1152/ajpregu.1997.272.6.R1747; HONGO K, 1988, STROKE, V19, P892, DOI 10.1161/01.STR.19.7.892; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Laurent S, 2007, HYPERTENSION, V49, P1202, DOI 10.1161/HYPERTENSIONAHA.106.076166; LeBlanc AJ, 2008, AM J PHYSIOL-HEART C, V295, pH2280, DOI 10.1152/ajpheart.00541.2008; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; LUSCHER TF, 1993, ANNU REV MED, V44, P395, DOI 10.1146/annurev.med.44.1.395; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mao M, 2012, FREE RADICAL BIO MED, V52, P427, DOI 10.1016/j.freeradbiomed.2011.09.020; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Six I, 2002, FEBS LETT, V532, P67, DOI 10.1016/S0014-5793(02)03630-X; Soucy KG, 2006, J APPL PHYSIOL, V101, P1751, DOI 10.1152/japplphysiol.00138.2006; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; STURGESS NC, 1985, LANCET, V2, P474; Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; Tarnawski AS, 2010, BIOCHEM BIOPH RES CO, V394, P291, DOI 10.1016/j.bbrc.2010.02.161; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Wang SX, 2002, J BIOL CHEM, V277, P9880, DOI 10.1074/jbc.M108360200; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Ying WZ, 2008, HYPERTENSION, V52, P1134, DOI 10.1161/HYPERTENSIONAHA.108.121582; Ying WZ, 2008, AM J PHYSIOL-RENAL, V295, pF406, DOI 10.1152/ajprenal.90294.2008; Ying WZ, 2009, HYPERTENSION, V54, P1159, DOI 10.1161/HYPERTENSIONAHA.109.138255; Ying WZ, 1999, AM J PHYSIOL-HEART C, V277, pH1293, DOI 10.1152/ajpheart.1999.277.4.H1293; Ying WZ, 2002, HYPERTENSION, V39, P239, DOI 10.1161/hy0202.104142; Ying WZ, 2003, AM J PHYSIOL-RENAL, V285, pF902, DOI 10.1152/ajprenal.00177.2003; Ying WZ, 1998, AM J PHYSIOL-RENAL, V275, pF18, DOI 10.1152/ajprenal.1998.275.1.F18; Ying WZ, 1998, AM J PHYSIOL-RENAL, V274, pF635, DOI 10.1152/ajprenal.1998.274.4.F635	54	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48715	10.1371/journal.pone.0048715	http://dx.doi.org/10.1371/journal.pone.0048715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144940	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800106
J	Abdulrahman, BA; Abu Khweek, A; Akhter, A; Caution, K; Tazi, M; Hassan, H; Zhang, YC; Rowland, PD; Malhotra, S; Aeffner, F; Davis, IC; Valvano, MA; Amer, AO				Abdulrahman, Basant A.; Abu Khweek, Arwa; Akhter, Anwari; Caution, Kyle; Tazi, Mia; Hassan, Hoda; Zhang, Yucheng; Rowland, Patrick D.; Malhotra, Sankalp; Aeffner, Famke; Davis, Ian C.; Valvano, Miguel A.; Amer, Amal O.			Depletion of the Ubiquitin-binding Adaptor Molecule SQSTM1/p62 from Macrophages Harboring cftr Delta F508 Mutation Improves the Delivery of Burkholderia cenocepacia to the Autophagic Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; LUNG INFLAMMATION; CYSTIC-FIBROSIS; P62; INFECTION; NBR1; INTERNALIZATION; FRANCISELLA; SALMONELLA; EXPRESSION	Cystic fibrosis is the most common inherited lethal disease in Caucasians. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), of which the cftr Delta F508 mutation is the most common. Delta F508 macrophages are intrinsically defective in autophagy because of the sequestration of essential autophagy molecules within unprocessed CFTR aggregates. Defective autophagy allows Burkholderia cenocepacia (B. cepacia) to survive and replicate in Delta F508 macrophages. Infection by B. cepacia poses a great risk to cystic fibrosis patients because it causes accelerated lung inflammation and, in some cases, a lethal necrotizing pneumonia. Autophagy is a cell survival mechanism whereby an autophagosome engulfs nonfunctional organelles and delivers them to the lysosome for degradation. The ubiquitin binding adaptor protein SQSTM1/p62 is required for the delivery of several ubiquitinated cargos to the autophagosome. In WT macrophages, p62 depletion and overexpression lead to increased and decreased bacterial intracellular survival, respectively. In contrast, depletion of p62 in Delta F508 macrophages results in decreased bacterial survival, whereas overexpression of p62 leads to increased B. cepacia intracellular growth. Interestingly, the depletion of p62 from Delta F508 macrophages results in the release of the autophagy molecule beclin1 (BECN1) from the mutant CFTR aggregates and allows its redistribution and recruitment to the B. cepacia vacuole, mediating the acquisition of the autophagy marker LC3 and bacterial clearance via autophagy. These data demonstrate that p62 differentially dictates the fate of B. cepacia infection in WT and Delta F508 macrophages.	[Abdulrahman, Basant A.; Abu Khweek, Arwa; Akhter, Anwari; Caution, Kyle; Tazi, Mia; Hassan, Hoda; Zhang, Yucheng; Rowland, Patrick D.; Amer, Amal O.] Ohio State Univ, Dept Microbial Infect & Immun, Dept Internal Med, Columbus, OH 43210 USA; [Abdulrahman, Basant A.; Abu Khweek, Arwa; Akhter, Anwari; Caution, Kyle; Tazi, Mia; Hassan, Hoda; Zhang, Yucheng; Rowland, Patrick D.; Amer, Amal O.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Abdulrahman, Basant A.] Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo, Egypt; [Malhotra, Sankalp] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Aeffner, Famke; Davis, Ian C.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Valvano, Miguel A.] Univ Western Ontario, Ctr Human Immunol, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Helwan University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Western University (University of Western Ontario); Queens University Belfast	Amer, AO (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Dept Internal Med, Biol Res Tower,460 W 12th Ave,Room 1014, Columbus, OH 43210 USA.	amal.amer@osumc.edu	Amer, Amal/E-2643-2011; Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641; Abdulrahman, Basant/0000-0002-4970-6835; Aeffner, Famke/0000-0002-1405-9228	Egyptian Bureau of Education; National Institutes of Health [R01HL094586]; Cystic Fibrosis Canada grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Egyptian Bureau of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Canada grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a doctoral fellowship from the Egyptian Bureau of Education (to B. A. A.). This work was supported, in whole or in part, by the National Institutes of Health (Grant R01HL094586 (to A. O. A.)) and a Cystic Fibrosis Canada grant (to M. A. V).	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Devenish RJ, 2011, AUTOPHAGY, V7, P1269, DOI 10.4161/auto.7.11.17941; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nezis IP, 2008, METHOD ENZYMOL, V451, P669, DOI 10.1016/S0076-6879(08)03237-0; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Saldias MS, 2009, MICROBIOL-SGM, V155, P2809, DOI 10.1099/mic.0.031344-0; Tolman JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-63; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Witko-Sarsat V, 1999, MEDIAT INFLAMM, V8, P7, DOI 10.1080/09629359990658; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	49	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2049	2058		10.1074/jbc.M112.411728	http://dx.doi.org/10.1074/jbc.M112.411728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23148214	hybrid, Green Published			2022-12-25	WOS:000313751400056
J	Wu, HM; Padhi, A; Xu, JQ; Gong, XY; Tien, P				Wu, Haoming; Padhi, Abinash; Xu, Junqiang; Gong, Xiaoyan; Tien, Po			Intra-Host Diversity and Emergence of Unique GBV-C Viral Lineages in HIV Infected Subjects in Central China	PLOS ONE			English	Article							HEPATITIS-G VIRUS; C/HEPATITIS-G VIRUS; CLINICAL-IMPLICATIONS; PHYLOGENETIC ANALYSIS; DISEASE PROGRESSION; RECOMBINATION; COINFECTION; PREVALENCE; C/HGV; IDENTIFICATION	GB virus C (GBV-C), which is highly prevalent among HIV/AIDS, seemed to slow the HIV disease progression. The HIV/GBV-C co-infected individuals may represent an interesting model for the investigation of the role played by HIV infection and/or the immune system in driving the evolution of the GBV-C viral populations. The present study investigated the prevalence and population dynamics of GB virus C in HIV infected individuals representing 13 geographic regions of Hubei Province of China. Approximately 37% of HIV-1 infected individuals were infected with GBV-C and genotype 3 is appeared to be predominant. Utilizing the 196 complete E2 nucleotide sequence data from 10 HIV/GBV-C infected individuals and employing coalescence based phylogenetic approaches; the present study has investigated the intra-host dynamics of GBV-C. The results revealed patient-specific unique GBV-C viral lineages and each viral lineage showed the evidence of rapid population expansion in respective HIV-1 infected patients, thus suggesting HIV-1 was unlikely to have been inhibiting effect on the GBV-C viral replication. GBV-C in all patients has experienced intense purifying selection, suggesting the GBV-C viral invasion and subsequent expansion within the HIV-1 infected hosts without any modification of the functional epitopes at their membrane protein. The finding of within host GBV-C recombinant sequences indicated recombination was one of the significant forces in the evolution and divergence of GBV-C.	[Gong, Xiaoyan] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Hubei, Peoples R China; [Wu, Haoming; Tien, Po] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Padhi, Abinash] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Xu, Junqiang] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Tien, Po] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gong, XY (corresponding author), Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Hubei, Peoples R China.	xygong@whu.edu.cn; tienpo@sun.im.ac.cn		Wu, Haoming/0000-0001-8117-654X	National Basic Research Program of China (973 Program) [2010CB530102, 2011CB504703]; National Natural Science Foundation of China (NSFC) [81021003, 81071341]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by the grants from the National Basic Research Program of China (973 Program) ( Nos. 2010CB530102 and 2011CB504703), and by the National Natural Science Foundation of China (NSFC, Grant Nos. 81021003 and 81071341). NSFC: http://www.nsfc.gov.cn/Portal0/default152.htm; http://www.973.gov.cn/English/Index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Odeh RO, 2005, J MED VIROL, V76, P534, DOI 10.1002/jmv.20394; Alcalde R, 2010, VIRUS RES, V151, P148, DOI 10.1016/j.virusres.2010.04.008; Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Alter HJ, 1996, NEW ENGL J MED, V334, P1536, DOI 10.1056/NEJM199606063342310; Berzsenyi MD, 2005, J CLIN VIROL, V33, P257, DOI 10.1016/j.jcv.2005.04.002; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Casteling A, 1998, J MED VIROL, V55, P103, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;103::AID-JMV4&gt;3.0.CO;2-6; Dawson GJ, 1996, J MED VIROL, V50, P97, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;97::AID-JMV16&gt;3.0.CO;2-V; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021151; Francesconi R, 1997, J HEPATOL, V26, P1165, DOI 10.1016/S0168-8278(97)80448-5; Fu YX, 1997, GENETICS, V147, P915; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Giret MTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018407; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Kaye S, 2005, CLIN INFECT DIS, V40, P876, DOI 10.1086/428123; Lau DTY, 1999, J INFECT DIS, V180, P1334, DOI 10.1086/315031; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Lu L, 2001, VIRUS RES, V73, P131, DOI 10.1016/S0168-1702(00)00231-8; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Muerhoff AS, 2003, J MED VIROL, V70, P141, DOI 10.1002/jmv.10375; Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5; Naito H, 1999, J CLIN MICROBIOL, V37, P1217, DOI 10.1128/JCM.37.4.1217-1220.1999; Nakao H, 1997, VIROLOGY, V233, P43, DOI 10.1006/viro.1997.8615; Neibecker M, 2011, J MED VIROL, V83, P685, DOI 10.1002/jmv.22029; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pavesi A, 2001, J MOL EVOL, V53, P104, DOI 10.1007/s002390010198; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sathar MA, 1999, VIRUS RES, V64, P151, DOI 10.1016/S0168-1702(99)00090-8; Schneider C, 2000, NEUROLOGY, V55, P383, DOI 10.1212/WNL.55.3.383; Shao L, 2000, VIRUS GENES, V21, P215, DOI 10.1023/A:1008195631870; Smith DB, 2000, J GEN VIROL, V81, P769, DOI 10.1099/0022-1317-81-3-769; Smith DB, 1997, J GEN VIROL, V78, P1533, DOI 10.1099/0022-1317-78-7-1533; SMITH JM, 1992, J MOL EVOL, V34, P126; Smith SM, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-38; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	56	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48417	10.1371/journal.pone.0048417	http://dx.doi.org/10.1371/journal.pone.0048417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152773	Green Submitted, Green Published, gold			2022-12-25	WOS:000311234000014
J	Rubolini, D; Colombo, G; Ambrosini, R; Caprioli, M; Clerici, M; Colombo, R; Dalle-Donne, I; Milzani, A; Romano, A; Romano, M; Saino, N				Rubolini, Diego; Colombo, Graziano; Ambrosini, Roberto; Caprioli, Manuela; Clerici, Marco; Colombo, Roberto; Dalle-Donne, Isabella; Milzani, Aldo; Romano, Andrea; Romano, Maria; Saino, Nicola			Sex-Related Effects of Reproduction on Biomarkers of Oxidative Damage in Free-living Barn Swallows (Hirundo rustica)	PLOS ONE			English	Article							HISTORY TRADE-OFFS; ARRIVAL DATE; PROTEIN CARBONYLATION; NATURAL-SELECTION; STRESS; COSTS; TESTOSTERONE; COVARIATION; MECHANISMS; RESISTANCE	According to life-history theory, the allocation of limiting resources to one trait has negative consequences for other traits requiring the same resource, resulting in trade-offs among life-history traits, such as reproduction and survival. In vertebrates, oxidative stress is increasingly being considered among the physiological mechanisms forming the currency of life-history trade-offs. In this study of the barn swallow (Hirundo rustica), we focus on the oxidative costs of reproduction, especially egg laying, by investigating the effects of breeding stage (pre- vs. post-laying) and progression of the season on three biomarkers of oxidative damage (OD) to plasma proteins, namely the concentration of malondialdehyde (MDA)-protein adducts and of protein thiol groups (PSH), and the protein carbonyl (PCO) content. Moreover, we investigated whether males and females differed in plasma OD levels, because the inherent sex differences in reproductive roles and physiology may originate sex-specific patterns of OD during breeding. We found that MDA-protein adduct levels were higher in the pre-laying than in the post-laying phase, that males had lower levels of MDA-modified proteins than females, and that the decline of MDA-protein adduct concentration between the pre- and the post-laying phase was more marked for females than males. In addition, MDA-protein adduct levels declined with sampling date, but only during the pre-laying phase. On the other hand, plasma PCO levels increased from the pre- to the post-laying phase in both sexes, and females had higher levels of PCO than males. PSH concentration was unaffected by breeding stage, sex or sampling date. On the whole, our findings indicate that biomarkers of protein oxidation closely track the short-term variation in breeding stage of both male and female barn swallows. Moreover, the higher protein OD levels observed among females compared to males suggest that egg laying entails oxidative costs, which might negatively affect female residual reproductive value. Citation: Rubolini D, Colombo G, Ambrosini R, Caprioli M, Clerici M, et al. (2012) Sex-Related Effects of Reproduction on Biomarkers of Oxidative Damage in Free-living Barn Swallows (Hirundo rustica). PLoS ONE 7(11): e48955. doi:10.1371/journal.pone.0048955	[Rubolini, Diego; Colombo, Graziano; Caprioli, Manuela; Clerici, Marco; Colombo, Roberto; Dalle-Donne, Isabella; Milzani, Aldo; Romano, Andrea; Romano, Maria; Saino, Nicola] Univ Milan, Dipartimento Biosci, Milan, Italy; [Ambrosini, Roberto] Unv Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Clerici, Marco] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy	University of Milan; University of Milano-Bicocca; University of Milan	Rubolini, D (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	diego.rubolini@unimi.it	Milzani, Aldo/AHE-3364-2022; Rubolini, Diego/F-2851-2011; Ambrosini, Roberto/F-3188-2012; Romano, Andrea/A-2780-2017; Romano, Andrea/B-3930-2012; Dalle-Donne, Isabella/AHE-8993-2022; Dalle-Donne, Isabella/K-1436-2018	Milzani, Aldo/0000-0002-1496-6872; Rubolini, Diego/0000-0003-2703-5783; Ambrosini, Roberto/0000-0002-7148-1468; Romano, Andrea/0000-0002-0945-6018; COLOMBO, GRAZIANO/0000-0001-8663-735X; Dalle-Donne, Isabella/0000-0001-7098-6213; Saino, Nicola/0000-0002-0230-3967	Universita degli Studi di Milano [2009-ATE-0015]; Fondazione Cariplo [UNIAGI 13357]	Universita degli Studi di Milano; Fondazione Cariplo(Fondazione Cariplo)	The study was partly funded by the Universita degli Studi di Milano (grant 2009-ATE-0015 to DR) and Fondazione Cariplo (grant UNIAGI 13357 to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; Angilletta MJ, 2000, FUNCT ECOL, V14, P39, DOI 10.1046/j.1365-2435.2000.00387.x; Bailey R. E., 1952, Condor, V54, P121, DOI 10.2307/1365062; Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bergeron P, 2011, FUNCT ECOL, V25, P1063, DOI 10.1111/j.1365-2435.2011.01868.x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Brambilla G, 2003, ANAL CHIM ACTA, V483, P281, DOI 10.1016/S0003-2670(02)01400-9; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Casagrande S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1319, DOI 10.1007/s00265-012-1387-3; Casagrande S, 2011, COMP BIOCHEM PHYS A, V160, P16, DOI 10.1016/j.cbpa.2011.04.011; Casagrande S, 2012, COMP BIOCHEM PHYS A, V163, P296, DOI 10.1016/j.cbpa.2012.07.018; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Colombo G, 2012, FREE RADICAL BIO MED, V52, P1584, DOI 10.1016/j.freeradbiomed.2012.02.030; Colombo G, 2010, ANTIOXID REDOX SIGN, V12, P349, DOI 10.1089/ars.2009.2806; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Costantini D, 2010, COMP BIOCHEM PHYS A, V156, P294, DOI 10.1016/j.cbpa.2010.02.021; Costantini D, 2009, PHYSIOL BIOCHEM ZOOL, V82, P430, DOI 10.1086/604668; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Dalle-Donne I, 2009, FREE RADICAL BIO MED, V46, P1411, DOI 10.1016/j.freeradbiomed.2009.02.024; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; FARNER DS, 1980, ANNU REV PHYSIOL, V42, P457, DOI 10.1146/annurev.ph.42.030180.002325; Farout L, 2006, ANTIOXID REDOX SIGN, V8, P205, DOI 10.1089/ars.2006.8.205; Garratt M, 2012, P ROY SOC B-BIOL SCI, V279, P3121, DOI 10.1098/rspb.2012.0568; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Halifeoglu I, 2003, CELL BIOCHEM FUNCT, V21, P133, DOI 10.1002/cbf.1009; Halliwell B., 2015, Free radicals in biology and medicine; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Hayward A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016557; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Higdon A, 2012, BIOCHEM J, V442, P453, DOI 10.1042/BJ20111752; Johnson A.L., 2000, P569, DOI 10.1016/B978-012747605-6/50023-7; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; King J.R., 1973, P78; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; Moller AP, 2004, ECOLOGY, V85, P206, DOI 10.1890/02-0451; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Moller AP., 1994, SEXUAL SELECTION BAR; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Ninni P, 2004, OIKOS, V105, P55, DOI 10.1111/j.0030-1299.2004.12516.x; NUR N, 1988, ARDEA, V76, P155; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Oettl K, 2011, ACTA OPHTHALMOL, V89, pE174, DOI 10.1111/j.1755-3768.2009.01824.x; PARTRIDGE L, 1985, NATURE, V316, P20, DOI 10.1038/316020a0; Rasband W., 2006, IMAGEJ; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Roff Derek A., 1992; Rossi R, 2009, J CELL MOL MED, V13, P3131, DOI 10.1111/j.1582-4934.2008.00417.x; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2012, J ANIM ECOL, V81, P1004, DOI 10.1111/j.1365-2656.2012.01989.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Sinervo B, 1996, EVOLUTION, V50, P1299, DOI 10.1111/j.1558-5646.1996.tb02370.x; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; Turner A., 2006, BARN SWALLOW; van de Crommenacker J, 2012, P ROY SOC B-BIOL SCI, V279, P1466, DOI 10.1098/rspb.2011.1865; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P1271, DOI 10.1098/rspb.2001.1661; Walsberg G.E., 1983, P161; Ward S, 2006, J AVIAN BIOL, V37, P179, DOI 10.1111/j.0908-8857.2006.03262.x; Ward S, 1996, PHYSIOL ZOOL, V69, P930, DOI 10.1086/physzool.69.4.30164236; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010; Wingfield John C., 1993, Avian Biology, V9, P163; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zuur Alain F., 2009, P1	85	17	17	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48955	10.1371/journal.pone.0048955	http://dx.doi.org/10.1371/journal.pone.0048955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145037	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500056
J	Alvarez-Fernandez, C; Guardo, AC; Garcia-Perez, J; Garcia, F; Blanco, J; Escriba-Garcia, L; Gatell, JM; Alcami, J; Plana, M; Sanchez-Palomino, S				Alvarez-Fernandez, Carmen; Crespo Guardo, Alberto; Garcia-Perez, Javier; Garcia, Felipe; Blanco, Julia; Escriba-Garcia, Laura; Maria Gatell, Jose; Alcami, Jose; Plana, Montserrat; Sanchez-Palomino, Sonsoles			Generation and Characterization of a Defective HIV-1 Virus as an Immunogen for a Therapeutic Vaccine	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CELL-ASSOCIATED ANTIGENS; FUSION INHIBITOR T-20; DENDRITIC CELLS; CROSS-PRESENTATION; RECOMBINANT VIRUSES; TYPE-1 REPLICATION; VIRION MATURATION; T-CELLS; INFECTION	Background: The generation of new immunogens able to elicit strong specific immune responses remains a major challenge in the attempts to obtain a prophylactic or therapeutic vaccine against HIV/AIDS. We designed and constructed a defective recombinant virus based on the HIV-1 genome generating infective but non-replicative virions able to elicit broad and strong cellular immune responses in HIV-1 seropositive individuals. Results: Viral particles were generated through transient transfection in producer cells (293-T) of a full length HIV-1 DNA carrying a deletion of 892 base pairs (bp) in the pol gene encompassing the sequence that codes for the reverse transcriptase (NL4-3/Delta RT clone). The viral particles generated were able to enter target cells, but due to the absence of reverse transcriptase no replication was detected. The immunogenic capacity of these particles was assessed by ELISPOT to determine gamma-interferon production in a cohort of 69 chronic asymptomatic HIV-1 seropositive individuals. Surprisingly, defective particles produced from NL4-3/Delta RT triggered stronger cellular responses than wild-type HIV-1 viruses inactivated with Aldrithiol-2 (AT-2) and in a larger proportion of individuals (55% versus 23% seropositive individuals tested). Electron microscopy showed that NL4-3/Delta RT virions display immature morphology. Interestingly, wild-type viruses treated with Amprenavir (APV) to induce defective core maturation also induced stronger responses than the same viral particles generated in the absence of protease inhibitors. Conclusions: We propose that immature HIV-1 virions generated from NL4-3/Delta RT viral clones may represent new prototypes of immunogens with a safer profile and stronger capacity to induce cellular immune responses than wild-type inactivated viral particles.	[Alvarez-Fernandez, Carmen; Crespo Guardo, Alberto; Garcia, Felipe; Escriba-Garcia, Laura; Maria Gatell, Jose; Plana, Montserrat; Sanchez-Palomino, Sonsoles] Hosp Clin Barcelona, Catalonian Ctr HIV Vaccines HIVACAT, Inst Invest Biomed August Pi & Sunyer IDIBAPS, AIDS Res Grp, Barcelona, Spain; [Alvarez-Fernandez, Carmen; Crespo Guardo, Alberto; Garcia, Felipe; Escriba-Garcia, Laura; Maria Gatell, Jose; Plana, Montserrat; Sanchez-Palomino, Sonsoles] Univ Barcelona, Barcelona, Spain; [Garcia-Perez, Javier; Alcami, Jose] Inst Salud Carlos III, AIDS Immunopathol Unit, Natl Ctr Microbiol, Madrid, Spain; [Blanco, Julia] IrsiCaixa, Inst Recerca Sindrome Inmunodeficencia Adquirida, Badalona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Institut de Recerca de la Sida - IrsiCaixa	Sanchez-Palomino, S (corresponding author), Hosp Clin Barcelona, Catalonian Ctr HIV Vaccines HIVACAT, Inst Invest Biomed August Pi & Sunyer IDIBAPS, AIDS Res Grp, Barcelona, Spain.	ssanchez@clinic.ub.es	García-Pérez, Javier/F-9248-2019; , Felipe/F-4242-2014; Alcami, Pepe/T-2242-2018; Plana, Montserrat/AAA-5124-2020; Blanco, Julià/A-5347-2008	García-Pérez, Javier/0000-0001-7551-7803; , Felipe/0000-0001-7658-5832; Alcami, Pepe/0000-0003-0023-7377; Blanco, Julià/0000-0002-2225-0217; Alvarez-Fernandez, Carmen/0000-0003-0060-0447; Escriba Garcia, Laura/0000-0002-3306-310X	Fundacion Mutua Madrilena; HIVACAT-HIV Development Program in Catalonia; UE;  [FIS PI050265];  [FIS PI040503];  [FIS PI070291];  [FIS Intrasalud 080752];  [FIS PS09/01297];  [FIS PI10/02984];  [SAF2006-26667-E];  [FIT 09-010-205-9];  [FIPSE 36780/08];  [TRA-094];  [EC10-153];  [ISCIII-RETIC RD06/0006];  [FIPSE 36630/07]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); HIVACAT-HIV Development Program in Catalonia; UE; ; ; ; ; ; ; ; ; ; ; ; ; 	This study was supported by grants FIS PI050265, FIS PI040503, FIS PI070291, FIS Intrasalud 080752, FIS PS09/01297, FIS PI10/02984, SAF2006-26667-E, FIT 09-010-205-9, FIPSE 36780/08, Fundacion Mutua Madrilena, TRA-094, EC10-153, ISCIII-RETIC RD06/0006, HIVACAT-HIV Development Program in Catalonia, FIPSE 36630/07, UE Program Health 2009 CHAARM. Spanish Health Institute Carlos III (ISCIII) and the Health Department of the Catalan Government (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cen Shan, 2004, Retrovirology, V1, P33, DOI 10.1186/1742-4690-1-33; Chhatbar C, 2011, DRUG DISCOV TODAY, V16, P948, DOI 10.1016/j.drudis.2011.08.013; Chiang CC, 2012, VIROLOGY, V422, P278, DOI 10.1016/j.virol.2011.11.001; Cranage MP, 1997, VIROLOGY, V229, P143, DOI 10.1006/viro.1996.8419; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Das Atze T., 2010, HIV Therapy, V4, P361, DOI 10.2217/HIV.10.20; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DESROSIERS RC, 1991, AM J PATHOL, V139, P29; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Evans DT, 2005, J VIROL, V79, P7707, DOI 10.1128/JVI.79.12.7707-7720.2005; Falkensammer B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-60; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Gamble LJ, 2010, DRUG DES DEV THER, V5, P9, DOI 10.2147/DDDT.S6959; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Garcia F, 2005, J INFECT DIS, V191, P1680, DOI 10.1086/429340; Garcia F, 2012, HUM VACC IMMUNOTHER, V8, P569, DOI 10.4161/hv.19555; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Garcia-Perez J, 2008, HIV MED, V9, P160, DOI 10.1111/j.1468-1293.2007.00540.x; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gorry PR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-66; Gundlach BR, 2000, J VIROL, V74, P3537, DOI 10.1128/JVI.74.8.3537-3542.2000; Hallengard D, 2010, VACCINE, V29, P839; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Igarashi T, 1999, P NATL ACAD SCI USA, V96, P14049, DOI 10.1073/pnas.96.24.14049; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Kahn JO, 2000, JAMA-J AM MED ASSOC, V284, P2193, DOI 10.1001/jama.284.17.2193; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Khorchid A, 2000, J MOL BIOL, V299, P17, DOI 10.1006/jmbi.2000.3709; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lakhashe SK, 2011, CURR OPIN VIROL, V1, P246, DOI 10.1016/j.coviro.2011.07.005; Larsson M, 2003, CURR TOP MICROBIOL, V276, P261; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; Larsson M, 2002, AIDS, V16, P171, DOI 10.1097/00002030-200201250-00005; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Libois A, 2006, AIDS RES HUM RETROV, V22, P657, DOI 10.1089/aid.2006.22.657; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Liu ZQ, 2006, VIROLOGY, V351, P444, DOI 10.1016/j.virol.2006.03.033; Lopez A, 2009, VACCINE, V27, P6166, DOI 10.1016/j.vaccine.2009.08.021; LOPEZIGLESIAS C, 1988, J ULTRA MOL STRUCT R, V101, P173, DOI 10.1016/0889-1605(88)90007-9; LOPEZIGLESIAS C, 1988, J ULTRA MOL STRUCT R, V101, P75, DOI 10.1016/0889-1605(88)90083-3; LOPEZIGLESIAS C, 1988, EUR J CELL BIOL, V46, P259; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Michelini Z, 2009, VACCINE, V27, P4622, DOI 10.1016/j.vaccine.2009.05.070; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Ohishi M, 2011, NUCLEIC ACIDS RES, V39, P3404, DOI 10.1093/nar/gkq1314; Plana M, 2004, JAIDS-J ACQ IMM DEF, V36, P791, DOI 10.1097/00126334-200407010-00005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rock KL, 1996, J IMMUNOL, V156, P3721; Rodriguez-Plata MT, 2012, J IMMUNOL, V188, P6036, DOI 10.4049/jimmunol.1200267; Ross AL, 2010, LANCET INFECT DIS, V10, P305, DOI 10.1016/S1473-3099(10)70069-4; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Routy J-PA, 2011, 18 C RETR OPP INF BO; Rutebemberwa A, 2007, AIDS RES HUM RETROV, V23, P532, DOI 10.1089/aid.2006.0136; Saadatmand J, 2008, VIROLOGY, V380, P109, DOI 10.1016/j.virol.2008.07.015; Singh DK, 2005, J VIROL, V79, P3419, DOI 10.1128/JVI.79.6.3419-3428.2005; Smith SM, 1996, P NATL ACAD SCI USA, V93, P7955, DOI 10.1073/pnas.93.15.7955; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Verhoef K, 2001, J VIROL, V75, P979, DOI 10.1128/JVI.75.2.979-987.2001; Visciano ML, 2011, VACCINE, V29, P4903, DOI 10.1016/j.vaccine.2011.05.005; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; WAGNER R, 1992, ARCH VIROL, V127, P117, DOI 10.1007/BF01309579; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999	76	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48848	10.1371/journal.pone.0048848	http://dx.doi.org/10.1371/journal.pone.0048848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144996	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800153
J	Boothroyd, LG; Tovee, MJ; Pollet, TV				Boothroyd, Lynda G.; Tovee, Martin J.; Pollet, Thomas V.			Visual Diet versus Associative Learning as Mechanisms of Change in Body Size Preferences	PLOS ONE			English	Article							TO-HIP RATIO; MASS INDEX; SHAPE; ATTRACTIVENESS; OBSERVERS; PERCEPTIONS; ATTITUDES; DENSITY; WOMEN	Systematic differences between populations in their preferences for body size may arise as a result of an adaptive 'prepared learning' mechanism, whereby cues to health or status in the local population are internalized and affect body preferences. Alternatively, differences between populations may reflect their 'visual diet' as a cognitive byproduct of mere exposure. Here we test the relative importance of these two explanations for variation in body preferences. Two studies were conducted where female observers were exposed to pictures of high or low BMI women which were either aspirational (healthy, attractive models in high status clothes) or non-aspirational (eating disordered patients in grey leotards), or to combinations thereof, in order to manipulate their body-weight preferences which were tested at baseline and at post-test. Overall, results showed good support for visual diet effects (seeing a string of small or large bodies resulted in a change from pre- to post-test whether the bodies were aspirational or not) and also some support for the associative learning explanation (exposure to aspirational images of overweight women induced a towards preferring larger bodies, even when accompanied by equal exposure to lower weight bodies in the non-aspirational category). Thus, both influences may act in parallel.	[Tovee, Martin J.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Boothroyd, Lynda G.] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Pollet, Thomas V.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands	Newcastle University - UK; Durham University; Vrije Universiteit Amsterdam	Tovee, MJ (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.j.tovee@ncl.ac.uk	Pollet, Thomas/M-6346-2019; Boothroyd, Lynda/B-9168-2009; Pollet, Thomas V/H-3397-2012	Pollet, Thomas/0000-0002-4210-935X; Boothroyd, Lynda/0000-0001-6660-5828; Pollet, Thomas V/0000-0002-4210-935X; Tovee, Martin/0000-0001-9642-4462	money and resources from the Durham Psychology Department	money and resources from the Durham Psychology Department	The work was supported by money and resources from the Durham Psychology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JL, 1992, ETHOL SOCIOBIOL, V13, P197, DOI 10.1016/0162-3095(92)90033-Z; Becker AE, 2002, BRIT J PSYCHIAT, V180, P509, DOI 10.1192/bjp.180.6.509; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Clark RA, 1999, J AM DIET ASSOC, V99, P735, DOI 10.1016/S0002-8223(99)00398-3; Cohan G., 1994, PERSPECTIVES APPL NU, V2, P10; Cornelissen PL, 2012, BODY IMAGE IN PRESS; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; DURNIN JVGA, 1960, J APPL PHYSIOL, V15, P142, DOI 10.1152/jappl.1960.15.1.142; Ember CR, 2005, EVOL HUM BEHAV, V26, P257, DOI 10.1016/j.evolhumbehav.2005.02.001; EVANS C, 1993, INT J EAT DISORDER, V13, P315, DOI 10.1002/1098-108X(199304)13:3&lt;315::AID-EAT2260130310&gt;3.0.CO;2-3; George HR, 2011, BRIT J PSYCHOL, V102, P340, DOI [10.1348/000712610X52429, 10.1348/000712610X524291]; Ghannam F, 1997, MONOGRAPHS REPROD HL, V3; James WPT, 1997, BRIT MED J, V314, P154; Kotler D P, 1995, AIDS Clin Rev, P229; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; MCGARVEY ST, 1991, AM J CLIN NUTR, V53, pS1586, DOI 10.1093/ajcn/53.6.1586S; Mvo Z, 1999, Curationis, V22, P27; NASSER M, 1988, SOC PSYCH PSYCH EPID, V23, P184, DOI 10.1007/BF01794786; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Rhodes G, 2006, VISION RES, V46, P2977, DOI 10.1016/j.visres.2006.03.002; Ricciardelli LA, 2001, CLIN PSYCHOL REV, V21, P325, DOI 10.1016/S0272-7358(99)00051-3; SINGH D, 1995, HUM NATURE-INT BIOS, V6, P51, DOI 10.1007/BF02734135; Swami V., 2007, IMAGINATION COGNITIO, V26, P139; Swami V., 2007, MISSING ARMS VENUS D; Swami V., 2007, J EVOLUTIONARY PSYCH, V5, P149, DOI [10.1556/JEP.2007.1005, DOI 10.1556/JEP.2007.1005]; Swami V, 2006, JASNH, V4, P1539; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Swami V, 2010, BODY IMAGE, V7, P194, DOI 10.1016/j.bodyim.2010.03.003; Swami V, 2009, BRIT J PSYCHOL, V100, P313, DOI 10.1348/000712608X329525; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6; Tovee MJ, 2000, P ROY SOC B-BIOL SCI, V267, P1987, DOI 10.1098/rspb.2000.1240; Tovee MJ, 2003, BRIT J PSYCHOL, V94, P501, DOI 10.1348/000712603322503060; Tovee MJ, 2007, BODY BEAUTIFUL EVOLU, P108, DOI DOI 10.1057/9780230596887_7; Tsao DY, 2006, TRENDS COGN SCI, V10, P391, DOI 10.1016/j.tics.2006.07.009; Voracek M, 2002, BRIT MED J, V325, P1447, DOI 10.1136/bmj.325.7378.1447; Wells JCK, 2008, INT J OBESITY, V32, P152, DOI 10.1038/sj.ijo.0803685; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; Wetsman A, 1999, EVOL HUM BEHAV, V20, P219, DOI 10.1016/S1090-5138(99)00007-0; Winkler C, 2005, BRIT J PSYCHOL, V96, P141, DOI 10.1348/000712605X36343	42	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48691	10.1371/journal.pone.0048691	http://dx.doi.org/10.1371/journal.pone.0048691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23144929	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800099
J	Chen, PL; Lee, WJ; Sun, WZ; Oyang, YJ; Fuh, JL				Chen, Pin-Liang; Lee, Wei-Ju; Sun, Wei-Zen; Oyang, Yen-Jen; Fuh, Jong-Ling			Risk of Dementia in Patients with Insomnia and Long-term Use of Hypnotics: A Population-based Retrospective Cohort Study	PLOS ONE			English	Article							COGNITIVE DECLINE; BENZODIAZEPINE USE; ALZHEIMERS-DISEASE; DEPRESSIVE SYMPTOMS; DAYTIME SLEEPINESS; IMPAIRMENT; OLDER; PERFORMANCE; RECEPTORS; ASSOCIATION	Background: Hypnotics have been reported to be associated with dementia. However, the relationship between insomnia, hypnotics and dementia is still controversial. We sought to examine the risk of dementia in patients with long-term insomnia and the contribution of hypnotics. Methods: Data was collected from Taiwan's Longitudinal Health Insurance Database. The study cohort comprised all patients aged 50 years or older with a first diagnosis of insomnia from 2002 to 2007. The comparison cohort consisted of randomly selected patients matched by age and gender. Each patient was individually tracked for 3 years from their insomnia index date to identify whether the patient had a first diagnosis of dementia. Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results: We identified 5693 subjects with long-term insomnia and 28,465 individuals without. After adjusting for hypertension, diabetes mellitus, hyperlipidemia, and stroke, those with long-term insomnia had significantly higher risks of dementia (HR, 2.34; 95% CI, 1.92-2.85). Patients with long-term insomnia and aged 50 to 65 years had a higher increased risk of dementia (HR, 5.22; 95% CI, 2.62-10.41) than those older than 65 years (HR, 2.33; 95% CI, 1.90-2.88). The use of hypnotics with a longer half-life and at a higher prescribed dose predicted a greater increased risk of dementia. Conclusions: Patients with long-term use of hypnotics have more than a 2-fold increased risk of dementia, especially those aged 50 to 65 years. In addition, the dosage and half-lives of the hypnotics used should be considered, because greater exposure to these medications leads to a higher risk of developing dementia.	[Fuh, Jong-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Chen, Pin-Liang; Lee, Wei-Ju; Oyang, Yen-Jen] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Lee, Wei-Ju] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Lee, Wei-Ju] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Sun, Wei-Zen] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Fuh, Jong-Ling] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Oyang, Yen-Jen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; National Taiwan University	Fuh, JL (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.	jlfuh@vghtpe.gov.tw		SUN, WEI-ZEN/0000-0001-8543-2600; Lee, Wei-Ju/0000-0002-3720-4539; Fuh, Jong-Ling/0000-0001-9135-3351	Taiwan National Science Council [100-2314-B-075-002-]; Taipei Veterans General Hospital [VGHUST101-G7-1-2, V101C-105]; NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC100-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education "Aim for the Top'' University Plan	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education "Aim for the Top'' University Plan(Ministry of Education, Taiwan)	This study was supported in part by grants from the following organizations: Taiwan National Science Council (100-2314-B-075-002-); Taipei Veterans General Hospital (VGHUST101-G7-1-2, V101C-105); NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC100-2911-I-008-001); the Brain Research Center, National Yang-Ming University; and the Ministry of Education "Aim for the Top'' University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton CH, 2002, BENZODIAZEPINES THEY; Ballard C, 1996, INT J GERIATR PSYCH, V11, P987, DOI 10.1002/(SICI)1099-1166(199611)11:11<987::AID-GPS422>3.0.CO;2-V; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; BLOCK RI, 1985, EXP AGING RES, V11, P151, DOI 10.1080/03610738508259179; BORNSTEIN RA, 1985, CLIN NEUROPHARMACOL, V8, P357, DOI 10.1097/00002826-198512000-00006; BOWEN JD, 1993, DRUG AGING, V3, P349, DOI 10.2165/00002512-199303040-00005; BUSTO U, 1986, NEW ENGL J MED, V315, P854, DOI 10.1056/NEJM198610023151403; Chang CH, 2011, GUT, V60, P1372, DOI 10.1136/gut.2010.229906; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cherin P, 1997, J CLIN EPIDEMIOL, V50, P313, DOI 10.1016/S0895-4356(96)00385-X; Dealberto MJ, 1997, INT J GERIATR PSYCH, V12, P567, DOI 10.1002/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V; Dotson VM, 2008, AM J GERIAT PSYCHIAT, V16, P318, DOI 10.1097/JGP.0b013e3181662a9c; Ellul J, 2007, J NEUROL NEUROSUR PS, V78, P233, DOI 10.1136/jnnp.2006.104034; Elwood PC, 2011, J EPIDEMIOL COMMUN H, V65, P820, DOI 10.1136/jech.2009.100503; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Foley D, 2001, J AM GERIATR SOC, V49, P1628, DOI 10.1111/j.1532-5415.2001.49271.x; Geerlings MI, 2000, BRIT J PSYCHIAT, V176, P568, DOI 10.1192/bjp.176.6.568; Gorenstein C, 1995, J PSYCHOPHARMACOL, V9, P313, DOI 10.1177/026988119500900404; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; GREENBLATT DJ, 1991, NEW ENGL J MED, V324, P1691, DOI 10.1056/NEJM199106133242403; GREENBLATT DJ, 1989, J CLIN PHARMACOL, V29, P866, DOI 10.1002/j.1552-4604.1989.tb03246.x; Hanlon JT, 1998, CLIN PHARMACOL THER, V64, P684, DOI 10.1016/S0009-9236(98)90059-5; HENDLER N, 1980, AM J PSYCHIAT, V137, P828; Hutchinson MA, 1996, PROG NEUROBIOL, V49, P73, DOI 10.1016/S0301-0082(96)00011-1; Ihara M, 2004, STROKE, V35, P942, DOI 10.1161/01.STR.0000122624.32167.e0; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Jorm AF, 2000, GERONTOLOGY, V46, P219, DOI 10.1159/000022163; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; KOELEGA HS, 1989, PSYCHOPHARMACOLOGY, V98, P145, DOI 10.1007/BF00444684; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Lanctot KL, 2004, CAN J PSYCHIAT, V49, P439, DOI 10.1177/070674370404900705; MAYEROAKES SA, 1993, ANN PHARMACOTHER, V27, P416, DOI 10.1177/106002809302700403; Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290; National Health Research Institutes, NAT HLTH INS RES DAT; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; SHADER RI, 1993, NEW ENGL J MED, V328, P1398; SHIMOHAMA S, 1988, ANN NEUROL, V23, P404, DOI 10.1002/ana.410230419; SKOOG I, 1993, INT J GERIATR PSYCH, V8, P247, DOI 10.1002/gps.930080308; SPECK CE, 1995, EPIDEMIOLOGY, V6, P366, DOI 10.1097/00001648-199507000-00006; STARR JM, 1994, DRUG SAFETY, V11, P310, DOI 10.2165/00002018-199411050-00003; Steffens DC, 1997, BIOL PSYCHIAT, V41, P851, DOI 10.1016/S0006-3223(96)00247-8; SWIFT CG, 1984, AGE AGEING, V13, P335, DOI 10.1093/ageing/13.6.335; Wan H, 2004, EUR J NEUROSCI, V20, P2214, DOI 10.1111/j.1460-9568.2004.03688.x; World Health Organization, 1996, PROGR SUBST AB RAT U; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu YH, 2007, SLEEP MED, V8, P623, DOI 10.1016/j.sleep.2006.11.010	50	93	99	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49113	10.1371/journal.pone.0049113	http://dx.doi.org/10.1371/journal.pone.0049113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23145088	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800208
J	Kiatpongsan, S; Campos, NG; Kim, JJ				Kiatpongsan, Sorapop; Campos, Nicole Gastineau; Kim, Jane J.			Potential Benefits of Second-Generation Human Papillomavirus Vaccines	PLOS ONE			English	Article							COST-EFFECTIVENESS; CERVICAL-CANCER; HPV VACCINATION; UNITED-STATES; COUNTRIES; DISEASE; IMPACT; WOMEN; METAANALYSIS; PREVALENCE	Background: Current prophylactic vaccines against human papillomavirus (HPV) target two oncogenic types (16 and 18) that contribute to 70% of cervical cancer cases worldwide. Our objective was to quantify the range of additional benefits conferred by second-generation HPV prophylactic vaccines that are expected to expand protection to five additional oncogenic types (31, 33, 45, 52 and 58). Methods: A microsimulation model of HPV and cervical cancer calibrated to epidemiological data from two countries (Kenya and Uganda) was used to estimate reductions in lifetime risk of cervical cancer from the second-generation HPV vaccines. We explored the independent and joint impact of uncertain factors (i. e., distribution of HPV types, co-infection with multiple HPV types, and unidentifiable HPV types in cancer) and vaccine properties (i. e., cross-protection against non-targeted HPV types), compared against currently-available vaccines. Results: Assuming complete uptake of the second-generation vaccine, reductions in lifetime cancer risk were 86.3% in Kenya and 91.8% in Uganda, representing an absolute increase in cervical cancer reduction of 26.1% in Kenya and 17.9% in Uganda, compared with complete uptake of current vaccines. The range of added benefits was 19.6% to 29.1% in Kenya and 14.0% to 19.5% in Uganda, depending on assumptions of cancers attributable to multiple HPV infections and unidentifiable HPV types. These effects were blunted in both countries when assuming vaccine cross-protection with both the current and second-generation vaccines. Conclusion: Second-generation HPV vaccines that protect against additional oncogenic HPV types have the potential to improve cervical cancer prevention. Co-infection with multiple HPV infections and unidentifiable HPV types can influence vaccine effectiveness, but the magnitude of effect may be moderated by vaccine cross-protective effects. These benefits must be weighed against the cost of the vaccines in future analyses.	[Kiatpongsan, Sorapop] Harvard Interfac Initiat Hlth Policy, Cambridge, MA USA; [Kiatpongsan, Sorapop] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand; [Campos, Nicole Gastineau; Kim, Jane J.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Chulalongkorn University; Harvard University; Harvard T.H. Chan School of Public Health	Kiatpongsan, S (corresponding author), Harvard Interfac Initiat Hlth Policy, Cambridge, MA USA.	kiatpong@fas.harvard.edu	Kiatpongsan, Sorapop/ABG-7845-2021		Bill and Melinda Gates Foundation [30505]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study has been supported by Bill and Melinda Gates Foundation (Grant #30505) [http://www.gatesfoundation.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EP, 2010, J MANAGE CARE PHARM, V16, P217, DOI 10.18553/jmcp.2010.16.3.217; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; ClinicalTrials. gov, BROAD SPECTR HPV HUM; De Vuyst H, 2008, INT J CANCER, V122, P244, DOI 10.1002/ijc.23045; De Vuyst H, 2007, CURR OPIN ONCOL, V19, P470, DOI 10.1097/CCO.0b013e3282c8c8fc; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Herrero R, 2009, J INFECT DIS, V199, P919, DOI 10.1086/597308; Holmes Jeremy, 2005, Eur J Health Econ, V6, P30, DOI 10.1007/s10198-004-0254-1; Jit M, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-54; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Kim SY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-174; Laz TH, 2012, VACCINE, V30, P3534, DOI 10.1016/j.vaccine.2012.03.067; Marra F, 2009, PHARMACOECONOMICS, V27, P127, DOI 10.2165/00019053-200927020-00004; Odida M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-85; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Regan DG, 2007, SEX HEALTH, V4, P147, DOI 10.1071/SH07042; Schiller JT, 2006, VACCINE, V24, P147, DOI 10.1016/j.vaccine.2006.05.123; Sroczynski Gaby, 2010, GMS Health Technol Assess, V6, pDoc05, DOI 10.3205/hta000083; Stanley M, 2010, CURR OPIN INFECT DIS, V23, P70, DOI 10.1097/QCO.0b013e328334c0e1; Techakehakij W, 2008, VACCINE, V26, P6258, DOI 10.1016/j.vaccine.2008.09.036; [WHO ICO Information Centre on Human Papilloma Virus (HPV) Cervical Cancer website], HPV TYP DISTR INV CE	26	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48426	10.1371/journal.pone.0048426	http://dx.doi.org/10.1371/journal.pone.0048426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144879	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800059
J	Kim, CK; Toft, JE; Papenfus, M; Verutes, G; Guerry, AD; Ruckelshaus, MH; Arkema, KK; Guannel, G; Wood, SA; Bernhardt, JR; Tallis, H; Plummer, ML; Halpern, BS; Pinsky, ML; Beck, MW; Chan, F; Chan, KMA; Levin, PS; Polasky, S				Kim, Choong-Ki; Toft, Jodie E.; Papenfus, Michael; Verutes, Gregory; Guerry, Anne D.; Ruckelshaus, Marry H.; Arkema, Katie K.; Guannel, Gregory; Wood, Spencer A.; Bernhardt, Joanna R.; Tallis, Heather; Plummer, Mark L.; Halpern, Benjamin S.; Pinsky, Malin L.; Beck, Michael W.; Chan, Francis; Chan, Kai M. A.; Levin, Phil S.; Polasky, Stephen			Catching the Right Wave: Evaluating Wave Energy Resources and Potential Compatibility with Existing Marine and Coastal Uses	PLOS ONE			English	Article							CONVERTERS; IMPACTS; POWER	Many hope that ocean waves will be a source for clean, safe, reliable and affordable energy, yet wave energy conversion facilities may affect marine ecosystems through a variety of mechanisms, including competition with other human uses. We developed a decision-support tool to assist siting wave energy facilities, which allows the user to balance the need for profitability of the facilities with the need to minimize conflicts with other ocean uses. Our wave energy model quantifies harvestable wave energy and evaluates the net present value (NPV) of a wave energy facility based on a capital investment analysis. The model has a flexible framework and can be easily applied to wave energy projects at local, regional, and global scales. We applied the model and compatibility analysis on the west coast of Vancouver Island, British Columbia, Canada to provide information for ongoing marine spatial planning, including potential wave energy projects. In particular, we conducted a spatial overlap analysis with a variety of existing uses and ecological characteristics, and a quantitative compatibility analysis with commercial fisheries data. We found that wave power and harvestable wave energy gradually increase offshore as wave conditions intensify. However, areas with high economic potential for wave energy facilities were closer to cable landing points because of the cost of bringing energy ashore and thus in nearshore areas that support a number of different human uses. We show that the maximum combined economic benefit from wave energy and other uses is likely to be realized if wave energy facilities are sited in areas that maximize wave energy NPV and minimize conflict with existing ocean uses. Our tools will help decision-makers explore alternative locations for wave energy facilities by mapping expected wave energy NPV and helping to identify sites that provide maximal returns yet avoid spatial competition with existing ocean uses.	[Kim, Choong-Ki; Toft, Jodie E.; Papenfus, Michael; Verutes, Gregory; Guerry, Anne D.; Ruckelshaus, Marry H.; Arkema, Katie K.; Guannel, Gregory; Wood, Spencer A.; Bernhardt, Joanna R.; Tallis, Heather] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA; [Kim, Choong-Ki] Inha Univ, Ocean Sci & Technol Inst, Inchon, South Korea; [Papenfus, Michael] US EPA, Western Ecol Div, Corvallis, OR USA; [Bernhardt, Joanna R.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Plummer, Mark L.; Levin, Phil S.] NOAA NW Fisheries Sci Ctr, Seattle, WA USA; [Halpern, Benjamin S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Pinsky, Malin L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Beck, Michael W.] Nature Conservancy, Global Marine Team, Santa Cruz, CA USA; [Chan, Francis] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Chan, Kai M. A.] Univ British Columbia, IRES, Vancouver, BC V5Z 1M9, Canada; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	Stanford University; Inha University; United States Environmental Protection Agency; University of British Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; National Center for Ecological Analysis & Synthesis; Princeton University; Nature Conservancy; Oregon State University; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Kim, CK (corresponding author), Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA.	ckim3@stanford.edu	Papenfus, Michael/GNM-9563-2022; Polasky, Stephen/AAC-5341-2019; Toft, Joachim/A-3641-2012; Pinsky, Malin L./K-2884-2015; Beck, Michael W./AAB-2844-2019; Chan, Kai M A/C-1682-2009; Wood, Spencer/A-3603-2009; Bernhardt, Joey/ABG-5168-2021	Toft, Joachim/0000-0003-1921-8168; Pinsky, Malin L./0000-0002-8523-8952; Beck, Michael W./0000-0002-5107-9973; Chan, Kai M A/0000-0002-7804-3276; Bernhardt, Joey/0000-0003-1824-2801; Verutes, Gregory/0000-0002-7667-7902	Gordon and Betty Moore Foundation [1874]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Funding was provided by the Gordon and Betty Moore Foundation (Grant 1874, http://www.moore.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030031; Barstow S, 2008, GREEN ENERGY TECHNOL, P93, DOI 10.1007/978-3-540-74895-3_4; Bedard R, 2005, 009 E2I EPRI GLOB WP; Boehlert GW, 2008, NOAA TECHNICAL MEMOR; *BRIT COL MAR CONS, 2011, MAR ATL PAC CAN PROD; British Columbia Marine Conservation Analysis, 2011, RENEWABLE OCEAN ENER; British Columbia Marine Conservation Analysis, 2011, OCEAN ENERGY WAVE EN; Cada G, 2007, FISHERIES, V32, P174, DOI 10.1577/1548-8446(2007)32[174:PIOHAW]2.0.CO;2; Cornett A, 2008, CHCTR51 CAN HYDR CTR; Cornett AM, 2008, INT OFFSHORE POLAR E, P318; Dalton G, 2010, RENEW SUST ENERG REV, V14, P2339, DOI 10.1016/j.rser.2010.04.007; Dalton GJ, 2010, RENEW ENERG, V35, P443, DOI 10.1016/j.renene.2009.07.003; Department of Fisheries and Oceans (DFO) Canada, 1993, ANN SUMM BRIT COL CO; Department of Fisheries and Oceans (DFO) Canada, 1993, BRIT COL COMM CATCH; Dively D. D., 1994, BENEFIT COST ANAL TH; Dunnett D, 2009, RENEW ENERG, V34, P179, DOI 10.1016/j.renene.2008.04.034; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Germain LAS, 2003, THESIS U VICTORIA VI; Grecian WJ, 2010, IBIS, V152, P683, DOI 10.1111/j.1474-919X.2010.01048.x; GSGislason Associates Ltd., 2007, EC CONTR OC SECT BRI; Guerry Anne D., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P107, DOI 10.1080/21513732.2011.647835; Hagerman G, 2004, EPRI007US E2I GLOB E; Iglesias G, 2010, RENEW ENERG, V35, P2490, DOI 10.1016/j.renene.2010.03.016; Integrated Science Data Management, 2010, WAV BUOY DAT; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Langhamer O, 2010, MAR ENVIRON RES, V69, P374, DOI 10.1016/j.marenvres.2010.01.002; Langhamer O, 2010, RENEW SUST ENERG REV, V14, P1329, DOI 10.1016/j.rser.2009.11.016; Langhamer O, 2009, MAR ENVIRON RES, V68, P151, DOI 10.1016/j.marenvres.2009.06.003; Langton R, 2011, MAR POLICY, V35, P623, DOI 10.1016/j.marpol.2011.02.002; Lester SE, MARINE POLI IN PRESS; National Weather Service-Environmental Modeling Center, 2010, NOAA WAVEWATCH 3 NWW; Nelson P. A., 2008, CEC5002008083 PIER E; Pelamis Wave Power Ltd, 2010, PEL WAV POW; Previsic M, 2004, 006ASF E2I EPRI EL P; Previsic M, 2004, EPRI006BSF E2I EL PO; Province of British Columbia, 2011, GEOBC GEOGR DAT DISC; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Spaulding ML, 2010, MAR TECHNOL SOC J, V44, P8, DOI 10.4031/MTSJ.44.1.8; Tallis H.T., 2011, INVEST 2 3 0 USERS G; Tallis H, 2012, MAR POLICY, V36, P303, DOI 10.1016/j.marpol.2011.03.013; Thorpe T. W., 1999, ETSUR120 UK DEP TRAD; Tolman H.L., 2009, MMAB CONTRIBUTION, V276; U.S. Environmental Protection Agency, 2010, 240R10001 EPA NAT CT; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109; Wilen J, 2006, ESTIMATES MAXIMUM PT; Wilhelmsson D., 2010, GREENING BLUE ENERGY	46	31	31	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47598	10.1371/journal.pone.0047598	http://dx.doi.org/10.1371/journal.pone.0047598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144824	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800024
J	Krzyzanowski, MK; Kozlowska, E; Kozlowski, P				Krzyzanowski, Marek K.; Kozlowska, Ewa; Kozlowski, Piotr			Identification and Functional Analysis of the erh1(+) Gene Encoding Enhancer of Rudimentary Homolog from the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							MAP KINASE; NITROGEN STARVATION; SEXUAL DEVELOPMENT; MOLECULAR PARTNER; CRYSTAL-STRUCTURE; DNA-REPLICATION; CELL INTEGRITY; PROTEIN; LOCALIZATION; PATHWAY	The ERH gene encodes a highly conserved small nuclear protein with a unique amino acid sequence and three-dimensional structure but unknown function. The gene is present in animals, plants, and protists but to date has only been found in few fungi. Here we report that ERH homologs are also present in all four species from the genus Schizosaccharomyces, S. pombe, S. octosporus, S. cryophilus, and S. japonicus, which, however, are an exception in this respect among Ascomycota and Basidiomycota. The ERH protein sequence is moderately conserved within the genus (58% identity between S. pombe and S. japonicus), but the intron-rich genes have almost identical intron-exon organizations in all four species. In S. pombe, erh1(+) is expressed at a roughly constant level during vegetative growth and adaptation to unfavorable conditions such as nutrient limitation and hyperosmotic stress caused by sorbitol. Erh1p localizes preferentially to the nucleus with the exception of the nucleolus, but is also present in the cytoplasm. Cells lacking erh1(+) have an aberrant cell morphology and a comma-like shape when cultured to the stationary phase, and exhibit a delayed recovery from this phase followed by slower growth. Loss of erh1(+) in an auxotrophic background results in enhanced arrest in the G1 phase following nutritional stress, and also leads to hypersensitivity to agents inducing hyperosmotic stress (sorbitol), inhibiting DNA replication (hydroxyurea), and destabilizing the plasma membrane (SDS); this hypersensitivity can be abolished by expression of S. pombe erh1(+) and, to a lesser extent, S. japonicus erh1(+) or human ERH. Erh1p fails to interact with the human Ciz1 and PDIP46/SKAR proteins, known molecular partners of human ERH. Our data suggest that in Schizosaccharomyces sp. erh1(+) is non-essential for normal growth and Erh1p could play a role in response to adverse environmental conditions and in cell cycle regulation.	[Krzyzanowski, Marek K.; Kozlowski, Piotr] Univ Warsaw, Dept Mol Biol, Fac Biol, Warsaw, Poland; [Kozlowska, Ewa] Univ Warsaw, Dept Immunol, Fac Biol, Warsaw, Poland	University of Warsaw; University of Warsaw	Kozlowski, P (corresponding author), Univ Warsaw, Dept Mol Biol, Fac Biol, Warsaw, Poland.	pkozlowski@biol.uw.edu.pl	Kozlowska, Ewa/ABB-8371-2020	Kozlowska, Ewa/0000-0002-8655-851X	Ministry of Science and Higher Education, Poland [N N301 158535]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by grant N N301 158535 from the Ministry of Science and Higher Education, Poland (to P. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arai R, 2005, PROTEIN SCI, V14, P1888, DOI 10.1110/ps.051484505; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bahler J, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P13; Bitton DA, 2011, GENETICS, V187, P1207, DOI 10.1534/genetics.110.123497; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Coverley D, 2005, J CELL SCI, V118, P101, DOI 10.1242/jcs.01599; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Furuya K, 2009, YEAST, V26, P221, DOI 10.1002/yea.1662; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gelsthorpe M, 1997, GENE, V186, P189, DOI 10.1016/S0378-1119(96)00701-9; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gomez E.B., 2004, METH MOL B, V241, P93; Hayashi A, 2009, GENES CELLS, V14, P217, DOI 10.1111/j.1365-2443.2008.01264.x; Helston RM, 2010, FEMS YEAST RES, V10, P779, DOI 10.1111/j.1567-1364.2010.00657.x; Isomura M, 1996, GENOMICS, V32, P125, DOI 10.1006/geno.1996.0086; Jin TC, 2007, PROTEINS, V68, P427, DOI 10.1002/prot.21343; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kawai M, 2001, CURR GENET, V39, P166; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2005, J BIOMOL NMR, V32, P329, DOI 10.1007/s10858-005-7959-z; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lukasik A, 2008, FEBS J, V275, P332, DOI 10.1111/j.1742-4658.2007.06203.x; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SAZER S, 1990, J CELL SCI, V97, P509; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Sipiczki M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P431; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; Toda T, 1996, MOL CELL BIOL, V16, P6752; Toone WM, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P57; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; von Strandmann EP, 2001, BIOL CHEM, V382, P1379; Wan C, 2005, BIOCHEMISTRY-US, V44, P5017, DOI 10.1021/bi047785w; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; WOJCIK E, 1994, GENETICS, V138, P1163; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	51	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49059	10.1371/journal.pone.0049059	http://dx.doi.org/10.1371/journal.pone.0049059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145069	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800195
J	Membrive, NA; Rodrigues, G; Gualda, KP; Bernal, MVZ; Oliveira, DM; Lonardoni, MVC; Teodoro, U; Teixeira, JJV; Silveira, TGV				Membrive, Norberto Assis; Rodrigues, Gesse; Gualda, Kezia Peres; Zandonadi Bernal, Marcos Vinicius; Oliveira, Diego Molina; Campana Lonardoni, Maria Valdrinez; Teodoro, Ueslei; Vieira Teixeira, Jorge Juarez; Verzignassi Silveira, Thais Gomes			Environmental and Animal Characteristics as Factors Associated with American Cutaneous Leishmaniasis in Rural Locations with Presence of Dogs, Brazil	PLOS ONE			English	Article							PARANA STATE; TEGUMENTARY LEISHMANIASIS; WHITMANI; MANAUS; AREA	The aim of the study was to investigate the importance of dogs, other domesticated animals and environmental characteristics as risk factors in the epidemiology of American cutaneous leishmaniasis (ACL). A retrospective survey of cases of human ACL in the last ten years and visits to homes in rural locations were carried out in the municipality of Arapongas (southern Brazil) from 2008 to 2010. ACL in humans was significantly associated with a distance of up to 25 meters from the residence to a forest area (OR 5.08; 95% CI: 1.35-21.04), undergrowth area (OR 6.80; 95% CI: 1.69-45.33) and stream (OR 5.87; 95% CI: 1.15-24.59); banana plants near the residence (OR 5.98; 95% CI: 1.49-39.84), absence of ceiling below the roof in the residence (OR 7.30; 95% CI: 1.26-158.1), the dumping of trash in the forest area (OR 26.33; 95% CI: 7.32-93.46) and presence of ACL in dogs in the surrounding area (OR 4.39; 95% CI: 1.37-13.45). In dogs, ACL was associated with a distance of 25 to 50 meters and 51 to 100 meters, respectively, from the residence to a forest area (OR 2.59; 95% CI: 1.08-5.98; OR 3.29; 95% CI: 1.64-6.62), the presence of a stream up to 25 m from the residence (OR 6.23; 95% CI: 2.34-16.54) and banana plants near the residence (OR 0.45; 95% CI: 0.25-0.80). In the locations studied in the municipality of Arapongas (Brazil), the results reveal that canine infection increases the risk of human infection by ACL and the characteristics surrounding the residence increase the risk of infection in both humans and dogs. Thus, integrated environmental management could be a useful measure to avoid contact between humans and phlebotomines.	[Campana Lonardoni, Maria Valdrinez; Teodoro, Ueslei; Vieira Teixeira, Jorge Juarez; Verzignassi Silveira, Thais Gomes] Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil; [Zandonadi Bernal, Marcos Vinicius] Univ Estadual Maringa, Curso Grad Farm, Maringa, Parana, Brazil; [Membrive, Norberto Assis; Rodrigues, Gesse] Secretaria Municipal Saude, Lab Entomol Med Arapongas, Arapongas, Parana, Brazil; [Membrive, Norberto Assis; Gualda, Kezia Peres; Oliveira, Diego Molina] Univ Estadual Maringa, Programa Posgrad Ciencias Saude, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Silveira, TGV (corresponding author), Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil.	tgvsilveira@uem.br		Lonardoni, Maria Valdrinez C./0000-0003-2185-4163	Fundacao Araucaria and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [410550/2006-0]	Fundacao Araucaria and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	The authors thank the Fundacao Araucaria and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - award number 410550/2006-0) for financial support. www.fundacaoaraucaria.org.br; www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar GM, 2003, FLEBOTOMINEOS BRASIL; Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; Aparicio C, 2004, REV SAUDE PUBL, V38, P511, DOI 10.1590/S0034-89102004000400005; Barros V L, 2000, Cad Saude Publica, V16, P265, DOI 10.1590/S0102-311X2000000100030; Castro EA, 2007, EXP PARASITOL, V117, P13, DOI 10.1016/j.exppara.2007.03.003; Constancio CN, 2008, MANEJO PRAGAS ESTABE; Coutinho S G, 1985, Mem Inst Oswaldo Cruz, V80, P17, DOI 10.1590/S0074-02761985000100003; Cunha Jane Cris de Lima, 2006, Rev. bras. epidemiol., V9, P425, DOI 10.1590/S1415-790X2006000400003; Dantas-Torres F, 2011, EMERG INFECT DIS, V17, P326, DOI 10.3201/eid1702.091823; Dantas-Torres F, 2010, VET PARASITOL, V170, P313, DOI 10.1016/j.vetpar.2010.02.019; Guerra JAD, 2007, CAD SAUDE PUBLICA, V23, P2215, DOI 10.1590/S0102-311X2007000900029; de Oliveira Guerra Jorge Augusto, 2007, Acta Amazonica, V37, P133, DOI 10.1590/S0044-59672007000100017; FALQUETO A, 1986, Memorias do Instituto Oswaldo Cruz, V81, P155, DOI 10.1590/S0074-02761986000200004; Falqueto A., 1995, THESIS, P84; Follador I, 1999, Rev Soc Bras Med Trop, V32, P497, DOI 10.1590/S0037-86821999000500005; Forattini O.P., 1973, Revista Saude publ, V7, P181, DOI 10.1590/S0034-89101973000200010; FORATTINI OP, 1973, ENTOMOLOGIA MED; FORATTINI OSWALDO P., 1960, REV INST MED TROP SAO PAULO, V2, P195; de Bustamante MCFS, 2009, REV BRAS PARASITOL V, V18, P34, DOI 10.4322/rbpv.01803006; Instituto Brasileiro de Geografia e Estatistica, 2007, CONT POP 2007; Lima Airton Pereira, 2002, An. Bras. Dermatol., V77, P681, DOI 10.1590/S0365-05962002000600005; Lonardoni Maria Valdrinez Campana, 2006, Cad. Saúde Pública, V22, P2713, DOI 10.1590/S0102-311X2006001200020; LONARDONI MVC, 1993, REV SAUDE PUBL, V27, P378, DOI 10.1590/S0034-89101993000500009; LOPEZ M, 1993, AM J TROP MED HYG, V49, P348, DOI 10.4269/ajtmh.1993.49.348; Luz E, 2000, ANN TROP MED PARASIT, V94, P623, DOI 10.1080/00034983.2000.11813585; Massunari GK, 2009, CAD SAUDE PUBLICA, V25, P97, DOI 10.1590/S0102-311X2009000100010; Membrive Norberto Assis, 2004, Entomologia y Vectores, V11, P673, DOI 10.1590/S0328-03812004000400009; Ministerio da Saude, 2007, MAN VIG LEISHM TEG A; Monteiro WM, 2008, CAD SAUDE PUBLICA, V24, P1291, DOI 10.1590/S0102-311X2008000600010; Pedrosa FDA, 2009, AM J TROP MED HYG, V81, P195; Reinhold-Castro KR, 2008, REV SOC BRAS MED TRO, V41, P269, DOI 10.1590/S0037-86822008000300009; Reithinger R, 1999, AM J TROP MED HYG, V61, P530, DOI 10.4269/ajtmh.1999.61.530; Roberto A. C. B. S., 1997, Anais Brasileiros de Dermatologia, V72, P129; Santos Ginelza Peres Lima dos, 2005, Rev. Soc. Bras. Med. Trop., V38, P161; Silveira, 1996, Cad Saude Publica, V12, P89, DOI 10.1590/S0102-311X1996000100020; Silveira T G, 1999, Rev Soc Bras Med Trop, V32, P413, DOI 10.1590/S0037-86821999000400013; Sosa-Estani S, 2001, Rev Soc Bras Med Trop, V34, P511, DOI 10.1590/S0037-86822001000600003; Teodoro U., 2001, Revista de Patologia Tropical, V30, P209; Teodoro U, 2006, CAD SAUDE PUBLICA, V40, P1; Teodoro U, 2007, REV SAUDE PUBL, V41, P383, DOI 10.1590/S0034-89102007000300009; Teodoro Ueslei, 2003, Cad. Saúde Pública, V19, P1801, DOI 10.1590/S0102-311X2003000600024; Thomaz-Soccol V., 2003, NEW HORIZONS BIOTECH, P429; VANZELI A. C., 2007, REV PANAM INFECT, V9, P20; Vedovello D, 2008, ZOONOSES PUBLIC HLTH, V55, P149, DOI 10.1111/j.1863-2378.2008.01106.x; Velasquez Leonardo Garcia, 2006, Cad. Saúde Pública, V22, P571, DOI 10.1590/S0102-311X2006000300012; Voltarelli EM, 2009, J VENOM ANIM TOXINS, V15, P732, DOI 10.1590/S1678-91992009000400011; WHO, 2011, LEISHM; Zanzarini Paulo Donizeti, 2005, Cad. Saúde Pública, V21, P1957, DOI 10.1590/S0102-311X2005000600047	48	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47050	10.1371/journal.pone.0047050	http://dx.doi.org/10.1371/journal.pone.0047050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144799	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400015
J	Hashimoto, S; Imaoka, S				Hashimoto, Shoko; Imaoka, Susumu			Protein-disulfide Isomerase Regulates the Thyroid Hormone Receptor-mediated Gene Expression via Redox Factor-1 through Thiol Reduction-Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; TISSUE FACTOR; BISPHENOL-A; ENDOPLASMIC-RETICULUM; CHOLERA-TOXIN; THIOREDOXIN; ACTIVATION; HYPOXIA; DOMAIN; CELLS	Protein-disulfide isomerase (PDI) is a dithiol/disulfide oxidoreductase that regulates the redox state of proteins. We previously found that overexpression of PDI in rat pituitary tumor (GH3) cells suppresses 3,3',5-triiodothyronine (T-3)-stimulated growth hormone (GH) expression, suggesting the contribution of PDI to the T-3-mediated gene expression via thyroid hormone receptor (TR). In the present study, we have clarified the mechanism of regulation by which TR function is regulated by PDI. Overexpression of wild-type but not redox-inactive mutant PDI suppressed the T-3-induced GH expression, suggesting that the redox activity of PDI contributes to the suppression of GH. We considered that PDI regulates the redox state of the TR and focused on redox factor-1 (Ref-1) as a mediator of the redox regulation of TR by PDI. Interaction between Ref-1 and TR beta 1 was detected. Overexpression of wild-type but not C64S Ref-1 facilitated the GH expression, suggesting that redox activity of Cys-64 in Ref-1 is involved in the TR-mediated gene expression. Moreover, PDI interacted with Ref-1 and changed the redox state of Ref-1, suggesting that PDI controls the redox state of Ref-1. Our studies suggested that Ref-1 contributes to TR-mediated gene expression and that the redox state of Ref-1 is regulated by PDI. Redox regulation of PDI via Ref-1 is a new aspect of PDI function.	[Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, Sanda, Hyogo 6691337, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan	Kwansei Gakuin University; Kwansei Gakuin University	Imaoka, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	imaoka@kwansei.ac.jp			Japan Society for the Promotion of Science; Hyogo Science and Technology Association; Kwansei Gakuin University; Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hyogo Science and Technology Association; Kwansei Gakuin University(Kwansei Gakuin University); Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by a grant-in-aid for scientific research (B) from the Japan Society for the Promotion of Science, a grant-in-aid from the Hyogo Science and Technology Association, and a grant-in-aid from Kwansei Gakuin University and by the Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science and Technology.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Burrows HL, 1998, J CLIN INVEST, V101, P1439, DOI 10.1172/JCI1963; Curbo S, 2009, BIOCHEM BIOPH RES CO, V390, P1272, DOI 10.1016/j.bbrc.2009.10.134; Curtis CD, 2009, MOL ENDOCRINOL, V23, P1346, DOI 10.1210/me.2009-0093; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Fu XM, 2009, J STEROID BIOCHEM, V115, P20, DOI 10.1016/j.jsbmb.2009.02.008; Grillo C, 2006, FREE RADICAL BIO MED, V41, P1113, DOI 10.1016/j.freeradbiomed.2006.06.016; Hashimoto S, 2008, J BIOCHEM, V144, P335, DOI 10.1093/jb/mvn075; Hashimoto S, 2012, CHEM RES TOXICOL, V25, P656, DOI 10.1021/tx200374s; Hashimoto S, 2012, J BIOCHEM, V151, P35, DOI 10.1093/jb/mvr122; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Hohenwarter O, 1996, ANAL BIOCHEM, V234, P56, DOI 10.1006/abio.1996.0049; HOLMGREN A, 1978, BIOCHEMISTRY-US, V17, P4071, DOI 10.1021/bi00612a031; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Kang K, 2009, ANTIOXID REDOX SIGN, V11, P2553, DOI [10.1089/ars.2009.2465, 10.1089/ARS.2009.2465]; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Klappa P, 2001, BIOCHEM J, V354, P553, DOI 10.1042/0264-6021:3540553; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Manukyan D, 2008, THROMB RES, V122, pS19, DOI 10.1016/S0049-3848(08)70013-6; OBATA T, 1988, J BIOL CHEM, V263, P782; Okada K, 2007, MOL CELL ENDOCRINOL, V278, P44, DOI 10.1016/j.mce.2007.08.005; Okada Kazushi, 2005, Osaka City Medical Journal, V51, P51; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Tell G, 2002, J BIOL CHEM, V277, P14564, DOI 10.1074/jbc.M200582200; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Vascotto C, 2011, MOL BIOL CELL, V22, P3887, DOI 10.1091/mbc.E11-05-0391; Versteeg HH, 2007, J BIOL CHEM, V282, P25416, DOI 10.1074/jbc.M702410200; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Ziel KA, 2004, FASEB J, V18, P986, DOI 10.1096/fj.03-1160fje	42	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1706	1716		10.1074/jbc.M112.365239	http://dx.doi.org/10.1074/jbc.M112.365239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23148211	Green Published, hybrid			2022-12-25	WOS:000313751400027
J	Ziarek, JJ; Veldkamp, CT; Zhang, FM; Murray, NJ; Kartz, GA; Liang, XL; Su, JD; Baker, JE; Linhardt, RJ; Volkman, BF				Ziarek, Joshua J.; Veldkamp, Christopher T.; Zhang, Fuming; Murray, Nathan J.; Kartz, Gabriella A.; Liang, Xinle; Su, Jidong; Baker, John E.; Linhardt, Robert J.; Volkman, Brian F.			Heparin Oligosaccharides Inhibit Chemokine (CXC Motif) Ligand 12 (CXCL12) Cardioprotection by Binding Orthogonal to the Dimerization Interface, Promoting Oligomerization, and Competing with the Chemokine (CXC Motif) Receptor 4 (CXCR4) N Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED FACTOR-1-ALPHA; FACTOR-I; VENTRICULAR-FUNCTION; STRUCTURAL BASIS; STEM; RECRUITMENT; PROGENITOR; HEART; GLYCOSAMINOGLYCANS; SULFOTYROSINE	The ability to interact with cell surface glycosaminoglycans (GAGs) is essential to the cell migration properties of chemokines, but association with soluble GAGs induces the oligomerization of most chemokines including CXCL12. Monomeric CXCL12, but not dimeric CXCL12, is cardioprotective in a number of experimental models of cardiac ischemia. We found that co-administration of heparin, a common treatment for myocardial infarction, abrogated the protective effect of CXCL12 in an ex vivo rat heart model for myocardial infarction. The interaction between CXCL12 and heparin oligosaccharides has previously been analyzed through mutagenesis, in vitro binding assays, and molecular modeling. However, complications from heparin-induced CXCL12 oligomerization and studies using very short oligosaccharides have led to inconsistent conclusions as to the residues involved, the orientation of the binding site, and whether it overlaps with the CXCR4 N-terminal site. We used a constitutively dimeric variant to simplify the NMR analysis of CXCL12-binding heparin oligosaccharides of varying length. Biophysical and mutagenic analyses reveal a CXCL12/heparin interaction surface that lies perpendicular to the dimer interface, does not involve the chemokine N terminus, and partially overlaps with the CXCR4-binding site. We further demonstrate that heparin-mediated enzymatic protection results from the promotion of dimerization rather than direct heparin binding to the CXCL12 N terminus. These results clarify the structural basis for GAG recognition by CXCL12 and lend insight into the development of CXCL12-based therapeutics.	[Ziarek, Joshua J.; Murray, Nathan J.; Su, Jidong; Baker, John E.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Kartz, Gabriella A.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Veldkamp, Christopher T.] Univ Wisconsin, Dept Chem, Whitewater, WI 53190 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Wisconsin System; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Volkman, BF (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	bvolkman@mcw.edu	Volkman, Brian F./ABE-7312-2020; Baker, John/V-8897-2019; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Baker, John/0000-0001-7899-3266; Volkman, Brian F./0000-0002-6681-5179; Ziarek, Joshua/0000-0002-3740-9999	National Institutes of Health [AI058072, GM097381, AI063325, 1-R15CA159202-01, GM38060, HL62244, HL54075, AI080363]; Medical College of Wisconsin Cancer Center; American Heart Association; NATIONAL CANCER INSTITUTE [R15CA159202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054075, R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080363, R56AI063325, R01AI063325, R01AI058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097381, R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Wisconsin Cancer Center; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058072, GM097381, and AI063325 (to B. F. V.); 1-R15CA159202-01 (to C. T. V.); GM38060 and HL62244 (to F. Z. and R. J. L.); and HL54075 and AI080363 (to J. E. B.). This work was also supported by a postdoctoral fellowship from the Medical College of Wisconsin Cancer Center (to J. J. Z.) and a predoctoral fellowship from the American Heart Association (to G. A. K.).	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Baker JE, 1997, CIRCULATION, V95, P1278; Baker JE, 2000, AM J PHYSIOL-HEART C, V278, pH1395, DOI 10.1152/ajpheart.2000.278.4.H1395; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chien CH, 2004, J BIOL CHEM, V279, P52338, DOI 10.1074/jbc.M406185200; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; Fermas S, 2008, GLYCOBIOLOGY, V18, P1054, DOI 10.1093/glycob/cwn088; Fuster V., 2004, HURSTS HEART; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Keller R., 2004, COMPUTER AIDED RESON, V1; Koch KC, 2006, BASIC RES CARDIOL, V101, P69, DOI 10.1007/s00395-005-0570-3; Laguri C, 2011, J AM CHEM SOC, V133, P9642, DOI 10.1021/ja201753e; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Penn MS, 2004, INT J CARDIOL, V95, pS23, DOI 10.1016/S0167-5273(04)90007-1; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proulx C, 2007, PFLUG ARCH EUR J PHY, V455, P241, DOI 10.1007/s00424-007-0284-5; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sasaki T, 2007, PEDIATR INT, V49, P966, DOI 10.1111/j.1442-200X.2007.02491.x; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Seibert C, 2008, BIOCHEMISTRY-US, V47, P11251, DOI 10.1021/bi800965m; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Takekoshi T, 2012, MOL CANCER THER, V11, P2516, DOI 10.1158/1535-7163.MCT-12-0494; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	46	67	69	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					737	746		10.1074/jbc.M112.394064	http://dx.doi.org/10.1074/jbc.M112.394064			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148226	Green Published, hybrid			2022-12-25	WOS:000313197200073
J	Gorjestani, S; Darnay, BG; Lin, X				Gorjestani, Sara; Darnay, Bryant G.; Lin, Xin			Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and TGF beta-activated Kinase 1 (TAK1) Play Essential Roles in the C-type Lectin Receptor Signaling in Response to Candida albicans Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PHOSPHOLIPASE C-GAMMA-2 PLC-GAMMA-2; PATTERN-RECOGNITION RECEPTOR; INNATE IMMUNE; ADAPTER PROTEIN; TAB2; CARD9; UBIQUITIN; DECTIN-2; INTERLEUKIN-1	Tumor necrosis factor receptor-associated factor 6 (TRAF6) and TGF beta-activated kinase 1 (TAK1) are considered as key intermediates in Toll-like receptor (TLR) signaling. However, the role of TRAF6 and TAK1 in C-type lectin receptors (CLRs) in response to fungal infection has not been studied. In this study, we have utilized macrophages derived from TRAF6 knock-out mice and myeloid-specific TAK1-deficient mice and determined the role of TRAF6 and TAK1 in CLR-induced signal transduction events. We demonstrate that TRAF6 and TAK1 are required for NF-kappa B and JNK activation, and expression of proinflammatory cytokines in response to Candida albicans infection. Our results highlight TRAF6 and TAK1 as key components in the signaling cascade downstream of C-type lectin receptors and as critical mediators of the anti-fungal immune response. Therefore, our studies provide a mechanistic understanding of the host immune response to C. albicans, which has a significant impact for the development of anti-fungal therapeutics and in understanding risk-factors and determining susceptibility to C. albicans infection.	[Gorjestani, Sara; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gorjestani, Sara; Lin, Xin] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA.	xllin@mdanderson.org			National Institutes of Health [RO1AI050848, RO1GM065899]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1AI050848 and RO1GM065899 (to X.L.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Eftychi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031550; Gorjestani S, 2011, J BIOL CHEM, V286, P43651, DOI 10.1074/jbc.M111.307389; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	45	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44143	44150		10.1074/jbc.M112.414276	http://dx.doi.org/10.1074/jbc.M112.414276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148225	hybrid, Green Published			2022-12-25	WOS:000312938600013
J	Kang, K; Zhang, XY; Liu, HT; Wang, ZW; Zhong, JS; Huang, ZT; Peng, X; Zeng, Y; Wang, YN; Yang, Y; Luo, J; Gou, DM				Kang, Kang; Zhang, Xiaoying; Liu, Hongtao; Wang, Zhiwei; Zhong, Jiasheng; Huang, Zhenting; Peng, Xiao; Zeng, Yan; Wang, Yuna; Yang, Yi; Luo, Jun; Gou, Deming			A Novel Real-Time PCR Assay of microRNAs Using S-Poly(T), a Specific Oligo(dT) Reverse Transcription Primer with Excellent Sensitivity and Specificity	PLOS ONE			English	Article							CIRCULATING MICRORNAS; MIRNA EXPRESSION; RT-PCR; CELL-PROLIFERATION; BIOMARKERS; HYPOXIA; CANCER; QUANTIFICATION; HYPERTENSION	Background: MicroRNAs (miRNAs) are small, non-coding RNAs capable of postranscriptionally regulating gene expression. Accurate expression profiling is crucial for understanding the biological roles of miRNAs, and exploring them as biomarkers of diseases. Methodology/Principal Findings: A novel, highly sensitive, and reliable miRNA quantification approach, termed S-Poly(T) miRNA assay, is designed. In this assay, miRNAs are subjected to polyadenylation and reverse transcription with a S-Poly(T) primer that contains a universal reverse primer, a universal Taqman probe, an oligo(dT)(11) sequence and six miRNA-specific bases. Individual miRNAs are then amplified by a specific forward primer and a universal reverse primer, and the PCR products are detected by a universal Taqman probe. The S-Poly(T) assay showed a minimum of 4-fold increase in sensitivity as compared with the stem-loop or poly(A)-based methods. A remarkable specificity in discriminating among miRNAs with high sequence similarity was also obtained with this approach. Using this method, we profiled miRNAs in human pulmonary arterial smooth muscle cells (HPASMC) and identified 9 differentially expressed miRNAs associated with hypoxia treatment. Due to its outstanding sensitivity, the number of circulating miRNAs from normal human serum was significantly expanded from 368 to 518. Conclusions/Significance: With excellent sensitivity, specificity, and high-throughput, the S-Poly(T) method provides a powerful tool for miRNAs quantification and identification of tissue-or disease-specific miRNA biomarkers.	[Kang, Kang; Zhang, Xiaoying; Liu, Hongtao; Zhong, Jiasheng; Huang, Zhenting; Peng, Xiao; Zeng, Yan; Wang, Yuna; Gou, Deming] Shenzhen Univ, Coll Life Sci, Shenzhen, Guangdong, Peoples R China; [Kang, Kang; Luo, Jun] NW A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Wang, Zhiwei] Shenzhen Sun Yat Sen Cardiovasc Hosp, Dept Cardiovasc Surg, Shenzhen, Guangdong, Peoples R China; [Yang, Yi] Shenzhen Univ, Sch Med, Shenzhen, Guangdong, Peoples R China	Shenzhen University; Northwest A&F University - China; Shenzhen University	Gou, DM (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen, Guangdong, Peoples R China.	dmgou@szu.edu.cn		zhong, jiasheng/0000-0001-6864-2294	National Natural Science Foundation of China [81170047]; National Basic Research Program of China (973 Program) [2012CB124701]; Shenzhen overseas high-level talents innovation program [YFZZ20111009]; Shenzhen Municipal Basic Research Program [JC201006010725A]; Shenzhen Pengcheng Distinguished Professor Funding [000233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenzhen overseas high-level talents innovation program; Shenzhen Municipal Basic Research Program; Shenzhen Pengcheng Distinguished Professor Funding	This study was supported by National Natural Science Foundation of China number 81170047 (to D.G.); National Basic Research Program of China (973 Program, 2012CB124701); Shenzhen overseas high-level talents innovation program No. YFZZ20111009 (to D.G.); Shenzhen Municipal Basic Research Program number JC201006010725A (to D.G.); Shenzhen Pengcheng Distinguished Professor Funding number 000233 (to D.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytekin M, 2010, TUBERK TORAK, V58, P100; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2010, ANN BIOL CLIN-PARIS, V68, P263, DOI 10.1684/abc.2010.0429; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Cortes-Sempere M, 2011, CLIN TRANSL ONCOL, V13, P357, DOI 10.1007/s12094-011-0668-z; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Di Masi A, 2010, CELL MOL BIOL NOIS S, V56; Diakos C, 2010, BLOOD, V116, P4885, DOI 10.1182/blood-2009-02-206706; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kumar P, 2011, RNA, V17, P365, DOI 10.1261/rna.2490111; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Reichenstein I, 2010, J VIROL METHODS, V163, P323, DOI 10.1016/j.jviromet.2009.10.018; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Shi L, 2012, ACTA PHYSL, V204, P105; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Thai TH, 2010, DISCOV MED, V10, P184; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Yang HP, 2009, PLANT BIOTECHNOL J, V7, P621, DOI 10.1111/j.1467-7652.2009.00429.x; Zahm AM, 2011, J PEDIATR GASTR NUTR, V53, P26, DOI 10.1097/MPG.0b013e31822200cc; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	49	82	90	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48536	10.1371/journal.pone.0048536	http://dx.doi.org/10.1371/journal.pone.0048536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152780	Green Submitted, Green Published, gold			2022-12-25	WOS:000311234600007
J	Sen, T; Sen, N; Noordhuis, MG; Ravi, R; Wu, TC; Ha, PK; Sidransky, D; Hoque, MO				Sen, Tanusree; Sen, Nilkantha; Noordhuis, Maartje G.; Ravi, Rajani; Wu, T-C; Ha, Patrick K.; Sidransky, David; Hoque, Mohammad Obaidul			OGDHL Is a Modifier of AKT-Dependent Signaling and NF-kappa B Function	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CANCER; APOPTOSIS; PATHWAY; EXPRESSION; PROTEINS; LOCALIZATION; CELLS; CHEMOTHERAPY	Oxoglutarate dehydrogenase (OGDH) is the first and rate-limiting component of the multi-enzyme OGDH complex (OGDHC) whose malfunction is associated with neuro-degeneration. The essential role of this complex is in the degradation of glucose and glutamate and the OGDHL gene (one component of OGDHC) is down-regulated by promoter hypermethylation in many different cancer types. These properties suggest a potential growth modulating role of OGDHL in cancer; however, the molecular mechanism through which OGDHL exerts its growth modulating function has not been elucidated. Here, we report that restoration of OGDHL expression in cervical cancer cells lacking endogenous OGDHL expression suppressed cell proliferation, invasion and soft agar colony formation in vitro. Knockdown of OGDHL expression in cervical cancer cells expressing endogenous OGDHL had the opposite effect. Forced expression of OGDHL increased the production of reactive oxygen species (ROS) leading to apoptosis through caspase 3 mediated down-regulation of the AKT signaling cascade and decreased NF-kappa B phosphorylation. Conversely, silencing OGDHL stimulated the signaling pathway via increased AKT phosphorylation. Moreover, the addition of caspase 3 or ROS inhibitors in the presence of OGDHL increased AKT signaling and cervical cancer cell proliferation. Taken together, these data suggest that inactivation of OGDHL can contribute to cervical tumorigenesis via activation of the AKT signaling pathway and thus support it as an important anti-proliferative gene in cervical cancer.	[Sen, Tanusree; Noordhuis, Maartje G.; Ravi, Rajani; Ha, Patrick K.; Sidransky, David; Hoque, Mohammad Obaidul] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Sen, Nilkantha] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Wu, T-C] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ha, Patrick K.] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	mhoque1@jhmi.edu	Sen, Nilkantha/AAW-9788-2020	Hoque, Mohammad Obaidul/0000-0001-6701-9978	Specialized Program of Research Excellence; National Institutes of Health (NIH)/National Cancer Institute (NCI) [P50 CA098252]; NATIONAL CANCER INSTITUTE [P50CA098252] Funding Source: NIH RePORTER	Specialized Program of Research Excellence; National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a career development award to M. O. Hoque from Specialized Program of Research Excellence and P50 CA098252 (T-C Wu) National Institutes of Health (NIH)/National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; An J, 2004, J BIOL CHEM, V279, P19133, DOI 10.1074/jbc.M400295200; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bunik VI, 2008, PROTEINS, V71, P874, DOI 10.1002/prot.21766; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Cankaya M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-232; Cao J, 2009, FREE RADICAL BIO MED, V47, P536, DOI 10.1016/j.freeradbiomed.2009.05.024; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fraser M, 2003, CANCER RES, V63, P7081; Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Hsu Y.L., 2010, J AGR FOOD CHEM; Jahani-Asl A, 2007, FEBS LETT, V581, P2883, DOI 10.1016/j.febslet.2007.05.033; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Ko LW, 2001, J MOL NEUROSCI, V17, P361, DOI 10.1385/JMN:17:3:361; Maduro JH, 2003, CANCER TREAT REV, V29, P471, DOI 10.1016/S0305-7372(03)00117-8; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oelke K, 2004, INT REV IMMUNOL, V23, P315, DOI 10.1080/08830180490452567; OFALLON JV, 1977, BIOCHIM BIOPHYS ACTA, V499, P321, DOI 10.1016/0304-4165(77)90063-0; Ostrow KL, 2009, CLIN CANCER RES, V15, P1184, DOI 10.1158/1078-0432.CCR-08-1304; Page C, 2000, ANTICANCER RES, V20, P407; Pruitt K, 2005, J BIOL CHEM, V280, P23363, DOI 10.1074/jbc.M503083200; Ramdass B, 2007, GYNECOL ONCOL, V104, P352, DOI 10.1016/j.ygyno.2006.08.054; Shehata MF, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-10; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Zerbini LF, 2003, CANCER RES, V63, P2206; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200	52	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48770	10.1371/journal.pone.0048770	http://dx.doi.org/10.1371/journal.pone.0048770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152800	Green Published, Green Submitted, gold			2022-12-25	WOS:000311234000028
J	Hadadeh, O; Barruet, E; Peiretti, F; Verdier, M; Bernot, D; Hadjal, Y; El Yazidi, C; Robaglia-Schlupp, A; De Paula, AM; Negre, D; Iacovino, M; Kyba, M; Alessi, MC; Binetruy, B				Hadadeh, Ola; Barruet, Emilie; Peiretti, Franck; Verdier, Monique; Bernot, Denis; Hadjal, Yasmine; El Yazidi, Claire; Robaglia-Schlupp, Andree; De Paula, Andre Maues; Negre, Didier; Iacovino, Michelina; Kyba, Michael; Alessi, Marie-Christine; Binetruy, Bernard			The Plasminogen Activation System Modulates Differently Adipogenesis and Myogenesis of Embryonic Stem Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; IN-VITRO; INHIBITOR-1; RECEPTOR; GROWTH; ANGIOGENESIS; VITRONECTIN; EXPRESSION; MIGRATION; INTEGRIN	Regulation of the extracellular matrix (ECM) plays an important functional role either in physiological or pathological conditions. The plasminogen activation (PA) system, comprising the uPA and tPA proteases and their inhibitor PAI-1, is one of the main suppliers of extracellular proteolytic activity contributing to tissue remodeling. Although its function in development is well documented, its precise role in mouse embryonic stem cell (ESC) differentiation in vitro is unknown. We found that the PA system components are expressed at very low levels in undifferentiated ESCs and that upon differentiation uPA activity is detected mainly transiently, whereas tPA activity and PAI-1 protein are maximum in well differentiated cells. Adipocyte formation by ESCs is inhibited by amiloride treatment, a specific uPA inhibitor. Likewise, ESCs expressing ectopic PAI-1 under the control of an inducible expression system display reduced adipogenic capacities after induction of the gene. Furthermore, the adipogenic differentiation capacities of PAI-1(-/-) induced pluripotent stem cells (iPSCs) are augmented as compared to wt iPSCs. Our results demonstrate that the control of ESC adipogenesis by the PA system correspond to different successive steps from undifferentiated to well differentiated ESCs. Similarly, skeletal myogenesis is decreased by uPA inhibition or PAI-1 overexpression during the terminal step of differentiation. However, interfering with uPA during days 0 to 3 of the differentiation process augments ESC myotube formation. Neither neurogenesis, cardiomyogenesis, endothelial cell nor smooth muscle formation are affected by amiloride or PAI-1 induction. Our results show that the PA system is capable to specifically modulate adipogenesis and skeletal myogenesis of ESCs by successive different molecular mechanisms.	[Hadadeh, Ola; Barruet, Emilie; Peiretti, Franck; Verdier, Monique; Bernot, Denis; Hadjal, Yasmine; El Yazidi, Claire; Alessi, Marie-Christine; Binetruy, Bernard] Fac Med Marseille, U626, INSERM, F-13385 Marseille, France; [Hadadeh, Ola; Barruet, Emilie; Peiretti, Franck; Verdier, Monique; Bernot, Denis; Hadjal, Yasmine; El Yazidi, Claire; Alessi, Marie-Christine; Binetruy, Bernard] Aix Marseille Univ, Fac Med, Marseille, France; [Robaglia-Schlupp, Andree; De Paula, Andre Maues] Fac Med Marseille, INSERM, U910, F-13385 Marseille, France; [Robaglia-Schlupp, Andree] CHU La Timone, AP HM, Lab Biol Cellulaire, Marseille, France; [De Paula, Andre Maues] CHU La Timone, AP HM, Serv Anat Pathol & Neuropathol, Marseille, France; [Negre, Didier] Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France; [Negre, Didier] Univ Lyon, Ecole Normale Super Lyon, UCB Lyon1, Lyon, France; [Iacovino, Michelina; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Iacovino, Michelina; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Binetruy, B (corresponding author), Fac Med Marseille, U626, INSERM, F-13385 Marseille, France.	Bernard.Binetruy@univ-amu.fr	Binetruy, Bernard/S-2062-2019; Binetruy, Bernard/AAG-7139-2022; Binetruy, Bernard/AFL-7188-2022; peiretti, franck/L-2718-2017; Binetruy, Bernard/A-6465-2009; Peiretti, Franck/GLV-3378-2022; ALESSI, Marie-christine/AAK-3582-2020	Binetruy, Bernard/0000-0001-8012-7092; peiretti, franck/0000-0001-7198-0534; Peiretti, Franck/0000-0001-7198-0534; ALESSI, Marie-christine/0000-0003-3927-5792; Kyba, Michael/0000-0002-5579-7534; iacovino, michelina/0000-0002-1076-3146; NEGRE, Didier/0000-0003-4769-0814	Agence Nationale pour la Recherche; Association Franc, aise contre les Myopathies	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association Franc, aise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by grants from the Agence Nationale pour la Recherche and the Association Franc, aise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Barruet E, 2011, STEM CELLS DEV, V20, P1233, DOI 10.1089/scd.2010.0213; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Bonavaud S, 1997, J CELL SCI, V110, P1083; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Caron L, 2005, ONCOGENE, V24, P6281, DOI 10.1038/sj.onc.1208781; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; Dani C, 1997, J CELL SCI, V110, P1279; Fibbi G, 2001, LAB INVEST, V81, P27, DOI 10.1038/labinvest.3780209; Halvorsen B, 2001, HYPERTENSION, V37, P1184, DOI 10.1161/01.HYP.37.4.1184; Iacovino M, 2011, STEM CELLS IN PRESS; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Ishida T, 2006, LUNG, V184, P15, DOI 10.1007/s00408-005-2557-0; Isogai C, 2001, CANCER RES, V61, P5587; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Lensch MW, 2006, STEM CELL REV, V2, P185, DOI 10.1007/s12015-006-0047-2; Liang XB, 2006, AM J PHYSIOL-ENDOC M, V290, pE103, DOI 10.1152/ajpendo.00605.2004; Lluis F, 2001, BLOOD, V97, P1703, DOI 10.1182/blood.V97.6.1703; Lopez-Alemany R, 2003, EUR J BIOCHEM, V270, P814, DOI 10.1046/j.1432-1033.2003.03453.x; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Morange PE, 2000, ARTERIOSCL THROM VAS, V20, P1150, DOI 10.1161/01.ATV.20.4.1150; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rifkin DB, 1999, APMIS, V107, P80, DOI 10.1111/j.1699-0463.1999.tb01529.x; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Suelves M, 2002, BLOOD, V99, P2835, DOI 10.1182/blood.V99.8.2835; VASSALLI JD, 1987, FEBS LETT, V214, P187, DOI 10.1016/0014-5793(87)80039-X; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wobus Anna M., 2001, Molecular Aspects of Medicine, V22, P149, DOI 10.1016/S0098-2997(01)00006-1	36	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49065	10.1371/journal.pone.0049065	http://dx.doi.org/10.1371/journal.pone.0049065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145071	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500070
J	Lee, SH; Zahoor, M; Hwang, JK; Min, DS; Choi, KY				Lee, Soung-Hoon; Zahoor, Muhammad; Hwang, Jae-Kwan; Min, Do Sik; Choi, Kang-Yell			Valproic Acid Induces Cutaneous Wound Healing In Vivo and Enhances Keratinocyte Motility	PLOS ONE			English	Article							DEPENDENT TRANSCRIPTIONAL ACTIVATION; BETA-CATENIN STABILIZATION; CANCER CELL-MIGRATION; WNT SIGNALING PATHWAY; STEM-CELLS; BIPOLAR DISORDER; MOOD STABILIZER; MOUSE MODEL; HAIR CYCLE; GROWTH	Background: Cutaneous wound healing is a complex process involving several signaling pathways such as the Wnt and extracellular signal-regulated kinase (ERK) signaling pathways. Valproic acid (VPA) is a commonly used antiepileptic drug that acts on these signaling pathways; however, the effect of VPA on cutaneous wound healing is unknown. Methods and Findings: We created full-thickness wounds on the backs of C3H mice and then applied VPA. After 7 d, we observed marked healing and reduced wound size in VPA-treated mice. In the neo-epidermis of the wounds, beta-catenin and markers for keratinocyte terminal differentiation were increased after VPA treatment. In addition, alpha-smooth muscle actin (alpha-SMA), collagen I and collagen III in the wounds were significantly increased. VPA induced proliferation and suppressed apoptosis of cells in the wounds, as determined by Ki67 and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining analyses, respectively. In vitro, VPA enhanced the motility of HaCaT keratinocytes by activating Wnt/bcatenin, ERK and phosphatidylinositol 3-kinase (PI3-kinase)/Akt signaling pathways. Conclusions: VPA enhances cutaneous wound healing in a murine model and induces migration of HaCaT keratinocytes.	[Lee, Soung-Hoon; Zahoor, Muhammad; Hwang, Jae-Kwan; Choi, Kang-Yell] Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea; [Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan, South Korea	Yonsei University; Pusan National University	Choi, KY (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Dept Biotechnol, Seoul 120749, South Korea.	kychoi@yonsei.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST); Translational Research Center for Protein Function Control [2009-0083522]; Stem Cell Research Project [2010-0020235]; Ministry of Knowledge Economy (through the Korea Research Institute of Chemical Technology) [SI-095]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Translational Research Center for Protein Function Control; Stem Cell Research Project; Ministry of Knowledge Economy (through the Korea Research Institute of Chemical Technology)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST); Translational Research Center for Protein Function Control (2009-0083522) and the Stem Cell Research Project (2010-0020235). This work was also partly supported by a grant from the Ministry of Knowledge Economy (through the Korea Research Institute of Chemical Technology [SI-095]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2007, J CELL BIOCHEM, V102, P1290, DOI 10.1002/jcb.21359; Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Atiba A, 2011, AM J SURG, V201, P809, DOI 10.1016/j.amjsurg.2010.06.017; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Blaheta RA, 2002, CURR MED CHEM, V9, P1417, DOI 10.2174/0929867023369763; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Cho CH, 2006, P NATL ACAD SCI USA, V103, P4946, DOI 10.1073/pnas.0506352103; Colwell AS, 2006, PLAST RECONSTR SURG, V117, P2297, DOI 10.1097/01.prs.0000218708.16909.31; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; de Mendonca RJ, 2009, AN BRAS DERMATOL, V84, P257, DOI 10.1590/S0365-05962009000300007; Fu Xiaobing, 2004, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V18, P508; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gould TD, 2004, NEUROPSYCHOPHARMACOL, V29, P32, DOI 10.1038/sj.npp.1300283; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gurpur PB, 2009, AM J PATHOL, V174, P999, DOI 10.2353/ajpath.2009.080537; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; Haddad PM, 2009, EXPERT OPIN DRUG MET, V5, P539, DOI [10.1517/17425250902911455 , 10.1517/17425250902911455]; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Jeong MR, 2003, FEBS LETT, V542, P74, DOI 10.1016/S0014-5793(03)00350-8; Kern F, 2011, BRIT J CANCER, V104, P229, DOI 10.1038/sj.bjc.6606009; Labus Marie B., 1998, Wound Repair and Regeneration, V6, P58, DOI 10.1046/j.1524-475X.1998.60109.x; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; Lee SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034152; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P28, DOI 10.1016/j.bbrc.2006.01.104; Pedroso DCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016114; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Reynolds MF, 2007, CURR MED CHEM, V14, P2799, DOI 10.2174/092986707782360088; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Saika Shizuya, 2004, Cornea, V23, pS25, DOI 10.1097/01.ico.0000136668.41000.73; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Tsai LK, 2010, NEUROPSYCHOPHARMACOL, V35, P2225, DOI 10.1038/npp.2010.97; Vollmar B, 2002, LAB INVEST, V82, P1063, DOI 10.1097/01.LAB.0000024363.37866.45; Watson A, 2009, ARCH DERMATOL RES, V301, P307, DOI 10.1007/s00403-009-0945-7; Weber TJ, 2010, J INVEST DERMATOL, V130, P1444, DOI 10.1038/jid.2009.383; Widelitz Randall B, 2008, Organogenesis, V4, P123; Xu KP, 2011, INVEST OPHTH VIS SCI, V52, P3301, DOI 10.1167/iovs.10-5670; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011; Zhang L, 2012, MOL CELL BIOCHEM, V361, P39, DOI 10.1007/s11010-011-1085-x; Zhang L, 2011, PHARMAZIE, V66, P614, DOI 10.1691/ph.2011.1506	55	37	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48791	10.1371/journal.pone.0048791	http://dx.doi.org/10.1371/journal.pone.0048791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144972	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800134
J	Pande, S; Sengupta, A; Srivastava, A; Gude, RP; Ingle, A				Pande, Sneha; Sengupta, Amit; Srivastava, Anurag; Gude, Rajiv P.; Ingle, Arvind			Re-Evaluate the Effect of Hyperbaric Oxygen Therapy in Cancer - A Preclinical Therapeutic Small Animal Model Study	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; MOUSE MODELS; TUMOR-GROWTH; BLOOD-FLOW; APOPTOSIS; ANEUPLOIDY; INDUCTION; HEAD	Tumor hypoxia is a known driver of angiogenesis that also facilitates tumor growth. Moreover, poorly oxygenated central tumor area remains relatively radio or chemo resistant. HBO therapy is known to elevate the levels of dissolved oxygen and eliminates tumor hypoxia. It has been one of the modalities in cancer treatment; therefore its optimization is important. In this experimental study, no cancer enhancing effect was seen during the course of HBO therapy; however, post therapy there was an accelerated growth and progression of tumor. HBO treated mice lived shorter and the response to therapy was dose & tumor volume dependent. HBO therapy probably exert its effect on the cancer proliferating cells through multiple pathways such as increased DNA damage, apoptosis & geno-toxicity leading to slow cancer progression while post therapy tumorigenic effect could be due to impaired DNA repair mechanism, mutagenic effect & aneuploidy as well as altered blood supply & nutrients. Tumor growth reached plateau with time and this finding validated theoretical model predicting tumor reaching an asymptotic limit. While, marked asymmetry observed in tumor volume progression or cancer cell proliferation rate in each of the experimental C3H mouse suggested a need for an alternate small animal pre-clinical cancer therapeutic model.	[Pande, Sneha; Sengupta, Amit] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Bioengn Lab, New Mumbai, Maharashtra, India; [Srivastava, Anurag] All India Inst Med Sci, Dept Canc Surg, New Delhi, India; [Gude, Rajiv P.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Gude Lab, New Mumbai, Maharashtra, India; [Ingle, Arvind] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Lab Anim Facil, New Mumbai, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Sengupta, A (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Bioengn Lab, New Mumbai, Maharashtra, India.	asengupta@actrec.gov.in		SENGUPTA, AMIT/0000-0002-9674-552X				Becher OJ, 2006, CANCER RES, V66, P3355, DOI 10.1158/0008-5472.CAN-05-3827; Bennett M, 2006, COCHRANE LIB; Borowsky AD, 2003, COMPARATIVE MED, V53, P248; Bradfield JJ, 1996, OTOLARYNG HEAD NECK, V114, P793, DOI 10.1016/S0194-5998(96)70103-1; Daruwalla J, 2006, WORLD J SURG, V30, P2112, DOI 10.1007/s00268-006-0190-6; DECOSSE JJ, 1966, CANCER RES, V26, P287; Fang X, 2011, SEMIN CELL DEV BIOL, V22, P595, DOI 10.1016/j.semcdb.2011.03.002; Feldmeier JJ, 2002, UNDERSEA HYPERBAR M, V29, P4; FELDMEIER JJ, 1994, UNDERSEA HYPERBAR M, V21, P467; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Ganguly BJ, 2002, APOPTOSIS, V7, P499, DOI 10.1023/A:1020686908831; Granowitz EV, 2005, ANTICANCER RES, V25, P3833; Groger M, 2009, J APPL PHYSIOL, V106, P311, DOI 10.1152/japplphysiol.90737.2008; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HENK JM, 1986, INT J RADIAT ONCOL, V12, P1339, DOI 10.1016/0360-3016(86)90167-7; Hironaka K, 2003, LAB INVEST, V83, P643, DOI 10.1097/01.LAB.0000067483.89649.11; JAMIESON D, 1963, BRIT J CANCER, V17, P70, DOI 10.1038/bjc.1963.11; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Kuffler Damien P, 2010, OPEN CIRCULATION VAS, V3, P72; Kulikovsky M, 2009, ISR MED ASSOC J, V11, P480; Laufer J, 2012, J BIOMEDICAL OPTICS, V17; Liu Rui-Duan, 2010, Zhongguo Gu Shang, V23, P860; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Matsunami T, 2011, INT J CLIN EXP PATHO, V4, P255; Meirovithz E, 2007, BRAIN RES REV, V54, P294, DOI 10.1016/j.brainresrev.2007.04.004; Milovanova TN, 2009, J APPL PHYSIOL, V106, P711, DOI 10.1152/japplphysiol.91054.2008; Nasu R, 1999, BRIT J CANCER, V79, P780, DOI 10.1038/sj.bjc.6690125; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Obst B, 2000, CARCINOGENESIS, V21, P1111, DOI 10.1093/carcin/21.6.1111; Ong M, 2008, SINGAP MED J, V49, P105; Rothfuss A, 2000, MUTAT RES-GEN TOX EN, V471, P87, DOI 10.1016/S1383-5718(00)00123-6; Sengupta, 1998, Blood Press Monit, V3, P241; Sengupta A, 1997, MED BIOL ENG COMPUT, V35, P223, DOI 10.1007/BF02530042; SENGUPTA A, 1994, MED HYPOTHESES, V43, P322, DOI 10.1016/0306-9877(94)90111-2; Singh M, 2006, CLIN CANCER RES, V12, P5312, DOI 10.1158/1078-0432.CCR-06-0437; Speit G, 2002, MUTAT RES-REV MUTAT, V512, P111, DOI 10.1016/S1383-5742(02)00045-5; Tang H, 2009, UROLOGY, V73, P205, DOI 10.1016/j.urology.2008.04.057; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Williams L, 2009, MUTAT RES-FUND MOL M, V669, P104, DOI 10.1016/j.mrfmmm.2009.05.009; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53; Zimanova J, 2011, BRATISL MED J, V112, P447	44	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48432	10.1371/journal.pone.0048432	http://dx.doi.org/10.1371/journal.pone.0048432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144880	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800060
J	Sancho-Bielsa, FJ; Navarro-Lopez, JD; Alonso-Llosa, G; Molowny, A; Ponsoda, X; Yajeya, J; Lopez-Garcia, C				Sancho-Bielsa, Francisco J.; Navarro-Lopez, Juan D.; Alonso-Llosa, Gregori; Molowny, Asuncion; Ponsoda, Xavier; Yajeya, Javier; Lopez-Garcia, Carlos			Neurons of the Dentate Molecular Layer in the Rabbit Hippocampus	PLOS ONE			English	Article							DORSOLATERAL PALLIAL REGIONS; CAJAL-RETZIUS CELLS; CEREBRAL HEMISPHERE; FETAL RABBITS; GYRUS; INTERNEURONS; CORTEX; MIGRATION; GOLGI; POPULATIONS	The molecular layer of the dentate gyrus appears as the main entrance gate for information into the hippocampus, i.e., where the perforant path axons from the entorhinal cortex synapse onto the spines and dendrites of granule cells. A few dispersed neuronal somata appear intermingled in between and probably control the flow of information in this area. In rabbits, the number of neurons in the molecular layer increases in the first week of postnatal life and then stabilizes to appear permanent and heterogeneous over the individuals' life span, including old animals. By means of Golgi impregnations, NADPH histochemistry, immunocytochemical stainings and intracellular labelings (lucifer yellow and biocytin injections), eight neuronal morphological types have been detected in the molecular layer of developing adult and old rabbits. Six of them appear as interneurons displaying smooth dendrites and GABA immunoreactivity: those here called as globoid, vertical, small horizontal, large horizontal, inverted pyramidal and polymorphic. Additionally there are two GABA negative types: the sarmentous and ectopic granular neurons. The distribution of the somata and dendritic trees of these neurons shows preferences for a definite sublayer of the molecular layer: small horizontal, sarmentous and inverted pyramidal neurons are preferably found in the outer third of the molecular layer; vertical, globoid and polymorph neurons locate the intermediate third, while large horizontal and ectopic granular neurons occupy the inner third or the juxtagranular molecular layer. Our results reveal substantial differences in the morphology and electrophysiological behaviour between each neuronal archetype in the dentate molecular layer, allowing us to propose a new classification for this neural population.	[Sancho-Bielsa, Francisco J.; Alonso-Llosa, Gregori; Molowny, Asuncion; Ponsoda, Xavier; Lopez-Garcia, Carlos] Univ Valencia, Dept Cell Biol, Valencia, Spain; [Sancho-Bielsa, Francisco J.; Navarro-Lopez, Juan D.] Univ Castilla La Mancha, Lab Neurophysiol & Behav, Sch Med Ciudad Real, E-13071 Ciudad Real, Spain; [Navarro-Lopez, Juan D.; Yajeya, Javier] Univ Salamanca, Dept Physiol & Pharmacol, E-37008 Salamanca, Spain	University of Valencia; Universidad de Castilla-La Mancha; University of Salamanca	Sancho-Bielsa, FJ (corresponding author), Univ Valencia, Dept Cell Biol, Valencia, Spain.	Francisco.Sancho@uclm.es; Juan.Navarro@uclm.es; Carlos.Lopez@uv.es	Sancho-Bielsa, Francisco/J-7339-2013; Garcia, Carlos Lopez/L-9060-2014; Ponsoda, Xavier/L-8272-2014; Yajeya, Javier/B-4325-2017; de Dios Navarro López, Juan/Q-9318-2019	Sancho-Bielsa, Francisco/0000-0003-3521-5477; Ponsoda, Xavier/0000-0002-4051-4458; de Dios Navarro López, Juan/0000-0002-1877-7833; Yajeya, Javier/0000-0003-1617-4227	Spanish Ministry of Science and Innovation [SAF2010-14878, BFU2011-22740]; Fundacion Eugenio Rodriguez Pascual	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Eugenio Rodriguez Pascual	This work has been supported by the Spanish Ministry of Science and Innovation (grants SAF2010-14878 and BFU2011-22740) and Fundacion Eugenio Rodriguez Pascual. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2005, NEUROSCIENCE, V136, P217, DOI 10.1016/j.neuroscience.2005.07.039; Abraham H, 2004, CEREB CORTEX, V14, P484, DOI 10.1093/cercor/bhh010; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Armstrong C, 2011, J COMP NEUROL, V519, P1476, DOI 10.1002/cne.22577; Ceranik K, 1997, J NEUROSCI, V17, P5380; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DELAIGLESIA JAL, 1994, J COMP NEUROL, V341, P184, DOI 10.1002/cne.903410205; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DelRio JA, 1996, J NEUROSCI, V16, P6896; Dupuy-Davies S, 1999, HIPPOCAMPUS, V9, P186, DOI 10.1002/(SICI)1098-1063(1999)9:2<186::AID-HIPO9>3.0.CO;2-B; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; HOLM IE, 1989, HISTOCHEMISTRY, V91, P133, DOI 10.1007/BF00492387; Holter NI, 2007, BRAIN RES, V1186, P56, DOI 10.1016/j.brainres.2007.09.089; Jinno S, 1999, J COMP NEUROL, V410, P398; MARTISUBIRANA A, 1986, J ANAT, V144, P31; MCDONALD AJ, 1992, NEUROREPORT, V3, P821, DOI 10.1097/00001756-199210000-00001; Mendizabal-Zubiaga JL, 2007, J ANAT, V211, P223, DOI 10.1111/j.1469-7580.2007.00779.x; Morozov YM, 2006, J NEUROSCI, V26, P5017, DOI 10.1523/JNEUROSCI.0272-06.2006; Navarro-Lopez JD, 2004, J NEUROSCI, V24, P5109, DOI 10.1523/JNEUROSCI.0235-04.2004; Navarro-Quiroga I, 2006, J COMP NEUROL, V497, P833, DOI 10.1002/cne.21037; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Ramon y Cajal S, 1883, AN SOC ESP HIST NAT, P53; Ribak CE, 2009, BRAIN STRUCT FUNCT, V214, P25, DOI 10.1007/s00429-009-0231-7; SERESS L, 1981, J ANAT, V133, P181; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STENSAAS LJ, 1968, J COMP NEUROL, V132, P93, DOI 10.1002/cne.901320105; STENSAAS LJ, 1967, J COMP NEUROL, V130, P149, DOI 10.1002/cne.901300204; STENSAAS LJ, 1967, J COMP NEUROL, V131, P423, DOI 10.1002/cne.901310403; STENSAAS LJ, 1967, J COMP NEUROL, V131, P409, DOI 10.1002/cne.901310402; VALTSCHANOFF JG, 1993, J COMP NEUROL, V331, P111, DOI 10.1002/cne.903310107; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Williams PA, 2007, J NEUROSCI, V27, P13756, DOI 10.1523/JNEUROSCI.4053-07.2007	36	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48470	10.1371/journal.pone.0048470	http://dx.doi.org/10.1371/journal.pone.0048470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144890	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800067
J	Schwarzbauer, K; Bodenhofer, U; Hochreiter, S				Schwarzbauer, Karin; Bodenhofer, Ulrich; Hochreiter, Sepp			Genome-Wide Chromatin Remodeling Identified at GC-Rich Long Nucleosome-Free Regions	PLOS ONE			English	Article							CPG-BINDING PROTEIN; T-CELL-ACTIVATION; CHIP-SEQ DATA; GENE-EXPRESSION; DNA-SEQUENCE; YEAST; ORGANIZATION; PROMOTER; TRANSCRIPTION; ISLANDS	To gain deeper insights into principles of cell biology, it is essential to understand how cells reorganize their genomes by chromatin remodeling. We analyzed chromatin remodeling on next generation sequencing data from resting and activated T cells to determine a whole-genome chromatin remodeling landscape. We consider chromatin remodeling in terms of nucleosome repositioning which can be observed most robustly in long nucleosome-free regions (LNFRs) that are occupied by nucleosomes in another cell state. We found that LNFR sequences are either AT-rich or GC-rich, where nucleosome repositioning was observed much more prominently in GC-rich LNFRs - a considerable proportion of them outside promoter regions. Using support vector machines with string kernels, we identified a GC-rich DNA sequence pattern indicating loci of nucleosome repositioning in resting T cells. This pattern appears to be also typical for CpG islands. We found out that nucleosome repositioning in GC-rich LNFRs is indeed associated with CpG islands and with binding sites of the CpG-island-binding ZF-CXXC proteins KDM2A and CFP1. That this association occurs prominently inside and also prominently outside of promoter regions hints at a mechanism governing nucleosome repositioning that acts on a whole-genome scale.	[Schwarzbauer, Karin; Bodenhofer, Ulrich; Hochreiter, Sepp] Johannes Kepler Univ Linz, Inst Bioinformat, A-4040 Linz, Austria	Johannes Kepler University Linz	Hochreiter, S (corresponding author), Johannes Kepler Univ Linz, Inst Bioinformat, A-4040 Linz, Austria.	hochreit@bioinf.jku.at	Hochreiter, Sepp/AAI-5904-2020; Bodenhofer, Ulrich/B-7030-2008	Hochreiter, Sepp/0000-0001-7449-2528; Bodenhofer, Ulrich/0000-0001-6859-8828				Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Attema JL, 2002, J IMMUNOL, V169, P2466, DOI 10.4049/jimmunol.169.5.2466; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Blackledge NP, 2011, EPIGENETICS-US, V6, P147, DOI 10.4161/epi.6.2.13640; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bodenhofer U, 2009, PROCEEDINGS OF THE JOINT 2009 INTERNATIONAL FUZZY SYSTEMS ASSOCIATION WORLD CONGRESS AND 2009 EUROPEAN SOCIETY OF FUZZY LOGIC AND TECHNOLOGY CONFERENCE, P1376; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Cakouros D, 2001, J IMMUNOL, V167, P302, DOI 10.4049/jimmunol.167.1.302; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Holloway AF, 2003, J EXP MED, V197, P413, DOI 10.1084/jem.20021039; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kuksa P., 2008, 8 INT WORKSH DAT MIN, P29; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LESLIE C, 2002, P PSB, V7, P566; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mahrenholz CC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004994; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Meinicke P, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-169; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rajapakse I, 2009, P NATL ACAD SCI USA, V106, P6679, DOI 10.1073/pnas.0900986106; Ratsch G, 2005, BIOINFORMATICS, V21, pI369, DOI 10.1093/bioinformatics/bti1053; Ratsch G., 2004, KERNEL METHODS COMPU, P277; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schu┬lkopf B., 2004, KERNEL METHODS COMPU; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Shannon Frances M., 2006, Current Immunology Reviews, V2, P273, DOI 10.2174/157339506778018587; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; van Holde KE., 1989, SPRINGER SERIES MOL; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wong HM, 2009, MOL BIOSYST, V5, P1713, DOI 10.1039/b905848f; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhou JC, 2012, MOL CELL BIOL, V32, P479, DOI 10.1128/MCB.06332-11	71	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47924	10.1371/journal.pone.0047924	http://dx.doi.org/10.1371/journal.pone.0047924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144837	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400033
J	Zimmerman, AL; Sawchuk, M; Hochman, S				Zimmerman, Amanda L.; Sawchuk, Michael; Hochman, Shawn			Monoaminergic Modulation of Spinal Viscero-Sympathetic Function in the Neonatal Mouse Thoracic Spinal Cord	PLOS ONE			English	Article							SYMPATHETIC PREGANGLIONIC NEURONS; PRIMARY AFFERENT DEPOLARIZATION; II MUSCLE AFFERENTS; MEDIATING PRESYNAPTIC INHIBITION; PRIMARY SENSORY NEURONS; DORSAL-HORN; REFLEX PATHWAYS; MEMBRANE-PROPERTIES; RECEPTOR SUBTYPES; VISCERAL PAIN	Descending serotonergic, noradrenergic, and dopaminergic systems project diffusely to sensory, motor and autonomic spinal cord regions. Using neonatal mice, this study examined monoaminergic modulation of visceral sensory input and sympathetic preganglionic output. Whole-cell recordings from sympathetic preganglionic neurons (SPNs) in spinal cord slice demonstrated that serotonin, noradrenaline, and dopamine modulated SPN excitability. Serotonin depolarized all, while noradrenaline and dopamine depolarized most SPNs. Serotonin and noradrenaline also increased SPN current-evoked firing frequency, while both increases and decreases were seen with dopamine. In an in vitro thoracolumbar spinal cord/sympathetic chain preparation, stimulation of splanchnic nerve visceral afferents evoked reflexes and subthreshold population synaptic potentials in thoracic ventral roots that were dose-dependently depressed by the monoamines. Visceral afferent stimulation also evoked bicuculline-sensitive dorsal root potentials thought to reflect presynaptic inhibition via primary afferent depolarization. These dorsal root potentials were likewise dose-dependently depressed by the monoamines. Concomitant monoaminergic depression of population afferent synaptic transmission recorded as dorsal horn field potentials was also seen. Collectively, serotonin, norepinephrine and dopamine were shown to exert broad and comparable modulatory regulation of viscero-sympathetic function. The general facilitation of SPN efferent excitability with simultaneous depression of visceral afferent-evoked motor output suggests that descending monoaminergic systems reconfigure spinal cord autonomic function away from visceral sensory influence. Coincident monoaminergic reductions in dorsal horn responses support a multifaceted modulatory shift in the encoding of spinal visceral afferent activity. Similar monoamine-induced changes have been observed for somatic sensorimotor function, suggesting an integrative modulatory response on spinal autonomic and somatic function.	[Zimmerman, Amanda L.; Hochman, Shawn] Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30322 USA; [Sawchuk, Michael; Hochman, Shawn] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Hochman, S (corresponding author), Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30322 USA.	shawn.hochman@emory.edu	Hochman, Shawn/ABG-3875-2020		Department of Defense [10494473]; National Institute of Neurological Disorders and Stroke [NS-65949]; Craig Neilsen Foundation [123877]; Pfizer [IIR WS753331]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065949] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Craig Neilsen Foundation; Pfizer(Pfizer); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Department of Defense #10494473; National Institute of Neurological Disorders and Stroke Grant NS-65949; the Craig Neilsen Foundation #123877; and Pfizer IIR WS753331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKEYSON EW, 1994, AM J PHYSIOL, V266, pR257, DOI 10.1152/ajpregu.1994.266.1.R257; ALBANO JP, 1983, RESP PHYSIOL, V51, P229, DOI 10.1016/0034-5687(83)90043-9; AMMONS WS, 1984, J NEUROPHYSIOL, V51, P592, DOI 10.1152/jn.1984.51.3.592; ANDERSON CR, 1989, J COMP NEUROL, V283, P269, DOI 10.1002/cne.902830208; ANGEL MJ, 1994, J PHYSIOL-LONDON, V479, P451, DOI 10.1113/jphysiol.1994.sp020309; BAHNS E, 1986, PFLUG ARCH EUR J PHY, V407, P510, DOI 10.1007/BF00657509; Bain WA, 1935, J PHYSIOL-LONDON, V84, P323, DOI 10.1113/jphysiol.1935.sp003281; Bannatyne BA, 2009, J PHYSIOL-LONDON, V587, P379, DOI 10.1113/jphysiol.2008.159129; Bardoni R, 2004, J NEUROSCI, V24, P2774, DOI 10.1523/JNEUROSCI.4637-03.2004; BELL JA, 1981, LIFE SCI, V29, P1507, DOI 10.1016/0024-3205(81)90250-2; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; BISCOE TJ, 1982, Q J EXP PHYSIOL CMS, V67, P473, DOI 10.1113/expphysiol.1982.sp002663; BJORKLUND A, 1979, BRAIN RES, V177, P170, DOI 10.1016/0006-8993(79)90927-2; BRAS H, 1989, EXP BRAIN RES, V76, P27; Bueno L, 2000, AM J PHYSIOL-GASTR L, V278, pG670, DOI 10.1152/ajpgi.2000.278.5.G670; Buss RR, 1999, J PHYSIOL-LONDON, V514, P593, DOI 10.1111/j.1469-7793.1999.593ae.x; CABOT JB, 1994, J COMP NEUROL, V347, P515, DOI 10.1002/cne.903470404; Calvo J. R., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Calvo JR, 2006, SOC NEUR ABSTR, V32; CERVERO F, 1984, J COMP NEUROL, V230, P88, DOI 10.1002/cne.902300108; CERVERO F, 1985, PHILOS T ROY SOC B, V308, P325, DOI 10.1098/rstb.1985.0033; CERVERO F, 1984, J COMP NEUROL, V228, P422, DOI 10.1002/cne.902280309; ChesnoyMarchais D, 1996, BRIT J PHARMACOL, V117, P133, DOI 10.1111/j.1476-5381.1996.tb15165.x; COOTE JH, 1981, BRAIN RES, V215, P135, DOI 10.1016/0006-8993(81)90497-2; DANZEBRINK RM, 1990, J PHARMACOL EXP THER, V253, P698; DANZEBRINK RM, 1991, BRAIN RES, V538, P64, DOI 10.1016/0006-8993(91)90377-8; DOWNMAN CBB, 1957, J PHYSIOL-LONDON, V137, P66, DOI 10.1113/jphysiol.1957.sp005796; DOWNMAN CBB, 1955, J NEUROPHYSIOL, V18, P217, DOI 10.1152/jn.1955.18.3.217; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P282, DOI 10.1113/jphysiol.1962.sp006886; Eisenach JC, 2005, NEUROSCIENCE, V131, P189, DOI 10.1016/j.neuroscience.2004.10.017; FLEETWOODWALKER SM, 1981, BRAIN RES, V206, P95, DOI 10.1016/0006-8993(81)90103-7; FLEETWOODWALKER SM, 1985, BRAIN RES, V334, P243, DOI 10.1016/0006-8993(85)90216-1; Formenti A, 1998, J PHYSIOL-LONDON, V509, P395, DOI 10.1111/j.1469-7793.1998.395bn.x; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; FRANZ DN, 1966, AM J PHYSIOL, V211, P1292, DOI 10.1152/ajplegacy.1966.211.6.1292; Garraway SM, 2001, J NEUROPHYSIOL, V86, P2183, DOI 10.1152/jn.2001.86.5.2183; GILBEY MP, 1991, J PHYSIOL-LONDON, V432, P427, DOI 10.1113/jphysiol.1991.sp018392; Gladwell SJ, 1999, BRAIN RES, V818, P397, DOI 10.1016/S0006-8993(98)01330-4; Gordon IT, 2006, J NEUROPHYSIOL, V96, P3122, DOI 10.1152/jn.00606.2006; GUYENET PG, 1981, J NEUROSCI, V1, P908; Hochman S, 2010, ANN NY ACAD SCI, V1198, P140, DOI 10.1111/j.1749-6632.2010.05436.x; Holzer P, 1998, GEN PHARMACOL, V30, P5, DOI 10.1016/S0306-3623(97)00078-5; INOKUCHI H, 1992, CAN J PHYSIOL PHARM, V70, pS92, DOI 10.1139/y92-249; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; Janig W, 1996, BIOL PSYCHOL, V42, P29, DOI 10.1016/0301-0511(95)05145-7; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; JANKOWSKA E, 1995, J PHYSIOL-LONDON, V483, P461, DOI 10.1113/jphysiol.1995.sp020597; Jankowska E, 2000, EUR J NEUROSCI, V12, P701, DOI 10.1046/j.1460-9568.2000.00955.x; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KASHIBA H, 1991, PEPTIDES, V12, P101, DOI 10.1016/0196-9781(91)90174-N; Khasabov SG, 1999, BRIT J PHARMACOL, V127, P843, DOI 10.1038/sj.bjp.0702592; KING BF, 1989, AM J PHYSIOL, V256, pG581, DOI 10.1152/ajpgi.1989.256.3.G581; KUO DC, 1982, J COMP NEUROL, V210, P49, DOI 10.1002/cne.902100106; LEW WYW, 1986, AM J PHYSIOL, V250, pR465, DOI 10.1152/ajpregu.1986.250.3.R465; LEWIS DI, 1993, BRAIN RES, V610, P267, DOI 10.1016/0006-8993(93)91410-T; LEWIS DI, 1990, BRAIN RES, V530, P229, DOI 10.1016/0006-8993(90)91287-Q; Lidierth M, 2006, J PHYSIOL-LONDON, V576, P309, DOI 10.1113/jphysiol.2006.110577; LopezGarcia JA, 1996, EUR J NEUROSCI, V8, P2188, DOI 10.1111/j.1460-9568.1996.tb00740.x; LOW PA, 1977, ACTA NEUROPATHOL, V40, P219, DOI 10.1007/BF00691957; MA RC, 1986, DEV BRAIN RES, V24, P89, DOI 10.1016/0165-3806(86)90176-8; Madden CJ, 2008, NEUROPHARMACOLOGY, V54, P487, DOI 10.1016/j.neuropharm.2007.10.019; Madriaga MA, 2004, J NEUROPHYSIOL, V92, P1566, DOI 10.1152/jn.01181.2003; MCPHERSON DR, 1994, NEUROSCI LETT, V166, P23, DOI 10.1016/0304-3940(94)90831-1; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; MILNER TA, 1988, BRAIN RES, V448, P205, DOI 10.1016/0006-8993(88)91258-9; MIYAZAKI T, 1989, BRAIN RES, V497, P108, DOI 10.1016/0006-8993(89)90976-1; MOLANDER C, 1987, NEUROSCI LETT, V74, P37, DOI 10.1016/0304-3940(87)90047-4; NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5; NEUHUBER WL, 1986, ANAT EMBRYOL, V174, P123, DOI 10.1007/BF00318344; PERTOVAARA A, 1993, PROG NEUROBIOL, V40, P691, DOI 10.1016/0301-0082(93)90011-G; PETRAS JM, 1972, J COMP NEUROL, V146, P189, DOI 10.1002/cne.901460205; PICKERING AE, 1994, J PHYSIOL-LONDON, V480, P109, DOI 10.1113/jphysiol.1994.sp020345; QUIGG M, 1990, BRAIN RES, V518, P173, DOI 10.1016/0006-8993(90)90969-I; RIDDELL JS, 1995, J PHYSIOL-LONDON, V483, P443, DOI 10.1113/jphysiol.1995.sp020596; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; SAH P, 1995, J AUTONOM NERV SYST, V53, P1, DOI 10.1016/0165-1838(94)00161-C; Sandkuhler J, 1997, J NEUROSCI, V17, P6483; SCHOTLAND J, 1995, NATURE, V374, P266, DOI 10.1038/374266a0; SELZER M, 1969, BRAIN RES, V14, P349, DOI 10.1016/0006-8993(69)90115-2; SHARKEY KA, 1989, NEUROSCIENCE, V32, P169, DOI 10.1016/0306-4522(89)90116-4; Shreckengost J, 2010, J NEUROSCI, V30, P5283, DOI 10.1523/JNEUROSCI.3873-09.2010; Sillar KT, 1998, ANN NY ACAD SCI, V860, P318, DOI 10.1111/j.1749-6632.1998.tb09059.x; SUGIURA Y, 1993, J COMP NEUROL, V332, P315, DOI 10.1002/cne.903320305; SUGIURA Y, 1989, J NEUROPHYSIOL, V62, P834, DOI 10.1152/jn.1989.62.4.834; TAKAHASHI T, 1992, J PHYSIOL-LONDON, V450, P593, DOI 10.1113/jphysiol.1992.sp019145; TATTERSALL JEH, 1986, J NEUROPHYSIOL, V56, P1411, DOI 10.1152/jn.1986.56.5.1411; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Vera PL, 2000, BRAIN RES, V883, P107, DOI 10.1016/S0006-8993(00)02732-3; WESTLUND KN, 1983, BRAIN RES, V263, P15, DOI 10.1016/0006-8993(83)91196-4; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; Wu HC, 2010, AM J PHYSIOL-RENAL, V299, pF681, DOI 10.1152/ajprenal.00090.2010; YOSHIMURA M, 1987, BRAIN RES, V419, P383, DOI 10.1016/0006-8993(87)90613-5; YOSHIMURA M, 1987, BRAIN RES, V414, P138, DOI 10.1016/0006-8993(87)91334-5; Zheng P, 1999, NEUROSCIENCE, V91, P527, DOI 10.1016/S0306-4522(98)00604-6; Zimmerman A, 2010, J NEUROPHYSIOL, V103, P490, DOI 10.1152/jn.00622.2009	98	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47213	10.1371/journal.pone.0047213	http://dx.doi.org/10.1371/journal.pone.0047213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144807	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400018
J	Kubli, DA; Zhang, XX; Lee, Y; Hanna, RA; Quinsay, MN; Nguyen, CK; Jimenez, R; Petrosyan, S; Murphy, AN; Gustafsson, AB				Kubli, Dieter A.; Zhang, Xiaoxue; Lee, Youngil; Hanna, Rita A.; Quinsay, Melissa N.; Nguyen, Christine K.; Jimenez, Rebecca; Petrosyan, Susanna; Murphy, Anne N.; Gustafsson, Asa B.			Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; AUTOPHAGY; BNIP3; MICE; CARDIOMYOPATHY; DEGRADATION; P62/SQSTM1; MUTATIONS; MITOPHAGY	It is known that loss-of-function mutations in the gene encoding Parkin lead to development of Parkinson disease. Recently, Parkin was found to play an important role in the removal of dysfunctional mitochondria via autophagy in neurons. Although Parkin is expressed in the heart, its functional role in this tissue is largely unexplored. In this study, we have investigated the role of Parkin in the myocardium under normal physiological conditions and in response to myocardial infarction. We found that Parkin-deficient (Parkin(-/-)) mice had normal cardiac function for up to 12 months of age as determined by echocardiographic analysis. Although ultrastructural analysis revealed that Parkin-deficient hearts had disorganized mitochondrial networks and significantly smaller mitochondria, mitochondrial function was unaffected. However, Parkin(-/-) mice were much more sensitive to myocardial infarction when compared with wild type mice. Parkin(-/-) mice had reduced survival and developed larger infarcts when compared with wild type mice after the infarction. Interestingly, Parkin protein levels and mitochondrial autophagy (mitophagy) were rapidly increased in the border zone of the infarct in wild type mice. In contrast, Parkin(-/-) myocytes had reduced mitophagy and accumulated swollen, dysfunctional mitochondria after the infarction. Overexpression of Parkin in isolated cardiac myocytes also protected against hypoxia-mediated cell death, whereas nonfunctional Parkinson disease-associated mutants ParkinR42P and ParkinG430D had no effect. Our results suggest that Parkin plays a critical role in adapting to stress in the myocardium by promoting removal of damaged mitochondria.	[Kubli, Dieter A.; Zhang, Xiaoxue; Lee, Youngil; Hanna, Rita A.; Quinsay, Melissa N.; Nguyen, Christine K.; Jimenez, Rebecca; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Petrosyan, Susanna; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gustafsson, AB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	asag@ucsd.edu	Lee, Youngil/AAX-2787-2021; Murphy, Anne N/H-3217-2016	Lee, Youngil/0000-0003-3819-2469; Murphy, Anne N/0000-0002-5222-9902	National Institutes of Health [R01HL087023, R01HL101217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087023, R01HL101217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087023 and R01HL101217 (to A. B. G.).	Aviv Y, 2011, ANTIOXID REDOX SIGN, V14, P2245, DOI 10.1089/ars.2010.3479; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; BENSHLOMO Y, 1995, J NEUROL NEUROSUR PS, V58, P293, DOI 10.1136/jnnp.58.3.293; Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Gottlieb RA, 2011, BBA-MOL CELL RES, V1813, P1295, DOI 10.1016/j.bbamcr.2010.11.017; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sayen MR, 2003, AM J PHYSIOL-CELL PH, V284, pC562, DOI 10.1152/ajpcell.00336.2002; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	44	321	334	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					915	926		10.1074/jbc.M112.411363	http://dx.doi.org/10.1074/jbc.M112.411363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23152496	hybrid, Green Published			2022-12-25	WOS:000313570300016
J	Lancaster, DL; Dobson, CM; Rachubinski, RA				Lancaster, David L.; Dobson, C. Melissa; Rachubinski, Richard A.			Chaperone Proteins Select and Maintain [PIN+] Prion Conformations in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO APPEARANCE; STRAIN VARIATION; ATPASE ACTIVITY; PSI+ PRION; HEAT-SHOCK; YEAST; HSP90; HSP104; PROPAGATION; SCRAPIE	Prions are proteins that can adopt different infectious conformations known as "strains" or "variants," each with a distinct, epigenetically inheritable phenotype. Mechanisms by which prion variants are determined remain unclear. Here we use the Saccharomyces cerevisiae prion Rnq1p/[PIN+] as a model to investigate the effects of chaperone proteins upon prion variant determination. We show that deletion of specific chaperone genes alters [PIN+] variant phenotypes, including [PSI+] induction efficiency, Rnq1p aggregate morphology/size and variant dominance. Mating assays demonstrate that gene deletion-induced phenotypic changes are stably inherited in a non-Mendelian manner even after restoration of the deleted gene, confirming that they are due to a bona fide change in the [PIN+] variant. Together, our results demonstrate a role for chaperones in regulating the prion variant complement of a cell.	[Lancaster, David L.; Dobson, C. Melissa; Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Lancaster, DL (corresponding author), Univ Alberta, Dept Cell Biol, Med Sci Bldg 5-14, Edmonton, AB T6G 2H7, Canada.	dll1@ualberta.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from the Canadian Institutes of Health Research. To whom correspondence should be addressed: Dept. of Cell Biology, University of Alberta, Medical Sciences Building 5-14, Edmonton, Alberta T6G 2H7, Canada. Tel.: 780-492-7407; Fax: 780-492-0450; E-mail: dll1@ualberta.ca.	Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Brown K, 2010, J GERIATR PSYCH NEUR, V23, P277, DOI 10.1177/0891988710383576; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kurahashi H, 2008, MOL CELL BIOL, V28, P3313, DOI 10.1128/MCB.01900-07; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Liebman SW, 2006, METHODS, V39, P23, DOI 10.1016/j.ymeth.2006.04.010; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Mayr C, 2000, J BIOL CHEM, V275, P34140, DOI 10.1074/jbc.M005251200; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Park KW, 2006, GENETICS, V173, P35, DOI 10.1534/genetics.105.054221; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Rose MD., 1990, METHODS YEAST GENETI; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Sharma J, 2012, MOL MICROBIOL, V86, P866, DOI 10.1111/mmi.12024; Sindi SS, 2009, CURR OPIN MICROBIOL, V12, P623, DOI 10.1016/j.mib.2009.09.003; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	60	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1266	1276		10.1074/jbc.M112.377564	http://dx.doi.org/10.1074/jbc.M112.377564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23148221	hybrid, Green Published			2022-12-25	WOS:000313570300046
J	Rosnoblet, C; Fritzinger, B; Legrand, D; Launay, H; Wieruszeski, JM; Lippens, G; Hanoulle, X				Rosnoblet, Claire; Fritzinger, Bernd; Legrand, Dominique; Launay, Helene; Wieruszeski, Jean-Michel; Lippens, Guy; Hanoulle, Xavier			Hepatitis C Virus NS5B and Host Cyclophilin A Share a Common Binding Site on NS5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; NONSTRUCTURAL PROTEIN 5A; CRYSTAL-STRUCTURE; MEMBRANE ASSOCIATION; ISOMERASE ACTIVITY; ANTIVIRAL THERAPY; CYCLOSPORINE-A; DOMAIN-II; REPLICATION; INHIBITORS	Nonstructural protein 5B (NS5B) is essential for hepatitis C virus (HCV) replication as it carries the viral RNA-dependent RNA polymerase enzymatic activity. HCV replication occurs in a membrane-associated multiprotein complex in which HCV NS5A and host cyclophilin A (CypA) have been shown to be present together with the viral polymerase. We used NMR spectroscopy to perform a per residue level characterization of the molecular interactions between the unfolded domains 2 and 3 of NS5A (NS5A-D2 and NS5A-D3), CypA, and NS5B(Delta 21). We show that three regions of NS5A-D2 (residues 250-262 (region A), 274-287 (region B), and 306-333 (region C)) interact with NS5B(Delta 21), whereas NS5A-D3 does not. We show that both NS5B(Delta 21) and CypA share a common binding site on NS5A that contains residues Pro-306 to Glu-323. No direct molecular interaction has been detected by NMR spectroscopy between HCV NS5B(Delta 21) and host CypA. We show that cyclosporine A added to a sample containing NS5B(Delta 21), NS5A-D2, and CypA specifically inhibits the interaction between CypA and NS5A-D2 without altering the one between NS5A-D2 and NS5B(Delta 21). A high quality heteronuclear NMR spectrum of HCV NS5B(Delta 21) has been obtained and was used to characterize the binding site on the polymerase of NS5A-D2. Moreover these data highlight the potential of using NMR of NS5B(Delta 21) as a powerful tool to characterize in solution the interactions of the HCV polymerase with all kinds of molecules (proteins, inhibitors, RNA). This work brings new insights into the comprehension of the molecular interplay between NS5B, NS5A, and CypA, three essentials proteins for HCV replication.	[Hanoulle, Xavier] Univ Lille Nord France, F-59000 Lille, France; CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, IFR 147, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Hanoulle, X (corresponding author), Univ Lille Nord France, F-59000 Lille, France.	xavier.hanoulle@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Legrand, Dominique/AAT-5715-2021; Rosnoblet, Claire/AAD-3462-2020; Hanoulle, Xavier/AAK-7236-2021	Rosnoblet, Claire/0000-0002-1906-0922; Hanoulle, Xavier/0000-0002-3755-2680; Launay, Helene/0000-0003-0639-2642; LEGRAND, Dominique/0000-0002-0814-221X; Lippens, Guy/0000-0002-8236-0901	CNR Sand University of Lille; French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research (ANR JCJC StruFunc5A5B); Region Nord-Pas de Calais (France); University of Lille 1; Institut Pasteur de Lille; University of Lille 2; CNRS	CNR Sand University of Lille; French National Agency for Research on AIDS and Viral Hepatitis(ANRS); French National Agency for Research (ANR JCJC StruFunc5A5B)(French National Research Agency (ANR)); Region Nord-Pas de Calais (France)(Region Hauts-de-France); University of Lille 1; Institut Pasteur de Lille; University of Lille 2; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the CNR Sand University of Lille and grants from the French National Agency for Research on AIDS and Viral Hepatitis and the French National Agency for Research (ANR JCJC StruFunc5A5B).; We gratefully acknowledge Drs. S. Bressanelli and D. Harrus (Laboratoire de Virologie Moleculaire et Structurale, CNRS UPR 3296, Gif-sur-Yvette, France) for providing the pET21-NS5B <INF>Delta 21</INF> plasmid and Drs. J. Neyts and L. Coelmont (Rega Institute for Medical Research, University of Leuven (KU Leuven), Leuven, Belgium) for providing the TCA-based inhibitor. The NMR facility used in this study was funded by the Region Nord-Pas de Calais (France), the CNRS, the Universities of Lille 1 and Lille 2, and the Institut Pasteur de Lille.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Biswal BK, 2006, J MOL BIOL, V361, P33, DOI 10.1016/j.jmb.2006.05.074; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chatterji U, 2010, J GEN VIROL, V91, P1189, DOI 10.1099/vir.0.018531-0; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Ciesek S, 2011, NAT REV GASTRO HEPAT, V8, P69, DOI 10.1038/nrgastro.2010.219; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Delang L, 2010, VIRUSES-BASEL, V2, P826, DOI 10.3390/v2040826; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hanoulle X, 2012, WILEY SER PROTEIN P, P409; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Heck JA, 2009, BIOCHEM PHARMACOL, V77, P1173, DOI 10.1016/j.bcp.2008.12.019; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; LaPlante SR, 2010, J AM CHEM SOC, V132, P15204, DOI 10.1021/ja101358s; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Moradpour D, 2004, J VIROL, V78, P13278, DOI 10.1128/JVI.78.23.13278-13284.2004; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Puyang XL, 2010, ANTIMICROB AGENTS CH, V54, P1981, DOI 10.1128/AAC.01236-09; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Quezada Elizabeth M, 2009, Open Biochem J, V3, P39, DOI 10.2174/1874091X00903010039; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Schlutter J, 2011, NATURE, V474, pS5, DOI 10.1038/474S5a; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07	75	29	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44249	44260		10.1074/jbc.M112.392209	http://dx.doi.org/10.1074/jbc.M112.392209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152499	Green Published, hybrid			2022-12-25	WOS:000312938600023
J	Schulz, EM; Correll, RN; Sheikh, HN; Lofrano-Alves, MS; Engel, PL; Newman, G; Schultz, JE; Molkentin, JD; Wolska, BM; Solaro, RJ; Wieczorek, DF				Schulz, Emily M.; Correll, Richard N.; Sheikh, Hajer N.; Lofrano-Alves, Marco S.; Engel, Patti L.; Newman, Gilbert; Schultz, Jo El J.; Molkentin, Jeffery D.; Wolska, Beata M.; Solaro, R. John; Wieczorek, David F.			Tropomyosin Dephosphorylation Results in Compensated Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ALPHA-ALPHA-TROPOMYOSIN; GENE-EXPRESSION; CARDIOMYOCYTE HYPERTROPHY; BETA-TROPOMYOSIN; RABBIT SKELETAL; PHOSPHORYLATION; EPSILON; BINDING; CA2+	Phosphorylation of tropomyosin (Tm) has been shown to vary in mouse models of cardiac hypertrophy. Little is known about the in vivo role of Tm phosphorylation. This study examines the consequences of Tm dephosphorylation in the murine heart. Transgenic (TG) mice were generated with cardiac specific expression of alpha-Tm with serine 283, the phosphorylation site of Tm, mutated to alanine. Echocardiographic analysis and cardiomyocyte cross-sectional area measurements show that alpha-Tm S283A TG mice exhibit a hypertrophic phenotype at basal levels. Interestingly, there are no alterations in cardiac function, myofilament calcium (Ca2+) sensitivity, cooperativity, or response to beta-adrenergic stimulus. Studies of Ca2+ handling proteins show significant increases in sarcoplasmic reticulum ATPase (SERCA2a) protein expression and an increase in phospholamban phosphorylation at serine 16, similar to hearts under exercise training. Compared with controls, the decrease in phosphorylation of alpha-Tm results in greater functional defects in TG animals stressed by transaortic constriction to induce pressure overload-hypertrophy. This is the first study to investigate the in vivo role of Tm dephosphorylation under both normal and cardiac stress conditions, documenting a role for Tm dephosphorylation in the maintenance of a compensated or physiological phenotype. Collectively, these results suggest that modification of the Tm phosphorylation status in the heart, depending upon the cardiac state/condition, may modulate the development of cardiac hypertrophy.	[Schulz, Emily M.; Sheikh, Hajer N.; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Correll, Richard N.; Molkentin, Jeffery D.] Univ Cincinnati, Coll Med, Dept Pediat, Howard Hughes Med Inst, Cincinnati, OH 45267 USA; [Newman, Gilbert; Schultz, Jo El J.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Lofrano-Alves, Marco S.; Wolska, Beata M.] Univ Illinois, Ctr Cardiovasc Res, Dept Med, Chicago, IL 60612 USA; [Engel, Patti L.; Wolska, Beata M.; Solaro, R. John] Univ Illinois, Ctr Cardiovasc Res, Dept Physiol & Biophys, Chicago, IL 60612 USA	University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wieczorek, DF (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	David.Wieczorek@uc.edu	Alves, Marco/H-5924-2013	LOFRANO-ALVES, MARCO/0000-0003-0794-7339; Sheikh, Hajer/0000-0002-6411-5259; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health [RO1 HL-081680, RO1 HL-064035, PO1 HL062427, T32 HL-07382, F32HL097551, T32 HL-07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, T32HL007692, R01HL081680, T32HL007382, R01HL062427, F32HL097551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-081680 (to D. F. W.), RO1 HL-064035 (to R. J. S. and B. M. W.), PO1 HL062427 (to R. J. S.), T32 HL-07382 (to E. M. S.), F32HL097551 (to R. N. C.), and T32 HL-07692 (to P. L. E.).	ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; BALL KL, 1994, J MOL CELL CARDIOL, V26, P519, DOI 10.1006/jmcc.1994.1062; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; DEBELLE I, 1987, BIOCHIM BIOPHYS ACTA, V925, P17, DOI 10.1016/0304-4165(87)90143-7; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Donaldson C, 2009, CIRC RES, V104, P265, DOI 10.1161/CIRCRESAHA.108.190397; Fidzianska A, 2010, J ELECTRON MICROSC, V59, P181, DOI 10.1093/jmicro/dfp048; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Gaffin RD, 2004, J PHYSIOL-LONDON, V561, P777, DOI 10.1113/jphysiol.2004.070631; Gaffin RD, 2011, J MOL CELL CARDIOL, V51, P812, DOI 10.1016/j.yjmcc.2011.07.026; Gardner JD, 2008, AM J PHYSIOL-HEART C, V294, pH198, DOI 10.1152/ajpheart.00281.2007; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Haines CD, 2012, ENDOCRINOLOGY, V153, P4480, DOI 10.1210/en.2012-1353; Hamilton M, 2001, J BIOL CHEM, V276, P29079, DOI 10.1074/jbc.M102001200; HEELEY DA, 1982, FEBS LETT, V146, P115, DOI 10.1016/0014-5793(82)80716-3; HEELEY DH, 1989, J BIOL CHEM, V264, P2424; HEELEY DH, 1994, EUR J BIOCHEM, V221, P129, DOI 10.1111/j.1432-1033.1994.tb18721.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hilioti Z, 2003, BIOCHEM BIOPH RES CO, V311, P1089, DOI 10.1016/S0006-291X(03)01515-8; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jiao QB, 2009, AM J PHYSIOL-HEART C, V297, pH576, DOI 10.1152/ajpheart.00946.2008; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kemi OJ, 2007, J MOL CELL CARDIOL, V43, P354, DOI 10.1016/j.yjmcc.2007.06.013; Khoynezhad A, 2007, TEX HEART I J, V34, P352; Liao SY, 2007, J MOL CELL CARDIOL, V42, P106, DOI 10.1016/j.yjmcc.2006.10.005; Lu L, 2002, J APPL PHYSIOL, V92, P1524, DOI 10.1152/japplphysiol.00405.2001; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; MAK A, 1978, P NATL ACAD SCI USA, V75, P3588, DOI 10.1073/pnas.75.8.3588; Mattiazzi A, 2006, BRAZ J MED BIOL RES, V39, P563, DOI 10.1590/S0100-879X2006000500001; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MONTGOMERY K, 1984, J BIOL CHEM, V259, P5555; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Moss RL, 2006, CIRC RES, V99, P225, DOI 10.1161/01.RES.0000236793.88131.dc; Muthuchamy M, 1999, CIRC RES, V85, P47; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; ONEILL L, 1991, CARDIOSCIENCE, V2, P1; Pena JR, 2010, J MOL CELL CARDIOL, V49, P993, DOI 10.1016/j.yjmcc.2010.09.010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinz I, 2011, J BIOL CHEM, V286, P10163, DOI 10.1074/jbc.M110.210757; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rajan S, 2010, CIRCULATION, V121, P410, DOI 10.1161/CIRCULATIONAHA.109.889725; REDDY YS, 1973, J MOL CELL CARDIOL, V5, P461, DOI 10.1016/0022-2828(73)90016-3; Robia SL, 2001, BIOPHYS J, V80, P2140, DOI 10.1016/S0006-3495(01)76187-5; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Schmidt U, 1999, AM J PHYSIOL-HEART C, V277, pH474, DOI 10.1152/ajpheart.1999.277.2.H474; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; van Deel ED, 2011, J MOL CELL CARDIOL, V50, P1017, DOI 10.1016/j.yjmcc.2011.01.016; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; Warren CM, 2008, PROTEOMICS, V8, P100, DOI 10.1002/pmic.200700772; WATSON MH, 1988, BIOCHEMISTRY-US, V27, P4506, DOI 10.1021/bi00412a043; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Wolska BM, 1999, CIRC RES, V84, P745; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008	66	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44478	44489		10.1074/jbc.M112.402040	http://dx.doi.org/10.1074/jbc.M112.402040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148217	Green Published, hybrid			2022-12-25	WOS:000312938600044
J	de Vienne, DM; Aze, J				de Vienne, Damien M.; Aze, Jerome			Efficient Prediction of Co-Complexed Proteins Based on Coevolution	PLOS ONE			English	Article							DATABASE; INFORMATION; SIMILARITY; ALIGNMENTS; INFERENCE; SELECTION	The prediction of the network of protein-protein interactions (PPI) of an organism is crucial for the understanding of biological processes and for the development of new drugs. Machine learning methods have been successfully applied to the prediction of PPI in yeast by the integration of multiple direct and indirect biological data sources. However, experimental data are not available for most organisms. We propose here an ensemble machine learning approach for the prediction of PPI that depends solely on features independent from experimental data. We developed new estimators of the coevolution between proteins and combined them in an ensemble learning procedure. We applied this method to a dataset of known co-complexed proteins in Escherichia coli and compared it to previously published methods. We show that our method allows prediction of PPI with an unprecedented precision of 95.5% for the first 200 sorted pairs of proteins compared to 28.5% on the same dataset with the previous best method. A close inspection of the best predicted pairs allowed us to detect new or recently discovered interactions between chemotactic components, the flagellar apparatus and RNA polymerase complexes in E. coli. Citation: de Vienne DM, Aze J (2012) Efficient Prediction of Co-Complexed Proteins Based on Coevolution. PLoS ONE 7(11): e48728. doi:10.1371/journal.pone.0048728	[de Vienne, Damien M.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain; [de Vienne, Damien M.] Univ Pompeu Fabra, Barcelona, Spain; [Aze, Jerome] Univ Paris 11, Rech Informat Lab, CNRS, UMR 8623, F-91405 Orsay, France	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	de Vienne, DM (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain.	damien.de-vienne@crg.es		de Vienne, Damien/0000-0001-9532-5251	Centre National de la Recherche Scientifique (CNRS) [UMR 8623]; University Paris-Sud 11; French National Agency for Research [ANR-05-MMSA-0009 MDMS NV 10]; ANR\Microbiogenomics	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud 11; French National Agency for Research(French National Research Agency (ANR)); ANR\Microbiogenomics(French National Research Agency (ANR))	The work was funded by the Centre National de la Recherche Scientifique (CNRS) (UMR 8623), the University Paris-Sud 11 and the French National Agency for Research (ANR-05-MMSA-0009 MDMS NV 10). DdV acknowledges a postodctoral grant from the ANR\Microbiogenomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Leon E, 2009, NUCLEIC ACIDS RES, V37, pD629, DOI 10.1093/nar/gkn853; Az J., 2002, P 16 EUR M CYB SYST, V2, P781; BLOOM M, 1986, J BACTERIOL, V166, P380, DOI 10.1128/jb.166.2.380-384.1986; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brin S., 1997, SIGMOD REC, P265, DOI [DOI 10.1145/253262.253327, 10.1145/253260.253327]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cohen J., 1960, ED PSYCHOL MEASUREME; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Craig RA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-6; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Domigos P., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P155; Dzeroski S., 2002, P 19 INT C MACH LEAR, P123; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ganascia JG, 1987, INT JOINT C ART INT, P345; Garcia-Jimenez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009969; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Good IJ, 2003, ESTIMATION PROBABILI; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hanks P., 1990, COMPUT LINGUIST, V16, P22, DOI DOI 10.3115/981623.981633; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kann MG, 2007, PROTEINS, V67, P811, DOI 10.1002/prot.21347; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Lallich S, 2004, EVALUATION VALIDATIO; Lavrac N, 1999, LECT NOTES ARTIF INT, V1634, P174; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Loevinger J, 1947, PSYCHOL MONOGR, V61, P1; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearson K., 1900, CRITERION GIVEN SYST; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Qiu J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000054; Rajagopala SV, 2009, PROTEOMICS, V9, P5296, DOI 10.1002/pmic.200900282; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Zhang T, 2000, LECT NOTES ARTIF INT, V1805, P245; Zhu XY, 1997, J BIOL CHEM, V272, P23758, DOI 10.1074/jbc.272.38.23758	49	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48728	10.1371/journal.pone.0048728	http://dx.doi.org/10.1371/journal.pone.0048728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152796	Green Published, gold, Green Submitted			2022-12-25	WOS:000312272600018
J	Ilhan, B; VanRullen, R				Ilhan, Barkin; VanRullen, Rufin			No Counterpart of Visual Perceptual Echoes in the Auditory System	PLOS ONE			English	Article							STEADY-STATE RESPONSES; 40-HZ; OSCILLATIONS; SPEECH; BRAIN; NOISE; POTENTIALS; MECHANISMS; TOOLBOX; MASKING	It has been previously demonstrated by our group that a visual stimulus made of dynamically changing luminance evokes an echo or reverberation at similar to 10 Hz, lasting up to a second. In this study we aimed to reveal whether similar echoes also exist in the auditory modality. A dynamically changing auditory stimulus equivalent to the visual stimulus was designed and employed in two separate series of experiments, and the presence of reverberations was analyzed based on reverse correlations between stimulus sequences and EEG epochs. The first experiment directly compared visual and auditory stimuli: while previous findings of similar to 10 Hz visual echoes were verified, no similar echo was found in the auditory modality regardless of frequency. In the second experiment, we tested if auditory sequences would influence the visual echoes when they were congruent or incongruent with the visual sequences. However, the results in that case similarly did not reveal any auditory echoes, nor any change in the characteristics of visual echoes as a function of audio-visual congruence. The negative findings from these experiments suggest that brain oscillations do not equivalently affect early sensory processes in the visual and auditory modalities, and that alpha (8-13 Hz) oscillations play a special role in vision. Citation: Ilhan B, VanRullen R (2012) No Counterpart of Visual Perceptual Echoes in the Auditory System. PLoS ONE 7(11): e49287. doi:10.1371/journal.pone.0049287	[Ilhan, Barkin; VanRullen, Rufin] Univ Toulouse 3, F-31062 Toulouse, France; [Ilhan, Barkin; VanRullen, Rufin] Fac Med Purpan, CNRS, Ctr Rech Cerveau & Cognit, UMR 5549, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ilhan, B (corresponding author), Univ Toulouse 3, F-31062 Toulouse, France.	barkin@unrlabs.org	Ilhan, Barkin/J-5059-2013; VanRullen, Rufin/B-2150-2008	Ilhan, Barkin/0000-0001-5757-9568; VanRullen, Rufin/0000-0002-3611-7716	EURYI Award	EURYI Award(European Science Foundation (ESF))	This research was funded by a EURYI Award to RV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Funke K, 2002, MODELS OF NEURAL NET, P131; GALAMBOS R, 1992, J ACOUST SOC AM, V92, P2683, DOI 10.1121/1.404383; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Kawase T, 2012, NEUROIMAGE, V59, P1037, DOI 10.1016/j.neuroimage.2011.08.108; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lalor EC, 2006, NEUROIMAGE, V32, P1549, DOI 10.1016/j.neuroimage.2006.05.054; Lalor EC, 2010, EUR J NEUROSCI, V31, P189, DOI 10.1111/j.1460-9568.2009.07055.x; Lalor EC, 2009, J NEUROPHYSIOL, V102, P349, DOI 10.1152/jn.90896.2008; Maki A, 2009, EAR HEARING, V30, P584, DOI 10.1097/AUD.0b013e3181acfb57; Muller N, 2012, CEREB CORTEX, V22, P1604, DOI 10.1093/cercor/bhr232; Nelken I, 2005, THE AUDITORY CORTEX; REGAN D, 1977, J OPT SOC AM, V67, P1475, DOI 10.1364/JOSA.67.001475; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; Saoud H, 2012, J NEUROSCI, V32, P275, DOI 10.1523/JNEUROSCI.3970-11.2012; Troxler D, 1804, OPHTHALMOLOGISCHE BI, P1; VanRullen R, 2012, CURR BIOL, V22, P995, DOI 10.1016/j.cub.2012.03.050; Weisz N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00073; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64	26	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49287	10.1371/journal.pone.0049287	http://dx.doi.org/10.1371/journal.pone.0049287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145143	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500097
J	Xu, GL; Stevens, SM; Kobiessy, F; Brown, H; McClung, S; Gold, MS; Borchelt, DR				Xu, Guilian; Stevens, Stanley M., Jr.; Kobiessy, Firas; Brown, Hilda; McClung, Scott; Gold, Mark S.; Borchelt, David R.			Identification of Proteins Sensitive to Thermal Stress in Human Neuroblastoma and Glioma Cell Lines	PLOS ONE			English	Article							HEAT-SHOCK; STATISTICAL-MODEL; EXPRESSION; UBIQUITIN; DATABASE; DEGENERATION; AGGREGATION; DISEASE; BINDING; TDP-43	Heat-shock is an acute insult to the mammalian proteome. The sudden elevation in temperature has far-reaching effects on protein metabolism, leads to a rapid inhibition of most protein synthesis, and the induction of protein chaperones. Using heat-shock in cells of neuronal (SH-SY5Y) and glial (CCF-STTG1) lineage, in conjunction with detergent extraction and sedimentation followed by LC-MS/MS proteomic approaches, we sought to identify human proteins that lose solubility upon heat-shock. The two cell lines showed largely overlapping profiles of proteins detected by LC-MS/MS. We identified 58 proteins in detergent insoluble fractions as losing solubility in after heat shock; 10 were common between the 2 cell lines. A subset of the proteins identified by LC-MS/MS was validated by immunoblotting of similarly prepared fractions. Ultimately, we were able to definitively identify 3 proteins as putatively metastable neural proteins; FEN1, CDK1, and TDP-43. We also determined that after heat-shock these cells accumulate insoluble polyubiquitin chains largely linked via lysine 48 (K-48) residues. Collectively, this study identifies human neural proteins that lose solubility upon heat-shock. These proteins may represent components of the human proteome that are vulnerable to misfolding in settings of proteostasis stress. Citation: Xu G, Stevens SM Jr, Kobiessy F, Brown H, McClung S, et al. (2012) Identification of Proteins Sensitive to Thermal Stress in Human Neuroblastoma and Glioma Cell Lines. PLoS ONE 7(11): e49021. doi:10.1371/journal.pone.0049021	[Xu, Guilian; Brown, Hilda; Borchelt, David R.] Univ Florida, Dept Neurosci, Santa Fe Hlth Alzheimers Dis Res Ctr, Gainesville, FL 32610 USA; [Stevens, Stanley M., Jr.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA; [Kobiessy, Firas; Gold, Mark S.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [McClung, Scott] Univ Florida, ICBR, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Xu, GL (corresponding author), Univ Florida, Dept Neurosci, Santa Fe Hlth Alzheimers Dis Res Ctr, Gainesville, FL 32610 USA.	xugl@ufl.edu; drb1@ufl.edu	Kobeissy, Firas/E-7042-2017; Stevens, Stanley M./E-4120-2013	Kobeissy, Firas/0000-0002-5008-6944; Stevens, Stanley/0000-0002-1399-0256	French Foundation Fellowship; National Institutes of Health [R21AG025426, R01NS44278]; SantaFe HealthCare Alzheimer's Disease Research Center; Huntington's Disease Society of America Coalition for a Cure; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG025426] Funding Source: NIH RePORTER	French Foundation Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SantaFe HealthCare Alzheimer's Disease Research Center; Huntington's Disease Society of America Coalition for a Cure; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by French Foundation Fellowship (GX), National Institutes of Health grants R21AG025426 (DRB), R01NS44278 (DRB), the SantaFe HealthCare Alzheimer's Disease Research Center, and the Huntington's Disease Society of America Coalition for a Cure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P62, DOI 10.1097/nen.0b013e3181609361; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Higgs RE, 2005, J PROTEOME RES, V4, P1442, DOI 10.1021/pr050109b; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NIEDZWIECKI A, 1993, DEV GENET, V14, P78, DOI 10.1002/dvg.1020140110; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Prokai L, 2009, J PROTEOME RES, V8, P3862, DOI 10.1021/pr900083v; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sokal R. R., 2012, BIOMETRY; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P1633, DOI 10.1093/hmg/ddr040; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tjong H, 2008, BIOPHYS J, V95, P2601, DOI 10.1529/biophysj.107.127746; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5	29	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49021	10.1371/journal.pone.0049021	http://dx.doi.org/10.1371/journal.pone.0049021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145051	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500060
J	Colleye, O; Parmentier, E				Colleye, Orphal; Parmentier, Eric			Overview on the Diversity of Sounds Produced by Clownfishes (Pomacentridae): Importance of Acoustic Signals in Their Peculiar Way of Life	PLOS ONE			English	Article							REPRODUCTIVE-BEHAVIOR; AMPHIPRION-CLARKII; SEX CHANGE; ANEMONEFISH; SIZE; HIERARCHIES; PISCES; CALLS	Background: Clownfishes (Pomacentridae) are brightly colored coral reef fishes well known for their mutualistic symbiosis with tropical sea anemones. These fishes live in social groups in which there is a size-based dominance hierarchy. In this structure where sex is socially controlled, agonistic interactions are numerous and serve to maintain size differences between individuals adjacent in rank. Clownfishes are also prolific callers whose sounds seem to play an important role in the social hierarchy. Here, we aim to review and to synthesize the diversity of sounds produced by clownfishes in order to emphasize the importance of acoustic signals in their way of life. Methodology/Principal Findings: Recording the different acoustic behaviors indicated that sounds are divided into two main categories: aggressive sounds produced in conjunction with threat postures (charge and chase), and submissive sounds always emitted when fish exhibited head shaking movements (i.e. a submissive posture). Both types of sounds showed size-related intraspecific variation in dominant frequency and pulse duration: smaller individuals produce higher frequency and shorter duration pulses than larger ones, and inversely. Consequently, these sonic features might be useful cues for individual recognition within the group. This observation is of significant importance due to the size-based hierarchy in clownfish group. On the other hand, no acoustic signal was associated with the different reproductive activities. Conclusions/Significance: Unlike other pomacentrids, sounds are not produced for mate attraction in clownfishes but to reach and to defend the competition for breeding status, which explains why constraints are not important enough for promoting call diversification in this group.	[Colleye, Orphal; Parmentier, Eric] Univ Liege, Lab Funct & Evolutionary Morphol, Liege, Belgium	University of Liege	Colleye, O (corresponding author), Univ Liege, Lab Funct & Evolutionary Morphol, Liege, Belgium.	O.Colleye@ulg.ac.be	Parmentier, Eric/P-9733-2018	Parmentier, Eric/0000-0002-0391-7530	Takeda Science Foundation; 21st Century Center of Excellence project entitled "The Comprehensive Analyses on Biodiversity in Coral Reef and Island Ecosystems in Asian and Pacific Regions" from the University of the Ryukyus via a Visiting Fellowship; "Concours des bourses de voyage 2009" from "Ministere de la Communaute francaise de Belgique"; Fonds de la Recherche Fondamentale Collective (FRFC) [2.4.535.10.F]; F.R.S.-FNRS (Bourse de Doctorat F.R.S.-FNRS)	Takeda Science Foundation(Takeda Science Foundation (TSF)); 21st Century Center of Excellence project entitled "The Comprehensive Analyses on Biodiversity in Coral Reef and Island Ecosystems in Asian and Pacific Regions" from the University of the Ryukyus via a Visiting Fellowship; "Concours des bourses de voyage 2009" from "Ministere de la Communaute francaise de Belgique"; Fonds de la Recherche Fondamentale Collective (FRFC)(Fonds de la Recherche Scientifique - FNRS); F.R.S.-FNRS (Bourse de Doctorat F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Takeda Science Foundation and a 21st Century Center of Excellence project entitled "The Comprehensive Analyses on Biodiversity in Coral Reef and Island Ecosystems in Asian and Pacific Regions" from the University of the Ryukyus via a Visiting Fellowship, by a grant entitled "Concours des bourses de voyage 2009" from "Ministere de la Communaute francaise de Belgique" attributed to OC, and by a grant from Fonds de la Recherche Fondamentale Collective (FRFC) (no. 2.4.535.10.F) delivered by the Belgian National Fund for Scientific Research. OC was supported by a grant from the F.R.S.-FNRS (Bourse de Doctorat F.R.S.-FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Allen GR, 1972, THE ANEMONEFISHES TH; Allen GR, 1991, DAMSELFISHES OF THE; Amorim MCP, 2008, J FISH BIOL, V73, P1267, DOI 10.1111/j.1095-8649.2008.01974.x; Amorim Maria Clara P., 2006, P71; Amorim MCP, 2004, J FISH BIOL, V65, P182, DOI 10.1111/j.0022-1112.2004.00443.x; Bee MA, 2001, ETHOLOGY, V107, P65, DOI 10.1046/j.1439-0310.2001.00640.x; BROWN DH, 1978, BEHAVIOUR, V67, P299, DOI 10.1163/156853978X00378; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Buston PM, 2006, OECOLOGIA, V149, P362, DOI 10.1007/s00442-006-0442-z; CHEN KC, 1988, JPN J ICHTHYOL, V35, P90; Christie PJ, 2004, BEHAVIOUR, V141, P101, DOI 10.1163/156853904772746628; Colleye O, 2009, J FISH BIOL, V75, P908, DOI 10.1111/j.1095-8649.2009.02316.x; Colleye O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-365; Crawford JD, 1997, J COMP PHYSIOL A, V159, P297; Dos Santos Manuel E., 2000, Bioacoustics, V10, P309; Egner SA, 2005, MAR ECOL PROG SER, V285, P213, DOI 10.3354/meps285213; Fautin DG, 1992, FIELD GUIDE TO ANEMO; Fay RR, 1988, HEARING IN VERTEBRAT; FRICKE H W, 1974, Zeitschrift fuer Tierpsychologie, V36, P429; FRICKE HW, 1979, Z TIERPSYCHOL, V50, P313; Gordon Andrew K., 2001, Aquarium Sciences and Conservation, V3, P307; Hawkins A.D., 1993, Fish and Fisheries Series, V7, P129; Hoff F.H., 1996, CONDITIONING SPAWNIN; Ladich F, 1997, MAR FRESHW BEHAV PHY, V29, P87, DOI 10.1080/10236249709379002; Lugli M, 1997, MAR FRESHW BEHAV PHY, V29, P109, DOI 10.1080/10236249709379003; Mann DA, 1998, ENVIRON BIOL FISH, V51, P421, DOI 10.1023/A:1007410429942; Mann David A., 2006, P107; MOYER J T, 1976, Japanese Journal of Ichthyology, V23, P23; OCHI H, 1989, ENVIRON BIOL FISH, V26, P257, DOI 10.1007/BF00002463; Parmentier E, 2005, P ROY SOC B-BIOL SCI, V272, P1697, DOI 10.1098/rspb.2005.3146; Parmentier E, 2007, SCIENCE, V316, P1006, DOI 10.1126/science.1139753; Parmentier E, 2010, MAR BIOL, V157, P2317, DOI 10.1007/s00227-010-1498-1; Parmentier E, 2009, J EXP BIOL, V212, P2022, DOI 10.1242/jeb.030270; Reese E. S., 1964, Oceanography and Marine Biology Annual Review, V2, P455; Richardson DL, 1997, MAR ECOL PROG SER, V156, P175, DOI 10.3354/meps156175; Riggio R, 1981, THESIS; ROSS RM, 1978, COPEIA, P103; SCHNEIDER H, 1967, P135; Schneider H., 1964, MORPHOL KOL TIERE, V53, P453; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; TAKEMURA A, 1983, B FAC FISH NAGASAKI, V54, P21; Tovolga W.N., 1971, P135; Winn H.E., 1964, MARINE BIOACOUSTICS, P213	44	39	40	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49179	10.1371/journal.pone.0049179	http://dx.doi.org/10.1371/journal.pone.0049179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145114	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800225
J	Fouts, DE; Szpakowski, S; Purushe, J; Torralba, M; Waterman, RC; MacNeil, MD; Alexander, LJ; Nelson, KE				Fouts, Derrick E.; Szpakowski, Sebastian; Purushe, Janaki; Torralba, Manolito; Waterman, Richard C.; MacNeil, Michael D.; Alexander, Leeson J.; Nelson, Karen E.			Next Generation Sequencing to Define Prokaryotic and Fungal Diversity in the Bovine Rumen	PLOS ONE			English	Article							RIBOSOMAL-RNA; MICROBIAL-POPULATIONS; GEL-ELECTROPHORESIS; GENES; DISCOVERY; QUALITY; IDENTIFICATION; COMMUNITY; DATABASE; ECOLOGY	A combination of Sanger and 454 sequences of small subunit rRNA loci were used to interrogate microbial diversity in the bovine rumen of 12 cows consuming a forage diet. Observed bacterial species richness, based on the V1-V3 region of the 16S rRNA gene, was between 1,903 to 2,432 species-level operational taxonomic units (OTUs) when 5,520 reads were sampled per animal. Eighty percent of species-level OTUs were dominated by members of the order Clostridiales, Bacteroidales, Erysipelotrichales and unclassified TM7. Abundance of Prevotella species varied widely among the 12 animals. Archaeal species richness, also based on 16S rRNA, was between 8 and 13 OTUs, representing 5 genera. The majority of archaeal OTUs (84%) found in this study were previously observed in public databases with only two new OTUs discovered. Observed rumen fungal species richness, based on the 18S rRNA gene, was between 21 and 40 OTUs with 98.4-99.9% of OTUs represented by more than one read, using Good's coverage. Examination of the fungal community identified numerous novel groups. Prevotella and Tannerella were overrepresented in the liquid fraction of the rumen while Butyrivibrio and Blautia were significantly overrepresented in the solid fraction of the rumen. No statistical difference was observed between the liquid and solid fractions in biodiversity of archaea and fungi. The survey of microbial communities and analysis of cross-domain correlations suggested there is a far greater extent of microbial diversity in the bovine rumen than previously appreciated, and that next generation sequencing technologies promise to reveal novel species, interactions and pathways that can be studied further in order to better understand how rumen microbial community structure and function affects ruminant feed efficiency, biofuel production, and environmental impact.	[Fouts, Derrick E.; Szpakowski, Sebastian; Purushe, Janaki; Torralba, Manolito; Nelson, Karen E.] JCVI, Rockville, MD USA; [Waterman, Richard C.; MacNeil, Michael D.; Alexander, Leeson J.] USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA	J. Craig Venter Institute; United States Department of Agriculture (USDA)	Fouts, DE (corresponding author), JCVI, Rockville, MD USA.	dfouts@jcvi.org		Purushe, Janaki/0000-0001-7767-2700	United States Department of Agriculture-Agricultural Research Service CRIS [5434-31000-014-00D]	United States Department of Agriculture-Agricultural Research Service CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by United States Department of Agriculture-Agricultural Research Service CRIS project # 5434-31000-014-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edwards JE, 2005, MICROBIOL-SGM, V151, P717, DOI 10.1099/mic.0.27602-0; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gihring TM, 2011, ENV MICROBIOLOGY; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hegarty RS, 2007, J ANIM SCI, V85, P1479, DOI 10.2527/jas.2006-236; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; KLIEVE AV, 1993, APPL ENVIRON MICROB, V59, P2299, DOI 10.1128/AEM.59.7.2299-2303.1993; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lissens G, 2004, BIODEGRADATION, V15, P173, DOI 10.1023/B:BIOD.0000026515.16311.4a; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MACKIE RI, 1990, J DAIRY SCI, V73, P2971, DOI 10.3168/jds.S0022-0302(90)78986-2; Mackie RI, 1997, GASTROINTESTINAL MIC; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seal BS, 2011, ARCH VIROL, V156, P25, DOI 10.1007/s00705-010-0812-z; Shin EC, 2004, J APPL MICROBIOL, V97, P378, DOI 10.1111/j.1365-2672.2004.02304.x; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Vianna ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006; Wright ADG, 2006, ANAEROBE, V12, P134, DOI 10.1016/j.anaerobe.2006.02.002; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	44	199	238	7	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48289	10.1371/journal.pone.0048289	http://dx.doi.org/10.1371/journal.pone.0048289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144861	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800043
J	Gokhin, DS; Nowak, RB; Kim, NE; Arnett, EE; Chen, AC; Sah, RL; Clark, JI; Fowler, VM				Gokhin, David S.; Nowak, Roberta B.; Kim, Nancy E.; Arnett, Ernest E.; Chen, Albert C.; Sah, Robert L.; Clark, John I.; Fowler, Velia M.			Tmod1 and CP49 Synergize to Control the Fiber Cell Geometry, Transparency, and Mechanical Stiffness of the Mouse Lens	PLOS ONE			English	Article							BOVINE ARTICULAR-CARTILAGE; DOMINANT CONGENITAL CATARACT; FILAMENT PROTEIN CP49; BEADED FILAMENT; MEMBRANE SKELETON; CRYSTALLINE LENS; INTERMEDIATE-FILAMENTS; CONFINED COMPRESSION; CHINESE FAMILY; BFSP2 MUTATION	The basis for mammalian lens fiber cell organization, transparency, and biomechanical properties has contributions from two specialized cytoskeletal systems: the spectrin-actin membrane skeleton and beaded filament cytoskeleton. The spectrin-actin membrane skeleton predominantly consists of alpha(2)beta(2)-spectrin strands interconnecting short, tropomyosin-coated actin filaments, which are stabilized by pointed-end capping by tropomodulin 1 (Tmod1) and structurally disrupted in the absence of Tmod1. The beaded filament cytoskeleton consists of the intermediate filament proteins CP49 and filensin, which require CP49 for assembly and contribute to lens transparency and biomechanics. To assess the simultaneous physiological contributions of these cytoskeletal networks and uncover potential functional synergy between them, we subjected lenses from mice lacking Tmod1, CP49, or both to a battery of structural and physiological assays to analyze fiber cell disorder, light scattering, and compressive biomechanical properties. Findings show that deletion of Tmod1 and/or CP49 increases lens fiber cell disorder and light scattering while impairing compressive load-bearing, with the double mutant exhibiting a distinct phenotype compared to either single mutant. Moreover, Tmod1 is in a protein complex with CP49 and filensin, indicating that the spectrin-actin network and beaded filament cytoskeleton are biochemically linked. These experiments reveal that the spectrin-actin membrane skeleton and beaded filament cytoskeleton establish a novel functional synergy critical for regulating lens fiber cell geometry, transparency, and mechanical stiffness.	[Gokhin, David S.; Nowak, Roberta B.; Kim, Nancy E.; Fowler, Velia M.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Arnett, Ernest E.; Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Chen, Albert C.; Sah, Robert L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Scripps Research Institute; University of Washington; University of Washington Seattle; University of California System; University of California San Diego	Fowler, VM (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	velia@scripps.edu		Fowler, Velia/0000-0002-3161-8802	National Institutes of Health/National Eye Institute [R01-EY017724, R01-EY004542]; National Institutes of Health/National Heart, Lung, and Blood Institute [T32-HL007195]; Howard Hughes Medical Institute through the HHMI Professors Program; NATIONAL EYE INSTITUTE [R01EY004542, R01EY017724, P30EY001730] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute through the HHMI Professors Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Eye Institute grant R01-EY017724 (to VMF), National Institutes of Health/National Heart, Lung, and Blood Institute vascular biology training grant T32-HL007195 (to DSG), National Institutes of Health/National Eye Institute grant R01-EY004542 (to JIC), and a grant to the University of California San Diego from the Howard Hughes Medical Institute through the HHMI Professors Program (to RLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Alizadeh A, 2003, INVEST OPHTH VIS SCI, V44, P5252, DOI 10.1167/iovs.03-0224; Alizadeh A, 2002, INVEST OPHTH VIS SCI, V43, P3722; Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; [Anonymous], 1981, MOL CELLULAR BIOL EY; Baradia H, 2010, EXP EYE RES, V91, P300, DOI 10.1016/j.exer.2010.06.003; Bassnett S, 2003, EXP EYE RES, V76, P291, DOI 10.1016/S0014-4835(02)00315-9; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Blankenship TN, 2001, INVEST OPHTH VIS SCI, V42, P735; Blankenship T, 2007, INVEST OPHTH VIS SCI, V48, P3269, DOI 10.1167/iovs.07-0109; Chen AC, 2001, J BIOMECH, V34, P1, DOI 10.1016/S0021-9290(00)00170-6; Chu X, 2003, AM J PHYSIOL-HEART C, V284, pH1827, DOI 10.1152/ajpheart.00947.2002; Conley YP, 2000, AM J HUM GENET, V66, P1426, DOI 10.1086/302871; Cooper MA, 2008, P NATL ACAD SCI USA, V105, P16620, DOI 10.1073/pnas.0808987105; Cui X, 2007, MOL VIS, V13, P2023; Duncan M.K., 2004, DEV OCULAR LENS; Fischer RS, 2000, INVEST OPHTH VIS SCI, V41, P166; Fischer RS, 2003, FEBS LETT, V547, P228, DOI 10.1016/S0014-5793(03)00711-7; FISHER RF, 1977, J PHYSIOL-LONDON, V270, P51, DOI 10.1113/jphysiol.1977.sp011938; FitzGerald PG, 2009, EXP EYE RES, V88, P165, DOI 10.1016/j.exer.2008.11.007; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Fudge DS, 2011, INVEST OPHTH VIS SCI, V52, P3860, DOI 10.1167/iovs.10-6231; Gokhin David S, 2011, Bioarchitecture, V1, P175; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Hozic A, 2012, INVEST OPHTH VIS SCI, V53, P2151, DOI 10.1167/iovs.11-8676; Jakobs PM, 2000, AM J HUM GENET, V66, P1432, DOI 10.1086/302872; Janmey P A, 1998, Subcell Biochem, V31, P381; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Klein TJ, 2007, J BIOMECH, V40, P182, DOI 10.1016/j.jbiomech.2005.11.002; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; Kuszak JR, 1995, INT REV CYTOL, V163, P305, DOI 10.1016/S0074-7696(08)62213-5; KUSZAK JR, 1983, SCAN ELECTRON MICROS, P1415; KUWABARA T, 1975, EXP EYE RES, V20, P427, DOI 10.1016/0014-4835(75)90085-8; Lee A, 2000, DEV DYNAM, V217, P257, DOI 10.1002/(SICI)1097-0177(200003)217:3<257::AID-DVDY4>3.0.CO;2-5; Maddala R, 2011, DEV BIOL, V357, P179, DOI 10.1016/j.ydbio.2011.06.036; McKeown CR, 2008, CIRC RES, V103, P1241, DOI 10.1161/CIRCRESAHA.108.178749; MOHANDAS N, 1983, SEMIN HEMATOL, V20, P225; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; More MI, 2001, J CELL BIOL, V154, P187, DOI 10.1083/jcb.200104038; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Nowak RB, 2012, J HISTOCHEM CYTOCHEM, V60, P414, DOI 10.1369/0022155412440881; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; Oka M, 2008, MOL VIS, V14, P815; Reilly M, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3072891; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Sandilands A, 2003, EXP EYE RES, V76, P385, DOI 10.1016/S0014-4835(02)00330-5; SANDILANDS A, 1995, EUR J CELL BIOL, V67, P238; SANDILANDS A, 1995, J CELL SCI, V108, P1397; Scarcelli G, 2011, BIOPHYS J, V101, P1539, DOI 10.1016/j.bpj.2011.08.008; Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404; Seeberger TM, 2004, J BIOMED OPT, V9, P116, DOI 10.1117/1.1630034; Simirskii VN, 2006, INVEST OPHTH VIS SCI, V47, P4931, DOI 10.1167/iovs.06-0423; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Suozzi KC, 2012, J CELL BIOL, V197, P465, DOI 10.1083/jcb.201112034; TARDIEU A, 1988, ANNU REV BIOPHYS BIO, V17, P47; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; WILLEKENS B, 1981, A GRAEF ARCH KLIN EX, V216, P275, DOI 10.1007/BF00455035; Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3; WOO MK, 1994, J CELL SCI, V107, P1359; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; Yoon KH, 2008, INVEST OPHTH VIS SCI, V49, P1030, DOI 10.1167/iovs.07-1149; Zhang L, 2006, MOL VIS, V12, P1626; Ziebarth NM, 2007, MOL VIS, V13, P504	67	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48734	10.1371/journal.pone.0048734	http://dx.doi.org/10.1371/journal.pone.0048734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144950	Green Submitted, gold, Green Published			2022-12-25	WOS:000311935800116
J	Gosenca, D; Gabriel, U; Steidler, A; Mayer, J; Diem, O; Erben, P; Fabarius, A; Leib-Mosch, C; Hofmann, WK; Seifarth, W				Gosenca, Darko; Gabriel, Ute; Steidler, Annette; Mayer, Jens; Diem, Olivia; Erben, Philipp; Fabarius, Alice; Leib-Moesch, Christine; Hofmann, Wolf-Karsten; Seifarth, Wolfgang			HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma	PLOS ONE			English	Article							HUMAN-ENDOGENOUS-RETROVIRUS; NATURAL ANTISENSE TRANSCRIPTS; LONG TERMINAL REPEAT; TRANSPOSABLE ELEMENTS; HUMAN TISSUES; HUMAN GENOME; GENE-EXPRESSION; BLADDER-CANCER; REGULATORY SEQUENCES; KIDNEY CANCER	Human endogenous retroviruses (HERV) and related elements account for more than 8% of the human genome and significantly contribute to the human transcriptome by long terminal repeat (LTR) promoter activity. In this context, HERVs are thought to intervene in the expression of adjacent genes by providing regulatory sequences (cis-effect) or via noncoding RNA including natural antisense transcripts. To address the potential impact of HERV activity in urothelial carcinoma, we comparatively analyzed the HERV transcription profiles in paired samples of non-malignant urothelium and urothelial carcinoma derived from 13 patients with bladder cancer by means of a retrovirus-specific microarray (RetroArray). We established a characteristic HERV signature consisting of six ubiquitously active HERV subgroups (E4-1, HERV-Rb, ERV9, HERV-K-T47D, NMWV3, HERV-KC4). The transcription pattern is largely identical in human urothelial carcinoma, nonmalignant urothelial tissue, four tumor-derived cell lines and in a non-malignant urothelial cell line (UROtsa). Quantitative reverse transcriptase PCR (qRT-PCR) of HERV-E4-1, HERV-K(HML-6) and HERV-T(S71-TK1) revealed a bias to lower HERV activity in carcinoma samples compared to non-malignant tissue. Determination of active HERV-E4-1 loci by cloning and sequencing revealed six HERV-E4-1 proviral loci that are differentially regulated in urothelial carcinoma cells and normal tissue. Two full-length HERV-E4-1 proviruses, HERV-Ec1 and HERV-Ec6, are located in antisense orientation in introns of the genes PLA2G4A and RNGTT, respectively. PLA2G4A encodes a cytosolic phospholipase A2 (cPLA2) that is dysregulated in many human tumors. PLA2G4A and HERV-Ec1 displayed reciprocal transcript levels in 7 of 11 urothelial carcinoma patients. Moreover, reciprocal shifts were observed after treatment of UROtsa cells with HERV-Ec1 and PLA2G4A-directed siRNAs or 5-aza-2'-deoxycytidine (aza-dC) pointing to an antagonistic regulation of PLA2G4A and HERV-Ec1 transcription in human urothelial cells. We suggest that transcription of HERV-Ec1 contributes to fine tuning of cPLA2 expression, thereby facilitating tumorigenesis.	[Gosenca, Darko; Erben, Philipp; Fabarius, Alice; Leib-Moesch, Christine; Hofmann, Wolf-Karsten; Seifarth, Wolfgang] Heidelberg Univ, Mannheim Med Ctr, Dept Hematol & Oncol, D-6800 Mannheim, Germany; [Gabriel, Ute; Steidler, Annette; Erben, Philipp] Heidelberg Univ, Mannheim Med Ctr, Dept Urol, D-6800 Mannheim, Germany; [Mayer, Jens] Univ Saarland, Fac Med, Ctr Human & Mol Biol, Dept Human Genet, D-6650 Homburg, Germany; [Diem, Olivia; Leib-Moesch, Christine] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Saarland University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gosenca, D (corresponding author), Heidelberg Univ, Mannheim Med Ctr, Dept Hematol & Oncol, D-6800 Mannheim, Germany.	darko.gosenca1@medma.uni-heidelberg.de	Mayer, Jens/P-4777-2019; Mayer, Jens/B-8506-2013; Erben, Philipp/AAR-4908-2020	Mayer, Jens/0000-0002-1090-5765; Mayer, Jens/0000-0002-1090-5765; Erben, Philipp/0000-0002-8279-7636	Deutsche Forschungsgemeinschaft (DFG) [AOBJ:578385]; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by grant AOBJ:578385 to WS and PE from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de). The research of JM is supported by DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruester V, 2002, CLIN CANCER RES, V8, P1800; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Baust C, 2000, GENOMICS, V66, P98, DOI 10.1006/geno.2000.6175; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Blomberg J, 2009, GENE, V448, P115, DOI 10.1016/j.gene.2009.06.007; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Britten R, 2006, P NATL ACAD SCI USA, V103, P1798, DOI 10.1073/pnas.0510007103; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Buzdin A, 2007, THESCIENTIFICWORLDJO, V7, P1848, DOI 10.1100/tsw.2007.270; Buzdin A, 2006, J VIROL, V80, P10752, DOI 10.1128/JVI.00871-06; Cherkasova E, 2011, ONCOGENE, V30, P4697, DOI 10.1038/onc.2011.179; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Domansky AN, 2000, FEBS LETT, V472, P191, DOI 10.1016/S0014-5793(00)01460-5; Doug M, 2003, CARCINOGENESIS, V24, P307, DOI 10.1093/carcin/24.2.307; Dunn CA, 2006, GENE, V366, P335, DOI 10.1016/j.gene.2005.09.003; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Flockerzi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-354; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Frank O, 2005, J VIROL, V79, P10890, DOI 10.1128/JVI.79.17.10890-10901.2005; Frank O, 2008, J VIROL, V82, P1808, DOI 10.1128/JVI.02115-07; Gabriel U, 2012, MOL CARCINOGEN, V51, P907, DOI 10.1002/mc.20860; Gabriel U, 2008, ONCOL REP, V20, P1419, DOI 10.3892/or_00000161; GATTONICELLI S, 1986, P NATL ACAD SCI USA, V83, P6127, DOI 10.1073/pnas.83.16.6127; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Gogvadze E, 2009, J VIROL, V83, P6098, DOI 10.1128/JVI.00123-09; Grignon DJ, 2009, MODERN PATHOL, V22, pS60, DOI 10.1038/modpathol.2008.235; Hatada S, 2003, GENE, V319, P55, DOI 10.1016/S0378-1119(03)00791-1; Haupt S, 2011, J GEN VIROL, V92, P2356, DOI 10.1099/vir.0.031518-0; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Hu LJ, 2006, AIDS RES HUM RETROV, V22, P551, DOI 10.1089/aid.2006.22.551; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ishida Toshiaki, 2008, Cancer Immun, V8, P15; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KATO N, 1990, MOL CELL BIOL, V10, P4401, DOI 10.1128/MCB.10.8.4401; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Lamprecht B, 2010, CELL CYCLE, V9, P4276, DOI 10.4161/cc.9.21.13682; Landry JR, 2002, MOL BIOL EVOL, V19, P1934, DOI 10.1093/oxfordjournals.molbev.a004017; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; Li KG, 2010, ONCOTARGET, V1, P447, DOI 10.18632/oncotarget.178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mager D.L., 2005, NATURE ENCY HUMAN GE, DOI 10.1038/npg.els.0005062; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mullins CS, 2012, CANCER IMMUNOL IMMUN, V61, P1093, DOI 10.1007/s00262-011-1183-3; Muradrasoli S, 2006, J VIROL METHODS, V136, P83, DOI 10.1016/j.jviromet.2006.04.005; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Prusty BK, 2008, VIROLOGY, V382, P37, DOI 10.1016/j.virol.2008.09.006; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; SAUTER M, 1995, J VIROL, V69, P414, DOI 10.1128/JVI.69.1.414-421.1995; Schiavetti F, 2002, CANCER RES, V62, P5510; Schon U, 2009, J VIROL, V83, P12643, DOI 10.1128/JVI.00858-09; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Seifarth W, 2003, J VIROL METHODS, V112, P79, DOI 10.1016/S0166-0934(03)00194-0; Seifarth W, 2000, AIDS RES HUM RETROV, V16, P721, DOI 10.1089/088922200308729; Seifarth W, 2011, ENCY DNA RES; Sin HS, 2006, GENES GENET SYST, V81, P333, DOI 10.1266/ggs.81.333; Solyom S, 2012, GENOME MED, V4, DOI 10.1186/gm311; Stauffer Yves, 2004, Cancer Immun, V4, P2; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Sverdlov ED, 2005, RETROVIRUSES PRIMATE; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; TOMITA N, 1990, BIOCHEM BIOPH RES CO, V166, P1, DOI 10.1016/0006-291X(90)91904-7; Tosato G, 2010, J NATL CANCER I, V102, P1377, DOI 10.1093/jnci/djq324; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Wang-Johanning F, 2003, CANCER-AM CANCER SOC, V98, P187, DOI 10.1002/cncr.11451; Yi JM, 2007, GENES GENET SYST, V82, P89, DOI 10.1266/ggs.82.89	90	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49341	10.1371/journal.pone.0049341	http://dx.doi.org/10.1371/journal.pone.0049341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145155	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800246
J	Ndolo, RA; Luan, YP; Duan, SF; Forrest, ML; Krise, JP				Ndolo, Rosemary A.; Luan, Yepeng; Duan, Shaofeng; Forrest, M. Laird; Krise, Jeffrey P.			Lysosomotropic Properties of Weakly Basic Anticancer Agents Promote Cancer Cell Selectivity In Vitro	PLOS ONE			English	Article							TUMOR-CELLS; FLUORESCENCE POLARIZATION; DEFECTIVE ACIDIFICATION; 20TH-CENTURY ADVANCES; DRUG DISCOVERY; LINE HL-60; HSP90; PH; LYSOSOMES; ASSAY	Drug distribution in cells is a fundamentally important, yet often overlooked, variable in drug efficacy. Many weakly basic anticancer agents accumulate extensively in the acidic lysosomes of normal cells through ion trapping. Lysosomal trapping reduces the activity of anticancer drugs, since anticancer drug targets are often localized in the cell cytosol or nucleus. Some cancer cells have defective acidification of lysosomes, which causes a redistribution of trapped drugs from the lysosomes to the cytosol. We have previously established that such differences in drug localization between normal and cancer cells can contribute to the apparent selectivity of weakly basic drugs to cancer cells in vitro. In this work, we tested whether this intracellular distribution-based drug selectivity could be optimized based on the acid dissociation constant (pKa) of the drug, which is one of the determinants of lysosomal sequestration capacity. We synthesized seven weakly basic structural analogs of the Hsp90 inhibitor geldanamycin (GDA) with pKa values ranging from 5 to 12. The selectivity of each analog was expressed by taking ratios of anti-proliferative IC50 values of the inhibitors in normal fibroblasts to the IC50 values in human leukemic HL-60 cells. Similar selectivity assessments were performed in a pair of cancer cell lines that differed in lysosomal pH as a result of siRNA-mediated alteration of vacuolar proton ATPase subunit expression. Optimal selectivity was observed for analogs with pKa values near 8. Similar trends were observed with commercial anticancer agents with varying weakly basic pKa values. These evaluations advance our understanding of how weakly basic properties can be optimized to achieve maximum anticancer drug selectivity towards cancer cells with defective lysosomal acidification in vitro. Additional in vivo studies are needed to examine the utility of this approach for enhancing selectivity.	[Ndolo, Rosemary A.; Duan, Shaofeng; Forrest, M. Laird; Krise, Jeffrey P.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Luan, Yepeng] Shandong Univ, Inst Med Chem, Jinan 250100, Shandong, Peoples R China	University of Kansas; Shandong University	Krise, JP (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.	krise@ku.edu		Forrest, Marcus Laird/0000-0002-0288-6138	NIH RO1 grant [CA106655]; NATIONAL CANCER INSTITUTE [R01CA106655] Funding Source: NIH RePORTER	NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by NIH RO1 grant CA106655 (http://grants.nih.gov/grants/oer.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR CG, 1986, CANCER CHEMOTH PHARM, V17, P95, DOI 10.1007/BF00299875; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]; Bocchetta M, 2008, CANCER RES, V68, P1022, DOI 10.1158/0008-5472.CAN-07-5203; Borrok MJ, 2007, J AM CHEM SOC, V129, P12780, DOI 10.1021/ja072944v; BULYCHEV A, 1978, EXP CELL RES, V115, P343, DOI 10.1016/0014-4827(78)90288-4; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dutcher JP, 2000, J CLIN PHARMACOL, V40, P1007, DOI 10.1177/00912700022009620; Dutcher JP, 2000, J CLIN PHARMACOL, V40, P1079; Duvvuri M, 2005, BIOCHEMISTRY-US, V44, P15743, DOI 10.1021/bi051759w; Duvvuri M, 2004, J BIOL CHEM, V279, P32367, DOI 10.1074/jbc.M400735200; Duvvuri M, 2006, ACS CHEM BIOL, V1, P309, DOI 10.1021/cb6001202; Duvvuri M, 2005, MOL PHARMACEUT, V2, P440, DOI 10.1021/mp050043s; EGORIN MJ, 1980, CANCER RES, V40, P4669; Fernandex-Carneado J, 2005, J AM CHEM SOC, V127, P869, DOI 10.1021/ja044006q; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Gong YP, 2003, J BIOL CHEM, V278, P50234, DOI 10.1074/jbc.M306606200; Grycova L, 2009, MAGN RESON CHEM, V47, P977, DOI 10.1002/mrc.2494; Hann MM, 2012, NAT REV DRUG DISCOV, V11, P355, DOI 10.1038/nrd3701; Houshmand P, 2003, CURR OPIN CELL BIOL, V15, P640, DOI 10.1016/S0955-0674(03)00106-6; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; JIANG LW, 1990, J BIOL CHEM, V265, P4775; Kang BH, 2011, BRIT J CANCER, V104, P629, DOI 10.1038/bjc.2011.9; Kang BH, 2009, ONCOGENE, V28, P3681, DOI 10.1038/onc.2009.227; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lansiaux A, 2002, CANCER RES, V62, P7219; Liao Z, 2008, CHIN GERM J CLIN ONC, V7, P631; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Llauger-Bufi L, 2003, BIOORG MED CHEM LETT, V13, P3975, DOI 10.1016/j.bmcl.2003.08.065; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; Meanwell NA, 2011, CHEM RES TOXICOL, V24, P1420, DOI 10.1021/tx200211v; MILANO G, 1989, CANCER CHEMOTH PHARM, V24, P197, DOI 10.1007/BF00300243; Ndolo Rosemary A, 2010, Mol Cell Pharmacol, V2, P131; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nilsson Cathrine, 2003, Methods Cell Sci, V25, P185; Petrak K, 2005, DRUG DISCOV TODAY, V10, P1667, DOI 10.1016/S1359-6446(05)03698-6; Reasor MJ, 2001, EXP BIOL MED, V226, P825, DOI 10.1177/153537020122600903; Schindler M, 1996, BIOCHEMISTRY-US, V35, P2811, DOI 10.1021/bi952234e; Szakacs Z, 2004, TALANTA, V62, P819, DOI 10.1016/j.talanta.2003.10.007; Tian ZQ, 2004, BIOORGAN MED CHEM, V12, P5317, DOI 10.1016/j.bmc.2004.07.053; Trapp S, 2008, EUR BIOPHYS J BIOPHY, V37, P1317, DOI 10.1007/s00249-008-0338-4; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	47	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49366	10.1371/journal.pone.0049366	http://dx.doi.org/10.1371/journal.pone.0049366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145164	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800255
J	Popova, OB; Baker, MR; Tran, TP; Le, T; Serysheva, II				Popova, Olga B.; Baker, Mariah R.; Tran, Tina P.; Le, Tri; Serysheva, Irina I.			Identification of ATP-Binding Regions in the RyR1 Ca2+ Release Channel	PLOS ONE			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; CARDIAC RYANODINE RECEPTOR; RABBIT SKELETAL-MUSCLE; CALCIUM-RELEASE; CA-2+ RELEASE; 3-DIMENSIONAL STRUCTURE; SULFONYLUREA RECEPTOR; PHOSPHORYLATION SITE; ENDOGENOUS EFFECTORS; INSULIN-SECRETION	ATP is an important modulator of gating in type 1 ryanodine receptor (RyR1), also known as a Ca2+ release channel in skeletal muscle cells. The activating effect of ATP on this channel is achieved by directly binding to one or more sites on the RyR1 protein. However, the number and location of these sites have yet to be determined. To identify the ATP-binding regions within RyR1 we used 2N(3)ATP-2',3'-Biotin-LC-Hydrazone (BioATP-HDZ), a photo-reactive ATP analog to covalently label the channel. We found that BioATP-HDZ binds RyR1 specifically with an IC50 = 0.6 +/- 0.2 mM, comparable with the reported EC50 for activation of RyR1 with ATP. Controlled proteolysis of labeled RyR1 followed by sequence analysis revealed three fragments with apparent molecular masses of 95, 45 and 70 kDa that were crosslinked by BioATP-HDZ and identified as RyR1 sequences. Our analysis identified four glycine-rich consensus motifs that can potentially constitute ATP-binding sites and are located within the N-terminal 95-kDa fragment. These putative nucleotide-binding sequences include amino acids 699-704, 701-706, 1081-1084 and 1195-1200, which are conserved among the three RyR isoforms. Located next to the N-terminal disease hotspot region in RyR1, these sequences may communicate the effects of ATP-binding to channel function by tuning conformational motions within the neighboring cytoplasmic regulatory domains. Two other labeled fragments lack ATP-binding consensus motifs and may form non-canonical ATP-binding sites. Based on domain topology in the 3D structure of RyR1 it is also conceivable that the identified ATP-binding regions, despite their wide separation in the primary sequence, may actually constitute the same non-contiguous ATP-binding pocket within the channel tetramer.	[Popova, Olga B.; Baker, Mariah R.; Tran, Tina P.; Le, Tri; Serysheva, Irina I.] Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Serysheva, II (corresponding author), Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX USA.	irina.i.serysheva@uth.tmc.edu		Baker, Mariah/0000-0002-1613-9387	NIH [R01GM072804, R01GM072804-05S1]; MDA [88677]; National Library of Medicine Training Program in Computational Biology and Biomedical Informatics by Keck Center and Gulf Coast Consortia [T15LM007093]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072804] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA(Muscular Dystrophy Association); National Library of Medicine Training Program in Computational Biology and Biomedical Informatics by Keck Center and Gulf Coast Consortia; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	These studies are supported by grants from the NIH (R01GM072804, R01GM072804-05S1) and a research grant 88677 from MDA. M. R. B. was supported by a postdoctoral training fellowship from the National Library of Medicine Training Program in Computational Biology and Biomedical Informatics provided by the Keck Center and Gulf Coast Consortia (T15LM007093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 2006, BIOCHEM SOC T, V34, P243, DOI 10.1042/BST0340243; Baker ML, 2002, P NATL ACAD SCI USA, V99, P12155, DOI 10.1073/pnas.182058899; Betzenhauser MJ, 2010, CURR TOP MEMBR, V66, P273, DOI 10.1016/S1063-5823(10)66012-7; Blayney L, 2010, BIOPHYS J S1, V09; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; CHAN WM, 2003, J BIOL CHEM, V63, P174; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Dias JM, 2006, BIOCHEMISTRY-US, V45, P9408, DOI 10.1021/bi060623a; Dias JM, 2009, PROTEIN J, V28, P240, DOI 10.1007/s10930-009-9189-9; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Du GG, 2001, BIOCHEM J, V360, P97, DOI 10.1042/0264-6021:3600097; Galperin MY, 1997, PROTEIN SCI, V6, P2639; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Haider S, 2005, BIOPHYS J, V88, P3310, DOI 10.1529/biophysj.104.052019; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; HAWKES MJ, 1989, MEMBRANE BIOCHEM, V8, P133, DOI 10.3109/09687688909025827; HOHENEGGER M, 1995, BIOCHEM J, V308, P119, DOI 10.1042/bj3080119; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Jha S, 2003, BIOCHEMISTRY-US, V42, P10822, DOI 10.1021/bi0345900; Jones PP, 2008, BIOCHEM J, V410, P261, DOI 10.1042/BJ20071257; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Laver DR, 2010, CURR TOP MEMBR, V66, P69, DOI 10.1016/S1063-5823(10)66004-8; Laver DR, 2001, J PHYSIOL-LONDON, V537, P763; LEGENDRE N, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P49; LIU QY, 1989, BIOPHYS J, V55, P415, DOI 10.1016/S0006-3495(89)82835-8; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MACLENNAN DH, 1974, J BIOL CHEM, V249, P980; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; MARTIN J, 1993, NATURE, V366, P279, DOI 10.1038/366279a0; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Miki T, 1999, J MOL ENDOCRINOL, V22, P113, DOI 10.1677/jme.0.0220113; Nagy M, 2009, PROTEIN SCI, V18, P287, DOI 10.1002/pro.36; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; OTSU K, 1990, J BIOL CHEM, V265, P13472; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Peralvarez-Marin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025813; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Serysheva II, 1999, BIOPHYS J, V77, P1936, DOI 10.1016/S0006-3495(99)77035-9; Serysheva II, 2000, BIOPHYS J, V78, p485A; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Sharma MR, 1998, J BIOL CHEM, V273, P18429, DOI 10.1074/jbc.273.29.18429; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; Yamaguchi N, 1998, BIOCHEM J, V335, P541, DOI 10.1042/bj3350541; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamamoto T, 2002, BIOCHEMISTRY-US, V41, P1492, DOI 10.1021/bi015581z; ZARKA A, 1993, EUR J BIOCHEM, V213, P147, DOI 10.1111/j.1432-1033.1993.tb17744.x; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200; Zhang XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1306, DOI 10.1152/ajpcell.1997.273.4.C1306; ZORZATO F, 1990, J BIOL CHEM, V265, P2244; Zucchi R, 1997, PHARMACOL REV, V49, P1	74	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48725	10.1371/journal.pone.0048725	http://dx.doi.org/10.1371/journal.pone.0048725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144945	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800111
J	Lin-Moshier, Y; Sebastian, PJ; Higgins, L; Sampson, ND; Hewitt, JE; Marchant, JS				Lin-Moshier, Yaping; Sebastian, Peter J.; Higgins, LeeAnn; Sampson, Natalie D.; Hewitt, Jane E.; Marchant, Jonathan S.			Re-evaluation of the Role of Calcium Homeostasis Endoplasmic Reticulum Protein (CHERP) in Cellular Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICING FACTOR; SUBNUCLEAR LOCALIZATION; CA2+ MOBILIZATION; RS DOMAIN; PROLIFERATION; EXPRESSION; KINETICS; RELEASE; NUCLEUS; BINDING	Changes in cytoplasmic Ca2+ concentration, resulting from activation of intracellular Ca2+ channels within the endoplasmic reticulum, regulate several aspects of cellular growth and differentiation. Ca2+ homeostasis endoplasmic reticulum protein (CHERP) is a ubiquitously expressed protein that has been proposed as a regulator of both major families of endoplasmic reticulum Ca2+ channels, inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and ryanodine receptors (RyRs), with resulting effects on mitotic cycling. However, the manner by which CHERP regulates intracellular Ca2+ channels to impact cellular growth is unknown. Here, we challenge previous findings that CHERP acts as a direct cytoplasmic regulator of IP(3)Rs and RyRs and propose that CHERP acts in the nucleus to impact cellular proliferation by regulating the function of the U2 snRNA spliceosomal complex. The previously reported effects of CHERP on cellular growth therefore are likely indirect effects of altered spliceosomal function, consistent with prior data showing that loss of function of U2 snRNP components can interfere with cell growth and induce cell cycle arrest.	[Lin-Moshier, Yaping; Sebastian, Peter J.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Higgins, LeeAnn] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sampson, Natalie D.; Hewitt, Jane E.] Univ Nottingham, Sch Biol, Queens Med Ctr, Nottingham NG7 2UH, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nottingham	Marchant, JS (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	march029@umn.edu	Marchant, Jonathan/Q-5484-2019; MARCHANT, Jonathan/B-8051-2009	Marchant, Jonathan/0000-0001-6592-0877; MARCHANT, Jonathan/0000-0001-6592-0877; Sampson, Natalie/0000-0001-9326-8177	National Science Foundation [NSF-DBI-0215759, 9871237]; National Institutes of Health [GM088790]; Biotechnology and Biological Sciences Research Council, UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Thompson and Metzger laboratories at the University of Minnesota for preparation of skeletal muscle slices and cardiac myocytes. We are also grateful for technical support from the Center for Mass Spectrometry and Proteomics at the University of Minnesota and the various supporting agencies of this facility, including National Science Foundation Major Research Instrumentation Grants NSF-DBI-0215759 and 9871237 used to purchase the core instruments used in this study.; This work was supported, in whole or in part, by National Institutes of Health Grant GM088790 (to J.S.M.).; Supported by a Ph.D. studentship from the Biotechnology and Biological Sciences Research Council, UK.	Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Benkusky NA, 2004, BIOCHEM BIOPH RES CO, V322, P1280, DOI 10.1016/j.bbrc.2004.08.033; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; Boucher L, 2001, RNA, V7, P1693; Boulware MJ, 2008, CURR BIOL, V18, pR769, DOI 10.1016/j.cub.2008.07.018; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Chaurasia G, 2009, NUCLEIC ACIDS RES, V37, pD657, DOI 10.1093/nar/gkn841; CHOE CU, 2006, SCI STKE, pRE15; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Hofmann JC, 2010, NUCLEUS-PHILA, V1, P447, DOI 10.4161/nucl.1.6.13328; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kostal V, 2011, ANAL BIOANAL CHEM, V400, P213, DOI 10.1007/s00216-011-4725-9; Kuwasako K, 2006, STRUCTURE, V14, P1677, DOI 10.1016/j.str.2006.09.009; LaPlante JM, 2000, BIOCHEM J, V348, P189, DOI 10.1042/0264-6021:3480189; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; O'Rourke FA, 2003, BIOCHEM J, V373, P133, DOI 10.1042/BJ20030013; OROURKE F, 1994, BIOCHEM J, V300, P673, DOI 10.1042/bj3000673; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rodenbaugh DW, 2007, AM J PHYSIOL-HEART C, V293, pH1705, DOI 10.1152/ajpheart.00232.2007; Ryan T, 2011, J BIOL CHEM, V286, P17060, DOI 10.1074/jbc.M110.197186; Rymond B, 2007, NAT CHEM BIOL, V3, P533, DOI 10.1038/nchembio0907-533; Sampson ND, 2003, GENE, V305, P91, DOI 10.1016/S0378-1119(02)01230-1; Shikata H, 2012, PLANT J, V70, P727, DOI 10.1111/j.1365-313X.2012.04937.x; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; Spector DL, 2011, COLD SPRING HARBOR P, P3; Takenaka K, 2004, BIOCHEM J, V382, P223, DOI 10.1042/BJ20040521; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480	38	70	71	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					355	367		10.1074/jbc.M112.405761	http://dx.doi.org/10.1074/jbc.M112.405761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148228	hybrid, Green Published			2022-12-25	WOS:000313197200037
J	Liu, SL; May, JR; Helgeson, LA; Nolen, BJ				Liu, Su-Ling; May, Jordan R.; Helgeson, Luke A.; Nolen, Brad J.			Insertions within the Actin Core of Actin-related Protein 3 (Arp3) Modulate Branching Nucleation by Arp2/3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; SACCHAROMYCES-CEREVISIAE; FILAMENT NUCLEATION; PROMOTING FACTORS; POINTED END	The Arp2/3 (actin-related protein 2/3) complex nucleates branched actin filaments involved in multiple cellular functions, including endocytosis and cellular motility. Two subunits (Arp2 and Arp3) in this seven-subunit assembly are closely related to actin and upon activation of the complex form a "cryptic dimer" that stably mimics an actin dimer to nucleate a new filament. Both Arps contain a shared actin core structure, and each Arp contains multiple insertions of unknown function at conserved positions within the core. Here we characterize three key insertions within the actin core of Arp3 and show that each one plays a distinct role in modulating Arp2/3 function. The beta 4/beta 5 insert mediates interactions of Arp2/3 complex with actin filaments and "dampers" the nucleation activity of the complex. The Arp3 hydrophobic plug plays an important role in maintaining the integrity of the complex but is not absolutely required for formation of the daughter filament nucleus. Deletion of the alpha K/beta 15 insert did not constitutively activate the complex, as previously hypothesized. Instead, it abolished in vitro nucleation activity and caused defects in endocytic actin patch assembly in fission yeast, indicating a role for the alpha K/beta 15 insert in the activated state of the complex. Biochemical characterization of each mutant revealed steps in the nucleation pathway influenced by each Arp3-specific insert to provide new insights into the structural basis of activation of the complex.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Nolen, BJ (corresponding author), 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bnolen@uoregon.edu		Nolen, Brad/0000-0002-0224-9980	National Institutes of Health [GM092917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM092917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM092917 (to B.J.N).	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Cabrera R, 2011, YEAST, V28, P495, DOI 10.1002/yea.1853; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; Dalhaimer P, 2010, BIOPHYS J, V99, P2568, DOI 10.1016/j.bpj.2010.08.027; Daugherty KM, 2008, J BIOL CHEM, V283, P16950, DOI 10.1074/jbc.M800783200; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KEENEY JB, 1994, GENETICS, V136, P849; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Narita A, 2011, EMBO J, V30, P1230, DOI 10.1038/emboj.2011.48; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Pfaendtner J, 2012, J MOL BIOL, V416, P148, DOI 10.1016/j.jmb.2011.12.025; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Shvetsov A, 2008, J MOL BIOL, V375, P793, DOI 10.1016/j.jmb.2007.10.076; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Takeda T, 2005, CURR BIOL, V15, P1331, DOI 10.1016/j.cub.2005.07.009; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; YU FX, 1991, J BIOL CHEM, V266, P19269; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	60	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					487	497		10.1074/jbc.M112.406744	http://dx.doi.org/10.1074/jbc.M112.406744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148219	Green Published, hybrid			2022-12-25	WOS:000313197200049
J	Ahn, J; Hogan, N				Ahn, Jooeun; Hogan, Neville			A Simple State-Determined Model Reproduces Entrainment and Phase-Locking of Human Walking	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; PASSIVE-DYNAMIC WALKING; BIPEDAL LOCOMOTION; SPINAL CIRCUITRY; STABILITY; GAIT; FOOT; VERTEBRATES; ENERGETICS; NETWORK	Theoretical studies and robotic experiments have shown that asymptotically stable periodic walking may emerge from nonlinear limit-cycle oscillators in the neuro-mechanical periphery. We recently reported entrainment of human gait to periodic mechanical perturbations with two essential features: 1) entrainment occurred only when the perturbation period was close to the original (preferred) walking period, and 2) entrainment was always accompanied by phase locking so that the perturbation occurred at the end of the double-stance phase. In this study, we show that a highly-simplified state-determined walking model can reproduce several salient nonlinear limit-cycle behaviors of human walking: 1) periodic gait that is 2) asymptotically stable; 3) entrainment to periodic mechanical perturbations only when the perturbation period is close to the model's unperturbed period; and 4) phase-locking to locate the perturbation at the end of double stance. Importantly, this model requires neither supra-spinal control nor an intrinsic self-sustaining neural oscillator such as a rhythmic central pattern generator. Our results suggest that several prominent limit-cycle features of human walking may stem from simple afferent feedback processes without significant involvement of supra-spinal control or a self-sustaining oscillatory neural network.	[Ahn, Jooeun; Hogan, Neville] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Hogan, Neville] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ahn, J (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	aje@mit.edu		Ahn, Jooeun/0000-0002-7964-5148	New York State Center of Research Excellence [CO19772]; Eric P. and Evelyn E. Newman Fund; Samsung Scholarship Foundation	New York State Center of Research Excellence; Eric P. and Evelyn E. Newman Fund; Samsung Scholarship Foundation(Samsung)	This work was supported in part by the New York State Center of Research Excellence (grant number CO19772), the Eric P. and Evelyn E. Newman Fund and by the Samsung Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031767; ALEXANDER RM, 1992, PHILOS T ROY SOC B, V338, P189, DOI 10.1098/rstb.1992.0138; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Aoi S, 2007, NONLINEAR DYNAM, V48, P1, DOI 10.1007/s11071-006-9030-3; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Borelli GA, 1680, DE MOTU ANIMALIUM; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Cazalets JR, 1996, J NEUROSCI, V16, P298; Coleman MJ, 1997, DYNAM STABIL SYST, V12, P139, DOI 10.1080/02681119708806242; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Collins SH, 2001, INT J ROBOT RES, V20, P607, DOI 10.1177/02783640122067561; Dawkins R., 1982, pi; DeVita P, 2007, J EXP BIOL, V210, P3361, DOI 10.1242/jeb.003970; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Gerasimenko Y, 2010, J NEUROSCI, V30, P3700, DOI 10.1523/JNEUROSCI.4751-09.2010; Geyer H, 2005, SIMPLE MODELS LEGGED; Ghigliazza RM, 2005, SIAM REV, V47, P519, DOI 10.1137/050626594; Goswami A, 1997, AUTON ROBOT, V4, P273, DOI 10.1023/A:1008844026298; Grasso R, 2004, BRAIN, V127, P1019, DOI 10.1093/brain/awh115; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Gurfinkel VS, 1998, EUR J NEUROSCI, V10, P1608, DOI 10.1046/j.1460-9568.1998.00179.x; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Ivanenko YP, 2005, J NEUROPHYSIOL, V94, P754, DOI 10.1152/jn.00088.2004; KRIELLAARS DJ, 1994, J NEUROPHYSIOL, V71, P2074, DOI 10.1152/jn.1994.71.6.2074; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Lee H, 2010, QUANTITATIVE CHARACT, P321; MCCAW ST, 1995, J BIOMECH, V28, P985, DOI 10.1016/0021-9290(94)00151-S; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; Miyakoshi S, 1998, 3 DIMENSIONAL BIPEDA, V81, P84; Nishii J, 2000, BIOL CYBERN, V83, P435, DOI 10.1007/s004220000175; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Perry J, 1992, GAIT ANAL NORMAL PAT, P52; Schmitt J, 2000, BIOL CYBERN, V83, P501, DOI 10.1007/s004220000181; Schulz BW, 2011, J BIOMECHANICS; Spong MW, 2007, IEEE ROBOT AUTOM MAG, V14, P30, DOI 10.1109/MRA.2007.380638; STEIN PSG, 1995, J NEUROSCI, V15, P4343; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; VanWezel BMH, 1997, J NEUROSCI, V17, P3804; Yang JF, 2006, NEUROSCIENTIST, V12, P379, DOI 10.1177/1073858406292151	45	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e47963	10.1371/journal.pone.0047963	http://dx.doi.org/10.1371/journal.pone.0047963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152761	Green Published, gold, Green Submitted			2022-12-25	WOS:000311234000005
J	Fernandez-Moya, SM; Garcia-Perez, A; Kramer, S; Carrington, M; Estevez, AM				Fernandez-Moya, Sandra M.; Garcia-Perez, Angelica; Kramer, Susanne; Carrington, Mark; Estevez, Antonio M.			Alterations in DRBD3 Ribonucleoprotein Complexes in Response to Stress in Trypanosoma brucei	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; RNA-BINDING PROTEINS; GENE-EXPRESSION; DEVELOPMENTAL REGULATION; MESSENGER-RNAS; CELL BIOLOGY; GRANULES; DIFFERENTIATION; KINETOPLASTIDS; TRANSCRIPTION	Regulation of RNA polymerase II transcription initiation is apparently absent in trypanosomes. Instead, these eukaryotes control gene expression mainly at the post-transcriptional level. Regulation is exerted through the action of numerous RNA-binding proteins that modulate mRNA processing, turnover, translation and localization. In this work we show that the RNA-binding protein DRBD3 resides in the cytoplasm, but localizes to the nucleus upon oxidative challenge and to stress granules under starvation conditions. DRBD3 associates with other proteins to form a complex, the composition of which is altered by cellular stress. Interestingly, target mRNAs remain bound to DRBD3 under stress conditions. Our results suggest that DRBD3 transports regulated mRNAs within the cell in the form of ribonucleoprotein complexes that are remodeled in response to environmental cues. Citation: Fernandez-Moya SM, Garcia-Perez A, Kramer S, Carrington M, Estevez AM (2012) Alterations in DRBD3 Ribonucleoprotein Complexes in Response to Stress in Trypanosoma brucei. PLoS ONE 7(11): e48870. doi:10.1371/journal.pone.0048870	[Fernandez-Moya, Sandra M.; Garcia-Perez, Angelica; Estevez, Antonio M.] IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Kramer, Susanne; Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Cambridge	Estevez, AM (corresponding author), IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	aestevez@ipb.csic.es	FERNÁNDEZ MOYA, SANDRA MARÍA Maria/AAB-1054-2020; Carrington, Mark/N-4892-2018; Kramer, Susanne/M-5026-2017; Carrington, Mark/N-3653-2019; Estevez, Antonio M/K-7835-2014	FERNÁNDEZ MOYA, SANDRA MARÍA Maria/0000-0002-5894-4296; Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Estevez, Antonio M/0000-0002-8272-5405	Royal Society Joint Project grant [2008/R2]; Spanish Plan Nacional [BFU 2009-07510]; Wellcome Trust [085956/Z/08/Z]	Royal Society Joint Project grant(Royal Society of London); Spanish Plan Nacional(Spanish Government); Wellcome Trust(Wellcome TrustEuropean Commission)	AME and MC were jointly funded by the Royal Society Joint Project grant, grant number 2008/R2; AME was funded by Spanish Plan Nacional, grant number BFU 2009-07510; MC was funded by The Wellcome Trust, grant number 085956/Z/08/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Clayton CE, 2005, METH MOL B, V309, P39; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Keene JD, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-95; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Noe G, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-107; Ouna BA, 2012, MOL BIOCHEM PARASIT, V183, P184, DOI 10.1016/j.molbiopara.2012.02.006; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Sharma R, 2009, TRENDS PARASITOL, V25, P517, DOI 10.1016/j.pt.2009.08.001; Siegel TN, 2011, TRENDS PARASITOL, V27, P434, DOI 10.1016/j.pt.2011.05.006; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	35	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48870	10.1371/journal.pone.0048870	http://dx.doi.org/10.1371/journal.pone.0048870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145003	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500040
J	Grapov, D; Adams, SH; Pedersen, TL; Garvey, WT; Newman, JW				Grapov, Dmitry; Adams, Sean H.; Pedersen, Theresa L.; Garvey, W. Timothy; Newman, John W.			Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; PULSATILE INSULIN; BETA-OXIDATION; CANNABINOIDS; PATHOGENESIS; METABOLISM; ACTIVATION	Type 2 diabetes has profound effects on metabolism that can be detected in plasma. While increases in circulating non-esterified fatty acids (NEFA) are well-described in diabetes, effects on signaling lipids have received little attention. Oxylipins and endocannabinoids are classes of bioactive fatty acid metabolites with many structural members that influence insulin signaling, adipose function and inflammation through autocrine, paracrine and endocrine mechanisms. To link diabetes-associated changes in plasma NEFA and signaling lipids, we quantitatively targeted >150 plasma lipidome components in age- and body mass index-matched, overweight to obese, non-diabetic (n = 12) and type 2 diabetic (n = 43) African-American women. Diabetes related NEFA patterns indicated similar to 60% increase in steroyl-CoA desaturase activity and similar to 40% decrease in very long chain polyunsaturated fatty acid chain shortening, patterns previously associated with the development of nonalcoholic fatty liver disease. Further, epoxides and ketones of eighteen carbon polyunsaturated fatty acids were elevated >80% in diabetes and strongly correlated with changes in NEFA, consistent with their liberation during adipose lipolysis. Endocannabinoid behavior differed by class with diabetes increasing an array of N-acylethanolamides which were positively correlated with pro-inflammatory 5-lipooxygenase-derived metabolites, while monoacylglycerols were negatively correlated with body mass. These results clearly show that diabetes not only results in an increase in plasma NEFA, but shifts the plasma lipidomic profiles in ways that reflect the biochemical and physiological changes of this pathological state which are independent of obesity associated changes. Citation: Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW (2012) Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids. PLoS ONE 7(11): e48852. doi: 10.1371/journal.pone.0048852	[Grapov, Dmitry; Adams, Sean H.; Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Grapov, Dmitry; Adams, Sean H.; Pedersen, Theresa L.; Newman, John W.] USDA, Obes & Metab Res Unit, ARS, Western Human Nutr Res Ctr, Davis, CA USA; [Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Garvey, W. Timothy] Birmingham VA Med Ctr, Birmingham, AL USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Newman, JW (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	john.newman@ars.usda.gov	ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319; Grapov, Dmitry/0000-0002-7204-3128; Newman, John/0000-0001-9632-6571	National Institute of General Medical Sciences-National Institutes of Health (NIGMS-NIH) [T32-GM008799]; intramural United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [5306-51530-019-00D]; National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) [R01DK078328-01]; NIH [DK-038764, DK-083562, P01 HL-055782]; Merit Review program of the Department of Veterans Affairs; University of Alabama (UAB) Center for Clinical and Translational Science [UL1 RR025777]; UAB Nutrition and Obesity Research Center [P30-DK56336]; UAB Diabetes Research and Training Center [P60 DK079626]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, P60DK079626, R01DK078328, R01DK083562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008799] Funding Source: NIH RePORTER	National Institute of General Medical Sciences-National Institutes of Health (NIGMS-NIH); intramural United States Department of Agriculture-Agricultural Research Service (USDA-ARS); National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review program of the Department of Veterans Affairs(US Department of Veterans Affairs); University of Alabama (UAB) Center for Clinical and Translational Science; UAB Nutrition and Obesity Research Center; UAB Diabetes Research and Training Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the following: National Institute of General Medical Sciences-National Institutes of Health (NIGMS-NIH) T32-GM008799 (D.G.); intramural United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Project 5306-51530-019-00D (J.W.N. and S.H.A.); National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) R01DK078328-01 (S.H.A.); NIH grants DK-038764, DK-083562, and P01 HL-055782 and the Merit Review program of the Department of Veterans Affairs (W.T.G.). The authors also acknowledge support from the research core facilities of the University of Alabama (UAB) Center for Clinical and Translational Science (UL1 RR025777), the UAB Nutrition and Obesity Research Center (P30-DK56336), and the UAB Diabetes Research and Training Center (P60 DK079626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2009, EUR J ENDOCRINOL; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; EARLES SM, 1991, BIOCHIM BIOPHYS ACTA, V1081, P174, DOI 10.1016/0005-2760(91)90023-B; Eriksson L., 2006, MULTIMEGAVARIATE DAT; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Grapov D, 2012, BIOINFORMATICS; Grapov D, 2012, THESIS U CALIFORNIA; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jelic K, 2009, ANN BIOMED ENG, V37, P1897, DOI 10.1007/s10439-009-9738-6; KOMJATI M, 1986, ENDOCRINOLOGY, V118, P312, DOI 10.1210/endo-118-1-312; Lambert DM, 1999, CURR MED CHEM, V6, P757; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Lunn CA, 2006, EXPERT OPIN THER TAR, V10, P653, DOI 10.1517/14728222.10.5.653; Luo PC, 2011, PROSTAG OTH LIPID M, V95, P1, DOI 10.1016/j.prostaglandins.2011.06.001; Mar-Heyming R, 2008, ARTERIOSCL THROM VAS, V28, P1193, DOI 10.1161/ATVBAHA.107.160150; MATTHEWS DR, 1983, DIABETES, V32, P617, DOI 10.2337/diabetes.32.7.617; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; PACEASCIAK CR, 1989, J LIPID RES, V30, P451; PAOLISSO G, 1991, J CLIN ENDOCR METAB, V72, P607, DOI 10.1210/jcem-72-3-607; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sale MM, 2009, DIABETES, V58, P260, DOI 10.2337/db08-0198; Sethom MM, 2011, PROSTAG LEUKOTR ESS, V85, P137, DOI 10.1016/j.plefa.2011.06.006; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Tomita K, 2011, DIGEST DIS SCI, V56, P3045, DOI 10.1007/s10620-011-1712-0; VOSS A, 1991, J BIOL CHEM, V266, P19995; Wehrens R., 2007, PLS PARTIAL LEAST SQ; Wold H., 1966, ESTIMATION PRINCIPAL; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Zeng MM, 2009, CHROMATOGRAPHIA, V69, P941, DOI 10.1365/s10337-009-1040-0	46	93	93	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48852	10.1371/journal.pone.0048852	http://dx.doi.org/10.1371/journal.pone.0048852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144998	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500039
J	Mendes-Silverio, CB; Leiria, LOS; Morganti, RP; Anhe, GF; Marcondes, S; Monica, FZ; De Nucci, G; Antunes, E				Mendes-Silverio, Camila B.; Leiria, Luiz O. S.; Morganti, Rafael P.; Anhe, Gabriel F.; Marcondes, Sisi; Monica, Fabiola Z.; De Nucci, Gilberto; Antunes, Edson			Activation of Haem-Oxidized Soluble Guanylyl Cyclase with BAY 60-2770 in Human Platelets Lead to Overstimulation of the Cyclic GMP Signaling Pathway	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; OXIDE-INDEPENDENT ACTIVATION; DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE; SMOOTH-MUSCLE; DOWN-REGULATION; CGMP; STIMULATOR; BAY-41-2272; RECEPTOR	Background and Aims: Nitric oxide-independent soluble guanylyl cyclase (sGC) activators reactivate the haem-oxidized enzyme in vascular diseases. This study was undertaken to investigate the anti-platelet mechanisms of the haem-independent sGC activator BAY 60-2770 in human washed platelets. The hypothesis that sGC oxidation potentiates the antiplatelet activities of BAY 60-2770 has been tested. Methods: Human washed platelet aggregation and adhesion assays, as well as flow cytometry for alpha(IIb)beta(3) integrin activation and Western blot for alpha 1 and beta 1 sGC subunits were performed. Intracellular calcium levels were monitored in platelets loaded with a fluorogenic calcium-binding dye (FluoForte). Results: BAY 60-2770 (0.001-10 mu M) produced significant inhibition of collagen (2 mu g/ml)- and thrombin (0.1 U/ml)-induced platelet aggregation that was markedly potentiated by the sGC inhibitor ODQ (10 mM). In fibrinogen-coated plates, BAY 60-2770 significantly inhibited platelet adhesion, an effect potentiated by ODQ. BAY 60-2770 increased the cGMP levels and reduced the intracellular Ca2+ levels, both of which were potentiated by ODQ. The cell-permeable cGMP analogue 8-Br-cGMP (100 mM) inhibited platelet aggregation and Ca2+ levels in an ODQ-insensitive manner. The cAMP levels remained unchanged by BAY 60-2770. Collagen-and thrombin-induced alpha(IIb)beta(3) activation was markedly inhibited by BAY 60-2770 that was further inhibited by ODQ. The effects of sodium nitroprusside (3 mu M) were all prevented by ODQ. Incubation with ODQ (10 mu M) significantly reduced the protein levels of alpha 1 and beta 1 sGC subunits, which were prevented by BAY 60-2770. Conclusion: The inhibitory effects of BAY 60-2770 on aggregation, adhesion, intracellular Ca2+ levels and alpha(IIb)beta(3) activation are all potentiated in haem-oxidizing conditions. BAY 60-2770 prevents ODQ-induced decrease in sGC protein levels. BAY 60-2770 could be of therapeutic interest in cardiovascular diseases associated with thrombotic complications. Mendes-Silverio CB, Leiria LOS, Morganti RP, Anhe GF, Marcondes S, et al. (2012) Activation of Haem-Oxidized Soluble Guanylyl Cyclase with BAY 602770 in Human Platelets Lead to Overstimulation of the Cyclic GMP Signaling Pathway. PLoS ONE 7(11): e47223. doi:10.1371/journal.pone.0047223	[Mendes-Silverio, Camila B.; Leiria, Luiz O. S.; Morganti, Rafael P.; Anhe, Gabriel F.; Marcondes, Sisi; Monica, Fabiola Z.; De Nucci, Gilberto; Antunes, Edson] Univ Estadual Campinas, UNICAMP, Fac Med Sci, Dept Pharmacol, Sao Paulo, Brazil	Universidade Estadual de Campinas	Antunes, E (corresponding author), Univ Estadual Campinas, UNICAMP, Fac Med Sci, Dept Pharmacol, Sao Paulo, Brazil.	edson.antunes@uol.com.br	De Nucci, Gilberto/J-5990-2012; ANTUNES, EDSON/F-6731-2012; Anhe, Gabriel F/C-1980-2012; Monica, Fabiola Zakia/B-4191-2013; Marcondes, Sisi/H-4912-2013	De Nucci, Gilberto/0000-0002-4346-7941; ANTUNES, EDSON/0000-0003-2201-8247; Monica, Fabiola Zakia/0000-0002-8449-6677; Anhe, Gabriel/0000-0002-7694-8397	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/01452-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	E. Antunes received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant 2010/01452-4). C.B. Mendes-Silverio received a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) during her M.Sci. degree. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS CS, 1990, BLOOD, V75, P128; Ahrens I, 2011, ATHEROSCLEROSIS, V218, P431, DOI 10.1016/j.atherosclerosis.2011.06.042; Baracat JS, 2003, EUR J PHARMACOL, V477, P163, DOI 10.1016/j.ejphar.2003.08.012; Bau FR, 2010, EUR J PHARMACOL, V637, P171, DOI 10.1016/j.ejphar.2010.04.008; BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066; Blackmore PF, 2011, THROMB RES, V127, pE8, DOI 10.1016/j.thromres.2010.10.002; Boerrigter G, 2007, CARDIOVASC DRUG REV, V25, P30, DOI 10.1111/j.1527-3466.2007.00003.x; Bonaventura D, 2008, NITRIC OXIDE-BIOL CH, V18, P287, DOI 10.1016/j.niox.2008.02.004; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Dangel O, 2010, J THROMB HAEMOST, V8, P1343, DOI 10.1111/j.1538-7836.2010.03806.x; de Oliveira-Junior EB, 2007, EUR J PHARMACOL, V567, P43, DOI 10.1016/j.ejphar.2007.04.018; Donato JL, 1996, BRIT J PHARMACOL, V119, P1447, DOI 10.1111/j.1476-5381.1996.tb16057.x; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Feijge MAH, 2004, BIOCHEM PHARMACOL, V67, P1559, DOI 10.1016/j.bcp.2003.12.028; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Hobbs AJ, 2003, VASC PHARMACOL, V40, P149, DOI 10.1016/S1537-1891(03)00046-6; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hwang TL, 2003, MOL PHARMACOL, V64, P1419, DOI 10.1124/mol.64.6.1419; Jones AW, 2010, J PHARMACOL EXP THER, V335, P85, DOI 10.1124/jpet.110.169755; Joshi CN, 2011, J PHARMACOL EXP THER, V339, P394, DOI 10.1124/jpet.111.183400; Kagota S, 2001, BRIT J PHARMACOL, V134, P737, DOI 10.1038/sj.bjp.0704300; Knorr A, 2008, ARZNEIMITTEL-FORSCH, V58, P71, DOI 10.1055/s-0031-1296471; Koglin M, 2002, BIOCHEM BIOPH RES CO, V292, P1057, DOI 10.1006/bbrc.2002.6764; Krieg T, 2009, EUR HEART J, V30, P1607, DOI 10.1093/eurheartj/ehp143; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Massberg S, 1999, J EXP MED, V189, P1255, DOI 10.1084/jem.189.8.1255; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Mendelev NN, 2009, J CARDIOVASC PHARM, V53, P121, DOI 10.1097/FJC.0b013e31819715c4; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Pankey EA, 2011, AM J PHYSIOL-HEART C, V300, pH792, DOI 10.1152/ajpheart.00953.2010; Payrastre B, 2000, BIOCHEM PHARMACOL, V60, P1069, DOI 10.1016/S0006-2952(00)00417-2; POLLOCK WK, 1986, BIOCHEM J, V235, P869, DOI 10.1042/bj2350869; Roger S, 2010, VASC PHARMACOL, V53, P281, DOI 10.1016/j.vph.2010.09.008; Roger S, 2010, BRIT J PHARMACOL, V161, P1044, DOI 10.1111/j.1476-5381.2010.00943.x; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Schafer A, 2010, PHARMACOL RES, V62, P432, DOI 10.1016/j.phrs.2010.06.008; Schmidt P, 2003, EUR J PHARMACOL, V468, P167, DOI 10.1016/S0014-2999(03)01674-1; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Surin WR, 2008, THROMB RES, V122, P786, DOI 10.1016/j.thromres.2007.10.005; Surmeli NB, 2012, CHEMBIOCHEM, V13, P977, DOI 10.1002/cbic.201100809; Teixeira CE, 2006, HYPERTENSION, V47, P596, DOI 10.1161/01.HYP.0000199914.36936.1b; Thomazzi SM, 2005, BIOCHEM PHARMACOL, V69, P875, DOI 10.1016/j.bcp.2004.12.007; Walter Ulrich, 2009, V191, P533, DOI 10.1007/978-3-540-68964-5_23; Wei AH, 2009, BRIT J HAEMATOL, V147, P415, DOI 10.1111/j.1365-2141.2009.07819.x; Weissmann N, 2009, AM J PHYSIOL-LUNG C, V297, pL658, DOI 10.1152/ajplung.00189.2009; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051; Zhou ZM, 2008, AM J PHYSIOL-HEART C, V295, pH1763, DOI 10.1152/ajpheart.51.2008	55	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e47223	10.1371/journal.pone.0047223	http://dx.doi.org/10.1371/journal.pone.0047223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144808	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500004
J	Nagata, S; Hirano, K; Kanemori, M; Sun, LT; Tada, T				Nagata, Shogo; Hirano, Kunio; Kanemori, Michele; Sun, Liang-Tso; Tada, Takashi			Self-Renewal and Pluripotency Acquired through Somatic Reprogramming to Human Cancer Stem Cells	PLOS ONE			English	Article							EMBRYONIC STEM; CIRCUITRY; NETWORK	Human induced pluripotent stem cells (iPSCs) are reprogrammed by transient expression of transcription factors in somatic cells. Approximately 1% of somatic cells can be reprogrammed into iPSCs, while the remaining somatic cells are differentially reprogrammed. Here, we established induced pluripotent cancer stem-like cells (iCSCs) as self-renewing pluripotent cell clones. Stable iCSC lines were established from unstable induced epithelial stem cell (iESC) lines through replating followed by embryoid body formation and serial transplantation. iCSCs shared the expression of pluripotent marker genes with iPSCs, except for REX1 and LIN28, while exhibited the expression of somatic marker genes EMP1 and PPAR gamma. iESCs and iCSCs could generate teratomas with high efficiency by implantation into immunodeficient mice. The second iCSCs isolated from dissociated cells of teratoma from the first iCSCs were stably maintained, showing a gene expression profile similar to the first iCSCs. In the first and second iCSCs, transgene-derived Oct4, Sox2, Klf4, and c-Myc were expressed. Comparative global gene expression analyses demonstrated that the first iCSCs were similar to iESCs, and clearly different from human iPSCs and somatic cells. In iCSCs, gene expression kinetics of the core pluripotency factor and the Myc-related factor were pluripotent type, whereas the polycomb complex factor was somatic type. These findings indicate that pluripotent tumorigenicity can be conferred on somatic cells through up-regulation of the core pluripotency and Myc-related factors, prior to establishment of the iPSC molecular network by full reprogramming through down-regulation of the polycomb complex factor.	[Nagata, Shogo; Hirano, Kunio; Kanemori, Michele; Sun, Liang-Tso; Tada, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Engn, Kyoto, Japan	Kyoto University	Tada, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Engn, Kyoto, Japan.	ttada@frontier.kyoto-u.ac.jp			JSPS Kakenhi [23390067]	JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by the JSPS Kakenhi, grant number 23390067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033544; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cole MD, 2006, SEMIN CANCER BIOL, V16, P241, DOI 10.1016/j.semcancer.2006.08.003; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Menendez S, 2010, CELL CYCLE, V9, P3887, DOI 10.4161/cc.9.19.13301; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009	17	29	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48699	10.1371/journal.pone.0048699	http://dx.doi.org/10.1371/journal.pone.0048699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144933	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500030
J	Rodriguez, A; Allegrucci, C; Alberio, R				Rodriguez, Aida; Allegrucci, Cinzia; Alberio, Ramiro			Modulation of Pluripotency in the Porcine Embryo and iPS Cells	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; GROUND-STATE PLURIPOTENCY; EARLY LINEAGE SEGREGATION; EPIBLAST STEM-CELLS; SELF-RENEWAL; IN-VITRO; PRIMITIVE ENDODERM; FGF; PIG; DERIVATION	The establishment of the pluripotent ICM during early mammalian development is characterized by the differential expression of the transcription factors NANOG and GATA4/6, indicative of the epiblast and hypoblast, respectively. Differences in the mechanisms regulating the segregation of these lineages have been reported in many species, however little is known about this process in the porcine embryo. The aim of this study was to investigate the signalling pathways participating in the formation of the porcine ICM, and to establish whether their modulation can be used to increase the developmental potential of pluripotent cells. We show that blocking MEK signalling enhances the proportion of NANOG expressing cells in the ICM, but does not prevent the segregation of GATA-4 cells. Interestingly, inhibition of FGF signalling does not alter the segregation of NANOG and GATA-4 cells, but affects the number of ICM cells. This indicates that FGF signalling participates in the formation of the founders of the ICM. Inhibition of MEK signalling combined with GSK3 beta inhibition and LIF supplementation was used to modulate pluripotency in porcine iPS (piPS) cells. We demonstrate that under these stringent culture conditions piPS cells acquire features of naive pluripotency, characterized by the expression of STELLA and REX1, and increased in vitro germline differentiation capacity. We propose that small molecule inhibitors can be used to increase the homogeneity of induced pluripotent stem cell cultures. These improved culture conditions will pave the way for the generation of germline competent stem cells in this species. Citation: Rodriguez A, Allegrucci C, Alberio R (2012) Modulation of Pluripotency in the Porcine Embryo and iPS Cells. PLoS ONE 7(11): e49079. doi:10.1371/journal.pone.0049079	[Rodriguez, Aida; Alberio, Ramiro] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Allegrucci, Cinzia] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England	University of Nottingham; University of Nottingham	Alberio, R (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	ramiro.alberio@nottingham.ac.uk	Rodríguez, Aida/E-7035-2010; Alberio, Ramiro/G-5955-2011; Rodriguez, Aida/F-9466-2016; Allegrucci, Cinzia/A-6110-2009	Rodríguez, Aida/0000-0002-9184-8757; Alberio, Ramiro/0000-0001-6560-3919; Allegrucci, Cinzia/0000-0001-8517-2423	Wellcome Trust, the University of Nottingham; Spanish Ministry of Science and Technolgy; Spanish Ministry of Education [EX2009-0116]	Wellcome Trust, the University of Nottingham; Spanish Ministry of Science and Technolgy; Spanish Ministry of Education(Spanish Government)	This study was funded by the Wellcome Trust, the University of Nottingham and the Spanish Ministry of Science and Technolgy. AR is supported by Spanish Ministry of Education (EX2009-0116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2012, REPROD DOMEST ANIM, V47, P98, DOI 10.1111/j.1439-0531.2012.02062.x; Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; du Puy L, 2011, THERIOGENOLOGY, V75, P513, DOI 10.1016/j.theriogenology.2010.09.019; Eckert J, 1997, BIOL REPROD, V57, P552, DOI 10.1095/biolreprod57.3.552; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirano K, 2012, STEM CELLS DEV, V21, P1287, DOI 10.1089/scd.2011.0283; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Honda A, 2009, EXP CELL RES, V315, P2033, DOI 10.1016/j.yexcr.2009.01.024; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Rodriguez A, 2007, THERIOGENOLOGY, V67, P1092, DOI 10.1016/j.theriogenology.2006.11.015; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Shen XH, 2012, J REPROD DEVELOP, V315, P2033; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson AJ, 2012, CELL REPROGRAM, V14, P112, DOI 10.1089/cell.2011.0078; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Van de Pavert SA, 2001, MOL REPROD DEV, V59, P390, DOI 10.1002/mrd.1045; Vassiliev I, 2010, CELL REPROGRAM, V12, P223, DOI 10.1089/cell.2009.0053; Wang SF, 2008, J BIOL CHEM, V283, P35929, DOI 10.1074/jbc.M804091200; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112	43	56	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49079	10.1371/journal.pone.0049079	http://dx.doi.org/10.1371/journal.pone.0049079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145076	Green Published, Green Submitted, gold			2022-12-25	WOS:000312269500073
J	Tada, S; Andou, T; Suzuki, T; Dohmae, N; Kobatake, E; Ito, Y				Tada, Seiichi; Andou, Takashi; Suzuki, Takehiro; Dohmae, Naoshi; Kobatake, Eiry; Ito, Yoshihiro			Genetic PEGylation	PLOS ONE			English	Article							SITE-SPECIFIC PEGYLATION; NONNATURAL AMINO-ACIDS; POSITION-SPECIFIC INCORPORATION; CELL-FREE TRANSLATION; IN-VITRO; FULL BIOACTIVITY; CYSTEINE ANALOGS; ORGANIC MEDIA; PROTEIN; BIOCONJUGATION	Polyethylene glycol (PEG) was genetically incorporated into a polypeptide. Stop-anticodon-containing tRNAs were acylated with PEG-containing amino acids and were then translated into polypeptides corresponding to DNA sequences containing the stop codons. The molecular weights of the PEG used were 170, 500, 700, 1000, and 2000 Da, and the translation was confirmed by mass spectrometry. The PEG incorporation ratio decreased as the molecular weight of PEG increased, and PEG with a molecular weight of 1000 Da was only slightly incorporated. Although improvement is required to increase the efficiency of the process, this study demonstrates the possibility of genetic PEGylation. Citation: Tada S, Andou T, Suzuki T, Dohmae N, Kobatake E, et al. (2012) Genetic PEGylation. PLoS ONE 7(11): e49235. doi:10.1371/journal.pone.0049235	[Tada, Seiichi; Andou, Takashi; Ito, Yoshihiro] RIKEN Adv Sci Inst, Nano Med Engn Lab, Wako, Saitama, Japan; [Andou, Takashi; Kobatake, Eiry; Ito, Yoshihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Suzuki, Takehiro; Dohmae, Naoshi] RIKEN Adv Sci Inst, Dept Biol Chem, Chem Biol Core Facil, Biomol Characterizat Team, Wako, Saitama, Japan	RIKEN; Tokyo Institute of Technology; RIKEN	Ito, Y (corresponding author), RIKEN Adv Sci Inst, Nano Med Engn Lab, Wako, Saitama, Japan.	y-ito@riken.jp	Ito, Yoshihiro/T-1095-2019; Suzuki, Takehiro/B-3210-2013; Dohmae, Naoshi/C-2040-2011; Ito, Yoshihiro/F-4370-2012	Ito, Yoshihiro/0000-0002-1154-253X; Dohmae, Naoshi/0000-0002-5242-9410; 	Grants-in-Aid for Scientific Research [22220009, 24656510] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abe R, 2010, J BIOSCI BIOENG, V110, P32, DOI 10.1016/j.jbiosc.2010.01.003; Abuchowsky A., 1977, J BIOL CHEM, V251, P3578; BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Berzozzi CR, 2011, ACCOUNTS CHEM RES, V44, P651; Boyce M, 2011, NAT METHODS, V8, P638, DOI 10.1038/nmeth.1657; Broyer RM, 2011, CHEM COMMUN, V47, P2212, DOI 10.1039/c0cc04062b; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Catillo B, 2007, BIOTECHNOL BIOENG, V99, P9; Cazalis CS, 2004, BIOCONJUGATE CHEM, V15, P1005, DOI 10.1021/bc049903y; Chen SY, 2005, CHEM BIOL, V12, P371, DOI 10.1016/j.chembiol.2005.01.017; Cong YH, 2012, BIOCONJUGATE CHEM, V23, P248, DOI 10.1021/bc200530x; de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a; Deiters A, 2004, BIOORG MED CHEM LETT, V14, P5743, DOI 10.1016/j.bmcl.2004.09.059; Doherty DH, 2005, BIOCONJUGATE CHEM, V16, P1291, DOI 10.1021/bc050172r; Elvira C, 2005, MOLECULES, V10, P114, DOI 10.3390/10010114; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hest JCMv, 2007, J MACROMOL SCI C, V47, P63; Hohsaka T, 1996, J AM CHEM SOC, V118, P9778, DOI 10.1021/ja9614225; Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109; Hu JL, 2010, BIOCONJUGATE CHEM, V21, P1762, DOI 10.1021/bc9005706; Ito Y, 1999, NAT BIOTECHNOL, V17, P73, DOI 10.1038/5250; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Joralemon MJ, 2010, CHEM COMMUN, V46, P1377, DOI 10.1039/b920570p; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Joshi NS, 2004, J AM CHEM SOC, V126, P15942, DOI 10.1021/ja0439017; Kajihara D, 2006, NAT METHODS, V3, P923, DOI 10.1038/NMETH945; Kalia J, 2010, CURR ORG CHEM, V14, P138, DOI 10.2174/138527210790069839; Kinstler O, 2002, ADV DRUG DELIVER REV, V54, P477, DOI 10.1016/S0169-409X(02)00023-6; Klok HA, 2009, MACROMOLECULES, V42, P7990, DOI 10.1021/ma901561t; Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085; Kostiainen MA, 2007, ACS NANO, V1, P103, DOI 10.1021/nn700053y; Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333; Kwon OH, 1999, BIOTECHNOL BIOENG, V66, P265, DOI 10.1002/(SICI)1097-0290(1999)66:4<265::AID-BIT8>3.0.CO;2-3; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Pennadam S, 2004, J NANOBIOTECHNOL, V2, P1; Sato H, 2002, ADV DRUG DELIVER REV, V54, P487, DOI 10.1016/S0169-409X(02)00024-8; Schumacher FF, 2011, BIOCONJUGATE CHEM, V22, P132, DOI 10.1021/bc1004685; Shozen N, 2009, BIOORG MED CHEM LETT, V19, P4909, DOI 10.1016/j.bmcl.2009.07.105; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/NCHEMBIO.720, 10.1038/nchembio.720]; Tilley SD, 2006, J AM CHEM SOC, V128, P1080, DOI 10.1021/ja057106k; Velonia K, 2010, POLYM CHEM-UK, V1, P944, DOI 10.1039/b9py00362b; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009354; Wang H, 2008, BIOMACROMOLECULES, V9, P3223, DOI 10.1021/bm800801b; Wang JH, 2004, BIOCHEM BIOPH RES CO, V317, P965, DOI 10.1016/j.bbrc.2004.03.139; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Watanabe T, 2007, BIOCHEM BIOPH RES CO, V361, P794, DOI 10.1016/j.bbrc.2007.07.099; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306	51	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49235	10.1371/journal.pone.0049235	http://dx.doi.org/10.1371/journal.pone.0049235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145132	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500091
J	Varsano, T; Taupin, V; Guo, LX; Baterina, OY; Farquhar, MG				Varsano, Tal; Taupin, Vanessa; Guo, Lixia; Baterina, Oscar Y., Jr.; Farquhar, Marilyn G.			The PDZ Protein GIPC Regulates Trafficking of the LPA(1) Receptor from APPL Signaling Endosomes and Attenuates the Cell's Response to LPA	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; MYOSIN-VI; COUPLED RECEPTORS; DOMAIN PROTEIN; GROWTH; INTERACTS; CANCER; EXPRESSION; BINDING; FAMILY	Lysophosphatidic acid (LPA) mediates diverse cellular responses through the activation of at least six LPA receptors - LPA(1-6), but the interacting proteins and signaling pathways that mediate the specificity of these receptors are largely unknown. We noticed that LPA(1) contains a PDZ binding motif (SVV) identical to that present in two other proteins that interact with the PDZ protein GIPC. GIPC is involved in endocytic trafficking of several receptors including TrkA, VEGFR2, lutropin and dopamine D2 receptors. Here we show that GIPC binds directly to the PDZ binding motif of LPA(1) but not that of other LPA receptors. LPA(1) colocalizes and coimmunoprecipitates with GIPC and its binding partner APPL, an activator of Akt signaling found on APPL signaling endosomes. GIPC depletion by siRNA disturbed trafficking of LPA(1) to EEA1 early endosomes and promoted LPA(1) mediated Akt signaling, cell proliferation, and cell motility. We propose that GIPC binds LPA(1) and promotes its trafficking from APPL-containing signaling endosomes to EEA1 early endosomes and thus attenuates LPA-mediated Akt signaling from APPL endosomes.	[Varsano, Tal; Taupin, Vanessa; Guo, Lixia; Baterina, Oscar Y., Jr.; Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	mfarquhar@ucsd.edu		Varsano, Tal/0000-0003-1237-3923	National Institutes of Health (NIH) [CA100768, DK17780]; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017780, R37DK017780] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants CA100768 and DK17780 to M.G.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama SK, 2002, METHOD CELL BIOL, V69, P281, DOI 10.1016/S0091-679X(02)69018-1; Alderton F, 2001, BRIT J PHARMACOL, V134, P6, DOI 10.1038/sj.bjp.0704278; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Choi JS, 2010, CANCER LETT, V294, P254, DOI 10.1016/j.canlet.2010.02.007; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii S, 2009, PROSTAG OTH LIPID M, V89, P57, DOI 10.1016/j.prostaglandins.2009.06.001; Jeanneteau F, 2004, MOL BIOL CELL, V15, P696, DOI 10.1091/mbc.E03-05-0293; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Lee JD, 2010, CARCINOGENESIS, V31, P175, DOI 10.1093/carcin/bgp271; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lin FT, 2008, BBA-MOL CELL BIOL L, V1781, P558, DOI 10.1016/j.bbalip.2008.04.013; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Murph MM, 2003, J CELL SCI, V116, P1969, DOI 10.1242/jcs.00397; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shano S, 2008, BBA-MOL CELL RES, V1783, P748, DOI 10.1016/j.bbamcr.2007.11.013; Shida D, 2003, CANCER RES, V63, P1706; Tan YF, 2010, J BIOL CHEM, V285, P6377, DOI 10.1074/jbc.M109.068452; Thomas RM, 2011, ENDOCRINOLOGY; Urs NM, 2008, J BIOL CHEM, V283, P5249, DOI 10.1074/jbc.M710003200; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Yamada T, 2008, CANCER SCI, V99, P1603, DOI 10.1111/j.1349-7006.2008.00848.x; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Zhang HC, 2007, CELL SIGNAL, V19, P261, DOI 10.1016/j.cellsig.2006.06.008; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	53	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49227	10.1371/journal.pone.0049227	http://dx.doi.org/10.1371/journal.pone.0049227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145131	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500090
J	Castro-Prieto, A; Wachter, B; Melzheimer, J; Thalwitzer, S; Hofer, H; Sommer, S				Castro-Prieto, Aines; Wachter, Bettina; Melzheimer, Joerg; Thalwitzer, Susanne; Hofer, Heribert; Sommer, Simone			Immunogenetic Variation and Differential Pathogen Exposure in Free-Ranging Cheetahs across Namibian Farmlands	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FREQUENCY-DEPENDENT SELECTION; ACINONYX-JUBATUS; EVOLUTIONARY GENETICS; INTEGRATED SOFTWARE; MHC LOCI; OVERDOMINANT; DIVERSITY; ANTIGEN; HETEROGENEITY	Background: Genes under selection provide ecologically important information useful for conservation issues. Major histocompatibility complex (MHC) class I and II genes are essential for the immune defence against pathogens from intracellular (e.g. viruses) and extracellular (e.g. helminths) origins, respectively. Serosurvey studies in Namibian cheetahs (Acinonyx juabuts) revealed higher exposure to viral pathogens in individuals from north-central than east-central regions. Here we examined whether the observed differences in exposure to viruses influence the patterns of genetic variation and differentiation at MHC loci in 88 free-ranging Namibian cheetahs. Methodology/Principal Findings: Genetic variation at MHC I and II loci was assessed through single-stranded conformation polymorphism (SSCP) analysis and sequencing. While the overall allelic diversity did not differ, we observed a high genetic differentiation at MHC class I loci between cheetahs from north-central and east-central Namibia. No such differentiation in MHC class II and neutral markers were found. Conclusions/Significance: Our results suggest that MHC class I variation mirrors the variation in selection pressure imposed by viruses in free-ranging cheetahs across Namibian farmland. This is of high significance for future management and conservation programs of this species.	[Castro-Prieto, Aines; Sommer, Simone] Leibniz Inst Zoo & Wildlife Res, Evolutionary Genet Res Grp, Berlin, Germany; [Wachter, Bettina; Melzheimer, Joerg; Thalwitzer, Susanne; Hofer, Heribert] Leibniz Inst Zoo & Wildlife Res, Evolutionary Ecol Res Grp, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Leibniz Institut fur Zoo und Wildtierforschung	Sommer, S (corresponding author), Leibniz Inst Zoo & Wildlife Res, Evolutionary Genet Res Grp, Berlin, Germany.	sommer@izw-berlin.de	Wachter, Bettina/AAJ-9663-2020; Hofer, Heribert/AAF-7854-2021	Hofer, Heribert/0000-0002-2813-7442; Wachter, Bettina/0000-0002-0414-2298	Messerli Foundation in Switzerland; Leibniz Institute for Zoo and Wildlife Research in Germany; Secretariat of Public Education; Mexican Government	Messerli Foundation in Switzerland; Leibniz Institute for Zoo and Wildlife Research in Germany; Secretariat of Public Education; Mexican Government	This work was supported by the Messerli Foundation in Switzerland and the Leibniz Institute for Zoo and Wildlife Research in Germany. Aines Castro-Prieto was additionally supported by the Secretariat of Public Education and the Mexican Government. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Castro-Prieto A, 2011, MOL BIOL EVOL, V28, P1455, DOI 10.1093/molbev/msq330; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; Drake GJC, 2004, MOL ECOL, V13, P221, DOI 10.1046/j.1365-294X.2003.02027.x; Edwards Scott V., 1996, P214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gamoh K, 2005, VET REC, V157, P285, DOI 10.1136/vr.157.10.285; Garrigan D, 2003, EVOLUTION, V57, P1707; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HANSSEN L, 2004, NAMIBIA LARGE CARNIV, V1; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; HEDRICK PW, 1987, BIOL J LINN SOC, V31, P311, DOI 10.1111/j.1095-8312.1987.tb01996.x; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; HILL AVS, 1991, MOL EVOLUTION MAJOR, P403, DOI DOI 10.1007/978-3-642-84622-9_33; HORIMOTO T, 1992, ARCH VIROL, V126, P283, DOI 10.1007/BF01309701; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; KLEIN J, 1986, NATURAL HIST MAJOR H; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kummrow M, 2005, CLIN DIAGN LAB IMMUN, V12, P1209, DOI 10.1128/CDLI.12.10.1209-1215.2005; Marker LL, 2008, J HERED, V99, P2, DOI 10.1093/jhered/esm081; Marker-Kraus L., 1996, CHEETAH SURVIVAL NAM; MARKERKRAUS L, 1995, ENVIRON CONSERV, V21, P369; Masuda M, 2006, COMP IMMUNOL MICROB, V29, P157, DOI 10.1016/j.cimid.2006.03.004; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Miller HC, 2008, ANIM CONSERV, V11, P206, DOI 10.1111/j.1469-1795.2008.00168.x; Munson L, 2004, J WILDLIFE DIS, V40, P23, DOI 10.7589/0090-3558-40.1.23; Munson Linda, 2010, P237; Nei M., 1987, MOL EVOLUTIONARY GEN; OLMSTED RA, 1992, J VIROL, V66, P6008, DOI 10.1128/JVI.66.10.6008-6018.1992; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Radford AD, 2003, VIRUS GENES, V27, P145, DOI 10.1023/A:1025772409539; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; RUCKERBAUER GM, 1971, CAN J COMPARAT MED, V35, P230; Ryman N, 2006, MOL ECOL NOTES, V6, P285, DOI 10.1111/j.1471-8286.2005.01146.x; Ryman N, 2001, MOL ECOL, V10, P2361, DOI 10.1046/j.0962-1083.2001.01345.x; Schneider, 1994, ANIMAL HLTH VET MED; SLADE RW, 1992, GENETICS, V132, P861; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; TAKAHATA N, 1990, GENETICS, V124, P967; Thalwitzer S, 2010, CLIN VACCINE IMMUNOL, V17, P232, DOI 10.1128/CVI.00345-09; Van Vuuren M, 2003, ONDERSTEPOORT J VET, V70, P1; Wachter B, 2011, CONSERV LETT, V4, P47, DOI 10.1111/j.1755-263X.2010.00142.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; YUHKI N, 1994, J MOL EVOL, V39, P22, DOI 10.1007/BF00178246	47	11	11	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49129	10.1371/journal.pone.0049129	http://dx.doi.org/10.1371/journal.pone.0049129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145096	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800215
J	Hung, YP; Lee, NY; Lin, SH; Chang, HC; Wu, CJ; Chang, CM; Chen, PL; Lin, HJ; Wu, YH; Tsai, PJ; Tsai, YS; Ko, WC				Hung, Yuan-Pin; Lee, Nan-Yao; Lin, Sheng-Hsiang; Chang, Ho-Ching; Wu, Chi-Jung; Chang, Chia-Ming; Chen, Po-Lin; Lin, Hsiao-Ju; Wu, Yi-Hui; Tsai, Pei-Jane; Tsai, Yau-Sheng; Ko, Wen-Chien			Effects of PPAR gamma and RBP4 Gene Variants on Metabolic Syndrome in HIV-Infected Patients with Anti-Retroviral Therapy	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; BODY MASS INDEX; INSULIN-RESISTANCE; HIV-1-INFECTED PATIENTS; DECLINING MORBIDITY; ALCOHOL-CONSUMPTION; NATIONAL-HEALTH; LIPID PROFILES; REGULATORY SNP; RISK-FACTORS	Background: PPAR gamma and RBP4 are known to regulate lipid and glucose metabolism and insulin resistance. The influences of PPAR gamma (C1431T and Pro12Ala) and RBP4 (-803GA) polymorphisms on metabolic syndrome in HIV-infected patients receiving anti-retroviral therapy were examined in this study. Materials and Methods: A cross-sectional study of HIV-1 infected adults with antiretroviral therapy for more than one year in the National Cheng Kung University Hospital was conducted. The gene polymorphisms were determined by quantitative PCR. Results: Ninety-one patients were included in the study. Eighty-two (90.1%)patients were males with a mean age of 44.4 years. For the C1431T polymorphism in PPAR gamma, while patients with the T allele (48.4%) had trends toward lower rate of hypertriglyceridemia, the borderline significance together with insignificant power did not support the protective effect of the T allele against development of hypertriglyceridemia. For the Pro12Ala polymorphism in PPAR gamma, although patients with the Pro/Ala genotype (8.8%) had a higher level of serum LDL (138.0 vs. 111.5 mg/dl, P = 0.04) and trends toward higher rates of hypercholesterolemia and serum LDL>110 mg/dl, these variables were found to be independent of the Pro/Ala genotype in the multivariate analysis. For the -803GA polymorphism in RBP4, patients with the A allele (23.1%) more often had insulin resistance (HOMA>3.8; 33.3 vs. 8.7%, P = 0.01) and more often received anti-hypoglycemic drugs (14.3 vs. 1.4%, P = 0.04). The detrimental effect of the A allele in RBP4 -803GA polymorphism on development of insulin resistance was supported by the multivariate analysis adjusting for covariates. Conclusion: The impacts of PPAR gamma C1431T and Pro12Ala polymorphisms on metabolism in HIV-infected patients are not significant. RBP4 -803GA polymorphism has increased risk of insulin resistance in HIV-infected patients with anti-retroviral therapy.	[Hung, Yuan-Pin; Lin, Sheng-Hsiang; Wu, Chi-Jung; Chen, Po-Lin; Tsai, Yau-Sheng] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju] Tainan Hosp, Dept Hlth, Dept Internal Med, Execut Yuan, Tainan, Taiwan; [Lee, Nan-Yao; Chang, Chia-Ming; Chen, Po-Lin; Lin, Hsiao-Ju; Wu, Yi-Hui; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Lee, Nan-Yao; Chang, Chia-Ming; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan 70428, Taiwan; [Chang, Ho-Ching] Chi Mei Hosp, Dept Nutr, Tainan, Taiwan; [Wu, Chi-Jung] Natl Hlth Res Inst, Div Clin Res, Tainan, Taiwan; [Wu, Yi-Hui] Pingtung Christian Hosp, Dept Internal Med, Pingtung, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Tsai, Pei-Jane; Tsai, Yau-Sheng; Ko, Wen-Chien] Natl Cheng Kung Univ, Res Ctr Infect Dis & Signaling, Tainan 70101, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Dept Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Tsai, YS (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan.	yaustsai@mail.ncku.edu.tw; winston@mail.ncku.edu.tw	Ko, Wen-Chien/ABG-4316-2020; Wu, Chi-Jung/F-8364-2011; hong, hesse/EUM-0179-2022; Tsai, Pei-Jane/G-3563-2011	Ko, Wen-Chien/0000-0001-7497-149X; hong, hesse/0000-0003-1006-705X; 	National Cheng Kung University Hospital [DOH100-TD-B-111-002]; National Science Council [100-2321-B-006-016]; National Health Research Institutes [NHRI-EX101-9823SC]; NCKU Aim for the Top University Project	National Cheng Kung University Hospital; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); NCKU Aim for the Top University Project	This work was supported by grants from National Cheng Kung University Hospital (DOH100-TD-B-111-002), National Science Council (100-2321-B-006-016), National Health Research Institutes (NHRI-EX101-9823SC), and NCKU Aim for the Top University Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens GMN, 2000, DRUG SAFETY, V23, P57, DOI 10.2165/00002018-200023010-00004; Chang SY, 2009, CLIN INFECT DIS, V48, P832, DOI 10.1086/597099; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Cheng DM, 2009, ALCOHOL, V43, P65, DOI 10.1016/j.alcohol.2008.09.004; Cook RL, 2009, AM J EPIDEMIOL, V169, P1025, DOI 10.1093/aje/kwp004; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Doney ASF, 2004, DIABETOLOGIA, V47, P555, DOI 10.1007/s00125-003-1323-1; Gibson RS, 2005, PRINCIPLES NUTR ASSE, pxx; Han SH, 2009, METABOLISM, V58, P1523, DOI 10.1016/j.metabol.2009.04.021; Jacobson DL, 2006, JAIDS-J ACQ IMM DEF, V43, P458, DOI 10.1097/01.qai.0000243093.34652.41; Jarero JPD, 2002, METABOLISM, V51, P218, DOI 10.1053/meta.2002.29993; Joy T, 2007, AIDS, V21, P1591, DOI 10.1097/QAD.0b013e32823644ff; Kannisto K, 2003, AIDS, V17, P1753, DOI 10.1097/00002030-200308150-00004; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Kovacs P, 2007, DIABETES, V56, P3095, DOI 10.2337/db06-1647; Lagou V, 2008, OBESITY, V16, P913, DOI 10.1038/oby.2008.1; Mahan LK, 2000, KRAUSES FOOD NUTR DI, pxxxiv; Masugi J, 2000, BIOCHEM BIOPH RES CO, V268, P178, DOI 10.1006/bbrc.2000.2096; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meirhaeghe A, 2004, MOL GENET METAB, V83, P93, DOI 10.1016/j.ymgme.2004.08.014; Michaels SH, 1998, NEW ENGL J MED, V339, P405, DOI 10.1056/NEJM199808063390612; Miguez-Burbano MJ, 2009, J ASSOC NURSE AIDS C, V20, P176, DOI 10.1016/j.jana.2009.02.004; Miller M, 2005, ARCH INTERN MED, V165, P2063, DOI 10.1001/archinte.165.18.2063; Moffett SP, 2005, METABOLISM, V54, P1552, DOI 10.1016/j.metabol.2005.05.025; Mohamed MBH, 2007, J ENDOCRINOL INVEST, V30, P937, DOI 10.1007/BF03349241; Mondy K, 2007, CLIN INFECT DIS, V44, P726, DOI 10.1086/511679; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Munkhtulga L, 2010, OBESITY, V18, P1006, DOI 10.1038/oby.2009.358; Nazih H, 2011, AIDS RES HUM RETROVI; Oh J, 2007, LANCET INFECT DIS, V7, P787, DOI 10.1016/S1473-3099(07)70287-6; Palacios R, 2006, ANTIVIR THER, V11, P529; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parienti JJ, 2007, CLIN INFECT DIS, V45, P263, DOI 10.1086/518973; Petit JM, 2010, ANTIVIR THER, V15, P797, DOI 10.3851/IMP1582; Poma BZ, 2008, AIDS, V22, P1769, DOI 10.1097/QAD.0b013e32830b3a96; Rosenkranz Susan L., 2007, Metabolic Syndrome and Related Disorders, V5, P163, DOI 10.1089/met.2006.0034; Saumoy M, 2009, CURR HIV RES, V7, P533, DOI 10.2174/157016209789346219; Schindler K, 2006, EUR J CLIN INVEST, V36, P640, DOI 10.1111/j.1365-2362.2006.01699.x; Shah M, 2005, HIV MED, V6, P291, DOI 10.1111/j.1468-1293.2005.00309.x; Tai ES, 2004, J LIPID RES, V45, P674, DOI 10.1194/jlr.M300363-JLR200; Tsai YS, 2005, TRENDS CARDIOVAS MED, V15, P81, DOI 10.1016/j.tcm.2005.04.002; Valve R, 1999, J CLIN ENDOCR METAB, V84, P3708, DOI 10.1210/jc.84.10.3708; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; van Leth F, 2004, PLOS MED, V1, P64, DOI 10.1371/journal.pmed.0010019; Wu PY, 2012, J ANTIMICROB CHEMOTH, V67, P1001, DOI 10.1093/jac/dkr558; Yang BC, 2005, BIOCHEM BIOPH RES CO, V334, P176, DOI 10.1016/j.bbrc.2005.06.078; Yang LL, 2009, ARCH MED RES, V40, P89, DOI 10.1016/j.arcmed.2008.11.005; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798; Young J, 2005, ANTIVIR THER, V10, P585	50	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49102	10.1371/journal.pone.0049102	http://dx.doi.org/10.1371/journal.pone.0049102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145084	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800205
J	Mao, JJ; Zeng, FR				Mao, Jianjun; Zeng, Fanrong			Feeding-Based RNA Intereference of a Gap Gene Is Lethal to the Pea Aphid, Acyrthosiphon pisum	PLOS ONE			English	Article							SYNTHASE GENE; HUNCHBACK; INTERFERENCE; SEGMENTATION; ORTHODENTICLE; PROTEIN; POSTERIOR; ANTERIOR	The gap gene hunchback (hb) is a key regulator in the anteroposterior patterning of insects. Loss-of-function of hb resulted in segmentation defects in the next generation. In this paper, hb expression level was investigated at different developmental stages of the pea aphid, Acyrthosiphon pisum (Ap). Aphb mRNA was most early detected at the first instar stage and showed an incontinuous increase in the whole life cycle. Ingested RNA interference was performed at the second instar stage to knockdown the Aphb expression. Continuous feeding of Aphb double-stranded RNA mixed in artificial diet led to reduction of Aphb transcripts and rise of insect lethality. These results indicated that hunchback was a good RNAi target in the management of insect pests.	[Mao, Jianjun; Zeng, Fanrong] Chinese Acad Agr Sci, Key Lab Pest Management Crops, Minist Agr, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Zeng, FR (corresponding author), Chinese Acad Agr Sci, Key Lab Pest Management Crops, Minist Agr, Inst Plant Protect, Beijing 100193, Peoples R China.	Zengfr@caas.net.cn			NSFC [31201570]; agriculture cooperative research fund [2011-G4]	NSFC(National Natural Science Foundation of China (NSFC)); agriculture cooperative research fund	This work was supported by Project NSFC 31201570 and agriculture cooperative research fund 2011-G4. The content is solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Liu PZ, 2004, DEVELOPMENT, V131, P1515, DOI 10.1242/dev.01046; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mito T, 2005, DEVELOPMENT, V132, P2069, DOI 10.1242/dev.01784; Novotny T, 2002, DEVELOPMENT, V129, P1027; Oerke E. C., 1994, CROP PRODUCTION CROP, P179; Pan Ke, 2006, Kunchong Zhishi, V43, P728; Patel NH, 2001, DEVELOPMENT, V128, P3459; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; RAHBE Y, 1993, ENTOMOL EXP APPL, V67, P149, DOI 10.1007/BF02386520; Rosa C, 2012, PEST MANAG SCI, V68, P995, DOI 10.1002/ps.3253; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Wolff C, 1995, DEVELOPMENT, V121, P4227; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhao YY, 2011, INSECT MOL BIOL, V20, P97, DOI 10.1111/j.1365-2583.2010.01049.x; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	38	41	49	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48718	10.1371/journal.pone.0048718	http://dx.doi.org/10.1371/journal.pone.0048718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144942	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800108
J	McKeon, S; Pace-Schott, EF; Spencer, RMC				McKeon, Shannon; Pace-Schott, Edward F.; Spencer, Rebecca M. C.			Interaction of Sleep and Emotional Content on the Production of False Memories	PLOS ONE			English	Article							COGNITIVE NEUROSCIENCE; DECLARATIVE MEMORY; ENHANCES MEMORY; CONSOLIDATION; RECALL; WORDS; LISTS	Sleep benefits veridical memories, resulting in superior recall relative to off-line intervals spent awake. Sleep also increases false memory recall in the Deese-Roediger-McDermott (DRM) paradigm. Given the suggestion that emotional veridical memories are prioritized for consolidation over sleep, here we examined whether emotion modulates sleep's effect on false memory formation. Participants listened to semantically related word lists lacking a critical lure representing each list's "gist.'' Free recall was tested after 12 hours containing sleep or wake. The Sleep group recalled more studied words than the Wake group but only for emotionally neutral lists. False memories of both negative and neutral critical lures were greater following sleep relative to wake. Morning and Evening control groups (20-minute delay) did not differ ruling out circadian accounts for these differences. These results support the adaptive function of sleep in both promoting the consolidation of veridical declarative memories and in extracting unifying aspects from memory details.	[McKeon, Shannon; Pace-Schott, Edward F.; Spencer, Rebecca M. C.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Pace-Schott, Edward F.; Spencer, Rebecca M. C.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA; [Pace-Schott, Edward F.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard Medical School; Massachusetts General Hospital	Spencer, RMC (corresponding author), Univ Massachusetts, Dept Psychol, Tobin Hall, Amherst, MA 01003 USA.	rspencer@psych.umass.edu		Spencer, Rebecca/0000-0002-8674-2384	Commonwealth College Honors Research Grant at the University of Massachusetts, Amherst [NIH R00 AG029710, NIH 1R21MH090357]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH090357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029710] Funding Source: NIH RePORTER	Commonwealth College Honors Research Grant at the University of Massachusetts, Amherst; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Commonwealth College Honors Research Grant at the University of Massachusetts, Amherst, NIH R00 AG029710, and NIH 1R21MH090357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, BEHAV NEUROSCI, V115, P983, DOI 10.1037//0735-7044.115.5.983; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Bauer LM, 2009, AM J PSYCHOL, V122, P469; Brainerd CJ, 2010, J EXP CHILD PSYCHOL, V107, P137, DOI 10.1016/j.jecp.2010.04.013; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Campanella C, 2011, 2011 ANN M COGN NEUR; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Dehon H, 2010, EMOTION, V10, P627, DOI 10.1037/a0019595; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Fenn KM, 2009, LEARN MEMORY, V16, P509, DOI 10.1101/lm.1500808; Gallo DA, 2010, MEM COGNITION, V38, P833, DOI 10.3758/MC.38.7.833; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P2619, DOI 10.1016/j.neuropsychologia.2011.05.009; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nelson D. L., 1999, U S FLORIDA WORD ASS; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Palmer J, 2009, COGNITION EMOTION, V23, P238, DOI 10.1080/02699930801976663; Payne JD, 2006, SLEEP, V29, pA373; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2011, NAT NEUROSCI, V14, P272, DOI 10.1038/nn0311-272; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Reyna VF, 2011, DEV REV, V31, P180, DOI 10.1016/j.dr.2011.07.004; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Saletin Jared M, 2012, Front Neurol, V3, P59, DOI 10.3389/fneur.2012.00059; Stadler MA, 1999, MEM COGNITION, V27, P494, DOI 10.3758/BF03211543; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Straube B, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-35; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	46	30	30	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49353	10.1371/journal.pone.0049353	http://dx.doi.org/10.1371/journal.pone.0049353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23145159	Green Published, gold			2022-12-25	WOS:000311935800250
J	Nowbahari, E; Hollis, KL; Durand, JL				Nowbahari, Elise; Hollis, Karen L.; Durand, Jean-Luc			Division of Labor Regulates Precision Rescue Behavior in Sand-Dwelling Cataglyphis cursor Ants: To Give Is to Receive	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; HYMENOPTERA; FORMICIDAE; WORKERS; POLYETHISM	Division of labor, an adaptation in which individuals specialize in performing tasks necessary to the colony, such as nest defense and foraging, is believed key to eusocial insects' remarkable ecological success. Here we report, for the first time, a completely novel specialization in a eusocial insect, namely the ability of Cataglyphis cursor ants to rescue a trapped nestmate using precisely targeted behavior. Labeled "precision rescue", this behavior involves the ability of rescuers not only to detect what, exactly, holds the victim in place, but also to direct specific actions to this obstacle. Individual ants, sampled from each of C. cursor's three castes, namely foragers, nurses and inactives, were experimentally ensnared (the "victim") and exposed to a caste-specific group of potential "rescuers." The data reveal that foragers were able to administer, and obtain, the most help while members of the youngest, inactive caste not only failed to respond to victims, but also received virtually no help from potential rescuers, regardless of caste. Nurses performed intermediate levels of aid, mirroring their intermediate caste status. Our results demonstrate that division of labor, which controls foraging, defense and brood care in C. cursor, also regulates a newly discovered behavior in this species, namely a sophisticated form of rescue, a highly adaptive specialization that is finely tuned to a caste member's probability of becoming, or encountering, a victim in need of rescue.	[Nowbahari, Elise; Hollis, Karen L.; Durand, Jean-Luc] Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France; [Hollis, Karen L.] Mt Holyoke Coll, Interdisciplinary Program Neurosci & Behav, S Hadley, MA 01075 USA	Universite Paris 13; Mount Holyoke College	Nowbahari, E (corresponding author), Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France.	Elise.Nowbahari@leec.univ-paris13.fr			Laboratoire d'Ethologie Experimentale et Comparee (LEEC); Mount Holyoke College	Laboratoire d'Ethologie Experimentale et Comparee (LEEC); Mount Holyoke College	The funding was provided by Laboratoire d'Ethologie Experimentale et Comparee (LEEC) and Mount Holyoke College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ANT ENCOUNTERS INTER; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; BLUM MS, 1966, ANN ENTOMOL SOC AM, V59, P774, DOI 10.1093/aesa/59.4.774; CAMMAERTSTRICOT MC, 1974, INSECT SOC, V21, P235, DOI 10.1007/BF02226916; Czechowski W, 2002, ANN ZOOL, V52, P423; Fourcassie V, 2000, NATURWISSENSCHAFTEN, V87, P355, DOI 10.1007/s001140050739; Gordon DM, 1999, ANTS AT WORK HOW AN; Holldobler B., 1990, pi; Hollis KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017958; Lenoir Alain, 2010, Israel Journal of Entomology, V39, P1; MAYADE S, 1993, BEHAV PROCESS, V30, P131, DOI 10.1016/0376-6357(93)90003-A; Nowbahari E, 2000, SOCIOBIOLOGY, V36, P485; Nowbahari Elise, 2010, Communicative & Integrative Biology, V3, P77; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Oster G.F., 1978, Monographs in Population Biology, pi; RETANA J, 1990, ETHOLOGY, V84, P105, DOI 10.1111/j.1439-0310.1990.tb00788.x; RETANA J, 1991, ETHOLOGY, V89, P275; ROBINSON GE, 1994, ANIM BEHAV, V48, P467, DOI 10.1006/anbe.1994.1260; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; SCHMIDHEMPEL P, 1984, INSECT SOC, V31, P345, DOI 10.1007/BF02223652; Seid MA, 2009, DEV NEUROBIOL, V69, P350, DOI 10.1002/dneu.20709; SPANGLER H G, 1968, Journal of the Kansas Entomological Society, V41, P318; WEHNER R., 1983, FORAGING STRATEGIES; WEHNER R, 1987, INDIVIDUAL COLLECTIV, P15, DOI DOI 10.1111/J.1365-3032.2011.00795.X; WILSON EDWARD O., 1958, PSYCHE, V65, P41, DOI 10.1155/1958/57483	26	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48516	10.1371/journal.pone.0048516	http://dx.doi.org/10.1371/journal.pone.0048516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144897	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800072
J	Rossano, R; Larocca, M; Polito, T; Perna, AM; Padula, MC; Martelli, G; Riccio, P				Rossano, Rocco; Larocca, Marilena; Polito, Teresa; Perna, Anna Maria; Padula, Maria Carmela; Martelli, Giuseppe; Riccio, Paolo			What Are the Proteolytic Enzymes of Honey and What They Do Tell Us? A Fingerprint Analysis by 2-D Zymography of Unifloral Honeys	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LONG-CHAIN; EXPRESSION; STORAGE; PROMOTER; TISSUE	Honey is a sweet and healthy food produced by honeybees (Apis mellifera L.) from flower nectars. Using bidimensional zymography, we have detected the, until now unrevealed, proteolytic activities present in row honey samples. The resulting zymograms were specific for each type of the four unifloral honey under study, and enzymes were identified as serine proteases by the use of specific inhibitors. Further, using bidimensional electrophoresis, we have shown that honey proteases are able to degrade the major Royal Jelly proteins and in particular MRPJ-1, the protein that promotes queen differentiation in honeybees. Our findings open new perspectives for the better understanding of honeybee development, social behaviour and role in honey production. The now discovered honey proteases may influence honey properties and quality, and bidimensional zymograms might be useful to distinguish between different honey types, establish their age and floral origin, and allow honey certification.	[Rossano, Rocco; Larocca, Marilena; Polito, Teresa; Padula, Maria Carmela; Martelli, Giuseppe; Riccio, Paolo] Univ Basilicata, Dept Biol Def & Agroforestal Biotechnol, I-85100 Potenza, Italy; [Rossano, Rocco; Larocca, Marilena; Polito, Teresa; Padula, Maria Carmela; Martelli, Giuseppe; Riccio, Paolo] Univ Basilicata, Ctr Bioprote, I-85100 Potenza, Italy; [Perna, Anna Maria] Univ Basilicata, Dept Anim Prod Sci, I-85100 Potenza, Italy	University of Basilicata; University of Basilicata; University of Basilicata	Rossano, R (corresponding author), Univ Basilicata, Dept Biol Def & Agroforestal Biotechnol, I-85100 Potenza, Italy.	rocco.rossano@unibas.it	Padula, Maria Carmela/S-8285-2019; Padula, Maria Carmela/O-3834-2019	Padula, Maria Carmela/0000-0003-0726-7085; ROSSANO, Rocco/0000-0002-3030-4190; PERNA, Anna Maria/0000-0002-6985-0842	University of Basilicata (Fondo Ateneo); Italian Foundation for Multiple Sclerosis (FISM); Bioplatforms Australia Services;  [2010/R/35]	University of Basilicata (Fondo Ateneo); Italian Foundation for Multiple Sclerosis (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Bioplatforms Australia Services; 	This study was supported by grants from University of Basilicata (Fondo Ateneo, 2008) for the research in food and in part by the project 2010/R/35 of PR on "The molecular basis of nutritional intervention in Multiple Sclerosis", funded by the Italian Foundation for Multiple Sclerosis (FISM)] for the development of bidimensional zymography (2-DZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dawar Hussain, Yoko Kennedy, Geraldine Lester, Lina Ma, Anne Mackenzie, Nathalie Niesner, Lijun Tian and Adam White for their excellent technical assistance. We also thank Dr James Horne at the Central Science Laboratory, University of Tasmania, for determining positional distribution of TAG by NMR, Dan Holdsworth for assistance with management of the GC and GC-MS facilities and Dr Damien Callahan at School of Botany, University of Melbourne, for assistance with LC-MS. LC-MS analysis was supported by Bioplatforms Australia Services.	Abeywardena Mahinda Y., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P232; Chaudhary S, 2001, International Patent Application, Patent No. [WO 2001/16340, 200116340]; Cheng BF, 2010, TRANSGENIC RES, V19, P221, DOI 10.1007/s11248-009-9302-z; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P8693, DOI 10.1093/nar/15.21.8693; HALL G, 1991, P NATL ACAD SCI USA, V88, P9320, DOI 10.1073/pnas.88.20.9320; Halweg C, 2005, PLANT CELL, V17, P418, DOI 10.1105/tpc.104.028100; KINNEY AJ, 2004, Patent No. 2004071467; Miller MR, 2006, LIPIDS, V41, P865, DOI 10.1007/s11745-006-5042-5; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Mori TA, 2006, CLIN EXP PHARMACOL P, V33, P842, DOI 10.1111/j.1440-1681.2006.04451.x; Nichols PD, 2010, NUTRIENTS, V2, P572, DOI 10.3390/nu2060572; Petrie JR, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr011; Petrie JR, 2012, TRANSGENIC RES, V21, P139, DOI 10.1007/s11248-011-9517-7; Petrie JR, 2010, METAB ENG, V12, P233, DOI 10.1016/j.ymben.2009.12.001; Petrie JR, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-8; Rossak M, 2001, PLANT MOL BIOL, V46, P717, DOI 10.1023/A:1011603923889; Ruiz-Lopez N, 2012, J EXP BOT, V63, P2397, DOI 10.1093/jxb/err454; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; SAMBROOK E, 1989, MOL CLONING LAB MANU; STALBERG K, 1993, PLANT MOL BIOL, V23, P671, DOI 10.1007/BF00021523; Truksa M, 2003, PLANT PHYSIOL BIOCH, V41, P141, DOI 10.1016/S0981-9428(02)00022-0; Turchini GM, 2012, CRIT REV FOOD SCI, V52, P795, DOI 10.1080/10408398.2010.509553; Venegas-Caleron M, 2010, PROG LIPID RES, V49, P108, DOI 10.1016/j.plipres.2009.10.001; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Zhan XX, 2008, YEAST, V25, P21, DOI 10.1002/yea.1546; Zhou XR, 2011, J BIOL CHEM, V286, P43644, DOI 10.1074/jbc.M111.266114	27	35	37	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49164	10.1371/journal.pone.0049164	http://dx.doi.org/10.1371/journal.pone.0049164			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145107	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800222
J	Stern, JH; Kim, K; Ramsey, JJ				Stern, Jennifer H.; Kim, Kyoungmi; Ramsey, Jon J.			The Influence of Shc Proteins and Aging on Whole Body Energy Expenditure and Substrate Utilization in Mice	PLOS ONE			English	Article							METABOLIC HEAT-PRODUCTION; MALE C57BL/6J MICE; AGE-RELATED DECREASE; MILD COLD STRESS; LIFE-SPAN; CALORIC RESTRICTION; OXIDATIVE STRESS; FISCHER-344 RATS; MASS; FAT	While it has been proposed that Shc family of adaptor proteins may influence aging by regulating insulin signaling and energy metabolism, the overall impact of Shc proteins on whole body energy metabolism has yet to be elucidated. Thus, the purpose of this study was to determine the influence of Shc proteins and aging on whole body energy metabolism in a mouse model under ambient conditions (22 degrees C) and acute cold exposure (12 degrees C for 24 hours). Using indirect respiration calorimetry, we investigated the impact of Shc proteins and aging on EE and substrate utilization (RQ) in p66 Shc-/- (ShcKO) and wild-type (WT) mice. Calorimetry measurements were completed in 3, 15, and 27 mo mice at 22 degrees C and 12 degrees C. At both temperatures and when analyzed across all age groups, ShcKO mice demonstrated lower 24 h total EE values than that of WT mice when EE data was expressed as either kJ per mouse, or adjusted by body weight or crude organ mass (ORGAN) (P <= 0.01 for all). The ShcKO mice also had higher (P < 0.05) fed state RQ values than WT animals at 22 degrees C, consistent with an increase in glucose utilization. However, Shc proteins did not influence age-related changes in energy expenditure or RQ. Age had a significant impact on EE at 22 degrees C, regardless of how EE data was expressed (P < 0.05), demonstrating a pattern of increase in EE from age 3 to 15 mo, followed by a decrease in EE at 27 mo. These results indicate a decline in whole body EE with advanced age in mice, independent of changes in body weight (BW) or fat free mass (FFM). The results of this study indicate that both Shc proteins and aging should be considered as factors that influence energy expenditure in mice.	[Stern, Jennifer H.; Ramsey, Jon J.] Univ Calif Davis, VM Mol Biosci, Davis, CA 95616 USA; [Kim, Kyoungmi] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Ramsey, JJ (corresponding author), Univ Calif Davis, VM Mol Biosci, Davis, CA 95616 USA.	jjramsey@ucdavis.edu			National Institutes of Health [PO1 AGO25532]; NATIONAL CANCER INSTITUTE [R25CA078447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (www.nia.nih.gov) grant PO1 AGO25532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DB, 1995, INT J OBESITY, V19, P644; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; BABINEAU LM, 1955, CAN J BIOCHEM PHYS, V33, P970; BAILEY C. B., 1960, CANADIAN JOUR ANIMAL SCI, V40, P143; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Bosy-Westphal A, 2003, J NUTR, V133, P2356, DOI 10.1093/jn/133.7.2356; BROZEK J, 1952, FED PROC, V11, P784; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; CALVERT CC, 1984, J ANIM SCI, V59, P361, DOI 10.2527/jas1984.592361x; Corva PM, 2000, PHYSIOL GENOMICS, V3, P17, DOI 10.1152/physiolgenomics.2000.3.1.17; DeGroot DW, 2007, AM J PHYSIOL-REG I, V292, pR103, DOI 10.1152/ajpregu.00074.2006; DeGroot DW, 2006, J APPL PHYSIOL, V101, P1607, DOI 10.1152/japplphysiol.00717.2006; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4; FUKAGAWA NK, 1990, AM J PHYSIOL, V259, pE233, DOI 10.1152/ajpendo.1990.259.2.E233; Giorgio M, 2011, AGING CELL; GRAD B, 1957, J GERONTOL, V12, P172, DOI 10.1093/geronj/12.2.172; Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9; Hagopian K, 2012, METABOLISM; Haramizu S, 2011, J GERONTOL A-BIOL, V66, P646, DOI 10.1093/gerona/glr037; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Hsu A, 2003, AM J CLIN NUTR, V77, P1506, DOI 10.1093/ajcn/77.6.1506; Hunter GR, 2001, AM J CLIN NUTR, V73, P333; Kenney WL, 2003, J APPL PHYSIOL, V95, P2598, DOI 10.1152/japplphysiol.00202.2003; KRZYWICKI HJ, 1974, AM J CLIN NUTR, V27, P1380, DOI 10.1093/ajcn/27.12.1380; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Migliaccio E, 2006, ANTIOXID REDOX SIGN, V8, P600, DOI 10.1089/ars.2006.8.600; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; PACE N, 1945, J BIOL CHEM, V158, P685; POEHLMAN ET, 1995, INT J OBESITY, V19, pS93; Puggaard L, 2002, AM J HUM BIOL, V14, P486, DOI 10.1002/ajhb.10066; Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007; Ramsey JJ, 1996, COMP BIOCHEM PHYS B, V113, P461, DOI 10.1016/0305-0491(95)02071-3; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Sasaoka T, 2000, ENDOCR J, V47, P373, DOI 10.1507/endocrj.47.373; SOBEL H, 1968, J GERONTOL, V23, P387, DOI 10.1093/geronj/23.3.387; Sohal RS, 2009, J NUTR, V139, P533, DOI 10.3945/jn.108.100313; TATELMAN HM, 1990, EXP GERONTOL, V25, P459, DOI 10.1016/0531-5565(90)90034-Y; TATELMAN HM, 1990, J GERONTOL, V45, pB215, DOI 10.1093/geronj/45.6.B215; TATELMAN HM, 1993, EXP GERONTOL, V28, P579, DOI 10.1016/0531-5565(93)90047-H; Tomilov AA, 2010, AGING CELL; Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x; Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Vaanholt LM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P314, DOI 10.1086/589727; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Widdowson EM, 1968, BODY COMPOSITION ANI, P71	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48790	10.1371/journal.pone.0048790	http://dx.doi.org/10.1371/journal.pone.0048790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144971	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800133
J	Tian, Q; Liang, LH; Ding, J; Zha, RP; Shi, HB; Wang, QF; Huang, SL; Guo, WJ; Ge, C; Chen, TY; Li, JJ; He, XH				Tian, Qi; Liang, Linhui; Ding, Jie; Zha, Ruopeng; Shi, Haibing; Wang, Qifeng; Huang, Shenglin; Guo, Weijie; Ge, Chao; Chen, Taoyang; Li, Jinjun; He, Xianghuo			MicroRNA-550a Acts as a Pro-Metastatic Gene and Directly Targets Cytoplasmic Polyadenylation Element-Binding Protein 4 in Hepatocellular Carcinoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; NERVE SHEATH TUMORS; DNA COPY NUMBER; CELL; EXPRESSION; SUBTYPES; PROFILE; MIRNAS; SITES; CPEB3	MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules that are often found at chromosomal breakpoints and play a vital role in human cancer. Our previous study found that miR-550a, a frequently amplified miRNA on 7p14.3, was upregulated in hepatocellular carcinoma (HCC). However, the possible functions and molecular mechanisms of miR-550a in HCC remain unknown. In this study, gain-of-function and loss-of-function assays revealed that miR-550a markedly promoted HCC cell migration and invasion. In addition, we discovered that cytoplasmic polyadenylation element binding protein 4 (CPEB4) was a potential target of miR-550a in HCC. Further analyses showed that knockdown of CPEB4 expression significantly facilitated HCC cell migration and invasion, which phenocopied the effects of miR-550a on HCC cells. Moreover, a decrease in CPEB4 expression mediated miR-550a-induced liver cancer cell migration and invasion. Interestingly, CPEB4 is frequently downregulated in HCC, and its expression levels correlate with the overall survival of HCC patients. Together, these results suggested that this newly identified miR-550a-CPEB4 axis may be involved in HCC cell metastasis. Moreover, the expression levels of CPEB4 could be used to predict outcomes in HCC patients. Our findings provide novel potential targets for HCC therapy and prognosis.	[Tian, Qi; Liang, Linhui; Ding, Jie; Zha, Ruopeng; Shi, Haibing; Wang, Qifeng; Huang, Shenglin; Guo, Weijie; Ge, Chao; Li, Jinjun; He, Xianghuo] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200030, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong, Jiangsu, Peoples R China	Shanghai Jiao Tong University	He, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200030, Peoples R China.	xhhe@shsci.org	Huang, Shenglin/N-9472-2018; liang, linhui/AAW-4176-2021; He, Xianghuo/I-1497-2014	Huang, Shenglin/0000-0003-1279-0794; He, Xianghuo/0000-0001-8872-668X; Guo, Weijie/0000-0001-7167-9899	National Natural Science Foundation of China [81125016, 81101481]; National 973 Key Basic Research Program [2011CB933100]; Science and Technology Commission of Shanghai Municipality [11XD1404500, 10JC1414200]; Shanghai Health Bureau [XYQ2011047, XBR2011039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Key Basic Research Program(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Health Bureau	This work was partially supported by the grants from The National Natural Science Foundation of China [81125016, 81101481], http://www.nsfc.gov.cn/Portal0/default152.htm; The National 973 Key Basic Research Program [2011CB933100], http://www.973.gov.cn/English/Index.aspx; the Science and Technology Commission of Shanghai Municipality [11XD1404500, 10JC1414200], http://www.stcsm.gov.cn/structure/index.htm; and Shanghai Health Bureau [XYQ2011047, XBR2011039], http://wsj.sh.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10; Katoh H, 2005, J HEPATOL, V43, P863, DOI 10.1016/j.jhep.2005.05.033; Koizumi Y, 1997, CLIN CANCER RES, V3, P1067; Krismann M, 2002, J PATHOL, V197, P363, DOI 10.1002/path.1128; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu Yuan, 2009, PLoS One, V4, pe6159, DOI 10.1371/journal.pone.0006159; Mantripragada KK, 2009, GENE CHROMOSOME CANC, V48, P897, DOI 10.1002/gcc.20695; Morgan M, 2010, NUCLEIC ACIDS RES, V38, P7698, DOI 10.1093/nar/gkq635; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Salgado R, 2011, CANCER GENET-NY, V204, P405, DOI 10.1016/j.cancergen.2011.05.004; Schmidt H, 2000, CANCER LETT, V155, P181, DOI 10.1016/S0304-3835(00)00426-2; Thorns C, 2012, VIRCHOWS ARCH, V460, P371, DOI 10.1007/s00428-012-1215-1; Wang CD, 2012, ONCOL REP, V27, P1312, DOI 10.3892/or.2012.1690; Wong N, 2003, CANCER GENET CYTOGEN, V140, P124, DOI 10.1016/S0165-4608(02)00657-X; Xu Ling, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P178; Yamada S, 2004, DNA RES, V11, P335, DOI 10.1093/dnares/11.5.335; Yen CC, 2003, INT J ONCOL, V23, P871; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	32	48	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48958	10.1371/journal.pone.0048958	http://dx.doi.org/10.1371/journal.pone.0048958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145039	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800178
J	Williamson, SC; Hepburn, AC; Wilson, L; Coffey, K; Ryan-Munden, CA; Pal, D; Leung, HY; Robson, CN; Heer, R				Williamson, Stuart C.; Hepburn, Anastasia C.; Wilson, Laura; Coffey, Kelly; Ryan-Munden, Claudia A.; Pal, Deepali; Leung, Hing Y.; Robson, Craig N.; Heer, Rakesh			Human alpha(2)beta(HI)(1) CD133(+VE) Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor	PLOS ONE			English	Article							TRANSIENT AMPLIFYING POPULATION; GENE-EXPRESSION; IN-VITRO; CANCER; DIFFERENTIATION; BASAL; IDENTIFICATION; ORIGIN; PROGRESSION; ACTIVATION	Stem cells are thought to be the cell of origin in malignant transformation in many tissues, but their role in human prostate carcinogenesis continues to be debated. One of the conflicts with this model is that cancer stem cells have been described to lack androgen receptor (AR) expression, which is of established importance in prostate cancer initiation and progression. We re-examined the expression patterns of AR within adult prostate epithelial differentiation using an optimised sensitive and specific approach examining transcript, protein and AR regulated gene expression. Highly enriched populations were isolated consisting of stem (alpha(2)beta(HI)(1) CD133(+VE)), transiently amplifying (alpha(2)beta(HI)(1) CD133(-VE)) and terminally differentiated (alpha(2)beta(LOW)(1) CD133(-VE)) cells. AR transcript and protein expression was confirmed in alpha(2)beta(HI)(1) CD133(+VE) and CD133(-VE) progenitor cells. Flow cytometry confirmed that median (+/- SD) fraction of cells expressing AR were 77% (+/- 66%) in alpha(2)beta(HI)(1) CD133(+VE) stem cells and 68% (+/- 12%) in alpha(2)beta(HI)(1) CD133(-VE) transiently amplifying cells. However, 3-fold lower levels of total AR protein expression (peak and median immunofluorescence) were present in alpha(2)beta(HI)(1) CD133(+VE) stem cells compared with differentiated cells. This finding was confirmed with dual immunostaining of prostate sections for AR and CD133, which again demonstrated low levels of AR within basal CD133(+VE) cells. Activity of the AR was confirmed in prostate progenitor cells by the expression of low levels of the AR regulated genes PSA, KLK2 and TMPRSS2. The confirmation of AR expression in prostate progenitor cells allows integration of the cancer stem cell theory with the established models of prostate cancer initiation based on a functional AR. Further study of specific AR functions in prostate stem and differentiated cells may highlight novel mechanisms of prostate homeostasis and insights into tumourigenesis.	[Williamson, Stuart C.; Hepburn, Anastasia C.; Wilson, Laura; Coffey, Kelly; Ryan-Munden, Claudia A.; Pal, Deepali; Robson, Craig N.; Heer, Rakesh] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Leung, Hing Y.] Beatson Inst Canc Res, Glasgow, East Dunbartons, Scotland	Newcastle University - UK; Beatson Institute	Heer, R (corresponding author), Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Rakesh.Heer@ncl.ac.uk	Coffey, Kelly/AAZ-4433-2020	Coffey, Kelly/0000-0003-0502-2914; Pal, Deepali/0000-0001-6326-5303; Williamson, Stuart/0000-0002-5209-4796; Wilson, Laura/0000-0002-7919-2230; Leung, Hing Y./0000-0002-3933-3975	Newcastle upon Tyne NHS Trustees; Cancer Research UK; Cancer Research UK [15151, 12173] Funding Source: researchfish	Newcastle upon Tyne NHS Trustees; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Work was supported by Newcastle upon Tyne NHS Trustees and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965; BONKHOFF H, 1993, VIRCHOWS ARCH A, V422, P35, DOI 10.1007/BF01605130; Bonkhoff H, 2010, PROSTATE, V70, P100, DOI 10.1002/pros.21042; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Cunha GR, 2008, DIFFERENTIATION, V76, P578, DOI 10.1111/j.1432-0436.2008.00290.x; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Heer R, 2007, J CELL PHYSIOL, V212, P572, DOI 10.1002/jcp.21154; Heer R, 2006, J CELL SCI, V119, P1416, DOI 10.1242/jcs.02802; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; Kumar SM, 2012, ONCOGENE; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee SO, 2012, J ENDOCRINOL, V213, P173, DOI 10.1530/JOE-11-0474; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Mousses S, 2001, ONCOGENE, V20, P6718, DOI 10.1038/sj.onc.1204889; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shepherd CJ, 2008, PROSTATE, V68, P1007, DOI 10.1002/pros.20765; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	40	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48944	10.1371/journal.pone.0048944	http://dx.doi.org/10.1371/journal.pone.0048944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145034	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000311935800176
J	You, J; Lee, E; Bonilla, L; Francis, J; Koh, J; Block, J; Chen, SX; Hansen, PJ				You, Jinyoung; Lee, Eunsong; Bonilla, Luciano; Francis, Jasmine; Koh, Jin; Block, Jeremy; Chen, Sixue; Hansen, Peter J.			Treatment with the Proteasome Inhibitor MG132 during the End of Oocyte Maturation Improves Oocyte Competence for Development after Fertilization in Cattle	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; IN-VITRO; BOVINE OOCYTES; HEAT-SHOCK; EXPRESSION; DEGRADATION; APOPTOSIS; EMBRYOS; CLONING; ACTIVATION	Maturation of the oocyte involves nuclear and cytoplasmic changes that include post-translational processing of proteins. The objective was to investigate whether inhibition of proteasomes during maturation would alter competence of the bovine oocyte for fertilization and subsequent development. Cumulus-oocyte complexes were cultured in the presence or absence of the proteasomal inhibitor MG132 from either 0-6 h or 16-22 h after initiation of maturation. Treatment with MG132 early in maturation prevented progression to meiosis II and reduced fertilization rate and the proportion of oocytes and cleaved embryos that became blastocysts. Conversely, treatment with MG132 late in maturation improved the percentage of oocytes and cleaved embryos that became blastocysts without affecting nuclear maturation or fertilization rate. Optimal results with MG132 were achieved at a concentration of 10 mu M - effects were generally not observed at lower or higher concentrations. Using proteomic analysis, it was found that MG132 at the end of maturation increased relative expression of 6 proteins and decreased relative expression of 23. Among those increased by MG132 that are potentially important for oocyte competence are GAPDH, involved in glycolysis, TUBA1C, needed for organellar movement, and two proteins involved in protein folding (P4HB and HYOU1). MG132 decreased amounts of several proteins that exert antiapoptotic actions including ASNS, HSP90B1, PDIA3 and VCP. Another protein decreased by MG132, CDK5, can lead to apoptosis if aberrantly activated and one protein increased by MG132, P4HB, is anti-apoptotic. Finally, the pregnancy rate of cows receiving embryos produced from oocytes treated with MG132 from 16-22 h of maturation was similar to that for control embryos, suggesting that use of MG132 for production of embryos in vitro does not cause a substantial decrease in embryo quality.	[Bonilla, Luciano; Francis, Jasmine; Block, Jeremy; Hansen, Peter J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Bonilla, Luciano; Francis, Jasmine; Block, Jeremy; Hansen, Peter J.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA; [You, Jinyoung; Lee, Eunsong] Kangwon Natl Univ, Coll Vet Med, Chunchon, South Korea; [Koh, Jin; Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Block, Jeremy] Ovatech LLC, Gainesville, FL USA; [Koh, Jin; Chen, Sixue] Univ Florida, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Kangwon National University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	Hansen@animal.ufl.edu	Hansen, Peter/AAI-4693-2021; Block, Jeremy/AAC-6408-2021; block, jeremy/B-2836-2013; CHEN, SI/GZL-4800-2022; Lee, Eunsong/AAJ-3848-2020	Hansen, Peter/0000-0003-3061-9333; Block, Jeremy/0000-0002-6279-8543; Lee, Eunsong/0000-0001-9654-7788; Kannampuzha Francis, Jasmine/0000-0001-8372-7747	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-85122-20623]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2010-85122-20623 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5; Berendt FJ, 2009, PROTEOMICS, V9, P550, DOI 10.1002/pmic.200700417; Block J, 2010, J DAIRY SCI, V93, P5234, DOI 10.3168/jds.2010-3443; BLUMENFELD N, 1994, J BIOL CHEM, V269, P9574; Brusveen DJ, 2008, J DAIRY SCI, V91, P1044, DOI 10.3168/jds.2007-0409; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui HY, 2007, CANCER RES, V67, P3345, DOI 10.1158/0008-5472.CAN-06-2519; Demant M, 2012, HUM REPROD, V27, P1096, DOI 10.1093/humrep/der453; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Gao SR, 2005, TRENDS BIOTECHNOL, V23, P66, DOI 10.1016/j.tibtech.2004.12.007; Hashida T, 2011, J TOXICOL SCI, V36, P1, DOI 10.2131/jts.36.1; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Kondoh E, 2008, DEV GROWTH DIFFER, V50, P665, DOI 10.1111/j.1440-169X.2008.01064.x; Krisher RL, 1999, MOL REPROD DEV, V53, P19, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;19::AID-MRD3&gt;3.0.CO;2-U; Law ME, 2012, ONCOGENE IN PRESS; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lopes JP, 2010, AGING CELL, V9, P64, DOI 10.1111/j.1474-9726.2009.00536.x; Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151; Mizumoto S, 2008, CLONING STEM CELLS, V10, P453, DOI 10.1089/clo.2008.0017; Nagyova E, 2012, DOMEST ANIM ENDOCRIN, V42, P50, DOI 10.1016/j.domaniend.2011.09.003; Nakajima N, 2008, CLONING STEM CELLS, V10, P461, DOI 10.1089/clo.2008.0038; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Ono T, 2011, GENESIS, V49, P460, DOI 10.1002/dvg.20756; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; Rivera RM, 2004, BIOL REPROD, V70, P1852, DOI 10.1095/biolreprod.103.024901; Robertson I., 1998, MANUAL INT EMBRYO TR, P103; Roth Z, 2004, BIOL REPROD, V71, P1898, DOI 10.1095/biolreprod.104.031690; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Usmani SZ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-40; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Whitworth KM, 2009, MOL REPROD DEV, V76, P490, DOI 10.1002/mrd.20987; Wu YG, 2007, CLONING STEM CELLS, V9, P417, DOI 10.1089/clo.2006.0023; Yang Q, 2010, BIOL REPROD, V82, P123, DOI 10.1095/biolreprod.109.076588; You J, 2012, MOL REPROD DEV, V79, P41, DOI 10.1002/mrd.21402; You J, 2010, MOL REPROD DEV, V77, P149, DOI 10.1002/mrd.21115; Yun JW, 2011, CANCER INVEST, V29, P93, DOI 10.3109/07357907.2010.535062	48	17	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48613	10.1371/journal.pone.0048613	http://dx.doi.org/10.1371/journal.pone.0048613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144909	Green Published, gold			2022-12-25	WOS:000311935800081
J	Babb, RC; Homer, KA; Robbins, J; Lax, AJ				Babb, Rebecca C.; Homer, Karen A.; Robbins, Jon; Lax, Alistair J.			Modification of Heterotrimeric G-Proteins in Swiss 3T3 Cells Stimulated with Pasteurella multocida Toxin	PLOS ONE			English	Article							2-DIMENSIONAL ELECTROPHORESIS; ALPHA-SUBUNITS; G-ALPHA(Q); ACTIVATION; CELLS; MECHANISMS; BOMBESIN; G(Q); TRANSGLUTAMINASES; DEAMIDATION	Many bacterial toxins covalently modify components of eukaryotic signalling pathways in a highly specific manner, and can be used as powerful tools to decipher the function of their molecular target(s). The Pasteurella multocida toxin (PMT) mediates its cellular effects through the activation of members of three of the four heterotrimeric G-protein families, G(q), G(12) and G(i). PMT has been shown by others to lead to the deamidation of recombinant G alpha(i) at Gln-205 to inhibit its intrinsic GTPase activity. We have investigated modification of native G alpha subunits mediated by PMT in Swiss 3T3 cells using 2-D gel electrophoresis and antibody detection. An acidic change in the isoelectric point was observed for the G alpha subunit of the G(q) and G(i) families following PMT treatment of Swiss 3T3 cells, which is consistent with the deamidation of these G alpha subunits. Surprisingly, PMT also induced a similar modification of G alpha(11), a member of the G(q) family of G-proteins that is not activated by PMT. Furthermore, an alkaline change in the isoelectric point of G alpha(13) was observed following PMT treatment of cells, suggesting differential modification of this G alpha subunit by PMT. G(s) was not affected by PMT treatment. Prolonged treatment with PMT led to a reduction in membrane-associated G alpha(i), but not G alpha(q). We also show that PMT inhibits the GTPase activity of G(q).	[Babb, Rebecca C.; Homer, Karen A.; Lax, Alistair J.] Kings Coll London, Dept Microbiol, Inst Dent, Guys Hosp, London WC2R 2LS, England; [Robbins, Jon] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Lax, AJ (corresponding author), Kings Coll London, Dept Microbiol, Inst Dent, Guys Hosp, London WC2R 2LS, England.	alistair.lax@kcl.ac.uk	Robbins, Jonathan/A-8661-2008	Robbins, Jonathan/0000-0003-1907-0714; Lax, Alistair/0000-0002-1424-5071	Biotechnology and Biological Sciences Research Council, UK	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a studentship grant to RCB from the Biotechnology and Biological Sciences Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpayee NS, 2010, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a000974.01, DOI 10.1038/MP.A000974.01]; Baldwin MR, 2003, J BIOL CHEM, V278, P32719, DOI 10.1074/jbc.M303524200; CASSEL D, 1976, BIOCHIM BIOPHYS ACTA, V452, P538, DOI 10.1016/0005-2744(76)90206-0; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hayat S, 2003, MOL CELL NEUROSCI, V22, P259, DOI 10.1016/S1044-7431(03)00051-4; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kamitani S, 2011, FEBS J, V278, P2702, DOI 10.1111/j.1742-4658.2011.08197.x; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Kurrasch DM, 2004, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a000970.01, DOI 10.1038/MP.A000970.01)]; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Matousek P, 2004, PHYSIOL RES, V53, P295; MILLIGAN G, 1993, TRENDS PHARMACOL SCI, V14, P413, DOI 10.1016/0165-6147(93)90064-Q; MILLIGAN G, 1989, BIOCHEM J, V262, P643, DOI 10.1042/bj2620643; Mullan PB, 1996, INFECT IMMUN, V64, P959, DOI 10.1128/IAI.64.3.959-965.1996; MULLANEY I, 1993, FEBS LETT, V324, P241, DOI 10.1016/0014-5793(93)81401-K; MURPHY AC, 1992, J BIOL CHEM, V267, P25296; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2004, J BIOL CHEM, V279, P34150, DOI 10.1074/jbc.M405353200; Orth JHC, 2008, J BIOL CHEM, V283, P23288, DOI 10.1074/jbc.M803435200; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; Schmidt G, 1998, J BIOL CHEM, V273, P13669, DOI 10.1074/jbc.273.22.13669; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stamnaes J, 2008, BBA-PROTEINS PROTEOM, V1784, P1804, DOI 10.1016/j.bbapap.2008.08.011; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Suzuki N, 2009, NEUROSIGNALS, V17, P55, DOI 10.1159/000186690; SVOBODA P, 1994, EUR J BIOCHEM, V224, P455, DOI 10.1111/j.1432-1033.1994.00455.x; TAKUWA N, 1987, J BIOL CHEM, V262, P182; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Ward PN, 1998, INFECT IMMUN, V66, P5636, DOI 10.1128/IAI.66.12.5636-5642.1998; Wettschureck N, 2009, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a000978.01, DOI 10.1038/MP.A000978.01)]; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	43	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47188	10.1371/journal.pone.0047188	http://dx.doi.org/10.1371/journal.pone.0047188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144805	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400017
J	Schlattner, U; Tokarska-Schlattner, M; Ramirez, S; Tyurina, YY; Amoscato, AA; Mohammadyani, D; Huang, ZT; Jiang, JF; Yanamala, N; Seffouh, A; Boissan, M; Epand, RF; Epand, RM; Klein-Seetharaman, J; Lacombe, ML; Kagan, VE				Schlattner, Uwe; Tokarska-Schlattner, Malgorzata; Ramirez, Sacnicte; Tyurina, Yulia Y.; Amoscato, Andrew A.; Mohammadyani, Dariush; Huang, Zhentai; Jiang, Jianfei; Yanamala, Naveena; Seffouh, Amal; Boissan, Mathieu; Epand, Raquel F.; Epand, Richard M.; Klein-Seetharaman, Judith; Lacombe, Marie-Lise; Kagan, Valerian E.			Dual Function of Mitochondrial Nm23-H4 Protein in Phosphotransfer and Intermembrane Lipid Transfer A CARDIOLIPIN-DEPENDENT SWITCH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE-DIPHOSPHATE-KINASE; CREATINE-KINASE; OUTER MEMBRANES; OPTIC ATROPHY; CYTOCHROME-C; APOPTOSIS; INNER; RESPIRATION; DISEASE; HEALTH	The nucleoside diphosphate kinase Nm23-H4/NDPK-D forms symmetrical hexameric complexes in the mitochondrial intermembrane space with phosphotransfer activity using mitochondrial ATP to regenerate nucleoside triphosphates. We demonstrate the complex formation between Nm23-H4 and mitochondrial GTPase OPA1 in rat liver, suggesting its involvement in local and direct GTP delivery. Similar to OPA1, Nm23-H4 is further known to strongly bind in vitro to anionic phospholipids, mainly cardiolipin, and in vivo to the inner mitochondrial membrane. We show here that such protein-lipid complexes inhibit nucleoside diphosphate kinase activity but are necessary for another function of Nm23-H4, selective intermembrane lipid transfer. Mitochondrial lipid distribution was analyzed by liquid chromatography-mass spectrometry using HeLa cells expressing either wild-type Nm23-H4 or a membrane binding-deficient mutant at a site predicted based on molecular modeling to be crucial for cardiolipin binding and transfer mechanism. We found that wild type, but not the mutant enzyme, selectively increased the content of cardiolipin in the outer mitochondrial membrane, but the distribution of other more abundant phospholipids (e.g. phosphatidylcholine) remained unchanged. HeLa cells expressing the wild-type enzyme showed increased accumulation of Bax in mitochondria and were sensitized to rotenone-induced apoptosis as revealed by stimulated release of cytochrome c into the cytosol, elevated caspase 3/7 activity, and increased annexin V binding. Based on these data and molecular modeling, we propose that Nm23-H4 acts as a lipid-dependent mitochondrial switch with dual function in phosphotransfer serving local GTP supply and cardiolipin transfer for apoptotic signaling and putative other functions.	[Schlattner, Uwe; Tokarska-Schlattner, Malgorzata; Ramirez, Sacnicte; Seffouh, Amal] Univ Grenoble 1, Lab Fundamental & Appl Bioenerget, INSERM, U1055, F-38041 Grenoble 9, France; [Tyurina, Yulia Y.; Amoscato, Andrew A.; Huang, Zhentai; Jiang, Jianfei; Yanamala, Naveena; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Mohammadyani, Dariush; Yanamala, Naveena; Klein-Seetharaman, Judith] Univ Pittsburgh, Dept Biol Struct, Sch Med, Pittsburgh, PA 15219 USA; [Boissan, Mathieu; Lacombe, Marie-Lise] INSERM, UMR S938, F-75012 Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] Univ Paris 06, F-75012 Paris, France; [Boissan, Mathieu] Hop Tenon, AP HP, Serv Biochim & Hormonol, F-75020 Paris, France; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; McMaster University	Schlattner, U (corresponding author), Univ Grenoble 1, Lab Fundamental & Appl Bioenerget, INSERM, U1055, BP 53, F-38041 Grenoble 9, France.	uwe.schlattner@ujf-grenoble.fr; kagan@pitt.edu	Yanamala, Naveena/AAA-6729-2022; , Richard/R-2316-2019; Schlattner, Uwe/D-1267-2009; Huang, Zhentai/C-6926-2012	, Richard/0000-0002-9602-9558; Schlattner, Uwe/0000-0003-1159-5911; Huang, Zhentai/0000-0002-8102-464X; Tyurina, Yulia/0000-0003-0287-2091; Amoscato, Andrew/0000-0002-1340-9150; Tokarska-Schlattner, Malgorzata/0000-0003-4401-7050; Kagan, Valerian E./0000-0002-7245-1885; Yanamala, Naveena/0000-0002-4454-4240	National Institutes of Health [U19AIO68021, HL70755, NS076511, ES020693, ES021068, R01 LM007994-07]; French "Agence Nationale de Recherche" "Chaire d'Excellence"; National Institute for Occupational Safety and Health [OH008282]; National Science Foundation [CCF-1144281]; Groupement des Entreprises Francaises Contre le Cancer; Canadian Natural Sciences and Engineering Research Council [9848]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020693, R21ES021068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076511] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French "Agence Nationale de Recherche" "Chaire d'Excellence"(French National Research Agency (ANR)); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Science Foundation(National Science Foundation (NSF)); Groupement des Entreprises Francaises Contre le Cancer; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants U19AIO68021, HL70755, NS076511, ES020693, and ES021068 (to V. K.) and Grant R01 LM007994-07 (to J. K. S.). This work was also supported by the French "Agence Nationale de Recherche" "Chaire d'Excellence" (to U. S.), National Institute for Occupational Safety and Health Grant OH008282 (to V. K.), National Science Foundation Grant CCF-1144281 (to J. K. S.), a grant from the "Groupement des Entreprises Francaises Contre le Cancer" (to M. L. L. and M. B.), and in part by the Canadian Natural Sciences and Engineering Research Council Grant 9848 (to R. M. E.).	Agarwal R P, 1978, Methods Enzymol, V51, P376; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Brahimi-Horn MC, 2012, CANCER RES, V72, P2140, DOI 10.1158/0008-5472.CAN-11-3940; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; Epand RF, 2007, BIOPHYS J, V92, P126, DOI 10.1529/biophysj.106.092353; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Fang HY, 2012, HUM PATHOL, V43, P105, DOI 10.1016/j.humpath.2011.04.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galluzzi L, 2012, EMBO REP, V13, P322, DOI 10.1038/embor.2012.19; GARCES E, 1969, BIOCHEMISTRY-US, V8, P633, DOI 10.1021/bi00830a026; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Isin Basak, 2012, Methods Mol Biol, V914, P285, DOI 10.1007/978-1-62703-023-6_17; Kagan VE, 2006, CHEM-BIOL INTERACT, V163, P15, DOI 10.1016/j.cbi.2006.04.019; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2011, BBA-BIOMEMBRANES, V1808, P2147, DOI 10.1016/j.bbamem.2011.04.009; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lacombe ML, 2009, BIOCHIMIE, V91, P779, DOI 10.1016/j.biochi.2009.02.006; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Landes T, 2010, EMBO REP, V11, P459, DOI 10.1038/embor.2010.50; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Li SJ, 2012, J BIOENERG BIOMEMBR, V44, P189, DOI 10.1007/s10863-012-9424-5; Liu JH, 2003, MOL CANCER RES, V1, P892; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2009, BBA-BIOMEMBRANES, V1788, P2032, DOI 10.1016/j.bbamem.2009.04.018; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Stachowiak O, 1998, MOL CELL BIOCHEM, V184, P141, DOI 10.1023/A:1006803431821; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Tokarska-Schlattner M, 2007, BBA-BIOENERGETICS, V1767, P1276, DOI 10.1016/j.bbabio.2007.08.006; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tyurina YY, 2011, ACS NANO, V5, P7342, DOI 10.1021/nn202201j; Walzel B, 2002, J BIOL CHEM, V277, P37503, DOI 10.1074/jbc.M201168200	49	76	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					111	121		10.1074/jbc.M112.408633	http://dx.doi.org/10.1074/jbc.M112.408633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150663	Green Published, hybrid			2022-12-25	WOS:000313197200011
J	Pilla, E; Moller, U; Sauer, G; Mattiroli, F; Melchior, F; Geiss-Friedlander, R				Pilla, Esther; Moeller, Ulrike; Sauer, Guido; Mattiroli, Francesca; Melchior, Frauke; Geiss-Friedlander, Ruth			A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-BINDING-MOTIF; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; UBIQUITIN; COMPLEX; IV; SUMOYLATION; REVEALS; LOCALIZATION; INHIBITORS	Sumoylation affects many cellular processes by regulating the interactions of modified targets with downstream effectors. Here we identified the cytosolic dipeptidyl peptidase 9 (DPP9) as a SUMO1 interacting protein. Surprisingly, DPP9 binds to SUMO1 independent of the well known SUMO interacting motif, but instead interacts with a loop involving Glu(67) of SUMO1. Intriguingly, DPP9 selectively associates with SUMO1 and not SUMO2, due to a more positive charge in the SUMO1-loop. We mapped the SUMO-binding site of DPP9 to an extended arm structure, predicted to directly flank the substrate entry site. Importantly, whereas mutants in the SUMO1-binding arm are less active compared with wild-type DPP9, SUMO1 stimulates DPP9 activity. Consistent with this, silencing of SUMO1 leads to a reduced cytosolic prolyl-peptidase activity. Taken together, these results suggest that SUMO1, or more likely, a sumoylated protein, acts as an allosteric regulator of DPP9.	[Pilla, Esther; Moeller, Ulrike; Sauer, Guido; Geiss-Friedlander, Ruth] Univ Goettingen, Dept Biochem 1, Fac Med, D-37073 Gottingen, Germany; [Mattiroli, Francesca] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Melchior, Frauke] Heidelberg Univ, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany	University of Gottingen; Netherlands Cancer Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Geiss-Friedlander, R (corresponding author), Univ Goettingen, Dept Biochem 1, Fac Med, Humboldtallee 23, D-37073 Gottingen, Germany.	rgeiss@gwdg.de	Geiss-Friedlander, Ruth/AAT-8768-2020; Melchior, Frauke/E-2014-2014; Geiss-Friedlander, Ruth/G-3569-2013; Mattiroli, Francesca/AAT-1489-2020	Geiss-Friedlander, Ruth/0000-0002-1720-3440; Melchior, Frauke/0000-0001-9546-8797; Geiss-Friedlander, Ruth/0000-0002-1720-3440; Mattiroli, Francesca/0000-0002-1574-7217	Deutsche Forschungsgemeinschaft [2234/1-1]; European Union NoE Rubicon	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union NoE Rubicon	This work was supported by Deutsche Forschungsgemeinschaft Grant 2234/1-1 and the European Union NoE Rubicon (until 2011).	Abbott CA, 2000, ADV EXP MED BIOL, V477, P103; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Alegre KO, 2011, J BIOL CHEM, V286, P36142, DOI 10.1074/jbc.M111.268847; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Connolly BA, 2008, J MED CHEM, V51, P6005, DOI 10.1021/jm800390n; Ding HS, 2005, BIOCHEMISTRY-US, V44, P2790, DOI 10.1021/bi0477586; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Dubois V, 2009, J HISTOCHEM CYTOCHEM, V57, P531, DOI 10.1369/jhc.2009.952739; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kotackova L, 2009, FOLIA BIOL-PRAGUE, V55, P77; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; McIntosh CHS, 2005, REGUL PEPTIDES, V128, P159, DOI 10.1016/j.regpep.2004.06.001; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Park J., 2008, OPEN ENZYM INHIB J, V1, P52, DOI [10.2174/1874940200801010052, DOI 10.2174/1874940200801010052]; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rummey C, 2007, PROTEINS, V66, P160, DOI 10.1002/prot.21138; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tang HK, 2011, FEBS LETT, V585, P3409, DOI 10.1016/j.febslet.2011.10.009; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Van Goethem S, 2011, J MED CHEM, V54, P5737, DOI 10.1021/jm200383j; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Yao TW, 2011, MOL CANCER RES, V9, P948, DOI 10.1158/1541-7786.MCR-10-0272; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	62	45	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44320	44329		10.1074/jbc.M112.397224	http://dx.doi.org/10.1074/jbc.M112.397224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152501	Green Published, hybrid			2022-12-25	WOS:000312938600029
J	van Wietmarschen, N; Moradian, A; Morin, GB; Lansdorp, PM; Uringa, EJ				van Wietmarschen, Niek; Moradian, Annie; Morin, Gregg B.; Lansdorp, Peter M.; Uringa, Evert-Jan			The Mammalian Proteins MMS19, MIP18, and ANT2 Are Involved in Cytoplasmic Iron-Sulfur Cluster Protein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TRANSCRIPTION; BIOGENESIS; REPAIR; IDENTIFICATION; METABOLISM; MATURATION; COMPONENT; COMPLEX	Iron-sulfur (Fe-S) clusters are essential cofactors of proteins with a wide range of biological functions. A dedicated cytosolic Fe-S cluster assembly (CIA) system is required to assemble Fe-S clusters into cytosolic and nuclear proteins. Here, we show that the mammalian nucleotide excision repair protein homolog MMS19 can simultaneously bind probable cytosolic iron-sulfur protein assembly protein CIAO1 and Fe-S proteins, confirming that MMS19 is a central protein of the CIA machinery that brings Fe-S cluster donor proteins and the receiving apoproteins into proximity. In addition, we show that mitotic spindle-associated MMXD complex subunit MIP18 also interacts with both CIAO1 and Fe-S proteins. Specifically, it binds the Fe-S cluster coordinating regions in Fe-S proteins. Furthermore, we show that ADP/ATP translocase 2 (ANT2) interacts with Fe-S apoproteins and MMS19 in the CIA complex but not with the individual proteins. Together, these results elucidate the composition and interactions within the late CIA complex.	[van Wietmarschen, Niek; Lansdorp, Peter M.; Uringa, Evert-Jan] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9713 AV Groningen, Netherlands; [Moradian, Annie; Morin, Gregg B.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Morin, Gregg B.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 4E3, Canada; [Lansdorp, Peter M.; Uringa, Evert-Jan] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Lansdorp, Peter M.] Univ British Columbia, Dept Med, Div Hematol, Vancouver, BC V5Z 4E3, Canada	University of Groningen; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Uringa, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	e.j.uringa@umcg.nl	Morin, Gregg B/E-9123-2012; van Wietmarschen, Niek/ABE-8269-2020	Morin, Gregg B/0000-0001-8949-4374; Lansdorp, Peter/0000-0001-7435-1071; van Wietmarschen, Niek/0000-0001-6136-5757	Terry Fox Foundation Program Project [018006]; Canadian Cancer Society [105265]	Terry Fox Foundation Program Project; Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by Grant 018006 awarded by the Terry Fox Foundation Program Project and Grant 105265 from the Canadian Cancer Society.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hatfield MD, 2006, DNA REPAIR, V5, P914, DOI 10.1016/j.dnarep.2006.05.007; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Jin FL, 2006, NAT METHODS, V3, P183, DOI 10.1038/nmeth859; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lombaerts M, 1997, NUCLEIC ACIDS RES, V25, P3974, DOI 10.1093/nar/25.20.3974; Mead CLR, 2010, J NEUROCHEM, V113, P1491, DOI 10.1111/j.1471-4159.2010.06690.x; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Uringa EJ, 2012, MOL BIOL CELL, V23, P2782, DOI 10.1091/mbc.E12-03-0179; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	23	32	32	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43351	43358		10.1074/jbc.M112.431270	http://dx.doi.org/10.1074/jbc.M112.431270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23150669	Green Published, hybrid			2022-12-25	WOS:000312940800016
J	Calaway, JD; Dominguez, JI; Hanson, ME; Cambranis, EC; de Villena, FPM; de la Casa-Esperon, E				Calaway, John D.; Ignacio Dominguez, Jose; Hanson, Megan E.; Cambranis, Ezequiel C.; Pardo-Manuel de Villena, Fernando; de la Casa-Esperon, Elena			Intronic Parent-of-Origin Dependent Differential Methylation at the Actn1 Gene Is Conserved in Rodents but Is Not Associated with Imprinted Expression	PLOS ONE			English	Article							MATERNAL-SPECIFIC METHYLATION; DNA METHYLATION; ALLELIC METHYLATION; NATURAL-SELECTION; IGF2R; SEQUENCE	Parent-of-origin differential DNA methylation has been associated with regulation of the preferential expression of paternal or maternal alleles of imprinted genes. Based on this association, recent studies have searched for parent-of-origin dependent differentially methylated regions in order to identify new imprinted genes in their vicinity. In a previous genome-wide analysis of mouse brain DNA methylation, we found a novel differentially methylated region in a CpG island located in the last intron of the alpha 1 Actinin (Actn1) gene. In this region, preferential methylation of the maternal allele was observed; however, there were no reports of imprinted expression of Actn1. Therefore, we have tested if differential methylation of this region is common to other tissues and species and affects the expression of Actn1. We have found that Actn1 differential methylation occurs in diverse mouse tissues. Moreover, it is also present in other murine rodents (rat), but not in the orthologous human region. In contrast, we have found no indication of an imprinted effect on gene expression of Actn1 in mice: expression is always biallelic regardless of sex, tissue type, developmental stage or isoform. Therefore, we have identified a novel parent-of-origin dependent differentially methylated region that has no apparent association with imprinted expression of the closest genes. Our findings sound a cautionary note to genome-wide searches on the use of differentially methylated regions for the identification of imprinted genes and suggest that parent-of-origin dependent differential methylation might be conserved for functions other that the control of imprinted expression.	[Ignacio Dominguez, Jose; de la Casa-Esperon, Elena] Univ Castilla La Mancha, Reg Ctr Biomed Res CRIB, Albacete, Spain; [Calaway, John D.; Pardo-Manuel de Villena, Fernando] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Calaway, John D.; Pardo-Manuel de Villena, Fernando] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Hanson, Megan E.; Cambranis, Ezequiel C.; de la Casa-Esperon, Elena] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	Universidad de Castilla-La Mancha; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Arlington	de la Casa-Esperon, E (corresponding author), Univ Castilla La Mancha, Reg Ctr Biomed Res CRIB, Albacete, Spain.	elena.casaesperon@uclm.es	Romo, José A./J-3024-2012; de la Casa Esperon, Elena/L-7474-2014	Romo, José A./0000-0003-2907-580X; de la Casa Esperon, Elena/0000-0001-6821-7896; Dominguez, Jose Ignacio/0000-0001-6547-052X	U.S. National Institute of General Medical Sciences, Center of Excellence in Systems Biology [1P50 GM076468]; National Institute of Health funded Center of Excellence in Genome Sciences [P50HG006582/P50MH090338]; "NRSA in Genetics'' training grant [T32 GM07092-34]; INCRECYT Program start-up funds; Consejeria de Educacion y Ciencia de Castilla-La Mancha; European Social Fund [PPII10-0259-4347]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468, T32GM007092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090338] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences, Center of Excellence in Systems Biology; National Institute of Health funded Center of Excellence in Genome Sciences; "NRSA in Genetics'' training grant; INCRECYT Program start-up funds; Consejeria de Educacion y Ciencia de Castilla-La Mancha; European Social Fund(European Social Fund (ESF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the U.S. National Institute of General Medical Sciences as part of the Center of Excellence in Systems Biology (1P50 GM076468), the National Institute of Health funded Center of Excellence in Genome Sciences (P50HG006582/P50MH090338), the "NRSA in Genetics'' training grant (T32 GM07092-34), the INCRECYT Program start-up funds and the Consejeria de Educacion y Ciencia de Castilla-La Mancha and European Social Fund (PPII10-0259-4347). ECE was supported by the INCRECYT Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bartolomei MS, 2011, COLD SPRING HARB PER, V3; BENSTEAD K, 1989, BRIT J CANCER, V59, P503, DOI 10.1038/bjc.1989.104; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Das R, 2009, MAMM GENOME, V20, P563, DOI 10.1007/s00335-009-9229-y; de la Casa-Esperon E, 2003, ANNU REV GENET, V37, P349, DOI 10.1146/annurev.genet.37.110801.143741; de la Casa-Esperon E, 2002, GENETICS, V161, P1651; de la Casa-Esperon ESC, 2006, ENCY GENETICS GENOMI; de Villena FPM, 2000, TRENDS GENET, V16, P573, DOI 10.1016/S0168-9525(00)02134-X; Dockery L, 2009, EPIGENETICS-US, V4, P241, DOI 10.4161/epi.9021; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; FEIL R, 1994, DEVELOPMENT, V120, P2933; Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kremerskothen J, 2002, BIOCHEM BIOPH RES CO, V295, P678, DOI 10.1016/S0006-291X(02)00734-9; Latham KE, 2000, METH MOL B, V136, P315; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; McMinn J, 2006, PLACENTA, V27, P119, DOI 10.1016/j.placenta.2004.12.003; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nomura S, 1996, BIOCHEM BIOPH RES CO, V226, P385, DOI 10.1006/bbrc.1996.1365; Riesewijk AM, 1996, GENOMICS, V31, P158, DOI 10.1006/geno.1996.0027; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; SMRZKA OW, 1995, HUM MOL GENET, V4, P1945, DOI 10.1093/hmg/4.10.1945; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; Weidman JR, 2006, EPIGENETICS-US, V1, P49; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	36	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48936	10.1371/journal.pone.0048936	http://dx.doi.org/10.1371/journal.pone.0048936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145029	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500050
J	Ke, W; Pattanaik, P; Bethel, CR; Sheri, A; Buynak, JD; Bonomo, RA; van den Akker, F				Ke, Wei; Pattanaik, Priyaranjan; Bethel, Christopher R.; Sheri, Anjaneyulu; Buynak, John D.; Bonomo, Robert A.; van den Akker, Focco			Structures of SHV-1 beta-Lactamase with Penem and Penam Sulfone Inhibitors That Form Cyclic Intermediates Stabilized by Carbonyl Conjugation	PLOS ONE			English	Article							CLASS-A; 6-METHYLIDENE PENEMS; CRYSTALLOGRAPHIC STRUCTURES; CRYSTAL-STRUCTURES; COMPLEXES; RESISTANCE; DESIGN; MODE	Bacterial beta-lactamase enzymes are in large part responsible for the decreased ability of beta-lactam antibiotics to combat infections. The inability to overcome beta-lactamase mediated resistance spurred the development of inhibitors with penems and penam sulfones being amongst the most potent and broad spectrum mechanism-based inactivators. These inhibitors form covalent, "suicide-type'' inhibitory intermediates that are attached to the catalytic S70 residue. To further probe the details of the mechanism of beta-lactamase inhibition by these novel compounds, we determined the crystal structures of SHV-1 bound with penem 1, and penam sulfones SA1-204 and SA3-53. Comparison with each other and with previously determined crystal structures of members of these classes of inhibitors suggests that the final conformation of the covalent adduct can vary greatly amongst the complex structures. In contrast, a common theme of carbonyl conjugation as a mechanism to avoid deacylation emerges despite that the penem and penam sulfone inhibitors form different types of intermediates. The detailed insights gained from this study could be used to further improve new mechanism-based inhibitors of these common class A serine beta-lactamases. Citation: Ke W, Pattanaik P, Bethel CR, Sheri A, Buynak JD, et al. (2012) Structures of SHV-1 beta-Lactamase with Penem and Penam Sulfone Inhibitors That Form Cyclic Intermediates Stabilized by Carbonyl Conjugation. PLoS ONE 7(11): e49035. doi:10.1371/journal.pone.0049035	[Ke, Wei; Pattanaik, Priyaranjan; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med Pharmacol & Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bethel, Christopher R.; Bonomo, Robert A.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, Cleveland, OH USA; [Sheri, Anjaneyulu; Buynak, John D.] So Methodist Univ, Dept Chem, Dallas, TX 75275 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Southern Methodist University	van den Akker, F (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu			National Institutes of Health [R01 AI062968, R01 AI063517]; United States Department of Veterans Affairs, Merit Review Program; Cleveland Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517, R01AI062968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs, Merit Review Program; Cleveland Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge the National Institutes of Health (R01 AI062968 to FVDA; R01 AI063517 to RAB), United States Department of Veterans Affairs, Merit Review Program (to RAB), and Cleveland Geriatric Research Education and Clinical Center (to RAB) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic M, 2006, DRUG RESIST UPDATE, V9, P142, DOI 10.1016/j.drup.2006.05.005; Beharry Z, 2004, BIOCHEM BIOPH RES CO, V313, P541, DOI 10.1016/j.bbrc.2003.11.158; Bethel CR, 2008, ANTIMICROB AGENTS CH, V52, P3135, DOI 10.1128/AAC.01677-07; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Buynak JD, 1999, BIOORG MED CHEM LETT, V9, P1997, DOI 10.1016/S0960-894X(99)00325-X; Che T, 2012, J AM CHEM SOC, V134, P11206, DOI 10.1021/ja303168n; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Drawz SM, 2009, BIOCHEMISTRY-US, V48, P4557, DOI 10.1021/bi9003292; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kalp M, 2007, J BIOL CHEM, V282, P21588, DOI 10.1074/jbc.C700080200; Ke W, 2011, ANTIMICROB AGENTS CH, V55, P174, DOI 10.1128/AAC.00930-10; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mansour TS, 2007, CHEMMEDCHEM, V2, P1713, DOI 10.1002/cmdc.200700144; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Michaux C, 2005, J AM CHEM SOC, V127, P3262, DOI 10.1021/ja0426241; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nukaga M, 2003, BIOCHEMISTRY-US, V42, P13152, DOI 10.1021/bi034986b; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Pattanaik P, 2009, J BIOL CHEM, V284, P945, DOI 10.1074/jbc.M806833200; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; TENEYCK LF, 1985, METHOD ENZYMOL, V115, P324; Thomson JM, 2007, BIOCHEMISTRY-US, V46, P11361, DOI 10.1021/bi700792a; van den Akker F, 1999, ACTA CRYSTALLOGR D, V55, P206, DOI 10.1107/S0907444998007161; Venkatesan AM, 2004, J MED CHEM, V47, P6556, DOI 10.1021/jm049680x; Weiss WJ, 2004, ANTIMICROB AGENTS CH, V48, P4589, DOI 10.1128/AAC.48.12.4589-4596.2004	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49035	10.1371/journal.pone.0049035	http://dx.doi.org/10.1371/journal.pone.0049035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145056	Green Submitted, Green Published, gold			2022-12-25	WOS:000312269500064
J	O'Shaughnessy, CM; Cunningham, AF; MacLennan, CA				O'Shaughnessy, Colette M.; Cunningham, Adam F.; MacLennan, Calman A.			The Stability of Complement-Mediated Bactericidal Activity in Human Serum against Salmonella	PLOS ONE			English	Article							NONTYPHOIDAL SALMONELLA; ANTIBODY	The complement cascade includes heat-labile proteins and care is required when handling serum in order to preserve its functional integrity. We have previously used a whole human serum bactericidal assay to show that antibody and an intact complement system are required in blood for killing of invasive isolates of Salmonella. The aim of the present study was to evaluate the conditions under which human serum can be stored and manipulated while maintaining complement integrity. Serum bactericidal activity against Salmonella was maintained for a minimum of 35 days when stored at 4 degrees C, eight days at 22 degrees C and 54 hours at 37 degrees C. Up to three freeze-thaw cycles had no effect on the persistence of bactericidal activity and hemolytic complement assays confirmed no effect on complement function. Delay in the separation of serum for up to four days from clotted blood stored at 22 degrees C did not affect bactericidal activity. Dilution of serum resulted in an increased rate of loss of bactericidal activity and so serum should be stored undiluted. These findings indicate that the current guidelines concerning manipulation and storage of human serum to preserve complement integrity and function leave a large margin for safety with regards to bactericidal activity against Salmonella. The study provides a scheme for determining the requirements for serum handling in relation to functional activity of complement in other systems. Citation: O'Shaughnessy CM, Cunningham AF, MacLennan CA (2012) The Stability of Complement-Mediated Bactericidal Activity in Human Serum against Salmonella. PLoS ONE 7(11): e49147. doi:10.1371/journal.pone.0049147	[O'Shaughnessy, Colette M.; Cunningham, Adam F.; MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res,Med Res Council,Ctr Immune Regula, Birmingham, W Midlands, England; [O'Shaughnessy, Colette M.; Cunningham, Adam F.; MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res,Clin Immunol Serv, Birmingham, W Midlands, England; [O'Shaughnessy, Colette M.; MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth, Siena, Italy	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Birmingham; University of Birmingham; Novartis	MacLennan, CA (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res,Med Res Council,Ctr Immune Regula, Birmingham, W Midlands, England.	calman.maclennan@novartis.com	MacLennan, Calman A/L-9343-2014	MacLennan, Calman A/0000-0001-9694-0846; Cunningham, Adam/0000-0003-0248-964X	Medical Research Council UK; GlaxoSmithKline; Medical Research Council [G9818340, G0701275] Funding Source: researchfish; MRC [G9818340, G0701275] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a PhD Studentship from the Medical Research Council UK to C.M. O'Shaughnessy and a Clinical Research Fellowship from GlaxoSmithKline to C.A. MacLennan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.A. MacLennan is an employee of the Novartis Vaccines Institute for Global Health and a recipient of a Clinical Research Fellowship from GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bordet J., 1895, ANN I PASTEUR PARIS, V9, P462; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Jones FS, 1927, J EXP MED, V46, P291, DOI 10.1084/jem.46.2.291; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lachmann PJ, 2010, J IMMUNOL METHODS, V352, P195, DOI 10.1016/j.jim.2009.11.003; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Noguchi H, 1911, J EXP MED, V13, P229, DOI 10.1084/jem.13.2.229; NUTTALL G, 1888, Z HYG, V4, P353, DOI DOI 10.1007/BF02188097; Pohl AW, 1944, J CLIN INVEST, V23, P177, DOI 10.1172/JCI101481; Rivers TM, 1927, J EXP MED, V45, P11; Santos GF, 2001, CLIN DIAGN LAB IMMUN, V8, P616, DOI 10.1128/CDLI.8.3.616-623.2001; Siggins MK, 2011, J IMMUNOL, V186, P2365, DOI 10.4049/jimmunol.1000284	13	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e49147	10.1371/journal.pone.0049147	http://dx.doi.org/10.1371/journal.pone.0049147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145102	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500078
J	Qiao, C; Wang, CH; Zhao, J; Liu, CX; Shang, T				Qiao, Chong; Wang, Chunhui; Zhao, Jiao; Liu, Caixia; Shang, Tao			Elevated Expression of KiSS-1 in Placenta of Chinese Women with Early-Onset Preeclampsia	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; TROPHOBLAST INVASION; IN-VITRO; CELLS; KISSPEPTINS; METALLOPROTEINASES; CONSEQUENCE; INHIBITOR	Preeclampsia (PE) is a heterogeneous syndrome affecting 2% to 8% of all pregnancies and is the world's leading cause of fetal and maternal morbidity and mortality. In many cases of PE, shallow trophoblast invasion results in inappropriate maternal spiral artery remodeling and impaired placental function. Multiple genes have been implicated in trophoblast invasion, among which are KiSS-1 and GPR54. The gene product of KiSS-1 is metastin, which is a ligand for the receptor GPR54. Both metastin and GPR54 are expressed in the placenta of normal pregnancy and have been implicated in modulating trophoblast invasion through inhibiting migration of trophoblast cells. We have previously reported that the expression level of KiSS-1 was higher in trophoblasts from women with preeclampsia as compared to normal controls. Here, using quantitative RT-PCR, Western blot analysis and immunohistochemistry, we extend our analysis to demonstrate that elevated KiSS-1 expression occurs only in early-onset preeclampsia (ePE) and not late-onset preeclampsia (lPE). However, no difference in the expression levels of GPR54 is observed between ePE, lPE, and normal controls. Further, we show that KiSS-1 expression is also increased in placenta of intrauterine death and birth asphyxia in comparison to normal newborns of ePE and lPE. Our findings suggest that aberrant upregulation of KiSS-1 expression may contribute to the underlying mechanism of ePE as well as birth asphyxia. Citation: Qiao C, Wang C, Zhao J, Liu C, Shang T (2012) Elevated Expression of KiSS-1 in Placenta of Chinese Women with Early-Onset Preeclampsia. PLoS ONE 7(11): e48937. doi:10.1371/journal.pone.0048937	[Qiao, Chong; Zhao, Jiao; Liu, Caixia; Shang, Tao] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning, Peoples R China; [Wang, Chunhui] Gen Hosp Shenyang Mil Reg, Dept Hepatobiliary Surg, Shenyang, Liaoning, Peoples R China	China Medical University	Qiao, C (corresponding author), China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning, Peoples R China.	qiaochong2002@hotmail.com			Liaoning Provincial Natural Science Foundation of China [20082096]; Scientific Research Fund of Liaoning Provincial Education Department [2008791]; Liaoning Provincial Natural Science Foundation of China (Doctor Startup Fund Program) [20071038]	Liaoning Provincial Natural Science Foundation of China; Scientific Research Fund of Liaoning Provincial Education Department; Liaoning Provincial Natural Science Foundation of China (Doctor Startup Fund Program)	This work is supported by Liaoning Provincial Natural Science Foundation of China (No. 20082096 http://www.lninfo.gov.cn/index.html), Scientific Research Fund of Liaoning Provincial Education Department (No. 2008791 http://www.lnein.gov.cn/kj/web/) and Liaoning Provincial Natural Science Foundation of China (Doctor Startup Fund Program) (No. 20071038 http://www.lninfo.gov.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200	31	29	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e48937	10.1371/journal.pone.0048937	http://dx.doi.org/10.1371/journal.pone.0048937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23145030	Green Published, gold, Green Submitted			2022-12-25	WOS:000312269500051
J	Becker, D; Willems, LM; Vnencak, M; Zahn, N; Schuldt, G; Jedlicka, P; Maggio, N; Deller, T; Vlachos, A				Becker, Denise; Willems, Laurent Maximilian; Vnencak, Matej; Zahn, Nadine; Schuldt, Gerlind; Jedlicka, Peter; Maggio, Nicola; Deller, Thomas; Vlachos, Andreas			Functional and Structural Properties of Dentate Granule Cells with Hilar Basal Dendrites in Mouse Entorhino-Hippocampal Slice Cultures	PLOS ONE			English	Article							PILOCARPINE-INDUCED SEIZURES; TEMPORAL-LOBE EPILEPSY; STATUS EPILEPTICUS; SILENT SYNAPSES; RAT MODEL; SYNAPTIC CONNECTIONS; GYRUS; SPINES; MATURATION; NEURONS	During postnatal development hippocampal dentate granule cells (GCs) often extend dendrites from the basal pole of their cell bodies into the hilar region. These so-called hilar basal dendrites (hBD) usually regress with maturation. However, hBDs may persist in a subset of mature GCs under certain conditions (both physiological and pathological). The functional role of these hBD-GCs remains not well understood. Here, we have studied hBD-GCs in mature ($18 days in vitro) mouse entorhino-hippocampal slice cultures under control conditions and have compared their basic functional properties (basic intrinsic and synaptic properties) and structural properties (dendritic arborisation and spine densities) to those of neighboring GCs without hBDs in the same set of cultures. Except for the presence of hBDs, we did not detect major differences between the two GC populations. Furthermore, paired recordings of neighboring GCs with and without hBDs did not reveal evidence for a heavy aberrant GC-to-GC connectivity. Taken together, our data suggest that in control cultures the presence of hBDs on GCs is neither sufficient to predict alterations in the basic functional and structural properties of these GCs nor indicative of a heavy GC-to-GC connectivity between neighboring GCs.	[Becker, Denise; Willems, Laurent Maximilian; Vnencak, Matej; Zahn, Nadine; Schuldt, Gerlind; Jedlicka, Peter; Deller, Thomas; Vlachos, Andreas] Goethe Univ Frankfurt, Neurosci Ctr, Inst Clin Neuroanat, Frankfurt, Germany; [Maggio, Nicola] Chaim Sheba Med Ctr, Dept Neurol, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, J Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel	Goethe University Frankfurt; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Vlachos, A (corresponding author), Goethe Univ Frankfurt, Neurosci Ctr, Inst Clin Neuroanat, Frankfurt, Germany.	a.vlachos@med.uni-frankfurt.de	Jedlicka, Peter/AAW-4207-2020; Jedlicka, Peter/B-6094-2012	Jedlicka, Peter/0000-0001-6571-5742; Jedlicka, Peter/0000-0001-6571-5742; Maggio, Nicola/0000-0001-5041-2108; Becker, Denise/0000-0003-0132-9986; Willems, Laurent Maximilian/0000-0001-8226-1674	Deutsche Forschungsgemeinschaft [DFG DE 551-10]; Young Investigators Grant (Faculty of Medicine Goethe-University); German-Israeli Foundation [GIF G-2239-2096.1/2009]; August Scheidel-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Young Investigators Grant (Faculty of Medicine Goethe-University); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); August Scheidel-Foundation	The work was supported by Deutsche Forschungsgemeinschaft (DFG DE 551-10 to TD), by a Young Investigators Grant (Faculty of Medicine Goethe-University to AV), German-Israeli Foundation (GIF G-2239-2096.1/2009 to AV) and the August Scheidel-Foundation (to AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Austin JE, 2004, J COMP NEUROL, V476, P205, DOI 10.1002/cne.20182; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; CACERES A, 1983, J COMP NEUROL, V214, P387, DOI 10.1002/cne.902140404; Dailey ME, 1996, J NEUROSCI, V16, P2983; Del Turco Domenico, 2007, V399, P55, DOI 10.1007/978-1-59745-504-6_5; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Diaz-Cintra S, 2009, BRAIN RES, V1285, P182, DOI 10.1016/j.brainres.2009.06.034; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Freiman TM, 2011, EXP NEUROL, V229, P332, DOI 10.1016/j.expneurol.2011.02.017; FROTSCHER M, 1995, PROG NEUROBIOL, V45, pR7, DOI 10.1016/0301-0082(95)90872-H; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Krueppel R, 2011, NEURON, V71, P512, DOI 10.1016/j.neuron.2011.05.043; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Muller CM, 2010, CELL CALCIUM, V47, P242, DOI 10.1016/j.ceca.2009.12.006; Murphy BL, 2011, J NEUROSCI, V31, P2959, DOI 10.1523/JNEUROSCI.3381-10.2011; Nakahara S, 2009, HIPPOCAMPUS, V19, P379, DOI 10.1002/hipo.20529; Rahimi O, 2007, PROG BRAIN RES, V163, P167, DOI 10.1016/S0079-6123(07)63010-6; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; Sanchez RM, 2012, EPILEPSIA, V53, P109, DOI 10.1111/j.1528-1167.2012.03481.x; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; SERESS L, 1990, J COMP NEUROL, V293, P253, DOI 10.1002/cne.902930208; SERESS L, 1992, BRAIN RES, V569, P353, DOI 10.1016/0006-8993(92)90651-O; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Shapiro LA, 2007, EUR J NEUROSCI, V26, P583, DOI 10.1111/j.1460-9568.2007.05662.x; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; Spigelman I, 1998, NEUROSCIENCE, V86, P109, DOI 10.1016/S0306-4522(98)00028-1; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thind KK, 2008, J COMP NEUROL, V509, P190, DOI 10.1002/cne.21745; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Vlachos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032883; Vlachos A, 2012, J COMP NEUROL, V520, P1891, DOI 10.1002/cne.23017; Vuksic M, 2011, EXP NEUROL, V230, P176, DOI 10.1016/j.expneurol.2011.04.011; Walter C, 2007, J NEUROSCI, V27, P7541, DOI 10.1523/JNEUROSCI.0431-07.2007; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; ZAFIROV S, 1994, J COMP NEUROL, V345, P472, DOI 10.1002/cne.903450312; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	55	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48500	10.1371/journal.pone.0048500	http://dx.doi.org/10.1371/journal.pone.0048500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144894	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800070
J	Fiebig, L; Kollan, C; Hauer, B; Gunsenheimer-Bartmeyer, B; an der Heiden, M; Hamouda, O; Haas, W				Fiebig, Lena; Kollan, Christian; Hauer, Barbara; Gunsenheimer-Bartmeyer, Barbara; an der Heiden, Matthias; Hamouda, Osamah; Haas, Walter			HIV-Prevalence in Tuberculosis Patients in Germany, 2002-2009: An Estimation Based on HIV and Tuberculosis Surveillance Data	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; COINFECTION; BURDEN; RISK; EPIDEMIOLOGY; METAANALYSIS; MANAGEMENT; COUNTRIES; AIDS	Tuberculosis (TB) and HIV comorbidity is a major challenge in TB prevention and control but difficult to assess in Germany as in other countries, where data confidentiality precludes notifying the HIV status of TB patients. We aimed to estimate the HIV-prevalence in TB patients in Germany, 2002-2009, and to characterize the HIV/TB patients demographically. Data from the long-term observational open multicentre cohort ClinSurv HIV were used to identify incident TB in HIV-positive individuals. We assessed the cohort's coverage for the nationwide HIV-positive population by contrasting ClinSurv HIV patients under antiretroviral therapy (ART) with national HIV patient numbers derived from ART prescriptions (data by Insight Health; available for 2006-2009). The HIV-prevalence in TB patients was calculated as the number of HIV/TB cases projected for Germany over all culture-positive TB notifications. From 2002 to 2009, 298 of 15,531 HIV-positive patients enrolled in the ClinSurv HIV cohort were diagnosed with TB. A 21% cohort coverage was determined. The annual estimates of the HIV-prevalence in TB patients were on average 4.5% and ranged from 3.5% (95% CI 2.3-5.1%) in 2007 to 6.6% (95% CI 5.0-8.5%) in 2005. The most recent estimate for 2009 was 4.0% (95% CI 2.6-5.9%). The 298 HIV/TB patients were characterized by a male-to-female ratio of 2.1, by a median age of 38 years at TB diagnosis, and by 59% of the patients having a foreign origin, mainly from Subsahara Africa. We provide, to our knowledge, the first estimate of the HIV-prevalence in TB patients for Germany by joint evaluation of anonymous HIV and TB surveillance data sources. The identified level of HIV in TB patients approximates available surveillance data from neighbouring countries and indicates a non-negligible HIV/TB burden in Germany. Our estimation approach is valuable for epidemiological monitoring of HIV/TB within the current legal frameworks.	[Fiebig, Lena; Hauer, Barbara; Haas, Walter] Robert Koch Inst, Dept Infect Dis Epidemiol, Resp Infect Unit, Berlin, Germany; [Kollan, Christian; Gunsenheimer-Bartmeyer, Barbara; an der Heiden, Matthias; Hamouda, Osamah] Robert Koch Inst, Dept Infect Dis Epidemiol, HIV AIDS STI & Blood Borne Infect Unit, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Fiebig, L (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Resp Infect Unit, Berlin, Germany.	FiebigL@rki.de		Fiebig, Lena/0000-0002-5977-0507; an der Heiden, Matthias/0000-0001-5863-4549	German Federal Ministry of Health [IIA5-2011-2511AUK385]	German Federal Ministry of Health	The German Federal Ministry of Health is acknowledged for funding this study (grant number: IIA5-2011-2511AUK385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; [Anonymous], 2000, BUNDESGESETZBLATT, V33, P1045; Batzing-Feigenbaum J, 2011, HIV MED, V12, P269, DOI 10.1111/j.1468-1293.2010.00879.x; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Centers for Disease Control and Prevention, 1992, MMWR RECOMM REP, P1; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Day JH, 2004, J INFECT DIS, V190, P1677, DOI 10.1086/424851; de Colombani P, 2004, EUR RESPIR J, V24, P493, DOI 10.1183/09031936.04.00064504; de Jong BC, 2004, ANNU REV MED, V55, P283, DOI 10.1146/annurev.med.55.091902.103753; European Centre for Disease Prevention and Control, 2008, FRAM ACT PLAN FIGHT; [European Centre for Disease Prevention and Control WHO Regional Office for Europe], 2011, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control, 2010, PROGR TB EL FOLL UP; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2012, TUB SURV MON EUR 201; European Commission - DG Sanco, 2002, DAT FIL SPEC EUR HIV; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Hauer B, 2006, UNTERSUCHUNGEN TUBER; Kipp AM, 2011, INT J TUBERC LUNG D, V15, P1540, DOI 10.5588/ijtld.10.0273; Kollan C, 2011, 5 DTSCH OST AIDS K H; Kruijshaar ME, 2011, EUR RESPIR J, V38, P1374, DOI 10.1183/09031936.00198310; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lazarus JV, 2008, HIV MED, V9, P406, DOI 10.1111/j.1468-1293.2008.00567.x; Migliori G B, 2002, Monaldi Arch Chest Dis, V57, P285; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Neves LAD, 2012, REV ESC ENFERM USP, V46, P700; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pimpin L, 2011, EUR RESPIR J, V38, P1382, DOI 10.1183/09031936.00198410; Pontali E, 2011, EUR RESPIR J, V38, P1258, DOI 10.1183/09031936.00143111; Pukenyte E, 2007, INT J TUBERC LUNG D, V11, P78; Robert Koch Institut, 2012, INF JB MELD KRANKH 2; Robert Koch Institute, 2007, TUB KOMPL AUSS BCG T; Robert Koch Institute, 2011, HIV AIDS RATG ARZT; Robert Koch-Institut, 2011, EPDEMIOLOGISCHES B, V46, P415; Rodger AJ, 2010, THORAX, V65, P63, DOI 10.1136/thx.2009.122754; Schaberg T, 2012, Pneumologie, V66, P133, DOI 10.1055/s-0031-1291619; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sharma SK, 2005, INDIAN J MED RES, V121, P550; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Stoll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023946; Stop TB Partnership and World Health Organization, 2006, GLOB PLAN STOP TB 3; *WHO, 2004, INT POL COLL TB HIV; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2012, WHOHTMTB20121; World Health Organization European Ministerial Forum, 2007, [The Berlin Declaration on Tuberculosis, EUR/07/5061622/5], Patent No. 0750616225	44	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49111	10.1371/journal.pone.0049111	http://dx.doi.org/10.1371/journal.pone.0049111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145087	Green Published, gold			2022-12-25	WOS:000311935800207
J	Khromov, T; Dressel, R; Siamishi, I; Nolte, J; Opitz, L; Engel, W; Pantakani, DVK				Khromov, Tatjana; Dressel, Ralf; Siamishi, Iliana; Nolte, Jessica; Opitz, Lennart; Engel, Wolfgang; Pantakani, D. V. Krishna			Apoptosis-Related Gene Expression Profiles of Mouse ESCs and maGSCs: Role of Fgf4 and Mnda in Pluripotent Cell Responses to Genotoxicity	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR DIFFERENTIATION ANTIGEN; SELF-RENEWAL; DNA-DAMAGE; MYELODYSPLASTIC SYNDROMES; STRESS DEFENSE; SOMATIC-CELLS; GERM-CELLS; GENERATION; PROTEIN	Stem cells in the developing embryo proliferate and differentiate while maintaining genomic integrity, failure of which may lead to accumulation of mutations and subsequent damage to the embryo. Embryonic stem cells (ESCs), the in vitro counterpart of embryo stem cells are highly sensitive to genotoxic stress. Defective ESCs undergo either efficient DNA damage repair or apoptosis, thus maintaining genomic integrity. However, the genotoxicity- and apoptosis-related processes in germ-line derived pluripotent cells, multipotent adult germ-line stem cells (maGSCs), are currently unknown. Here, we analyzed the expression of apoptosis-related genes using OligoGEArray in undifferentiated maGSCs and ESCs and identified a similar set of genes expressed in both cell types. We detected the expression of intrinsic, but not extrinsic, apoptotic pathway genes in both cell types. Further, we found that apoptosis-related gene expression patterns of differentiated ESCs and maGSCs are identical to each other. Comparative analysis revealed that several pro-and antiapoptotic genes are expressed specifically in pluripotent cells, but markedly downregulated in the differentiated counterparts of these cells. Activation of the intrinsic apoptotic pathway cause approximately similar to 35% of both ESCs and maGSCs to adopt an early-apoptotic phenotype. Moreover, we performed transcriptome studies using early-apoptotic cells to identify novel pluripotency- and apoptosis-related genes. From these transcriptome studies, we selected Fgf4 (Fibroblast growth factor 4) and Mnda (Myeloid cell nuclear differentiating antigen), which are highly downregulated in early-apoptotic cells, as novel candidates and analyzed their roles in apoptosis and genotoxicity responses in ESCs. Collectively, our results show the existence of common molecular mechanisms for maintaining the pristine stem cell pool of both ESCs and maGSCs.	[Khromov, Tatjana; Siamishi, Iliana; Nolte, Jessica; Engel, Wolfgang; Pantakani, D. V. Krishna] Univ Goettingen, Inst Human Genet, Gottingen, Germany; [Dressel, Ralf] Univ Goettingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Opitz, Lennart] Univ Goettingen, DNA Microarray Facil, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Pantakani, DVK (corresponding author), Univ Goettingen, Inst Human Genet, Gottingen, Germany.	krishna.if1@gmail.com	Dressel, Ralf/R-7065-2016	Dressel, Ralf/0000-0002-1651-1214	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG SPP1356 (EN 84/22-1), DFG FOR 1041 (EN 84/23-1)]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was partly supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) DFG SPP1356 (EN 84/22-1) and DFG FOR 1041 (EN 84/23-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aglipay JA, 2003, ONCOGENE, V22, P8931, DOI 10.1038/sj.onc.1207057; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Bretz F, 2005, METHOD INFORM MED, V44, P431; Briggs RC, 2006, CANCER RES, V66, P4645, DOI 10.1158/0008-5472.CAN-06-0229; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chan WH, 2008, IUBMB LIFE, V60, P171, DOI 10.1002/iub.30; Chuykin IA, 2008, CELL CYCLE, V7, P2922, DOI 10.4161/cc.7.18.6699; D'Souza S, 2001, J BIOL CHEM, V276, P298, DOI 10.1074/jbc.M007155200; Dihazi H, 2009, J PROTEOME RES, V8, P5497, DOI 10.1021/pr900565b; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-31; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Fotouhi-Ardakani N, 2010, AM J RESP CRIT CARE, V182, P341, DOI 10.1164/rccm.201001-0075OC; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hirai K, 2004, EXP CELL RES, V294, P77, DOI 10.1016/j.yexcr.2003.11.012; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Izadyar F, 2008, REPRODUCTION, V135, P771, DOI 10.1530/REP-07-0479; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Khromov T, 2011, MOL HUM REPROD, V17, P166, DOI 10.1093/molehr/gaq085; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Kosaka N, 2009, DEV DYNAM, V238, P265, DOI 10.1002/dvdy.21699; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meyer S, 2010, MOL HUM REPROD, V16, P846, DOI 10.1093/molehr/gaq060; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Pradhan A, 2004, LEUKEMIA, V18, P449, DOI 10.1038/sj.leu.2403265; Roos WP, 2007, CELL DEATH DIFFER, V14, P1422, DOI 10.1038/sj.cdd.4402136; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Stambrook PJ, 2007, MECH AGEING DEV, V128, P31, DOI 10.1016/j.mad.2006.11.007; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Wen Y, 2000, CANCER RES, V60, P42; Westerman BA, 2011, J EXP MED, V208, P2675, DOI 10.1084/jem.20102037; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zechner U, 2009, MOL HUM REPROD, V15, P345, DOI 10.1093/molehr/gap023; Zovoilis A, 2008, MOL HUM REPROD, V14, P521, DOI 10.1093/molehr/gan044	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48869	10.1371/journal.pone.0048869	http://dx.doi.org/10.1371/journal.pone.0048869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145002	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800158
J	Li, H; Wijekoon, A; Leipzig, ND				Li, Hang; Wijekoon, Asanka; Leipzig, Nic D.			3D Differentiation of Neural Stem Cells in Macroporous Photopolymerizable Hydrogel Scaffolds	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENT; TISSUE ENGINEERING SCAFFOLDS; GROWTH-FACTOR-AA; PORE-SIZE; IN-VITRO; CHITOSAN SCAFFOLDS; MATRIX; POROSITY; SUBSTRATE; HYPOXIA	Neural stem/progenitor cells (NSPCs) are the stem cell of the adult central nervous system (CNS). These cells are able to differentiate into the major cell types found in the CNS (neurons, oligodendrocytes, astrocytes), thus NSPCs are the mechanism by which the adult CNS could potentially regenerate after injury or disorder. Microenviromental factors are critical for guiding NSPC differentiation and are thus important for neural tissue engineering. In this study, D-mannitol crystals were mixed with photocrosslinkable methacrylamide chitosan (MAC) as a porogen to enhance pore size during hydrogel formation. D-mannitol was admixed to MAC at 5, 10 and 20 wt% D-mannitol per total initial hydrogel weight. D-mannitol crystals were observed to dissolve and leave the scaffold within 1 hr. Quantification of resulting average pore sizes showed that D-mannitol addition resulted in larger average pore size (5 wt%, 4060+/-160 mu m(2), 10 wt%, 6330+/-1160 mu m(2), 20 wt%, 7600+/-1550 mu m(2)) compared with controls (0 wt%, 3150+/-220 mu m(2)). Oxygen diffusion studies demonstrated that larger average pore area resulted in enhanced oxygen diffusion through scaffolds. Finally, the differentiation responses of NSPCs to phenotypic differentiation conditions were studied for neurons, astrocytes and oligodendrocytes in hydrogels of varied porosity over 14 d. Quantification of total cell numbers at day 7 and 14, showed that cell numbers decreased with increased porosity and over the length of the culture. At day 14 immunohistochemistry quantification for primary cell types demonstrated significant differentiation to the desired cells types, and that total percentages of each cell type was greatest when scaffolds were more porous. These results suggest that larger pore sizes in MAC hydrogels effectively promote NSPC 3D differentiation.	[Li, Hang; Wijekoon, Asanka; Leipzig, Nic D.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron	Leipzig, ND (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	nl21@uakron.edu	Li, Hang/ABO-8259-2022; Leipzig, Nic D/AAM-6654-2021	Leipzig, Nic D/0000-0002-6356-7691	University of Akron	University of Akron	The work was supported by University of Akron startup funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002429; Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018; Arkudas A, 2007, TISSUE ENG, V13, P1549, DOI 10.1089/ten.2006.0387; Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI 10.1227/01.NEU.0000311081.50648.4C; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380; Brown DM, 2004, DRUG DELIVERY SYSTEM; Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033; Cassimeris L, 2011, LEWINS CELLS, Vxxiv; Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045; Den Buijs JO, 2009, ANN BIOMED ENG, V37, P1601, DOI 10.1007/s10439-009-9712-3; FABBRI M, 1994, BIOMATERIALS, V15, P474, DOI 10.1016/0142-9612(94)90228-3; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Fujimoto T, 2006, INT J FOOD MICROBIOL, V112, P96, DOI 10.1016/j.ijfoodmicro.2006.06.003; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007; Hing KA, 1999, J MATER SCI-MATER M, V10, P663, DOI 10.1023/A:1008900127475; Hu JG, 2008, NEUROSCIENCE, V151, P138, DOI 10.1016/j.neuroscience.2007.10.050; Hulbert SFMS, 1971, J BIOMECHANICAL MA A, P5; Ji CD, 2011, BIOMATERIALS, V32, P9719, DOI 10.1016/j.biomaterials.2011.09.003; Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2; Kilinc A, 2002, TURK J CHEM, V26, P311; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; Kim J, 2009, TISSUE ENG PART C-ME, V15, P583, DOI [10.1089/ten.tec.2008.0642, 10.1089/ten.TEC.2008.0642]; Kuberka M, 2002, INT J ARTIF ORGANS, V25, P67, DOI 10.1177/039139880202500111; Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605; Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Lia SC, 2005, BIOESSAYS, V27, P697; Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030; Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020; Lin HQ, 2005, MACROMOLECULES, V38, P8381, DOI 10.1021/ma0510136; LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802; Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918; Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417; Markovic M, 2000, KEY ENG MATER, V192-1, P773, DOI 10.4028/www.scientific.net/KEM.192-195.773; Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R; Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036; Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X; O'Brien Fergal J, 2007, Technol Health Care, V15, P3; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Polderman KH, 2003, CRIT CARE MED, V31, P584, DOI 10.1097/01.CCM.0000050287.68977.84; Ranucci CS, 2000, BIOMATERIALS, V21, P783, DOI 10.1016/S0142-9612(99)00238-0; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sachlos E., 2003, European Cells & Materials, V5, P29; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Scott RA, 2011, ACTA BIOMATER, V7, P3841, DOI 10.1016/j.actbio.2011.06.054; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007; Takagi S, 2001, J MATER SCI-MATER M, V12, P135, DOI 10.1023/A:1008917910468; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tonti GA, 2009, INT J DEV BIOL, V53, P1, DOI 10.1387/ijdb.082573gt; Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231; West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k; Xu HHK, 2004, J BIOMED MATER RES A, V68A, P725, DOI 10.1002/jbm.a.20093; Xu HHK, 2001, J BIOMED MATER RES, V57, P457, DOI 10.1002/1097-4636(20011205)57:3<457::AID-JBM1189>3.0.CO;2-X; Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001; Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069; Zhang HL, 2007, ACTA MATER, V55, P171, DOI 10.1016/j.actamat.2006.07.032; Zhang RY, 1999, J BIOMED MATER RES, V44, P446; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	79	65	67	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48824	10.1371/journal.pone.0048824	http://dx.doi.org/10.1371/journal.pone.0048824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144988	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800147
J	Luise, C; Merolla, F; Leone, V; Paladino, S; Sarnataro, D; Fusco, A; Celetti, A				Luise, Chiara; Merolla, Francesco; Leone, Vincenza; Paladino, Simona; Sarnataro, Daniela; Fusco, Alfredo; Celetti, Angela			Identification of Sumoylation Sites in CCDC6, the First Identified RET Partner Gene in Papillary Thyroid Carcinoma, Uncovers a Mode of Regulating CCDC6 Function on CREB1 Transcriptional Activity	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; SUMO-2 TARGET PROTEINS; CELL-LINE; IN-VIVO; UBIQUITIN; CANCER; PHOSPHORYLATION; REARRANGEMENTS; PROTOONCOGENE; H4(D10S170)	CCDC6 was originally identified in chimeric genes as caused by chromosomal translocation involving the RET protooncogene in some thyroid tumors. Recognised as a 65 kDa pro-apoptotic phosphoprotein, CCDC6 has been enrolled as an ATM substrate that contribute to protect genome integrity by modulating PP4c activity in response to genotoxic stress. Recently, CCDC6 has been identified as a repressor of CREB1-dependent transcription. Sumoylation has emerged as an important mechanism in transcriptional control. Here, we report the identification and characterization of three sites of sumoylation in CCDC6 (K74, K266 and K424) which are highly conserved in vertebrates. We demonstrate that the post-translational modifications by SUMO2 constrain most of the CCDC6 protein in the cytosol and affect its functional interaction with CREB1 with a decrease of CCDC6 repressive function on CREB1 transcriptional activity. Indeed, the impairment of functional outcome of sumoylated CCDC6 is obtained knocking down all three the sumoylation sites. Interestingly, in thyroid cells the SUMO2-mediated CCDC6 post-translational modifications are induced by Forskolin, a cAMP analog. Signal transduction via the cAMP pathway is known to be ubiquitous and represents a major line of communication between many organisms and their environment. We believe that CCDC6 could be an important player in the dynamics of cAMP signaling by fine regulating CREB1 transcriptional activity in normal and transformed thyroid cells.	[Luise, Chiara; Merolla, Francesco; Leone, Vincenza; Fusco, Alfredo; Celetti, Angela] Univ Naples Federico II, CNR, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Luise, Chiara; Paladino, Simona; Sarnataro, Daniela; Fusco, Alfredo] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Paladino, Simona; Sarnataro, Daniela] CEINGE Biotecnol Avanzate, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Celetti, A (corresponding author), Univ Naples Federico II, CNR, Ist Endocrinol & Oncol Sperimentale, Naples, Italy.	celetti@unina.it	Paladino, Simona/J-5383-2018; Sarnataro, Daniela/X-5629-2019; Celetti, Angela/AAY-7172-2020; Paladino, Simona/ABH-7826-2020	Paladino, Simona/0000-0001-5332-6774; Sarnataro, Daniela/0000-0002-6094-8384; Fusco, Alfredo/0000-0003-3332-5197	Istituto Superiore di Oncologia [MIUR PON01-02782/12]; Associazione Italiana Ricerca sul Cancro (AIRC) [4952]; Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN 20072JHN5W_003]; CNR	Istituto Superiore di Oncologia; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); CNR(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by the Istituto Superiore di Oncologia (MIUR PON01-02782/12); by the Associazione Italiana Ricerca sul Cancro (AIRC n. 4952 to AC; www.airc.it) and by the "Ministero dell'Istruzione, dell'Universita e della Ricerca'' (PRIN 20072JHN5W_003 to AC; www.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank those who very kindly provided us with materials: Gianni Del Sal (Trieste, Italy) for 3x-FLAG-SUMO1 and -SUMO2 cDNAs; David Baker (Leiden, Netherlands) for His-SUMO1 and His-SUMO2 plasmids; Ellis Jaffray and RonT Hay (Dundee, United Kingdom) for Hela-YFP-SUMO2 cells and YFP-SUMO2 plasmid. We also acknowledge Professore Giancarlo Vecchio for his encouragement and support. We are grateful to Mario Berardone for artwork. The FRET experiments were performed at the DIM Facility - CEINGE Biotecnologie Avanzate, Napoli, Italy. Angela Celetti is grateful to CNR for a Short Term Mobility Fellowship in 2010.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; BERLINGIERI MT, 1988, MOL CELL BIOL, V8, P2261, DOI 10.1128/MCB.8.5.2261; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; De Martino I, 2009, CANCER RES, V69, P1844, DOI 10.1158/0008-5472.CAN-08-4133; Degerny C, 2005, J BIOL CHEM, V280, P24330, DOI 10.1074/jbc.M411250200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Fusco A, 1985, ONCOGENES TUMOR ANTI, P17; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; GRIECO M, 1994, ONCOGENE, V9, P2531; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Haymart MR, 2008, J CLIN ENDOCR METAB, V93, P809, DOI 10.1210/jc.2007-2215; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kenworthy AK, 1999, METH MOL B, V116, P37; Kim YP, 2009, BIOCHEM BIOPH RES CO, V382, P530, DOI 10.1016/j.bbrc.2009.03.055; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Leone V, 2010, ONCOGENE, V29, P4341, DOI 10.1038/onc.2010.179; Li X, 2010, BIOCHEM J, V428, P55, DOI 10.1042/BJ20091672; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Merolla F, 2012, PLOS ONE, V7; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Pierantoni GM, 2006, CELL DEATH DIFFER, V13, P1554, DOI 10.1038/sj.cdd.4401839; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; SANTORO M, 1994, ONCOGENE, V9, P509; Santoro M, 2006, EUR J ENDOCRINOL, V155, P645, DOI 10.1530/eje.1.02289; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tong Q, 1997, J BIOL CHEM, V272, P9043; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Yang SH, 2010, METHODS MOL BIOL, V661, P343, DOI 10.1007/978-1-60761-795-2_21	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49298	10.1371/journal.pone.0049298	http://dx.doi.org/10.1371/journal.pone.0049298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145146	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800241
J	Passamonti, L; Fairchild, G; Fornito, A; Goodyer, IM; Nimmo-Smith, I; Hagan, CC; Calder, AJ				Passamonti, Luca; Fairchild, Graeme; Fornito, Alex; Goodyer, Ian M.; Nimmo-Smith, Ian; Hagan, Cindy C.; Calder, Andrew J.			Abnormal Anatomical Connectivity between the Amygdala and Orbitofrontal Cortex in Conduct Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; DIFFUSION TENSOR TRACTOGRAPHY; CALLOUS-UNEMOTIONAL TRAITS; WHITE-MATTER; EARLY-ONSET; MALE-ADOLESCENTS; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; FRACTIONAL ANISOTROPY; AFFECTIVE MODULATION	Objective: Previous research suggested that structural and functional abnormalities within the amygdala and orbitofrontal cortex contribute to the pathophysiology of Conduct Disorder (CD). Here, we investigated whether the integrity of the white-matter pathways connecting these regions is abnormal and thus may represent a putative neurobiological marker for CD. Methods: Diffusion Tensor Imaging (DTI) was used to investigate white-matter microstructural integrity in male adolescents with childhood-onset CD, compared with healthy controls matched in age, sex, intelligence, and socioeconomic status. Two approaches were employed to analyze DTI data: voxel-based morphometry of fractional anisotropy (FA), an index of white-matter integrity, and virtual dissection of white-matter pathways using tractography. Results: Adolescents with CD displayed higher FA within the right external capsule relative to controls (T = 6.08, P < 0.05, Family-Wise Error, whole-brain correction). Tractography analyses showed that FA values within the uncinate fascicle (connecting the amygdala and orbitofrontal cortex) were abnormally increased in individuals with CD relative to controls. This was in contrast with the inferior frontal-occipital fascicle, which showed no significant group differences in FA. The finding of increased FA in the uncinate fascicle remained significant when factoring out the contribution of attention-deficit/hyperactivity disorder symptoms. There were no group differences in the number of streamlines in either of these anatomical tracts. Conclusions: These results provide evidence that CD is associated with white-matter microstructural abnormalities in the anatomical tract that connects the amygdala and orbitofrontal cortex, the uncinate fascicle. These results implicate abnormal maturation of white-matter pathways which are fundamental in the regulation of emotional behavior in CD.	[Passamonti, Luca] CNR, Unita Ric Neuroimmagini, Catanzaro, Italy; [Passamonti, Luca; Nimmo-Smith, Ian; Calder, Andrew J.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Fairchild, Graeme; Goodyer, Ian M.; Hagan, Cindy C.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Fairchild, Graeme] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Fornito, Alex] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic 3010, Australia; [Goodyer, Ian M.] Cambridge & Peterborough Natl Hlth Serv Fdn Trust, Cambridge, England	Consiglio Nazionale delle Ricerche (CNR); University of Cambridge; University of Southampton; University of Melbourne	Passamonti, L (corresponding author), CNR, Unita Ric Neuroimmagini, Catanzaro, Italy.	luca.passamonti@cnr.it	Passamonti, Luca/I-7057-2019; Alex, Fornito/N-8214-2013	Passamonti, Luca/0000-0002-7937-0615; Alex, Fornito/0000-0001-9134-480X; Hagan, Cindy/0000-0002-4576-7120	Clare Hall College of the University of Cambridge; Wellcome Trust [083140]; Medical Research Council [MC_US_A060_5PQ50]; Medical Research Council [G0802226, MC_U105579214] Funding Source: researchfish; MRC [MC_U105579214, G0802226] Funding Source: UKRI	Clare Hall College of the University of Cambridge(University of Cambridge); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Passamonti was funded by the Betty Behrens Research Fellowship at the Clare Hall College of the University of Cambridge. This study was supported by the Wellcome Trust (Project Grant #083140 to Professor Goodyer and Dr. Fairchild) and by Medical Research Council (Project Code MC_US_A060_5PQ50 to Dr. Calder). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andershed H, 2002, ACTA PSYCHIAT SCAND, V106, P75, DOI 10.1034/j.1600-0447.106.s412.17.x; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Casey BJ, 2007, AM J PSYCHIAT, V164, P1729, DOI 10.1176/appi.ajp.2007.06101754; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Colman I, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2981; Constable RT, 2008, PEDIATRICS, V121, P306, DOI 10.1542/peds.2007-0414; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; Cullen KR, 2010, J AM ACAD CHILD PSY, V49, P173, DOI 10.1016/j.jaac.2009.11.005; Davenport ND, 2010, PSYCHIAT RES-NEUROIM, V181, P193, DOI 10.1016/j.pscychresns.2009.10.012; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fairchild G, 2008, BIOL PSYCHIAT, V63, P279, DOI 10.1016/j.biopsych.2007.06.019; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Fairchild G, 2009, J CHILD PSYCHOL PSYC, V50, P627, DOI 10.1111/j.1469-7610.2008.02020.x; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Haas BW, 2009, DEV MED CHILD NEUROL, V51, P593, DOI 10.1111/j.1469-8749.2009.03295.x; Herpertz SC, 2008, J CHILD PSYCHOL PSYC, V49, P781, DOI 10.1111/j.1469-7610.2008.01905.x; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Houenou J, 2007, MOL PSYCHIATR, V12, P1001, DOI 10.1038/sj.mp.4002010; Huang H, 2010, THESCIENTIFICWORLDJO, V10, P135, DOI 10.1100/tsw.2010.21; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Klein RG, 1997, ARCH GEN PSYCHIAT, V54, P1073; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Mabbott DJ, 2006, NEUROIMAGE, V33, P936, DOI 10.1016/j.neuroimage.2006.07.024; Mabbott DJ, 2009, BRAIN RES, V1294, P80, DOI 10.1016/j.brainres.2009.07.046; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; MCCONAUGHY SH, 1994, J CHILD PSYCHOL PSYC, V35, P1141, DOI 10.1111/j.1469-7610.1994.tb01814.x; Moffitt T. E., 2001, SEX DIFFERENCES ANTI; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; Moffitt TE, 2008, J CHILD PSYCHOL PSYC, V49, P3, DOI 10.1111/j.1469-7610.2007.01823.x; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Odgers CL, 2007, ARCH GEN PSYCHIAT, V64, P476, DOI 10.1001/archpsyc.64.4.476; Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Rempel-Clower NL, 2007, ANN NY ACAD SCI, V1121, P72, DOI 10.1196/annals.1401.026; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Sarkar S., 2012, 18 IEEE NATL C COMMU, P1, DOI DOI 10.1017/S003329171200116X; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stadler C, 2007, J PSYCHIATR RES, V41, P410, DOI 10.1016/j.jpsychires.2006.01.006; Sterzer P, 2005, BIOL PSYCHIAT, V57, P7, DOI 10.1016/j.biopsych.2004.10.008; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; Wechsler D., 1999, WECHSLER ABBREVIATED	64	85	89	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48789	10.1371/journal.pone.0048789	http://dx.doi.org/10.1371/journal.pone.0048789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144970	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800132
J	Taylor, AB; Kurbatova, EV; Cegielski, JP				Taylor, Allison B.; Kurbatova, Ekaterina V.; Cegielski, J. Peter			Prevalence of Anti-Tuberculosis Drug Resistance in Foreign-Born Tuberculosis Cases in the US and in Their Countries of Origin	PLOS ONE			English	Article							UNITED-STATES; INFECTION	Background: Foreign-born individuals comprise > 50% of tuberculosis (TB) cases in the U.S. Since anti-TB drug resistance is more common in most other countries, when evaluating a foreign-born individual for TB, one must consider the risk of drug resistance. Naturally, clinicians query The Global Project on Anti-tuberculosis Drug Resistance Surveillance (Global DRS) which provides population-based data on the prevalence of anti-TB drug resistance in 127 countries starting in 1994. However, foreign-born persons in the U.S. are a biased sample of the population of their countries of origin, and Global DRS data may not accurately predict their risk of drug resistance. Since implementing drug resistance surveillance in 1993, the U.S. National TB Surveillance System (NTSS) has accumulated systematic data on over 130,000 foreign-born TB cases from more than 200 countries and territories. Our objective was to determine whether the prevalence of drug resistance among foreign-born TB cases correlates better with data from the Global DRS or with data on foreign-born TB cases in the NTSS. Methods and Findings: We compared the prevalence of resistance to isoniazid and rifampin among foreign-born TB cases in the U.S., 2007-2009, with US NTSS data from 1993 to 2006 and with Global DRS data from 1994-2007 visually with scatterplots and statistically with correlation and linear regression analyses. Among foreign-born TB cases in the U.S., 2007-2009, the prevalence of isoniazid resistance and multidrug resistance (MDR, i.e. resistance to isoniazid and rifampin), correlated much better with 1993-2006 US surveillance data (isoniazid: r = 0.95, P <.001, MDR: r = 0.75, P <.001) than with Global DRS data, 1994-2007 (isoniazid: r = 0.55, P = .001; MDR: r = 0.50, P <.001). Conclusion: Since 1993, the US NTSS has accumulated sufficient data on foreign-born TB cases to estimate the risk of drug resistance among such individuals better than data from the Global DRS.	[Taylor, Allison B.; Kurbatova, Ekaterina V.; Cegielski, J. Peter] US Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Cegielski, JP (corresponding author), US Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.	pcegielski@cdc.gov						[Anonymous], 2010, CDC REP TUB US 2009; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2008, 4 WHO; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Granich RM, 2001, INT J TUBERC LUNG D, V5, P53; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; Moniruzzaman A, 2006, INT J TUBERC LUNG D, V10, P844; Reichman LB, 2004, AM J RESP CRIT CARE, V170, P832, DOI 10.1164/rccm.200405-584PP; *WHO, 2006, GLOB TUB CONTR SURV; WHO/IUATLD, 2000, 2 WHOIUATLD; *WHO IUATLD, 2004, 3 WHOIUATLD; WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 1997, ANT DRUG RES WORLD W	14	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49355	10.1371/journal.pone.0049355	http://dx.doi.org/10.1371/journal.pone.0049355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145161	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800252
J	Petrie, JR; Vanhercke, T; Shrestha, P; El Tahchy, A; White, A; Zhou, XR; Liu, Q; Mansour, MP; Nichols, PD; Singh, SP				Petrie, James R.; Vanhercke, Thomas; Shrestha, Pushkar; El Tahchy, Anna; White, Adam; Zhou, Xue-Rong; Liu, Qing; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.			Recruiting a New Substrate for Triacylglycerol Synthesis in Plants: The Monoacylglycerol Acyltransferase Pathway	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID-PHOSPHATASE; DIACYLGLYCEROL ACYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; GENE; IDENTIFICATION; MGAT2; YEAST; SEEDS; BIOSYNTHESIS	Background: Monoacylglycerol acyltransferases (MGATs) are predominantly associated with lipid absorption and resynthesis in the animal intestine where they catalyse the first step in the monoacylglycerol (MAG) pathway by acylating MAG to form diacylglycerol (DAG). Typical plant triacylglycerol (TAG) biosynthesis routes such as the Kennedy pathway do not include an MGAT step. Rather, DAG and TAG are synthesised de novo from glycerol-3-phosphate (G-3-P) by a series of three subsequent acylation reactions although a complex interplay with membrane lipids exists. Methodology/Principal Findings: We demonstrate that heterologous expression of a mouse MGAT acyltransferase in Nicotiana benthamiana significantly increases TAG accumulation in vegetative tissues despite the low levels of endogenous MAG substrate available. In addition, DAG produced by this acyltransferase can serve as a substrate for both native and coexpressed diacylglycerol acyltransferases (DGAT). Finally, we show that the Arabidopsis thaliana GPAT4 acyltransferase can produce MAG in Saccharomyces cerevisiae using oleoyl-CoA as the acyl-donor. Conclusions/Significance: This study demonstrates the concept of a new method of increasing oil content in vegetative tissues by using MAG as a substrate for TAG biosynthesis. Based on in vitro yeast assays and expression results in N. benthamiana, we propose that co-expression of a MAG synthesising enzyme such as A. thaliana GPAT4 and a MGAT or bifunctional M/DGAT can result in DAG and TAG synthesis from G-3-P via a route that is independent and complementary to the endogenous Kennedy pathway and other TAG synthesis routes.	[Petrie, James R.; Shrestha, Pushkar; El Tahchy, Anna; White, Adam; Liu, Qing; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.] CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Vanhercke, Thomas; Zhou, Xue-Rong] CSIRO Plant Ind, Canberra, ACT, Australia; [Mansour, Maged P.; Nichols, Peter D.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Petrie, JR (corresponding author), CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia.	surinder.singh@csiro.au	Zhou, Xue-Rong/D-4706-2009; singh, surinder/C-9528-2009; El Tahchy, Anna/AAE-8701-2022; Nichols, Peter D/C-5128-2011; Petrie, James R/D-4598-2009; Vanhercke, Thomas/B-6647-2011; tahchy, Anna El/B-6997-2012; Shrestha, Pushkar/A-2728-2010; Liu, Qing/A-1395-2010	Zhou, Xue-Rong/0000-0003-3717-2984; singh, surinder/0000-0003-4488-8147; Petrie, James R/0000-0002-5892-798X; Vanhercke, Thomas/0000-0003-1397-7622; Shrestha, Pushkar/0000-0001-9642-6636; Liu, Qing/0000-0001-6617-6859; Belide, Srinivas/0000-0001-9536-8200; , Maged/0000-0002-4646-8472	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The authors are all employees of the funder of the study, CSIRO. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Athenstaedt K, 2011, EUR J LIPID SCI TECH, V113, P1188, DOI 10.1002/ejlt.201100051; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; HIRAYAMA O, 1965, AGR BIOL CHEM TOKYO, V29, P1; Igal RA, 2001, J LIPID RES, V42, P88; James CN, 2010, P NATL ACAD SCI USA, V107, P17833, DOI 10.1073/pnas.0911359107; KENNEDY EP, 1961, FED PROC, V20, P934; LAKSHMINARAYANA G, 1984, J AM OIL CHEM SOC, V61, P1249, DOI 10.1007/BF02636264; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; PANEKINA T V, 1978, Chemistry of Natural Compounds (English Translation of Khimiya Prirodnykh Soedinenii), V14, P33, DOI 10.1007/BF00565871; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; PERRY HJ, 1993, PHYTOCHEMISTRY, V33, P329, DOI 10.1016/0031-9422(93)85512-P; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Reddy VS, 2010, BBA-MOL CELL BIOL L, V1801, P455, DOI 10.1016/j.bbalip.2009.12.005; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; Vogel G, 1996, PLANT PHYSIOL, V110, P923, DOI 10.1104/pp.110.3.923; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; Zhou XR, 2011, J BIOL CHEM, V286, P43644, DOI 10.1074/jbc.M111.266114	36	122	160	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e35214	10.1371/journal.pone.0035214	http://dx.doi.org/10.1371/journal.pone.0035214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	23145108	Green Published, gold, Green Submitted			2022-12-25	WOS:000305345000048
J	Kim, YS; Kim, KS; Han, I; Kim, MH; Jung, MH; Park, HK				Kim, Young-Sun; Kim, Kyung Sook; Han, Ihn; Kim, Mi-Hyun; Jung, Min Hyung; Park, Hun-Kuk			Quantitative and Qualitative Analysis of the Antifungal Activity of Allicin Alone and in Combination with Antifungal Drugs	PLOS ONE			English	Article							CANDIDA-ALBICANS; AMPHOTERICIN-B; INHIBITION; CELLS	The antifungal activity of allicin and its synergistic effects with the antifungal agents flucytosine and amphotericin B (AmB) were investigated in Candida albicans (C. albicans). C. albicans was treated with different conditions of compounds alone and in combination (allicin, AmB, flucytosine, allicin + AmB, allicin + flucytosine, allicin + AmB + flucytosine). After a 24-hour treatment, cells were examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM) to measure morphological and biophysical properties associated with cell death. The clearing assay was conducted to confirm the effects of allicin. The viability of C. albicans treated by allicin alone or with one antifungal drug (AmB, flucytosine) in addition was more than 40% after a 24-hr treatment, but the viability of groups treated with combinations of more than two drugs was less than 32%. When the cells were treated with allicin alone or one type of drug, the morphology of the cells did not change noticeably, but when cells were treated with combinations of drugs, there were noticeable morphological changes. In particular, cells treated with allicin + AmB had significant membrane damage (burst or collapsed membranes). Classification of cells according to their cell death phase (CDP) allowed us to determine the relationship between cell viability and treatment conditions in detail. The adhesive force was decreased by the treatment in all groups compare to the control. Cells treated with AmB + allicin had a greater adhesive force than cells treated with AmB alone because of the secretion of molecules due to collapsed membranes. All cells treated with allicin or drugs were softer than the control cells. These results suggest that allicin can reduce MIC of AmB while keeping the same efficacy.	[Kim, Young-Sun; Jung, Min Hyung] Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Seoul, South Korea; [Han, Ihn] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Park, Hun-Kuk] Kyung Hee Univ, Program Med Engn, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, YS (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea.	webhospital@naver.com; sigmoidus@khu.ac.kr	Kim, Youngsun/AAY-5946-2021; Han, Ihn/ABH-6275-2020	Kim, Youngsun/0000-0002-1725-0968; Han, Ihn/0000-0002-1372-7319	Kyung Hee University [KHU-20110093]; Seoul Research and Business Development program [CR070054]	Kyung Hee University; Seoul Research and Business Development program(Seoul RBD program)	This study was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program (Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADETUMBI M, 1986, ANTIMICROB AGENTS CH, V30, P499, DOI 10.1128/AAC.30.3.499; An MM, 2009, INT J ANTIMICROB AG, V33, P258, DOI 10.1016/j.ijantimicag.2008.09.014; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aplin AE, 1998, PHARMACOL REV, V50, P197; Brito GNB, 2011, BRAZ ORAL RES, V25, P28, DOI 10.1590/S1806-83242011005000001; Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Borjihan H, 2009, J ANTIBIOT, V62, P691, DOI 10.1038/ja.2009.103; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Davis SR, 2005, MYCOSES, V48, P95, DOI 10.1111/j.1439-0507.2004.01076.x; GHANNOUM MA, 1990, J APPL BACTERIOL, V68, P163, DOI 10.1111/j.1365-2672.1990.tb02562.x; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Khodavandi A, 2010, MYCOPATHOLOGIA, V169, P287, DOI 10.1007/s11046-009-9251-3; Kim KSKim, PLOS ONE, V6; Lee Jeong Ah, 2010, Mycobiology, V38, P328, DOI 10.4489/MYCO.2010.38.4.328; Low CF, 2008, J APPL MICROBIOL, V105, P2169, DOI 10.1111/j.1365-2672.2008.03912.x; Lyon GM, 2010, J CLIN MICROBIOL, V48, P1270, DOI 10.1128/JCM.02363-09; Na G, 2010, FEMS IMMUNOL MED MIC, V58, P193; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ogita A, 2005, TOXICOLOGY, V215, P205, DOI 10.1016/j.tox.2005.07.006; Okamoto Y, 2004, MYCOPATHOLOGIA, V158, P9, DOI 10.1023/B:MYCO.0000038430.20669.80; Shuford JA, 2005, ANTIMICROB AGENTS CH, V49, P473, DOI 10.1128/AAC.49.1.473.2005; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; YAMADA Y, 1977, ANTIMICROB AGENTS CH, V11, P743, DOI 10.1128/AAC.11.4.743; Zakaria Z, 2011, ASIAN PACIFIC J TROP, V1, P20; Zhang JD, 2006, J ETHNOPHARMACOL, V103, P76, DOI 10.1016/j.jep.2005.07.006	26	38	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38242	10.1371/journal.pone.0038242	http://dx.doi.org/10.1371/journal.pone.0038242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	23144990	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343900023
J	Zhao, JP; Diao, S; Zhang, BY; Niu, BQ; Wang, QL; Wan, XC; Luo, YQ				Zhao, Jia-Ping; Diao, Shu; Zhang, Bing-Yu; Niu, Bao-Qing; Wang, Qing-Ling; Wan, Xian-Chong; Luo, You-Qing			Phylogenetic Analysis and Molecular Evolution Patterns in the MIR482-MIR1448 Polycistron of Populus L	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; STRESS-RESPONSIVE MICRORNAS; COMPENSATORY MUTATIONS; TARGET SEQUENCES; SALICACEAE; CONSERVATION; DUPLICATION; BIOGENESIS; PREDICTION; DIVERSE	The microRNAs (miRNAs) miR482 and miR1448 are disease resistance-related miRNAs; the former is ubiquitously distributed in seed plants whereas the latter has only been reported in Populus trichocarpa. The precursor and mature sequences of poplar miR1448 are highly homologous to those of poplar miR482, and these two miRNAs are located in one transcript as a polycistron. Therefore, we hypothesized that the MIR1448 gene may have evolved from the MIR482 gene in poplar. However, the molecular evolution patterns of this process remain unclear. In this study, utilizing cloning and Blast analysis in NCBI ESTs and whole-genome shotgun contigs (WGS) dataset, we determined that the MIR482-MIR1448 polycistron is a family-specific clustered miRNA in Salicaceae. Moreover, phylogenetic analysis illustrated that MIR1448 is the product of a tandem duplication event from MIR482. Nucleotide substitution analysis revealed that both MIR482 and MIR1448 have more rapid evolution ratios than ribosomal DNA (rDNA) genes, and that compensatory mutations that occurred in the stem region of the secondary structure were the main mechanisms that drove the evolution of these MIRNA genes. Furthermore, by comparing the substitution patterns in the miRNA-target complexes of miR482 and miR1448, we inferred that co-evolution between miRNAs and their targets was the major force that drove the "duplicated MIR482" evolve to MIR1448. We propose a novel miRNA-target pairing pattern called the "frameshift targeted mechanism" to explain the gain of target genes by miR1448. The results also imply that the major role of miR482 was in resistance to disease or other stresses via NBS-LRR proteins, whereas the biological functions of miR1448 are more diverse.	[Zhao, Jia-Ping; Wan, Xian-Chong] Chinese Acad Forestry, Inst New Forestry Technol, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Zhao, Jia-Ping; Luo, You-Qing] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Diao, Shu; Zhang, Bing-Yu] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Niu, Bao-Qing; Wang, Qing-Ling] Agr Univ Hebei, Baoding, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry New Technology, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Hebei Agricultural University	Zhao, JP (corresponding author), Chinese Acad Forestry, Inst New Forestry Technol, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	zhaojiaping@gmail.com; yqluo@bjfu.edu.cn		Yan, Xiaodong/0000-0002-0774-9140; Jia, Gensuo/0000-0001-5950-9555	National Program on Key Basic Research Project of China (973 Program) [2009CB119107]; National Natural Science Foundation of China [30872048]; Chinese Postdoctoral Funding [20110490302]; National Science & Technology Basic Program of China [2009FY210100]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Funding; National Science & Technology Basic Program of China	This work was financially supported by National Program on Key Basic Research Project of China (973 Program) (No. 2009CB119107), National Natural Science Foundation of China (No. 30872048), Chinese Postdoctoral Funding (No. 20110490302) and National Science & Technology Basic Program of China (No. 2009FY210100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chakraborty S, 2012, RNA, V18, P1014, DOI 10.1261/rna.031039.111; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; COLLINSON ME, 1992, P ROY SOC EDINB B, V98, P155, DOI 10.1017/S0269727000007521; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; Guo XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-454; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Leskinen E, 1999, PLANT SYST EVOL, V215, P209, DOI 10.1007/BF00984656; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merchan F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r136; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81	41	20	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47811	10.1371/journal.pone.0047811	http://dx.doi.org/10.1371/journal.pone.0047811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23144853	gold, Green Published, Green Submitted			2022-12-25	WOS:000312384500027
J	Li, JL; Qin, HR; Wu, J; Sadd, BM; Wang, XH; Evans, JD; Peng, WJ; Chen, YP				Li, Jilian; Qin, Haoran; Wu, Jie; Sadd, Ben M.; Wang, Xiuhong; Evans, Jay D.; Peng, Wenjun; Chen, Yanping			The Prevalence of Parasites and Pathogens in Asian Honeybees Apis cerana in China	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; BEE COLONY COLLAPSE; NOSEMA-CERANAE; GUT BACTERIA; MELLIFERA L.; MOLECULAR DIAGNOSIS; BOMBUS-TERRESTRIS; VARROA-JACOBSONI; PARALYSIS VIRUS; BUMBLE BEES	Pathogens and parasites represent significant threats to the health and well-being of honeybee species that are key pollinators of agricultural crops and flowers worldwide. We conducted a nationwide survey to determine the occurrence and prevalence of pathogens and parasites in Asian honeybees, Apis cerana, in China. Our study provides evidence of infections of A. cerana by pathogenic Deformed wing virus (DWV), Black queen cell virus (BQCV), Nosema ceranae, and C. bombi species that have been linked to population declines of European honeybees, A. mellifera, and bumble bees. However, the prevalence of DWV, a virus that causes widespread infection in A. mellifera, was low, arguably a result of the greater ability of A. cerana to resist the ectoprasitic mite Varroa destructor, an efficient vector of DWV. Analyses of microbial communities from the A. cerana digestive tract showed that Nosema infection could have detrimental effects on the gut microbiota. Workers infected by N. ceranae tended to have lower bacterial quantities, with these differences being significant for the Bifidobacterium and Pasteurellaceae bacteria groups. The results of this nationwide screen show that parasites and pathogens that have caused serious problems in European honeybees can be found in native honeybee species kept in Asia. Environmental changes due to new agricultural practices and globalization may facilitate the spread of pathogens into new geographic areas. The foraging behavior of pollinators that are in close geographic proximity likely have played an important role in spreading of parasites and pathogens over to new hosts. Phylogenetic analyses provide insights into the movement and population structure of these parasites, suggesting a bidirectional flow of parasites among pollinators. The presence of these parasites and pathogens may have considerable implications for an observed population decline of Asian honeybees.	[Li, Jilian; Qin, Haoran; Wu, Jie; Wang, Xiuhong; Peng, Wenjun] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing 100193, Peoples R China; [Evans, Jay D.; Chen, Yanping] ARS, USDA, Bee Res Lab, Beltsville, MD USA; [Sadd, Ben M.] Eth Zurich Univ Str, Inst Integrat Biol, Zurich, Switzerland	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA)	Peng, WJ (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing 100193, Peoples R China.	bumblebeeljl@hotmail.com; judy.chen@ars.usda.gov	Evans, Jay D/C-8408-2012	Evans, Jay D/0000-0002-0036-4651; Chen, Chen/0000-0001-6741-7036; Sadd, Ben/0000-0003-3136-5144	Chinese Academy of Agricultural Sciences (CAAS), Beijing, China; Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland [2009DFA32600]; Beijing Natural Science Foundation [6122032]; Chinese National Natural Science Foundation [30700606, 30972149]; China Agriculture Research System (CARS-45) [201203080-4]; Special Fund for Agricultural Research in the Public Interest [201203080-4]	Chinese Academy of Agricultural Sciences (CAAS), Beijing, China; Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Agriculture Research System (CARS-45); Special Fund for Agricultural Research in the Public Interest	Funding was provided by an international joint research project between the Chinese Academy of Agricultural Sciences (CAAS), Beijing, China and Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland (No. 2009DFA32600), Beijing Natural Science Foundation (No. 6122032), Chinese National Natural Science Foundation (No. 30700606, 30972149), the China Agriculture Research System (CARS-45) (201203080-4), the Special Fund for Agricultural Research in the Public Interest (201203080-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carreck NL, 2010, J APICULT RES, V49, P93, DOI 10.3896/IBRA.1.49.1.13; Chaimanee V, 2011, J INVERTEBR PATHOL, V107, P229, DOI 10.1016/j.jip.2011.05.012; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Chen YP, 2004, AM BEE J, V144, P557; Choe SE, 2012, J INVERTEBR PATHOL, V109, P330, DOI 10.1016/j.jip.2012.01.003; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; GILLIAM M, 1988, MICROBIOS, V55, P95; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; He X., 2011, APICULTURE CHINA, V62, P21; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huang WF, 2008, J INVERTEBR PATHOL, V97, P9, DOI 10.1016/j.jip.2007.07.001; Inglis GD, 1998, APIDOLOGIE, V29, P327, DOI 10.1051/apido:19980403; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; [季荣 Ji Rong], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P70; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Pedersen AB, 2005, INT J PARASITOL, V35, P647, DOI 10.1016/j.ijpara.2005.01.005; Peng WJ, 2011, APIDOLOGIE, V42, P650, DOI 10.1007/s13592-011-0061-5; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Singh R, 2010, PLOS ONE, V5, P1, DOI DOI 10.1371/J0URNAL.P0NE.0014357; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Wu J, 2006, AM BEE J, V146, P153; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Yoshiyama M, 2009, J INVERTEBR PATHOL, V102, P91, DOI 10.1016/j.jip.2009.07.005; Yourth CP, 2008, INSECT SOC, V55, P86, DOI 10.1007/s00040-007-0974-1	70	67	88	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47955	10.1371/journal.pone.0047955	http://dx.doi.org/10.1371/journal.pone.0047955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144838	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800030
J	Kim, SJ; Peshkin, L; Mitchison, TJ				Kim, Sujeong; Peshkin, Leonid; Mitchison, Timothy J.			Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton	PLOS ONE			English	Article							5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; COMBRETASTATIN A4 PHOSPHATE; TUMOR-NECROSIS-FACTOR; FLAVONE ACETIC-ACID; MICROTUBULE DYNAMICS; ANTITUMOR-ACTIVITY; KNOCKOUT MICE; IN-VIVO; CANCER; CELLS	Vascular disrupting agents (VDAs), anti-cancer drugs that target established tumor blood vessels, fall into two main classes: microtubule targeting drugs, exemplified by combretastatin A4 (CA4), and flavonoids, exemplified by 5,6-dimethylxanthe-none-4-acetic acid (DMXAA). Both classes increase permeability of tumor vasculature in mouse models, and DMXAA in particular can cause massive tumor necrosis. The molecular target of CA4 is clearly microtubules. The molecular target(s) of DMXAA remains unclear. It is thought to promote inflammatory signaling in leukocytes, and has been assumed to not target microtubules, though it is not clear from the literature how carefully this assumption has been tested. An earlier flavone analog, flavone acetic acid, was reported to promote mitotic arrest suggesting flavones might possess anti-microtubule activity, and endothelial cells are sensitive to even mild disruption of microtubules. We carefully investigated whether DMXAA directly affects the microtubule or actin cytoskeletons of endothelial cells by comparing effects of CA4 and DMXAA on human umbilical vein endothelial cells (HUVEC) using time-lapse imaging and assays for cytoskeleton integrity. CA4 caused retraction of the cell margin, mitotic arrest and microtubule depolymerization, while DMXAA, up to 500 mu M, showed none of these effects. DMXAA also had no effect on pure tubulin nucleation and polymerization, unlike CA4. We conclude that DMXAA exhibits no direct anti-microtubule action and thus cleanly differs from CA4 in its mechanism of action at the molecular level.	[Kim, Sujeong; Peshkin, Leonid; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kim, SJ (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Sujeong_Kim@hms.harvard.edu		Mond, Jonathan/0000-0002-0410-091X; Hay, Phillipa/0000-0003-0296-6856; Peshkin, Leonid/0000-0002-6420-848X; MITCHISON, DEBORAH/0000-0002-6736-7937; Giannakakou, Paraskevi/0000-0001-7378-262X	Korea Research Foundation; Korean Government [KRF-2008-357-C00112];  [CA139980]; NATIONAL CANCER INSTITUTE [P01CA139980] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Korea Research Foundation Grant funded by the Korean Government [KRF-2008-357-C00112] and New Initiative Grant CA139980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley BC, 2003, LANCET ONCOL, V4, P141, DOI 10.1016/S1470-2045(03)01018-0; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; Ching LM, 1999, CANCER RES, V59, P3304; CUSHMAN M, 1991, J MED CHEM, V34, P2579, DOI 10.1021/jm00112a036; Dark GG, 1997, CANCER RES, V57, P1829; Eichhorn ME, 2007, LANGENBECK ARCH SURG, V392, P371, DOI 10.1007/s00423-007-0150-0; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Galbraith SM, 2001, ANTICANCER RES, V21, P93; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; Head M, 2010, EXPERT OPIN INV DRUG, V19, P295, DOI 10.1517/13543780903540214; JORDAN MA, 1992, J CELL SCI, V102, P401; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Nam NH, 2003, CURR MED CHEM, V10, P1697, DOI 10.2174/0929867033457151; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Panaro NJ, 1999, BRIT J CANCER, V80, P1905, DOI 10.1038/sj.bjc.6690619; PLOWMAN J, 1986, CANCER TREAT REP, V70, P631; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Vincent L, 2005, J CLIN INVEST, V115, P2992, DOI 10.1172/JCI24586; Wang LCS, 2004, BIOCHEM PHARMACOL, V67, P937, DOI 10.1016/j.bcp.2003.10.023; Wu Q, 2012, J PHARMACOL EXP THER; Zhao L, 2002, BRIT J CANCER, V87, P465, DOI 10.1038/sj.bjc.6600479; Zweifel M, 2011, ANN ONCOL, V22, P2036, DOI 10.1093/annonc/mdq708; ZWI LJ, 1994, ONCOL RES, V6, P79	31	58	58	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e40177	10.1371/journal.pone.0040177	http://dx.doi.org/10.1371/journal.pone.0040177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848372	Green Submitted, Green Published, gold			2022-12-25	WOS:000306751300007
J	Ferreira, CM; Chen, JL; Li, JR; Shimomura, K; Yang, XN; Lussier, YA; Pinto, LH; Solway, J				Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Shimomura, Kazuhiro; Yang, Xinan; Lussier, Yves A.; Pinto, Lawrence H.; Solway, Julian			Genetic Interactions between Chromosomes 11 and 18 Contribute to Airway Hyperresponsiveness in Mice	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; SMOOTH-MUSCLE; CHOLESTEROL; ASTHMA; TRAIT; MOUSE; C1; RESPONSIVENESS; ATHEROSCLEROSIS; HYPERREACTIVITY	We used two-dimensional quantitative trait locus analysis to identify interacting genetic loci that contribute to the native airway constrictor hyperresponsiveness to methacholine that characterizes A/J mice, relative to C57BL/6J mice. We quantified airway responsiveness to intravenous methacholine boluses in eighty-eight (C57BL/6J X A/J) F-2 and twenty-seven (A/J X C57BL/6J) F2 mice as well as ten A/J mice and six C57BL/6J mice; all studies were performed in male mice. Mice were genotyped at 384 SNP markers, and from these data two-QTL analyses disclosed one pair of interacting loci on chromosomes 11 and 18; the homozygous A/J genotype at each locus constituted the genetic interaction linked to the hyperresponsive A/J phenotype. Bioinformatic network analysis of potential interactions among proteins encoded by genes in the linked regions disclosed two high priority subnetworks - Myl7, Rock1, Limk2; and Npc1, Npc1/1. Evidence in the literature supports the possibility that either or both networks could contribute to the regulation of airway constrictor responsiveness. Together, these results should stimulate evaluation of the genetic contribution of these networks in the regulation of airway responsiveness in humans.	[Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Yang, Xinan; Lussier, Yves A.; Solway, Julian] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ferreira, Caroline M.; Shimomura, Kazuhiro; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Chicago; Northwestern University	Ferreira, CM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jsolway@medicine.bsd.uchicago.edu	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	CNPq (National Council for Scientific and Technological Development) [UL1RR024999-04]; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT) [U54CA121852-5, K22LM008308, R01HL079398]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by CNPq (National Council for Scientific and Technological Development), UL1RR024999-04, National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT; U54CA121852-5), K22LM008308, R01HL079398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buchele G, 2010, PEDIATR PULM, V45, P796, DOI 10.1002/ppul.21259; Camateros P, 2010, MAMM GENOME, V21, P28, DOI 10.1007/s00335-009-9236-z; Chen BH, 2006, J APPL PHYSIOL, V101, P249, DOI 10.1152/japplphysiol.01010.2004; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; Davis HR, 2008, ATHEROSCLEROSIS SUPP, V9, P77, DOI 10.1016/j.atherosclerosissup.2008.05.008; Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Dowell ML, 2010, EUR RESPIR J, V36, P630, DOI 10.1183/09031936.00160209; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Ewart SL, 1996, AM J RESP CELL MOL, V14, P487, DOI 10.1165/ajrcmb.14.5.8624254; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Iyer SPN, 2005, BBA-GEN SUBJECTS, V1722, P282, DOI 10.1016/j.bbagen.2004.12.021; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovesi TA, 1996, J INHERIT METAB DIS, V19, P792, DOI 10.1007/BF01799175; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Nicholson AG, 2006, HISTOPATHOLOGY, V48, P596, DOI 10.1111/j.1365-2559.2006.02355.x; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Otera H, 2009, AM J PHYSIOL-LUNG C, V296, pL594, DOI 10.1152/ajplung.90530.2008; Palmeri S, 2005, NEUROL SCI, V26, P171, DOI 10.1007/s10072-005-0456-z; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Schlenz H, 2010, AM J PHYSIOL-LUNG C, V298, pL626, DOI 10.1152/ajplung.00261.2009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer B, 2009, CAN J PHYSIOL PHARM, V87, P180, DOI [10.1139/Y08-114, 10.1139/y08-114]; Tossa P, 2010, AM J RESP CRIT CARE, V182, P738, DOI 10.1164/rccm.200903-0415OC; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss LA, 2005, AM J RESP CRIT CARE, V172, P67, DOI 10.1164/rccm.200411-1555OC; Woolcock AJ, 1997, ASTHMA, P27; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Yeh YF, 2004, J BIOMED SCI, V11, P599, DOI 10.1007/BF02256124	49	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					100	106	e29579	10.1371/journal.pone.0029579	http://dx.doi.org/10.1371/journal.pone.0029579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	23071617	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900011
J	Chen, S; Cai, WP; He, JY; Vidal, N; Lai, CH; Guo, WZ; He, HL; Chen, XJ; Fu, LS; Peeters, M; Delaporte, E; Andrieu, JM; Lu, W				Chen, Song; Cai, Weiping; He, Jingyang; Vidal, Nicole; Lai, Chunhui; Guo, Weizhong; He, Haolan; Chen, Xiejie; Fu, Linsheng; Peeters, Martine; Delaporte, Eric; Andrieu, Jean-Marie; Lu, Wei			Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; DRUG-RESISTANCE; SUBTYPE C; HIV-1; TRANSMISSION; RISK; DIVERSITY	Background: Although the outbreak of human immunodeficiency virus type 1 (HIV-1) in Guangdong has been documented for more than a decade, the molecular characteristics of such a regional HIV-1 epidemic remained unknown. Methodology/Principal Findings: By sequencing of HIV-1 pol/env genes and phylogenetic analysis, we performed a molecular epidemiologic study in a representative subset (n = 200) of the 508 HIV-1-seropositive individuals followed up at the center for HIV/AIDS care and treatment of Guangzhou Hospital of Infectious Diseases. Of 157 samples (54.1% heterosexual acquired adults, 20.4% needle-sharing drug users, 5.7% receivers of blood transfusion, 1.3% men who have sex with men, and 18.5% remained unknown) with successful sequencing for both pol and env genes, 105 (66.9%) HIV-1 subtype CRF01_AE and 24 (15.3%) CRF07_BC, 9 (5.7%) B', 5 (3.2%) CRF08_BC, 5 (3.2%) B, 1 (0.6%) C, 3 (1.9%) CRF02_AG, and 5 (3.2%) inter-region recombinants were identified within pol/env sequences. Thirteen (8.3%) samples (3 naives, 6 and 5 received with antiretroviral treatment [ART] 1-21 weeks and >= 24 weeks respectively) showed mutations conferring resistance to nucleoside/nonnucleoside reverse transcriptase inhibitors or protease inhibitors. Among 63 ART-naive patients, 3 (4.8%) showed single or multiple drug resistant mutations. Phylogenetic analysis showed 8 small clusters (2-3 sequences/cluster) with only 17 (10.8%) sequences involved. Conclusion/Significance: This study confirms that sexual transmission with dominant CRF01_AE strain is a major risk for current HIV-1 outbreak in the Guangdong's general population. The transmission with drug-resistant variants is starting to emerge in this region.	[Chen, Song; He, Jingyang; Lai, Chunhui; Guo, Weizhong; Fu, Linsheng; Lu, Wei] Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China; [Chen, Song; Andrieu, Jean-Marie] Univ Paris 05, Lab Oncol & Virol Mol, Paris, France; [Cai, Weiping; He, Haolan; Chen, Xiejie] Guangzhou Hosp Infect Dis, Guangzhou, Guangdong, Peoples R China; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Inst Rech Dev, UMI 233, Montpellier, France; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Univ Monpellier 1, Montpellier, France	Guangzhou University of Chinese Medicine; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lu, W (corresponding author), Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China.	louis.luwei@ird.fr	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Institut de Recherche pour le Developpement (IRD) and the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS). S. C. was supported by a fellowship from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Lin P, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P194; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meyerhans A, 2003, SWISS MED WKLY, V133, P451; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	33	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48747	10.1371/journal.pone.0048747	http://dx.doi.org/10.1371/journal.pone.0048747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23071617	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800118
J	Ferreira, TH; Gentile, A; Vilela, RD; Costa, GGL; Dias, LI; Endres, L; Menossi, M				Ferreira, Thais Helena; Gentile, Agustina; Vilela, Romel Duarte; Lacerda Costa, Gustavo Gilson; Dias, Lara Isys; Endres, Lauricio; Menossi, Marcelo			microRNAs Associated with Drought Response in the Bioenergy Crop Sugarcane (Saccharum spp.)	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; SMALL RNAS; TRANSCRIPTION FACTORS; SOYBEAN MICRORNAS; GENE-EXPRESSION; DOWN-REGULATION; SALT TOLERANCE; ORYZA-SATIVA; ARABIDOPSIS; IDENTIFICATION	Sugarcane (Saccharum spp.) is one of the most important crops in the world. Drought stress is a major abiotic stress factor that significantly reduces sugarcane yields. However the gene network that mediates plant responses to water stress remains largely unknown in several crop species. Although several microRNAs that mediate post-transcriptional regulation during water stress have been described in other species, the role of the sugarcane microRNAs during drought stress has not been studied. The objective of this work was to identify sugarcane miRNAs that are differentially expressed under drought stress and to correlate this expression with the behavior of two sugarcane cultivars with different drought tolerances. The sugarcane cultivars RB867515 (higher drought tolerance) and RB855536 (lower drought tolerance) were cultivated in a greenhouse for three months and then subjected to drought for 2, 4, 6 or 8 days. By deep sequencing of small RNAs, we were able to identify 18 miRNA families. Among all of the miRNAs thus identified, seven were differentially expressed during drought. Six of these miRNAs were differentially expressed at two days of stress, and five miRNAs were differentially expressed at four days. The expression levels of five miRNAs (ssp-miR164, ssp-miR394, ssp-miR397, ssp-miR399-seq 1 and miR528) were validated by RT-qPCR (quantitative reverse transcriptase PCR). Six precursors and the targets of the differentially expressed miRNA were predicted using an in silico approach and validated by RT-qPCR; many of these targets may play important roles in drought tolerance. These findings constitute a significant increase in the number of identified miRNAs in sugarcane and contribute to the elucidation of the complex regulatory network that is activated by drought stress.	[Ferreira, Thais Helena; Gentile, Agustina; Dias, Lara Isys; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Vilela, Romel Duarte; Endres, Lauricio] Univ Fed Alagoas, Ctr Ciencias Agr, Rio Largo, Alagoas, Brazil; [Lacerda Costa, Gustavo Gilson] Univ Estadual Campinas, Lab Cent Tecnol Alto Desempenho, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Alagoas; Universidade Estadual de Campinas	Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil.	menossi@unicamp.br	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation); CNPq (The National Council for Scientific and Technological Development); CAPES (Co-ordination of Improvement of Higher Education Personnel); NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Co-ordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by the following Brazilian funding institutions: FINEP (The Financiadora de Estudos e Projetos), FAPESP (Sao Paulo Research Foundation), CNPq (The National Council for Scientific and Technological Development) and CAPES (Co-ordination of Improvement of Higher Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; CACHORRO P, 1993, PHYTON-ANN REI BOT A, V33, P33; Calvino M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-356; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Ditt RF, 2011, SCI AGR, V68, P454, DOI 10.1590/S0103-90162011000400010; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Giordani T, 2011, THEOR APPL GENET, V122, P1039, DOI 10.1007/s00122-010-1509-0; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoopes JT, 2004, PLANT PHYSIOL BIOCH, V42, P27, DOI 10.1016/j.plaphy.2003.10.011; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Inman-Bamber NG, 2005, FIELD CROP RES, V92, P185, DOI 10.1016/j.fcr.2005.01.023; Islam MS, 2010, HORTIC ENVIRON BIOTE, V51, P556; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jeong MJ, 2000, BIOCHEM BIOPH RES CO, V278, P192, DOI 10.1006/bbrc.2000.3732; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; NEUMANN PM, 1994, PLANT CELL ENVIRON, V17, P303, DOI 10.1111/j.1365-3040.1994.tb00296.x; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Pillai MA, 2002, THEOR APPL GENET, V105, P34, DOI 10.1007/s00122-001-0833-9; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei JZ, 2000, PLANT SCI, V159, P135, DOI 10.1016/S0168-9452(00)00344-7; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yang XZ, 2011, GENOMICS, V98, P40, DOI 10.1016/j.ygeno.2011.03.011; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang H, 2011, PLANT SIGNAL BEHAV, V6, P861, DOI 10.4161/psb.6.6.15223; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	81	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46703	10.1371/journal.pone.0046703	http://dx.doi.org/10.1371/journal.pone.0046703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071617	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700025
